PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Knudsen, ES; Kumarasamy, V; Ruiz, A; Sivinski, J; Chung, SJ; Grant, A; Vail, P; Chauhan, SS; Jie, T; Riall, TS; Witkiewicz, AK				Knudsen, Erik S.; Kumarasamy, Vishnu; Ruiz, Amanda; Sivinski, Jared; Chung, Sejin; Grant, Adam; Vail, Paris; Chauhan, Shailender S.; Jie, Tun; Riall, Taylor S.; Witkiewicz, Agnieszka K.			Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer	ONCOGENE			English	Article							BREAST-CANCER; CDK6; PROLIFERATION; COMBINATION; PATHWAY; SENSITIVITY; ABERRATIONS; PROGRESSION; MECHANISMS; SENESCENCE	Pancreatic ductal adenocarcinoma (PDAC), like many KRAS-driven tumors, preferentially loses CDKN2A that encodes an endogenous CDK4/6 inhibitor to bypass the RB-mediated cell cycle suppression. Analysis of a panel of patient-derived cell lines and matched xenografts indicated that many pancreatic cancers have intrinsic resistance to CDK4/6 inhibition that is not due to any established mechanism or published biomarker. Rather, there is a KRAS-dependent rapid adaptive response that leads to the upregulation of cyclin proteins, which participate in functional complexes to mediate resistance. In vivo, the degree of response is associated with the suppression of a gene expression signature that is strongly prognostic in pancreatic cancer. Resistance is associated with an adaptive gene expression signature that is common to multiple kinase inhibitors, but is attenuated with MTOR inhibitors. Combination treatment with MTOR and CDK4/6 inhibitors had potent activity across a large number of patient-derived models of PDAC underscoring the potential clinical efficacy.	[Knudsen, Erik S.; Kumarasamy, Vishnu; Ruiz, Amanda; Chung, Sejin; Grant, Adam; Vail, Paris; Witkiewicz, Agnieszka K.] Roswell Pk Canc Inst, Ctr Personalized Med, Buffalo, NY 14263 USA; [Knudsen, Erik S.; Kumarasamy, Vishnu; Ruiz, Amanda; Chung, Sejin; Grant, Adam; Vail, Paris] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Sivinski, Jared] Univ Arizona, Dept Pharmacol, Tucson, AZ USA; [Chauhan, Shailender S.] Univ Arizona, Cellular & Mol Med, Tucson, AZ USA; [Jie, Tun; Riall, Taylor S.] Univ Arizona, Dept Surg, Tucson, AZ USA; [Witkiewicz, Agnieszka K.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Arizona; University of Arizona; University of Arizona; Roswell Park Cancer Institute	Knudsen, ES; Witkiewicz, AK (corresponding author), Roswell Pk Canc Inst, Ctr Personalized Med, Buffalo, NY 14263 USA.; Knudsen, ES (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.; Witkiewicz, AK (corresponding author), Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA.	Erik.Knudsen@roswellpark.org; Agnieszka.Witkiewicz@roswellpark.org	Kumarasamy, Vishnu/AAV-8896-2021; Chauhan, Shailender Singh/AAM-5269-2020	Chauhan, Shailender Singh/0000-0002-1975-2734; Sivinski, Jared/0000-0003-2696-6279	NCI; NATIONAL CANCER INSTITUTE [R01CA211878] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank all members of the laboratory group and colleagues in the discussion and preparation of this paper. The research was supported by a grant to AKW from the NCI.	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cheema AR, 2016, SURG CLIN N AM, V96, P1391, DOI 10.1016/j.suc.2016.07.011; Chou A, 2018, GUT, V67, P2142, DOI 10.1136/gutjnl-2017-315144; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Cowan RW, 2014, CANCER J, V20, P80, DOI 10.1097/PPO.0000000000000011; Driscoll DR, 2016, CANCER RES, V76, P6911, DOI 10.1158/0008-5472.CAN-16-0810; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Franco J, 2016, CELL REP, V14, P979, DOI 10.1016/j.celrep.2015.12.094; Franco J, 2014, ONCOTARGET, V5, P6512, DOI 10.18632/oncotarget.2270; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gao SQ, 2017, ONCOTARGET, V8, P98233, DOI 10.18632/oncotarget.21004; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; Goel S, 2016, CANCER CELL, V29, P255, DOI 10.1016/j.ccell.2016.02.006; Gong XQ, 2017, CANCER CELL, V32, P761, DOI 10.1016/j.ccell.2017.11.006; Heilmann AM, 2014, CANCER RES, V74, P3947, DOI 10.1158/0008-5472.CAN-13-2923; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Johnson GL, 2014, CLIN CANCER RES, V20, P2516, DOI 10.1158/1078-0432.CCR-13-1081; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Knudsen ES, 2018, GUT, V67, P508, DOI 10.1136/gutjnl-2016-313133; Knudsen ES, 2017, TRENDS CANCER, V3, P39, DOI 10.1016/j.trecan.2016.11.006; Knudsen ES, 2016, GASTROENTEROLOGY, V150, P48, DOI 10.1053/j.gastro.2015.08.056; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Ono H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096060; Ottaiano A, 2017, ACTA ONCOL, V56, P377, DOI 10.1080/0284186X.2017.1288922; Patel P, 2018, MOL CANCER RES, V16, P361, DOI 10.1158/1541-7786.MCR-17-0602; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Raspe E, 2017, EMBO MOL MED, V9, P1052, DOI 10.15252/emmm.201607084; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Teh JLF, 2018, CANCER DISCOV, V8, P568, DOI 10.1158/2159-8290.CD-17-0699; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Witkiewicz AK, 2016, CELL REP, V16, P2017, DOI 10.1016/j.celrep.2016.07.023; Witkiewicz AK, 2015, ONCOTARGET, V6, P15788, DOI 10.18632/oncotarget.3819; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Yoshida A, 2016, CANCER RES, V76, P2990, DOI 10.1158/0008-5472.CAN-15-2931; Yuan TL, 2018, CELL REP, V22, P1889, DOI 10.1016/j.celrep.2018.01.051; Zhang JF, 2016, MOL CELL, V62, P929, DOI 10.1016/j.molcel.2016.04.023; 2004, MOL CANC THER, V3, P1427	51	30	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 2	2019	38	18					3355	3370		10.1038/s41388-018-0650-0	http://dx.doi.org/10.1038/s41388-018-0650-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HW3RI	30696953	Green Accepted			2022-12-26	WOS:000466610000003
J	Unciuleac, MC; Goldgur, Y; Shuman, S				Unciuleac, Mihaela-Carmen; Goldgur, Yehuda; Shuman, Stewart			Structures of ATP-bound DNA ligase D in a closed domain conformation reveal a network of amino acid and metal contacts to the ATP phosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; enzyme structure; ATP; metal ion-protein interaction; catalysis; Mycobacterium tuberculosis; covalent nucleotidyltransferase; DNA ligase; lysyl-AMP; two metal mechanism	END-JOINING FUNCTION; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; RNA; REPAIR; MECHANISM; COMPONENT; RECOGNITION; DISPLAYS; 2-METAL	DNA ligases are the sine qua non of genome integrity and essential for DNA replication and repair in all organisms. DNA ligases join 3'-OH and 5'-PO4 ends via a series of three nucleotidyl transfer steps. In step 1, ligase reacts with ATP or NAD(+) to form a covalent ligase-(lysyl-N zeta)-AMP intermediate and release pyrophosphate (PPi) or nicotinamide mononucleotide. In step 2, AMP is transferred from ligase-adenylate to the 5'-PO4 DNA end to form a DNA-adenylate intermediate (AppDNA). In step 3, ligase catalyzes attack by a DNA 3'-OH on the DNA-adenylate to seal the two ends via a phosphodiester bond and release AMP. Eukaryal, archaeal, and many bacterial and viral DNA ligases are ATP-dependent. The catalytic core of ATP-dependent DNA ligases consists of an N-terminal nucleotidyltransferase domain fused to a C-terminal OB domain. Here we report crystal structures at 1.4-1.8 angstrom resolution of Mycobacterium tuberculosis LigD, an ATP-dependent DNA ligase dedicated to nonhomologous end joining, in complexes with ATP that highlight large movements of the OB domain (similar to 50 angstrom), from a closed conformation in the ATP complex to an open conformation in the covalent ligase-AMP intermediate. The LigD center dot ATP structures revealed a network of amino acid contacts to the ATP phosphates that stabilize the transition state and orient the PPi leaving group. Acomplex with ATP and magnesium suggested a two-metal mechanism of lysine adenylylation driven by a catalytic Mg2+ that engages the ATP alpha phosphate and a second metal that bridges the ATP beta and gamma phosphates.	[Unciuleac, Mihaela-Carmen; Shuman, Stewart] Sloan Kettering Inst, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA; [Goldgur, Yehuda] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM126945, AI64693]; NCI, National Institutes of Health [P30-CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103403, R35GM126945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM126945 and AI64693. The Memorial Sloan Kettering Cancer Center structural biology core laboratory is supported by NCI, National Institutes of Health Grant P30-CA008748. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Banerjee A, 2019, NUCLEIC ACIDS RES, V47, P1428, DOI 10.1093/nar/gky1275; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; Gu HQ, 2016, NUCLEIC ACIDS RES, V44, P2337, DOI 10.1093/nar/gkw094; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaminski AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05024-8; Kim DJ, 2009, ACTA CRYSTALLOGR F, V65, P544, DOI 10.1107/S1744309109017485; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nair PA, 2010, P NATL ACAD SCI USA, V107, P12822, DOI 10.1073/pnas.1005830107; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Nishida H, 2006, J MOL BIOL, V360, P956, DOI 10.1016/j.jmb.2006.05.062; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2008, CURR OPIN STRUC BIOL, V18, P96, DOI 10.1016/j.sbi.2007.12.008; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Petrova T, 2012, ACTA CRYSTALLOGR F, V68, P1440, DOI 10.1107/S1744309112043394; Piserchio A, 2010, J MOL BIOL, V395, P291, DOI 10.1016/j.jmb.2009.11.007; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Sawaya R, 2003, BIOCHEMISTRY-US, V42, P8240, DOI 10.1021/bi034396d; Shi K, 2018, NUCLEIC ACIDS RES, V46, P10474, DOI 10.1093/nar/gky776; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Smith P, 2012, P NATL ACAD SCI USA, V109, P2296, DOI 10.1073/pnas.1116827109; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; Unciuleac MC, 2017, P NATL ACAD SCI USA, V114, P2592, DOI 10.1073/pnas.1619220114; Unciuleac MC, 2015, P NATL ACAD SCI USA, V112, P13868, DOI 10.1073/pnas.1516536112; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang P, 2012, P NATL ACAD SCI USA, V109, P13248, DOI 10.1073/pnas.1209805109; Williamson A, 2018, NUCLEIC ACIDS RES, V46, P8616, DOI 10.1093/nar/gky622; Williamson A, 2014, ACTA CRYSTALLOGR D, V70, P3043, DOI 10.1107/S1399004714021099; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2008, J BIOL CHEM, V283, P8331, DOI 10.1074/jbc.M705476200; Zhu H, 2007, NUCLEIC ACIDS RES, V35, P3631, DOI 10.1093/nar/gkm145	43	7	7	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5094	5104		10.1074/jbc.RA119.007445	http://dx.doi.org/10.1074/jbc.RA119.007445			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718283	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000463985600031
J	Liu, Y; Xu, XF; Lin, P; He, YM; Zhang, YW; Cao, BY; Zhang, ZB; Sethi, G; Liu, JB; Zhou, XM; Mao, XL				Liu, Yan; Xu, Xiaofeng; Lin, Peng; He, Yuanming; Zhang, Yawen; Cao, Biyin; Zhang, Zubin; Sethi, Gautam; Liu, Jinbao; Zhou, Xiumin; Mao, Xinliang			Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; drug resistance; ubiquitylation (ubiquitination); deubiquitylation (deubiquitination); cancer; apoptosis; pre-B cell leukemia homeobox-1; prostate cancer; protein degradation; USP9x	PROLIFERATION; CHEMORESISTANCE; TARGET	Chemoresistance is a leading obstacle in effective management of advanced prostate cancer (PCa). A better understanding of the molecular mechanisms involved in PCa chemoresistance could improve treatment of patients with PCa. In the present study, using immune histochemical, chemistry, and precipitation assays with cells from individuals with benign or malignant prostate cancer or established PCa cell lines, we found that the oncogenic transcription factor pre-B cell leukemia homeobox-1 (PBX1) promotes PCa cell proliferation and confers to resistance against common anti-cancer drugs such as doxorubicin and cisplatin. We observed that genetic PBX1 knockdown abrogates this resistance, and further experiments revealed that PBX1 stability was modulated by the ubiquitin-proteasomal pathway. To directly probe the impact of this pathway on PBX1 activity, we screened for PBX1-specific deubiquitinases (Dubs) and found that ubiquitin-specific peptidase 9 X-linked (USP9x) interacted with and stabilized the PBX1 protein by attenuating its Lys-48-linked polyubiquitination. Moreover, the USP9x inhibitor WP1130 markedly induced PBX1 degradation and promoted PCa cell apoptosis. The results in this study indicate that PBX1 confers to PCa chemoresistance and identify USP9x as a Dub of PBX1. We concluded that targeting the USP9x/PBX1 axis could be a potential therapeutic strategy for managing advanced prostate cancer.	[Liu, Yan; Zhang, Zubin; Liu, Jinbao; Mao, Xinliang] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou 511436, Guangdong, Peoples R China; [Liu, Yan; Lin, Peng; He, Yuanming; Zhang, Yawen; Cao, Biyin; Zhang, Zubin; Mao, Xinliang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Xiaofeng] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Urol, Nanjing 21002, Jiangsu, Peoples R China; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore; [Zhou, Xiumin] Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou 215006, Jiangsu, Peoples R China; [Liu, Yan] Sichuan Kelun Pharmaceut Co Ltd, Chengdu 610071, Sichuan, Peoples R China	Guangzhou Medical University; Soochow University - China; Nanjing University; National University of Singapore; Soochow University - China	Zhou, XM (corresponding author), Soochow Univ, Affiliated Hosp 1, 188 Shizi St, Suzhou 215006, Jiangsu, Peoples R China.; Mao, XL (corresponding author), Guangzhou Med Univ, Key Lab Prot Modificat & Degradat, Guangzhou 511436, Guangdong, Peoples R China.	alice-xm@163.com; xinliangmao@gzhmu.edu.cn	Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475	National Natural Science Foundation of China [81770154, 30901716, 81320108023, 81770215]; Natural Science Foundation of Jiangsu Higher Education Institutes of China [17KJA180010]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BK2013003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutes of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory of Neuropsychiatric Diseases	This work was supported by National Natural Science Foundation of China Grants 81770154 (to X. M.), 30901716 (to X. X.), 81320108023 (to X. M.), and 81770215 (to B. C.), Natural Science Foundation of Jiangsu Higher Education Institutes of China Grant 17KJA180010 (to X. M.), the Priority Academic Program Development of Jiangsu Higher Education Institutions (to X. M.), and Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BK2013003 (to X. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Chang AJ, 2014, NAT REV CLIN ONCOL, V11, P308, DOI 10.1038/nrclinonc.2014.68; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; He CY, 2017, ONCOTARGET, V8, P46818, DOI 10.18632/oncotarget.17473; Jiang N, 2017, ONCOTARGET, V8; Jung JG, 2016, CANCER RES, V76, P6351, DOI 10.1158/0008-5472.CAN-16-0980; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; Li L, 2018, ONCOGENE, V37, P2422, DOI 10.1038/s41388-018-0134-2; Lin CL, 2017, BBA-MOL CELL RES, V1864, P1867, DOI 10.1016/j.bbamcr.2017.07.015; Magnani L, 2015, ONCOTARGET, V6, P21878, DOI 10.18632/oncotarget.4243; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mao XL, 2011, MOL PHARMACOL, V79, P672, DOI 10.1124/mol.110.068122; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Ramberg H, 2016, INT J CANCER, V139, P1810, DOI 10.1002/ijc.30220; Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shen JJ, 2018, CANCER RES, V78, P359, DOI 10.1158/0008-5472.CAN-17-1805; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Sykes DB, 2004, MOL CELL BIOL, V24, P1256, DOI 10.1128/MCB.24.3.1256-1269.2004; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Trivigno D, 2012, NEOPLASIA, V14, P893, DOI 10.1593/neo.12598; Wade CA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030904; Wang S, 2014, P NATL ACAD SCI USA, V111, P4251, DOI 10.1073/pnas.1322198111; Xu X, 2016, J BIOL CHEM, V291, P9617, DOI 10.1074/jbc.M115.701979; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Zhang W, 2015, INT J BIOL SCI, V11, P1160, DOI 10.7150/ijbs.11439; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203; Zhu XM, 2017, AM J CANCER RES, V7, P1642	31	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4572	4582		10.1074/jbc.RA118.006057	http://dx.doi.org/10.1074/jbc.RA118.006057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30718275	Green Published, hybrid			2022-12-26	WOS:000462969500024
J	Suarez-Moo, PD; Vovides, AP; Griffith, MP; Barona-Gomez, F; Cibrian-Jaramillo, A				de Jesus Suarez-Moo, Pablo; Vovides, Andrew P.; Griffith, M. Patrick; Barona-Gomez, Francisco; Cibrian-Jaramillo, Angelica			Unlocking a high bacterial diversity in the coralloid root microbiome from the cycad genus Dioon	PLOS ONE			English	Article							SYMBIOTIC CYANOBACTERIA; CYANOBIONT DIVERSITY; APOGEOTROPIC ROOTS; GENETIC DIVERSITY; PLANT; RHIZOSPHERE; GROWTH; COMMUNITIES; MAIZE	Cycads are among the few plants that have developed specialized roots to host nitrogen-fixing bacteria. We describe the bacterial diversity of the coralloid roots from seven Dioon species and their surrounding rhizosphere and soil. Using 16S rRNA gene amplicon sequencing, we found that all coralloid roots are inhabited by a broad diversity of bacterial groups, including cyanobacteria and Rhizobiales among the most abundant groups. The diversity and composition of the endophytes are similar in the six Mexican species of Dioon that we evaluated, suggesting a recent divergence of Dioon populations and/or similar plant-driven restrictions in maintaining the coralloid root microbiome. Botanical garden samples and natural populations have a similar taxonomic composition, although the beta diversity differed between these populations. The rhizosphere surrounding the coralloid root serves as a reservoir and source of mostly diazotroph and plant growth-promoting groups that colonize the coralloid endosphere. In the case of cyanobacteria, the endosphere is enriched with Nostoc spp and Calothrix spp that are closely related to previously reported symbiont genera in cycads and other early divergent plants. The data reported here provide an in-depth taxonomic characterization of the bacterial community associated with coralloid root microbiome. The functional aspects of the endophytes, their biological interactions, and their evolutionary history are the next research step in this recently discovered diversity within the cycad coralloid root microbiome.	[de Jesus Suarez-Moo, Pablo; Cibrian-Jaramillo, Angelica] CINVESTAV, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada Langebio, Ecol & Evolutionary Genom Lab,IPN, Guanajuato, Mexico; [Vovides, Andrew P.] Inst Ecol AC, Red Ecol Evolut, Xalapa, Veracruz, Mexico; [Griffith, M. Patrick] Montgomery Bot Ctr, Miami, FL USA; [Barona-Gomez, Francisco] CINVESTAV, IPN, Ctr Invest & Estudios Avanzados, Evolut Metab Div Lab,Unidad Genom Avanzada Langeb, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto de Ecologia - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Cibrian-Jaramillo, A (corresponding author), CINVESTAV, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada Langebio, Ecol & Evolutionary Genom Lab,IPN, Guanajuato, Mexico.	angelica.cibrian@cinvestav.mx	Cibrian-Jaramillo, Angelica/I-8614-2016	Cibrian-Jaramillo, Angelica/0000-0002-7974-455X; Suarez-Moo, Pablo/0000-0002-7918-3000; Barona Gomez, Francisco/0000-0003-1492-9497	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [169701, FON.INST./265/2016(901)]; Gregory Family Charitable Fund; CONACYT [242938, 285746]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Gregory Family Charitable Fund; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We are grateful to Consejo Nacional de Ciencia y Tecnologia (CONACYT; www.conacyt.mx) award 169701 and FON.INST./265/2016(901) to ACJ; CONACyT award 285746 to FBG and CONACYT 242938 to PJSM. ACJ also thanks the Gregory Family Charitable Fund for their kind support. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	AHERN CP, 1994, AM J BOT, V81, P1559, DOI 10.2307/2445333; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Berrendero E, 2011, INT J SYST EVOL MICR, V61, P3039, DOI 10.1099/ijs.0.027581-0; Bidyarani N, 2015, J BASIC MICROB, V55, P407, DOI 10.1002/jobm.201400591; Boon E, 2014, FEMS MICROBIOL REV, V38, P90, DOI 10.1111/1574-6976.12035; Bottomley WB, 1909, P R SOC LOND B-CONTA, V81, P287, DOI 10.1098/rspb.1909.0024; Bouffaud ML, 2014, ENVIRON MICROBIOL, V16, P2804, DOI 10.1111/1462-2920.12442; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cibrian-Jaramillo A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00004; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; de Souza RSC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28774; Costa JL, 2004, FEMS MICROBIOL ECOL, V49, P481, DOI 10.1016/j.femsec.2004.05.001; Costa JL, 1999, FEMS MICROBIOL ECOL, V28, P85; Cuddy WS, 2012, FEMS MICROBIOL ECOL, V80, P204, DOI 10.1111/j.1574-6941.2011.01288.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards JA, 2018, PLOS BIOL, P1; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Elbeltagy A, 2000, SOIL SCI PLANT NUTR, V46, P617, DOI 10.1080/00380768.2000.10409127; Fitzpatrick CR, 2018, P NATL ACAD SCI USA, V115, pE1157, DOI 10.1073/pnas.1717617115; Fonseca-Garcia C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00150; Foster ZSL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005404; Garrido-Oter R, 2018, CELL HOST MICROBE, V24, P155, DOI 10.1016/j.chom.2018.06.006; Gehringer MM, 2010, MOL PLANT MICROBE IN, V23, P811, DOI 10.1094/MPMI-23-6-0811; Goudjal Y, 2013, WORLD J MICROB BIOT, V29, P1821, DOI 10.1007/s11274-013-1344-y; Gutierrez-Garcia K, 2019, GENOME BIOL EVOL, V11, P319, DOI 10.1093/gbe/evy266; Gutierrez-Ortega JS, 2018, ANN BOT-LONDON, V121, P535, DOI 10.1093/aob/mcx165; Gutierrez-Ortega JS, 2018, ANN BOT-LONDON, V121, P47, DOI [10.1093/aob/mcx201, 10.1093/aob/mcx123]; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hale M., 1980, ADV AGRON, V31, P93, DOI DOI 10.1016/S0065-2113(08)60137-6; Heimann K., 2015, HDB MARINE MICROALGA, P501, DOI [10.1016/B978-0-12-800776-1.00033-9, DOI 10.1016/B978-0-12-800776-1.00033-9]; Herendeen PS, 1999, ANN MO BOT GARD, V86, P407, DOI 10.2307/2666182; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lagkouvardos I, 2017, PEERJ, V5, DOI 10.7717/peerj.2836; Li YH, 2010, FEMS MICROBIOL LETT, V309, P84, DOI 10.1111/j.1574-6968.2010.02015.x; Lobakova ES, 2003, MICROBIOLOGY+, V72, P634, DOI 10.1023/A:1026067906000; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; NATHANIELSZ CP, 1975, AM J BOT, V62, P232, DOI 10.2307/2441856; Nilsson M, 2002, NEW PHYTOL, V156, P517, DOI 10.1046/j.1469-8137.2002.00534.x; NORSTOG K, 1997, BIOL CYCADS; Ofek-Lalzar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5950; Oksanen AJ, 2010, PACKAGE VEGAN; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; PATE JS, 1988, PLANTA, V176, P461, DOI 10.1007/BF00397652; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Rascovan N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28084; Raven JA, 2002, BIOL ENVIRON, V102B, DOI [10.1177/0022002706293470, DOI 10.1177/0022002706293470]; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Samad A, 2017, ENVIRON MICROBIOL, V19, P1407, DOI 10.1111/1462-2920.13618; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider A., 1894, BOT GAZ, V19, P25; Spratt ER, 1915, ANN BOT-LONDON, V29, P619, DOI 10.1093/oxfordjournals.aob.a089570; STOREY WB, 1968, SCIENCE, V159, P648, DOI 10.1126/science.159.3815.648; Thajuddin N, 2010, J BASIC MICROB, V50, P254, DOI 10.1002/jobm.200900343; Tsujimoto R, 2014, P NATL ACAD SCI USA, V111, P6762, DOI 10.1073/pnas.1323570111; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Vo ATE, 2014, MOL ECOL RESOUR, V14, P1183, DOI 10.1111/1755-0998.12269; Warnes G, 2016, R PACKAGE VERSION 3; Wei N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23518-9; Wilmotte A, 2015, BERGEYS MANUAL SYSTE, DOI [10.1002/9781118960608.cbm00021, DOI 10.1002/9781118960608.CBM00021]; Xiao X, 2017, MOL ECOL, V26, P1641, DOI 10.1111/mec.14027; Yamada S, 2012, FEMS MICROBIOL ECOL, V81, P696, DOI 10.1111/j.1574-6941.2012.01403.x; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zheng WW, 2002, FEMS MICROBIOL ECOL, V40, P215, DOI 10.1111/j.1574-6941.2002.tb00954.x; Zheng Y, 2018, J MICROBIOL, V56, P337, DOI 10.1007/s12275-018-7438-3; ZIMMERMAN WJ, 1992, CAN J MICROBIOL, V38, P1324, DOI 10.1139/m92-218	78	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211271	10.1371/journal.pone.0211271	http://dx.doi.org/10.1371/journal.pone.0211271			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726265	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000062
J	Riley, AC; Ashlock, DA; Graether, SP				Riley, Andrew C.; Ashlock, Daniel A.; Graether, Steffen P.			Evolution of the modular, disordered stress proteins known as dehydrins	PLOS ONE			English	Article							LEA PROTEINS; GENE FAMILY; CRYOPROTECTIVE ACTIVITY; EXPRESSION PATTERNS; SEQUENCE ALIGNMENT; CITRUS DEHYDRIN; GENOME; TOLERANCE; DUPLICATION; BIOLOGY	Dehydrins, plant proteins that are upregulated during dehydration stress conditions, have modular sequences that can contain three conserved motifs (the Y-, S-, and K-segments). The presence and order of these motifs are used to classify dehydrins into one of five architectures: K-n, SKn, KnS, YnKn, and YnSKn, where the subscript n describes the number of copies of that motif. In this study, an architectural and phylogenetic analysis was performed on 426 dehydrin sequences that were identified in 53 angiosperm and 3 gymnosperm genomes. It was found that angiosperms contained all five architectures, while gymnosperms only contained K-n and SKn dehydrins. This suggests that the ancestral dehydrin in spermatophytes was either K-n or SKn, and the Y- segment containing dehydrins first arose in angiosperms. A high-level split between the YnSKn dehydrins from either the K-n or SKn dehydrins could not be confidently identified, however, two lower level architectural divisions appear to have occurred after different duplication events. The first likely occurred after a whole genome duplication, resulting in the duplication of a Y3SK2 dehydrin; the duplicate subsequently lost an S- and K- segment to become a Y3K1 dehydrin. The second split occurred after a tandem duplication of a Y1SK2 dehydrin, where the duplicate lost both the Y- and S-segment and gained four K-segments, resulting in a K-6 dehydrin. We suggest that the newly arisen Y3K1 dehydrin is possibly on its way to pseudogenization, while the newly arisen K-6 dehydrin developed a novel function in cold protection.	[Riley, Andrew C.; Ashlock, Daniel A.; Graether, Steffen P.] Univ Guelph, Grad Program Bioinformat, Guelph, ON, Canada; [Riley, Andrew C.; Graether, Steffen P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Ashlock, Daniel A.] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Graether, SP (corresponding author), Univ Guelph, Grad Program Bioinformat, Guelph, ON, Canada.; Graether, SP (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	graether@uoguelph.ca	Graether, Steffen P./AFU-0892-2022; Graether, Steffen P./AAR-8849-2021	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936	SPG NSERC Discovery Grant	SPG NSERC Discovery Grant	This work was funded by a SPG NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini R, 2017, J PLANT RES, V130, P747, DOI 10.1007/s10265-017-0941-5; Amara I., 2014, American Journal of Plant Sciences, V5, P3440; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bhagat K.P., 2014, APPROACHES PLANT STR, P191, DOI DOI 10.1007/978-81-322-1620-9_10; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Buels R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0924-1; Cedeno C, 2017, BIOMOL NMR ASSIGN, V11, P127, DOI 10.1007/s12104-017-9732-0; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; Drira M, 2013, MOL BIOTECHNOL, V54, P643, DOI 10.1007/s12033-012-9606-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Findlater EE, 2009, BIOMOL NMR ASSIGN, V3, P273, DOI 10.1007/s12104-009-9192-2; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; GODAY A, 1994, PLANT CELL, V6, P351, DOI 10.1105/tpc.6.3.351; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 2001, J PLANT PHYSIOL, V158, P1333, DOI 10.1078/0176-1617-00600; Hara M, 2013, J EXP BOT, V64, P1615, DOI 10.1093/jxb/ert016; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Hughes S, 2011, PROTEIN SCI, V20, P42, DOI 10.1002/pro.534; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ismail AM, 1997, CROP SCI, V37, P1270, DOI 10.2135/cropsci1997.0011183X003700040041x; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jaume U, 2013, ELIKA, V40, P1, DOI [10.3389/fphys.2013.00093, DOI 10.3389/FPHYS.2013.00093]; Jimenez-Bremont JF, 2013, PLANT MOL BIOL REP, V31, P128, DOI 10.1007/s11105-012-0483-x; Kagale S, 2014, PLANT CELL, V26, P2777, DOI 10.1105/tpc.114.126391; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Liang D, 2012, MOL BIOL REP, V39, P10759, DOI 10.1007/s11033-012-1968-2; Liang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24265; Lin CH, 2012, PLANT CELL PHYSIOL, V53, P930, DOI 10.1093/pcp/pcs040; Liu CC, 2012, PLANT MOL BIOL REP, V30, P848, DOI 10.1007/s11105-011-0395-1; Malik AA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00709; Momma M, 2003, BIOSCI BIOTECH BIOCH, V67, P1832, DOI 10.1271/bbb.67.1832; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Perdiguero P, 2012, PLANTA, V236, P1863, DOI 10.1007/s00425-012-1737-4; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riikonen P., MULTIDISP; Rinne PLH, 1999, PLANTA, V209, P377, DOI 10.1007/s004250050740; Saunders A, 2018, IEEE C COMP INT BIOI, P1, DOI [10.1109/CIBCB.2018.8404978, DOI 10.1109/CIBCB.2018.8404978]; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sibout R, 2017, NEW PHYTOL, V215, P1009, DOI 10.1111/nph.14635; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Sneddon TP, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-11; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strimbeck GR, 2017, PLANTA, V245, P1061, DOI 10.1007/s00425-017-2679-7; Sundell D, 2015, NEW PHYTOL, V208, P1149, DOI 10.1111/nph.13557; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tompa P, 2006, BIOPHYS J, V91, P2243, DOI 10.1529/biophysj.106.084723; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2016, J BIOL CHEM, V291, P6681, DOI 10.1074/jbc.R115.685859; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Verma G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176399; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wisniewski M, 1999, PHYSIOL PLANTARUM, V105, P600, DOI 10.1034/j.1399-3054.1999.105402.x; Xing X, 2011, PLANT GROWTH REGUL, V65, P109, DOI 10.1007/s10725-011-9580-3; Xu J, 2008, MOL BIOTECHNOL, V38, P91, DOI 10.1007/s12033-007-9005-8; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang YQ, 2014, BIOCHEM BIOPH RES CO, V448, P145, DOI 10.1016/j.bbrc.2014.04.075; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao ZC, 2010, AFR J BIOTECHNOL, V9, P972, DOI 10.5897/AJB09.1450	81	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211813	10.1371/journal.pone.0211813	http://dx.doi.org/10.1371/journal.pone.0211813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726271	gold, Green Submitted, Green Published			2022-12-26	WOS:000457874000077
J	Feng, Q; Yu, H; Sun, SH; Ma, ZJ				Feng, Qiang; Yu, Hong; Sun, Shihang; Ma, Zhijun			The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings	PLOS ONE			English	Article							NEOADJUVANT CHEMORADIATION; TUMOR RESPONSES; P53 EXPRESSION; CHEMORADIOTHERAPY; PREDICTOR; BIOMARKER; THERAPY; SYSTEM; MRI	Purpose To determine the correlation between the parameters of MR diffusion kurtosis imaging (MR-DKI) and mismatch repair gene expression (MMR) for rectal carcinomas. Materials and methods Data from 80 patients with rectal carcinoma were analyzed in this prospective study. High-resolution T2WI and DKI (b = 0, 800 and 1600 s/mm(2), respectively) were performed. Mean kurtosis (MK) and mean diffusivity (MD) from DKI were measured. MMR-positive expression and HER-2 expression were classified into two groups. For comparison between different grades, the Mann-Whitney U test, receiver operating characteristic curve, and Spearman's correlation analysis were used for statistical analyses. Results The MK values in identifying positive MMR expressions (MLH1, MSH2, and MSH6) were more reliable than the MD values (r(s) value: 0.772 vs. 0.448, 0.733 vs. 0.499, and 0.828 vs. 0.633 respectively, P<0.01). Receiver operating curve analysis showed that the performances of the MK values were better than those of the MD values (z = 2.835, 2.000, and 2.827, respectively, P<0.05), while the performances of the MK and MD-MK values were not statistically significant (z = 0.808, 1.557, and 0.596, respectively, P>0.05). Similarly, MK values were better than MD values in identifying HER2 expression (z = 2.795, P<0.05). Conclusions MK derived from DKI demonstrated a greater correlation than MD with MMR expression. It also showed better performance in differentiating between high- and low-grade positive MMR expression and HER2 expression. Thus, DKI may be valuable for the prognoses and evaluation of non-invasive therapies.	[Feng, Qiang; Yu, Hong; Sun, Shihang; Ma, Zhijun] Weifang Med Univ, Dept Radiol, Yidu Cent Hosp, Qingzhou City, Shandong, Peoples R China	Weifang Medical University	Feng, Q (corresponding author), Weifang Med Univ, Dept Radiol, Yidu Cent Hosp, Qingzhou City, Shandong, Peoples R China.	fengqiang1975@163.com						Akashi M, 2014, ACTA RADIOL, V55, P524, DOI 10.1177/0284185113503154; Allen SD, 2007, AM J ROENTGENOL, V188, P442, DOI 10.2214/AJR.05.1967; Bartley AN, 2016, AM J CLIN PATHOL, V146, P647, DOI [10.1093/AJCP/AQW206, 10.1093/ajcp/aqw206]; Bertolini F, 2007, INT J RADIAT ONCOL, V68, P1455, DOI 10.1016/j.ijrobp.2007.02.018; Dewhurst C, 2012, J AM COLL RADIOL, V9, P775, DOI 10.1016/j.jacr.2012.07.025; Duval A, 2002, CANCER RES, V62, P2447; Garcia-Aguilar J, 2011, ANN SURG, V254, P486, DOI 10.1097/SLA.0b013e31822b8cfa; Gorlick S, 2014, PEDIATR BLOOD CANCER, V61, P1558, DOI 10.1002/pbc.25074; Huh JW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002582; Huh JW, 2014, J SURG ONCOL, V109, P848, DOI 10.1002/jso.23592; Huh JW, 2014, ANN SURG, V259, P508, DOI 10.1097/SLA.0b013e31829b3916; Kim HR, 2013, ANN SURG ONCOL, V20, P4031, DOI 10.1245/s10434-012-2455-7; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Samee A, 2011, WORLD J GASTROENTERO, V17, P828, DOI 10.3748/wjg.v17.i7.828; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Sun YS, 2010, RADIOLOGY, V254, P170, DOI 10.1148/radiol.2541082230; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Yu J, 2017, EUR RADIOL, V27, P1848, DOI 10.1007/s00330-016-4529-6; Zhu L, 2017, RADIOLOGY, V284, P66, DOI 10.1148/radiol.2016160094	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211461	10.1371/journal.pone.0211461	http://dx.doi.org/10.1371/journal.pone.0211461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716105	gold, Green Submitted, Green Published			2022-12-26	WOS:000457744200024
J	Collij, V; Imhann, F; Vila, AV; Fu, JY; Dijkstra, G; Festen, EAM; Voskuil, MD; Daly, MJ; Xavier, RJ; Wijmenga, C; Zhernakova, A; Weersma, RK				Collij, Valerie; Imhann, Floris; Vila, Arnau Vich; Fu, Jingyuan; Dijkstra, Gerard; Festen, Eleonora A. M.; Voskuil, Michiel D.; Daly, Mark J.; Xavier, Ramnik J.; Wijmenga, Cisca; Zhernakova, Alexandra; Weersma, Rinse K.			SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME; ZINC	Background Gene-microbiome interactions are important in aetiology and pathogenesis of inflammatory bowel disease, a chronic inflammatory disorder of the gastrointestinal tract consisting of Crohn's disease and ulcerative colitis. Scarce studies on gene-microbiome interactions show very little overlap in their results. Therefore, it is of utmost importance that gene-microbiome studies are repeated. We aimed to replicate the association between the SLC39A8[Thr]391 risk allele and gut microbiome composition in patients with inflammatory bowel disease and healthy controls. Methods We collected faecal samples, peripheral blood and extensive phenotype data from 291 patients with inflammatory bowel disease and 476 healthy controls. Carrier status information was obtained from whole exome sequencing data, generated using the Illumina HiSeq. The gut microbiome composition was determined by tag-sequencing the 16S rRNA gene. Associations between carrier status and disease were tested using the Wilcoxon-Mann-Whitney test. Associations between carriers and gut microbiome composition were determined using principal coordinate analyses, variance explained, alpha diversity and additive general linear models in inflammatory bowel disease, healthy controls and all groups combined. Results Crohn's disease patients were more often carriers of the missense variant (21/171, 12.3%) than controls (30/476, 6.3%) (OR = 2.1, P = 0.01). We could not identify associations between carrier status and overall gut microbiome composition and microbial richness in all tested groups after correcting for potential confounding factors. We did identify 37 different operational taxonomical units to be associated with carrier status among the tested groups. Two of these 37 were identified before in the discovery study. Conclusions We could confirm the genetic association of the SLC39A8[Thr]391 risk allele with Crohn's disease but we could only limited replicate the association in gut microbiome composition. Independent replication of gene-microbiome studies is warranted to identify true biological mechanisms.	[Collij, Valerie; Imhann, Floris; Vila, Arnau Vich; Dijkstra, Gerard; Festen, Eleonora A. M.; Voskuil, Michiel D.; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Collij, Valerie; Imhann, Floris; Vila, Arnau Vich; Festen, Eleonora A. M.; Voskuil, Michiel D.; Wijmenga, Cisca; Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Groningen, Netherlands; [Daly, Mark J.; Xavier, Ramnik J.] Harvard MIT Hlth Sci & Technol Inst, Cambridge, MA USA	University of Groningen; University of Groningen; University of Groningen; Harvard University	Weersma, RK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	r.k.weersma@umcg.nl	Wijmenga, Cisca/AAE-7719-2019; Weersma, Rinse/ABE-3807-2021; Fu, Jingyuan/E-8980-2012; Zhernakova, Alexandra/ABA-9372-2020; Daly, Mark J/B-2453-2017; Fu, Jingyuan/ABE-6868-2020; Fu, JY/GRR-6179-2022	Wijmenga, Cisca/0000-0002-5635-1614; Daly, Mark J/0000-0002-0949-8752; Fu, Jingyuan/0000-0001-5578-1236; /0000-0003-4563-7462; Collij, Valerie/0000-0003-3743-1544	VIDI grants from the Netherlands Organization for Scientific Research (NWO) [016.136.308, 864.13.013]; Dutch Top Institute Food and Nutrition [GH001]; ERC [ERC-671274, ERC-715772]; Spinoza award [NWO SPI 92-266]; CardioVasculair Onderzoek Nederland [CVON 2012-03]; Rosalind Franklin fellowship (University of Groningen)	VIDI grants from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Top Institute Food and Nutrition; ERC(European Research Council (ERC)European Commission); Spinoza award; CardioVasculair Onderzoek Nederland; Rosalind Franklin fellowship (University of Groningen)	This work was supported by VIDI grants (grant numbers 016.136.308 and 864.13.013 to RKW and JF) from the Netherlands Organization for Scientific Research (NWO). Sequencing of the control cohort was funded by the Dutch Top Institute Food and Nutrition (grant number GH001 to CW); CW is further supported by an ERC advanced grant (grant number ERC-671274) and a Spinoza award (grant number NWO SPI 92-266). AZ holds a Rosalind Franklin fellowship (University of Groningen) and an ERC Starting Grant (grant number ERC-715772). JF and AZ are also supported by a CardioVasculair Onderzoek Nederland (grant number CVON 2012-03).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Benson AK, 2016, NAT GENET, V48, P1301, DOI 10.1038/ng.3707; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Eun CS, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0437-0; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaakoush NO, 2012, J CLIN MICROBIOL, V50, P3258, DOI 10.1128/JCM.01396-12; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Li DL, 2016, GASTROENTEROLOGY, V151, P724, DOI 10.1053/j.gastro.2016.06.051; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Oksanen J, 2022, R PACKAGE VERSION; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rivas MA, 2018, INSIGHTS GENETIC EPI, V14, DOI [10.1371/journal.pgen.1007329, DOI 10.1371/JOURNAL.PGEN.1007329]; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Tropini C, 2018, CELL, V173, P1742, DOI 10.1016/j.cell.2018.05.008; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; Wang J, 2016, NAT GENET, V48, P1396, DOI 10.1038/ng.3695; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Zang ZS, 2016, TOXICOL RES-UK, V5, P987, DOI 10.1039/c5tx00424a; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	30	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211328	10.1371/journal.pone.0211328	http://dx.doi.org/10.1371/journal.pone.0211328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703110	gold, Green Submitted, Green Published			2022-12-26	WOS:000457301600035
J	Damaziak, K; Stelmasiak, A; Riedel, J; Zdanowska-Sasiadek, Z; Buclaw, M; Gozdowski, D; Michalczuk, M				Damaziak, Krzysztof; Stelmasiak, Adrian; Riedel, Julia; Zdanowska-Sasiadek, Zaneta; Buclaw, Mateusz; Gozdowski, Dariusz; Michalczuk, Monika			Sensory evaluation of poultry meat: A comparative survey of results from normal sighted and blind people	PLOS ONE			English	Article							QUALITY; BREAST; FOOD; ACCEPTANCE; CHICKENS; TRAITS; TASTE; EYES	Visual assessment is one of the key criteria in the sensory evaluation of foods. The appearance of food products may affect their perception by other senses, sometimes giving a false picture of their quality. A true assessment of such sensory attributes as aroma, taste, tenderness, and juiciness, which are components of the overall liking of food, without the use of instrumental methods is feasible only by blind people. We have advanced a hypothesis that blindness may modify the impressions perceived through other senses used in food evaluation. To confirm this hypothesis, a sensory testing of cooked breast and leg meat from various poultry species was conducted by normal sighted and blind panelists aged from 18 to 26 years. It has been demonstrated that the lack of sight is compensated by other senses, the intensified perception of which enables a more precise sensory evaluation of food in terms of such parameters as the aroma, tenderness and juiciness. Thus, blind people can be recommended as panelists evaluating the sensory profile of food products. Scores given by the sensory panel allowed the conclusion that the most desirable poultry meat was BM of broiler chicken and capon, followed by Guinea fowl. Lower scores were given by the panelists to meat of water fowl (goose, duck), whereas the lowest ones were assigned to cooked ostrich meat.	[Damaziak, Krzysztof; Riedel, Julia; Michalczuk, Monika] Univ Life Sci, Poultry Breeding Div, Dept Anim Breeding & Prod, Warsaw, Poland; [Stelmasiak, Adrian] Univ Life Sci, Div Engn Nutr, Dept Tech & Food Dev, Warsaw, Poland; [Zdanowska-Sasiadek, Zaneta] Polish Acad Sci, Dept Anim Improvement, Inst Genet & Anim Breeding, Magdalenka, Poland; [Buclaw, Mateusz] West Pomeranian Univ Technol, Fac Biotechnol & Anim Husb, Dept Poultry & Ornamental Bird Breeding, Szczecin, Poland; [Gozdowski, Dariusz] Univ Life Sci, Dept Expt Design & Bioinformat, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; West Pomeranian University of Technology; Warsaw University of Life Sciences	Damaziak, K (corresponding author), Univ Life Sci, Poultry Breeding Div, Dept Anim Breeding & Prod, Warsaw, Poland.	krzysztof_damaziak@sggw.pl	; Buclaw, Mateusz/G-1153-2016	Damaziak, Krzysztof/0000-0001-5940-266X; Gozdowski, Dariusz/0000-0002-7365-7607; Riedel, Julia/0000-0001-8975-5554; Buclaw, Mateusz/0000-0002-3457-9140	Warsaw University of Life Science: Faculty of Animal Science; Warsaw University of Life Science: Faculty of Human Nutrition and Consumer Sciences	Warsaw University of Life Science: Faculty of Animal Science; Warsaw University of Life Science: Faculty of Human Nutrition and Consumer Sciences	The author received no specific funding for this work. The research leading to these results was only funded by Warsaw University of Life Science: Faculty of Animal Science and Faculty of Human Nutrition and Consumer Sciences.	Amorim A, 2016, POULTRY SCI, V95, P1211, DOI 10.3382/ps/pev448; [Anonymous], 85862 ISO; [Anonymous], 85861 ISO; Bauer CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173064; Bilyk MC, 2009, CAN J DIET PRACT RES, V70, P13, DOI 10.3148/70.1.2009.13; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Breslin PAS, 2013, CURR BIOL, V23, pR409, DOI 10.1016/j.cub.2013.04.010; Catania KC, 2012, CURR OPIN NEUROBIOL, V22, P251, DOI 10.1016/j.conb.2011.11.014; Cavalheiro CP, 2013, FOOD SCI TECH-BRAZIL, V33, P660, DOI 10.1590/S0101-20612013000400010; Chen YL, 2016, ASIAN AUSTRAL J ANIM, V29, P855, DOI 10.5713/ajas.15.0840; Damaziak K, 2016, POULTRY SCI, V95, P2186, DOI 10.3382/ps/pew138; Damaziak K, 2016, BRIT POULTRY SCI, V57, P51, DOI 10.1080/00071668.2015.1120273; Damaziak K, 2014, S AFR J ANIM SCI, V44, P97, DOI 10.4314/sajas.v44i2.1; Delwiche JF, 2012, PHYSIOL BEHAV, V107, P502, DOI 10.1016/j.physbeh.2012.07.007; Gagnon L, 2013, CHEM SENSES, V38, P509, DOI 10.1093/chemse/bjt021; Gengler I, 2009, ASQ STAT DIVISION NE, V27, P9; Grimaud Freres, 2018, BREED GUIN FOWLS; Hansen S., 2008, Food, Culture & Society, V11, P49, DOI 10.2752/155280108X276050; Horbanczuk OK, 2017, J VET RES, V61, P279, DOI 10.1515/jvetres-2017-0031; Hurling R, 2003, APPETITE, V41, P167, DOI 10.1016/S0195-6663(03)00058-8; Hwang YH, 2017, KOREAN J FOOD SCI AN, V37, P153, DOI 10.5851/kosfa.2017.37.2.153; ISO, 1988, 8589 ISO; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kim DH, 2017, KOREAN J FOOD SCI AN, V37, P360, DOI 10.5851/kosfa.2017.37.3.360; Knaapila A, 2012, CHEM SENSES, V37, P869, DOI 10.1093/chemse/bjs070; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Koutsoklenis A, 2011, J VISUAL IMPAIR BLIN, V105, P692, DOI 10.1177/0145482X1110501015; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Luckett CR, 2014, J SENS STUD, V29, P171, DOI 10.1111/joss.12092; Mottram DS, 1998, FOOD CHEM, V62, P415, DOI 10.1016/S0308-8146(98)00076-4; Musundire MT, 2017, BRIT POULTRY SCI, V58, P390, DOI 10.1080/00071668.2017.1313961; Nsoso SJ, 2008, RES J ANIM SCI, V2, P36; Petkova VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035912; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Reed DR, 2010, PROG MOL BIOL TRANSL, V94, P213, DOI 10.1016/S1877-1173(10)94008-8; Roder B., 2004, HDB MULTISENSORY PRO, P719; Silva, 2012, J HUMAN GROWTH DEV, V22, P53, DOI DOI 10.7322/JHGD.20050; Singh-Ackbarali D, 2014, J CURRIC TEACH, V3, P10, DOI DOI 10.5430/JCT.V3N1P10; Sipos L, 2011, ACTA ALIMENT HUNG, V40, P198, DOI 10.1556/AAlim.40.2011.Suppl.19; Spence C., 2014, PERFECT MEAL MULTISE; Spence C, 2016, BRAIN COGNITION, V110, P53, DOI 10.1016/j.bandc.2015.08.006; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Van der Laan LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041738; Wadhera D, 2014, EAT BEHAV, V15, P132, DOI 10.1016/j.eatbeh.2013.11.003; Wirsenius S, 2010, AGR SYST, V103, P621, DOI 10.1016/j.agsy.2010.07.005; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Yeu K, 2008, J FOOD SCI, V73, pS20, DOI 10.1111/j.1750-3841.2007.00601.x; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	51	10	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210722	10.1371/journal.pone.0210722	http://dx.doi.org/10.1371/journal.pone.0210722			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699202	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600046
J	Ayuda-Duran, B; Gonzalez-Manzano, S; Miranda-Vizuete, A; Duenas, M; Santos-Buelga, C; Gonzalez-Paramas, AM				Ayuda-Duran, Begona; Gonzalez-Manzano, Susana; Miranda-Vizuete, Antonio; Duenas, Montserrat; Santos-Buelga, Celestino; Gonzalez-Paramas, Ana M.			Epicatechin modulates stress-resistance in C. elegans via insulin/IGF-1 signaling pathway	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; OXIDATIVE-STRESS; TRANSCRIPTION FACTOR; METHYLATED METABOLITES; FACTOR SKN-1; DAF-16; LONGEVITY; QUERCETIN; MITOHORMESIS	The nematode Caenorhabditis elegans has been used to examine the influence of epicatechin (EC), an abundant flavonoid in the human diet, in some stress biomarkers (ROS production, lipid peroxidation and protein carbonylation). Furthermore, the ability of EC to modulate the expression of some key genes in the insulin/IGF-1 signaling pathway (IIS), involved in longevity and oxidative or heat shock stress response, has also been explored. The final aim was to contribute to the elucidation of the mechanisms involved in the biological effects of flavonoids. The results showed that EC-treated wild-type C. elegans exhibited increased survival and reduced oxidative damage of biomolecules when submitted to thermal stress. EC treatment led to a moderate elevation in ROS levels, which might activate endogenous mechanisms of defense protecting against oxidative insult. The enhanced stress resistance induced by EC was found to be mediated through the IIS pathway, since assays in daf-2, age-1, akt-1, akt-2, sgk-1, daf-16, skn-1 and hsf-1 loss of function mutant strains failed to show any heat-resistant phenotype against thermal stress when treated with EC. Consistently, EC treatment upregulated the expression of some stress resistance associated genes, such as gst-4, hsp-16.2 and hsp-70, which are downstream regulated by the IIS pathway.	[Ayuda-Duran, Begona; Gonzalez-Manzano, Susana; Duenas, Montserrat; Santos-Buelga, Celestino; Gonzalez-Paramas, Ana M.] Univ Salamanca, Grp Invest Polifenoles, Campus Miguel de Unamuno, Salamanca, Spain; [Miranda-Vizuete, Antonio] Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Santos-Buelga, C (corresponding author), Univ Salamanca, Grp Invest Polifenoles, Campus Miguel de Unamuno, Salamanca, Spain.	csb@usal.es	González-Paramás, Ana M/D-2229-2011; Santos-Buelga, Celestino/A-1071-2008; Ayuda-Durán, Begoña/AAH-6908-2019; Santos-Buelga, Celestino/U-1358-2019; González-Paramás, Ana María/O-3771-2019; Miranda-Vizuete, Antonio/D-6927-2012	González-Paramás, Ana M/0000-0001-5477-0703; Santos-Buelga, Celestino/0000-0001-6592-5299; Ayuda-Durán, Begoña/0000-0001-9001-7399; González-Paramás, Ana María/0000-0001-5477-0703; Gonzalez Manzano, Susana/0000-0002-5739-515X; Miranda-Vizuete, Antonio/0000-0002-6856-5396	MINECO [AGL2015-64522-C2, BFU2015-64408-P]; FEDER-Interreg Espana-Portugal Programme [0377_IBERPHENOL_6_E]; Junta de Castilla y Leon [Orden EDU/310/2015]	MINECO(Spanish Government); FEDER-Interreg Espana-Portugal Programme(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was funded by MINECO (Spanish National Projects AGL2015-64522-C2 to CS-B and BFU2015-64408-P to AM-V) and FEDER-Interreg Espana-Portugal Programme (Ref. 0377_IBERPHENOL_6_E). Author BA-D is recipient of a PhD fellowship from the Junta de Castilla y Leon (Orden EDU/310/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by MINECO (Spanish National Project AGL2015-64522-C2) (BFU2015-64408-P) and FEDER-Interreg Espana-Portugal Programme (Project ref. 0377_IBERPHENOL_6_E). B.A-D is recipient of PhD fellowships from the Junta de Castilla y Leon (Orden EDU/310/2015). The authors are thankful to Marta Rodriguez-Romero and Jose Antonio Mora-Lorca for providing the necessary help with the assays of RT-qPCR and fluorescence microscopy, respectively.	Abbas S, 2010, PHYTOMEDICINE, V17, P902, DOI 10.1016/j.phymed.2010.03.008; Altintas O, 2016, BMB REP, V49, P81, DOI 10.5483/BMBRep.2016.49.2.261; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Asthana J, 2016, FREE RADICAL RES, V50, P861, DOI 10.1080/10715762.2016.1187268; Bahia PK, 2008, J NEUROCHEM, V106, P2194, DOI 10.1111/j.1471-4159.2008.05542.x; Granado-Serrano AB, 2010, BRIT J NUTR, V103, P168, DOI 10.1017/S0007114509991747; Bonomo LDF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089933; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Cai WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028835; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Desjardins D, 2017, AGING CELL, V16, P104, DOI 10.1111/acel.12528; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Gonzalez-Manzano S, 2012, J AGR FOOD CHEM, V60, P8911, DOI 10.1021/jf3004256; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Koch K, 2014, SCI WORLD J, DOI 10.1155/2014/920398; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lapointe J, 2009, J BIOL CHEM, V284, P20364, DOI 10.1074/jbc.M109.006569; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansuri ML, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0400-z; Martorell P, 2011, J AGR FOOD CHEM, V59, P2077, DOI 10.1021/jf104217g; Meng J, 2017, REDOX BIOL, V11, P365, DOI 10.1016/j.redox.2016.12.026; Miranda-Vizuete A, 2017, REDOX BIOL, V11, P708, DOI 10.1016/j.redox.2016.12.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sanz A, 2016, BBA-BIOENERGETICS, V1857, P1116, DOI 10.1016/j.bbabio.2016.03.018; Saul N, 2008, MECH AGEING DEV, V129, P611, DOI 10.1016/j.mad.2008.07.001; Saul N, 2009, MECH AGEING DEV, V130, P477, DOI 10.1016/j.mad.2009.05.005; Schuster E, 2010, MOL SYST BIOL, V10, P6; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Surco-Laos F, 2012, FOOD RES INT, V46, P514, DOI 10.1016/j.foodres.2011.10.014; Surco-Laos F, 2011, FOOD FUNCT, V2, P445, DOI 10.1039/c1fo10049a; Tissenbaum HA, 2015, INVERTEBR REPROD DEV, V59, P59, DOI 10.1080/07924259.2014.940470; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tullet JMA, 2017, AGING CELL, V16, P1191, DOI 10.1111/acel.12627; Upadhyay A, 2013, BIOSCI BIOTECH BIOCH, V77, P217, DOI 10.1271/bbb.120351; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Xiong LG, 2018, REDOX BIOL, V14, P305, DOI 10.1016/j.redox.2017.09.019; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105	58	31	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0199483	10.1371/journal.pone.0199483	http://dx.doi.org/10.1371/journal.pone.0199483			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689636	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800001
J	Tombak, EM; Mannik, A; Burk, RD; Le Grand, R; Ustav, E; Ustav, M				Tombak, Eva-Maria; Mannik, Andres; Burk, Robert D.; Le Grand, Roger; Ustav, Ene; Ustav, Mart			The molecular biology and HPV drug responsiveness of cynomolgus macaque papillomaviruses support their use in the development of a relevant in vivo model for antiviral drug testing	PLOS ONE			English	Article							DNA-REPLICATION; EPIDERMODYSPLASIA-VERRUCIFORMIS; TRANSCRIPTION MAP; CERVICAL-CANCER; MESSENGER-RNAS; PHYSICAL STATE; GENE-PRODUCT; TYPE-16 DNA; E2 PROTEINS; CELL-LINES	Due to the extreme tissue and species restriction of the papillomaviruses (PVs), there is a great need for animal models that accurately mimic PV infection in humans for testing therapeutic strategies against human papillomaviruses (HPVs). In this study, we present data that demonstrate that in terms of gene expression during initial viral DNA amplification, Macaca fascicularis PV (MfPV) types 5 and 8 appear to be similar to mucosal oncogenic HPVs, while MfPV1 (isolated from skin) resembles most high-risk cutaneous beta HPVs (HPV5). Similarities were also observed in replication properties during the initial amplification phase of the MfPV genomes. We demonstrate that high-risk mucosal HPV-specific inhibitors target the transient replication of the MfPV8 genomes, which indicates that similar pathways are used by the high-risk HPVs and MfPVs during their genome replication. Taking all into account, we propose that Macaca fascicularis may serve as a highly relevant model for preclinical tests designed to evaluate therapeutic strategies against HPV-associated lesions.	[Tombak, Eva-Maria; Mannik, Andres; Ustav, Ene; Ustav, Mart] Univ Tartu, Inst Technol, Tartu, Estonia; [Tombak, Eva-Maria; Mannik, Andres; Ustav, Mart] Icosagen Cell Factory Ltd, Eerika Tee 1, Kambja, Tartumaa, Estonia; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Genet, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Le Grand, Roger] Univ Paris Sud, INSERM, U1184,IDMIT Dept,IBFJ, Immunol Viral Infect & Autoimmune Dis IMVA,CEA, Fontenay Aux Roses, France; [Ustav, Mart] Estonian Acad Sci, Tallinn, Estonia	University of Tartu; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Tartu, Estonia.; Ustav, M (corresponding author), Icosagen Cell Factory Ltd, Eerika Tee 1, Kambja, Tartumaa, Estonia.; Ustav, M (corresponding author), Estonian Acad Sci, Tallinn, Estonia.	mart.ustav@icosagen.ee			Estonian Research Council [PRG198, IUT 20-27]; Center of Excellence in Molecular Cell Engineering through the European Regional Development Fund [2014-2020.4.01.15-0013]	Estonian Research Council; Center of Excellence in Molecular Cell Engineering through the European Regional Development Fund	This study was funded by the Estonian Research Council, http://www.etag.ee/en/, funding numbers PRG198 (recipient Prof. Mart Ustav) and IUT 20-27 (recipient Prof. Andres Merits); and by the Center of Excellence in Molecular Cell Engineering (2014-2020.4.01.15-0013) through the European Regional Development Fund (recipient Prof. Tanel Tenson), http://ec.europa.eu/regional_policy/en/funding/erdf/.The funder provided support in the form of salaries for authors [MU, EMT, AM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi A, 1996, J CLIN MICROBIOL, V34, P369, DOI 10.1128/JCM.34.2.369-375.1996; Alazawi W, 2002, CANCER RES, V62, P6959; Ammermann I, 2008, J VIROL, V82, P5127, DOI 10.1128/JVI.02647-07; Antony S, 2007, NUCLEIC ACIDS RES, V35, P4474, DOI 10.1093/nar/gkm463; ATANASIU P, 1948, ANN I PASTEUR PARIS, V74, P246; Benoit RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153158; Bergin IL, 2013, VET PATHOL, V50, P200, DOI 10.1177/0300985812439725; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chan SY, 1997, J VIROL, V71, P4938, DOI 10.1128/JVI.71.7.4938-4943.1997; Chen ZG, 2009, VIROLOGY, V393, P304, DOI 10.1016/j.virol.2009.07.012; CHESTERS PM, 1985, J GEN VIROL, V66, P615, DOI 10.1099/0022-1317-66-3-615; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; CHIANG CM, 1992, J VIROL, V66, P5224, DOI 10.1128/JVI.66.9.5224-5231.1992; CHOO KB, 1987, J MED VIROL, V21, P101, DOI 10.1002/jmv.1890210202; CHOW LT, 1987, J VIROL, V61, P2581, DOI 10.1128/JVI.61.8.2581-2588.1987; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; Dexheimer TS, 2009, J MED CHEM, V52, P7122, DOI 10.1021/jm901061s; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; DURST M, 1985, J GEN VIROL, V66, P1515, DOI 10.1099/0022-1317-66-7-1515; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Flores ER, 1997, J VIROL, V71, P7167, DOI 10.1128/JVI.71.10.7167-7179.1997; FRATTINI MG, 1994, VIROLOGY, V204, P799, DOI 10.1006/viro.1994.1596; Fu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115318; Gao G, 2016, CYTOGENET GENOME RES, V150, P185, DOI 10.1159/000458166; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Grassmann K, 1996, J VIROL, V70, P2339, DOI 10.1128/JVI.70.4.2339-2349.1996; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Henno Liisi, 2017, Curr Protoc Microbiol, V45, DOI 10.1002/cpmc.28; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hong SY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003295; Isok-Paas H, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0292-6; Jeckel S, 2003, J VIROL, V77, P8736, DOI 10.1128/JVI.77.16.8736-8744.2003; Joh J, 2009, J GEN VIROL, V90, P987, DOI 10.1099/vir.0.006544-0; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; KRISTIANSEN E, 1994, J CLIN PATHOL, V47, P253, DOI 10.1136/jcp.47.3.253; Kumar Sushil, 2015, Med J Armed Forces India, V71, P171, DOI 10.1016/j.mjafi.2015.02.006; Kurg R, 2010, VIROLOGY, V408, P159, DOI 10.1016/j.virol.2010.09.010; Lace MJ, 2008, J VIROL, V82, P10841, DOI 10.1128/JVI.01481-08; Lacey CJN, 2013, J EUR ACAD DERMATOL, V27, pe263, DOI 10.1111/j.1468-3083.2012.04493.x; LAMBERT PF, 1990, J VIROL, V64, P950, DOI 10.1128/JVI.64.2.950-956.1990; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; Nicol AF, 2015, ANN DIAGN PATHOL, V19, P418, DOI 10.1016/j.anndiagpath.2015.07.008; Orav M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15952; Orav M, 2013, J VIROL, V87, P12051, DOI 10.1128/JVI.01798-13; OSTROW RS, 1990, P NATL ACAD SCI USA, V87, P8170, DOI 10.1073/pnas.87.20.8170; Peh WL, 2002, J VIROL, V76, P10401, DOI 10.1128/JVI.76.20.10401-10416.2002; Pfister H, 2003, ARCH DERMATOL RES, V295, P273, DOI 10.1007/s00403-003-0435-2; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Pim D, 2012, FEBS J, V279, P3530, DOI 10.1111/j.1742-4658.2012.08709.x; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Rosales R, 2014, WORLD J CLIN ONCOL, V5, P1002, DOI 10.5306/wjco.v5.i5.1002; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHVARTZMAN JB, 1990, MOL CELL BIOL, V10, P3078, DOI 10.1128/MCB.10.6.3078; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; Sedman J, 1995, EMBO J, V14, P6218, DOI 10.1002/j.1460-2075.1995.tb00312.x; SEDMAN SA, 1991, J VIROL, V65, P4860, DOI 10.1128/JVI.65.9.4860-4866.1991; Sedman T, 1997, J VIROL, V71, P2887, DOI 10.1128/JVI.71.4.2887-2896.1997; SMOTKIN D, 1989, J VIROL, V63, P1441, DOI 10.1128/JVI.63.3.1441-1447.1989; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; SVERDRUP F, 1994, J VIROL, V68, P505, DOI 10.1128/JVI.68.1.505-509.1994; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; THIERRY F, 1987, J VIROL, V61, P134, DOI 10.1128/JVI.61.1.134-142.1987; Toots M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006168; Toots M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116151; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; Van Doorslaer K, 2013, VIROLOGY, V445, P11, DOI 10.1016/j.virol.2013.05.012; VANRANST M, 1991, J ORAL PATHOL MED, V20, P325; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wood CE, 2011, VET PATHOL, V48, P731, DOI 10.1177/0300985810383875; Wood CE, 2004, VET PATHOL, V41, P108, DOI 10.1354/vp.41-2-108; Wood CE, 2007, J VIROL, V81, P6339, DOI 10.1128/JVI.00233-07; Zobel T, 2003, MOL CELL BIOL, V23, P8352, DOI 10.1128/MCB.23.22.8352-8362.2003	83	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211235	10.1371/journal.pone.0211235	http://dx.doi.org/10.1371/journal.pone.0211235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682126	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500130
J	Lehane, AM; Dennis, ASM; Bray, KO; Li, DD; Rajendran, E; McCoy, JM; McArthur, HM; Winterberg, M; Rahimi, F; Tonkin, CJ; Kirk, K; van Dooren, GG				Lehane, Adele M.; Dennis, Adelaide S. M.; Bray, Katherine O.; Li, Dongdi; Rajendran, Esther; McCoy, James M.; McArthur, Hillary M.; Winterberg, Markus; Rahimi, Farid; Tonkin, Christopher J.; Kirk, Kiaran; van Dooren, Giel G.			Characterization of the ATP4 ion pump in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toxoplasma gondii; membrane transport; drug action; ATPase; malaria; cipargamin; Na+ pump; protozoan parasite; sodium transporter; TgATP4	INTRAERYTHROCYTIC MALARIA PARASITE; X-RAY-MICROANALYSIS; PLASMODIUM-FALCIPARUM; CATION ATPASE; NA+; SPIROINDOLONE; EXTRUSION; PROTEIN; PFATP4; SURVIVAL	The Plasmodium falciparum ATPase PfATP4 is the target of a diverse range of antimalarial compounds, including the clinical drug candidate cipargamin. PfATP4 was originally annotated as a Ca2+ transporter, but recent evidence suggests that it is a Na+ efflux pump, extruding Na+ in exchange for H+. Here we demonstrate that ATP4 proteins belong to a clade of P-type ATPases that are restricted to apicomplexans and their closest relatives. We employed a variety of genetic and physiological approaches to investigate the ATP4 protein of the apicomplexan Toxoplasma gondii, TgATP4. We show that TgATP4 is a plasma membrane protein. Knockdown of TgATP4 had no effect on resting pH or Ca2+ but rendered parasites unable to regulate their cytosolic Na+ concentration ([Na+](cyt)). PfATP4 inhibitors caused an increase in [Na+](cyt) and a cytosolic alkalinization in WT but not TgATP4 knockdown parasites. Parasites in which TgATP4 was knocked down or disrupted exhibited a growth defect, attributable to reduced viability of extracellular parasites. Parasites in which TgATP4 had been disrupted showed reduced virulence in mice. These results provide evidence for ATP4 proteins playing a key conserved role in Na+ regulation in apicomplexan parasites.	[Lehane, Adele M.; Dennis, Adelaide S. M.; Bray, Katherine O.; Li, Dongdi; Rajendran, Esther; McArthur, Hillary M.; Winterberg, Markus; Rahimi, Farid; Kirk, Kiaran; van Dooren, Giel G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [McCoy, James M.; Tonkin, Christopher J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [McCoy, James M.; Tonkin, Christopher J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Winterberg, Markus] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Winterberg, Markus] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand	Australian National University; Walter & Eliza Hall Institute; University of Melbourne; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Lehane, AM; Kirk, K; van Dooren, GG (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia.	adele.lehane@anu.edu.au; kiaran.kirk@anu.edu.au; giel.vandooren@anu.edu.au	Kirk, Kiaran/C-8299-2009; Lehane, Adele M/B-4127-2012; Bray, Kate/ABE-4038-2021; Rahimi, Farid/E-6522-2018; van Dooren, Giel/A-8896-2012; Tonkin, Christopher/J-2580-2016	Kirk, Kiaran/0000-0002-5613-2622; Lehane, Adele M/0000-0002-0050-9101; Bray, Kate/0000-0002-3990-2429; Rahimi, Farid/0000-0002-0920-8188; van Dooren, Giel/0000-0003-2455-9821; Tonkin, Christopher/0000-0002-7036-6222	National Health and Medical Research Council [1042272]; Australian Research Council [DP150102883, LP150101226, DE160101035, DP110103144, FT120100164]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council Grant 1042272 (to K. K.) and Australian Research Council Discovery Project Grant DP150102883 (to K. K. and G. G. v. D.), Linkage Project Grant LP150101226 (to K. K.), Discovery Early Career Researcher Award DE160101035 (to A. M. L.), QEII Fellowship DP110103144 (to G. G. v. D.), and Future Fellowship FT120100164 (to C. J. T.). C. J. T. is grateful for institutional support from the Victorian State Government Operational Infrastructure Support Program and the National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme. The authors declare that they have no conflicts of interest with the contents of this article.	Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Arrizabalaga G, 2004, J CELL BIOL, V165, P653, DOI 10.1083/jcb.200309097; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BARNES H, 1954, J EXP BIOL, V31, P582; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Blaustein M. P., 2004, CELLULAR PHYSL, P37; Borel E, 1998, PARASITE, V5, P371, DOI 10.1051/parasite/1998054371; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Das S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005647; Dennis ASM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26819-1; Dennis ASM, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00087-18, 10.1128/aac.00087-18]; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Dyer M, 1996, MOL BIOCHEM PARASIT, V78, P1, DOI 10.1016/S0166-6851(96)02593-5; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Foth Bernardo J., 2007, V390, P467; Francia ME, 2011, EXP CELL RES, V317, P1382, DOI 10.1016/j.yexcr.2011.03.020; Goldgof GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27806; Gornik SG, 2015, P NATL ACAD SCI USA, V112, P5767, DOI 10.1073/pnas.1423400112; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Katris NJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004074; Kirk K, 2015, ANNU REV MICROBIOL, V69, P341, DOI 10.1146/annurev-micro-091014-104506; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Lehane AM, 2014, MOL MICROBIOL, V94, P327, DOI 10.1111/mmi.12765; Mauritz JMA, 2011, BIOPHYS J, V100, P1438, DOI 10.1016/j.bpj.2011.02.007; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moreno SNJ, 1998, BIOCHEM J, V330, P853; Rajendran E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14455; Rodriguez-Navarro A, 2010, BBA-BIOMEMBRANES, V1798, P1841, DOI 10.1016/j.bbamem.2010.07.009; Rosling JEO, 2018, J BIOL CHEM, V293, P13327, DOI 10.1074/jbc.RA118.003640; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; SIBLEY LD, 1986, J CELL BIOL, V103, P867, DOI 10.1083/jcb.103.3.867; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Spillman NJ, 2008, MOL BIOCHEM PARASIT, V162, P96, DOI 10.1016/j.molbiopara.2008.07.001; Spillman NJ, 2013, MOL BIOCHEM PARASIT, V189, P1, DOI 10.1016/j.molbiopara.2013.04.004; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROTTEIN F, 1995, GENE, V158, P133, DOI 10.1016/0378-1119(95)00158-3; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2016, J BIOL CHEM, V291, P19335, DOI 10.1074/jbc.M116.725069; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; Van Voorhis WC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005763; Winterberg M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29241; Zhou Y, 2014, ANTIMICROB AGENTS CH, V58, P1789, DOI 10.1128/AAC.02225-13	59	8	8	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5720	5734		10.1074/jbc.RA118.006706	http://dx.doi.org/10.1074/jbc.RA118.006706			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723156	Green Published, hybrid			2022-12-26	WOS:000464517500038
J	Kim, D; Kang, H				Kim, Donghyun; Kang, Hyunsik			Exercise training modifies gut microbiota with attenuated host responses to sepsis in wild-type mice	FASEB JOURNAL			English	Article						physical fitness; systemic inflammation; survival; organ injury	INFLAMMATION; ADAPTATIONS; MORTALITY; RISK	This study investigated the effects of exercise preconditioning-induced modification in gut microbiota composition and host responses to cecal ligation and puncture (CLP)-induced sepsis. Four-week-old C57BL/6N male mice were randomly assigned to either CLP (n = 30) or CLP-exercise (CLP+Exe; n = 30) groups. Prior to CLP-induced sepsis, the CLP+Exe mice were subjected to 8 wk of treadmill running. Fecal samples were collected and analyzed by 16S rRNA amplification sequencing to assess gut microbiota composition. Diversity analyses such as principal coordinates analysis and rarefaction curves showed that exercise preconditioning was associated with differences in gut microbiota community structure and species richness. Exercise preconditioning-induced differences in gut microbiota composition were also evident at the family level of taxonomic analysis, with the dominant phyla being Bacteriodetes, Firmicutes, Verrucomicrobia, and, to a lesser extent, Cyanobacteria. Compared with control mice, preconditioned mice had a higher survival rate and less organ damage during the acute phase of sepsis, secondary to attenuation of the host response to septic shock. The current findings suggest that exercise preconditioning-induced modification in gut microbiota composition may lead to an attenuated host response to CLP-induced sepsis in wild-type mice, as shown by increased survival and less organ damage, as well as the establishment of a balance between pro- and anti-inflammatory responses.	[Kim, Donghyun; Kang, Hyunsik] Sungkyunkwan Univ, Coll Sport Sci, Suwon, South Korea	Sungkyunkwan University (SKKU)	Kang, H (corresponding author), Sungkyunkwan Univ, Coll Sport Sci, Lab Exercise Physiol & Biochem, 2066 Seobu Ro, Suwon 16419, South Korea.	hkang@skku.edu			National Research Foundation - Korean Government [NRF-2018R1D1A1B07048153, NRF-2016R1A6A3A11932432]	National Research Foundation - Korean Government(Korean Government)	The National Research Foundation Grant funded by the Korean Government (NRF-2018R1D1A1B07048153 and NRF-2016R1A6A3A11932432) supported this work. The authors declare no conflicts of interest.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Al-Nassan S, 2018, GEN PHYSIOL BIOPHYS, V37, P433, DOI 10.4149/gpb_2018001; Allen JM, 2018, GUT MICROBES, V9, P115, DOI 10.1080/19490976.2017.1372077; Allen JM, 2018, MED SCI SPORT EXER, V50, P747, DOI [10.1249/MSS.0000000000001495, 10.1249/mss.0000000000001495]; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Bermon S, 2015, EXERC IMMUNOL REV, V21, P70; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen MF, 2010, MED SCI SPORT EXER, V42, P2173, DOI 10.1249/MSS.0b013e3181e2158d; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; de Araujo CC, 2012, J APPL PHYSIOL, V112, P1206, DOI 10.1152/japplphysiol.01061.2011; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; French JP, 2008, FASEB J, V22, P2862, DOI 10.1096/fj.07-102541; Giamarellos-Bourboulis E, 2015, SCAND J GASTROENTERO, V50, P1076, DOI 10.3109/00365521.2015.1027261; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee SK, 2015, J EXP MED, V212, P1381, DOI 10.1084/jem.20141813; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01687; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marcinko K, 2015, MOL METAB, V4, P903, DOI 10.1016/j.molmet.2015.09.006; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; McFadzean R., 2014, THESIS; Olivo CR, 2014, J APPL PHYSIOL, V117, P998, DOI 10.1152/japplphysiol.00290.2014; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Sossdorf M, 2013, CRIT CARE MED, V41, pE246, DOI 10.1097/CCM.0b013e31828a2ae3; Tyml K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1783-1; Yamada M, 2018, BIOCHEM BIOPHYS REP, V15, DOI 10.1016/j.bbrep.2018.06.001; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	39	15	17	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5772	5781		10.1096/fj.201802481R	http://dx.doi.org/10.1096/fj.201802481R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702933				2022-12-26	WOS:000462888500090
J	Sun, RF; Liu, ZG; Han, L; Yang, Y; Wu, F; Jiang, QY; Zhang, HH; Ma, RL; Miao, JY; He, K; Wang, XF; Zhou, D; Huang, C				Sun, Ruifang; Liu, Zhigang; Han, Lin; Yang, Yang; Wu, Fei; Jiang, Qiuyu; Zhang, Huahua; Ma, Ruili; Miao, Jiyu; He, Kang; Wang, Xiaofei; Zhou, Dangxia; Huang, Chen			miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer	FASEB JOURNAL			English	Article						BCL9-2; EMT; microRNA-22; microRNA-214; carcinoma of colon	SUPPRESSES GROWTH; PROSTATE-CANCER; CERVICAL-CANCER; TUMOR-GROWTH; E-CADHERIN; EXPRESSION; PROMOTES; MIGRATION; INVASION; GENE	The epithelial-mesenchymal transition (EMT) is crucial for cancer progression. Evidence has shown that miR-22 and miR-214 play a key role in colon cancer progression; however, the underlying mechanism remains to be known. The effects of miR-22 and miR-214 on EMT are contradictory in different cancers, and whether miR-22 and miR-214 are involved in the colon cancer EMT process needs to be elucidated. In this study, we evaluated the exact role and the regulation mechanism of miR-22 and miR-214 in colon cancer. After transfection with miR-22 expression vector, the cell proliferation and migration capacity of HCT116 and RKO cells were significantly suppressed. Also, E-cadherin was increased and vimentin was decreased by miR-22 overexpression. Similar effects were also observed after miR-214 expression vector transfection. Dual-luciferase reporter confirmed that BCL9L is the target gene of both miR-22 and miR-214. Silencing of BCL9L inhibits cell proliferation and migration, and the expression of E-cadherin and vimentin was also altered by BCL9L knockdown, which was consistent with miR-22 or miR-214 transfection. Furthermore, miR-22 and miR-214 inhibited tumor growth in nude mice. Moreover, although the association between BCL9L's lower expression and longer survival time was statistically nonsignificant, a trend existed; further studies in a larger cohort are needed. Collectively, these data suggest that miR-22 and miR-214 inhibit cell proliferation, migration, and EMT of colon cancer, most likely by targeting BCL9L.	[Sun, Ruifang; Zhou, Dangxia] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Pathol, Xian, Shaanxi, Peoples R China; [Han, Lin; Wu, Fei; Jiang, Qiuyu; Miao, Jiyu; Wang, Xiaofei; Huang, Chen] Xi An Jiao Tong Univ, Stomatol Hosp, Sch Basic Med Sci, Dept Cell Biol & Genet, Xian, Shaanxi, Peoples R China; [Sun, Ruifang; Han, Lin; Yang, Yang; Wu, Fei; Jiang, Qiuyu; Miao, Jiyu; He, Kang; Wang, Xiaofei; Zhou, Dangxia; Huang, Chen] Xi An Jiao Tong Univ, Stomatol Hosp, Minist Educ China, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Yang, Yang] Xi An Jiao Tong Univ, Stomatol Hosp, Sch Publ Hlth, Xian, Shaanxi, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Stomatol Hosp, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [He, Kang] Xi An Jiao Tong Univ, Stomatol Hosp, Dept Periodontol, Xian, Shaanxi, Peoples R China; [Liu, Zhigang] Shaanxi Prov Tumor Hosp, Dept Thorac Surg, Xian, Shaanxi, Peoples R China; [Zhang, Huahua] Yanan Univ, Med Coll, Yanan, Peoples R China; [Ma, Ruili] Xian Med Univ, Sch Basic Med Sci, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Ministry of Education, China; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Yanan University; Xi'an Medical University	Zhou, D (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pathol, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.; Huang, C (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	zhoudangxia@163.com; hchen@mail.xjtu.edu.cn			National Natural Science Foundation of China [81802788]; Shaanxi Provincial Natural Science Foundation of China [2018JM7028]; Postdoctoral Science Foundation of China [2017M620458]; Fundamental Research Funds for the Central Universities [xjj2017192]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Foundation of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by National Natural Science Foundation of China (81802788), Shaanxi Provincial Natural Science Foundation of China (2018JM7028), Postdoctoral Science Foundation of China (2017M620458), and the Fundamental Research Funds for the Central Universities (xjj2017192). The authors declare no conflicts of interest.	Adachi S, 2004, CANCER RES, V64, P8496, DOI 10.1158/0008-5472.CAN-04-2254; Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Brembeck FH, 2011, GASTROENTEROLOGY, V141, P1359, DOI 10.1053/j.gastro.2011.06.039; Cai ZG, 2013, CELL BIOL INT, V37, P669, DOI 10.1002/cbin.10087; Chandrasekaran KS, 2017, CELL BIOCHEM FUNCT, V35, P464, DOI 10.1002/cbf.3304; Chandrasekaran KS, 2016, BRIT J CANCER, V115, P741, DOI 10.1038/bjc.2016.234; Chang SE, 2015, ONCOTARGET, V6, P7675, DOI 10.18632/oncotarget.3048; Chatterjee K, 2018, FASEB J, V32, P4560, DOI 10.1096/fj.201701382RR; Choi S, 2017, FASEB J, V31, P1516, DOI 10.1096/fj.201601098R; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Dhar S, 2017, FEBS LETT, V591, P924, DOI 10.1002/1873-3468.12603; El-Hage P, 2015, MOL CANCER RES, V13, P902, DOI 10.1158/1541-7786.MCR-14-0180; He GY, 2016, BRIT J CANCER, V115, P1367, DOI 10.1038/bjc.2016.362; Hu Y., 2018, FASEB J; Katoh M, 2003, INT J MOL MED, V12, P643; Li B, 2013, ONCOL REP, V29, P1932, DOI 10.3892/or.2013.2300; Li JJ, 2017, FASEB J, V31, P3774, DOI 10.1096/fj.201601140RR; Li Y, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0471-1; Liu ZG, 2017, INT J CLIN EXP PATHO, V10, P6799; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long HX, 2015, ONCOTARGET, V6, P38705, DOI 10.18632/oncotarget.5478; Long LM, 2015, ONCOL LETT, V9, P645, DOI 10.3892/ol.2014.2746; Lopez-Garcia C, 2017, CANCER CELL, V31, P79, DOI 10.1016/j.ccell.2016.11.001; Lu J, 2018, FASEB J, V32, P6123, DOI 10.1096/fj.201800113R; Lv JW, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.98; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Miller TCR, 2010, J MOL BIOL, V401, P969, DOI 10.1016/j.jmb.2010.07.007; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng RQ, 2017, BIOCHEM BIOPH RES CO, V484, P623, DOI 10.1016/j.bbrc.2017.01.152; Sannino G, 2016, ONCOTARGET, V7, P73725, DOI 10.18632/oncotarget.12455; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sun RF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.134; Xia SS, 2017, ONCOTARGET, V8, P36266, DOI 10.18632/oncotarget.16742; Xin M, 2016, ONCOTARGET, V7, P44252, DOI 10.18632/oncotarget.10020; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang LQ, 2018, CANCER LETT, V414, P44, DOI 10.1016/j.canlet.2017.11.007; Yang Y, 2015, ONCOTARGET, V6, P16227, DOI 10.18632/oncotarget.3970; Zatula N, 2014, ONCOTARGET, V5, P6770, DOI 10.18632/oncotarget.2252; Zhang GJ, 2012, MED ONCOL, V29, P3108, DOI 10.1007/s12032-012-0233-9; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086149; Zhao LY, 2017, EBIOMEDICINE, V16, P87, DOI 10.1016/j.ebiom.2017.01.021; Zhao XJ, 2016, DNA CELL BIOL, V35, P715, DOI 10.1089/dna.2016.3398; Zheng LF, 2018, FASEB J, V32, P588, DOI 10.1096/fj.201700461RR; Zhu XB, 2017, MOL MED REP, V15, P1884, DOI 10.3892/mmr.2017.6203; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297	47	22	23	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5411	5424		10.1096/fj.201801798RR	http://dx.doi.org/10.1096/fj.201801798RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698996	Bronze			2022-12-26	WOS:000462888500063
J	Hedglin, M; Aitha, M; Pedley, A; Benkovic, SJ				Hedglin, Mark; Aitha, Mahesh; Pedley, Anthony; Benkovic, Stephen J.			Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proliferating cell nuclear antigen (PCNA); ubiquitin-conjugating enzyme (E2 enzyme); E3 ubiquitin ligase; ubiquitylation (ubiquitination); DNA damage; DNA replication; PCNA monoubiquitination; posttranslational modification (PTM); Rad6; Rad18; replication protein A (RPA); translesion DNA synthesis (TLS); DNA polymerase; DNA-binding protein; sliding clamp; cell cycle	SINGLE-STRANDED-DNA; LAGGING STRANDS; DAMAGE BYPASS; LIGASE RAD18; PCNA; BINDING; UBIQUITIN; REPAIR; CYCLE; P53	DNA damage tolerance permits bypass of DNA lesions encountered during S-phase and may be carried out by translesion DNA synthesis (TLS). Human TLS requires selective monoubiquitination of proliferating cell nuclear antigen (PCNA) sliding clamps encircling damaged DNA. This posttranslational modification (PTM) is catalyzed by Rad6/Rad18. Recent studies revealed that replication protein A (RPA), the major ssDNA-binding protein, is involved in the regulation of PCNA monoubiquitination and interacts directly with Rad18 on chromatin and in the nucleoplasm. However, it is unclear how RPA regulates this critical PTM and what functional role(s) these interactions serve. Here, we developed an in vitro assay to quantitatively monitor PCNA monoubiquitination under in vivo scenarios. Results from extensive experiments revealed that RPA regulates Rad6/Rad18 activity in an ssDNA-dependent manner. We found that "DNA-free" RPA inhibits monoubiquitination of free PCNA by directly interacting with Rad18. This interaction is promoted under native conditions when there is an overabundance of free RPA in the nucleoplasm where Rad6/Rad18 and a significant fraction of PCNA reside. During DNA replication stress, RPA binds the ssDNA exposed downstream of stalled primer/template (P/T) junctions, releasing Rad6/Rad18. RPA restricted the resident PCNAs to the upstream duplex regions by physically blocking diffusion of PCNA along ssDNA, and this activity was required for efficient monoubiquitination of PCNA on DNA. Furthermore, upon binding ssDNA, RPA underwent a conformational change that increased its affinity for Rad18. Rad6/Rad18 complexed with ssDNA-bound RPA was active, and this interaction may selectively promote monoubiquitination of PCNA on long RPA-coated ssDNA.	[Hedglin, Mark; Aitha, Mahesh; Pedley, Anthony; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hedglin, M (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	muh218@psu.edu		Pedley, Anthony/0000-0003-1034-5072; Hedglin, Mark/0000-0003-2599-1691	National Institute of General Medical Sciences (NIGMS), National Institutes of Health [R01 GM013306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (NIGMS), National Institutes of Health Grant R01 GM013306. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Brown S, 2009, CELL CYCLE, V8, P689, DOI 10.4161/cc.8.5.7707; Cooper GM., 2016, CELL MOL APPROACH, V89, P424; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; Elia AEH, 2015, MOL CELL, V60, P280, DOI 10.1016/j.molcel.2015.09.011; Flynn RL, 2010, CRIT REV BIOCHEM MOL, V45, P266, DOI 10.3109/10409238.2010.488216; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; Hedglin M, 2017, BIOCHEMISTRY-US, V56, P3415, DOI 10.1021/acs.biochem.7b00386; Hedglin M, 2017, CHEM REV, V117, P7857, DOI 10.1021/acs.chemrev.7b00046; Hedglin M, 2017, BIOCHEMISTRY-US, V56, P1824, DOI 10.1021/acs.biochem.6b01213; Hedglin M, 2015, ANNU REV BIOPHYS, V44, P207, DOI 10.1146/annurev-biophys-060414-033841; Hedglin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010165; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Li FF, 2018, CURR GENET, V64, P459, DOI 10.1007/s00294-017-0753-0; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; Lin YL, 1996, J BIOL CHEM, V271, P17190, DOI 10.1074/jbc.271.29.17190; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Masuyama S, 2005, GENES CELLS, V10, P753, DOI 10.1111/j.1365-2443.2005.00874.x; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Miller SD, 1997, MOL CELL BIOL, V17, P2194, DOI 10.1128/MCB.17.4.2194; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Prakash Aishwarya, 2012, Subcell Biochem, V62, P171, DOI 10.1007/978-94-007-4572-8_10; SASAKI K, 1993, CYTOMETRY, V14, P876, DOI 10.1002/cyto.990140805; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Soria G, 2006, ONCOGENE, V25, P2829, DOI 10.1038/sj.onc.1209315; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Waldman VM, 2016, NUCLEIC ACIDS RES, V44, P4317, DOI 10.1093/nar/gkw262; Wang ZF, 2016, J CELL SCI, V129, P1223, DOI 10.1242/jcs.179408; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang Y, 2013, NUCLEIC ACIDS RES, V41, P2296, DOI 10.1093/nar/gks1325; Yoon JH, 2012, P NATL ACAD SCI USA, V109, P7799, DOI 10.1073/pnas.1204105109; Yu CH, 2014, MOL CELL, V56, P551, DOI 10.1016/j.molcel.2014.09.017; Zessin PJM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18779	58	15	15	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5157	5168		10.1074/jbc.RA118.005297	http://dx.doi.org/10.1074/jbc.RA118.005297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700555	Green Published, hybrid			2022-12-26	WOS:000463985600036
J	Salazar, AJ; Sherekar, M; Tsai, J; Sacchettini, JC				Salazar, Adam J.; Sherekar, Mukul; Tsai, Jennifer; Sacchettini, James C.			R pyocin tail fiber structure reveals a receptor-binding domain with a lectin fold	PLOS ONE			English	Article							T-EVEN BACTERIOPHAGE; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; PROTEIN; PHAGE; TAILSPIKE; RECOGNIZE	R pyocins are phi CTX-like myophage tailocins of Pseudomonas sp. Adsorption of R pyocins to target strains occurs by the interaction of tail fiber proteins with core lipopolysaccharide (LPS). Here, we demonstrate that N-terminally truncated R pyocin tail fibers corresponding to a region of variation between R-subtypes are sufficient to bind target strains according to R-subtype. We also report the crystal structures of these tail fiber proteins and show that they form an elongated helical trimer composed of three domains arranged linearly from N- to C-terminus: a baseplate proximal head, medial shaft, and distal foot. The head and shaft domains contain novel structural motifs. The foot domain, however, is composed of a conserved jellyroll fold and shares high structural similarity to the tail fiber of myophage AP22, podophage tailspike C-terminal domains (LKA-1 and phi 297), and several eukaryotic adhesins (discoidin I/II, agglutinin, and octocoral lectin). Many of these proteins bind polysaccharides by means of their distal loop network, a series of highly variable loops at one end of the conserved jellyroll fold backbone. Our structures reveal that the majority of R-subtype specific polymorphisms cluster in patches covering a cleft formed at the oligomeric interface of the head domain and in a large patch covering much of the foot domain, including the distal loop network. Based on the structural variation in distal loops within the foot region, we propose that the foot is the primary sugar-binding domain of R pyocins and R-subtype specific structural differences in the foot domain distal loop network are responsible for binding target strains in an R-subtype dependent manner.	[Salazar, Adam J.; Sherekar, Mukul; Tsai, Jennifer; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu	Salazar, Adam J./AAS-2526-2020	Salazar, Adam/0000-0002-4614-0952	Welch foundation [A-0015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	Welch foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by (JCS) Welch foundation grant (A-0015), Welch foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aragao KS, 2008, PROTEINS, V73, P43, DOI 10.1002/prot.22038; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Buth SA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080427; Chayen NE, 2008, NAT METHODS, V5, P147, DOI 10.1038/NMETH.F.203; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; FYFE JAM, 1984, J CLIN MICROBIOL, V20, P47, DOI 10.1128/JCM.20.1.47-50.1984; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Ghequire MGK, 2018, MBIO, V9, DOI 10.1128/mBio.02138-17; Ghequire MGK, 2015, GENOME BIOL EVOL, V7, P2810, DOI 10.1093/gbe/evv184; Ghequire MGK, 2015, TRENDS MICROBIOL, V23, P587, DOI 10.1016/j.tim.2015.07.011; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; GOLDENBERG DP, 1982, J BIOL CHEM, V257, P7864; HAYASHI T, 1994, FEMS MICROBIOL LETT, V122, P239, DOI 10.1111/j.1574-6968.1994.tb07174.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hernandez-Morales AC, 2018, J VIROL, V92, DOI 10.1128/JVI.01064-17; HIGERD TB, 1967, J BACTERIOL, V93, P1976, DOI 10.1128/JB.93.6.1976-1986.1967; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JACOB F, 1954, ANN I PASTEUR PARIS, V86, P149; Kocincova D, 2013, MOL MICROBIOL, V89, P464, DOI 10.1111/mmi.12289; Kohler T, 2010, J BACTERIOL, V192, P1921, DOI 10.1128/JB.01459-09; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Marti R, 2013, MOL MICROBIOL, V87, P818, DOI 10.1111/mmi.12134; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Olszak T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16411-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ritchie JM, 2011, ANTIMICROB AGENTS CH, V55, P5469, DOI 10.1128/AAC.05031-11; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Saraboji K, 2012, BIOCHEMISTRY-US, V51, P296, DOI 10.1021/bi201459p; Scholl D, 2017, ANNU REV VIROL, V4, P453, DOI 10.1146/annurev-virology-101416-041632; Scholl D, 2009, ANTIMICROB AGENTS CH, V53, P3074, DOI 10.1128/AAC.01660-08; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Tetart F, 1998, J MOL BIOL, V282, P543, DOI 10.1006/jmbi.1998.2047; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williams SR, 2008, APPL ENVIRON MICROB, V74, P3868, DOI 10.1128/AEM.00141-08	40	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211432	10.1371/journal.pone.0211432	http://dx.doi.org/10.1371/journal.pone.0211432			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721244	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300014
J	Joung, I; Kim, JY; Joo, K; Lee, J				Joung, Insuk; Kim, Jong Yun; Joo, Keehyoung; Lee, Jooyoung			Non-sequential protein structure alignment by conformational space annealing and local refinement	PLOS ONE			English	Article							SIMILARITIES; ALGORITHM; SEQUENCE; TOOL	Protein structure alignment is an important tool for studying evolutionary biology and protein modeling. A tool which intensively searches for the globally optimal non-sequential alignments is rarely found. We propose ALIGN-CSA which shows improvement in scores, such as DALI-score, SP-score, SO-score and TM-score over the benchmark set including 286 cases. We performed benchmarking of existing popular alignment scoring functions, where the dependence of the search algorithm was effectively eliminated by using ALIGN-CSA. For the benchmarking, we set the minimum block size to 4 to prevent much fragmented alignments where the biological relevance of small alignment blocks is hard to interpret. With this condition, globally optimal alignments were searched by ALIGN-CSA using the four scoring functions listed above, and TM-score is found to be the most effective in generating alignments with longer match lengths and smaller RMSD values. However, DALI-score is the most effective in generating alignments similar to the manually curated reference alignments, which implies that DALI-score is more biologically relevant score. Due to the high demand on computational resources of ALIGN-CSA, we also propose a relatively fast local refinement method, which can control the minimum block size and whether to allow the reverse alignment. ALIGN-CSA can be used to obtain much improved alignment at the cost of relatively more extensive computation. For faster alignment, we propose a refinement protocol that improves the score of a given alignment obtained by various external tools.	[Joung, Insuk; Kim, Jong Yun; Lee, Jooyoung] Korea Inst Adv Study, Ctr Sil Prot Sci, Seoul, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Ctr Adv Computat, Seoul, South Korea	Korea Institute for Advanced Study (KIAS); Korea Institute for Advanced Study (KIAS); Korea Institute for Advanced Study (KIAS)	Lee, J (corresponding author), Korea Inst Adv Study, Ctr Sil Prot Sci, Seoul, South Korea.; Lee, J (corresponding author), Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea.; Lee, J (corresponding author), Korea Inst Adv Study, Ctr Adv Computat, Seoul, South Korea.	jlee@kias.re.kr			National Research Foundation of Korea (NRF) - the Ministry of Science and ICT [NRF-2017R1E1A1A01077717]; Basic Science Research Program through the National Research Foundation of Korea(NRF)	National Research Foundation of Korea (NRF) - the Ministry of Science and ICT; Basic Science Research Program through the National Research Foundation of Korea(NRF)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1E1A1A01077717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF). Authors also acknowledge Center for Advanced Computation (CAC) in the Korea Institute for Advanced Study (KIAS) for providing computing resources (Linux Cluster System).	Abyzov A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-78; Brown P, 2016, BIOINFORMATICS, V32, P370, DOI 10.1093/bioinformatics/btv580; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Joo K, 2008, BIOPHYS J, V95, P4813, DOI 10.1529/biophysj.108.129684; Joo K, 2015, PROTEINS, V83, P2251, DOI 10.1002/prot.24941; Joo K, 2009, PROTEINS, V75, P1010, DOI 10.1002/prot.22312; Joung I, 2018, COMPUT PHYS COMMUN, V223, P28, DOI 10.1016/j.cpc.2017.09.028; Kim SY, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.184412; Kim SY, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011916; Kim SY, 2004, J KOREAN PHYS SOC, V44, P589, DOI 10.3938/jkps.44.589; Kim SY, 2003, J CHEM PHYS, V119, P10274, DOI 10.1063/1.1616917; Lackner P, 2000, PROTEIN ENG, V13, P745, DOI 10.1093/protein/13.11.745; Lee IH, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.115209; Lee J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080201; Lee J, 1998, BIOPOLYMERS, V46, P103, DOI 10.1002/(SICI)1097-0282(199808)46:2&lt;103::AID-BIP5&gt;3.0.CO;2-Q; Lee J, 1999, P NATL ACAD SCI USA, V96, P2025, DOI 10.1073/pnas.96.5.2025; Lee J, 1997, J COMPUT CHEM, V18, P1222, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1222::AID-JCC10>3.0.CO;2-7; Lee J, 2017, NATURE COMMUNICATION, V8; Lee J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056702; Lee K, 2005, J COMPUT CHEM, V26, P78, DOI 10.1002/jcc.20147; Mayr G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-50; Minami S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-24; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Naiem A, 2009, 7 INT C NUM AN APPL, P9999; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr348; Oh YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18086; Salem S, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-12; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Wohlers I, 2013, IEEE ACM T COMPUT BI, V10, P26, DOI 10.1109/TCBB.2012.143; Yang YD, 2012, PROTEINS, V80, P2080, DOI 10.1002/prot.24100; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210177	10.1371/journal.pone.0210177	http://dx.doi.org/10.1371/journal.pone.0210177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699145	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600023
J	Li, J; Xui, FJ; Sun, ZJ; Wang, JF				Li, Jie; Xui, Fangjin; Sun, Zhaojun; Wang, Jinfeng			Regional differences and spatial patterns of health status of the member states in the "Belt and Road" Initiative	PLOS ONE			English	Article							LIFE EXPECTANCY; COUNTRIES	The strategy of the "Belt and Road" initiative aims not only to promote the cooperation and the development of economic trade, but also to boost the integration and development in multiple fields-especially in the field of health. This paper explores the health levels of member-states in the Belt and Road initiative from the perspective of regional differences and spatial patterns. Data from the 68 member-states in the Belt and Road initiative were selected from the statistical data on disease and socioeconomics in all countries from the 2015 publication by the World Bank and the World Health Organization. Health indicators that can reflect health levels of member states were selected. Moran's I and Getis-Ord Gi* were used to analyze the spatial clustering and hot/cold spots of the health status. After that a novel spatial statistical method "geographical detector" was used to analysis the spatial stratified heterogeneity of the selected health indicators. The result showed that the health level of the member states fluctuated around the world average and varied greatly within the member states. The health status of the member states showed spatial clustering, and the q-statistics of the geographical detector confirmed that the health status demonstrated statistically significant spatial heterogeneity for different continent the member states reside. In general, member states in Europe and Oceania demonstrated higher health status, while those in South Asia, Southeast Asia, Africa and part of Middle East have lower health status. In particular, special attention should be paid to control communicable diseases in African member states. Different regions and member states face different kinds of health threats in various degrees. Member states should strengthen health cooperation between themselves and work closely with other countries to make the "belt and road" a healthy road.	[Li, Jie; Xui, Fangjin; Sun, Zhaojun] Ningxia Univ, Dept Resources & Environm, Ningxia, Yinchuan, Peoples R China; [Li, Jie; Sun, Zhaojun] Ningxia Univ, Ningxia China Arab Key Lab Resource Assessment &, Ningxia, Yinchuan, Peoples R China; [Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Ningxia University; Ningxia University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	wangjf@lreis.ac.cn	Li, Jie/AAV-1219-2021	Li, Jie/0000-0001-9632-3733	Major Innovation Projects for Building First-class Universities in China's Western Region [ZKZD2017004]; Major Innovation Projects for Building First-class Universities in China's Western Region" in Ningxia University [ZKZD2017004]	Major Innovation Projects for Building First-class Universities in China's Western Region; Major Innovation Projects for Building First-class Universities in China's Western Region" in Ningxia University	The study was supported by Major Innovation Projects for Building First-class Universities in China's Western Region (Number: ZKZD2017004).; The study was supported by Major Innovation Projects for Building First-class Universities in China's Western Region" in Ningxia University (Number: ZKZD2017004).	[Anonymous], 2017, ENERGY SAVING NONFER, V33, P62; Arabic compiling Department of foreign languages press, 2015, VIS PROP ACT OUTL JO; Beaglehole R, 2011, UN HIGH LEV M NONC D; Geneva World Health Organization, GLOB HLTH EST 2015 D; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Information Office of the State Council of the People's Republic of China, PUT FORW SPEC ID BAC; Levine AC, 2015, BMC INT HEALTH HUM R, V14, P17; Liu BZ, 2011, PACIFIC J, V19, P82; Lu BuLai, 2010, Disease Surveillance, V25, P394; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; [王瑞江 Wang Ruijiang], 2016, [地球学报, Acta Geoscientia Sinica], V37, P433; World Bank, STAT AND EC; World Health Organization, 2018 GLOB REF LIST 1; World Health Organization, TUBERCULOSIS TB; World Health Organization (WHO), MAT REPR HLTH; Zeng Xianghong, 2016, WORLD EC POLITICS, V1, P46; Zeng Z, 2016, COMMUNIQUE STATE COU, P5; [张松林 ZHANG Songlin], 2007, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V46, P93	21	1	1	11	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211264	10.1371/journal.pone.0211264	http://dx.doi.org/10.1371/journal.pone.0211264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699174	gold, Green Submitted, Green Published			2022-12-26	WOS:000457155600069
J	Xiong, HC; Guo, HJ; Zhou, CY; Guo, XT; Xie, YD; Zhao, LS; Gu, JY; Zhao, SR; Ding, YP; Liu, LX				Xiong, Hongchun; Guo, Huijun; Zhou, Chunyun; Guo, Xiaotong; Xie, Yongdun; Zhao, Linshu; Gu, Jiayu; Zhao, Shirong; Ding, Yuping; Liu, Luxiang			A combined association mapping and t-test analysis of SNP loci and candidate genes involving in resistance to low nitrogen traits by a wheat mutant population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NBS-LRR PROTEINS; USE EFFICIENCY; SPRING WHEAT; AGRONOMIC TRAITS; SEEDLING TRAITS; BREAD WHEAT; TRANSPORTER; YIELD; TRANSCRIPTION	Crop productivity is highly dependent on the application of N fertilizers, but ever-increasing N application is causing serious environmental impacts. To facilitate the development of new wheat cultivars that can thrive in low N growth conditions, key loci and genes associated with wheat responses to low N must be identified. In this GWAS and t-test study of 190 M-6 mutant wheat lines (Jing 411-derived) based on genotype data from the wheat 660k SNP array, we identified a total of 221 significant SNPs associated four seedling phenotypic traits that have been implicated in resistance to low N: relative root length, relative shoot length, relative root weight, and relative shoot weight. Notably, we detected large numbers of significantly associated SNP in what appear to be genomic 'hotspots' for resistance to low N on chromosomes 2A and 6B, strongly suggesting that these regions are functionally related to the resistance phenotypes that we observed in some of the mutant lines. Moreover, the candidate genes, including genes encoding high-affinity nitrate transporter 2.1, gibberellin responsive protein, were identified for resistance to low N. This study raises plausible mechanistic hypotheses that can be evaluated in future applied or basic efforts by breeders or plant biologists seeking to develop new high-NUE wheat cultivars.	[Xiong, Hongchun; Guo, Huijun; Zhou, Chunyun; Xie, Yongdun; Zhao, Linshu; Gu, Jiayu; Zhao, Shirong; Ding, Yuping; Liu, Luxiang] Chinese Acad Agr Sci, Natl Engn Lab Crop Mol Breeding, Natl Ctr Space Mutagenesis Crop Improvement, Inst Crop Sci, Beijing, Peoples R China; [Guo, Xiaotong] Ludong Univ, Coll Agr, Yantai, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ludong University	Liu, LX (corresponding author), Chinese Acad Agr Sci, Natl Engn Lab Crop Mol Breeding, Natl Ctr Space Mutagenesis Crop Improvement, Inst Crop Sci, Beijing, Peoples R China.	liuluxiang@caas.cn			National Key Research and Development Program of China [2016YFD0101802]; China Agriculture Research System [CARS-03]	National Key Research and Development Program of China; China Agriculture Research System	This work was financially supported by The National Key Research and Development Program of China (Grant No. 2016YFD0101802 to LL) and the China Agriculture Research System (Grant No. CARS-03 to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156188; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bellegarde F, 2017, J EXP BOT, V68, P2553, DOI 10.1093/jxb/erx062; Bordes J, 2013, THEOR APPL GENET, V126, P805, DOI 10.1007/s00122-012-2019-z; Chen GF, 2016, EUPHYTICA, V212, P173, DOI 10.1007/s10681-016-1750-y; Cormier F, 2014, THEOR APPL GENET, V127, P2679, DOI 10.1007/s00122-014-2407-7; Cui F, 2016, THEOR APPL GENET, V129, P469, DOI 10.1007/s00122-015-2641-7; Cui F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-57; David LC, 2016, PLANTA, V244, P1315, DOI 10.1007/s00425-016-2588-1; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Gao LL, 2017, CROP SCI, V57, P2575, DOI 10.2135/cropsci2017.03.0159; Garnett T, 2015, FUNCT PLANT BIOL, V42, P921, DOI 10.1071/FP15025; Gooding MJ, 2012, J AGR SCI-CAMBRIDGE, V150, P3, DOI 10.1017/S0021859611000414; Guo HJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01404; Guo TC, 2014, J PLANT GROWTH REGUL, V33, P837, DOI 10.1007/s00344-014-9435-z; Guo Y, 2012, THEOR APPL GENET, V124, P851, DOI 10.1007/s00122-011-1749-7; Gutierrez RA, 2012, SCIENCE, V336, P1673, DOI 10.1126/science.1217620; Han M, 2015, ANNU REV GENET, V49, P269, DOI 10.1146/annurev-genet-112414-055037; He X, 2015, PLANT PHYSIOL, V169, P1991, DOI 10.1104/pp.15.00568; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; Li GT, 2017, PLANT CELL, V29, P1218, DOI 10.1105/tpc.17.00154; Li TY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01637; Li YH, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.04.0020; Liu YX, 2017, PLANT J, V91, P861, DOI 10.1111/tpj.13614; Liu ZG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00436; Liu ZY, 2016, FUNCT INTEGR GENOMIC, V16, P323, DOI 10.1007/s10142-016-0486-z; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Mahjourimajd S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159374; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Nawaz Z, 2014, PLANT GENET RESOUR-C, V12, pS74, DOI 10.1017/S1479262114000318; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Pandey GC, 2014, CEREAL RES COMMUN, V42, P38, DOI 10.1556/CRC.2013.0041; Park BS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1408; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Pasam RK, 2017, THEOR APPL GENET, V130, P777, DOI 10.1007/s00122-016-2851-7; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Sajjad M, 2014, CEREAL RES COMMUN, V42, P177, DOI 10.1556/CRC.2013.0061; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Sun CW, 2017, PLANT BIOTECHNOL J, V15, P953, DOI 10.1111/pbi.12690; Sun JJ, 2013, EUPHYTICA, V191, P317, DOI 10.1007/s10681-012-0834-6; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; Wang Yu-Qi, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P403; Xiong HC, 2018, PLANT GENET RESOUR-C, V16, P74, DOI 10.1017/S1479262116000459; Xu N, 2016, PLANT CELL, V28, P485, DOI 10.1105/tpc.15.00567; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; Xuan W, 2017, CURR OPIN PLANT BIOL, V39, P57, DOI 10.1016/j.pbi.2017.05.010; Yang TR, 2016, PLANT PHYSIOL BIOCH, V104, P99, DOI 10.1016/j.plaphy.2016.03.023; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang YQ, 2017, PLANT CELL REP, V36, P557, DOI 10.1007/s00299-017-2102-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou SH, 2018, PLANT BIOTECHNOL J, V16, P818, DOI 10.1111/pbi.12831; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	56	11	11	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211492	10.1371/journal.pone.0211492	http://dx.doi.org/10.1371/journal.pone.0211492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699181	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600082
J	Adem, KS; Janakiraman, B; Gebremeskel, BF; Chala, MB; Gelaw, AY; Alemu, K				Adem, Kedir Sany; Janakiraman, Balamurugan; Gebremeskel, Berihu Fisseha; Chala, Mulugeta Bayisa; Gelaw, Asmare Yitayeh; Alemu, Kassahun			Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SENSORY NEUROPATHY; SCREENING TOOL; RISK; ART; TOLERABILITY; AFRICA	Background Antiretroviral therapy has surely increased the life expectancy of people living with HIV. However, long term complications like HIV associated sensory neuropathy has a negative impact on quality of life among people living with HIV (PLHIV). In Ethiopia, lack of data on magnitude of the burden and predictors of HIV associated sensory neuropathy in many resource limited setting has led to under diagnosis and eventually under management of HIV-SN. Hence, this study was set out to establish the burden of HIV-associated sensory neuropathy and, its association with demographic, health and clinical characteristics among people living with HIV in Ethiopia. Methods Cross-sectional study was conducted to assess the prevalence of HIV-associated sensory neuropathy and the associated factors among adult HIV patients at University of Gondar Teaching Hospital, Gondar, Ethiopia. Brief Peripheral Neuropathy Screening tool validated by AIDs Clinical trial group was used for screening HIV-associated sensory neuropathy. Data were analyzed descriptively and through uni-and multivariate logistic regression. Results In total 359 adult PLHIV with a mean age of 36.5 +/- 9.07 years participated, their median duration of HIV infection was 60 months (IQR 36-84) and their median CD4 count 143cells/mu L (IQR 69.5-201.5). Age above 40 years, anti-tuberculosis regimen, tallness, and exposure to didanosine contained antiretroviral therapy were found to be associated with HIVassociated sensory neuropathy (AOR 1.82, 1.84, 1.98 and 4.33 respectively). Conclusions More than half of the HIV patients who attended HIV care clinic at University of Gondar hospital during the study period were found to present with peripheral sensory neuropathy. Higher age, tallness, TB medication, and didanosine in ART were significantly associated with HIV-SN as screened by effective diagnostic (BPNS) tool.	[Adem, Kedir Sany; Janakiraman, Balamurugan; Chala, Mulugeta Bayisa; Gelaw, Asmare Yitayeh] Univ Gondar, Dept Physiotherapy, Coll Med & Hlth Sci, Gondar, Ethiopia; [Gebremeskel, Berihu Fisseha] Mekelle Univ, Dept Physiotherapy, Sch Med, Coll Hlth Sci, Mekelle, North Ethiopia, Ethiopia; [Gebremeskel, Berihu Fisseha] Mekelle Univ, Ayder Comprehens Specialized Hosp, Mekelle, North Ethiopia, Ethiopia; [Gelaw, Asmare Yitayeh] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Alemu, Kassahun] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; Mekelle University; Mekelle University; Monash University; University of Gondar	Janakiraman, B (corresponding author), Univ Gondar, Dept Physiotherapy, Coll Med & Hlth Sci, Gondar, Ethiopia.	bala77physio@gmail.com	Janakiraman, Balamurugan/AAG-9563-2020; Chala, Mulugeta/R-7878-2019; Gelaw, Asmare Yitayeh/N-6610-2017	Janakiraman, Balamurugan/0000-0003-3866-9351; Gelaw, Asmare Yitayeh/0000-0002-7050-7961; Chala, Mulugeta Bayisa/0000-0002-4851-5025	University of Gondar	University of Gondar	The total budget and other necessary equipment were totally funded by the University of Gondar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Firstly, we would like to express our deepest gratitude to the University of Gondar for ethical approval and funding. Our gratitude and appreciation go to data collectors, adults living with HIV attending HIV care clinic who participated in this study. We are also grateful to all hospital authorities and HIV care clinic staffs for their cooperation.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Arenas-Pinto A, 2016, J NEUROVIROL, V22, P104, DOI 10.1007/s13365-015-0374-7; Balamurugan J, 2013, INT J MED RES HEALTH, V2, P479, DOI 10.5958/j.2319-5886.2.3.083; Biraguma J, 2012, SAHARA J-J SOC ASP H, V9, P88, DOI 10.1080/17290376.2012.683582; Chai NC, 2016, CHRONIC PAIN HIV PRA, P51; Chen HC, 2013, J NEUROVIROL, V19, P557, DOI 10.1007/s13365-013-0216-4; Cherry CL, 2009, NEUROLOGY, V73, P315, DOI 10.1212/WNL.0b013e3181af7a22; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cochran WG., 1963, SAMPLING TECHNIQUES; Colvin M, 2008, ANAL HIV PREVENTION; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Evans S, 2005, STAT MED, V24, P1245, DOI 10.1002/sim.2023; Evans SR, 2012, J NEUROVIROL, V18, P428, DOI 10.1007/s13365-012-0119-9; Evans SR, 2011, AIDS, V25, P919, DOI 10.1097/QAD.0b013e328345889d; Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Hoffmann CJ, 2008, AIDS, V22, P67, DOI 10.1097/QAD.0b013e3282f2306e; Jember G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0295-5; Kamerman PR, 2012, CURR PAIN HEADACHE R, V16, P226, DOI 10.1007/s11916-012-0257-z; Lichtenstein KA, 2005, CLIN INFECT DIS, V40, P148, DOI 10.1086/426076; Lifson AR, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-016-0069-2; Luma HN, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-35; Mehta SA, 2010, AM J TROP MED HYG, V83, P565, DOI 10.4269/ajtmh.2010.09-0629; Menezes CN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-244; Modayil RR, 2010, PHARMACOEPIDEM DR S, V19, P247, DOI 10.1002/pds.1907; Mullin S, 2011, TROP MED INT HEALTH, V16, P1291, DOI 10.1111/j.1365-3156.2011.02825.x; Oshinaike O, 2012, AIDS RES TREAT, V2012, P2012, DOI DOI 10.HTTP://DX.D0I.0RG/10.1155/2012/961510; Pettersen JA, 2006, ANN NEUROL, V59, P816, DOI 10.1002/ana.20816; Saylor D, 2017, NEUROLOGY, V89, P485, DOI 10.1212/WNL.0000000000004136; Shurie Jaffer Shiffa, 2010, Ethiop Med J, V48, P85; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Skopelitis EE, 2006, INT J STD AIDS, V17, P467, DOI 10.1258/095646206777689062; Theroux N, 2013, J NEUROSCI NURS, V45, P5, DOI 10.1097/JNN.0b013e318275b1b2; Venkataramana Anita B, 2005, AIDS Read, V15, P341; Wadley AL, 2011, J PAIN SYMPTOM MANAG, V41, P700, DOI 10.1016/j.jpainsymman.2010.07.006; Wang X, 2011, J NEUROIMMUNE PHARM, V6, P477, DOI 10.1007/s11481-011-9296-1; World Health Organization, 2007, WHO CASE DEFINITIONS	38	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211354	10.1371/journal.pone.0211354	http://dx.doi.org/10.1371/journal.pone.0211354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695060	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400028
J	O'Brien, KT; Golla, K; Kranjc, T; O'Donovan, D; Allen, S; Maguire, P; Simpson, JC; O'Connell, D; Moran, N; Shields, DC				O'Brien, Kevin T.; Golla, Kalyan; Kranjc, Tilen; O'Donovan, Darragh; Allen, Seamus; Maguire, Patricia; Simpson, Jeremy C.; O'Connell, David; Moran, Niamh; Shields, Denis C.			Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CYTOPLASMIC DOMAIN; STRUCTURE PREDICTION; BINDING; CELL; ADHESION; ACTIVATION; ACTIN; TAIL; RECEPTORS	Therapeutic modulation of protein interactions is challenging, but short linear motifs (SLiMs) represent potential targets. Focal adhesions play a central role in adhesion by linking cells to the extracellular matrix. Integrins are central to this process, and many other intracellular proteins are components of the integrin adhesome. We applied a peptide network targeting approach to explore the intracellular modulation of integrin function in platelets. Firstly, we computed a platelet-relevant integrin adhesome, inferred via homology of known platelet proteins to adhesome components. We then computationally selected peptides from the set of platelet integrin adhesome cytoplasmic and membrane adjacent protein-protein interfaces. Motifs of interest in the intracellular component of the platelet integrin adhesome were identified using a predictor of SLiMs based on analysis of protein primary amino acid sequences (SLiMPred), a predictor of strongly conserved motifs within disordered protein regions (SLiMPrints), and information from the literature regarding protein interactions in the complex. We then synthesized peptides incorporating these motifs combined with cell penetrating factors (tat peptide and palmitylation for cytoplasmic and membrane proteins respectively). We tested for the platelet activating effects of the peptides, as well as their abilities to inhibit activation. Bioactivity testing revealed a number of peptides that modulated platelet function, including those derived from a-actinin (ACTN1) and syndecan (SDC4), binding to vinculin and syntenin respectively. Both chimeric peptide experiments and peptide combination experiments failed to identify strong effects, perhaps characterizing the adhesome as relatively robust against within-adhesome synergistic perturbation. We investigated in more detail peptides targeting vinculin. Combined experimental and computational evidence suggested a model in which the positively charged tat-derived cell penetrating part of the peptide contributes to bioactivity via stabilizing charge interactions with a region of the ACTN1 negatively charged surface. We conclude that some interactions in the integrin adhesome appear to be capable of modulation by short peptides, and may aid in the identification and characterization of target sites within the complex that may be useful for therapeutic modulation.	[O'Brien, Kevin T.; Shields, Denis C.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [O'Brien, Kevin T.; Kranjc, Tilen; O'Donovan, Darragh; Allen, Seamus; Maguire, Patricia; Simpson, Jeremy C.; O'Connell, David; Shields, Denis C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Golla, Kalyan; Moran, Niamh] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Kranjc, Tilen; Simpson, Jeremy C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland; [O'Donovan, Darragh; Allen, Seamus; Maguire, Patricia; O'Connell, David] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin, Ireland	University College Dublin; University College Dublin; Royal College of Surgeons - Ireland; University College Dublin; University College Dublin	Shields, DC (corresponding author), Univ Coll Dublin, Sch Med, Dublin, Ireland.; Shields, DC (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland.	Denis.shields@ucd.ie		O'Connell, David/0000-0002-6461-7750; Maguire, Patricia/0000-0002-0362-3778; Shields, Denis/0000-0003-4015-2474; Simpson, Jeremy/0000-0002-7956-7805	Irish Research Council; Science Foundation Ireland [08/IN1/B1864]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Irish Research Council (www.research.ie) grant for the Bioinformatics and Systems Biology PhD Programme GREP 2007-2015 to DCS; and by Science Foundation Ireland (www.sfi.ie) Principal Investigator (08/IN1/B1864) Award to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Aylward K, 2006, J THROMB HAEMOST, V4, P1804, DOI 10.1111/j.1538-7836.2006.02041.x; Baciu PC, 2000, J CELL SCI, V113, P315; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Boyanova Desislava, 2012, Blood, V119, pe22, DOI 10.1182/blood-2011-10-387308; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Davey NE, 2012, NUCLEIC ACIDS RES, V40, P10628, DOI 10.1093/nar/gks854; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dimitriou AA, 2009, PLATELETS; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Haslam NJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003372; Horton ER, 2016, J CELL SCI, V129, P4159, DOI 10.1242/jcs.192054; Inomata M, 1996, ARCH BIOCHEM BIOPHYS, V328, P129, DOI 10.1006/abbi.1996.0152; Jiang Q, 2017, J MOL GRAPH MODEL, V76, P379, DOI 10.1016/j.jmgm.2017.07.015; Johannessen L, 2011, CHEMBIOCHEM, V12, P914, DOI 10.1002/cbic.201000563; Koloka V, 2008, PLATELETS, V19, P502, DOI 10.1080/09537100802266875; Landesberg R, 2005, J ORAL MAXIL SURG, V63, P529, DOI 10.1016/j.joms.2004.12.007; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Liu SC, 2000, J CELL SCI, V113, P3563; Lombardi F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004119; Mirabello C, 2013, BIOINFORMATICS, V29, P2056, DOI 10.1093/bioinformatics/btt344; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nanda SY, 2014, J CELL BIOCHEM, V115, P1206, DOI 10.1002/jcb.24772; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nelson ES, 2011, MOL CANCER RES, V9, P712, DOI 10.1158/1541-7786.MCR-10-0599; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Raab M, 2010, PROTEOMICS, V10, P2790, DOI 10.1002/pmic.200900621; Schwab N, 2015, INT IMMUNOL, V27, P47, DOI 10.1093/intimm/dxu096; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Sheibani N, 2008, J CELL PHYSIOL, V214, P655, DOI 10.1002/jcp.21256; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tompa P, 2002, J BIOL CHEM, V277, P9022, DOI 10.1074/jbc.C100700200; Van Roey K, 2012, CURR OPIN STRUC BIOL, V22, P378, DOI 10.1016/j.sbi.2012.03.004; Wagner CL, 1996, BLOOD, V88, P907; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Wu HY, 2003, NEUROSCI RES, V47, P131, DOI 10.1016/S0168-0102(03)00195-0; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210337	10.1371/journal.pone.0210337	http://dx.doi.org/10.1371/journal.pone.0210337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689642	Green Submitted, Green Published, gold			2022-12-26	WOS:000457041800006
J	Ohashi, T; Nakade, Y; Ibusuki, M; Kitano, R; Yamauchi, T; Kimoto, S; Inoue, T; Kobayashi, Y; Sumida, Y; Ito, K; Nakao, H; Umezawa, K; Yoneda, M				Ohashi, Tomohiko; Nakade, Yukiomi; Ibusuki, Mayu; Kitano, Rena; Yamauchi, Taeko; Kimoto, Satoshi; Inoue, Tadahisa; Kobayashi, Yuji; Sumida, Yoshio; Ito, Kiyoaki; Nakao, Haruhisa; Umezawa, Kazuo; Yoneda, Masashi			Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice	PLOS ONE			English	Article							HEPATIC STEATOSIS; GENE-EXPRESSION; STELLATE CELLS; PPAR AGONISTS; STEATOHEPATITIS; FIBROSIS; MODEL; OBESE; EPIDEMIOLOGY; INDUCTION	Conophylline (CnP), a vinca alkaloid extracted from the leaves of the tropical plant Tabernaemontana divaricate, attenuates hepatic fibrosis in mice. We have previously shown that CnP inhibits non-alcoholic steatohepatitis (NASH) using a methionine-choline-deficient (MCD) diet-fed mouse model. However, little is known about the CnP mediated inhibition of hepatic steatosis in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) mouse models. CnP (0.5 and 1 mu g/g/body weight) was co-administered along with a high-fat diet to male BALB/c mice. After nine weeks of administering the high-fat diet, hepatic steatosis, triglyceride, and hepatic fat metabolism-related markers were examined. Administration of a high-fat diet for 9 weeks was found to induce hepatic steatosis. CnP dose-dependently attenuated the high-fat diet-induced hepatic steatosis. The diet also attenuated hepatic peroxisome proliferator-activated receptor alpha (PPARA) mRNA levels. PPARA is known to be involved in beta-oxidation. CnP upregulated the mRNA levels of hepatic PPARA and its target genes, such as carnitine palmitoyl transferase 1 (CPT1) and CPT2, in a dose-dependent manner in the liver. Furthermore, levels of hepatic beta-hydroxybutyrate, which is a type of ketone body, were increased by CnP in a dose-dependent manner. Finally, CnP increased the expression of the autophagosomal marker LC3-II and decreased the expression of p62, which are known to be selectively degraded during autophagy. These results indicate that CnP inhibits hepatic steatosis through the stimulation of beta-oxidation and autophagy in the liver. Therefore, CnP might prove to be a suitable therapeutic target for NAFLD.	[Ohashi, Tomohiko; Nakade, Yukiomi; Ibusuki, Mayu; Kitano, Rena; Yamauchi, Taeko; Kimoto, Satoshi; Inoue, Tadahisa; Kobayashi, Yuji; Sumida, Yoshio; Ito, Kiyoaki; Nakao, Haruhisa; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan; [Umezawa, Kazuo] Aichi Med Univ, Dept Mol Target Med, Nagakute, Aichi, Japan	Aichi Medical University; Aichi Medical University	Nakade, Y (corresponding author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan.	ynakade@aichi-med-u.ac.jp	Inoue, Tadahisa/AFK-7576-2022; Sumida, Yoshio/AAL-6723-2020	Inoue, Tadahisa/0000-0003-0718-9099; 	Program for the Strategic Research Foundation at Private Universities [S1101027]; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)	Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for the Strategic Research Foundation at Private Universities 2011-2015 (S1101027 to M.Y.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeda-Valdes P, 2009, ANN HEPATOL, V8, pS18, DOI 10.1016/S1665-2681(19)31822-8; Atsumi S, 2003, CELL MOL LIFE SCI, V60, P2516, DOI 10.1007/s00018-003-3299-x; Barbosa-da-Silva S, 2015, LIFE SCI, V127, P73, DOI 10.1016/j.lfs.2015.02.003; BRANDES R, 1990, BIOCHIM BIOPHYS ACTA, V1034, P53, DOI 10.1016/0304-4165(90)90152-M; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Christel CM, 2007, J COMP PHYSIOL B, V177, P129, DOI 10.1007/s00360-006-0115-6; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Fujii M, 2009, BIOMED PHARMACOTHER, V63, P710, DOI 10.1016/j.biopha.2009.01.006; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012; Kam TS, 2003, ORG BIOMOL CHEM, V1, P1292, DOI 10.1039/b301167d; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Kawaguchi K, 2004, BIOCHEM BIOPH RES CO, V315, P187, DOI 10.1016/J.BBRC.2004.01.038; Kawakami M, 2010, BIOMED PHARMACOTHER, V64, P226, DOI 10.1016/j.biopha.2009.09.025; Kubo N, 2014, LIVER INT, V34, P1057, DOI 10.1111/liv.12328; Kudo H, 2009, LIVER INT, V29, P988, DOI 10.1111/j.1478-3231.2009.02006.x; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Mukai K, 2016, J IMMUNOL, V196, P395, DOI 10.4049/jimmunol.1402709; Nakade Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178436; Nakano S, 2015, J CLIN EXP HEPATOL, V5, P190, DOI 10.1016/j.jceh.2015.02.005; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Okada Y, 2013, LIVER INT, V33, P301, DOI 10.1111/liv.12033; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; Rao MS, 2001, SEMIN LIVER DIS, V21, P43, DOI 10.1055/s-2001-12928; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Saito R, 2012, ENDOCRINOLOGY, V153, P621, DOI 10.1210/en.2011-1767; Sasazawa Y, 2015, J BIOL CHEM, V290, P6168, DOI 10.1074/jbc.M114.606293; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Umezawa K, 2003, BIOMED PHARMACOTHER, V57, P341, DOI 10.1016/S0753-3322(03)00096-9; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	44	17	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210068	10.1371/journal.pone.0210068	http://dx.doi.org/10.1371/journal.pone.0210068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689650	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800004
J	Denaro, M; Navari, E; Ugolini, C; Seccia, V; Donati, V; Casani, AP; Basolo, F				Denaro, Maria; Navari, Elena; Ugolini, Clara; Seccia, Veronica; Donati, Valentina; Casani, Augusto Pietro; Basolo, Fulvio			A microRNA signature for the differential diagnosis of salivary gland tumors	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; DOWN-REGULATION; EXPRESSION; CANCER; INVASION; BETA; METASTASIS; BIOMARKERS; TARGETS; MATRIX	Salivary gland tumors (SGTs) are rare tumors of the head and neck with different clinical behavior. Preoperative diagnosis, based on instrumental and cytologic examinations, is crucial for their correct management. The identification of molecular markers might improve the accuracy of pre-surgical diagnosis helping to plan the proper treatment especially when a definitive diagnosis based only on cytomorphology cannot be achieved. miRNAs appear to be new promising biomarkers in the diagnosis and prognosis of cancer. Studies concerning the useful of miRNA expression in clinical decision-making regarding SGTs remain limited and controversial. The expression of a panel of 798 miRNAs was investigated using Nano-string technology in 14 patients with malignant SGTs (6 mucoepidermoid carcinomas, 4 adenoid cystic carcinomas, 1 acinic cell carcinoma, 1 ductal carcinoma, 1 cystadenocarcinoma and 1 adenocarcinoma) and in 10 patients with benign SGTs (pleomorphic adenomas). The DNA Intelligent Analysis (DIANA)-miRPath v3.0 software was used to determinate the miRNA regulatory roles and to identify the controlled significant Kyoto Encyclopedia of Genes and Genomes (KEGG) molecular pathways. Forty six miRNAs were differentially expressed (False Discovery Rate-FDR<0.05) between malignant and benign SGTs. DIANA miRPath software revealed enriched pathways involved in cancer processes as well as tumorigenesis, cell proliferation, cell growth and survival, tumor suppressor expression, angiogenesis and tumor progression. Interestingly, clustering analysis showed that this signature of 46 miRNAs is able to differentiate the two analyzed groups. We found a correlation between histological diagnosis (benign or malignant) and miRNA expression profile. The molecular signature identified in this study might become an important preoperative diagnostic tool.	[Denaro, Maria; Basolo, Fulvio] Univ Pisa, Dept Surg Pathol Med Mol & Crit Area, Pisa, Italy; [Navari, Elena; Seccia, Veronica; Casani, Augusto Pietro] Azienda Osped Univ Pisana, Dept Surg Pathol Med Mol & Crit Area, Otorhinolaryngol Unit, Pisa, Italy; [Ugolini, Clara] Azienda Osped Univ Pisana, Dept Lab Med, Sect Pathol, Pisa, Italy; [Donati, Valentina] Azienda Osped Univ Pisana, Unit Anat Pathol 2, Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Basolo, F (corresponding author), Univ Pisa, Dept Surg Pathol Med Mol & Crit Area, Pisa, Italy.	fulvio.basolo@med.unipi.it	Seccia, Veronica/AAN-9738-2020; Basolo, Fulvio/AAC-2727-2019; UGOLINI, CLARA/AAI-6489-2021; UGOLINI, Clara/AAG-1760-2019	Basolo, Fulvio/0000-0003-1657-5020; UGOLINI, Clara/0000-0002-3489-8280				Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baroni S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.224; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binmadi NO, 2018, ORAL DIS, V24, P537, DOI 10.1111/odi.12800; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/nnodpathol.2016.157, 10.1038/modpathol.2016.157]; Santos PRB, 2017, PATHOL RES PRACT, V213, P1470, DOI 10.1016/j.prp.2017.10.012; Brennan PA, 2010, BRIT J ORAL MAX SURG, V48, P26, DOI 10.1016/j.bjoms.2008.12.014; Brinkmann O, 2011, ADV CLIN CHEM, V55, P21, DOI 10.1016/B978-0-12-387042-1.00002-2; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Cardo LF, 2013, J NEUROL, V260, P1420, DOI 10.1007/s00415-013-6900-8; Chen W, 2014, ONCOL LETT, V7, P2029, DOI 10.3892/ol.2014.1975; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cinpolat O, 2017, BRAZ J OTORHINOLAR, V83, P276, DOI 10.1016/j.bjorl.2016.03.013; Colella G, 2010, J ORAL MAXIL SURG, V68, P2146, DOI 10.1016/j.joms.2009.09.064; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fabregat I, 2014, CURR PHARM DESIGN, V20, P2934, DOI 10.2174/13816128113199990591; Farhan M, 2017, INT J BIOL SCI, V13, P815, DOI 10.7150/ijbs.20052; Gallo Alessia, 2013, Methods Mol Biol, V1024, P183, DOI 10.1007/978-1-62703-453-1_14; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gurha P, 2016, CURR OPIN CARDIOL, V31, P249, DOI 10.1097/HCO.0000000000000280; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liu L, 2013, J ORAL PATHOL MED, V42, P140, DOI 10.1111/j.1600-0714.2012.01189.x; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mairembam P, 2016, CYTOPATHOLOGY, V27, P91, DOI 10.1111/cyt.12232; Matse JH, 2013, CLIN CANCER RES, V19, P3032, DOI 10.1158/1078-0432.CCR-12-3505; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066778; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Pfeiffer J, 2012, INT J ORAL MAX SURG, V41, P437, DOI 10.1016/j.ijom.2011.12.005; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Pusztaszeri MP, 2015, SEMIN DIAGN PATHOL, V32, P264, DOI 10.1053/j.semdp.2014.12.008; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schena FP, 2014, NEPHROL DIAL TRANSPL, V29, P755, DOI 10.1093/ndt/gft223; Shang C, 2012, MED SCI MONITOR, V18, pBR149, DOI 10.12659/MSM.882617; Stewart CJR, 2000, DIAGN CYTOPATHOL, V22, P139; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang M, 2015, INT J CLIN EXP PATHO, V8, P14110; Wasylishen AR, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026211; Xu K, 2014, BBA-REV CANCER, V1846, P638, DOI 10.1016/j.bbcan.2014.10.007; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	64	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210968	10.1371/journal.pone.0210968	http://dx.doi.org/10.1371/journal.pone.0210968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682201	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500082
J	Di Tella, M; Ghiggia, A; Testa, S; Castelli, L; Adenzato, M				Di Tella, Marialaura; Ghiggia, Ada; Testa, Silvia; Castelli, Lorys; Adenzato, Mauro			The Fear of Pain Questionnaire: Factor structure, validity and reliability of the Italian translation	PLOS ONE			English	Article							MEASUREMENT INVARIANCE; AVOIDANCE MODEL; INVENTORY-II; FIT INDEXES; SHORT-FORM; BACK-PAIN; SENSITIVITY; PREDICTION; PERCEPTION; ANXIETY	Background The Fear of Pain Questionnaire-III (FPQ-III) is a self-report instrument developed to assess fear of different stimuli usually causing pain. The present study aimed to construct an Italian version of the FPQ-III and examine its psychometric properties in a heterogeneous sample of Italian healthy individuals. Methods The questionnaire was translated following the forward-backward method and completed by 511 Italian adults who met the inclusion criteria. Within 2 months of the first assessment, a subgroup of participants (n = 164) was re-tested. The factorial structure of the FPQ-III was assessed by confirmatory factor analysis (CFA). To better comprehend the FPQ-III's factorial structure, a CFA was also performed for each of the two reduced versions of the FPQ-III, namely the FPQ-Short Form and the FPQ-9. Divergent validity, test-retest reliability, and gender/age measurement invariance were also evaluated. Results The results of the CFA revealed that the original three-factor model poorly fitted the data, but it became satisfactory after allowing correlated error terms. Concerning divergent validity, correlations between FPQ-III scores and pain intensity, depression, and anxiety were found to be positive but weak in magnitude (<.20). FPQ-III subscales and total scores showed good internal consistency and time reliability. Finally, scalar invariance was only partially obtained, whereas all the other types of invariance were fully respected both for gender and age. Conclusions The current findings indicate that the Italian version of the FPQ-III provides valid and reliable scores for the assessment of fear of pain in the Italian population.	[Di Tella, Marialaura; Ghiggia, Ada; Testa, Silvia; Castelli, Lorys; Adenzato, Mauro] Univ Turin, Dept Psychol, Via Verdi, Turin, Italy	University of Turin	Testa, S (corresponding author), Univ Turin, Dept Psychol, Via Verdi, Turin, Italy.	silvia.testa@unito.it	Castelli, Lorys/G-9973-2012; Adenzato, Mauro/I-5127-2012; Adenzato, Mauro/AFQ-8675-2022; Testa, Silvia/AAH-2129-2021; Di Tella, Marialaura/V-4975-2017	Castelli, Lorys/0000-0001-5009-2271; Adenzato, Mauro/0000-0002-6997-9283; Adenzato, Mauro/0000-0002-6997-9283; Testa, Silvia/0000-0002-8732-4790; DI TELLA, MARIALAURA/0000-0003-3616-2434	University of Turin (Ricerca scientifica finanziata dall'Universita)	University of Turin (Ricerca scientifica finanziata dall'Universita)	Mauro Adenzato was supported by the University of Turin (Ricerca scientifica finanziata dall'Universita). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaret MC, 2004, EUR J PAIN, V8, P273, DOI 10.1016/j.ejpain.2003.09.005; Alodaibi FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193566; Asmundson GJG, 2008, PAIN, V134, P51, DOI 10.1016/j.pain.2007.03.033; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cardoso S, 2016, REV BRAS REUMATOL, V56, P377, DOI [10.1016/j.rbre.2016.02.012, 10.1016/j.rbr.2015.10.006]; Carleton RN, 2016, J ANXIETY DISORD, V41, P5, DOI 10.1016/j.janxdis.2016.03.011; Carleton RN, 2009, J PAIN, V10, P29, DOI 10.1016/j.jpain.2008.06.007; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Gatzounis R, 2017, SCAND J PAIN, V17, P132, DOI 10.1016/j.sjpain.2017.07.020; Ghisi M., 2006, BDI 2 BECK DEPRESSIO, DOI [10.1007/s12144-019-0132-8, DOI 10.1007/s12144-019-0132-8]; Haukenes I, 2015, EUR J PAIN, V19, P826, DOI 10.1002/ejp.609; Hirsh AT, 2008, J PAIN, V9, P806, DOI 10.1016/j.jpain.2008.03.012; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Linton SJ, 2018, PHYS THER, V98, P315, DOI 10.1093/ptj/pzy027; McNeil DW, 2018, EUR J PAIN, V22, P39, DOI 10.1002/ejp.1074; McNeil DW, 2001, PAIN, V89, P245, DOI 10.1016/S0304-3959(00)00368-7; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Meier ML, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000601; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Nees F, 2018, NEUROSCIENCE, V387, P72, DOI 10.1016/j.neuroscience.2017.08.051; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Osman A, 2002, J BEHAV MED, V25, P155, DOI 10.1023/A:1014884704974; Pedrabissi L, 1989, INVENTARIO ANSIA STA; Peters ML, 2002, BEHAV RES THER, V40, P85, DOI 10.1016/S0005-7967(01)00005-5; Poiraudeau S, 2006, PAIN, V124, P305, DOI 10.1016/j.pain.2006.04.019; Poole H, 2006, CLIN J PAIN, V22, P790, DOI 10.1097/01.ajp.0000210930.20322.93; Roelofs J, 2005, PAIN, V116, P339, DOI 10.1016/j.pain.2005.05.003; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schumacker, 2001, NEW DEV TECHNIQUES S, P269, DOI DOI 10.4324/9781410601858; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SLADE PD, 1983, BEHAV RES THER, V21, P409, DOI 10.1016/0005-7967(83)90010-4; Sole E, 2019, J HEALTH PSYCHOL, V24, P1134, DOI 10.1177/1359105316686669; Spielberger CD., 1983, STAI MANUAL STATE TR, DOI DOI 10.1037/T06496-000; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; van Wijk AJ, 2006, EUR J PAIN, V10, P479, DOI 10.1016/j.ejpain.2005.06.008; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Volders S, 2015, BEHAV RES THER, V64, P31, DOI 10.1016/j.brat.2014.11.003; Widaman K.F., 1997, SCI PREVENTION METHO, P281, DOI [10.1037/10222-009, DOI 10.1037/10222-009]; Zaman J, 2015, NEUROSCI BIOBEHAV R, V51, P118, DOI 10.1016/j.neubiorev.2015.01.009; Zvolensky MJ, 2001, BEHAV RES THER, V39, P683, DOI 10.1016/S0005-7967(00)00049-8	49	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210757	10.1371/journal.pone.0210757	http://dx.doi.org/10.1371/journal.pone.0210757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682182	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500060
J	Humiston, GB; Wamsley, EJ				Humiston, Graelyn B.; Wamsley, Erin J.			Unlearning implicit social biases during sleep: A failure to replicate	PLOS ONE			English	Article							MEMORY; PREJUDICE; REACTIVATION; HIPPOCAMPUS; REDUCTION; REPLAY	A 2015 article in Science (Hu et al.) proposed a new way to reduce implicit racial and gender biases during sleep. The method built on an existing counter-stereotype training procedure, using targeted memory reactivation to strengthen counter-stereotype memory by playing cues associated with the training during a 90min nap. If effective, this procedure would have potential real-world usefulness in reducing implicit biases and their myriad effects. We replicated this procedure on a sample of n = 31 college students. Contrary to the results reported by Hu et al., we found no effect of cueing on implicit bias, either immediately following the nap or one week later. In fact, bias was non-significantly greater for cued than for uncued stimuli. Our failure to detect an effect of cueing on implicit bias could indicate either that the original report was a false positive, or that the current study is a false negative. However, several factors argue against Type II error in the current study. Critically, this replication was powered at 0.9 for detecting the originally reported cueing effect. Additionally, the 95% confidence interval for the cueing effect in the present study did not overlap with that of the originally reported effect; therefore, our observations are not easily explained as a noisy estimate of the same underlying effect. Ultimately, the outcome of this replication study reduces our confidence that cueing during sleep can reduce implicit bias.	[Humiston, Graelyn B.; Wamsley, Erin J.] Furman Univ, Dept Psychol, Greenville, SC 29613 USA; [Humiston, Graelyn B.; Wamsley, Erin J.] Furman Univ, Program Neurosci, Greenville, SC 29613 USA		Wamsley, EJ (corresponding author), Furman Univ, Dept Psychol, Greenville, SC 29613 USA.	erin.wamsley@furman.edu		Humiston, Graelyn/0000-0002-1875-5546	South Carolina IDeA Networks of Biomedical Research Excellence [P20GM103499]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	South Carolina IDeA Networks of Biomedical Research Excellence; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.B.H. was supported by a summer fellowship from South Carolina IDeA Networks of Biomedical Research Excellence (https://sites.google.com/view/scinbre/home), funded by grant P20GM103499 from the National Institute of General Medical Sciences (https://www.nigms.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Burns MD, 2017, J EXP SOC PSYCHOL, V73, P97, DOI 10.1016/j.jesp.2017.06.003; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Feld GB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00622; Forscher PS, 2016, PSYARXIV, DOI [10.17605/OSF.IO/DV8TU, DOI 10.17605/OSF.IO/DV8TU]; Gawronski B, 2008, J EXP SOC PSYCHOL, V44, P370, DOI 10.1016/j.jesp.2006.12.004; Goff PA, 2008, J PERS SOC PSYCHOL, V94, P292, DOI 10.1037/0022-3514.94.2.292; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Harrison MS, 2009, J APPL SOC PSYCHOL, V39, P134, DOI 10.1111/j.1559-1816.2008.00433.x; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hu XQ, 2015, SCIENCE, V348, P1013, DOI 10.1126/science.aaa3841; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lai CK, 2016, J EXP PSYCHOL GEN, V145, DOI 10.1037/xge0000179; Lai CK, 2014, J EXP PSYCHOL GEN, V143, P1765, DOI 10.1037/a0036260; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Penner LA, 2010, J EXP SOC PSYCHOL, V46, P436, DOI 10.1016/j.jesp.2009.11.004; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sara SJ, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00185; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211416	10.1371/journal.pone.0211416	http://dx.doi.org/10.1371/journal.pone.0211416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682167	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500167
J	Shirakawa, K; Yano, W; Inoue, K; Katsumata, Y; Endo, J; Sano, M				Shirakawa, Kohsuke; Yano, Wataru; Inoue, Keisuke; Katsumata, Yoshinori; Endo, Jin; Sano, Motoaki			Influence of long term administration of tofogliflozin on chronic inflammation of visceral adipose tissue in mice with obesity induced by a high-fat diet	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITOR; T-CELLS; CARDIOVASCULAR-DISEASE; DIABETIC-NEPHROPATHY; SKELETAL-MUSCLE; OSTEOPONTIN; SENESCENCE; MORTALITY	We previously found that senescence of cluster of differentiation 4 (CD4) T cells is accelerated in the visceral adipose tissue (VAT) of mice with diet-induced obesity (DIO) due to a high-fat diet (HFD), and that these senescent-associated T cells cause chronic inflammation of visceral adipose tissue through secretion of osteopontin, provoking systemic insulin resistance. In this study, we examined whether the development of chronic inflammation and senescence-associated T cells in VAT of DIO mice was improved by long-term weight loss after switching to normal chow (NC) or by administration of a sodium glucose cotransporter 2 inhibitor (tofogliflozin). Wild-type mice were fed an HFD for 26 weeks from 4 weeks old. At 30 weeks of age, half of these DIO mice were switched to NC with or without 0.005% tofogliflozin for 38 weeks. The other mice remained on the HFD with or without 0.005% tofogliflozin for 38 weeks. When DIO mice were switched to NC, their weight decreased to that of mice kept on NC since weaning. After 38 weeks (68 weeks of age), chronic inflammation of the VAT subsided with disappearance of senescence-associated T cells. In the HFD groups, the carbohydrate intake per mouse was half or less of that in the NC group, and urinary glucose excretion by the effect of tofogliflozin was lower in the HFD mice than in the NC mice. Mice that remained on the HFD showed no improvement in chronic inflammation in VAT, possibly because urinary glucose excretion was not sufficiently promoted by tofogliflozin due to the low carbohydrate intake. Thus, no improvement in glucose metabolism or weight loss was observed in these mice.	[Shirakawa, Kohsuke; Katsumata, Yoshinori; Endo, Jin; Sano, Motoaki] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Yano, Wataru; Inoue, Keisuke] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan	Keio University; Kowa Company, Ltd.	Sano, M (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	msano@a8.keio.jp	Katsumata, Yoshinori/AAC-4159-2021; Sano, Motoaki/L-3405-2013	Katsumata, Yoshinori/0000-0001-5576-5789; Sano, Motoaki/0000-0003-1771-8310; Yano, Wataru/0000-0002-6866-8520	Kowa Company, Ltd.;  [18K15197]	Kowa Company, Ltd.; 	A joint research agreement was concluded between Keio University and Kowa Company, Ltd. Tofogliflozin was provided by Kowa Company, Ltd. and this joint research project was funded by Kowa Company, Ltd. The funder provided support in the form of salaries for the authors W.Y. and K.I., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by Grant-in-Aid for Scientific Research Grant Number 18K15197. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalrhim AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156965; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Benetti E, 2016, J PHARMACOL EXP THER, V359, P45, DOI 10.1124/jpet.116.235069; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Chiba Y, 2007, HYPERTENS RES, V30, P229, DOI 10.1291/hypres.30.229; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Gordin D, 2014, DIABETES CARE, V37, P2593, DOI 10.2337/dc14-0065; Itoh H, 2006, DRUGS TODAY, V42, P9; Ji WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179960; Jia YL, 2018, CELL PHYSIOL BIOCHEM, V45, P1747, DOI 10.1159/000487783; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Mattoo H, 2009, INT IMMUNOL, V21, P1277, DOI 10.1093/intimm/dxp094; Naznin F, 2017, EUR J PHARMACOL, V794, P37, DOI 10.1016/j.ejphar.2016.11.028; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obata A, 2016, ENDOCRINOLOGY, V157, P1029, DOI 10.1210/en.2015-1588; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shirakawa K, 2018, CIRCULATION, V138, P2021, DOI 10.1161/CIRCULATIONAHA.118.035047; Shirakawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186303; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Stromnes IM, 2007, NAT IMMUNOL, V8, P19, DOI 10.1038/ni0107-19; Suzuki M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.20; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; Takagi S, 2018, J DIABETES INVEST, V9, P1025, DOI 10.1111/jdi.12802; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Wang XXX, 2017, J BIOL CHEM, V292, P5335, DOI 10.1074/jbc.M117.779520; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yokono M, 2014, EUR J PHARMACOL, V727, P66, DOI 10.1016/j.ejphar.2014.01.040	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211387	10.1371/journal.pone.0211387	http://dx.doi.org/10.1371/journal.pone.0211387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682139	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500163
J	Zhang, R; He, GZ; Wang, YK; Wang, J; Chen, W; Xu, YC				Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei; Xu, Yingchun			The effect of different treatments of lymph after intestinal ischemia-reperfusion in rats on macrophages in vitro	PLOS ONE			English	Article								Background To observe the effects of different treatments of lymph after intestinal I/R in rats on macrophages in vitro. Methods Forty-eight healthy SPF SD rats weighing 300 +/- 20 g, were randomly divided into two groups: group A, and group B. The rats in group A were drained of lymph fluid for 180 min; the rats in group B were subjected to 60 min ischemia by clamping the SMA, followed by 120 min reperfusion and 180 min of lymph drainage. The lymph fluid collected was divided into 4 sub-groups: 1. no treatment (A1, Ly, and B1, I/R Ly); 2. protein degradation (A2, Ly PD, and B2 I/R PD); 3. endotoxin removal (A3, Ly ER, and B3, I/R ER); 4. protein degradation plus endotoxin removal (A4, Ly PD+ER, and B4, I/R PD+ER), then used to stimulate a monocyte-macrophage cell line. Results Compared with group A1, the levels of the inflammatory cytokines, chemokines, HMGB1 concentration, protein and mRNA expression of TLR4, HMGB1 and NF-kappa Bp65 were significantly increased in group B1. There was a significant reduction in proinflammatory cytokines and of the expression of TLR4, NF-kappa Bp65, and chemokines in groups A2, B2, A4, and B4. However, there were no significant decrease of these factors in groups A3 and B3. Conclusions The lymph fluid drained after intestinal I/R can cause inflammation in vivo and in vitro. Deproteinization of lymph fluid with proteinase K significantly reduced the concentration of proinflammatory cytokines, chemokines, TLR4 and NF-kappa Bp65 in cell culture supernatant, exerting a protective effect on inflammatory reaction caused by the intestinal I/R. Passage of lymph fluid through an endotoxin removal column did not reduce the levels of active proinflammatory factors produced by macrophages in vitro.	[Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing, Peoples R China; [Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei; Xu, Yingchun] Peking Union Med Coll, CAMS, Beijing, Peoples R China; [Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei; Xu, Yingchun] PUMC, Beijing, Peoples R China; [Zhang, Rui; Xu, Yingchun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	He, GZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing, Peoples R China.; He, GZ (corresponding author), Peking Union Med Coll, CAMS, Beijing, Peoples R China.; He, GZ (corresponding author), PUMC, Beijing, Peoples R China.	hegzhpumch@163.com			National Natural Sciences Foundation of China [30940069]; National Natural Sciences Foundation of Beijing [7102127]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Sciences Foundation of Beijing	This study was supported by the National Natural Sciences Foundation of China (30940069) and by the National Natural Sciences Foundation of Beijing (7102127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2001, SURGERY, V129, P351, DOI 10.1067/msy.2001.111698; Ben DF, 2012, J SURG RES, V174, P326, DOI 10.1016/j.jss.2010.12.005; Damle SS, 2007, J SURG RES, V143, P136, DOI 10.1016/j.jss.2007.04.016; Fanous MYZ, 2007, J PANCREAS, V8, P374; Feinman R, 2010, AM J PHYSIOL-GASTR L, V1, P833; Guzel A, 2013, TOXICOL IND HEALTH, V29, P633, DOI 10.1177/0748233711430984; Jordan JR, 2008, J APPL PHYSIOL, V104, P1161, DOI 10.1152/japplphysiol.00022.2007; Kougias P, 2007, J VASC SURG, V46, P467, DOI 10.1016/j.jvs.2007.04.045; Lin ZL, 2014, WORLD J GASTROENTERO, V20, P17905, DOI 10.3748/wjg.v20.i47.17905; Liu Mu-Lin, 2008, Zhonghua Yi Xue Za Zhi, V88, P225; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; van der Heijden KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108453; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Watkins AC, 2008, J TRAUMA, V64, P126, DOI 10.1097/TA.0b013e3181574a8a; Wohlauer MV, 2011, J SURG RES, V170, P314, DOI 10.1016/j.jss.2011.03.045; Wu H, 2014, WORLD J GASTROENTERO, V20, P15327, DOI 10.3748/wjg.v20.i41.15327; Yang H, 2013, NEUROPEPTIDES, V47, P237, DOI 10.1016/j.npep.2013.04.003; Zhao Z, 2008, CHINESE J PATHOPHYSI, V10, P2051	20	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211195	10.1371/journal.pone.0211195	http://dx.doi.org/10.1371/journal.pone.0211195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682177	gold, Green Submitted, Green Published			2022-12-26	WOS:000457037500121
J	Sackett, SD; Otto, T; Mohs, A; Sander, LE; Strauch, S; Streetz, KL; Kroy, DC; Trautwein, C				Sackett, Sara Dutton; Otto, Tobias; Mohs, Antje; Sander, Leif E.; Strauch, Sonja; Streetz, Konrad L.; Kroy, Daniela C.; Trautwein, Christian			Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis	FASEB JOURNAL			English	Article						IL-6; STAT3; M1 macrophages; M2 macrophages; macrophage polarization	ALTERNATIVE ACTIVATION; INTERLEUKIN-6 FAMILY; MACROPHAGES; EXPRESSION; CYTOKINE; SURVIVAL; TRANSDUCER; PROGRESS; GROWTH; MICE	Sepsis represents a major health problem worldwide because of high mortality rates and cost-intensive therapy. Immunomodulatory strategies as a means of controlling overshooting inflammatory responses during sepsis have thus far not been effective, and there is a general paucity of new therapies. Regulatory immune cells have been shown to play important roles in limiting systemic inflammation. However, the signals inducing a regulatory phenotype in myeloid cells during infection are unknown. Here, we report that myeloid cell-intrinsic glycoprotein 130 (gp130) signals constitute a critical element for immune homeostasis during polymicrobial sepsis. We identify an essential role for gp130 signaling in myeloid cells during M2 macrophage polarization in vitro and in vivo. Myeloid cell-specific deletion of gp130 signaling leads to a defective M2 macrophage polarization followed by exacerbated inflammatory responses and increased mortality during sepsis. These data provide new insights into the molecular basis of M1 and M2 phenotypic dichotomy and identify gp130 as a key regulator of immune homeostasis during sepsis. Our study highlights the Janus-faced role of IL-6 family cytokines during inflammation, which may explain the failure of IL-6-targeted anti-inflammatory approaches in the treatment of sepsis.Sackett, S. D., Otto, T., Mohs, A., Sander, L. E., Strauch, S., Streetz, K. L., Kroy, D. C., Trautwein, C. Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis.	[Sackett, Sara Dutton; Otto, Tobias; Mohs, Antje; Sander, Leif E.; Strauch, Sonja; Streetz, Konrad L.; Kroy, Daniela C.; Trautwein, Christian] Univ Hosp Rheinisch Westfalische TH RWTH Aachen, Dept Internal Med 3, Aachen, Germany; [Sackett, Sara Dutton] Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI USA; [Sander, Leif E.] Charite Univ Med Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany; [Sander, Leif E.] Free Univ Berlin, Berlin, Germany; [Sander, Leif E.] Humboldt Univ, Berlin, Germany; [Sander, Leif E.] Berlin Inst Hlth, Berlin, Germany; [Sander, Leif E.] German Ctr Lung Res DZL, Berlin, Germany	University of Wisconsin System; University of Wisconsin Madison; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health	Trautwein, C (corresponding author), RWTH Aachen Univ Hosp, Dept Internal Med 3, Pauwelsstr 30, D-52074 Aachen, Germany.	ctrautwein@ukaachen.de	Sander, Leif Erik/AAI-8619-2020; Otto, Tobias/AAH-5141-2021	Otto, Tobias/0000-0001-5594-3055; Mohs, Antje/0000-0001-5937-0696	German Research Foundation [TR285/10-1, SFB/TRR57]; Interdisciplinary Center for Clinical Research within the Faculty of Medicine at the RWTH Aachen University [O3-6]	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research within the Faculty of Medicine at the RWTH Aachen University	The authors thank Dr. Gernot Sellge and Dr. Roland Sonntag [both from the University Hospital Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen] for discussion of the results and critical review of the manuscript, as well as Dr. Francisco J. Cubero (University Hospital RWTH Aachen) for valuable discussions. The authors thank Malika Al Masaoudi (University Hospital RWTH Aachen) for technical support. The authors also thank the excellent assistance of Carmen G. Tag and Sibille Sauer-Lehnen from the Core Unit "Q3 - Cell Isolation" of the SFB/TRR57 (Aachen, Germany) for sorting of peritoneal exudate cells. This study was supported by grants from the German Research Foundation (TR285/10-1 and SFB/TRR57 to C.T.) and by a grant from the Interdisciplinary Center for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (O3-6 to T.O. and C.T). The authors declare no conflicts of interest.	Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Dubey A, 2018, IMMUNOL CELL BIOL, V96, P257, DOI 10.1111/imcb.1035; Evans TJ, 1996, IMMUNOBIOLOGY, V195, P655, DOI 10.1016/S0171-2985(96)80029-5; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kroy DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039728; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Minnich DJ, 2004, P NUTR SOC, V63, P437, DOI 10.1079/PNS2004378; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munder M, 1999, J IMMUNOL, V163, P3771; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Oishi S, 2016, IMMUNOLOGY, V149, P320, DOI 10.1111/imm.12647; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITO M, 1992, J IMMUNOL, V148, P4066; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Wang Y., 2017, ONCOTARGET, V8; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	36	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6035	6044		10.1096/fj.201802118R	http://dx.doi.org/10.1096/fj.201802118R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726111				2022-12-26	WOS:000466932600020
J	Jing, H; Zhang, XY; Gao, MC; Luo, K; Fu, W; Yin, M; Wang, W; Zhu, ZQ; Zheng, JH; He, XM				Jing, Hui; Zhang, Xiaoyang; Gao, Manchen; Luo, Kai; Fu, Wei; Yin, Meng; Wang, Wei; Zhu, Zhongqun; Zheng, Jinghao; He, Xiaomin			Kartogenin preconditioning commits mesenchymal stem cells to a precartilaginous stage with enhanced chondrogenic potential by modulating JNK and beta-catenin-related pathways	FASEB JOURNAL			English	Article						chondrogenic; differentiation; endochondral ossification; TGF-beta 3; tracheal defect	ENGINEERED TRACHEAL REPLACEMENT; CROSS-TALK; GROWTH; DIFFERENTIATION; EXPRESSION; CHILD	Cartilage engineering strategies using mesenchymal stem cells (MSCs) could provide preferable solutions to resolve long-segment tracheal defects. However, the drawbacks of widely used chondrogenic protocols containing TGF-beta 3, such as inefficiency and unstable cellular phenotype, are problematic. In our research, to optimize the chondrogenic differentiation of human umbilical cord MSCs (hUCMSCs), kartogenin (KGN) preconditioning was performed prior to TGF-beta 3 induction. hUCMSCs were preconditioned with 1 mu M of KGN for 3 d, sequentially pelleted, and incubated with TGF-beta 3 for 28 d. Then, the expression of chondrogenesis- and ossification-related genes was evaluated by immunohistochemistry and RT-PCR. The underlying mechanism governing the beneficial effects of KGN preconditioning was explored by phosphorylated kinase screening and validated in vitro and in vivo using JNK inhibitor (SP600125) and beta-catenin activator (SKL2001). After KGN preconditioning, expression of fibroblast growth factor receptor 3, a marker of precartilaginous stem cells, was up-regulated in hUCMSCs. Furthermore, the KGN-preconditioned hUCMSCs efficiently differentiated into chondrocytes with elevated chondrogenic gene (SOX9, aggrecan, and collagen II) expression and reduced expression of ossific genes (collagen X and MMP13) compared with hUCMSCs treated with TGF-beta 3 only. Phosphokinase screening indicated that the beneficial effects of KGN preconditioning are directly related to an up-regulation of JNK phosphorylation and a suppression of beta-catenin levels. Blocking and activating tests revealed that the prochondrogenic effects of KGN preconditioning was achieved mainly by activating the JNK/Runt-related transcription factor (RUNX)1 pathway, and antiossific effects were imparted by suppressing the beta-catenin/RUNX2 pathway. Eventually, tracheal patches, based on KGN-preconditioned hUCMSCs and TGF-beta 3 encapsulated electrospun poly(l-lactic acid-co-epsilon-caprolactone)/collagen nanofilms, were successfully used for restoring tracheal defects in rabbit models. In summary, KGN preconditioning likely improves the chondrogenic differentiation of hUCMSCs by committing them to a precartilaginous stage with enhanced JNK phosphorylation and suppressed beta-catenin. This novel protocol consisting of KGN preconditioning and subsequent TGF-beta 3 induction might be preferable for cartilage engineering strategies using MSCs.	[Jing, Hui; Zhang, Xiaoyang; Gao, Manchen; Luo, Kai; Fu, Wei; Yin, Meng; Wang, Wei; Zhu, Zhongqun; Zheng, Jinghao; He, Xiaomin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Cardiothorac Surg, 1678 Dong Fang Rd, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University	Zheng, JH; He, XM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Cardiothorac Surg, 1678 Dong Fang Rd, Shanghai 200127, Peoples R China.	zhengjh210@163.com; mrxmhe@163.com	He, Xiaomin/AAH-5620-2020; Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252	National Natural Science Foundation of China [81501604, 81771997, 31370982]; Science and Technology Development Fund of Shanghai Pudong New Area [PKJ2017-Y02]; Biomedical Engineering Fund of Shanghai Jiao Tong University [YG2015MS34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund of Shanghai Pudong New Area; Biomedical Engineering Fund of Shanghai Jiao Tong University	This research was supported by the National Natural Science Foundation of China (Grants 81501604, 81771997, and 31370982), the Science and Technology Development Fund of Shanghai Pudong New Area (Grant PKJ2017-Y02), and the Biomedical Engineering Fund of Shanghai Jiao Tong University (Grant YG2015MS34). The authors declare no conflicts of interest.	[Anonymous], 2017, MED BALTIM; Branly T, 2017, STEM CELL REV REP, V13, P611, DOI 10.1007/s12015-017-9748-y; Cai GR, 2019, J DRUG TARGET, V27, P28, DOI 10.1080/1061186X.2018.1464011; Chen XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0279-5; Cheng L, 2014, INT J MOL SCI, V15, P12665, DOI 10.3390/ijms150712665; Coleman CM, 2013, STEM CELLS DEV, V22, P1968, DOI 10.1089/scd.2012.0282; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Decker RS, 2014, DEV BIOL, V395, P255, DOI 10.1016/j.ydbio.2014.09.011; Dexheimer V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36655; Donders R, 2018, STEM CELLS DEV, V27, P65, DOI 10.1089/scd.2017.0029; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Etienne H, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02211-2017; Fan WS, 2018, DRUG DELIV, V25, P1004, DOI 10.1080/10717544.2018.1461279; Gao XR, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0216-4; Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318; He XM, 2013, J NANOSCI NANOTECHNO, V13, P3818, DOI 10.1166/jnn.2013.7436; Hu Q, 2017, NANOMED-NANOTECHNOL, V13, P2189, DOI 10.1016/j.nano.2017.05.011; Huang H, 2017, AM J SPORT MED, V45, P3289, DOI 10.1177/0363546517721192; Im GI, 2018, J BIOMED MATER RES A, V106, P1141, DOI 10.1002/jbm.a.36300; Jing H, 2018, ARTIF CELL NANOMED B, V46, pS985, DOI 10.1080/21691401.2018.1439844; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kim D, 2012, J BIOL CHEM, V287, P12501, DOI 10.1074/jbc.M111.264382; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee PT, 2017, J CELL BIOCHEM, V118, P172, DOI 10.1002/jcb.25623; Liu C, 2015, CELL BIOL INT, V39, P1026, DOI 10.1002/cbin.10476; Marmotti A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1732094; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Wang J, 2017, MAT SCI ENG C-MATER, V70, P637, DOI 10.1016/j.msec.2016.09.044; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Wang YM, 2017, AM J TRANSL RES, V9, P2656; Wu XW, 2018, BIOMATER SCI-UK, V6, P1147, DOI [10.1039/C8BM00127H, 10.1039/c8bm00127h]; Yang JH, 2007, J KOREAN MED SCI, V22, P491, DOI 10.3346/jkms.2007.22.3.491; Zhang TT, 2015, BIOMATERIALS, V38, P72, DOI 10.1016/j.biomaterials.2014.10.010	33	30	31	4	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5641	5653		10.1096/fj.201802137RRR	http://dx.doi.org/10.1096/fj.201802137RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30694703	Bronze			2022-12-26	WOS:000462888500080
J	Bahudhanapati, H; Tan, JN; Dutta, JA; Strock, SB; Sembrat, J; Alvarez, D; Rojas, M; Jager, B; Prasse, A; Zhang, YZ; Kass, DJ				Bahudhanapati, Harinath; Tan, Jiangning; Dutta, Justin A.; Strock, Stephen B.; Sembrat, John; Alvarez, Diana; Rojas, Mauricio; Jaeger, Benedikt; Prasse, Antje; Zhang, Yingze; Kass, Daniel J.			MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						relaxin; fibroblast; myofibroblast; microRNA (miRNA); pulmonary fibrosis; transforming growth factor (TGF-B); post-transcriptional regulation; epigenetics; idiopathic pulmonary fibrosis; lung disease; lung fibroblasts; miR-144-3p; relaxin; insulin-like family peptide receptor 1 (RXFP1)	RELAXIN RECEPTOR; ACTIVATION; AP-1; PATHOGENESIS; INFLAMMATION; PROGRESSION; MECHANISM; FOS	The hormone relaxin is considered a potential therapy for idiopathic pulmonary fibrosis (IPF). We have previously shown that a potential limitation to relaxin-based IPF therapy is decreased expression of a relaxin receptor, relaxin/insulin-like family peptide receptor 1 (RXFP1), in IPF fibroblasts. The mechanism that down-regulates RXFP1 in IPF remains unclear. To determine whether microRNAs (miRs) regulate RXFP1 gene expression, here we employed a bioinformatics approach to identify miRs predicted to target RXFP1 and identified a putative miR-144-3p target site in the RXFP1 mRNA. In situ hybridization of IPF lung biopsies revealed that miR-144-3p is expressed in fibroblastic foci. Furthermore, we found that miR-144-3p is up-regulated in IPF fibroblasts compared with lung fibroblasts from healthy donors. Transforming growth factor beta increased miR-144-3p expression in both healthy and IPF lung fibroblasts in a SMAD family 2/3 (SMAD2/3)-dependent manner, and Jun proto-oncogene AP-1 transcription factor subunit (AP-1) was required for constitutive miR-144-3p expression. Overexpression of an miR-144-3p mimic significantly reduced RXFP1 mRNA and protein levels and increased expression of the myofibroblast marker alpha-smooth muscle actin (alpha-SMA) in healthy lung fibroblasts. IPF lung fibroblasts transfected with anti-miR-144-3p had increased RXFP1 expression and reduced alpha-SMA expression. Of note, a lentiviral luciferase reporter carrying the WT 3' UTR of RXFP1 was significantly repressed in IPF lung fibroblasts, whereas a reporter carrying a mutated miR-144-3p-binding site exhibited less sensitivity toward endogenous miR-144-3p expression, indicating that miR-144-3p down-regulates RXFP1 in IPF lung fibroblasts by targeting its 3' UTR. We conclude that miR-144-3p directly represses RXFP1 mRNA and protein expression.	[Bahudhanapati, Harinath; Tan, Jiangning; Dutta, Justin A.; Strock, Stephen B.; Sembrat, John; Alvarez, Diana; Rojas, Mauricio; Zhang, Yingze; Kass, Daniel J.] Univ Pittsburgh, Sch Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Prasse, Antje] Hannover Med Sch, Dept Pulmonol, DZL, BREATH, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Jaeger, Benedikt; Prasse, Antje] Fraunhofer ITEM, DZL, BREATH, Nicolai Fuchs Str 1, D-30625 Hannover, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hannover Medical School	Kass, DJ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Simmons Ctr Interstitial Lung Disease, 200 Lothrop St, Pittsburgh, PA 15260 USA.	kassd2@upmc.edu	Prasse, Antje/AAY-6279-2020; Prasse, Antje/AAM-7521-2021	Prasse, Antje/0000-0002-7336-7458; Zhang, YIngze/0000-0001-8042-6105; Dutta, Justin/0000-0002-1740-0639	National Institutes of Health [R01 HL126990, P50AR060780]; Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126990, R01HL123766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in whole or part by National Institutes of Health Grants R01 HL126990 and P50AR060780 (to D. J. K.) and the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bahudhanapati H, 2017, AM J RESP CELL MOL, V57, P10, DOI 10.1165/rcmb.2017-0079ED; Baig S, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0315-6; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; CHIHAL HJ, 1973, ENDOCRINOLOGY, V93, P1441, DOI 10.1210/endo-93-6-1441; Christmann RB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1054-6; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Dehghan F, 2014, INT J MED SCI, V11, P180, DOI 10.7150/ijms.6283; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Li HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27914; Li YR, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22044; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Mazella J, 2004, HUM REPROD, V19, P1513, DOI 10.1093/humrep/deh274; Mercer PF, 2016, THORAX, V71, P701, DOI 10.1136/thoraxjnl-2015-207429; Mizuno K, 2017, J HUM GENET, V62, P57, DOI 10.1038/jhg.2016.98; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Moore XL, 2014, CARDIOVASC DRUG THER, V28, P221, DOI 10.1007/s10557-014-6525-x; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; O'Dwyer DN, 2016, AM J PHYSIOL-LUNG C, V311, pL590, DOI 10.1152/ajplung.00221.2016; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Parikh Victoria N, 2013, Methods Mol Biol, V1024, P157, DOI 10.1007/978-1-62703-453-1_12; Raghu G, 2014, LANCET RESP MED, V2, P277, DOI 10.1016/S2213-2600(14)70011-6; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P182, DOI 10.1196/annals.1282.026; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Snowdon VK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002248; Tan JN, 2017, J IMMUNOL, V198, P2269, DOI 10.4049/jimmunol.1600610; Tan JN, 2016, AM J RESP CRIT CARE, V194, P1392, DOI 10.1164/rccm.201509-1865OC; UNEMORI EN, 1992, J INVEST DERMATOL, V99, P337, DOI 10.1111/1523-1747.ep12616665; Wu C, 2018, CELL PHYSIOL BIOCHEM, V48, P2493, DOI 10.1159/000492687; Xu ZP, 2015, J HEART LUNG TRANSPL, V34, P1154, DOI 10.1016/j.healun.2015.03.021; Yong K L, 2013, Ital J Anat Embryol, V118, P10	48	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5008	5022		10.1074/jbc.RA118.004910	http://dx.doi.org/10.1074/jbc.RA118.004910			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30709904	hybrid, Green Published			2022-12-26	WOS:000463985600024
J	Gregg, T; Sdao, SM; Dhillon, RS; Rensvold, JW; Lewandowski, SL; Pagliarini, DJ; Denu, JM; Merrins, MJ				Gregg, Trillian; Sdao, Sophia M.; Dhillon, Rashpal S.; Rensvold, Jarred W.; Lewandowski, Sophie L.; Pagliarini, David J.; Denu, John M.; Merrins, Matthew J.			Obesity-dependent CDK1 signaling stimulates mitochondrial respiration at complex I in pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; complex I; insulin secretion; obesity; calcium; cyclin B1; cyclin-dependent kinase 1 (CDK1); ob; ob mice; pancreatic cell; RO-3306	GLUCOSE-REGULATED ANAPLEROSIS; BETA-CELLS; INSULIN-SECRETION; NADH FLUORESCENCE; ISLETS; DEHYDROGENASE; EXPRESSION; RELEASE; MODEL; MICE	beta-Cell mitochondria play a central role in coupling glucose metabolism with insulin secretion. Here, we identified a metabolic function of cyclin-dependent kinase 1 (CDK1)/cyclin B1the activation of mitochondrial respiratory complex Ithat is active in quiescent adult -cells and hyperactive in -cells from obese (ob/ob) mice. In WT islets, respirometry revealed that 65% of complex I flux and 49% of state 3 respiration is sensitive to CDK1 inhibition. Islets from ob/ob mice expressed more cyclin B1 and exhibited a higher sensitivity to CDK1 blockade, which reduced complex I flux by 76% and state 3 respiration by 79%. The ensuing reduction in mitochondrial NADH utilization, measured with two-photon NAD(P)H fluorescence lifetime imaging (FLIM), was matched in the cytosol by a lag in citrate cycling, as shown with a FRET reporter targeted to -cells. Moreover, time-resolved measurements revealed that in ob/ob islets, where complex I flux dominates respiration, CDK1 inhibition is sufficient to restrict the duty cycle of ATP/ADP and calcium oscillations, the parameter that dynamically encodes -cell glucose sensing. Direct complex I inhibition with rotenone mimicked the restrictive effects of CDK1 inhibition on mitochondrial respiration, NADH turnover, ATP/ADP, and calcium influx. These findings identify complex I as a critical mediator of obesity-associated metabolic remodeling in -cells and implicate CDK1 as a regulator of complex I that enhances -cell glucose sensing.	[Gregg, Trillian; Sdao, Sophia M.; Lewandowski, Sophie L.; Merrins, Matthew J.] Univ Wisconsin, Dept Med, Div Endocrinol Diabet & Metab, Madison, WI 53705 USA; [Dhillon, Rashpal S.; Denu, John M.; Merrins, Matthew J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53705 USA; [Rensvold, Jarred W.; Pagliarini, David J.] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53715 USA; [Rensvold, Jarred W.; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, Madison, WI 53715 USA; [Merrins, Matthew J.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Merrins, MJ (corresponding author), Med Fdn Centennial Bldg,1600 Overlook Terrace, Madison, WI 53705 USA.	merrins@wisc.edu		Pagliarini, David J./0000-0002-0001-0087; Merrins, Matthew J./0000-0003-1599-9227; LEWANDOWSKI, SOPHIE/0000-0002-2838-7054	American Diabetes Association Grant [1-16-IBS-212]; NIDDK, National Institutes of Health [R01DK098672, R01DK113103]; NIA, National Institutes of Health [R21AG050135]; New Investigator Award from the Wisconsin Partnership Program; Central Society for Clinical and Translational Research; National Institutes of Health Molecular Biophysics Training Grant [T32GM08293]; Laboratory for Optical and Computational Instrumentation; Wisconsin Alumni Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098672, R01DK113103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050135] Funding Source: NIH RePORTER	American Diabetes Association Grant(American Diabetes Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Investigator Award from the Wisconsin Partnership Program; Central Society for Clinical and Translational Research; National Institutes of Health Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory for Optical and Computational Instrumentation; Wisconsin Alumni Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work in the Merrins laboratory was supported by American Diabetes Association Grant 1-16-IBS-212; NIDDK, National Institutes of Health Grant R01DK113103; NIA, National Institutes of Health Grant R21AG050135; a New Investigator Award from the Wisconsin Partnership Program; and an Early Career Development Award from the Central Society for Clinical and Translational Research. The work in the Pagliarini laboratory was supported by NIDDK, National Institutes of Health Grant R01DK098672. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of additional support from National Institutes of Health Molecular Biophysics Training Grant T32GM08293, the Laboratory for Optical and Computational Instrumentation, and a Wisconsin Alumni Research Foundation dissertation fellowship.	Affourtit C, 2018, BIOCHEM SOC T, V46, P555, DOI 10.1042/BST20170505; Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Ewald JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028245; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; Forstner H., 1983, POLAROGRAPHIC OXYGEN, P321; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/bst0300252; Gregg T, 2016, DIABETES, V65, P2700, DOI 10.2337/db16-0432; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Irles E, 2015, MOL CELL ENDOCRINOL, V404, P46, DOI 10.1016/j.mce.2015.01.033; Jorda R, 2018, J MED CHEM, V61, P9105, DOI 10.1021/acs.jmedchem.8b00049; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kim SY, 2017, J BIOL CHEM, V292, P3841, DOI 10.1074/jbc.M116.754077; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Li HB, 2016, DNA CELL BIOL, V35, P680, DOI 10.1089/dna.2016.3271; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; MIURA RM, 1995, B MATH BIOL, V57, P229, DOI 10.1016/0092-8240(94)00035-B; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Qin LL, 2015, CELL REP, V13, P2056, DOI 10.1016/j.celrep.2015.11.015; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shirakawa J, 2017, CELL METAB, V25, P868, DOI 10.1016/j.cmet.2017.02.004; Solaki M, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00093; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; de Tudela MVP, 2015, J NEUROSCI, V35, P9287, DOI 10.1523/JNEUROSCI.4712-14.2015; Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Zhao C, 2001, DIABETES, V50, P361, DOI 10.2337/diabetes.50.2.361	46	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4656	4666		10.1074/jbc.RA118.006085	http://dx.doi.org/10.1074/jbc.RA118.006085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30700550	hybrid, Green Published			2022-12-26	WOS:000462969500031
J	Besnard, S; Carvalhais, N; Arain, MA; Black, A; Brede, B; Buchmann, N; Chen, JQ; Clevers, JGPW; Dutrieux, LP; Gans, F; Herold, M; Jung, M; Kosugi, Y; Knohl, A; Law, BE; Paul-Limoges, E; Lohila, A; Merbold, L; Roupsard, O; Valentini, R; Wolf, S; Zhang, XD; Reichstein, M				Besnard, Simon; Carvalhais, Nuno; Arain, M. Altaf; Black, Andrew; Brede, Benjamin; Buchmann, Nina; Chen, Jiquan; Clevers, Jan G. P. W.; Dutrieux, Loic P.; Gans, Fabian; Herold, Martin; Jung, Martin; Kosugi, Yoshiko; Knohl, Alexander; Law, Beverly E.; Paul-Limoges, Eugenie; Lohila, Annalea; Merbold, Lutz; Roupsard, Olivier; Valentini, Riccardo; Wolf, Sebastian; Zhang, Xudong; Reichstein, Markus			Memory effects of climate and vegetation affecting net ecosystem CO2 fluxes in global forests	PLOS ONE			English	Article							DOUGLAS-FIR FORESTS; CARBON-DIOXIDE; NEURAL-NETWORKS; EDDY COVARIANCE; CLOUD SHADOW; DISTURBANCE; EXTREMES; LEGACY; ASSIMILATION; RESPIRATION	Forests play a crucial role in the global carbon (C) cycle by storing and sequestering a substantial amount of C in the terrestrial biosphere. Due to temporal dynamics in climate and vegetation activity, there are significant regional variations in carbon dioxide (CO2) fluxes between the biosphere and atmosphere in forests that are affecting the global C cycle. Current forest CO2 flux dynamics are controlled by instantaneous climate, soil, and vegetation conditions, which carry legacy effects from disturbances and extreme climate events. Our level of understanding from the legacies of these processes on net CO2 fluxes is still limited due to their complexities and their long-term effects. Here, we combined remote sensing, climate, and eddy-covariance flux data to study net ecosystem CO2 exchange (NEE) at 185 forest sites globally. Instead of commonly used non-dynamic statistical methods, we employed a type of recurrent neural network (RNN), called Long Short-Term Memory network (LSTM) that captures information from the vegetation and climate's temporal dynamics. The resulting data-driven model integrates interannual and seasonal variations of climate and vegetation by using Landsat and climate data at each site. The presented LSTM algorithm was able to effectively describe the overall seasonal variability (Nash-Sutcliffe efficiency, NSE = 0.66) and across-site (NSE = 0.42) variations in NEE, while it had less success in predicting specific seasonal and interannual anomalies (NSE = 0.07). This analysis demonstrated that an LSTM approach with embedded climate and vegetation memory effects outperformed a non-dynamic statistical model (i.e. Random Forest) for estimating NEE. Additionally, it is shown that the vegetation mean seasonal cycle embeds most of the information content to realistically explain the spatial and seasonal variations in NEE. These findings show the relevance of capturing memory effects from both climate and vegetation in quantifying spatio-temporal variations in forest NEE.	[Besnard, Simon; Carvalhais, Nuno; Gans, Fabian; Jung, Martin; Reichstein, Markus] Max Planck Inst Biochem, Dept Biogeochem Integrat, Jena, Germany; [Besnard, Simon; Brede, Benjamin; Clevers, Jan G. P. W.; Herold, Martin] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands; [Carvalhais, Nuno] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias & Engn Ambiente, CENSE, Caparica, Portugal; [Arain, M. Altaf] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON, Canada; [Black, Andrew] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada; [Buchmann, Nina; Paul-Limoges, Eugenie] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Chen, Jiquan] Michigan State Univ, CGCEO Geog, E Lansing, MI 48824 USA; [Dutrieux, Loic P.] Natl Commiss Knowledge & Use Biodivers CONABIO, Mexico City, DF, Mexico; [Kosugi, Yoshiko] Kyoto Univ, Grad Sch Agr, Lab Forest Hydrol, Kyoto, Japan; [Knohl, Alexander] Univ Goettingen, Fac Forest Sci, Gottingen, Germany; [Law, Beverly E.] Oregon State Univ, Coll Forestry, Corvallis, OR 97331 USA; [Lohila, Annalea] Finnish Meteorol Inst, Helsinki, Finland; [Merbold, Lutz] ILRI, Mazingira Ctr, Nairobi, Kenya; [Roupsard, Olivier] CIRAD, UMR Eco&Sols, LMI IESOL, Dakar, Senegal; [Roupsard, Olivier] Univ Montpellier, Montpellier SupAgro, CIRAD, INRA,IRD,Eco&Sols, Montpellier, France; [Valentini, Riccardo] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst DIBAF, Viterbo, Italy; [Wolf, Sebastian] Swiss Fed Inst Technol, Dept Environm Syst Sci, Phys Environm Syst, Zurich, Switzerland; [Zhang, Xudong] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Max Planck Society; Wageningen University & Research; Universidade Nova de Lisboa; McMaster University; McMaster University; University of British Columbia; Swiss Federal Institutes of Technology Domain; ETH Zurich; Michigan State University; Kyoto University; University of Gottingen; Oregon State University; Finnish Meteorological Institute; CGIAR; International Livestock Research Institute (ILRI); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Tuscia University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Besnard, S (corresponding author), Max Planck Inst Biochem, Dept Biogeochem Integrat, Jena, Germany.; Besnard, S (corresponding author), Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands.	sbesnard@bgc-jena.mpg.de	Roupsard, Olivier/C-1219-2008; Chen, Jiquan/D-1955-2009; Lohila, Annalea/C-7307-2014; Merbold, Lutz/K-6103-2012; Herold, Martin/F-8553-2012; Reichstein, Markus/A-7494-2011; Law, Beverly Elizabeth/G-3882-2010; Wolf, Sebastian/B-4580-2010; Knohl, Alexander/F-9453-2014; Kosugi, Yoshiko/GQP-3103-2022; Buchmann, Nina/E-6095-2011; Brede, Benjamin/AAJ-4238-2020; Arain, M. Altaf/ABA-9750-2020; Clevers, Jan/N-1278-2014	Roupsard, Olivier/0000-0002-1319-142X; Lohila, Annalea/0000-0003-3541-672X; Merbold, Lutz/0000-0003-4974-170X; Herold, Martin/0000-0003-0246-6886; Reichstein, Markus/0000-0001-5736-1112; Law, Beverly Elizabeth/0000-0002-1605-1203; Wolf, Sebastian/0000-0001-7717-6993; Knohl, Alexander/0000-0002-7615-8870; Buchmann, Nina/0000-0003-0826-2980; Brede, Benjamin/0000-0001-9253-4517; Arain, M. Altaf/0000-0002-1433-5173; Chen, Jiquan/0000-0003-0761-9458; Clevers, Jan/0000-0002-0046-082X; Dutrieux, Loic/0000-0002-5058-2526; Carvalhais, Nuno/0000-0003-0465-1436; Besnard, Simon/0000-0002-1137-103X; Paul-Limoges, Eugenie/0000-0002-0365-7353				Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Aubinet M, 2018, AGR FOREST METEOROL, V262, P340, DOI 10.1016/j.agrformet.2018.07.024; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Besnard S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaeaeb; Birdsey R, 2006, J ENVIRON QUAL, V35, P1461, DOI 10.2134/jeq2005.0162; Bodesheim P, 2018, EARTH SYST SCI DATA, V10, P1327, DOI 10.5194/essd-10-1327-2018; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carvalhais N, 2010, GLOBAL CHANGE BIOL, V16, P2813, DOI 10.1111/j.1365-2486.2010.02173.x; Chazdon RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501639; Ciais P, 2014, BIOGEOSCIENCES, V11, P3547, DOI 10.5194/bg-11-3547-2014; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Desai AR, 2014, PHOTOSYNTH RES, V119, P31, DOI 10.1007/s11120-013-9925-z; Donato DC, 2013, ECOL APPL, V23, P3, DOI 10.1890/12-0772.1; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; Frank D, 2015, GLOBAL CHANGE BIOL, V21, P2861, DOI 10.1111/gcb.12916; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Gough CM, 2007, GLOBAL CHANGE BIOL, V13, P1935, DOI 10.1111/j.1365-2486.2007.01406.x; Gough CM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1375; Gower ST, 2003, ANNU REV ENV RESOUR, V28, P169, DOI 10.1146/annurev.energy.28.050302.105515; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Kingma DP., 2014, ADAM METHOD STOCHAST; Kuhn M, 2012, CARET CLASSIFICATION; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Le Quere C, 2016, EARTH SYSTEM SCI DAT, V8; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu SG, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001585; Meigs GW, 2009, ECOSYSTEMS, V12, P1246, DOI 10.1007/s10021-009-9285-x; Monger C, 2015, FRONT ECOL ENVIRON, V13, P13, DOI 10.1890/140269; Moore DJP, 2013, ECOL LETT, V16, P731, DOI 10.1111/ele.12097; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Omlin M, 1999, ECOL MODEL, V115, P45, DOI 10.1016/S0304-3800(98)00174-4; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2018, INT GEOSCI REMOTE SE, P7640; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rodriguez-Calcerrada J, 2012, TREE PHYSIOL, V32, P464, DOI 10.1093/treephys/tps020; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Russwurm M, 2017, IEEE COMPUT SOC CONF, P1496, DOI 10.1109/CVPRW.2017.193; Schimel D, 2007, P NATL ACAD SCI USA, V104, P18353, DOI 10.1073/pnas.0709331104; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Schmidt G., 2013, 20131057 US GEOL SUR; Seidl R, 2014, ECOL APPL, V24, P2063, DOI 10.1890/14-0255.1; Seidl R, 2011, GLOBAL CHANGE BIOL, V17, P2842, DOI 10.1111/j.1365-2486.2011.02452.x; Shen W, 2016, BIOGEOSCIENCES, V13, P425, DOI 10.5194/bg-13-425-2016; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Tramontana G, 2016, BIOGEOSCIENCES, V13, P4291, DOI 10.5194/bg-13-4291-2016; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Vicca S, 2014, BIOGEOSCIENCES, V11, P3307, DOI 10.5194/bg-11-3307-2014; Williams CA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003947; Woodbury PB, 2007, FOREST ECOL MANAG, V241, P14, DOI 10.1016/j.foreco.2006.12.008; Wu J, 2016, SCIENCE, V351, P972, DOI 10.1126/science.aad5068; Zhang T, 2015, J PLANT ECOL, V8, P291, DOI 10.1093/jpe/rtu026; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/nclimate3004, 10.1038/NCLIMATE3004]; Zhu Z, 2015, REMOTE SENS ENVIRON, V159, P269, DOI 10.1016/j.rse.2014.12.014; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028; Zielis S, 2014, BIOGEOSCIENCES, V11, P1627, DOI 10.5194/bg-11-1627-2014; Zscheischler J, 2017, BIOGEOSCIENCES, V14, P3685, DOI 10.5194/bg-14-3685-2017	69	24	25	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211510	10.1371/journal.pone.0211510	http://dx.doi.org/10.1371/journal.pone.0211510			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726269	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000457874000068
J	Calderon, R; Morgan, MC; Kuiper, M; Nambuya, H; Wangwe, N; Somoskovi, A; Lieberman, D				Calderon, Ryan; Morgan, Melissa C.; Kuiper, Mark; Nambuya, Harriet; Wangwe, Nicholas; Somoskovi, Akos; Lieberman, Daniel			Assessment of a storage system to deliver uninterrupted therapeutic oxygen during power outages in resource-limited settings	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SEVERE PNEUMONIA; RURAL AFRICA; CONCENTRATORS; HYPOXEMIA; CHILDREN; IMPLEMENTATION; HOSPITALS; GAMBIA; CARE	Access to therapeutic oxygen remains a challenge in the effort to reduce pneumonia mortality among children in low- and middle-income countries. The use of oxygen concentrators is common, but their effectiveness in delivering uninterrupted oxygen is gated by reliability of the power grid. Often cylinders are employed to provide continuous coverage, but these can present other logistical challenges. In this study, we examined the use of a novel, low-pressure oxygen storage system to capture excess oxygen from a concentrator to be delivered to patients during an outage. A prototype was built and tested in a non-clinical trial in Jinja, Uganda. The trial was carried out at Jinja Regional Referral Hospital over a 75-day period. The flow rate of the unit was adjusted once per week between 0.5 and 5 liters per minute. Over the trial period, 1284 power failure episodes with a mean duration of 3.1 minutes (range 0.08 to 1720 minutes) were recorded. The low-pressure system was able to deliver oxygen over 56% of the 4,295 power outage minutes and cover over 99% of power outage events over the course of the study. These results demonstrate the technical feasibility of a method to extend oxygen availability and provide a basis for clinical trials.	[Calderon, Ryan; Kuiper, Mark; Lieberman, Daniel] Intellectual Ventures Lab, Bellevue, WA 98007 USA; [Morgan, Melissa C.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Morgan, Melissa C.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Morgan, Melissa C.] London Sch Hyg & Trop Med, Maternal Adolescent Reprod & Child Hlth Ctr, London, England; [Nambuya, Harriet; Wangwe, Nicholas] Jinja Reg Referral Hosp, Dept Pediat, Jinja, Uganda; [Somoskovi, Akos] Intellectual Ventures Global Good Fund, Bellevue, WA USA	Intellectual Ventures; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Lieberman, D (corresponding author), Intellectual Ventures Lab, Bellevue, WA 98007 USA.	dalieberman@intven.com	Somoskovi, Akos/GMX-3546-2022	Medvedev, Melissa/0000-0003-3457-8452	Global Good Fund I, LLC	Global Good Fund I, LLC	Funding provided by The Global Good Fund I, LLC (www.globalgood.com).The funder provided support in the form of salaries for authors RC, MK, AS, DL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; [Anonymous], 2010, 15001 ISO; ASTM, 2005, ANN B, V14.04, P418, DOI [10.1520/g0088, DOI 10.1520/G0088]; Beeson HD, 2009, SAFE USE OXYGEN OXYG; Belle J, 2010, J INFECT DEV COUNTR, V4, P419, DOI 10.3855/jidc.859; Bradley BD, 2016, INT J TUBERC LUNG D, V20, P1130, DOI 10.5588/ijtld.15.0889; Bradley B. D., 2012, 2012 IEEE Global Humanitarian Technology Conference (GHTC 2012), P356, DOI 10.1109/GHTC.2012.53; Bradley BD, 2015, HEALTH TECHNOL-GER, V4, P319, DOI 10.1007/s12553-015-0094-2; Catto AG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S28; Dobson M, 1996, LANCET, V347, P1597, DOI 10.1016/S0140-6736(96)91080-6; DOBSON MB, 1991, ANAESTHESIA, V46, P217, DOI 10.1111/j.1365-2044.1991.tb09413.x; Dobson MB, 2001, INT J TUBERC LUNG D, V5, P520; Duke T, 2010, ANN TROP PAEDIATR, V30, P87, DOI 10.1179/146532810X12637745452356; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; Duke T, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010411; Duke Trevor, 2010, Papua New Guinea Medical Journal, V53, P126; Enarson P, 2008, B WORLD HEALTH ORGAN, V86, P344, DOI 10.2471/BLT.07.048017; FAROOQ S, 1989, CHEM ENG SCI, V44, P2809, DOI 10.1016/0009-2509(89)85090-0; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Graham H, 2017, PROVIDING OXYGEN CHI, P288, DOI [10.2471/BLT.16.186676, DOI 10.2471/BLT.16.186676]; Graham HR, 2017, TRIALS, V18, P1, DOI [10.1186/s13063-016-1752-z, DOI 10.1186/S13063-016-1752-Z]; Hill SE, 2009, INT J TUBERC LUNG D, V13, P587; Howie SRC, 2009, B WORLD HEALTH ORGAN, V87, P763, DOI 10.2471/BLT.08.058370; Junge S, 2006, TROP MED INT HEALTH, V11, P367, DOI 10.1111/j.1365-3156.2006.01570.x; Matai S, 2008, ANN TROP PAEDIATR, V28, P71, DOI 10.1179/146532808X270716; Mokuolu OA, 2002, ANN TROP PAEDIATR, V22, P209, DOI 10.1179/027249302125001499; Mwaniki MK, 2009, B WORLD HEALTH ORGAN, V87, P263, DOI 10.2471/BLT.07.049148; Nabwire J, 2018, J TROP PEDIATRICS, V64, P97, DOI 10.1093/tropej/fmx033; Nyende S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0814-y; Peel D, 2013, ANAESTHESIA, V68, P706, DOI 10.1111/anae.12260; Perrelet A, 2004, INT J TUBERC LUNG D, V8, P1138; Rassool RP, 2017, RESP CARE, V62, P1582, DOI 10.4187/respcare.05532; Schneider G, 2001, INT J TUBERC LUNG D, V5, P524; Shrestha BM, 2002, CAN J ANAESTH, V49, P8, DOI 10.1007/BF03020412; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Towey RM, 2008, AFR HEALTH SCI, V8, P61; Turnbull H, 2016, INT J TUBERC LUNG D, V20, P696, DOI 10.5588/ijtld.15.0796; Walters EM, 2009, HIST SPERM CRYOPRESE; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO , 2016, OX THER CHILDR; World Health Organization, 2015, TECHN SPEC OX CONC	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211027	10.1371/journal.pone.0211027	http://dx.doi.org/10.1371/journal.pone.0211027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726247	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000457874000044
J	Ddungu, H; Krantz, EM; Kajja, I; Naluzze, S; Nabbanja, H; Nalubwama, F; Phipps, W; Orem, J; Kiwanuka, N; Wald, A				Ddungu, Henry; Krantz, Elizabeth M.; Kajja, Isaac; Naluzze, Sandra; Nabbanja, Hanifah; Nalubwama, Flavia; Phipps, Warren; Orem, Jackson; Kiwanuka, Noah; Wald, Anna			How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa	PLOS ONE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; ACUTE-LEUKEMIA; AUDIT; BLOOD; CANCER; ADULTS; COMPLICATIONS; CHALLENGES; CHILDREN; RISKS	Background Despite the importance of platelet transfusions in treatment of hematologic cancer patients, the optimal platelet count threshold for prophylactic transfusion is unknown in sub-Saharan Africa. Methods We followed patients admitted to the Uganda Cancer Institute with a hematological malignancy in 3 sequential 4-month time-periods using incrementally lower thresholds for prophylactic platelet transfusion: platelet counts <= 30 x 10(9)/L in period 1, <= 20 x 10(9)/L in period 2, and <= 10 x 10(9)/L in period 3. Clinically significant bleeding was defined as WHO grade >= 2 bleeding. We used generalized estimating equations (GEE) to compare the frequency of clinically significant bleeding and platelet transfusions by study period, adjusting for age, sex, cancer type, chemotherapy, baseline platelet count, and baseline hemoglobin. Results Overall, 188 patients were enrolled. The median age was 22 years (range 1-80). Platelet transfusions were given to 42% of patients in period 1, 55% in period 2, and 45% in period 3. These transfusions occurred on 8% of days in period 1, 12% in period 2, and 8% in period 3. In adjusted models, period 3 had significantly fewer transfusions than period 1 (RR = 0.6, 95% CI 0.4-0.9; p = 0.01) and period 2 (RR = 0.5, 95% CI 0.4-0.7; p< 0.001). Eighteen patients (30%) had clinically significant bleeding on at least one day in period 1, 23 (30%) in period 2, and 15 (23%) in period 3. Clinically significant bleeding occurred on 8% of patientdays in period 1, 9% in period 2, and 5% in period 3 (adjusted p = 0.41). Thirteen (21%) patients died in period 1, 15 (22%) in period 2, and 11 (19%) in period 3 (adjusted p = 0.96). Conclusion Lowering the threshold for platelet transfusion led to fewer transfusions and did not change the incidence of clinically significant bleeding or mortality, suggesting that a threshold of 10 x 10(9) /L platelets, used in resource-rich countries, may be implemented as a safe level for transfusions in sub-Saharan Africa.	[Ddungu, Henry; Naluzze, Sandra; Nabbanja, Hanifah; Nalubwama, Flavia; Orem, Jackson] Uganda Canc Inst, Upper Mulago Hill Rd, Kampala, Uganda; [Krantz, Elizabeth M.; Phipps, Warren; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Kajja, Isaac] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Phipps, Warren; Wald, Anna] Univ Washington, Dept Med, Seattle, WA USA; [Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Makerere University; University of Washington; University of Washington Seattle; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ddungu, H (corresponding author), Uganda Canc Inst, Upper Mulago Hill Rd, Kampala, Uganda.	hddungu@fredhutch.org		Ddungu, Henry/0000-0001-9227-4030	Fogarty/NCI D43 Training Grants [D43 CA153720, D43 TW009759]; FOGARTY INTERNATIONAL CENTER [D43TW009759] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA190146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Fogarty/NCI D43 Training Grants; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	sThis study was supported by the Fogarty/NCI D43 Training Grants (D43 CA153720; D43 TW009759).	BELT RJ, 1978, JAMA-J AM MED ASSOC, V239, P2571, DOI 10.1001/jama.239.24.2571; Buhrkuhl DC, 2012, INTERN MED J, V42, P65, DOI 10.1111/j.1445-5994.2010.02358.x; Callow CR, 2002, BRIT J HAEMATOL, V118, P677, DOI 10.1046/j.1365-2141.2002.03616.x; Dhingra N, 2012, VOX SANG, V103, P337, DOI 10.1111/j.1423-0410.2012.01630.x; Diedrich B, 2005, TRANSFUSION, V45, P1064, DOI 10.1111/j.1537-2995.2005.04157.x; Estcourt LJ, 2016, JAMA ONCOL, V2, P1091, DOI 10.1001/jamaoncol.2016.2466; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAYDOS LA, 1962, NEW ENGL J MED, V266, P905, DOI 10.1056/NEJM196205032661802; Gopal S, 2012, BLOOD, V119, P5078, DOI 10.1182/blood-2012-02-387092; HAN T, 1966, CANCER, V19, P1937, DOI 10.1002/1097-0142(196612)19:12<1937::AID-CNCR2820191221>3.0.CO;2-G; Heckman KD, 1997, J CLIN ONCOL, V15, P1143, DOI 10.1200/JCO.1997.15.3.1143; Josephson CD, 2012, BLOOD, V120, P748, DOI 10.1182/blood-2011-11-389569; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Lund TC, 2013, TRANSFUS APHER SCI, V49, P416, DOI 10.1016/j.transci.2013.06.014; MURPHY S, 1982, AM J HEMATOL, V12, P347, DOI 10.1002/ajh.2830120406; Orem J, 2009, ONCOLOGY-BASEL, V77, P272, DOI 10.1159/000259258; Osaro E, 2011, J BLOOD MED, V2, P7, DOI 10.2147/JBM.S17194; Politsmakher A, 2013, AM J MED, V126, P894, DOI 10.1016/j.amjmed.2013.06.013; Qureshi H, 2007, TRANSFUS CLIN BIOL, V14, P509, DOI 10.1016/j.tracli.2008.01.002; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; SLICHTER SJ, 1976, BRIT J HAEMATOL, V34, P403, DOI 10.1111/j.1365-2141.1976.tb03587.x; Solves P, 2014, TRANSFUS APHER SCI, V50, P228, DOI 10.1016/j.transci.2013.11.009; Sonnekus PH, 2014, TRANSFUS APHER SCI, V51, P44, DOI 10.1016/j.transci.2014.10.011; Stanworth SJ, 2005, BRIT J HAEMATOL, V131, P588, DOI 10.1111/j.1365-2141.2005.05769.x; van Veen JJ, 2010, BRIT J HAEMATOL, V148, P15, DOI 10.1111/j.1365-2141.2009.07899.x; Vavricka SR, 2003, ANN HEMATOL, V82, P570, DOI 10.1007/s00277-003-0707-0; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zumberg MS, 2002, BIOL BLOOD MARROW TR, V8, P569, DOI 10.1053/bbmt.2002.v8.pm12434952	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211648	10.1371/journal.pone.0211648	http://dx.doi.org/10.1371/journal.pone.0211648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726290	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000070
J	Le, PVV; Kumar, P; Ruiz, MO; Mbogo, C; Muturi, EJ				Le, Phong V. V.; Kumar, Praveen; Ruiz, Marilyn O.; Mbogo, Charles; Muturi, Ephantus J.			Predicting the direct and indirect impacts of climate change on malaria in coastal Kenya	PLOS ONE			English	Article							ELEVATED ATMOSPHERIC CO2; MODEL; TRANSMISSION; ACCLIMATION; TEMPERATURE; CARBON; RISK; FUTURE; RESURGENCE; HIGHLANDS	Background The transmission of malaria is highly variable and depends on a range of climatic and anthropogenic factors. This study investigates the combined, i.e. direct and indirect, impacts of climate change on the dynamics of malaria through modifications in: (i) the sporogonic cycle of Plasmodium induced by air temperature increase, and (ii) the life cycle of Anopheles vector triggered by changes in natural breeding habitat arising from the altered moisture dynamics resulting from acclimation responses of vegetation under climate change. The study is performed for a rural region in Kilifi county, Kenya. Methods and findings We use a stochastic lattice-based malaria (SLIM) model to make predictions of changes in Anopheles vector abundance, the life cycle of Plasmodium parasites, and thus malaria transmission under projected climate change in the study region. SLIM incorporates a nonlinear temperature-dependence of malaria parasite development to estimate the extrinsic incubation period of Plasmodium. It is also linked with a spatially distributed eco-hydrologic modeling framework to capture the impacts of climate change on soil moisture dynamics, which served as a key determinant for the formation and persistence of mosquito larval habitats on the land surface. Malaria incidence data collected from 2008 to 2013 is used for SLIM model validation. Projections of climate change and human population for the region are used to run the models for prediction scenarios. Under elevated atmospheric CO2 concentration ([CO2]) only, modeled results reveal wetter soil moisture in the root zone due to the suppression of transpiration from vegetation acclimation, which increases the abundance of Anopheles vectors and the risk of malaria. When air temperature increases are also considered along with elevated [CO2], the life cycle of Anopheles vector and the extrinsic incubation period of Plasmodium parasites are shortened nonlinearly. However, the reduction of soil moisture resulting from higher evapotranspiration due to air temperature increase also reduces the larval habitats of the vector. Our findings show the complicated role of vegetation acclimation under elevated [CO2] on malaria dynamics and indicate an indirect but ignored impact of air temperature increase on malaria transmission through reduction in larval habitats and vector density. Conclusions Vegetation acclimation triggered by elevated [CO2] under climate change increases the risk of malaria. In addition, air temperature increase under climate change has opposing effects on mosquito larval habitats and the life cycles of both Anopheles vectors and Plasmodium parasites. The indirect impacts of temperature change on soil moisture dynamics are significant and should be weighed together with the direct effects of temperature change on the life cycles of mosquitoes and parasites for future malaria prediction and control.	[Le, Phong V. V.; Kumar, Praveen] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Le, Phong V. V.] Vietnam Natl Univ, Fac Hydrol Meteorol & Oceanog, Hanoi, Vietnam; [Kumar, Praveen] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Ruiz, Marilyn O.] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA; [Mbogo, Charles] Kenya Govt Med Res Ctr, Malaria Publ Hlth Res, Wellcome Trust Res Programme, Nairobi, Kenya; [Muturi, Ephantus J.] ARS, Crop Bioprotect Res Unit, USDA, Peoria, IL 61604 USA	University of Illinois System; University of Illinois Urbana-Champaign; Vietnam National University Hanoi; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Kenya Medical Research Institute; United States Department of Agriculture (USDA)	Kumar, P (corresponding author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.; Kumar, P (corresponding author), Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA.	kumar1@illinois.edu	C, Praveen Kumar/AAA-8227-2019; Kumar, Praveen/D-2036-2010	Kumar, Praveen/0000-0002-4787-0308; Le, Phong/0000-0001-5558-1023	National Science Foundation [CBET1209402, ACI 1261582, ACI 1429699, EAR 1331906, EAR 1417444]	National Science Foundation(National Science Foundation (NSF))	PVVL and PK was funded by National Science Foundation (https://www.nsf.gov) grants CBET1209402, ACI 1261582, ACI 1429699, EAR 1331906, and EAR 1417444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M., 2014, IPCC 5 ASSESSMENT SY; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; ANDERSON R M, 1991; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2008, MED ENTOMOLOGY STUDE; Bagley J, 2015, GLOBAL BIOGEOCHEM CY, V29, P194, DOI 10.1002/2014GB004848; Beguin A, 2011, GLOBAL ENVIRON CHANG, V21, P1209, DOI 10.1016/j.gloenvcha.2011.06.001; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Chitnis N, 2006, BIFURCATION ANAL MAT; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-328; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Drewry DT, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001340; Ermert V, 2012, ENVIRON HEALTH PERSP, V120, P77, DOI 10.1289/ehp.1103681; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Hales S, 2003, LANCET, V362, P1775, DOI 10.1016/S0140-6736(03)14939-2; Hawkins E, 2017, B AM METEOROL SOC, V98, P1841, DOI 10.1175/BAMS-D-16-0007.1; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kenya Agricultural Research Institute, 2004, P 7 E SO AFR REG MAI; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Larsen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136413; Le PVV, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2397-z; Le PVV, 2017, WATER RESOUR RES, V53, P8383, DOI 10.1002/2017WR020377; Le PVV, 2015, ENVIRON MODELL SOFTW, V73, P1, DOI 10.1016/j.envsoft.2015.07.015; Le PVV, 2014, GEOPHYS RES LETT, V41, P1553, DOI 10.1002/2013GL059114; Le PVV, 2012, COMPUT GEOSCI-UK, V49, P91, DOI 10.1016/j.cageo.2012.07.007; Le PVV, 2011, P NATL ACAD SCI USA, V108, P15085, DOI 10.1073/pnas.1107177108; Le PVB, 2016, THESIS; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Lutambi AM, 2013, MATH BIOSCI, V241, P198, DOI 10.1016/j.mbs.2012.11.013; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Montosi E, 2012, HYDROL EARTH SYST SC, V16, P2759, DOI 10.5194/hess-16-2759-2012; Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44; Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Paaijmans KP, 2011, NAT CLIM CHANGE, V1, P349; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Reiter P, 2004, LANCET INFECT DIS, V4, P323, DOI 10.1016/S1473-3099(04)01038-2; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Ruktanonchai NW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004846; Shaman J, 2002, EMERG INFECT DIS, V8, P6; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Smith C, 2013, J MED ENTOMOL, V50, P521, DOI 10.1603/ME12149; Stern DI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024524; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tuchman NC, 2003, FRESHWATER BIOL, V48, P1432, DOI 10.1046/j.1365-2427.2003.01102.x; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wythers KR, 2005, GLOBAL CHANGE BIOL, V11, P435, DOI 10.1111/j.1365-2486.2005.00922.x; Yamana TK, 2013, ENVIRON HEALTH PERSP, V121, P1179, DOI 10.1289/ehp.1206174; Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-235; Zulu E, 2012, POPULATION DYNAMICS	71	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211258	10.1371/journal.pone.0211258	http://dx.doi.org/10.1371/journal.pone.0211258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726279	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000061
J	Chen, ZJ; Han, YY; Ning, K; Luo, C; Sheng, W; Wang, SL; Fan, SX; Wang, YF; Wang, Q				Chen, Zijing; Han, Yingyan; Ning, Kang; Luo, Chen; Sheng, Wei; Wang, Shenglin; Fan, Shuangxi; Wang, Yanfang; Wang, Qian			Assessing the performance of different irrigation systems on lettuce (Lactuca sativa L.) in the greenhouse	PLOS ONE			English	Article							WATER-USE EFFICIENCY; DRIP IRRIGATION; ROOT DISTRIBUTION; PLASTIC MULCH; SOIL-TEMPERATURE; LOESS PLATEAU; SPRING WHEAT; YIELD; GROWTH; COTTON	Lettuce (Lactuca sativa L.) is a very important leafy vegetable in China and is commonly grown using furrow irrigation. In order to improve production efficiency, greenhouse experiments were conducted at Experimental Station, China Agricultural University, Beijing, China using furrow irrigation (FI), micro-sprinkler irrigation (MS), plastic film mulching irrigation (PF) and a combined plastic film mulching micro-sprinkler irrigation system (PF+MS) to study their effects on soil physical characteristics, water distribution, root morpho-physiological traits, nutrition absorption, lettuce yield and water use efficiency for a spring crop and autumn crop in 2015 (Fig 1). Root length, root surface area, and root density were significantly higher under PF and PF+MS than under FI. Moreover, these traits were higher under MS than under Fl but these differences were not significant. The soluble protein, soluble sugar, and Vitamin C content of lettuce decreased in the order PF+MS > PF > MS > FI in both crops. In the spring crop, the biological yield of MS, PF, and PF+MS was 7.22%, 36.77%, 43.20% higher than FI, respectively. In the spring crop, biological water use efficiency (BWUE) of FI, MS, PF and PF+MS was 20.93, 25.24, 36.81 and 38.54 kg m(-3), respectively. The BWUE of MS, PF, and PF+MS was 20.59%, 75.87% and 84.14% higher than FI. Economic water use efficiency (EWUE) of FI, MS, PF and PF+MS was 17.06, 21.31, 31.11 and 32.31 kg m(-3), respectively. The EWUE of MS, PF, and PF+MS was 24.91%, 82.36% and 89.39% higher than FI, respectively. The autumn crop achieved a higher WUE than the spring crop. The results suggested that the combined plastic film mulching-micro-sprinkler irrigation was the most suitable irrigation approach for increasing lettuce yield.	[Chen, Zijing; Ning, Kang; Luo, Chen; Sheng, Wei; Wang, Shenglin; Wang, Qian] China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing, Peoples R China; [Chen, Zijing] Shan Dong Agr Univ, Minist Agr, State Key Lab Crop Biol, Sci Observing & Expt Stn Environm Controlled Agr, Tai An, Shandong, Peoples R China; [Han, Yingyan; Fan, Shuangxi] Beijing Univ Agr, Plant Sci & Technol Coll, Beijing, Peoples R China; [Wang, Yanfang] Beijing Agr Technol Promot Stn, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Beijing University of Agriculture	Wang, Q (corresponding author), China Agr Univ, Dept Vegetable Sci, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing, Peoples R China.	wangq@cau.edu.cn			Beijing Innovation Consortium of Agricultural Research System [BAIC07-2018]; Foundation Improvement Funds of Beijing University of Agriculture [YQ201604]; Beijing Municipal National Science Foundation [KZ201610020019]	Beijing Innovation Consortium of Agricultural Research System; Foundation Improvement Funds of Beijing University of Agriculture; Beijing Municipal National Science Foundation	This study was supported by Beijing Innovation Consortium of Agricultural Research System (BAIC07-2018). The Foundation Improvement Funds of Beijing University of Agriculture (YQ201604) and the Beijing Municipal National Science Foundation (KZ201610020019).	Bhunia S. R., 2015, International Journal of Agricultural Sciences, V11, P45, DOI 10.15740/HAS/IJAS/11.1/45-49; BOWEN GD, 1970, AUST J SOIL RES, V8, P31, DOI 10.1071/SR9700031; Chakraboyty D, 2008, AGR WATER MANAGE, V95, P1323, DOI 10.1016/j.agwat.2008.06.001; Chien S. C, 2017, ENV SCI POLLUT RES I; Christopoulou M, 2015, G3-GENES GENOM GENET, V5, P2655, DOI 10.1534/g3.115.020818; CUMBUS IP, 1985, J EXP BOT, V36, P219, DOI 10.1093/jxb/36.2.219; Deravel J, 2014, APPL MICROBIOL BIOT, V98, P6255, DOI 10.1007/s00253-014-5663-1; Dukes MD, 2010, HORTTECHNOLOGY, V20, P133, DOI 10.21273/HORTTECH.20.1.133; Fan YQ, 2017, AGR WATER MANAGE, V179, P122, DOI 10.1016/j.agwat.2016.08.019; Fiebig A, 2016, PHYSIOL PLANTARUM, V156, P70, DOI 10.1111/ppl.12343; Filipovic V, 2016, AGR WATER MANAGE, V176, P100, DOI 10.1016/j.agwat.2016.04.020; Gao Y, 2010, AGR WATER MANAGE, V98, P199, DOI 10.1016/j.agwat.2010.08.021; Gao YH, 2014, FIELD CROP RES, V156, P40, DOI 10.1016/j.fcr.2013.10.016; Gercek S, 2017, AGR WATER MANAGE, V180, P172, DOI 10.1016/j.agwat.2016.11.012; Gong DZ, 2017, AGR WATER MANAGE, V179, P215, DOI 10.1016/j.agwat.2016.06.006; HODGSON AS, 1990, IRRIGATION SCI, V11, P143, DOI 10.1007/BF00189451; Hooper L, 2006, J SCI FOOD AGR, V86, P1805, DOI 10.1002/jsfa.2599; Hou XY, 2010, AGR FOREST METEOROL, V150, P115, DOI 10.1016/j.agrformet.2009.09.007; Hou ZN, 2007, PLANT SOIL, V290, P115, DOI 10.1007/s11104-006-9140-1; Hulugalle NR, 2015, CROP PASTURE SCI, V66, P158, DOI 10.1071/CP14184; Jiang YW, 2002, CROP SCI, V42, P202, DOI 10.2135/cropsci2002.0202; Jones HG, 2007, J EXP BOT, V58, P119, DOI 10.1093/jxb/erl118; Kadirbeyoglu Z, 2015, ENVIRON POLICY GOV, V25, P157, DOI 10.1002/eet.1673; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kashiwagi J, 2015, FIELD CROP RES, V170, P47, DOI 10.1016/j.fcr.2014.10.003; Kasirajan S, 2013, AGRON SUSTAIN DEV, V33, P443, DOI 10.1007/s13593-012-0132-7; Li FM, 2004, SOIL TILL RES, V78, P9, DOI 10.1016/j.still.2003.12.009; Li YS, 2007, SOIL TILL RES, V93, P370, DOI 10.1016/j.still.2006.05.010; Liu CA, 2009, EUR J AGRON, V31, P241, DOI 10.1016/j.eja.2009.08.004; Liu Wangou, 2003, Yingyong Shengtai Xuebao, V14, P1906; Maisiri N, 2005, PHYS CHEM EARTH, V30, P783, DOI 10.1016/j.pce.2005.08.021; Maurel C, 2016, PLANT CELL ENVIRON, V39, P2580, DOI 10.1111/pce.12814; Mbarki S, 2008, BIORESOURCE TECHNOL, V99, P6745, DOI 10.1016/j.biortech.2008.01.010; Namara RE, 2007, IRRIGATION SCI, V25, P283, DOI 10.1007/s00271-007-0065-0; Pardossi A, 2009, SENSORS-BASEL, V9, P2809, DOI 10.3390/s90402809; Pereira LS, 2012, AGR WATER MANAGE, V108, P39, DOI 10.1016/j.agwat.2011.08.022; PHENE CJ, 1991, IRRIGATION SCI, V12, P135, DOI 10.1007/BF00192284; Qin SH, 2014, AGR WATER MANAGE, V131, P87, DOI 10.1016/j.agwat.2013.09.015; Salgado E, 2008, AGR WATER MANAGE, V95, P817, DOI 10.1016/j.agwat.2008.02.005; Sarkar S, 2008, AGR WATER MANAGE, V95, P625, DOI 10.1016/j.agwat.2008.01.002; Sezen SM, 2006, AGR WATER MANAGE, V81, P115, DOI 10.1016/j.agwat.2005.04.002; Shen Xiao-jun, 2013, Yingyong Shengtai Xuebao, V24, P3153; Slattery R. A, 2017, PLANT PHYSL; Slessarev E. W, 2016, NATURE; Stanghellini C, 2014, ACTA HORTIC, V1034, P25, DOI 10.17660/ActaHortic.2014.1034.1; Sun-JaeJin, 2002, Journal of Applied Biological Chemistry, V45, P191; Tang LS, 2005, FIELD CROP RES, V94, P214, DOI 10.1016/j.fcr.2005.01.005; Tennakoon SB, 2003, AGR WATER MANAGE, V61, P179, DOI 10.1016/S0378-3774(03)00023-4; Wang Bo, 2000, CRRN, Chinese Rice Research Newsletter, V8, P10; Wang FX, 2011, FIELD CROP RES, V122, P78, DOI 10.1016/j.fcr.2011.02.009; Wang FX, 2009, FIELD CROP RES, V110, P123, DOI 10.1016/j.fcr.2008.07.014; Wang SQ, 2008, SPECTROSC SPECT ANAL, V28, P808; Wang Y, 2017, GLOB CHANG BIOL; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Warren CR, 2003, TREE PHYSIOL, V23, P793, DOI 10.1093/treephys/23.12.793; Wilson ML, 2010, J ENVIRON QUAL, V39, P492, DOI 10.2134/jeq2009.0265; Xie ZK, 2005, AGR WATER MANAGE, V75, P71, DOI 10.1016/j.agwat.2004.12.014; Zhang XY, 2009, FIELD CROP RES, V114, P75, DOI 10.1016/j.fcr.2009.07.006; Zhang YL, 2017, SOIL TILL RES, V172, P1, DOI 10.1016/j.still.2017.04.010; Zhang YL, 2017, AGR WATER MANAGE, V180, P160, DOI 10.1016/j.agwat.2016.11.018; Zhou SQ, 2012, HYDROL PROCESS, V26, P1169, DOI 10.1002/hyp.8208	61	10	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0209329	10.1371/journal.pone.0209329	http://dx.doi.org/10.1371/journal.pone.0209329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716102	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200004
J	Macken, J				Maecken, Jana			Work stress among older employees in Germany: Effects on health and retirement age	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; RISK-FACTOR; JOB STRAIN; DEPRESSION; SYMPTOMS; EUROPE; SCALE; EXIT	Background Policy makers in aging societies aim for the extension of work lives by increasing the official retirement age. Despite these efforts, many people stop working before reaching this retirement age. The main reason for early retirement is poor health. Health in turn is influenced by exposure to the work environment. Furthermore, health and work stress are influenced by education, which may lead to different effects for the lowly and the highly educated. Objective This study examines the relationship between work stress and retirement age. It investigates whether this relationship is mediated by health and moderated by education. Three dimensions of health are taken into account: self-rated health (SRH), depressive symptoms, and high cardiovascular risk diseases (HCVR). Methods A German subsample of the longitudinal Survey of Health, Aging and Retirement in Europe (SHARE) was linked with register data of the German Public Pension Scheme (SHARE-RV). The sample followed 302 individuals aged 50 to 65 years at baseline from 2004 to 2014. The data contains information on work stress, measured by job control and effort-reward-imbalance (ERI), health, and age of retirement. Multi-group structural equation modeling was applied to analyze the direct and indirect effects of work stress on retirement age via health. Work stress was lagged so that it temporally preceded health and retirement age. Results Lower job control and poorer SRH lead to a lower retirement age. Health does not operate as a mediator in the relationship between work stress and retirement age. Education moderates the relationship between work stress and health: high ERI leads to better SRH and better physical health of higher educated persons. Low job control increases the risk of depressive symptoms for persons with less education. Conclusions Improving stressful working conditions, particularly improving job control, can prolong the working lives of employees and postpone retirement.	[Maecken, Jana] Univ Cologne, Inst Sociol & Social Psychol, Cologne, Germany	University of Cologne	Macken, J (corresponding author), Univ Cologne, Inst Sociol & Social Psychol, Cologne, Germany.	maecken@wiso.uni-koeln.de		Macken, Jana/0000-0003-3503-7340	Research Network on Old-Age Provision (FNA - Forschungsnetzwerk Alterssicherung) of the German Statutory Pension Insurance Scheme [JM FNA-ST-2016-04]; European Commission through FP5 [QLK6-CT-2001-00360]; European Commission through FP6 [SHARE-I3:RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812]; German Ministry of Education and Research; Max Planck Society for the Advancement of Science; U.S. National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C]; European Commission through FP7 (SHARE-PREP) [211909]; European Commission through FP7 (SHARE-LEAP) [227822]; European Commission through FP7 (SHARE M4) [261982]; NATIONAL INSTITUTE ON AGING [P30AG012815, P01AG005842, U01AG009740, P01AG008291] Funding Source: NIH RePORTER	Research Network on Old-Age Provision (FNA - Forschungsnetzwerk Alterssicherung) of the German Statutory Pension Insurance Scheme; European Commission through FP5; European Commission through FP6; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society for the Advancement of Science(Max Planck Society); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Commission through FP7 (SHARE-PREP); European Commission through FP7 (SHARE-LEAP); European Commission through FP7 (SHARE M4); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was funded by the Research Network on Old-Age Provision (FNA -Forschungsnetzwerk Alterssicherung) of the German Statutory Pension Insurance Scheme (JM FNA-ST-2016-04). The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3:RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: no 211909, SHARE-LEAP: no 227822, SHARE M4: no 261982). Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C) and from various national funding sources is gratefully acknowledged (see www.share-project.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Doherty M, 2009, WORK EMPLOY SOC, V23, P84, DOI 10.1177/0950017008099779; Ebbinghaus B, 2013, COMP POPUL STUD, V38, P807, DOI 10.12765/CPoS-2013-24en; Fisher GG, 2016, WORK AGING RETIRE, V2, P230, DOI 10.1093/workar/waw001; Hintsa T, 2015, J EPIDEMIOL COMMUN H, V69, P543, DOI 10.1136/jech-2014-205148; Hoven H, 2015, J EPIDEMIOL COMMUN H, V69, P447, DOI 10.1136/jech-2014-205206; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Juvani A, 2014, SCAND J WORK ENV HEA, V40, P266, DOI 10.5271/sjweh.3402; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Karasek R, 2007, INT J BEHAV MED, V14, P189, DOI 10.1007/BF03002993; Karpansalo M, 2005, J EPIDEMIOL COMMUN H, V59, P70, DOI 10.1136/jech.2003.010702; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2015, PLOS MED; Konig S., 2016, DELAYING RETIREMENT, P23, DOI [10.1057/978-1-137-56697-3_2, DOI 10.1057/978-1-137-56697-3_2]; Korbmacher JM, 2014, RECALL ERROR YEAR RE; Lahelma E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-309; Lunau T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121573; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; OECD, 2018, AG EMPL POL STAT AV; Olesen SC, 2012, SOC PSYCH PSYCH EPID, V47, P735, DOI 10.1007/s00127-011-0375-7; Pietilainen O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025004; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Radl J, 2013, EUR SOCIOL REV, V29, P654, DOI 10.1093/esr/jcs045; Radl J, 2012, WORK EMPLOY SOC, V26, P755, DOI 10.1177/0950017012451644; Schreurs B, 2011, ECON IND DEMOCRACY, V32, P47, DOI 10.1177/0143831X10365931; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J., 2006, KOLNER Z SOZIOL SOZI, V46, P109; Siegrist J, 2014, INT ARCH OCC ENV HEA, V87, P249, DOI 10.1007/s00420-013-0855-z; Siegrist J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-27; Smith PM, 2012, AM J PUBLIC HEALTH, V102, P352, DOI 10.2105/AJPH.2011.300376; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Topa G, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02157; Torquati L, 2017, SCAND J WORK ENV HLT; van den Berg TIJ, 2010, J OCCUP ENVIRON MED, V52, P576, DOI 10.1097/JOM.0b013e3181de8133; van Rijn RM, 2014, OCCUP ENVIRON MED, V71, P295, DOI 10.1136/oemed-2013-101591; Wahrendorf M, 2013, EUR SOCIOL REV, V29, P792, DOI 10.1093/esr/jcs058; World Health Organization, 2017, FACTSH CARD DIS CVDS; World Health Organization (WHO), 2017, DEPRESSION	43	15	15	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211487	10.1371/journal.pone.0211487	http://dx.doi.org/10.1371/journal.pone.0211487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2LY	30716089	gold, Green Published, Green Submitted			2022-12-26	WOS:000457744200027
J	Szabo, K; Konya, Z; Erdodi, F; Farkas, I; Dombradi, V				Szabo, Krisztina; Konya, Zoltan; Erdodi, Ferenc; Farkas, Ilona; Dombradi, Viktor			Dissection of the regulatory role for the N-terminal domain in Candida albicans protein phosphatase Z1	PLOS ONE			English	Article							YEAST; RESISTANCE; PPZ1	The novel type, fungus specific protein phosphatase Z1 of the opportunistic pathogen, Candida albicans (CaPpz1) has several important physiological roles. It consists of a conserved C-terminal catalytic domain and a variable, intrinsically disordered, N-terminal regulatory domain. To test the function of these domains we modified the structure of CaPpz1 by in vitro mutagenesis. The two main domains were separated, four potential protein binding regions were deleted, and the myristoylation site as well as the active site of the enzyme was crippled by point mutations G2A and R262L, respectively. The in vitro phosphatase activity assay of the bacterially expressed recombinant proteins indicated that the N-terminal domain was inactive, while the C-terminal domain became highly active against myosin light chain substrate. The deletion of the N-terminal 1-16 amino acids and the G2A mutation significantly decreased the specific activity of the enzyme. Complementation of the ppz1 Saccharomyces cerevisiae deletion mutant strain with the different CaPpz1 forms demonstrated that the scission of the main domains, the two point mutations and the N-terminal 1-16 deletion rendered the phosphatase incompetent in the in vivo assays of LiCl tolerance and caffeine sensitivity. Thus our results confirmed the functional role of the N-terminal domain and highlighted the significance of the very N-terminal part of the protein in the regulation of CaPpz1.	[Szabo, Krisztina; Konya, Zoltan; Erdodi, Ferenc; Farkas, Ilona; Dombradi, Viktor] Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary	University of Debrecen	Farkas, I; Dombradi, V (corresponding author), Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary.	farkas@med.unideb.hu; dombradi@med.unideb.hu	Ilona, Farkas/AAX-8344-2021	Szabo, Krisztina/0000-0002-8461-9294	NKFIH [K108989]; Hungarian National Research, Development and Innovation Office [UNKP-18-3]; New National Excellence Program of the Ministry of Human Capacities	NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); New National Excellence Program of the Ministry of Human Capacities	This work was supported by the NKFIH K108989 grant to VD from the Hungarian National Research, Development and Innovation Office, http://nkfih.gov.hu/english, and UNKP-18-3 New National Excellence Program of the Ministry of Human Capacities to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; Arino J, 2002, EUR J BIOCHEM, V269, P1072, DOI 10.1046/j.0014-2956.2002.02753.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Chen E, 2016, MBIO, V7, DOI 10.1128/mBio.00872-16; Clotet J, 1996, J BIOL CHEM, V271, P26349, DOI 10.1074/jbc.271.42.26349; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; ERDODI F, 1995, AM J PHYSIOL-CELL PH, V269, pC1176, DOI 10.1152/ajpcell.1995.269.5.C1176; Kovacs L, 2010, J BASIC MICROB, V50, pS74, DOI 10.1002/jobm.200900434; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leiter E, 2012, FUNGAL GENET BIOL, V49, P708, DOI 10.1016/j.fgb.2012.06.010; Liu SY, 2015, EUKARYOT CELL, V14, P324, DOI 10.1128/EC.00271-14; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Minhas A, 2012, J BIOL CHEM, V287, P7301, DOI 10.1074/jbc.M111.299438; Molero C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09360-5; Morschhauser J, 2016, J MICROBIOL, V54, P192, DOI 10.1007/s12275-016-5628-4; Naglik JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004257; Nagy G, 2014, APPL MICROBIOL BIOT, V98, P5185, DOI 10.1007/s00253-014-5696-5; Pappas PC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.26; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Perlin DS, 2014, DRUGS, V74, P1573, DOI 10.1007/s40265-014-0286-5; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Petrenyi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160965; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; POSAS F, 1995, FEBS LETT, V368, P39, DOI 10.1016/0014-5793(95)00593-X; POSAS F, 1992, J BIOL CHEM, V267, P11734; Poulain D, 2015, CRIT REV MICROBIOL, V41, P208, DOI 10.3109/1040841X.2013.813904; Prieto D, 2016, FUTURE MICROBIOL, V11, P567, DOI 10.2217/fmb.16.1; Robbins N, 2017, ANNU REV MICROBIOL, V71, P753, DOI 10.1146/annurev-micro-030117-020345; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211426	10.1371/journal.pone.0211426	http://dx.doi.org/10.1371/journal.pone.0211426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707732	Green Published, gold			2022-12-26	WOS:000457742900024
J	Torell, MF; Stromsoe, A; Herlitz, J; Claesson, A; Svensson, L; Borjesson, M				Torell, Matilda Frisk; Stromsoe, Anneli; Herlitz, Johan; Claesson, Andreas; Svensson, Leif; Borjesson, Mats			Outcome of exercise-related out-of-hospital cardiac arrest is dependent on location: Sports arenas vs outside of arenas	PLOS ONE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; PUBLIC-ACCESS DEFIBRILLATION; PHYSICAL-ACTIVITY; AMERICAN-COLLEGE; UNITED-STATES; SUDDEN-DEATH; HIGH-SCHOOLS; SURVIVAL; ASSOCIATION; MORTALITY	Background The chance of surviving an out-of-hospital cardiac arrest (OHCA) seems to be increased if the cardiac arrests occurs in relation to exercise. Hypothetically, an exercise-related OHCA at a sports arena would have an even better prognosis, because of an increased likelihood of bystander cardiopulmonary resuscitation (CPR) and higher availability of automated external defibrillators (AEDs). The purpose of the study was to compare survival rates between exercise-related OHCA at sports arenas versus outside of sports arenas. Methods Data from all treated exercise-related OHCA outside home reported to the Swedish Register of Cardiopulmonary Resuscitation (SRCR) from 2011 to 2014 in 10 counties of Sweden was analyzed (population 6 million). The registry has in those counties a coverage of almost 100% of all OHCAs. Results 3714 cases of OHCA outside of home were found. Amongst them, 268(7%) were exercise-related and 164 (61.2%) of those occurred at sports arenas. The 30-day survival rate was higher for exercise-related OHCA at sports arenas compared to outside (55.7% vs 30.0%, p<0.0001). OHCA-victims at sports arenas were younger (mean age +/- SD 57.6 +/- 16.3 years compared to 60.9 +/- 17.0 years, p = 0.05), less likely female (4.3% vs 12.2%, p = 0.02) and had a higher frequency of shockable rhythm (73.0% vs 54.3%, p = 0.004). OHCAs at arenas were more often witnessed (83.9% vs 68.9%, p = 0.007), received bystander CPR to a higher extent (90.0% vs 56.8%, p<0.0001) and the AED-use before EMS-arrival was also higher in this group (29.8% vs 11.1%, p = 0.009). Conclusion The prognosis is markedly better for exercise-related OHCA occurring at sports arenas compared to outside. Victims of exercise-related OHCA at sports arenas are more likely to receive bystander CPR and to be connected to a public AED. These findings support an increased use of public AEDs and implementation of Medical Action Plans (MAP), to possibly increase survival of exercise-related OHCA even further.	[Torell, Matilda Frisk] Gothenburg Univ, Inst Neurosci & Physiol, Gothenburg, Sweden; [Stromsoe, Anneli] Dalarna Univ, Cty Council Dalarna, Falun, Sweden; [Herlitz, Johan] Fac Caring Sci Work Life & Social Welf, Prehospen Ctr Preshospital Res, Boras, Sweden; [Claesson, Andreas; Svensson, Leif] Karolinska Inst, Ctr Resuscitat & Sci, Stockholm, Sweden; [Borjesson, Mats] Univ Gothenburg, Sahlgrenska Univ Hosp Ostra, Inst Nutr & Sport Sci, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; Dalarna University; Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg	Torell, MF (corresponding author), Gothenburg Univ, Inst Neurosci & Physiol, Gothenburg, Sweden.	Matilda.frisk@vgregion.se		Claesson, Andreas/0000-0002-0499-9929	Swedish Heart Foundation; Laerdal Foundation	Swedish Heart Foundation; Laerdal Foundation	This work was funded from The Swedish Heart Foundation which was used for this research (https://www.hjart-lungfonden.se) to JH. This is an charitable fundrasing organisation which did not take part in study design, data collecction/analysis, decision to publish or preparation of the manuscript. This work was also supported by the Laerdal Foundation, which was used for this research to JH. The Laerdal Foundation did not take part in study design, data collecction/analysis, decision to publish or preparation of the manuscript.	Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Berdowski J, 2013, EUR HEART J, V34, P3616, DOI 10.1093/eurheartj/eht401; Bohm P, 2016, EUR J PREV CARDIOL, V23, P649, DOI 10.1177/2047487315594087; Borjesson M, 2011, EUR HEART J, V32, P2119, DOI 10.1093/eurheartj/ehr178; Borjesson M, 2010, EUR HEART J, V31, P1438, DOI 10.1093/eurheartj/ehq006; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Claesson A, 2017, RESUSCITATION, V110, P48, DOI 10.1016/j.resuscitation.2016.10.019; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Drezner JA, 2013, BRIT J SPORT MED, V47, P1179, DOI 10.1136/bjsports-2013-092786; Drezner JA, 2009, CIRCULATION, V120, P518, DOI 10.1161/CIRCULATIONAHA.109.855890; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Goodman JM, 2016, CAN J CARDIOL, V32, P523, DOI 10.1016/j.cjca.2016.01.019; Grani C, 2016, EUR J PREV CARDIOL, V23, P1228, DOI 10.1177/2047487316632967; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Jae SY, 2016, AM J CARDIOL, V118, P1282, DOI 10.1016/j.amjcard.2016.07.064; Kim C, 2001, CIRCULATION, V104, P2699, DOI 10.1161/hc4701.099784; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Lear A, 2015, J ATHL TRAINING, V50, P1054, DOI 10.4085/1062-6050-50.8.01; Marijon E, 2015, AM HEART J, V170, P339, DOI 10.1016/j.ahj.2015.03.022; Marijon E, 2013, EUR HEART J, V34, P3632, DOI 10.1093/eurheartj/eht282; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Meyer L, 2012, CIRCULATION, V126, P1363, DOI 10.1161/CIRCULATIONAHA.111.076810; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Page RL, 2013, J AM COLL CARDIOL, V62, P2102, DOI 10.1016/j.jacc.2013.06.048; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Ringh M, 2015, RESUSCITATION, V91, P1, DOI 10.1016/j.resuscitation.2015.02.032; Risgaard B, 2014, HEART RHYTHM, V11, P1673, DOI 10.1016/j.hrthm.2014.05.026; Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023; Stromsoe A, 2015, EUR HEART J, V36, P863, DOI 10.1093/eurheartj/ehu240; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Torell MF, 2017, EUR J PREV CARDIOL, V24, P1673, DOI 10.1177/2047487317729251; Toukola TM, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00102; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Wassertheil J, 2000, RESUSCITATION, V44, P97, DOI 10.1016/S0300-9572(99)00168-9; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Williams PT, 2014, MAYO CLIN PROC, V89, P1187, DOI 10.1016/j.mayocp.2014.05.006; Wissenberg M, 2015, CIRCULATION, V131, P1536, DOI 10.1161/CIRCULATIONAHA.114.013122	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211723	10.1371/journal.pone.0211723	http://dx.doi.org/10.1371/journal.pone.0211723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707745	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900044
J	Dang, DKD; Patterson, AC; Carrasco, LR				Dang, Doan K. D.; Patterson, Amy C.; Carrasco, Luis R.			An analysis of the spatial association between deforestation and agricultural field sizes in the tropics and subtropics	PLOS ONE			English	Article							SCALE LAND ACQUISITIONS; BIODIVERSITY; CHALLENGES	Tropical deforestation is one of the most pressing threats to biodiversity, and substantially reduces ecosystem services at the global scale. Little is known however about the global spatial distribution of the actors behind tropical deforestation. Newly available maps of global cropland field size offer an opportunity to gain understanding towards the spatial distribution of tropical deforestation actors. Here we use a map of global cropland field size and combine it with maps of forest loss to study the spatial association between field size and deforestation while accounting for other anthropogenic and geographical drivers of deforestation. We then use linear mixed-effects models and bootstrapping to determine what factors affect field sizes within deforested areas across all countries in the global tropics and subtropics. We find that field size within deforested areas is largely determined by country-level effects indicating the importance of socio-economic, cultural and institutional factors on the distribution of field sizes. Typically, small field sizes appear more commonly in deforested areas in Africa and Asia while the association was with larger field sizes in Australia and the Americas. In general, we find that smaller field sizes are associated with deforestation in protected areas and large field sizes with areas with lower agricultural value, although these results have low explanatory power. Our results suggest that the spatial patterns of actors behind deforestation are aggregated geographically which could help target conservation and sustainable land-use strategies.	[Dang, Doan K. D.; Patterson, Amy C.; Carrasco, Luis R.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	National University of Singapore	Carrasco, LR (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	dbsctlr@nus.edu.sg	Carrasco, Luis R/H-8017-2012	Carrasco, Luis R/0000-0002-2894-1473	Ministry of Education of Singapore [MOE2015-T2-2-121]	Ministry of Education of Singapore(Ministry of Education, Singapore)	L.R.C., A.C.P. and D.K.D.D. were supported by the Ministry of Education of Singapore under the Tier 2 grant MOE2015-T2-2-121.	Austin KG, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6a88; BERRY RA, 1972, AM ECON REV, V62, P403; Brun C, 2015, GLOBAL ENVIRON CHANG, V31, P285, DOI 10.1016/j.gloenvcha.2015.02.004; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carrasco LR, 2014, SCIENCE, V346, P38, DOI 10.1126/science.1256685; Carrasco LR, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001657; Carrasco LR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602602; Cederberg C, 2011, ENVIRON SCI TECHNOL, V45, P1773, DOI 10.1021/es103240z; [CIAT CIESIN], 2005, GRIDD POP WORLD VERS; Corley R. H. V, 2008, OIL PALM; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Davis KF, 2015, NAT GEOSCI, V8, P772, DOI [10.1038/ngeo2540, 10.1038/NGEO2540]; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Etongo D, 2015, FOREST POLICY ECON, V61, P51, DOI 10.1016/j.forpol.2015.08.006; FAO GR, 2015, EC LIV SMALLH FARM A; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Fritz S, 2015, GLOBAL CHANGE BIOL, V21, P1980, DOI 10.1111/gcb.12838; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Godar J, 2014, P NATL ACAD SCI USA, V111, P15591, DOI 10.1073/pnas.1322825111; Graesser J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034017; Gutierrez-Velez VH, 2013, REMOTE SENS ENVIRON, V129, P154, DOI 10.1016/j.rse.2012.10.033; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Gasparri NI, 2016, CONSERV LETT, V9, P21, DOI 10.1111/conl.12173; Kalamandeen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19358-2; KLEINMAN PJA, 1995, AGR ECOSYST ENVIRON, V52, P235, DOI 10.1016/0167-8809(94)00531-I; Kuemmerle T, 2013, CURR OPIN ENV SUST, V5, P484, DOI 10.1016/j.cosust.2013.06.002; Lee JSH, 2014, CONSERV LETT, V7, P25, DOI 10.1111/conl.12039; Levin Gregor., 2006, DANISH J GEOGRAPHY, V106, P45, DOI [10.1080/00167223.2006.10649556, DOI 10.1080/00167223.2006.10649556]; Mayaux P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0300; Messerli P, 2014, APPL GEOGR, V53, P449, DOI 10.1016/j.apgeog.2014.07.005; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson A, 2009, ACCESSIBILITY MODEL; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pacheco P, 2009, WORLD DEV, V37, P1337, DOI 10.1016/j.worlddev.2008.08.019; Papworth S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46594; Phelps J, 2013, P NATL ACAD SCI USA, V110, P7601, DOI 10.1073/pnas.1220070110; Pinheiro J, 2006, VENTORSNLME LINEAR N; Pirard R, 2015, ZERO DEFORESTATION C; R Core Team, 2016, R FDN STAT COMP; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Furumo PR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5892; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; See LD, 2015, GLOB FOOD SECUR-AGR, V4, P37, DOI 10.1016/j.gfs.2014.10.004; Sheil D, 2014, TRENDS PLANT SCI, V19, P209, DOI 10.1016/j.tplants.2014.01.002; Symes WS, 2015, GLOBAL CHANGE BIOL; WDPA Consortium, 2018, WORLD DAT PROT AR; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0209918	10.1371/journal.pone.0209918	http://dx.doi.org/10.1371/journal.pone.0209918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699139	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600015
J	Ghosh, T; Bhaduri, S; Montemagno, C; Kumar, A				Ghosh, Tanushree; Bhaduri, Swayamdipta; Montemagno, Carlo; Kumar, Aloke			Sporosarcina pasteurii can form nanoscale calcium carbonate crystals on cell surface	PLOS ONE			English	Article							PRECIPITATION; BIOMINERALIZATION; STRAIN; NUCLEATION; UREASE; GROWTH	The bacterium Sporosarcina pasteurii (SP) is known for its ability to cause the phenomenon of microbially induced calcium carbonate precipitation (MICP). We explored bacterial participation in the initial stages of the MICP process at the cellular length scale under two different growth environments (a) liquid culture (b) MICP in a soft agar (0.5%) column. In the liquid culture, ex-situ imaging of the cellular environment indicated that S. pasteurii was facilitating nucleation of nanoscale crystals of calcium carbonate on bacterial cell surface and its growth via ureolysis. During the same period, the meso-scale environment (bulk medium) was found to have overgrown calcium carbonate crystals. The effect of media components (urea, CaCl2), presence of live and dead in the growth medium were explored. The agar column method allows for in-situ visualization of the phenomena, and using this platform, we found conclusive evidence of the bacterial cell surface facilitating formation of nanoscale crystals in the microenvironment. Here also the bulk environment or the meso-scale environment was found to possess overgrown calcium carbonate crystals. Extensive elemental analysis using Energy dispersive X-ray spectroscopy (EDS) and X-ray powder diffraction (XRD), confirmed that the crystals to be calcium carbonate, and two different polymorphs (calcite and vaterite) were identified. Active participation of S. pasteurii cell surface as the site of calcium carbonate precipitation has been shown using EDS elemental mapping with Scanning transmission electron microscopy (STEM) and scanning electron microscopy (SEM).	[Ghosh, Tanushree; Bhaduri, Swayamdipta] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Montemagno, Carlo] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Kumar, Aloke] Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India	University of Alberta; University of Alberta; Indian Institute of Science (IISC) - Bangalore	Kumar, A (corresponding author), Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India.	alokekumar@iisc.ac.in		Kumar, Aloke/0000-0002-7797-8336	NSERC, Canada; Indian Institute of Science	NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Indian Institute of Science	AK acknowledges partial support from NSERC, Canada. AK acknowledges partial support from the Startup Grant provided by the Indian Institute of Science. There were no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achal V, 2009, J IND MICROBIOL BIOT, V36, P981, DOI 10.1007/s10295-009-0578-z; Anbu P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1869-2; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; Bang SS, 2001, ENZYME MICROB TECH, V28, P404, DOI 10.1016/S0141-0229(00)00348-3; Bhaduri S, 2016, JOVE-J VIS EXP, DOI 10.3791/53253; Bundeleva IA, 2012, CHEM GEOL, V291, P116, DOI 10.1016/j.chemgeo.2011.10.003; Cao H, 2013, MACROMOL BIOSCI, V13, P650, DOI 10.1002/mabi.201200334; Castanier S, 1999, SEDIMENT GEOL, V126, P9, DOI 10.1016/S0037-0738(99)00028-7; De Muynck W, 2010, ECOL ENG, V36, P118, DOI 10.1016/j.ecoleng.2009.02.006; Deng H, 2015, REGEN BIOMATER, V2, P187, DOI 10.1093/rb/rbv010; Dhami NK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00314; Douglas S, 1998, FEMS MICROBIOL ECOL, V26, P79, DOI 10.1111/j.1574-6941.1998.tb00494.x; Ehrlich HL, 1998, EARTH-SCI REV, V45, P45, DOI 10.1016/S0012-8252(98)00034-8; Ehrlich HL, 1996, CHEM GEOL, V132, P5, DOI 10.1016/S0009-2541(96)00035-6; FERRIS F, 1997, J CANADIAN PETROLEUM, V0036; Fischer BTH E. R, 2012, CURRENT PROTOCOLS MI; Ghashghaei S, 2013, CURR MICROBIOL, V67, P406, DOI 10.1007/s00284-013-0379-5; Ghosh T, 2014, J BIOSCIENCES, V39, P805, DOI 10.1007/s12038-014-9476-2; Glauert AM, 2014, BIOL SPECIMEN PREPAR; Hammes F, 2003, APPL ENVIRON MICROB, V69, P4901, DOI 10.1128/AEM.69.8.4901-4909.2003; Hammes Frederik, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P3, DOI 10.1023/A:1015135629155; Harris D, 2016, ANALYST, V141, P2887, DOI 10.1039/c6an00007j; Ivanov V, 2016, CONSTRUCTION BIOTECH; Kawaguchi T, 2002, J CRYST GROWTH, V240, P230, DOI 10.1016/S0022-0248(02)00918-1; Li MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16128; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; Mitchell AC, 2006, GEOMICROBIOL J, V23, P213, DOI 10.1080/01490450600724233; MORITA RY, 1980, GEOMICROBIOL J, V2, P63, DOI 10.1080/01490458009377751; Nguyen JNT, 2017, SCANNING ELECT MICRO, P71; Okwadha GDO, 2010, CHEMOSPHERE, V81, P1143, DOI 10.1016/j.chemosphere.2010.09.066; Phillips AJ, 2016, ENVIRON SCI TECHNOL, V50, P4111, DOI 10.1021/acs.est.5b05559; Phillips AJ, 2013, BIOFOULING, V29, P715, DOI 10.1080/08927014.2013.796550; Qian CX, 2009, MAT SCI ENG C-BIO S, V29, P1273, DOI 10.1016/j.msec.2008.10.025; Rodriguez-Navarro C, 2015, CRYSTENGCOMM, V17, P58, DOI 10.1039/c4ce01562b; Sarikaya M, 1999, P NATL ACAD SCI USA, V96, P14183, DOI 10.1073/pnas.96.25.14183; Seifan M, 2016, APPL MICROBIOL BIOT, V100, P2591, DOI 10.1007/s00253-016-7316-z; Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; THOMPSON JB, 1990, GEOLOGY, V18, P995, DOI 10.1130/0091-7613(1990)018<0995:CPOGCA>2.3.CO;2; Tziviloglou E, 2016, ADV POLYM SCI, V273, P345, DOI 10.1007/12_2015_332; Warren LA, 2001, GEOMICROBIOL J, V18, P93, DOI 10.1080/01490450151079833; Warthmann R, 2000, GEOLOGY, V28, P1091, DOI 10.1130/0091-7613(2000)028<1091:BIDPIA>2.3.CO;2; Zhang W, 2018, ENVIRON SCI TECHNOL; Zhu TT, 2015, ECOL ENG, V82, P459, DOI 10.1016/j.ecoleng.2015.05.017	43	52	52	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210339	10.1371/journal.pone.0210339	http://dx.doi.org/10.1371/journal.pone.0210339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699142	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000457155600030
J	Yang, B; Jiang, WD; Wu, P; Liu, Y; Zeng, YY; Jiang, J; Kuang, SY; Tang, L; Tang, WN; Wang, SW; Zhou, XQ; Feng, L				Yang, Bo; Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Zeng, Yun-Yun; Jiang, Jun; Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng; Wang, Shang-Wen; Zhou, Xiao-Qiu; Feng, Lin			Soybean isoflavones improve the health benefits, flavour quality indicators and physical properties of grass carp (Ctenopharygodon idella)	PLOS ONE			English	Article							WATER-HOLDING CAPACITY; NF-KAPPA-B; FLESH QUALITY; SOY ISOFLAVONES; AMINO-ACIDS; ANTIOXIDANT CAPACITY; GROWTH-PERFORMANCE; PROTEIN-SYNTHESIS; MEAT QUALITY; FATTY-ACIDS	Health benefits, flavour quality indicators and physical properties were analysed after feeding grass carp graded concentrations of soybean isoflavones (SIF) (0, 25, 50, 75, 100 and 125 mg/kg) for 60 days. The results demonstrated that optimal dietary SIF supplementation improved the protein and total PUFA content, especially healthcare n-3 PUFA (C18: 3n-3, EPA and DHA), and increased the flavour-related free amino acid [especially umami amino acid] and 5'-inosine monophosphate content, improving the health benefits and flavour quality indicators in the muscle of grass carp. In addition, optimal dietary SIF supplementation (25 or 50 mg SIF/kg diet) enhanced some physical properties [water-holding capacity and tenderness] and increased the collagen content; however, it reduced cathepsin activity and apoptosis. SIF supplementation enhanced the glutathione content and the activity of antioxidant enzymes (except CuZnSOD) by regulating their gene expression. The gene expression could be regulated by NF-E2-related factor 2 (Nrf2) signalling in the muscle of grass carp. We demonstrated that optimal dietary SIF supplementation elevated the health benefits, flavour quality indicators and physical properties of fish muscle.	[Yang, Bo; Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Zeng, Yun-Yun; Jiang, Jun; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Zhou, Xiao-Qiu; Feng, Lin] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Wang, Shang-Wen] Tongwei Res Inst, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.; Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China.; Zhou, XQ; Feng, L (corresponding author), Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu, Sichuan, Peoples R China.	xqzhouqq@tom.com; fenglin@sicau.edu.cn	Jun, Jiang/CAE-8962-2022; jiang, jun/GWC-9329-2022; liu, yang/HHY-8583-2022		National Basic Research Program of China (973 Program) [2014CB138600]; National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Earmarked Fund for China Agriculture Research System [CARS-45]; Outstanding Talents and Innovative Team of Agricultural Scientific Research (Ministry of Agriculture); Science and Technology Support Program of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2013NC0045]; Foundation of Sichuan Youth Science and Technology Innovation Research Team [2017TD0002]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Modern Agricultural Industry Technology System of Sichuan Freshwater Fish Innovation Team; 111 Project [D17015]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Department Public Benefit Research Foundation (Agriculture) of China; Earmarked Fund for China Agriculture Research System; Outstanding Talents and Innovative Team of Agricultural Scientific Research (Ministry of Agriculture); Science and Technology Support Program of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Foundation of Sichuan Youth Science and Technology Innovation Research Team; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Modern Agricultural Industry Technology System of Sichuan Freshwater Fish Innovation Team; 111 Project(Ministry of Education, China - 111 Project)	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600) to XQZ, National Department Public Benefit Research Foundation (Agriculture) of China (201003020) to XQZ, The Earmarked Fund for China Agriculture Research System (CARS-45) to XQZ, Outstanding Talents and Innovative Team of Agricultural Scientific Research (Ministry of Agriculture) to XQZ, Science and Technology Support Program of Sichuan Province of China (2014NZ0003) to XQZ, Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2013NC0045) to XQZ, Foundation of Sichuan Youth Science and Technology Innovation Research Team (2017TD0002) to LF, The Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011) to XQZ and the Modern Agricultural Industry Technology System of Sichuan Freshwater Fish Innovation Team and the 111 Project (D17015) to LF. The authors would like to thank the personnel of these teams for their kind assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), National Department Public Benefit Research Foundation (Agriculture) of China (201003020), The Earmarked Fund for China Agriculture Research System (CARS-45), Outstanding Talents and Innovative Team of Agricultural Scientific Research (Ministry of Agriculture), Science and Technology Support Program of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2013NC0045), Foundation of Sichuan Youth Science and Technology Innovation Research Team (2017TD0002), The Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), the Modern Agricultural Industry Technology System of Sichuan Freshwater Fish Innovation Team and the 111 Project (D17015). The authors would like to thank the personnel of these teams for their kind assistance.	Achouri A, 2005, FOOD RES INT, V38, P1199, DOI 10.1016/j.foodres.2005.05.005; Alexander AN, 2002, DIGEST DIS SCI, V47, P1129, DOI 10.1023/A:1015010728696; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; Archile-Contreras AC, 2011, FOOD RES INT, V44, P582, DOI 10.1016/j.foodres.2010.12.002; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; Briggs MA, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020029; Caballero-Benitez A, 2003, J NEUROSCI RES, V71, P383, DOI 10.1002/jnr.10493; Calvo L, 2016, MEAT SCI, V121, P1, DOI 10.1016/j.meatsci.2016.05.006; CAMBERO MI, 1992, J FOOD SCI, V57, P1285, DOI 10.1111/j.1365-2621.1992.tb06838.x; CASSIDY A, 1995, BRIT J NUTR, V74, P587, DOI 10.1079/BJN19950160; Cha Y. J., 1998, J FOOD SCI NUTR, V3, P15; Chen W, 2014, FOOD CHEM TOXICOL, V67, P72, DOI 10.1016/j.fct.2014.02.004; Chen XX, 2017, J AGR FOOD CHEM, V65, P3986, DOI 10.1021/acs.jafc.7b01267; Ganguly S, 2018, FOOD RES INT, V103, P21, DOI 10.1016/j.foodres.2017.10.017; Hagen O, 2008, J AGR FOOD CHEM, V56, P5953, DOI 10.1021/jf801215b; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; Houlihan D.F., 1995, Biochemistry and Molecular Biology of Fishes, V4, P191; JACKIM E, 1973, COMP BIOCHEM PHYSIOL, V44, P851, DOI 10.1016/0300-9629(73)90148-5; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Jiang J, 2015, FOOD CHEM, V167, P91, DOI [10.1016/j.foodchem.2014.06.091, DOI 10.1016/J.FOODCHEM.2014.06.091]; Jiang WD, 2016, FOOD RES INT, V89, P670, DOI 10.1016/j.foodres.2016.09.020; Jiang WD, 2016, FOOD CHEM, V199, P210, DOI 10.1016/j.foodchem.2015.12.003; Jiang ZY, 2007, POULTRY SCI, V86, P1356, DOI 10.1093/ps/86.7.1356; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; Jurado A, 2007, MEAT SCI, V75, P585, DOI 10.1016/j.meatsci.2006.09.006; Kawai M, 2002, CHEM SENSES, V27, P739, DOI 10.1093/chemse/27.8.739; Lee DH, 2012, ASIAN AUSTRAL J ANIM, V25, P1419, DOI 10.5713/ajas.2012.12184; Li FN, 2011, ANIMAL, V5, P1903, DOI 10.1017/S1751731111001194; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MP, 2008, NUTR RES, V28, P464, DOI 10.1016/j.nutres.2008.03.009; Marcincak S, 2011, SLOV VET RES, V48, P27; NAIM M, 1974, J AGR FOOD CHEM, V22, P806, DOI 10.1021/jf60195a031; Navarrogarcia G, 2014, INT FOOD RES J; Nguyen NH, 2010, WIR COMM NETW C WCNC, P1; NISHIMURA T, 1988, AGR BIOL CHEM TOKYO, V52, P2323; Pan FY, 2016, FISH SHELLFISH IMMUN, V56, P208, DOI 10.1016/j.fsi.2016.07.020; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; Rossi R, 2017, J SCI FOOD AGR, V97, P4690, DOI 10.1002/jsfa.8334; Rowe LJ, 2004, J ANIM SCI, V82, P785; Ruiz-Capillas C, 2004, FOOD CHEM, V86, P85, DOI 10.1016/j.foodchem.2003.08.019; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Suh KS, 2003, PHYTOCHEMISTRY, V63, P209, DOI 10.1016/S0031-9422(03)00101-8; Takahashi Y, 2007, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.011.2007; Tomobe K, 2012, ARCH GERONTOL GERIAT, V54, pE1, DOI 10.1016/j.archger.2011.06.006; USA CoNRoF, 2011, NUTR REQ FISH SHRIMP; Vani ND, 2006, LWT-FOOD SCI TECHNOL, V39, P627, DOI 10.1016/j.lwt.2005.05.003; Vicario M, 2007, J NUTR, V137, P1931, DOI 10.1093/jn/137.8.1931; Viji P, 2017, FISH TECHNOL, V54, P145; Wang B, 2015, AQUAT TOXICOL, V158, P125, DOI 10.1016/j.aquatox.2014.10.025; Wang B, 2017, EXP THER MED, V14, P276, DOI 10.3892/etm.2017.4469; Wang XF, 2014, POULTRY SCI, V93, P2802, DOI 10.3382/ps.2013-03815; Wen J, 2015, ANIM NUTR, V1, P77, DOI 10.1016/j.aninu.2015.05.004; Williams CD, 2011, NUTR RES, V31, P1, DOI 10.1016/j.nutres.2011.01.002; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Wu YP, 2015, AQUAC RES, V46, P2360, DOI 10.1111/are.12392; Xi YD, 2014, NEUROCHEM RES, V39, P1374, DOI 10.1007/s11064-014-1319-x; Xu HJ, 2016, FISH SHELLFISH IMMUN, V58, P177, DOI 10.1016/j.fsi.2016.09.029; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yamanaka H, 1996, FISHERIES SCI, V62, P821, DOI 10.2331/fishsci.62.821; Yu DW, 2018, FOOD CHEM, V242, P412, DOI 10.1016/j.foodchem.2017.09.037; Yurko-Mauro K, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0109-z; Zeng YY, 2015, AQUACULT NUTR, DOI [10.1111/anu.12403, DOI 10.1111/ANU.12403]; Zhang L, 2016, AQUACULT NUTR, V22, P191, DOI 10.1111/anu.12237; Zhang MH, 2013, FOOD CHEM, V138, P96, DOI 10.1016/j.foodchem.2012.10.142; Zhao HF, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0531-4; Zheng JY, 2015, FISHERIES SCI, V81, P559, DOI 10.1007/s12562-015-0858-7; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zhou CP, 2015, FISH SHELLFISH IMMUN, V47, P1043, DOI 10.1016/j.fsi.2015.10.036	69	14	14	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0209570	10.1371/journal.pone.0209570	http://dx.doi.org/10.1371/journal.pone.0209570			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699129	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600012
J	Griffin, LP; Griffin, CR; Finn, JT; Prescott, RL; Faherty, M; Still, BM; Danylchuk, AJ				Griffin, Lucas P.; Griffin, Curtice R.; Finn, John T.; Prescott, Robert L.; Faherty, Mark; Still, Brett M.; Danylchuk, Andy J.			Warming seas increase cold-stunning events for Kemp's ridley sea turtles in the northwest Atlantic	PLOS ONE			English	Article							GULF-OF-MEXICO; OIL-SPILL; PATTERNS; STRANDINGS; MORTALITY; HABITAT; MODELS; WATERS; LAGOON; LOST	Since the 1970s, the magnitude of turtle cold-stun strandings have increased dramatically within the northwestern Atlantic. Here, we examine oceanic, atmospheric, and biological factors that may affect the increasing trend of cold-stunned Kemp's ridleys in Cape Cod Bay, Massachusetts, United States of America. Using machine learning and Bayesian inference modeling techniques, we demonstrate higher cold-stunning years occur when the Gulf of Maine has warmer sea surface temperatures in late October through early November. Surprisingly, hatchling numbers in Mexico, a proxy for population abundance, was not identified as an important factor. Further, using our Bayesian count model and forecasted sea surface temperature projections, we predict more than 2,300 Kemp's ridley turtles may coldstun annually by 2031 as sea surface temperatures continue to increase within the Gulf of Maine. We suggest warmer sea surface temperatures may have modified the northerly distribution of Kemp's ridleys and act as an ecological bridge between the Gulf Stream and nearshore waters. While cold-stunning may currently account for a minor proportion of juvenile mortality, we recommend continuing efforts to rehabilitate cold-stunned individuals to maintain population resiliency for this critically endangered species in the face of a changing climate and continuing anthropogenic threats.	[Griffin, Lucas P.; Griffin, Curtice R.; Finn, John T.; Danylchuk, Andy J.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Prescott, Robert L.; Faherty, Mark] Massachusetts Audubon Soc, Wellfleet Bay Wildlife Sanctuary, South Wellfleet, MA USA; [Still, Brett M.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Rhode Island	Griffin, LP (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	lucaspgriffin@gmail.com		Griffin, Lucas/0000-0002-8560-0683				Avens L, 2012, P 31 ANN S SEA TURTL; Bailey LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167980; Bevan E, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1244; BLEAKNEY J. SHERMAN, 1965, CAN FIELD NATUR, V79, P120; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briscoe DK, 2017, DEEP-SEA RES PT II, V140, P182, DOI 10.1016/j.dsr2.2016.11.004; BURKE VJ, 1991, COPEIA, P1136; Butt N, 2016, BIOL CONSERV, V204, P189, DOI 10.1016/j.biocon.2016.10.012; Caillouet Charles W. Jr, 2011, Marine Turtle Newsletter, V130, P1; Caillouet Charles W. Jr., 2014, Marine Turtle Newsletter, P1; Caillouet Charles W. Jr, 2010, Marine Turtle Newsletter, V128, P1; CARR A, 1986, BIOSCIENCE, V36, P92, DOI 10.2307/1310109; CARR A, 1987, Conservation Biology, V1, P103, DOI 10.1111/j.1523-1739.1987.tb00020.x; Clayton D., 1992, STAT MODELS LONGITUD, P301; Coles WC, 2000, COPEIA, P551, DOI 10.1643/0045-8511(2000)000[0551:SSSTAA]2.0.CO;2; Crowder L, 2011, SOLUTIONS, V2, P67; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; EPPERLY SP, 1995, CONSERV BIOL, V9, P384, DOI 10.1046/j.1523-1739.1995.9020384.x; Gallaway Benny J., 2016, Gulf of Mexico Science, V33, P138; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Heppell SS, 2002, BIOL SEA TURTLES, VII, P275; Hunt KE, 2016, CONSERV PHYSIOL, V4; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Bellido JJ, 2010, CHELONIAN CONSERV BI, V9, P276, DOI 10.2744/CCB-0802.1; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Kocmoud AR, 2019, ECOL MODEL, V392, P159, DOI 10.1016/j.ecolmodel.2018.11.014; Laloe JO, 2016, J EXP MAR BIOL ECOL, V474, P92, DOI 10.1016/j.jembe.2015.09.015; LAZELL JD, 1980, COPEIA, P290, DOI 10.2307/1444006; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; Martino S., 2009, IMPLEMENTING APPROXI; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; Mazaris AD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600730; MEYLAN AB, 1986, NAT HIST, V95, P90; Monzon-Arguello C, 2012, J R SOC INTERFACE, V9, P1725, DOI 10.1098/rsif.2011.0788; Morreale SJ, 2005, CHELONIAN CONSERV BI, V4, P872; MORREALE SJ, 1992, J HERPETOL, V26, P301, DOI 10.2307/1564885; Muff S, 2015, J R STAT SOC C-APPL, V64, P231, DOI 10.1111/rssc.12069; Musick John A., 1997, P137; Musick John A., 1994, NOAA Technical Memorandum NMFS-SEFSC, V341, P121; National Marine Fisheries Service (NMFS) and US Fish and Wildlife Service (US FWS), 2015, KEMPS RIDL SEA TURTL; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pirhalla DE, 2015, ESTUAR COAST, V38, P2310, DOI 10.1007/s12237-014-9918-y; Provancha JA, 2012, P 31 ANN S SEA TURTL; Putman NF, 2015, CURR BIOL, V25, P1221, DOI 10.1016/j.cub.2015.03.014; Putman NF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0345; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Roberts K, 2014, PHYS GEOGR, V35, P134, DOI 10.1080/02723646.2014.898573; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schwartz FJ, 1978, FLORIDA MARINE RES P, V33, P16; Shoop C.R., 1992, Herpetological Monographs, P43; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spotila James R., 1997, P297; Still BM, 2005, CHELONIAN CONSERV BI, V4; Taylor AH, 1998, TELLUS A, V50, P134, DOI 10.1034/j.1600-0870.1998.00010.x; Team RS, 2015, RSTUDIO INT DEV ENV; Turner BE, 2000, IAU SYMP, P31; Turtle Expert Working Group, 2000, NMFSSEFSC444 NOAA TU, V444, P115; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; Visbeck M., 2003, GEOPHYS MONOGR SER, V134, P113, DOI DOI 10.1029/134GM06; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; WITHERINGTON BE, 1989, COPEIA, P696; Zuur A. F., 2017, BEGINNERS GUIDE SPAT	67	21	23	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211503	10.1371/journal.pone.0211503	http://dx.doi.org/10.1371/journal.pone.0211503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695074	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400040
J	Jiao, Y; Fu, Z; Li, YQ; Zhang, W; Liu, YH				Jiao, Yan; Fu, Zhuo; Li, Yanqing; Zhang, Wei; Liu, Yahui			Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer	PLOS ONE			English	Article							INTERACTOR CATS; PROTEIN; GENES; CALM	FAM64A, a marker of cell proliferation, has been investigated as a potential biomarker in several cancers. In the present study, we examined the value of FAM64A expression in the diagnosis and prognosis of pancreatic cancer through bioinformatics analysis of data obtained from The Cancer Genome Atlas (TCGA) database. The diagnostic value of FAM64A expression in pancreatic cancer tissue was deteremined through receiver operating characteristic (ROC) curve analysis, and based on the obtained cut-off value, patients were divided into two groups (high FAM64A expression and low FAM64A expression). Chi-square and Fisher exact tests were applied to identify associations between FAM64A expression and clinical features. Moreover, the effect of FAM64A expression in the survival of pancreatic cancer patients was observed by Kaplan-Meier and Cox analyses. Gene set enrichment analysis (GSEA) was performed using the TCGA dataset. Our results showed that high FAM64A expression in pancreatic cancer was associated with survival status, overall survival (OS), and recurrence. The area under the ROC curve was 0.736, which indicated modest diagnostic value. Patients with higher FAM64A expression had significantly shorter OS and recurrence-free survival (RFS) times. Multivariate survival analysis demonstrated that high FAM64A expression was an independent risk factor for OS and RFS. GSEA identified mitotic spindles, myc targets, MTORC1 signaling, G2M checkpoint, E2F targets, DNA repair, glycolysis and unfolded protein response as differentially enriched with the high FAM64A expression phenotype. In conclusion, high FAM64A mRNA expression is an independent risk factor for poor prognosis in pancreatic cancer.	[Jiao, Yan; Zhang, Wei; Liu, Yahui] Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Fu, Zhuo] Jilin Univ, Hosp 1, Dept Hand & Foot Surg, Changchun, Jilin, Peoples R China; [Li, Yanqing] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Liu, YH (corresponding author), Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China.	liuyahui2008@yeah.net	jiao, yan/Q-1481-2019; , 付卓/AAV-3208-2020	jiao, yan/0000-0001-6914-7949; Fu, Zhuo/0000-0001-6462-7695				Archangelo LF, 2006, ONCOGENE, V25, P4099, DOI 10.1038/sj.onc.1209438; Archangelo LF, 2013, BBA-MOL CELL RES, V1833, P1269, DOI 10.1016/j.bbamcr.2013.02.004; Archangelo LF, 2008, MOL ONCOL, V2, P356, DOI 10.1016/j.molonc.2008.08.001; Barbutti I, 2016, ONCOTARGET, V7, P68385, DOI 10.18632/oncotarget.11630; Hashimoto K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04823-1; Hu SF, 2017, ONCOTARGET, V8, P41334, DOI 10.18632/oncotarget.17295; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kimes PK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku521; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Stelzer G, 2016, GENECARDS SUITE GENE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RDC, 2012, COMPUTING, V1, P12; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Therneau TM, 2000, TECHNOMETRICS, V97, P353; Tony G, 2012, HALLMARKS CANC, V9, P703, DOI [10.4161/rna.20481, DOI 10.4161/RNA.20481]; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yamada Y, 2018, CANCER SCI, V109, P2919, DOI 10.1111/cas.13722; Zhang C, 2014, INT J ONCOL, V44, P2025, DOI 10.3892/ijo.2014.2352; Zhang LL, 2018, WORLD J GASTROENTERO, V24, P2047, DOI 10.3748/wjg.v24.i19.2047	20	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211291	10.1371/journal.pone.0211291	http://dx.doi.org/10.1371/journal.pone.0211291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695070	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400023
J	Kanmiki, EW; Awoonor-Williams, JK; Phillips, JF; Kachur, SP; Achana, SF; Akazili, J; Bawah, AA				Kanmiki, Edmund Wedam; Awoonor-Williams, John Koku; Phillips, James F.; Kachur, Stephen Patrick; Achana, Sabastian F.; Akazili, James; Bawah, Ayaga A.			Socio-economic and demographic disparities in ownership and use of insecticide- treated bed nets for preventing malaria among rural reproductive-aged women in northern Ghana	PLOS ONE			English	Article								Background Malaria continues to be a leading cause of morbidity and mortality in most countries in SubSaharan Africa. Insecticide-treated bed nets (ITNs) is one of the cost-effective interventions for preventing malaria in endemic settings. Ghana has made tremendous efforts to ensure widespread ownership and use of ITNs. However, national coverage statistics can mask important inequities that demand targeted attention. This study assesses the disparities in ownership and utilization of ITNs among reproductive-aged women in a rural impoverished setting of Ghana. Methods Population-based cross-sectional data of 3,993 women between the age of 15 and 49 years were collected in seven districts of the Upper East region of Ghana using a two-stage cluster sampling approach. Bivariate and multivariate regression models were used to assess the social, economic and demographic disparities in ownership and utilization of ITN and to compare utilization rates among women in households owning at least one ITN. Results As high as 79% of respondents were found to own ITN while 62% of ITN owners used them the night preceding the survey. We identified disparities in both ownership and utilization of ITNs in wealth index, occupational status, religion, and district of residence. Respondents in the relative richest wealth quintile were 74% more likely to own ITNs compared to those in the poorest quintile (p-value< 0.001, CI = 1.29-2.34) however, they were 33% less likely to use ITNs compared to the poorest (p-value = 0.01, CI = 0.50-0.91). Conclusion Interventions aimed at preventing and controlling malaria through the use of bed nets in rural Ghana and other similar settings should give more attention to disadvantage populations such as the poor and unemployed. Tailored massages and educational campaigns are required to ensure consistent use of treated bed nets.	[Kanmiki, Edmund Wedam; Bawah, Ayaga A.] Univ Ghana, Reg Inst Populat Studies, Accra, Ghana; [Awoonor-Williams, John Koku] Ghana Hlth Serv, Policy Planning Monitoring & Evaluat Div, Accra, Ghana; [Phillips, James F.; Kachur, Stephen Patrick] Columbia Univ, Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY USA; [Achana, Sabastian F.; Akazili, James] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Upper East Region, Navrongo, Ghana	University of Ghana; Ghana Health Service; Columbia University; Ghana Health Service; Navrongo Health Research Center	Kanmiki, EW (corresponding author), Univ Ghana, Reg Inst Populat Studies, Accra, Ghana.	eddykan100@gmail.com	Kachur, Patrick/ABE-7220-2021; Kanmiki, Edmund Wedam/AAF-7415-2020; Phillips, James F./AAE-5123-2019	Kanmiki, Edmund Wedam/0000-0001-7175-5222; Phillips, James F./0000-0002-6720-7204	Doris Duke Charitable Foundation's (DDCF) African Health Initiative [200905813]	Doris Duke Charitable Foundation's (DDCF) African Health Initiative(Doris Duke Charitable Foundation (DDCF))	The Ghana Essential Health Intervention Program (GEHIP) was supported by grants from the Doris Duke Charitable Foundation's (DDCF) African Health Initiative. Grant number 200905813. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Akazili J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0637-7; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; Ankomah A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-105; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; [Anonymous], 1998, COCHRANE DB SYST REV; Awintuen I, 2018, SOCIODEMOGRAPHIC DE, P1; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Batisso E, 2012, MALARIA J, V11, P1; Baume CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-265; Centers for Disease Control and Prevention, MAL WORLDW IMP MAL; Ernst KC, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1660-4; Eteng M, 2014, MALARIA J, V13, P1; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Ghana Health Service, 2015, GHAN HLTH SERV 2014; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV R; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV R; Ghana Statistical Service (GSS) GHSG and ICF, 2017, GHAN MAL IND SURV 20; Goesch JN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-60; Graves PM., 2011, MALARIA J, V10, P1; GSS, 2016, POP STAT; Kanmiki EW, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-24; Manu Grace, 2017, Malar Res Treat, V2017, P7481210, DOI 10.1155/2017/7481210; Mueller DH, MALAR J, V7, P1; National Malaria Control Programme Ghana, 2015, 2015 ANN REP NAT MAL; Roll Back Malaria, 2005, GLOB ESTR PLAN ROLL; Roll Back Malaria, GLOB ESTR PLAN ROLL; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Singh M, 2013, MALARIA J, V12, P1; Willey BA, 2012, B WORLD HEALTH ORGAN, V90, P672, DOI 10.2471/BLT.11.094771; World Health Organization, 2017, DEPRESSION	31	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211365	10.1371/journal.pone.0211365	http://dx.doi.org/10.1371/journal.pone.0211365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695044	gold, Green Published, Green Submitted			2022-12-26	WOS:000457046400031
J	Fung, JST; Akech, S; Kissoon, N; Wiens, MO; English, M; Ansermino, JM				Fung, Jollee S. T.; Akech, Samuel; Kissoon, Niranjan; Wiens, Matthew O.; English, Mike; Ansermino, J. Mark			Determining predictors of sepsis at triage among children under 5 years of age in resource-limited settings: A modified Delphi process	PLOS ONE			English	Article							MORTALITY	Sepsis is a life-threatening dysfunction of the immune system leading to multiorgan failure that is precipitated by infectious diseases and is a leading cause of death in children under 5 years of age. It is necessary to be able to identify a sick child at risk of developing sepsis at the earliest point of presentation to a healthcare facility so that appropriate care can be provided as soon as possible. Our study objective was to generate a list of consensus-driven predictor variables for the derivation of a prediction model that will be incorporated into a mobile device and operated by low-skilled healthcare workers at triage. By conducting a systematic literature review and examination of global guideline documents, a list of 72 initial candidate predictor variables was generated. A two-round modified Delphi process involving 26 experts from both resource-rich and resource-limited settings, who were also encouraged to suggest new variables, yielded a final list of 45 predictor variables after evaluating each variable based on three domains: predictive potential, measurement reliability, and level of training and resources required. The final list of predictor variables will be used to collect data and contribute to the derivation of a prediction model.	[Fung, Jollee S. T.; Kissoon, Niranjan; Wiens, Matthew O.; Ansermino, J. Mark] BC Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC, Canada; [Fung, Jollee S. T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Akech, Samuel; English, Mike] KEMRI Wellcome Trust, CanadaHlth Serv Unit, Nairobi, Kenya; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat & Emergency Med, Vancouver, BC, Canada; [Wiens, Matthew O.; Ansermino, J. Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Ansermino, J. Mark] Univ British Columbia, CanadaSch Populat & Publ Hlth, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Ansermino, JM (corresponding author), BC Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC, Canada.; Ansermino, JM (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.; Ansermino, JM (corresponding author), Univ British Columbia, CanadaSch Populat & Publ Hlth, Vancouver, BC, Canada.	anserminos@yahoo.ca	Wiens, Matthew/J-9249-2019; Kissoon, Niranjan/AAC-6140-2021	English, Michael/0000-0002-7427-0826; Ansermino, J Mark/0000-0001-8427-2035; Akech, Samuel/0000-0001-5126-1225; Kissoon, Niranjan/0000-0001-8847-9973; Wiens, Matthew/0000-0002-3287-5181				[Anonymous], 2011, CAR SICK CHILD; Eubank BH, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0165-8; Fleischmann-Struzek C, 2018, LANCET RESP MED, V6, P223, DOI 10.1016/S2213-2600(18)30063-8; Global Sepsis Alliance, 2017, WHA AD RES SEPS; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hsu CC, 2007, PARE, V12, P1; Kissoon N, 2017, PEDIATR CRIT CARE ME, V18, pE625, DOI 10.1097/PCC.0000000000001340; Kissoon N, 2016, JAMA PEDIATR, V170, P107, DOI 10.1001/jamapediatrics.2015.3241; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Pashankar D, 2001, Pediatr Rev, V22, P219, DOI 10.1542/pir.22-7-219; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Rudd KE, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2157-z; The Emergency Medicine Society of South Africa, 2012, S AFR TRIAG SCAL SAT S AFR TRIAG SCAL SAT; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; WHO, 2014, IMCI CHART BOOKL; Wiens MO, 2016, AFR HEALTH SCI, V16, P162, DOI 10.4314/ahs.v16i1.22; World Health Organization, 2005, EM TRIAG ASS TREATM; World Health Organization, 2017, CHILDREN REDUCING MO	18	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211274	10.1371/journal.pone.0211274	http://dx.doi.org/10.1371/journal.pone.0211274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689660	Green Submitted, Green Published, gold			2022-12-26	WOS:000457041800024
J	Koeppen, K; Barnaby, R; Jackson, AA; Gerber, SA; Hogan, DA; Stanton, BA				Koeppen, Katja; Barnaby, Roxanna; Jackson, Angelyca A.; Gerber, Scott A.; Hogan, Deborah A.; Stanton, Bruce A.			Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles	PLOS ONE			English	Article							CYSTIC-FIBROSIS; INHALED TOBRAMYCIN; ALKALINE PROTEASE; BIOFILM FORMATION; GENE-EXPRESSION; ACTIVATION; CFTR; AZTREONAM; TRANSPORT; PROTEINS	Tobramycin is commonly used to treat Pseudomonas aeruginosa lung infections in patients with Cystic Fibrosis (CF). Tobramycin treatment leads to increased lung function and fewer clinical exacerbations in CF patients, and modestly reduces the density of P. aeruginosa in the lungs. P. aeruginosa resides primarily in the mucus overlying lung epithelial cells and secretes outer membrane vesicles (OMVs) that diffuse through the mucus and fuse with airway epithelial cells, thus delivering virulence factors into the cytoplasm that modify the innate immune response. The goal of this study was to test the hypothesis that Tobramycin reduces the abundance of virulence factors in OMVs secreted by P. aeruginosa. Characterization of the proteome of OMVs isolated from control or Tobramycin-exposed P. aeruginosa strain PAO1 revealed that Tobramycin reduced several OMV-associated virulence determinants, including AprA, an alkaline protease that enhances P. aeruginosa survival in the lung, and is predicted to contribute to the inhibitory effect of P. aeruginosa on Phe508del-CFTR Cl(-)secretion by primary human bronchial epithelial cells. Deletion of the gene encoding AprA reduced the inhibitory effect of P. aeruginosa on Phe508del-CFTR Cl- secretion. Moreover, as predicted by our proteomic analysis, OMVs isolated from Tobramycin treated P. aeruginosa had a diminished inhibitory effect on Phe508del-CFTR Cl- secretion compared to OMVs isolated from control P. aeruginosa. Taken together, our proteomic analysis of OMVs and biological validation suggest that Tobramycin may improve lung function in CF patients infected with P. aeruginosa by reducing several key virulence factors in OMVs that reduce CFTR Cl- secretion, which is essential for bacterial clearance from the lungs.	[Koeppen, Katja; Barnaby, Roxanna; Jackson, Angelyca A.; Hogan, Deborah A.; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Gerber, Scott A.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA	Dartmouth College; Dartmouth College	Koeppen, K (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	Katja.UU.Koeppen@Dartmouth.edu		Gerber, Scott/0000-0002-2964-5051	Cystic Fibrosis Foundation [STANTO16G0, STANTO19R0]; National Institutes of Health [R01-HL-074175, P30-GM106394, R01-AI091702, R01-GM122846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394, R01GM122846] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Cystic Fibrosis Foundation (www.cff.org), STANTO16G0 and STANTO19R0 to BAS as well as the National Institutes of Health (www.nih.gov), R01-HL-074175 and P30-GM106394 to BAS, R01-AI091702 to DAH, and R01-GM122846 to SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; Reales-Calderon JA, 2015, J PROTEOMICS, V127, P352, DOI 10.1016/j.jprot.2015.06.009; Ballok AE, 2014, J BACTERIOL, V196, P3633, DOI 10.1128/JB.01760-14; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bonnington KE, 2014, BBA-MOL CELL RES, V1843, P1612, DOI 10.1016/j.bbamcr.2013.12.011; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Butterworth MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100313; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Chen H P, 2016, APPL SCI, V179, P1, DOI DOI 10.1038/SREP28902; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Choi H, 2015, J PROTEOMICS, V129, P121, DOI 10.1016/j.jprot.2015.07.036; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Firoved AM, 2003, J BACTERIOL, V185, P1071, DOI 10.1128/JB.185.3.1071-1081.2003; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Hampton CM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02177; Hodson M E, 2002, J Cyst Fibros, V1, P199, DOI 10.1016/S1569-1993(02)00004-8; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; Hvorecny KL, 2018, AM J PHYSIOL-LUNG C, V314, pL150, DOI 10.1152/ajplung.00383.2017; Jackson AA, 2014, MICROBIOL-SGM, V160, P2215, DOI 10.1099/mic.0.081158-0; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; Klimentova J, 2015, MICROBIOL RES, V170, P1, DOI 10.1016/j.micres.2014.09.006; Koeppen K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005672; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; Lee SA, 2018, DEV COMP IMMUNOL, V81, P116, DOI 10.1016/j.dci.2017.11.014; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Maille E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00470; McFarland KA, 2015, P NATL ACAD SCI USA, V112, P8433, DOI 10.1073/pnas.1506299112; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Moss RB, 2002, CHEST, V121, P55, DOI 10.1378/chest.121.1.55; Trinh NTN, 2015, EUR RESPIR J, V45, P1590, DOI 10.1183/09031936.00076214; Park AJ, 2015, J PROTEOME RES, V14, P4524, DOI 10.1021/acs.jproteome.5b00262; Perez-Cruz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116896; RAMSEY BW, 1993, NEW ENGL J MED, V328, P1740, DOI 10.1056/NEJM199306173282403; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; READ RC, 1992, J APPL PHYSIOL, V72, P2271, DOI 10.1152/jappl.1992.72.6.2271; Rubino R, 2014, PFLUG ARCH EUR J PHY, V466, P2269, DOI 10.1007/s00424-014-1474-6; Saint-Criq V, 2018, THORAX, V73, P49, DOI 10.1136/thoraxjnl-2017-210298; Saint-Criq V, 2017, CELL MOL LIFE SCI, V74, P93, DOI 10.1007/s00018-016-2391-y; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Stanton BA, 2017, AM J PHYSIOL-CELL PH, V312, pC357, DOI 10.1152/ajpcell.00373.2016; Stanton BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127742; Talebian L, 2009, CELL PHYSIOL BIOCHEM, V23, P199, DOI 10.1159/000204108; Team R Core, 2017, R LANG ENV STAT COMP; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wu X, 2015, MOL CELL PROTEOMICS, V14, P2126, DOI 10.1074/mcp.M115.050161; Yu QR, 2012, J ANTIMICROB CHEMOTH, V67, P2673, DOI 10.1093/jac/dks296; Zhang AD, 2012, EUKARYOT CELL, V11, P874, DOI 10.1128/EC.00095-12	60	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211290	10.1371/journal.pone.0211290	http://dx.doi.org/10.1371/journal.pone.0211290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682135	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500144
J	Saari, H; Wahlgren, M; Rayner, M; Sjoo, M; Matos, M				Saari, Hisfazilah; Wahlgren, Marie; Rayner, Marilyn; Sjoo, Malin; Matos, Maria			A comparison of emulsion stability for different OSA-modified waxy maize emulsifiers: Granules, dissolved starch, and non-solvent precipitates	PLOS ONE			English	Article							HYDROPHOBICALLY-MODIFIED STARCH; PICKERING-TYPE EMULSIONS; PARTICLES; NANOPARTICLES; FOOD; RETROGRADATION; SIZE; EMULSIFICATION; STABILIZATION; DISSOLUTION	This work investigates the stability of emulsions prepared by using octenyl succinic anhydride (OSA)-modified waxy maize starch in the form of granules, dissolved starch, and non-solvent precipitated starch as Pickering emulsion stabilisers. The aim of this study was to investigate the effects of different forms of starches on the stability of emulsion using light microscopy, light scattering, and static multiple light scattering. All starch samples were hydrophobically modified with 3% (w/w) n-octenyl succinyl anhydride (OSA). Starch polymer solutions were prepared by dissolving OSA-modified starch in water in an autoclave at 140 degrees C. Non-solvent precipitates were obtained through ethanol precipitation of dissolved waxy maize. The stability of the oil/water emulsions were different for the three forms of starches used. The granule-based emulsions were unstable, with only a small proportion of the granules adsorbed onto oil droplets, as viewed under a light microscope. The emulsions were observed to cream after 2 hours. The dissolved starch and non-solvent precipitate-based emulsions were stable towards creaming for months, and they had almost 100% emulsifying index (EI = 1) by visual observation and EI similar to 0.9 by multiple light scattering measurements. The results from light microscopy and multiple light scattering measurements indicated the occurrence of coalescence for all three types of emulsions. The coalescence was fastest within days for the granule stabilised system while it was slower both for the dissolved starch and non-solvent precipitate-based emulsions. The latter demonstrated the least degree of coalescence over time. Thus, it was concluded that differences in starch particle size and molecular structure influenced the emulsion droplet size and stability. A decreased particle size correlates to a decrease in droplet size, thus increasing stabilisation against creaming. However, stability towards coalescence was low for the large granules but was best for the non-solvent precipitate starch indicating that there is a window of optimal particle size for stability. Thus, best emulsifying properties were obtained with the non-solvent precipitates (similar to 120 nm particle size) where the emulsions remained stable after one year of storage. In conclusion, this study illustrated the potentiality of non-solvent precipitated starch as emulsion stabilizers.	[Saari, Hisfazilah; Wahlgren, Marie; Rayner, Marilyn; Sjoo, Malin] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Matos, Maria] Univ Oviedo, Dept Chem & Environm Engn, Julian Claveria 8, Oviedo, Spain	Lund University; University of Oviedo	Saari, H (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden.	hisfazilah@gmail.com	Rayner, Marilyn D/B-2679-2017	Rayner, Marilyn D/0000-0001-6338-7124; Wahlgren, Marie/0000-0002-1705-3964	Vetenskapsradet (Swedish research council) [2010-5393]	Vetenskapsradet (Swedish research council)(Swedish Research Council)	This work was supported by grant number: 2010-5393, http://www.vr.se/, Vetenskapsradet (Swedish research council). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berton-Carabin CC, 2015, ANNU REV FOOD SCI T, V6, P263, DOI 10.1146/annurev-food-081114-110822; Bromley EHC, 2002, J COLLOID INTERF SCI, V245, P75, DOI 10.1006/jcis.2001.8005; Chin SF, 2011, CARBOHYD POLYM, V86, P1817, DOI 10.1016/j.carbpol.2011.07.012; Dickinson E, 2017, FOOD HYDROCOLLOID, V68, P219, DOI 10.1016/j.foodhyd.2016.06.024; Dickinson E, 2010, CURR OPIN COLLOID IN, V15, P40, DOI 10.1016/j.cocis.2009.11.001; Dokic L, 2012, FOOD HYDROCOLLOID, V29, P185, DOI 10.1016/j.foodhyd.2012.02.008; Eliasson A-C., 2006, CARBOHYDRATES FOOD, V159, P391; Fredriksson H, 1998, CARBOHYD POLYM, V35, P119, DOI 10.1016/S0144-8617(97)00247-6; GUDMUNDSSON M, 1994, THERMOCHIM ACTA, V246, P329, DOI 10.1016/0040-6031(94)80100-2; HALL DM, 1971, TEXT RES J, V41, P880, DOI 10.1177/004051757104101102; Hoover R, 2010, FOOD RES INT, V43, P399, DOI 10.1016/j.foodres.2009.09.001; JANE JL, 1994, STARCH-STARKE, V46, P121, DOI 10.1002/star.19940460402; Kim HY, 2015, COLLOID SURFACE B, V126, P607, DOI 10.1016/j.colsurfb.2014.11.011; Li C, 2012, STARCH-STARKE, V64, P497, DOI 10.1002/star.201100178; Liu HS, 2007, CARBOHYD POLYM, V69, P756, DOI 10.1016/j.carbpol.2007.02.011; Lyklema J, 2005, FUND INTERFACE COLL, V5, P1; Magnusson E, 2011, FOOD HYDROCOLLOID, V25, P764, DOI 10.1016/j.foodhyd.2010.09.006; Marku D, 2012, INT J PHARMACEUT, V428, P1, DOI 10.1016/j.ijpharm.2012.01.031; Matos M, 2017, CARBOHYD POLYM, V169, P127, DOI 10.1016/j.carbpol.2017.04.006; Matos M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160140; Matos M, 2013, COLLOID SURFACE A, V423, P147, DOI 10.1016/j.colsurfa.2013.01.060; Modig G, 2006, FOOD HYDROCOLLOID, V20, P1087, DOI 10.1016/j.foodhyd.2005.12.011; Nilsson L, 2007, LANGMUIR, V23, P2346, DOI 10.1021/la062483b; Nilsson L, 2007, J AGR FOOD CHEM, V55, P1469, DOI 10.1021/jf062087z; Perez-Rea D, 2015, ANAL BIOANAL CHEM, V407, P4315, DOI 10.1007/s00216-015-8611-8; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; Qin Y, 2016, IND CROP PROD, V87, P182, DOI 10.1016/j.indcrop.2016.04.038; Ramsden W, 1903, P R SOC LONDON, V72, P156, DOI 10.1098/rspl.1903.0034; Rayner M, 2014, COLLOID SURFACE A, V458, P48, DOI 10.1016/j.colsurfa.2014.03.053; Rayner M, 2012, FARADAY DISCUSS, V158, P139, DOI 10.1039/c2fd20038d; Saari H., 2017, STARCH STABILIZED PI; Saari H, 2017, CARBOHYD POLYM, V157, P558, DOI 10.1016/j.carbpol.2016.10.003; Saari H, 2016, CEREAL CHEM, V93, P116, DOI 10.1094/CCHEM-05-15-0107-R; Singh N., 2014, MAIZE NUTR DYNAMICS, P65, DOI DOI 10.1007/978-81-322-1623-0_5; Sjoo M, 2015, J COLLOID INTERF SCI, V450, P182, DOI 10.1016/j.jcis.2015.03.004; Sweedman MC, 2014, CARBOHYD POLYM, V112, P85, DOI 10.1016/j.carbpol.2014.05.067; Sweedman MC, 2013, CARBOHYD POLYM, V92, P905, DOI 10.1016/j.carbpol.2012.09.040; Tan Y, 2009, ACS APPL MATER INTER, V1, P956, DOI 10.1021/am900054f; Tang JT, 2015, SOFT MATTER, V11, P3512, DOI 10.1039/c5sm00247h; Tcholakova S, 2008, PHYS CHEM CHEM PHYS, V10, P1608, DOI 10.1039/b715933c; Tesch S, 2002, J FOOD ENG, V54, P167, DOI 10.1016/S0260-8774(01)00206-0; Timgren A, 2013, FOOD SCI NUTR, V1, P157, DOI 10.1002/fsn3.17; Timgren A, 2011, PROC FOOD SCI, V1, P95, DOI 10.1016/j.profoo.2011.09.016; Viswanathan A, 1999, J ENVIRON POLYM DEGR, V7, P191, DOI 10.1023/A:1022830715565; Wahlgren M, 2013, CURR PHARM BIOTECHNO, V14, P1222; WALSTRA P, 1993, CHEM ENG SCI, V48, P333, DOI 10.1016/0009-2509(93)80021-H; Yusoff A, 2011, FOOD HYDROCOLLOID, V25, P42, DOI 10.1016/j.foodhyd.2010.05.004	47	17	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210690	10.1371/journal.pone.0210690	http://dx.doi.org/10.1371/journal.pone.0210690			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726246	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000023
J	Bikbov, MM; Kazakbaeva, GM; Gilmanshin, TR; Zainullin, RM; Arslangareeva, II; Salavatova, VF; Bikbova, GM; Panda-Jonas, S; Nikitin, NA; Zaynetdinov, AF; Nuriev, IF; Khikmatullin, RI; Uzianbaeva, YV; Yakupova, DF; Aminev, SK; Jonas, JB				Bikbov, Mukharram M.; Kazakbaeva, Gyulli M.; Gilmanshin, Timur R.; Zainullin, Rinat M.; Arslangareeva, Inga I.; Salavatova, Venera F.; Bikbova, Guzel M.; Panda-Jonas, Songhomitra; Nikitin, Nikolai A.; Zaynetdinov, Artur F.; Nuriev, Ildar F.; Khikmatullin, Renat I.; Uzianbaeva, Yulia V.; Yakupova, Dilya F.; Aminev, Said K.; Jonas, Jost B.			Axial length and its associations in a Russian population: The Ural Eye and Medical Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AGE-RELATED MACULOPATHY; OCULAR BIOMETRY; INTRAOCULAR-PRESSURE; ADULT-POPULATION; RISK-FACTORS; MACULAR DEGENERATION; VISION IMPAIRMENT; REFRACTIVE ERROR; SYSTEMIC FACTORS	Purpose To assess the normal distribution of axial length and its associations in a population of Russia. Methods The population-based Ural Eye and Medical Study included 5,899 (80.5%) individuals out of 7328 eligible individuals aged 40+ years. The participants underwent an ocular and systemic examination. Axial length was measured sonographically (Ultra-compact A/B/P ultrasound system, Quantel Medical, Cournon d'Auvergne, France). Results Biometric data were available for 5707 (96.7%) individuals with a mean age of 58.8 +/- 10.6 years (range: 40-94 years; 25%, 50%, 75% quartile: 51.0, 58.0, 66.0 years, respectively). Mean axial length was 23.30 +/- 1.10 mm (range: 19.02-32.87mm; 95% confidence interval (CI): 21.36-25.89; 25%, 50%, 75% quartile: 22.65mm, 23.23mm, 23.88mm, resp.). Prevalences of moderate myopia (axial length: 24.5-<26.5mm) and high myopia (axial length >26.5mm) were 555/5707 (8.7%; 95% CI: 9.0,10.5) and 78/5707 (1.4%; 95% CI: 1.1,1.7), respectively. Longer axial length (mean: 23.30 +/- 1.10mm) was associated (correlation coefficient r(2) :0.70) with older age (P<0.001; standardized regression coefficient beta:0.14), taller body height (P<0.001; beta: 0.07), higher level of education (P<0.001; beta:0.04), higher intraocular pressure (P<0.001; beta: 0.03), more myopic spherical refractive error (P<0.001; beta:-0.55), lower corneal refractive power (P<0.001; beta:-0.44), deeper anterior chamber depth (P<0.001; beta:0.20), wider anterior chamber angle (P<0.001; beta:0.05), thinner peripapillary retinal nerve fiber layer thickness (P<0.001; beta:-0.04), higher degree of macular fundus tessellation (P<0.001; beta:0.08), lower prevalence of epiretinal membranes (P = 0.01; beta-0.02) and pseudoexfoliation (P = 0.007; beta:-0.02) and higher prevalence of myopic maculopathy (P<0.001; beta:0.08). In that model, prevalence of age-related macular degeneration (any type: P = 0.84; early type: P = 0.46), diabetic retinopathy (P = 0.16), and region of habitation (P = 0.27) were not significantly associated with axial length. Conclusions Mean axial length in this typically multi-ethnic Russian study population was comparable with values from populations in Singapore and Beijing. In contrast to previous studies, axial length was not significantly related with the prevalences of age-related macular degeneration and diabetic retinopathy or region of habitation.	[Bikbov, Mukharram M.; Kazakbaeva, Gyulli M.; Gilmanshin, Timur R.; Zainullin, Rinat M.; Arslangareeva, Inga I.; Salavatova, Venera F.; Bikbova, Guzel M.; Nikitin, Nikolai A.; Zaynetdinov, Artur F.; Nuriev, Ildar F.; Khikmatullin, Renat I.; Uzianbaeva, Yulia V.; Yakupova, Dilya F.; Aminev, Said K.] Ufa Eye Res Inst, Ufa, Bashkortostan, Russia; [Panda-Jonas, Songhomitra] Seegartenklinik, Augenpraxis, Heidelberg, Germany; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Ufa Eye Research Institute; Ruprecht Karls University Heidelberg	Bikbov, MM (corresponding author), Ufa Eye Res Inst, Ufa, Bashkortostan, Russia.; Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.	Bikbov.m@gmail.com; Jost.Jonas@medma.uni-heidelberg.de	Zainullin, Rinat/AAR-6362-2021; Bikbov, Mukharram/AAO-7624-2021; Bikbova, Guzel/B-1751-2018	Bikbova, Guzel/0000-0002-7715-7466; Kazakbaeva, Gyulli/0000-0002-0569-1264	Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding program Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Aleksandrov A S, 2000, Vestn Oftalmol, V116, P29; Aleksandrova L A, 1996, Vestn Oftalmol, V112, P39; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Bikbov M, 2018, OPHTHAL EPIDEMIOL, V25, P187, DOI 10.1080/09286586.2017.1384504; Bikbov MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25928-1; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Gololobov V T, 2009, Vestn Oftalmol, V125, P21; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Ikram MK, 2003, INVEST OPHTH VIS SCI, V44, P3778, DOI 10.1167/iovs.03-0120; Jonas JB, 2002, AM J OPHTHALMOL, V134, P547, DOI 10.1016/S0002-9394(02)01644-6; Jonas JB, 2007, OPHTHAL RES, V39, P139, DOI 10.1159/000102935; Jonas JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175120; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe185, DOI 10.1111/j.1755-3768.2011.02316.x; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Kuzin AA, 2010, OPHTHALMOLOGY, V117, P1713, DOI 10.1016/j.ophtha.2010.01.035; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Mamatkhuzhaeva G N, 2002, Vestn Oftalmol, V118, P47; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Naidoo KS, 2016, OPTOMETRY VISION SCI, V93, P227, DOI 10.1097/OPX.0000000000000796; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Nowak Michal S, 2008, Klin Oczna, V110, P55; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wickremasinghe S, 2004, INVEST OPHTH VIS SCI, V45, P776, DOI 10.1167/iovs.03-0456; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2007, ACTA OPHTHALMOL SCAN, V85, P914, DOI 10.1111/j.1600-0420.2007.00966.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yan YN, 2015, OPHTHALMOLOGY, V122, P1873, DOI 10.1016/j.ophtha.2015.05.031; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	44	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211186	10.1371/journal.pone.0211186	http://dx.doi.org/10.1371/journal.pone.0211186			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707718	gold, Green Submitted, Green Published			2022-12-26	WOS:000457742900020
J	Roncolini, A; Milanovic, V; Cardinali, F; Osimani, A; Garofalo, C; Sabbatini, R; Clementi, F; Pasquini, M; Mozzon, M; Foligni, R; Raffaelli, N; Zamporlini, F; Minazzato, G; Trombetta, MF; Van Buitenen, A; Van Campenhout, L; Aquilanti, L				Roncolini, Andrea; Milanovic, Vesna; Cardinali, Federica; Osimani, Andrea; Garofalo, Cristiana; Sabbatini, Riccardo; Clementi, Francesca; Pasquini, Marina; Mozzon, Massimo; Foligni, Roberta; Raffaelli, Nadia; Zamporlini, Federica; Minazzato, Gabriele; Trombetta, Maria Federica; Van Buitenen, Anse; Van Campenhout, Leen; Aquilanti, Lucia			Protein fortification with mealworm (Tenebrio molitor L.) powder: Effect on textural, microbiological, nutritional and sensory features of bread	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; TRANSFERABLE ANTIBIOTIC RESISTANCES; EDIBLE INSECTS; INDEPENDENT METHODS; TRITICUM-AESTIVUM; FOOD; MICROBIOTA; DOUGH; SOURDOUGHS; DIVERSITY	In the present study, inclusion of mealworm (Tenebrio molitor L.) powder into bread doughs at 5 and 10% substitution level of soft wheat (Triticum aestivum L.) flour was tested to produce protein fortified breads. The addition of mealworm powder (MP) did not negatively affect the technological features of either doughs or breads. All the tested doughs showed the same leavening ability, whereas breads containing 5% MP showed the highest specific volume and the lowest firmness. An enrichment in protein content was observed in experimental breads where the highest values for this parameter were recorded in breads containing 10% MP. Breads fortified with 10% MP also exhibited a significant increase in the content of free amino acids, and especially in the following essential amino acids: tyrosine, methionine, isoleucine, and leucine. By contrast, no differences in nutritional quality of lipids were seen between fortified and control breads. Results of sensory analyses revealed that protein fortification of bread with MP significantly affected bread texture and overall liking, as well as crust colour, depending on the substitution level. Overall, proof of concept was provided for the inclusion of MP into bread doughs started with different leavening agents (sourdough and/or baker's yeast), at 5 or 10% substitution level of soft wheat flour. Based on the Technology Readiness Level (TRL) scale, the proposed bread making technology can be situated at level 4 (validation in laboratory environment), thus suggesting that the production of breads with MP might easily be scaled up at industrial level. However, potential spoilage and safety issues that need to be further considered were highlighted.	[Roncolini, Andrea; Milanovic, Vesna; Cardinali, Federica; Osimani, Andrea; Garofalo, Cristiana; Sabbatini, Riccardo; Clementi, Francesca; Pasquini, Marina; Mozzon, Massimo; Foligni, Roberta; Raffaelli, Nadia; Zamporlini, Federica; Minazzato, Gabriele; Trombetta, Maria Federica; Aquilanti, Lucia] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Via Brecce Bianche, Ancona, Italy; [Van Buitenen, Anse; Van Campenhout, Leen] Katholieke Univ Leuven, Dept Microbial & Mol Syst M2S, Fac Engn Technol, Lab4Food, Technol Campus Geel, Geel, Belgium; [Van Buitenen, Anse; Van Campenhout, Leen] Katholieke Univ Leuven, Leuven Food Sci & Nutr Rese Ctr LFoRCe, Leuven, Belgium	Marche Polytechnic University; KU Leuven; KU Leuven	Osimani, A; Aquilanti, L (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Via Brecce Bianche, Ancona, Italy.	a.osimani@univpm.it; l.aquilanti@univpm.it		Van Campenhout, Leen/0000-0003-4920-0102; OSIMANI, ANDREA/0000-0003-4095-6181; Milanovic, Vesna/0000-0001-8548-366X; MOZZON, Massimo/0000-0002-5132-5070	Universita Politecnica delle Marche, Ancona, Italy	Universita Politecnica delle Marche, Ancona, Italy	This study was partly financed by the Universita Politecnica delle Marche, Ancona, Italy, within the project "Edible insects: new frontiers in food-FOODIN". There was no additional external funding received for this study.	Ahmad BS, 2018, FOODS, V7, DOI 10.3390/foods7030028; Alessandria V, 2010, WORLD J MICROB BIOT, V26, P2211, DOI 10.1007/s11274-010-0406-7; Alfonzo A, 2017, FOOD MICROBIOL, V62, P256, DOI 10.1016/j.fm.2016.10.014; Ampe F, 1999, APPL ENVIRON MICROB, V65, P5464; [Anonymous], INT J FOOD MICROBIOL; BAILEY CP, 1993, FOOD MICROBIOL, V10, P287, DOI 10.1006/fmic.1993.1033; Barroso FG, 2014, AQUACULTURE, V422, P193, DOI 10.1016/j.aquaculture.2013.12.024; Belluco S, 2013, COMPR REV FOOD SCI F, V12, P296, DOI 10.1111/1541-4337.12014; Cardinali F, 2016, YEAST, V33, P403, DOI 10.1002/yea.3168; Cocolin L, 2013, INT J FOOD MICROBIOL, V167, P29, DOI 10.1016/j.ijfoodmicro.2013.05.008; Coda R, 2010, J APPL MICROBIOL, V108, P925, DOI 10.1111/j.1365-2672.2009.04497.x; De Bellis P, 2015, INT J FOOD MICROBIOL, V197, P30, DOI 10.1016/j.ijfoodmicro.2014.12.017; de Oliveira LM, 2017, INNOV FOOD SCI EMERG, V44, P30, DOI 10.1016/j.ifset.2017.08.015; Deer RR, 2015, CURR OPIN CLIN NUTR, V18, P248, DOI 10.1097/MCO.0000000000000162; EFSA Sci Comm, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4257; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2832; European Nutrition for Health Aliance, 2005, IN C EUR NUTR HLTH A; Franco-Miranda H, 2017, LWT-FOOD SCI TECHNOL, V80, P250, DOI 10.1016/j.lwt.2017.02.034; Garofalo C, 2017, FOOD MICROBIOL, V62, P15, DOI 10.1016/j.fm.2016.09.012; Gasco L, 2016, ANIM FEED SCI TECH, V220, P34, DOI 10.1016/j.anifeedsci.2016.07.003; Gobbetti M, 1996, APPL ENVIRON MICROB, V62, P3220, DOI 10.1128/AEM.62.9.3220-3226.1996; Gonzalez CM, 2019, INNOV FOOD SCI EMERG, V51, P205, DOI 10.1016/j.ifset.2018.03.021; Grabowski NT, 2017, TRENDS FOOD SCI TECH, V63, P80, DOI 10.1016/j.tifs.2017.01.007; Graca C, 2018, LWT-FOOD SCI TECHNOL, V89, P466, DOI 10.1016/j.lwt.2017.11.024; Henderson J. W., 2010, INSTRUMENTATION SEPA; Henderson JW, 2006, 200659801193EN HPLC; Hoglund E, 2017, INT J FOOD SCI NUTR, V2; Jonas-Levi A, 2017, J FOOD COMPOS ANAL, V62, P184, DOI 10.1016/j.jfca.2017.06.004; KHAN MA, 1978, J SCI FOOD AGR, V29, P1069, DOI 10.1002/jsfa.2740291212; Klunder HC, 2012, FOOD CONTROL, V26, P628, DOI 10.1016/j.foodcont.2012.02.013; Kourimska L., 2016, NFS Journal, V4, P22, DOI 10.1016/j.nfs.2016.07.001; Lavermicocca P, 2016, FOOD HYGIENE AND TOXICOLOGY IN READY-TO-EAT FOODS, P275, DOI 10.1016/B978-0-12-801916-0.00016-9; Liu R, 2015, FOOD CHEM, V188, P328, DOI 10.1016/j.foodchem.2015.04.045; Mariotti M, 2014, LWT-FOOD SCI TECHNOL, V59, P973, DOI 10.1016/j.lwt.2014.06.052; Martinez M, 2013, J CEREAL SCI, V57, P424, DOI 10.1016/j.jcs.2013.01.007; Merrill A.L., 1973, AGR HDB, P74; Milanovic V, 2016, INT J FOOD MICROBIOL, V227, P22, DOI 10.1016/j.ijfoodmicro.2016.03.018; Minervini F, 2012, APPL ENVIRON MICROB, V78, P5328, DOI 10.1128/AEM.00572-12; Morales FJ, 2007, J AGR FOOD CHEM, V55, P6793, DOI 10.1021/jf071036e; Mouliney M, 2011, J CEREAL SCI, V54, P317, DOI 10.1016/j.jcs.2011.06.009; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Osimani A, 2009, ITAL J FOOD SCI, V21, P269; Osimani A, 2018, INNOV FOOD SCI EMERG, V48, P150, DOI 10.1016/j.ifset.2018.06.007; Osimani A, 2018, INT J FOOD MICROBIOL, V276, P54, DOI 10.1016/j.ijfoodmicro.2018.04.013; Osimani A, 2018, INT J FOOD MICROBIOL, V272, P49, DOI 10.1016/j.ijfoodmicro.2018.03.001; Osimani A, 2017, EUR FOOD RES TECHNOL, V243, P1157, DOI 10.1007/s00217-016-2828-4; Osimani A, 2017, INT J FOOD MICROBIOL, V263, P38, DOI 10.1016/j.ijfoodmicro.2017.10.009; Osimani A, 2017, J FOOD SCI, V82, P1184, DOI 10.1111/1750-3841.13700; Osimani A, 2015, INT J FOOD MICROBIOL, V194, P62, DOI 10.1016/j.ijfoodmicro.2014.11.011; Pacetti D, 2013, CURR NUTR FOOD SCI, V9, P283, DOI 10.2174/15734013113096660015; Pareyt B, 2011, J CEREAL SCI, V54, P266, DOI 10.1016/j.jcs.2011.08.011; Pasqualone A, 2017, LWT-FOOD SCI TECHNOL, V78, P151, DOI 10.1016/j.lwt.2016.12.032; Pepe O, 2013, APPL ENVIRON MICROB, V69, P2321; Pojicc M., 2011, ROLE EMPIRICAL RHEOL; Ramos-Elorduy J., 1998, INSECTOS COMESTIBLES, V69, P65; Reale A, 2016, LWT-FOOD SCI TECHNOL, V73, P622, DOI 10.1016/j.lwt.2016.06.065; Rollan G, 2005, J APPL MICROBIOL, V99, P1495, DOI 10.1111/j.1365-2672.2005.02730.x; Roncolini A., 2018, Industrie Alimentari, V57, P3; Rydberg P, 2005, ADV EXP MED BIOL, V561, P317; Song X, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081006; Stoops J, 2017, INNOV FOOD SCI EMERG, V41, P1, DOI 10.1016/j.ifset.2017.02.001; Tabata E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19940-8; Taccari M, 2016, J FOOD SCI, V81, pM1996, DOI 10.1111/1750-3841.13372; Tavoletti S, 2018, J CEREAL SCI, V82, P198, DOI 10.1016/j.jcs.2018.06.012; van Huis A., 2013, FAO FORESTRY PAPER; Vandeweyer D, 2017, INT J FOOD MICROBIOL, V261, P11, DOI 10.1016/j.ijfoodmicro.2017.08.018; Vandeweyer D, 2017, FOOD CONTROL, V71, P311, DOI 10.1016/j.foodcont.2016.07.011; VOGEL RF, 1994, INT J SYST BACTERIOL, V44, P223, DOI 10.1099/00207713-44-2-223; Wandersleben T, 2018, LWT-FOOD SCI TECHNOL, V91, P48, DOI 10.1016/j.lwt.2018.01.029; Watanabe A, 2003, CEREAL CHEM, V80, P281, DOI 10.1094/CCHEM.2003.80.3.281; WHO INT AGCY RES CANC, 1994, IARC MONOG EVAL CARC, V60, P389; Wynants E, 2017, INNOV FOOD SCI EMERG, V42, P8, DOI 10.1016/j.ifset.2017.06.004; Yilmaz C, 2014, J AGR FOOD CHEM, V62, P2900, DOI 10.1021/jf500294b; Zannini E, 2009, FOOD MICROBIOL, V26, P744, DOI 10.1016/j.fm.2009.07.014; Zhao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147791; Ziane M, 2014, FOOD CONTROL, V45, P16, DOI 10.1016/j.foodcont.2014.04.003	76	58	59	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211747	10.1371/journal.pone.0211747	http://dx.doi.org/10.1371/journal.pone.0211747			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707742	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900047
J	Antonioli, E; Torres, N; Ferretti, M; Piccinato, CD; Sertie, AL				Antonioli, Eliane; Torres, Natalia; Ferretti, Mario; Piccinato, Carla de Azevedo; Sertie, Andrea Laurato			Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells	PLOS ONE			English	Article							CELLULAR SENESCENCE; TUMOR-SUPPRESSOR; LIFE-SPAN; P16(INK4A); AUTOPHAGY; GROWTH	Background aims Delaying replicative senescence and extending lifespan of human mesenchymal stromal cells (MSCs) may enhance their potential for tissue engineering and cell based therapies. Accumulating evidence suggests that inhibitors of the mTOR signaling pathway, such as rapamycin, constitute promising pharmacological agents to retard senescence and extend stemness properties of various progenitor cell types. Here, we investigated whether the ability of rapamycin to postpone replicative senescence varies among bone marrow MSC samples (BM-MSCs) derived from different healthy donors, and explored the molecular mechanisms that drive rapamycin-mediated lifespan increment. Methods BM-MSCs at early passages were serially passaged either in absence or continuous presence of rapamycin and the number of cell population doublings until growth arrest was measured. The inhibition of mTOR signaling was assessed by the phosphorylation status of the downstream target RPS6. The expression levels of several senescence and pluripotency markers at early and late/senescent passages were analyzed by RT-qPCR, flow cytometry and western blot. Results We found that the lifespan extension in response to the continuous rapamycin treatment was highly variable among samples, but effective in most BM-MSCs. Despite all rapamycin-treated cells secreted significantly reduced levels of IL6, a major SASP cytokine, and expressed significantly higher levels of the pluripotency marker NANOG, the expression patterns of these markers were not correlated with the rapamycin-mediated increase in lifespan. Interestingly, rapamycin-mediated life-span extension was significantly associated only with repression of p16(INK4A) protein accumulation. Conclusions Taken together, our results suggest that some, but not all, BM-MSC samples would benefit from using rapamycin to postpone replicative arrest and reinforce a critical role of p16(INK4A) protein downregulation in this process.	[Antonioli, Eliane; Torres, Natalia; Ferretti, Mario; Piccinato, Carla de Azevedo; Sertie, Andrea Laurato] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein	Sertie, AL (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.	andrea.sertie@einstein.br	Sertie, Andrea Laurato/H-8312-2014; Antonioli, Eliane/C-9152-2012	Sertie, Andrea Laurato/0000-0002-7453-0560; Torres, Natalia/0000-0001-6143-4513; Antonioli, Eliane/0000-0002-8563-877X	Sao Paulo Research Foundation (FAPESP) [2014/25646-3, 2014/5093-3, 2012/00831-7]; Sociedade Beneficiente Israelita Brasileira Albert Einstein	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sociedade Beneficiente Israelita Brasileira Albert Einstein	This work was supported by grants from The Sao Paulo Research Foundation (FAPESP): 2014/25646-3 to ALS, 2014/5093-3 to ALS, and 2012/00831-7 to MF. CAP was supported by an institutional grant from Sociedade Beneficiente Israelita Brasileira Albert Einstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2017, ONCOTARGET, V8, P35492, DOI 10.18632/oncotarget.18033; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gharibi B, 2014, STEM CELLS, V32, P2256, DOI 10.1002/stem.1709; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Leontieva OV, 2016, AGING-US, V8, P3535, DOI 10.18632/aging.101155; Lerner C, 2013, AGING CELL, V12, P966, DOI 10.1111/acel.12122; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Piccinato CA, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/369828; Pospelova TV, 2013, CELL CYCLE, V12, P3841, DOI 10.4161/cc.27396; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019557; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263	30	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0204784	10.1371/journal.pone.0204784	http://dx.doi.org/10.1371/journal.pone.0204784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703123	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600006
J	Bozorgi, F; Seiedy, M; Malek, M; Aira, M; Perez-Losada, M; Dominguez, J				Bozorgi, Farnaz; Seiedy, Marjan; Malek, Masoumeh; Aira, Manuel; Perez-Losada, Marcos; Dominguez, Jorge			Multigene phylogeny reveals a new Iranian earthworm genus (Lumbricidae: Philomontanus) with three new species	PLOS ONE			English	Article							OLIGOCHAETA; EVOLUTIONARY; MITOCHONDRIAL; DIVERGENCE; DIVERSITY; ANNELIDA	Lumbricidae taxonomy is vastly restricted by the morphological simplicity of earthworms and their lack of complex appendices. This has led to confusing results in the Lumbricidae classifications, which in turn, has hindered our ability to identify and assign new and cryptic species to the family. Here we propose the addition of a new Lumbricidae genus from the Zagros and Elburz Mountains of Iran, i.e. Philomontanus gen. nov, including three new species. Our taxonomic inferences were based on the phylogenetic analysis of two nuclear gene regions (28S rDNA and 18S rDNA) and 11 mitochondrial gene regions (16S rDNA, 12S rDNA, NADH dehydrogenase I, cytochrome oxidase subunits I and II and tRNAs Asn, Asp, Val, Leu, Ala and Ser). Philomontanus gen. nov comprises the earthworm species Philomontanus sarii sp. nov., Philomontanus mahmoudi sp. nov. and Philomontanus baloutchi sp. nov. These three species are morphologically similar to each other with only a few characters separating them (e.g. size, pigmentation and position of clitellum). Our findings support the adoption of an integrative approach including molecular information (e.g., DNA sequences) to aid earthworm classification and develop a robust taxonomy.	[Bozorgi, Farnaz; Seiedy, Marjan; Malek, Masoumeh] Univ Tehran, Coll Sci, Sch Biol, Tehran, Iran; [Bozorgi, Farnaz; Seiedy, Marjan; Malek, Masoumeh] Univ Tehran, Coll Sci, Ctr Excellence Phylogeny Living Organisms, Tehran, Iran; [Aira, Manuel; Dominguez, Jorge] Univ Vigo, Dept Ecoloxia & Bioloxia Anim, E Vigo, Spain; [Perez-Losada, Marcos] George Washington Univ, Milken Inst Sch Publ Hlth, Computat Biol Inst, Ashburn, VA USA; [Perez-Losada, Marcos] Smithsonian Inst, US Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Perez-Losada, Marcos] Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal	University of Tehran; University of Tehran; Universidade de Vigo; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade do Porto	Malek, M (corresponding author), Univ Tehran, Coll Sci, Sch Biol, Tehran, Iran.; Malek, M (corresponding author), Univ Tehran, Coll Sci, Ctr Excellence Phylogeny Living Organisms, Tehran, Iran.	mmalek@khayam.ut.ac.ir	Seiedy, Marjan/X-4969-2019; Domínguez, Jorge/M-2046-2014; Aira, Manuel/B-4506-2016; Malek, Masoumeh/AAG-3851-2020; Domínguez, Jorge/T-7647-2019; Perez-Losada, Marcos/I-4407-2013	Domínguez, Jorge/0000-0002-4313-8582; Aira, Manuel/0000-0002-2513-4609; Domínguez, Jorge/0000-0002-4313-8582; Perez-Losada, Marcos/0000-0002-2585-4657; Seiedy, Marjan/0000-0002-7661-9905	Spanish Ministerio de Economia y Competitividad [CTM2013-42540-R, AGL2017-86813-R]; Xunta de Galicia [ED431B-2016/043]; Research Affairs of the University of Tehran	Spanish Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Research Affairs of the University of Tehran	This study was funded by the Spanish Ministerio de Economia y Competitividad (projects CTM2013-42540-R and AGL2017-86813-R), the Xunta de Galicia (project ED431B-2016/043).; We would like to thank the Research Affairs of the University of Tehran for their financial support. We gratefully acknowledge Mr. Kazemi, Mohammadi and Alizadeh for helping in collecting and processing samples. We thank our colleagues Dr. Ahmad Reza Katouzian, who provided insight and expertise that greatly assisted the research.	[Anonymous], 2010, GATEWAY COMPUTING EN; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Benham W., 1890, QJ SCI; Blakemore RJ., 2006, COSMOPOLITAN EARTHWO; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Csuzdi C.S., 2003, EARTHWORMS HUNGARY A; de Lamarck J, 1802, HYDROGEOLOGIE AGASSE; Dominguez J, 2017, ZOOLOGICAL J LINNEAN, V182, P258; Dominguez J, 2015, MOL PHYLOGENET EVOL, V83, P7, DOI 10.1016/j.ympev.2014.10.024; Dupont L, 2011, PEDOBIOLOGIA, V54, P217, DOI 10.1016/j.pedobi.2011.03.004; Eisen G., 1873, Ofversigt Ak Forhandlingar, VNo. 8, P43; Farhadi Z, 2013, ZOOTAXA, V3670, P440, DOI 10.11646/zootaxa.3670.4.2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Marchan DF, 2018, INVERTEBR SYST, V32, P652, DOI 10.1071/IS17048; Fernandez R, 2011, SOIL BIOL BIOCHEM, V43, P2085, DOI 10.1016/j.soilbio.2011.06.007; Giska I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0488-9; Grube AE, 1850, FAMILIEN ANNELIDEN; Hollingsworth J, 2010, GEOPHYS J INT, V181, P1214, DOI 10.1111/j.1365-246X.2010.04591.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khadivi S, 2010, BASIN RES, V22, P918, DOI 10.1111/j.1365-2117.2009.00446.x; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Latif R, 2017, N W J ZOOLOGY, V13; Michaelsen W., 1900, TIERREICH 10 VERMES; Michaelsen W., 1919, MITT ZOOL MUS HAMBUR, V36, P131; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Novo M, 2012, MOL ECOL, V21, P3776, DOI 10.1111/j.1365-294X.2012.05648.x; Novo M, 2010, MOL PHYLOGENET EVOL, V56, P507, DOI 10.1016/j.ympev.2010.04.010; Novo Marta, 2009, Zoologica Scripta, V38, P537, DOI 10.1111/j.1463-6409.2009.00389.x; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M., 2015, J PHYLOGENETICS EVOL, V2015; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028153; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Proudlove G, 2003, TRENDS ECOL EVOL, V18, P272, DOI 10.1016/S0169-5347(03)00095-8; Qiu J, 1998, DOCUMENTS PEDOZOOLOG, V4, P17; Qiu J, 1998, DOCUMENTS PEDOZOOLOG, V4, P140; Qiu J.P., 1998, DOCUMENTS PEDOZOOLOG, V4, P181; Qiu J.-P., 1998, DOCUMENTS PEDOZOOLOG, V3, P179; Qiu J-P, 1998, DOC PEDOZOOLOGIQ INT, V4, P65; Rafinesque C. S., 1815, ANAL NATURE TABLEAU, DOI 10.5962/bhl.title.106607; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sims RW, 1985, EARTHWORMS KEYS NOTE; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Szederjesi T, 2017, ZOOLOGICAL J LINNEAN, V182, P500, DOI DOI 10.1093/Z00LINNEAN/ZLX049; Szederjesi T, 2014, ACTA ZOOL ACAD SCI H, V60, P85; Szederjesi T, 2014, ZOOTAXA, V 3764, P555, DOI 10.11646/zootaxa.3764.5.4; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Viaggi del E, 1893, B MUSEI ZOOLOGIA ANA, V8, P1; Wiens JJ, 1998, SYST BIOL, V47, P568, DOI 10.1080/106351598260581	51	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0208904	10.1371/journal.pone.0208904	http://dx.doi.org/10.1371/journal.pone.0208904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699114	Green Submitted, gold, Green Published			2022-12-26	WOS:000457155600009
J	Hanslik, KL; Allen, SR; Harkenrider, TL; Fogerson, SM; Guadarrama, E; Morgan, JR				Hanslik, Kendra L.; Allen, Scott R.; Harkenrider, Tessa L.; Fogerson, Stephanie M.; Guadarrama, Eduardo; Morgan, Jennifer R.			Regenerative capacity in the lamprey spinal cord is not altered after a repeated transection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; AXON REGENERATION; FUNCTIONAL REGENERATION; SYNUCLEIN ACCUMULATION; SYNAPTIC REGENERATION; LOCOMOTOR RECOVERY; NEURONAL SURVIVAL; GROWTH CONES; NEW-MODEL; EXPRESSION	The resilience of regeneration in vertebrates is not very well understood. Yet understanding if tissues can regenerate after repeated insults, and identifying limitations, is important for elucidating the underlying mechanisms of tissue plasticity. This is particularly challenging in tissues, such as the nervous system, which possess a large number of terminally differentiated cells and often exhibit limited regeneration in the first place. However, unlike mammals, which exhibit very limited regeneration of spinal cord tissues, many non-mammalian vertebrates, including lampreys, bony fishes, amphibians, and reptiles, regenerate their spinal cords and functionally recover even after a complete spinal cord transection. It is well established that lampreys undergo full functional recovery of swimming behaviors after a single spinal cord transection, which is accompanied by tissue repair at the lesion site, as well as axon and synapse regeneration. Here we begin to explore the resilience of spinal cord regeneration in lampreys after a second spinal transection (re-transection). We report that by all functional and anatomical measures tested, lampreys regenerate after spinal re-transection just as robustly as after single transections. Recovery of swimming, synapse and cytoskeletal distributions, axon regeneration, and neuronal survival were nearly identical after spinal transection or re-transection. Only minor differences in tissue repair at the lesion site were observed in re-transected spinal cords. Thus, regenerative potential in the lamprey spinal cord is largely unaffected by spinal re-transection, indicating a greater persistent regenerative potential than exists in some other highly regenerative models. These findings establish a new path for uncovering pro-regenerative targets that could be deployed in non-regenerative conditions.	[Hanslik, Kendra L.; Allen, Scott R.; Harkenrider, Tessa L.; Fogerson, Stephanie M.; Guadarrama, Eduardo; Morgan, Jennifer R.] Marine Biol Lab, Eugene Bell Ctr Regenerat Biol & Tissue Engn, Woods Hole, MA 02543 USA; [Allen, Scott R.] Duke Univ, Sch Med, Program Cell & Mol Biol, Durham, NC USA	Marine Biological Laboratory - Woods Hole; Duke University	Morgan, JR (corresponding author), Marine Biol Lab, Eugene Bell Ctr Regenerat Biol & Tissue Engn, Woods Hole, MA 02543 USA.	jmorgan@mbl.edu		Morgan, Jennifer/0000-0001-9915-6360; Hanslik, Kendra/0000-0002-8029-3717; Allen, Scott/0000-0002-4809-0493	Marine Biological Laboratory; National Science Foundation Research Experiences for Undergraduates Award [1659604]; NSF REU Award [1659604]	Marine Biological Laboratory; National Science Foundation Research Experiences for Undergraduates Award; NSF REU Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	Support for this study was provided by the Marine Biological Laboratory (to JRM). Author EG was also supported in part by a National Science Foundation Research Experiences for Undergraduates Award (#1659604: Biological Discovery in Woods Hole at the Marine Biological Laboratory; PI: Allen Mensinger). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Cristina Roman-Vendrell and Louie Kerr, Director of the Central Microscopy Facility at the MBL, for technical support. We also thank Dr. Juan Diaz-Quiroz for helpful comments on the manuscript. EG was supported in part by an NSF REU Award (#1659604: Biological Discovery in Woods Hole at the Marine Biological Laboratory).	Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022820; Barreiro-Iglesias A, 2015, NEURAL REGEN RES, V10, P25, DOI 10.4103/1673-5374.150642; Barreiro-Iglesias Anton, 2012, Enzyme Res, V2012, P835731, DOI 10.1155/2012/835731; Bely AE, 2014, INTEGR COMP BIOL, V54, P688, DOI 10.1093/icb/icu109; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bloom O, 2014, EXP NEUROL, V258, P130, DOI 10.1016/j.expneurol.2013.12.023; Bryant DM, 2017, DEV BIOL, V424, P1, DOI 10.1016/j.ydbio.2017.02.013; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Busch DJ, 2014, MOL BIOL CELL, V25, P3926, DOI 10.1091/mbc.E14-02-0708; Busch DJ, 2012, J COMP NEUROL, V520, P1751, DOI 10.1002/cne.23011; COHEN AH, 1986, P NATL ACAD SCI USA, V83, P2763, DOI 10.1073/pnas.83.8.2763; Cooke RM, 2009, J NEUROTRAUM, V26, P597, DOI 10.1089/neu.2008.0660; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DAVIS GR, 1994, EXP NEUROL, V127, P94, DOI 10.1006/exnr.1994.1083; DAVIS GR, 1993, EXP BRAIN RES, V97, P83; DEARLOVE GE, 1976, J EXP ZOOL, V196, P251, DOI 10.1002/jez.1401960212; Diaz Quiroz JF, 2013, BIOCHEM J, V451, P353, DOI 10.1042/BJ20121807; Dolan CP, 2018, STEM CELL TRANSL MED, V7, P262, DOI 10.1002/sctm.17-0236; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Eguchi G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1389; Erickson JR, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.16; Cornide-Petronio ME, 2014, NEUROPHARMACOLOGY, V77, P369, DOI 10.1016/j.neuropharm.2013.10.017; FAWCETT JW, 1981, BRAIN RES, V229, P487, DOI 10.1016/0006-8993(81)91009-X; Fernandez-Lopez B, 2016, SCI REP-UK, V6, DOI 10.1038/srep37786; Fernandez-Lopez B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/350750; Fogerson SM, 2016, EXP NEUROL, V278, P105, DOI 10.1016/j.expneurol.2016.02.004; Frobisch NB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1550; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gibbs KM, 2011, EUR J NEUROSCI, V33, P9, DOI 10.1111/j.1460-9568.2010.07477.x; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gorsuch RA, 2014, EXP EYE RES, V123, P131, DOI 10.1016/j.exer.2013.07.012; Herman PE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18757-1; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jin LQ, 2009, J COMP NEUROL, V515, P295, DOI 10.1002/cne.22057; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; Lau BYB, 2011, EXP NEUROL, V228, P283, DOI 10.1016/j.expneurol.2011.02.003; LURIE DI, 1994, J COMP NEUROL, V344, P559, DOI 10.1002/cne.903440406; MACKLER SA, 1987, J PHYSIOL-LONDON, V388, P183, DOI 10.1113/jphysiol.1987.sp016609; MACKLER SA, 1985, SCIENCE, V229, P774, DOI 10.1126/science.2992085; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Monaghan JR, 2007, J NEUROCHEM, V101, P27, DOI 10.1111/j.1471-4159.2006.04344.x; Morgan J, 2014, NONMAMMALIAN MODELS; Morgan T. H., 1898, Archiv fuer Entwicklungsmechanik, Vvii, P364; MUNEOKA K, 1982, NATURE, V298, P369, DOI 10.1038/298369a0; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Oliphint PA, 2010, J COMP NEUROL, V518, P2854, DOI 10.1002/cne.22368; Parker D, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00084; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Romaus-Sanjurjo D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0704-9; Rosas-Arellano A, 2016, HISTOCHEM CELL BIOL, V146, P421, DOI 10.1007/s00418-016-1447-2; ROVAINEN CM, 1967, J NEUROPHYSIOL, V30, P1000, DOI 10.1152/jn.1967.30.5.1000; ROVAINEN CM, 1976, J COMP NEUROL, V168, P545, DOI 10.1002/cne.901680407; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; SELZER ME, 1978, J PHYSIOL-LONDON, V277, P395, DOI 10.1113/jphysiol.1978.sp012280; Shifman MI, 2008, J COMP NEUROL, V510, P269, DOI 10.1002/cne.21789; Shifman MI, 2000, NEUROREHAB NEURAL RE, V14, P49, DOI 10.1177/154596830001400106; Shifman MI, 2007, J COMP NEUROL, V501, P631, DOI 10.1002/cne.21283; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SPERRY RW, 1947, ANAT REC, V97, P293, DOI 10.1002/ar.1090970306; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; Vergara MN, 2009, MOL VIS, V15, P1000; Voss GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067274; Voss SR, 2010, EMERGING MODEL ORGANISMS: LABORATORY MANUAL, VOL 2, P397, DOI 10.1101/pdb.emo128; Wang S, 2017, CURR TOP DEV BIOL, V124, P161, DOI 10.1016/bs.ctdb.2016.11.012; Williams RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118918; WOOD MR, 1981, J NEUROCYTOL, V10, P57, DOI 10.1007/BF01181745; YIN HS, 1983, J NEUROSCI, V3, P1135; YIN HS, 1981, EXP NEUROL, V73, P750, DOI 10.1016/0014-4886(81)90210-7; Zhang GX, 2014, J COMP NEUROL, V522, P1316, DOI 10.1002/cne.23485; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	76	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0204193	10.1371/journal.pone.0204193	http://dx.doi.org/10.1371/journal.pone.0204193			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699109	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600002
J	Ito, F; Mori, T; Tarumi, Y; Okimura, H; Kataoka, H; Tanaka, Y; Koshiba, A; Kitawaki, J				Ito, Fumitake; Mori, Taisuke; Tarumi, Yosuke; Okimura, Hiroyuki; Kataoka, Hisashi; Tanaka, Yukiko; Koshiba, Akemi; Kitawaki, Jo			Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-kappa B signaling	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; FLOW CONDITIONS; CELL; EXPRESSION; MOLECULE-1; DISEASE; BETA; PROGRESSION; ACTIVATION	The adhesion of monocytes to endothelial cells, which is mediated by adhesion molecules, plays a crucial role in the onset of atherosclerosis. Conjugated equine estrogen, which is widely used for estrogen-replacement therapy, contains both estrone sulfate and various nonhuman estrogens, including equilin. To investigate the association between various estrogen types and atherosclerosis risk, we examined their effect on adhesion-molecule expression in human umbilical vein endothelial cells (HUVECs). In estrogen-treated HUVECs, the mRNA and protein expression levels of adhesion molecules were quantified by real-time polymerase chain reaction and enzyme immunoassay. Additionally, a flow-chamber system was used to assess the effects of estrogens on the adherence of U937 monocytoid cells to HUVECs. Equilin, but not 17 beta-estradiol (E2) or other types of estrogen, significantly increased the mRNA (P < 0.01) and protein (P < 0.05) expression of the adhesion molecules E-selectin and intercellular adhesion molecule-1 as compared with levels in controls. Equilin treatment increased the adherence of U937 monocytoid cells to HUVECs relative to the that in the control (P < 0.05), decreased estrogen receptor (ER)beta expression, and increased the expression of proteins involved in nuclear factor kappa-B (NF-kappa B) activation relative to levels in controls. Furthermore, the accumulation of NF-kappa B subunit p65 in HUVEC nuclei was promoted by equilin treatment. By contrast, E2 treatment neither increased the number of adhered monocytoid cells to HUVECs nor altered the expression of ER beta or NF-kappa B-activating proteins. Our findings suggest that in terms of the adhesion of monocytes at the onset of atherosclerosis, E2 may be preferable for estrogen-replacement therapy. Further studies comparing equilin treatment with that of E2 are needed to investigate their differential impacts on atherosclerosis.	[Ito, Fumitake; Mori, Taisuke; Tarumi, Yosuke; Okimura, Hiroyuki; Kataoka, Hisashi; Tanaka, Yukiko; Koshiba, Akemi; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan	Kyoto Prefectural University of Medicine	Ito, F (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan.	fitoh@koto.kpu-m.ac.jp	Tarumi, Yosuke/AAH-1291-2021; Kataoka, Hisashi/AHA-8964-2022	Tarumi, Yosuke/0000-0002-6058-594X; 	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [16K20201]	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research 16K20201 from the Ministry of Education, Culture, Sports, Science, and Technology (Japan).FI received the funding.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Bhavnani BR, 1998, P SOC EXP BIOL MED, V217, P6; CaulinGlaser T, 1996, J CLIN INVEST, V98, P36, DOI 10.1172/JCI118774; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Gerszten RE, 1996, CIRC RES, V79, P1205, DOI 10.1161/01.RES.79.6.1205; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Ho JYP, 2006, HUM REPROD, V21, P2715, DOI 10.1093/humrep/del245; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Ito F, 2016, EUR J OBSTET GYN R B, V201, P113, DOI 10.1016/j.ejogrb.2016.03.044; Ito F, 2014, J CLIN ENDOCR METAB, V99, P2188, DOI 10.1210/jc.2013-2925; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kuhl H, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500148875; Lacut K, 2003, THROMB HAEMOSTASIS, V90, P124; Luscinskas FW, 2000, ANN NY ACAD SCI, V902, P288; Mak P, 2015, ONCOTARGET, V6, P40247, DOI 10.18632/oncotarget.5377; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b; Ouyang P, 2006, J AM COLL CARDIOL, V47, P1741, DOI 10.1016/j.jacc.2005.10.076; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Rodriguez E, 2002, LIFE SCI, V71, P2181, DOI 10.1016/S0024-3205(02)01999-9; Rosenfeld ME, 2002, ATHEROSCLEROSIS, V164, P251, DOI 10.1016/S0021-9150(02)00178-8; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Scortegagna M, 2008, BLOOD, V111, P3343, DOI 10.1182/blood-2007-10-115758; Smith NL, 2014, JAMA INTERN MED, V174, P25, DOI 10.1001/jamainternmed.2013.11074; Sumino H, 2006, ATHEROSCLEROSIS, V189, P436, DOI 10.1016/j.atherosclerosis.2005.12.030; Tatsumi H, 2002, MATURITAS, V42, P287, DOI 10.1016/S0378-5122(02)00157-3; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645; Yoshida N, 1997, LIFE SCI, V60, P2341, DOI 10.1016/S0024-3205(97)00290-7	37	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211462	10.1371/journal.pone.0211462	http://dx.doi.org/10.1371/journal.pone.0211462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699196	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600079
J	Rantshabeng, P; Kasvosve, I; Ndlovu, A; Gaseitsiwe, S; Moyo, S				Rantshabeng, Patricia; Kasvosve, Ishmael; Ndlovu, Andrew; Gaseitsiwe, Simani; Moyo, Sikhulile			Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay	PLOS ONE			English	Article							HIV-INFECTED WOMEN; CERVICAL-CANCER; EPIDEMIOLOGY; POPULATION; PREVENTION; GENOTYPE; VACCINE; OLDER	Background High-risk human papillomavirus (HR-HPV) has been demonstrated to be the necessary cause of cervical carcinoma. High-risk HPV detection has a prognostic significance for the women who are at increased risk of disease progression. HPV genotyping in cervical cancer precursor lesions is crucial for prevention and management of cervical cancer. This study was designed to investigate the distribution of HR-HPV genotypes among a group of patients with high-grade squamous intraepithelial lesions and higher, of the cervix, in Botswana. Materials and methods 185-archived residual formalin-fixed paraffin-embedded cervical biopsies collected between the years, 2006 and 2008 were studied. These tissues were diagnosed with HSIL (n = 146) and squamous cell carcinoma (n = 39). DNA was extracted using the Abbott m2000 analyser (Abbott Laboratories, Illinois) using reagents provided by the manufacturer. HPV genotyping was done using the Abbott RealTime HR-HPV PCR, which qualitatively detects 14 HR-HPV (reported as HPV 16, 18 & Other HR-HPV). Results DNA was successfully extracted from 162/185 (87.6%) tissues as indicated by a positive beta-globin test. 132/162 (82%) tested positive for HR-HPV The HPV 16 prevalence was 50% (66/132), HPV 18 at 15.2% (20/132) and other Group 1 HR-HPV plus HPV 66 and 68 had a prevalence of 56.1% (74/132). Other HR-HPV types were common in HSIL than in carcinoma, while HPV 16 was more prevalent in carcinomas than other HR-HPV genotypes. Conclusion In this study, HPV 16 and other HR-HPV genotypes were commonly associated with HSIL but HPV 18 was uncommon among Botswana women. Our data highlights the need for multivalent HPV vaccines with cross coverage for other high risk HPV other than HPV 16 and 18.	[Rantshabeng, Patricia; Kasvosve, Ishmael; Ndlovu, Andrew] Univ Botswana, Dept Med Lab Sci, Fac Hlth Sci, Gaborone, Botswana; [Gaseitsiwe, Simani; Moyo, Sikhulile] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Gaseitsiwe, Simani; Moyo, Sikhulile] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	University of Botswana; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health	Rantshabeng, P (corresponding author), Univ Botswana, Dept Med Lab Sci, Fac Hlth Sci, Gaborone, Botswana.	trishrant@gmail.com	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Rantshabeng, Patricia/0000-0001-5799-9810; Kasvosve, Ishmael/0000-0002-2046-545X	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; UK government; Fogarty International Center; National Institute of Mental Health, of the National Institutes of Health [D43 TW010543]; FOGARTY INTERNATIONAL CENTER [D43TW010543] Funding Source: NIH RePORTER	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	PR & SM were partly supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant # 107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of MS, NEPAD Agency, Wellcome Trust or the UK government. SM was partially supported was supported by the Fogarty International Center and National Institute of Mental Health, of the National Institutes of Health under Award Number D43 TW010543. PR received donations of testing kits from Abbott Laboratories in South Africa. The funders had no role in the design and the conduct of the study and the decision to publish.	Adewole IF, 2005, GYNECOL ONCOL, V99, pS209, DOI 10.1016/j.ygyno.2005.07.086; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bosch X, 2006, GYNECOL ONCOL, V103, P21, DOI 10.1016/j.ygyno.2006.07.019; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Carozzi FM, 2011, J CLIN MICROBIOL, V49, P1446, DOI 10.1128/JCM.02311-10; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dryden-Peterson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135602; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Grover S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00239; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hariri S, 2015, EMERG INFECT DIS, V21, P1557, DOI 10.3201/eid2109.141841; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; KIVIAT NB, 1992, INT J GYNECOL PATHOL, V11, P197, DOI 10.1097/00004347-199207000-00005; Konopnicki D, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18023; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; MacLeod IJ, 2011, J MED VIROL, V83, P1689, DOI 10.1002/jmv.22178; Meijer CJ, 2006, GYNECOL ONCOL, V103, P12, DOI 10.1016/j.ygyno.2006.07.031; Moussavou-Boundzanga P, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0906-2; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naryshkin S, 2012, DRUG HEALTHC PATIENT, V4, P167, DOI 10.2147/DHPS.S37273; Nayar R, 2015, ACTA CYTOL, V59, P121, DOI [10.1002/cncy.21521, 10.1159/000381842]; Ndiaye C, 2012, TROP MED INT HEALTH, V17, P1432, DOI 10.1111/tmi.12004; Ng'andwe C, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-77; Nyitray AG, 2014, CURR PROBL DERMATOL, V45, P75, DOI 10.1159/000358370; Poljak M, 2013, ACTA DERMATOVEN ALP, V22, P43, DOI 10.2478/v10162-012-0031-2; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Ramogola-Masire D, 2011, INT J GYNECOL PATHOL, V30, P591, DOI 10.1097/PGP.0b013e31821bf2a6; Sukasem C, 2011, J MED VIROL, V83, P119, DOI 10.1002/jmv.21948; Vidal AC, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-20; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	33	8	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211260	10.1371/journal.pone.0211260	http://dx.doi.org/10.1371/journal.pone.0211260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699172	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600068
J	Izuegbuna, O; Otunola, G; Bradley, G				Izuegbuna, Ogochukwu; Otunola, Gloria; Bradley, Graeme			Chemical composition, antioxidant, anti-inflammatory, and cytotoxic activities of Opuntia stricta cladodes	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ESSENTIAL OILS; FICUS-INDICA; VITAMIN-C; ANTINOCICEPTIVE ACTIVITY; ALPHA-PINENE; BETA-IONONE; CELL-DEATH; CANCER	Background The Opuntia spp. have been used in traditional medicine for many centuries. It is used in the management of diseases that involves oxidative stress, especially diabetes, obesity and cancer. Opuntia stricta (Haw) is one of the relatively unknown species in South Africa where it is regarded more as a weed. Because of this, not much is known about its chemical composition. Aim To determine the chemical composition, antioxidant, anti-inflammatory, and cytotoxic activities of Opuntia stricta cladodes. Methods The phytochemical composition of acetone, aqueous and ethanol extract of cladodes of Opuntia stricta (Haw), as well as the vitamins A, C and E of its dried weight cladodes and the antioxidant activities, were evaluated using standard in vitro methods. The anti-inflammatory and cytotoxic activities were evaluated using cell-based assays. The phytochemical composition and vitamins were determined spectrophotometrically, while the antioxidant activities were determined by DPPH, nitric oxide, hydrogen peroxide scavenging activity and phosphomolybdenum (total) antioxidant activity. Anti-inflammatory activity was determined using RAW 264.7 cells, while cytotoxicity was determined using U937 cells. Results The phytochemical composition showed a significant difference in the various extracts. The total phenolics were higher than other phytochemicals in all the extracts used. All the extracts displayed antioxidant activity, while most of the extracts showed anti-inflammatory activity. Only one extract showed cytotoxicity, and it was mild. Conclusion The results show that the Opuntia stricta is rich in polyphenolic compounds and has good antioxidant activity as well as anti-inflammatory activities.	[Izuegbuna, Ogochukwu; Bradley, Graeme] Univ Ft Hare, Fac Sci & Agr, Dept Biochem, Alice, South Africa; [Otunola, Gloria] Univ Ft Hare, Med Plants & Econ Dev MPED Res Ctr, Dept Bot, Fac Sci & Agr, Alice, South Africa	University of Fort Hare; University of Fort Hare	Bradley, G (corresponding author), Univ Ft Hare, Fac Sci & Agr, Dept Biochem, Alice, South Africa.	gbradley@ufh.ac.za	Otunola, Gloria A/AAG-5334-2020; Bradley, Graeme/B-8604-2009; izuegbuna, ogochukwu/AGH-0578-2022	Otunola, Gloria A/0000-0003-2613-2741; Bradley, Graeme/0000-0002-9036-9869; izuegbuna, ogochukwu/0000-0001-8395-8967	University of Fort Hare, Govan Mbeki Research and Development Centre Seed Grant [C168]	University of Fort Hare, Govan Mbeki Research and Development Centre Seed Grant	This work was supported by University of Fort Hare, Govan Mbeki Research and Development Centre Seed Grant - C168; Recipient GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Ahmed D, 2015, ANTIOXIDANTS-BASEL, V4, P394, DOI 10.3390/antiox4020394; Albano SM, 2012, REC NAT PROD, V6, P35; Alves F. A. L., 2016, Journal of Medicinal Plants Research, V10, P732; Ansari M, 2016, EUR J MED CHEM, V123, P141, DOI 10.1016/j.ejmech.2016.07.037; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Ashraf MF, 2013, SCI WORLD J, DOI 10.1155/2013/216894; Asokkumar S, 2012, MOL CELL BIOCHEM, V363, P335, DOI 10.1007/s11010-011-1186-6; Aydin E, 2013, ARH HIG RADA TOKSIKO, V64, P415, DOI 10.2478/10004-1254-64-2013-2365; Aydin E, 2013, BIOLOGIA, V68, P1004, DOI 10.2478/s11756-013-0230-2; Barbieri SS, 2003, CARDIOVASC RES, V60, P187, DOI 10.1016/S0008-6363(03)00365-1; Basholli-Salihu M, 2017, PHARM BIOL, V55, P1553, DOI 10.1080/13880209.2017.1309555; Beg Sarwar, 2011, Pharmacogn Rev, V5, P120, DOI 10.4103/0973-7847.91102; Bendaoud H, 2010, J FOOD SCI, V75, pC466, DOI 10.1111/j.1750-3841.2010.01711.x; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Boddu SHS, 2015, INT J PHARMACEUT, V479, P207, DOI 10.1016/j.ijpharm.2014.12.051; Boligon AA, 2013, NAT PROD RES, V27, P68, DOI 10.1080/14786419.2011.653971; Boora F., 2014, J FOOD PROCESS PRES, V2014, DOI DOI 10.1155/2014/918018; Caceres-Mella A, 2013, INT J FOOD SCI TECH, V48, P2588, DOI 10.1111/ijfs.12253; Chen MF, 2016, BMC CANCER, V16; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Correa Mariana Goncalves, 2016, Asian Pac J Cancer Prev, V17, P4199; Csanyi G, 2014, INT J MOL SCI, V15, P6002, DOI 10.3390/ijms15046002; Dagdemir A, 2004, SUPPORT CARE CANCER, V12, P263, DOI 10.1007/s00520-004-0591-8; DIB H, 2013, INT J MED PHARM SCI, V3, P147; El-Mostafa K, 2014, MOLECULES, V19, P14879, DOI 10.3390/molecules190914879; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Gandia-Herrero F, 2016, CRIT REV FOOD SCI, V56, P937, DOI 10.1080/10408398.2012.740103; Garoby-Salom S, 2016, J PHYSIOL BIOCHEM, V72, P59, DOI 10.1007/s13105-015-0461-5; Gebre-Mariam T., 2012, J BIOMATERIALS NANOB, V3, P79, DOI [10.4236/jbnb.2012.31010, DOI 10.4236/JBNB.2012.31010]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gupta RK, 2014, ASIAN PAC J CANCER P, V15, P4405, DOI 10.7314/APJCP.2014.15.11.4405; Hahm SW, 2010, PLANT FOOD HUM NUTR, V65, P247, DOI 10.1007/s11130-010-0188-y; Hansen JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120083; Harrabi B, 2017, ARCH PHYSIOL BIOCHEM, V123, P225, DOI 10.1080/13813455.2017.1307413; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Iachininoto MG, 2013, MOLECULES, V18, P10132, DOI 10.3390/molecules180910132; Igwe O. U., 2013, International Research Journal of Pharmaceutical and Applied Sciences, V3, P51; Iwasaki K, 2016, WORLD J GASTROENTERO, V22, P9765, DOI 10.3748/wjg.v22.i44.9765; Jana D, 2014, INDIA J SURG ONCOL, V5, P59, DOI 10.1007/s13193-014-0290-y; Kang CH, 2013, TOXICOL IN VITRO, V27, P782, DOI 10.1016/j.tiv.2012.12.012; Kazemi M, 2015, NAT PROD RES, V29, P551, DOI 10.1080/14786419.2014.951934; Khan M, 2016, J CELL MOL MED, V20, P389, DOI 10.1111/jcmm.12749; Khor SC, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/914853; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Kim DS, 2015, AM J CHINESE MED, V43, P731, DOI 10.1142/S0192415X15500457; Kim J, 2015, J SCI FOOD AGR, V95, P2601, DOI 10.1002/jsfa.6968; Kim MJ, 2014, NAT PROD COMMUN, V9, P727; Kim YS, 2009, CANCER PREV RES, V2, P200, DOI 10.1158/1940-6207.CAPR-08-0141; Koki Alane T, 2002, Cancer Control, V9, P28; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Macedo EMA, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165103, 10.1590/1414-431x20165103]; Miller PG, 2017, NATURE, V549, P462, DOI 10.1038/nature23548; Mishra A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/915436; Montecinos V, 2007, J BIOL CHEM, V282, P15506, DOI 10.1074/jbc.M608361200; Noori S, 2012, J CLIN CELL IMMUNOL, V01, P1, DOI DOI 10.4172/SCIENTIFICREPORTS.413; Nowacki L, 2015, PHYTOTHER RES, V29, P1964, DOI 10.1002/ptr.5491; Olajuyigbe OO, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-130; Omoruyi BE, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-215; Onodera Y, 2015, FEBS OPEN BIO, V5, P492, DOI 10.1016/j.fob.2015.06.001; Onyesife C. O., 2014, Annals of Biological Research, V5, P20; Osorio-Esquivel O, 2012, PLANT FOOD HUM NUTR, V67, P365, DOI 10.1007/s11130-012-0320-2; Osuna-Martinez U., 2014, NAT PROD CHEM RES, V2, P2, DOI [10.4172/2329-6836.1000153, DOI 10.4172/2329-6836.1000153]; Oyedemi SO, 2010, AFR J PHARM PHARMACO, V4, P70; Peana AT, 2006, LIFE SCI, V78, P719, DOI 10.1016/j.lfs.2005.05.065; Pinheiro BG, 2011, J ETHNOPHARMACOL, V138, P479, DOI 10.1016/j.jep.2011.09.037; Prabhakaran D, 2017, J PHARM RES, V11, P793; Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Salleh WMNHW, 2016, NAT PROD COMMUN, V11, P853; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Diaz MDS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8634249; Saravanakumar A, 2015, FRONT LIFE SCI, V8, P182, DOI 10.1080/21553769.2015.1028655; Schepetkin IA, 2008, INT IMMUNOPHARMACOL, V8, P1455, DOI 10.1016/j.intimp.2008.06.003; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; Schuurman AG, 2002, CANCER CAUSE CONTROL, V13, P573, DOI 10.1023/A:1016332208339; Siddiqui F, 2016, J ETHNOPHARMACOL, V182, P221, DOI 10.1016/j.jep.2016.02.016; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Sobolewski Cyril, 2010, Int J Cell Biol, V2010, P215158, DOI 10.1155/2010/215158; Sreekanth D, 2007, PHYTOMEDICINE, V14, P739, DOI 10.1016/j.phymed.2007.03.017; Tambe V.D., 2014, RRJPP, V2, P41; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Turkez H, 2014, BIOLOGIA, V69, P936, DOI 10.2478/s11756-014-0393-5; Turkez H, 2014, CYTOTECHNOLOGY, V66, P597, DOI 10.1007/s10616-013-9611-1; Unuofin JO, 2017, ASIAN PAC J TROP BIO, V7, P901, DOI 10.1016/j.apjtb.2017.09.008; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Varela-Lopez A, 2015, ANTIOXIDANTS-BASEL, V4, P447, DOI 10.3390/antiox4030447; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wintola OA, 2011, PHARMACOGN MAG, V7, P325, DOI 10.4103/0973-1296.90414; Xiang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36291; Yasueda A, 2016, INTEGR CANCER THER, V15, P17, DOI 10.1177/1534735415610427; Zhang YB, 2014, J OLEO SCI, V63, P1251, DOI 10.5650/jos.ess14061	93	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0209682	10.1371/journal.pone.0209682	http://dx.doi.org/10.1371/journal.pone.0209682			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695064	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400007
J	Kulan, H; Dag, T				Kulan, Handan; Dag, Tamer			In silico identification of critical proteins associated with learning process and immune system for Down syndrome	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TS65DN MOUSE; MEMORY; MODEL; MEMANTINE; ACTIVATION; MECHANISMS; EXPRESSION; DEFICITS; STRESS	Understanding expression levels of proteins and their interactions is a key factor to diagnose and explain the Down syndrome which can be considered as the most prevalent reason of intellectual disability in human beings. In the previous studies, the expression levels of 77 proteins obtained from normal genotype control mice and from trisomic Ts65Dn mice have been analyzed after training in contextual fear conditioning with and without injection of the memantine drug using statistical methods and machine learning techniques. Recent studies have also pointed out that there may be a linkage between the Down syndrome and the immune system. Thus, the research presented in this paper aim at in silico identification of proteins which are significant to the learning process and the immune system and to derive the most accurate model for classification of mice. In this paper, the features are selected by implementing forward feature selection method after preprocessing step of the dataset. Later, deep neural network, gradient boosting tree, support vector machine and random forest classification methods are implemented to identify the accuracy. It is observed that the selected feature subsets not only yield higher accuracy classification results but also are composed of protein responses which are important for the learning and memory process and the immune system.	[Kulan, Handan; Dag, Tamer] Kadir Has Univ, Comp Engn Dept, Istanbul, Turkey	Kadir Has University	Kulan, H (corresponding author), Kadir Has Univ, Comp Engn Dept, Istanbul, Turkey.	20161102001@stu.khas.edu.tr	Dag, Tamer/K-7830-2014; Dag, Tamer/T-4593-2019	Dag, Tamer/0000-0001-7020-3741; Kulan, Handan/0000-0001-8166-1967	Tubitak 2211 A National Scholarship Programme for PhD Students	Tubitak 2211 A National Scholarship Programme for PhD Students(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	HK holds a PhD Scholarship from Tubitak 2211 A National Scholarship Programme for PhD Students. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P935; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119491; Ahmed MM, 2014, MOL CELL PROTEOMICS, V13, P919, DOI 10.1074/mcp.M113.035568; [Anonymous], 2005, TECHNICAL REPORT; Bergstra J., 2011, ADV NEURAL INFORM PR, P2546; Berthold MR, 2007, STUDIES CLASSIFICATI; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Block A, 2018, NEUROSCIENCE, V372, P192, DOI 10.1016/j.neuroscience.2017.12.038; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Busciglio J, 2013, CYTOGENET GENOME RES, V141, P260, DOI 10.1159/000354306; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.3.CO;2-G; Chen HSV, 2005, J PHARMACOL EXP THER, V314, P961, DOI 10.1124/jpet.105.085142; Chen JN, 2009, EXPERT SYST APPL, V36, P5432, DOI 10.1016/j.eswa.2008.06.054; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Corrales A, 2013, J PINEAL RES, V54, P346, DOI 10.1111/jpi.12037; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Das I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005983; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eicher T, 2016, THESIS; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Feng Bing, 2018, INT C INT INT SYST A, P302, DOI [10.1007/978-3-319-69096-4_42, DOI 10.1007/978-3-319-69096-4_42]; Gardiner KJ, 2014, DRUG DES DEV THER, V9, P103, DOI 10.2147/DDDT.S51476; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Head E, 2016, CURR ALZHEIMER RES, V13, P18, DOI 10.2174/1567205012666151020114607; Higuera C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129126; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Iannello RC, 1999, J NEURAL TRANSM-SUPP, P257; Kamat PK, 2013, NEUROSCIENCE, V238, P97, DOI 10.1016/j.neuroscience.2013.01.075; Kidambi Srivatsan, 2010, BMC Res Notes, V3, P201, DOI 10.1186/1756-0500-3-201; Kulan H, 2018, 2 INT C BIOINF COMP; Kumar V., 2014, SMART COMPUTING REV, V4, P211, DOI [DOI 10.6029/SMARTCR.2014.03.007, 10.6029/smartcr.2014.03.007]; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; McCombe PA, 2011, CURR MOL MED, V11, P246; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Nguyen CD, 2011, J NEUROGENET, V25, P40, DOI 10.3109/01677063.2011.558606; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pollonini G, 2008, NEUROSCIENCE, V156, P99, DOI 10.1016/j.neuroscience.2008.07.025; RAHMANI Z, 1990, AM J MED GENET, P98; Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Shupp A, 2017, ONCOTARGET, V8, P17373, DOI 10.18632/oncotarget.14538; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Sujashvili R, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4190390; Sullivan KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13858-3; Tano T, 2013, NEOPLASIA, V15, P305, DOI 10.1593/neo.121528; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tsoumakas G., 2009, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Yu X, 2016, NEUROPSYCH DIS TREAT, V12, P685, DOI 10.2147/NDT.S98387; Zhang GR, 2009, HIPPOCAMPUS, V19, P413, DOI 10.1002/hipo.20506	70	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210954	10.1371/journal.pone.0210954	http://dx.doi.org/10.1371/journal.pone.0210954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689644	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800015
J	Strauch, MA; Tomaz, MA; Monteiro-Machado, M; Cons, BL; Patrao-Neto, FC; Teixeira-Cruz, JD; Tavares-Henriques, MD; Nogueira-Souza, PD; Gomes, SLS; Costa, PRR; Schaeffer, E; da Silva, AJM; Melo, PA				Strauch, Marcelo A.; Tomaz, Marcelo Amorim; Monteiro-Machado, Marcos; Cons, Bruno Lemos; Patrao-Neto, Fernando Chagas; Teixeira-Cruz, Jhonatha da Mota; Tavares-Henriques, Matheus da Silva; Nogueira-Souza, Pamella Dourila; Gomes, Sara L. S.; Costa, Paulo R. R.; Schaeffer, Edgar; da Silva, Alcides J. M.; Melo, Paulo A.			Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms	PLOS ONE			English	Article							PRELIMINARY PHARMACOLOGICAL EVALUATION; HEMORRHAGIC ACTIVITIES; PHOSPHOLIPASE A(2); JARARACUSSU VENOM; AQUEOUS EXTRACT; NEUTRALIZATION; INHIBITION; METALLOPROTEINASES; PURIFICATION; JARARHAGIN	Background It is known that local tissue injuries incurred by snakebites are quickly instilled causing extensive, irreversible, tissue destruction that may include loss of limb function or even amputation. Such injuries are not completely neutralized by the available antivenins, which in general are focused on halting systemic effects. Therefore it is prudent to investigate the potential antiophidic effects of natural and synthetic compounds, perhaps combining them with serum therapy, to potentially attenuate or eliminate the adverse local and systemic effects of snake venom. This study assessed a group of quinones that are widely distributed in nature and constitute an important class of natural products that exhibit a range of biological activities. Of these quinones, lapachol is one of the most important compounds, having been first isolated in 1882 from the bark of Tabebuia avellanedae. Methodology/Principal findings It was investigated the ability of lapachol and some new potential active analogues based on the 2-hydroxi-naphthoquinone scaffold to antagonize important activities of Bothrops venoms (Bothrops atrox and Bothrops jararaca) under different experimental protocols in vitro and in vivo. The bioassays used to test the compounds were: procoagulant, phospholipase A(2), collagenase and proteolytic activities in vitro, venom-induced hemorrhage, edematogenic, and myotoxic effects in mice. Proteolytic and collagenase activities of Bothrops atrox venom were shown to be inhibited by lapachol and its analogues 3a, 3b, 3c, 3e. The inhibition of these enzymatic activities might help to explain the effects of the analogue 3a in vivo, which decreased skin hemorrhage induced by Bothrops venom. Lapachol and the synthetic analogues 3a and 3b did not inhibit the myotoxic activity induced by Bothrops atrox venom. The negative protective effect of these compounds against the myotoxicity can be partially explained by their lack of ability to effectively inhibit phospholipase A(2) venom activity. Bothrops atrox venom also induced edema, which was significantly reduced by the analogue 3a. Conclusions This research using a natural quinone and some related synthetic quinone compounds has shown that they exhibit antivenom activity; especially the compound 3a. The data from 3a showed a decrease in inflammatory venom effects, presumably those that are metalloproteinase- derived. Its ability to counteract such snake venom activities contributes to the search for improving the management of venomous snakebites.	[Strauch, Marcelo A.; Tomaz, Marcelo Amorim; Monteiro-Machado, Marcos; Cons, Bruno Lemos; Patrao-Neto, Fernando Chagas; Teixeira-Cruz, Jhonatha da Mota; Tavares-Henriques, Matheus da Silva; Nogueira-Souza, Pamella Dourila; Melo, Paulo A.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Toxinas, Rio De Janeiro, RJ, Brazil; [Strauch, Marcelo A.] Inst Vital Brazil, Niteroi, RJ, Brazil; [Gomes, Sara L. S.; Schaeffer, Edgar; da Silva, Alcides J. M.] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat Walter Mors, Lab Quim Bioorgan, Rio De Janeiro, RJ, Brazil; [Gomes, Sara L. S.; Costa, Paulo R. R.] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat Walter Mors, Lab Catalise Organ, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Strauch, MA; Tomaz, MA; Melo, PA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Toxinas, Rio De Janeiro, RJ, Brazil.; Strauch, MA (corresponding author), Inst Vital Brazil, Niteroi, RJ, Brazil.	strauchmarcelo@yahoo.com.br; marcelotomaz.fisio@gmail.com; melo.pa@gmail.com	Monteiro-Machado, Marcos/J-4931-2016; da Silva, Alcides José/AAV-6031-2020; Patrão-Neto, Fernando C/L-3516-2017; Costa, Paulo Roberto Ribeiro/F-1153-2013; da Mota Teixeira Cruz, Jhonatha/AAT-8226-2020; Costa, Paulo Roberto Ribeiro/AAH-4777-2021; Strauch, Marcelo A/J-2443-2016	Monteiro-Machado, Marcos/0000-0002-1657-1356; da Silva, Alcides José/0000-0002-3200-0318; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; da Mota Teixeira Cruz, Jhonatha/0000-0002-3167-0723; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Patrao-Neto, Fernando/0000-0002-4583-0476; Melo, Paulo A/0000-0003-1250-6933	Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ E_02/2017 - CNE]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306969/2015-7]; FAPERJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	PAM received awards from Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ E_02/2017 - CNE - 2014/2017 http://www.faperj.br/) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process 306969/2015-7 http://www.cnpq.br/). MAS received PhD fellowship from FAPERJ. MAT received PhD fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MI, 2003, J ETHNOPHARMACOL, V86, P75, DOI 10.1016/S0378-8741(03)00049-7; Anz AW, 2010, J AM ACAD ORTHOP SUR, V18, P749, DOI 10.5435/00124635-201012000-00005; Baldo C, 2015, TOXICON, V108, P240, DOI 10.1016/j.toxicon.2015.10.016; Barbosa-Filho Jose Maria, 2004, Phyton (Buenos Aires), V2004, P221; Borges MH, 2005, J ETHNOPHARMACOL, V98, P21, DOI 10.1016/j.jep.2004.12.014; Buarque CD, 2011, BIOORGAN MED CHEM, V19, P6885, DOI 10.1016/j.bmc.2011.09.025; Castellanos JRG, 2009, J ETHNOPHARMACOL, V121, P1, DOI 10.1016/j.jep.2008.10.004; Cavalcante WLG, 2007, J ETHNOPHARMACOL, V112, P490, DOI 10.1016/j.jep.2007.04.002; Chandra JNNS, 2007, CURR TOP MED CHEM, V7, P787, DOI 10.2174/156802607780487678; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Chippaux JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005662; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; da Silva AJM, 2002, BIOORGAN MED CHEM, V10, P2731, DOI 10.1016/S0968-0896(02)00100-1; da Silva AJM, 2001, BIOORG MED CHEM LETT, V11, P283, DOI 10.1016/S0960-894X(00)00621-1; da Silva NMV, 2007, TOXICON, V50, P196, DOI 10.1016/j.toxicon.2007.03.010; DEALMEIDA ER, 1990, J ETHNOPHARMACOL, V29, P239, DOI 10.1016/0378-8741(90)90061-W; DRISCOLL JS, 1974, CANCER CHEMOTH REP 2, V4, P1; Epifano F, 2014, PHYTOCHEM REV, V13, P37, DOI 10.1007/s11101-013-9289-1; Feitosa ES, 2015, REV SOC BRAS MED TRO, V48, P34, DOI 10.1590/0037-8682-0105-2013; Fernandes FFA, 2014, J ETHNOPHARMACOL, V155, P552, DOI 10.1016/j.jep.2014.05.056; GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0; Gomes SLS, 2017, J BRAZIL CHEM SOC, V28, P1573, DOI 10.21577/0103-5053.20160326; GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]; Gutierrez JM, 2016, TOXINS, V8, DOI 10.3390/toxins8040093; HOMMA M, 1971, BRIT J EXP PATHOL, V52, P538; Hussain H, 2007, ARKIVOC, P145, DOI 10.3998/ark.5550190.0008.204; KAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; Kohlhoff M, 2012, J PROTEOMICS, V75, P2181, DOI 10.1016/j.jprot.2012.01.020; Lee RI, 1913, AM J MED SCI, V145, P495, DOI 10.1097/00000441-191304000-00004; LEGAT FJ, 1994, BRIT J PHARMACOL, V112, P453, DOI 10.1111/j.1476-5381.1994.tb13094.x; Gutierrez JM, 2016, TOXINS, V8, DOI 10.3390/toxins8100304; MARINETT.GV, 1965, BIOCHIM BIOPHYS ACTA, V98, P554, DOI 10.1016/0005-2760(65)90152-9; MELO PA, 1988, TOXICON, V26, P87, DOI 10.1016/0041-0101(88)90140-7; MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545; MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0; MELO PA, 1993, TOXICON, V31, P285, DOI 10.1016/0041-0101(93)90146-A; Melo PA, 2010, TOXICON, V55, P488, DOI 10.1016/j.toxicon.2009.09.021; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Monteiro-Machado M, 2015, TOXICON, V98, P20, DOI 10.1016/j.toxicon.2015.02.010; MORS WB, 1989, TOXICON, V27, P1003, DOI 10.1016/0041-0101(89)90151-7; Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newman DJ, 2017, J BRAZIL CHEM SOC, V28, P402, DOI 10.21577/0103-5053.20160225; NISHIOKA SD, 1992, AM J TROP MED HYG, V47, P805, DOI 10.4269/ajtmh.1992.47.805; Oliveira CZ, 2005, J ETHNOPHARMACOL, V98, P213, DOI 10.1016/j.jep.2004.12.028; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; PAINE MJI, 1992, J BIOL CHEM, V267, P22869; Patrao-Neto FC, 2013, TOXICON, V69, P55, DOI 10.1016/j.toxicon.2013.01.023; PEREIRA NA, 1994, PLANTA MED, V60, P99, DOI 10.1055/s-2006-959425; Regalado AI, 2015, J PHARM PHARMACOGN R, V3, P109; Reis FP, 2014, J ETHNOPHARMACOL, V158, P352, DOI 10.1016/j.jep.2014.10.045; Rios-Luci C, 2012, EUR J MED CHEM, V53, P264, DOI 10.1016/j.ejmech.2012.04.008; RIZZINI CT, 1988, REV BRAS FARM, V69, P82; Rojas E, 2005, ACTA TROP, V93, P85, DOI 10.1016/j.actatropica.2004.09.008; Rosenfeld G., 1971, VENOMOUS ANIMALS THE, P687, DOI DOI 10.1016/B978-0-12-138902-4.50021-0; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Souto AL, 2011, MOLECULES, V16, P8515, DOI 10.3390/molecules16108515; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Strauch MA, 2013, J ETHNOPHARMACOL, V145, P50, DOI 10.1016/j.jep.2012.10.033; Tan NH, 2009, J ETHNOPHARMACOL, V123, P356, DOI 10.1016/j.jep.2009.03.025; Toschi E, 2001, MOL BIOL CELL, V12, P2934, DOI 10.1091/mbc.12.10.2934; WARRELL DA, 2004, VENOMOUS REPTILES W; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, WORK OV GLOB IMP NEG; [No title captured]	71	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211229	10.1371/journal.pone.0211229	http://dx.doi.org/10.1371/journal.pone.0211229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689661	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800023
J	Chu, Y; Elrod, N; Wang, CJ; Li, L; Chen, T; Routh, A; Xia, Z; Li, W; Wagner, EJ; Ji, P				Chu, Yuan; Elrod, Nathan; Wang, Chaojie; Li, Lei; Chen, Tao; Routh, Andrew; Xia, Zheng; Li, Wei; Wagner, Eric J.; Ji, Ping			Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients	ONCOGENE			English	Article							CLEAVAGE FACTOR IM; BREAST-CANCER; UNTRANSLATED REGIONS; RNA; CELLS; EXPRESSION; GROWTH; ASSOCIATION; RESISTANCE; MELANOMA	Alternative polyadenylation (APA) has emerged as a prevalent feature associated with cancer development and progression. The advantage of APA to tumor progression is to induce oncogenes through 3'-UTR shortening, and to inactivate tumor suppressor genes via the re-routing of microRNA competition. We previously identified the Mammalian Cleavage Factor I-25 (CFIm25) (encoded by Nudt21 gene) as a master APA regulator whose expression levels directly impact the tumorigenicity of glioblastoma (GBM) in vitro and in vivo. Despite its importance, the role of Nudt21 in GBM development is not known and the genes subject to Nudt21 APA regulation that contribute to GBM progression have not been identified. Here, we find that Nudt21 is reduced in low grade glioma (LGG) and all four subtypes of high grade glioma (GBM). Reduced expression of Nudt21 associates with worse survival in TCGA LGG cohorts and two TCGA GBM cohorts. Moreover, although CFIm25 was initially identified as biochemically associated with both CFIm59 and CFIm68, we observed three CFIm distinct subcomplexes exist and CFIm59 protein level is dependent on Nudt21 expression in GBM cells, but CFIm68 is not, and that only CFIm59 predicts prognosis of GBM patients similar to Nudt21. Through the use of Poly(A)-Click-Seq to characterize APA, we define the mRNAs subject to 3'-UTR shortening upon Nudt21 depletion in GBM cells and observed enrichment in genes important in the Ras signaling pathway, including Pak1. Remarkably, we find that Pak1 expression is regulated by Nudt21 through its 3'-UTR APA, and the combination of Pak1 and Nudt21 expression generates an even stronger prognostic indicator of GBM survival versus either value used alone. Collectively, our data uncover Nudt21 and its downstream target Pak1 as a potential "combination biomarker" for predicting prognosis of GBM patients.	[Chu, Yuan; Elrod, Nathan; Routh, Andrew; Wagner, Eric J.; Ji, Ping] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Chu, Yuan; Chen, Tao] Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Shanghai, Peoples R China; [Chu, Yuan; Chen, Tao] Fudan Univ, Endoscopy Res Inst, Shanghai, Peoples R China; [Wang, Chaojie; Xia, Zheng] OHSU, Dept Mol Microbiol & Immunol, Computat Biol Program, Portland, OR 97273 USA; [Li, Lei; Li, Wei] Baylor Coll Med, Daniel Duncan Canc Ctr, Houston, TX 77030 USA; [Routh, Andrew; Wagner, Eric J.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Fudan University; Fudan University; Oregon Health & Science University; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston	Wagner, EJ; Ji, P (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Wagner, EJ (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.	ejwagner@utmb.edu; piji@utmb.edu	Wang, Chaojie/AAX-3167-2021; Routh, Andrew/J-7486-2019; Elrod, Nathan/Q-5610-2019; Xia, Zheng/AAC-5360-2022; Elrod, Nathan/N-5956-2016; Li, Lei/S-9028-2016	Wang, Chaojie/0000-0002-5865-1397; Routh, Andrew/0000-0002-2874-5990; Xia, Zheng/0000-0003-3364-8324; Elrod, Nathan/0000-0003-1310-6026; Li, Lei/0000-0003-3924-2544; Ji, Ping/0000-0001-7103-1507	US National Institutes of Health (NIH) [R01CA193466-01]; Cancer Prevention Research Institute of Texas grant [CPRIT RP140800]; NIH [R03 CA223893-01]; NATIONAL CANCER INSTITUTE [R01CA193466, R03CA223893, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health (NIH) grants R01CA193466-01 to W.L. and E.J.W., the Cancer Prevention Research Institute of Texas grant CPRIT RP140800 to E.J.W., and NIH R03 CA223893-01 to P.J.	Akman BH, 2012, NUCLEIC ACIDS RES, V40, P10679, DOI 10.1093/nar/gks855; Aoki H, 2007, CLIN CANCER RES, V13, P6603, DOI 10.1158/1078-0432.CCR-07-0145; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Brumbaugh J, 2018, CELL, V172, P629, DOI 10.1016/j.cell.2017.12.035; Brumbaugh J, 2018, CELL, V172, P106, DOI 10.1016/j.cell.2017.11.023; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cornett AL, 2014, METHODS MOL BIOL, V1125, P157, DOI 10.1007/978-1-62703-971-0_14; Creemers EE, 2016, CIRC RES, V118, P433, DOI 10.1161/CIRCRESAHA.115.307082; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Edlinger L, 2017, BRIT J HAEMATOL, V179, P229, DOI 10.1111/bjh.14833; Elkon R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r59; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; Gruber AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6465; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; Han T, 2014, CELL RES, V24, P1023, DOI 10.1038/cr.2014.88; Hardy JG, 2016, BIOCHEM SOC T, V44, P1051, DOI 10.1042/BST20160078; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; JASONNI VM, 1995, ANTICANCER RES, V15, P1327; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Johnson DB, 2014, CLIN CANCER RES, V20, P4186, DOI 10.1158/1078-0432.CCR-13-3270; Kang TW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05546; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim S, 2010, GENES CELLS, V15, P1003, DOI 10.1111/j.1365-2443.2010.01436.x; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Larson KC, 2010, INFLAMM RES, V59, P15, DOI 10.1007/s00011-009-0062-2; Li TF, 2015, ONCOL REP, V34, P2357, DOI 10.3892/or.2015.4226; Masamha CP, 2018, CARCINOGENESIS, V39, P2, DOI 10.1093/carcin/bgx096; Masamha CP, 2016, RNA, V22, P830, DOI 10.1261/rna.055939.116; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Muller S, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau076; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Park HJ, 2018, NAT GENET, V50, P783, DOI 10.1038/s41588-018-0118-8; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22000; Riemann K, 2009, ANTICANCER RES, V29, P1271; Routh A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx286; Routh A, 2015, J MOL BIOL, V427, P2610, DOI 10.1016/j.jmb.2015.06.011; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Shao JF, 2013, OMICS, V17, P136, DOI 10.1089/omi.2012.0098; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Sun M, 2017, CANCER LETT, V410, P158, DOI 10.1016/j.canlet.2017.09.026; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yajima I, 2014, AM J CANCER RES, V4, P182; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Zhu Y, 2018, MOL CELL, V69, P62, DOI 10.1016/j.molcel.2017.11.031; Zimmermannova O, 2017, ONCOGENE, V36, P5985, DOI 10.1038/onc.2017.210	60	34	35	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4154	4168		10.1038/s41388-019-0714-9	http://dx.doi.org/10.1038/s41388-019-0714-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30705404	Green Accepted			2022-12-26	WOS:000468740200013
J	Eggink, D; Bontjer, I; de Taeye, SW; Langedijk, JPM; Berkhout, B; Sanders, RW				Eggink, Dirk; Bontjer, Ilja; de Taeye, Steven W.; Langedijk, Johannes P. M.; Berkhout, Ben; Sanders, Rogier W.			HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); drug resistance; inhibition mechanism; virus entry; fusion protein; membrane fusion; peptides; anchor inhibitor; antiviral drug; fusion peptide (FP)	TYPE-1 GP41; PROMISCUOUS BINDING; 6-HELIX BUNDLE; ENFUVIRTIDE; RESISTANCE; MUTATIONS; PEPTIDE; INTERMEDIATE; EMERGENCE; DOMAIN	HIV-1 entry into cells is mediated by the envelope glycoprotein (Env) and represents an attractive target for therapeutic intervention. Two drugs that inhibit HIV entry are approved for clinical use: the membrane fusion-inhibitor T20 (Fuzeon, enfuvirtide) and the C-C chemokine receptor type 5 (CCR5) blocker maraviroc (Selzentry). Another class of entry inhibitors supposedly target the fusion peptide (FP) and are termed anchor inhibitors. These include the VIRIP peptide and VIRIP derivatives such as VIR165, VIR353, and VIR576. Here, we investigated the mechanism of inhibition by VIR165. We show that substitutions within the FP modulate sensitivity to VIR165, consistent with the FP being the drug target. Our results also revealed that VIR165 acts during an intermediate post-CD4-binding entry step that is overlapping but not identical to the step inhibited by fusion inhibitors such as T20. We found that some but not all resistance mutations to heptad repeat 2 (HR2)-targeting fusion inhibitors can provide cross-resistance to VIR165. In contrast, resistance mutations in the HR1-binding site for the fusion inhibitors did not cause cross-resistance to VIR165. However, Env with mutations located outside this binding site and thought to affect fusion kinetics, exhibited decreased sensitivity to VIR165. Although we found a strong correlation between Env stability and resistance to HR2-based fusion inhibitors, such correlation was not observed for Env stability and VIR165 resistance. We conclude that VIRIP analogs target the FP during an intermediate, post-CD4-binding entry step that overlaps with but is distinct from the step(s) inhibited by HR2-based fusion inhibitors.	[Eggink, Dirk; Bontjer, Ilja; de Taeye, Steven W.; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Amsterdam Univ Med Ctr Amsterdam UMC, Locat AMC, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Langedijk, Johannes P. M.] Pepscan Therapeut BV, Zuidersluisweg 2, NL-8243 RC Lelystad, Netherlands; [Langedijk, Johannes P. M.] Janssen Vaccines & Prevent, Archimedesweg 4-6, NL-2333 Leiden, Netherlands	University of Amsterdam; Cornell University; Pepscan Therapeutics B.V.	Sanders, RW (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr Amsterdam UMC, Locat AMC, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Eggink, Dirk/0000-0002-4248-6008	Aids Fonds Netherlands [2005021, 2008013]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [OPP1111923, OPP1132237]; National Institutes of Health [P01 AI110657]; European Union's Horizon 2020 research and innovation program [68113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110657] Funding Source: NIH RePORTER	Aids Fonds Netherlands; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union's Horizon 2020 research and innovation program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Aids Fonds Netherlands Grants 2005021 and 2008013, the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) Grants OPP1111923 and OPP1132237, National Institutes of Health Grant P01 AI110657, and the European Union's Horizon 2020 research and innovation program under Grant 68113. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrahamyan LG, 2003, J VIROL, V77, P5829, DOI 10.1128/JVI.77.10.5829-5836.2003; Agrawal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021339; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; BUCHSCHACHER GL, 1995, J VIROL, V69, P1344, DOI 10.1128/JVI.69.2.1344-1348.1995; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Das AT, 1999, J VIROL, V73, P81, DOI 10.1128/JVI.73.1.81-91.1999; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Delahunty MD, 1996, VIROLOGY, V218, P94, DOI 10.1006/viro.1996.0169; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Dingens AS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007159; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2016, J VIROL, V90, P10587, DOI 10.1128/JVI.01616-16; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Ekins S, 2004, DRUG DISCOV TODAY, V9, P276, DOI 10.1016/S1359-6446(03)03008-3; Forssmann WG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001697; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; FREED EO, 1992, P NATL ACAD SCI USA, V89, P70, DOI 10.1073/pnas.89.1.70; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Gonzalez E, 2011, AIDS, V25, P1575, DOI 10.1097/QAD.0b013e328348a733; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Herold N, 2014, J VIROL, V88, P13956, DOI 10.1128/JVI.01543-14; Huang K, 1998, STRUCTURE, V6, P697, DOI 10.1016/S0969-2126(98)00072-0; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; Jeeninga RE, 2001, VIROLOGY, V283, P294, DOI 10.1006/viro.2001.0888; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474; Konuma T, 2007, J MOL BIOL, V368, P209, DOI 10.1016/j.jmb.2007.01.077; Lalezari Jacob P, 2003, AIDS Read, V13, pS9; Leaman DP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003184; Leitner T., 2008, HIV SEQUENCE COMPEND; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2006, J VIROL, V80, P3249, DOI 10.1128/JVI.80.7.3249-3258.2006; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Pritsker M, 1999, BIOCHEMISTRY-US, V38, P11359, DOI 10.1021/bi990232e; Quinones-Mateu ME, 2011, AIDS, V25, P1663, DOI 10.1097/QAD.0b013e32834a36ea; Raviv Y, 2002, VIROLOGY, V293, P243, DOI 10.1006/viro.2001.1237; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reynes J, 2007, AIDS PATIENT CARE ST, V21, P533, DOI 10.1089/apc.2006.0174; Sanders Rogier W, 2004, Retrovirology, V1, P3, DOI 10.1186/1742-4690-1-3; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; SANDERS RW, 2002, HIV SEQUENCE COMPEND, P43; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shafer RW, 2008, AIDS REV, V10, P67; Tolstrup M, 2007, AIDS, V21, P519, DOI 10.1097/QAD.0b013e3280187558; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; van Gils MJ, 2018, IMMUNITY, V49, P14, DOI 10.1016/j.immuni.2018.07.003; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	75	14	14	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5736	5746		10.1074/jbc.RA119.007360	http://dx.doi.org/10.1074/jbc.RA119.007360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30696772	Green Published, hybrid			2022-12-26	WOS:000465077500001
J	Mak, SOK; Zhang, L; Chow, BKC				Mak, Sarah O. K.; Zhang, Li; Chow, Billy K. C.			In vivo actions of SCTR/AT1aR heteromer in controlling Vp expression and release via cFos/cAMP/CREB pathway in magnocellular neurons of PVN	FASEB JOURNAL			English	Article						secretin receptor; GPCR heteromerization; vasopressin; transmembrane peptides	SIGNALING PATHWAY; GENE-EXPRESSION; SECRETIN; VASOPRESSIN; ANGIOTENSIN; ACTIVATION; ELEMENT; HETERODIMERIZATION; IDENTIFICATION; DIMERIZATION	With an increasing body of evidence regarding GPCR oligomerization and its clinical implications over the last decade, the modulation and dynamics of GPCR homo- and hetero-oligomers has more recently become an area of intense research focus. Previously, our lab showed in vitro heteromer formation between angiotensin II receptor type 1 subtype a (AT1aR) and secretin receptor (SCTR), which is involved in in vivo control of hyperosmolality-induced water drinking behavior. Because the secretin (SCT)/SCTR axis is crucial to the central actions of angiotensin II (ANGII) and both SCT and ANGII are capable of triggering vasopressin (Vp) release from hypothalamus, we investigated here the in vivo role of SCTR-AT1aR heteromer in regulating Vp release in hypothalamus using transmembrane peptides as tools. We showed that SCTR-AT1aR heteromer mediates stimulatory actions of both SCT and ANGII in hypothalamic Vp expression and release as well as neuronal activities via the immediate early gene cFos. The results from this study not only are consistent with our hypothesis that SCT and ANGII interact at the receptor level to mediate their water homeostatic activities but also provide evidence for in vivo functions of cross-class GPCR heteromers.	[Mak, Sarah O. K.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, 4N-12,Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong 12345, Peoples R China; [Zhang, Li] Jinan Univ, Cent Nervous Syst CNS Regenerat, Guangdong Hong Kong Macau GHM Inst, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; Jinan University	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, 4N-12,Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong 12345, Peoples R China.	bkcc@hku.hk	ZHANG, Li/L-7460-2019	ZHANG, Li/0000-0003-1489-0879; Chow, Billy, KC/0000-0003-3390-0307; Mak, Oi Kwan/0000-0002-1761-6931	Hong Kong Government Research Grant Council [GRF 17127718, 764812M]	Hong Kong Government Research Grant Council	The authors thank Dr. Harald Janovjak (Monash University, Clayton, VIC, Australia) for proofreading the article. This work is supported by Hong Kong Government Research Grant Council Grants GRF 17127718 and 764812M (to B.K.C.C.). The authors declare no conflicts of interest.	Althammer F, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12549; Bailey WJ, 2001, EXPERT OPIN THER PAT, V11, P1861; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Carlsson PO, 2001, WORLD J SURG, V25, P835, DOI 10.1007/s00268-001-0037-0; Chen J, 2015, CELL SIGNAL, V27, P1426, DOI 10.1016/j.cellsig.2015.03.027; Cheng CYY, 2011, NEUROPSYCHOPHARMACOL, V36, P459, DOI 10.1038/npp.2010.178; Cheng LC, 2015, J NUTR BIOCHEM, V26, P541, DOI 10.1016/j.jnutbio.2014.12.011; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hallbeck M, 1999, J COMP NEUROL, V411, P201; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Ihnatko R, 2013, BRIT J CANCER, V109, P1867, DOI 10.1038/bjc.2013.525; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Kabli N, 2014, MOL PSYCHIATR, V19, P986, DOI 10.1038/mp.2013.115; Kamal M, 2011, PHARMACEUTICALS-BASE, V4, P273, DOI 10.3390/ph4020273; Kasai RS, 2018, CELL BIOCHEM BIOPHYS, V76, P29, DOI 10.1007/s12013-017-0829-y; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Nikitina LS, 2014, BIOTECH HISTOCHEM, V89, P199, DOI 10.3109/10520295.2013.832799; O'Dowd BF, 2012, BIOCHEM BIOPH RES CO, V422, P556, DOI 10.1016/j.bbrc.2012.05.023; Paxinos G, 2013, PAXINOS FRANKLINS MO; PHILLIPS PA, 1985, CLIN SCI, V68, P669, DOI 10.1042/cs0680669; Premer C, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/175428; Rana BK, 2001, ANNU REV PHARMACOL, V41, P593, DOI 10.1146/annurev.pharmtox.41.1.593; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sekar R, 2014, FASEB J, V28, P3494, DOI 10.1096/fj.13-247536; Sladek CD, 1996, AM J PHYSIOL-REG I, V271, pR554, DOI 10.1152/ajpregu.1996.271.3.R554; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; SWAAB DF, 1975, J ENDOCRINOL, V67, P461, DOI 10.1677/joe.0.0670461; Tabor A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33233; Walton KLW, 2009, ADV PHYSIOL EDUC, V33, P165, DOI 10.1152/advan.00023.2009; Xue QJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00245; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Zhang L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00077	50	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5389	5398		10.1096/fj.201801732RR	http://dx.doi.org/10.1096/fj.201801732RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702925	Bronze			2022-12-26	WOS:000462888500061
J	Bucki, R; Wang, YH; Yang, CS; Kandy, SK; Fatunmbi, O; Bradley, R; Pogoda, K; Svitkina, T; Radhakrishnan, R; Janmey, PA				Bucki, Robert; Wang, Yu-Hsiu; Yang, Changsong; Kandy, Sreeja Kutti; Fatunmbi, Ololade; Bradley, Ryan; Pogoda, Katarzyna; Svitkina, Tatyana; Radhakrishnan, Ravi; Janmey, Paul A.			Lateral distribution of phosphatidylinositol 4,5-bisphosphate in membranes regulates formin- and ARP2/3-mediated actin nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid; phosphatidylinositol; membrane; actin; cell biology; actin assembly; biological membrane; cholesterol; formins; PI(4; 5)P2	CLUSTER FORMATION; PLASMA-MEMBRANE; PROTEIN; CHOLESTEROL; MODEL; PHOSPHOINOSITIDES; POLYMERIZATION; ORGANIZATION; CYTOSKELETON; INHIBITOR	Spatial and temporal control of actin polymerization is fundamental for many cellular processes, including cell migration, division, vesicle trafficking, and response to agonists. Many actin-regulatory proteins interact with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) and are either activated or inactivated by local PI(4,5)P-2 concentrations that form transiently at the cytoplasmic face of cell membranes. The molecular mechanisms of these interactions and how the dozens of PI(4,5)P-2-sensitive actin-binding proteins are selectively recruited to membrane PI(4,5)P-2 pools remains undefined. Using a combination of biochemical, imaging, and cell biologic studies, combined with molecular dynamics and analytical theory, we test the hypothesis that the lateral distribution of PI(4,5)P-2 within lipid membranes and native plasma membranes alters the capacity of PI(4,5)P-2 to nucleate actin assembly in brain and neutrophil extracts and show that activities of formins and the Arp2/3 complex respond to PI(4,5)P-2 lateral distribution. Simulations and analytical theory show that cholesterol promotes the cooperative interaction of formins with multiple PI(4,5)P-2 headgroups in the membrane to initiate actin nucleation. Masking PI(4,5)P-2 with neomycin or disrupting PI(4,5)P-2 domains in the plasma membrane by removing cholesterol decreases the ability of these membranes to nucleate actin assembly in cytoplasmic extracts.	[Bucki, Robert; Pogoda, Katarzyna; Janmey, Paul A.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Yang, Changsong; Svitkina, Tatyana] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kandy, Sreeja Kutti; Fatunmbi, Ololade; Bradley, Ryan; Radhakrishnan, Ravi] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Bucki, Robert] Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, PL-15089 Bialystok, Poland; [Pogoda, Katarzyna] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland; [Wang, Yu-Hsiu; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Medical University of Bialystok; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Pennsylvania; Pennsylvania Medicine	Bucki, R (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.; Bucki, R (corresponding author), Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, PL-15089 Bialystok, Poland.	buckirobert@gmail.com	Pogoda, Katarzyna/AAD-2057-2020; Wang, Yu-Hsiu/N-8094-2013	Pogoda, Katarzyna/0000-0001-6994-3435; Radhakrishnan, Ravi/0000-0003-0686-2851; Wang, Yu-Hsiu/0000-0001-9753-5535; Bradley, Ryan/0000-0001-9190-8409; Bucki, Robert/0000-0001-7664-9226	National Institutes of Health [GM111942]; National Science Center, Poland [UMO-2015/17/B/NZ6/03473]; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center, Poland(National Science Centre, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM111942 (to P. A. J.) and the National Science Center, Poland, under Grant UMO-2015/17/B/NZ6/03473 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alwarawrah M, 2017, J PHYS CHEM B, V121, P78, DOI 10.1021/acs.jpcb.6b10188; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bilkova E, 2017, J AM CHEM SOC, V139, P4019, DOI 10.1021/jacs.6b11760; Bradley RP, 2016, P NATL ACAD SCI USA, V113, pE5117, DOI 10.1073/pnas.1605259113; Bucki R, 2004, ANTIMICROB AGENTS CH, V48, P1526, DOI 10.1128/AAC.48.5.1526-1533.2004; Chierico L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06056; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Huang MZ, 2005, CELL MOTIL CYTOSKEL, V62, P232, DOI 10.1002/cm.20097; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janmey PA, 2018, BIOCHEM BIOPH RES CO, V506, P307, DOI 10.1016/j.bbrc.2018.07.155; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Kang JK, 2017, P NATL ACAD SCI USA, V114, P11926, DOI 10.1073/pnas.1706489114; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LASSING I, 1988, EXP CELL RES, V174, P1, DOI 10.1016/0014-4827(88)90136-X; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lee S, 2014, J PHYS CHEM B, V118, P547, DOI 10.1021/jp410344g; Levental I, 2008, BIOPHYS J, V95, P1199, DOI 10.1529/biophysj.107.126615; Lewis AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003376; Ma L, 1998, J CELL BIOL, V140, P1125; Mahammad S, 2015, METHODS MOL BIOL, V1232, P91, DOI 10.1007/978-1-4939-1752-5_8; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ramakrishnan N, 2014, PHYS REP, V543, P1, DOI 10.1016/j.physrep.2014.05.001; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rusinova R, 2013, J GEN PHYSIOL, V141, P673, DOI 10.1085/jgp.201310960; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Senju Y, 2017, P NATL ACAD SCI USA, V114, pE8977, DOI 10.1073/pnas.1705032114; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Stocker U, 2000, PROTEINS, V40, P145, DOI 10.1002/(SICI)1097-0134(20000701)40:1<145::AID-PROT160>3.0.CO;2-Y; Suetsugu S, 2001, J CELL SCI, V114, P4533; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Wang YH, 2016, BIOCHEMISTRY-US, V55, P3361, DOI 10.1021/acs.biochem.5b01363; Wang YH, 2014, CHEM PHYS LIPIDS, V182, P38, DOI 10.1016/j.chemphyslip.2014.01.001; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zigmond SH, 1998, J CELL BIOL, V142, P1001, DOI 10.1083/jcb.142.4.1001	55	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4704	4722		10.1074/jbc.RA118.005552	http://dx.doi.org/10.1074/jbc.RA118.005552			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30692198	Green Published, hybrid			2022-12-26	WOS:000462969500035
J	Antunovic, V; Ilic, M; Baosic, R; Jelic, D; Lolic, A				Antunovic, Vesna; Ilic, Marija; Baosic, Rada; Jelic, Dijana; Lolic, Aleksandar			Synthesis of MnCo2O4 nanoparticles as modifiers for simultaneous determination of Pb(II) and Cd(II)	PLOS ONE			English	Article							ULTRASOUND-ASSISTED EXTRACTION; HEAVY-METAL IONS; NI-ZN FERRITE; VOLTAMMETRIC DETERMINATION; ACTIVATED CARBON; PASTE ELECTRODE; SPINEL OXIDES; COBALT; MANGANESE; GRAPHENE	The porous spinel oxide nanoparticles, MnCo2O4, were synthesized by citrate gel combustion technique. Morphology, crystallinity and Co/Mn content of modified electrode was characterized and determined by Fourier transform infra-red spectroscopy (FT-IR), scanning electron microscopy (SEM), energy dispersive spectrometry (EDS), X-ray diffraction pattern analysis (XRD), simultaneous thermogravimetry and differential thermal analysis (TG/DTA). Nanoparticles were used for modification of glassy carbon electrode (GCE) and new sensor was applied for simultaneous determination of Pb(II) and Cd(II) ions in water samples with the linear sweep anodic stripping voltammetry (LSASV). The factors such as pH, deposition potential and deposition time are optimized. Under optimal conditions the wide linear concentration range from 0.05 to 40 mu mol/dm(3) was obtained for Pb(II), with limit of detection (LOD) of 8.06 nmol/dm(3) and two linear concentration ranges were obtained for Cd(II), from 0.05 to 1.6 mu mol/dm(3) and from 1.6 to 40 mu mol/dm(3), with calculated LOD of 7.02 nmol/dm(3). The selectivity of the new sensor was investigated in the presence of interfering ions. The sensor is stable and it gave reproducible results. The new sensor was succesfully applied on determination of heavy metals in natural waters.	[Antunovic, Vesna; Jelic, Dijana] Univ Banja Luka, Fac Med, Banja Luka, Bosnia & Herceg; [Ilic, Marija] Univ Belgrade, Fac Min & Geol, Belgrade, Serbia; [Baosic, Rada; Lolic, Aleksandar] Univ Belgrade, Dept Analyt Chem, Fac Chem, Belgrade, Serbia	University of Banja Luka (UNIBL); University of Belgrade; University of Belgrade	Lolic, A (corresponding author), Univ Belgrade, Dept Analyt Chem, Fac Chem, Belgrade, Serbia.	lolix@chem.bg.ac.rs	Lolić, Aleksandar/Q-5177-2016; Baosic, Rada/Q-4509-2016	Lolić, Aleksandar/0000-0002-5354-9019; Baosic, Rada/0000-0003-2778-9980				Akturk M, 2018, ELECTROANAL, V30, P238, DOI 10.1002/elan.201700590; Anandhakumar S, 2013, ANALYST, V138, P5674, DOI 10.1039/c3an01070h; Aziz SFNA, 2018, ELECTROANAL, V30, P533, DOI 10.1002/elan.201700736; Bagheri H, 2012, TALANTA, V97, P87, DOI 10.1016/j.talanta.2012.03.066; Barros JM, 2013, AN ACAD BRAS CIENC, V85, P891, DOI 10.1590/S0001-37652013000300005; Batista BL, 2009, FORENSIC SCI INT, V192, P88, DOI 10.1016/j.forsciint.2009.08.003; Bhanjana G, 2015, ELECTROCHIM ACTA, V169, P97, DOI 10.1016/j.electacta.2015.04.045; Bhujun B, 2017, RESULTS PHYS, V7, P345, DOI 10.1016/j.rinp.2016.04.010; Cadevall M, 2015, ELECTROPHORESIS, V36, P1872, DOI 10.1002/elps.201400609; Chen DH, 2001, MATER RES BULL, V36, P1369, DOI 10.1016/S0025-5408(01)00620-1; Cheng FY, 2011, NAT CHEM, V3, P79, DOI [10.1038/nchem.931, 10.1038/NCHEM.931]; Chong J, 2012, J POWER SOURCES, V200, P67, DOI 10.1016/j.jpowsour.2011.10.073; Crowley K, 2002, ELECTROANAL, V14, P1077, DOI 10.1002/1521-4109(200208)14:15/16<1077::AID-ELAN1077>3.0.CO;2-3; Dai HX, 2016, CHEM ENG J, V299, P150, DOI 10.1016/j.cej.2016.04.083; Gul IH, 2008, J MAGN MAGN MATER, V320, P270, DOI 10.1016/j.jmmm.2007.05.032; Gumpu MB, 2017, TALANTA, V162, P574, DOI 10.1016/j.talanta.2016.10.076; Hamdani M, 2010, INT J ELECTROCHEM SC, V5, P556; Hristozov D, 2004, ANAL CHIM ACTA, V516, P187, DOI 10.1016/j.aca.2004.04.026; Imran M, 2013, POLYM DEGRAD STABIL, V98, P904, DOI 10.1016/j.polymdegradstab.2013.01.007; Janegitz BC, 2011, J ELECTROANAL CHEM, V660, P209, DOI 10.1016/j.jelechem.2011.07.001; Jelic D, 2018, J THERM ANAL CALORIM, V132, P77, DOI 10.1007/s10973-017-6921-0; Jiang H, 2011, J MATER CHEM, V21, P3818, DOI 10.1039/c0jm03830j; Kale SB, 2015, PHYS CHEM CHEM PHYS, V17, P31850, DOI 10.1039/c5cp05546f; Klissurski DG, 2003, APPL SURF SCI, V214, P370, DOI 10.1016/S0169-4332(03)00524-5; Kosak A, 2004, J EUR CERAM SOC, V24, P959, DOI 10.1016/S0955-2219(03)00524-7; Koudelkova Z, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081832; Lavela P, 2007, ELECTROCHIM ACTA, V52, P7986, DOI 10.1016/j.electacta.2007.06.066; Lee GJ, 2010, ELECTROANAL, V22, P530, DOI 10.1002/elan.200900356; Li C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8345; Li T, 2018, ENVIRON SCI-WAT RES, V4, P1671, DOI 10.1039/c8ew00517f; Liang YY, 2012, J AM CHEM SOC, V134, P3517, DOI 10.1021/ja210924t; Losev VN, 2015, MICROCHEM J, V123, P84, DOI 10.1016/j.microc.2015.05.022; Madhu R, 2014, RSC ADV, V4, P1225, DOI 10.1039/c3ra45089a; Maerle AA, 2017, RUSS J PHYS CHEM A+, V91, P910, DOI 10.1134/S003602441705017X; Malisic M, 2012, ELECTROCHIM ACTA, V74, P158, DOI 10.1016/j.electacta.2012.04.049; Mishra YK, 2018, MATER TODAY, V21, P631, DOI 10.1016/j.mattod.2017.11.003; Modi KB, 2006, CERAM INT, V32, P111, DOI 10.1016/j.ceramint.2005.01.005; Mondal A, 2016, RSC ADV, V6, P82484, DOI 10.1039/c6ra15119a; Muneam H, 2016, INT J IND CHEM, V7, P93, DOI 10.1007/s40090-015-0069-1; Munjal S, 2016, J MAGN MAGN MATER, V404, P166, DOI 10.1016/j.jmmm.2015.12.017; Naik KK, 2015, MATER RES EXPRESS, V2, DOI 10.1088/2053-1591/2/9/095011; Newman J., 2004, ELECTROCHEMICAL SYST; Pirogova GN, 2001, RUSS CHEM B+, V50, P2377, DOI 10.1023/A:1015083529355; Sharma M, 2019, CHEM ENG J, V358, P540, DOI 10.1016/j.cej.2018.10.031; Sitko R, 2015, ANAL CHEM, V87, P3535, DOI 10.1021/acs.analchem.5b00283; Stankovic DM, 2014, ELECTROANAL, V26, P1536, DOI 10.1002/elan.201400095; Stoilova D, 2000, J MOL STRUCT, V553, P131, DOI 10.1016/S0022-2860(00)00541-X; Sun YF, 2014, J ELECTROANAL CHEM, V714, P97, DOI 10.1016/j.jelechem.2013.12.030; Sutka A, 2012, FRONT MATER SCI, V6, P128, DOI 10.1007/s11706-012-0167-3; Takayama A, 2004, SOLID STATE IONICS, V172, P257, DOI 10.1016/j.ssi.2004.02.040; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P3982, DOI 10.1021/acssuschemeng.6b03182; Tripathi KM, 2016, ACS SUSTAIN CHEM ENG, V4, P6399, DOI 10.1021/acssuschemeng.6b01045; Velmurugan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00748-x; Wanekaya AK, 2011, ANALYST, V136, P4383, DOI 10.1039/c1an15574a; Wang H, 2015, ANALYST, V140, P5619, DOI 10.1039/c5an00736d; Wang K, 2009, ELECTROCHIM ACTA, V54, P2861, DOI 10.1016/j.electacta.2008.11.012; WHO, 2011, GUID DRINK WAT QUAL; Xiao LL, 2014, ELECTROCHIM ACTA, V143, P143, DOI 10.1016/j.electacta.2014.08.021; Zahi S, 2007, J MAGN MAGN MATER, V308, P177, DOI 10.1016/j.jmmm.2006.05.033; Zhang B, 2016, ELECTROCHIM ACTA, V196, P422, DOI 10.1016/j.electacta.2016.02.163; Zhang YQ, 2016, ELECTROCHIM ACTA, V206, P278, DOI 10.1016/j.electacta.2016.04.137; Zhang YT, 2015, BIOSENS BIOELECTRON, V66, P308, DOI 10.1016/j.bios.2014.11.040; Zhou L, 2012, ADV MATER, V24, P745, DOI 10.1002/adma.201104407	63	14	14	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210904	10.1371/journal.pone.0210904	http://dx.doi.org/10.1371/journal.pone.0210904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726233	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000037
J	Patlan, AG; Ayala-Garcia, VM; Valenzuela-Garcia, LI; Meneses-Plascencia, J; Vargas-Arias, PL; Barraza-Salas, M; Setlow, P; Brieba, LG; Pedraza-Reyes, M				Patlan, Adriana G.; Ayala-Garcia, Victor M.; Valenzuela-Garcia, Luz I.; Meneses-Plascencia, Jimena; Vargas-Arias, Pedro L.; Barraza-Salas, Marcelo; Setlow, Peter; Brieba, Luis G.; Pedraza-Reyes, Mario			YwqL (EndoV), ExoA and PolA act in a novel alternative excision pathway to repair deaminated DNA bases in Bacillus subtilis	PLOS ONE			English	Article							DEOXYINOSINE-SPECIFIC ENDONUCLEASE; ESCHERICHIA-COLI; POLYMERASE-I; APURINIC/APYRIMIDINIC ENDONUCLEASES; NITROUS-ACID; CLEAVAGE; GLYCOSYLASE; URACIL; ENZYME; PROTEIN	DNA deamination generates base transitions and apurinic/apyrimidinic (AP)-sites which are potentially genotoxic and cytotoxic. In Bacillus subtilis uracil can be removed from DNA by the uracil DNA-glycosylase through the base excision repair pathway. Genetic evidence suggests that B. subtilis YwqL, a homolog of Endonuclease-V (EndoV), acts on a wider spectrum of deaminated bases but the factors that complete this pathway have remained elusive. Here, we report that a purified His(6)-YwqL (hereafter BsEndoV) protein had in vitro endonuclease activity against double-stranded DNAs containing a single uracil (U), hypoxanthine (Hx), xanthine (X) or an AP site. Interestingly, while BsEndoV catalyzed a single strand break at the second phosphodiester bond towards the 3'-end of the U and AP lesions, there was an additional cleavage of the phosphodiester bond preceding the Hx and X lesions. Remarkably, the repair event initiated by BsEndoV on Hx and X, was completed by a recombinant B. subtilis His(6)-DNA polymerase A (BsPolA), but not on BsEndoV-processed U and AP lesions. For the latter lesions a second excision event performed by a recombinant B. subtilis His(6)-ExoA (BsExoA) was necessary before completion of their repair by BsPolA. These results suggest the existence of a novel alternative excision repair pathway in B. subtilis that counteracts the genotoxic effects of base deamination. The presence of this novel pathway in vivo in B. subtilis was also supported by analysis of effects of single or multiple deletions of exoA, endoV and polA on spontaneous mutations in growing cells, and the sensitivity of growing wild-type and mutant cells to a DNA deaminating agent.	[Patlan, Adriana G.; Ayala-Garcia, Victor M.; Valenzuela-Garcia, Luz I.; Meneses-Plascencia, Jimena; Vargas-Arias, Pedro L.; Pedraza-Reyes, Mario] Univ Guanajuato, Dept Biol, Guanajuato, Mexico; [Ayala-Garcia, Victor M.; Barraza-Salas, Marcelo] Univ Juarez Estado Durango, Fac Ciencias Quim, Durango, Durango, Mexico; [Setlow, Peter] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT USA; [Brieba, Luis G.] Langebiocinvestav Sede Irapuato, Km 9-6 Libramiento Norte Carretera Irapuato Leon, Guanajuato, Mexico	Universidad de Guanajuato; Universidad Juarez del Estado de Durango	Pedraza-Reyes, M (corresponding author), Univ Guanajuato, Dept Biol, Guanajuato, Mexico.	pedrama@ugto.mx	Ayala-Garcia, Victor M./AAE-9775-2020; Brieba, Luis G./I-8447-2016	Ayala-Garcia, Victor M./0000-0003-4629-9645; Brieba, Luis G./0000-0002-6073-5207	National Council of Science and Technology (CONACYT), Mexico [221231]; University of Guanajuato, Mexico [CIIC 188/2018]; CONACyT	National Council of Science and Technology (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Guanajuato, Mexico; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by: 1) MPR, Grant 221231 National Council of Science and Technology (CONACYT), Mexico; 2) MPR, Grant CIIC 188/2018 University of Guanajuato, Mexico; 3) AGP, VMAG, LIVG, PLVA and JMP were supported by scholarships from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 1996, GENET ANAL-BIOMOL E, V12, P185; Ambriz-Avina V, 2016, CURR MICROBIOL, V73, P721, DOI 10.1007/s00284-016-1122-9; Ayala-Garcia VM, 2016, J BACTERIOL, V198, P3345, DOI 10.1128/JB.00625-16; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Cao WG, 2013, CELL MOL LIFE SCI, V70, P3145, DOI 10.1007/s00018-012-1222-z; CHEN H, 1993, BIOCHEMISTRY-US, V32, P3535, DOI 10.1021/bi00065a003; Cutting S., 1990, MOL BIOL METHODS BAC; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Duigou S, 2005, MOL MICROBIOL, V57, P678, DOI 10.1111/j.1365-2958.2005.04725.x; Feng H, 2005, BIOCHEMISTRY-US, V44, P11486, DOI 10.1021/bi050837c; Forouhar F, 2009, CRYSTAL STRUCTURE EN; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; GATES FT, 1977, J BIOL CHEM, V252, P1647; Gomez-Marroquin M, 2016, GENES-BASEL, V7, DOI 10.3390/genes7070033; He B, 2000, MUTAT RES-DNA REPAIR, V459, P109, DOI 10.1016/S0921-8777(99)00063-4; Hitchcock TM, 2004, NUCLEIC ACIDS RES, V32, P4071, DOI 10.1093/nar/gkh747; Huang JM, 2001, BIOCHEMISTRY-US, V40, P8738, DOI 10.1021/bi010183h; Ibarra JR, 2008, J BACTERIOL, V190, P2031, DOI 10.1128/JB.01625-07; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kornberg A., 1992, DNA REPLICATION; Kow YW, 2002, FREE RADICAL BIO MED, V33, P886, DOI 10.1016/S0891-5849(02)00902-4; Krokan HE, 1997, BIOCHEM J, V325, P1; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CC, 2010, DNA REPAIR, V9, P1073, DOI 10.1016/j.dnarep.2010.07.007; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; Liu J, 2000, MUTAT RES-DNA REPAIR, V461, P169, DOI 10.1016/S0921-8777(00)00054-9; Lopez-Olmos K, 2012, J BACTERIOL, V194, P243, DOI 10.1128/JB.06082-11; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mi RJ, 2011, NUCLEIC ACIDS RES, V39, P536, DOI 10.1093/nar/gkq791; Patlan AG, 2018, DNA REPAIR, V70, P1, DOI 10.1016/j.dnarep.2018.07.007; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Perez-Lago L, 2011, MOL MICROBIOL, V80, P1657, DOI 10.1111/j.1365-2958.2011.07675.x; PONNAMPERUMA C, 1961, SCIENCE, V134, P113, DOI 10.1126/science.134.3472.113; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Salas-Pacheco JA, 2005, J BACTERIOL, V187, P7374, DOI 10.1128/JB.187.21.7374-7381.2005; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHAPIRO R, 1968, BIOCHEMISTRY-US, V7, P448, DOI 10.1021/bi00841a057; SHAPIRO R, 1969, BIOCHIM BIOPHYS ACTA, V174, P403, DOI 10.1016/0005-2787(69)90268-8; Shida T, 1999, BIOSCI BIOTECH BIOCH, V63, P1528, DOI 10.1271/bbb.63.1528; Su KY, 2018, DNA REPAIR, V64, P59, DOI 10.1016/j.dnarep.2018.02.005; Thomaides HB, 2007, J BACTERIOL, V189, P591, DOI 10.1128/JB.01381-06; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; Utepbergenov D, 2009, CRYSTAL STRUCTURE TM; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; YAO M, 1994, ANN NY ACAD SCI, V726, P315, DOI 10.1111/j.1749-6632.1994.tb52837.x; Yao M, 1996, J BIOL CHEM, V271, P30672, DOI 10.1074/jbc.271.48.30672; YAO M, 1994, J BIOL CHEM, V269, P31390; YAO M, 1994, J BIOL CHEM, V269, P16260; Zhang ZM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12754	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211653	10.1371/journal.pone.0211653	http://dx.doi.org/10.1371/journal.pone.0211653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726292	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000071
J	McCall, SJ; Li, ZY; Kurinczuk, JJ; Sullivan, E; Knight, M				McCall, Stephen J.; Li, Zhuoyang; Kurinczuk, Jennifer J.; Sullivan, Elizabeth; Knight, Marian			Maternal and perinatal outcomes in pregnant women with BMI > 50: An international collaborative study	PLOS ONE			English	Article							BODY-MASS INDEX; SURVEILLANCE SYSTEM; EXTREME OBESITY; SUPER-OBESITY; MOTHER; RISK	Objective To examine the association between maternal BMI>50kg/m(2) during pregnancy and maternal and perinatal outcomes. Materials and methods An international cohort study was conducted using data from separate national studies in the UK and Australia. Outcomes of pregnant women with BMI>50 were compared to those of pregnant women with BMI<50. Multivariable logistic regression estimated the association between BMI>50 and perinatal and maternal outcomes. Results 932 pregnant women with BM1>50 were compared with 1232 pregnant women with BMI<50. Pregnant women with BMI>50 were slightly older, more likely to be multiparous, and have pre-existing comorbidities. There were no maternal deaths, however, extremely obese women had a nine-fold increase in the odds of thrombotic events compared to those with a BMI<50 (uOR: 9.39 (95%Cl:1.15-76.43)). After adjustment, a BMI>50 during pregnancy had significantly raised odds of preeclampsia/eclampsia (aOR:4.88(95%Cl: 3.11-7.65)), caesarean delivery (aOR: 2.77 (95%Cl: 2.31-3.32)), induction of labour (aOR: 2.45 (95% Cl:2.00-2.99)) post caesarean wound infection (aOR:7.25(95%Cl: 3.28-16.07)), macrosomia (aOR: 8.05(95%Cl: 4.70-13.78)) compared a BMI<50. Twelve of the infants born to women in the extremely obese cohort died in the early neonatal period or were stillborn. Conclusions Pregnant women with BMI>50 have a high risk of inferior maternal and perinatal outcomes.	[McCall, Stephen J.; Kurinczuk, Jennifer J.; Knight, Marian] Univ Oxford, Nuffield Dept Populat Hlth, NPEU, Oxford, England; [Li, Zhuoyang; Sullivan, Elizabeth] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia	University of Oxford; University of Technology Sydney	McCall, SJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, NPEU, Oxford, England.	Stephen.mccall@npeu.ox.ac.uk	Li, Zhuoyang/B-2842-2015; Li, Zhuoyang/P-7433-2019; Knight, Marian/B-6225-2009	Li, Zhuoyang/0000-0002-7622-150X; Li, Zhuoyang/0000-0002-7622-150X; Knight, Marian/0000-0002-1984-4575; McCall, Stephen/0000-0003-0078-7010	Medical Research Council (MRC) [MR/K501256/1]; NIHR Research Professorship; National Health and Medical Research Council [510298]; Nuffield Department of Population Health	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Research Professorship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Nuffield Department of Population Health	SJM is funded by the Nuffield Department of Population Health and Medical Research Council (MRC) training grant MR/K501256/1. MK is funded by an NIHR Research Professorship. The views expressed in this publication are those of the author(s), and not necessarily those of the MRC, the NHIR or the Department of Health. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the article. The National Health and Medical Research Council Project Grant (application 510298) for funding The Australian Maternity Outcomes Surveillance System: Improving safety and quality of maternity care in Australia (AMOSS) from 2008-2012.	Alanis MC, 2010, ACTA OBSTET GYN SCAN, V89, P924, DOI 10.3109/00016341003657884; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Cheng W, 2012, AM J OBSTET GYNECOL, V206, pS250; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Crane JMG, 2013, J OBSTET GYNAECOL CA, V35, P606, DOI 10.1016/S1701-2163(15)30879-3; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Halliday LE, 2013, AUST NZ J OBSTET GYN, V53, P152, DOI 10.1111/ajo.12020; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2010, OBSTET GYNECOL, V115, P989, DOI 10.1097/AOG.0b013e3181da8f09; Lindquist A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002742; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; Marshall NE, 2014, AM J PERINAT, V31, P249, DOI 10.1055/s-0033-1347363; Martin A, 2014, J PERINATOL, V34, P495, DOI 10.1038/jp.2014.4; National Institute for Health and Care Excellence, 2011, CAES SECT; Niewoudt M, 2014, SAJOG-S AFR J OBSTET, V20, P67; Rao DP, 2010, INDIAN J ANAESTH, V54, P508, DOI 10.4103/0019-5049.72639; Rogers WH, 1993, STATA TECHN B, V13, P19; Sullivan EA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0693-y; Wang Z, 2013, OBES REV, V14, P508, DOI 10.1111/obr.12025; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhu T, 2015, SCI REPORTS, V5	23	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211278	10.1371/journal.pone.0211278	http://dx.doi.org/10.1371/journal.pone.0211278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716114	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200018
J	Chong, LC; Ganesan, H; Yong, CY; Tan, WS; Ho, L				Chong, Li Chuin; Ganesan, Hagilaa; Yong, Chean Yeah; Tan, Wen Siang; Ho, Lian			Expression, purification and characterization of the dimeric protruding domain of Macrobrachium rosenbergii nodavirus capsid protein expressed in Escherichia coli	PLOS ONE			English	Article							FRESH-WATER PRAWN; VIRUS-LIKE PARTICLES; WHITE TAIL DISEASE; MRNV; SPECTRA; CULTURE; BINDING	Macrobrachium rosenbergii nodavirus (MrNV) is the causative agent of white tail disease (WTD) which seriously impedes the production of the giant freshwater prawn and has a major economic impact. MrNV contains two segmented RNA molecules, which encode the RNA dependent RNA polymerase (RdRp) and the capsid protein (MrNV-CP) containing 371 amino acid residues. MrNV-CP comprises of the Shell (S) and the Protruding (P) domains, ranging from amino acid residues 1-252 and 253-371, respectively. The P-domain assembles into dimeric protruding spikes, and it is believed to be involved in host cell attachment and internalization. In this study, the recombinant P-domain of MrNV-CP was successfully cloned and expressed in Escherichia coli, purified with an immobilized metal affinity chromatography (IMAC) and size exclusion chromatography (SEC) up to similar to 90% purity. Characterization of the purified recombinant P-domain with SEC revealed that it formed dimers, and dynamic light scattering (DLS) analysis demonstrated that the hydrodynamic diameter of the dimers was similar to 6 nm. Circular dichroism (CD) analysis showed that the P-domain contained 67.9% of beta-sheets, but without alpha-helical structures. This is in good agreement with the cryo-electron microscopic analysis of MrNV which demonstrated that the P-domain contains only beta-stranded structures. Our findings of this study provide essential information for the production of the P-domain of MrNV-CP that will aid future studies particularly studies that will shed light on anti-viral drug discovery and provide an understanding of virus-host interactions and the viral pathogenicity.	[Chong, Li Chuin] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Upm Serdang, Selangor, Malaysia; [Ganesan, Hagilaa; Yong, Chean Yeah; Tan, Wen Siang] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Upm Serdang, Selangor, Malaysia; [Tan, Wen Siang] Univ Putra Malaysia, Inst Biosci, Upm Serdang, Selangor, Malaysia; [Ho, Lian] Univ Putra Malaysia, Dept Pathol, Fac Med & Hlth Sci, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ho, L (corresponding author), Univ Putra Malaysia, Dept Pathol, Fac Med & Hlth Sci, Upm Serdang, Selangor, Malaysia.	klho@upm.edu.my	Tan, Wen Siang/C-1433-2017	Tan, Wen Siang/0000-0001-9452-198X; Ho, Kok Lian/0000-0002-5778-4729; Chong, Li Chuin/0000-0002-3574-1365	Ministry of Education of Malaysia through the Fundamental Research Grant Scheme [01-01-18-1988FR]; Universiti Putra Malaysia (UPM) Putra Grant [GP-IPS/2018/9602500]	Ministry of Education of Malaysia through the Fundamental Research Grant Scheme; Universiti Putra Malaysia (UPM) Putra Grant	This work was supported by the Ministry of Education of Malaysia through the Fundamental Research Grant Scheme (Grant number: 01-01-18-1988FR) and Universiti Putra Malaysia (UPM) Putra Grant (Grant number: GP-IPS/2018/9602500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcier JM, 1999, DIS AQUAT ORGAN, V38, P177, DOI 10.3354/dao038177; Banu R., 2016, J AQUACULTURE RES DE, V7, P423, DOI DOI 10.4172/2155-9546.1000423; Bonami JR, 2005, J FISH DIS, V28, P23, DOI 10.1111/j.1365-2761.2004.00595.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Eaton P, 2017, ULTRAMICROSCOPY, V182, P179, DOI 10.1016/j.ultramic.2017.07.001; Goh ZH, 2014, J GEN VIROL, V95, P1919, DOI 10.1099/vir.0.064014-0; Goh ZH, 2011, J VIROL METHODS, V175, P74, DOI 10.1016/j.jviromet.2011.04.021; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hameed ASS, 2012, INDIAN J VIROL, V23, P134, DOI 10.1007/s13337-012-0087-y; Hameed ASS, 2004, DIS AQUAT ORGAN, V62, P191, DOI 10.3354/dao062191; Hayakijkosol O, 2013, J FISH DIS, V36, P401, DOI 10.1111/j.1365-2761.2012.01414.x; Ho KL, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000038; Ho KL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02292-0; Jariyapong P, 2014, VIRUS RES, V179, P140, DOI 10.1016/j.virusres.2013.10.021; Kinjo AR, 2004, BIOINFORMATICS, V20, P2504, DOI 10.1093/bioinformatics/bth297; Kueh CL, 2017, BIOTECHNOL PROGR, V33, P549, DOI 10.1002/btpr.2409; Li M, 2013, J VIROL, V87, P12166, DOI 10.1128/JVI.01965-13; Murwantoko M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3127-z; NaveenKumar S, 2013, VIRUS RES, V173, P377, DOI 10.1016/j.virusres.2013.01.003; NEW MB, 1990, AQUACULTURE, V88, P99, DOI 10.1016/0044-8486(90)90288-X; Qian D, 2003, J FISH DIS, V26, P521, DOI 10.1046/j.1365-2761.2003.00486.x; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Somrit M, 2017, VIRUS RES, V227, P41, DOI 10.1016/j.virusres.2016.09.017; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yong CY, 2017, PEERJ, V5, DOI 10.7717/peerj.3841; Yoon KY, 2013, ELECTROPHORESIS, V34, P244, DOI 10.1002/elps.201200257	28	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211740	10.1371/journal.pone.0211740	http://dx.doi.org/10.1371/journal.pone.0211740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707739	Green Submitted, gold, Green Published			2022-12-26	WOS:000457742900046
J	Gonzalez, J; Rodriguez-Fraile, M; Rivera, P; Restituto, P; Colina, I; Calleja, MD; Alcaide, AB; Campo, A; Berto, J; Seijo, LM; Perez, T; Zulueta, J; Varo, N; de-Torres, JP				Gonzalez, Jessica; Rodriguez-Fraile, Macarena; Rivera, Pilar; Restituto, Patricia; Colina, Inmaculada; de los Desamparados Calleja, Maria; Alcaide, Ana B.; Campo, Aranzazu; Berto, Juan; Seijo, Luis M.; Perez, Teresa; Zulueta, Javier; Varo, Nerea; de-Torres, Juan P.			Trabecular bone score in active or former smokers with and without COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MINERAL DENSITY; OSTEOPOROTIC FRACTURES; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE; CAUCASIAN WOMEN; LUNG-FUNCTION; RISK; DIAGNOSIS; TBS	Background Smoking is a recognized risk factor for osteoporosis. Trabecular bone score (TBS) is a novel texture parameter to evaluate bone microarchitecture. TBS and their main determinants are unknown in active and former smokers. Objective To assess TBS in a population of active or former smokers with and without Chronic Obstructive Pulmonary Disease (COPD) and to determine its predictive factors. Methods Active and former smokers from a pulmonary clinic were invited to participate. Clinical features were recorded and bone turnover markers (BTMs) measured. Lung function, low dose chest Computed Tomography scans (LDCT), dual energy absorptiometry (DXA) scans were performed and TBS measured. Logistic regression analysis explored the relationship between measured parameters and TBS. Results One hundred and forty five patients were included in the analysis, 97 (67.8%) with COPD. TBS was lower in COPD patients (median 1.323; IQR: 0.13 vs 1.48; IQR: 0.16, p = 0.003). Regression analysis showed that a higher body mass index (BMI), younger age, less number of exacerbations and a higher forced expiratory volume-one second (FEV1%) was associated with better TBS (beta = 0.005, 95% CI: 0.000-0.011, p = 0.032; beta = -0.003, 95% CI:0.007(-)- 0.000, p = 0.008; beta = -0.019, 95% CI:-0.034(-)-0.004, p = 0.015; beta = 0.001, 95% CI: 0.000-0.002, p = 0.012 respectively). The same factors with similar results were found in COPD patients. Conclusions A significant proportion of active and former smokers with and without COPD have an affected TBS. BMI, age, number of exacerbations and the degree of airway obstruction predicts TBS values in smokers with and without COPD. This important information should be considered when evaluating smokers at risk of osteoporosis.	[Gonzalez, Jessica; Rivera, Pilar; Alcaide, Ana B.; Campo, Aranzazu; Berto, Juan; Zulueta, Javier; de-Torres, Juan P.] Clin Univ Navarra, Pulm Dept, Pamplona, Spain; [Rodriguez-Fraile, Macarena] Clin Univ Navarra, Nucl Med Dept, Pamplona, Spain; [Rodriguez-Fraile, Macarena] Clin Univ Navarra, Clin Densitometry Certified, Pamplona, Spain; [Restituto, Patricia; Varo, Nerea] Clin Univ Navarra, Biochem Anal Dept, Pamplona, Spain; [Colina, Inmaculada] Clin Univ Navarra, Dept Internal Med, Pamplona, Spain; [de los Desamparados Calleja, Maria] Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain; [Seijo, Luis M.; Perez, Teresa] Clin Univ Navarra, Pulm Dept, Madrid, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Gonzalez, J (corresponding author), Clin Univ Navarra, Pulm Dept, Pamplona, Spain.	jgonzalez.3@unav.es	Varo, Nerea/AAB-3569-2019; Zulueta, Javier J/GXZ-5810-2022; Rivera-Ortega, Pilar/X-7083-2019; Fraile, Macarena Rodríguez/P-2261-2017; Zulueta, Javier J/H-5127-2011; Campo, Arantza/F-9487-2017	Varo, Nerea/0000-0002-2362-9472; Rivera-Ortega, Pilar/0000-0002-7960-8822; Fraile, Macarena Rodríguez/0000-0002-9069-7918; Zulueta, Javier J/0000-0003-3182-3555; Berto, Juan/0000-0001-5673-2954; Gonzalez Gutierrez, Jessica/0000-0002-6847-5315; Campo, Arantza/0000-0001-9700-4355; Alcaide Ocana, Ana Belen/0000-0003-0733-3564; de Torres, Juan Pablo/0000-0003-1231-4894	Roche	Roche(Roche Holding)	Funding was provided by Roche to Dr Nerea Varo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; [Anonymous], 1991, Osteoporos Int, V1, P114; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Bolton CE, 2008, RESP MED, V102, P651, DOI 10.1016/j.rmed.2007.12.027; Botella S, 2013, J CLIN ENDOCRINOL ME, V98; Bousson V, 2012, OSTEOPOROSIS INT, V23, P1489, DOI 10.1007/s00198-011-1824-6; Briot K, 2013, BONE, V57, P232, DOI 10.1016/j.bone.2013.07.040; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Connors AF, 1996, AM J RESP CRIT CARE; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; Cote CG, 2007, CHEST; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Oca MM, 2008, RESP MED, V102, P642, DOI 10.1016/j.rmed.2007.12.025; de Vries F, 2005, EUR RESPIR J, V25, P879, DOI 10.1183/09031936.05.00058204; Dempster DW, 2003, OSTEOPOROSIS INT, V14, pS54, DOI 10.1007/s00198-003-1474-4; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408; Graat-Verboom L, 2009, RESP MED, V103, P1143, DOI 10.1016/j.rmed.2009.02.014; Groenewegen KH, 2007, RESP MED; Gross N J, 2001, Curr Opin Pulm Med, V7, P84, DOI 10.1097/00063198-200103000-00006; Gunen H, 2005, EUR RESP J; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Hordon LD, 2000, BONE, V27, P271, DOI 10.1016/S8756-3282(00)00329-X; Iki M, 2015, OSTEOPOROSIS INT, V26, P1841, DOI 10.1007/s00198-015-3092-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kanner RE, 2001, AM J RESP CRIT CARE; Kiyokawa H, 2012, COPD, V9, P235, DOI 10.3109/15412555.2011.650243; KLEEREKOPER M, 1985, CALCIFIED TISSUE INT, V37, P594, DOI 10.1007/BF02554913; Kulak CAM, 2010, J BONE MINER RES, V25, P1931, DOI 10.1002/jbmr.88; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leslie WD, 2013, J CLIN DENSITOM; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Misof BM, 2015, BONE, V79, P1, DOI 10.1016/j.bone.2015.05.018; Piperno D, 2003, RESP MED; Pothuaud L, 2009, J CLIN DENSITOM, V12, P170, DOI 10.1016/j.jocd.2008.11.006; Rabier B, 2010, BONE, V46, P176, DOI 10.1016/j.bone.2009.06.032; Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sin DD, 2003, AM J MED, V114, P10, DOI 10.1016/S0002-9343(02)01297-4; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Vrieze A, 2007, OSTEOPOROSIS INT, V18, P1197, DOI 10.1007/s00198-007-0355-7; Watanabe R, 2018, OSTEOPOROSIS INT, V29, P615, DOI 10.1007/s00198-017-4314-7; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Winzenrieth R, 2013, J CLIN DENSITOM, V16, P287, DOI 10.1016/j.jocd.2012.05.001; Winzenrieth R, 2010, CALCIFIED TISSUE INT, V86, P104, DOI 10.1007/s00223-009-9322-y	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0209777	10.1371/journal.pone.0209777	http://dx.doi.org/10.1371/journal.pone.0209777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707701	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900003
J	Loef, B; van Baarle, D; van der Beek, AJ; Beekhof, PK; van Kerkhof, LW; Proper, KI				Loef, Bette; van Baarle, Debbie; van der Beek, Allard J.; Beekhof, Piet K.; van Kerkhof, Linda W.; Proper, Karin I.			The association between exposure to different aspects of shift work and metabolic risk factors in health care workers, and the role of chronotype	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; SLEEP; METAANALYSIS; PARTICIPANTS; CHOLESTEROL; STATEMENT; EFFICACY; MARKERS; OBESITY	Objective Shift work has been linked to cardio-metabolic diseases, but insight into different shift work-related aspects and chronotype of shift workers and their relation with metabolic risk factors is limited. This study examined the association between current shift work status, frequency and duration of night shift work, chronotype, and metabolic risk factors in a population of health care workers. Methods Anthropometrics, questionnaires, and blood samples were collected from 503 shift working and 93 non-shift working health care workers employed in hospitals. Body mass index, waist circumference, cholesterol (total, HDL, LDL), triglycerides, and high-sensitivity C-reactive protein were measured. Associations of current shift work, frequency (non-night shift worker, 1-2, 3-4, >= 5 night shifts/month) and duration of night shift work (non-night shift workers, < 10, 10-19, >= 20 years), and shift workers' chronotype, with metabolic risk factors were studied using linear regression analysis. Results Compared to non-shift workers, shift workers' total cholesterol level was 0.38 mmol/L lower (95%-CI = -0.73 --0.04) and LDL cholesterol was 0.34 mmol/L lower (95%-CI = -0.60 --0.08). For all other metabolic risk factors, no differences were found. The association between shift work and LDL cholesterol was especially found among shift workers working night shifts for >= 20 years (B = -0.49 (95%-CI = -0.78 --0.19)). No differences were found for night shift frequency and chronotype. Conclusion In this population of health care workers employed in hospitals, no evidence for differences in metabolic risk factors was observed that could underlie a link between shift work and cardio-metabolic diseases. Further research using different aspects of shift work to study the association with metabolic risk factors is recommended.	[Loef, Bette; Proper, Karin I.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Loef, Bette; van der Beek, Allard J.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [van Baarle, Debbie] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [van Baarle, Debbie] Univ Med Ctr, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Beekhof, Piet K.; van Kerkhof, Linda W.] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Proper, KI (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	karin.proper@rivm.nl		van der Beek, Allard/0000-0002-4672-9062	Strategic Program project 24/7 Health of the Dutch National Institute for Public Health and the Environment (RIVM)	Strategic Program project 24/7 Health of the Dutch National Institute for Public Health and the Environment (RIVM)	This study was funded by the Strategic Program project 24/7 Health of the Dutch National Institute for Public Health and the Environment (RIVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akour A, 2017, SLEEP BIOL RHYTHMS, V15, P283, DOI 10.1007/s41105-017-0109-7; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Blokstra A, 2012, MEASURING NETHERLAND; Burdelak W, 2012, MED PR, V63, P517; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clearfield Michael B, 2005, J Am Osteopath Assoc, V105, P409; Costa G, 2010, SAF HEALTH WORK, V1, P112, DOI 10.5491/SHAW.2010.1.2.112; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5; Esquirol Y, 2011, ARCH CARDIOVASC DIS, V104, P636, DOI 10.1016/j.acvd.2011.09.004; Gan Y, 2015, OCCUP ENVIRON MED, V72, P72, DOI 10.1136/oemed-2014-102150; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; Hulsegge G, 2018, J SLEEP RES; Kantermann T, 2010, SLEEP BIOL RHYTHMS, V8, P95, DOI 10.1111/j.1479-8425.2010.00432.x; Kim SW, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0135-y; Lennernas M, 1999, APPETITE, V32, P53, DOI 10.1006/appe.1998.0196; Loef B, 2018, SCAND J WORK ENV HEA, V44, P265, DOI 10.5271/sjweh.3709; Loef B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3317-1; Lotta LA, 2015, DIABETES CARE, V38, P2177, DOI 10.2337/dc15-1218; Merikanto I, 2013, CHRONOBIOL INT, V30, P470, DOI 10.3109/07420528.2012.741171; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nordestgaard BG, 2016, EUR HEART J, V37, P1944, DOI 10.1093/eurheartj/ehw152; Parhofer KG, 2015, DIABETES METAB J, V39, P353, DOI 10.4093/dmj.2015.39.5.353; Pavanello S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00516; Proper Karin I, 2016, Am J Prev Med, V50, pe147, DOI 10.1016/j.amepre.2015.11.013; Puttonen S, 2011, CHRONOBIOL INT, V28, P528, DOI 10.3109/07420528.2011.580869; Reutrakul S, 2015, SLEEP MED CLIN, V10, P455, DOI 10.1016/j.jsmc.2015.07.005; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Saksvik IB, 2011, SLEEP MED REV, V15, P221, DOI 10.1016/j.smrv.2010.07.002; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; Sun M, 2018, OBES REV, V19, P28, DOI 10.1111/obr.12621; Torquati L, 2018, SCAND J WORK ENV HEA, V44, P229, DOI 10.5271/sjweh.3700; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Vetter C, 2015, DIABETES CARE, V38, P1707, DOI 10.2337/dc15-0302; Viitasalo K, 2015, ERGONOMICS, V58, P65, DOI 10.1080/00140139.2014.958573; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang F, 2014, OBES REV, V15, P709, DOI 10.1111/obr.12194; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211557	10.1371/journal.pone.0211557	http://dx.doi.org/10.1371/journal.pone.0211557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707727	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900030
J	Ayaki, M; Tsuneyoshi, Y; Yuki, K; Tsubota, K; Negishi, K				Ayaki, Masahiko; Tsuneyoshi, Yukari; Yuki, Kenya; Tsubota, Kazuo; Negishi, Kazuno			Latanoprost could exacerbate the progression of presbyopia	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; ACCOMMODATION; SEGMENT; VISION	Purpose Prostaglandin analogues (PG) reduce intra-ocular pressure by enhancing uveoscleral flow at the ciliary body, which controls accommodation via the ciliary muscle. We investigated the effect of PG on accommodation and presbyopia progression in glaucoma patients. Methods We conducted a clinic-based, retrospective, cross-sectional study. Inclusion criteria were bilateral phakic patients aged 40-69 years with best corrected visual acuity better than 20/30. Exclusion criteria were any disease affecting vision other than glaucoma and history of ocular surgery. Subjects with no prescription or vision-affecting disease served as controls (n = 260). The glaucoma patients were prescribed eye drops containing 0.005% latanoprost for more than six months (n = 23). We measured the binocular near add power at a distance of 30 cm in both groups and compared the results using Kaplan-Meier analysis. Results The mean age (+/- SD) of the control subjects was 51.5 +/- 5.2 years and 39% were male. Similarly, the glaucoma patients had a mean age of 51.0 +/- 7.2 years and 39% were male. There were no significant differences in age, gender, intra-ocular pressure, spherical equivalent, astigmatism, or anisometropia between groups. Survival analysis indicated that the glaucoma patients in this study reached the endpoint (near add power of +3.00 D) significantly earlier than control patients (P = 0.0001; generalized Wilcoxon test). Conclusions Exacerbation of presbyopia progression in glaucoma patients is a potential side effect of latanoprost eyedrops.	[Ayaki, Masahiko; Tsuneyoshi, Yukari; Yuki, Kenya; Tsubota, Kazuo; Negishi, Kazuno] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Ayaki, Masahiko] Moon View Eye Ctr, Otake Clin, Yamato, Japan	Keio University	Ayaki, M; Negishi, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.; Ayaki, M (corresponding author), Moon View Eye Ctr, Otake Clin, Yamato, Japan.	mayaki@olive.ocn.ne.jp; kazunonegishi@keio.jp	Negishi, Kazuno/AAG-3260-2021; Tsubota, Kazuo/M-1915-2013	Negishi, Kazuno/0000-0002-2892-9810; Tsubota, Kazuo/0000-0002-8874-7111				Abdelkader A, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0065-3; Abdelkader A, 2015, EYE CONTACT LENS, V41, P323, DOI 10.1097/ICL.0000000000000137; Alphen G W, 1977, Doc Ophthalmol, V42, P397, DOI 10.1007/BF02742255; Ayaki M., 2013, CML OPHTHALMOL, V23, P45; Benozzi Jorge, 2012, Med Hypothesis Discov Innov Ophthalmol, V1, P3; CRAWFORD KS, 1991, INVEST OPHTH VIS SCI, V32, P510; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; Frick KD, 2015, OPHTHALMOLOGY, V122, P1706, DOI 10.1016/j.ophtha.2015.04.014; Goertz AD, 2014, ACTA OPHTHALMOL, V92, P497, DOI 10.1111/aos.12308; Gualdi L, 2017, J REFRACT SURG, V33, P578, DOI 10.3928/1081597X-20170621-05; Hickenbotham A, 2012, INVEST OPHTH VIS SCI, V53, P3215, DOI 10.1167/iovs.12-9791; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; Kaufman PL, 2008, EXP EYE RES, V86, P3, DOI 10.1016/j.exer.2007.10.007; KERSTETTER JR, 1988, AM J OPHTHALMOL, V105, P30, DOI 10.1016/0002-9394(88)90117-1; Kurtz S, 2003, J GLAUCOMA, V12, P54, DOI 10.1097/00061198-200302000-00011; LUTJENDRECOLL E, 1988, EXP EYE RES, V47, P761, DOI 10.1016/0014-4835(88)90043-7; Millar JC, 1995, EXP EYE RES, V61, P677, DOI 10.1016/S0014-4835(05)80018-1; Muhammad Nasiru, 2015, Niger Med J, V56, P317, DOI 10.4103/0300-1652.170379; Otsuka Norika, 1996, Nippon Ganka Gakkai Zasshi, V100, P531; Ra S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188534; Renna A, 2017, EYE VISION, V4, DOI 10.1186/s40662-017-0068-8; Renna A, 2016, OPHTHALMOL THER, V5, P63, DOI 10.1007/s40123-016-0050-x; Richter M, 2003, INVEST OPHTH VIS SCI, V44, P4419, DOI 10.1167/iovs.02-1281; Romano MR, 2007, INVEST OPHTH VIS SCI, V48, P3677, DOI 10.1167/iovs.06-0896; Troiano P, 2000, ACTA OPHTHALMOL SCAN, V78, P52, DOI 10.1111/j.1600-0420.2000.tb01104.x; Tsuneyoshi Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07208-6; Tsuneyoshi Y, 2014, AM J OPHTHALMOL, V158, P286, DOI 10.1016/j.ajo.2014.05.006; WEBER J, 1989, DOC OPHTHALMOL, V72, P341, DOI 10.1007/BF00153502	28	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211631	10.1371/journal.pone.0211631	http://dx.doi.org/10.1371/journal.pone.0211631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703139	Green Submitted, Green Published, gold			2022-12-26	WOS:000457301600063
J	Chida-Nagai, A; Shintani, M; Sato, H; Nakayama, T; Nii, M; Akagawa, H; Furukawa, T; Rana, A; Furutani, Y; Inai, K; Nonoyama, S; Nakanishi, T				Chida-Nagai, Ayako; Shintani, Masaki; Sato, Hiroki; Nakayama, Tomotaka; Nii, Masaki; Akagawa, Hiroyuki; Furukawa, Toru; Rana, Amer; Furutani, Yoshiyuki; Inai, Kei; Nonoyama, Shigeaki; Nakanishi, Toshio			Role of BRCA1-associated protein (BRAP) variant in childhood pulmonary arterial hypertension	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; BETA-RECEPTOR; MUTATIONS; RISK; GENE; IDENTIFICATION; INCREASES; BMPR2	Although mutations in several genes have been reported in pulmonary arterial hypertension (PAH), most of PAH cases do not carry these mutations. This study aimed to identify a novel cause of PAH. To determine the disease-causing variants, direct sequencing and multiplex ligation-dependent probe amplification were performed to analyze 18 families with multiple affected family members with PAH. In one of the 18 families with PAH, no disease-causing variants were found in any of BMPR2, ACVRL1, ENG, SMAD1/4/8, BMPR1B, NOTCH3, CAV1, or KCNK3. In this family, a female proband and her paternal aunt developed PAH in their childhood. Whole-exome next-generation sequencing was performed in the 2 PAH patients and the proband's healthy mother, and a BRCA1-associated protein (BRAP) gene variant, p.Arg554Leu, was identified in the 2 family members with PAH, but not in the proband's mother without PAH. Functional analyses were performed using human pulmonary arterial smooth muscle cells (hPASMCs). Knockdown of BRAP via small interfering RNA in hPASMCs induced p53 signaling pathway activation and decreased cell proliferation. Overexpression of either wild-type BRAP or p.Arg554Leu-BRAP cDNA constructs caused cell death confounding these studies, however we observed higher levels of p53 signaling inactivation and hPASMC proliferation in cells expressing p.Arg554Leu-BRAP compared to wild-type BRAP. In addition, p.Arg554Leu-BRAP induced decreased apoptosis of hPASMCs compared with wild-type BRAP. In conclusion, we have identified a novel variant of BRAP in a Japanese family with PAH and our results suggest it could have a gain-of-function. This study sheds light on new mechanism of PAH pathogenesis.	[Chida-Nagai, Ayako; Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama, Japan; [Chida-Nagai, Ayako; Shintani, Masaki; Furutani, Yoshiyuki; Inai, Kei; Nakanishi, Toshio] Tokyo Womens Med Univ, Dept Pediat Cardiol, Shinjuku Ku, Tokyo, Japan; [Sato, Hiroki] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan; [Nakayama, Tomotaka] Toho Univ, Dept Pediat, Omori Med Ctr, Ota, Tokyo, Japan; [Nii, Masaki] Shizuoka Childrens Hosp, Dept Cardiol, Shizuoka, Shizuoka, Japan; [Akagawa, Hiroyuki; Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ku, Tokyo, Japan; [Furukawa, Toru] Tohoku Univ, Grad Sch Med, Dept Histopathol, Sendai, Miyagi, Japan; [Rana, Amer] Univ Cambridge, Div Resp Med, Dept Med, Cambridge, England	National Defense Medical College - Japan; Tokyo Women's Medical University; Tokyo Medical University; Toho University; Tokyo Women's Medical University; Tohoku University; University of Cambridge	Nakanishi, T (corresponding author), Tokyo Womens Med Univ, Dept Pediat Cardiol, Shinjuku Ku, Tokyo, Japan.	pnakanis@hij.twmu.ac.jp	Chida-Nagai, Ayako/AAH-4126-2020; Furukawa, Toru/AAF-5596-2021	Furukawa, Toru/0000-0002-1083-2324; Nii, Masaki/0000-0002-7498-7181; Sato, Hiroki/0000-0002-6061-1511	MEXT KAKENHI [15K19639]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grant Number 15K19639 (http://www.mext.go.jp/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Chida A, 2014, MOL GENET GENOM MED, V2, P229, DOI 10.1002/mgg3.58; Chida A, 2012, CIRC J, V76, P1501, DOI 10.1253/circj.CJ-11-1281; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Dendo K, 2018, CARCINOGENESIS, V39, P202, DOI 10.1093/carcin/bgx124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Fujiwara M, 2008, CIRC J, V72, P127, DOI 10.1253/circj.72.127; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hinohara K, 2009, J HUM GENET, V54, P642, DOI 10.1038/jhg.2009.87; Hock AK, 2014, BBA-MOL CELL RES, V1843, P137, DOI 10.1016/j.bbamcr.2013.05.022; Jacquin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131940; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liao YC, 2011, MOL MED, V17, P1065, DOI 10.2119/molmed.2011.00043; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Mache CJ, 2008, THORAX, V63, P85, DOI 10.1136/thx.2007.076109; Medvar B, 2016, PHYSIOL GENOMICS, V48, P502, DOI 10.1152/physiolgenomics.00031.2016; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Mouraret N, 2013, CIRCULATION, V127, P1664, DOI 10.1161/CIRCULATIONAHA.113.002434; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Piccolo MT, 2012, J CAN RES UPDATES, V1, P189; Rothman AMK, 2016, J CLIN INVEST, V126, P2495, DOI 10.1172/JCI83361; Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tang JJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0541-8; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Yamada Y, 2017, ONCOTARGET, V8, P43068, DOI 10.18632/oncotarget.17474; YOSHIDA MC, 1986, JPN J CANCER RES, V77, P1059; Zhang FQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086037; Zhao YJ, 2017, GASTROENTEROLOGY, V153, P1304, DOI 10.1053/j.gastro.2017.07.042	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211450	10.1371/journal.pone.0211450	http://dx.doi.org/10.1371/journal.pone.0211450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703135	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600044
J	Pushkin, AN; Eugene, AJ; Lallai, V; Torres-Mendoza, A; Fowler, JP; Chen, E; Fowler, CD				Pushkin, Anna N.; Eugene, Angeline J.; Lallai, Valeria; Torres-Mendoza, Alan; Fowler, J. P.; Chen, Edison; Fowler, Christie D.			Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood	PLOS ONE			English	Article							ADDING TOBACCO; RATS; DEPRESSION; DOPAMINE; USERS; MICE	Nicotine and cannabis use during adolescence has the potential to induce long lasting changes on affective and cognitive function. Here, we examined whether adolescent exposure to nicotine, the cannabinoid agonist WIN55-212,2 (WIN), or co-exposure to both would alter operant learning, locomotion, and anxiety-and reward-related behaviors in male and female mice during adulthood. Males exposed to a moderate dose of WIN (2 mg/kg) or co-exposed to nicotine and the moderate dose of WIN exhibited decreased anxiety-associated behaviors and increased cognitive flexibility, but did not differ in operant learning or generalized locomotion. In contrast, differences were not found among the females in these measures at the moderate WIN dose or in both sexes with exposure to a low WIN dose (0.2 mg/kg). Furthermore, a sex-dependent dissociative effect was found in natural reward consumption. Males exposed to the moderate dose of WIN or co-exposed to nicotine and the moderate dose of WIN demonstrated increased sucrose consumption. In contrast, females exposed to the moderate dose of WIN exhibited a decrease in sucrose consumption, which was ameliorated with co-administration of nicotine. Together, these novel findings demonstrate that adolescent exposure to cannabinoids in the presence or absence of nicotine results in altered affective and reward-related behaviors during adulthood.	[Pushkin, Anna N.; Eugene, Angeline J.; Lallai, Valeria; Torres-Mendoza, Alan; Fowler, J. P.; Chen, Edison; Fowler, Christie D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine	Fowler, CD (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	cdfowler@uci.edu	lallai, valeria/AHE-2859-2022; Fowler, Christie D/A-1754-2015	Dukes, Angeline/0000-0001-7025-5947; Chen, Edison/0000-0002-7073-9279; Fowler, Christie/0000-0003-2864-2163	Tobacco-Related Disease Research Program (TRDRP) [26IP-0043]; University of California Smoke and Tobacco Free Fellowship; National Institutes of Health (NIDA) [DA032543]	Tobacco-Related Disease Research Program (TRDRP)(University of California System); University of California Smoke and Tobacco Free Fellowship; National Institutes of Health (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by the Tobacco-Related Disease Research Program (TRDRP, http://www.trdrp.org) (Grant 26IP-0043) to C.D. Fowler, University of California Smoke and Tobacco Free Fellowship (https://www.ucop.edu/risk-services/loss-prevention-control/uc-smoke-tobacco-free.html) to A.N. Pushkin, and National Institutes of Health (NIDA, https://www.drugabuse.gov) (Grant DA032543) to C.D. Fowler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2016, INT J DEV NEUROSCI, V52, P93, DOI 10.1016/j.ijdevneu.2016.06.002; ALBUQUERQUE EX, 1995, ANN NY ACAD SCI, V757, P48, DOI 10.1111/j.1749-6632.1995.tb17464.x; [Anonymous], 2014, NAT NEUROSCI, V17, P1013, DOI 10.1038/nn.3777; [Anonymous], 2015, PUBL HLTH IMPL RAIS; Bambico FR, 2010, NEUROBIOL DIS, V37, P641, DOI 10.1016/j.nbd.2009.11.020; Belanger RE, 2013, NICOTINE TOB RES, V15, P1832, DOI 10.1093/ntr/ntt063; Belanger RE, 2011, NICOTINE TOB RES, V13, P746, DOI 10.1093/ntr/ntr043; Biscaia M, 2003, PSYCHOPHARMACOLOGY, V170, P301, DOI 10.1007/s00213-003-1550-7; Bortolato M, 2014, EUR NEUROPSYCHOPHARM, V24, P974, DOI 10.1016/j.euroneuro.2013.12.011; Caldarone BJ, 2008, NEUROSCI LETT, V439, P187, DOI 10.1016/j.neulet.2008.05.023; Crane NA, 2015, ADDICT BEHAV, V49, P33, DOI 10.1016/j.addbeh.2015.05.014; Cross SJ, 2017, J NEUROSCI RES, V95, P422, DOI 10.1002/jnr.23878; Flatz A, 2013, NICOTINE TOB RES, V15, P557, DOI 10.1093/ntr/nts138; Fowler CD, 2013, PSYCHOPHARMACOLOGY, V229, P503, DOI 10.1007/s00213-013-3235-1; Iniguez SD, 2009, NEUROPSYCHOPHARMACOL, V34, P1609, DOI 10.1038/npp.2008.220; Kann L, 2016, MMWR-MORBID MORTAL W, V65, P106, DOI 10.15585/mmwr.mm6505a2; Kirschmann EK, 2017, NEUROPSYCHOPHARMACOL, V42, P989, DOI 10.1038/npp.2016.178; Kutlu MG, 2016, BRAIN RES, V1642, P445, DOI 10.1016/j.brainres.2016.04.023; Lee TTY, 2012, NEUROSCIENCE, V204, P17, DOI 10.1016/j.neuroscience.2011.10.006; Lena C, 1998, J PHYSIOL-PARIS, V92, P63, DOI 10.1016/S0928-4257(98)80140-X; Levin ED, 2003, PSYCHOPHARMACOLOGY, V169, P141, DOI 10.1007/s00213-003-1486-y; Levin ED, 2007, NEUROTOXICOL TERATOL, V29, P458, DOI 10.1016/j.ntt.2007.02.002; Nisell M, 1996, SYNAPSE, V22, P369, DOI 10.1002/(SICI)1098-2396(199604)22:4<369::AID-SYN8>3.0.CO;2-9; Polissidis A, 2013, INT J NEUROPSYCHOPH, V16, P393, DOI 10.1017/S1461145712000156; Portugal GS, 2012, NEUROBIOL LEARN MEM, V97, P482, DOI 10.1016/j.nlm.2012.04.003; Raver SM, 2014, NEUROPHARMACOLOGY, V86, P161, DOI 10.1016/j.neuropharm.2014.07.006; Renard J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00361; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Schoch H, 2018, PSYCHOPHARMACOLOGY, V235, P121, DOI 10.1007/s00213-017-4749-8; Slawecki CJ, 2003, PHARMACOL BIOCHEM BE, V75, P355, DOI 10.1016/S0091-3057(03)00093-5; Spaeth AM, 2010, PHARMACOL BIOCHEM BE, V96, P501, DOI 10.1016/j.pbb.2010.07.011; Squeglia LM, 2009, CLIN EEG NEUROSCI, V40, P31, DOI 10.1177/155005940904000110; Tuesta LM, 2011, BIOCHEM PHARMACOL, V82, P984, DOI 10.1016/j.bcp.2011.06.026; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; Van Laere K, 2008, NEUROIMAGE, V39, P1533, DOI 10.1016/j.neuroimage.2007.10.053; Wright NE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166005; Yuan ML, 2015, J PHYSIOL-LONDON, V593, P3397, DOI 10.1113/JP270492	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211346	10.1371/journal.pone.0211346	http://dx.doi.org/10.1371/journal.pone.0211346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703155	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600038
J	Schwarzkopf, KM; Queck, A; Thomas, D; Angioni, C; Cai, CC; Freygang, Y; Ruschenbaum, S; Geisslinger, G; Zeuzem, S; Welsch, C; Lange, CM				Schwarzkopf, Katharina Maria; Queck, Alexander; Thomas, Dominique; Angioni, Carlo; Cai, Chengcong; Freygang, Ylva; Rueschenbaum, Sabrina; Geisslinger, Gerd; Zeuzem, Stefan; Welsch, Christoph; Lange, Christian Markus			Omega-3 and-6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation	PLOS ONE			English	Article							FAILURE; DIET	Background Liver cirrhosis is associated with profound immunodysfunction, i.e. a parallel presence of chronic systemic inflammation and immunosuppression, which can result in acute-onchronic liver failure (ACLF). Omega-3 fatty acids are precursors of pro-resolving mediators and support the resolution of inflammation. Objective The aim of this study was to determine plasma levels of omega-3 fatty acids in patients with liver cirrhosis and ACLF. Methods Patients with liver cirrhosis with and without ACLF were enrolled in a prospective cohort study and analyzed post-hoc for the present sub-study. Clinical data and biomaterials were collected at baseline and at day 7, 28 and after 3 months of follow-up. Plasma concentrations of arachidonic acid (ARA) and docosahexaenoic acid (DHA), which represent key omega-6 and -3 fatty acids, respectively, were quantified and associated with markers of systemic inflammation and severity of liver cirrhosis. Results A total of 117 patients were included in the present analyses. Of those, 26 (22.2%), 51 (43.6%) and 40 (34.2%) patients had compensated or decompensated liver cirrhosis, and ACLF. Plasma levels of ARA and DHA were similar in patients with compensated cirrhosis, decompensated cirrhosis, and ACLF. Furthermore, no significant association between plasma ARA or DHA and C-reactive protein or peripheral blood leukocytes were observed (P>0.05). Conclusion In our study plasma levels of key omega-3 and omega-6 fatty acid are neither associated with the severity of liver cirrhosis nor with liver-cirrhosis-associated systemic inflammation.	[Schwarzkopf, Katharina Maria; Queck, Alexander; Cai, Chengcong; Freygang, Ylva; Rueschenbaum, Sabrina; Zeuzem, Stefan; Welsch, Christoph; Lange, Christian Markus] Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Thomas, Dominique; Angioni, Carlo; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany; [Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Fraunhofer Gesellschaft	Lange, CM (corresponding author), Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.	Christian.Lange@uk-essen.de	Welsch, Christoph/AAF-6785-2020; Zeuzem, Stefan/AAE-7435-2019	Welsch, Christoph/0000-0002-1823-4863; 	Deutsche Forschungsgemeinschaft [LA 2806/2-1, LA 2806/5-1]; LOEWE Center for Translational Medicine and Pharmacology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Center for Translational Medicine and Pharmacology	This study was supported by the Deutsche Forschungsgemeinschaft http://www.dfg.de (LA 2806/2-1 and LA 2806/5-1 to CML) and by the LOEWE Center for Translational Medicine and Pharmacology (http://www.proloewe.de/en/loewe-research-initiatives/loewe-research-initiatives/pharmaceutical-research.html) TMP to DT, GG, SZ, CW and CML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain SQ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0437-2; Arroyo V, 2017, CLIN GASTROENTEROL H; Basili S, 2014, DIGEST LIVER DIS, V46, P632, DOI 10.1016/j.dld.2014.02.021; Bernsmeier C, 2015, GASTROENTEROLOGY, V148, P603, DOI 10.1053/j.gastro.2014.11.045; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Broughton KS, 1997, AM J CLIN NUTR, V65, P1011, DOI 10.1093/ajcn/65.4.1011; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Claria J, 2016, HEPATOLOGY, V64, P1249, DOI 10.1002/hep.28740; D'Eliseo D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020015; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; James MJ, 1997, SEMIN ARTHRITIS RHEU, V27, P85, DOI 10.1016/S0049-0172(97)80009-1; Kajikawa S, 2011, DIGEST DIS SCI, V56, P1065, DOI 10.1007/s10620-010-1400-5; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ristic-Medic D, 2013, J CLIN BIOCHEM NUTR, V53, P49, DOI 10.3164/jcbn.12-79; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Skarke C, 2015, J LIPID RES, V56, P1808, DOI 10.1194/jlr.M060392; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yan JH, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000012271, 10.1097/md.0000000000012271]; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30029	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211537	10.1371/journal.pone.0211537	http://dx.doi.org/10.1371/journal.pone.0211537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703151	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600055
J	Thwaites, MJ; Cecchini, MJ; Passos, DT; Zakirova, K; Dick, FA				Thwaites, Michael J.; Cecchini, Matthew J.; Passos, Daniel T.; Zakirova, Komila; Dick, Frederick A.			Context dependent roles for RB-E2F transcriptional regulation in tumor suppression	PLOS ONE			English	Article							RB; P53; PROLIFERATION; INHIBITION; COOPERATE; CYCLINS; PROTEIN; CANCER; LEADS; PRB	RB-E2F transcriptional control plays a key role in regulating the timing of cell cycle progression from G1 to S-phase in response to growth factor stimulation. Despite this role, it is genetically dispensable for cell cycle exit in primary fibroblasts in response to growth arrest signals. Mice engineered to be defective for RB-E2F transcriptional control at cell cycle genes were also found to live a full lifespan with no susceptibility to cancer. Based on this background we sought to probe the vulnerabilities of RB-E2F transcriptional control defects found in Rb1(R461E,K542E) mutant mice (Rb1(G)) through genetic crosses with other mouse strains. We generated Rb1(G/G) mice in combination with Trp53 and Cdkn1a deficiencies, as well as in combination with Kras(G12D). The Rb1(G) mutation enhanced Trp53 cancer susceptibility, but had no effect in combination with Cdkn1a deficiency or Kras(G12D). Collectively, this study indicates that compromised RB-E2F transcriptional control is not uniformly cancer enabling, but rather has potent oncogenic effects when combined with specific vulnerabilities.	[Thwaites, Michael J.; Passos, Daniel T.; Zakirova, Komila; Dick, Frederick A.] Lawson Hlth Res Inst, London Reg Canc Program, London, ON, Canada; [Thwaites, Michael J.; Passos, Daniel T.; Dick, Frederick A.] Western Univ, Dept Biochem, London, ON, Canada; [Cecchini, Matthew J.; Zakirova, Komila] Western Univ, Dept Pathol, London, ON, Canada; [Dick, Frederick A.] Lawson Hlth Res Inst, Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dick, FA (corresponding author), Lawson Hlth Res Inst, London Reg Canc Program, London, ON, Canada.; Dick, FA (corresponding author), Western Univ, Dept Biochem, London, ON, Canada.; Dick, FA (corresponding author), Lawson Hlth Res Inst, Childrens Hlth Res Inst, London, ON, Canada.	fdick@uwo.ca	Passos, Daniel Thompsen/K-5520-2012	Passos, Daniel Thompsen/0000-0002-3530-2821; Dick, Fred/0000-0002-0047-9985	Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer; Ontario Graduate Scholarship; CIHR [MOP-89765]; OGS; Wolfe Foundation	Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); CIHR(Canadian Institutes of Health Research (CIHR)); OGS(Ontario Graduate Scholarship); Wolfe Foundation	MJT was a recipient of funding from a Canadian Institutes of Health Research (CIHR - http://www.cihr-irsc.gc.ca/e/193.html) Strategic Training Program in Cancer Research and Technology Transfer. MJT was also a recipient of an Ontario Graduate Scholarship through funds provided to Western University. FAD is the recipient of operating grant funds from the CIHR (MOP-89765). FAD receives salary support from the Wolfe Foundation through funds provided to Western University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank colleagues in the London Regional Cancer Program for frequent discussions and encouragement during the course of this study. MJT was a members of the CIHR Strategic Training Program in Cancer Research (CaRTT), and a recipient of funding from OGS. FAD is the Wolfe Senior Fellow in Tumor Suppressor Genes at Western University.	Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cecchini MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3491; Cecchini MJ, 2014, MOL CELL BIOL, V34, P2029, DOI 10.1128/MCB.01589-13; Cecchini MJ, 2011, BIOCHEM J, V434, P297, DOI 10.1042/BJ20101210; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Coschi CH, 2014, CANCER DISCOV, V4, P840, DOI 10.1158/2159-8290.CD-14-0215; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Kareta MS, 2015, CELL STEM CELL, V16, P39, DOI 10.1016/j.stem.2014.10.019; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Manning AL, 2014, ONCOGENE, V33, P2487, DOI 10.1038/onc.2013.201; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Thwaites MJ, 2017, MOL CELL BIOL, V37, DOI [10.1128/MCB.00567-16, 10.1128/MCB.00561-16]; Thwaites MJ, 2016, METHODS MOL BIOL, V1342, P91, DOI 10.1007/978-1-4939-2957-3_5; Thwaites MJ, 2014, METHODS MOL BIOL, V1170, P449, DOI 10.1007/978-1-4939-0888-2_24; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480	39	0	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0203577	10.1371/journal.pone.0203577	http://dx.doi.org/10.1371/journal.pone.0203577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703085	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600002
J	Phanthavong, S; Nonaka, D; Phonaphone, T; Kanda, K; Sombouaphan, P; Wake, N; Sayavong, S; Nakasone, T; Phongsavath, K; Arasaki, A				Phanthavong, Somphone; Nonaka, Daisuke; Phonaphone, Thongsavanh; Kanda, Kyoko; Sombouaphan, Phouphachanh; Wake, Norie; Sayavong, Sangvane; Nakasone, Toshiyuki; Phongsavath, Khampe; Arasaki, Akira			Oral health behavior of children and guardians' beliefs about children's dental caries in Vientiane, Lao People's Democratic Republic (Lao PDR)	PLOS ONE			English	Article							SELF-EFFICACY; ATTITUDES; INTENTION	Dental caries is considered a major health problem among schoolchildren in Lao People's Democratic Republic (Lao PDR). According to Health Belief Model (HBM)-based research, children's oral health behavior can be determined by their guardians' beliefs. This study aimed to describe children's oral health behavior and its association with childhood dental caries, as well as to assess associations between children's tooth-brushing behavior and guardians' beliefs in an urban area of Lao PDR, using HBM. Data were collected from ten primary schools in the Sisattanak district, the Vientiane capital, between 2013 and 2014. Ten dentists with the help of dental hygienists and schoolteachers conducted dental health check-ups at the schools that diagnosed dental caries based on visual inspection. They also conducted a questionnaire-based survey with the schoolchildren's guardians to collect data including socio-economic and demographic information, their children's oral health behavior, and guardians' beliefs derived from HBM, including perceived susceptibility to and perceived severity of child dental caries, perceived benefit of and perceived barrier to child's tooth brushing, and self-efficacy in making their children brush their teeth twice daily. A mixed-effects logistic regression model assessed the association between dental caries and children's oral health behavior and between children's tooth-brushing behavior and guardians' beliefs. Data from 1161 of 1304 (89.0%) children registered at the schools were used. The prevalence of dental caries was 82%. Children who brushed their teeth >= twice/day were significantly less likely to have dental caries than those brushing once or seldom (OR: 0.64, 95% CI: 0.45 to 0.91). The number of children who brushed twice daily also significantly increased with the increased level of guardians' self-efficacy (OR: 2.14, 95% CI: 1.91 to 2.41). In conclusion, childhood dental caries was associated with daily tooth brushing. Children's tooth-brushing behavior was associated with guardians' self-efficacy in making their children brush twice daily.	[Phanthavong, Somphone; Phonaphone, Thongsavanh; Sombouaphan, Phouphachanh; Sayavong, Sangvane; Phongsavath, Khampe] Setthathirath Hosp, Dent Div, Viangchan, Laos; [Phanthavong, Somphone] Univ Hlth Sci, Fac Dent, Viangchan, Laos; [Nonaka, Daisuke; Wake, Norie] Univ Ryukyus, Sch Hlth Sci, Fac Med, Nishihara, Okinawa, Japan; [Kanda, Kyoko] Univ Ryukyus, Int Collaborat Sect, Gen Strateg Planning Div, Nishihara, Okinawa, Japan; [Nakasone, Toshiyuki; Arasaki, Akira] Univ Ryukyus, Dept Oral & Maxillofacial Funct Rehabil, Grad Sch Med, Nishihara, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Nonaka, D (corresponding author), Univ Ryukyus, Sch Hlth Sci, Fac Med, Nishihara, Okinawa, Japan.	nonakad@med.u-ryukyu.ac.jp	Daisuke, Nonaka/AAB-8509-2020; Nonaka, Daisuke/AAP-7918-2021	Daisuke, Nonaka/0000-0001-6793-2062; 	Japan International Cooperation Agency; University of the Ryukyus	Japan International Cooperation Agency; University of the Ryukyus	This study used a part of data collected for the Cha-Ganjyu (long-life) School and Community based Oral Health Promotion Project that was funded by the Japan International Cooperation Agency. University of the Ryukyus received the fund for the project implementation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair PM, 2004, COMMUNITY DENT HLTH, V21, P102; Albino J, 2016, J DENT RES, V95, P35, DOI 10.1177/0022034515609034; Anagnostopoulos F, 2011, BEHAV MED, V37, P132, DOI 10.1080/08964289.2011.636770; Buglar ME, 2010, PATIENT EDUC COUNS, V78, P269, DOI 10.1016/j.pec.2009.06.014; Cooper AM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009378.pub2; de Silva-Sanigorski A, 2013, COMMUNITY DENT ORAL, V41, P345, DOI 10.1111/cdoe.12019; Duijster D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4203-1; Duijster D, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0145-0; Dumitrescu AL, 2014, ORAL HLTH PREV DENT, V12, P345, DOI 10.3290/j.ohpd.a31662; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Finlayson TL, 2007, COMMUNITY DENT ORAL, V35, P272, DOI 10.1111/j.1600-0528.2007.00313.x; Glanz K., 2008, HLTH BEHAV HLTH ED T; Hollister M Catherine, 2004, J Dent Hyg, V78, P6; Huebner CE, 2015, INT J DENT HYG, V13, P65, DOI 10.1111/idh.12100; Huebner CE, 2010, PEDIATR DENT, V32, P48; Jurgensen N, 2011, COMMUNITY DENT HLTH, V28, P280, DOI 10.1922/CDH_2600Jurgensen06; Jurgensen Nanna, 2009, BMC Oral Health, V9, P29, DOI 10.1186/1472-6831-9-29; Kasmaei P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-8; Kumar S, 2016, J DENT RES, V95, P1230, DOI 10.1177/0022034516655315; O'Malley L, 2017, HEALTH PSYCHOL, V36, P152, DOI 10.1037/hea0000428; Thornley S, 2017, J PAEDIATR CHILD H, V53, P494, DOI 10.1111/jpc.13449; Vanagas G, 2009, MEDICINA-LITHUANIA, V45, P718, DOI 10.3390/medicina45090094; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2003, DIET NUTR PREVENTION, V916; World Health Organization, 2003, WHO INF SER SCH HLTH; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th	26	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211257	10.1371/journal.pone.0211257	http://dx.doi.org/10.1371/journal.pone.0211257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682133	gold, Green Published			2022-12-26	WOS:000457037500135
J	Das, AK; Kudlacek, O; Baumgart, F; Jaentsch, K; Stockner, T; Sitte, HH; Schutz, GJ				Das, Anand Kant; Kudlacek, Oliver; Baumgart, Florian; Jaentsch, Kathrin; Stockner, Thomas; Sitte, Harald H.; Schuetz, Gerhard J.			Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate-independent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; dopamine transporter; single-molecule biophysics; dimerization; inositol phospholipid; protein-protein interaction; neurotransmitter; single-molecule brightness analysis; synaptic transmission	SINGLE-MOLECULE ANALYSIS; SEROTONIN-TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; OLIGOMER FORMATION; CHOLESTEROL OXIDASES; CROSS-LINKING; LIVING CELLS; AMPHETAMINE; COCAINE	The human dopamine transporter (hDAT) regulates the level of the neurotransmitter dopamine (DA) in the synaptic cleft and recycles DA for storage in the presynaptic vesicular pool. Many neurotransmitter transporters exist as oligomers, but the physiological role of oligomerization remains unclear; for example, it has been speculated to be a prerequisite for amphetamine-induced release and protein trafficking. Previous studies point to an oligomeric quaternary structure of hDAT; however, the exact stoichiometry and the fraction of co-existing oligomeric states are not known. Here, we used single-molecule brightness analysis to quantify the degree of oligomerization of heterologously expressed hDAT fused to monomeric GFP (mGFP-hDAT) in Chinese hamster ovary (CHO) cells. We observed that monomers and dimers of mGFP-hDAT co-exist and that higher-order molecular complexes of mGFP-hDAT are absent at the plasma membrane. The mGFP-hDAT dimers were stable over several minutes, and the fraction of dimers was independent of the mGFP-hDAT surface density. Furthermore, neither oxidation nor depletion of cholesterol had any effect on the fraction of dimers. Unlike for the human serotonin transporter (hSERT), in which direct binding of phosphatidylinositol 4,5-bisphosphate (PIP2) stabilized the oligomers, the stability of mGFP-hDAT dimers was PIP2 independent.	[Das, Anand Kant; Baumgart, Florian; Schuetz, Gerhard J.] TU Wien, Inst Appl Phys, Getreidemarkt 9, A-1060 Vienna, Austria; [Kudlacek, Oliver; Jaentsch, Kathrin; Stockner, Thomas; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria	Technische Universitat Wien; Medical University of Vienna	Schutz, GJ (corresponding author), TU Wien, Inst Appl Phys, Getreidemarkt 9, A-1060 Vienna, Austria.; Sitte, HH (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	harald.sitte@meduniwien.ac.at; schuetz@iap.tuwien.ac.at	Sitte, Harald/O-7025-2019; Stockner, Thomas/A-9509-2014	Sitte, Harald/0000-0002-1339-7444; Stockner, Thomas/0000-0002-7071-8283; Das, Anand/0000-0003-0740-8140; Kudlacek, Oliver/0000-0002-3086-8551	Austrian Science Fund/FWF; Vienna Science and Technology Fund [CS15-033]	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Vienna Science and Technology Fund	This work was supported by Austrian Science Fund/FWF F35 (to T. S., H. H. S., and G. J. S) and Vienna Science and Technology Fund Grant CS15-033 (to H. H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Alguel Y, 2016, BIOCHEM SOC T, V44, P1737, DOI 10.1042/BST20160217; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Anderluh A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14089; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Barrera NP, 2013, TRENDS CELL BIOL, V23, P1, DOI 10.1016/j.tcb.2012.08.007; Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; BERGER SP, 1994, MOL PHARMACOL, V46, P726; Block ER, 2015, J NEUROSCI, V35, P12845, DOI 10.1523/JNEUROSCI.1391-15.2015; Brameshuber M, 2012, METHOD ENZYMOL, V505, P159, DOI 10.1016/B978-0-12-388448-0.00017-6; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Christian AE, 1997, J LIPID RES, V38, P2264; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Das AK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0187; de Meyer FJM, 2008, BIOPHYS J, V95, P1851, DOI 10.1529/biophysj.107.124164; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Javanainen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187936; Jayaraman K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006229; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Ma SQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05637-x; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Masson J, 1999, PHARMACOL REV, V51, P439; METZGER H, 1992, J IMMUNOL, V149, P1477; MILNER HE, 1994, BBA-BIOMEMBRANES, V1190, P185, DOI 10.1016/0005-2736(94)90051-5; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; MOLNAR I, 1993, MOL MICROBIOL, V7, P419, DOI 10.1111/j.1365-2958.1993.tb01133.x; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sampson NS, 2003, ACCOUNTS CHEM RES, V36, P713, DOI 10.1021/ar9800587; Sarkar B, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00084; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sevcsik E, 2016, BIOESSAYS, V38, P129, DOI 10.1002/bies.201500150; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sweeney CG, 2017, J BIOL CHEM, V292, P1302, DOI 10.1074/jbc.M116.762872; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004; Zhen J, 2018, J NEUROCHEM, V144, P162, DOI 10.1111/jnc.14259	77	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5632	5642		10.1074/jbc.RA118.006178	http://dx.doi.org/10.1074/jbc.RA118.006178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30705091	Green Published, hybrid			2022-12-26	WOS:000464517500031
J	Cho, E; Kang, H; Kang, DK; Lee, Y				Cho, Eunjin; Kang, HyunJun; Kang, Dae-Ki; Lee, Youngsook			Myocardial-specific ablation of Jumonji and AT-rich interaction domain-containing 2 (Jarid2) leads to dilated cardiomyopathy in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart failure; cardiomyopathy; gene regulation; cardiomyocyte; gene expression; Cardiomyocyte maturation; Dilated cardiomyopathy; Jarid2; Jumonji family; muscle contraction	CARDIAC DEVELOPMENT; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; HEART-FAILURE; JUMONJI; PROTEIN; TRANSCRIPTION; REGENERATION; MUSCLE; ROLES	Cardiomyopathy is a common myocardial disease that can lead to sudden death. However, molecular mechanisms underlying cardiomyopathy remain unclear. Jumonji and AT-rich interaction domain-containing 2 (Jarid2) is necessary for embryonic heart development, but functions of Jarid2 after birth remain to be elucidated. Here, we report that myocardial-specific deletion of Jarid2 using alpha MHC::Cre mice (Jarid2(alpha MHC)) causes dilated cardiomyopathy (DCM) and premature death 6-9 months after birth. To determine functions of Jarid2 in the adult heart and DCM, we analyzed gene expression in the heart at postnatal day (p)10 (neonatal) and 7 months (DCM). Pathway analyses revealed that dysregulated genes in Jarid2(alpha MHC) hearts at p10, prior to cardiomyopathy, represented heart development and muscle contraction pathways. At 7 months, down-regulated genes in Jarid2(alpha MHC) hearts were enriched in metabolic process and ion channel activity pathways and up-regulated genes in extracellular matrix components. In normal hearts, expression levels of contractile genes were increased from p10 to 7 months but were not sufficiently increased in Jarid2(alpha MHC) hearts. Moreover, Jarid2 was also necessary to repress fetal contractile genes such as TroponinI1, slow skeletal type (Tnni1) and Actin alpha 2, smooth muscle (Acta2) in neonatal stages through ErbB2-receptor tyrosine kinase 4 (ErbB4) signaling. Interestingly, Ankyrin repeat domain 1 (Ankrd1) and Neuregulin 1 (Nrg1), whose expression levels are known to be increased in the failing heart, were already elevated in Jarid2(alpha MHC) hearts within 1 month of birth. Thus, we demonstrate that ablation of Jarid2 in cardiomyocytes results in DCM and suggest that Jarid2 plays important roles in cardiomyocyte maturation during neonatal stages.	[Cho, Eunjin; Lee, Youngsook] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Cho, Eunjin; Lee, Youngsook] Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53705 USA; [Kang, HyunJun] Univ Wisconsin, Natl Primate Res Ctr, Madison, WI 53705 USA; [Kang, Dae-Ki] Dongseo Univ, Dept Comp Engn, Busan 47011, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Dongseo University	Lee, Y (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res 2, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, 1111 Highland Ave, Madison, WI 53705 USA.	youngsooklee@wisc.edu	Kang, Dae-Ki/AAL-2185-2020	Kang, Dae-Ki/0000-0002-4147-2835	National Institutes of Health [HL067050]; American Heart Association [12GRNT12070021]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported in part by National Institutes of Health Grant HL067050 and American Heart Association Grant 12GRNT12070021 (to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker AH, 2016, CELL STEM CELL, V19, P563, DOI 10.1016/j.stem.2016.10.011; Bang ML, 2017, J CELL PHYSIOL, V232, P38, DOI 10.1002/jcp.25424; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bovill E, 2008, J THORAC CARDIOV SUR, V136, P709, DOI 10.1016/j.jtcvs.2008.02.020; Brody MJ, 2013, J MOL CELL CARDIOL, V62, P237, DOI 10.1016/j.yjmcc.2013.05.020; Brody MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051621; Burke MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86898; Camacho P, 2016, AM J CARDIOVASC DIS, V6, P70; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104040; Cho EJ, 2018, J BIOL CHEM, V293, P11659, DOI 10.1074/jbc.RA118.002482; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Dupays L, 2009, DEV BIOL, V333, P121, DOI 10.1016/j.ydbio.2009.06.025; Elahi MM, 2014, MOL BIOL REP, V41, P7209, DOI 10.1007/s11033-014-3605-8; Fahrenbach JP, 2014, FASEB J, V28, P2804, DOI 10.1096/fj.13-244459; Ghosh AK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063825, 10.1371/journal.pone.0069949]; Goldbergova MP, 2012, GENET TEST MOL BIOMA, V16, P1172, DOI 10.1089/gtmb.2012.0120; Gorsi B, 2010, DEV DYNAM, V239, P3312, DOI 10.1002/dvdy.22456; Hafver TL, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600417; Hall DD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92476; Harvey RP, 2016, HEART LUNG CIRC, V25, P4, DOI 10.1016/j.hlc.2015.08.014; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hou N, 2017, EXP MOL PATHOL, V103, P267, DOI 10.1016/j.yexmp.2017.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang DD, 2018, BIOCHEM BIOPH RES CO, V499, P403, DOI 10.1016/j.bbrc.2018.03.052; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kumar D, 2016, J MOL ENDOCRINOL, V56, pT63, DOI 10.1530/JME-15-0266; Laforet P, 2017, CURR OPIN NEUROL, V30, P449, DOI 10.1097/WCO.0000000000000484; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2018, MATRIX BIOL, V68-69, P490, DOI 10.1016/j.matbio.2018.01.013; Ling SSM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071362; Louzao-Martinez L, 2016, INT J CARDIOL, V220, P634, DOI 10.1016/j.ijcard.2016.06.253; Major JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170066; Mao X, 2017, J NEUROPHYSIOL, V117, P28, DOI 10.1152/jn.00307.2016; Maurer SF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17704; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Mercurio V, 2016, J CARD FAIL, V22, P449, DOI 10.1016/j.cardfail.2016.04.008; Mizuta K, 2015, DEV DYNAM, V244, P31, DOI 10.1002/dvdy.24216; Morton SU, 2016, CLIN PERINATOL, V43, P395, DOI 10.1016/j.clp.2016.04.001; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Mysliwiec MR, 2012, J BIOL CHEM, V287, P1235, DOI 10.1074/jbc.M111.315945; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Nevil M, 2017, GENETICS, V205, P605, DOI 10.1534/genetics.116.195685; O'Donnell PJ, 2003, J MOL CELL CARDIOL, V35, P915, DOI 10.1016/S0022-2828(03)00171-8; Perez-Serra A, 2016, INT J CARDIOL, V224, P461, DOI 10.1016/j.ijcard.2016.09.068; Porayette P, 2014, PEDIATR DEVEL PATHOL, V17, P209, DOI 10.2350/13-08-1370-CR.1; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Rupert CE, 2015, BIOMARK INSIGHTS, V10, P1, DOI [10.4137/BMI.S20061, 10.4137/BMIMI.S20061]; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Shameem K, 2015, INT J CARDIOL, V189, P73, DOI 10.1016/j.ijcard.2015.04.069; Smith SJ, 2016, DEV BIOL, V416, P373, DOI 10.1016/j.ydbio.2016.05.006; Somekawa S, 2012, P NATL ACAD SCI USA, V109, P12064, DOI 10.1073/pnas.1207210109; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Talukder MAH, 2007, AM J PHYSIOL-HEART C, V293, pH2418, DOI 10.1152/ajpheart.00663.2007; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; Ujfalusi Z, 2018, J BIOL CHEM, V293, P9017, DOI 10.1074/jbc.RA118.001938; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Wang F, 2012, MOL BIOL REP, V39, P9075, DOI 10.1007/s11033-012-1778-6; Yin ZY, 2015, BBA-MOL BASIS DIS, V1852, P47, DOI 10.1016/j.bbadis.2014.11.003; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhao J, 2016, METHOD ENZYMOL, V568, P477, DOI 10.1016/bs.mie.2015.09.012; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	79	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4981	4996		10.1074/jbc.RA118.005634	http://dx.doi.org/10.1074/jbc.RA118.005634			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700554	Green Published, hybrid			2022-12-26	WOS:000463985600022
J	Strogolova, V; Hoang, NH; Hosler, J; Stuart, RA				Strogolova, Vera; Hoang, Ngoc H.; Hosler, Jonathan; Stuart, Rosemary A.			The yeast mitochondrial proteins Rcf1 and Rcf2 support the enzymology of the cytochrome c oxidase complex and generation of the proton motive force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; proton motive force; cytochrome oxidase; bioenergetics; mitochondrial respiratory chain complex; OXPHOS; Rcf1; Rcf2	SUBUNIT-III; SACCHAROMYCES-CEREVISIAE; RHODOBACTER-SPHAEROIDES; SUICIDE INACTIVATION; REGULATORY ROLE; MEMBRANE; SUPERCOMPLEX; MODULATION; SAFRANINE; GLUCOSE	The yeast mitochondrial proteins Rcf1 and Rcf2 are associated with a subpopulation of the cytochrome bc(1)-cytochrome c oxidase supercomplex and have been proposed to play a role in the assembly and/or modulation of the activity of the cytochrome c oxidase (complex IV, CIV). Yeast mutants deficient in either Rcf1 or Rcf2 proteins can use aerobic respiration-based metabolism for growth, but the absence of both proteins results in a strong growth defect. In this study, using assorted biochemical and biophysical analyses of Rcf1/Rcf2 single and double null-mutant yeast cells and mitochondria, we further explored how Rcf1 and Rcf2 support aerobic respiration and growth. We show that the absence of Rcf1 physically reduces the levels of CIV and diminishes the ability of the CIV that is present to maintain a normal mitochondrial proton motive force (PMF). Although the absence of Rcf2 did not noticeably affect the physical content of CIV, the PMF generated by CIV was also lower than normal. Our results indicate that the detrimental effects of the absence of Rcf1 and Rcf2 proteins on the CIV complex are distinct in terms of CIV assembly/accumulation and additive in terms of the ability of CIV to generate PMF. Thus, the combined absence of Rcf1 and Rcf2 alters both CIV physiology and assembly. We conclude that the slow aerobic growth of the Rcf1/Rcf2 double null mutant results from diminished generation of mitochondrial PMF by CIV and limits the level of CIV activity required for maintenance of the PMF and growth under aerobic conditions.	[Strogolova, Vera; Stuart, Rosemary A.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Hoang, Ngoc H.; Hosler, Jonathan] Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, Jackson, MS 39216 USA	Marquette University; University of Mississippi; University of Mississippi Medical Center	Stuart, RA (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	rosemary.stuart@marquette.edu		Stuart, Rosemary/0000-0002-9751-5494	National Science Foundation [MCB-1157722]; National Institutes of Health [R15GM101594, R15GM117551, P20GM121334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121334] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-1157722 and National Institutes of Health Grants R15GM101594 and R15GM117551 (to R. A. S.) and P20GM121334 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Ameri Kurosh, 2015, Mol Cell Oncol, V2, pe1030537, DOI 10.1080/23723556.2015.1030537; Ameri K, 2015, CELL REP, V10, P891, DOI 10.1016/j.celrep.2015.01.020; Ameri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062758; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Blomberg MRA, 2012, BBA-BIOENERGETICS, V1817, P495, DOI 10.1016/j.bbabio.2011.09.014; Bratton MR, 1999, BIOCHEMISTRY-US, V38, P16236, DOI 10.1021/bi9914107; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Ferguson-Miller S., 2018, MECH PRIMARY ENERGY, P215; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Garlich J, 2017, J BIOL CHEM, V292, P5216, DOI 10.1074/jbc.M116.758045; Gilderson G, 2003, BIOCHEMISTRY-US, V42, P7400, DOI 10.1021/bi0341298; HILL BC, 1986, J BIOL CHEM, V261, P5356; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P341, DOI 10.1016/0167-4889(82)90088-X; Krumschnabel G, 2014, METHOD ENZYMOL, V542, P163, DOI 10.1016/B978-0-12-416618-9.00009-1; Lee HJ, 2010, J AM CHEM SOC, V132, P16225, DOI 10.1021/ja107244g; Liang RB, 2017, P NATL ACAD SCI USA, V114, P5924, DOI 10.1073/pnas.1703654114; Lundin CR, 2017, FEBS LETT, V591, P4049, DOI 10.1002/1873-3468.12918; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Nguyen XT, 2002, PROTEIN EXPRES PURIF, V26, P122, DOI 10.1016/S1046-5928(02)00503-X; Rompler K, 2016, J BIOL CHEM, V291, P23769, DOI 10.1074/jbc.M116.734665; SARTI P, 1985, P NATL ACAD SCI USA, V82, P4876, DOI 10.1073/pnas.82.15.4876; Schafer J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29567-4; Schafer J, 2018, BBA-BIOENERGETICS, V1859, P699, DOI 10.1016/j.bbabio.2018.05.004; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Varanasi L, 2006, BIOCHEMISTRY-US, V45, P14896, DOI 10.1021/bi061390q; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wikstrom M, 2018, CHEM REV, V118, P2469, DOI 10.1021/acs.chemrev.7b00664; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Yoshikawa S, 2012, BBA-BIOENERGETICS, V1817, P579, DOI 10.1016/j.bbabio.2011.12.012	36	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4867	4877		10.1074/jbc.RA118.006888	http://dx.doi.org/10.1074/jbc.RA118.006888			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30683696	Green Published, hybrid			2022-12-26	WOS:000463985600012
J	Parreira, L; Marinheiro, R; Carmo, P; Amador, P; Mesquita, D; Farinha, J; Cavaco, D; Jeronimo, R; Costa, F; Adragao, P				Parreira, Leonor; Marinheiro, Rita; Carmo, Pedro; Amador, Pedro; Mesquita, Dinis; Farinha, Jose; Cavaco, Diogo; Jeronimo, Rafael; Costa, Francisco; Adragao, Pedro			Isolated diastolic potentials as predictors of success in ablation of right ventricular outflow tract idiopathic premature ventricular contractions	PLOS ONE			English	Article							TACHYCARDIA; ARRHYTHMIAS; UTILITY	Background and aims Discrete potentials, low voltage and fragmented electrograms, have been previously reported at ablation site, in patients with premature ventricular contractions (PVCs) originating in the right ventricular outflow tract (RVOT). The aim of this study was to review the electrograms at ablation site and assess the presence of diastolic potentials and their association with success. Methods We retrospectively reviewed the electrograms obtained at the radiofrequency (RF) delivery sites of 48 patients subjected to ablation of RVOT frequent PVCs. We assessed the duration and amplitude of local electrogram, local activation time, and presence of diastolic potentials and fragmented electrograms. Results We reviewed 134 electrograms, median 2 (1-4) per patient. Success was achieved in 40 patients (83%). At successful sites the local activation time was earlier-54 (-35 to -77) ms vs -26 (-12 to -35) ms, p<0.0001; the local electrogram had lower amplitude 1 (0.45-1.15) vs 1.5 (0.5-2.1) mV, p = 0.006, and longer duration 106 (80-154) vs 74 (60-90) ms, p<0.0001. Diastolic potentials and fragmented electrograms were more frequently present, respectively 76% vs 9%, p < 0.0001 and 54% vs 11%, p<0.0001. In univariable analysis these variables were all associated with success. In multivariable analysis only the presence of diastolic potentials [OR 15.5 (95% CI: 3.92-61.2; p<0.0001)], and the value of local activation time OR 1.11 (95% CI: 1.049-1.172 p<0.0001)], were significantly associated with success. Conclusion In this group of patients the presence of diastolic potentials at the ablation site was associated with success.	[Parreira, Leonor; Carmo, Pedro; Cavaco, Diogo; Jeronimo, Rafael; Costa, Francisco; Adragao, Pedro] Hosp Luz, Arrhythmol Dept, Lisbon, Portugal; [Parreira, Leonor; Marinheiro, Rita; Amador, Pedro; Mesquita, Dinis; Farinha, Jose] Ctr Hosp Setubal, Cardiol Dept, Setubal, Portugal		Parreira, L (corresponding author), Hosp Luz, Arrhythmol Dept, Lisbon, Portugal.; Parreira, L (corresponding author), Ctr Hosp Setubal, Cardiol Dept, Setubal, Portugal.	leonor.parreira@gmail.com	Mesquita, Dinis/AAM-9204-2020	Mesquita, Dinis/0000-0002-3409-2471; Moscoso Costa, Francisco/0000-0003-4019-5618; Parreira, Leonor/0000-0003-3159-4852				Baser K, 2014, J CARDIOVASC ELECTR, V25, P597, DOI 10.1111/jce.12400; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; GILL JS, 1993, AM HEART J, V126, P1126, DOI 10.1016/0002-8703(93)90664-U; John Roy M, 2016, Card Electrophysiol Clin, V8, P545, DOI 10.1016/j.ccep.2016.04.004; Kim RJ, 2007, J AM COLL CARDIOL, V49, P2035, DOI 10.1016/j.jacc.2007.01.085; Kuteszko R, 2015, EUROPACE, V17, P1428, DOI 10.1093/europace/euu392; Latchamsetty Rakesh, 2015, JACC Clin Electrophysiol, V1, P116, DOI 10.1016/j.jacep.2015.04.005; Lerman B., 2009, CARDIAC ELECTROPHYSI, V5, P657; Lerman BB, 2007, HEART RHYTHM, V4, P973, DOI 10.1016/j.hrthm.2007.03.007; Lerman BB, 2015, TRENDS CARDIOVAS MED, V25, P550, DOI 10.1016/j.tcm.2015.01.011; Liu EZ, 2015, EUROPACE, V17, P453, DOI 10.1093/europace/euu184; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Pappone C, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005053; Parreira L, 2019, REV PORT CARDIOL, DOI [10.1016/j.repc.2018.12.001, DOI 10.1016/J.REPC.2018.12.001]; Parreira L, 2013, REV PORT CARDIOL, V32, P489, DOI 10.1016/j.repc.2012.12.012; Pedersen CT, 2014, EUROPACE, V16, P1257, DOI 10.1093/europace/euu194; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; ROSEN MR, 1985, J AM COLL CARDIOL, V5, pA22, DOI 10.1016/S0735-1097(85)80460-5; Saha SA, 2016, CARDIOL THER, V5, P229, DOI 10.1007/s40119-016-0072-4; Srivathsan KS, 2008, CIRC-ARRHYTHMIA ELEC, V1, P30, DOI 10.1161/CIRCEP.107.750315; Stevenson William G., 2018, CARDIAC ELECTROPHYSI, P127; Tada H, 2008, HEART RHYTHM, V5, P419, DOI 10.1016/j.hrthm.2007.12.021; Thomsen PEB, 2010, EUROPACE, V12, P850, DOI 10.1093/europace/euq090; Timmermans C, 2003, CIRCULATION, V108, P1960, DOI 10.1161/01.CIR.0000095026.19339.BB; Tomaselli G., 2019, BRAUNWALDS HEART DIS, V34, P619; van Taxis CFBV, 2011, HEART RHYTHM, V8, P665, DOI 10.1016/j.hrthm.2010.12.049	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211232	10.1371/journal.pone.0211232	http://dx.doi.org/10.1371/journal.pone.0211232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726274	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000059
J	Patel, DC; Gaba, RC; Liu, L; Lokken, RP				Patel, Darshan C.; Gaba, Ron C.; Liu, Li; Lokken, R. Peter			Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism	PLOS ONE			English	Article							ULTRASOUND-ACCELERATED THROMBOLYSIS; DEEP-VEIN THROMBOSIS; ASSISTED THROMBOLYSIS; TRIAL; RISK; MORTALITY; EFFICACY; THERAPY	Purpose The purpose of this study is to assess the incremental effect of tissue plasminogen activator (t-PA) dose on pulmonary artery pressure (PAP) and bleeding during catheter directed thrombolysis (CDT) of submassive pulmonary embolism (PE). Materials and methods Records of 46 consecutive patients (25 men, 21 women, mean age 55 +/- 14 y) who underwent CDT for submassive PE between September 2009 and February 2017 were retrospectively reviewed. Mean t-PA rate was 0.7 +/- 0.3 mg/h. PAP was measured at baseline and daily until CDT termination. Mixed-effects regression modeling was performed of repeated PAP measures in individual patients. Bleeding events were classified by Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) and t-PA dose at onset. Results Mean t-PA dose was 43.0 +/- 30.0 mg over 61.9 +/- 28.8 h. Mean systolic PAP decreased from 51.7 +/- 15.5 mmHg at baseline to 35.6 +/- 12.7 mmHg at CDT termination (p<0.001). Mixe-deffects regression revealed a linear decrease in systolic PAP over time (beta = -0.37 (SE = 0.05), p<0.001) with reduction in mean systolic PAP to 44.8 +/- 1.9 mmHg at 12 mg t-PA/20 h, 39.5 +/- 2.0 mmHg at 24 mg t-PA/40 h, and 34.9 +/- 2.1 mmHg at 36 mg/60 h. No severe, one moderate, and 8 mild bleeding events occurred; bleeding onset was more frequent at. 24 mg t-PA (p < 0.001). One patient expired from cardiopulmonary arrest after 16 h of CDT (15.4 mg t-PA); no additional intra-procedural fatalities occurred. Conclusion Increased total t-PA dose and CDT duration were associated with greater PAP reduction without increased bleeding events.	[Patel, Darshan C.; Gaba, Ron C.] Univ Illinois Hlth, Dept Radiol, Chicago, IL USA; [Liu, Li] Univ Illinois, Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL USA; [Lokken, R. Peter] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco	Lokken, RP (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	rpeter.lokken@ucsf.edu		Lokken, R. Peter/0000-0003-1669-5188; Patel, Darshan/0000-0002-2236-7757	National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR002003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002003] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1TR002003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagla S, 2015, J VASC INTERV RADIOL, V26, P1001, DOI 10.1016/j.jvir.2014.12.017; Banovac F, 2010, J VASC INTERV RADIOL, V21, P44, DOI 10.1016/j.jvir.2009.09.018; BRAUNWALD E, 1993, NEW ENGL J MED, V329, P1650, DOI 10.1056/NEJM199311253292211; Chamsuddin A, 2008, J VASC INTERV RADIOL, V19, P372, DOI 10.1016/j.jvir.2007.10.019; Chatterjee S, 2014, JAMA-J AM MED ASSOC, V311, P2414, DOI 10.1001/jama.2014.5990; Dumantepe M, 2014, J CARDIAC SURG, V29, P455, DOI 10.1111/jocs.12354; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Engelberger RP, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002027; Engelhardt TC, 2011, THROMB RES, V128, P149, DOI 10.1016/j.thromres.2011.05.014; Gaba RC, 2014, AM J ROENTGENOL, V202, P1355, DOI 10.2214/AJR.13.11366; Graif A., 2017, J VASC INTERV RADIOL; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Kennedy RJ, 2013, J VASC INTERV RADIOL, V24, P841, DOI 10.1016/j.jvir.2013.02.023; Khalilzadeh O, 2017, J VASC INTERV RADIOL; Kucher N, 2014, CIRCULATION, V129, P479, DOI 10.1161/CIRCULATIONAHA.113.005544; Kuo WT, 2015, CHEST, V148, P667, DOI 10.1378/chest.15-0119; Liang NL, 2016, VASC ENDOVASC SURG, V50, P405, DOI 10.1177/1538574416666228; Lin PH, 2009, VASCULAR, V17, pS137, DOI 10.2310/6670.2009.00063; Marti C, 2015, EUR HEART J, V36, P605, DOI 10.1093/eurheartj/ehu218; Nakamura S, 2014, J THROMB HAEMOST, V12, P1086, DOI 10.1111/jth.12608; Piazza G, 2015, JACC-CARDIOVASC INTE, V8, P1382, DOI 10.1016/j.jcin.2015.04.020; Quintana D, 2014, CARDIOVASC INTER RAD, V37, P420, DOI 10.1007/s00270-013-0696-x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sadiq I, 2017, VASC MED, V22, P44, DOI 10.1177/1358863X16676355; Sista AK, 2018, JACC-CARDIOVASC INTE, V11, P1411, DOI 10.1016/j.jcin.2018.05.014; Tapson VF, 2018, JACC-CARDIOVASC INTE, V11, P1401, DOI 10.1016/j.jcin.2018.04.008	27	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211701	10.1371/journal.pone.0211701	http://dx.doi.org/10.1371/journal.pone.0211701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726288	Green Submitted, gold, Green Published			2022-12-26	WOS:000457874000074
J	Leone, AB; Ferraro, GB; Boitani, L; Blasi, MF				Leone, Andrea Benedetto; Ferraro, Giusy Bonanno; Boitani, Luigi; Blasi, Monica Francesca			Skin marks in bottlenose dolphins (Tursiops truncatus) interacting with artisanal fishery in the central Mediterranean Sea	PLOS ONE			English	Article							INDIAN RIVER LAGOON; DORSAL FIN DISFIGUREMENTS; PHYSICAL DEFORMITIES; VIOLENT INTERACTIONS; POSSIBLE INDICATOR; SEXUAL-DIMORPHISM; SMALL CETACEANS; ORCINUS-ORCA; DISEASE; INJURIES	Skin marks occur frequently in many cetacean species across the globe revealing a broad spectrum of causes, including social interactions, infectious diseases and injuries produced by anthropogenic factors. The current study used photo-id data from 2005-2014 to estimate the skin mark pattern on resident bottlenose dolphins (Tursiops truncatus) from the Aeolian Archipelago (Italy). Thirteen skin mark types were identified and their origin, prevalence and permanence time were examined. The pattern of skin marks was assessed for the abundance, richness, distribution and severity in six body regions and compared among age classes, sex and degree of dolphins' interaction with trammel nets (DIN). Our results showed higher prevalence, abundance, richness and distribution of skin marks in adults than in the younger age classes, with the exception of black marks and white ring lesions. The prevalence and abundance of skin marks were higher in males than females, with the exception of scratches and white patches. Moreover, gunshot wounds, mutilations and irregular dorsal fin edges were found only on adult males. Since males showed higher DIN than females and, in dolphins with higher DIN, skin marks were more abundant and frequently distributed in different body regions, the skin mark pattern in regard to DIN seems to be sex-related. The more severe marks were observed on adults, males and dolphins with higher DIN, namely skin disorder, tooth rake marks, small shallow indentations, deep indentations and mutilations. On the contrary, the severity of scratches, white patches and dark ring lesions was higher in females than males, but not significantly related to DIN and age of the individuals. Our results showed that photo-id data provide an efficient and cost-effective approach to document the occurrence of skin marks in free-ranging bottlenose dolphin populations, a critical step toward understanding the cause and supporting the conservation strategies.	[Leone, Andrea Benedetto; Ferraro, Giusy Bonanno; Blasi, Monica Francesca] Filicudi WildLife Conservat, Lipari, ME, Italy; [Boitani, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol, Rome, Italy	Sapienza University Rome	Blasi, MF (corresponding author), Filicudi WildLife Conservat, Lipari, ME, Italy.	blasimf@yahoo.com	Ferraro, Giusy Bonanno/AAA-2269-2019; Leone, Andrea Benedetto/N-1279-2016	Ferraro, Giusy Bonanno/0000-0002-1998-7517; 				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Azevedo Alexandre F., 2009, Marine Biodiversity Records, V2, pe22, DOI 10.1017/S1755267208000262; Baird RW, 2005, PAC SCI, V59, P593, DOI 10.1353/psc.2005.0042; BAKER J R, 1992, Aquatic Mammals, V18, P27; Barnett J, 2009, VET REC, V165, P441, DOI 10.1136/vr.165.15.441; BARR B, 1989, J WILDLIFE DIS, V25, P608, DOI 10.7589/0090-3558-25.4.608; Bas A, 2016, HYLA HERPETOLOGICAL, V1, P1; Bearzi M, 2009, AMBIO, V38, P66, DOI 10.1579/0044-7447-38.2.66; Bechdel Sarah E., 2009, Aquatic Mammals, V35, P367, DOI 10.1578/AM.35.3.2009.367; Bertulli CG, 2016, J MAR BIOL ASSOC UK, V96, P807, DOI 10.1017/S0025315415000284; Bigg M.A., 1987, KILLER WHALES STUDY; Blasi MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114849; Blasi Monica F., 2012, Endangered Species Research, V17, P269, DOI 10.3354/esr00422; Blasi MF, 2015, AQUAT MAMM, V41, P295, DOI 10.1578/AM.41.3.2015.295; Bloom Peter, 1994, Aquatic Mammals, V20, P59; Bossart GD, 2017, DIS AQUAT ORGAN, V125, P141, DOI 10.3354/dao03142; Byard RW, 2013, FORENSIC SCI MED PAT, V9, P103, DOI 10.1007/s12024-012-9335-0; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; CORKERON P J, 1987, Aquatic Mammals, V13, P109; CORKERON P J, 1987, Aquatic Mammals, V13, P96; DUNN JL, 1982, J AM VET MED ASSOC, V181, P1316; Durden WN, 2009, J WILDLIFE DIS, V45, P849, DOI 10.7589/0090-3558-45.3.849; Elwen SH, 2010, AQUAT MAMM, V36, P382, DOI 10.1578/AM.36.4.2010.382; GERACI JR, 1979, CAN J COMP MED, V43, P399; Greenwood A.G., 1974, P73; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Hart LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033081; Harzen Stefan, 1997, Aquatic Mammals, V23, P59; Heithaus MR, 2001, MAR MAMMAL SCI, V17, P526, DOI 10.1111/j.1748-7692.2001.tb01002.x; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; Herzing D. L., 1997, Aquatic Mammals, V23, P85; Hupman KE, 2017, AQUAT MAMM, V43, P264, DOI 10.1578/AM.43.3.2017.264; Jepson PD, 1998, VET REC, V143, P614, DOI 10.1136/vr.143.22.614; Kiszka Jeremy, 2008, Western Indian Ocean Journal of Marine Science, V7, P185; Knowlton AR, 2016, CONSERV BIOL, V30, P318, DOI 10.1111/cobi.12590; Lauriano G., 2004, Journal of Cetacean Research and Management, V6, P165; Lockyer C, 1985, AQUAT MAMM, V2, P42; Lockyer C. H., 1990, REPORTS INT WHALING, V12, P113; Luksenburg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088988; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mariani M, 2016, J MAMMAL, V97, P1512, DOI 10.1093/jmammal/gyw109; Marley SA, 2013, AQUAT MAMM, V39, P107, DOI 10.1578/AM.39.2.2013.107; Martin AR, 2006, MAR MAMMAL SCI, V22, P25, DOI 10.1111/j.1748-7692.2006.00003.x; Martinez-Levasseur LM, 2011, P ROY SOC B-BIOL SCI, V278, P1581, DOI 10.1098/rspb.2010.1903; Melero M, 2001, DIS AQUAT ORGAN, V97, P167; NAKEEB S, 1977, J AM VET MED ASSOC, V171, P961; Nery MF, 2008, BRAZ J OCEANOGR, V56, P313, DOI 10.1590/S1679-87592008000400007; Orams MB, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P170; Patterson IAP, 1998, P ROY SOC B-BIOL SCI, V265, P1167, DOI 10.1098/rspb.1998.0414; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Reif JS, 2006, JAVMA-J AM VET MED A, V228, P104, DOI 10.2460/javma.228.1.104; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; Rotstein DS, 2009, EMERG INFECT DIS, V15, P588, DOI 10.3201/eid1504.081358; Rowe LE, 2009, MAR MAMMAL SCI, V25, P19, DOI 10.1111/j.1748-7692.2008.00235.x; Samarra FIP, 2012, MAR MAMMAL SCI, V28, P395, DOI 10.1111/j.1748-7692.2011.00486.x; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Shane SH., 1990, BOTTLENOSE DOLPHIN, P267; SIMPSON CHARLES F., 1958, JOUR AMER VET MED ASSOC, V133, P558; Slijper E.J., 1962, WHALES; SWEENEY JC, 1975, J AM VET MED ASSOC, V167, P533; SYMMERS WS, 1983, B SOC PATHOL EXOT, V76, P777; THOMPSON PM, 1992, AMBIO, V21, P135; TOLLEY KA, 1995, J MAMMAL, V76, P1190, DOI 10.2307/1382611; Van Bressem MF, 2009, DIS AQUAT ORGAN, V85, P225, DOI 10.3354/dao02080; Van Bressem Marie-Francoise, 2007, Latin American Journal of Aquatic Mammals, V6, P7; Van Bressem MF, 2003, DIS AQUAT ORGAN, V56, P171, DOI 10.3354/dao056171; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; Van Bressem MF, 2017, SEX DIFFERENCES EPID, DOI [10.1101/101915, DOI 10.1101/101915]; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; VANBRESSEM MF, 1994, MAR MAMMAL SCI, V10, P354; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; Viddi FA, 2005, 16 BIENN C BIOL MAR, P292; Visser IN, 1999, NEW ZEAL J MAR FRESH, V33, P635, DOI 10.1080/00288330.1999.9516906; Wedekin Leonardo L., 2004, Aquatic Mammals, V30, P391, DOI 10.1578/AM.30.3.2004.391; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells RS, 2008, MAR MAMMAL SCI, V24, P774, DOI 10.1111/j.1748-7692.2008.00212.x; Wells RS, 1997, MAR MAMMAL SCI, V13, P475, DOI 10.1111/j.1748-7692.1997.tb00654.x; Wilson B, 1997, AMBIO, V26, P243; Wilson B, 1999, P ROY SOC B-BIOL SCI, V266, P1077, DOI 10.1098/rspb.1999.0746; Wilson B, 2000, MAR ECOL PROG SER, V205, P283, DOI 10.3354/meps205283; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	82	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211767	10.1371/journal.pone.0211767	http://dx.doi.org/10.1371/journal.pone.0211767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721248	Green Published, Green Submitted, gold			2022-12-26	WOS:000457746300027
J	Tochigi, K; Aoki, Y; Maruyama, T; Yamazaki, K; Kozakai, C; Naganuma, T; Inagaki, A; Masaki, T; Koike, S				Tochigi, Kahoko; Aoki, Yukino; Maruyama, Tetsuya; Yamazaki, Koji; Kozakai, Chinatsu; Naganuma, Tomoko; Inagaki, Akino; Masaki, Takashi; Koike, Shinsuke			Does hard mast production affect patterns of cementum annuli formation in premolar teeth of Asian black bears (Ursus thibetanus)?	PLOS ONE			English	Article							BLOOD-CHEMISTRY; POLAR BEARS; GROWTH; REPRODUCTION; POPULATIONS; REGRESSION; HABITS; COUNTS	Cementum annuli widths in mammals are is influenced by the nutrition of mammals. Reproductive stress has been is suggested to reduce the width of lead to narrower cementum annuli widths in female Asian black bears (Ursus thibetanus); however, food availability in autumn strongly impacts bear nutrition and likely impacts cementum widths as well. This study aimed to test how cementum annuli widths and the formation of false annuli were influenced by hard mast production. We established two hypotheses: (1) cementum annuli widths become narrower in poor mast years owing to inadequate nutritional conditions and (2) false annuli occur more frequently in poor mast years. We used teeth samples from male bears to avoid reproductive influences and separated width data into "adult" and "subadult" groups. We calculated the proportional width index (PWI) and used linear mixed models to estimate the masting effects on PWI. Generalized linear mixed models estimated the masting effects on false annuli frequency. True annuli widths and false annuli formation showed no significant relationship with mast production in adults. In subadults, poor mast production weak negative influence on false annuli formation. These new data resolve previous questions, allowing us to deduce that cementum annuli widths are a reliable index of reproductive success in female bears.	[Tochigi, Kahoko; Aoki, Yukino; Naganuma, Tomoko; Inagaki, Akino; Koike, Shinsuke] Tokyo Univ Agr & Technol, Fuchu, Tokyo, Japan; [Maruyama, Tetsuya] Tochigi Prefectural Forestry Res Ctr, Utsunomiya, Tochigi, Japan; [Yamazaki, Koji] Tokyo Univ Agr, Setagaya Ku, Tokyo, Japan; [Kozakai, Chinatsu] Natl Agr & Food Res Org, Tsukuba, Ibaraki, Japan; [Masaki, Takashi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture; National Agriculture & Food Research Organization - Japan; Forestry & Forest Products Research Institute - Japan	Tochigi, K (corresponding author), Tokyo Univ Agr & Technol, Fuchu, Tokyo, Japan.	k.koro722@gmail.com	Koike, Shinsuke/C-4619-2013	Koike, Shinsuke/0000-0002-2926-8196; Tochigi, Kahoko/0000-0002-1610-7828; Naganuma, Tomoko/0000-0002-6646-8779	 [JP25850103];  [JP16H04932];  [JP17H00797];  [JP17H05971]	; ; ; 	This study was supported by grants to Shinsuke Koike, Takashi Masaki, and Koji Yamazaki: JP25850103 (Shinsuke Koike), JP16H04932 (Koji Yamazaki and Shinsuke Koike), JP17H00797 (Takashi Masaki and Shinsuke Koike), JP17H05971 (Shinsuke Koike); JP25850103 (Foraging variation of Asiatic black bears:evidence for individual differences in diet), JP17H00797 (The geohistorical role of mountainous environment causing high diversity of woody plants in Japan); JP25850103(https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25850103/), JP16H04932 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-16H04932/), JP17H00797 (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-17H00797/), JP17H05971 (https://kaken.nii.ac.jp/grant/KAKENHI-PUBLICLY-17H05971/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2004, J MAMMAL, V85, P311, DOI 10.1644/1545-1542(2004)085<0311:MDBAPO>2.0.CO;2; American Veterinary Medical Association, 2013, AVMA GUIDELINES EUTH; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BURKE A, 1995, J ARCHAEOL SCI, V22, P479, DOI 10.1006/jasc.1995.0047; Calvert W, 1998, URSUS-SERIES, V10, P449; Carrel W.K., 1994, INT C BEAR RES MANAG, V9, P205, DOI DOI 10.2307/3872703; Costello CM, 2003, URSUS-SERIES, V14, P1; COY PL, 1992, CAN J ZOOL, V70, P2150, DOI 10.1139/z92-290; Grue H., 1979, Danish Review of Game Biology, V11, P1; Hashimoto Y, 2003, ECOL RES, V18, P485, DOI 10.1046/j.1440-1703.2003.00572.x; Hashimoto Yukihiko, 1997, Honyurui Kagaku, V37, P1; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Iibuchi R, 2009, JPN J VET RES, V57, P13; Kamine A, 2012, JPN J VET RES, V60, P5; Klevezal G.A., 1996, RECORDING STRUCTURES; KOENIG WD, 1994, ECOLOGY, V75, P99, DOI 10.2307/1939386; Koike S, 2008, URSUS, V19, P80, DOI 10.2192/1537-6176(2008)19[80:NOABBD]2.0.CO;2; Koike S, 2010, MAMM BIOL, V75, P17, DOI 10.1016/j.mambio.2009.03.008; Komatsu T., 1994, J REPROD DEVELOP, V40, pj65, DOI [10.1262/jrd.40.6_j65, DOI 10.1262/JRD.40.6_J65]; Kozakai C, 2013, J MAMMAL, V94, P351, DOI 10.1644/11-MAMM-A-246.1; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; LIEBERMAN DE, 1994, J ARCHAEOL SCI, V21, P525, DOI 10.1006/jasc.1994.1052; Lockyer Christina, 1993, V14, P137; Mansfield A. W, 1958, J FISH RES BOARD CAN, V653, P1; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; Medill S, 2010, POLAR BIOL, V33, P115, DOI 10.1007/s00300-009-0689-z; Medill S, 2009, J MAMMAL, V90, P1256, DOI 10.1644/08-MAMM-A-186.1; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Nakajima A., 2015, OPEN J FOR, V05, P651, DOI DOI 10.4236/0JF.2015.57057; Ohtaishi N., 1990, Journal of the Mammalogical Society of Japan, V15, P15; Oi T, 2009, URSUS, V20, P22, DOI 10.2192/1537-6176-20.1.22; Pike-Tay Anne, 1995, Archaeofauna, V4, P273; Proper J, 2007, ETHNIC DIS, V17, pS45; R Core Team, 2021, R LANGUAGE ENV STAT; Scheffer V.B., 1980, International Whaling Commission Report of the Commission, P51; Stewart REA, 1996, MAR MAMMAL SCI, V12, P383, DOI 10.1111/j.1748-7692.1996.tb00591.x; STORM GL, 1988, J WILDLIFE DIS, V24, P515, DOI 10.7589/0090-3558-24.3.515; Tochigi K, 2018, MAMM STUDY, V43, P261, DOI 10.3106/ms2018-0016; Tochigi Prefecture, 2015, MAN PLAN AS BLACK BE; Umemura Y, 2018, MAMMALIA, V82, P288, DOI 10.1515/mammalia-2015-0172; Von Biela VR, 2008, J WILDLIFE MANAGE, V72, P618, DOI 10.2193/2007-218; Yang JJ, 2017, VET MED-CZECH, V62, P533, DOI 10.17221/166/2016-VETMED; ZIMNY ML, 1978, COMP BIOCHEM PHYS A, V60, P257, DOI 10.1016/0300-9629(78)90244-X	43	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211561	10.1371/journal.pone.0211561	http://dx.doi.org/10.1371/journal.pone.0211561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716134	gold, Green Published, Green Submitted			2022-12-26	WOS:000457744200031
J	Hidalgo, C; Stoore, C; Strull, K; Franco, C; Correa, F; Jimenez, M; Hernandez, M; Lorenzatto, K; Ferreira, HB; Galanti, N; Paredes, R				Hidalgo, Christian; Stoore, Caroll; Strull, Karen; Franco, Carmen; Correa, Felipe; Jimenez, Mauricio; Hernandez, Marcela; Lorenzatto, Karina; Ferreira, Henrique B.; Galanti, Norbel; Paredes, Rodolfo			New insights of the local immune response against both fertile and infertile hydatid cysts	PLOS ONE			English	Article							ECHINOCOCCUS-GRANULOSUS; LAMINATED LAYER; PREVALENCE; CATTLE; BIOLOGY; OVINE; EXPRESSION; PARTICLES; RUMINANTS; GENE	Background Cystic echinococcosis is caused by the metacestode of the zoonotic flatworm Echinococcus granulosus. Within the viscera of the intermediate host, the metacestode grows as a unilocular cyst known as hydatid cyst. This cyst is comprised of two layers of parasite origin: germinal and laminated layers, and one of host origin: the adventitial layer, that encapsulates the parasite. This adventitial layer is composed of collagen fibers, epithelioid cells, eosinophils and lymphocytes. To establish itself inside the host, the germinal layer produces the laminated layer, and to continue its life cycle, generates protoscoleces. Some cysts are unable to produce protoscoleces, and are defined as infertile cysts. The molecular mechanisms involved in cyst fertility are not clear, however, the host immune response could play a crucial role. Methodology/Principal findings We collected hydatid cysts from both liver and lungs of slaughtered cattle, and histological sections of fertile, infertile and small hydatid cysts were stained with haematoxylin-eosin. A common feature observed in infertile cysts was the disorganization of the laminated layer by the infiltration of host immune cells. These infiltrating cells eventually destroy parts of laminated layer. Immunohistochemical analysis of both parasite and host antigens, identify these cells as cattle macrophages and are present inside the cysts associated to germinal layer. Conclusions/Significance This is the first report that indicates to cell from immune system present in adventitial layer of infertile bovine hydatid cysts could disrupt the laminated layer, infiltrating and probably causing the infertility of cyst.	[Hidalgo, Christian; Stoore, Caroll; Strull, Karen; Correa, Felipe; Jimenez, Mauricio; Paredes, Rodolfo] Univ Andres Bello, Fac Ciencias Vida, Escuela Med Vet, Santiago, Chile; [Franco, Carmen] Clin Santa Maria, Santiago, Chile; [Hernandez, Marcela] Univ Chile, Fac Odontol, Lab Biol Periodontal, Santiago, Chile; [Hernandez, Marcela] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile; [Lorenzatto, Karina; Ferreira, Henrique B.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Genom Estrutural & Func, Porto Alegre, RS, Brazil; [Lorenzatto, Karina; Ferreira, Henrique B.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Biol Mol Cestodeos, Porto Alegre, RS, Brazil; [Galanti, Norbel] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago, Chile	Universidad Andres Bello; Universidad de Chile; Universidad Autonoma de Chile; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidad de Chile	Paredes, R (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Escuela Med Vet, Santiago, Chile.	rparedes@unab.cl	/AHC-8464-2022; Hernández, Marcela/I-3266-2013; Stoore, Caroll/V-8723-2019; Ferreira, Henrique B/H-4189-2012; paredes, rodolfo/V-1151-2019	Hernández, Marcela/0000-0001-8289-7314; Stoore, Caroll/0000-0001-9499-4314; Ferreira, Henrique B/0000-0003-3611-6040; paredes, rodolfo/0000-0002-5909-9362; Jimenez, Mauricio/0000-0003-4811-2514; Hidalgo, Christian/0000-0002-0780-6969; Correa, Felipe/0000-0002-4919-5764	FONDECYT-CONICYT Chile [1161475]	FONDECYT-CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	RP received grant #1161475 from FONDECYT-CONICYT Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboelhadid SM, 2013, VET PARASITOL, V193, P292, DOI 10.1016/j.vetpar.2012.11.019; Al Kitani FA, 2015, VET PARASITOL, V211, P208, DOI 10.1016/j.vetpar.2015.06.011; Amri M, 2015, ACTA TROP, V149, P186, DOI 10.1016/j.actatropica.2015.05.027; Aziz A, 2011, J PROTEOMICS, V74, P1560, DOI 10.1016/j.jprot.2011.02.021; Barnes TS, 2011, J COMP PATHOL, V144, P113, DOI 10.1016/j.jcpa.2010.07.003; BOWLES J, 1993, MOL BIOCHEM PARASIT, V57, P231, DOI 10.1016/0166-6851(93)90199-8; Bulashev AK, 2017, FOLIA PARASIT, V64, DOI 10.14411/fp.2017.005; Casaravilla C, 2014, INFECT IMMUN, V82, P3164, DOI 10.1128/IAI.01959-14; Chihai O, 2016, J HELMINTHOL, V90, P279, DOI 10.1017/S0022149X15000103; Diaz A, 2000, MOL MED, V6, P648, DOI 10.1007/BF03402045; Diaz A, 2015, EXP PARASITOL, V158, P23, DOI 10.1016/j.exppara.2015.03.019; Diaz A, 2011, TRENDS PARASITOL, V27, P204, DOI 10.1016/j.pt.2010.12.012; Dorosti Zahra, 2016, J Parasit Dis, V40, P855, DOI 10.1007/s12639-014-0593-5; Dueger EL, 2001, T ROY SOC TROP MED H, V95, P379, DOI 10.1016/S0035-9203(01)90188-9; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Ehsan M, 2017, VET PARASITOL, V239, P80, DOI 10.1016/j.vetpar.2017.04.006; Founta A, 2016, VET ITAL, V52, P123, DOI 10.12834/VetIt.123.347.2; Haleem S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5042430; Jawad Rana A., 2018, Annals of Parasitology, V64, P211, DOI 10.17420/ap6403.154; Kamelli Mehrab, 2016, Annals of Parasitology, V62, P301, DOI 10.17420/ap6204.65; Kul O, 2010, VET PARASITOL, V170, P162, DOI 10.1016/j.vetpar.2010.01.045; Lahmar S, 2013, J HELMINTHOL, V87, P318, DOI 10.1017/S0022149X12000430; Lahmar S, 2009, ANN TROP MED PARASIT, V103, P593, DOI 10.1179/000349809X12502035776153; Laskin DL, 2001, J LEUKOCYTE BIOL, V70, P163; Lewall DB, 1998, CLIN RADIOL, V53, P863, DOI 10.1016/S0009-9260(98)80212-2; Marco M, 2006, PARASITOL RES, V100, P131, DOI 10.1007/s00436-006-0237-5; da Silva AM, 2011, CHINESE MED J-PEKING, V124, P2806, DOI 10.3760/cma.j.issn.0366-6999.2011.18.002; Moro P, 2006, PARASITOL INT, V55, pS181, DOI 10.1016/j.parint.2005.11.048; Munoz J. P., 2005, Parasitologia Latinoamericana, V60, P69; Nabavi Reza, 2014, J Parasit Dis, V38, P371, DOI 10.1007/s12639-013-0262-0; Odongo DO, 2018, PARASITOL RES, V117, P2065, DOI 10.1007/s00436-018-5889-4; Paoletti B, 2019, PARASITOL RES, V118, P43, DOI 10.1007/s00436-018-6112-3; Paredes R, 2007, J CELL BIOCHEM, V100, P1200, DOI 10.1002/jcb.21108; Paredes R, 2011, J CELL BIOCHEM, V112, P189, DOI 10.1002/jcb.22916; Riesle S, 2014, VET PARASITOL, V205, P125, DOI 10.1016/j.vetpar.2014.06.003; Rogan MT, 2015, PARASITE IMMUNOL, V37, P1, DOI 10.1111/pim.12149; Sakamoto T, 2003, ACTA TROP, V85, P271, DOI 10.1016/S0001-706X(02)00226-7; Salem C B Ould Ahmed, 2011, Bull Soc Pathol Exot, V104, P1, DOI 10.1007/s13149-010-0099-z; Seoane PI, 2016, SCI REP-UK, V6, DOI 10.1038/srep39204; Siracusano A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639362; Stoore C, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3128-6; Thapa NK, 2017, PARASITOL INT, V66, P139, DOI 10.1016/j.parint.2016.12.010; Thompson RCA, 2017, ADV PARASIT, V95, P65, DOI 10.1016/bs.apar.2016.07.001; Vatankhah A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1252-x; Vismarra A, 2015, VET PARASITOL, V209, P285, DOI 10.1016/j.vetpar.2015.02.027; Zait H, 2013, Med Sante Trop, V23, P235, DOI 10.1684/mst.2013.0205; Zeghir-Bouteldja R, 2013, PARASITOL RES, V112, P649, DOI 10.1007/s00436-012-3181-6	47	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211542	10.1371/journal.pone.0211542	http://dx.doi.org/10.1371/journal.pone.0211542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699191	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600085
J	Kohl, MT; Messmer, TA; Crabb, BA; Guttery, MR; Dahlgren, DK; Larsen, RT; Frey, SN; Liguori, S; Baxter, RJ				Kohl, Michel T.; Messmer, Terry A.; Crabb, Benjamin A.; Guttery, Michael R.; Dahlgren, David K.; Larsen, Randy T.; Frey, Shandra N.; Liguori, Sherry; Baxter, Rick J.			The effects of electric power lines on the breeding ecology of greater sage-grouse	PLOS ONE			English	Article							ENERGY DEVELOPMENT; CENTROCERCUS-UROPHASIANUS; HABITAT SELECTION; PERCH DETERRENTS; TALL STRUCTURES; GOLDEN EAGLES; LAND-USE; POPULATIONS; SURVIVAL; INFRASTRUCTURE	Anthropogenic infrastructure can negatively affect wildlife through direct mortality and/or displacement behaviors. Some tetranoids (grouse spp.) species are particularly vulnerable to tall anthropogenic structures because they evolved in ecosystems void of vertical structures. In western North America, electric power transmission and distribution lines (power lines) occur in sagebrush (Artemisia spp.) landscapes within the range of the greater sage-grouse (Centrocercus urophasianus; sage-grouse). The U.S. Fish and Wildlife Service recommended using buffer zones near leks to mitigate the potential impacts of power lines on sage-grouse. However, recommended buffer distances are inconsistent across state and federal agencies because data are lacking. To address this, we evaluated the effects of power lines on sage-grouse breeding ecology within Utah, portions of southeastern Idaho, and southwestern Wyoming from 1998-2013. Overall, power lines negatively affected lek trends up to a distance of 2.7 and 2.8 km, respectively. Power lines died not affect lek persistence. Female sage-grouse avoided transmission lines during the nesting and brooding seasons at distances up to 1.1 and 0.8 km, respectively. Nest and brood success were negatively affected by transmission lines up to distances of 2.6 and 1.1 km, respectively. Distribution lines did not appear to affect sage-grouse habitat selection or reproductive fitness. Our analyses demonstrated the value of sagebrush cover in mitigating potential power line impacts. Managers can minimize the effects of new transmission power lines by placing them in existing anthropogenic corridors and/or incorporating buffers at least 2.8 km from active leks. Given the uncertainty we observed in our analyses regarding sage-grouse response to distribution lines coupled with their role in providing electric power service directly to individual consumers, we recommend that buffers for these power lines be considered on a case-by-case basis. Micrositing to avoid important habitats and habitat reclamation may reduce the potential impacts of new power line construction.	[Kohl, Michel T.; Messmer, Terry A.; Guttery, Michael R.; Dahlgren, David K.; Frey, Shandra N.] Utah State Univ, Dept Wildland Resources, Jack H Berryman Inst, Logan, UT 84322 USA; [Crabb, Benjamin A.] Utah State Univ, Quinney Coll Nat Resources, Remote Sensing GIS Lab, Logan, UT 84322 USA; [Larsen, Randy T.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Larsen, Randy T.; Baxter, Rick J.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA; [Liguori, Sherry] Rocky Mt Power Pacific Power, Salt Lake City, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Brigham Young University; Brigham Young University	Kohl, MT (corresponding author), Utah State Univ, Dept Wildland Resources, Jack H Berryman Inst, Logan, UT 84322 USA.	michel.kohl@usu.edu		Kohl, Michel/0000-0001-8218-1455	Utah Public Lands Policy Coordinating Office; Jack H. Berryman Institute; Quinney Professorship for Wildlife Conflict Management; U.S. Bureau of Land Management; Utah Division of Wildlife Resources; Utah State University Extension	Utah Public Lands Policy Coordinating Office; Jack H. Berryman Institute; Quinney Professorship for Wildlife Conflict Management; U.S. Bureau of Land Management; Utah Division of Wildlife Resources; Utah State University Extension	This work was supported by Utah Public Lands Policy Coordinating Office, Jack H. Berryman Institute, Quinney Professorship for Wildlife Conflict Management, U.S. Bureau of Land Management, Utah Division of Wildlife Resources, and Utah State University Extension. SH was employed by Rocky Mountain Power/Pacific Power, 1407 West North Temple, Salt Lake City, Utah, United States of America. The funder provided support in the form of salaries for this author [SH], but did not have any additional role in the study design, data collection and analysis, or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], 2013, FINAL CONSERVATION P; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Avian Power Line Interaction Committee (APLIC), 2015, BEST MAN PRACT EL UT; Baddeley A, 2015, SPATIAL POINT PATTER; Beck JL, 2003, WEST N AM NATURALIST, V63, P203; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; Boarman William I., 1999, Birds of North America, V476, P1; BRAUN C E, 1977, Wildlife Society Bulletin, V5, P99; Bui TVD, 2010, CONDOR, V112, P65, DOI 10.1525/cond.2010.090132; Burnham KP, 2014, ECOLOGY, V95, P627, DOI 10.1890/13-1066.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CONNELLY J.W., 2003, STATION B, V80; Connelly J. W., 2004, UNPUB; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Connelly JW, 2011, STUD AVIAN BIOL, P53; Connelly JW, 2011, STUD AVIAN BIOL, P69; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Dahlgren DK, 2016, WILDLIFE SOC B, V40, P288, DOI 10.1002/wsb.643; Dahlgren DK, 2015, RANGELAND ECOL MANAG, V68, P375, DOI 10.1016/j.rama.2015.07.003; Dahlgren DK, 2010, J WILDLIFE MANAGE, V74, P1286, DOI 10.2193/2009-093; Dinkins JB, 2014, CAN J ZOOL, V92, P319, DOI 10.1139/cjz-2013-0263; Dinkins JB, 2014, CONDOR, V116, P629, DOI 10.1650/CONDOR-13-163.1; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Environment Canada, 2013, AM REC STRAT GREAT S; Garton EO, 2011, STUD AVIAN BIOL, P293; Gibson D, 2014, WILD MONOG, V92, P319; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hansen EP, 2016, HUM-WILDL INTERACT, V10, P169; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hovick TJ, 2014, J APPL ECOL, V51, P1680, DOI 10.1111/1365-2664.12331; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson DJ, 2011, STUDIES AVIAN BIOL, V38; Knick ST, 2011, STUD AVIAN BIOL, P1; Knick ST, 2013, ECOL EVOL, V3, P1539, DOI 10.1002/ece3.557; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Lammers WM, 2007, J WILDLIFE MANAGE, V71, P2752, DOI 10.2193/2005-752; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; Mabey S, 2007, CRITICAL LIT REV IMP; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Manier Daniel J., 2014, U S Geological Survey Open-File Report, V1239, P1; Manly B.F.J., 2002, RESOURCE SELECTION A; Marzluff JM, 1997, AUK, V114, P673, DOI 10.2307/4089287; McIntyre CL, 2002, J RAPTOR RES, V36, P50; Messmer Terry A., 2013, Human-Wildlife Interactions, V7, P273; Prather PR, 2010, J WILDLIFE MANAGE, V74, P796, DOI 10.2193/2009-204; RCore Team, 2020, R LANG ENV STAT COMP; Rowland MN, 2004, EFFECTS MANAGEMENT P; Sandford CP, 2017, RANGELAND ECOL MANAG, V70, P59, DOI 10.1016/j.rama.2016.09.002; Schroeder MA, 2003, WILDLIFE BIOL, V9, P291, DOI 10.2981/wlb.2003.017; Smith JA, 2016, CONDOR, V118, P411, DOI 10.1650/CONDOR-15-61.1; STEENHOF K, 1993, J WILDLIFE MANAGE, V57, P271, DOI 10.2307/3809424; Stiver S. J., 2006, UNPUB; U.S. Bureau of Land Management (BLM), 2011, REP NAT GREAT SAG GR; U.S. Bureau of Land Management (BLM), 2004, NAT SAG GROUS HAB CO; U. S. Fish and Wildlife Service (USFWS), 2010, NOT 12 MONTH PET FIN; US Census Bureau, TIGER PROD; USFWS (US Fish and Wildlife Ser-vice), 2003, INT GUID AV MIN WILD; Utah Division of Wildlife Resources [UDWR], 2009, USITC PUBL, V09-17; Utah Wildlife in Need Foundation (UWIN), 2010, CONT KNOWL RES NEEDS; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; WALLESTAD R, 1974, J WILDLIFE MANAGE, V38, P630, DOI 10.2307/3800029; Walters K, 2014, WILDLIFE SOC B, V38, P250, DOI 10.1002/wsb.394; West N.E., 1983, P331; Westover M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156290; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wisdom MJ, 2011, STUD AVIAN BIOL, P451; Wyoming Executive Order (Wyoming EO), 2015, GREAT SAG GROUS COR	73	7	7	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0209968	10.1371/journal.pone.0209968	http://dx.doi.org/10.1371/journal.pone.0209968			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699130	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600016
J	Awasthi, S; Singh, B; Ramani, V; Xie, J; Kosanke, S				Awasthi, Shanjana; Singh, Bhupinder; Ramani, Vijay; Xie, Jun; Kosanke, Stanley			TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SURFACTANT PROTEIN-A; GRAM-NEGATIVE BACTERIA; PULMONARY SURFACTANT; LACTATE PRODUCTION; TLR4; INHIBITION; COLLECTINS; RESISTANCE; RESPONSES	Interaction between surfactant protein-A (SP-A) and toll-like receptor (TLR) 4 plays a critical role in host defense. In this work, we studied the host defense function of SPA4 peptide (amino acids GDFRYSDGTPVNYTNWYRGE), derived from the TLR4-interacting region of SP-A, against Pseudomonas aeruginosa. We determined the binding of SPA4 peptide to live bacteria, and its direct antibacterial activity against P. aeruginosa. Pro-phagocytic and antiinflammatory effects were investigated in JAWS II dendritic cells and primary alveolar macrophages. The biological relevance of SPA4 peptide was evaluated in a mouse model of acute lung infection induced by intratracheal challenge with P. aeruginosa. Our results demonstrate that the SPA4 peptide does not interact with or kill P. aeruginosa when cultured outside the host. The SPA4 peptide treatment induces the uptake and localization of bacteria in the phagolysosomes of immune cells. At the same time, the secreted amounts of TNF-alpha are significantly reduced in cell-free supernatants of SPA4 peptide-treated cells. In cells overexpressing TLR4, the TLR4-induced phagocytic response is maintained, but the levels of TLR4-stimulated TNF-alpha are reduced. Furthermore, our results demonstrate that the therapeutic administration of SPA4 peptide reduces bacterial burden, inflammatory cytokines and chemokines, intracellular signaling, and lactate levels, and alleviates lung edema and tissue damage in P. aeruginosa-infected mice. Together, our results suggest that the treatment with SPA4 peptide can help control the bacterial burden, inflammation, and tissue injury in a P. aeruginosa lung infection model.	[Awasthi, Shanjana; Singh, Bhupinder; Ramani, Vijay; Xie, Jun] OUHSC, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA; [Kosanke, Stanley] OUHSC, Dept Pathol, Oklahoma City, OK USA; [Singh, Bhupinder; Xie, Jun] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Ramani, Vijay] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Kosanke, Stanley] OUHSC, Dept Microbiol & Immunol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma Health Sciences Center	Awasthi, S (corresponding author), OUHSC, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA.	Shanjana-Awasthi@ouhsc.edu		Singh, Bhupinder/0000-0002-9185-7944	American Heart Association [11GRNT7220012]; University of Oklahoma Growth Fund; National Institute of General Medical Sciences of the National Institute of Health (NIH) [P20GM103648]; National Heart, Lung, and Blood Institute of the NIH [1R01 HL136325-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103648] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Oklahoma Growth Fund; National Institute of General Medical Sciences of the National Institute of Health (NIH); National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Initital of author who received each award: SA Name of each funder and (Grant numbers): American Heart Association Grant-in-Aid (11GRNT7220012), the University of Oklahoma Growth Fund, National Institute of General Medical Sciences of the National Institute of Health (NIH; Award number P20GM103648), and National Heart, Lung, and Blood Institute of the NIH (Award number 1R01 HL136325-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalili RN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081363; Awasthi S, 1999, AM J RESP CRIT CARE, V160, P942, DOI 10.1164/ajrccm.160.3.9806061; Awasthi S, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-28; Awasthi S, 2005, J IMMUNOL, V175, P3900, DOI 10.4049/jimmunol.175.6.3900; Awasthi S, 2003, BIOTECHNIQUES, V35, P600, DOI 10.2144/03353dd03; Awasthi S, 2001, AM J RESP CRIT CARE, V163, P389, DOI 10.1164/ajrccm.163.2.2004168; Awasthi S, 2015, RSC ADV, V5, P27431, DOI 10.1039/c4ra16731g; Awasthi S, 2011, CELL IMMUNOL, V268, P87, DOI 10.1016/j.cellimm.2011.02.009; Awasthi S, 2011, J PHARMACOL EXP THER, V336, P672, DOI 10.1124/jpet.110.173765; Benincasa M, 2009, ANTIMICROB AGENTS CH, V53, P3501, DOI 10.1128/AAC.01620-08; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; DARZINS A, 1984, J BACTERIOL, V159, P9, DOI 10.1128/JB.159.1.9-18.1984; DeBacker D, 1997, AM J RESP CRIT CARE, V156, P1099, DOI 10.1164/ajrccm.156.4.9701048; Domingues MM, 2012, BIOPOLYMERS, V98, P338, DOI 10.1002/bip.22095; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hampton T, 2015, JAMA-J AM MED ASSOC, V313, P2411, DOI 10.1001/jama.2015.4738; Hickling TP, 1998, FEBS LETT, V437, P65, DOI 10.1016/S0014-5793(98)01200-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kellum JA, 1997, CHEST, V111, P1301, DOI 10.1378/chest.111.5.1301; Kim HS, 2002, J IMMUNOL, V168, P2356, DOI 10.4049/jimmunol.168.5.2356; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Madhusoodhanan R., 2012, ONCOIMMUNOLOGY, V1, P1495, DOI DOI 10.4161/ONCI.22089; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; Mehrad B, 2015, CHEST, V147, P1413, DOI 10.1378/chest.14-2171; Metkar S, 2007, INFECT IMMUN, V75, P5415, DOI 10.1128/IAI.00601-07; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mizock BA, 1999, CRIT CARE MED, V27, P2585, DOI 10.1097/00003246-199911000-00052; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Piao W, 2013, J IMMUNOL, V190, P2263, DOI 10.4049/jimmunol.1202703; Qureshi ST, 1999, TRENDS GENET, V15, P291, DOI 10.1016/S0168-9525(99)01782-5; Ramani V, 2015, J LEUKOCYTE BIOL, V98, P1037, DOI 10.1189/jlb.3A1114-570R; Ramani V, 2013, INNATE IMMUN-LONDON, V19, P596, DOI 10.1177/1753425912474851; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Roy A, 2016, INT IMMUNOPHARMACOL, V40, P79, DOI 10.1016/j.intimp.2016.08.026; Schaeffer LM, 2004, INFECT IMMUN, V72, P7124, DOI 10.1128/IAI.72.12.7124-7130.2004; Schaeffer LM, 2004, J IMMUNOL, V173, P1959, DOI 10.4049/jimmunol.173.3.1959; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Vilekar P, 2012, INT IMMUNOL, V24, P455, DOI 10.1093/intimm/dxr121; Vilekar P, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-60; Vouga M, 2016, CLIN MICROBIOL INFEC, V22, P12, DOI 10.1016/j.cmi.2015.10.010; Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564	58	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210979	10.1371/journal.pone.0210979	http://dx.doi.org/10.1371/journal.pone.0210979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689633	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800017
J	Jeong, S; Kwon, H; Chang, JW; Kim, MJ; Ganbold, K; Han, Y; Kwon, TW; Cho, YP				Jeong, Seonjeong; Kwon, Hyunwook; Chang, Jai Won; Kim, Min-Ju; Ganbold, Khaliun; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil			Patency rates of arteriovenous fistulas created before versus after hemodialysis initiation	PLOS ONE			English	Article							VASCULAR ACCESS USE; DIALYSIS ACCESS; OUTCOMES; SURVIVAL; 1ST; CONSTRUCTION; CANNULATION; POPULATION; MATURATION; ADVANTAGES	In an incident hemodialysis (HD)population, we aimed to investigate whether arteriovenous fistula (AVF) creation before HD initiation was associated with improved AVF patency compared with AVF creation from a central venous catheter (CVC), and also to compare patient survival between these patients. Between January 2011 and December 2013, 524 incident HD patients with identified first predialysis vascular access with an AVF (pre-HD group, n = 191) or an AVF from a CVC (on-HD group, n = 333) were included and analyzed retrospectively. The study outcome was defined as AVF patency and all-cause mortality (time to death). On Kaplan-Meier survival analysis, primary and secondary AVF patency rates did not differ significantly between the two groups (P = 0.812 and P = 0.586, respectively), although the overall survival rate was significantly higher in the pre-HD group compared with the on-HD group (P = 0.013). On multivariate analysis, well-known patient factors were associated with decreased primary (older age and diabetes mellitus [DM]) and secondary (DM and peripheral arterial occlusive disease) AVF patency, whereas use of a CVC as the initial predialysis access (hazard ratios, 1.84; 95% confidence intervals, 1.20-2.75; P = 0.005) was significantly associated with worse survival in addition to well-known patient factors (older age, diabetes mellitus, and peripheral arterial occlusive disease). Worse survival in the on-HD group was likely confounded by selection bias because of the retrospective nature of our study. Therefore, the observed lower mortality associated with AVF creation before HD initiation is not fully attributable to CVC use, but rather, affected by other patient-level prognostic factors. There were no CVC-related complications in the pre-HD group, whereas 10.2% of CVC-related complications were noted in the on-HD group. In conclusion, among incident HD patients, compared with patients who underwent creation of an AVF from a CVC, initial AVF creation showed similar primary and secondary AVF patency rates, but lower mortality risk. We also observed that an initial CVC use was an independent risk factor associated with worse survival. A fistula-first strategy might be the best option for incident HD patients who are good candidates for AVF creation.	[Jeong, Seonjeong; Kwon, Hyunwook; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg,Div Vasc Surg, Seoul, South Korea; [Chang, Jai Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Min-Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Ganbold, Khaliun] Mongolian Natl Univ Med Sci, Dept Surg, Ulaanbaatar, Mongolia	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Mongolian National University of Medical Sciences	Cho, YP (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg,Div Vasc Surg, Seoul, South Korea.	ypcho@amc.seoul.kr						Al-Jaishi AA, 2015, CLIN J AM SOC NEPHRO, V10, P418, DOI 10.2215/CJN.06220614; Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Allon M, 2010, CLIN J AM SOC NEPHRO, V5, P2348, DOI 10.2215/CJN.06050710; [Anonymous], 2001, Am J Kidney Dis, V37, pS137; Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Bashar K, 2016, SURG-J R COLL SURG E, V14, P294, DOI 10.1016/j.surge.2016.02.001; Brothers TE, 1996, J SURG RES, V60, P312, DOI 10.1006/jsre.1996.0049; Bylsma LC, 2017, EUR J VASC ENDOVASC, V54, P513, DOI 10.1016/j.ejvs.2017.06.024; Chan MR, 2007, SEMIN DIALYSIS, V20, P606, DOI 10.1111/j.1525-139X.2007.00370.x; Dember LM, 2014, AM J KIDNEY DIS, V63, P104, DOI 10.1053/j.ajkd.2013.06.024; DeSilva RN, 2013, J AM SOC NEPHROL, V24, P1297, DOI 10.1681/ASN.2012060632; Foley RN, 2009, HEMODIAL INT, V13, P533, DOI 10.1111/j.1542-4758.2009.00396.x; Han YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184168; Kim SM, 2016, ANN SURG TREAT RES, V90, P224, DOI 10.4174/astr.2016.90.4.224; Ko GJ, 2020, NEPHROL DIAL TRANSPL, V35, P503, DOI 10.1093/ndt/gfy254; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Lazarides MK, 2007, J VASC SURG, V45, P420, DOI 10.1016/j.jvs.2006.10.035; Lee T, 2005, AM J KIDNEY DIS, V46, P501, DOI 10.1053/j.ajkd.2005.05.024; Lok CE, 2007, CLIN J AM SOC NEPHRO, V2, P1043, DOI 10.2215/CJN.01080307; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; Miller PE, 1999, KIDNEY INT, V56, P275, DOI 10.1046/j.1523-1755.1999.00515.x; Morsy M, 2011, NEPHROL DIAL TRANSPL, V26, P3666, DOI 10.1093/ndt/gfr104; National Kidney Foundation, 2006, 2006 UPD CLIN PRACT, P244; Ohira S, 2006, THER APHER DIAL, V10, P449, DOI 10.1111/j.1744-9987.2006.00410.x; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Pisoni RL, 2015, AM J KIDNEY DIS, V65, P905, DOI 10.1053/j.ajkd.2014.12.014; Praga M, 2013, NEPHRON CLIN PRACT, V124, P47, DOI 10.1159/000355694; Quarello F, 2006, J NEPHROL, V19, P265; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Richardson AI, 2009, J VASC ACCESS, V10, P199, DOI 10.1177/112972980901000311; Saad TF, 2015, SEMIN DIALYSIS, V28, P94, DOI 10.1111/sdi.12249; Sidawy AN, 2008, J VASC SURG S, V48, P25; Tamura MK, 2012, KIDNEY INT, V82, P261, DOI 10.1038/ki.2011.384; United States Renal Data System, 2016, 2016 USRDA ANN DAT R, P261; Vassalotti JA, 2012, SEMIN DIALYSIS, V25, P303, DOI 10.1111/j.1525-139X.2012.01069.x; Watorek E, 2014, HEMODIAL INT, V18, P113, DOI 10.1111/hdi.12076; Weyde W, 2006, BLOOD PURIFICAT, V24, P190, DOI 10.1159/000090518; WINDUS DW, 1993, AM J KIDNEY DIS, V21, P457, DOI 10.1016/S0272-6386(12)80391-X	39	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211296	10.1371/journal.pone.0211296	http://dx.doi.org/10.1371/journal.pone.0211296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689672	Green Submitted, Green Published, gold			2022-12-26	WOS:000457041800028
J	Omana-Zapata, I; Mutschmann, C; Schmitz, J; Gibson, S; Judge, K; Indig, MA; Lu, B; Taufman, D; Sanfilippo, AM; Shallenberger, W; Graminske, S; McLean, R; Hsen, RI; d'Empaire, N; Dean, K; O'Gorman, M				Omana-Zapata, Imelda; Mutschmann, Caren; Schmitz, John; Gibson, Sarah; Judge, Kevin; Indig, Monika Aruda; Lu, Beverly; Taufman, Doreen; Sanfilippo, Alan M.; Shallenberger, Wendy; Graminske, Sharon; McLean, Rachel; Hsen, Rubal I.; d'Empaire, Nicole; Dean, Kimberly; O'Gorman, Maurice			Accurate and reproducible enumeration of T-, B-, and NK lymphocytes using the BD FACSLyric 10-color system: A multisite clinical evaluation	PLOS ONE			English	Article							REFERENCE RANGES; HEALTHY-ADULTS; CELL; SUBSETS; TRANSPLANTATION; THERAPY	Clinical flow cytometry is a reliable methodology for whole blood cell phenotyping for different applications. The BD FACSLyric (TM) system comprises a flow cytometer available in different optical configurations, BD FACSuite (TM) Clinical software, and optional BD FACS (TM) Universal Loader. BD FACSuite Clinical software used with BD (TM) FC Beads and BD CS&T Beads enable universal setup for performance QC, instrument control, data acquisition/storage, online/offline data analysis, and instrument standardization. BD Biosciences sponsored the clinical evaluation of the BD FACSLyric 10-color configuration at seven clinical sites using delinked and de-identified blood specimens from HIV-infected and uninfected subjects to enumerate T-, B-, and NK-lymphocytes with the BD Multitest (TM) reagents (BD Multitest IMK kit and BD Multitest 6-color TBNK). Samples were analyzed on the BD FACSLyric system with BD FACSuite Clinical software, and on the BD FACSCanto (TM) II system with BD FACSCanto clinical software and BD FACS 7-Color Setup beads. For equivalency between methods, data (n = 362) were analyzed with Deming regression for absolute count and percentage of lymphocytes. Results gave R-2 >= 0.98, with slope values > 0.96, and slope ranges between 0.90-1.05. The percent (%) bias values were <10% for T- and NK cells and < 15% for B-cells. The between-site (n = 4) total precision was tested for 5 days (2 runs/day), and gave % coefficient of variation below 10% for absolute cell counts. The stability claims were confirmed (n = 186) for the two BD Multitest reagents. The reference intervals were re-established in male and female adults (n = 134). The analysis by gender showed statistically significant differences for CD3(+) and CD4(+) T-cell counts and % CD4. In summary, the BD FACSLyric and the BD FACSCanto II systems generated comparable measurements of T-, B-, and NK- cells using BD Multitest assays.	[Omana-Zapata, Imelda; Judge, Kevin; Lu, Beverly; Dean, Kimberly] BD Biosci, San Jose, CA 95131 USA; [Mutschmann, Caren; Taufman, Doreen] SYNLAB Unweltinst GmbH, Berlin, Germany; [Schmitz, John; Sanfilippo, Alan M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Gibson, Sarah; Shallenberger, Wendy] Univ Pittsburgh, Med Ctr Presbyterian, Dept Pathol, Pittsburgh, PA USA; [Indig, Monika Aruda; Graminske, Sharon] BloodCtr Wisconsin, Clin Trial & Cellular Therapy Serv, Milwaukee, WI USA; [McLean, Rachel; Hsen, Rubal I.; O'Gorman, Maurice] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA; [d'Empaire, Nicole] BioCollections Inc, Miami, FL USA; [Sanfilippo, Alan M.] Beth Israel Deaconess Med Ctr, Histocompatibil Lab, Boston, MA 02215 USA	SYNLAB Group; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Versiti Blood Center of Wisconsin; Children's Hospital Los Angeles; Harvard University; Beth Israel Deaconess Medical Center	Omana-Zapata, I (corresponding author), BD Biosci, San Jose, CA 95131 USA.	imelda_omana-zapata@bd.com	Laboratory Core, HIV STD/AGD-7085-2022; Schmitz, John/HHS-0634-2022; Schmitz, John/AAF-9053-2019	Omana-Zapata, Imelda/0000-0001-5358-4490	BD Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	BD Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The studies were funded by BD Biosciences. BD Biosciences, SYNLAB Unweltinstitut GmbH and BioCollections Inc. provided support in the form of salaries for authors IOZ, KJ, BL, KD, CM, DT and NdE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1997, FED REG; Berzins SP, 2014, NAT REV IMMUNOL, V14, P640, DOI 10.1038/nri3725; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borghans JA, 2006, BLOOD, V108, P763, DOI 10.1182/blood-2006-01-009241; CDC, 1997, REV GUID PERF CD4 T; CDC, 2019, HIV SURVEILLANCE REP; CLSI, 2010, EP28 A3C DEFINING ES, VThird; CLSI, 2014, EP5A3 CLSI; CLSI, 2009, EP25A CLSI; CLSI, 2013, CLSI DOCUMENT EP09 A, V3rd; Deming W.E., 1985, STAT ADJUSTMENT DATA; Gebo KA, 2004, JAIDS-J ACQ IMM DEF, V36, P1028, DOI 10.1097/00126334-200408150-00005; Jentsch-Ullrich K, 2005, CLIN IMMUNOL, V116, P192, DOI 10.1016/j.clim.2005.03.020; Kay AB, 2006, NEW ENGL J MED, V354, P1186, DOI 10.1056/NEJMe068024; Kook H, 1996, BLOOD, V88, P1089; Linnet K, 1998, CLIN CHEM, V44, P1024; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Melet J, 2013, ARTHRITIS RHEUM-US, V65, P2783, DOI 10.1002/art.38107; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; NIH, 2014, GUID US ANT AG HIV 1; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; O'Corman Maurice R. G., 2008, P267; Park SK, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160064; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Valiathan R, 2014, IMMUNOBIOLOGY, V219, P487, DOI 10.1016/j.imbio.2014.02.010; WHO, 2010, ANT THER HIV INF AD; WHO, 2014, CONS GUID US ANT DRU, P56; Wong WS, 2013, CLIN VACCINE IMMUNOL, V20, P602, DOI 10.1128/CVI.00476-12	28	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211207	10.1371/journal.pone.0211207	http://dx.doi.org/10.1371/journal.pone.0211207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689658	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800022
J	Fill, JM; Pearson, E; Knight, TM; Crandall, RM				Fill, Jennifer M.; Pearson, Eleanor; Knight, Tiffany M.; Crandall, Raelene M.			An invasive legume increases perennial grass biomass: An indirect pathway for plant community change	PLOS ONE			English	Article							LESPEDEZA-CUNEATA; DIVERSITY; RESTORATION; POPULATION; RESISTANCE; IMPACTS; DISTURBANCE; COMPETITION; HERBIVORY; DYNAMICS	The presence of native grasses in communities can suppress native forbs through competition and indirectly benefit these forbs by suppressing the invasion of highly competitive exotic species. We conducted a greenhouse experiment to examine the potential of direct and indirect interactions to influence the aboveground biomass of four native forb species in the presence of the native perennial grass Schizachyrium scoparium and exotic invasive Lespedeza cuneata. We examined patterns of growth for the invasive legume, the perennial grass, and four native species in four scenarios: 1) native species grown with the grass, 2) native species grown with the legume, 3) native species grown with both the grass and legume together, and 4) native species grown alone. Schizachyrium scoparium significantly decreased biomass of all forb species (p<0.05). In contrast, L. cuneata alone only significantly affected biomass of Asclepias tuberosa; L. cuneata increased the biomass of A. tuberosa only when the grass was present. When S. scoparium and L. cuneata were grown together, L. cuneata had significantly lower biomass (p = 0.007) and S. scoparium had significantly greater biomass (p = 0.002) than when each grew alone. These reciprocal effects suggest a potential pathway by which L. cuneata could alter forb diversity in grassland communities In this scenario, L. cuneata facilitates grass growth and competition with other natives. Our results emphasize the importance of monitoring interactions between exotic invasive plant species and dominant native species in grassland communities to understand pathways of plant community change.	[Fill, Jennifer M.; Crandall, Raelene M.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Pearson, Eleanor; Crandall, Raelene M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Knight, Tiffany M.] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany; [Knight, Tiffany M.] Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Knight, Tiffany M.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	State University System of Florida; University of Florida; Washington University (WUSTL); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Fill, JM (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.	jenna999@gmail.com			U.S.A. National Science Foundation [DEB 1145274]; Washington University Biology Summer Undergraduate Research Fellowship; National Science Foundation Advancing Informal STEM Education Program [DRL 0739874]	U.S.A. National Science Foundation(National Science Foundation (NSF)); Washington University Biology Summer Undergraduate Research Fellowship; National Science Foundation Advancing Informal STEM Education Program	Funding for this research was provided by the U.S.A. National Science Foundation (DEB 1145274 to T.M.K) and the Washington University Biology Summer Undergraduate Research Fellowship (to E.P.). Support for high school youth in the Tyson Environmental Research Fellowships (TERF) program at Tyson Research Center was provided by a grant to Washington University in St. Louis from the National Science Foundation Advancing Informal STEM Education Program (DRL 0739874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 2011, THESIS; Becerra PI, 2013, APPL VEG SCI, V16, P173, DOI 10.1111/j.1654-109X.2012.01221.x; Beck A.S., 2017, THESIS; Brandon AL, 2004, BIOL INVASIONS, V6, P483, DOI 10.1023/B:BINV.0000041561.71407.f5; BRISKE DD, 1989, J ECOL, V77, P963, DOI 10.2307/2260816; Burns JH, 2013, ECOLOGY, V94, P995, DOI 10.1890/12-1310.1; Coykendall KE, 2014, BIOL INVASIONS, V16, P1735, DOI 10.1007/s10530-013-0623-8; Craine JM, 2003, PLANT ECOL, V165, P85, DOI 10.1023/A:1021414615001; Crandall R, 2015, ECOL LETT, V18, P883, DOI 10.1111/ele.12473; Crawford KM, 2017, OECOLOGIA, V183, P211, DOI 10.1007/s00442-016-3759-2; D'Antonio C, 2017, J ECOL, V105, P1459, DOI 10.1111/1365-2745.12879; Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2; Davies KW, 2011, RESTOR ECOL, V19, P159, DOI 10.1111/j.1526-100X.2009.00548.x; Dostal P, 2013, ECOL LETT, V16, P1277, DOI 10.1111/ele.12166; Fill JM, 2016, PLANT ECOL, V217, P331, DOI 10.1007/s11258-016-0574-0; Flory SL, 2010, BIOL INVASIONS, V12, P1285, DOI 10.1007/s10530-009-9546-9; Foster BL, 2004, ECOLOGY, V85, P1541, DOI 10.1890/03-3165; Gould AMA, 2000, AM MIDL NAT, V144, P36, DOI 10.1674/0003-0031(2000)144[0036:EOTEIS]2.0.CO;2; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; HOLL KD, 1994, B TORREY BOT CLUB, V121, P327, DOI 10.2307/2997006; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Loydi A, 2015, BIOL INVASIONS, V17, P581, DOI 10.1007/s10530-014-0750-x; McCain KNS, 2010, RESTOR ECOL, V18, P40, DOI 10.1111/j.1526-100X.2010.00669.x; Munson SM, 2009, J VEG SCI, V20, P224, DOI 10.1111/j.1654-1103.2009.05556.x; Nelson P.W, 2010, TERRESTRIAL NATURAL; Ohlenbusch PD, 2001, SERICEA LESPEDEZA HI; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Prober Suzanne M., 2005, Ecological Management & Restoration, V6, P16, DOI 10.1111/j.1442-8903.2005.00215.x; Prober SM, 2009, BIOL INVASIONS, V11, P171, DOI 10.1007/s10530-008-9222-5; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Quinos PM, 1998, OECOLOGIA, V114, P427, DOI 10.1007/PL00008819; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Schutzenhofer MR, 2007, ECOL APPL, V17, P965, DOI 10.1890/06-1282; Schutzenhofer MR, 2009, OECOLOGIA, V161, P57, DOI 10.1007/s00442-009-1354-5; Sheley RL, 2010, INVAS PLANT SCI MANA, V3, P294, DOI 10.1614/IPSM-D-09-00056.1; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Snyman HA, 2013, AFR J RANGE FOR SCI, V30, P99, DOI 10.2989/10220119.2013.831375; Svriz M, 2013, FOREST ECOL MANAG, V289, P234, DOI 10.1016/j.foreco.2012.09.037; Vaughn KJ, 2015, ECOL APPL, V25, P791, DOI 10.1890/14-0922.1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; WEDIN DA, 1990, OECOLOGIA, V84, P433, DOI 10.1007/BF00328157; West JB., 2002, THESIS; Woods TM, 2009, BIOL INVASIONS, V11, P1913, DOI 10.1007/s10530-008-9369-0; Yannarell AC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00127	46	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211295	10.1371/journal.pone.0211295	http://dx.doi.org/10.1371/journal.pone.0211295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682179	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500145
J	Marchand, B; Pitarresi, JR; Reichert, M; Suzuki, K; Laczko, D; Rustgi, AK				Marchand, Benoit; Pitarresi, Jason R.; Reichert, Maximilian; Suzuki, Kensuke; Laczko, Dorottya; Rustgi, Anil K.			PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HOMEOBOX GENE; TRANSCRIPTION FACTORS; METASTATIC COLONIZATION; BREAST-CANCER; COMET ASSAY; EXPRESSION; PRX2; INHIBITION; REPAIR	PRRX1 is a homeodomain transcriptional factor, which has two isoforms, PRXX1A and PRRX1B. The PRRX1 isoforms have been demonstrated to be important in pancreatic cancer, especially in the regulation of epithelial-to-mesenchymal transition (EMT) in Pancreatic Ductal Adenocarcinoma (PDAC) and of mesenchymal-to-epithelial transition (MET) in liver metastasis. In order to determine the functional underpinnings of PRRX1 and its isoforms, we have unraveled a new interplay between PRRX1 and the FOXM1 transcriptional factors. Our detailed biochemical analysis reveals the direct physical interaction between PRRX1 and FOXM1 proteins that requires the PRRX1A/B 200-222/217 amino acid (aa) region and the FOXM1 Forkhead domain. Additionally, we demonstrate the cooperation between PRRX1 and FOXM1 in the regulation of FOXM1-dependent transcriptional activity. Moreover, we establish FOXM1 as a critical downstream target of PRRX1 in pancreatic cancer cells. We demonstrate a novel role for PRRX1 in the regulation of genes involved in DNA repair pathways. Indeed, we show that expression of PRRX1 isoforms may limit the induction of DNA damage in pancreatic cancer cells. Finally, we demonstrate that targeting FOXM1 with the small molecule inhibitor FDI6 suppress pancreatic cancer cell proliferation and induces their apoptotic cell death. FDI6 sensitizes pancreatic cancer cells to Etoposide and Gemcitabine induced apoptosis. Our data provide new insights into PRRX1's involvement in regulating DNA damage and provide evidence of a possible PRRX1-FOXM1 axis that is critical for PDAC cells.	[Marchand, Benoit; Pitarresi, Jason R.; Reichert, Maximilian; Suzuki, Kensuke; Laczko, Dorottya; Rustgi, Anil K.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Marchand, Benoit; Pitarresi, Jason R.; Suzuki, Kensuke; Laczko, Dorottya; Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reichert, Maximilian] Tech Univ Munich, Med Klin 2, D-81675 Munich, Germany; [Reichert, Maximilian; Rustgi, Anil K.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Pennsylvania; Pennsylvania Medicine	Rustgi, AK (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.; Rustgi, AK (corresponding author), Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.; Rustgi, AK (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	anil2@pennmedicine.upenn.edu	Reichert, Maximilian/GOH-1246-2022	Marchand, Benoit/0000-0001-9302-6688	NIH/NIDDK [R01 DK060694]; Center for Molecular Studies in Digestive and Liver Diseases [NIH P30 DK050306]; American Cancer Society; Fonds de recherche en sante du Quebec [P-Marchand-35978]; National Pancreas Foundation; German Cancer Aid Foundation (Max Eder Program, Deutsche Krebshilfe) [111273]; AGA-Actavis Research Award in Pancreatic Disorders; NIH loan repayment program; NCI [F32 CA221094]; NATIONAL CANCER INSTITUTE [F32CA221094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066, R01DK060694, P30DK050306] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Molecular Studies in Digestive and Liver Diseases; American Cancer Society(American Cancer Society); Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Pancreas Foundation; German Cancer Aid Foundation (Max Eder Program, Deutsche Krebshilfe); AGA-Actavis Research Award in Pancreatic Disorders; NIH loan repayment program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Zheng Fu (Virginia Commonwealth University) for providing the 6xFOXM1 luciferase reporter construct. We thank Dr. Kaori Ihida-Stansbury (University of Pennsylvania) for the PRRX1 wild type and Knockout mouse embryonic fibroblasts (MEFs). The Tenascin-C (TN7) luciferase construct was kindly provided by Dr. Edward E. Morrisey (University of Pennsylvania). We are thankful to the Molecular Pathology and Imaging Core, the Cell Culture and iPS Core and the HumanMicrobial Analytic and Repository Core Facilities. This work was supported by the NIH/NIDDK R01 DK060694 (BM, MR, JRP, AKR), the Center for Molecular Studies in Digestive and Liver Diseases (NIH P30 DK050306), the American Cancer Society, Fonds de recherche en sante du Quebec P-Marchand-35978 (BM), National Pancreas Foundation (MR), German Cancer Aid Foundation (Max Eder Program, Deutsche Krebshilfe 111273 to MR), AGA-Actavis Research Award in Pancreatic Disorders (MR), NCI F32 CA221094 (JRP) and the NIH loan repayment program (JRP).	American Cancer Society, 2018, CANC FACTS FIG 2018; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Baranski OA, 2015, CELL PROLIFERAT, V48, P105, DOI 10.1111/cpr.12153; Bergwerff M, 2000, VIRCHOWS ARCH, V436, P12, DOI 10.1007/PL00008193; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Copertino DW, 1997, P NATL ACAD SCI USA, V94, P1846, DOI 10.1073/pnas.94.5.1846; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Foucher I, 2003, DEVELOPMENT, V130, P1867, DOI 10.1242/dev.00414; Gartel AL, 2017, CANCER RES, V77, P3135, DOI 10.1158/0008-5472.CAN-16-3566; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Gormally MV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6165; Guo JB, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0393-x; Guo Y, 2002, P NATL ACAD SCI USA, V99, P3663, DOI 10.1073/pnas.062041099; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang C, 2014, CLIN CANCER RES, V20, P1477, DOI 10.1158/1078-0432.CCR-13-2311; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Ihida-Stansbury K, 2004, CIRC RES, V94, P1507, DOI 10.1161/01.RES.0000130656.72424.20; Jones FS, 2001, CIRC RES, V89, P131, DOI 10.1161/hh1401.093582; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KERN MJ, 1992, NUCLEIC ACIDS RES, V20, P5189, DOI 10.1093/nar/20.19.5189; KERN MJ, 1994, GENOMICS, V19, P334, DOI 10.1006/geno.1994.1066; Khongkow P, 2014, ONCOGENE, V33, P4144, DOI 10.1038/onc.2013.457; Kong XY, 2013, CANCER RES, V73, P3987, DOI 10.1158/0008-5472.CAN-12-3859; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laczko D, 2017, AM J PATHOL, V187, P1787, DOI 10.1016/j.ajpath.2017.04.013; Lu MF, 1999, DEV BIOL, V205, P145, DOI 10.1006/dbio.1998.9116; Lu MF, 1999, DEVELOPMENT, V126, P495; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Marshak S, 2000, MOL CELL BIOL, V20, P7583, DOI 10.1128/MCB.20.20.7583-7590.2000; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Monteiro LJ, 2013, ONCOGENE, V32, P4634, DOI 10.1038/onc.2012.491; Norris RA, 2001, DNA CELL BIOL, V20, P89, DOI 10.1089/104454901750070292; Norris RA, 2001, J BIOL CHEM, V276, P26829, DOI 10.1074/jbc.M100239200; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Qu SM, 1999, DEVELOPMENT, V126, P359; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339; Takano S, 2016, GENE DEV, V30, P233, DOI 10.1101/gad.263327.115; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Tucker SC, 1999, J BIOL CHEM, V274, P32325, DOI 10.1074/jbc.274.45.32325; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069; Zheng L, 2015, INT J CLIN EXP PATHO, V8, P10534; Zona S, 2014, BBA-GENE REGUL MECH, V1839, P1316, DOI 10.1016/j.bbagrm.2014.09.016	60	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4325	4339		10.1038/s41388-019-0725-6	http://dx.doi.org/10.1038/s41388-019-0725-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30705403	Green Accepted			2022-12-26	WOS:000469339100009
J	Lu, P; Geng, J; Zhang, L; Wang, Y; Niu, NN; Fang, Y; Liu, F; Shi, JJ; Zhang, ZG; Sun, YW; Wang, LW; Tang, YJ; Xue, J				Lu, Ping; Geng, Jing; Zhang, Lei; Wang, Yu; Niu, Ningning; Fang, Yuan; Liu, Fang; Shi, Juanjuan; Zhang, Zhi-Gang; Sun, Yong-Wei; Wang, Li-Wei; Tang, Yujie; Xue, Jing			THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer	ONCOGENE			English	Article							TARGETING TRANSCRIPTION; EXPRESSION; INHIBITION; THERAPY; GROWTH	Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with high mortality. Lack of effective treatment makes novel therapeutic discovery an urgent demand in PDAC research. By screening an epigenetic-related compound library, we identified THZ1, a covalent inhibitor of CDK7, as a promising candidate. Multiple long-established and patient-derived PDAC cell lines (PDC) were used to validate the efficacy of THZ1 in vitro. In addition, patient-derived xenograft (PDX) models and animal models of PDAC were utilized for examining THZ1 efficacy in vivo. Furthermore, RNA-Seq analyse was performed to reveal the molecular mechanism of THZ1 treatment. Finally, PDAC cell lines with primary or acquired resistance to THZ1 were investigated to explore the potential mechanism of THZ1 susceptibility. CDK7 inhibition was identified as a selective and potent therapeutic strategy for PDAC progression in multiple preclinical models. Mechanistic analyses revealed that CDK7 inhibition led to a pronounced downregulation of gene transcription, with a preferential repression of mitotic cell cycle and NF-kappa B signaling-related transcripts. MYC transcriptional was found to be involved in susceptibility of PDAC cells to CDK7 inhibition. In conclusion, Identification of CDK7-dependent transcriptional addiction in PDACs provides a potent therapeutic strategy that targets highly aggressive pancreatic cancer.	[Lu, Ping; Geng, Jing; Niu, Ningning; Shi, Juanjuan; Xue, Jing] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Stem Cell Res Ctr, Renji Hosp,Sch Med, Shanghai, Peoples R China; [Zhang, Lei; Liu, Fang; Tang, Yujie] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Natl Minist Educ, Dept Pathophysiol,Sch Med, Shanghai, Peoples R China; [Wang, Yu; Wang, Li-Wei] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China; [Fang, Yuan] Shanghai Jiao Tong Univ, Ruijin Hosp, Res Inst Pancreat Dis, Sch Med, Shanghai, Peoples R China; [Zhang, Zhi-Gang; Wang, Li-Wei] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai, Peoples R China; [Sun, Yong-Wei] Shanghai Jiao Tong Univ, Dept Biliary Pancreat Surg, Renji Hosp, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xue, J (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Stem Cell Res Ctr, Renji Hosp,Sch Med, Shanghai, Peoples R China.; Tang, YJ (corresponding author), Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Natl Minist Educ, Dept Pathophysiol,Sch Med, Shanghai, Peoples R China.; Wang, LW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Oncol, Shanghai, Peoples R China.; Wang, LW (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai, Peoples R China.	liweiwang@shsmu.edu.cn; yujietang@shsmu.edu.cn; jingxue@sjtu.edu.cn		Sun, Yongwei/0000-0002-5937-634X; Zhang, Zhi-gang/0000-0001-8965-223X	Program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [TP2015007, TP2015017]; National Natural Science Foundation of China [81702938, 81770628, 81572761, 81772655]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20161312]; Recruitment Program of Global Experts of China (National 1000-Youth Talents Program); Shanghai Rising-Star Program	Program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Recruitment Program of Global Experts of China (National 1000-Youth Talents Program); Shanghai Rising-Star Program	This work was supported by the Program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning No. TP2015007 to J.X., TP2015017 to Y.T.), National Natural Science Foundation of China (81702938 and 81770628 to J.X.; 81572761 and 81772655 to Y.T.), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support No. 20161312 (J.X.), The Recruitment Program of Global Experts of China (National 1000-Youth Talents Program to Y.T.), Shanghai Rising-Star Program (Y.T.).	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Cao KX, 2014, CANCER CELL, V26, P158, DOI 10.1016/j.ccr.2014.07.020; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Corcoran RB, 2015, CANCER RES, V71, P5020; Franco HL, 2015, CELL, V163, P28, DOI 10.1016/j.cell.2015.09.013; Gao Y, 2018, CELL CHEM BIOL, V25, P135, DOI 10.1016/j.chembiol.2017.11.007; Garcia PL, 2016, ONCOGENE, V35, P833, DOI 10.1038/onc.2015.126; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Guo JC, 2004, ONCOGENE, V23, P71, DOI 10.1038/sj.onc.1206926; Hessmann E, 2017, GUT, V66, P168, DOI 10.1136/gutjnl-2016-312539; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jiang YY, 2017, GUT, V66, P1358, DOI 10.1136/gutjnl-2016-311818; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Ochiai Takanori, 2008, J Med Dent Sci, V55, P49; Prabhu L, 2014, ONCOTARGET, V5, P10969, DOI 10.18632/oncotarget.2624; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang JQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11363; Wang XJ, 2016, ONCOTARGET, V7, P21441, DOI 10.18632/oncotarget.7375; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Wong MH, 2014, CLIN CANCER RES, V20, P4047, DOI 10.1158/1078-0432.CCR-13-3377; Wong RWJ, 2017, BLOOD, V130, P2326, DOI 10.1182/blood-2017-06-792184; Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yuan J, 2017, CANCER RES, V77, P6614, DOI 10.1158/0008-5472.CAN-17-1143; Zhang ZF, 2017, MOL CANCER THER, V16, P1739, DOI 10.1158/1535-7163.MCT-17-0078	34	29	30	4	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3932	3945		10.1038/s41388-019-0701-1	http://dx.doi.org/10.1038/s41388-019-0701-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30692639				2022-12-26	WOS:000468035600012
J	Gonzalez-Mariscal, I; Montoro, RA; O'Connell, JF; Kim, Y; Gonzalez-Freire, M; Liu, QR; Alfaras, I; Carlson, OD; Lehrmann, E; Zhang, YQ; Becker, KG; Hardiville, S; Ghosh, P; Egan, JM				Gonzalez-Mariscal, Isabel; Montoro, Rodrigo A.; O'Connell, Jennifer F.; Kim, Yoo; Gonzalez-Freire, Marta; Liu, Qing-Rong; Alfaras, Irene; Carlson, Olga D.; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Hardiville, Stephan; Ghosh, Paritosh; Egan, Josephine M.			Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism	FASEB JOURNAL			English	Article						CB1R; insulin sensitivity; myokines; skeletal muscle	SKELETAL-MUSCLE; MYOBLAST DIFFERENTIATION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GENE-EXPRESSION; MECHANISMS; OBESITY; INHIBITION; ANTAGONIST; ACTIVATION	Sarcopenic obesity, the combination of skeletal muscle mass and function loss with an increase in body fat, is associated with physical limitations, cardiovascular diseases, metabolic stress, and increased risk of mortality. Cannabinoid receptor type 1 (CB1R) plays a critical role in the regulation of whole-body energy metabolism because of its involvement in controlling appetite, fuel distribution, and utilization. Inhibition of CB1R improves insulin secretion and insulin sensitivity in pancreatic -cells and hepatocytes. We have now developed a skeletal muscle-specific CB1R-knockout (Skm-CB1R(-/-)) mouse to study the specific role of CB1R in muscle. Muscle-CB1R ablation prevented diet-induced and age-induced insulin resistance by increasing IR signaling. Moreover, muscle-CB1R ablation enhanced AKT signaling, reducing myostatin expression and increasing IL-6 secretion. Subsequently, muscle-CB1R ablation increased myogenesis through its action on MAPK-mediated myogenic gene expression. Consequently, Skm-CB1R(-/-) mice had increased muscle mass and whole-body lean/fat ratio in obesity and aging. Muscle-CB1R ablation improved mitochondrial performance, leading to increased whole-body muscle energy expenditure and improved physical endurance, with no change in body weight. These results collectively show that CB1R in muscle is sufficient to regulate whole-body metabolism and physical performance and is a novel target for the treatment of sarcopenic obesity. Gonzalez-Mariscal, I., Montoro, R. A., O'Connell, J. F., Kim, Y., Gonzalez-Freire, M., Liu, Q.-R., Alfaras, I., Carlson, O. D., Lehrmann, E., Zhang, Y., Becker, K. G., Hardiville, S., Ghosh, P., Egan, J. M. Muscle cannabinoid 1 receptor regulates Il-6 and myostatin expression, governing physical performance and whole-body metabolism.	[Gonzalez-Mariscal, Isabel; Montoro, Rodrigo A.; O'Connell, Jennifer F.; Kim, Yoo; Liu, Qing-Rong; Carlson, Olga D.; Ghosh, Paritosh; Egan, Josephine M.] NIA, Lab Clin Invest, NIH, 251 Bayview Blvd,Suite 100, Bethesda, MD 21224 USA; [Gonzalez-Freire, Marta; Alfaras, Irene] NIA, Translat Gerontol Branch, NIH, Bethesda, MD 21224 USA; [Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.] NIA, Lab Genet & Genom, NIH, Bethesda, MD 21224 USA; [Hardiville, Stephan] Univ Lille, Unite Rech 8576, UGSF, Ctr Natl Rech CNRS, Lille, France	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Lille - ISITE; Universite de Lille	Gonzalez-Mariscal, I; Egan, JM (corresponding author), NIA, Lab Clin Invest, NIH, 251 Bayview Blvd,Suite 100, Bethesda, MD 21224 USA.	isabel.gonzalez@ibima.com; eganj@grc.nia.nih.gov	Gonzalez-Freire, Marta/ABG-1197-2020; Montoro, Rodrigo/AAM-2105-2020; Liu, Qing-Rong/A-3059-2012	Montoro, Rodrigo/0000-0002-3830-2827; Liu, Qing-Rong/0000-0001-8477-6452; Gonzalez Mariscal, Isabel/0000-0003-1186-1212; Alfaras Cardenal, Irene/0000-0002-2073-9641; Hardiville, Stephan/0000-0002-3554-277X; Lehrmann, Elin/0000-0002-9869-9475; Gonzalez-Freire, Marta/0000-0001-9741-2826	U.S. National Institutes of Health, National Institute on Aging Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging Intramural Research Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U.S. National Institutes of Health, National Institute on Aging Intramural Research Program. S961 was donated by Novo Nordisk. The authors declare no conflicts of interest.	Ali S, 2014, GERONTOLOGY, V60, P294, DOI 10.1159/000356760; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; Bogdanis GC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00142; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Cinar R, 2014, HEPATOLOGY, V59, P143, DOI 10.1002/hep.26606; de Azua IR, 2017, J CLIN INVEST, V127, P4148, DOI 10.1172/JCI83626; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Gonzalez-Freire M, 2018, AGING CELL, V17, DOI 10.1111/acel.12725; Gonzalez-Freire M, 2017, J CACHEXIA SARCOPENI, V8, P5, DOI 10.1002/jcsm.12121; Gonzalez-Mariscal I, 2018, DIABETOLOGIA, V61, P1470, DOI 10.1007/s00125-018-4576-4; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Holmes AG, 2004, METABOLISM, V53, P1492, DOI 10.1016/j.metabol.2004.05.015; Iannotti FA, 2014, P NATL ACAD SCI USA, V111, pE2472, DOI 10.1073/pnas.1406728111; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Liao YL, 2013, INT J CARDIOL, V167, P1936, DOI 10.1016/j.ijcard.2012.05.033; Lindborg KA, 2011, CARDIORENAL MED, V1, P31, DOI 10.1159/000322826; Lipina C, 2010, DIABETES, V59, P375, DOI 10.2337/db09-0979; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mazier W, 2015, TRENDS ENDOCRIN MET, V26, P524, DOI 10.1016/j.tem.2015.07.007; Mendizabal-Zubiaga J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00476; Nordfors L, 1998, DIABETOLOGIA, V41, P935, DOI 10.1007/s001250051010; Olah T, 2016, J PHYSIOL-LONDON, V594, P7381, DOI 10.1113/JP272449; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Stern-Straeter J, 2011, J TISSUE ENG REGEN M, V5, pE197, DOI 10.1002/term.417; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Trouwborst I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050605; Trujillo X, 2014, J MEMBRANE BIOL, V247, P1199, DOI 10.1007/s00232-014-9721-5; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Waters DL, 2011, CLIN GERIATR MED, V27, P401, DOI 10.1016/j.cger.2011.03.007; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673	44	21	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5850	5863		10.1096/fj.201801145R	http://dx.doi.org/10.1096/fj.201801145R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726112	Green Published			2022-12-26	WOS:000466932600005
J	Gao, Y; Liu, JF; Bai, ZZ; Sink, S; Zhao, CT; Lorenzo, FR; McClain, DA				Gao, Yan; Liu, Jingfang; Bai, Zhenzhong; Sink, Sandy; Zhao, Chengyu; Lorenzo, Felipe Ramos; McClain, Donald A.			Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc); leptin; iron; adipocyte; diabetes	GENE-EXPRESSION; GLUCOSE-HOMEOSTASIS; TRANSFERASE; KINASE; PHOSPHORYLATION; ADIPOGENESIS; MECHANISMS; MUSCLE; C/EBP; LIVER	We previously reported that iron down-regulates transcription of the leptin gene by increasing occupancy of phosphorylated cAMP response element-binding protein (pCREB) at two sites in the leptin gene promoter. Several nutrient-sensing pathways including O-GlcNAcylation also regulate leptin. We therefore investigated whether O-glycosylation plays a role in iron- and CREB-mediated regulation of leptin. We found that high iron decreases protein O-GlcNAcylation both in cultured 3T3-L1 adipocytes and in mice fed high-iron diets and down-regulates leptin mRNA and protein levels. Glucosamine treatment, which bypasses the rate-limiting step in the synthesis of substrate for glycosylation, increased both O-GlcNAc and leptin, whereas inhibition of O-glycosyltransferase (OGT) decreased O-GlcNAc and leptin. The increased leptin levels induced by glucosamine were susceptible to the inhibition by iron, but in the case of OGT inhibition, iron did not further decrease leptin. Mice with deletion of the O-GlcNAcase gene, either via whole-body heterozygous deletion or through adipocyte-targeted homozygous deletion, exhibited increased O-GlcNAc levels in adipose tissue and increased leptin levels that were inhibited by iron. Of note, iron increased the occupancy of pCREB and decreased the occupancy of O-GlcNAcylated CREB on the leptin promoter. These patterns observed in our experimental models suggest that iron exerts its effects on leptin by decreasing O-glycosylation and not by increasing protein deglycosylation and that neither O-GlcNAcase nor OGT mRNA and protein levels are affected by iron. We conclude that iron down-regulates leptin by decreasing CREB glycosylation, resulting in increased CREB phosphorylation and leptin promoter occupancy by pCREB.	[Gao, Yan; Liu, Jingfang; Bai, Zhenzhong; Sink, Sandy; Zhao, Chengyu; Lorenzo, Felipe Ramos; McClain, Donald A.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [McClain, Donald A.] WG Hefner Vet Affairs Med Ctr, Salisbury, NC 28144 USA; [Gao, Yan] Univ Illinois Chicago & Rockford, Sch Pharm, 1601 Parkview Ave, Rockford, IL 61107 USA; [Bai, Zhenzhong; Zhao, Chengyu] Qinghai Sch Med, Inst High Altitude Med, Xining 820012, Qinghai, Peoples R China	Wake Forest University	McClain, DA (corresponding author), 1 Med Ctr Dr,Meads Bldg,1st Floor, Winston Salem, NC 27157 USA.	dmcclain@wakehealth.edu		McClain, Don/0000-0002-3310-2359	National Institutes of Health [1R01 DK081842]; Research Service of the Department of Veterans Affairs Grant [2I01 BX001140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Department of Veterans Affairs Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant 1R01 DK081842 and Research Service of the Department of Veterans Affairs Grant 2I01 BX001140. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azuma Y, 2007, BIOL PHARM BULL, V30, P2284, DOI 10.1248/bpb.30.2284; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Gao Y, 2015, J CLIN INVEST, V125, P3681, DOI 10.1172/JCI81860; Groussaud D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006518; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Huang JH, 2007, J BIOL CHEM, V282, P37501, DOI 10.1074/jbc.M703625200; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; Jin NN, 2018, BIOCHEM BIOPH RES CO, V497, P194, DOI 10.1016/j.bbrc.2018.02.053; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Katai E, 2016, J CELL MOL MED, V20, P2269, DOI 10.1111/jcmm.12910; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-3082; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2000, ENDOCRINOLOGY, V141, P1999, DOI 10.1210/en.141.6.1999; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zachara N, 2015, ESSENTIALS GLYCOBIOL, P239; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang PL, 2002, ENDOCRINOLOGY, V143, P99, DOI 10.1210/en.143.1.99; Zhang X, 2018, CELL REP, V24, P3180, DOI 10.1016/j.celrep.2018.08.055	43	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5487	5495		10.1074/jbc.RA118.005183	http://dx.doi.org/10.1074/jbc.RA118.005183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30709903	hybrid, Green Published			2022-12-26	WOS:000464517500020
J	Le, T; Le, SC; Yang, HH				Le, Trieu; Le, Son C.; Yang, Huanghe			Drosophila Subdued is a moonlighting transmembrane protein 16 (TMEM16) that transports ions and phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; membrane biophysics; ion channel; Drosophila; calcium-binding protein; Anoctamin; CaCC; phospholipid scramblase; protein moonlighting; TMEM16	PHOSPHATIDYLSERINE EXPOSURE; WEB TOOL; CHANNEL; SCRAMBLASE; CHOPCHOP	Transmembrane protein 16 (TMEM16) family members play numerous important physiological roles, ranging from controlling membrane excitability and secretion to mediating blood coagulation and viral infection. These diverse functions are largely due to their distinct biophysical properties. Mammalian TMEM16A and TMEM16B are Ca2+-activated Cl- channels (CaCCs), whereas mammalian TMEM16F, fungal afTMEM16, and nhTMEM16 are moonlighting (multifunctional) proteins with both Ca2+-activated phospholipid scramblase (CaPLSase) and Ca2+-activated, nonselective ion channel (CAN) activities. To further understand the biological functions of the enigmatic TMEM16 proteins in different organisms, here, by combining an improved annexin V-based CaPLSase-imaging assay with inside-out patch clamp technique, we thoroughly characterized Subdued, a Drosophila TMEM16 ortholog. We show that Subdued is also a moonlighting transport protein with both CAN and CaPLSase activities. Using a TMEM16F-deficient HEK293T cell line to avoid strong interference from endogenous CaPLSases, our functional characterization and mutagenesis studies revealed that Subdued is a bona fide CaPLSase. Our finding that Subdued is a moonlighting TMEM16 expands our understanding of the molecular mechanisms of TMEM16 proteins and their evolution and physiology in both Drosophila and humans.	[Le, Trieu; Le, Son C.; Yang, Huanghe] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Yang, Huanghe] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Yang, HH (corresponding author), DUMC, Box 3711, Durham, NC 27710 USA.	huanghe.yang@duke.edu		Le, Son/0000-0002-7647-5307; Yang, Huanghe/0000-0001-9521-9328	National Institutes of Health [DP2 GM126898, R00-NS086916]; Whitehead Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM126898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS086916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants DP2 GM126898 (to H. Y.) and R00-NS086916 (to H. Y.) and by funds from the Whitehead Foundation (to H. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Copley SD, 2014, BIOCHEM SOC T, V42, P1684, DOI 10.1042/BST20140245; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Falzone ME, 2018, J GEN PHYSIOL, V150, P933, DOI 10.1085/jgp.201711957; Gyobu S, 2017, P NATL ACAD SCI USA, V114, P6274, DOI 10.1073/pnas.1703391114; Hu Y, 2016, J EXP MED, V213, P2759, DOI 10.1084/jem.20160612; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2016, J PROTEOMICS, V134, P19, DOI 10.1016/j.jprot.2015.10.003; Jiang T, 2017, ELIFE, V6, DOI 10.7554/eLife.28671; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05724-1; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Medrano-Soto A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192851; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pelz T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191219; Sapar ML, 2018, CELL REP, V24, P2273, DOI 10.1016/j.celrep.2018.07.095; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Whitlock JM, 2018, J GEN PHYSIOL, V150, P1498, DOI 10.1085/jgp.201812097; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wong XM, 2013, ELIFE, V2, DOI 10.7554/eLife.00862; Yang H, 2016, PERSP TRANS CELL BIO, P165, DOI 10.1016/B978-0-12-802002-9.00007-8; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901	41	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4529	4537		10.1074/jbc.AC118.006530	http://dx.doi.org/10.1074/jbc.AC118.006530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30700552	Green Published, hybrid			2022-12-26	WOS:000462969500021
J	Torcato, IM; Kasal, MR; Brito, PH; Miller, ST; Xavier, KB				Torcato, Ines M.; Kasal, Meghann R.; Brito, Patricia H.; Miller, Stephen T.; Xavier, Karina B.			Identification of novel autoinducer-2 receptors in Clostridia reveals plasticity in the binding site of the LsrB receptor family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; isothermal titration calorimetry (ITC); microbiome; cell signaling; crystal structure; ABC transporters; autoinducer-2; Clostridium autoethanogenum; Clostridium saccharobutylicum; LsrB receptors	QUORUM-SENSING SIGNAL; ESCHERICHIA-COLI; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; ABC TRANSPORTER; SP-NOV; AI-2; EXPRESSION; SEQUENCE; SYSTEMS	Autoinducer-2 (AI-2) is unique among quorum-sensing signaling molecules, as it is produced and recognized by a wide variety of bacteria and thus facilitates interspecies communication. To date, two classes of AI-2 receptors have been identified: the LuxP-type, present in the Vibrionales, and the LsrB-type, found in a number of phylogenetically distinct bacterial families. Recently, AI-2 was shown to affect the colonization levels of a variety of bacteria in the microbiome of the mouse gut, including members of the genus Clostridium, but no AI-2 receptor had been identified in this genus. Here, we identify a noncanonical, functional LsrB-type receptor in Clostridium saccharobutylicum. This novel LsrB-like receptor is the first one reported with variations in the binding-site amino acid residues that interact with AI-2. The crystal structure of the C. saccharobutylicum receptor determined at 1.35 resolution revealed that it binds the same form of AI-2 as the other known LsrB-type receptors, and isothermal titration calorimetry (ITC) assays showed that binding of AI-2 occurs at a submicromolar concentration. Using phylogenetic analysis, we inferred that the newly identified noncanonical LsrB receptor shares a common ancestor with known LsrB receptors and that noncanonical receptors are present in bacteria from different phyla. This led us to identify putative AI-2 receptors in bacterial species in which no receptors were known, as in bacteria belonging to the Spirochaetes and Actinobacteria phyla. Thus, this work represents a significant step toward understanding how AI-2-mediated quorum sensing influences bacterial interactions in complex biological niches.	[Torcato, Ines M.; Brito, Patricia H.; Xavier, Karina B.] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal; [Torcato, Ines M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Ave Republ, P-2780157 Oeiras, Portugal; [Miller, Stephen T.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Brito, Patricia H.] Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, NOVA Med Sch, Rua Camara Pestana 6, P-1150082 Lisbon, Portugal; [Kasal, Meghann R.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; Swarthmore College; Universidade Nova de Lisboa; Massachusetts Institute of Technology (MIT)	Xavier, KB (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.; Miller, ST (corresponding author), 500 Coll Ave, Swarthmore, PA 19081 USA.	smiller1@swarthmore.edu; kxavier@igc.gulbenkian.pt	Brito, Patricia H./ABD-8695-2020; Xavier, Karina/B-9425-2008	Torcato, Ines/0000-0001-8311-1096; Xavier, Karina/0000-0001-5210-1434; Brito, Patricia H./0000-0002-2457-7520	Portuguese National funds Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-MIC/4188/14]; Swarthmore College; FCT [PD/BD/105736/2014, PD/00133/2012, IF/00831/2015]; Mayer Davidson '57 Womens Science research fellowship; Frances Velay Womens Science research fellowship	Portuguese National funds Fundacao para a Ciencia e Tecnologia (FCT); Swarthmore College; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Mayer Davidson '57 Womens Science research fellowship; Frances Velay Womens Science research fellowship	This work was supported by Portuguese National funds Fundacao para a Ciencia e Tecnologia (FCT) Grant PTDC/BIA-MIC/4188/14 (to K. B. X.) and the Swarthmore College (to S. T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FCT Grant PD/BD/105736/2014, within the scope of Ph.D. program Molecular Biosciences Grant PD/00133/2012.; Supported by Mayer Davidson '57 and Frances Velay Womens Science research fellowships.; Supported by FCT Grant IF/00831/2015.	ABRINI J, 1994, ARCH MICROBIOL, V161, P345, DOI 10.1007/BF00303591; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alou M. T., 2018, New Microbes and New Infections, V21, P128, DOI 10.1016/j.nmni.2017.11.003; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Ascenso OS, 2011, BIOORGAN MED CHEM, V19, P1236, DOI 10.1016/j.bmc.2010.12.036; Bansal T, 2008, APPL MICROBIOL BIOT, V78, P811, DOI 10.1007/s00253-008-1359-8; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bin Darwish N, 2015, DESALINATION, V370, P1, DOI 10.1016/j.desal.2015.05.009; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Ha JH, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7063; Hegde M, 2011, J BACTERIOL, V193, P768, DOI 10.1128/JB.01196-10; Jani S, 2017, MICROBIOL-SGM, V163, P1778, DOI 10.1099/mic.0.000567; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kavanaugh JS, 2011, ACTA CRYSTALLOGR F, V67, P1501, DOI 10.1107/S1744309111042953; Laganenka L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12984; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Marques JC, 2014, P NATL ACAD SCI USA, V111, P14235, DOI 10.1073/pnas.1408691111; Marques JC, 2011, J BIOL CHEM, V286, P18331, DOI 10.1074/jbc.M111.230227; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Pereira CS, 2012, MOL MICROBIOL, V84, P93, DOI 10.1111/j.1365-2958.2012.08010.x; Pereira CS, 2009, J BACTERIOL, V191, P6975, DOI 10.1128/JB.00976-09; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Rivers DMR, 2015, J BACTERIOL, V197, P3812, DOI 10.1128/JB.00510-15; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Solbach P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196977; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Thompson JA, 2015, CELL REP, V10, P1861, DOI 10.1016/j.celrep.2015.02.049; van Sambeek DM, 2016, J ANIM SCI, V94, P387, DOI 10.2527/jas.2015-9861; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whiteley M, 2017, NATURE, V551, P313, DOI 10.1038/nature24624; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Wu MH, 2013, J BIOL CHEM, V288, P15878, DOI 10.1074/jbc.M112.417634; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhu JG, 2008, ACS CHEM BIOL, V3, P110, DOI 10.1021/cb7002048	57	14	15	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4450	4463		10.1074/jbc.RA118.006938	http://dx.doi.org/10.1074/jbc.RA118.006938			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696769	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000462969500014
J	Martin, AR; Cadotte, MW; Isaac, ME; Milla, R; Vile, D; Violle, C				Martin, Adam R.; Cadotte, Marc W.; Isaac, Marney E.; Milla, Ruben; Vile, Denis; Violle, Cyrille			Regional and global shifts in crop diversity through the Anthropocene	PLOS ONE			English	Article							FOOD SOVEREIGNTY; GLOBALIZATION; BIODIVERSITY; CONSERVATION; PATTERNS	The Anthropocene epoch is partly defined by anthropogenic spread of crops beyond their centres of origin. At global scales, evidence indicates that species-level taxonomic diversity of crops being cultivated on large-scale agricultural lands has increased linearly over the past 50 years. Yet environmental and socio-economic differences support expectations that temporal changes in crop diversity vary across regions. Ecological theory also suggests that changes in crop taxonomic diversity may not necessarily reflect changes in the evolutionary diversity of crops. We used data from the Food and Agricultural Organization (FAO) of the United Nations to assess changes in crop taxonomic- and phylogenetic diversity across 22 subcontinental-scale regions from 1961-2014. We document certain broad consistencies across nearly all regions: i) little change in crop diversity from 1961 through to the late 1970s; followed by ii) a 10-year period of sharp diversification through the early 1980s; followed by iii) a "levelling-off" of crop diversification beginning in the early 1990s. However, the specific onset and duration of these distinct periods differs significantly across regions and are unrelated to agricultural expansion, indicating that unique policy or environmental conditions influence the crops being grown within a given region. Additionally, while the 1970s and 1980s are defined by region-scale increases in crop diversity this period marks the increasing dominance of a small number of crop species and lineages; a trend resulting in detectable increases in the similarity of crops being grown across regions. Broad similarities in the species-level taxonomic and phylogenetic diversity of crops being grown across regions, primarily at large industrial scales captured by FAO data, represent a unique feature of the Anthropocene epoch. Yet nuanced asymmetries in regional-scale trends suggest that environmental and socio-economic factors play a key role in shaping observed macro-ecological changes in the plant diversity on agricultural lands.	[Martin, Adam R.; Isaac, Marney E.] Univ Toronto Scarborough, Dept Phys & Environm Sci, Scarborough, ON, Canada; [Martin, Adam R.; Isaac, Marney E.] Univ Toronto Scarborough, Ctr Crit Dev Studies, Scarborough, ON, Canada; [Cadotte, Marc W.] Univ Toronto Scarborough, Dept Biol Sci, Scarborough, ON, Canada; [Milla, Ruben] Univ Rey Juan Carlos, Dept Biol & Geol Fis & Quim Inorgan, Mostoles, Spain; [Vile, Denis] Univ Montpellier, INRA, UMR759, LEPSE, Montpellier, France; [Violle, Cyrille] Univ Montpellier 3, Univ Montpellier, EPHE, UMR 5175,Ctr Ecol Fonct & Evolut, Montpellier, France	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough; Universidad Rey Juan Carlos; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Martin, AR (corresponding author), Univ Toronto Scarborough, Dept Phys & Environm Sci, Scarborough, ON, Canada.; Martin, AR (corresponding author), Univ Toronto Scarborough, Ctr Crit Dev Studies, Scarborough, ON, Canada.	adam.martin@utoronto.ca	Cadotte, Marc/AAG-8147-2020; Vile, Denis/A-5637-2008	Cadotte, Marc/0000-0002-5816-7693; Vile, Denis/0000-0002-7948-1462; Martin, Adam Robert/0000-0002-7207-4004	Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Canada Foundation for Innovation; Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada [386151]; European Union; Region Languedoc-Roussillon "Chercheur d'Avenir" (FEDER FSE IEJ 2014-2020; Grant Project "APSEVIR"); Ministerio de Economia y Competitividad of Spain [CGL2014-56567-R, PCIN-2014-053]; European Union (Eco-serve project) [BiodivERsA/001/2014]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program (DiversiTraits project) [221060]; European Research Council (ERC) Starting Grant [StG-2014-639706-CONSTRAINTS]	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Union(European Commission); Region Languedoc-Roussillon "Chercheur d'Avenir" (FEDER FSE IEJ 2014-2020; Grant Project "APSEVIR"); Ministerio de Economia y Competitividad of Spain(Spanish Government); European Union (Eco-serve project); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program (DiversiTraits project); European Research Council (ERC) Starting Grant(European Research Council (ERC))	This research was undertaken in part based on funding from the Canada Research Chairs program and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to Marney E. Isaac. Marc W. Cadotte is supported by the TD Professor of Urban Forest Conservation and Biology chair program, the Canada Foundation for Innovation, Ontario Research Fund, and the Natural Sciences and Engineering Research Council of Canada (Grant number 386151). Denis Vile is supported by the European Union and the Region Languedoc-Roussillon "Chercheur d'Avenir" (FEDER FSE IEJ 2014-2020; Grant Project "APSEVIR"). Ruben Milla is supported by Ministerio de Economia y Competitividad of Spain (grants CGL2014-56567-R and PCIN-2014-053), and the European Union (Eco-serve project, BiodivERsA/001/2014, Horizon 2020). Cyrille Violle was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program (DiversiTraits project, no. 221060) and by the European Research Council (ERC) Starting Grant Project StG-2014-639706-CONSTRAINTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M. A, 1980, AGROECOLOGY SCI SUST; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; [Anonymous], 2003, COLUMBIAN EXCHANGE B; Boivin N, 2012, WORLD ARCHAEOL, V44, P452, DOI 10.1080/00438243.2012.729404; BOYLE B, 2013, BMC BIOINFORMATICS, V14, DOI DOI 10.1186/471-2105-14-16; Brooker RW, 2015, NEW PHYTOL, V206, P107, DOI 10.1111/nph.13132; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Capinha C, 2015, SCIENCE, V348, P1248, DOI 10.1126/science.aaa8913; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fox J., 2018, R COMPANION APPL REG, VThird; Gastauer M, 2016, BRAZ J BIOL, V76, P619, DOI 10.1590/1519-6984.20814; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Graeub BE, 2016, WORLD DEV, V87, P1, DOI 10.1016/j.worlddev.2015.05.012; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Isaac ME, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093299; Isakson SR, 2014, J AGRAR CHANGE, V14, P347, DOI 10.1111/joac.12023; Isakson SR, 2009, J PEASANT STUD, V36, P725, DOI 10.1080/03066150903353876; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Jones M, 2011, WORLD ARCHAEOL, V43, P665, DOI 10.1080/00438243.2011.624764; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Khoury CK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0792; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Li TM, 2015, J PEASANT STUD, V42, P205, DOI 10.1080/03066150.2014.938058; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Martin AR, 2018, J APPL ECOL, V55, P5, DOI 10.1111/1365-2664.13039; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Muggeo V.M., 2008, R NEWS, V8, P20; Nelson EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163002; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pimbert MP, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10020505; R Core Team, 2021, R LANGUAGE ENV STAT; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; Remans R, 2014, GLOB FOOD SECUR-AGR, V3, P174, DOI 10.1016/j.gfs.2014.07.001; Smykal P, 2015, CRIT REV PLANT SCI, V34, P43, DOI 10.1080/07352689.2014.897904; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WISE TA, 2007, 0701 TUFTS U GLOB DE; Wood SN, 2001, BIOMETRICS, V57, P240, DOI 10.1111/j.0006-341X.2001.00240.x; Wood SA, 2018, NAT SUSTAIN, V1, P34, DOI 10.1038/s41893-017-0008-6; Zoltan D, 2005, B U AGR MED VET M-VE, V62, P105	46	25	25	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0209788	10.1371/journal.pone.0209788	http://dx.doi.org/10.1371/journal.pone.0209788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726231	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000010
J	Zhao, HY; Basu, U; Kebede, B; Qu, CM; Li, JN; Rahman, H				Zhao, Huiyan; Basu, Urmila; Kebede, Berisso; Qu, Cunmin; Li, Jiana; Rahman, Habibur			Fine mapping of the major QTL for seed coat color in Brassica rapa var. Yellow Sarson by use of NIL populations and transcriptome sequencing for identification of the candidate genes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FLAVONOID BIOSYNTHESIS; NAPUS L.; RNA-SEQ; EXPRESSION; TT8; INHERITANCE; OIL; CONSTRUCTION; ACCUMULATION	Yellow seed is a desirable trait in Brassica oilseed crops. The B. rapa var. Yellow Sarson carry unique yellow seed color genes which are not only important for the development of yellow-seeded oilseed B. rapa cultivars but this variant can also be used to develop yellow seeded B. napus. In this study, we developed near-isogenic lines (NILs) of Yellow Sarson for the major seed coat color QTL SCA9-2 of the chromosome A9 and used the NILs to fine map this QTL region and to identify the candidate genes through linkage mapping and transcriptome sequencing of the developing seeds. From the 18.4 to 22.79 Mb region of SCA92, six SSR markers showing 0.63 to 5.65% recombination were developed through linkage analysis and physical mapping. A total of 55 differentially expressed genes (DEGs) were identified in the SCA9-2 region through transcriptome analysis; these included three transcription factors, Bra028039 (NAC), Bra023223 (C2H2 type zinc finger), Bra032362 (TIFY), and several other genes which encode unknown or nucleic acid binding protein; these genes might be the candidates and involved in the regulation of seed coat color in the materials used in this study. Several biosynthetic pathways, including the flavonoid, phenylpropanoid and suberin biosynthetic pathways were significantly enriched through GO and KEGG enrichment analysis of the DEGs. This is the first comprehensive study to understand the yellow seed trait of Yellow Sarson through employing linkage mapping and global transcriptome analysis approaches.	[Zhao, Huiyan; Basu, Urmila; Kebede, Berisso; Rahman, Habibur] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Zhao, Huiyan; Qu, Cunmin; Li, Jiana] Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China	University of Alberta; Southwest University - China	Rahman, H (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	Habibur.Rahman@ualberta.ca			Genome Canada; Genome Alberta; Natural Science and Engineering Research Council of Canada (NSERC) [298778-2011 RGPIN]; China Scholarship Council; Ministry of Education, State Administration of Foreign Experts Affairs [B12006]; Chongqing Science and Technology Bureau [cstc2016shms-zta80010, cstc2017jcyjAX0321]; Southwest University [XDJK2016B030]	Genome Canada(Genome Canada); Genome Alberta; Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); China Scholarship Council(China Scholarship Council); Ministry of Education, State Administration of Foreign Experts Affairs; Chongqing Science and Technology Bureau; Southwest University(Southwest University - China)	This study was supported by the Genome Canada; DOTM; HR; https://votost.genomecanada.cal; Genome Alberta; DOTM; HR; hits://genomealherta.cal; Natural Science and Engineering Research Council of Canada (NSERC); 298778-2011 RGPIN; HR; littp://www.nserc-crsng.gc.ca/; China Scholarship Council; HZ; Ministry of Education, State Administration of Foreign Experts Affairs; B12006; JL; http://www.moe.gov.cn/http://www.safea.gov.cn/; Chongqing Science and Technology Bureau; cstc2016shms-zta80010, cstc2017jcyjAX0321; CQ; tom://www.cstc.gov.cn/;Southwest University; XDJK2016B030; CQ; http://kic.swu.edu.cn/s/kjc/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SU, 1971, CROP SCI, V11, P309, DOI 10.2135/cropsci1971.0011183X001100020047x; Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Appelhagen I, 2014, PLANTA, V240, P955, DOI 10.1007/s00425-014-2088-0; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Auger B, 2010, J AGR FOOD CHEM, V58, P6246, DOI 10.1021/jf903619v; Bagheri H, 2013, SPAN J AGRIC RES, V11, P1085, DOI 10.5424/sjar/2013114-4160; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; CHEN BY, 1989, HEREDITAS, V111, P255, DOI 10.1111/j.1601-5223.1990.tb00404.x; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126250; Chen JJ, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01183; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004; George D., 2003, COMPUT SOFTW, V4th ed.; HAWK JA, 1982, CAN J PLANT SCI, V62, P331, DOI 10.4141/cjps82-051; Hobson N, 2016, CAN J PLANT SCI, V96, P808, DOI 10.1139/cjps-2015-0250; Hong MY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01674; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Huang SN, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0452-4; Jiang JJ, 2015, MOLECULES, V20, P21204, DOI 10.3390/molecules201219761; JONSSON R, 1977, HEREDITAS, V87, P205; Jonsson R., 1975, J SWED SEED ASS, V85, P271; Kang JE, 2014, MOL BIOL REP, V41, P2005, DOI 10.1007/s11033-014-3048-2; Kebede B, 2014, PLANT BREEDING, V133, P609, DOI 10.1111/pbr.12193; Kebede B, 2012, GENOME, V55, P813, DOI 10.1139/g2012-066; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lee K, 2016, MOL CELLS, V39, P179, DOI 10.14348/molcells.2016.2359; LI J, 2007, P 12 INT RAP C, P11; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044145; Lian JP, 2017, PLANT SCI, V254, P32, DOI 10.1016/j.plantsci.2016.10.012; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071110; Lopez-Maestre H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw655; Lou P, 2007, J EXP BOT, V58, P4005, DOI 10.1093/jxb/erm255; Luo JL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00044; Luo XB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3874-4; Marles MAS, 2004, J SCI FOOD AGR, V84, P251, DOI 10.1002/jsfa.1621; Meng JL, 1998, EUPHYTICA, V103, P329, DOI 10.1023/A:1018646223643; Mohammad Ali, 1942, INDIAN JOUR GENETICS AND PL BREEDING, V2, P112; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Padmaja LK, 2014, THEOR APPL GENET, V127, P339, DOI 10.1007/s00122-013-2222-6; Pandit A, 2010, MOL GENET GENOMICS, V284, P121, DOI 10.1007/s00438-010-0551-6; Park YR, 2017, PHYSIOL PLANTARUM, V159, P93, DOI 10.1111/ppl.12488; Parkin I, 2011, PLANT GENET GENOMICS, V9, P153, DOI 10.1007/978-1-4419-7118-0_5; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; QU CM, 2016, FRONT PLANT SCI, V7, DOI DOI 10.3389/FPLS.2016; Qu CM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01755; Qu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144118; Qu CM, 2015, CAN J PLANT SCI, V95, P387, DOI 10.4141/CJPS2013-411; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Rahman H, 2014, CROP SCI, V54, P537, DOI 10.2135/cropsci2013.06.0391; Rahman MH, 2001, PLANT BREEDING, V120, P463, DOI 10.1046/j.1439-0523.2001.00640.x; Rahman MH, 2001, PLANT BREEDING, V120, P473, DOI 10.1046/j.1439-0523.2001.00639.x; Rahman MH, 2001, PLANT BREEDING, V120, P197, DOI 10.1046/j.1439-0523.2001.00607.x; Rahman M, 2014, PLANT BREEDING, V133, P381, DOI 10.1111/pbr.12165; Rahman M, 2010, MOL BREEDING, V26, P439, DOI 10.1007/s11032-009-9384-6; Rakow G., 2011, P 13 INT RAP C PRAG, P55; Rakow G, 1999, P 10 INT RAP C CANB, P26; RASHID A, 1994, PLANT BREEDING, V112, P127, DOI 10.1111/j.1439-0523.1994.tb00660.x; Ren YJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01410; Ren YJ, 2017, BIOL OPEN, V6, P278, DOI 10.1242/bio.021592; ROBBELEN G, 1960, CHROMOSOMA, V11, P205, DOI 10.1007/BF00328652; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWETKA A, 1982, THEOR APPL GENET, V62, P161, DOI 10.1007/BF00293352; Stein A, 2013, PLANT BREEDING, V132, P382, DOI 10.1111/pbr.12073; STRINGAM GR, 1980, CAN J PLANT SCI, V60, P331, DOI 10.4141/cjps80-054; STRINGAM GR, 1974, P 4 INT RAP C GIESS, P99; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang ZL, 1997, PLANT BREEDING, V116, P471, DOI 10.1111/j.1439-0523.1997.tb01033.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang FL, 2016, G3-GENES GENOM GENET, V6, P1073, DOI 10.1534/g3.116.027110; Wang J, 2017, J AGR FOOD CHEM, V65, P5229, DOI 10.1021/acs.jafc.7b01226; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang YH, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0736-3; Wang YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166464; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao L, 2012, THEOR APPL GENET, V124, P903, DOI 10.1007/s00122-011-1754-x; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiong HC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03024-0; Xu WJ, 2013, NEW PHYTOL, V198, P59, DOI 10.1111/nph.12142; YOUNG MD, 2010, GENOME BIOL, V11; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y; Zhang Y, 2011, MOL BREEDING, V28, P335, DOI 10.1007/s11032-010-9486-1; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014	93	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0209982	10.1371/journal.pone.0209982	http://dx.doi.org/10.1371/journal.pone.0209982			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716096	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200007
J	Abegaz, T; Gebremedhin, S				Abegaz, Teferi; Gebremedhin, Samson			Magnitude of road traffic accident related injuries and fatalities in Ethiopia	PLOS ONE			English	Article							GENDER	Background In many developing countries there is paucity of evidence regarding the epidemiology of road traffic accidents (RTAs). The study determines the rates of injuries and fatalities associated with RTAs in Ethiopia based on the data of a recent national survey. Methods The study is based on the secondary data of the Ethiopian Demographic and Health Survey conducted in 2016. The survey collected information about occurrence injuries and accidents including RTAs in the past 12 months among 75,271 members of 16,650 households. Households were selected from nine regions and two city administrations of Ethiopia using stratified cluster sampling procedure. Results Of the 75,271 household members enumerated, 123 encountered RTAs in the reference period and rate of RTA-related injury was 163 (95% confidence interval (CI): 136-195) per 100,000 population. Of the 123 causalities, 28 were fatal, making the fatality rate 37 (95% CI: 25-54) per 100,000 population. The RTA-related injuries and fatalities per 100,000 motor vehicles were estimated as 21,681 (95% CI: 18,090-25,938) and 4,922 (95% CI: 3325-7183), respectively. Next to accidental falls, RTAs were the second most common form of accidents and injuries accounting for 22.8% of all such incidents. RTAs contributed to 43.8% of all fatalities secondary to accidents and injuries. Among RTA causalities, 21.9% were drivers, 35.0% were passenger vehicle occupants and 36.0% were vulnerable road users including: motorcyclists (21.0%), pedestrians (12.1%) and cyclists (2.9%). Approximately half (47.1%) of the causalities were between 15-29 years of age and 15.3% were either minors younger than 15 years or seniors older than 64 years of age. Nearly two-thirds (65.0%) of the victims were males. Conclusion RTA-related causalities are extremely high in Ethiopia. Male young adults and vulnerable road users are at increased risk of RTAs. There is a urgent need for bringing road safety to the country's public health agenda.	[Abegaz, Teferi] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Gebremedhin, Samson] Hawassa Univ, Sch Publ Hlth, Hawassa, Ethiopia	Addis Ababa University; Hawassa University	Abegaz, T (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.	teferiabegaz@gmail.com	Gebremedhin, Samson/O-2121-2019	Gebremedhin, Samson/0000-0002-7838-2470; Abegaz, Teferi/0000-0002-9830-1869				Abegaz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103001; Al-Balbissi Adli H, 2003, Traffic Inj Prev, V4, P64, DOI 10.1080/15389580309857; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], 2018, DAT; Baker D R, 2000, J Okla State Med Assoc, V93, P496; Bener A, 2008, INT J CRASHWORTHINES, V13, P331, DOI 10.1080/13588260801942684; Bishai D, 2006, HEALTH ECON, V15, P65, DOI 10.1002/hec.1020; Bodalal Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040454; Brown L H, 2000, Prehosp Emerg Care, V4, P7, DOI 10.1080/10903120090941551; Central Statistical Agency and ICF, 2017, ETH DEM HLTH SURV 20; Cordellieri P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01412; Dandona R, 2008, INJURY PREV, V14, P354, DOI 10.1136/ip.2008.019620; Elvik R, 2010, ACCIDENT ANAL PREV, V42, P245, DOI 10.1016/j.aap.2009.08.002; Ethiopian Federal Police Commission, 2017, ROAD TRAFF ACC REP; Glendon AI, 1996, RISK ANAL, V16, P755, DOI 10.1111/j.1539-6924.1996.tb00826.x; Martin JL, 2004, REV EPIDEMIOL SANTE, V52, P357, DOI 10.1016/S0398-7620(04)99065-7; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Nepal S, 2015, LANCET, V385, P7; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; Peden M., 2004, WORLD REPORT ROAD TR; Persson A., 2008, ADV T STUD, V15, P5; Population Census Comission [Ethiopia], 2008, SUMM STAT REP 2007 P; Qirjako G, 2008, CROAT MED J, V49, P734, DOI 10.3325/cmj.2008.49.734; Santamarina-Rubio E, 2014, ACCIDENT ANAL PREV, V65, P1, DOI 10.1016/j.aap.2013.11.015; Sehat M, 2012, INT J PREVENTIVE MED, V3, P181; Sleet DA, 2011, J SAFETY RES, V42, P147, DOI 10.1016/j.jsr.2011.02.001; United Nations Development Programme, 2018, SUST DEV GOALS; Watkins K., 2012, SAFE SUSTAINABLE ROA; World Health Organisation, 2018, GLOB STAT REP ROAD S; World Health Organization, 2002, GENDER ROAD TRAFFIC; World Health Organization, 2018, ROAD TRAFF INJ KEY F; Zimmerman K, 2012, ACCIDENT ANAL PREV, V45, P204, DOI 10.1016/j.aap.2011.06.018; Zwerling C, 2005, INJURY PREV, V11, P24, DOI 10.1136/ip.2004.005959	34	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0202240	10.1371/journal.pone.0202240	http://dx.doi.org/10.1371/journal.pone.0202240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695028	Green Submitted, gold, Green Published			2022-12-26	WOS:000457046400002
J	Miyoshi, Y; Ohtsuki, T; Kashida, H; Asanuma, H; Watanabe, K				Miyoshi, Yuichi; Ohtsuki, Takashi; Kashida, Hiromu; Asanuma, Hiroyuki; Watanabe, Kazunori			In-stem molecular beacon targeted to a 5 '-region of tRNA inclusive of the D arm that detects mature tRNA with high sensitivity	PLOS ONE			English	Article							CYTOPLASMIC TRANSFER-RNA; MESSENGER-RNA; THREONINOL NUCLEOTIDES; CHEMICAL-MODIFICATION; BASE-PAIR; TRANSPORT; NUCLEUS; ACCUMULATION; REVEALS; DESIGN	Cellular functions are regulated by the up-and down-regulation and localization of RNA molecules. Therefore, many RNA detection methods have been developed to analyze RNA levels and localization. Molecular beacon (MB) is one of the major methods for quantitative RNA detection and analysis of RNA localization. Most oligonucleotide-based probes, including MB, are designed to target a long flexible region on the target RNA molecule, e.g., a single-stranded region. Recently, analyses of tRNA localization and levels became important, as it has been shown that environmental stresses and chemical reagents induce nuclear accumulation of tRNA and tRNA degradation in mammalian cells. However, tRNA is highly structured and does not harbor any long flexible regions. Hence, only a few methods are currently available for detecting tRNA. In the present study, we attempted to detect elongator tRNA(Met) (eMet) and initiator tRNA(Met) (iMet) by using an in-stem molecular beacon (ISMB), characterized by more effective quenching and significantly higher sensitivity than those of conventional MB. We found that ISMB1 targeted a 5'-region that includes the D arm of tRNA and that it detected eMet and iMet transcripts as well as mature eMet with high sensitivity. Moreover, the analysis revealed that the formation of the ISMB/tRNA transcript complex required more time than the formation of an ISMB/unstructured short RNA complex. These results suggest that ISMB-based tRNA detection can be a useful tool for various biological and medical studies.	[Miyoshi, Yuichi; Ohtsuki, Takashi; Watanabe, Kazunori] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Ohtsuki, Takashi] Okayama Univ, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Okayama, Japan; [Kashida, Hiromu; Asanuma, Hiroyuki] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi, Japan	Okayama University; Okayama University; Nagoya University	Watanabe, K (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.	k_watanabe@okayama-u.ac.jp	Kashida, Hiromu/K-7486-2012; OHTSUKI, Takashi/B-1471-2011; Watanabe, Kazunori/G-6671-2012	Kashida, Hiromu/0000-0002-0946-0113; OHTSUKI, Takashi/0000-0002-3183-5305; Watanabe, Kazunori/0000-0003-3678-636X	JSPS KAKENHI [26840010, 16H05925, 17H05150, 18H03933, 15K13746]; Japan Science and Technology Agency (JST)(A-STEP); Asahi Glass Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST)(A-STEP); Asahi Glass Foundation	This research was supported by a grant, JSPS KAKENHI (26840010) to K. W. (16H05925 and 17H05150) to H. K. (18H03933) to H. A. and (15K13746) to T. O. and by a grant, Japan Science and Technology Agency (JST)(A-STEP) and the Asahi Glass Foundation to H. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma H, 2012, CHEM COMMUN, V48, P1760, DOI 10.1039/c2cc16812j; Baker MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1016; Barhoom S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr601; Bohlander PR, 2016, ORG BIOMOL CHEM, V14, P5001, DOI 10.1039/c6ob00691d; Chafe SC, 2011, MOL BIOL CELL, V22, P1091, DOI 10.1091/mbc.E09-07-0594; Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Farruggio D, 1996, MOL CELL BIOL, V16, P4248; Fujii T, 2009, CHEM-EUR J, V15, P10092, DOI 10.1002/chem.200900962; Hagedorn PH, 2018, DRUG DISCOV TODAY, V23, P101, DOI 10.1016/j.drudis.2017.09.018; Hara Y, 2010, ANGEW CHEM INT EDIT, V49, P5502, DOI 10.1002/anie.201001459; Hiley SL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni002; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Kamiya Y, 2017, CHEMBIOCHEM, V18, P1917, DOI 10.1002/cbic.201700272; Kashida H, 2015, BIOORGAN MED CHEM, V23, P1758, DOI 10.1016/j.bmc.2015.02.030; Kashida H, 2009, ANGEW CHEM INT EDIT, V48, P7044, DOI 10.1002/anie.200902367; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li J, 2017, ANAL METHODS-UK, V9, P2971, DOI 10.1039/c7ay00341b; Li M, 2010, J AM CHEM SOC, V132, P8676, DOI 10.1021/ja101384k; Liu JQ, 2014, J CELL PHYSIOL, V229, P1121, DOI 10.1002/jcp.24630; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Ma Z, 2017, GENOM PROTEOM BIOINF, V15, P279, DOI 10.1016/j.gpb.2017.04.004; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Miyagawa R, 2012, BIOCHEM BIOPH RES CO, V418, P149, DOI 10.1016/j.bbrc.2011.12.150; Murayama K, 2015, CHEMBIOCHEM, V16, P1298, DOI 10.1002/cbic.201500167; Okamoto M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004639; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; RHODES D, 1977, EUR J BIOCHEM, V81, P91, DOI 10.1111/j.1432-1033.1977.tb11930.x; Ryder PV, 2018, TRAFFIC, V19, P496, DOI 10.1111/tra.12571; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, P1, DOI [10.1093/nar/gkg933, DOI 10.1093/NAR/GKG933]; Schwarzer A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00212-4; Shaheen HH, 2007, P NATL ACAD SCI USA, V104, P8845, DOI 10.1073/pnas.0700765104; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Vilaivan T, 2018, BEILSTEIN J ORG CHEM, V14, P253, DOI 10.3762/bjoc.14.17; Watanabe K, 2018, GENES CELLS, V23, P225, DOI 10.1111/gtc.12559; Watanabe K, 2014, FEBS LETT, V588, P3454, DOI 10.1016/j.febslet.2014.08.003; Watanabe K, 2013, NUCLEIC ACIDS RES, V41, P4671, DOI 10.1093/nar/gkt153; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Yang CJ, 2007, NUCLEIC ACIDS RES, V35, P4030, DOI 10.1093/nar/gkm358	41	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211505	10.1371/journal.pone.0211505	http://dx.doi.org/10.1371/journal.pone.0211505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695081	Green Published, gold			2022-12-26	WOS:000457046400041
J	Tanabu, R; Sato, K; Monai, N; Yamauchi, K; Gonome, T; Xie, YT; Takahashi, S; Ishiguro, S; Nakazawa, M				Tanabu, Reiko; Sato, Kota; Monai, Natsuki; Yamauchi, Kodai; Gonome, Takayuki; Xie, Yuting; Takahashi, Shizuka; Ishiguro, Sei-ichi; Nakazawa, Mitsuru			The findings of optical coherence tomography of retinal degeneration in relation to the morphological and electroretinographic features in RPE65(-/-) mice	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; GENE-THERAPY; MOUSE MODEL; SD-OCT; MUTATIONS; DYSTROPHY; THICKNESS; PHOTORECEPTORS; PROGRESSION	Purpose Mutations of the gene encoding RPE65 cause Leber congenital amaurosis (LCA) retinitis pigmentosa (RP). The optical coherence tomography (OCT) is increasingly utilized to noninvasively evaluate various types of retinal diseases, including RP. The present study was conducted to characterize the OCT findings of the RPE65(-/-) mice-an animal model of LCA and RP-in relation to the morphological features based on histological and electron microscopic findings as well as electroretinography (ERG) features. Materials and methods RPE65(-/-) mice were employed as a model of retinal degeneration. C57BL/6J mice were used as a wild-type control. OCT was performed on the RPE65(-/-) mice from postnatal day (P) 22 to 170. The longitudinal changes in the OCT images and fundus pictures were analyzed both qualitatively and quantitatively in comparison to those of C57BL/6J mice. The OCT images were also compared to the histological and electron microscopic findings. Full field combined rod and cone ERG was performed to analyze the relationship between morphology based on OCT and the amplitudes of the a- and b-waves. Results In the RPE65(-/-) mice, the photoreceptor rod and cone layer appeared as a diffuse hyperreflective zone contiguous with the inner segment ellipsoid zone (IS-EZ) on OCT, even on P22, whereas the IS-EZ and interdigitation zone were clearly identified in the age-matched C57BL/6J mice. The histological analyses revealed that the regular arrangement of the photoreceptor inner and outer segments was gradually lost in the RPE65(-/-) mice. On electron microscopy, most of the rod outer segments were degenerated from P21 to P35, whereas outer segments became variably shorter after P49 although ultrastructure appeared to normalize. The thickness of the outer nuclear layer of RPE65(-/-) mice was slowly and progressively reduced in comparison to C57BL/6J mice. Although the thickness of the inner and outer segment layer of RPE65(-/-) mice was significantly decreased in comparison to C57BL/6J mice, the change was not progressive, at least until P170. Even at P35, the amplitudes of both a- and b-waves on ERG were severely deteriorated in comparison to those of C57BL/6J mice. Mottled depigmented spots appeared throughout the fundus in RPE65(-/-) mice after P72, and were detected as hyperreflective deposits under the retinal pigment epithelium on OCT. Discussion The pathological changes in the inner and outer segments layer of RPE65(-/-) mice were identified as diffuse hyperreflective changes on OCT. The rod outer segments showed degeneration in the early postnatal periods but became morphologically normalized in the disc structure after P49, although the sizes of the length of the rod outer segments were variable. OCT could not qualitatively differentiate the early degeneration of rods from the late variability in size of rods. Although the morphology of the photoreceptor outer segments was relatively preserved in the RPE65(-/-) mice, the amplitudes of ERG were severely disturbed. These structural and functional deficits may be derived from the defective supply of 11-cisretinol to the photoreceptors.	[Tanabu, Reiko; Monai, Natsuki; Yamauchi, Kodai; Gonome, Takayuki; Xie, Yuting; Takahashi, Shizuka; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan; [Sato, Kota; Ishiguro, Sei-ichi] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan	Hirosaki University; Tohoku University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan.	mitsuru@hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712; Takahashi, Shizuka/0000-0001-7225-979X	Japan Society of the Promotion of Science [C-16K11313, B-17K16954, B-17K16955]; Alcon; Santen; Novartis; Phizer; HOYA; K-Vision; Flower Medical; Eisai; Hirosaki University Eye Bank	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alcon(Novartis); Santen; Novartis(Novartis); Phizer; HOYA; K-Vision; Flower Medical; Eisai(Eisai Co Ltd); Hirosaki University Eye Bank	This work was supported by: Grant-in Aid for Scientific Research (C-16K11313), Japan Society of the Promotion of Science (http://www.jsps.go.jp/), MN; Grant-in Aid for Scientific Research for Young Investigators (B-17K16954), Japan Society of the Promotion of Science (http://www.jsps.go.jp), NM; Grant-in Aid for Scientific Research for Young Investigators (B-17K16955), Japan Society of the Promotion of Science (http://www.jsps.go.jp), ST; and research fundings from Alcon, Santen, Novartis, Phizer, HOYA, K-Vision, Flower Medical, Eisai, Hirosaki University Eye Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162835; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Caruso RC, 2010, INVEST OPHTH VIS SCI, V51, P5304, DOI 10.1167/iovs.10-5559; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; Dhoot DS, 2013, BRIT J OPHTHALMOL, V97, P66, DOI 10.1136/bjophthalmol-2012-301917; Grover S, 2006, AM J OPHTHALMOL, V141, P850, DOI 10.1016/j.ajo.2005.12.030; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hamada S, 2000, OPHTHALMIC SURG LAS, V31, P253; Harris EW, 2001, INT OPHTHALMOL CLIN, V41, P73, DOI 10.1097/00004397-200101000-00008; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Levine ES, 2014, VISION RES, V102, P71, DOI 10.1016/j.visres.2014.07.011; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lupo S, 2011, AM J OPHTHALMOL, V151, P106, DOI 10.1016/j.ajo.2010.07.026; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1998, EUR J HUM GENET, V6, P527, DOI 10.1038/sj.ejhg.5200205; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Monai N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193778; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Orhan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127319; Phelan JK, 2000, MOL VIS, V6, P116; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ryals RC, 2017, INVEST OPHTH VIS SCI, V58, P1378, DOI 10.1167/iovs.16-20363; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P4568, DOI 10.1167/iovs.08-1992; Sato K, 2010, EXP EYE RES, V91, P54, DOI 10.1016/j.exer.2010.03.020; Schatz P, 2003, ACTA OPHTHALMOL SCAN, V81, P500, DOI 10.1034/j.1600-0420.2003.00134.x; Sugita T, 2008, INVEST OPHTH VIS SCI, V49, P3551, DOI 10.1167/iovs.08-1954; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Witkin AJ, 2006, AM J OPHTHALMOL, V142, P945, DOI 10.1016/j.ajo.2006.07.024; Xu F, 2012, MOL VIS, V18, P744; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	44	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210439	10.1371/journal.pone.0210439	http://dx.doi.org/10.1371/journal.pone.0210439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695025	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400008
J	Yeoh, YS; Koh, GCH; Tan, CS; Tu, TM; Singh, R; Chang, HM; De Silva, DA; Ng, YS; Ang, YH; Yap, P; Chew, E; Merchant, RA; Yeo, TT; Chou, N; Venketasubramanian, N; Lee, KE; Young, SH; Hoenig, H; Matchar, DB; Luo, N				Yeoh, Yen Shing; Koh, Gerald Choon-Huat; Tan, Chuen Seng; Tu, Tian Ming; Singh, Rajinder; Chang, Hui Meng; De Silva, Deidre A.; Ng, Yee Sien; Ang, Yan Hoon; Yap, Philip; Chew, Effie; Merchant, Reshma A.; Yeo, Tseng Tsai; Chou, Ning; Venketasubramanian, N.; Lee, Kim En; Young, Sherry H.; Hoenig, Helen; Matchar, David Bruce; Luo, Nan			Health-related quality of life loss associated with first-time stroke	PLOS ONE			English	Article							SELF-REPORT QUESTIONNAIRE; MINI-MENTAL-STATE; RHEUMATIC-DISEASES; POPULATION NORMS; EQ-5D; EUROQOL; VALIDATION; DISABILITY; RELIABILITY; PREVALENCE	Objectives This study aimed to quantify health-related quality of life (HRQoL) loss associated with first episode of stroke by comparing patient-reported HRQoL before and after stroke onset. The impact of stroke in local population was also evaluated by comparing the pre- and post-stroke HRQoL with that of the general population. Methods The HRQoL of stroke survivors was assessed with the EQ-5D-3L index score at recruitment, for recalled pre- stroke HRQoL, and at 3 and 12 month post-stroke. Change in HRQoL from pre- stroke to 3 and 12 month was self-reported by 285 and 238 patients, respectively. Mean EQ index score at each time point (baseline: 464 patients; 3 month post-stroke: 306 patients; 12 month post-stroke: 258 patients) was compared with published population norms for EQ-5D-3L. Results There was a significant decrease in HRQoL at 3 (0.25) and 12 month (0.09) post-stroke when compared to the retrospectively recalled patients' mean pre- stroke HRQoL level 0.87). The reduction at 3 month was associated with the reduction in all EQ-5D-3L health dimensions; reductions remaining at 12 month were limited to dimensions of mobility, self-care, usual activities, and anxiety/depression. Stroke patients had a lower mean EQ index than the general population by 0.07 points pre-stroke (0.87 vs. 0.94), 0.33 points at 3 month (0.61 vs. 0.94) and 0.18 points at 12 month (0.76 vs. 0.94) post-stroke. Conclusions Stroke has a substantial impact on HRQoL in Singapore, especially in the first three months post-stroke. Compared to the general population, stroke survivors have lower HRQoL even before stroke onset. This pre-stroke deficit in HRQoL should be taken into account when quantifying health burden of stroke or setting goals for stroke rehabilitation.	[Yeoh, Yen Shing; Koh, Gerald Choon-Huat; Tan, Chuen Seng; Luo, Nan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tu, Tian Ming; Singh, Rajinder] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Chang, Hui Meng; De Silva, Deidre A.] Natl Neurosci Inst, Dept Neurol, Singapore Gen Hosp Campus, Singapore, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Ang, Yan Hoon; Yap, Philip] Khoo Teck Puat Hosp, Dept Geriatr Med, Singapore, Singapore; [Chew, Effie] Natl Univ Singapore Hosp, Dept Rehabil Med, Singapore, Singapore; [Merchant, Reshma A.] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore; [Yeo, Tseng Tsai; Chou, Ning] Natl Univ Singapore Hosp, Dept Neurosurg, Singapore, Singapore; [Venketasubramanian, N.] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Lee, Kim En] Farrer Pk Hosp, Farrer Pk Med Ctr, Singapore, Singapore; [Young, Sherry H.] Changi Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Hoenig, Helen] Durham Vet Affairs Med Ctr, Phys Med & Rehabil Serv, Durham, NC USA; [Hoenig, Helen] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Matchar, David Bruce] Duke NUS Med Sch, Hlth Serv & Syst Res Programme, Singapore, Singapore; [Matchar, David Bruce] Duke Univ, Ctr Clin Hlth Policy Res, Med Ctr, Durham, NC USA	National University of Singapore; National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Raffles Hospital; Changi General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; National University of Singapore; Duke University	Luo, N (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	ephln@nus.edu.sg	Venketasubramanian, Narayanaswamy/GPP-5948-2022; Merchant, Reshma Aziz/I-3033-2019; Tu, Tian Ming/AAI-3949-2020; Tan, Chuen Seng/K-1078-2013; Yeo, Tseng Tsai/U-8864-2017; Merchant, Reshma/ABD-4044-2020; Chou, Ning/B-5314-2011	Merchant, Reshma Aziz/0000-0002-9032-0184; Tu, Tian Ming/0000-0002-7175-0357; Tan, Chuen Seng/0000-0002-6513-2309; Matchar, David/0000-0003-3020-2108; De Silva, Deidre Anne/0000-0002-7123-2381; Ng, Yee-Sien/0000-0003-1377-5852	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre [NMRC/CG/C026/2017_NUHS]; Health Services Research Competitive Research Grant [HSRG/0006/2010]	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre; Health Services Research Competitive Research Grant	This study was supported by the Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre (NMRC/CG/C026/2017_NUHS to GCHK) and Health Services Research Competitive Research Grant (HSRG/0006/2010 to GCHK). The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin E, 2015, QUAL LIFE RES, V24, P1545, DOI 10.1007/s11136-014-0859-5; Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898; Bour A, 2010, J NEUROL, V257, P630, DOI 10.1007/s00415-009-5387-9; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cameron CM, 2005, B WORLD HEALTH ORGAN, V83, P345; Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS39, DOI 10.1097/PHM.0b013e31823d4df7; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Dorman PJ, 1997, STROKE, V28, P1883, DOI 10.1161/01.STR.28.10.1883; Fang J, 2016, SCI REPORTS, V6; Fayers P.M., 2013, QUALITY LIFE ASSESSM; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabbe BJ, 2007, J ORTHOP TRAUMA, V21, P223, DOI 10.1097/BOT.0b013e31803eb13c; Gokkaya NKO, 2005, INT J REHABIL RES, V28, P229, DOI 10.1097/00004356-200509000-00005; Golicki D, 2015, QUAL LIFE RES, V24, P1555, DOI 10.1007/s11136-014-0873-7; Hunger M, 2012, QUAL LIFE RES, V21, P1205, DOI 10.1007/s11136-011-0024-3; Luo N, 2003, ANN ACAD MED SINGAP, V32, P685; Luo N, 2003, QUAL LIFE RES, V12, P87, DOI 10.1023/A:1022063721237; Luo N, 2014, PHARMACOECONOMICS, V32, P495, DOI 10.1007/s40273-014-0142-1; Luo YH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0246-0; Min KB, 2015, AGE AGEING, V44, P700, DOI 10.1093/ageing/afv060; Ministry of Health, 2011, NAT HLTH SURV 2010; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ng TP, 2007, AM J GERIAT PSYCHIAT, V15, P130, DOI 10.1097/01.JGP.0000235710.17450.9a; Pinto EB, 2011, ARQ NEURO-PSIQUIAT, V69, P320, DOI 10.1590/S0004-282X2011000300010; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sneeuw KCA, 1997, STROKE, V28, P1541, DOI 10.1161/01.STR.28.8.1541; Staquet M, 1992, QUAL LIFE RES, V1; StataCorp, 2021, STATA STAT SOFTWARE; Subramaniam M, 2014, PSYCHIAT RES, V215, P46, DOI 10.1016/j.psychres.2013.10.002; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; Wee HL, 2007, ANN ACAD MED SINGAP, V36, P403; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362; Xie JP, 2006, STROKE, V37, P2567, DOI 10.1161/01.STR.0000240506.34616.10	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211493	10.1371/journal.pone.0211493	http://dx.doi.org/10.1371/journal.pone.0211493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689666	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800036
J	Galvao, EL; Pedras, MJ; Cota, GF; Rabello, A; Simoes, TC				Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Rabello, Ana; Simoes, Taynana Cesar			How cutaneous leishmaniasis and treatment impacts in the patients' lives: A cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; DISEASE	Background Until now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patients' quality of life, and none have used a specific instrument to measure this effect. The objective of this study was to identify factors that may be associated with the high impact of CL and to assess patients' satisfaction with treatment and health services by utilizing a disease-specific questionnaire. Methodology Between December 2015 and May 2017, 100 patients with localized cutaneous leishmaniasis were interviewed at a leishmaniasis referral center in Brazil. Data were collected by two questionnaires. One questionnaire compiled the sociodemographic, economic, and clinical information related to the disease. The second questionnaire was the Cutaneous Leishmaniasis Impact Questionnaire (CLIQ), which consisted of two subscales that measured 1) the general impact of CL and 2) patients' perceptions of treatment and health services. The median scores from each of these two subscales were used to dichotomize the dependent variables. Risk factors for the high impact of CL and for low patient satisfaction with treatment and health services were analyzed with a logistic regression analysis. Results The chance of higher impact of CL was increased in patients with the presence of comorbidities (OR: 3.9; CI 1.25-12.36), in those with absences from work (OR: 12.0; CI 3.78-42.55), in those who relied on public transportation by a municipal bus (OR: 5.8; CI 1.27-26.77), and in those who had illness-related expenses greater than U$137 (OR: 3.5; CI 1.17-10.24). The chance of patient dissatisfaction with treatment and health services increased with higher education (OR: 5.0; CI 1.19-21.03) and with illness-related expenses exceeding U$ 137 (OR: 4.64; CI 1.49-14.48). Once the sample was non-probabilistic, findings are not representative of CL patients in general. Conclusions CL and its treatment have a negative impact on patients' quality of life. Considering these effects during public health planning may help patients to confront the disease.	[Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Rabello, Ana; Simoes, Taynana Cesar] Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infect Parasit, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Galvao, EL (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infect Parasit, Belo Horizonte, MG, Brazil.	endilanza@yahoo.com.br	Junqueira Pedras, Mariana/ABF-1228-2021; Cota, Glaucia/ABC-5378-2020; Simões, Taynãna César/ABE-8964-2021	Junqueira Pedras, Mariana/0000-0003-2494-6178; Cota, Glaucia/0000-0003-0538-7403; Galvao, Endi Lanza/0000-0002-5648-3932	CNPq (National Counsel of Technological and Scientific Development) [311641/2009-1]; FAPEMIG (Foundation for Research Support of the State of Minas Gerais) [12504]	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Foundation for Research Support of the State of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	AR is currently receiving a grant [311641/2009-1] from CNPq (National Counsel of Technological and Scientific Development). ELG is Ph.D. student and is reciving a scholarship from FAPEMIG (Foundation for Research Support of the State of Minas Gerais) [12504]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kamel Mohamed A, 2016, Int J Womens Dermatol, V2, P93, DOI 10.1016/j.ijwd.2016.04.003; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x; Arana BA, 2000, ANN TROP MED PARASIT, V94, P779, DOI 10.1080/0003490020012416; Bennis I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5260-9; Bennis I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189906; Bennis I, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0267-5; Berger BA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005459; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Brito NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184777; Chahed MK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005090; da Silva RD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4752-3; Martins AMEDL, 2009, CAD SAUDE PUBLICA, V25, P421, DOI 10.1590/S0102-311X2009000200021; Toledo Jr ACD, 2013, T ROY SOC TROP MED H, V107, P335, DOI 10.1093/trstmh/trt021; Duncan P, 2015, INT J HEALTH SERV, V45, P545, DOI 10.1177/0020731415584558; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gallegos-Carrillo K, 2006, REV SAUDE PUBL, V40, P792, DOI 10.1590/S0034-89102006000600008; Galvao EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203378; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Molarius A, 2002, J CLIN EPIDEMIOL, V55, P364, DOI 10.1016/S0895-4356(01)00491-7; PAHO, 2013, PAN AM HLTH ORG 2013; Passero LG, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00065015; Pavao ALB, 2013, SELF RATED HLTH ASS; Pereira RHM, 2016, REV SAUDE PUBL, P50, DOI [10.1590/S1518-8787, DOI 10.1590/S1518-8787]; Peres MA, 2010, REV SAUDE PUBL, V44, DOI 10.1590/S0034-89102010000500016; Petarli GB, 2015, CAD SAUDE PUBLICA, V31, P787, DOI 10.1590/0102-311X00083114; Ranawaka R R, 2014, Mymensingh Med J, V23, P345; Ribeiro MN, 2014, REV INST MED TROP SP, V56, P291, DOI 10.1590/S0036-46652014000400004; Ruo B, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.01.012; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Vares B, 2013, ARCH IRAN MED, V16, P474, DOI 013168/AIm.008; Yanik M, 2004, CLIN EXP DERMATOL, V29, P464, DOI 10.1111/j.1365-2230.2004.01605.x	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211374	10.1371/journal.pone.0211374	http://dx.doi.org/10.1371/journal.pone.0211374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682151	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500158
J	Helm, M; Ritzmann, R; Gollhofer, A; Freyler, K				Helm, Michael; Ritzmann, Ramona; Gollhofer, Albert; Freyler, Kathrin			Anticipation modulates neuromechanics of drop jumps in known or unknown ground stiffness	PLOS ONE			English	Article							NEUROMUSCULAR CONTROL; SURFACE INSTABILITY; LEG STIFFNESS; FORCE ENHANCEMENT; STRETCH REFLEXES; NEURAL-CONTROL; PERFORMANCE; MUSCLES; COCONTRACTION; HEIGHT	With an emphasis on ballistic movements, an accurately anticipated neural control is an essential prerequisite to deliver a motor response coincidentally with the event of ground contact. This study investigated how previous knowledge of the ground condition affects proactive and reactive motor control in drop jumps (DJ). Thereby, human anticipatory capacity of muscle activation was investigated regarding neuromuscular activation, joint kinematics and peak forces associated with DJ performance. In 18 subjects, the effect of knowledge of two different surface conditions during DJs was evaluated. Peak force, ground-contact-time (GCT), rate of force development (RFD) and jump height were assessed. Electromyographic (EMG) activities of the m. soleus (SOL) and gastrocnemius medialis (GM) were assessed for 150 ms before (PRE) and during ground contact (GC) for the short-, medium-, and long-latency responses. Ankle and knee joint kinematics were recorded in the sagittal plane. In the unknown conditions peak force, RFD and jump height declined, GCT was prolonged, proactive EMG activity (PRE) in SOL and GM was diminished (P<0.05). During GC, a decline in EMG activity in the unknown condition was manifested for SOL and GM for the SLR, MLR and LLR (P<0.05). Ankle and knee joint deflections during GC were increased in the unknown vs. known condition (P<0.05). Peak force, RFD and jump height were positively correlated to GM-EMG in PRE, SLR, MLR and LLR (P<0.05). Results revealed that proactive and reactive modulations in muscle activity prior and during GC are interrelated to the force-time characteristics and height of the jumps. The unknown condition revealed a comparable neuromuscular activity during pre-activation for both conditions, followed by an inhibition in the subsequent phase after touch down. These findings underline that anticipation is a determining factor influencing timing and adjustment of motor responses to accomplish ballistic movements regarding precision and performance.	[Helm, Michael; Ritzmann, Ramona; Gollhofer, Albert; Freyler, Kathrin] Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany	University of Freiburg	Helm, M (corresponding author), Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany.	michael.helm@sport.uni-freiburg.de	Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019		German Aerospace Center [DLR 50WB1715]; Albert-Ludwigs-University Freiburg	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); Albert-Ludwigs-University Freiburg	This study was funded by the German Aerospace Center (DLR 50WB1715). The article processing charge was funded by the open access publication fund of the Albert-Ludwigs-University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arai A, 2013, EUR J SPORT SCI, V13, P490, DOI 10.1080/17461391.2013.764930; Arampatzis A, 2004, MED SCI SPORT EXER, V36, P451, DOI 10.1249/01.MSS.0000117166.87736.0A; Arampatzis A, 2001, MED SCI SPORT EXER, V33, P923, DOI 10.1097/00005768-200106000-00011; Avela J, 1996, EUR J APPL PHYSIOL, V72, P553, DOI 10.1007/BF00242290; Behm DG, 2010, APPL PHYSIOL NUTR ME, V35, P109, DOI 10.1139/H09-128; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOBBERT MF, 1987, MED SCI SPORT EXER, V19, P339; BOBBERT MF, 1987, MED SCI SPORT EXER, V19, P332; Chappell JD, 2007, AM J SPORT MED, V35, P235, DOI 10.1177/0363546506294077; Cohen J.E., 1988, STAT POWER ANAL BEHA; da Fonseca ST, 2004, J ELECTROMYOGR KINES, V14, P239, DOI 10.1016/j.jelekin.2003.09.003; DE LUCA CJ, 1987, J NEUROPHYSIOL, V58, P525, DOI 10.1152/jn.1987.58.3.525; DIETZ V, 1979, J NEUROPHYSIOL, V42, P1212, DOI 10.1152/jn.1979.42.5.1212; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Fagnani F, 2006, AM J PHYS MED REHAB, V85, P956, DOI 10.1097/01.phm.0000247652.94486.92; Farley CT, 1998, J APPL PHYSIOL, V85, P1044, DOI 10.1152/jappl.1998.85.3.1044; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferris DP, 1997, J APPL PHYSIOL, V82, P15, DOI 10.1152/jappl.1997.82.1.15; Finni T, 2001, ACTA PHYSIOL SCAND, V173, P369, DOI 10.1046/j.1365-201X.2001.00915.x; Fong SSM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001785; Freyler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167557; GOLLHOFER A, 1991, INT J SPORTS MED, V12, P34, DOI 10.1055/s-2007-1024652; GOLLHOFER A, 1992, EUR J APPL PHYSIOL, V64, P283, DOI 10.1007/BF00636213; GREENWOOD R, 1976, BRAIN, V99, P375, DOI 10.1093/brain/99.2.375; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Komi P.V., 2003, STRENGTH POWER SPORT, P184, DOI [10.1002/9780470757215.ch10, DOI 10.1002/9780470757215.CH10]; KOMI PV, 1984, MED SCI SPORT EXER, V16, P26; Komi PV, 1997, J APPL BIOMECH, V13, P451, DOI 10.1123/jab.13.4.451; Lee R G, 1975, Can J Neurol Sci, V2, P285; Leonhart R, 2004, LEHRBUCH STAT EINSTI; Lesinski M, 2017, SCAND J MED SCI SPOR, V27, P1090, DOI 10.1111/sms.12732; Lesinski M, 2018, INT J SPORTS MED, V39, P50, DOI 10.1055/s-0043-117610; Leukel C, 2012, HUM MOVEMENT SCI, V31, P152, DOI 10.1016/j.humov.2011.04.006; Makaruk H, 2011, BIOL SPORT, V28, P63, DOI 10.5604/935873; Marquez G, 2014, ACTA PHYSIOL, V212, P214, DOI 10.1111/apha.12356; Marquez G, 2010, EXP BRAIN RES, V204, P575, DOI 10.1007/s00221-010-2324-1; Marsden CD, 1978, PROGR CLIN NEUROPHYS, V4, P167; Mayer F, 2007, PRAVENTION VERLETZUN; McLean SG, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029278; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Milner TE, 1995, EXP BRAIN RES, V107, P293; Moritz CT, 2005, J EXP BIOL, V208, P939, DOI 10.1242/jeb.01472; NIELSEN J, 1992, J PHYSIOL-LONDON, V456, P373, DOI 10.1113/jphysiol.1992.sp019341; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Prieske O, 2015, INT J SPORTS MED, V36, P75, DOI 10.1055/s-0034-1384549; Prieske O, 2013, EUR J APPL PHYSIOL, V113, P2943, DOI 10.1007/s00421-013-2724-6; Ritzmann R, 2016, J APPL PHYSIOL, V121, P1187, DOI 10.1152/japplphysiol.00692.2016; Roelants M, 2004, J AM GERIATR SOC, V52, P901, DOI 10.1111/j.1532-5415.2004.52256.x; Rosa M, 2015, J NOV PHYSIOTHER, V5, P1, DOI DOI 10.4172/2165-7025.1000248; SCHMIDT RA, 1968, PSYCHOL BULL, V70, P631, DOI 10.1037/h0026740; Sinkjaer T, 1999, CLIN NEUROPHYSIOL, V110, P951, DOI 10.1016/S1388-2457(99)00034-6; Taube W, 2012, SCAND J MED SCI SPOR, V22, P671, DOI 10.1111/j.1600-0838.2011.01293.x; Taube W, 2008, J NEUROPHYSIOL, V99, P1243, DOI 10.1152/jn.01118.2007; Taube W, 2012, EXERC SPORT SCI REV, V40, P106, DOI 10.1097/JES.0b013e31824138da; THOMPSON HW, 1995, NEUROREPORT, V6, P581, DOI 10.1097/00001756-199502000-00043; Walsh M, 2004, J STRENGTH COND RES, V18, P561; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x; Wong AL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14624; Zuur AT, 2010, J PHYSIOL-LONDON, V588, P799, DOI 10.1113/jphysiol.2009.182709	61	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211276	10.1371/journal.pone.0211276	http://dx.doi.org/10.1371/journal.pone.0211276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682132	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500139
J	Elsemuller, AK; Tomalla, V; Gartner, U; Troidl, K; Jeratsch, S; Graumann, J; Baal, N; Hackstein, H; Lasch, M; Deindl, E; Preissner, KT; Fischer, S				Elsemueller, Ann-Kathrin; Tomalla, Vanessa; Gaertner, Ulrich; Troidl, Kerstin; Jeratsch, Sylvia; Graumann, Johannes; Baal, Nelli; Hackstein, Holger; Lasch, Manuel; Deindl, Elisabeth; Preissner, Klaus T.; Fischer, Silvia			Characterization of mast cell-derived rRNA-containing microvesicles and their inflammatory impact on endothelial cells	FASEB JOURNAL			English	Article						MC degranulation; ECs; cytokines; inflammation; extracellular RNA	EXTRACELLULAR RNA; VASCULAR SYSTEM; IDENTIFICATION; GROWTH; PERMEABILITY; ARTERIOGENESIS; ANGIOGENESIS; STABILITY; PLATELETS; PROTEINS	Tissue-resident mast cells (MCs) are well known for their role in inflammatory responses and allergic and anaphylactic reactions, but they also contribute to processes of arterial remodeling. Although ribosomes and cytosolic RNAs are located around secretory granules in mature MCs, their functional role in MC responses remains unexplored. Previous studies by our group characterized extracellular RNA (eRNA) as an inflammatory and pathogenetic factor in vitro and in vivo. In the present study, RNA-containing MCs and eRNA were located in close proximity to growing collateral arteries in vivo. In vitro, various agonists were found to induce the degranulation of MCs and the concomitant release of eRNA in association with microvesicles (MVs). The liberation of eRNA from MCs was abolished by MC stabilizers or by preventing the increase of intracellular Ca2+ in MCs. eRNA was found to be mainly contained inside MVs, as demonstrated by electron microscopy and immunocytochemistry. The exposure to and the uptake of MC-released MVs by cultured endothelial cells increased their expression of cytokines, such as monocyte chemoattractant protein or IL-6, in a dose- and time-dependent manner. These results indicate that RNA-containing MC-derived MVs are likely to be involved in inflammatory responses, relevant, for example, to processes of vascular remodeling.	[Elsemueller, Ann-Kathrin; Tomalla, Vanessa; Preissner, Klaus T.; Fischer, Silvia] Justus Liebig Univ, Med Fac, Dept Biochem, Giessen, Germany; [Gaertner, Ulrich] Justus Liebig Univ, Dept Anat & Cell Biol, Giessen, Germany; [Baal, Nelli] Justus Liebig Univ, Med Fac, Dept Clin Immunol & Transfus Med, Giessen, Germany; [Troidl, Kerstin; Jeratsch, Sylvia; Graumann, Johannes] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Troidl, Kerstin] Univ Hosp Frankfurt, Dept Vasc & Endovasc Surg, Frankfurt, Germany; [Hackstein, Holger] Friedrich Alexander Univ, Univ Hosp Erlangen, Dept Transfus Med & Haemostaseol, Erlangen, Germany; [Lasch, Manuel; Deindl, Elisabeth] Ludwig Maximilians Univ Munchen, Univ Hosp, Walter Brendel Ctr Expt Med, Munich, Germany; [Lasch, Manuel] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Erlangen Nuremberg; University of Munich; University of Munich	Fischer, S (corresponding author), Univ Giessen, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	silvia.fischer@biochemie.med.uni-giessen.de	Deindl, Elisabeth/A-2511-2013; Fischer, Silvia/ABG-3104-2021; Graumann, Johannes/C-5241-2008	Graumann, Johannes/0000-0002-3015-5850	German Research Foundation (DFG) (Bonn, Germany) [SFB-TR84, FI543/4-1, TR1137/2-1]; von Behring-Rontgen Foundation (Marburg, Germany) [62780212]; Excellence Cluster Cardio-Pulmonary System (ECCPS) (Giessen, Germany)	German Research Foundation (DFG) (Bonn, Germany)(German Research Foundation (DFG)); von Behring-Rontgen Foundation (Marburg, Germany); Excellence Cluster Cardio-Pulmonary System (ECCPS) (Giessen, Germany)	The authors thank Silke Leiting, Sabrina Glasenhardt, and Dimitri Grun (all from Department of Biochemistry, Medical Faculty, Justus-Liebig-University) for skillful and dedicated technical assistance. Studies were generously supported in part by grants to K.T.P., S.F., and K.T. from the German Research Foundation (DFG) (Bonn, Germany; http://www.dfg.de), including SFB-TR84 (to S.F. and K.T.P.), FI543/4-1 (to S.F.), and TR1137/2-1 (to K.T.); the von Behring-Rontgen Foundation (Marburg, Germany; 62780212, to S.F.); and the Excellence Cluster Cardio-Pulmonary System (ECCPS) (Giessen, Germany; http://eccps.de, to K.T.P.). The authors declare no conflicts of interest.	Aharon A, 2016, ISR MED ASSOC J, V18, P530; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Benito-Martin A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00066; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Chillo O, 2016, CELL REP, V16, P2197, DOI 10.1016/j.celrep.2016.07.040; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Dvorak AM, 2003, HISTOL HISTOPATHOL, V18, P943, DOI 10.14670/HH-18.943; Dvorak AM, 2000, J HISTOCHEM CYTOCHEM, V48, P1; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; Fischer S, 2013, HAMOSTASEOLOGIE, V33, P37, DOI 10.5482/HAMO-13-01-0001; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2012, THROMB HAEMOSTASIS, V108, P730, DOI 10.1160/TH12-03-0186; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; Frenzel L, 2013, JOINT BONE SPINE, V80, P141, DOI 10.1016/j.jbspin.2012.08.013; Galli SJ, 1997, J EXP MED, V186, P343, DOI 10.1084/jem.186.3.343; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Grutzkau A, 1998, MOL BIOL CELL, V9, P875, DOI 10.1091/mbc.9.4.875; Ito WD, 1997, CIRC RES, V80, P829; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kitamura Y, 2005, P NATL ACAD SCI USA, V102, P11129, DOI 10.1073/pnas.0505073102; Kleinert E, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003429; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Lasser C, 2017, RNA BIOL, V14, P58, DOI 10.1080/15476286.2016.1249092; Li Y, 2011, ACTA BIOCH BIOPH SIN, V43, P69, DOI 10.1093/abbs/gmq114; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Mulloy B, 2017, GLYCOCONJUGATE J, V34, P351, DOI 10.1007/s10719-016-9749-0; Nakazawa S, 2014, EUR J IMMUNOL, V44, P204, DOI 10.1002/eji.201343838; Noll F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190002; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Shefler I, 2011, CURR PHARM DESIGN, V17, P3797, DOI 10.2174/138161211798357836; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Vajen T, 2015, THROMB HAEMOSTASIS, V114, P228, DOI 10.1160/TH14-11-0962; Vukman KV, 2017, SEMIN CELL DEV BIOL, V67, P65, DOI 10.1016/j.semcdb.2017.02.002; Wei ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01196-x; Woska JR, 2012, J CELL MOL MED, V16, P649, DOI 10.1111/j.1582-4934.2011.01443.x; Zernecke A, 2016, CIRC RES, V118, P469, DOI 10.1161/CIRCRESAHA.115.307961; ZIMMERMAN SB, 1965, ANAL BIOCHEM, V10, P444, DOI 10.1016/0003-2697(65)90313-1	54	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5457	5467		10.1096/fj.201801853RR	http://dx.doi.org/10.1096/fj.201801853RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702929				2022-12-26	WOS:000462888500066
J	Novoa-Aponte, L; Ramirez, D; Arguello, JM				Novoa-Aponte, Lorena; Ramirez, David; Arguello, Jose M.			The interplay of the metallosensor CueR with two distinct CopZ chaperones defines copper homeostasis in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; Pseudomonas; homeostasis; metal ion-protein interaction; metalloprotein; metal sensor; metallochaperone; stress response; transcriptional regulation	BACILLUS-SUBTILIS; MERR-FAMILY; WEB SERVER; ATPASES; EFFLUX; SELECTIVITY; ACTIVATION; MECHANISMS; EXPRESSION; RESISTANCE	Copper homeostasis in pathogenic bacteria is critical for cuproprotein assembly and virulence. However, in vivo biochemical analyses of these processes are challenging, which has prevented defining and quantifying the homeostatic interplay between Cu+-sensing transcriptional regulators, chaperones, and sequestering molecules. The cytoplasm of Pseudomonas aeruginosa contains a Cu+-sensing transcriptional regulator, CueR, and two homologous metal chaperones, CopZ1 and CopZ2, forming a unique system for studying Cu+ homeostasis. We found here that both chaperones exchange Cu+, albeit at a slow rate, reaching equilibrium after 3 h, a time much longer than P. aeruginosa duplication time. Therefore, they appeared as two separate cellular Cu+ pools. Although both chaperones transferred Cu+ to CueR in vitro, experiments in vivo indicated that CopZ1 metallates CueR, eliciting the translation of Cu+ efflux transporters involved in metal tolerance. Although this observation was consistent with the relative Cu+ affinities of the three proteins (CopZ1 < CueR < CopZ2), in vitro and in silico analyses also indicated a stronger interaction between CopZ1 and CueR that was independent of Cu+. In contrast, CopZ2 function was defined by its distinctly high abundance during Cu2+ stress. Under resting conditions, CopZ2 remained largely in its apo form. Metal stress quickly induced CopZ2 expression, and its holo form predominated, reaching levels commensurate with the cytoplasmic Cu+ levels. In summary, these results show that CopZ1 acts as chaperone delivering Cu+ to the CueR sensor, whereas CopZ2 functions as a fast-response Cu+-sequestering storage protein. We propose that equivalent proteins likely play similar roles in most bacterial systems.	[Novoa-Aponte, Lorena; Ramirez, David; Arguello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01605 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), 60 Prescott St, Worcester, MA 01605 USA.	arguello@wpi.edu	Ramirez, David/X-4233-2019	Ramirez, David/0000-0003-0002-1189; Novoa-Aponte, Lorena/0000-0003-3348-8383	National Institutes of Health [R01GM114949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114949 (to J. M. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2016, METALLOMICS, V8, P906, DOI 10.1039/c6mt00089d; Banci L, 2003, BIOCHEMISTRY-US, V42, P2467, DOI 10.1021/bi0205810; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chaplin AK, 2015, METALLOMICS, V7, P145, DOI 10.1039/c4mt00250d; Chen P, 2013, BIOCHEMISTRY-US, V52, P7170, DOI 10.1021/bi400597v; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cubillas C, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.452; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dennison C, 2018, J BIOL CHEM, V293, P4616, DOI 10.1074/jbc.TM117.000180; Desideri A, 2003, BIOCHEM SOC T, V31, P1322; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Gaballa A, 2003, BIOMETALS, V16, P497, DOI 10.1023/A:1023425321617; Glauninger H, 2018, CHEM SCI, V9, P105, DOI 10.1039/c7sc04396a; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Hearnshaw S, 2009, BIOCHEMISTRY-US, V48, P9324, DOI 10.1021/bi9011995; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Joshi CP, 2012, P NATL ACAD SCI USA, V109, P15121, DOI 10.1073/pnas.1208508109; Kay KL, 2016, METALLOMICS, V8, P709, DOI 10.1039/c6mt00036c; Kihlken MA, 2002, BIOCHEM J, V368, P729, DOI 10.1042/BJ20021036; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaBauve AE., 2012, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc06e01s25, DOI 10.1002/9780471729259.MC06E01S25]; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Nawapan S, 2009, J BACTERIOL, V191, P5159, DOI 10.1128/JB.00384-09; NEUBERT M, 2017, COPPER, V2, pe0037, DOI DOI 10.1128/MSPHERE.00372-17; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Osman D, 2015, J BIOL CHEM, V290, P19806, DOI 10.1074/jbc.M115.663427; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Parmar JH, 2018, MOL MICROBIOL, V110, P357, DOI 10.1111/mmi.14086; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philips SJ, 2015, SCIENCE, V349, P877, DOI 10.1126/science.aaa9809; Quintana J, 2017, J BIOL CHEM, V292, P15691, DOI 10.1074/jbc.M117.804492; Radford DS, 2003, FEMS MICROBIOL LETT, V220, P105, DOI 10.1016/S0378-1097(03)00095-8; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger, 2017, MAESTR REL 2017 3; Thaden JT, 2010, J BACTERIOL, V192, P2557, DOI 10.1128/JB.01528-09; Urvoas A, 2004, EUR J BIOCHEM, V271, P993, DOI 10.1111/j.1432-1033.2004.04001.x; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2015, J AM CHEM SOC, V137, P15358, DOI 10.1021/jacs.5b09895; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang XX, 2008, ENVIRON MICROBIOL, V10, P3284, DOI 10.1111/j.1462-2920.2008.01720.x	66	13	13	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4934	4945		10.1074/jbc.RA118.006316	http://dx.doi.org/10.1074/jbc.RA118.006316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718281	hybrid, Green Published			2022-12-26	WOS:000463985600018
J	Van Ommen, CE; Albert, AYK; Piske, M; Money, DM; Cote, HCF; Lima, VD; Maan, EJ; Alimenti, A; van Schalkwyk, J; Pick, N; Murray, MCM				Van Ommen, Clara E.; Albert, Arianne Y. K.; Piske, Micah; Money, Deborah M.; Cote, Helene C. F.; Lima, Viviane D.; Maan, Evelyn J.; Alimenti, Ariane; van Schalkwyk, Julianne; Pick, Neora; Murray, Melanie C. M.			Exploring the live birth rates of women living with HIV in British Columbia, Canada	PLOS ONE			English	Article							REPRODUCTIVE AGE; POSITIVE WOMEN; FERTILITY; PREGNANCY; CARE; INTENTIONS; TRENDS; IMPACT	Objective To evaluate the birth rates of women living with HIV (WLWH) compared to the general population in British Columbia (BC), Canada. Methods We retrospectively reviewed clinical and population level surveillance data from 1997 to 2015. Live birth rates from 1997 to 2015 among WLWH aged 15-49 years were compared with those of all BC women. Next, the number of live births among WLWH with a live birth between 1997-2012 and HIV-negative controls matched 1: 3 by geocode were compared. Results WLWH had a lower birth rate compared to all BC women [31.4 (95% CI, 28.6-34.3) vs. 40.0 (39.3-40.1)/1000 person years]. Stratified by age, WLWH aged 15-24 years had a higher birth rate while WLWH aged 25-49 years had a lower birth rate than BC women (p<0.01). Between 1997 and 2015, birth rates for both populations decreased among women aged 15-24 years, and increased among women aged 25-49 years, most strikingly among WLWH 35-49 years (p<0.01). When comparing WLWH with a live birth to HIV-negative geocode matched controls, WLWH aged 15-24 years (p = 0.03) and aged 25-34 years (p<0.01) had more live births than controls while WLWH aged 35-49 years did not (p = 0.06). Conclusions On a population level, WLWH have lower birth rates than the general population. However, this is not observed among WLWH who have ever given birth compared with matched controls, suggesting that sociodemographic factors may play an important role. WLWH are increasingly giving birth in their later reproductive years. Taken together, our data supports the integration of reproductive health and HIV care.	[Van Ommen, Clara E.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Albert, Arianne Y. K.; Money, Deborah M.; Cote, Helene C. F.; Maan, Evelyn J.; van Schalkwyk, Julianne; Pick, Neora; Murray, Melanie C. M.] British Columbia Womens Hosp, Womens Hlth Res Inst, Vancouver, BC, Canada; [Albert, Arianne Y. K.; Money, Deborah M.; van Schalkwyk, Julianne] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Piske, Micah] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Piske, Micah; Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Money, Deborah M.; Maan, Evelyn J.; Alimenti, Ariane; van Schalkwyk, Julianne; Pick, Neora; Murray, Melanie C. M.] British Columbia Womens Hosp, Oak Tree Clin, Vancouver, BC, Canada; [Lima, Viviane D.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada; [Alimenti, Ariane] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC, Canada; [Pick, Neora; Murray, Melanie C. M.] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of London; London School of Hygiene & Tropical Medicine; University of British Columbia; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia	Murray, MCM (corresponding author), British Columbia Womens Hosp, Womens Hlth Res Inst, Vancouver, BC, Canada.; Murray, MCM (corresponding author), British Columbia Womens Hosp, Oak Tree Clin, Vancouver, BC, Canada.; Murray, MCM (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada.	Melanie.Murray@cw.bc.ca	Albert, Arianne/AAG-7518-2019	Albert, Arianne/0000-0002-3050-0888; Alimenti, Ariane/0000-0003-4999-8230	Canadian Institutes of Health Research (CIHR) [TCO-125269]; Canadian HIV Trials Network (CTN) [CTN277]; BC Vital Statistics Agency	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network (CTN); BC Vital Statistics Agency	The matched analysis component of this study was funded by a team grant from The Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/e/193.html) (Team Grant TCO-125269) awarded to HCFC, NP and DMM and The Canadian HIV Trials Network (CTN, http://www.hivnet.ubc.ca) (study number CTN277) awarded to MCMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank all CARMA team co-investigators as well as the Oak Tree Clinic staff for their support and contributions to this research. We would like to thank Tim Choi at Population BC for his contributions and we gratefully acknowledge support from BC Vital Statistics Agency.	[Anonymous], 2016, SUMM MEAS CAN PROGR; Antoniou T, 2014, INT J STD AIDS, V25, P960, DOI 10.1177/0956462414526861; BC Stats Ministry of Technology, 2015, VIT STAT; BC Vital Statistics Agency, 2014, VIT STAT BIRTHS POP; Berkowitz SA, 2015, HEALTH SERV RES, V50, P398, DOI 10.1111/1475-6773.12229; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Chapman L, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.006; Duff P, 2018, AIDS BEHAV, P1, DOI [10.1007/s10461-017-1906-3, DOI 10.1007/S10461-017-1906-3]; Finocchario-Kessler S, 2010, AIDS BEHAV, V14, P1106, DOI 10.1007/s10461-009-9637-8; Glynn JR, 2000, J ACQ IMMUN DEF SYND, V25, P345, DOI 10.1097/00126334-200012010-00008; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; Haddad LB, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.079; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Johnson JA, 2012, J OBSTET GYNAECOL CA, V34, P80, DOI 10.1016/S1701-2163(16)35138-6; Kabami J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-81; Kaida A, 2017, PERSPECT SEX REPRO H, V49, P223, DOI 10.1363/psrh.12046; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; Loutfy M, 2018, J OBSTET GYNAECOL CA, V40, P94, DOI 10.1016/j.jogc.2017.06.033; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; McLean E, 2017, JAIDS-J ACQ IMM DEF, V75, P391, DOI 10.1097/QAI.0000000000001395; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; O'Brien N, 2017, WOMEN HEALTH ISS, V27, P721, DOI 10.1016/j.whi.2017.08.001; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Piske M, 2018, AIDS; Poda A, 2016, PAN AFRICAN MED J, P23; Public Health Agency of Canada, 2014, HIV AIDS EP UPD NAT; RCore Team, 2020, R LANG ENV STAT COMP; Salters K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180524; Santulli P, 2016, AIDS, V30, P1083, DOI 10.1097/QAD.0000000000001025; Statistics Canada, 2009, POP SEL ETHN OR PROV; STOP HIV/AIDS Technical Monitoring Committee, 2016, HIV MON Q REP BRIT C; Sutton MY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197216; Westreich D, 2012, INFECT DIS OBSTET GY, P2012; Zaba B, 1998, AIDS, V12, pS41	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211434	10.1371/journal.pone.0211434	http://dx.doi.org/10.1371/journal.pone.0211434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726263	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000066
J	Das, S; Chandra, H; Saha, UR				Das, Sumonkanti; Chandra, Hukum; Saha, Unnati Rani			District level estimates and mapping of prevalence of diarrhoea among under-five children in Bangladesh by combining survey and census data	PLOS ONE			English	Article							SMALL-AREA ESTIMATION; RISK-FACTORS; POVERTY; DISEASE; GHANA; MODEL	The demand for district level statistics has increased tremendously in Bangladesh due to existence of decentralised approach to governance and service provision. The Bangladesh Demographic Health Surveys (BDHS) provide a wide range of invaluable data at the national and divisional level but they cannot be used directly to produce reliable district-level estimates due to insufficient sample sizes. The small area estimation (SAE) technique overcomes the sample size challenges and can produce reliable estimates at the district level. This paper uses SAE approach to generate model-based district-level estimates of diarrhoea prevalence among under-5 children in Bangladesh by linking data from the 2014 BDHS and the 2011 Population Census. The diagnostics measures show that the model-based estimates are precise and representative when compared to the direct survey estimates. Spatial distribution of the precise estimates of diarrhoea prevalence reveals significant inequality at district-level (ranged 1.1-13.4%) with particular emphasis in the coastal and north-eastern districts. Findings of the study might be useful for designing effective policies, interventions and strengthening local-level governance.	[Das, Sumonkanti] Shahjalal Univ Sci & Technol, Sylhet, Bangladesh; [Chandra, Hukum] IASRI, New Delhi, India; [Saha, Unnati Rani] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands	Shahjalal University of Science & Technology (SUST); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Erasmus University Rotterdam; Erasmus MC	Das, S (corresponding author), Shahjalal Univ Sci & Technol, Sylhet, Bangladesh.	sumonkanti-sta@sust.edu	Chandra, Hukum/AAA-2815-2021; Das, Sumonkanti/AAY-3810-2020	Chandra, Hukum/0000-0002-8502-7354; Das, Sumonkanti/0000-0003-1560-2349				[Anonymous], 2016, BANGL DEM HLTH SURV; Bado AR, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.30166; Bangladesh Bureau of Statistics, 2011, REP BANGL HOUS POP C; BATTESE GE, 1988, J AM STAT ASSOC, V83, P28, DOI 10.2307/2288915; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brown G., 2001, P STAT CAN S 2001 AC; CCC, 2009, CLIM CHANG HLTH IMP; Chandra H, 2018, SURV METHODOL; Chandra H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198502; Chandra H, 2011, J APPL STAT, V38, P2413, DOI 10.1080/02664763.2011.559202; Chowdhury F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130105; Das SK, 2013, J INFECT DEV COUNTR, V7, P900, DOI 10.3855/jidc.3003; Das S, 2017, J R STAT SOC A STAT, V180, P1137, DOI 10.1111/rssa.12311; Elbers C, 2003, ECONOMETRICA, V71, P355, DOI 10.1111/1468-0262.00399; FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505; Gebru T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-395; George CM, 2014, AM J TROP MED HYG, V91, P1190, DOI 10.4269/ajtmh.14-0057; Gonzalez-Manteiga W, 2007, COMPUT STAT DATA AN, V51, P2720, DOI 10.1016/j.csda.2006.01.012; Haslett S, 2014, SMALL AREA ESTIMATIO; Johnson FA, 2012, POP STUD-J DEMOG, V66, P105, DOI 10.1080/00324728.2012.678585; Johnson FA, 2010, J OFF STAT, V26, P341; Korn EL, 1998, SURV METHODOL, V23, P192; National Institute of Population Research and Training Mitra and Associates ICF International, 1997, BANGL DEM HLTH SURV; Pfeffermann D, 2002, INT STAT REV, V70, P125, DOI 10.1111/j.1751-5823.2002.tb00352.x; Qiao CG, 2005, LABOUR-ENGL, V19, P767, DOI 10.1111/j.1467-9914.2005.00314.x; Rana A., 2013, CLIMATE CHANGE IMPAC; Rao JN, 2015, SMALL AREA ESTIMATIO; Saei A, 2003, M0315 U SOUTH SOUTH; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; WHO, 2015, UN SUST DEV SUMM SUS; World Health Organization, DIARRH DIS 2013A; World Health Organization UNICEF, 2013, END PREV CHILD DEATH; Zhao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043749	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211062	10.1371/journal.pone.0211062	http://dx.doi.org/10.1371/journal.pone.0211062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707712	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900017
J	Jang, HD; Park, JS; Kim, DW; Han, K; Shin, BJ; Lee, JC; Choi, SW; Suh, SW; Yang, JH; Park, SY; Cho, WJ; Hong, JY				Jang, Hae-Dong; Park, Jin-Sung; Kim, Dae Woong; Han, Kyungdo; Shin, Byung-Joon; Lee, Jae Chul; Choi, Sung-Woo; Suh, Seung-Woo; Yang, Jae-Hyuk; Park, Si-Young; Cho, Whi Je; Hong, Jae-Young			Relationship between dementia and ankylosing spondylitis: A nationwide, population-based, retrospective longitudinal cohort study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PSYCHOLOGICAL STATUS; INFLAMMATION; INDICATOR; QUALITY; IMPACT	Among a variety of comorbidities of ankylosing spondylitis (AS), the association between dementia and AS by using an extensive dataset from the Korean National Health Insurance System was evaluated in this study. We extracted 15,547 newly diagnosed AS subjects among the entire Korean population and excluded wash-out patients (n = 162) and patients that were inappropriate for cohort match (n = 1192). Finally, 14,193 subjects were chosen as the AS group, and through 1: 5 age-and sex-stratified matching, 70,965 subjects were chosen as the control group. We evaluated patient demographics, household incomes, and comorbidities, including hypertension, diabetes, and dyslipidemia. The prevalence of overall dementia (1.37%) and Alzheimer's dementia (AD) (0.99%) in the AS group was significantly higher than in the control group (0.87% and 0.63%), respectively. The adjusted hazard ratio of the AS group for overall dementia (1.758) and AD (1.782) showed statistical significance also. On the other hand, the prevalence of vascular dementia did not differ significantly between the two groups. Subgroup analyses revealed the following risk factors for dementia in the AS group: male gender, greater than 65 years in age, fair income (household income greater than 20% of the median), urban residency, no diabetes, and no hypertension. From the nationwide, population-based, retrospective, longitudinal cohort study, AS patients showed a significantly higher prevalence of overall dementia and Alzheimer's dementia. Comprehensive patient assessment using our subgroup analysis could help to prevent dementia in patients suffering from AS.	[Jang, Hae-Dong; Cho, Whi Je] Soonchunhyang Univ Hosp, Dept Orthopaed Surg, Bucheon Si, Gyeonggi Do, South Korea; [Park, Jin-Sung; Hong, Jae-Young] Univ Korea Hosp, Dept Orthoped, Ansan, Gyeonggi Do, South Korea; [Kim, Dae Woong; Shin, Byung-Joon; Lee, Jae Chul; Choi, Sung-Woo] Soonchunhyang Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Han, Kyungdo] Catholic Univ, Dept Biostat, Coll Med, Seoul, South Korea; [Suh, Seung-Woo; Yang, Jae-Hyuk] Korea Univ, Coll Med, Guro Hosp, Scoliosis Res Inst,Dept Orthoped, Guro gu, Seoul, South Korea; [Park, Si-Young] Korea Univ, Coll Med, Anam Hosp, Dept Orthopaed Surg, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University; Soonchunhyang University Hospital; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Hong, JY (corresponding author), Univ Korea Hosp, Dept Orthoped, Ansan, Gyeonggi Do, South Korea.	osspine@korea.ac.kr			Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	The Manuscript submitted does not contain information about medical device(s)/drug (s). This work was supported by the Soonchunhyang University Research Fund. No relevant financial activities outside the submitted work.	Altun I, 2016, ASIAN SPINE J, V10, P655, DOI 10.4184/asj.2016.10.4.655; Batmaz I, 2013, RHEUMATOL INT, V33, P1039, DOI 10.1007/s00296-012-2513-2; Baysal O, 2011, RHEUMATOL INT, V31, P795, DOI 10.1007/s00296-010-1381-x; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Schneeberger EE, 2015, CLIN RHEUMATOL, V34, P497, DOI 10.1007/s10067-014-2682-3; Fiest KM, 2016, CAN J NEUROL SCI, V43, pS51, DOI 10.1017/cjn.2016.36; Marengo MF, 2008, JCR-J CLIN RHEUMATOL, V14, P273, DOI 10.1097/RHU.0b013e31817d1089; Haapasalo A, 2015, NEURODEGENER DIS MAN, V5, P379, DOI 10.2217/nmt.15.31; Hanamsagar R, 2016, J STEROID BIOCHEM, V160, P127, DOI 10.1016/j.jsbmb.2015.09.039; Haroon NN, 2015, ANN INTERN MED, V163, P409, DOI 10.7326/M14-2470; Healey EL, 2009, RHEUMATOLOGY, V48, P1378, DOI 10.1093/rheumatology/kep143; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jung SY, 2007, YONSEI MED J, V48, P218, DOI 10.3349/ymj.2007.48.2.218; Kai K, 2018, ASIAN SPINE J, V12, P434, DOI 10.4184/asj.2018.12.3.434; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kivimaki M, 2014, MOL PSYCHIATR, V19, P149, DOI 10.1038/mp.2013.35; Lange U, 2000, RHEUMATOL INT, V19, P119, DOI 10.1007/s002960050114; Lee DH, 2018, ACTA NEUROCHIR, V160, P949, DOI 10.1007/s00701-018-3499-7; Li Y, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4054; Martindale J, 2006, RHEUMATOLOGY, V45, P1288, DOI 10.1093/rheumatology/kel115; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Nurmohamed MT, 2012, CURR RHEUMATOL REP, V14, P415, DOI 10.1007/s11926-012-0270-6; Sun XY, 2008, ARCH GEN PSYCHIAT, V65, P542, DOI 10.1001/archpsyc.65.5.542; Webers C, 2016, RHEUMATOLOGY, V55, P419, DOI 10.1093/rheumatology/kev340; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143	25	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210335	10.1371/journal.pone.0210335	http://dx.doi.org/10.1371/journal.pone.0210335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703142	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600015
J	Alikhani, M; Alikhani, M; Alansari, S; Almansour, A; Hamidaddin, MA; Khoo, E; Lopez, JA; Nervina, JM; Nho, JY; Oliveira, SM; Sangsuwon, C; Teixeira, CC				Alikhani, Mani; Alikhani, Mona; Alansari, Sarah; Almansour, Abdullah; Hamidaddin, Mohammad A.; Khoo, Edmund; Lopez, Jose A.; Nervina, Jeanne M.; Nho, Joo Y.; Oliveira, Serafim M.; Sangsuwon, Chinapa; Teixeira, Cristina C.			Therapeutic effect of localized vibration on alveolar bone of osteoporotic rats	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; FREQUENCY MECHANICAL VIBRATION; MESENCHYMAL STEM-CELLS; MINERAL DENSITY; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; ESTROGEN-DEFICIENCY; CALCIUM INTAKE; LOW-MAGNITUDE; TIBIAL BONE	Objectives Vibration, in the form of high frequency acceleration (HFA), stimulates alveolar bone formation under physiologic conditions and during healing after dental extractions. It is not known if HFA has an anabolic effect on osteoporotic alveolar bone. Our objective is to determine if HFA has a regenerative effect on osteoporotic alveolar bone. Methods and materials Adult female Sprague-Dawley rats were divided into five groups: 1) Ovariectomized Group (OVX), 2) Sham-OVX Group that received surgery without ovariectomy, 3) OVX-HFA Group that was ovariectomized and treated daily with HFA, 4) OVX+ Static Force Group that was ovariectomized and received the same force as HFA, but without vibration, and 5) Control Group that did not receive any treatment. All animals were fed a low mineral diet for 3 months. Osteoporosis was confirmed by micro-CT of the fifth lumbar vertebra and femoral head. HFA was applied to the maxillary first molar for 5 minutes/day for 28 and 56 days. Maxillae were collected for micro-CT, histology, fluorescent microscopy, protein and RNA analysis, and three-point bending mechanical testing. Results Micro-CT analysis revealed significant alveolar bone osteoporosis in the OVX group. Vibration restored the quality and quantity of alveolar bone to levels similar to the Sham-OVX group. Animals exposed to HFA demonstrated higher osteoblast activity and lower osteoclast activity. Osteogenic transcription factors (RUNX2, Foxo1, Osterix and Wnt signaling factors) were upregulated following vibration, while RANKL/RANK and Sclerostin were downregulated. HFA did not affect serum TRAcP-5b or CTx-1 levels. The osteogenic effect was highest at the point of HFA application and extended along the hemimaxillae this effect did not cross to the contra-lateral side. Conclusions Local application of vibration generated gradients of increased anabolic metabolism and decreased catabolic metabolism in alveolar bone of osteoporotic rats. Our findings suggest that HFA could be a predictable treatment for diminished alveolar bone levels in osteoporosis patients.	[Alikhani, Mani] Harvard Sch Dent Med, Dept Dev Biol, Adv Grad Educ Program Orthodont, Boston, MA USA; [Alikhani, Mani; Alansari, Sarah] Forsyth Inst, Cambridge, MA USA; [Alikhani, Mani; Alikhani, Mona; Alansari, Sarah; Almansour, Abdullah; Hamidaddin, Mohammad A.; Lopez, Jose A.; Nervina, Jeanne M.; Nho, Joo Y.; Oliveira, Serafim M.; Sangsuwon, Chinapa; Teixeira, Cristina C.] CTOR Acad, Hoboken, NJ 07030 USA; [Khoo, Edmund; Sangsuwon, Chinapa; Teixeira, Cristina C.] NYU, Coll Dent, Dept Orthodont, New York, NY 10003 USA; [Oliveira, Serafim M.] Polytech Inst Viseu, Dept Mech Engn, Viseu, Portugal; [Teixeira, Cristina C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Forsyth Institute; New York University; Instituto Politecnico de Viseu; New York University	Teixeira, CC (corresponding author), CTOR Acad, Hoboken, NJ 07030 USA.; Teixeira, CC (corresponding author), NYU, Coll Dent, Dept Orthodont, New York, NY 10003 USA.; Teixeira, CC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	cristina.teixeira@nyu.edu	de Oliveira, Serafim Paulo Melo/Y-3066-2019; Hamidaddin, Mohammad/GXF-1687-2022	de Oliveira, Serafim Paulo Melo/0000-0002-3499-6681; Hamidaddin, Mohammad/0000-0002-5092-264X	Small Business Technology Transfer Grant(STTR) [R41 DE025518]; NIDCR	Small Business Technology Transfer Grant(STTR); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by Small Business Technology Transfer Grant(STTR)#R41 DE025518 from NIDCR (nidcr.nih.gov) that was granted to Mani Alikhani and C.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2016, J DENT RES, V95, P311, DOI 10.1177/0022034515621495; Alikhani M, 2012, J DENT RES, V91, P413, DOI 10.1177/0022034512438590; Alikhani M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196540; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Brouwers JEM, 2010, J ORTHOP RES, V28, P62, DOI 10.1002/jor.20951; Civitelli R, 2002, ARCH INTERN MED, V162, P1409, DOI 10.1001/archinte.162.12.1409; Darcey J, 2013, BRIT DENT J, V214, DOI 10.1038/sj.bdj.2013.165; Du ZB, 2015, TISSUE ENG PART C-ME, V21, P458, DOI [10.1089/ten.TEC.2014.0268, 10.1089/ten.tec.2014.0268]; Ejiri S, 2008, J BONE MINER METAB, V26, P409, DOI 10.1007/s00774-008-0870-4; ELOVIC RP, 1994, J DENT RES, V73, P1735, DOI 10.1177/00220345940730110901; Ervin RB, 2009, J PUBLIC HEALTH DENT, V69, P207, DOI 10.1111/j.1752-7325.2009.00124.x; Han JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181175; Hara T, 2001, ARCH ORAL BIOL, V46, P443, DOI 10.1016/S0003-9969(00)00135-7; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Herring SW, 2007, ARCH ORAL BIOL, V52, P296, DOI 10.1016/j.archoralbio.2006.09.010; Iwasaki M, 2012, J BONE MINER METAB, V30, P447, DOI 10.1007/s00774-011-0337-x; Jiang GZ, 2003, J BONE MINER METAB, V21, P388, DOI 10.1007/s00774-003-0433-7; Jiang JMY, 2008, J NUTR, V138, P2106, DOI 10.3945/jn.108.093781; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kasturi GC, 2011, PM&R, V3, P562, DOI 10.1016/j.pmrj.2010.12.014; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Martinez H, 2001, CLIN ORAL IMPLAN RES, V12, P423, DOI 10.1034/j.1600-0501.2001.120501.x; Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020; Mavropoulos A, 2007, J BONE MINER RES, V22, P403, DOI 10.1359/JBMR.061208; Mavropoulos A, 2014, J BIOMECH, V47, P2666, DOI 10.1016/j.jbiomech.2014.05.012; Moriya Y, 1998, J Oral Sci, V40, P171; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nicopoulou-Karayianni K, 2009, J CLIN PERIODONTOL, V36, P190, DOI 10.1111/j.1600-051X.2008.01365.x; Ota T, 2016, CYTOTECHNOLOGY, V68, P2287, DOI 10.1007/s10616-016-0023-x; Passos JS, 2013, OSTEOPOROSIS INT, V24, P1275, DOI 10.1007/s00198-012-2130-7; Pavone V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00803; Payne JB, 1999, OSTEOPOROSIS INT, V10, P34, DOI 10.1007/s001980050191; Prado RFD, 2012, INT J EXP PATHOL, V93, P139, DOI 10.1111/j.1365-2613.2012.00809.x; Qing FZ, 2016, J ORTHOP RES, V34, P1147, DOI 10.1002/jor.23128; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Slatkovska L, 2011, ANN INTERN MED, V155, P668, DOI 10.7326/0003-4819-155-10-201111150-00005; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stolina M, 2014, BONE, V67, P305, DOI 10.1016/j.bone.2014.07.031; Taguchi A, 2004, MENOPAUSE, V11, P556, DOI 10.1097/01.GME.0000113845.74462.BF; Tanaka M, 2003, ORAL SURG ORAL MED O, V95, P495, DOI 10.1067/moe.2003.135; Teixeira CC, 2010, J DENT RES, V89, P1135, DOI 10.1177/0022034510373764; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; Tezal M, 2000, J PERIODONTOL, V71, P1492, DOI 10.1902/jop.2000.71.9.1492; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Uusi-Rasi K, 1998, J BONE MINER RES, V13, P133, DOI 10.1359/jbmr.1998.13.1.133; Uzer G, 2013, J BIOMECH, V46, P2296, DOI 10.1016/j.jbiomech.2013.06.008; van der Jagt OP, 2012, J BONE MINER METAB, V30, P40, DOI 10.1007/s00774-011-0293-5; Vanleene M, 2013, BONE, V53, P507, DOI 10.1016/j.bone.2013.01.023; von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Yadav S, 2016, EUR J ORTHODONT, V38, P44, DOI 10.1093/ejo/cjv006; Yadav S, 2015, AM J ORTHOD DENTOFAC, V148, P440, DOI 10.1016/j.ajodo.2015.03.031; Yang J, 2003, DENTOMAXILLOFAC RAD, V32, P247, DOI 10.1259/dmfr/12560890; Yang P, 2009, AVIAT SPACE ENVIR MD, V80, P88, DOI 10.3357/ASEM.2368.2009; Yoshihara A, 2005, J ORAL REHABIL, V32, P735, DOI 10.1111/j.1365-2842.2005.01491.x; Zhou Y, 2015, BONE, V71, P17, DOI 10.1016/j.bone.2014.09.026	63	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211004	10.1371/journal.pone.0211004	http://dx.doi.org/10.1371/journal.pone.0211004			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695073	Green Submitted, Green Published, gold			2022-12-26	WOS:000457046400014
J	Turner, KJ; Hoyle, J; Valdivia, LE; Cerveny, KL; Hart, W; Mangoli, M; Geisler, R; Rees, M; Houart, C; Poole, RJ; Wilson, SW; Gestri, G				Turner, Katherine J.; Hoyle, Jacqueline; Valdivia, Leonardo E.; Cerveny, Kara L.; Hart, Wendy; Mangoli, Maryam; Geisler, Robert; Rees, Michele; Houart, Corinne; Poole, Richard J.; Wilson, Stephen W.; Gestri, Gaia			Abrogation of Stem Loop Binding Protein (Slbp) function leads to a failure of cells to transition from proliferation to differentiation, retinal coloboma and midline axon guidance deficits	PLOS ONE			English	Article							HISTONE MESSENGER-RNA; GENE-EXPRESSION; 3' END; TRIGGERS DEGRADATION; EMBRYONIC ZEBRAFISH; DROSOPHILA; MUTATIONS; NEUROGENESIS; BRAIN; WNT	Through forward genetic screening for mutations affecting visual system development, we identified prominent coloboma and cell-autonomous retinal neuron differentiation, lamination and retinal axon projection defects in eisspalte (ele) mutant zebrafish. Additional axonal deficits were present, most notably at midline axon commissures. Genetic mapping and cloning of the ele mutation showed that the affected gene is slbp, which encodes a conserved RNA stem-loop binding protein involved in replication dependent histone mRNA metabolism. Cells throughout the central nervous system remained in the cell cycle in ele mutant embryos at stages when, and locations where, post-mitotic cells have differentiated in wild-type siblings. Indeed, RNAseq analysis showed down-regulation of many genes associated with neuronal differentiation. This was coincident with changes in the levels and spatial localisation of expression of various genes implicated, for instance, in axon guidance, that likely underlie specific ele phenotypes. These results suggest that many of the cell and tissue specific phenotypes in ele mutant embryos are secondary to altered expression of modules of developmental regulatory genes that characterise, or promote transitions in, cell state and require the correct function of Slbp-dependent histone and chromatin regulatory genes.	[Turner, Katherine J.; Hoyle, Jacqueline; Valdivia, Leonardo E.; Cerveny, Kara L.; Hart, Wendy; Mangoli, Maryam; Poole, Richard J.; Wilson, Stephen W.; Gestri, Gaia] UCL, Div Biosci, Dept Cell & Dev Biol, London, England; [Hoyle, Jacqueline; Rees, Michele] UCL, Dept Paediat & Child Hlth, London, England; [Valdivia, Leonardo E.] Univ Mayor, Fac Ciencias, Ctr Integrat Biol, Santiago, Chile; [Geisler, Robert] KIT, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Houart, Corinne] Kings Coll London, Dept Dev Neurobiol, London, England; [Houart, Corinne] Kings Coll London, MRC Ctr Dev Disorders, London, England; [Cerveny, Kara L.] Reed Coll, Dept Biol, Portland, OR 97202 USA	University of London; University College London; University of London; University College London; Universidad Mayor; Helmholtz Association; Karlsruhe Institute of Technology; University of London; King's College London; University of London; King's College London; Reed College - Oregon	Wilson, SW; Gestri, G (corresponding author), UCL, Div Biosci, Dept Cell & Dev Biol, London, England.	s.wilson@ucl.ac.uk; g.gestri@ucl.ac.uk	Houart, Corinne/B-5128-2009; Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008; Geisler, Robert/K-6201-2013	Houart, Corinne/0000-0002-2062-3964; Wilson, Stephen W/0000-0002-8557-5940; Geisler, Robert/0000-0002-3909-8311; Cerveny, Kara/0000-0003-0667-827X; Gestri, Gaia/0000-0001-8854-1546; Valdivia, Leonardo E./0000-0002-9589-2114; Turner, Katherine/0000-0002-3867-2684; Poole, Richard/0000-0001-6414-2479	Medical Research Council [G0900994, MR/L003775/1]; Wellcome Trust [095722/Z/11/Z, 207483/Z/17/Z, 089227/Z09/Z, 104682/Z/14/Z]; FONDECYT [11160951]; MRC [MR/L003775/1, G0900994] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council [G0900994 and MR/L003775/1 to S.W.W. and G.G] and Wellcome Trust [095722/Z/11/Z and 207483/Z/17/Z to R.J.P, and 089227/Z09/Z and 104682/Z/14/Z to S.W.W. and FONDECYT [11160951 to L.E.V]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldiri I, 2013, DEVELOPMENT, V140, P2867, DOI 10.1242/dev.088096; Arnold DR, 2008, DEV BIOL, V313, P347, DOI 10.1016/j.ydbio.2007.10.032; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basson MA, 2015, TRENDS GENET, V31, P600, DOI 10.1016/j.tig.2015.05.009; Bazin-Lopez N, 2015, CURR OPIN GENET DEV, V32, P73, DOI 10.1016/j.gde.2015.02.004; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; BOND UM, 1991, GENE DEV, V5, P1709, DOI 10.1101/gad.5.9.1709; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; Dankert JF, 2017, CELL CYCLE, V16, P556, DOI 10.1080/15384101.2017.1284715; Doitsidou M, 2016, GENETICS, V204, P451, DOI 10.1534/genetics.115.186197; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2005, RNA, V11, P1835, DOI 10.1261/rna.2179305; Gao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036516; Gestri G, 2012, DEV NEUROBIOL, V72, P302, DOI 10.1002/dneu.20919; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; He WX, 2018, RNA, V24, P1738, DOI 10.1261/rna.067090.118; He YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep16535; Husken U, 2014, CURR BIOL, V24, P2217, DOI 10.1016/j.cub.2014.08.006; Imai F, 2014, DEV BIOL, V394, P94, DOI 10.1016/j.ydbio.2014.07.020; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Knapik EW, 1996, DEVELOPMENT, V123, P451; Knock E, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0040-z; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Kodama Y, 2002, DEVELOPMENT, V129, P187; Koseoglu MM, 2008, MOL CELL BIOL, V28, P4469, DOI 10.1128/MCB.01416-07; LaFave MC, 2014, GENETICS, V198, P167, DOI 10.1534/genetics.114.166769; Lanzotti DJ, 2002, MOL CELL BIOL, V22, P2267, DOI 10.1128/MCB.22.7.2267-2282.2002; Lee RS, 2013, BRAIN PATHOL, V23, P200, DOI 10.1111/bpa.12021; Lefebvre FA, 2017, J MOL BIOL, V429, P3264, DOI 10.1016/j.jmb.2017.01.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04289; Lupo G, 2011, P NATL ACAD SCI USA, V108, P8698, DOI 10.1073/pnas.1103802108; Macdonald R, 1997, DEVELOPMENT, V124, P2397; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Marzluff WF, 2017, TRENDS GENET, V33, P745, DOI 10.1016/j.tig.2017.07.014; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Nambiar RM, 2004, DEV BIOL, V267, P165, DOI 10.1016/j.ydbio.2003.11.019; Nambiar RM, 2007, MECH DEVELOP, V124, P682, DOI 10.1016/j.mod.2007.07.003; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Obholzer N, 2012, DEVELOPMENT, V139, P4280, DOI 10.1242/dev.083931; Okano HJ, 1997, J NEUROSCI, V17, P3024; Pettitt J, 2002, J CELL SCI, V115, P857; Raphael AR, 2011, CURR TOP DEV BIOL, V97, P1, DOI 10.1016/B978-0-12-385975-4.00007-3; Rauch G. -J., 1997, TECHNICAL TIPS ONLIN, V2, P148, DOI [10.1016/S1366-2120(08)70068-0, DOI 10.1016/S1366-2120(08)70068-0]; Ritchie K, 2014, BIOL OPEN, V3, P1158, DOI 10.1242/bio.20148730; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Saldi T, 2018, GENE DEV, V32, P297, DOI 10.1101/gad.310896.117; Salzler HR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008168; SCHAUFELE F, 1986, NATURE, V323, P777, DOI 10.1038/323777a0; Stadler JA, 2005, DEV DYNAM, V233, P883, DOI 10.1002/dvdy.20427; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner KJ, 2014, METHODS MOL BIOL, V1082, P197, DOI 10.1007/978-1-62703-655-9_14; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Wagner EJ, 2005, BIOCHEM SOC T, V33, P471, DOI 10.1042/BST0330471; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; WILSON SW, 1990, DEVELOPMENT, V108, P121; WOO K, 1995, CURR OPIN GENET DEV, V5, P439, DOI 10.1016/0959-437X(95)90046-J; Xu RH, 2000, DEV DYNAM, V218, P628, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1024>3.0.CO;2-H; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yano M, 2016, INT J DEV NEUROSCI, V55, P124, DOI 10.1016/j.ijdevneu.2016.01.002; You LY, 2015, J BIOL CHEM, V290, P11349, DOI 10.1074/jbc.M115.643189; Zhao XJ, 2004, J CELL SCI, V117, P6043, DOI 10.1242/jcs.01523; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	78	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211073	10.1371/journal.pone.0211073	http://dx.doi.org/10.1371/journal.pone.0211073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695021	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400015
J	Stabler, M; Kempf, A; Smout, S; Temming, A				Staebler, Moritz; Kempf, Alexander; Smout, Sophie; Temming, Axel			Sensitivity of multispecies maximum sustainable yields to trends in the top (marine mammals) and bottom (primary production) compartments of the southern North Sea food-web	PLOS ONE			English	Article							EUTROPHICATION STATUS; FISHERIES MANAGEMENT; OXYGEN DEFICIENCY; CLIMATE-CHANGE; PHYTOPLANKTON; PLANKTON; COASTAL; OLIGOTROPHICATION; CONSEQUENCES; POPULATION	In marine ecosystems, maximum sustainable yield considerations are affected by any substantial changes that occur in the top and bottom compartments of the food-web. This study explores how the southern North Sea's fisheries may need to adjust their fishing efforts to maintain optimum yields of sole, plaice, cod and brown shrimps under increased marine mammal populations and a reduced primary productivity. We constructed plausible scenarios of ongoing food-web changes using the results of Bayesian age-structured population models to estimate carrying capacities of harbour porpoises (Phocoena phocoena) and grey seals (Halichoerus grypus). Losses in primary productivity were predicted by lower trophic level ecosystem models. These scenarios were implemented in a food-web model of the southern North Sea. For each scenario, we sought mixed-fleet fishing efforts that would deliver maximum yields of sole, plaice, cod and brown shrimp combined. We also did so for a baseline run with unaltered mammal and primary production, and compared the differences in optimal fishing strategies, predicted yields, and states of the stocks between the scenarios. We found stocks and yields to be far more sensitive to changes in primary productivity than to increased marine mammal predation. The latter predominantly impacted cod, and even benefitted brown shrimps compared to the baseline run. Under 30% reduced primary productivity, fishing efforts had to be reduced by 50% to still provide maximum yields, whereas the marine mammal scenario induced no need to adjust the fishing regime. This draws attention to the potential gains of incorporating bottom-up processes into long-term management considerations, while marine mammal predation may be less of a concern, in particular for flatfish fisheries in the North Sea, and may even benefit shrimp trawlers because of reduced predation on shrimp from fish predators.	[Staebler, Moritz] Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany; [Staebler, Moritz; Temming, Axel] Univ Hamburg, Inst Hydrobiol & Fishery Sci IHF, Hamburg, Germany; [Staebler, Moritz; Kempf, Alexander] Thunen Inst Sea Fisheries, Bremerhaven, Germany; [Smout, Sophie] Scottish Oceans Inst, St Andrews, Fife, Scotland	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Hamburg; Johann Heinrich von Thunen Institute; University of St Andrews	Stabler, M (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany.; Stabler, M (corresponding author), Univ Hamburg, Inst Hydrobiol & Fishery Sci IHF, Hamburg, Germany.; Stabler, M (corresponding author), Thunen Inst Sea Fisheries, Bremerhaven, Germany.	moritz.staebler@posteo.de			European Commission [289257]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors (MS, AK, SS, AT) gratefully acknowledge financial support through the European Commission's MYFISH project (Maximising yield of fisheries while balancing ecosystem, economic and social concerns, FP7/2007-2013 under grant agreement no 289257; http://myfishproject.eu), and thank its organizers for providing the opportunity to draft this study during its meetings and the 2016 Athens symposium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2015, ICES J MAR SCI, V72, P436, DOI 10.1093/icesjms/fsu149; [Anonymous], 2007, E MOD EC APPR FISH; [Anonymous], 2015, REPORT WORKING GROUP; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Beukema JJ, 2002, J SEA RES, V48, P111, DOI 10.1016/S1385-1101(02)00162-4; BEUKEMA JJ, 1986, OPHELIA, V26, P55, DOI 10.1080/00785326.1986.10421978; Boddeke R, 1996, ICES J MAR SCI, V53, P995, DOI 10.1006/jmsc.1996.0124; BURKILL PH, 1987, MAR BIOL, V93, P581, DOI 10.1007/BF00392796; Camphuysen Kees C. J., 2004, Lutra, V47, P113; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Claussen U, 2009, HYDROBIOLOGIA, V629, P49, DOI 10.1007/s10750-009-9763-3; COLEBROOK JM, 1979, MAR BIOL, V51, P23, DOI 10.1007/BF00389027; Colijn F, 2002, HYDROBIOLOGIA, V484, P133, DOI 10.1023/A:1021361206529; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; de Jong F, 2006, MARINE EUTROPHICATIO; DETHLEFSEN V, 1983, MEERESFORSCHUNG, V30, P42; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Gerdeaux D, 2006, ACTA OECOL, V30, P161, DOI 10.1016/j.actao.2006.02.007; Grosse F, 2016, BIOGEOSCIENCES, V13, P2511, DOI 10.5194/bg-13-2511-2016; HAGERMAN L, 1995, MAR BIOL, V123, P235, DOI 10.1007/BF00353614; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Hilborn R, 2010, MAR POLICY, V34, P193, DOI 10.1016/j.marpol.2009.04.013; Hislop J., 1997, DATABASE REPORT STOM; Jones EL, 2015, MAR ECOL PROG SER, V534, P235, DOI 10.3354/meps11370; Kempf A, 2016, MAR POLICY, V69, P146, DOI 10.1016/j.marpol.2016.04.012; Lenhart HJ, 2010, J MARINE SYST, V81, P148, DOI 10.1016/j.jmarsys.2009.12.014; Ludsin SA, 2001, ECOL APPL, V11, P731, DOI 10.2307/3061113; MacKenzie BR, 2012, AMBIO, V41, P626, DOI 10.1007/s13280-012-0325-y; Mackinson S., 2007, 142 CEFAS; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; Miller D, 2010, COMBINED EXPOST EXAN; Niiranen S, 2013, GLOBAL CHANGE BIOL, V19, P3327, DOI 10.1111/gcb.12309; Plikshs M., 1993, 1993J22 ICES CM; REISE K, 1982, NETH J SEA RES, V16, P29, DOI 10.1016/0077-7579(82)90014-X; Rijnsdorp A, 2004, CM2004K ICES, P13; Rijnsdorp AD, 1996, ICES J MAR SCI, V53, P1199, DOI 10.1006/jmsc.1996.0145; Stabler M, OCEAN COASTAL MANAGE; Stabler M, 2016, WISSENSCHAFT ERLEBEN, V1, P12, DOI [10.1111/j.1365-2486.2009.02063.x, DOI 10.1111/J.1365-2486.2009.02063.X]; Stabler M, 2014, FISHERIES CTR RES RE, V22; Stabler M, 2016, ECOL MODEL, V331, P17, DOI 10.1016/j.ecolmodel.2016.01.020; Stockner JG, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:CO>2.0.CO;2; Stottrup JC, 2017, J SEA RES, V127, P164, DOI 10.1016/j.seares.2017.01.001; Temming A, 2015, ICES J MAR SCI, V72, P804, DOI 10.1093/icesjms/fsu194; TMAP, 2013, PAR GROUP MAR MAMM; Trites AW, 1999, LOW WAKE FI, V16, P609; Ulrich C, 2001, AQUAT LIVING RESOUR, V14, P267, DOI 10.1016/S0990-7440(01)01132-9; Ulrich C, 2012, OCEAN COAST MANAGE, V70, P38, DOI 10.1016/j.ocecoaman.2012.06.002; Vinther M, 2004, ICES J MAR SCI, V61, P1398, DOI 10.1016/j.icesjms.2004.08.018; WGNSSK, 2015, REP WORK GROUP ASS D; WGNSSK, 2014, REP WORK GROUP ASS D; WKMSYREF3, 2014, JOINT ICES MYFISH WO; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	53	6	7	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210882	10.1371/journal.pone.0210882	http://dx.doi.org/10.1371/journal.pone.0210882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689649	gold, Green Published			2022-12-26	WOS:000457041800013
J	Mishra, AK; Placzek, C; Jones, R				Mishra, Ashish Kumar; Placzek, Christa; Jones, Rhondda			Coupled influence of precipitation and vegetation on millennial-scale erosion rates derived from Be-10	PLOS ONE			English	Article							WEAK CLIMATIC CONTROL; SITU-PRODUCED BE-10; DENUDATION RATES; SOIL-EROSION; COSMOGENIC NUCLIDES; SEDIMENT TRANSPORT; PLATEAU UPLIFT; SOUTHERN ASIA; ROCK UPLIFT; HALF-LIFE	Water is one of the main agent of erosion in many environmental settings, but erosion rates derived from beryllium-10 (Be-10) suggests that a relationship between precipitation and erosion rate is statistically non-significant on a global scale. This might be because of the strong influence of other variables on erosion rate. In this global Be-10 compilation, we examine if mean annual precipitation has a statistically significant secondary control on erosion rate. Our secondary variable assessment suggests a significant secondary influence of precipitation on erosion rate. This is the first time that the influence of precipitation on Be-10-derived erosion rate is recognized on global scale. In fact, in areas where slope is <200m/km (similar to 11 degrees), precipitation influences erosion rate as much as mean basin slope, which has been recognized as the most important variable in previous Be-10 compilations. In areas where elevation is <1000m and slope is <11 degrees, the correlation between precipitation and erosion rate improves considerably. These results also suggest that erosion rate responds to change in mean annual precipitation nonlinearly and in three regimes: 1) it increases with an increase in precipitation until similar to 1000 mm/yr; 2) erosion rate stabilizes at similar to 1000 mm/yr and decreases slightly with increased precipitation until similar to 2200 mm/yr; and 3) it increases again with further increases in precipitation. This complex relationship between erosion rate and mean annual precipitation is best explained by the interrelationship between mean annual precipitation and vegetation. Increased vegetation, particularly the presence of trees, is widely recognized to lower erosion rate. Our results suggest that tree cover of 40% or more reduces erosion rate enough to outweigh the direct erosive effects of increased rainfall. Thus, precipitation emerges as a stronger secondary control on erosion rate in hyper-arid areas, as well as in hyper-wet areas. In contrast, the regime between similar to 1000 and similar to 2200 mm/yr is dominated by opposing relationships where higher rainfall acts to increase erosion rate, but more water also increases vegetation/tree cover, which slows erosion. These results suggest that when interpreting the sedimentological record, high sediment fluxes are expected to occur when forests transition to grasslands/savannahs; however, aridification of grasslands or savannahs into deserts will result in lower sediment fluxes. This study also implies that anthropogenic deforestation, particularly in regions with high rainfall, can greatly increase erosion.	[Mishra, Ashish Kumar; Placzek, Christa] James Cook Univ, Geosci, Coll Sci & Engn, Townsville, Qld, Australia; [Mishra, Ashish Kumar; Placzek, Christa] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Townsville, Qld, Australia; [Jones, Rhondda] James Cook Univ, StatsHelp Serv, Grad Res Sch, Townsville, Qld, Australia	James Cook University; James Cook University; James Cook University	Mishra, AK (corresponding author), James Cook Univ, Geosci, Coll Sci & Engn, Townsville, Qld, Australia.; Mishra, AK (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Townsville, Qld, Australia.	ashish.mishra@my.jcu.edu.au						Acosta VT, 2015, LITHOSPHERE-US, V7, P408, DOI 10.1130/L402.1; [Anonymous], 1960, CLIMAT EROSION RELAT; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Balco G, 2009, EARTH PLANET SC LETT, V286, P570, DOI 10.1016/j.epsl.2009.07.025; Bermudez MA, 2013, LITHOSPHERE-US, V5, P3, DOI 10.1130/L212.1; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Bierman P, 1996, EARTH SURF PROC LAND, V21, P125, DOI 10.1002/(SICI)1096-9837(199602)21:2<125::AID-ESP511>3.0.CO;2-8; Bierman PR, 2002, GEOL SOC AM BULL, V114, P787, DOI 10.1130/0016-7606(2002)114<0787:CEAEHO>2.0.CO;2; Bierman PR, 2001, AM J SCI, V301, P326, DOI 10.2475/ajs.301.4-5.326; Binnie SA, 2007, GEOLOGY, V35, P743, DOI 10.1130/G23641A.1; Bochet E, 2006, EARTH SURF PROC LAND, V31, P536, DOI 10.1002/esp.1351; Bonnet S, 2003, GEOLOGY, V31, P123, DOI 10.1130/0091-7613(2003)031<0123:LRTCCI>2.0.CO;2; BROWN ET, 1995, EARTH PLANET SC LETT, V129, P193, DOI 10.1016/0012-821X(94)00249-X; Brown ET, 1998, EARTH PLANET SC LETT, V160, P723, DOI 10.1016/S0012-821X(98)00123-X; BROWN L, 1988, EARTH SURF PROC LAND, V13, P441, DOI 10.1002/esp.3290130509; Buechi MW, 2014, QUAT GEOCHRONOL, V19, P135, DOI 10.1016/j.quageo.2013.06.005; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Carretier S, 2013, GEOLOGY, V41, P195, DOI 10.1130/G33735.1; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Cyr AJ, 2010, LITHOSPHERE-US, V2, P188, DOI 10.1130/L96.1; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Dedkov AP, 1984, EROSION SEDIMENT RUN; Defries RS, 2000, GLOBAL CHANGE BIOL, V6, P247, DOI 10.1046/j.1365-2486.2000.00296.x; DiBiase RA, 2010, EARTH PLANET SC LETT, V289, P134, DOI 10.1016/j.epsl.2009.10.036; DiBiase RA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002095; Dixon JL, 2009, GEOLOGY, V37, P975, DOI 10.1130/G30045A.1; Dixon JL, 2009, EARTH SURF PROC LAND, V34, P1507, DOI 10.1002/esp.1836; DOUGLAS I, 1967, NATURE, V215, P925, DOI 10.1038/215925a0; Zuazo VHD, 2008, AGRON SUSTAIN DEV, V28, P65, DOI [10.1051/agro:2007062, 10.1007/978-90-481-2666-8_48]; Finnegan NJ, 2008, GEOL SOC AM BULL, V120, P142, DOI 10.1130/B26224.1; Gabrovsek F, 2009, GEOMORPHOLOGY, V106, P9, DOI 10.1016/j.geomorph.2008.09.008; Garcia-Ruiz JM, 2015, GEOMORPHOLOGY, V239, P160, DOI 10.1016/j.geomorph.2015.03.008; Granger DE, 1996, J GEOL, V104, P249, DOI 10.1086/629823; Grujic D, 2006, GEOLOGY, V34, P801, DOI 10.1130/G22648.1; Harel MA, 2016, GEOMORPHOLOGY, V268, P184, DOI 10.1016/j.geomorph.2016.05.035; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; Heimsath AM, 2010, GEOL SOC SPEC PUBL, V346, P225, DOI 10.1144/SP346.12; Henck AC, 2011, EARTH PLANET SC LETT, V303, P71, DOI 10.1016/j.epsl.2010.12.038; Hewawasam T, 2003, GEOLOGY, V31, P597, DOI 10.1130/0091-7613(2003)031<0597:IOHONE>2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JANSSON MB, 1988, GEOGR ANN A, V70, P81, DOI 10.2307/521127; Kaspari M, 2008, FUNCT ECOL, V22, P919, DOI 10.1111/j.1365-2435.2008.01447.x; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Kirchner JW, 2001, GEOLOGY, V29, P591, DOI 10.1130/0091-7613(2001)029<0591:MEOYKY>2.0.CO;2; KNOX JC, 1972, ANN ASSOC AM GEOGR, V62, P401, DOI 10.1111/j.1467-8306.1972.tb00872.x; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; LAL D, 1991, EARTH PLANET SC LETT, V104, P424, DOI 10.1016/0012-821X(91)90220-C; Lal R., 1990, Advances in Soil Science, V11, P129; Lal R, 2001, LAND DEGRAD DEV, V12, P519, DOI 10.1002/ldr.472; Langbein W. B., 1958, AM GEOPHYS UNION T, V39, P1076, DOI DOI 10.1029/TR039I006P01076; Matmon A, 2018, GEOMORPHOLOGY, V313, P72, DOI 10.1016/j.geomorph.2018.04.008; Matmon A, 2009, GEOL SOC AM BULL, V121, P688, DOI 10.1130/B26422.1; Meade R. H., 1988, PHYS CHEM WEATHERING, P165; Merritt WS, 2003, ENVIRON MODELL SOFTW, V18, P761, DOI 10.1016/S1364-8152(03)00078-1; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Moon S, 2011, NAT GEOSCI, V4, P469, DOI [10.1038/NGEO1159, 10.1038/ngeo1159]; Mutz SG, 2018, EARTH SURF DYNAM, V6, P271, DOI 10.5194/esurf-6-271-2018; Neyman J., 1937, PHILOS T R SOC S-A, V236, P333, DOI DOI 10.1098/RSTA.1937.0005; Nichols KK, 2014, GEOMORPHOLOGY, V224, P102, DOI 10.1016/j.geomorph.2014.07.019; NISHIIZUMI K, 1986, NATURE, V319, P134, DOI 10.1038/319134a0; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimentel D, 1998, ECOSYSTEMS, V1, P416, DOI 10.1007/s100219900035; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; Placzek CJ, 2010, EARTH PLANET SC LETT, V295, P12, DOI 10.1016/j.epsl.2010.03.006; Placzek C, 2014, AM J SCI, V314, P1462, DOI 10.2475/10.2014.03; Portenga E, 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/G111A.1; Portenga EW, 2016, GEOLOGY, V44, P131, DOI 10.1130/G37257.1; Portenga EW, 2013, GEOL SOC AM BULL, V125, P201, DOI 10.1130/B30559.1; Quigley M, 2007, EARTH PLANET SC LETT, V261, P120, DOI 10.1016/j.epsl.2007.06.020; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Reusser L, 2015, GEOLOGY, V43, P171, DOI 10.1130/G36272.1; Rey F, 2003, CATENA, V50, P549, DOI 10.1016/S0341-8162(02)00121-2; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; Riebe CS, 2001, GEOLOGY, V29, P447, DOI 10.1130/0091-7613(2001)029<0447:MCCOER>2.0.CO;2; Riebe CS, 2001, GEOLOGY, V29, P511, DOI 10.1130/0091-7613(2001)029<0511:STAWCC>2.0.CO;2; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; ROGERS RD, 1991, J HYDROL, V123, P19, DOI 10.1016/0022-1694(91)90065-P; Rosenkranz R, 2018, EARTH PLANET SC LETT, V483, P39, DOI 10.1016/j.epsl.2017.11.047; RUDDIMAN WF, 1989, J GEOPHYS RES-ATMOS, V94, P18379, DOI 10.1029/JD094iD15p18379; RUDDIMAN WF, 1989, J GEOPHYS RES-ATMOS, V94, P18409, DOI 10.1029/JD094iD15p18409; Ryb U, 2014, EARTH PLANET SC LETT, V406, P142, DOI 10.1016/j.epsl.2014.09.008; Schaller M, 2018, EARTH PLANET SC LETT, V489, P111, DOI 10.1016/j.epsl.2018.02.026; Schaller M, 2001, EARTH PLANET SC LETT, V188, P441, DOI 10.1016/S0012-821X(01)00320-X; Scherler D, 2014, J GEOPHYS RES-EARTH, V119, P83, DOI 10.1002/2013JF002955; Schumm S. A., 1963, DISPARITY PRESENT RA; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; SUMMERFIELD MA, 1994, J GEOPHYS RES-SOL EA, V99, P13871, DOI 10.1029/94JB00715; Trimble SW, 2000, SCIENCE, V289, P248, DOI 10.1126/science.289.5477.248; Tucker GE, 1998, WATER RESOUR RES, V34, P2751, DOI 10.1029/98WR01474; Tucker GE, 2000, WATER RESOUR RES, V36, P1953, DOI 10.1029/2000WR900065; Vanacker V, 2007, EARTH PLANET SC LETT, V253, P402, DOI 10.1016/j.epsl.2006.11.003; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Walling D, 1987, WATER FUTURE HYDROLO; WALLING DE, 1996, P INT S HELD EX UK 1; Walling DE, 1983, BACKGROUND PALAEOHYD, V158, P69; Whiting PJ, 2006, J AM WATER RESOUR AS, V42, P769, DOI 10.1111/j.1752-1688.2006.tb04491.x; Willenbring JK, 2013, GEOLOGY, V41, P343, DOI 10.1130/G33918.1; Wittmann H, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000729; Xu JX, 2005, CATENA, V64, P103, DOI 10.1016/j.catena.2005.07.004; Yanites BJ, 2015, NAT GEOSCI, V8, P462, DOI 10.1038/NGEO2429; Zimmermann A, 2012, J HYDROL, V428, P170, DOI 10.1016/j.jhydrol.2012.01.039	106	14	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211325	10.1371/journal.pone.0211325	http://dx.doi.org/10.1371/journal.pone.0211325			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682174	Green Published, gold, Green Accepted			2022-12-26	WOS:000457037500149
J	Wodlej, C; Riedl, S; Rinner, B; Leber, R; Drechsler, C; Voelker, DR; Choi, JY; Lohner, K; Zweytick, D				Wodlej, Christina; Riedl, Sabrina; Rinner, Beate; Leber, Regina; Drechsler, Carina; Voelker, Dennis R.; Choi, Jae-Yeon; Lohner, Karl; Zweytick, Dagmar			Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; HOST-DEFENSE PEPTIDES; DE-NOVO PEPTIDE; ANTIMICROBIAL PEPTIDE; HUMAN LACTOFERRICIN; CANCER-CELLS; TUMOR-CELLS; GD3 GANGLIOSIDE; PEP-FOLD; APOPTOSIS	R-DIM-P-LF11-322 and DIM-LF11-318, derived from the cationic human host defense peptide lactoferricin show antitumor activity against human melanoma. While R-DIM-P-LF11-322 interacts specifically with cancer cells, the non-specific DIM-LF11-318 exhibits as well activity against non-neoplastic cells. Recently we have shown that cancer cells expose the negatively charged lipid phosphatidylserine (PS) in the outer leaflet of the plasma membrane, while non-cancer cells just expose zwitterionic or neutral lipids, such as phosphatidylcholine (PC) or cholesterol. Calorimetric and zeta potential studies with R-DIM-P-LF11-322 and cancer-mimetic liposomes composed of PS, PC and cholesterol indicate that the can-cer-specific peptide interacts specifically with PS. Cholesterol, however, reduces the effectiveness of the peptide. The non-specific DIM-LF11-318 interacts with PC and PS. Cholesterol does not affect its interaction. The dependence of activity of R-DIM-P-LF11-322 on the presence of exposed PS was also confirmed in vitro upon PS depletion of the outer leaflet of cancer cells by the enzyme PS-decarboxylase. Further corresponding to model studies, cholesterol depleted melanoma plasma membranes showed increased sensitivity to R-DIM-P-LF11-322, whereas activity of DIM-LF11-318 was unaffected. Microscopic studies using giant unilamellar vesicles and melanoma cells revealed strong changes in lateral distribution and domain formation of lipids upon addition of both peptides. Whereas R-DIM-P-LF11-322 enters the cancer cell specifically via PS and reaches an intracellular organelle, the Golgi, inducing mitochondrial swelling and apoptosis, DIM-LF11-318 kills rapidly and non-specifically by lysis of the plasma membrane. In conclusion, the specific interaction of R-DIM-P-LF11-322 with PS and sensitivity to cholesterol seem to modulate its specificity for cancer membranes.	[Wodlej, Christina; Riedl, Sabrina; Leber, Regina; Lohner, Karl; Zweytick, Dagmar] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Riedl, Sabrina; Leber, Regina; Lohner, Karl; Zweytick, Dagmar] BioTechMed Graz, Graz, Austria; [Rinner, Beate] Med Univ Graz, Med Res Ctr, Graz, Austria; [Drechsler, Carina] Univ Freiburg, BIOSS, Freiburg, Germany; [Drechsler, Carina] Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany; [Voelker, Dennis R.; Choi, Jae-Yeon] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Wodlej, Christina] Med Univ Graz, Diagnost & Res Inst Pathol, Neue Graz, Austria	University of Graz; Medical University of Graz; University of Freiburg; University of Freiburg; National Jewish Health; Medical University of Graz	Riedl, S; Zweytick, D (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria.; Riedl, S; Zweytick, D (corresponding author), BioTechMed Graz, Graz, Austria.	sabrina.riedl@uni-graz.at; dagmar.zweytick@uni-graz.at		Leber, Regina/0000-0001-5306-5834; Zweytick, Dagmar/0000-0002-4766-7713; Rinner, Beate/0000-0002-6340-4905	Austrian Science Fund [P24608-B23]; Austrian Research Promotion Agency [855671]; National Institute of Health NIH [GM104485]	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency; National Institute of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Investigations were supported by the Austrian Science Fund (grant no. P24608-B23 to DZ; https://www.fwf.ac.at/), Austrian Research Promotion Agency (grant no. 855671 to DZ; https://www.ffg.at/) and National Institute of Health NIH grant (GM104485 to DRV; https://www.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; [Anonymous], 2002, MEL TREATM PDQ HLTH; Bevers EM, 1996, LUPUS, V5, P480, DOI 10.1177/096120339600500531; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Dejgaard SY, 2001, ELS, P1; Epand RM, 2010, BBA-BIOMEMBRANES, V1798, P1272, DOI 10.1016/j.bbamem.2010.03.012; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Garbe C, 2000, HAUTARZT, V51, P518, DOI 10.1007/s001050051166; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jobin ML, 2013, BBA-BIOMEMBRANES, V1828, P1457, DOI 10.1016/j.bbamem.2013.02.008; Lee DK, 2015, BIOCHEMISTRY-US, V54, P1897, DOI 10.1021/bi501418m; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Maak M, 2011, MOL CANCER THER, V10, P1918, DOI 10.1158/1535-7163.MCT-11-0006; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Maverakis E, 2015, ACTA DERM-VENEREOL, V95, P516, DOI 10.2340/00015555-2035; MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6; McHenry AJ, 2012, BBA-BIOMEMBRANES, V1818, P3019, DOI 10.1016/j.bbamem.2012.07.021; MCMULLEN TPW, 1993, BIOCHEMISTRY-US, V32, P516, DOI 10.1021/bi00053a016; OLEARY TJ, 1983, BIOCHIM BIOPHYS ACTA, V731, P47, DOI 10.1016/0005-2736(83)90396-6; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Pokorny A, 2002, BIOCHEMISTRY-US, V41, P11044, DOI 10.1021/bi020244r; Prenner EJ, 2001, BBA-BIOMEMBRANES, V1510, P83, DOI 10.1016/S0005-2736(00)00337-0; Ran S, 1998, CANCER RES, V58, P4646; Ran S, 2002, CANCER RES, V62, P6132; RAO LVM, 1992, THROMB RES, V67, P517, DOI 10.1016/0049-3848(92)90013-Z; Riedl S, 2015, BBA-BIOMEMBRANES, V1848, P2918, DOI 10.1016/j.bbamem.2015.07.018; Riedl S, 2014, BIOMETALS, V27, P981, DOI 10.1007/s10534-014-9749-0; Riedl S, 2014, BIOPHYS J, V106, p88A, DOI 10.1016/j.bpj.2013.11.558; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9; Sandru A, 2014, J Med Life, V7, P572; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; Shah DJ, 2014, MAYO CLIN PROC, V89, P504, DOI 10.1016/j.mayocp.2014.02.002; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; UTSUGI T, 1991, CANCER RES, V51, P3062; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Woehlecke H, 2003, BIOCHEM J, V376, P489, DOI 10.1042/BJ20030886; Woehlecke H, 2003, INT J CANCER, V107, P721, DOI 10.1002/ijc.11444; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Won A, 2012, BBA-BIOMEMBRANES, V1818, P3072, DOI 10.1016/j.bbamem.2012.07.030; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zweytick D, 2006, BBA-BIOMEMBRANES, V1758, P1426, DOI 10.1016/j.bbamem.2006.02.032; Zweytick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090228; Zweytick D, 2011, J BIOL CHEM, V286, P21266, DOI 10.1074/jbc.M110.195412	77	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211187	10.1371/journal.pone.0211187	http://dx.doi.org/10.1371/journal.pone.0211187			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682171	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500119
J	Tew, BY; Legendre, C; Gooden, GC; Johnson, KN; Martinez, RA; Kiefer, J; Bernstein, M; Glen, J; Butry, L; Hinek, A; Toms, SA; Salhia, B				Tew, Ben Yi; Legendre, Christophe; Gooden, Gerald C.; Johnson, Kyle N.; Martinez, Rae Anne; Kiefer, Jeff; Bernstein, Mark; Glen, Jennifer; Butry, Loren; Hinek, Aleksander; Toms, Steven A.; Salhia, Bodour			Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; BREAST-CANCER; BRAIN METASTASES; EXPRESSION; CARCINOMA; FIBROBLASTS; GENERATION; TUMORS; NICHE	The functional role of human derived stromal cells in the tumor microenviornment of CNS metastases (CM) remain understudied. The purpose of the current study was to isolate and characterize stromal cells of the tumor microenvironment in CM. Four different patient-derived cell lines (PDCs) of stromal and one PDC of tumorigenic origin were generated from breast or lung CM. PDCs were analyzed by DNA/RNA sequencing, DNA methylation profiling, and immunophenotypic assays. The stromal derived PDCs were termed CNS metastasis-associated stromal cells (cMASCs). Functional analysis of cMASCs was tested by co-implanting them with tumorigenic cells in mice. cMASCs displayed normal genotypes compared with tumorigenic cell lines. RNA-seq and DNA methylation analyses demonstrated that cMASCs highly resembled each other, suggesting a common cell of origin. Additionally, cMASCs revealed gene expression signatures associated with cancer associated fibroblasts (CAFs), epithelial to mesenchymal transition, mesenchymal stem cells and expressed high levels of collagen. Functionally, cMASCs restricted tumor growth, and induced desmoplasia in vivo, suggesting that cMASCs may promote a protective host response to impede tumor growth. In summary, we demonstrated the isolation, molecular characterization and functional role of human derived cMASCs, a subpopulation of cells in the microenvironment of CM that have tumor inhibitory functions.	[Tew, Ben Yi; Gooden, Gerald C.; Salhia, Bodour] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Translat Genom, Los Angeles, CA 90033 USA; [Legendre, Christophe; Gooden, Gerald C.; Johnson, Kyle N.; Martinez, Rae Anne; Kiefer, Jeff; Salhia, Bodour] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Bernstein, Mark; Glen, Jennifer] Univ Hlth Network, Div Neurosurg, Toronto, ON, Canada; [Hinek, Aleksander] Hosp Sickkids, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [Butry, Loren] Geisinger Hlth Syst, Dept Neurosurg, Danville, PA USA; [Toms, Steven A.] Brown Univ, Lifespan Hlth Syst, Dept Neurosurg, Providence, RI 02912 USA; [Toms, Steven A.] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA	University of Southern California; Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Geisinger Health System; Brown University; Brown University	Salhia, B (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Translat Genom, Los Angeles, CA 90033 USA.; Salhia, B (corresponding author), Translat Genom Res Inst, Phoenix, AZ 85004 USA.	salhia@usc.edu	Hinek, Aleksander/V-8790-2019	HINEK, Aleksander/0000-0002-5498-6261; Martinez, Rae Anne M./0000-0003-0262-1049	Avon Foundation; Avon Foundation for Women grant [02-2014-064]; National Center for Research Resources [C06RR030524]	Avon Foundation; Avon Foundation for Women grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a grant from the Avon Foundation (BS). Avon Foundation for Women grant#02-2014-064. Animal studies in this work were performed at the University of Arizona Phoenix Campus Vivarium. The University of Arizona Phoenix Campus Vivarium was supported by Award Number C06RR030524 from the National Center for Research Resources. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The authors would also like to thank the patients who contributed their tumors for our study.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Cheng JC, 2011, CANCER LETT, V304, P107, DOI 10.1016/j.canlet.2011.02.008; Christoforides A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-302; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cirri P, 2011, AM J CANCER RES, V1, P482; Cook D, 2013, ADV EXP MED BIOL, V786, P213, DOI 10.1007/978-94-007-6621-1_12; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661; Hasebe T, 2002, MODERN PATHOL, V15, P502, DOI 10.1038/modpathol.3880555; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Kim HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0587-9; Kim J, 2013, THORAC CANCER, V4, P167, DOI 10.1111/j.1759-7714.2012.00164.x; Kim LS, 2004, CLIN EXP METASTAS, V21, P107, DOI 10.1023/B:CLIN.0000024761.00373.55; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Legendre CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150629; Li AQ, 2010, ONCOL REP, V23, P1247, DOI 10.3892/or_00000757; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lillie RD, 1940, STAIN TECHNOL, V15, P17, DOI 10.3109/10520294009110327; Lojewski X, 2015, STEM CELL TRANSL MED, V4, P1223, DOI 10.5966/sctm.2015-0057; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	42	7	9	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4002	4014		10.1038/s41388-019-0680-2	http://dx.doi.org/10.1038/s41388-019-0680-2			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30700832	Green Published, hybrid			2022-12-26	WOS:000468740200003
J	Cardenas, EI; Gonzalez, R; Breaux, K; Da, Q; Gutierrez, BA; Ramos, MA; Cardenas, RA; Burns, AR; Rumbaut, RE; Adachi, R				Cardenas, Eduardo I.; Gonzalez, Ricardo; Breaux, Keegan; Da, Qi; Gutierrez, Berenice A.; Ramos, Marco A.; Cardenas, Rodolfo A.; Burns, Alan R.; Rumbaut, Rolando E.; Adachi, Roberto			Munc18-2, but not Munc18-1 or Munc18-3, regulates platelet exocytosis, hemostasis, and thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; SNARE proteins; platelet; hemostasis; thrombosis; secretion; Munc18	MOLECULAR-MECHANISMS; ALPHA-GRANULE; SYNTAXIN; SECRETION; PROTEINS; SNARE; RELEASE; ACTIVATION; ROLES; MICE	Platelet degranulation, a form of regulated exocytosis, is crucial for hemostasis and thrombosis. Exocytosis in platelets is mediated by SNARE proteins, and in most mammalian cells this process is controlled by Munc18 (mammalian homolog of Caenorhabditis elegans uncoordinated gene 18) proteins. Platelets express all Munc18 paralogs (Munc18-1, -2, and -3), but their roles in platelet secretion and function have not been fully characterized. Using Munc18-1, -2, and -3 conditional knockout mice, here we deleted expression of these proteins in platelets and assessed granule exocytosis. We measured products secreted by each type of platelet granule and analyzed EM platelet profiles by design-based stereology. We observed that the removal of Munc18-2 ablates the release of alpha, dense, and lysosomal granules from platelets, but we found no exocytic role for Munc18-1 or -3 in platelets. In vitro, Munc18-2-deficient platelets exhibited defective aggregation at low doses of collagen and impaired thrombus formation under shear stress. In vivo, megakaryocyte-specific Munc18-2 conditional knockout mice had a severe hemostatic defect and prolonged arterial and venous bleeding times. They were also protected against arterial thrombosis in a chemically induced model of arterial injury. Taken together, our results indicate that Munc18-2, but not Munc18-1 or Munc18-3, is essential for regulated exocytosis in platelets and platelet participation in thrombosis and hemostasis.	[Cardenas, Eduardo I.; Gonzalez, Ricardo; Breaux, Keegan; Gutierrez, Berenice A.; Ramos, Marco A.; Cardenas, Rodolfo A.; Burns, Alan R.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Cardenas, Eduardo I.; Gonzalez, Ricardo; Gutierrez, Berenice A.] Inst Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey 64849, Nuevo Leon, Mexico; [Da, Qi; Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA; [Da, Qi; Rumbaut, Rolando E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Cardenas, Rodolfo A.] Inst Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey 64710, Nuevo Leon, Mexico; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Baylor College of Medicine; Baylor College of Medicine; Tecnologico de Monterrey; University of Houston System; University of Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Cardenas, Eduardo/0000-0001-5973-5675; Adachi, Roberto/0000-0002-0146-0768; Rumbaut, Rolando/0000-0002-8486-1013	National Institutes of Health [AI093533A, AI137319, CA016672, HL116524, EY007551]; U.S. Dept. of Veterans Affairs [I01 BX002551]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [352566, 446906, 448085]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007551] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI137319] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by National Institutes of Health Grants AI093533A, AI137319, and CA016672 (to R. A.), HL116524 (to R. E. R.), and EY007551 (to A. R. B.). This project was also supported by Merit Review Award I01 BX002551 (to R. E. R.) from the U.S. Dept. of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs, or the United States government.; These authors were supported by PhD Grant Scholarships 352566 (to E. I. C.), 446906 (to R. G.), and 448085 (to B. A. G.) from the Consejo Nacional de Ciencia y Tecnologia (CONACyT).	Adhikari P, 2018, INFLAMM RES, V67, P1, DOI 10.1007/s00011-017-1097-4; Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Cardenas EI, 2018, HAEMATOLOGICA, V103, P1235, DOI 10.3324/haematol.2017.185637; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Ciferri S, 2000, THROMB HAEMOSTASIS, V83, P157; Da Q, 2015, BLOOD, V126, P2338, DOI 10.1182/blood-2015-05-648030; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; Graham GJ, 2009, BLOOD, V114, P1083, DOI 10.1182/blood-2009-03-210211; Gutierrez BA, 2018, J BIOL CHEM, V293, P7148, DOI 10.1074/jbc.RA118.002455; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jaramillo AM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124815; Jarvis GE, 2004, PLATELETS, V15, P303, DOI 10.1080/09537100410001710254; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Pagel J, 2012, BLOOD, V119, P6016, DOI 10.1182/blood-2011-12-398958; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; Sandrock K, 2010, BLOOD, V116, P6148, DOI 10.1182/blood-2010-08-302943; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Schraw TD, 2004, THROMB HAEMOSTASIS, V92, P829, DOI 10.1160/TH04-04-0263; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004	50	5	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4784	4792		10.1074/jbc.RA118.006922	http://dx.doi.org/10.1074/jbc.RA118.006922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30696774	Green Published, hybrid			2022-12-26	WOS:000463985600005
J	Correia, JC; Golay, A; Lachat, S; Singh, SB; Manandhar, V; Jha, N; Chappuis, F; Beran, D; Miranda, J; Damasceno, A; Somerville, C; Suggs, LS				Correia, Jorge Cesar; Golay, Alain; Lachat, Sarah; Singh, Suman Bahadur; Manandhar, Varsha; Jha, Nilambar; Chappuis, Francois; Beran, David; Miranda, Jaime; Damasceno, Albertino; Somerville, Claire; Suggs, L. Suzanne		COHESION Project	"If you will counsel properly with love, they will listen": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal	PLOS ONE			English	Article							CARE; BEHAVIOR; STIGMA; REFLECTIONS; INDONESIA; LESSONS; PROGRAM; CIREBON; IMPACT; TIME	Background Leprosy remains a disease of concern in many countries including Nepal. To achieve the target of elimination, the WHO strategy promotes comprehensive education of patients, healthcare workers (HCWs), and the public on leprosy-related issues. However most educational programs are based on the concerns of HCWs and not on patients' needs. The objective of this paper is to explore the educational needs of leprosy affected patients in Nepal and compare them to the needs perceived by HCWs. Methodology/principal findings Semi directive interviews were conducted with patients and HCWs. The data was analyzed using the basic interpretative qualitative framework. The study was conducted in two leprosy referral centers, one university hospital and one primary health care center: Lalgadh Leprosy Hospital and Services Centre, Anandaban Hospital and its satellite clinic in Patan, B. P. Koirala Institute of Health Sciences in Dharan, and the Itahari primary health care centre. The results show that there remains a lack of knowledge regarding the disease (origins, manifestations, prevention and treatment) contributing to late care seeking behavior and high levels of stigma, with an important psychological and financial stress for patients. All of the HCWs displayed a good understanding of patients' difficulties and needs and acknowledged the key role of patient education. However, they expressed several challenges in managing patients due to lack of time, human resources and training in patient education. Conclusions/significance Further efforts need to be made to increase patients' general knowledge of the disease in order to motivate them to seek healthcare earlier and change their perception of the disease to reduce stigma. HCWs need proper training in patient education and counseling for them to acquire the necessary skills required to address the different educational needs of their patients. The use of lay and peer counselors would be an option to address the workload and lack of time expressed by HCWs.	[Correia, Jorge Cesar; Lachat, Sarah; Chappuis, Francois; Beran, David] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland; [Correia, Jorge Cesar; Lachat, Sarah; Chappuis, Francois; Beran, David] Univ Geneva, Geneva, Switzerland; [Golay, Alain] Geneva Univ Hosp, Div Therapeut Patient Educ Chron Dis, Geneva, Switzerland; [Singh, Suman Bahadur; Manandhar, Varsha; Jha, Nilambar] BP Koirala Inst Hlth Sci, Sch Publ Hlth & Community Med, Dharan, Nepal; [Miranda, Jaime] Univ Peruana Cayetano Heredia, Lima, Peru; [Damasceno, Albertino] Eduardo Mondlane Univ, Maputo, Mozambique; [Somerville, Claire] Grad Inst Int & Dev Studies, Geneva, Switzerland; [Suggs, L. Suzanne] Univ Svizzera Italiana, Lugano, Switzerland	University of Geneva; University of Geneva; University of Geneva; B.P. Koirala Institute of Health Sciences; Universidad Peruana Cayetano Heredia; Eduardo Mondlane University; Universita della Svizzera Italiana	Correia, JC (corresponding author), Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland.; Correia, JC (corresponding author), Univ Geneva, Geneva, Switzerland.	jorgecesar.correia@hcuge.ch	Correia, Jorge César/AAG-2062-2020; Beran, David/E-4422-2013	Correia, Jorge César/0000-0002-7020-0695; Beran, David/0000-0001-7229-3920; Singh, Suman/0000-0002-5375-1110; Chappuis, Francois/0000-0003-0442-7610	Swiss National Science Foundation; Swiss Development Cooperation under the Swiss Program for Research on Global Issues for Development [160366]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Development Cooperation under the Swiss Program for Research on Global Issues for Development	The COHESION (COmmunity HEalth System InnovatiON) Project is funded by the Swiss National Science Foundation and the Swiss Development Cooperation under the Swiss Program for Research on Global Issues for Development (grant number 160366, http://www.r4d.ch/) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002940; Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008; [Anonymous], 1988, INT J LEPROSY, V56; [Anonymous], 1997, LEPROSY REV, V68; Bellamy R, 2004, MED TEACH, V26, P359, DOI 10.1080/01421590410001679398; Bense N, 2013, LEPROSY REV, V84, P199; Brouwers C, 2011, ASIA PACIFIC DISABIL, V22, P16, DOI DOI 10.5463/DCID.V22I1.15; Buring SM, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710108; Chalise S C, 2005, JNMA J Nepal Med Assoc, V44, P39; d'Ivernois J.F., 2002, ADSP, V39, P14; Dadun D, 2017, LEPROSY REV, V88, P2; de Stigter DH, 2000, LEPROSY REV, V71, P492; Ebenso B, 2010, LEPROSY REV, V81, P318; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Foucaud J, ED THERAPEUTIQUE PAT, V5, P123; Global leprosy update, 2013, RELEVE EPIDEMIOL HEB, V89, P389; Heritier Barras A-C, 2012, PATIENTS SOIGNANTS F; Ivernois J-F, 1995, APPRENDRE EDUQUER PA; Jha A K, 2012, Kathmandu Univ Med J (KUMJ), V10, P1; Komalaningsih S, 2017, ADV SCI LETT, V23, P3474, DOI 10.1166/asl.2017.9137; Lusli M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005088; Lusli M, 2015, LEPROSY REV, V86, P37; Lynch P, 2000, LEPROSY REV, V71, P62; Maes AC, 2013, ANAL CROISEE BESOINS; Martin JP, 2013, FORMATEUR ADULTES SE, V6th; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Merriam SB., 2002, INTRO QUALITATIVE RE, P6; Moreira P., 2015, THESIS; Muthuvel T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005192; Organization WH, 2013, AS RO S E SIT AN COM; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Philibert I, 2012, MAYO CLIN PROC, V87, P311, DOI 10.1016/j.mayocp.2012.03.001; Sandrin-Berthon B, 2010, MED MAL METAB, V4, P38, DOI DOI 10.1016/S1957-2557(10)70006-7; Sarkar J, 2012, INDIAN J DERMATOL VE, V78, P328, DOI 10.4103/0378-6323.95449; SCHLUNDT DG, 1994, PATIENT EDUC COUNS, V24, P165, DOI 10.1016/0738-3991(94)90010-8; Sermrittirong S, 2014, LEPROSY REV, V85, P149; Singh S., 2013, DISABIL CBR INCL DEV, V23, P67; Smith WC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003658; Stewart M, 2000, J FAM PRACTICE, V49, P796; Stewart M, 2003, PATIENT CENTERED MED; Thakor Hitendrasinh Gulabsinh, 2004, J Indian Med Assoc, V102, P684; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Traynard P-Y, 2010, MED MAL METABOLIQUES, V4, P31; Varkevisser CM, 2009, LEPROSY REV, V80, P65; WHO, 2012, ACC WORK OV GLOB IMP, P13; WHO, WORLD HLTH ASS WHA R; *WHO, 1998, THER PAT ED CONT ED; WHO &VERBAR; Global leprosy update, 2014, NEED EARL CAS DET; World Health Organization, 2016, GLOB LEPR STRAT 2016; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Zhang FR, 2009, LEPROSY REV, V80, P416	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210955	10.1371/journal.pone.0210955	http://dx.doi.org/10.1371/journal.pone.0210955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726259	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000040
J	Grant, BD; Quang, T; Possati-Resende, JC; Scapulatempo-Neto, C; Matsushita, GD; Mauad, EC; Stoler, MH; Castle, PE; Fregnani, JHTG; Schmeler, KM; Richards-Kortum, R				Grant, Benjamin D.; Quang, Timothy; Possati-Resende, Julio Cesar; Scapulatempo-Neto, Cristovam; Matsushita, Graziela de Macedo; Mauad, Edmundo Carvalho; Stoler, Mark H.; Castle, Philip E.; Tavares Guerreiro Fregnani, Jose Humberto; Schmeler, Kathleen M.; Richards-Kortum, Rebecca			A mobile-phone based high-resolution microendoscope to image cervical precancer	PLOS ONE			English	Article							VISUAL INSPECTION; HPV VACCINE; ACETIC-ACID; CANCER; INFECTION; EFFICACY; WOMEN	Nearly 90% of cervical cancer cases and deaths occur in low- and middle-income countries that lack comprehensive national HPV immunization and cervical cancer screening programs. In these settings, it is difficult to implement screening programs due to a lack of infrastructure and shortage of trained personnel. Screening programs based on visual inspection with acetic acid (VIA) have been successfully implemented in some low- resource settings. However, VIA has poor specificity and up to 90% of patients receiving treatment based on a positive VIA exam are over-treated. A number of studies have suggested that high-resolution cervical imaging to visualize nuclear morphology in vivo can improve specificity by better distinguishing precancerous and benign lesions. To enable high-resolution imaging in low-resource settings, we developed a portable, low-cost, high-resolution microendoscope that uses a mobile phone to detect and display images of cervical epithelium in vivo with subcellular resolution. The device was fabricated for less than $2,000 using commercially available optical components including filters, an LED and triplet lenses assembled in a 3D-printed opto-mechanical mount. We show that the mobile high-resolution microendoscope achieves similar resolution and signal-to-background ratio as previously reported high-resolution microendoscope systems using traditional cameras and computers to detect and display images. Finally, we demonstrate the ability of the mobile high-resolution microendoscope to image normal and precancerous squamous epithelium of the cervix in vivo in a gynecological referral clinic in Barretos, Brazil.	[Grant, Benjamin D.; Quang, Timothy; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Possati-Resende, Julio Cesar; Mauad, Edmundo Carvalho] Barretos Canc Hosp, Pio XII Fdn, Dept Canc Prevent, Barretos, Brazil; [Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Pio XII Fdn, Mol Oncol Res Ctr, Barretos, Brazil; [Scapulatempo-Neto, Cristovam; Matsushita, Graziela de Macedo] Barretos Canc Hosp, Pio XII Fdn, Dept Pathol, Barretos, Brazil; [Stoler, Mark H.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Castle, Philip E.] Global Coalit Cerv Canc, Arlington, VA USA; [Castle, Philip E.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Tavares Guerreiro Fregnani, Jose Humberto] Barretos Canc Hosp, Pio XII Fdn, Ctr Researcher Support, Barretos, Brazil; [Schmeler, Kathleen M.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Tavares Guerreiro Fregnani, Jose Humberto] Intellectual Ventures, Bellevue, WA USA; [Tavares Guerreiro Fregnani, Jose Humberto] AC Camargo Canc Ctr, Sao Paulo, SP, Brazil	Rice University; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; University of Virginia; Yeshiva University; Albert Einstein College of Medicine; Hospital de Cancer de Barretos; University of Texas System; UTMD Anderson Cancer Center; Intellectual Ventures; A.C.Camargo Cancer Center	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	rkortum@rice.edu	Castle, Philip/AAP-6395-2020; Fregnani, José H/H-4238-2012	Castle, Philip/0000-0003-1082-6554; Fregnani, José H/0000-0002-5235-6469; De Luca Canto, Graziela/0000-0002-7986-8317; Grant, Benjamin/0000-0001-7168-6474	National Cancer Institute of the National Institutes of Health [UH2CA189910, R01CA186132]; NATIONAL CANCER INSTITUTE [R01CA186132] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number UH2CA189910 and R01CA186132 to RR-K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Bedard N, 2012, BIOMED OPT EXPRESS, V3, P2428, DOI 10.1364/BOE.3.002428; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; BUCKLEY CH, 1982, J CLIN PATHOL, V35, P1, DOI 10.1136/jcp.35.1.1; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Grant B. D., 2015, EUR J CANC PREV; Grant BD, 2017, EUR J CANCER PREV, V26, P63, DOI 10.1097/CEJ.0000000000000219; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; International Agency on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P201; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pierce M, 2011, JOVE-J VIS EXP, DOI 10.3791/2306; Pierce MC, 2012, CANCER PREV RES, V5, P1273, DOI 10.1158/1940-6207.CAPR-12-0221; Quang T, 2016, GASTROINTEST ENDOSC, V84, P834, DOI 10.1016/j.gie.2016.03.1472; Quinn MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044924; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Shin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011218; Thekkek N, 2008, NAT REV CANCER, V8, P725, DOI 10.1038/nrc2462; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	29	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211045	10.1371/journal.pone.0211045	http://dx.doi.org/10.1371/journal.pone.0211045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726252	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000048
J	Kabo, I; Orobaton, N; Abdulkarim, M; Otolorin, E; Akomolafe, T; Abegunde, D; Williams, E; Sadauki, H				Kabo, Ibrahim; Orobaton, Nosa; Abdulkarim, Masduk; Otolorin, Emmanuel; Akomolafe, Toyin; Abegunde, Dele; Williams, Emma; Sadauki, Habib			Strengthening and monitoring health system's capacity to improve availability, utilization and quality of emergency obstetric care in northern Nigeria	PLOS ONE			English	Article							MATERNAL MORTALITY; NEONATAL HEALTH; SERVICES; EXPERIENCES; EMOC	Background Quality improvement in emergency obstetric care (EmOC) is a critical and cost-effective suite of interventions for the reduction of maternal and newborn mortality and morbidity. This study was undertaken to evaluate the impact of quality improvement interventions following a baseline assessment in Bauchi state, Nigeria. Methods This was a prospective before and after study between June 2012, and April 2015 in Bauchi State, Nigeria. The surveys included 21 hospitals designated by Ministry of Health (MoH) as comprehensive EmOC centers and 38 primary healthcare centers (PHCs) designated as basic EmOC centers. Data on EmOC services was collected using structured established EmOC tools developed by the Averting Maternal Death and Disability (AMDD), and analyzed using univariate and bivariate statistical analyses. Results Facilities providing seven or nine signal EmOC functions increased from 6 (10.2%) in 2012 to 21 (35.6%) in 2015. Basic EmOC facilities increased from 1 (2.6%) to 7 (18.4%) and comprehensive EmOC facilities rose from 3 (14.3%) to 13 (61.9%). Facility birth increased from 3.6% to 8.0%. Cesarean birth rates increased from 3.8% in 2012 to 5.6% in 2015. Met need for EmOC more than doubled from 3.3% in 2012 to 9.9% in 2015. Direct obstetric case fatality rates increased from 3.1% in 2012 to 4.0% in 2015. Major direct obstetric complications as a percent of total maternal deaths was 70.9%, down from 80.1% in 2012. Conclusion The rise in the percent of facility-based births and in met need for EmOC suggest that interventions recommended and implemented after the baseline study resulted in increased availability, access and utilization of EmOC. Higher patient load, late arrival and better record keeping may explain the associated increase in case fatality rates.	[Kabo, Ibrahim; Otolorin, Emmanuel; Sadauki, Habib] Johns Hopkins Univ, TSHIP, Jhpiego, Bauchi, Nigeria; [Orobaton, Nosa; Abdulkarim, Masduk; Akomolafe, Toyin; Abegunde, Dele] JSI Res & Training Inst, TSHIP, Bauchi, Nigeria; [Williams, Emma] Jhpiego, Baltimore, MD USA	Jhpiego; Jhpiego	Kabo, I (corresponding author), Johns Hopkins Univ, TSHIP, Jhpiego, Bauchi, Nigeria.	ikabo2000@yahoo.com	Kabo, Ibrahim Alhassan/AAU-9671-2020	Williams, Emma/0000-0003-0547-0194	Targeted States High Impact Project (TSHIP/USAID)	Targeted States High Impact Project (TSHIP/USAID)(United States Agency for International Development (USAID))	We acknowledge the contributions of the staff of Ministry of Health (MOH) and Bauchi State Primary Healthcare Development Agency (SPHCDA). Targeted States High Impact Project (TSHIP/USAID) supported Bauchi State MOH (SMOH) to conduct baseline EmOC assessment, strengthen health facilities and to conduct this follow-up assessment. We thank Bamidele Abiodun, Dr Halima Mukaddas, Gbenga Ishola, Dr Adetiloye Oniyire, Dr. Blami Dao, Susheela Engelbrecht, Cynthia Geary and Sharon Kibwana who reviewed earlier drafts of this paper. The views expressed here are those of the authors and do not necessarily reflect those of the United States Agency for International Development.	Abegunde D, 2015, INT J GYNECOL OBSTET, V128, P251, DOI 10.1016/j.ijgo.2014.09.029; Accorsi S, 2010, T ROY SOC TROP MED H, V104, P336, DOI 10.1016/j.trstmh.2009.12.009; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Admasu K, 2011, INT J GYNECOL OBSTET, V115, P101; Bailey P, 2006, INT J GYNECOL OBSTET, V93, P285, DOI 10.1016/j.ijgo.2006.01.028; Bailey P., 2009, MON EM OBST CAR HDB; Echoka E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-113; Holmer H, 2015, BJOG-INT J OBSTET GY, V122, P183, DOI 10.1111/1471-0528.13230; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P291, DOI 10.1016/j.ijgo.2005.10.030; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P299, DOI 10.1016/j.ijgo.2005.12.005; Kim YM, 2012, INT J GYNECOL OBSTET, V116, P192, DOI 10.1016/j.ijgo.2011.10.017; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mirkuzie AH, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-354; National Population Commission (NPC) II, 2014, NIG DEM HLTH SURV ND; [Nigeria] FRoN, 2010, COUNTD STRAT 2010 20; [Nigeria] FRoN, 2011, EX SESS PRES SAV NEW; [Nigeria] FRoN, 2010, MDG REP 2010 NIG MIL; Nigeria NPCFRo, 2009, NIG DEM HLTH SURV 20; Otchere SA, 2007, INT J GYNECOL OBSTET, V99, P173, DOI 10.1016/j.ijgo.2007.07.004; Oyerinde K, 2011, INT J GYNECOL OBSTET, V114, P168, DOI 10.1016/j.ijgo.2011.05.006; Saidu Rakiya, 2013, Afr J Reprod Health, V17, P41; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; United Nations, 2014, MILL DEV GOALS REP 2; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0018-7; World Health Organization. World Bank. UNICEF United Nations Population Fund, 2014, TRENDS MAT MORT 1990, Vviii	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211858	10.1371/journal.pone.0211858	http://dx.doi.org/10.1371/journal.pone.0211858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726275	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000082
J	Minaidou, A; Nicolaou, P; Christodoulou, K				Minaidou, Anna; Nicolaou, Paschalis; Christodoulou, Kyproula			Deregulation of LRSAM1 expression impairs the levels of TSG101, UBE2N, VPS28, MDM2 and EGFR	PLOS ONE			English	Article							MARIE-TOOTH DISEASE; CELL-GROWTH; ACCUMULATION; DEPLETION; MUTATION	CMT is the most common hereditary neuromuscular disorder of the peripheral nervous system with a prevalence of 1/2500 individuals and it is caused by mutations in more than 80 genes. LRSAM1, a RING finger ubiquitin ligase also known as TSG101-associated ligase (TAL), has been associated with Charcot-Marie-Tooth disease type 2P (CMT2P) and to date eight causative mutations have been identified. Little is currently known on the pathogenetic mechanisms that lead to the disease. We investigated the effect of LRSAM1 deregulation on possible LRSAM1 interacting molecules in cell based models. Possible LRSAM1 interacting molecules were identified using protein-protein interaction databases and literature data. Expression analysis of these molecules was performed in both CMT2P patient and control lymphoblastoid cell lines as well as in LRSAM1 and TSG101 downregulated SH-SY5Y cells. TSG101, UBE2N, VPS28, EGFR and MDM2 levels were significantly decreased in the CMT2P patient lymphoblastoid cell line as well as in LRSAM1 downregulated cells. TSG101 downregulation had a significant effect only on the expression of VPS28 and MDM2 and it did not affect the levels of LRSAM1. This study confirms that LRSAM1 is a regulator of TSG101 expression. Furthermore, deregulation of LRSAM1 significantly affects the levels of UBE2N, VPS28, EGFR and MDM2.	[Minaidou, Anna; Nicolaou, Paschalis; Christodoulou, Kyproula] Cyprus Inst Neurol & Genet, Neurogenet Dept, Nicosia, Cyprus; [Minaidou, Anna; Nicolaou, Paschalis; Christodoulou, Kyproula] Cyprus Sch Mol Med, Nicosia, Cyprus		Christodoulou, K (corresponding author), Cyprus Inst Neurol & Genet, Neurogenet Dept, Nicosia, Cyprus.; Christodoulou, K (corresponding author), Cyprus Sch Mol Med, Nicosia, Cyprus.	roula@cing.ac.cy		Christodoulou, Kyproula/0000-0002-0622-7594	Cyprus TELETHON [73115]	Cyprus TELETHON	This work was supported by a grant of the Cyprus TELETHON (Grant number: 73115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Cheng J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.54; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Engeholm M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-118; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Guernsey DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001081; Hakonen JE, 2017, HUM MOL GENET, V26, P2034, DOI 10.1093/hmg/ddx089; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lee J.-A., 2012, NEUROBIOLOGY, V21, P9, DOI DOI 10.5607/EN.2012.21.1.9; Li BL, 2003, J CELL BIOCHEM, V90, P1224, DOI 10.1002/jcb.10674; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; McDonald B, 2008, MOL BIOL CELL, V19, P754, DOI 10.1091/mbc.E07-09-0957; Minaidou A, 2018, CELL J, V20, P340, DOI 10.22074/cellj.2018.5352; Nicolaou P, 2013, EUR J HUM GENET, V21, P190, DOI 10.1038/ejhg.2012.146; Nicolaou P, 2010, NEUROEPIDEMIOLOGY, V35, P171, DOI 10.1159/000314351; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shy ME, 2011, CURR OPIN NEUROL, V24, P475, DOI 10.1097/WCO.0b013e32834aa331; Tamai K, 2008, AM J PATHOL, V173, P1806, DOI 10.2353/ajpath.2008.080684; Teixeira Ana L., 2012, Frontiers in Genetics, V3, P286, DOI 10.3389/fgene.2012.00286; Traikov S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109372; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Yin P, 2015, HUM MOL GENET, V24, P1350, DOI 10.1093/hmg/ddu544; Zhao GH, 2018, J PERIPHER NERV SYST, V23, P55, DOI 10.1111/jns.12247	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211814	10.1371/journal.pone.0211814	http://dx.doi.org/10.1371/journal.pone.0211814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726272	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000078
J	Mitchell, KA; Moore, JX; Rosenson, RS; Irvin, R; Guirgis, FW; Shapiro, N; Safford, M; Wang, HE				Mitchell, Kellie A.; Moore, Justin Xavier; Rosenson, Robert S.; Irvin, Ryan; Guirgis, Faheem W.; Shapiro, Nathan; Safford, Monika; Wang, Henry E.			PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort	PLOS ONE			English	Article							SEQUENCE VARIATIONS; CHOLESTEROL; INFLAMMATION; EPIDEMIOLOGY; LIPOPROTEINS; ASSOCIATION; INHIBITION; EVOLOCUMAB; EXPRESSION; PREVENTION	Background Elevated proprotein convertase subtilisin/kexin type 9 (PCSK9) levels have been associated with adverse outcomes in patients hospitalized for sepsis. PCSK9 loss-of-function (LOF) variants area associated with lower low-density lipoprotein cholesterol (LDL-C) levels. Decreased LDL-C is a biomarker of acute and chronic infection and sepsis risk. We examined the association between presence of two genetic PCSK9 LOF variants and risk of infection and sepsis in community-dwelling adults. Methods We analyzed data from 10,924 Black participants tested for PCSK9 LOF variants in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The primary endpoint was hospitalization for a serious infection. Within serious infection hospitalizations, we defined sepsis as. 2 system inflammatory response syndrome criteria. Using multivariable Cox and logistic regression, we investigated the association between LOF variants and hospitalization for infection and sepsis events, adjusting for sociodemographics, health behaviors, chronic medical conditions and select biomarkers. Results Among 10,924 Black participants, PCSK9 LOF variants were present in 244 (2.2%). Serious infection hospitalizations occurred in 779 participants (14 with PCSK9 variants and 765 without). The presence of PCSK9 variants was not associated with infection risk (adjusted HR 0.68; 95% CI: 0.38-1.25). Among participants hospitalized for a serious infection, the presence of PCSK9 variants was not associated with sepsis (adjusted OR 7.31; 95% CI = 0.91-58.7). Conclusions PCSK9 LOF variants are not associated with increased risk of hospitalization for a serious infection. Among those hospitalized for a serious infection, PCSK9 LOF variants was not associated with odds of sepsis.	[Mitchell, Kellie A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Moore, Justin Xavier; Irvin, Ryan] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Moore, Justin Xavier; Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35294 USA; [Rosenson, Robert S.] Icahn Sch Med Mt Sinai, Mt Sinai Heart, New York, NY 10029 USA; [Guirgis, Faheem W.] Univ Florida, Dept Emergency Med, Jacksonville, FL USA; [Shapiro, Nathan] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Safford, Monika] Weill Cornell Sch Med, Dept Med, New York, NY USA; [Wang, Henry E.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of Florida; Harvard University; Beth Israel Deaconess Medical Center; Cornell University; University of Texas System; University of Texas Health Science Center Houston	Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35294 USA.; Wang, HE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA.	Henry.e.wang@uth.tmc.edu		Moore, Justin Xavier/0000-0002-5496-752X	National Institute for Nursing Research [R01-NR012726]; National Center for Research Resources [UL1-RR025777]; Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01-NS041588]; Cancer Prevention and Control Training Program grant - National Cancer Institute, National Institutes of Health [R25-CA4788]; National Institute of Health [NIH T35HL007473]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cancer Prevention and Control Training Program grant - National Cancer Institute, National Institutes of Health; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Representatives of the funding agencies have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. Mr. Moore received grant support from R25-CA4788, the Cancer Prevention and Control Training Program grant, funded by the National Cancer Institute, National Institutes of Health. Ms. Mitchell received grant support from NIH T35HL007473 from the National Institute of Health.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berger JM, 2017, J LIPID RES, V58, P1661, DOI 10.1194/jlr.M076844; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Boyd JH, 2016, J INNATE IMMUN, V8, P211, DOI 10.1159/000442976; Cariou B, 2011, ATHEROSCLEROSIS, V216, P258, DOI 10.1016/j.atherosclerosis.2011.04.018; Chiarla C, 2004, AMINO ACIDS, V27, P97, DOI 10.1007/s00726-004-0064-x; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dixon DL, 2016, J CLIN LIPIDOL, V10, P1073, DOI 10.1016/j.jacl.2016.07.004; Dwivedi DJ, 2016, SHOCK, V46, P672, DOI 10.1097/SHK.0000000000000682; Feingold KR, 1997, HEPATOLOGY, V26, P1685; Feingold KR, 2020, ENDOTEXT INTERNET; Green P, 2016, CURR OPIN CLIN NUTR, V19, P111, DOI 10.1097/MCO.0000000000000253; Grion CMC, 2010, EUR J CLIN INVEST, V40, P330, DOI 10.1111/j.1365-2362.2010.02269.x; Guirgis FW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203813; Guirgis FW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1579-8; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Huang CC, 2009, CIRC-CARDIOVASC GENE, V2, P354, DOI 10.1161/CIRCGENETICS.108.828467; Jellinger PS, 2017, ENDOCR PRACT, V23, P479, DOI 10.4158/EP171764.GL; Khademi F, 2018, J CELL PHYSIOL, V233, P2920, DOI 10.1002/jcp.26040; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lagrost L, 2014, CRIT CARE MED, V42, P1065, DOI 10.1097/CCM.0000000000000165; Liberale L, 2016, EUR J CLIN INVEST, V46, P1053, DOI 10.1111/eci.12692; Madsen CM, 2018, EUR HEART J, V39, P610, DOI 10.1093/eurheartj/ehx659; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Mbikay M, 2007, MED HYPOTHESES, V69, P1010, DOI 10.1016/j.mehy.2007.03.018; Powell TC, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0055-z; Raal FJ, 2017, LANCET DIABETES ENDO, V5, P280, DOI 10.1016/S2213-8587(17)30044-X; Ricci C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20425-x; Ruscica M, 2016, J BIOL CHEM, V291, P3508, DOI 10.1074/jbc.M115.664706; Tang ZH, 2017, ATHEROSCLEROSIS, V262, P113, DOI 10.1016/j.atherosclerosis.2017.04.023; Topchiy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155030; Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD; von Eckardstein AaKDe, 2015, HDB EXP PHARM, V224, P483, DOI [10.1007/978-3-319-09665-0_15, DOI 10.1007/978-3-319-09665-0_15]; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; Wang HE, 2016, CRIT CARE MED, V44, P1285, DOI 10.1097/CCM.0000000000001666; Wang HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069232; Willenbring ML, 2009, AM FAM PHYSICIAN, V80, P44; Wilson RF, 2003, CRIT CARE, V7, P413, DOI 10.1186/cc2390	40	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210808	10.1371/journal.pone.0210808	http://dx.doi.org/10.1371/journal.pone.0210808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726226	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000032
J	Wagner, MA; Reynolds, JD				Wagner, Marlene A.; Reynolds, John D.			Salmon increase forest bird abundance and diversity	PLOS ONE			English	Article							MARINE-DERIVED NUTRIENTS; RIPARIAN FOOD WEBS; STREAM PRODUCTIVITY; TROPHIC CASCADES; PACIFIC SALMON; TERRESTRIAL; NITROGEN; ECOLOGY; ECOSYSTEM; ALASKA	Resource subsidies across ecosystems can have strong and unforeseen ecological impacts. Marine-derived nutrients from Pacific salmon (Onchorhycus spp.) can be transferred to streams and riparian forests through diverse food web pathways, fertilizing forests and increasing invertebrate abundance, which may in turn affect breeding birds. We quantified the influence of salmon on the abundance and composition of songbird communities across a wide range of salmon-spawning biomass on 14 streams along a remote coastal region of British Columbia, Canada. Point-count data spanning two years were combined with salmon biomass and 13 environmental covariates in riparian forests to test for correlates with bird abundance, foraging guilds, individual species, and avian diversity. We show that bird abundance and diversity increase with salmon biomass and that watershed size and forest composition are less important predictors. This work provides new evidence for the importance of salmon to terrestrial ecosystems and information that can inform ecosystem-based management.	[Wagner, Marlene A.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC, Canada; [Wagner, Marlene A.; Reynolds, John D.] Hakai Inst, Heriot Bay, BC, Canada	Simon Fraser University; Hakai Institute	Wagner, MA (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC, Canada.; Wagner, MA (corresponding author), Hakai Inst, Heriot Bay, BC, Canada.	mawagner@sfu.ca			Natural Sciences and Engineering Research Council; Tom Buell BC Leadership Chair endowment - Pacific Salmon Foundation; BC Leading Edge Endowment Fund; Hakai Scholarship through the Tula Foundation; Anne Vallee Ecological Fund; Simon Fraser University	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tom Buell BC Leadership Chair endowment - Pacific Salmon Foundation; BC Leading Edge Endowment Fund; Hakai Scholarship through the Tula Foundation; Anne Vallee Ecological Fund; Simon Fraser University	This study was supported by the Natural Sciences and Engineering Research Council and the Tom Buell BC Leadership Chair endowment funded by the Pacific Salmon Foundation and the BC Leading Edge Endowment Fund. Marlene Wagner was supported by a Hakai Scholarship through the Tula Foundation, with additional support from the Anne Vallee Ecological Fund and Simon Fraser University.	AIROLA DA, 1985, CONDOR, V87, P205, DOI 10.2307/1366884; Anderson D.R, 2007, MODEL BASED INFERENC, DOI [10.2307/23014412, DOI 10.2307/23014412]; Barton K., 2015, MUMIN MULTIMODEL INF; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; BERENBAUM M, 1983, EVOLUTION, V37, P163, DOI 10.1111/j.1558-5646.1983.tb05524.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Buxton TH, 2015, CAN J FISH AQUAT SCI, V72, P1146, DOI 10.1139/cjfas-2014-0413; Carey AB, 2003, FORESTRY, V76, P127, DOI 10.1093/forestry/76.2.127; Christie KS, 2008, AUK, V125, P51, DOI 10.1525/auk.2008.125.1.51; Christie KS, 2008, CAN J ZOOL, V86, P1317, DOI 10.1139/Z08-110; DFO, 2005, CAN POL CONS WILD PA; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; ENGLISH KK, 1992, CAN J FISH AQUAT SCI, V49, P1982, DOI 10.1139/f92-220; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Field RD, 2013, J AVIAN BIOL, V44, P9, DOI 10.1111/j.1600-048X.2012.05601.x; Field RD, 2011, P ROY SOC B-BIOL SCI, V278, P3081, DOI 10.1098/rspb.2010.2731; Folkard NFG, 1995, CAN J ZOOL, V73, P2231, DOI 10.1139/z95-264; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; Gende SM, 2001, CONDOR, V103, P624, DOI 10.1650/0010-5422(2001)103[0624:PDIRFO]2.0.CO;2; Gresh T, 2000, FISHERIES, V25, P15, DOI 10.1577/1548-8446(2000)025<0015:AEOHAC>2.0.CO;2; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harding JN, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00207.1; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Hicks BJ, 2005, OECOLOGIA, V144, P558, DOI 10.1007/s00442-005-0035-2; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Hocking MD, 2006, CAN J FISH AQUAT SCI, V63, P2076, DOI 10.1139/F06-110; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hocking MD, 2009, ECOL RES, V24, P1091, DOI 10.1007/s11284-009-0586-5; Hurteau LA, 2016, ECOLOGY, V97, P450, DOI 10.1890/15-0379.1; Iwata T, 2003, ECOGRAPHY, V26, P325, DOI 10.1034/j.1600-0587.2003.03355.x; Jackrel SL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2522; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2004, AM NAT, V163, P606, DOI 10.1086/382600; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Mathewson D D, 2003, BMC Ecol, V3, P4, DOI 10.1186/1472-6785-3-4; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL, V1, P1; Merz JE, 2006, ECOL APPL, V16, P999, DOI 10.1890/1051-0761(2006)016[0999:SWAWMN]2.0.CO;2; Moore JW, 2004, OECOLOGIA, V139, P298, DOI 10.1007/s00442-004-1509-3; Murakami M, 2002, ECOL LETT, V5, P333, DOI 10.1046/j.1461-0248.2002.00321.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nur N., 1999, STAT GUIDE DATA ANAL; Nur N, 2008, WILSON J ORNITHOL, V120, P840, DOI 10.1676/06-098.1; Obermeyer KE, 2006, NORTHWEST SCI, V80, P26; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Panella NA, 2005, J MED ENTOMOL, V42, P352, DOI 10.1603/0022-2585(2005)042[0352:UONCFP]2.0.CO;2; Payne LX, 2006, OIKOS, V115, P69; PIELOU EC, 1966, J THEOR BIOL, V10, P370, DOI 10.1016/0022-5193(66)90133-0; Pinheiro J, 2015, DEV CORE TEAM R NLME, P1; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Price K, 2009, FOREST ECOL MANAG, V258, P495, DOI 10.1016/j.foreco.2008.10.010; Price P.W., 2011, P1; Quinn Thomas P., 2005, P1; R Core Team, 2016, R FDN STAT COMP; RALPH C. J., 1995, MONITORING BIRD POPU; Reimchen TE, 2003, AM FISH S S, V34, P59; Reimchen TE, 2017, DIVERSE ECOLOGICAL P, P350, DOI [10.22621/cfn.v131i4.1965, DOI 10.22621/CFN.V131I4.1965]; Reimchen TE, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-38; RICHEY JE, 1975, J FISH RES BOARD CAN, V32, P817, DOI 10.1139/f75-109; Rinella DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00112.1; Schindler DE, 2017, ECOSYSTEMS, V20, P78, DOI 10.1007/s10021-016-0050-7; Sharpe F, 1996, NORTHWEST SCI, V70, P86; SWEENEY BW, 1982, EVOLUTION, V36, P810, DOI 10.1111/j.1558-5646.1982.tb05447.x; Tonra CM, 2016, ECOGRAPHY, V39, P1056, DOI 10.1111/ecog.02014; Tonra CM, 2015, BIOL CONSERV, V192, P130, DOI 10.1016/j.biocon.2015.09.009; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Verspoor JJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00011.1; Willson MF, 1998, BIOSCIENCE, V48, P455, DOI 10.2307/1313243; Willson MF, AM DIPPER CINCLUS ME; Wipfli MS, 1998, CAN J FISH AQUAT SCI, V55, P1503, DOI 10.1139/cjfas-55-6-1503; Wipfli MS, 1999, CAN J FISH AQUAT SCI, V56, P1600, DOI 10.1139/cjfas-56-9-1600; Xiang HongYong, 2017, Riparian Ecology and Conservation, V3, P1, DOI 10.1515/remc-2016-0001; Zuur Alain F., 2009, P1	80	12	13	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210031	10.1371/journal.pone.0210031	http://dx.doi.org/10.1371/journal.pone.0210031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726212	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000014
J	Akiyama, Y; Akamatsu, T; Rasmussen, MH; Iversen, MR; Iwata, T; Goto, Y; Aoki, K; Sato, K				Akiyama, Yu; Akamatsu, Tomonari; Rasmussen, Marianne H.; Iversen, Maria R.; Iwata, Takashi; Goto, Yusuke; Aoki, Kagari; Sato, Katsufumi			Leave or stay? Video-logger revealed foraging efficiency of humpback whales under temporal change in prey density	PLOS ONE			English	Article							WEDDELL SEALS; BEHAVIOR; PERFORMANCE; KINEMATICS; DECISIONS; PATTERNS; MODELS; TIME	Central place foraging theory (CPF) has been used to predict the optimal patch residence time for air-breathing marine predators in response to patch quality. Humpback whales (Megaptera novaeangliae) forage on densely aggregated prey, which may induce drastic change in prey density in a single feeding event. Thus, the decision whether to leave or stay after each feeding event in a single dive in response to this drastic change, should have a significant effect on prey exploitation efficiency. However, whether humpback whales show adaptive behavior in response to the diminishing prey density in a single dive has been technically difficult to test. Here, we studied the foraging behavior of humpback whales in response to change in prey density in a single dive and calculated the efficiency of each foraging dive using a model based on CPF approach. Using animal-borne accelerometers and video loggers attached to whales, foraging behavior and change in relative prey density in front of the whales were successfully quantified. Results showed diminishing rate of energy intake in consecutive feeding events, and humpback whales efficiently fed by bringing the rate of energy intake close to maximum in a single dive cycle. This video-based method also enabled us to detect the presence of other animals around the tagged whales, showing an interesting trend in behavioral changes where feeding duration was shorter when other animals were present. Our results have introduced a new potential to quantitatively investigate the effect of other animals on free-ranging top predators in the context of optimal foraging theory.	[Akiyama, Yu; Iwata, Takashi; Goto, Yusuke; Aoki, Kagari; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Akamatsu, Tomonari] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Rasmussen, Marianne H.; Iversen, Maria R.] Univ Iceland, Res Ctr Husavik, Husavik, Iceland; [Iwata, Takashi] Univ St Andrews, Sch Biol, Sea Mammal Res Unit, Bute Bldg, St Andrews, Fife, Scotland	University of Tokyo; Japan Fisheries Research & Education Agency (FRA); University of Iceland; University of St Andrews	Akiyama, Y (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	yu_akiyama@aori.u-tokyo.ac.jp		Goto, Yusuke/0000-0003-2767-1501	Japan Society for the Promotion of Science [17H00776]; Bio-Logging Science, The University of Tokyo; Japan Science and Technology Agency [JPMJCR11A1]; University of Iceland's research fund; Japan Society for the Promotion of Science Bilateral Open Partnership Joint Research Program	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bio-Logging Science, The University of Tokyo; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); University of Iceland's research fund; Japan Society for the Promotion of Science Bilateral Open Partnership Joint Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (grant number 17H00776 to K.S.); Bio-Logging Science, The University of Tokyo to K.S.; the Japan Science and Technology Agency (grant number JPMJCR11A1 to T.A.); and the University of Iceland's research fund to M.H.R.; the Japan Society for the Promotion of Science Bilateral Open Partnership Joint Research Program, to K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2014, J ACOUST SOC AM, V136, P939, DOI 10.1121/1.4887439; BERTA A, 2005, MARINE MAMMALS EVOLU; Cade DE, 2016, CURR BIOL, V26, P2617, DOI 10.1016/j.cub.2016.07.037; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Doniol-Valcroze T, 2011, BEHAV ECOL, V22, P880, DOI 10.1093/beheco/arr038; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Foo D, 2016, ANIM BEHAV, V112, P127, DOI 10.1016/j.anbehav.2015.11.028; Friedlaender AS, 2016, ECOL APPL, V26, P1075, DOI 10.1002/15-0783; Friedlaender AS, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160043; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Goldbogen JA, 2015, FUNCT ECOL, V29, P951, DOI 10.1111/1365-2435.12395; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Hazen EL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500469; HOUSTON AI, 1992, BEHAV ECOL, V3, P255, DOI 10.1093/beheco/3.3.255; Iwata T, 2012, MAR MAMMAL SCI, V28, P345, DOI 10.1111/j.1748-7692.2011.00482.x; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MCNAMARA JM, 1985, J THEOR BIOL, V117, P231, DOI 10.1016/S0022-5193(85)80219-8; Mori T, 2015, FISHERIES SCI, V81, P871, DOI 10.1007/s12562-015-0910-7; Mori Y, 2002, ANIM BEHAV, V64, P739, DOI 10.1006/anbe.2002.3093; Mori Y, 2004, ECOLOGY, V85, P398; Narazaki T, 2010, RECONSTRUCTION 3 D P; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Orians G.H., 1979, P155; Potvin J, 2010, J THEOR BIOL, V267, P437, DOI 10.1016/j.jtbi.2010.08.026; Rasband WS, 1997, IMAGEJ; Rasmussen M., 2009, ENVIRON IMPACT ASSES, P16; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Saunders RA, 2007, PROG OCEANOGR, V72, P313, DOI 10.1016/j.pocean.2006.09.005; Shiomi K, 2010, AQUAT BIOL, V8, P299, DOI 10.3354/ab00239; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Stephens D.W., 1986, pi; Stephens DW, 2007, FORAGING BEHAV ECOLO; Tanaka H, 2001, J EXP BIOL, V204, P3895; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Tyson RB, 2016, ANIM BEHAV, V116, P223, DOI 10.1016/j.anbehav.2016.03.034; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanabe YY, 2014, P R SOC B, V281; Woodward BL, 2006, J MORPHOL, V267, P1284, DOI 10.1002/jmor.10474	44	4	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211138	10.1371/journal.pone.0211138	http://dx.doi.org/10.1371/journal.pone.0211138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721236	Green Published, gold			2022-12-26	WOS:000457746300009
J	Nerad, E; Delli Pizzi, A; Lambregts, DMJ; Maas, M; Wadhwani, S; Bakers, FCH; van den Bosch, HCM; Beets-Tan, RGH; Lahaye, MJ				Nerad, Elias; Delli Pizzi, Andrea; Lambregts, Doenja M. J.; Maas, Monique; Wadhwani, Sharan; Bakers, Frans C. H.; van den Bosch, Harrie C. M.; Beets-Tan, Regina G. H.; Lahaye, Max J.			The Apparent Diffusion Coefficient (ADC) is a useful biomarker in predicting metastatic colon cancer using the ADC-value of the primary tumor	PLOS ONE			English	Article							IMAGING BIOMARKER; NEOADJUVANT TREATMENT; BREAST-CANCER; MRI; AGGRESSIVENESS; CLASSIFICATION; SECTION	Purpose To investigate the role of the apparent diffusion coefficient (ADC) as a potential imaging bio-marker to predict metastasis (lymph node metastasis and distant metastasis) in colon cancer based on the ADC-value of the primary tumor. Methods Thirty patients (21M, 9F) were included retrospectively. All patients received a 1.5T MRI of the colon including T2 and DWI sequences. ADC maps were calculated for each patient. An expert reader manually delineated all colon tumors to measure mean ADC and histogram metrics (mean, min, max, median, standard deviation (SD), skewness, kurtosis, 5th-95th percentiles) were calculated. Advanced colon cancer was defined as lymph node mestastasis (N+) or distant metastasis (M+). The student Mann Whitney U-test was used to assess the differences between the ADC means of early and advanced colon cancer. To compare the accuracy of lymph node metastasis (N+) prediction based on morpholigical criteria versus ADC-value of the primary tumor, two blinded readers, determined the lymph node metastasis (N0 vs N+) based on morphological criteria. The sensitivity and specificity in predicting lymph node metastasis was calculated for both readers and for the ADC-value of the primary tumor, with histopathology results as the gold standard. Results There was a significant difference between the mean ADC-value of advanced versus early tumors (p = 0.002). The optimal cut off value was 1179 * 10(-3) mm2/s with an area under the curve (AUC) of 0.83 and a sensitivity and specificity of 81% and 86% respectively to predict advanced tumors. Histogram analyses did not add any significant additional value. The sensitivity and specificity for the prediction of lymph node metastasis based on morphological criteria were 40% and 63% for reader 1 and 30% and 88% for reader 2 respectively. The primary tumor ADC-value using 1.179* 10(-3) mm2/s as threshold had a 100% sensitivity and specificity in predicting lymph node metastasis. Conclusion The ADC-value of the primary tumor has the potential to predict advanced colon cancer, defined as lymph node metastasis or distant metastasis, with lower ADC values significantly associated with advanced tumors. Furthermore the ADC-value of the primary tumor increases the prediction accuracy of lymph node metastasis compared with morphological criteria.	[Nerad, Elias; Beets-Tan, Regina G. H.] Univ Maastricht, Maastricht, Netherlands; [Nerad, Elias; Beets-Tan, Regina G. H.] GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Nerad, Elias; Lambregts, Doenja M. J.; Maas, Monique; Beets-Tan, Regina G. H.; Lahaye, Max J.] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands; [Nerad, Elias] Cambridge Univ Hosp NHS trust, Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Delli Pizzi, Andrea] Gabriele dAnnunzio Univ, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Wadhwani, Sharan] Univ Birmingham Hosp NHS Trust, Queen Elizabeth Hosp, Dept Radiol, Birmingham, W Midlands, England; [Bakers, Frans C. H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [van den Bosch, Harrie C. M.] Catharina Hosp, Dept Radiol, Eindhoven, Netherlands	Maastricht University; Maastricht University; Netherlands Cancer Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; G d'Annunzio University of Chieti-Pescara; University of Birmingham; Maastricht University; Catharina Hospital	Nerad, E (corresponding author), Univ Maastricht, Maastricht, Netherlands.; Nerad, E (corresponding author), GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.; Nerad, E (corresponding author), Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands.; Nerad, E (corresponding author), Cambridge Univ Hosp NHS trust, Addenbrookes Hosp, Dept Radiol, Cambridge, England.	Nerad19@hotmail.com	Delli Pizzi, Andrea/J-6903-2019; Beets-Tan, Regina/AAZ-9119-2020	Delli Pizzi, Andrea/0000-0002-2011-3753; 				Akashi M, 2014, ACTA RADIOL, V55, P524, DOI 10.1177/0284185113503154; Arredondo J, 2014, J GASTROINTEST ONCOL, V5, P148, DOI 10.3978/j.issn.2078-6891.2014.015; Bickel H, 2015, INVEST RADIOL, V50, P95, DOI 10.1097/RLI.0000000000000104; Curvo-Semedo L, 2012, J MAGN RESON IMAGING, V35, P1365, DOI 10.1002/jmri.23589; Dam C, 2017, ACTA RADIOL OPEN, V6, DOI 10.1177/2058460117720957; Dam C, 2015, DAN MED J, V62; Hunter C, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160257; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Lambregts DMJ, 2011, EUR RADIOL, V21, P2567, DOI 10.1007/s00330-011-2220-5; Li C, 2016, ACTA RADIOL, DOI DOI 10.2214/AJR.15.15894; Miquel ME, 2012, BRIT J RADIOL, V85, P1507, DOI 10.1259/bjr/32269440; Mori N, 2015, RADIOLOGY, V274, P66, DOI 10.1148/radiol.14140283; Morton UKD, 2012, LANCET ONCOL, V13, P1152, DOI 10.1016/S1470-2045(12)70348-0; Nerad E, 2016, AM J ROENTGENOL, P1; Nerad E, 2017, DIS COLON RECTUM, V60, P385, DOI 10.1097/DCR.0000000000000794; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Nougaret S, 2016, RADIOLOGY, V280, P446, DOI 10.1148/radiol.2016150702; Ojima Eisuke, 2013, Gan To Kagaku Ryoho, V40, P1962; Rollven E, 2013, ACTA RADIOL, V54, P722, DOI 10.1177/0284185113484018; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sener RN, 2001, COMPUT MED IMAG GRAP, V25, P299, DOI 10.1016/S0895-6111(00)00083-5; Shin HJ, 2016, NMR BIOMED, V29, P1070, DOI 10.1002/nbm.3571; Sun YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109371; Tong T, 2014, J MAGN RESON IMAGING, V40, P738, DOI 10.1002/jmri.24398; Trojan J, 2008, Z GASTROENTEROL, V46, P776, DOI 10.1055/s-2007-963717; Tudyka V, 2014, EJSO-EUR J SURG ONC, V40, P469, DOI 10.1016/j.ejso.2013.10.029; van Heeswijk MM, 2017, ABDOM RADIOL, V42, P1627, DOI 10.1007/s00261-017-1062-2; Vernmark K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1908-3; Woo S, 2016, AM J ROENTGENOL, V207, P114, DOI 10.2214/AJR.15.15894; Wu X, 2016, DIAGN INTERV IMAGING	30	21	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211830	10.1371/journal.pone.0211830	http://dx.doi.org/10.1371/journal.pone.0211830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721268	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300031
J	de Oliveira, AR; da Silva, FS; Bortolin, RH; Marques, DED; Ramos, GV; Marqueti, RC; da Silva, NB; Medeiros, KCD; Correa, MA; Lima, JPMS; de Rezende, AA; Ackermann, PW; Abreu, BJ; Vieira, WHD				de Oliveira, Anderson Rodrigues; da Silva, Flavio Santos; Bortolin, Raul Hernandes; da Silva Marques, Dafiny Emanuele; Ramos, Gracielle Vieira; Marqueti, Rita C.; da Silva, Naisandra Bezerra; de Paula Medeiros, Karina Carla; Correa, Marcio Assolin; Matos Santos Lima, Joao Paulo; de Rezende, Adriana Augusto; Ackermann, Paul W.; Abreu, Bento J.; de Brito Vieira, Wouber Herickson			Effect of photobiomodulation and exercise on early remodeling of the Achilles tendon in streptozotocin-induced diabetic rats	PLOS ONE			English	Article							LEVEL LASER THERAPY; INFLAMMATORY MEDIATORS; EXPERIMENTAL-MODEL; GENE-EXPRESSION; GROWTH-FACTORS; MELLITUS; NM; REPAIR; TENDINOPATHY; TENDINITIS	The aim of this study was to compare the treatment effects of laser photobiomodulation (LPBM) therapy and aerobic exercise on the biomechanical properties, tissue morphology and the expression of tendon matrix molecules during early remodeling of Achilles tendon (AT) injury in diabetic rats. Animals were randomly assigned to five groups: injured non diabetic (I, n = 15), injured diabetic (ID, n = 15), injured diabetic plus LPBM (IDL, n = 16), injured diabetic plus aerobic exercise (IDE, n = 16) and injured diabetic plus aerobic exercise and LPBM (IDEAL, n = 17). Type 1 diabetes was induced via a single intravenous injection of Streptozotocin at a dose of 40 mg/kg. A partial tenotomy was performed in the right AT. LPBM was performed with an indium-gallium-aluminum-phosphide 660 nm 10 mW laser device (spot size 0.04 cm(2), power density 250 mW/cm(2), irradiation duration 16 s, energy 0.16 J, energy density 4 J/cm(2)) on alternate days for a total of 9 sessions over 3 weeks (total energy 1.44 J), using a stationary contact technique to a single point over the dorsal aspect of the AT. Moderate aerobic exercise was performed on a motorized treadmill (velocity 9 m/min for 60 minutes). At 3 weeks post-injury, biomechanical analyzes as well as assessment of fibroblast number and orientation were performed. Collagen 1 (Col1) and 3 (Col3) and matrix metalloproteinases (MMPs)-3 and 13 protein distributions were studied by immunohistochemistry; while Col1 and Col3 and MMP-2 and 9 gene expression were assessed by quantitative RT-PCR (qRT-PCR). IDEAL exhibited significant increases in several bio-mechanical parameters in comparison to the other groups. Moreover, IDEAL presented stronger Col1 immunoreactivity when compared to ID, and weaker Col3 immunoreactivity than IDE. Both IDL and IDEAL demonstrated weaker expression of MMP-3 in comparison to I, while IDL presented no expression of MMP-13 when compared to ID. ID, IDL and IDE showed an increased number of fibroblasts in comparison to I, while IDEAL decreased the number of these cells in comparison to ID and IDE. IDL and IDEAL groups exhibited decreased angular dispersion among the fibroblasts when compared to I. The gene expression results showed that IDE demonstrated a downregulation in Col1 mRNA expression in comparison to I and ID. IDEAL demonstrated upregulation of Col1 mRNA expression when compared to IDL or IDE alone and increased MMP-2 expression when compared to IDL and IDE. MMP-9 expression was upregulated in IDEAL when compared to I, IDL and IDE. Our results suggest a beneficial interaction of combining both treatment strategies i.e., aerobic exercise and LPBM, on the biomechanical properties, tissue morphology and the expression of matrix molecules in diabetic tendons.	[de Oliveira, Anderson Rodrigues; de Brito Vieira, Wouber Herickson] Univ Fed Rio Grande do Norte, Dept Phys Therapy, Natal, RN, Brazil; [da Silva, Flavio Santos] Fed Univ Semiarid Reg, Dept Hlth Sci, Mossoro, Brazil; [Bortolin, Raul Hernandes; de Rezende, Adriana Augusto] Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, Natal, RN, Brazil; [da Silva Marques, Dafiny Emanuele; da Silva, Naisandra Bezerra; de Paula Medeiros, Karina Carla; Abreu, Bento J.] Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil; [Ramos, Gracielle Vieira] Univ Paulista UNIP, Brasilia, DF, Brazil; [Marqueti, Rita C.] Univ Brasilia UnB, Brasilia, DF, Brazil; [Correa, Marcio Assolin] Univ Fed Rio Grande do Norte, Dept Phys, Natal, RN, Brazil; [Matos Santos Lima, Joao Paulo] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil; [Ackermann, Paul W.] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden	Universidade Federal do Rio Grande do Norte; Universidade Federal Rural do Semi-Arido (UFERSA); Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Paulista; Universidade de Brasilia; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Karolinska Institutet; Karolinska University Hospital	Abreu, BJ (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil.	abreubj@gmail.com	W, Ackermann P/B-9714-2008; Abreu, Bento J/E-2607-2015; DE REZENDE, ADRIANA AUGUSTO/L-4170-2018; Lima, João Paulo Matos Santos/AAS-7878-2021; Marqueti, Rita de Cassia/D-1622-2012; Bortolin, Raul H/O-2277-2016; VIEIRA, WOUBER BRITO/R-3933-2018; Corrêa, Marcio/E-1510-2013; Ramos, Gracielle/D-8926-2017	W, Ackermann P/0000-0002-5520-169X; DE REZENDE, ADRIANA AUGUSTO/0000-0003-2452-4047; Lima, João Paulo Matos Santos/0000-0002-6113-8834; Marqueti, Rita de Cassia/0000-0001-9126-3882; VIEIRA, WOUBER BRITO/0000-0003-3588-5577; Corrêa, Marcio/0000-0002-8904-4151; Abreu, Bento Joao/0000-0001-8010-806X; Bortolin, Raul Hernandes/0000-0003-3424-3281; Ramos, Gracielle/0000-0003-4746-0357	Brazilian National Council for Scientific and Technological (CNPq) [480758/2013-1]	Brazilian National Council for Scientific and Technological (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	W.H.B.V. received support from the Brazilian National Council for Scientific and Technological (CNPq grant number 480758/2013-1).	Abreu BJ, 2016, ADV EXP MED BIOL, V920, P185, DOI 10.1007/978-3-319-33943-6_17; Ahmed AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170748; Ahmed AS, 2012, J APPL PHYSIOL, V113, P1784, DOI 10.1152/japplphysiol.00767.2012; Aliodoust M, 2014, LASER MED SCI, V29, P1495, DOI 10.1007/s10103-014-1561-0; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; Ayuk SM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2897656; Bezerra MA, 2016, MLTJ-MUSCLE LIGAMENT, V6, P97, DOI 10.11138/mltj/2016.6.1.097; Bortolin RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125349; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Chung SW, 2017, ARTHROSCOPY, V33, P518, DOI 10.1016/j.arthro.2016.08.017; Vieira WHD, 2014, PHOTOMED LASER SURG, V32, P678, DOI 10.1089/pho.2014.3812; de Oliveira RR, 2011, DIABETIC MED, V28, P886, DOI 10.1111/j.1464-5491.2010.03197.x; de Oliveira RR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169513; de Oliveira RR, 2012, J DIABETES COMPLICAT, V26, P163, DOI 10.1016/j.jdiacomp.2012.03.017; Egemen O, 2012, J HAND MICROSURG, V4, P60, DOI 10.1007/s12593-012-0074-y; Elwakil TF, 2007, LASER MED SCI, V22, P53, DOI 10.1007/s10103-006-0423-9; Enwemeka CS, 2004, PHOTOMED LASER SURG, V22, P323, DOI 10.1089/1549541041797841; Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072; Fox AJS, 2011, J ORTHOP RES, V29, P880, DOI 10.1002/jor.21327; FRIEDER S, 1988, Journal of Orthopaedic and Sports Physical Therapy, V10, P39; Grant W P, 1997, J Foot Ankle Surg, V36, P272; Hapa O, 2009, ARCH ORTHOP TRAUM SU, V129, P1721, DOI 10.1007/s00402-009-0877-x; Helrigle C, 2016, LASER MED SCI, V31, P33, DOI 10.1007/s10103-015-1821-7; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Kobayashi M, 2006, J SHOULDER ELB SURG, V15, P371, DOI 10.1016/j.jse.2005.09.003; Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC; Marcos RL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1447, DOI 10.1111/j.1751-1097.2011.00999.x; Mohsenifar Z, 2014, FOOT ANKLE SURG, V20, P186, DOI 10.1016/j.fas.2014.04.003; Ng GYF, 2008, PHOTOMED LASER SURG, V26, P137, DOI 10.1089/pho.2007.2145; Nouruzian M, 2013, LASER MED SCI, V28, P399, DOI 10.1007/s10103-012-1074-7; Ohan Z, 2004, J BONE JOINT SURG BR, V86, P613; Pasternak B, 2009, ACTA ORTHOP, V80, P693, DOI 10.3109/17453670903448257; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Ranger TA, 2016, BRIT J SPORT MED, V50, P982, DOI 10.1136/bjsports-2015-094735; Rees J, 2016, ADV EXP MED BIOL, V920, P199, DOI 10.1007/978-3-319-33943-6_19; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Rezende SB, 2007, J PHOTOCH PHOTOBIO B, V87, P145, DOI 10.1016/j.jphotobiol.2007.02.005; Shi L, 2015, INT ORTHOP, V39, P1465, DOI 10.1007/s00264-015-2775-x; Silva FS, 2013, REV MED BIOL, V12, P15; Snedeker Jess G, 2014, Muscles Ligaments Tendons J, V4, P303; SUKENIK S, 1987, DIABETES METAB, V13, P187; Torres-Silva R, 2015, LASER MED SCI, V30, P1985, DOI 10.1007/s10103-014-1676-3; Tsai WC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-255; Tsai WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038235; Tumilty S, 2010, PHOTOMED LASER SURG, V28, P3, DOI 10.1089/pho.2008.2470; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Volper BD, 2015, AM J PHYSIOL-REG I, V309, pR1135, DOI 10.1152/ajpregu.00189.2015; Wu YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep44199; Zhang JY, 2016, ONCOTARGET, V7, P8498, DOI 10.18632/oncotarget.7381; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123	52	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211643	10.1371/journal.pone.0211643	http://dx.doi.org/10.1371/journal.pone.0211643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716140	gold, Green Submitted, Green Published			2022-12-26	WOS:000457744200034
J	Sueyoshi, K; Watanabe, Y; Inoue, T; Ohno, Y; Nakajima, H; Okada, H				Sueyoshi, Keita; Watanabe, Yusuke; Inoue, Tsutomu; Ohno, Yoichi; Nakajima, Hiroyuki; Okada, Hirokazu			Predictors of long-term prognosis in acute kidney injury survivors who require continuous renal replacement therapy after cardiovascular surgery	PLOS ONE			English	Article							COMPETING RISKS; HOSPITAL DISCHARGE; CARDIAC-SURGERY; RIFLE CRITERIA; OLDER-ADULTS; MORTALITY; DISEASE; DIALYSIS; FRAILTY; INDEX	The long-term prognosis of patients with postoperative acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) after cardiovascular surgery is unclear. We aimed to investigate long-term renal outcomes and survival in these patients to determine the risk factors for negative outcomes. Long-term prognosis was examined in 144 hospital survivors. All patients were independent and on renal replacement therapy at hospital discharge. The median age at operation was 72.0 years, and the median pre-operative estimated glomerular filtration rate (eGFR) was 39.5 mL/min/1.73 m(2). The median follow-up duration was 1075 days. The endpoints were death, chronic maintenance dialysis dependence, and a composite of death and chronic dialysis. Predictors for death and dialysis were evaluated using Fine and Gray's competing risk analysis. The cumulative incidence of death was 34.9%, and the chronic dialysis rate was 13.3% during the observation period. In the multivariate proportional hazards analysis, eGFR <30 mL/min/1.73 m(2) at discharge was associated with the composite endpoint of death and dialysis [hazard ratio (HR), 2.1; 95% confidence interval (CI), 1.1-3.8; P = 0.02]. Hypertension (HR 8.7, 95% CI, 2.2-35.4; P = 0.002) and eGFR <30 mL/min/1.73 m(2) at discharge (HR 26.4, 95% CI, 2.6-267.1; P = 0.006) were associated with dialysis. Advanced age (>= 75 years) was predictive of death. Patients with severe CRRT-requiring AKI after cardiovascular surgery have increased risks of chronic dialysis and death. Patients with eGFR <30 mL/min/1.73 m(2) at discharge should be monitored especially carefully by nephrologists due to the risk of chronic dialysis and death.	[Sueyoshi, Keita; Watanabe, Yusuke; Inoue, Tsutomu; Ohno, Yoichi; Okada, Hirokazu] Saitama Med Univ, Dept Nephrol, Saitama, Japan; [Sueyoshi, Keita; Watanabe, Yusuke; Inoue, Tsutomu; Ohno, Yoichi; Okada, Hirokazu] Saitama Med Univ, Int Med Ctr, Div Dialysis Ctr, Saitama, Japan; [Sueyoshi, Keita; Watanabe, Yusuke; Inoue, Tsutomu; Ohno, Yoichi; Okada, Hirokazu] Saitama Med Univ, Int Med Ctr, Dept Nephrol, Saitama, Japan; [Sueyoshi, Keita] Musashiranzan Hosp, Saitama, Japan; [Nakajima, Hiroyuki] Saitama Med Univ, Int Med Ctr, Dept Cardiovasc Surg, Saitama, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University	Okada, H (corresponding author), Saitama Med Univ, Dept Nephrol, Saitama, Japan.; Okada, H (corresponding author), Saitama Med Univ, Int Med Ctr, Div Dialysis Ctr, Saitama, Japan.; Okada, H (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Nephrol, Saitama, Japan.	hirookda@saitama-med.ac.jp						CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; de Arenaza DP, 2010, HEART, V96, P113, DOI 10.1136/hrt.2008.161174; Dignam JJ, 2008, J CLIN ONCOL, V26, P4027, DOI 10.1200/JCO.2007.12.9866; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ferreiro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181158; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gardner SC, 2001, ANN THORAC SURG, V72, P2033, DOI 10.1016/S0003-4975(01)03217-9; Goldstein SL, 2013, CLIN J AM SOC NEPHRO, V8, P476, DOI 10.2215/CJN.12101112; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Harel Z, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-114; Harel Z, 2013, KIDNEY INT, V83, P901, DOI 10.1038/ki.2012.451; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Hu JC, 2016, J CARDIOTHOR VASC AN, V30, P82, DOI 10.1053/j.jvca.2015.06.017; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Iwagami M, 2015, NEPHROL DIAL TRANSPL, V30, P988, DOI 10.1093/ndt/gfv069; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kim DH, 2016, ANN INTERN MED, V165, P650, DOI 10.7326/M16-0652; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Lim CC, 2015, CARDIORENAL MED, V5, P157, DOI 10.1159/000381068; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lombardi R, 2008, RENAL FAILURE, V30, P155, DOI 10.1080/08860220701808129; MAHONEY F I, 1965, Md State Med J, V14, P61; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Puls M, 2014, EUROINTERVENTION, V10, P609, DOI 10.4244/EIJY14M08_03; Rahmanian PB, 2007, AM J CARDIOL, V100, P1702, DOI 10.1016/j.amjcard.2007.07.017; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Sawhney S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006497; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; Silver SA, 2015, NEPHRON, V131, P43, DOI 10.1159/000438871; Stads S, 2013, CLIN J AM SOC NEPHRO, V8, P1284, DOI 10.2215/CJN.06650712; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259	37	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211429	10.1371/journal.pone.0211429	http://dx.doi.org/10.1371/journal.pone.0211429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703146	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600042
J	Andrews, GD; McGrady, AT; Brown, SR; Maynard, SM				Andrews, Graham D.; McGrady, Andrew T.; Brown, Sarah R.; Maynard, Shannon M.			First description of subglacial megalineations from the late Paleozoic ice age in southern Africa	PLOS ONE			English	Article							EROSIONAL LANDFORMS; PARANA BASIN; GLACIATION; LANDSCAPE; STREAMS; TUFFS; FLOW	We identify late Paleozoic ice age (LPIA) subglacial megalineations from field and geospatial imagery of the Twyfelfontein area of northern Namibia, and present the results of a geomorphometric analysis of those data. Asymmetric 0.1-1.5 km-long megawhalebacks indicate a paleo-ice flow to the northwest. We infer that an ice stream draining the LPIA Kaokoveld ice sheet existed within the proto-Huab River valley and that was comparable to ice streams in modern Antarctica. Recognition of a paleo-ice stream in northern Namibia supports interpretations of glaciogenic sedimentary successions (Itarare Group) in southern Brazil that suggest the presence of major, terrestrial glacial outlet systems in southern Africa during the LPIA.	[Andrews, Graham D.; McGrady, Andrew T.; Brown, Sarah R.; Maynard, Shannon M.] West Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA	West Virginia University	Andrews, GD (corresponding author), West Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA.	graham.andrews@mail.wvu.edu	Andrews, Graham/AAN-8676-2020	Andrews, Graham/0000-0002-7911-702X; Brown, Sarah/0000-0002-8762-3301	West Virginia Space Grant Consortium	West Virginia Space Grant Consortium	This work was supported by the West Virginia Space Grant Consortium (awarded to Andrew McGrady). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, REV BRAS GEOCIENC; Assine ML, 2018, SEDIMENT GEOL, V369, P1, DOI 10.1016/j.sedgeo.2018.03.011; Bamber JL, 2000, SCIENCE, V287, P1248, DOI 10.1126/science.287.5456.1248; Bennett MR, 2003, EARTH-SCI REV, V61, P309, DOI 10.1016/S0012-8252(02)00130-7; Bussert R, 2010, GONDWANA RES, V18, P356, DOI 10.1016/j.gr.2009.10.009; Clifford TM, NAMIBIA S AFR J GEOL, V200, P117; CROWELL JC, 1972, GEOL SOC AM BULL, V83, P2887, DOI 10.1130/0016-7606(1972)83[2887:LPGPVK]2.0.CO;2; Ely JC, 2016, GEOMORPHOLOGY, V257, P108, DOI 10.1016/j.geomorph.2016.01.001; Fallgatter C, 2017, ORIGIN ITARARE GROUP; FRAKES LA, 1970, GEOL SOC AM BULL, V81, P2261, DOI 10.1130/0016-7606(1970)81[2261:LPGIAE]2.0.CO;2; Holzfoerster Frank, 2000, Communications of the Geological Survey of Namibia, V12, P247; King EC, 2009, NAT GEOSCI, V2, P585, DOI 10.1038/NGEO581; Krabbendam M, 2016, SEDIMENT GEOL, V338, P24, DOI 10.1016/j.sedgeo.2015.12.007; Le Heron DP, 2018, GEOLOGY, V46, P91, DOI 10.1130/G39510.1; Lopez-Gamundi O, 2000, PALAEOGEOGR PALAEOCL, V159, P145, DOI 10.1016/S0031-0182(00)00044-4; Martin H., 1981, GEOL RUNDSCH, V70, P480, DOI DOI 10.1007/BF01822128; Martin H., 1981, EARTHS PREPLEISTOCEN, P61; da Rosa ELM, 2016, BRAZ J GEOL, V46, P147, DOI 10.1590/2317-4889201620160050; Newton M, 2018, EARTH-SCI REV, V185, P57, DOI 10.1016/j.earscirev.2018.03.007; Pillans B, 2007, J QUATERNARY SCI, V22, P439, DOI [10.1002/jqs.1131, 10.1002/jqs.1311]; Scotese CR, ATLAS PERMOCARBONIFE, V4; Stokes CR, 2013, QUATERNARY SCI REV, V77, P190, DOI 10.1016/j.quascirev.2013.06.003; Stollhofen H, 2000, PALAEOGEOGR PALAEOCL, V161, P127, DOI 10.1016/S0031-0182(00)00120-6; Stollhofen H, 2008, GEOL SOC AM SPEC PAP, V441, P83, DOI 10.1130/2008.2441(06); Vesely FF, 2015, SEDIMENT GEOL, V326, P45, DOI 10.1016/j.sedgeo.2015.06.012; Visser J.N.J., 1988, S AFRICAN J GEOLOGY, V91, P350; Wanke A., 2000, COMMUNICATIONS GEOLO, V12, P259; Winsborrow MCM, 2010, EARTH-SCI REV, V103, P45, DOI 10.1016/j.earscirev.2010.07.003	28	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210673	10.1371/journal.pone.0210673	http://dx.doi.org/10.1371/journal.pone.0210673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699176	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600045
J	Costamagna, E; Thies, SB; Kenney, LPJ; Howard, D; Lindemann, U; Klenk, J; Baker, R				Costamagna, Eleonora; Thies, Sibylle B.; Kenney, Laurence P. J.; Howard, David; Lindemann, Ulrich; Klenk, Jochen; Baker, Rose			Objective measures of rollator user stability and device loading during different walking scenarios	PLOS ONE			English	Article							CARPAL-TUNNEL SYNDROME; DWELLING OLDER-PEOPLE; RISK-FACTORS; FALLS	Walking aids are widely used by older adults, however, alarmingly, their use has been linked to increased falls-risk, yet clinicians have no objective way of assessing user stability. This work aims to demonstrate the application of a novel methodology to investigate how the type of walking task, the amount of body weight supported by the device (i.e., device loading), and task performance strategy affect stability of rollator users. In this context, ten users performed six walking tasks with an instrumented rollator. The combined stability margin "SM" was calculated, which considers user and rollator as a combined system. A Friedman Test was used to investigate the effects of task on SM and a least-squares regression model was applied to investigate the relationship between device loading and SM. In addition, the effects of task performance strategy on SM were explored. As a result, it was found that: the minimum SM for straight line walking was higher than for more complex tasks (p<0.05); an increase in device loading was associated with an increase in SM (p<0.05); stepping up a kerb with at least 1 rollator wheel in ground contact at all times resulted in higher SM than lifting all four wheels simultaneously. Hence, we conclude that training should not be limited to straight line walking but should include various everyday tasks. Within person, SM informs on which tasks need practicing, and which strategy facilitates stability, thereby enabling person-specific guidance/training. The relevance of this work lies in an increase in walking aid users, and the costs arising from fall-related injuries.	[Costamagna, Eleonora; Thies, Sibylle B.; Kenney, Laurence P. J.] Salford Univ, Ctr Hlth Sci Res, Sch Hlth & Soc, Salford, Lancs, England; [Howard, David] Salford Univ, Sch Comp Sci & Engn, Salford, Lancs, England; [Lindemann, Ulrich; Klenk, Jochen] Robert Bosch Krankenhaus, Dept Geriatr, Stuttgart, Germany; [Lindemann, Ulrich; Klenk, Jochen] Robert Bosch Krankenhaus, Clin Geriatr Rehabil, Stuttgart, Germany; [Baker, Rose] Salford Univ, Sch Business, Salford, Lancs, England	University of Salford; University of Salford; Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus; University of Salford	Costamagna, E (corresponding author), Salford Univ, Ctr Hlth Sci Res, Sch Hlth & Soc, Salford, Lancs, England.	E.Costamagna@edu.salford.ac.uk	Klenk, Jochen/R-3614-2019; Klenk, Jochen/C-2164-2012	Klenk, Jochen/0000-0002-5987-447X; Thies, Sibylle/0000-0001-9889-2243; Kenney, Laurence/0000-0003-2164-3892	University of Salford under the Pathway to Excellence Research Studentship; Research Impact Fund	University of Salford under the Pathway to Excellence Research Studentship; Research Impact Fund	The research leading to these results has received funding from the University of Salford under the Pathway to Excellence Research Studentship awarded to EC and from the Research Impact Fund awarded to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Brandt A, 2003, DISABIL REHABIL, V25, P343, DOI 10.1080/0963828021000058495; Costamagna E, 2017, MED ENG PHYS, V47, P167, DOI 10.1016/j.medengphy.2017.06.013; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Faes MC, 2010, AGING MENT HEALTH, V14, P834, DOI 10.1080/13607861003781825; GELBERMAN RH, 1981, J BONE JOINT SURG AM, V63, P380, DOI 10.2106/00004623-198163030-00009; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hefflin BJ, 2004, AM J PREV MED, V27, P246, DOI 10.1016/j.amepre.2004.04.005; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Lindemann U, 2016, AGING CLIN EXP RES, V28, P215, DOI 10.1007/s40520-015-0410-8; Liu H, 2009, GERIATR GERONTOL INT, V9, P124, DOI 10.1111/j.1447-0594.2008.00497.x; Lofqvist C, 2007, AGING CLIN EXP RES, V19, P497; NHS, 2014, FALLS NHS CHIC; NICE,, 2013, FALLS OLD PEOPL ASS; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schoon Y, 2014, EUR J PHYS REHAB MED, V50, P693; van Riel KMM, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2012-040593; Vanselow KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148930; WARING WP, 1989, J HAND SURG-AM, V14A, P865, DOI 10.1016/S0363-5023(89)80092-9	20	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210960	10.1371/journal.pone.0210960	http://dx.doi.org/10.1371/journal.pone.0210960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699170	gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600062
J	Natsume, M; Tanaka, Y; Kappers, AML				Natsume, Makiko; Tanaka, Yoshihiro; Kappers, Astrid M. L.			Individual differences in cognitive processing for roughness rating of fine and coarse textures	PLOS ONE			English	Article							TACTILE ROUGHNESS; PERCEIVED ROUGHNESS; GROOVED SURFACES; PERCEPTION; VIBRATION; DISCRIMINATION; FRICTION; FORCE; CODES	Previous studies have demonstrated that skin vibration is an important factor affecting the roughness perception of fine textures. For coarse textures, the determining physical factor is much less clear and there are indications that this might be participant-dependent. In this paper, we focused on roughness perception of both coarse and fine textures of different materials (glass particle surfaces and sandpapers). We investigated the relationship between subjective roughness ratings and three physical parameters (skin vibration, friction coefficient, and particle size) within a group of 30 participants. Results of the glass particle surfaces showed both spatial information (particle size) and temporal information (skin vibration) had a high correlation with subjective roughness ratings. The former correlation was slightly but significantly higher than the latter. The results also indicated different weights of temporal information and spatial information for roughness ratings among participants. Roughness ratings of a different material (sandpaper versus glass particles) could be either larger, similar or smaller, indicating differences among individuals. The best way to describe our results is that in their perceptual evaluation of roughness, different individuals weight temporal information, spatial information, and other mechanical properties differently.	[Natsume, Makiko; Tanaka, Yoshihiro] Nagoya Inst Technol, Dept Elect & Mech Engn, Nagoya, Aichi, Japan; [Tanaka, Yoshihiro] JST, PRESTO, Kawaguchi, Saitama, Japan; [Kappers, Astrid M. L.] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Kappers, Astrid M. L.] Eindhoven Univ Technol, Eindhoven, Netherlands	Nagoya Institute of Technology; Japan Science & Technology Agency (JST); Vrije Universiteit Amsterdam; Eindhoven University of Technology	Tanaka, Y (corresponding author), Nagoya Inst Technol, Dept Elect & Mech Engn, Nagoya, Aichi, Japan.; Tanaka, Y (corresponding author), JST, PRESTO, Kawaguchi, Saitama, Japan.	tanaka.yoshihiro@nitech.ac.jp		Kappers, Astrid/0000-0003-4101-7717	Japan Science and Technology Agency, PRESTO [JPMJPR14D7]; Japan Society for the Promotion of Science [JP17H01252]	Japan Science and Technology Agency, PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by grants from Japan Science and Technology Agency, PRESTO No. JPMJPR14D7 and Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (A) No. JP17H01252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; Coren S, 1992, LEFT HANDER SYNDROME; Delhaye B, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00037; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Gescheider GA, 2018, SOMATOSENS MOT RES, V35, P59, DOI 10.1080/08990220.2018.1460262; Gescheider GA, 2013, SOMATOSENS MOT RES, V30, P120, DOI 10.3109/08990220.2013.779242; Goodman JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46699; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2002, BEHAV BRAIN RES, V135, P51, DOI 10.1016/S0166-4328(02)00154-7; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; LEDERMAN SJ, 1974, PERCEPT PSYCHOPHYS, V16, P385, DOI 10.3758/BF03203958; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; LEDERMAN SJ, 1982, PERCEPT PSYCHOPHYS, V32, P109, DOI 10.3758/BF03204270; Libouton X, 2012, BEHAV BRAIN RES, V229, P273, DOI 10.1016/j.bbr.2012.01.018; Libouton X, 2010, BEHAV BRAIN RES, V208, P473, DOI 10.1016/j.bbr.2009.12.017; Lieber JD, 2017, J NEUROPHYSIOL, V118, P3107, DOI 10.1152/jn.00374.2017; Manfredi LR, 2014, J NEUROPHYSIOL, V111, P1792, DOI 10.1152/jn.00680.2013; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; Natsume M, 2016, WORLD AUTOMAT CONG, DOI 10.1109/WAC.2016.7583001; Natsume M, 2017, IEEE ROMAN, P1479; Okamoto S, 2013, IEEE T HAPTICS, V6, P81, DOI [10.1109/TOH.2012.32, 10.1109/ToH.2012.32]; Peters RM, 2009, J NEUROSCI, V29, P15756, DOI 10.1523/JNEUROSCI.3684-09.2009; Smith AM, 2010, EXP BRAIN RES, V202, P33, DOI 10.1007/s00221-009-2105-x; Smith AM, 2002, EXP BRAIN RES, V144, P211, DOI 10.1007/s00221-002-1015-y; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Tanaka Y, 2017, 2017 IEEE WORLD HAPTICS CONFERENCE (WHC), P623, DOI 10.1109/WHC.2017.7989973; Tanaka Y, 2015, 2015 IEEE WORLD HAPTICS CONFERENCE (WHC), P146, DOI 10.1109/WHC.2015.7177705; Tanaka Y, 2015, EXP BRAIN RES, V233, P1721, DOI 10.1007/s00221-015-4246-4; TAYLOR MM, 1975, PERCEPT PSYCHOPHYS, V17, P23, DOI 10.3758/BF03203993; Tiest WMB, 2007, ACTA PSYCHOL, V124, P177, DOI 10.1016/j.actpsy.2006.03.002; Tsuboi H, 2014, LECT NOTES COMPUT SC, V8618, P446, DOI 10.1007/978-3-662-44193-0_56; Weber AI, 2013, P NATL ACAD SCI USA, V110, P17107, DOI 10.1073/pnas.1305509110; Yoshioka T, 2001, J NEUROSCI, V21, P6905, DOI 10.1523/JNEUROSCI.21-17-06905.2001	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211407	10.1371/journal.pone.0211407	http://dx.doi.org/10.1371/journal.pone.0211407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699197	Green Submitted, gold, Green Published			2022-12-26	WOS:000457155600075
J	Echizen, K; Horiuchi, K; Aoki, Y; Yamada, Y; Minamoto, T; Oshima, H; Oshima, M				Echizen, Kanae; Horiuchi, Keigo; Aoki, Yayoi; Yamada, Yoichi; Minamoto, Toshinari; Oshima, Hiroko; Oshima, Masanobu			NF-kappa B-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells	ONCOGENE			English	Article							OXIDATIVE STRESS; ROS GENERATION; STEM; INFLAMMATION; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; SURVIVAL; OXIDASES; STOMACH	We previously showed that NADPH oxidase organizer 1 (Noxol), a component of NADPH oxidase 1 (NOX1), is a TNF-alpha-induced tumor-promoting factor in gastric tumorigenesis. However, the mechanism of NOX1-induced reactive oxygen species (ROS) signaling for the gastric tumorigenesis has not been understood. Here, we showed that expression of NOX1 complex components, including Noxol, but not other NOX family members was significantly upregulated in both mouse models for gastritis and gastric tumors, which was associated with increased ROS levels. We also found that NF-kB directly regulated NOXO1 expression in TNF-a-stimulated gastric cancer cells, suggesting that inflammation induces NOX1 complex activation through TNF-alpha/NF-kappa B pathway. Notably, in situ hybridization indicated that Noxol mRNA was detected in proliferating cells of gastritis and gastric tumors, and pharmacological inhibition of NOX activity significantly suppressed the proliferation of MKN45 gastric cancer cells and gastric hyperplasia of K19-C2mE mice. These results suggest that NOX1/ROS signaling has an important role in increased proliferation of stomach epithelial cells in the inflamed mucosa. Moreover, we found that expression of SOX2, a marker of gastric epithelial stem cells, was increased by NOX1/ROS signaling. Furthermore, disruption of Noxol in K19-C2mE mice significantly suppressed gastritis-associated metaplastic hyperplasia, a potent preneoplastic lesion, which was associated with decreased number of SOX2-positive cells. These results indicate that inflammation-induced Noxol expression is responsible for development of metaplastic hyperplasia in the stomach through an increase in SOX2-expressing undifferentiated epithelial cells. Therefore, inhibition of the NOX1/ROS signaling pathway is a possible strategy for prevention and therapy for gastric cancer development.	[Echizen, Kanae; Horiuchi, Keigo; Aoki, Yayoi; Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Echizen, Kanae; Oshima, Masanobu] Japan Agcy Med Res & Dev, AMED, AMED CREST, Tokyo 1000004, Japan; [Yamada, Yoichi] Kanazawa Univ, Fac Elect & Comp Engn, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Minamoto, Toshinari] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 9208640, Japan; [Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, WPI Nano Life Sci Inst, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University	Oshima, M (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan.; Oshima, M (corresponding author), Japan Agcy Med Res & Dev, AMED, AMED CREST, Tokyo 1000004, Japan.; Oshima, M (corresponding author), Kanazawa Univ, WPI Nano Life Sci Inst, Kanazawa, Ishikawa 9201192, Japan.	oshimam@staff.kanazawa-u.ac.jp	Minamoto, Toshinari/D-8442-2015; Oshima, Masanobu/F-9958-2014	Minamoto, Toshinari/0000-0003-4168-996X; Oshima, Masanobu/0000-0002-3304-0004; Oshima, Hiroko/0000-0001-6855-4008	AMEDCREST [JP17gm0410014]; AMED [JP18ck0106259]; Japan Agency for Medical Research and Development, Japan [JP15H02362, JP15K18405]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Foundation; Mitsubishi Foundation	AMEDCREST; AMED(Japan Agency for Medical Research and Development (AMED)); Japan Agency for Medical Research and Development, Japan(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	We thank Ayako Tsuda and Manami Watanabe for their technical assistance. This work was supported by AMEDCREST (JP17gm0410014) and AMED (JP18ck0106259), Japan Agency for Medical Research and Development, Japan; Grants-in-Aid for Scientific Research (A) (JP15H02362), and Grants-in-Aid for Young Scientists (B) (JP15K18405) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and Takeda Foundation and The Mitsubishi Foundation.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Butcher LD, 2017, CELL MOL GASTROENTER, V3, P316, DOI 10.1016/j.jcmgh.2017.02.002; Debbabi M, 2013, FASEB J, V27, P1733, DOI 10.1096/fj.12-216432; Echizen K, 2016, CANCER SCI, V107, P391, DOI 10.1111/cas.12901; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Goldenring JR, 2006, AM J PHYSIOL-GASTR L, V291, pG999, DOI 10.1152/ajpgi.00187.2006; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Joo JH, 2016, CANCER RES, V76, P855, DOI 10.1158/0008-5472.CAN-15-1512; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kennedy CL, 2014, ONCOGENE, V33, P2540, DOI 10.1038/onc.2013.205; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Maeda Y, 2016, CANCER PREV RES, V9, P253, DOI 10.1158/1940-6207.CAPR-15-0315; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima H, 2011, CANCER SCI, V102, P713, DOI 10.1111/j.1349-7006.2011.01847.x; Oshima M, 2005, CANCER RES, V65, P9147, DOI 10.1158/0008-5472.CAN-05-1936; Park MT, 2014, CELL DEATH DIFFER, V21, P1185, DOI 10.1038/cdd.2014.34; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Ristimaki A, 1997, CANCER RES, V57, P1276; Roy K, 2015, CLIN SCI, V128, P863, DOI 10.1042/CS20140542; Sarkar A, 2016, CELL REP, V16, P1929, DOI 10.1016/j.celrep.2016.07.034; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421	38	35	36	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4250	4263		10.1038/s41388-019-0702-0	http://dx.doi.org/10.1038/s41388-019-0702-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30700829	Green Published, hybrid			2022-12-26	WOS:000469339100004
J	Li, ZP; Jiao, XM; Di Sante, G; Ertel, A; Casimiro, MC; Wang, M; Katiyar, S; Ju, XM; Klopfenstein, DV; Tozeren, A; Dampier, W; Chepelev, I; Jeltsch, A; Pestell, RG				Li, Zhiping; Jiao, Xuanmao; Di Sante, Gabriele; Ertel, Adam; Casimiro, Mathew C.; Wang, Min; Katiyar, Sanjay; Ju, Xiaoming; Klopfenstein, D., V; Tozeren, Aydin; Dampier, William; Chepelev, Iouri; Jeltsch, Albert; Pestell, Richard G.			Cyclin D1 integrates G9a-mediated histone methylation	ONCOGENE			English	Article							NUCLEAR LAMINA INTERACTIONS; METHYLTRANSFERASE G9A; LYSINE METHYLTRANSFERASE; CHROMOSOMAL INSTABILITY; NEGATIVE REGULATION; CHROMATIN DYNAMICS; PROTEIN FAMILIES; DI-METHYLATION; CELLS; CANCER	Lysine methylation of histones and non-histone substrates by the SET domain containing protein lysine methyltransferase (KMT) G9a/EHMT2 governs transcription contributing to apoptosis, aberrant cell growth, and pluripotency. The positioning of chromosomes within the nuclear three-dimensional space involves interactions between nuclear lamina (NL) and the lamina-associated domains (LAD). Contact of individual LADs with the NL are dependent upon H3K9me2 introduced by G9a. The mechanisms governing the recruitment of G9a to distinct subcellular sites, into chromatin or to LAD, is not known. The cyclin D1 gene product encodes the regulatory subunit of the holoenzyme that phosphorylates pRB and NRF1 thereby governing cell-cycle progression and mitochondrial metabolism. Herein, we show that cyclin D1 enhanced H3K9 dimethylation though direct association with G9a. Endogenous cyclin D1 was required for the recruitment of G9a to target genes in chromatin, for G9a-induced H3K9me2 of histones, and for NL-LAD interaction. The finding that cyclin D1 is required for recruitment of G9a to target genes in chromatin and for H3K9 dimethylation, identifies a novel mechanism coordinating protein methylation.	[Li, Zhiping; Jiao, Xuanmao; Di Sante, Gabriele; Casimiro, Mathew C.; Wang, Min; Katiyar, Sanjay; Pestell, Richard G.] Penn Biotechnol Ctr, Baruch S Blumberg Inst, Penn Canc & Regenerat Med Res Ctr, 3805 Old Easton Rd, Doylestown, PA 18902 USA; [Ertel, Adam; Ju, Xiaoming] Thomas Jefferson Univ, Dept Canc Biol, 233 South 10th St, Philadelphia, PA 19107 USA; [Klopfenstein, D., V; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Dampier, William] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA; [Chepelev, Iouri] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Chepelev, Iouri] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Jeltsch, Albert] Univ Stuttgart, Inst Biochem & Tech Biochem, Dept Biochem, Allmandring 31, D-70569 Stuttgart, Germany; [Pestell, Richard G.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637551, Singapore	Jefferson University; Drexel University; Drexel University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Stuttgart; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Pestell, RG (corresponding author), Penn Biotechnol Ctr, Baruch S Blumberg Inst, Penn Canc & Regenerat Med Res Ctr, 3805 Old Easton Rd, Doylestown, PA 18902 USA.; Pestell, RG (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637551, Singapore.	richard.pestell@bblumberg.org	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290; Chepelev, Iouri/0000-0002-2121-8805; Klopfenstein, DV/0000-0003-0161-7603	Breast Cancer Research Foundation; Pennsylvania Department of Health; Dr. Ralph and Marian C. Falk Medical Research Trust;  [R01CA70896];  [R01CA75503];  [R01CA86072]	Breast Cancer Research Foundation; Pennsylvania Department of Health; Dr. Ralph and Marian C. Falk Medical Research Trust; ; ; 	This work was supported in part by R01CA70896, R01CA75503, and R01CA86072 (RGP). This project was funded in part from the Dr. Ralph and Marian C. Falk Medical Research Trust (RGP), a grant from the Breast Cancer Research Foundation (RGP), and a grant from the Pennsylvania Department of Health (RGP).	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Amendola M, 2015, EMBO REP, V16, P610, DOI 10.15252/embr.201439789; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bizen N, 2014, STEM CELLS, V32, P1602, DOI 10.1002/stem.1613; Casimiro MC, 2015, ONCOTARGET, V6, P8525, DOI 10.18632/oncotarget.3267; Casimiro MC, 2013, MOL ENDOCRINOL, V27, P1415, DOI 10.1210/me.2013-1065; Casimiro MC, 2012, J CLIN INVEST, V122, P833, DOI 10.1172/JCI60256; Chen WL, 2017, CURR CANCER DRUG TAR, V17, P555, DOI 10.2174/1568009616666160512145303; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Collins R, 2010, NUCLEIC ACIDS RES, V38, P3503, DOI 10.1093/nar/gkq081; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deimling S.J., 2017, NEUROGENESIS AUSTIN, V4; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Fu MF, 2005, J BIOL CHEM, V280, P29728, DOI 10.1074/jbc.M503188200; Gong Z, 2018, GENET MOL BIOL, V41, P488, DOI [10.1590/1678-4685-GMB-2017-0164, 10.1590/1678-4685-gmb-2017-0164]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Huang TH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.65; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Ju XM, 2014, CANCER RES, V74, P508, DOI 10.1158/0008-5472.CAN-13-1313; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Li Y, 2016, NUCLEIC ACIDS RES, V44, P7173, DOI 10.1093/nar/gkw327; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Lukaszewicz AI, 2011, P NATL ACAD SCI USA, V108, P11632, DOI 10.1073/pnas.1106230108; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pestell RG, 2013, AM J PATHOL, V183, P3, DOI 10.1016/j.ajpath.2013.03.001; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Shambaugh GE, 1996, J NEUROPATH EXP NEUR, V55, P1009, DOI 10.1097/00005072-199609000-00008; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Stahl M, 2006, CANCER RES, V66, P7562, DOI 10.1158/0008-5472.CAN-06-0974; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang CG, 2006, P NATL ACAD SCI USA, V103, P11567, DOI 10.1073/pnas.0603363103; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	71	16	17	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4232	4249		10.1038/s41388-019-0723-8	http://dx.doi.org/10.1038/s41388-019-0723-8			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30718920	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000469339100003
J	Almutairi, SM; Ali, AK; He, W; Yang, DS; Ghorbani, P; Wang, LS; Fullerton, MD; Lee, SH				Almutairi, Saeedah Musaed; Ali, Alaa Kassim; He, William; Yang, Doo-Seok; Ghorbani, Peyman; Wang, Lisheng; Fullerton, Morgan D.; Lee, Seung-Hwan			Interleukin-18 up-regulates amino acid transporters and facilitates amino acid-induced mTORC1 activation in natural killer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural killer cells (NK cells); cell proliferation; cell metabolism; amino acid; mammalian target of rapamycin (mTOR); interleukin-18 (IL-18); nutrient uptake; mTORC1	HEAVY-CHAIN GENE; P70 S6 KINASE; CUTTING EDGE; NK CELLS; GAMMA PRODUCTION; T-CELLS; IL-18; PROLIFERATION; EXPRESSION; CYTOKINE	Upon inflammation, natural killer (NK) cells undergo metabolic changes to support their high energy demand for effector function and proliferation. The metabolic changes are usually accompanied by an increase in the expression of nutrient transporters, leading to increased nutrient uptake. Among various cytokines inducing NK cell proliferation, the mechanisms underlying the effect of interleukin (IL)-18 in promoting NK cell proliferation are not completely understood. Here, we demonstrate that IL-18 is a potent cytokine that can enhance the expression of the nutrient transporter CD98/LAT1 for amino acids independently of the mTORC1 pathway and thereby induce a dramatic metabolic change associated with increased proliferation of NK cells. Notably, treatment of IL-18-stimulated NK cells with leucine activates the metabolic sensor mTORC1, indicating that the high expression of amino acid transporters induces amino acid-driven mTORC1 activation. Inhibition of the amino acid transporter CD98/LAT1 abrogated the leucine-driven mTORC1 activation and reduced NK cell effector function. Taken together, our study identified a novel role of IL-18 in up-regulating nutrient transporters on NK cells and thereby inducing metabolic changes, including the mTORC1 activation by amino acids.	[Almutairi, Saeedah Musaed; Ali, Alaa Kassim; He, William; Yang, Doo-Seok; Ghorbani, Peyman; Wang, Lisheng; Fullerton, Morgan D.; Lee, Seung-Hwan] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Almutairi, Saeedah Musaed] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia	University of Ottawa; King Saud University	Lee, SH (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	seunglee@uottawa.ca	Almutairi, Saeedah/ABC-6653-2020	Lee, Seung-Hwan/0000-0001-7703-6421; Yang, Doo/0000-0001-8420-6302; Ghorbani, Peyman/0000-0002-7398-5141; Ali, Alaa/0000-0002-7490-0592	Canadian Institutes of Health Research Grants [MOP-130385, PJT-156106]; Canadian Cancer Society Research Institute [704316]; King Saud University; Saudi Ministry of High Education, Saudi Arabia; Ontario graduate scholarship	Canadian Institutes of Health Research Grants(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); King Saud University(King Saud University); Saudi Ministry of High Education, Saudi Arabia; Ontario graduate scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Grants MOP-130385 and PJT-156106 and Canadian Cancer Society Research Institute Grant 704316 (to S.-H. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a scholarship from King Saud University and the Saudi Ministry of High Education, Saudi Arabia.; Recipient of an Ontario graduate scholarship.	Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; BIRON CA, 1983, J IMMUNOL, V131, P1539; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Cantor J, 2011, J IMMUNOL, V187, P851, DOI 10.4049/jimmunol.1100002; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006; Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013; Goodier MR, 2000, J IMMUNOL, V165, P139, DOI 10.4049/jimmunol.165.1.139; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Hyodo Y, 1999, J IMMUNOL, V162, P1662; Jensen H, 2017, J IMMUNOL, V199, P1967, DOI 10.4049/jimmunol.1700497; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lauwerys BR, 1999, CYTOKINE, V11, P822, DOI 10.1006/cyto.1999.0501; Lee SH, 2012, J IMMUNOL, V189, P2712, DOI 10.4049/jimmunol.1201528; Leong JW, 2014, BIOL BLOOD MARROW TR, V20, P463, DOI 10.1016/j.bbmt.2014.01.006; Lian GJ, 2012, J IMMUNOL, V188, P2227, DOI 10.4049/jimmunol.1102586; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; LINDSTEN T, 1988, MOL CELL BIOL, V8, P3820, DOI 10.1128/MCB.8.9.3820; Loftus RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04719-2; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; McCracken AN, 2013, TRENDS ENDOCRIN MET, V24, P200, DOI 10.1016/j.tem.2013.01.002; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Son YI, 2001, CANCER RES, V61, P884; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wawrocki S, 2016, ACTA BIOCHIM POL, V63, P59, DOI 10.18388/abp.2015_1153; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x	55	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4644	4655		10.1074/jbc.RA118.005892	http://dx.doi.org/10.1074/jbc.RA118.005892			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696773	Green Published, hybrid			2022-12-26	WOS:000462969500030
J	Gremillet, D; Collet, J; Weimerskirch, H; Courbin, N; Ryan, PG; Pichegru, L				Gremillet, David; Collet, Julien; Weimerskirch, Henri; Courbin, Nicolas; Ryan, Peter G.; Pichegru, Lorien			Radar detectors carried by Cape gannets reveal surprisingly few fishing vessel encounters	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; FORAGING BEHAVIOR; SOUTHERN BENGUELA; GPS-TRACKING; SEABIRDS; FISHERY; COMPETITION; INDICATORS; MITIGATION; SHIFTS	Fisheries compete with seabirds for vanishing marine resources, but also produce fishery waste consumed by seabirds. Marine birds may therefore avoid or seek fishing vessels, and have evolved complex, plastic behavioural responses to vessel presence. Understanding these responses is essential to the conservation of a globally declining seabird community. We studied Cape gannets (Morus capensis), which compete with fisheries for reduced sardine (Sardinops sagax) resources in the Benguela upwelling region off South Africa. Using bird-borne GPS trackers coupled with newly-developed ship-radar detectors we show that foraging gannets seldom attended fishing vessels. Rather, they switched from eating scarce sardines or energetically-poor fishery waste to targeting locally abundant saury (Scomberesox saurus). This pelagic fish is brought into the seascape by warm water influx, and is not commercially exploited by fisheries. Cape gannets thereby show dietary plasticity, allowing them to maintain adult body condition and chick growth rates. This diet switch is a strong indicator that Cape gannets forage in an ecologically perturbed marine environment.	[Gremillet, David; Courbin, Nicolas] Univ Paul Valery Montpellier, Univ Montpellier, CNRS, Ctr Ecol Fonct & Evolut,EPHE,UMR 5175, Montpellier, France; [Gremillet, David; Ryan, Peter G.] Univ Cape Town, NRF DST Ctr Excellence, Percy Fitzpatrick Inst African Ornithol, Rondebosch, South Africa; [Collet, Julien; Weimerskirch, Henri] Univ La Rochelle, CNRS, Ctr Etud Biol Chize, UMR 7372, 405 Route Prisse Charriere, Villiers En Bois, France; [Pichegru, Lorien] Nelson Mandela Univ, Inst Coastal Marine Res, Port Elizabeth, South Africa; [Pichegru, Lorien] Nelson Mandela Univ, Dept Zool, Port Elizabeth, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Nelson Mandela University; Nelson Mandela University	Gremillet, D (corresponding author), Univ Paul Valery Montpellier, Univ Montpellier, CNRS, Ctr Ecol Fonct & Evolut,EPHE,UMR 5175, Montpellier, France.; Gremillet, D (corresponding author), Univ Cape Town, NRF DST Ctr Excellence, Percy Fitzpatrick Inst African Ornithol, Rondebosch, South Africa.	david.gremillet@cefe.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Fennell, Hannah/AAI-1408-2019; Collet, Julien/AAO-3785-2020	Collet, Julien/0000-0002-3285-5535; Pichegru, Lorien/0000-0003-3815-9845	Percy FitzPatrick Institute of African Ornithology, University of Cape Town (South Africa); Centre National de la Recherche Scientifique (CEFE-CNRS, Montpellier, France)) [UMR5175]	Percy FitzPatrick Institute of African Ornithology, University of Cape Town (South Africa); Centre National de la Recherche Scientifique (CEFE-CNRS, Montpellier, France))	This study was funded by the Percy FitzPatrick Institute of African Ornithology, University of Cape Town (South Africa) and the Centre National de la Recherche Scientifique (CEFE-CNRS, UMR5175 Montpellier, France).	Assali C., 2017, THESIS; BATCHELOR AL, 1984, OSTRICH, V55, P45, DOI 10.1080/00306525.1984.9634757; BERRUTI A, 1988, S AFR J MARINE SCI, V6, P183, DOI 10.2989/025776188784480690; BERRUTI A, 1993, COLON WATERBIRD, V16, P158, DOI 10.2307/1521434; BirdLife International, 2017, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2017-1.RLTS.T22696027A110443604.en; Blamey LK, 2015, J MARINE SYST, V144, P9, DOI 10.1016/j.jmarsys.2014.11.006; Bodey TW, 2014, CURR BIOL, V24, pR514, DOI 10.1016/j.cub.2014.04.041; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; Capricorn Marine Environmental (PTY) LTD (Capmarine), 2017, STAT MAN S AFR SMALL, P1; Cohen LA, 2014, MAR ECOL PROG SER, V505, P281, DOI 10.3354/meps10762; Collet J, 2017, BEHAV ECOL, V28, P1337, DOI 10.1093/beheco/arx097; Crawford RJM., 1985, S AFR J MARINE SCI, V3, P215, DOI [https://doi.org/10.2989/025776185784461252, DOI 10.2989/025776185784461252]; Crawford RJM, 2014, OSTRICH, V85, P111, DOI 10.2989/00306525.2014.955141; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dudley SFJ, 1985, S AFR J MAR SCI, V3, P229; Durholtz M. D., 2017, MARAMIWS2017HAKEBG1, P1; Gaglio D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190444; Green DB, 2015, ICES J MAR SCI, V72, P771, DOI 10.1093/icesjms/fsu203; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Gremillet D, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2798-2; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Griffiths CL, 2004, OCEANOGR MAR BIOL, V42, P303; Ismail HE, 2015, INT J OCEANOGR, V2015; Le Bot T, 2018, ICES J MAR SCI, V75, P1513, DOI 10.1093/icesjms/fsy038; Ludynia K., 2007, THESIS; Mangel JC, 2018, ROY SOC OPEN SCI, V5, DOI [10.1098/rsos.180254;180254, 10.1098/rsos.180254]; Melanie Williamson, 2017, STATUS MANAGEMENT S, P1; Melvin EF, 2014, FISH RES, V149, P5, DOI 10.1016/j.fishres.2013.07.012; Mills KL, 2007, FISH OCEANOGR, V16, P273, DOI 10.1111/j.1365-2419.2007.00429.x; Montevecchi WA, 1996, SARSIA, V80, P313, DOI 10.1080/00364827.1996.10413606; Navarro J, 2017, MAR ECOL PROG SER, V578, P243, DOI 10.3354/meps12124; Okes NC, 2009, BIOL CONSERV, V142, P2361, DOI 10.1016/j.biocon.2009.05.031; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; PIEROTTI R, 1991, ECOLOGY, V72, P319, DOI 10.2307/1938925; Schreiber EA, 2001, BIOL MARINE BIRDS; Stephens D.W., 1986, pi; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Sydeman WJ, 2017, FISH RES, V194, P209, DOI 10.1016/j.fishres.2017.05.018; Tew-Kai E, 2013, J APPL ECOL, V50, P659, DOI 10.1111/1365-2664.12086; WAHL TR, 1979, CONDOR, V81, P390, DOI 10.2307/1366965; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; Weimerskirch H, 2018, CONSERV BIOL, V32, P240, DOI 10.1111/cobi.12965; Zeller D, 2018, FISH FISH, V19, P30, DOI 10.1111/faf.12233	44	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210328	10.1371/journal.pone.0210328	http://dx.doi.org/10.1371/journal.pone.0210328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726223	Green Published, gold			2022-12-26	WOS:000457874000019
J	Schoonvelde, M; Brosius, A; Schumacher, G; Bakker, BN				Schoonvelde, Martijn; Brosius, Anna; Schumacher, Gijs; Bakker, Bert N.			Liberals lecture, conservatives communicate: Analyzing complexity and ideology in 381,609 political speeches	PLOS ONE			English	Article							LANGUAGE USE; INTEGRATIVE COMPLEXITY; INDIVIDUAL-DIFFERENCES; QUESTION READABILITY; COGNITIVE-STYLE; TEXT ANALYSIS; PERSONALITY; WAR; SIMPLICITY; WORDS	There is some evidence that liberal politicians use more complex language than conservative politicians. This evidence, however, is based on a specific set of speeches of US members of Congress and UK members of Parliament. This raises the question whether the relationship between ideology and linguistic complexity is a more general phenomenon or specific to this small group of politicians. To address this question, this paper analyzes 381,609 speeches given by politicians from five parliaments, by twelve European prime ministers, as well as speeches from party congresses over time and across countries. Our results replicate and generalize earlier findings: speakers from culturally liberal parties use more complex language than speakers from culturally conservative parties. Economic left-right differences, on the other hand, are not systematically linked to linguistic complexity.	[Schoonvelde, Martijn] Univ Coll Dublin, Sch Polit & Int Relat, Dublin, Ireland; [Brosius, Anna; Bakker, Bert N.] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Noord Holland, Netherlands; [Schumacher, Gijs] Univ Amsterdam, Dept Polit Sci, Amsterdam, Noord Holland, Netherlands	University College Dublin; University of Amsterdam; University of Amsterdam	Schoonvelde, M (corresponding author), Univ Coll Dublin, Sch Polit & Int Relat, Dublin, Ireland.	mschoonvelde@gmail.com	Bakker, Bert/AAJ-2408-2021	Bakker, Bert/0000-0002-6491-5045; Schoonvelde, Martijn/0000-0003-4370-2654; Schumacher, Gijs/0000-0002-6503-4514	European Union [649281]; Amsterdam School of Communication Research	European Union(European Commission); Amsterdam School of Communication Research	For collecting data for part of this paper, Schoonvelde & Schumacher received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 649281, EUENGAGE. Bakker received support from the Amsterdam School of Communication Research.; We thank Zoltan Fazekas, Randy Stevenson and panelists at the 2017 European Political Science Association Meeting, the 2017 and 2018 Midwest Political Science Association Meeting and the 2017 International Communication Association Meeting for feedback. This study has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 649281, EUENGAGE. It also received generous support of the Amsterdam School of Communication Research (Bakker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study first started from Anna Brosius' master's thesis.	Abe JAA, 2011, J LANG SOC PSYCHOL, V30, P212, DOI 10.1177/0261927X10397152; Bakker BN, 2017, POLIT PSYCHOL, V38, P1025, DOI 10.1111/pops.12349; BEATTIE WE, 1959, CENT STATES SPEECH J, V10, P16, DOI 10.1080/10510975909362498; Benoit K, AM J POLITICAL SCI; Bischof D, 2017, EUROPEAN J POLITICAL; Brundidge J, 2014, POLIT PSYCHOL, V35, P741, DOI 10.1111/pops.12201; Cann DM, 2014, PS-POLIT SCI POLIT, V47, P663, DOI 10.1017/S1049096514000808; Caprara G, 2003, J PERS SOC PSYCHOL, V84, P849, DOI 10.1037/0022-3514.84.4.849; Caprara GV, 2004, AM PSYCHOL, V59, P581, DOI 10.1037/0003-066X.59.7.581; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; Cichocka A, 2016, POLIT PSYCHOL, V37, P799, DOI 10.1111/pops.12327; Coatney C, 2015, COMMUN POLITICS CULT, V48, P66; Conway LG, 2014, POLIT PSYCHOL, V35, P603, DOI 10.1111/pops.12021; Dalvean M, 2017, ICAME J, V41, P5, DOI [10.1515/icame-2017-0001, DOI 10.1515/ICAME-2017-0001]; Degani M., 2016, IPERSTORIA TESTI LET, V8, P131; Dewaele JM, 1999, LANG LEARN, V49, P509, DOI 10.1111/0023-8333.00098; Dietrich BJ, 2012, POLIT PSYCHOL, V33, P195, DOI 10.1111/j.1467-9221.2012.00870.x; Feldman S, 2014, POLIT PSYCHOL, V35, P337, DOI 10.1111/pops.12055; Gerber AS, 2010, AM POLIT SCI REV, V104, P111, DOI 10.1017/S0003055410000031; Haberman F., 1951, GEN MACARTHURS SPEEC; Harmon MD, 2001, INT J PUBLIC OPIN R, V13, P72, DOI 10.1093/ijpor/13.1.72; Heilke T, 2003, PS-POLIT SCI POLIT, V36, P229, DOI 10.1017/S1049096503002130; Johnston C.D., 2017, OPEN VS CLOSED PERSO; Joly JK, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00552; Jost JT, 2009, PSYCHOL INQ, V20, P129, DOI 10.1080/10478400903028599; KATZ RS, 1995, PARTY POLIT, V1, P5, DOI 10.1177/1354068895001001001; Kayam O, 2018, POLIT STUD REV, V16, P73, DOI 10.1177/1478929917706844; Kincaid J.P., 1975, TECHNICAL REPORT; Lelkes Y, 2016, PUBLIC OPIN QUART, V80, P392, DOI 10.1093/poq/nfw005; Lim E., 2008, ANTI INTELLECTUAL PR; Lin N, 2018, RES POLITICS, V5, DOI 10.1177/2053168018795598; Malka A, 2014, J PERS SOC PSYCHOL, V106, P1031, DOI 10.1037/a0036170; MANDEL DR, 1993, J SOC ISSUES, V49, P201, DOI 10.1111/j.1540-4560.1993.tb01188.x; Merry MK, 2012, ENVIRON POLIT, V21, P49, DOI 10.1080/09644016.2011.643368; Oberlander J, 2006, DISCOURSE PROCESS, V42, P239, DOI 10.1207/s15326950dp4203_1; Olds C, 2015, POLITICS GOV, V3, P90, DOI 10.17645/pag.v3i2.303; PANCER SM, 1992, POLIT PSYCHOL, V13, P31, DOI 10.2307/3791422; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 2002, J RES PERS, V36, P271, DOI 10.1006/jrpe.2002.2349; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Pitman T, 2012, AUST J EDUC, V56, P226, DOI 10.1177/000494411205600303; Rauh Christian, 2017, PARLSPEECH DATA SET, DOI [10.7910/DVN/E4RSP9, DOI 10.7910/DVN/E4RSP9]; Reilly S, 2011, POLIT RES QUART, V64, P59, DOI 10.1177/1065912909349629; Schumacher E., 2016, READABILITY ANAL CAM; Schumacher G, 2016, EUSPEECH, DOI [10.7910/DVN/XPCVEI, DOI 10.7910/DVN/XPCVEI]; Schumacher G, 2018, DAT DUTCH DAN PART C, DOI [10.7910/DVN/SFZI8O, DOI 10.7910/DVN/SFZI8O]; Schumacher G., 2016, P INT C ADV COMPUTAT, P75; Sieberer U, 2006, J LEGIS STUD, V12, P150, DOI 10.1080/13572330600739413; Siegel AI, 1953, J APPL PSYCHOL, V37, P105, DOI 10.1037/h0062848; Sigelman L, 1996, POLIT COMMUN, V13, P81, DOI 10.1080/10584609.1996.9963096; Spirling A, 2016, J POLIT, V78, P120, DOI 10.1086/683612; Suedfeld P, 2002, POLIT PSYCHOL, V23, P585, DOI 10.1111/0162-895X.00299; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Teten Ryan L., 2003, PRESIDENTIAL STUDIES, V33, P333, DOI DOI 10.1111/J.1741-5705.2003.TB00033.X; TETLOCK PE, 1984, J PERS SOC PSYCHOL, V46, P979, DOI 10.1037/0022-3514.46.5.979; TETLOCK PE, 1984, J PERS SOC PSYCHOL, V46, P365, DOI 10.1037/0022-3514.46.2.365; TETLOCK PE, 1981, J PERS SOC PSYCHOL, V41, P207, DOI 10.1037/0022-3514.41.2.207; TETLOCK PE, 1983, J PERS SOC PSYCHOL, V45, P118, DOI 10.1037/0022-3514.45.1.118; Valkenburg PM, 2013, J COMMUN, V63, P221, DOI 10.1111/jcom.12024; Van der Brug W, 2009, EUR J POLIT RES, V48, P309, DOI 10.1111/j.1475-6765.2009.00841.x; Wang YQ, 2018, DISCOURSE SOC, V29, P299, DOI 10.1177/0957926517734659; Wasike B., 2016, JOURNALISM, P1; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049	63	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0208450	10.1371/journal.pone.0208450	http://dx.doi.org/10.1371/journal.pone.0208450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726227	Green Submitted, gold, Green Published			2022-12-26	WOS:000457874000006
J	Prinja, S; Bahuguna, P; Gupta, I; Chowdhury, S; Trivedi, M				Prinja, Shankar; Bahuguna, Pankaj; Gupta, Indrani; Chowdhury, Samik; Trivedi, Mayur			Role of insurance in determining utilization of healthcare and financial risk protection in India	PLOS ONE			English	Article							SECTOR; STATE	Background Universal health coverage has become a policy goal in most developing economies. We assess the association of health insurance (HI) schemes in general, and RSBY (National Health Insurance Scheme) in particular, on extent and pattern of healthcare utilization. Secondly, we assess the relationship of HI and RSBY on out-of-pocket (OOP) expenditures and financial risk protection (FRP). Methods A cross-sectional study was undertaken to interview 62335 individuals among 12,134 households in 8 districts of three states in India i.e. Gujarat, Haryana and Uttar Pradesh (UP). Data on socio-demographic characteristics, assets, education, occupation, consumption expenditure, illness in last 15 days or hospitalization during last 365 days, treatment sought and its OOP expenditure was collected. We computed catastrophic health expenditures (CHE) as indicator for FRP. Hospitalization rate, choice of care provider and CHE were regressed to assess their association with insurance status and type of insurance scheme, after adjusting for other covariates. Results Mean OOP expenditures for outpatient care among insured and uninsured were INR 961 (USD 16) and INR 840 (USD 14); and INR 32573 (USD 543) and INR 24788 (USD 413) for an episode of hospitalization respectively. The prevalence of CHE for hospitalization was 28% and 26% among the insured and uninsured population respectively. No significant association was observed in multivariate analysis between hospitalization rate, choice of care provider or CHE with insurance status or RSBY in particular. Conclusion Health insurance in its present form does not seem to provide requisite improvement in access to care or financial risk protection.	[Prinja, Shankar; Bahuguna, Pankaj] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Gupta, Indrani; Chowdhury, Samik] Univ Delhi Enclave, Inst Econ Growth, Hlth Policy Res Unit, Delhi, India; [Trivedi, Mayur] Indian Inst Publ Hlth, Gandhinagar, Gujarat, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Delhi	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com	Chowdhury, Samik/AAM-9819-2020; Trivedi, Mayur/AFU-4877-2022; Trivedi, Mayur/AHA-6256-2022	Trivedi, Mayur/0000-0002-4532-2340; Bahuguna, Pankaj/0000-0001-9952-6077	Indian Council of Social Science Research (ICSSR), New Delhi, India	Indian Council of Social Science Research (ICSSR), New Delhi, India	The study was funded by the Indian Council of Social Science Research (ICSSR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A., 2012, IMPACT NATL HLTH INS; Aiyar A, 2013, RASHTRIYA SWASTHYA B; Amicus Advisory Private Limited, RASHTR SWASTHV BIM Y; Bergkvist S, 2014, WORLD BANK POLICY RE; Bhat R, 20060702 IND I MAN; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; GoI, 2013, STAT WIS PER CAP INC; GoI, 2014, KEY IND SOC CONS IND; Gupta I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166775; Hou X, 2011, HOSP PATTERNS RSBY P; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Indrani Gupta, 2017, Journal of Social and Economic Development, V19, P83, DOI 10.1007/s40847-017-0040-4; IRDAI, 2014, ANN REP 2013 14; IRDAI, 2017, ANN REP 2016 17; Katyal A, 2015, HEALTH POLICY PLANN, V30, pi23, DOI 10.1093/heapol/czu061; Krishnaswamy K, 2011, PERFORMANCE TRENDS P; La Forgia G, 2012, GOVT SPONSERED HLTH; Manager of Publications, 1946, REPORT HLTH SURVEY D; MHFW, 2018, INF ED COMM IEC GUID; Ministry of Statistics and Programme Implementation (MOSPI), 2006, MORB HLTH CAR COND A; Nandi A, 2015, INDIAN J MED RES, V142, P383, DOI 10.4103/0971-5916.169194; Nandi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066296; Narayana D., 2010, ECON POLIT WEEKLY, V45, P13; Palacios Robert, 2011, INDIAS HLTH INSURANC, P1; Philip NE, 2012, BMC P; Planning Commission Government of India, 2013, 12 5 YEAR PLAN 2012, VII; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Prinja S, 2019, INT J HEALTH PLAN M, V34, P277, DOI 10.1002/hpm.2628; Prinja S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170996; Prinja S, 2017, HEALTH POLICY PLANN, V32, P43, DOI 10.1093/heapol/czw097; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Prinja S, 2012, INDIAN J MED RES, V136, P421; Rao M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004471; Reddy K.S., 2011, PUBLIC HLTH FDN INDI, V4, P1; RGI, 2013, SRS B SAMPL REG SYST; RGI, 2011, MAT MORT RAT B; Selvaraj Sakthivel, 2012, ECON POLIT WEEKLY, V47, P61; Sharma D, 2017, INDIAN J MED RES, V146, P759, DOI 10.4103/ijmr.IJMR_2003_15; Shoree S, 2014, EVALUATION RSBYS KEY; Sood N, 2014, BMJ, V13; United Nations, 2015, IND MDGS SUST FUT AL; Vellakkal S, 2009, MICROECONOMICS WORKI; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776	43	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211793	10.1371/journal.pone.0211793	http://dx.doi.org/10.1371/journal.pone.0211793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721253	Green Published, gold			2022-12-26	WOS:000457746300029
J	He, SJ; Carman, CV; Lee, JH; Lan, B; Koehler, S; Atia, L; Park, CY; Kim, JH; Mitchel, JA; Park, JA; Butler, JP; Lu, Q; Fredberg, JJ				He, Shijie; Carman, Christopher V.; Lee, Jung Hyun; Lan, Bo; Koehler, Stephan; Atia, Lior; Park, Chan Young; Kim, Jae Hun; Mitchel, Jennifer A.; Park, Jin-Ah; Butler, James P.; Lu, Quan; Fredberg, Jeffrey J.			The tumor suppressor p53 can promote collective cellular migration	PLOS ONE			English	Article							CANCER; INVASION; TRANSITION; PATHWAYS; MOTILITY; MUTANTS; GENE; RHOA	Loss of function of the tumor suppressor p53 is known to increase the rate of migration of cells transiting the narrow pores of the traditional Boyden chamber assay. Here by contrast we investigate how p53 impacts the rate of cellular migration within a 2D confluent cell layer and a 3D collagen-embedded multicellular spheroid. We use two human carcinoma cell lines, the bladder carcinoma EJ and the colorectal carcinoma HCT116. In the confluent 2-D cell layer, for both EJ and HCT cells the migratory speeds and effective diffusion coefficients for the p53 null cells were significantly smaller than in p53-expressing cells. Compared to p53 expressers, p53-null cells exhibited more organized cortical actin rings together with reduced front-rear cell polarity. Furthermore, loss of p53 caused cells to exert smaller traction forces upon their substrates, and reduced formation of cryptic lamellipodia. In the 3D multicellular spheroid, loss of p53 consistently reduced collective cellular migration into surrounding collagen matrix. As regards the role of p53 in cellular migration, extrapolation from the Boyden chamber assay to other cellular microenvironments is seen to be fraught even in terms of the sign of the effect. Together, these paradoxical results show that the effects of p53 on cellular migration are context-dependent.	[He, Shijie; Carman, Christopher V.; Lan, Bo; Koehler, Stephan; Atia, Lior; Park, Chan Young; Kim, Jae Hun; Mitchel, Jennifer A.; Park, Jin-Ah; Butler, James P.; Lu, Quan; Fredberg, Jeffrey J.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Lee, Jung Hyun] Massachusetts Gen Hosp, Charlestown, MA USA; [Lee, Jung Hyun] Harvard Med Sch, Charlestown, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Fredberg, JJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	jfredber@hsph.harvard.edu	Fredberg, Jeffrey/M-9877-2019	Atia, Lior/0000-0001-9467-5997; Mitchel, Jennifer/0000-0002-4480-3193; HE, SHIJIE/0000-0002-0400-2543	National Cancer Institute [U01CA202123]; National Heart Lung and Blood Institute [R01HL107561, PO1HL120839, T32 HL007118]; NATIONAL CANCER INSTITUTE [U01CA202123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120839, T32HL007118] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Cancer Institute (grant number U01CA202123, https://www.cancer.gov), the National Heart Lung and Blood Institute (grant numbers R01HL107561, PO1HL120839 and T32 HL007118, https://www.nhlbi.nih.gov) to JJF.	Atia L, 2018, NAT PHYS, P1; Aylon Y, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026328; Bi DP, 2015, NAT PHYS, V11, P1074, DOI [10.1038/NPHYS3471, 10.1038/nphys3471]; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Golubovskaya VM, 2010, FRONT BIOSCI-LANDMRK, V15, P901, DOI 10.2741/3653; Good M, 2018, NATURE, V563, P188, DOI 10.1038/d41586-018-07246-8; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Haeger A, 2014, BBA-GEN SUBJECTS, V1840, P2386, DOI 10.1016/j.bbagen.2014.03.020; He S, 2016, ACS BIOMATERIALS SCI; He SJ, 2015, BIOPHYS J, V109, P489, DOI 10.1016/j.bpj.2015.06.058; He SJ, 2014, J MECH PHYS SOLIDS, V70, P116, DOI 10.1016/j.jmps.2014.05.016; Khalil AA, 2017, CLIN EXP METASTAS, V34, P421, DOI 10.1007/s10585-017-9858-6; Kim JH, 2013, NAT MATER, V12, P856, DOI [10.1038/NMAT3689, 10.1038/nmat3689]; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Mak AS, 2014, CELL ADHES MIGR, V8, P205, DOI 10.4161/cam.27841; Mak AS, 2011, CELL ADHES MIGR, V5, P144, DOI 10.4161/cam.5.2.14375; Malinverno C, 2017, NAT MATER, V16, P587, DOI [10.1038/NMAT4848, 10.1038/nmat4848]; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1638, DOI 10.1210/en.2011-2131; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Namba T, 2015, ONCOTARGET, V6, P19990, DOI 10.18632/oncotarget.4598; Park JA, 2016, J CELL SCI, V129, P3375, DOI 10.1242/jcs.187922; Park JA, 2015, NAT MATER, V14, P1040, DOI [10.1038/NMAT4357, 10.1038/nmat4357]; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Sablina AA, 2003, J BIOL CHEM, V278, P27362, DOI 10.1074/jbc.M300547200; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Sui X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0541-x; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vig DK, 2016, BIOPHYS J, V110, P1469, DOI 10.1016/j.bpj.2016.02.032; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wu JX, 2015, CELL SIGNAL, V27, P1198, DOI 10.1016/j.cellsig.2015.02.026; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669	43	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0202065	10.1371/journal.pone.0202065	http://dx.doi.org/10.1371/journal.pone.0202065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707705	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900001
J	Kaiyala, KJ; Wisse, BE; Lighton, JRB				Kaiyala, Karl J.; Wisse, Brent E.; Lighton, John R. B.			Validation of an equation for energy expenditure that does not require the respiratory quotient	PLOS ONE			English	Article							NITROUS-OXIDE; SYSTEMS; TEMPERATURE; TOLERANCE	Background Energy expenditure (EE) calculated from respirometric indirect calorimetry is most accurate when based on oxygen consumption (VO2), carbon dioxide production (VCO2) and estimated protein metabolism (PM). EE has a substantial dependence of similar to 7% on the respiratory quotient (RQ, VCO2/VO2) and a lesser dependence on PM, yet many studies have instead estimated EE from VO2 only while PM has often been ignored, thus reducing accuracy. In 1949 Weir proposed a method to accurately calculate EE without using RQ, which also adjusts for estimated PM based on dietary composition. This RQ(-) method utilizes the calorimeter airflow rate (FR), the change in fractional O-2 concentration (Delta FO2) and the dietary protein fraction. The RQ(-) method has not previously been empirically validated against the standard RQ(+) method using both VO2 and RQ. Our aim was to do that. Methods VO2 and VCO2 were measured repeatedly in 8 mice fed a high protein diet (HPD) during exposure to different temperatures (n = 168 measurements of 24h gas exchange). The HPD-adjusted RQ(+) equation was: EE [kcal/time] = VO2 [L/time] x(3.853+1.081RQ) while the corresponding RQ(-) equation was: EE = 4.934xFRx Delta FO2. Agreement was analyzed using the ratios of the RQ(-) to RQ(+) methods along with regression and Bland-Altman agreement analyses. We also evaluated the standard equation using the dietary food quotient (FQ) of 0.91 as a proxy for RQ (FQ(+) method). Results Ratio analysis revealed that the mean error of the RQ(-) method was only 0.11 +/- 0.042% while the maximum error was only 0.21%. Error using the FQ(+) method was 4 -and 10-fold greater, respectively. Bland-Altman analysis demonstrated that the RQ(-) method very slightly overestimates EE as RQ decreases. Theoretically, this error can be eliminated completely by imposing an incurrent fractional oxygen concentration at a value only slightly greater than the atmospheric level. Conclusions The Weir 'RQ-free' method for calculating EE is a highly valid alternative to the 'gold standard' method that requires RQ. The RQ(-) approach permits reduced cost and complexity in studies focused on EE and provides a way to rescue EE measurement in studies compromised by faulty CO2 measurements. Practitioners of respirometry should consider adjusting EE calculations for estimated protein metabolism based on dietary composition.	[Kaiyala, Karl J.] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Wisse, Brent E.] Univ Washington, Dept Med, Seattle, WA USA; [Lighton, John R. B.] Sable Syst Int Inc, North Las Vegas, NV USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaiyala, KJ (corresponding author), Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	kkaiyala@uw.edu		Lighton, John/0000-0002-9264-924X	National Mouse Metabolic Phenotyping Centers [NIH-NIDDK U24DK076169]; National Institutes of Health [DK074758, DK090320, DK076126]; Sable Systems International Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169] Funding Source: NIH RePORTER	National Mouse Metabolic Phenotyping Centers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sable Systems International Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KJK received salary support from the National Mouse Metabolic Phenotyping Centers (Working Group Award by NIH-NIDDK U24DK076169). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. BEW received support from the National Institutes of Health (DK074758, DK090320, and DK076126). Sable Systems International Inc., provided support in the form of salaries for author JRBL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abreu-Vieira G, 2015, MOL METAB, V4, P461, DOI 10.1016/j.molmet.2015.03.001; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Deem JD, 2018, AM J PHYSIOL-ENDOC M, V315, pE552, DOI 10.1152/ajpendo.00462.2017; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Gordon CJ, 2017, PHYSIOL BEHAV, V179, P55, DOI 10.1016/j.physbeh.2017.05.026; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hall KD, 2016, AM J CLIN NUTR, V104, P324, DOI 10.3945/ajcn.116.133561; Hall KD, 2015, CELL METAB, V22, P427, DOI 10.1016/j.cmet.2015.07.021; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P243, DOI 10.1007/s00213-006-0657-z; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P233, DOI 10.1007/s00213-006-0655-1; Kaiyala KJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194794; Kaiyala KJ, 2016, MOL METAB, V5, P892, DOI 10.1016/j.molmet.2016.07.005; Kaiyala Karl J, 2014, Temperature (Austin), V1, P268; Kaiyala KJ, 2012, J THERM BIOL, V37, P30, DOI 10.1016/j.jtherbio.2011.10.004; Kaiyala KJ, 2005, AM J PHYSIOL-REG I, V288, pR692, DOI 10.1152/ajpregu.00412.2004; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Koteja P, 1996, FUNCT ECOL, V10, P675, DOI 10.2307/2390179; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; Lighton JRB, 2008, MEASURING METABOLIC; McLean J., 1987, ANIMAL HUMAN CALORIM; Melanson EL, 2010, AM J PHYSIOL-REG I, V298, pR1571, DOI 10.1152/ajpregu.00055.2010; Ramsay Douglas S, 2014, Temperature (Austin), V1, P257; Ramsay Douglas S, 2014, Temperature (Austin), V1, P157, DOI 10.4161/23328940.2014.982048; Ramsay DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124740; Tohjima Y, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005595; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	29	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211585	10.1371/journal.pone.0211585	http://dx.doi.org/10.1371/journal.pone.0211585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707737	gold, Green Published, Green Submitted			2022-12-26	WOS:000457742900035
J	Mutyambizi, C; Booysen, F; Stokes, A; Pavlova, M; Groot, W				Mutyambizi, Chipo; Booysen, Frederik; Stokes, Andrew; Pavlova, Milena; Groot, Wim			Lifestyle and socio-economic inequalities in diabetes prevalence in South Africa: A decomposition analysis	PLOS ONE			English	Article							HEALTH; RISK; OBESITY; INCOME; CONSUMPTION; MORTALITY; MELLITUS; ALCOHOL; SMOKING; DISEASE	Background Inequalities in diabetes are widespread and are exacerbated by differences in lifestyle. Many studies that have estimated inequalities in diabetes make use of self-reported diabetes which is often biased by differences in access to health care and diabetes awareness. This study adds to this literature by making use of a more objective standardised measure of diabetes in South Africa. The study estimates socio-economic inequalities in undiagnosed diabetes, diagnosed diabetes (self-reported), as well as total diabetes (undiagnosed diabetics + diagnosed diabetics). The study also examines the contribution of lifestyle factors to diabetes inequalities in South Africa. Methods This cross sectional study uses data from the 2012 South African National Health and Nutrition Examination Survey (SANHANES-1) and applies the Erreygers Concentration Indices to assess socio-economic inequalities in diabetes. Contributions of lifestyle factors to inequalities in diabetes are assessed using a decomposition method. Results Self-reported diabetes and total diabetes (undiagnosed diabetics + diagnosed diabetics) were significantly concentrated amongst the rich (CI = 0.0746; p < 0.05 and CI = 0.0859; p < 0.05). The concentration index for undiagnosed diabetes was insignificant but pro-poor. The decomposition showed that lifestyle factors contributed 22% and 35% to socioeconomic inequalities in self-reported and total diabetes, respectively. Conclusion Diabetes in South Africa is more concentrated amongst higher socio-economic groups when measured using self-reported diabetes or clinical data. Our findings also show that the extent of inequality is worse in the total diabetes outcome (undiagnosed diabetics + diagnosed diabetics) when compared to the self-reported diabetes outcome. Although in comparison to other determinants, the contribution of lifestyle factors was modest, these contributions are important in the development of policies that address socio-economic inequalities in the prevalence of diabetes.	[Mutyambizi, Chipo] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Pretoria, South Africa; [Booysen, Frederik] Univ Witwatersrand, Johannesburg, South Africa; [Stokes, Andrew] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Pavlova, Milena; Groot, Wim] Maastricht Univ, Med Ctr, Dept Hlth Serv Res, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Pavlova, Milena; Groot, Wim] Maastricht Univ, Med Ctr, CAPHRI, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Human Sciences Research Council-South Africa; University of Witwatersrand; Boston University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Mutyambizi, C (corresponding author), Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Pretoria, South Africa.	CMutyambizi@hsrc.ac.za	Pavlova, Milena/B-4778-2011; Booysen, Frederik/ABB-2868-2021; le R Booysen, Frederik/K-9152-2015	Pavlova, Milena/0000-0002-6082-8446; le R Booysen, Frederik/0000-0001-7449-3221; Mutyambizi, Chipo/0000-0003-4749-7280	South African Department of Health, UK Department for International Development (DFID); Human Sciences Research Council (HSRC)	South African Department of Health, UK Department for International Development (DFID); Human Sciences Research Council (HSRC)	The authors received no specific funding for this research articles. However the SANHANES-1 survey was funded by the South African Department of Health, UK Department for International Development (DFID) and the Human Sciences Research Council (HSRC)	Addo J, 2017, J EPIDEMIOL COMMUNIT; Agardh EE, 2004, DIABETES CARE, V27, P716, DOI 10.2337/diacare.27.3.716; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alaba O, 2014, INT J ENV RES PUB HE, V11, P3387, DOI 10.3390/ijerph110303387; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2008, ANAL HLTH EQUITY USI; Ataguba JE, 2016, HEALTH POLICY PLANN, V31, P1212, DOI 10.1093/heapol/czw053; Ataguba JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-48; Ataguba JEO, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28865; Ataguba JEO, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-64; Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Balanda KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078406; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bazzano A. L, 2005, DIETARY INTAKE FRUIT; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Borg V, 2000, SOC SCI MED, V51, P1019, DOI 10.1016/S0277-9536(00)00011-3; Carlsson S, 2003, DIABETES CARE, V26, P2785, DOI 10.2337/diacare.26.10.2785; CARTER P, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C4229; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85; De Silva AP, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0759-3; Doherty E, 2014, VACCINE, V32, P3438, DOI 10.1016/j.vaccine.2014.03.084; Du HD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002279; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Erreygers G, 2013, RES ECON INEQUAL, V21, P227, DOI 10.1108/S1049-2585(2013)0000021010; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Firpo S, 2009, ECONOMETRICA, V77, P953, DOI 10.3982/ECTA6822; Gonzalo-Almorox E, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0394-9; Guan WH, 2003, STATA J, V3, P71, DOI 10.1177/1536867X0300300105; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Heckley G, 2016, J HEALTH ECON, V48, P89, DOI 10.1016/j.jhealeco.2016.03.006; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Kessels R, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0134-2; Kunna R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0578-y; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Makate Marshall, 2017, Glob Health Res Policy, V2, P1, DOI 10.1186/s41256-016-0021-8; Manne-Goehler J, 2016, LANCET DIABETES ENDO, V4, P903, DOI 10.1016/S2213-8587(16)30181-4; McGrail KM, 2009, AM J PUBLIC HEALTH, V99, P1856, DOI 10.2105/AJPH.2007.129361; Moradi Ghobad, 2016, Med J Islam Repub Iran, V30, P375; Mukong AK, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0598-7; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Obuaku-Igwe CC, 2015, AFR SOCIOL REV, V19, P97; Organization WH, 2016, GLOB REP DIAB, DOI [10.2337/db15-0956, DOI 10.2337/DB15-0956]; Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2; Rarani MA, 2017, INT J HEALTH POLICY, V6, P219, DOI 10.15171/ijhpm.2016.127; Sartorius B, 2017, INT J EPIDEMIOL, V47, P942; Shisana O, 2014, S AFRICAN NATL HLTH; Solar O, 2010, 2 WHO; Statistics South Africa, 2017, MORT CAUS DEATH S AF; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170219; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Vallejo-Torres L, 2010, SOC SCI MED, V71, P1189, DOI 10.1016/j.socscimed.2010.06.008; Vellakkal S, 2015, J EPIDEMIOL COMMUN H, V69, P218, DOI 10.1136/jech-2014-204621; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization, 2003, FOOD AGR ORG DIET NU; World Health Organization, 1990, DIET NUTR PREV CHRON; Yiengprugsawan Vasoontara, 2010, BMC Res Notes, V3, P57, DOI 10.1186/1756-0500-3-57	67	26	26	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211208	10.1371/journal.pone.0211208	http://dx.doi.org/10.1371/journal.pone.0211208			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699173	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600066
J	Pagan-Jimenez, M; Ruiz-Calderon, JF; Dominguez-Bello, MG; Garcia-Arraras, JE				Pagan-Jimenez, Maria; Ruiz-Calderon, Jean F.; Dominguez-Bello, Maria G.; Garcia-Arraras, Jose E.			Characterization of the intestinal microbiota of the sea cucumber Holothuria glaberrima	PLOS ONE			English	Article							AEROBIC CULTURABLE BACTERIA; GUT MICROBIOTA; DIGESTIVE-TRACTS; SP-NOV.; FLORA; MICROFLORA; DIVERSITY; MODEL; REGENERATION; MECHANISMS	High-throughput 16S rRNA gene sequencing has been used to identify the intestinal microbiota of many animal species, but that of marine invertebrate organisms remains largely unknown. There are only a few high-throughput sequencing studies on the intestinal microbiota of echinoderms (non-vertebrate Deuterostomes). Here we describe the intestinal microbiota of the sea cucumber Holothuria glaberrima, an echinoderm, well-known for its remarkable power of regeneration. We characterized the microbiota from the anterior descending intestine, the medial intestine (these two comprise the small intestine) and the posterior descending intestine (or large intestine), using pyrosequencing to sequence the V4 region of the 16S rRNA gene. We compared animals in their natural marine environment and in sea-water aquaria. A total of 8,172 OTU's were grouped in 10 bacterial phyla, 23 classes, 44 orders, 83 families, 127 genera and 1 group of unknown bacteria, present across the digestive tract of 10 specimens. The results showed that the anterior intestine is dominated by Proteobacteria (61%) and Bacteroidetes (22%), the medium intestine is similar but with lower Bacteroidetes (4%), and the posterior intestine was remarkably different, dominated by Firmicutes (48%) and Bacteroidetes (35%). The structure of the community changed in animals kept in aquaria, which had a general dominance of Firmicutes and Bacteroidetes, regardless the intestinal segment. Our results evidence that in the natural sea environment, there is intestinal segment differentiation in the microbiota of H. glaberrima, which is lost in artificial conditions. This is relevant for physiological studies, such as mechanisms of digestive regeneration, which might be affected by the microbiota.	[Pagan-Jimenez, Maria; Ruiz-Calderon, Jean F.; Dominguez-Bello, Maria G.; Garcia-Arraras, Jose E.] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA; [Pagan-Jimenez, Maria] Inter Amer Univ, Arecibo Campus, Arecibo, PR USA; [Ruiz-Calderon, Jean F.] Univ Puerto Rico, Lab A646, San Juan, PR 00936 USA; [Dominguez-Bello, Maria G.] Rutgers State Univ, Dept Biochem & Microbiol & Anthropol, New Brunswick, NJ USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; Inter American University of Puerto Rico-San German; University of Puerto Rico; Rutgers State University New Brunswick	Garcia-Arraras, JE (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.	jegarcia@hpcf.upr.edu		Garcia-Arraras, Jose/0000-0001-9038-7330	Puerto Rico Science and Technology Research Trust; University of Puerto Rico Sequencing Genomic Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475] Funding Source: NIH RePORTER	Puerto Rico Science and Technology Research Trust; University of Puerto Rico Sequencing Genomic Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Puerto Rico Science and Technology Research Trust (http://prsciencetrust.org); University of Puerto Rico Sequencing Genomic Facility (http://www.mcc.com.pr/facilities/sequencing-and-genotyping-facility-sgf-2/).	Amaro T, 2009, DEEP-SEA RES PT I, V56, P1834, DOI 10.1016/j.dsr.2009.05.014; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Becker PT, 2008, J INVERTEBR PATHOL, V98, P136, DOI 10.1016/j.jip.2007.12.002; BEESON RJ, 1967, J INVERTEBR PATHOL, V9, P104, DOI 10.1016/0022-2011(67)90049-3; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi DH, 2006, INT J SYST EVOL MICR, V56, P1869, DOI 10.1099/ijs.0.64235-0; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLORNI A, 1985, AQUACULTURE, V49, P1, DOI 10.1016/0044-8486(85)90185-1; Corthier G, 2010, GASTROEN CLIN BIOL, V34, pS1, DOI 10.1016/S0399-8320(10)70014-2; DEMING JW, 1981, MICROBIAL ECOL, V7, P85, DOI 10.1007/BF02010480; DEMING JW, 1982, APPL ENVIRON MICROB, V44, P1222, DOI 10.1128/AEM.44.5.1222-1230.1982; DEMPSEY AC, 1987, CRUSTACEANA, V52, P90, DOI 10.1163/156854087X00105; DERIDDER C, 1985, J EXP MAR BIOL ECOL, V91, P65, DOI 10.1016/0022-0981(85)90221-7; DILMORE LA, 1986, FEMS MICROBIOL LETT, V35, P221, DOI 10.1111/j.1574-6968.1986.tb01531.x; Duzong J, 2009, J ANHUI AGR SC, V27, P13113; Dyall-Smith M, 2006, APPL ENVIRON MICROB, V72, P7427, DOI 10.1128/AEM.01401-06; Gao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100092; Garcia-Arraras JE, 1998, J EXP ZOOL, V281, P288, DOI 10.1002/(SICI)1097-010X(19980701)281:4<288::AID-JEZ5>3.0.CO;2-K; Garcia-Arraras JE, 2018, RESULTS PROBL CELL D, V65, P255, DOI 10.1007/978-3-319-92486-1_13; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GUERINOT ML, 1981, CAN J MICROBIOL, V27, P311, DOI 10.1139/m81-048; Hakim JA, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw146; Harley ITW, 2012, MOL METAB, P1, DOI [10.1016/j.molmet.2012.08.005, DOI 10.1016/J.MOLMET.2012.08.005]; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HUSEBYE E, 1994, DIGEST DIS SCI, V39, P946, DOI 10.1007/BF02087542; Hyun DW, 2013, INT J SYST EVOL MICR, V63, P4248, DOI 10.1099/ijs.0.053140-0; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Lau WWY, 2002, MICROBIAL ECOL, V43, P455, DOI 10.1007/s00248-001-1043-3; LOPEZ GR, 1987, Q REV BIOL, V62, P235, DOI 10.1086/415511; Lucas C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061310; LYNCH JAMES E., 1929, UNIV CALIFORNIA PUBL ZOOL, V33, P27; LYNCH JAMES E., 1930, UNIV CALIFORNIA PUBL ZOOL, V33, P307; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mashanov VS, 2014, CURR TOP DEV BIOL, V108, P185, DOI 10.1016/B978-0-12-391498-9.00006-1; Massin C., 1982, P43; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Michio K, 2003, MAR POLLUT BULL, V47, P118, DOI 10.1016/S0025-326X(02)00411-3; MORIARTY DJW, 1982, AUST J MAR FRESH RES, V33, P255, DOI 10.1071/MF9820255; Navarro PG, 2013, MAR BIOL, V160, P2957, DOI 10.1007/s00227-013-2286-5; ODINTSOV VS, 1981, MAR BIOL LETT, V2, P259; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sandle GI, 1998, GUT, V43, P294, DOI 10.1136/gut.43.2.294; Savignac HM, 2015, BEHAV BRAIN RES, V287, P59, DOI 10.1016/j.bbr.2015.02.044; Savignac HM, 2014, NEUROGASTROENT MOTIL, V26, P1615, DOI 10.1111/nmo.12427; Selkrig J, 2014, GUT MICROBES, V5, P369, DOI 10.4161/gmic.28681; SLOAN NA, 1980, MAR ECOL PROG SER, V2, P257, DOI 10.3354/meps002257; SUGITA H, 1987, B JPN SOC SCI FISH, V53, P511; Sun Yi, 1989, Oceanologia et Limnologia Sinica, V20, P300; Sweijd N.A., 1989, Elektronmikroskopievereniging van Suidelike Afrika Verrigtings, V19, P99; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; UNKLES SE, 1977, APPL ENVIRON MICROB, V34, P347, DOI 10.1128/AEM.34.4.347-350.1977; Uribe A, 1997, SCAND J GASTROENTERO, V32, P691, DOI 10.3109/00365529708996520; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; Uthicke S, 2001, J EXP MAR BIOL ECOL, V265, P153, DOI 10.1016/S0022-0981(01)00329-X; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vindigni SM, 2016, THER ADV GASTROENTER, V9, P606, DOI 10.1177/1756283X16644242; Walter J, 2001, ANNU REV MICROBIOL, V65, P411; WardRainey N, 1996, J EXP MAR BIOL ECOL, V203, P11, DOI 10.1016/0022-0981(96)02566-X; Webster NS, 2016, MBIO, V7, DOI 10.1128/mBio.00135-16; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yasoda H, 2006, SPC BECHE DE MER INF, V24, P45; YINGST JY, 1976, J EXP MAR BIOL ECOL, V23, P55, DOI 10.1016/0022-0981(76)90085-X; Zhang XC, 2013, J GEN APPL MICROBIOL, V59, P1; Zhang XC, 2012, J GEN APPL MICROBIOL, V58, P447, DOI 10.2323/jgam.58.447; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	75	18	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0208011	10.1371/journal.pone.0208011	http://dx.doi.org/10.1371/journal.pone.0208011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699110	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600006
J	Illanes, A; Esmaeili, N; Poudel, P; Balakrishnan, S; Friebe, M				Illanes, Alfredo; Esmaeili, Nazila; Poudel, Prabal; Balakrishnan, Sathish; Friebe, Michael			Parametrical modelling for texture characterization-A novel approach applied to ultrasound thyroid segmentation	PLOS ONE			English	Article							LESION CLASSIFICATION; NODULES; BENIGN; COMBINATION; FEATURES; CANCER	Texture analysis is an important topic in Ultrasound (US) image analysis for structure segmentation and tissue classification. In this work a novel approach for US image texture feature extraction is presented. It is mainly based on parametrical modelling of a signal version of the US image in order to process it as data resulting from a dynamical process. Because of the predictive characteristics of such a model representation, good estimations of texture features can be obtained with less data than generally used methods require, allowing higher robustness to low Signal-to-Noise ratio and a more localized US image analysis. The usability of the proposed approach was demonstrated by extracting texture features for segmenting the thyroid in US images. The obtained results showed that features corresponding to energy ratios between different modelled texture frequency bands allowed to clearly distinguish between thyroid and non-thyroid texture. A simple k-means clustering algorithm has been used for separating US image patches as belonging to thyroid or not. Segmentation of thyroid was performed in two different datasets obtaining Dice coefficients over 85%.	[Illanes, Alfredo; Esmaeili, Nazila; Poudel, Prabal; Balakrishnan, Sathish; Friebe, Michael] Otto von Guericke Univ, INKA, Inst Med Technol, Magdeburg, Germany	Otto von Guericke University	Illanes, A (corresponding author), Otto von Guericke Univ, INKA, Inst Med Technol, Magdeburg, Germany.	alfredo.illanes@ovgu.de	Friebe, Michael/E-3187-2015	Friebe, Michael/0000-0002-8624-0800; Illanes, Alfredo/0000-0002-0118-0483	Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research) [03IPT7100X]	Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research)	This work was supported by Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research) - 03IPT7100X.	Acharya UR, 2011, TECHNOL CANCER RES T, V10, P371, DOI 10.7785/tcrt.2012.500214; Acharya UR, 2016, KNOWL-BASED SYST, V107, P235, DOI 10.1016/j.knosys.2016.06.010; Acharya UR, 2014, TECHNOL CANCER RES T, V13, P289, DOI 10.7785/tcrt.2012.500381; Acharya UR, 2013, P I MECH ENG H, V227, P284, DOI 10.1177/0954411912472422; Acharya UR, 2012, COMPUT METH PROG BIO, V107, P233, DOI 10.1016/j.cmpb.2011.10.001; Acharya UR, 2012, ULTRASONICS, V52, P508, DOI 10.1016/j.ultras.2011.11.003; Acharya UR., 2007, ADV CARDIAC SIGNAL P; Ardakani AA, 2015, J ULTRAS MED, V34, P1983, DOI 10.7863/ultra.14.09057; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chi JN, 2017, J DIGIT IMAGING, V30, P477, DOI 10.1007/s10278-017-9997-y; Debarghya C, 2018, IEEE J BIOMEDICAL HL; Iakovidis DK, 2010, ARTIF INTELL MED, V50, P33, DOI 10.1016/j.artmed.2010.04.004; Koprowski R, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-91; Koundal D, 2013, ADV INTELL SYST, V177, P459; Manolakis D.G., 2000, STAT ADAPTIVE SIGNAL; Mirmehdi M., 2008, HDB TEXTURE ANAL; Ozyilmaz L, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P2033, DOI 10.1109/ICONIP.2002.1199031; Poudel P., 2018, P IEEE ENG MED BIOL; Poudel P, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/8087624; Raghavendra U, 2018, COMPUT BIOL MED, V95, P55, DOI 10.1016/j.compbiomed.2018.02.002; Raghavendra U, 2017, ULTRASONICS, V77, P110, DOI 10.1016/j.ultras.2017.02.003; Selvathi D., 2011, Proceedings 2011 International Conference on Signal Processing, Communication, Computing and Networking Technologies (ICSCCN 2011), P836, DOI 10.1109/ICSCCN.2011.6024666; Sheeja A, 2012, INT J EMERGING TECHN, V2; Sollini M, 2018, EUR J RADIOL, V99, P1, DOI 10.1016/j.ejrad.2017.12.004; Wunderling T, 2017, PROC SPIE, V10133, DOI 10.1117/12.2254234	25	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211215	10.1371/journal.pone.0211215	http://dx.doi.org/10.1371/journal.pone.0211215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695052	Green Submitted, Green Published, gold			2022-12-26	WOS:000457046400020
J	Nakayama, A; Abe, H; Kunita, A; Saito, R; Kanda, T; Yamashita, H; Seto, Y; Ishikawa, S; Fukayama, M				Nakayama, Atsuhito; Abe, Hiroyuki; Kunita, Akiko; Saito, Ruri; Kanda, Teru; Yamashita, Hiroharu; Seto, Yasuyuki; Ishikawa, Shumpei; Fukayama, Masashi			Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma	PLOS ONE			English	Article							EBV; DNA; CANCER	Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC), one of four major gastric cancer types, consists of clonal growth of EBV-infected epithelial cells. However, the significance of viral loads in each tumor cell has not been evaluated. EBV-DNA is stably maintained in episomal form in the nucleus of each cancer cell. To estimate EBV copy number per genome (EBV-CN), qPCR of viral EBNA1 and host GAPDH, standardized by Namalwa DNA (one copy/genome), was applied to the formalin-fixed paraffin embedded (FFPE) surgically resected EBVaGC specimens (n = 43) and EBVaGC cell lines (SNU-719 and NCC-24). In surgical specimens, the cancer cell ratio (CCR) was determined with image analysis, and EBV-CN was obtained by adjusting qPCR value with CCR. Fluorescent in situ hybridization (FISH) was also applied to the FFPE sections using the whole EBVgenome as a probe. In surgical specimens, EBV-CN obtained by qPCR/CCR was between 1.2 and 185 copies with a median of 9.9. EBV-CN of SNU-719 and NCC-24 was 42.0 and 1.1, respectively. A linear correlation was observed with qPCR/CCR data up to 20 copies/genome (40 signals/nucleus), the limit of FISH analysis. In addition, substantial variation in the number of EBV foci was observed. Based on qPCR/CCR, high EBV-CN (> 10 copies) correlated with PD-L1 expression in cancer cells (P = 0.015), but not with other pathological indicators. Furthermore, EBVaGC with high EBV-CN showed worse disease-specific survival (P = 0.041). Our findings suggest that cancer cell viral loads may contribute to expression of the immune checkpoint molecule and promotion of cancer progression in EBVaGC.	[Nakayama, Atsuhito; Abe, Hiroyuki; Kunita, Akiko; Saito, Ruri; Ishikawa, Shumpei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Kanda, Teru] Tohoku Med & Pharmaceut Univ, Dept Microbiol, Sendai, Miyagi, Japan; [Yamashita, Hiroharu; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan	University of Tokyo; Tohoku Medical & Pharmaceutical University; University of Tokyo	Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan.	mfukayama-tky@umin.org	Kanda, Teru/J-7313-2019; Yamashita, Hiroharu/E-7058-2011	Yamashita, Hiroharu/0000-0002-9468-3716; Fukayama, Masashi/0000-0002-0460-064X; Kanda, Teru/0000-0002-1391-3349; Nakayama, Atsuhito/0000-0002-9832-9415	Japan Society for the Promotion of Science [26253021]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant Number 26253021, Japan Society for the Promotion of Science, URL: https://www.jsps.go.jp/, to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2015, PATHOBIOLOGY, V82, P212, DOI 10.1159/000434683; Anastasiadou E, 2019, LEUKEMIA, V33, P132, DOI 10.1038/s41375-018-0178-x; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Chen HS, 2014, J VIROL, V88, P1703, DOI 10.1128/JVI.02209-13; Derks S, 2016, ONCOTARGET, V7, P32925, DOI 10.18632/oncotarget.9076; Feng WH, 2002, CANCER RES, V62, P1920; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Grywalska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140178; Hohaus S, 2011, CLIN CANCER RES, V17, P2885, DOI 10.1158/1078-0432.CCR-10-3327; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16; Khoja L, 2017, ANN ONCOL, V28, P2377, DOI 10.1093/annonc/mdx286; Kuzushima K, 1999, J CLIN INVEST, V104, P163, DOI 10.1172/JCI6062; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; LAWRENCE JB, 1988, CELL, V52, P51; Li ZW, 2016, HUM PATHOL, V55, P182, DOI 10.1016/j.humpath.2016.05.012; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Liu Y, 2016, ONCOTARGET, V7, P4903, DOI 10.18632/oncotarget.6751; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pyzer AR, 2017, LEUKEMIA, V31, P2780, DOI 10.1038/leu.2017.163; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Ryan JL, 2009, LAB INVEST, V89, P80, DOI 10.1038/labinvest.2008.103; Saito R, 2017, MODERN PATHOL, V30, P427, DOI 10.1038/modpathol.2016.202; Sasaki S, 2019, GASTRIC CANCER, V22, P486, DOI 10.1007/s10120-018-0880-4; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Veroni C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0353-1	28	24	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211358	10.1371/journal.pone.0211358	http://dx.doi.org/10.1371/journal.pone.0211358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695048	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400029
J	Santacruz-Castro, AM				Santacruz-Castro, Adriana Maria			Regional variability in reproductive traits of the Acropora hyacinthus species complex in the Western Pacific Region	PLOS ONE			English	Article							CORAL PORITES-ASTREOIDES; SEXUAL REPRODUCTION; LIFE-HISTORY; COLONY SIZE; SOFT CORAL; TRADE-OFF; SEASONALITY; RECRUITMENT; POPULATIONS; BOUNDARIES	Understanding natural variations in the life history traits of reef-building corals under different environmental conditions is an area of active research. This study compares variability in the reproductive and genetic traits of the hermaphroditic broadcast spawning coral Acropora hyacinthus, from the Western Pacific Region, across six different latitudes [Japan (33 degrees and 31 degrees N), Taiwan (23 degrees, 22 degrees and 21 degrees N), and Indonesia (5 degrees S)]. Egg sizes among corals in the lowest latitude studied were significantly larger than those at high latitudes, while the mean number of eggs were significantly different only among high latitude and two out of the three mid latitude locations studied. Egg numbers were significantly negatively correlated with egg and testis volumes, indicating reproductive trade-offs across locations. Female gonad volumes were smaller at high latitudes but significantly larger at lower latitudes, being positively correlated with seawater temperatures. Furthermore, high genetic similarities among populations suggest active gene flow among low-, mid- and high-latitude locations. An exception to this trend, the mid- latitude location of Penghu (off western Taiwan) formed an independent group with highly similar genetic and reproductive traits, suggesting reproductive isolation with local adaptations. This study reports natural spatial variations in the reproductive traits of A. hyacinthus at different latitudinal locations, which may serve as baseline information to predict how the life histories of corals in general respond to the impacts of climate change.	[Santacruz-Castro, Adriana Maria] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Santacruz-Castro, Adriana Maria] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan	National Taiwan Normal University; Academia Sinica - Taiwan	Santacruz-Castro, AM (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.; Santacruz-Castro, AM (corresponding author), Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan.	adrianamsc@gmail.com			Taiwan International Graduate Student Program in Academia Sinica; Taiwan Ministry of Science and Technology	Taiwan International Graduate Student Program in Academia Sinica; Taiwan Ministry of Science and Technology	This study was sponsored by two grants, the Taiwan International Graduate Student Program in Academia Sinica and the Taiwan Ministry of Science and Technology.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Acosta A, 1997, MAR BIOL, V128, P141, DOI 10.1007/s002270050077; Airi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091792; [Anonymous], 2021, LANG ENV STAT COMP; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Baird AH, 2000, P 9 INT COR REEF S B, P23; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BENAYAHU Y, 1986, BIOL BULL, V170, P32, DOI 10.2307/1541378; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; CLARKE A, 1992, INVERTEBR REPROD DEV, V22, P175, DOI 10.1080/07924259.1992.9672270; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; Crook E, 2013, BIOGEOSCIENCES DISCU, V10, P7761; Dahan M, 1997, MAR BIOL, V129, P573, DOI 10.1007/s002270050198; Dai C, 2009, SCLERACTINIA FAUNA T; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; de Putron SJ, 2011, B MAR SCI, V87, P75, DOI 10.5343/bms.2009.1027; de Putron SJ, 2017, CORAL REEFS, V36, P383, DOI 10.1007/s00338-016-1527-8; DeBoer Jason A., 2015, Great Plains Research, V25, P25; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; Fan TY, 2005, B MAR SCI, V76, P143; Fan TY, 1999, MAR ECOL PROG SER, V190, P297, DOI 10.3354/meps190297; Fernandez M, 2009, ECOL LETT, V12, P601, DOI 10.1111/j.1461-0248.2009.01315.x; FLEMING IA, 1990, ECOLOGY, V71, P1, DOI 10.2307/1940241; Foster T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03175-2; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Harii S, 2001, CORAL REEFS, V20, P19; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hartmann AC, 2017, CONSERVATION LETT; HELMUTH B, 1993, J EXP MAR BIOL ECOL, V165, P251, DOI 10.1016/0022-0981(93)90109-2; Hwang SJ, 2012, ANIM CELLS SYST, V16, P135, DOI 10.1080/19768354.2011.622486; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Kasyanov VL, 2001, REPROD STRATEGY MARI; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Kruger A, 1998, MAR BIOL, V131, P423, DOI 10.1007/s002270050335; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Ladner JT, 2012, HIDDEN DIVERSITY COR; Laptikhovsky V, 2006, MAR ECOL-EVOL PERSP, V27, P7, DOI 10.1111/j.1439-0485.2006.00077.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Marshall DJ, 2015, ECOL LETT, V18, P174, DOI 10.1111/ele.12402; Mezaki T., 2007, KUROSHIO BIOSPHERE, V3, P33; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nozawa Y, 2014, CORAL REEFS, V33, P1057, DOI 10.1007/s00338-014-1185-7; Nozawa Y, 2012, BIOL BULL-US, V222, P192, DOI 10.1086/BBLv222n3p192; Padilla-Gamino JL, 2013, CORAL REEFS, V32, P137, DOI 10.1007/s00338-012-0957-1; Permata D, 2012, CORAL REEFS, V31, P907, DOI 10.1007/s00338-012-0909-9; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Shieh Ying-Tzung, 1995, Acta Oceanographica Taiwanica, V34, P73; SIER CJS, 1994, MAR BIOL, V118, P713, DOI 10.1007/BF00347520; Simonini R, 2003, J EXP MAR BIOL ECOL, V291, P79, DOI 10.1016/S0022-0981(03)00099-6; Suzuki G, 2016, CORAL REEFS, V35, P1419, DOI 10.1007/s00338-016-1484-2; Tsounis G, 2006, MAR BIOL, V148, P513, DOI 10.1007/s00227-005-0100-8; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; VANWOESIK R, 1995, CORAL REEFS, V14, P119, DOI 10.1007/BF00303433; Veron J. E., 2000, CORALS WORLD, V1-3, P404; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Waller RG, 2002, CORAL REEFS, V21, P325, DOI 10.1007/s00338-002-0252-7; Wei NV, 2012, ZOOL STUD, V51, P85; Zuur Alain F., 2009, P1	66	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0208605	10.1371/journal.pone.0208605	http://dx.doi.org/10.1371/journal.pone.0208605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695041	Green Submitted, Green Published, gold			2022-12-26	WOS:000457046400005
J	Howard, NP; Tillman, J; Vanderzande, S; Luby, JJ				Howard, Nicholas P.; Tillman, John; Vanderzande, Stijn; Luby, James J.			Genetics of zonal leaf chlorosis and genetic linkage to a major gene regulating skin anthocyanin production (MdMYB1) in the apple (Malus x domestica) cultivar Honeycrisp	PLOS ONE			English	Article							CROP LOAD; STARCH; TRAITS; MUTANT	'Honeycrisp' is a widely grown and acclaimed apple cultivar that is commonly used in breeding programs. It also has a well-documented tendency to develop the physiological disorder, zonal leaf chlorosis (ZLC). This disorder causes reduced photosynthetic capacity and is thought to be due to a problem with phloem loading, although the underlying genetics of the disorder have not previously been discerned. In order to understand the breeding implications of the disorder, six families with 'Honeycrisp' as a parent and one family with 'Honeycrisp' as both a maternal and paternal grandparent were evaluated for ZLC incidence over two years. One major quantitative trait locus (QTL) for ZLC incidence was identified on linkage group (LG) 9. A haplotype in 'Honeycrisp' that originated from grandparent 'Duchess of Oldenburg' was associated with increased ZLC incidence in offspring in both years and all families evaluated. The LG9 QTL was 5 to 10 cM from MdMYB1, which is a major gene regulating fruit skin anthocyanin production. 'Honeycrisp' is heterozygous for red fruit skin overcolor at MdMYB1. The 'Honeycrisp' haplotype at the LG9 QTL associated with increased ZLC is in linkage phase with the allele at MdMYB1 associated with red color. Selection for the red allele from 'Honeycrisp' at MdMYB1 will result in most offspring also inheriting the haplotype at the LG9 QTL associated with high ZLC. The occurrence of two copies of this haplotype was sub-lethal in seedlings of a family where both parents inherited both the red overcolor allele at MdMYB1 and the haplotype at the LG9 QTL associated with high ZLC. This is the first study to have identified a genetic component of ZLC with clear breeding implications.	[Howard, Nicholas P.; Tillman, John; Luby, James J.] Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA; [Howard, Nicholas P.] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, Oldenburg, Germany; [Vanderzande, Stijn] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA	University of Minnesota System; University of Minnesota Twin Cities; Carl von Ossietzky Universitat Oldenburg; Washington State University	Howard, NP (corresponding author), Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA.; Howard, NP (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, Oldenburg, Germany.	howar622@umn.edu			USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae" [2009-51181-05808]; USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" [2014-51181-22378]; EU [265582]	USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae"; USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars"; EU(European Commission)	This work was partially supported by the USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative projects, "RosBREED: Enabling marker-assisted breeding in Rosaceae" (2009-51181-05808) and "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" (2014-51181-22378). Some genetic data was provided by the FruitBreedomics project: Integrated approach for increasing breeding efficiency in fruit tree crops (http://fruitbreedomics.com/), which was co-funded by the EU seventh Framework Programme, project No 265582.	Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Bedford D, 2016, United States patent US, Patent No. PP26412; Bedford DS, 2008, United States patent, Patent No. [US PP18812, PP18812]; Bink MCAM, 2008, EUPHYTICA, V161, P85, DOI 10.1007/s10681-007-9516-1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chen LS, 2010, ACTA PHYSIOL PLANT, V32, P253, DOI 10.1007/s11738-009-0402-4; Cheng FS, 1996, THEOR APPL GENET, V93, P222, DOI 10.1007/BF00225749; Clark MD, 2014, EUR J PLANT PATHOL, V140, P69, DOI 10.1007/s10658-014-0444-3; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Das SB, 1998, CROP SCI, V38, P722, DOI 10.2135/cropsci1998.0011183X003800030018x; DAYTON DF, 1979, HORTSCIENCE, V14, P551; Doyle J. J., 1987, PHYTOCHEM B, P11; Evans K., 2011, ACTA HORTIC, V945, P233; Fleck S, 2008, 9 INT S INT CAN ROOT, V903, P767; Gallardo RK, 2015, HORTTECHNOLOGY, V25, P575, DOI 10.21273/HORTTECH.25.4.575; Gao ZS, 2006, EUPHYTICA, V151, P123, DOI 10.1007/s10681-005-9082-3; Howard NP, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-017-1216-y; Howard NP, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.3; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Mann H, 2005, HORTSCIENCE, V40, P1815, DOI 10.21273/HORTSCI.40.6.1815; McKay SJ, 2011, J AM SOC HORTIC SCI, V136, P408, DOI 10.21273/JASHS.136.6.408; Moriya S, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1864-x; R Core Team, R LANG ENV STAT COMP; Rippke G, 2016, FARM PROGR REPORTS, V2015, P57; Rom Curt R., 1998, Hortscience, V33, P531; Rosenberger D. A., 2001, NY FRUIT Q, V9, P9; SCHAFFER AA, 1986, J PLANT PHYSIOL, V124, P111, DOI 10.1016/S0176-1617(86)80183-3; Schupp J., 2001, Compact Fruit Tree, V34, P107; Schupp JR, 2003, NEW YORK FRUIT Q, V11, P3; Simko I, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0022-5; Snyder-Leiby TE, 2008, HORTSCIENCE, V43, P1819, DOI 10.21273/HORTSCI.43.6.1819; Takle B, 2017, FARM PROGR REPORTS, V2016, P44; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tong CBS, 2003, HORTSCIENCE, V38, P1153, DOI 10.21273/HORTSCI.38.6.1153; Trujillo DI, 2012, TREE GENET GENOMES, V8, P27, DOI 10.1007/s11295-011-0417-z; Wang HC, 2010, PLANTA, V232, P511, DOI 10.1007/s00425-010-1194-x; Yue CY, 2011, HORTTECHNOLOGY, V21, P376, DOI 10.21273/HORTTECH.21.3.376; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210611	10.1371/journal.pone.0210611	http://dx.doi.org/10.1371/journal.pone.0210611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689634	Green Submitted, gold, Green Published			2022-12-26	WOS:000457041800008
J	Zang, GX; Mu, YB; Gao, LL; Bergh, A; Landstrom, M				Zang, Guangxiang; Mu, Yabing; Gao, Linlin; Bergh, Anders; Landstrom, Marene			PKC sigma facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model	ONCOGENE			English	Article							KINASE-C-ZETA; TUMOR-ASSOCIATED MACROPHAGES; NODE METASTASIS; GROWTH; LYMPHANGIOGENESIS; MECHANISMS; MIGRATION; INVASION; HYALURONAN; PHOSPHORYLATION	Prostate cancer disseminates primarily into the adjacent lymph nodes, which is related to a poor outcome. Atypical protein kinase C sigma (PKC sigma) is highly expressed in aggressive prostate cancer and correlates with Gleason score, clinical stage, and poor prognosis. Here, we report the molecular mechanisms of PKC sigma in lymphatic metastasis during prostate cancer progression. Using zinc-finger nuclease technology or PKC shRNA lentiviral particles, and orthotopic mouse xenografts, we show that PKC sigma-knockout or knockdown from aggressive prostate cancer (PC3 and PC3U) cells, decreasesd tumor growth and lymphatic metastasis in vivo. Intriguingly, PKC sigma-knockout or knockdown impaired the activation of AKT, ERK, and NF-kappa B signaling in prostate cancer cells, thereby impairing the expression of lymphangiogenic factors and macrophage recruitment, resulting in aberrant lymphangiogenesis. Moreover, PKC sigma regulated the expression of hyaluronan synthase enzymes, which is important for hyaluronan-mediated lymphatic drainage and tumor dissemination. Thus, PKC sigma plays a crucial oncogenic role in the lymphatic metastasis of prostate cancer and is predicted to be a novel therapeutic target for prostate cancer.	[Zang, Guangxiang; Mu, Yabing; Gao, Linlin; Bergh, Anders; Landstrom, Marene] Umea Univ, Dept Med Biosci, Bldg 6M,2nd Floor, SE-90185 Umea, Sweden; [Gao, Linlin] Natl Inst Biol Sci, 7 Sci Pk Rd ZGC Life Sci Pk, Beijing 102206, Peoples R China	Umea University; National Institute of Biological Sciences, Beijing	Landstrom, M (corresponding author), Umea Univ, Dept Med Biosci, Bldg 6M,2nd Floor, SE-90185 Umea, Sweden.	Marene.Landstrom@umu.se		Landstrom, Marene/0000-0001-6737-7230	RFI/VR and Science for Life Laboratory, Sweden; Bioinformatics Infrastructure for Life Sciences (BILS); Swedish Medical Research Council [K2016-02513]; Swedish Cancer Society [CAN 2017/544, 2016/387]; Knut and Alice Wallenberg Foundation [2012.0090]; Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University;  [ALF-VLL464591];  [ALF-VLL-738911]	RFI/VR and Science for Life Laboratory, Sweden; Bioinformatics Infrastructure for Life Sciences (BILS); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Cancer Research Foundation in Northern Sweden; Lion's Cancer Research Foundation; Umea University; ; 	We would like to acknowledge the National Genomics Infrastructure (NGI)/Uppsala Genome Center and UPPMAX for providing assistance in massive parallel sequencing and computational infrastructure. Work performed at the NGI/Uppsala Genome Center was funded by the RFI/VR and Science for Life Laboratory, Sweden. We would like to thank Dr. Jeanette Tangrot for the exome sequencing analysis and support from the Bioinformatics Infrastructure for Life Sciences (BILS) and Dr. Xiaolian Gu for valuable advices on data achieved from whole genome sequencing of PC3 and PC3U cells. We acknowledge the skillful technical assistance performed by Pernilla Andersson and Susanne Gidlund at Department of Medical Bioscience, Umea University. This work was supported by grants from the Swedish Medical Research Council (K2016-02513), the Swedish Cancer Society (CAN 2017/544; 2016/387), ALF-VLL464591 and ALF-VLL-738911, the Knut and Alice Wallenberg Foundation (2012.0090), the Cancer Research Foundation in Northern Sweden, Lion's Cancer Research Foundation, and Umea University.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Daneshmand S, 2004, J UROLOGY, V172, P2252, DOI 10.1097/01.ju.0000143448.04161.cc; Datta K, 2010, FUTURE ONCOL, V6, P823, DOI 10.2217/FON.10.33; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Evans JD, 2003, AM J CLIN PATHOL, V119, P392, DOI 10.1309/BKPC9DX98R781B87; FRANZEN P, 1993, EXP CELL RES, V207, P1, DOI 10.1006/excr.1993.1156; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Hagemann T, 2009, BLOOD, V113, P3139, DOI 10.1182/blood-2008-12-172825; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Izumi K, 2016, ONCOTARGET, V7, P8389, DOI 10.18632/oncotarget.6690; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim JY, 2013, P NATL ACAD SCI USA, V110, P6418, DOI 10.1073/pnas.1221799110; Kyzas PA, 2005, J PATHOL, V206, P170, DOI 10.1002/path.1776; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Monslow J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00231; Mu Y, 2015, BRIT J CANCER, V112, P1223, DOI 10.1038/bjc.2015.71; Nguyen DP, 2014, BJU INT, V114, P168, DOI [10.1111/bju.12488, 10.1111/j.1464-410X.2013.11397_10.x]; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sato K, 2016, CELL STEM CELL, V19, P127, DOI 10.1016/j.stem.2016.06.003; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Shiao SL, 2016, CANCER LETT, V380, P340, DOI 10.1016/j.canlet.2015.12.022; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667; Yao Sheng, 2010, Genes Cancer, V1, P444, DOI 10.1177/1947601910376079; Yokoyama Y, 2003, BRIT J CANCER, V88, P237, DOI 10.1038/sj.bjc.6600701; Zeng YP, 2005, PROSTATE, V65, P222, DOI 10.1002/pros.20288; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	45	8	8	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4215	4231		10.1038/s41388-019-0722-9	http://dx.doi.org/10.1038/s41388-019-0722-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30705401	Green Published, hybrid			2022-12-26	WOS:000469339100002
J	Woosley, AN; Dalton, AC; Hussey, GS; Howley, BV; Mohanty, BK; Grelet, S; Dincman, T; Bloos, S; Olsen, SK; Howe, PH				Woosley, Alec N.; Dalton, Annamarie C.; Hussey, George S.; Howley, Breege V.; Mohanty, Bidyut K.; Grelet, Simon; Dincman, Toros; Bloos, Sean; Olsen, Shaun K.; Howe, Philip H.			TGF beta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS SUPPRESSOR; TUMOR CELLS; IN-VITRO; LIFR; EMT; CARCINOMA; EVOLUTION; ILEI; IDENTIFICATION	FAM3C/Interleukin-like EMT Inducer (ILEI) is an oncogenic member of the FAM3 cytokine family and serves essential roles in both epithelial-mesenchymal transition (EMT) and breast cancer metastasis. ILEI expression levels are regulated through a non-canonical TGF beta signaling pathway by 3'-UTR-mediated translational silencing at the mRNA level by hnRNP E1. TGF beta stimulation or silencing of hnRNP E1 increases ILEI translation and induces an EMT program that correlates with enhanced invasion and migration. Recently, EMT has been linked to the formation of breast cancer stem cells (BCSCs) that confer both tumor cell heterogeneity as well as chemoresistant properties. Herein, we demonstrate that hnRNP E1 knockdown significantly shifts normal mammary epithelial cells to mesenchymal BCSCs in vitro and in vivo. We further validate that modulating ILEI protein levels results in the abrogation of these phenotypes, promoting further investigation into the unknown mechanism of ILEI signaling that drives tumor progression. We identify LIFR as the receptor for ILEI, which mediates signaling through STAT3 to drive both EMT and BCSC formation. Reduction of either ILEI or LIFR protein levels results in reduced tumor growth, fewer tumor initiating cells and reduced metastasis within the hnRNP E1 knockdown cell populations in vivo. These results reveal a novel ligand-receptor complex that drives the formation of BCSCs and represents a unique target for the development of metastatic breast cancer therapies.	[Woosley, Alec N.; Dalton, Annamarie C.; Hussey, George S.; Howley, Breege V.; Mohanty, Bidyut K.; Grelet, Simon; Dincman, Toros; Bloos, Sean; Olsen, Shaun K.; Howe, Philip H.] Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA	Medical University of South Carolina	Howe, PH (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	howep@musc.edu	Bloos, Sean/AAD-4630-2021	Dincman, Toros/0000-0002-4449-0510; Olsen, Shaun/0000-0002-1265-7101; Howe, Philip/0000-0002-1358-1313; Bloos, Sean/0000-0002-1044-4823	DOD BCRP [BC170301]; NIH NCI [RO1CA154663, T32 CA193201, F31 CA213627]; Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program [W81XWH-18-1-0003]; U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD; NATIONAL CANCER INSTITUTE [T32CA193201, R01CA154663, F31CA213627] Funding Source: NIH RePORTER	DOD BCRP(United States Department of Defense); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program; U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ken Noguchi and the Howe laboratory members for their helpful discussions and critical reading of the manuscript. The SUM cell lines and HMLE cell lines were a generous gift from Dr. Steven Ethier and Dr. Juan Massague, respectively. Funding for this project was provided by DOD BCRP BC170301 to ACD, NIH NCI T32 CA193201 to ACD, NIH NCI F31 CA213627 to ANW, and NIH NCI RO1CA154663 to PHH. Cores at MUSC used for this project include the shRNA Shared Technology Resource, Flow Cytometry and Cell Sorting Unit, Laboratory Core in the Center for Oral Health Research, Cell and Molecular Imaging Core and the Biorepository and Tissue Analysis Shared Resource. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office for ACD. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program, under Award No. W81XWH-18-1-0003. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. In conducting research using animals, the investigators adhere to the laws of the United States and regulations of the Department of Agriculture.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Brill B, 2008, LAB ANIM-UK, V42, P104, DOI 10.1258/la.2007.06003e; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Csiszar A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0433-7; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Grelet S, 2017, NAT CELL BIOL, V19, P1105, DOI 10.1038/ncb3595; Guo HW, 2015, ONCOTARGET, V6, P25484, DOI 10.18632/oncotarget.4688; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Howley BV, 2016, ONCOGENE, V35, P1725, DOI 10.1038/onc.2015.238; Howley BV, 2018, ONCOGENE, V37, P1308, DOI 10.1038/s41388-017-0023-0; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Ishihara K, 2002, BBA-MOL CELL RES, V1592, P281, DOI 10.1016/S0167-4889(02)00321-X; James P, 1996, GENETICS, V144, P1425; Johnson RW, 2016, NAT CELL BIOL, V18, P1078, DOI 10.1038/ncb3408; Junk DJ, 2017, ONCOGENE, V36, P4001, DOI 10.1038/onc.2017.33; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katahira T, 2010, BIOCHEM BIOPH RES CO, V392, P301, DOI 10.1016/j.bbrc.2009.12.180; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu F, 2016, ONCOL LETT, V12, P4869, DOI 10.3892/ol.2016.5369; Luo Q, 2015, CARCINOGENESIS, V36, P1201, DOI 10.1093/carcin/bgv108; Lv SD, 2018, ONCOGENE, V37, P1354, DOI 10.1038/s41388-017-0026-x; Ma D, 2016, ONCOL REP, V36, P827, DOI 10.3892/or.2016.4865; Maatta JA, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.14; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MATSUI WH, 2016, MEDICINE S1, V95, DOI DOI 10.1097/MD.0000000000004765; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Port MD, 2007, J NEUROCHEM, V101, P782, DOI 10.1111/j.1471-4159.2007.04471.x; Richards EJ, 2015, J BIOL CHEM, V290, P6857, DOI 10.1074/jbc.M114.610915; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Thomas SJ, 2015, BRIT J CANCER, V113, P365, DOI 10.1038/bjc.2015.233; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Velasco-Velazquez MA, 2012, INT J BIOCHEM CELL B, V44, P573, DOI 10.1016/j.biocel.2011.12.020; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wahl GM, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0012-z; Wang TY, 2018, CELL METAB, V27, P136, DOI 10.1016/j.cmet.2017.11.001; Wang XY, 2012, J BIOMED RES, V26, P325, DOI 10.7555/JBR.26.20110050; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yue Xuetian, 2015, Cancer Cell Microenviron, V2; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816	60	42	43	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3794	3811		10.1038/s41388-019-0703-z	http://dx.doi.org/10.1038/s41388-019-0703-z			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30692635	Green Accepted			2022-12-26	WOS:000468035600003
J	Robinson, LS; Schwebke, J; Lewis, WG; Lewis, AL				Robinson, Lloyd S.; Schwebke, Jane; Lewis, Warren G.; Lewis, Amanda L.			Identification and characterization of NanH2 and NanH3, enzymes responsible for sialidase activity in the vaginal bacterium Gardnerella vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gardnerella vaginalis; sialidase; sialic acid; recombinant protein expression; enzyme catalysis; Bacterial vaginosis; glycoside hydrolase family 33; virulence	SIALATE O-ACETYLESTERASE; LOW-BIRTH-WEIGHT; STREPTOCOCCUS-PNEUMONIAE; BIOFILM FORMATION; PRETERM DELIVERY; SIGNAL PEPTIDES; PREGNANT-WOMEN; VAGINOSIS; NEURAMINIDASE; ACID	Gardnerella vaginalis is abundant in bacterial vaginosis (BV), a condition associated with adverse reproductive health. Sialidase activity is a diagnostic feature of BV and is produced by a subset of G. vaginalis strains. Although its genetic basis has not been formally identified, sialidase activity is presumed to derive from the sialidase A gene, named here nanH1. In this study, BLAST searches predicted two additional G. vaginalis sialidases, NanH2 and NanH3. When expressed in Escherichia coli, NanH2 and NanH3 both displayed broad abilities to cleave sialic acids from 2-3- and 2-6-linked N- and O-linked sialoglycans, including relevant mucosal substrates. In contrast, recombinant NanH1 had limited activity against synthetic and mucosal substrates under the conditions tested. Recombinant NanH2 was much more effective than NanH3 in cleaving sialic acids bearing a 9-O-acetyl ester. Similarly, G. vaginalis strains encoding NanH2 cleaved and foraged significantly more Neu5,9Ac(2) than strains encoding only NanH3. Among a collection of 34 G. vaginalis isolates, nanH2, nanH3, or both were present in all 15 sialidase-positive strains but absent from all 19 sialidase-negative isolates, including 16 strains that were nanH1-positive. We conclude that NanH2 and NanH3 are the primary sources of sialidase activity in G. vaginalis and that these two enzymes can account for the previously described substrate breadth cleaved by sialidases in human vaginal specimens of women with BV. Finally, PCRs of nanH2 or nanH3 from human vaginal specimens had 81% sensitivity and 78% specificity in distinguishing between Lactobacillus dominance and BV, as determined by Nugent scoring.	[Robinson, Lloyd S.; Lewis, Warren G.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Robinson, Lloyd S.; Lewis, Warren G.; Lewis, Amanda L.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Schwebke, Jane] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Lewis, Amanda/0000-0001-6195-3030	NIAID, National Institutes of Health [AI114635, AI127554]; Burroughs Wellcome Fund (BWF) Preterm Birth Initiative; Metrodora Therapeutics (2018 - 2019); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127554, R01AI114635] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund (BWF) Preterm Birth Initiative; Metrodora Therapeutics (2018 - 2019); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grants AI114635 and AI127554 (to W. G. L and A. L. L.) and the Burroughs Wellcome Fund (BWF) Preterm Birth Initiative (to A. L. L.). A. L. L. has had consulting relationships with Talis Biomedical Corporation (2018), Tennor Therapeutics (2016), and Toltec Pharmaceuticals (2017). A. L. L. and W. G. L. have performed contract research for Metis Therapeutics (2017). A. L. L., W. G. L., and L. S. R. have an ongoing research project funded by Metrodora Therapeutics (2018 - 2019). Although all of these relationships pertain to our specific expertise on bacterial vaginosis, none are directly related to the specific topics or assays of interest in this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Amegashie CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177797; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; BERARDIGRASSIAS L, 1988, EUR J CLIN MICROBIOL, V7, P406, DOI 10.1007/BF01962348; Berry AM, 1996, J BACTERIOL, V178, P4854, DOI 10.1128/jb.178.16.4854-4860.1996; Blanchette KA, 2016, INFECT IMMUN, V84, P2922, DOI 10.1128/IAI.00277-16; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Brittan JL, 2012, MOL ORAL MICROBIOL, V27, P270, DOI 10.1111/j.2041-1014.2012.00658.x; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; CAMARA M, 1994, INFECT IMMUN, V62, P3688; Castro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11640; CAUCI S, 1993, MOL MICROBIOL, V9, P1143, DOI 10.1111/j.1365-2958.1993.tb01244.x; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Chang YC, 2012, MBIO, V3, DOI 10.1128/mBio.00220-11; Chen G. W., 2014, XINJIANG RECLAIM SCI, V1, P3, DOI DOI 10.7554/ELIFE.04066; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; Cox C, 2017, INT J STD AIDS, V28, P708, DOI 10.1177/0956462416665060; Cox C, 2015, J MED MICROBIOL, V64, P978, DOI 10.1099/jmm.0.000118; Di Paola M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09842-6; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gilbert NM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006238; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172522; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hilbert DW, 2016, J CLIN MICROBIOL, V54, P1017, DOI 10.1128/JCM.03104-15; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Janulaitiene M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200625; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P804, DOI 10.1128/JCM.01545-07; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis AL, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00887-16; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Li JH, 2014, APPL ENVIRON MICROB, V80, P1701, DOI 10.1128/AEM.03440-13; Li JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002429; LOCK RA, 1988, MICROB PATHOGENESIS, V4, P33, DOI 10.1016/0882-4010(88)90046-0; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Malki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166757; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marrazzo JM, 2012, J INFECT DIS, V205, P1580, DOI 10.1093/infdis/jis242; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; MCGREGOR JA, 1992, AM J OBSTET GYNECOL, V167, P1588, DOI 10.1016/0002-9378(92)91746-W; Meyn LA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.011; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Myhre AK, 2002, ACTA PAEDIATR, V91, P885, DOI 10.1080/080352502760148586; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; NEUBERGER A, 1972, BIOCHEM J, V129, P683, DOI 10.1042/bj1290683; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Randis TM, 2013, INFECT IMMUN, V81, P4544, DOI 10.1128/IAI.00627-13; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Robinson LS, 2017, J BIOL CHEM, V292, P11861, DOI 10.1074/jbc.M116.769232; Robinson LS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00879-16; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; SADHU K, 1989, J MED MICROBIOL, V29, P229, DOI 10.1099/00222615-29-3-229; Schauer R, 1978, Methods Enzymol, V50, P64; Schellenberg JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146510; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sharapova Y, 2018, FEBS J, V285, P2428, DOI 10.1111/febs.14486; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7; Singh AK, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00774-16; Smayevsky J, 2001, Infect Dis Obstet Gynecol, V9, P17, DOI 10.1155/S1064744901000047; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Thompson H, 2009, J BACTERIOL, V191, P3623, DOI 10.1128/JB.01618-08; Varki A., 2009, ESSENTIALS GLYCOBIOL; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; VONNICOLAI H, 1984, ZBL BAKT-INT J MED M, V258, P20, DOI 10.1016/S0176-6724(84)80003-6; Watson JN, 2005, CHEMBIOCHEM, V6, P1999, DOI 10.1002/cbic.200500114; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiggins R, 2000, J CLIN MICROBIOL, V38, P3096, DOI 10.1128/JCM.38.8.3096-3097.2000; Wiggins R, 2002, INT J STD AIDS, V13, P755, DOI 10.1258/095646202320753709; Wong A, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00068-18; Xu GG, 2011, J AM CHEM SOC, V133, P1718, DOI 10.1021/ja110733q; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	92	25	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5230	5245		10.1074/jbc.RA118.006221	http://dx.doi.org/10.1074/jbc.RA118.006221			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723162	hybrid, Green Published			2022-12-26	WOS:000464517500001
J	Konovalov, KA; Pardo-Avila, F; Tse, CKM; Oh, J; Wang, D; Huang, XH				Konovalov, Kirill A.; Pardo-Avila, Fatima; Tse, Carmen Ka Man; Oh, Juntaek; Wang, Dong; Huang, Xuhui			8-Oxo-guanine DNA damage induces transcription errors by escaping two distinct fidelity control checkpoints of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; DNA damage; transcription; mutagenesis mechanism; molecular dynamics; 8-oxo-guanine (8OG); transcriptional bypass; nucleotide misincorporation; transcriptional fidelity	STRUCTURAL BASIS; TRIGGER LOOP; MOLECULAR-DYNAMICS; ELONGATION	RNA polymerase II (Pol II) has an intrinsic fidelity control mechanism to maintain faithful genetic information transfer during transcription. 8-Oxo-guanine (8OG), a commonly occurring damaged guanine base, promotes misincorporation of adenine into the RNA strand. Recent structural work has shown that adenine can pair with the syn conformation of 8OG directly upstream of the Pol II active site. However, it remains unknown how 8OG is accommodated in the active site as a template base for the incoming ATP. Here, we used molecular dynamics (MD) simulations to investigate two consecutive steps that may contribute to the adenine misincorporation by Pol II. First, the mismatch is located in the active site, contributing to initial incorporation of adenine. Second, the mismatch is in the adjacent upstream position, contributing to extension from the mismatched bp. These results are supported by an in vitro transcription assay, confirming that 8OG can induce adenine misincorporation. Our simulations further suggest that 8OG forms a stable bp with the mismatched adenine in both the active site and the adjacent upstream position. This stability predominantly originates from hydrogen bonding between the mismatched adenine and 8OG in a noncanonical syn conformation. Interestingly, we also found that an unstable bp present directly upstream of the active site, such as adenine paired with 8OG in the canonical anti conformation, largely disrupts the stability of the active site. Our findings have uncovered two main factors contributing to how 8OG induces transcriptional errors and escapes Pol II transcriptional fidelity control checkpoints.	[Konovalov, Kirill A.; Huang, Xuhui] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518057, Peoples R China; [Konovalov, Kirill A.; Pardo-Avila, Fatima; Tse, Carmen Ka Man; Huang, Xuhui] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Dept Chem,Kowloon, Hong Kong, Peoples R China; [Oh, Juntaek; Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Pardo-Avila, Fatima] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of California System; University of California San Diego; Stanford University	Huang, XH (corresponding author), HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518057, Peoples R China.; Huang, XH (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Dept Chem,Kowloon, Hong Kong, Peoples R China.; Wang, D (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dongwang@ucsd.edu; xuhuihuang@ust.hk	Oh, Juntaek/AAH-2692-2022; Huang, Xuhui/ABE-3207-2021; Oh, Juntaek/AFM-0371-2022	Huang, Xuhui/0000-0002-7119-9358; Wang, Dong/0000-0002-2829-1546; Oh, Juntaek/0000-0002-7625-2779	Hong Kong Ph.D. Fellowship [PF16-06144]; Hong Kong Research Grant Council [HKUST C6009-15G, 16302214, 16307718, AoE/P-705/16]; Shenzhen Science and Technology Innovation Committee [JCYJ20170413173837121]; Guangzhou Science Technology and Innovation Commission [201704030116]; Innovation and Technology Commission [ITC-CNERC14SC01]; National Institutes of Health [GM102362]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102362] Funding Source: NIH RePORTER	Hong Kong Ph.D. Fellowship; Hong Kong Research Grant Council(Hong Kong Research Grants Council); Shenzhen Science and Technology Innovation Committee; Guangzhou Science Technology and Innovation Commission; Innovation and Technology Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hong Kong Ph.D. Fellowship Scheme No. PF16-06144 (K. K.). This work was also supported by Hong Kong Research Grant Council HKUST C6009-15G, 16302214, 16307718, and AoE/P-705/16 (to X. H.); Shenzhen Science and Technology Innovation Committee Grant JCYJ20170413173837121 (to X. H.); Guangzhou Science Technology and Innovation Commission Grant 201704030116 (to X. H.); and Innovation and Technology Commission Grant ITC-CNERC14SC01 (to X. H.). This work was also supported by National Institutes of Health Grant GM102362 (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Da LT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11244; Da LT, 2012, J AM CHEM SOC, V134, P2399, DOI 10.1021/ja210656k; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Frisch G. W., 2013, GAUSSIAN 09; Huang XH, 2010, P NATL ACAD SCI USA, V107, P15745, DOI 10.1073/pnas.1009898107; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Unarta IC, 2018, CURR OPIN STRUC BIOL, V49, P54, DOI 10.1016/j.sbi.2018.01.002; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Wang BB, 2015, NUCLEIC ACIDS RES, V43, P1133, DOI 10.1093/nar/gku1370; Wang BB, 2013, CHEM REV, V113, P8546, DOI 10.1021/cr400046x; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang W, 2018, P NATL ACAD SCI USA, V115, pE2538, DOI 10.1073/pnas.1722050115; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; Xu L, 2015, CRIT REV BIOCHEM MOL, V50, P503, DOI 10.3109/10409238.2015.1087960; Zgarbova M, 2015, J CHEM THEORY COMPUT, V11, P5723, DOI 10.1021/acs.jctc.5b00716; Zhang L, 2016, ACCOUNTS CHEM RES, V49, P687, DOI 10.1021/acs.accounts.5b00536	31	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4924	4933		10.1074/jbc.RA118.007333	http://dx.doi.org/10.1074/jbc.RA118.007333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718278	hybrid, Green Published			2022-12-26	WOS:000463985600017
J	Drescher, N; Klein, AM; Schmitt, T; Leonhardt, SD				Drescher, Nora; Klein, Alexandra-Maria; Schmitt, Thomas; Leonhardt, Sara Diana			A clue on bee glue: New insight into the sources and factors driving resin intake in honeybees (Apis mellifera)	PLOS ONE			English	Article							BETULA-PENDULA ROTH; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; EUROPEAN PROPOLIS; PLANT; IMMUNITY; BEHAVIOR; DEFENSE; COLONIES; ORGANIZATION	Honeybees (Apis mellifera) are threatened by numerous pathogens and parasites. To prevent infections they apply cooperative behavioral defenses, such as allo-grooming and hygiene, or they use antimicrobial plant resin. Resin is a chemically complex and highly variable mixture of many bioactive compounds. Bees collect the sticky material from different plant species and use it for nest construction and protection. Despite its importance for colony health, comparatively little is known about the precise origins and variability in resin spectra collected by honeybees. To identify the botanical resin sources of A. mellifera in Western Europe we chemically compared resin loads of individual foragers and tree resins. We further examined the resin intake of 25 colonies from five different apiaries to assess the effect of location on variation in the spectra of collected resin. Across all colonies and apiaries, seven distinct resin types were categorized according to their color and chemical composition. Matches between bee-collected resin and tree resin indicated that bees used poplar (Populus balsamifera, P. x canadensis), birch (Betula alba), horse chestnut (Aesculus hippocastanum) and coniferous trees (either Picea abies or Pinus sylvestris) as resin sources. Our data reveal that honeybees collect a comparatively broad and variable spectrum of resin sources, thus assuring protection against a variety of antagonists sensitive to different resins and/or compounds. We further unravel distinct preferences for specific resins and resin chemotypes, indicating that honeybees selectively search for bioactive resin compounds.	[Drescher, Nora] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Klein, Alexandra-Maria] Univ Freiburg, Chair Nat Conservat & Landscape Ecol, Freiburg, Germany; [Schmitt, Thomas; Leonhardt, Sara Diana] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr Hubland, Wurzburg, Germany	Leuphana University Luneburg; University of Freiburg; University of Wurzburg	Leonhardt, SD (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr Hubland, Wurzburg, Germany.	sara.leonhardt@uni-wuerzburg.de	Klein, Alexandra-Maria/J-5871-2016; Leonhardt, Sara/AAI-6901-2020	Klein, Alexandra-Maria/0000-0003-2139-8575; Leonhardt, Sara/0000-0002-8154-9569	Deutsche Forschungsgemeinschaft (DFG) [LE 2750/1-1]; University of Wurzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wurzburg	Funding was provided by the Deutsche Forschungsgemeinschaft (DFG project: LE 2750/1-1) to SDL and the University of Wurzburg in the funding programme Open Access Publishing to ND. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We like to thank all beekeepers that participated in this study for their support and the permission to collect propolis from their hives. We further thank Bjorn Ludeke for his support with taxonomic determination of trees and Manfred Lutke for assistance with practical bee keeping. We are further very grateful for the detailed and constructive comments provided by two expert reviewers, which greatly improved our manuscript. Funding was provided by the Deutsche Forschungsgemeinschaft (DFG project: LE 2750/1-1) and the University of Wurzburg in the funding programme Open Access Publishing.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; ALFONSUS ERWIN C., 1933, GLEANINGS IN BEE CULT, V61, P92; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; Bankova V, 2002, Z NATURFORSCH C, V57, P530; Bankova V, 2006, NAT PROD COMMUN, V1, P1023; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Bastos EMAF, 2008, J INVERTEBR PATHOL, V97, P273, DOI 10.1016/j.jip.2007.10.007; Borba CM, 2015, CONSTITUTIVE THERAPE; Borba RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11689-w; Borba RS, 2015, J EXP BIOL, V218, P3689, DOI 10.1242/jeb.127324; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BROWN AE, 1971, PHYSIOL PLANT PATHOL, V1, P469, DOI 10.1016/0048-4059(71)90009-9; Bryant JP., 1992, HERBIVORES THEIR INT, DOI DOI 10.1002/9783527630295.FMATTER; CEULEMANS R, 1992, CAN J FOREST RES, V22, P1937, DOI 10.1139/x92-253; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Crane E, 1988, BEEKEEPING; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cronk QCB, 2005, NEW PHYTOL, V166, P39, DOI 10.1111/j.1469-8137.2005.01369.x; DeGrandi-Hoffman G, 2015, CURR OPIN INSECT SCI, V10, P170, DOI 10.1016/j.cois.2015.05.007; del Olmo A, 2017, CRIT REV FOOD SCI, V57, P3084, DOI 10.1080/10408398.2015.1087964; DELORME L, 1990, EUR J FOREST PATHOL, V20, P304; Donkersley P, 2017, OECOLOGIA, V185, P749, DOI 10.1007/s00442-017-3968-3; Drescher N, 2017, INSECTS, V8, DOI 10.3390/insects8010015; Drescher N, 2014, OECOLOGIA, V176, P943, DOI 10.1007/s00442-014-3070-z; Duangphakdee O, 2009, INSECT SOC, V56, P333, DOI 10.1007/s00040-009-0027-z; Eckenwalder James E., 1996, P7; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gardiner AS, 1978, BOT SOC EDINBURGH, V43, P91; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; Gisder S, 2015, VIRUSES-BASEL, V7, P5603, DOI 10.3390/v7102885; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; GREENAWAY W, 1990, BEE WORLD, V71, P107, DOI 10.1080/0005772X.1990.11099047; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; HOWLAND DE, 1995, NEW PHYTOL, V130, P117, DOI 10.1111/j.1469-8137.1995.tb01821.x; Huber F, 1814, AM BEE J; Ibrahim A, 2007, APIDOLOGIE, V38, P67, DOI 10.1051/apido:2006065; Isidorov V, 2014, BIOCHEM SYST ECOL, V52, P41, DOI 10.1016/j.bse.2013.12.008; Isidorov VA, 2016, J CHEM ECOL, V42, P475, DOI 10.1007/s10886-016-0708-9; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; JOHNSSON H, 1945, HEREDITAS, V31, P174; Orantes-Bermejo FJ, 2010, J APICULT RES, V49, P243, DOI 10.3896/IBRA.1.49.3.03; Kaluza BF, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1758; Kaskoniene V, 2010, COMPR REV FOOD SCI F, V9, P620, DOI 10.1111/j.1541-4337.2010.00130.x; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Langenheim J.H., 2003, PLANT RESINS CHEM EV; Leonhardt SD, 2010, CHEM SENSES, V35, P603, DOI 10.1093/chemse/bjq058; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; Lindtke D, 2013, HEREDITY, V111, P474, DOI 10.1038/hdy.2013.69; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Migalina SV, 2010, RUSS J ECOL+, V41, P293, DOI 10.1134/S106741361004003X; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; Nakamura J, 2006, BEHAV ECOL SOCIOBIOL, V60, P339, DOI 10.1007/s00265-006-0170-8; Nicodemo D, 2014, APIDOLOGIE, V45, P269, DOI 10.1007/s13592-013-0249-y; Nino EL, 2015, CURR OPIN INSECT SCI, V10, P163, DOI 10.1016/j.cois.2015.05.005; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Otti O, 2014, TRENDS ECOL EVOL, V29, P625, DOI 10.1016/j.tree.2014.09.002; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; REICHARDT PB, 1984, OECOLOGIA, V65, P58, DOI 10.1007/BF00384463; REICHARDT PB, 1990, J CHEM ECOL, V16, P1941, DOI 10.1007/BF01020507; Roubik DW, 2006, APIDOLOGIE, V37, P124, DOI 10.1051/apido:2006026; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M., 2017, Bee World, V94, P21, DOI 10.1080/0005772X.2017.1307800; Simone-Finstrom M, 2017, INSECTS, V8, DOI 10.3390/insects8020046; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; SMITH RL, 1990, AM J BOT, V77, P1176, DOI 10.2307/2444628; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Sugio A, 2015, J EXP BOT, V66, P467, DOI 10.1093/jxb/eru435; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; Unsicker SB, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.987522; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wallace HM, 2010, APIDOLOGIE, V41, P428, DOI 10.1051/apido/2009074; WALTERS S. M., 1968, Proceedings of the Botanical Society of the British Isles, V7, P179; Widhalm JR, 2015, MOL PLANT, V8, P83, DOI 10.1016/j.molp.2014.12.001; Wilson MB, 2015, J INVERTEBR PATHOL, V124, P44, DOI 10.1016/j.jip.2014.10.005; Wilson MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077512	84	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210594	10.1371/journal.pone.0210594	http://dx.doi.org/10.1371/journal.pone.0210594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726258	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000022
J	Kiweewa, F; Esber, A; Musingye, E; Reed, D; Crowell, TA; Cham, F; Semwogerere, M; Namagembe, R; Nambuya, A; Kafeero, C; Tindikahwa, A; Eller, LA; Millard, M; Gelderblom, HC; Keshinro, B; Adamu, Y; Maswai, J; Owuoth, J; Sing'oei, VC; Maganga, L; Bahemana, E; Khamadi, S; Robb, ML; Ake, JA; Polyak, CS; Kibuuka, H				Kiweewa, Francis; Esber, Allahna; Musingye, Ezra; Reed, Domonique; Crowell, Trevor A.; Cham, Fatim; Semwogerere, Michael; Namagembe, Rosemary; Nambuya, Alice; Kafeero, Cate; Tindikahwa, Allan; Eller, Leigh Anne; Millard, Monica; Gelderblom, Huub C.; Keshinro, Babajide; Adamu, Yakubu; Maswai, Jonah; Owuoth, John; Sing'oei, Valentine Chepkorir; Maganga, Lucas; Bahemana, Emmanuel; Khamadi, Samoel; Robb, Merlin L.; Ake, Julie A.; Polyak, Christina S.; Kibuuka, Hannah			HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; IMMUNOLOGICAL RESPONSE; VIRAL SUPPRESSION; DRUG-RESISTANCE; SUBTYPE; COUNTRIES; DISCONTINUATION; INDIVIDUALS; OUTCOMES; REASONS	Introduction The 2016 WHO consolidated guidelines on the use of antiretroviral drugs defines HIV virologic failure for low and middle income countries (LMIC) as plasma HIV-RNA >= 1000 copies/mL. We evaluated virologic failure and predictors in four African countries. Materials and methods We included HIV-infected participants on a WHO recommended antiretroviral therapy (ART) regimen and enrolled in the African Cohort Study between January 2013 and October 2017. Studied outcomes were virologic failure (plasma HIV-RNA >= 1000 copies/mL at the most recent visit), viraemia (plasma HIV-RNA >= 50 copies/mL at the most recent visit); and persistent viraemia (plasma HIV-RNA >= 50 copies/mL at two consecutive visits). Generalized linear models were used to estimate relative risks with their 95% confidence intervals. Results 2054 participants were included in this analysis. Viraemia, persistent viraemia and virologic failure were observed in 396 (19.3%), 160 (7.8%) and 184 (9%) participants respectively. Of the participants with persistent viraemia, only 57.5% (92/160) had confirmed virologic failure. In the multivariate analysis, attending clinical care site other than the Uganda sitebeing on 2nd line ART (aRR 1.8, 95% CI 1. 28-2. 66); other ART combinations not first line and not second line (aRR 3.8, 95% CI 1.18-11.9), a history of fever in the past week (aRR 3.7, 95% CI 1.69-8.05), low CD4 count (aRR 6.9, 95% CI 4.7-10.2) and missing any day of ART (aRR 1. 8, 95% CI 1. 27-2.57) increased the risk of virologic failure. Being on 2nd line therapy, the site where one receives care and CD4 count < 500 predicted viraemia, persistent viraemia and virologic failure. Conclusion In conclusion, these findings demonstrate that HIV-infected patients established on ART for more than six months in the African setting frequently experienced viraemia while continuing to be on ART. The findings also show that being on second line, low CD4 count, missing any day of ART and history of fever in the past week remain important predictors of virologic failure that should trigger intensified adherence counselling especially in the absence of reliable or readily available viral load monitoring. Finally, clinical care sites are different calling for further analyses to elucidate on the unique features of these sites.	[Kiweewa, Francis; Musingye, Ezra; Semwogerere, Michael; Namagembe, Rosemary; Nambuya, Alice; Kafeero, Cate; Tindikahwa, Allan; Kibuuka, Hannah] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Esber, Allahna; Reed, Domonique; Crowell, Trevor A.; Eller, Leigh Anne; Millard, Monica; Robb, Merlin L.; Ake, Julie A.; Polyak, Christina S.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Esber, Allahna; Reed, Domonique; Crowell, Trevor A.; Cham, Fatim; Eller, Leigh Anne; Robb, Merlin L.; Polyak, Christina S.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Gelderblom, Huub C.] Int AIDS Vaccine Initiat, New York, NY USA; [Keshinro, Babajide; Adamu, Yakubu] HJF Med Res Int, Abuja, Nigeria; [Maswai, Jonah; Sing'oei, Valentine Chepkorir] HJF Med Res Int, Kericho, Kenya; [Owuoth, John] HJF Med Res Int, Kisumu, Kenya; [Maganga, Lucas] Mbeya Med Res Ctr, Mbeya, Tanzania; [Bahemana, Emmanuel; Khamadi, Samoel] HJF Med Res Int, Mbeya, Tanzania	Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; International AIDS Vaccine Initiative	Kiweewa, F (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	fkiweewa@muwrp.org	Crowell, Trevor A./W-3904-2019; Kiweewa, Francis/AAD-6790-2022; Khamadi, Samoel Ashimosi/GXZ-6071-2022	Crowell, Trevor A./0000-0001-5947-265X; Kiweewa, Francis/0000-0003-4938-9558	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Defense; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174]; U.S. Department of Defense (DOD) [W81XWH-11-2-0174]; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH [R25MH064712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Defense(United States Department of Defense); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Defense and funded via a cooperative agreement (W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). We also wish to acknowledge support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH, R25MH064712. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 2015, J INT AIDS SOC, V18, P7, DOI 10.7448/IAS.18.7.20296; Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Ake J., 2018, CLIN INFECT DIS; Amstutz A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2979-y; Arnedo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047391; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; BULAGE L, 2017, BMC INFECT DIS, V17; Church K, 2015, B WORLD HEALTH ORGAN, V93, P457, DOI 10.2471/BLT.14.147215; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Denoeud-Ndam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059446; Duber HC, 2016, TROP MED INT HEALTH, V21, P750, DOI 10.1111/tmi.12694; Elvstam O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180761; Fokam J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187566; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Huong DTM, 2011, INT J STD AIDS, V22, P659, DOI 10.1258/ijsa.2011.010515; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316; Labhardt ND, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21803; Leng XB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005886; Lihana RW, 2012, AIDS REV, V14, P83; Lodi S, 2015, LANCET HIV, V2, pE335, DOI 10.1016/S2352-3018(15)00108-3; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Mujugira A, 2016, AIDS RES HUM RETROV, V32, P148, DOI [10.1089/aid.2015.0296, 10.1089/AID.2015.0296]; O'Connor J, 2017, LANCET HIV, V4, pE295, DOI 10.1016/S2352-3018(17)30053-X; Paraskevis D, 2013, AIDS RES HUM RETROV, V29, P461, DOI [10.1089/aid.2012.0143, 10.1089/AID.2012.0143]; Parczewski M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21847; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Pillay D, 2002, J INFECT DIS, V186, P617, DOI 10.1086/342680; Ramadhani HO, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu079; Reynolds SJ, 2017, AIDS RES HUM RETROV, V33, P448, DOI [10.1089/aid.2015.0370, 10.1089/AID.2015.0370]; Scherrer AU, 2011, CLIN INFECT DIS, V53, P1143, DOI 10.1093/cid/cir669; Semvua SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189460; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Tanner Z, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1926-z; UNAIDS, 2015, 15 15 GLOB TARG UNAI; UNAIDS, 2014, UND FAST TRACK ACC A; van Snippenburg W, 2017, J VIRUS ERAD, V3, P34; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2016, CONSOLIDATED GUIDELI	47	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211344	10.1371/journal.pone.0211344	http://dx.doi.org/10.1371/journal.pone.0211344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721233	Green Published, gold, Green Submitted			2022-12-26	WOS:000457746300012
J	Elstrom, P; Astrup, E; Hegstad, K; Samuelsen, O; Enger, H; Kacelnik, O				Elstrom, Petter; Astrup, Elisabeth; Hegstad, Kristin; Samuelsen, Orjan; Enger, Hege; Kacelnik, Oliver			The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006-2017	PLOS ONE			English	Article							LENGTH-OF-STAY; BLOOD-STREAM INFECTION; BACTEREMIA; MORTALITY; PREVENTION; OUTCOMES; FAECIUM; BURDEN; IMPACT; SPREAD	Introduction Scandinavian countries have traditionally had a low prevalence of resistant organisms, but have in recent years experienced a change in their epidemiology. We aim to describe the epidemiology of carbapenemase-producing organisms (CPOs), vancomycin-resistant enterococci (VRE) and methicillin-resistant S. aureus (MRSA) in Norway, measure the importance of infections contracted abroad, and assess the morbidity and mortality associated with these resistant bacteria in Norway. Methods and materials We used data from the Norwegian surveillance system for communicable diseases covering all findings of the selected resistant bacteria including both infections and colonisation, in the period 2006-2017. Annual trends were assessed using negative binomial regression. For MRSA, we were able to calculate the Morisita-Horn index and transmission numbers following importation in order to assess the effect this had on further domestic transmission. Results The incidence rates (per 100,000 personyears) of the three groups of resistant bacteria have increased during the period. In 2017 the incidence rates were 0.82 for CPOs, 7.09 for VRE and 43.8 for MRSA. 81% of CPO cases were diagnosed in hospitals, but 73% were infected abroad. Most VRE cases were infected in Norwegian hospitals, 85% were associated with hospitals outbreaks. MRSA was predominantly diagnosed in the community, only 21% were diagnosed in hospitals. Of all MRSA cases, 35% were infected in other countries. Most MRSA spa-types were not identified again after introduction, resulting in a transmission of MRSA equivalent to a mean of 0.30 persons infected from each spa-type identified (range: 0-22). The proportion of infections among all notified cases within each diagnose was 44% for MRSA, 9% for VRE and 45% for CPOs. Among persons notified with bacteraemia, the 30 days all-cause mortality were 20%, 16% and 50% for MRSA, VRE and CPOs respectively. Discussion The incidence rates of CPOs, VRE and MRSA in Norway are low, but increasing. The continuing increase of notified resistant bacteria highlights the need for a revision of existing infection prevention and control guidelines.	[Elstrom, Petter; Astrup, Elisabeth; Kacelnik, Oliver] Norwegian Inst Publ Hlth, Dept Antibiot Resistance & Infect Prevent, Oslo, Norway; [Hegstad, Kristin; Samuelsen, Orjan] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway; [Hegstad, Kristin] Artic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Med Biol,Res Grp Host Microbe Interact, Tromso, Norway; [Samuelsen, Orjan] Artic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Pharm,Microbial Pharmacol & Populat Dynam Re, Tromso, Norway; [Enger, Hege] St Olavs Univ Hosp, Norwegian Reference Lab MRSA, Trondheim, Norway	Norwegian Institute of Public Health (NIPH); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU)	Elstrom, P (corresponding author), Norwegian Inst Publ Hlth, Dept Antibiot Resistance & Infect Prevent, Oslo, Norway.	petter.elstrom@fhi.no	Samuelsen, Ørjan/K-9068-2019	Samuelsen, Ørjan/0000-0002-5525-2614; Elstrom, Petter/0000-0003-0778-2247; Enger, Hege/0000-0001-9574-179X; Hegstad, Kristin/0000-0002-1314-0497				Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Bearman G, 2018, INFECT CONT HOSP EP, V39, P676, DOI 10.1017/ice.2018.57; Becketti S., 2013, INTRO TIME SERIES US; Blomfeldt A, 2016, EUR J CLIN MICROBIOL, V35, P803, DOI 10.1007/s10096-016-2601-4; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Cheah ALY, 2013, CLIN MICROBIOL INFEC, V19, pE181, DOI 10.1111/1469-0691.12132; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; De Angelis G, 2014, J ANTIMICROB CHEMOTH, V69, P1185, DOI 10.1093/jac/dkt525; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Di Ruscio F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179771; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; ECDC, 2017, ANN REPORT EUROPEAN, P1, DOI DOI 10.2900/296939; Elstrom P, 2012, J HOSP INFECT, V80, P36, DOI 10.1016/j.jhin.2011.10.004; Elstrom P, 2018, FRONT MICROBIOL; European Centre for Disease Prevention and Control, 2018, DAT ECDC SURV ATL AN; European Centre for Disease Prevention and Control, 2009, ECDC EMEA JOINT TECH, DOI 10.2900/2518; Galloway-Pena JR, 2009, J INFECT DIS, V200, P1566, DOI 10.1086/644790; Gouliouris T, 2018, J ANTIMICROB CHEMOTH, V73, P1692, DOI 10.1093/jac/dky075; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; Grontvedt CA, 2016, CLIN INFECT DIS, V63, P1431, DOI 10.1093/cid/ciw552; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Howden BP, 2013, MBIO, V4, DOI 10.1128/mBio.00412-13; Hughes C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006354.pub4; Kalenic S., 2010, INT J INFECT CONTROL, DOI [10.3396/ijic.V6i2.016.10, DOI 10.3396/IJIC.V6I2.016.10]; Karah N, 2011, J MED MICROBIOL, V60, P515, DOI 10.1099/jmm.0.028340-0; Kinross P, 2017, EUROSURVEILLANCE, V22, P32, DOI 10.2807/1560-7917.ES.2017.22.44.16-00696; Loveday HP, 2006, J HOSP INFECT, V63, pS45, DOI 10.1016/j.jhin.2006.01.002; Macedo-Vinas M, 2013, J HOSP INFECT, V84, P132, DOI 10.1016/j.jhin.2013.02.015; Mehl A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2291-2; Norwegian Ministry of Health and Care Services, 2003, FOR20030620740 NORW; Norwegian Veterinary Institute, 2019, ANT MESS PROT US THI; Otter JA, 2015, CLIN MICROBIOL INFEC, V21, P1057, DOI 10.1016/j.cmi.2015.09.021; Pidot SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar6115; Pinholt M, 2015, J ANTIMICROB CHEMOTH, V70, P2474, DOI 10.1093/jac/dkv142; Prematunge C, 2016, INFECT CONT HOSP EP, V37, P26, DOI 10.1017/ice.2015.228; Samuelsen O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187832; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Top J, 2007, CLIN MICROBIOL INFEC, V13, P316, DOI 10.1111/j.1469-0691.2006.01631.x; Wagenvoort JHT, 2011, J HOSP INFECT, V77, P282, DOI 10.1016/j.jhin.2010.11.008; Werner G, 2008, Euro Surveill, V13; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211741	10.1371/journal.pone.0211741	http://dx.doi.org/10.1371/journal.pone.0211741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716133	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200046
J	Orbegozo-Medina, RA; Martinez-Sernandez, V; Perteguer, MJ; Hernandez-Gonzalez, A; Mezo, M; Gonzalez-Warleta, M; Romaris, F; Paniagua, E; Garate, T; Ubeira, FM				Orbegozo-Medina, Ricardo A.; Martinez-Sernandez, Victoria; Perteguer, Maria J.; Hernandez-Gonzalez, Ana; Mezo, Mercedes; Gonzalez-Warleta, Marta; Romaris, Fernanda; Paniagua, Esperanza; Garate, Teresa; Ubeira, Florencio M.			In-plate recapturing of a dual-tagged recombinant Fasciola antigen (FhLAP) by a monoclonal antibody (US9) prevents nonspecific binding in ELISA	PLOS ONE			English	Article							LEUCINE AMINOPEPTIDASE; ESCHERICHIA-COLI; EARLY IMMUNODIAGNOSIS; IGG ANTIBODIES; PURIFICATION; PROTEINS; MILK; SERODIAGNOSIS; EXPRESSION; PROTECTION	Recombinant proteins expressed in E. coli are frequently purified by immobilized metal affinity chromatography (IMAC). By means of this technique, tagged proteins containing a polyhistidine sequence can be obtained up to 95% pure in a single step, but some host proteins also bind with great affinity to metal ions and contaminate the sample. A way to overcome this problem is to include a second tag that is recognized by a preexistent monoclonal antibody (mAb) in the gene encoding the target protein, allowing further purification. With this strategy, the recombinant protein can be directly used as target in capture ELISA using plates sensitized with the corresponding mAb. As a proof of concept, in this study we engineered a Trichinella-derived tag (MTFSVPIS, recognized by mAb US9) into a His-tagged recombinant Fasciola antigen (rFhLAP) to make a new chimeric recombinant protein (rUS9-FhLAP), and tested its specificity in capture and indirect ELISAs with sera from sheep and cattle. FhLAP was selected since it was previously reported to be immunogenic in ruminants and is expressed in soluble form in E. coli, which anticipates a higher contamination by host proteins than proteins expressed in inclusion bodies. Our results showed that a large number of sera from non-infected ruminants (mainly cattle) reacted in indirect ELISA with rUS9-FhLAP after single-step purification by IMAC, but that this reactivity disappeared testing the same antigen in capture ELISA with mAb US9. These results demonstrate that the 6XHis and US9 tags can be combined when double purification of recombinant proteins is	[Orbegozo-Medina, Ricardo A.; Martinez-Sernandez, Victoria; Romaris, Fernanda; Paniagua, Esperanza; Ubeira, Florencio M.] Fac Farm, Lab Parasitol, Santiago De Compostela, Spain; [Perteguer, Maria J.; Hernandez-Gonzalez, Ana; Garate, Teresa] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Mezo, Mercedes; Gonzalez-Warleta, Marta] INGACAL, Ctr Invest Agr Mabegondo, Lab Parasitol, Abegondo, A Coruna, Spain	Universidade de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Ubeira, FM (corresponding author), Fac Farm, Lab Parasitol, Santiago De Compostela, Spain.	fm.ubeira@usc.es	PERTEGUER, MARIA J/T-1266-2018; González-Warleta, Marta/R-5124-2019; Mezo, Mercedes/R-4703-2019	PERTEGUER, MARIA J/0000-0002-7533-5134; González-Warleta, Marta/0000-0003-3315-5757; Mezo, Mercedes/0000-0001-8819-453X; Orbegozo Medina, Ricardo Alfredo/0000-0002-5281-9718; Ubeira, Florencio/0000-0001-7312-2752; Paniagua Crespo, Maria Esperanza/0000-0002-4435-0200	Ministerio de Economia y Competitividad (Spain) [AGL2011-30563-C03, AGL2014-57125R]; Ministerio de Economia, Industria y Competitividad (INIA, Spain) [RTA2017-00010-C02-01, RTA2017-00010-C02-02]; Conselleria de Cultura, Educacion e Ordenacion Universitaria (Xunta de Galicia, Spain) [ED431B 2017/18]; Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador)	Ministerio de Economia y Competitividad (Spain); Ministerio de Economia, Industria y Competitividad (INIA, Spain); Conselleria de Cultura, Educacion e Ordenacion Universitaria (Xunta de Galicia, Spain); Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador)	This work was supported by: Ministerio de Economia y Competitividad (Spain) [grant number AGL2011-30563-C03 and AGL2014-57125R], Ministerio de Economia, Industria y Competitividad (INIA, Spain) [grants numbers RTA2017-00010-C02-01 and RTA2017-00010-C02-02] and the Conselleria de Cultura, Educacion e Ordenacion Universitaria (Xunta de Galicia, Spain) [grant number ED431B 2017/18]. RAOM holds a predoctoral fellowship from the Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador). VMS is supported by a contract under the grant ED431B 2017/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 1998, J PARASITOL, V84, P1, DOI 10.2307/3284518; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Anderson N, 1999, VET PARASITOL, V83, P15, DOI 10.1016/S0304-4017(99)00026-6; Ben David A, 2015, PROTEIN EXPRES PURIF, V110, P122, DOI 10.1016/j.pep.2015.02.008; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Brizzard B, 2008, BIOTECHNIQUES, V44, P693, DOI 10.2144/000112841; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206; Cornelissen JBWJ, 2001, INT J PARASITOL, V31, P728, DOI 10.1016/S0020-7519(01)00175-8; Eggenreich Britta, 2016, Biotechnol Rep (Amst), V10, P75, DOI 10.1016/j.btre.2016.03.005; Figueroa-Santiago O, 2011, DIAGN MICR INFEC DIS, V70, P355, DOI 10.1016/j.diagmicrobio.2011.03.016; Fujii Yuki, 2017, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V36, P68, DOI 10.1089/mab.2016.0052; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kimple ME, 2013, CURR PROTOC PROTEIN, V73, DOI [10.1002/0471140864.ps0909s73, DOI 10.1002/0471140864.PS0909S73]; Kuerpick B, 2013, VET PARASITOL, V193, P206, DOI 10.1016/j.vetpar.2012.11.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YX, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-79; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Liu ZQ, 2005, IMMUNOL LETT, V97, P41, DOI 10.1016/j.imlet.2004.09.012; MAFF, 1971, USDA TECHNICAL B, V18; Maggioli G, 2011, VACCINE, V29, P9057, DOI 10.1016/j.vaccine.2011.09.020; Marcilla A, 2008, CLIN VACCINE IMMUNOL, V15, P95, DOI 10.1128/CVI.00338-07; Martinez-Sernandez V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004872; Martinez-Sernandez V, 2014, J BIOL CHEM, V289, P1441, DOI 10.1074/jbc.M113.499517; Martinez-Sernandez V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001376; MARTINEZSERNANDEZ V, 2018, PARASITOL RES, V117, P1521, DOI DOI 10.1007/s00436-018-5809-7; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2003, J PARASITOL, V89, P843, DOI 10.1645/GE-74RI.1; Mezo M, 2010, PARASITOL INT, V59, P610, DOI 10.1016/j.parint.2010.09.001; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Mezo M, 2011, VET PARASITOL, V180, P237, DOI 10.1016/j.vetpar.2011.03.009; Mezo M, 2010, VET PARASITOL, V168, P36, DOI 10.1016/j.vetpar.2009.10.007; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; Norbury LJ, 2011, BIOCHIMIE, V93, P604, DOI 10.1016/j.biochi.2010.12.004; Perteguer MJ, 2004, MOL IMMUNOL, V41, P421, DOI 10.1016/j.molimm.2004.03.032; Piacenza L, 1999, INFECT IMMUN, V67, P1954; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Romaris F, 2003, PARASITE IMMUNOL, V25, P297, DOI 10.1046/j.1365-3024.2003.00635.x; Romaris F, 2002, MOL BIOCHEM PARASIT, V125, P173, DOI 10.1016/S0166-6851(02)00239-6; Sambrook J., 2001, MOL CLONING LAB MANU; Santana BG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002414; Saraswat M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/312709; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; van Altena SEC, 2016, VET IMMUNOL IMMUNOP, V171, P21, DOI 10.1016/j.vetimm.2016.01.009; Zhao XY, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/581093	48	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211035	10.1371/journal.pone.0211035	http://dx.doi.org/10.1371/journal.pone.0211035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707711	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900015
J	Qiao, L; Wang, Y				Qiao, Lei; Wang, Yan			Effort-aware and just-in-time defect prediction with neural network	PLOS ONE			English	Article							MODELS	Effort-aware just-in-time (JIT) defect prediction is to rank source code changes based on the likelihood of detects as well as the effort to inspect such changes. Accurate defect prediction algorithms help to find more defects with limited effort. To improve the accuracy of defect prediction, in this paper, we propose a deep learning based approach for effort-aware just-in-time defect prediction. The key idea of the proposed approach is that neural network and deep learning could be exploited to select useful features for defect prediction because they have been proved excellent at selecting useful features for classification and regression. First, we preprocess ten numerical metrics of code changes, and then feed them to a neural network whose output indicates how likely the code change under test contains bugs. Second, we compute the benefit cost ratio for each code change by dividing the likelihood by its size. Finally, we rank code changes according to their benefit cost ratio. Evaluation results on a well-known data set suggest that the proposed approach outperforms the state-of-the-art approaches on each of the subject projects. It improves the average recall and popt by 15.6% and 8.1%, respectively.	[Qiao, Lei; Wang, Yan] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China	Beijing Institute of Technology	Qiao, L (corresponding author), Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China.	qiaolei@bit.edu.cn	Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022; Wang, Yin/HCI-9352-2022; Wang, Yijun/GXW-1763-2022; Qiao, Lei/V-8363-2019; wang, yi/GVT-8516-2022	Qiao, Lei/0000-0002-8221-3741				Aizenberg I, 2007, SOFT COMPUT, V11, P169, DOI 10.1007/s00500-006-0075-5; Akiyama F., 1971, IFIP C, P353; Lam AN, 2015, IEEE INT CONF AUTOM, P476, DOI 10.1109/ASE.2015.73; [Anonymous], 2009, P INT C PRED MOD SOF, DOI [10.1145/1540438.1540448, DOI 10.1145/1540438.1540448]; Arisholm E, 2007, ISSRE 2007: 18TH IEEE INTERNATIONAL SYMPOSIUM ON SOFTWARE RELIABILITY ENGINEERING, PROCEEDINGS, P215, DOI 10.1109/ISSRE.2007.22; Benni KE, 2018, IEEE T SOFTWARE ENG, V44, P534, DOI 10.1109/TSE.2017.2731766; Bennin KE, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE QUALITY, RELIABILITY AND SECURITY (QRS 2016), P214, DOI 10.1109/QRS.2016.33; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Feng Changyong, 2014, Shanghai Arch Psychiatry, V26, P105, DOI 10.3969/j.issn.1002-0829.2014.02.009; Fu W, 2017, ESEC/FSE 2017: PROCEEDINGS OF THE 2017 11TH JOINT MEETING ON FOUNDATIONS OF SOFTWARE ENGINEERING, P72, DOI 10.1145/3106237.3106257; Fukushima Takafumi, 2014, PROC 11 WORK C MININ, P172, DOI [DOI 10.1145/2597073.2597075, 10.1145/2597073.2597075]; Ghotra B, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 1, P789, DOI 10.1109/ICSE.2015.91; Giger E, 2012, INT SYMP EMP SOFTWAR, P171, DOI 10.1145/2372251.2372285; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Halstead M. H., 1977, OPERATING PROGRAMMIN; Harrison R, 1998, IEEE T SOFTWARE ENG, V24, P491, DOI 10.1109/32.689404; Hata H, 2012, PROC INT CONF SOFTW, P200, DOI 10.1109/ICSE.2012.6227193; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Huang Q, 2017, DATASET SOURCE CODE, DOI [10.5281/zenodo.836352, DOI 10.5281/ZENODO.836352]; Jain YK, 2011, INT J COMPUT COMMUN, P2; Jayanthi R, 2019, CLUSTER COMPUT, V22, P77, DOI 10.1007/s10586-018-1730-1; Jiang T, 2013, IEEE INT CONF AUTOM, P279, DOI 10.1109/ASE.2013.6693087; Jing XY, 2014, 36TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2014), P414, DOI 10.1145/2568225.2568320; Kamei Y, 2013, IEEE T SOFTWARE ENG, V39, P757, DOI 10.1109/TSE.2012.70; Kim S, 2006, IEEE INT CONF AUTOM, P81; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lessmann S, 2008, IEEE T SOFTWARE ENG, V34, P485, DOI 10.1109/TSE.2008.35; Li J, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE QUALITY, RELIABILITY AND SECURITY (QRS), P318, DOI 10.1109/QRS.2017.42; Li M, 2012, AUTOMAT SOFTW ENG, V19, P201, DOI 10.1007/s10515-011-0092-1; Ling W, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P599; Liu XY, 2009, IEEE T SYST MAN CY B, V39, P539, DOI 10.1109/TSMCB.2008.2007853; Lou JG, 2016, NEUROCOMPUTING, V186, P66, DOI 10.1016/j.neucom.2015.12.077; Manjula C, 2019, CLUSTER COMPUT, V22, pS9847, DOI 10.1007/s10586-018-1696-z; McIntosh S, 2018, IEEE T SOFTWARE ENG, V44, P412, DOI 10.1109/TSE.2017.2693980; Mende T, 2010, EUR CON SFTWR MTNCE, P107, DOI 10.1109/CSMR.2010.18; Mende T, 2009, EUR CON SFTWR MTNCE, P247, DOI 10.1109/CSMR.2009.55; Meneely Andrew, 2008, P INT S FDN SOFTWARE, P13, DOI [10.1145/1453101.1453106, DOI 10.1145/1453101.1453106]; Mishra B., 2012, INT J COMPUTER APPL, V60, P8; Mockus A, 2000, BELL LABS TECH J, V5, P169, DOI 10.1002/bltj.2229; Mou LL, 2016, AAAI CONF ARTIF INTE, P1287; Nagappan N, 2005, PROC INT CONF SOFTW, P284, DOI 10.1145/1062455.1062514; Nam J, 2018, IEEE T SOFTWARE ENG, V44, P874, DOI 10.1109/TSE.2017.2720603; Niu N, 2014, INT REQUIR ENG CONF, P133, DOI 10.1109/RE.2014.6912255; Ostrand TJ, 2005, IEEE T SOFTWARE ENG, V31, P340, DOI 10.1109/TSE.2005.49; Pan J., 2016, COMMUN COMPUT PHYS, V652, P72, DOI DOI 10.1007/978-981-10-2777-2_7; Patro S.G.K., 2015, IARJSET, V2, P20, DOI [10.17148/IARJSET.2015.2305, DOI 10.17148/IARJSET.2015.2305]; Raychev V, 2014, ACM SIGPLAN NOTICES, V49, P419, DOI [10.1145/2666356.2594321, 10.1145/2594291.2594321]; Ryu D, 2015, J COMPUT SCI TECH-CH, V30, P969, DOI 10.1007/s11390-015-1575-5; Schroter A., 2006, P 2006 ACMIEEE INT S, P18, DOI [10.1145/1159733.1159739, DOI 10.1145/1159733.1159739.]; Singh PD, 2017, PROCEEDINGS OF THE 7TH INTERNATIONAL CONFERENCE ON CLOUD COMPUTING, DATA SCIENCE AND ENGINEERING (CONFLUENCE 2017), P775, DOI 10.1109/CONFLUENCE.2017.7943255; Sliwerski J, 2005, SIGSOFT SOFTW ENG NO, P1, DOI [10.1145/1082983.1083147, DOI 10.1145/1082983.1083147]; Sola J, 1997, IEEE T NUCL SCI, V44, P1464, DOI 10.1109/23.589532; Tan M, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 2, P99, DOI 10.1109/ICSE.2015.139; Tantithamthavorn C, 2019, IEEE T SOFTWARE ENG, V45, P683, DOI 10.1109/TSE.2018.2794977; Tantithamthavorn C, 2017, IEEE T SOFTWARE ENG, V43, P1, DOI 10.1109/TSE.2016.2584050; Wang HJ, 2012, NEUROCOMPUTING, V92, P124, DOI 10.1016/j.neucom.2011.08.040; Wang L., 2017, P 39 INT C SOFTW ENG, V2017, P189, DOI DOI 10.1109/ICSE-C.2017.102; Wang S, 2016, PROC INT CONF SOFTW, P297, DOI 10.1145/2884781.2884804; White M, 2015, 12TH WORKING CONFERENCE ON MINING SOFTWARE REPOSITORIES (MSR 2015), P334, DOI 10.1109/MSR.2015.38; Wong TT, 2017, IEEE T KNOWL DATA EN, V29, P2417, DOI 10.1109/TKDE.2017.2740926; Wu F, 2018, IEEE T RELIAB, V67, P581, DOI 10.1109/TR.2018.2804922; Yang XL, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE SECURITY AND RELIABILITY (QRS 2015), P17, DOI 10.1109/QRS.2015.14; Yang YB, 2016, FSE'16: PROCEEDINGS OF THE 2016 24TH ACM SIGSOFT INTERNATIONAL SYMPOSIUM ON FOUNDATIONS OF SOFTWARE ENGINEERING, P157, DOI 10.1145/2950290.2950353; Yin Z., 2011, P 19 ACM SIGSOFT S 1, P26, DOI [DOI 10.1145/2025113.2025121, 10.1145/2025113.2025121]; Yu TT, 2019, IEEE T SOFTWARE ENG, V45, P558, DOI 10.1109/TSE.2018.2791521; Zhang F, 2016, PROC INT CONF SOFTW, P309, DOI 10.1145/2884781.2884839; Zhiqiang L, 2018, PROGR APPROACHES SOF, DOI [10.1049/iet-sen.2017.0148, DOI 10.1049/IET-SEN.2017.0148]; Zhong S, 2004, EIGHTH IEEE INTERNATIONAL SYMPOSIUM ON HIGH ASSURANCE SYSTEMS ENGINEERING, PROCEEDINGS, P149	68	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211359	10.1371/journal.pone.0211359	http://dx.doi.org/10.1371/journal.pone.0211359			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707738	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900022
J	Detotto, C; Isler, S; Wehrle, M; Vyssotski, AL; Bettschart-Wolfensberger, R; Gent, TC				Detotto, Carlotta; Isler, Sarah; Wehrle, Martin; Vyssotski, Alexei L.; Bettschart-Wolfensberger, Regula; Gent, Thomas C.			Nitrogen gas produces less behavioural and neurophysiological excitation than carbon dioxide in mice undergoing euthanasia	PLOS ONE			English	Article							FLOW-RATE; AVERSION; RATS; ANESTHESIA; CO2; STRESS; ARGON; PAIN; STIMULATION; ISOFLURANE	Carbon dioxide (CO2) is one of the most commonly used gas euthanasia agents in mice, despite reports of aversion and nociception. Inert gases such as nitrogen (N-2) may be a viable alternative to carbon dioxide. Here we compared behavioural and electrophysiological reactions to CO2 or N-2 at either slow fill or rapid fill in C57Bl/6 mice undergoing gas euthanasia. We found that mice euthanised with CO2 increased locomotor activity compared to baseline, whereas mice exposed to N-2 decreased locomotion. Furthermore, mice exposed to CO2 showed significantly more vertical jumps and freezing episodes than mice exposed to N-2. We further found that CO2 exposure resulted in increased theta: delta of the EEG, a measure of excitation, whereas the N-2 decreased theta: delta. Differences in responses were not oxygen-concentration dependent. Taken together, these results demonstrate that CO2 increases both behavioural and electrophysiological excitation as well as producing a fear response, whereas N-2 reduces behavioural activity and central neurological depression and may be less aversive although still produces a fear response. Further studies are required to evaluate N-2 as a suitable euthanasia agent for mice.	[Detotto, Carlotta; Bettschart-Wolfensberger, Regula; Gent, Thomas C.] Univ Zurich, Vetsuisse Fac, Sect Anaesthesiol, Zurich, Switzerland; [Isler, Sarah; Wehrle, Martin] Nat & Tierpk Goldau, Goldau, Switzerland; [Vyssotski, Alexei L.] Swiss Fed Inst Technol, Inst Neuroinformat, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gent, TC (corresponding author), Univ Zurich, Vetsuisse Fac, Sect Anaesthesiol, Zurich, Switzerland.	tgent@vetclinics.uzh.ch	; Bettschart, Regula/B-9197-2018	Gent, Thomas/0000-0002-0478-5461; Bettschart, Regula/0000-0001-6259-9678	Swiss Federal Veterinary Office (Bundesamt fur Lebensmittelsicherheit und Veterinarwesen) [2.16.01]	Swiss Federal Veterinary Office (Bundesamt fur Lebensmittelsicherheit und Veterinarwesen)	Funding from this work was provided by a grant from the Swiss Federal Veterinary Office (Bundesamt fur Lebensmittelsicherheit und Veterinarwesen). Grant number: 2.16.01 "Tierschuztgerechte Euthanasie von Nagern mittels inerten Gasen".	Anisimov VN, 2014, NAT METHODS, V11, P1135, DOI [10.1038/NMETH.3114, 10.1038/nmeth.3114]; Artwohl J, 2006, J AM ASSOC LAB ANIM, V45, P98; Benedetti F, 2015, PAIN, V156, P2326, DOI 10.1097/j.pain.0000000000000288; Boivin GP, 2017, J AM ASSOC LAB ANIM, V56, P491; Boivin GP, 2016, J AM ASSOC LAB ANIM, V55, P451; Brankack J, 2010, BRAIN RES, V1322, P59, DOI 10.1016/j.brainres.2010.01.069; Burkholder TH, 2010, J AM ASSOC LAB ANIM, V49, P448; Castelhano-Carlos MJ, 2009, LAB ANIM-UK, V43, P311, DOI 10.1258/la.2009.0080098; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; Conlee KM, 2005, LAB ANIM-UK, V39, P137, DOI 10.1258/0023677053739747; Danneman PJ, 1997, LAB ANIM SCI, V47, P376; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Dryden R, 2018, RISK ANAL, V38, P525, DOI 10.1111/risa.12856; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gelegen C, 2014, EUR J NEUROSCI, V40, P2311, DOI 10.1111/ejn.12570; Gent TC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195872; Guedes SR, 2017, APPL ANIM BEHAV SCI, V189, P91, DOI 10.1016/j.applanim.2017.01.012; Hawkins P., 2006, NEWCASTLE CONSENSUS; Hawkins P, 2016, ANIMALS, V6, DOI 10.3390/ani6090050; HEWETT TA, 1993, LAB ANIM SCI, V43, P579; Hwang E, 2010, J NEUROSCI METH, V188, P14, DOI 10.1016/j.jneumeth.2010.01.028; Kaur S, 2017, NEURON, V96, P1153, DOI 10.1016/j.neuron.2017.10.009; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2004, ANIM WELFARE, V13, pS77; Leach MC, 2002, VET REC, V150, P808, DOI 10.1136/vr.150.26.808; Leach MC, 2002, COMPARATIVE MED, V52, P249; Leary S, 2013, AVMA GUIDELINES EUTH; Makowska IJ, 2008, APPL ANIM BEHAV SCI, V114, P572, DOI 10.1016/j.applanim.2008.04.005; Makowska IJ, 2009, APPL ANIM BEHAV SCI, V121, P230, DOI 10.1016/j.applanim.2009.10.001; Mongeluzi DL, 2003, BEHAV MODIF, V27, P620, DOI 10.1177/0145445503256316; Moody CM, 2014, LAB ANIM-UK, V48, P298, DOI 10.1177/0023677214546509; Moody CM, 2014, APPL ANIM BEHAV SCI, V158, P95, DOI 10.1016/j.applanim.2014.04.011; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Neuhaus C, 2014, PSYCHOL RES BEHAV MA, V7, P297, DOI 10.2147/PRBM.S51844; Niel L, 2008, APPL ANIM BEHAV SCI, V109, P77, DOI 10.1016/j.applanim.2007.02.004; Niel L, 2007, APPL ANIM BEHAV SCI, V107, P100, DOI 10.1016/j.applanim.2006.08.002; Okitsu Y, 2004, CLIN EXP PHARMACOL P, V31, P14, DOI 10.1111/j.1440-1681.2004.03944.x; Powell K, 2016, LAB ANIMAL, V45, P386, DOI 10.1038/laban.1117; Qiu MH, 2016, CURR BIOL, V26, P2301, DOI 10.1016/j.cub.2016.07.054; SAINSBURY RS, 1987, PHYSIOL BEHAV, V39, P513, DOI 10.1016/0031-9384(87)90382-9; Sharp J, 2006, J AM ASSOC LAB ANIM, V45, P21; Shusterman D, 1996, J ALLERGY CLIN IMMUN, V97, P86; Thomas AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032290; THURAUF N, 1993, BRAIN RES, V629, P293, DOI 10.1016/0006-8993(93)91333-N; Valentim AM, 2016, LAB ANIM-UK, V50, P241, DOI 10.1177/0023677215618618; Valentine H, 2012, J AM ASSOC LAB ANIM, V51, P50; van Rijn CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016514; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WAHLSTEN D, 1972, BEHAV GENET, V2, P211, DOI 10.1007/BF01065691; Wise PM, 2003, CHEM SENSES, V28, P751, DOI 10.1093/chemse/bjg065; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	52	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210818	10.1371/journal.pone.0210818	http://dx.doi.org/10.1371/journal.pone.0210818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703117	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600024
J	Moriarty, KM; Verschuyl, J; Kroll, AJ; Davis, R; Chapman, J; Hollen, B				Moriarty, Katie M.; Verschuyl, Jake; Kroll, Andrew J.; Davis, Raymond; Chapman, Joshua; Hollen, Bruce			Describing vegetation characteristics used by two rare forest-dwelling species: Will established reserves provide for coastal marten in Oregon?	PLOS ONE			English	Article							AMERICAN MARTENS; MICROSATELLITE LOCI; HABITAT SELECTION; CONSERVATION; CALIFORNIA; AMPLIFICATION; VARIABILITY; PREDICTION; MANAGEMENT; WOLVERINE	Forest management guidelines for rare or declining species in the Pacific Northwest, USA, include both late successional reserves and specific vegetation management criteria. However, whether current management practices for well-studied species such as northern spotted owls (Strix occidentallis caurina) can aid in conserving a lesser known subspecies-Humboldt martens (Martes caurina humboldtensis)-is unclear. To address the lack of information for martens in coastal Oregon, USA, we quantified vegetation characteristics at locations used by Humboldt martens and spotted owls in two regions (central and southern coast) and at two spatial scales (the site level summarizing extensive vegetation surveys and regionally using remotely sensed vegetation and estimated habitat models). We estimated amount of predicted habitat for both species in established reserves. If predicted overlap in established reserves was low, then we reported vegetation characteristics to inform potential locations for reserves or management opportunities. In the Central Coast, very little overlap existed in vegetation characteristics between Humboldt martens and spotted owls at either the site or regional level. Humboldt martens occurred in young forests composed of small diameter trees with few snags or downed logs. Humboldt martens were also found in areas with very dense vegetation when overstory canopy and shrub cover percentages were combined. In the South Coast, Humboldt martens occurred in forests with smaller diameter trees than spotted owl sites on average. Coastal Humboldt martens may use stands of predicted high quality spotted owl habitat in the Pacific Northwest. Nonetheless, our observations suggest that coastal Humboldt martens exist in areas that include a much higher diversity of conifer size classes as long as extensive dense shrub cover, predominantly in the form of high salal and evergreen huckleberry, are available. We suggest that managers consider how structural characteristics (e.g., downed logs, shrub cover, patch size), are associated with long-term species persistence rather than relying on reserves based on broad cover types. Describing vegetation may partially describe suitability, but available prey or predation risk ultimately influence likelihood of individual Humboldt marten use. Guidelines for diversifying vegetation management, and retaining or restoring appropriate habitat conditions at both the stand level and regionally, may increase management flexibility and identify forest conditions that support both spotted owls and Humboldt martens.	[Moriarty, Katie M.] US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA 98502 USA; [Verschuyl, Jake] Natl Council Air & Stream Improvement, Western Sustainable Forestry Program, Anacortes, WA USA; [Kroll, Andrew J.] Weyerhaeuser, Springfield, OR USA; [Davis, Raymond] US Forest Serv, USDA, Reg 6, Corvallis, OR USA; [Chapman, Joshua] US Forest Serv, USDA, Reg Reg Off 6, Portland, OR USA; [Hollen, Bruce] USDI Bur Land Management, Reg Off, Portland, OR USA; [Moriarty, Katie M.] Natl Council Air & Stream Improvement, Corvallis, OR 97330 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Moriarty, KM (corresponding author), US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA 98502 USA.; Moriarty, KM (corresponding author), Natl Council Air & Stream Improvement, Corvallis, OR 97330 USA.	ktmoriarty22@gmail.com	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X; Verschuyl, Jacob/0000-0002-6374-298X; Moriarty, Katie/0000-0002-3348-3403	National Council for Air and Stream Improvement (NCASI); Coos Bay Bureau of Land Management [L12AC20563]; Oregon State University Fish and Wildlife Habitat in Managed Forests Research Program; NCASI; Oregon State University; Oregon Forest and Industries Council; U.S. Bureau of Land Management; BLM	National Council for Air and Stream Improvement (NCASI); Coos Bay Bureau of Land Management; Oregon State University Fish and Wildlife Habitat in Managed Forests Research Program; NCASI; Oregon State University; Oregon Forest and Industries Council; U.S. Bureau of Land Management; BLM	Vegetation surveys were funded by the National Council for Air and Stream Improvement (NCASI). Owl telemetry was largely funded by the Coos Bay Bureau of Land Management (grant number L12AC20563). Marten survey efforts were largely funded by the Oregon State University Fish and Wildlife Habitat in Managed Forests Research Program and NCASI. Dr. Katie Moriarty and Dr. John Bailey received the grant from Oregon State University. The Oregon Forest and Industries Council funded surveys within 5-km of prior marten locations. Significant support was provided by the USDA Forest Service, Pacific Northwest Research Station, USDA Forest Service Region 6, Siuslaw and Rogue-Siskiyou National Forests, the US Fish and Wildlife Service, and the Bureau of Land Management. Dr. Jake Verschuyl and Mr. Dennis Rock received the grant from the U.S. Bureau of Land Management. The study design for the owl portion of the data was funded jointly by BLM and NCASI, whose support required a robust study design and the publication of the material. The funders had no role in the data collection and analysis, or preparation of the manuscript.	Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; [Anonymous], 2014, FOREST PRACTICES ACT; BAKER WILLIAM H., 1956, AMER MIDLAND NAT, V56, P1, DOI 10.2307/2422444; Bingham BB, 1997, CONSERV BIOL, V11, P127, DOI 10.1046/j.1523-1739.1997.95331.x; Bodkin JL, 1997, J WILDLIFE MANAGE, V61, P967, DOI 10.2307/3802207; Burnett RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123778; Buskirk Steven W., 1994, P283; California Fish and Wildlife Commission, 2018, HUMB MART STAT END M; Carlson SM, 2017, P NATL ACAD SCI USA, V114, P10309, DOI 10.1073/pnas.1713968114; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Center for Biological Diversity, 2010, PET LIST HUMB UNPUB; Christy JA, 1998, PLANT ASS OREGON DUN; CORN JG, 1992, J WILDLIFE MANAGE, V56, P442, DOI 10.2307/3808856; Dallas JF, 1998, MOL ECOL, V7, P1248; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Davis R.J., 2015, NW FOREST PLAN 1 20; Davis RJ., 2016, NW FOREST PLAN THE 1, DOI [10.2737/PNW-GTR-929, DOI 10.2737/PNW-GTR-929]; Diller LV, 2016, J WILDLIFE MANAGE, V80, P691, DOI 10.1002/jwmg.1046; Duffy AJ, 1998, ANIM GENET, V29, P63; Dugger KM, 2016, CONDOR, V118, P57, DOI 10.1650/CONDOR-15-24.1; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Eriksson C, 2016, THESIS; Eriksson CE, PLOS ONE; Fair J, 2013, GUIDELINES USE WILD; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Franklin J. F., 1973, NATURAL VEGETATION O; Frey SJK, 2016, DIVERS DISTRIB, V22, P944, DOI 10.1111/ddi.12456; Fuller A. K., 2006, THESIS; Furnas BJ, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1747; Glenn EM, 2004, J WILDLIFE MANAGE, V68, P33, DOI 10.2193/0022-541X(2004)068[0033:SOHAHU]2.0.CO;2; HAMILTON GJ, 1969, FORESTRY, V42, P133, DOI 10.1093/forestry/42.2.133; Hargis CD, 1999, J APPL ECOL, V36, P157, DOI 10.1046/j.1365-2664.1999.00377.x; Harrison S, 2006, ECOL MONOGR, V76, P41, DOI 10.1890/05-0910; Hedmark E, 2004, CONSERV GENET, V5, P405, DOI 10.1023/B:COGE.0000031224.88778.f5; Holm SR, 2016, WILDLIFE SOC B, V40, P615, DOI 10.1002/wsb.714; Jensen PG, 2012, J WILDLIFE MANAGE, V76, P489, DOI 10.1002/jwmg.322; Johnsen K, 2017, ECOL EVOL, V7, P115, DOI 10.1002/ece3.2635; Jones GM, 2018, DIVERS DISTRIB, V24, P341, DOI 10.1111/ddi.12682; Jordan MJ, 2007, MOL ECOL NOTES, V7, P797, DOI 10.1111/j.1471-8286.2007.01708.x; Joyce M. J., 2017, MARTES COMPLEX 21 CE, P181; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kroll AJ, 2012, WEST J APPL FOR, V27, P128, DOI 10.5849/wjaf.10-021; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; Lindenmayer DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089807; Linnell MA, 2018, PEERJ, V6, DOI 10.7717/peerj.4530; Long JW., 2014, SCI SYNTHESIS SUPPOR; Lyons AJ, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-2; Marcot B. G., 2007, CONT CLIN TRIALS, P90; Maser C., 1979, U S Department of Agriculture Agriculture Handbook, P78; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P439, DOI 10.2193/0022-541X(2004)068[0439:GEAWPE]2.0.CO;2; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moeur M., 2005, NW FOREST PLAN 1 10; Moriarty K. M, 2017, IDENTIFYING OPPORTUN; Moriarty KM, 2018, WILDLIFE SOC B, V42, P403, DOI 10.1002/wsb.896; Moriarty KM, 2017, J MAMMAL, V98, P679, DOI 10.1093/jmammal/gyx014; Moriarty Katie M., 2016, Northwestern Naturalist, V97, P71; Moriarty KM, 2016, J WILDLIFE MANAGE, V80, P621, DOI 10.1002/jwmg.1060; Moriarty KM, 2015, LANDSCAPE ECOL, V30, P1865, DOI 10.1007/s10980-015-0216-2; Mortenson JA, 2015, J WILDLIFE DIS, V51, P250, DOI 10.7589/2014-02-031; North M, 2000, J WILDLIFE MANAGE, V64, P797, DOI 10.2307/3802750; North MP, 2017, FOREST ECOL MANAG, V405, P166, DOI 10.1016/j.foreco.2017.09.019; Ohmann JL, 2002, CAN J FOREST RES, V32, P725, DOI [10.1139/x02-011, 10.1139/X02-011]; Oregon Department of Fish and Wildlife, OR CONS STRAT 2016; Oregon Department of Geology and Mineral Industries (DOGAMI), 2015, CAN HEIGHT COV DAT; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Porter AD, 2005, CAN J FOREST RES, V35, P901, DOI 10.1139/X05-014; Potvin F, 1999, CAN J FOREST RES, V29, P1120, DOI 10.1139/cjfr-29-7-1120; SHERBURNE SS, 1994, J WILDLIFE MANAGE, V58, P400, DOI 10.2307/3809309; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Sikes RS, 2015, ILAR J, V56, P335, DOI 10.1093/ilar/ilv071; Singleton PH, 2010, J WILDLIFE MANAGE, V74, P285, DOI 10.2193/2008-548; Slauson K. M., 2018, PSWGTR260 USDA FOR S; Slauson KM, 2007, J WILDLIFE MANAGE, V71, P458, DOI 10.2193/2004-332; Slauson KM, 2017, J MAMMAL, V98, P1697, DOI 10.1093/jmammal/gyx118; Slauson KM, 2009, NORTHWEST SCI, V83, P35, DOI 10.3955/046.083.0104; Sullivan TP, 2018, MAMMAL RES, V63, P11, DOI 10.1007/s13364-017-0336-y; Sullivan TP, 2017, FOREST ECOL MANAG, V399, P143, DOI 10.1016/j.foreco.2017.05.028; Thomas J.W., 1979, U S Department of Agriculture Agriculture Handbook, P60; Thomas JW, 1990, CONSERVATION STRATEG; Thompson C. M., 2015, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P83; Thompson I, 2012, IMPROVED INSIGHTS US, P209; U. S. Fish & Wildlife Service, 2015, FED REGISTER, V80, P18741; United States Fish Wildlife Service [USFWS], 2011, REV REC PLAN NO SPOT; US Fish and Wildlife Service (USFWS), 2018, FED REGISTER, V83, P50574; *USDA USDI, 1994, REC DEC AM FOR SERV; USDI Bureau of Land Management, 2016, NW COAST OR REC DEC; USDI Bureau of Land Management, 2016, SW OR REC DEC APPR R; USFWS, 2018, SPEC STAT ASS COAST; USFWS, 1990, FED REGISTER, V55, P26114; Wiens JD, 2014, WILDLIFE MONOGR, V185, P1, DOI 10.1002/wmon.1009; WILCOX B. A., 1984, NATL PARKS CONSERVAT, P18, DOI DOI 10.13140/2.1.4879.2322; Williams Michael S., 1994, Southern Journal of Applied Forestry, V18, P76; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; Zielinski WJ, 2006, BIOL CONSERV, V133, P409, DOI 10.1016/j.biocon.2006.07.003; Zielinski WJ, 2001, J MAMMAL, V82, P478, DOI 10.1644/1545-1542(2001)082&lt;0478:SOAMIC&gt;2.0.CO;2	98	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210865	10.1371/journal.pone.0210865	http://dx.doi.org/10.1371/journal.pone.0210865			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703124	Green Published, gold			2022-12-26	WOS:000457301600025
J	Minami, T; Ishida, W; Kishimoto, T; Nakajima, I; Hino, S; Arai, R; Matsunaga, T; Fukushima, A; Yamagami, S				Minami, Takahiro; Ishida, Waka; Kishimoto, Tatsuma; Nakajima, Isana; Hino, Shiori; Arai, Ritsuko; Matsunaga, Toru; Fukushima, Atsuki; Yamagami, Satoru			In vitro and in vivo performance of epinastine hydrochloride-releasing contact lenses	PLOS ONE			English	Article							ALLERGIC CONJUNCTIVITIS; DELIVERY; HYDROGEL; EFFICACY	A number of drug-releasing contact lenses are currently being studied to address issues inherent in eye drops as a drug delivery method. In this study, we developed epinastine hydrochloride-releasing daily soft contact lenses for treatment of allergic conjunctivitis and examined their in vitro and in vivo performance. Preformed soft contact lenses with/without ionic functional groups were soaked in a solution of epinastine hydrochloride in phosphate-buffered saline to prepare epinastine hydrochloride-releasing soft contact lenses. Among these contact lenses with different ionicities, anionic lenses demonstrated the maximum, relatively linear epinastine hydrochloride release, in vitro. The amount of epinastine hydrochloride release was directly proportional to the concentration of the epinastine hydrochloride solution used to prepare the contact lens. The epinastine hydrochloride-releasing anionic soft contact lens also demonstrated prolonged drug release and significantly greater efficacy compared with epinastine hydrochloride eye drops 12 h after treatment, in vivo. Further studies are required to determine the appropriate amount of epinastine hydrochloride to be contained in the anionic soft contact lenses.	[Minami, Takahiro] Univ Tokyo, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan; [Ishida, Waka; Kishimoto, Tatsuma; Nakajima, Isana; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol, Nankoku, Kochi, Japan; [Hino, Shiori; Arai, Ritsuko; Matsunaga, Toru] SEED CO LTD, Bunkyo Ku, Tokyo, Japan; [Yamagami, Satoru] Nihon Univ, Dept Ophthalmol, Itaba, Tokyo, Japan	University of Tokyo; Kochi University; Nihon University	Fukushima, A (corresponding author), Kochi Med Sch, Dept Ophthalmol, Nankoku, Kochi, Japan.; Yamagami, S (corresponding author), Nihon Univ, Dept Ophthalmol, Itaba, Tokyo, Japan.	fukusima@kochi-u.ac.jp; yamagami.satoru@nihon-u.ac.jp		Kishimoto, Tatsuma/0000-0002-5437-7298	SEED CO., LTD.	SEED CO., LTD.	The authors (TM and AF) received funding for this work from SEED CO., LTD. (no grant number; http://www.seed.co.jp/).The funder had roles in material design and in vitro data collection.	Center for Drug Evaluation and Research, 2003, PHARMACOL REV, P44; Ciolino JB, 2009, SEMIN OPHTHALMOL, V24, P156, DOI 10.1080/08820530902802161; Fujishima H, 2014, ANN ALLERG ASTHMA IM, V113, P476, DOI 10.1016/j.anai.2014.07.007; Ghate D, 2008, J GLAUCOMA, V17, P147, DOI 10.1097/IJG.0b013e31814b990d; Gomes PJ, 2014, CURR OPIN ALLERGY CL, V14, P451, DOI 10.1097/ACI.0000000000000100; Hui A, 2008, EYE CONTACT LENS, V34, P266, DOI 10.1097/ICL.0b013e3181812ba2; Kakisu K, 2013, INVEST OPHTH VIS SCI, V54, P2551, DOI 10.1167/iovs.12-10614; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Sato T, 2005, J APPL POLYM SCI, V98, P731, DOI 10.1002/app.22080; Smith AF, 2005, OPHTHAL EPIDEMIOL, V12, P233, DOI 10.1080/09286580590967781; Soluri A, 2012, OPTOMETRY VISION SCI, V89, P1140, DOI 10.1097/OPX.0b013e3182639dc8; Takahashi A, 2010, BRIT J OPHTHALMOL, V94, P1657, DOI 10.1136/bjo.2010.180422; Tieppo A, 2012, J CONTROL RELEASE, V157, P391, DOI 10.1016/j.jconrel.2011.09.087; Uchida R, 2003, J CONTROL RELEASE, V92, P259, DOI 10.1016/S0168-3659(03)00368-7; Urgacz A, 2015, POSTEP DERM ALERGOL, V32, P204, DOI 10.5114/pdia.2015.48071; Xu JW, 2018, J CONTROL RELEASE, V281, P97, DOI 10.1016/j.jconrel.2018.05.020; Yamazaki Y, 2013, J APPL POLYM SCI, V127, P5022, DOI 10.1002/app.38114	17	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210362	10.1371/journal.pone.0210362	http://dx.doi.org/10.1371/journal.pone.0210362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699147	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600031
J	Bort, A; Sanchez, BG; Spinola, E; Mateos-Gomez, PA; Rodriguez-Henche, N; Diaz-Laviada, I				Bort, Alicia; Sanchez, Belen G.; Spinola, Elena; Mateos-Gomez, Pedro A.; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines			The red pepper's spicy ingredient capsaicin activates AMPK in HepG2 cells through CaMKK beta	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; AUTOPHAGY; GUIDELINES; ASSAYS	Capsaicin is a natural compound present in chili and red peppers and the responsible of their spicy flavor. It has recently provoked interest because of its antitumoral effects in many cell types although its action mechanism is not clearly understood. As metabolic dysregulation is one of the hallmarks of cancer cells and the key metabolic sensor in the AMP-activated kinase (AMPK), in this study we explored the ability of capsaicin to modulate AMPK activity. We found that capsaicin activated AMPK in HepG2 cells by increasing AMPK phosphorylation and its downstream target ACC. Mechanistically, we determined that capsaicin activated AMPK through the calcium/calmodulin-dependent protein kinase kinase beta, CaMKK beta as either the CaMKK inhibitor STO-609 or CaMKK knock down with siRNA abrogated the activation of AMPK. Moreover, capsaicin decreased cell viability, inhibited Akt/mTOR pathway and increased reactive oxygen species (ROS) in HepG2 cells. AMPK activation was involved in the underpinning mechanism of capsaicin-induced cell death.	[Bort, Alicia; Sanchez, Belen G.; Mateos-Gomez, Pedro A.; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines] Univ Alcala, Sch Med & Hlth Sci, Dept Syst Biol, Madrid, Spain; [Spinola, Elena] Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol Physiol Genet & Immunol, Univ Inst Biomed & Hlth Res IUIBS, Las Palmas Gran Canaria, Spain; [Diaz-Laviada, Ines] Univ Alcala de Henares, Chem Res Inst Andres M del Rio IQAR, Madrid, Spain	Universidad de Alcala; Universidad de Las Palmas de Gran Canaria; Universidad de Alcala	Diaz-Laviada, I (corresponding author), Univ Alcala, Sch Med & Hlth Sci, Dept Syst Biol, Madrid, Spain.; Diaz-Laviada, I (corresponding author), Univ Alcala de Henares, Chem Res Inst Andres M del Rio IQAR, Madrid, Spain.	ines.diazlaviada@uah.es	Mateos-Gomez, Pedro A/E-9924-2018; Diaz-Laviada, Ines/I-2838-2015; Rodriguez-Henche, Nieves/K-6828-2017; Bueno, Bort/AAC-1242-2019	Mateos-Gomez, Pedro A/0000-0002-5539-2289; Diaz-Laviada, Ines/0000-0001-9704-4373; Rodriguez-Henche, Nieves/0000-0001-9798-359X; Bueno, Bort/0000-0003-1490-5823; Spinola Lasso, Elena/0000-0003-2207-5786; Belen, Sanchez Gomez/0000-0003-0971-1522	Fundacion Tatiana Perez de Guzman [Patrocinio 2013-01]; Universidad de Alcala [UAH-GC 2018-1]	Fundacion Tatiana Perez de Guzman; Universidad de Alcala	IDL has received the grants no Patrocinio 2013-01 from Fundacion Tatiana Perez de Guzman and no UAH-GC 2018-1 from Universidad de Alcala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantini C, 2016, ONCOTARGET, V7, P50180, DOI 10.18632/oncotarget.10326; Bloomer RJ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-72; Bort A, 2017, ONCOTARGET, V8, P87684, DOI 10.18632/oncotarget.21196; Chen X, 2016, FREE RADICAL RES, V50, P744, DOI 10.3109/10715762.2016.1173689; Clark R, 2016, ANTICANCER RES, V36, P837; Diaz-Laviada I, 2014, PROG DRUG RES, V68, P181, DOI 10.1007/978-3-0348-0828-6_8; Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Friedman JR, 2018, J PHARMACOL EXP THER, V364, P462, DOI 10.1124/jpet.117.243691; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Leung FW, 2014, PROG DRUG RES, V68, P171, DOI 10.1007/978-3-0348-0828-6_7; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; Narang Nithida, 2017, Pharmacogn Rev, V11, P23, DOI 10.4103/phrev.phrev_48_16; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Ramos-Torres A, 2016, ONCOTARGET, V7, P1569, DOI 10.18632/oncotarget.6415; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Scherz-Shouval R, 2019, EMBO J, V38, DOI 10.15252/embj.2019101812; Sengupta S, 2017, ONCOGENE, V36, P5709, DOI 10.1038/onc.2017.164; Shen W, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.00272; Song JX, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00602; Sun LC, 2018, BBA-REV CANCER, V1870, P51, DOI 10.1016/j.bbcan.2018.06.005; Tian N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030191; Wang Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0922-0; Wang ZY, 2016, EXPERIENTIA SUPPL, V107, P203, DOI 10.1007/978-3-319-43589-3_9; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Zang YF, 2018, J AGR FOOD CHEM, V66, P6772, DOI 10.1021/acs.jafc.8b01831; Zhao HJ, 2017, IEEE T INTELL TRANSP, V18, P192, DOI 10.1109/TITS.2016.2571726	32	13	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211420	10.1371/journal.pone.0211420	http://dx.doi.org/10.1371/journal.pone.0211420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695053	Green Submitted, gold, Green Published			2022-12-26	WOS:000457046400034
J	Grievink, H; Kuzmina, N; Chevion, M; Drenger, B				Grievink, Hilbert; Kuzmina, Natalia; Chevion, Mordechai; Drenger, Benjamin			Sevoflurane postconditioning is not mediated by ferritin accumulation and cannot be rescued by simvastatin in isolated streptozotocin-induced diabetic rat hearts	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; POSSIBLE PREDICTIVE CRITERIA; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; IRON; INHIBITION; PROTECTION; EXPRESSION; HALOTHANE	Sevoflurane postconditioning (sevo postC) is an attractive and amenable approach that can protect the myocardium against ischemia/reperfusion (I/R)-injury. Unlike ischemic preconditioning (IPC), sevo postC does not require additional induced ischemic periods to a heart that is already at risk. IPC was previously shown to generate myocardial protection against I/R-injury through regulation of iron homeostasis and de novo ferritin synthesis, a process found to be impaired in the diabetic state. The current study investigated whether alterations in iron homeostasis and ferritin mRNA and protein accumulation are also involved in the cardioprotective effects generated by sevo postC. It was also investigated whether the protective effects of sevo postC in the diabetic state can be salvaged by simvastatin, through inducing nitric oxide (NO) bioavailability/activity, in isolated streptozotocin (STZ)-induced diabetic hearts (DH). Isolated rat hearts from healthy Controls and diabetic animals were retrogradely perfused using the Langendorff configuration and subjected to prolonged ischemia and reperfusion, with and without (2.4 and 3.6%) sevo postC and/or pre-treatment with simvastatin (0.5 mg/kg). Sevo postC significantly reduced infarct size and improved myocardial function in healthy Controls but not in isolated DH. The sevo postC mediated myocardial protection against I/R-injury was not associated with de novo ferrtin synthesis. Furthermore, simvastatin aggravated myocardial injury after sevo postC in STZ-induced DHs, likely due to increasing NO levels. Despite the known mechanistic overlaps between PC and postC stimuli, distinct differences underlie the cardioprotective interventions against myocardial I/R-injury and are impaired in the DH. Sevo postC mediated cardioprotection, unlike IPC, does not involve de novo ferritin accumulation and cannot be rescued by simvastatin in STZ-induced DHs.	[Grievink, Hilbert; Kuzmina, Natalia; Drenger, Benjamin] Hadassah Hebrew Univ Hosp, Dept Anesthesiol & Crit Care & Pain Med, Jerusalem, Israel; [Grievink, Hilbert; Chevion, Mordechai] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Jerusalem, Israel; [Grievink, Hilbert] Hadassah Med Org, Cyclotron Radiochem MicroPET Unit, Hadassah Hebrew Univ Hosp, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Grievink, H (corresponding author), Hadassah Hebrew Univ Hosp, Dept Anesthesiol & Crit Care & Pain Med, Jerusalem, Israel.; Grievink, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Jerusalem, Israel.; Grievink, H (corresponding author), Hadassah Med Org, Cyclotron Radiochem MicroPET Unit, Hadassah Hebrew Univ Hosp, Jerusalem, Israel.	hilbert@hadassah.org.il			Dr. Avraham Moshe and Pepka Bergman Memorial Fund; German-Israel Foundation for Scientific Research and Development [GIF 1061-59.2/2008]; Israel Science Foundation [ISF489/12]; Lady Davis Post-doctoral Fellowship	Dr. Avraham Moshe and Pepka Bergman Memorial Fund; German-Israel Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Lady Davis Post-doctoral Fellowship	This research was supported by research grants (awarded to MC) from the Dr. Avraham Moshe and Pepka Bergman Memorial Fund, by the German-Israel Foundation for Scientific Research and Development (GIF 1061-59.2/2008), and by the Israel Science Foundation (ISF489/12). A Lady Davis Post-doctoral Fellowship was awarded to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1092015; Berenshtein E, 1997, J MOL CELL CARDIOL, V29, P3025, DOI 10.1006/jmcc.1997.0535; Berenshtein E, 2002, MOL CELL BIOCHEM, V234, P283, DOI 10.1023/A:1015923202082; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Brandenburger T, 2014, SHOCK, V42, P234, DOI 10.1097/SHK.0000000000000201; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Bulvik BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048947; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Cao J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00160; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Chevion M, 2008, J MOL CELL CARDIOL, V45, P839, DOI 10.1016/j.yjmcc.2008.08.011; Drenger B, 2011, ANESTHESIOLOGY, V114, P1364, DOI 10.1097/ALN.0b013e31820efafd; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Ge ZD, 2018, ANESTHESIOLOGY, V128, P117, DOI 10.1097/ALN.0000000000001926; Gorbe A, 2011, AM J PHYSIOL-HEART C, V300, pH1907, DOI 10.1152/ajpheart.01242.2010; Gong JS, 2012, MOL BIOL REP, V39, P6417, DOI 10.1007/s11033-012-1447-9; Grievink H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159951; Gu WD, 2008, ANESTHESIOLOGY, V108, P634, DOI 10.1097/ALN.0b013e3181672590; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hotta H, 2010, CIRC RES, V106, P129, DOI 10.1161/CIRCRESAHA.109.205385; Huhn R, 2008, BRIT J ANAESTH, V100, P465, DOI 10.1093/bja/aen022; Kersten JR, 2001, AM J PHYSIOL-HEART C, V280, pH1744, DOI 10.1152/ajpheart.2001.280.4.H1744; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Lefer DJ, 2001, FASEB J, V15, P1454, DOI 10.1096/fj.00-0819fje; LENK SE, 1992, AM J PHYSIOL, V263, pE856, DOI 10.1152/ajpendo.1992.263.5.E856; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Malone MA, 2007, METABOLISM, V56, P1118, DOI 10.1016/j.metabol.2007.04.005; Marfella R, 2006, ACTA CARDIOL, V61, P630, DOI 10.2143/AC.61.6.2017962; Marfella R, 2009, CARDIOVASC PATHOL, V18, P332, DOI 10.1016/j.carpath.2008.09.008; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Obal D, 2001, BRIT J ANAESTH, V87, P905, DOI 10.1093/bja/87.6.905; Okon EB, 2005, DIABETES, V54, P2415, DOI 10.2337/diabetes.54.8.2415; Park WK, 1996, ANESTHESIOLOGY, V84, P1166, DOI 10.1097/00000542-199605000-00019; Povlsen JA, 2009, CLIN EXP PHARMACOL P, V36, P892, DOI 10.1111/j.1440-1681.2009.05166.x; Schlack W, 1998, BRIT J ANAESTH, V81, P913, DOI 10.1093/bja/81.6.913; Schlack W, 1997, BRIT J ANAESTH, V79, P88, DOI 10.1093/bja/79.1.88; Sivaraman V, 2010, J CELL MOL MED, V14, P1740, DOI 10.1111/j.1582-4934.2009.00796.x; Smith JM, 1997, J MOL CELL CARDIOL, V29, P2393, DOI 10.1006/jmcc.1997.0474; Song T, 2011, EXP BIOL MED, V236, P1427, DOI 10.1258/ebm.2011.011165; Stockklauser-Farber K, 2000, BBA-MOL BASIS DIS, V1535, P10, DOI 10.1016/S0925-4439(00)00078-8; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Thirunavukkarasu M, 2013, INT J CARDIOL, V168, P2474, DOI 10.1016/j.ijcard.2013.03.005; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Van Allen NR, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-22; Vinokur V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062948; WARLTIER DC, 1988, ANESTHESIOLOGY, V69, P552, DOI 10.1097/00000542-198810000-00016; Whittington HJ, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/845698; Yao YY, 2013, J ZHEJIANG UNIV-SC B, V14, P511, DOI 10.1631/jzus.B1200195; Yao YT, 2009, BIOL PHARM BULL, V32, P1854, DOI 10.1248/bpb.32.1854; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075927; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	58	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211238	10.1371/journal.pone.0211238	http://dx.doi.org/10.1371/journal.pone.0211238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682140	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500133
J	Villafanez, F; Garcia, IA; Carbajosa, S; Pansa, MF; Mansilla, S; Llorens, MC; Angiolini, V; Guantay, L; Jacobs, H; Madauss, KP; Gloger, I; Gottifredi, V; Bocco, JL; Soria, G				Villafanez, Florencia; Alejandra Garcia, Iris; Carbajosa, Sofia; Florencia Pansa, Maria; Mansilla, Sabrina; Candelaria Llorens, Maria; Angiolini, Virginia; Guantay, Laura; Jacobs, Heinz; Madauss, Kevin P.; Gloger, Israel; Gottifredi, Vanesa; Luis Bocco, Jose; Soria, Gaston			AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress	ONCOGENE			English	Article							PROTEIN-KINASE B; NUCLEAR ANTIGEN UBIQUITINATION; DNA-DAMAGE RESPONSE; SIGNALING PATHWAY; P21 DEGRADATION; REPAIR; ETA; POLYMERASES; AKT/PKB; CANCER	Translesion DNA synthesis (TLS) and homologous recombination (HR) cooperate during S-phase to safeguard replication forks integrity. Thus, the inhibition of TLS becomes a promising point of therapeutic intervention in HR-deficient cancers, where TLS impairment might trigger synthetic lethality (SL). The main limitation to test this hypothesis is the current lack of selective pharmacological inhibitors of TLS. Herein, we developed a miniaturized screening assay to identify inhibitors of PCNA ubiquitylation, a key post-translational modification required for efficient TLS activation. After screening a library of 627 kinase inhibitors, we found that targeting the pro-survival kinase AKT leads to strong impairment of PCNA ubiquitylation. Mechanistically, we found that AKT-mediated modulation of Proliferating Cell Nuclear Antigen (PCNA) ubiquitylation after UV requires the upstream activity of DNA PKcs, without affecting PCNA ubiquitylation levels in unperturbed cells. Moreover, we confirmed that persistent AKT inhibition blocks the recruitment of TLS polymerases to sites of DNA damage and impairs DNA replication forks processivity after UV irradiation, leading to increased DNA replication stress and cell death. Remarkably, when we compared the differential survival of HR-proficient vs HR-deficient cells, we found that the combination of UV irradiation and AKT inhibition leads to robust SL induction in HR-deficient cells. We link this phenotype to AKT ability to inhibit PCNA ubiquitylation, since the targeted knockdown of PCNA E3-ligase (RAD18) and a non-ubiquitylable (PCNA K164R) knock-in model recapitulate the observed SL induction. Collectively, this work identifies AKT as a novel regulator of PCNA ubiquitylation and provides the proof-of-concept of inhibiting TLS as a therapeutic approach to selectively kill HR-deficient cells submitted to replication stress.	[Villafanez, Florencia; Alejandra Garcia, Iris; Carbajosa, Sofia; Florencia Pansa, Maria; Candelaria Llorens, Maria; Angiolini, Virginia; Guantay, Laura; Luis Bocco, Jose; Soria, Gaston] Consejo Nacl Invest Cient & Tecn, CIBICI, Ctr Invest Bioquim Clin & Inmunol, Cordoba, Argentina; [Villafanez, Florencia; Alejandra Garcia, Iris; Carbajosa, Sofia; Florencia Pansa, Maria; Candelaria Llorens, Maria; Angiolini, Virginia; Guantay, Laura; Luis Bocco, Jose; Soria, Gaston] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Cordoba, Argentina; [Mansilla, Sabrina; Gottifredi, Vanesa] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Jacobs, Heinz] Netherlands Canc Inst, Tumor Biol & Immunol, Amsterdam, Netherlands; [Madauss, Kevin P.] GlaxoSmithKline Trust Sci, Global Hlth R&D, Upper Providence, PA USA; [Gloger, Israel] GlaxoSmithKline Trust Sci, Global Hlth R&D, Stevenage, Herts, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Leloir Institute; Netherlands Cancer Institute	Soria, G (corresponding author), Consejo Nacl Invest Cient & Tecn, CIBICI, Ctr Invest Bioquim Clin & Inmunol, Cordoba, Argentina.; Soria, G (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Cordoba, Argentina.	gsoria29@gmail.com	Carbajosa, Sofía/AAB-1554-2020; Gottifredi, Vanesa/AAI-1788-2019	Mansilla, Sabrina Florencia/0000-0001-7752-3377; Villafanez, Florencia/0000-0001-9835-2343; Gottifredi, Vanesa/0000-0001-9656-5951; Carbajosa Gonzalez, Sofia/0000-0002-0133-8287	Start-up grant from the Fondo para la Investigacion Cientifica y Tecnologica (FONCyT PICT start-up) [2013-1553]; KWF [10796/2016-2, 10032/2016-1]; FONCyT; Trust in Science (Global Health R& D) from GlaxoSmithKline [PAE-GLAXO 2014-0005]; National Institute of Cancer; CONICET	Start-up grant from the Fondo para la Investigacion Cientifica y Tecnologica (FONCyT PICT start-up); KWF; FONCyT(FONCyT); Trust in Science (Global Health R& D) from GlaxoSmithKline; National Institute of Cancer; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	We thank the flow cytometry, microscopy and cell culture facilities of CIBICI-CONICET for technical support. We thank Nicolas Nieto Moreno for careful reading of the manuscript and helpful suggestions. We would like to thank Gerard Drewes of CellZome (a GSK company) for his scientific advice. This work was supported by a Start-up grant from the Fondo para la Investigacion Cientifica y Tecnologica (FONCyT PICT start-up 2013-1553), by KWF projects 10796/2016-2 and 10032/2016-1 to HJ and by a consortium grant of FONCyT and the Trust in Science (Global Health R& D) from GlaxoSmithKline (PAE-GLAXO 2014-0005). S.M, V.G., J.L.B. and G.S. are researchers from CONICET. FV, IAG, SC, and MCL were supported by fellowships from FONCyT, MFP and LG were supported by fellowships from the National Institute of Cancer and CONICET.	Joray MB, 2017, FOOD CHEM TOXICOL, V109, P888, DOI 10.1016/j.fct.2017.04.039; Bertolin AP, 2015, DNA REPAIR, V32, P158, DOI 10.1016/j.dnarep.2015.04.027; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Branzei D, 2016, DNA REPAIR, V44, P68, DOI 10.1016/j.dnarep.2016.05.008; Brown JS, 2017, PHARMACOL THERAPEUT, V172, P101, DOI 10.1016/j.pharmthera.2016.12.001; Brun Jan, 2010, BMC Res Notes, V3, P85, DOI 10.1186/1756-0500-3-85; Ceppi P, 2009, CLIN CANCER RES, V15, P1039, DOI 10.1158/1078-0432.CCR-08-1227; Cipolla L, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00105; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jia JH, 2013, CELL SIGNAL, V25, P1498, DOI 10.1016/j.cellsig.2013.02.021; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Liu Q, 2014, NEURO-ONCOLOGY, V16, P1313, DOI 10.1093/neuonc/nou058; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mansilla SF, 2013, NUCLEIC ACIDS RES, V41, P6942, DOI 10.1093/nar/gkt475; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; McIntyre J, 2015, DNA REPAIR, V29, P166, DOI 10.1016/j.dnarep.2015.02.011; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Nitulescu GM, 2016, INT J ONCOL, V48, P869, DOI 10.3892/ijo.2015.3306; Park J, 2009, J BIOL CHEM, V284, P6169, DOI 10.1074/jbc.C800210200; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, J CELL SCI, V125, P1633, DOI 10.1242/jcs.094748; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sharma S, 2012, MOL PHARMACOL, V81, P778, DOI 10.1124/mol.111.076828; Sokol AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03277; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Soria G, 2006, ONCOGENE, V25, P2829, DOI 10.1038/sj.onc.1209315; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Soria G, 2013, CELL CYCLE, V12, P422, DOI 10.4161/cc.23215; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Soria G, 2009, CELL CYCLE, V8, P3340, DOI 10.4161/cc.8.20.9836; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Tu Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-172; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; Wang SC, 2014, TRENDS PHARMACOL SCI, V35, P178, DOI 10.1016/j.tips.2014.02.004; Wang ZF, 2016, J CELL SCI, V129, P1223, DOI 10.1242/jcs.179408; Wit N, 2015, NUCLEIC ACIDS RES, V43, P282, DOI 10.1093/nar/gku1301; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yamanaka K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006842; Zhang WW, 2011, FEBS LETT, V585, P2786, DOI 10.1016/j.febslet.2011.04.044	54	22	22	8	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4310	4324		10.1038/s41388-019-0724-7	http://dx.doi.org/10.1038/s41388-019-0724-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30705406	Green Published, hybrid			2022-12-26	WOS:000469339100008
J	Bergeron, MJ; Feau, N; Stewart, D; Tanguay, P; Hamelin, RC				Bergeron, Marie-Josee; Feau, Nicolas; Stewart, Don; Tanguay, Philippe; Hamelin, Richard C.			Genome-enhanced detection and identification of fungal pathogens responsible for pine and poplar rust diseases	PLOS ONE			English	Article							REAL-TIME PCR; MELAMPSORA-LARICI-POPULINA; BLISTER RUST; FORMAE-SPECIALES; WHITE PINES; PLANT; MEDUSAE; PHYLOGENY; GROWTH; ASSAY	Biosurveillance is a proactive approach that may help to limit the spread of invasive fungal pathogens of trees, such as rust fungi which have caused some of the world's most damaging diseases of pines and poplars. Most of these fungi have a complex life cycle, with up to five spore stages, which is completed on two different hosts. They have a biotrophic lifestyle and may be propagated by asymptomatic plant material, complicating their detection and identification. A bioinformatics approach, based on whole genome comparison, was used to identify genome regions that are unique to the white pine blister rust fungus, Cronartium ribicola, the poplar leaf rust fungi Melampsora medusae and Melampsora larici-populina or to members of either the Cronartium and Melampsora genera. Species- and genus-specific real-time PCR assays, targeting these unique regions, were designed with the aim of detecting each of these five taxonomic groups. In total, twelve assays were developed and tested over a wide range of samples, including different spore types, different infected plant parts on the pycnioaecial or uredinio-telial host, and captured insect vectors. One hundred percent detection accuracy was achieved for the three targeted species and two genera with either a single assay or a combination of two assays. This proof of concept experiment on pine and poplar leaf rust fungi demonstrates that the genome-enhanced detection and identification approach can be translated into effective real-time PCR assays to monitor tree fungal pathogens.	[Bergeron, Marie-Josee; Stewart, Don; Tanguay, Philippe] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Feau, Nicolas; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Forest Sci Ctr, Vancouver, BC, Canada; [Hamelin, Richard C.] Univ Laval, Inst Biol Integrat Syst, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service; University of British Columbia; Laval University	Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Forest Sci Ctr, Vancouver, BC, Canada.; Hamelin, RC (corresponding author), Univ Laval, Inst Biol Integrat Syst, Quebec City, PQ, Canada.	richard.hamelin@ubc.ca		Bergeron, Marie-Josee/0000-0002-4308-5695	Genome Canada; Genome British Columbia; Genome Quebec Large-Scale Applied Research Program [2112, 10106]; Government of Canada from the Genomic Research and Development Initiative program	Genome Canada(Genome Canada); Genome British Columbia; Genome Quebec Large-Scale Applied Research Program; Government of Canada from the Genomic Research and Development Initiative program	This research was funded by Genome Canada, Genome British Columbia and Genome Quebec Large-Scale Applied Research Program, projects #2112 and #10106 to RCH; https://www.genomecanada.ca/en/genomics-based-foresthealth-diagnostics-and-monitoring; https://www.genomecanada.ca/en/biosurveillance-alien-forest-enemies-biosafe.Author PT received funding from the Government of Canada from the Genomic Research and Development Initiative program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutigny AL, 2013, FUNGAL BIOL-UK, V117, P389, DOI 10.1016/j.funbio.2013.04.001; Boutigny AL, 2013, EUR J PLANT PATHOL, V136, P433, DOI 10.1007/s10658-013-0180-0; Boyle B, 2006, PHYTOPATHOLOGY, V96, pS15; Boyle B, 2005, APPL ENVIRON MICROB, V71, P1546, DOI 10.1128/AEM.71.3.1546-1552.2005; Carnegie AJ, 2016, BIOL INVASIONS, V18, P127, DOI 10.1007/s10530-015-0996-y; Chandelier A., 2010, Bulletin OEPP, V40, P52, DOI 10.1111/j.1365-2338.2009.02354.x; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Feau N, 2007, CAN J BOT, V85, P1127, DOI 10.1139/B07-102; Feau N, 2018, PEERJ, V6, DOI 10.7717/peerj.4392; Feau N, 2011, MYCOLOGIA, V103, P1250, DOI 10.3852/10-426; Feau N, 2009, MYCOL RES, V113, P713, DOI 10.1016/j.mycres.2009.02.007; Firrincieli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00978; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frey P, 2005, RUST DISEASES OF WILLOW AND POPLAR, P63, DOI 10.1079/9780851999999.0063; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geils BW, 2010, FOREST PATHOL, V40, P147, DOI 10.1111/j.1439-0329.2010.00654.x; Grondin J, 2005, PLANT DIS, V89, P1242, DOI 10.1094/PD-89-1242B; Grosdidier M, 2017, PLANT PATHOL, V66, P359, DOI 10.1111/ppa.12591; Guinet C, 2016, PLANT PATHOL, V65, P380, DOI 10.1111/ppa.12426; Hamelin RC, 1996, PHYTOPATHOLOGY, V86, P875, DOI 10.1094/Phyto-86-875; HUNT RS, 1985, CAN J BOT, V63, P1086, DOI 10.1139/b85-149; Husson C, 2013, FOREST PATHOL, V43, P1, DOI 10.1111/efp.12007; Innes L, 2004, PLANT DIS, V88, P85, DOI 10.1094/PDIS.2004.88.1.85B; Jalkanen R, 2016, FORESTS, V7, DOI 10.3390/f7010025; Kim MS, 2010, FOREST PATHOL, V40, P382, DOI 10.1111/j.1439-0329.2010.00664.x; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI 10.1007/S10462-007-9052-3; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; Lowd Daniel, 2005, P 22 INT C MACH LEAR; Maier W, 2003, CAN J BOT, V81, P12, DOI [10.1139/B02-113, 10.1139/b02-113]; Maier WFA, 2005, M MYC SOC JAP, V49, P156; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Organization EaMPP, 2018, EPPO GLOB DAT DISTR; Organization EaMPP, 2018, EPPO A2 LIST PESTS R; Ostry M, 2014, POPLARS AND WILLOWS: TREES FOR SOCIETY AND THE ENVIRONMENT, P443, DOI 10.1079/9781780641089.0443; Pautasso M, 2015, MICROB ECOL, V69, P826, DOI 10.1007/s00248-014-0545-8; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Richardson BA., 2009, BREEDING GENETIC RES, P56; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; SHAIN L, 1988, MYCOLOGIA, V80, P729, DOI 10.2307/3807726; Sinclair W.A., 2005, DIS TREES SHRUBS; Sniezko RA, 2014, FORESTS, V5, P2050, DOI 10.3390/f5092050; Toome M, 2014, NEW PHYTOL, V202, P554, DOI 10.1111/nph.12653; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vialle A, 2013, MOL PHYLOGENET EVOL, V66, P628, DOI 10.1016/j.ympev.2012.10.021; Vialle A, 2009, MOL ECOL RESOUR, V9, P99, DOI 10.1111/j.1755-0998.2009.02637.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Withers S, 2016, PHYTOPATHOLOGY, V106, P1105, DOI 10.1094/PHYTO-10-15-0260-FI; Zhang XY, 2010, FOREST PATHOL, V40, P369, DOI 10.1111/j.1439-0329.2010.00663.x	52	8	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210952	10.1371/journal.pone.0210952	http://dx.doi.org/10.1371/journal.pone.0210952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726264	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000039
J	Rub, MA				Rub, Malik Abdul			Aggregation and interfacial phenomenon of amphiphilic drug under the influence of pharmaceutical excipients (green/biocompatible gemini surfactant)	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; MIXED MICELLE FORMATION; NONIONIC SURFACTANTS; CATIONIC GEMINI; BINARY-MIXTURES; TETRADECYLTRIMETHYLAMMONIUM BROMIDE; IMIPRAMINE HYDROCHLORIDE; CONVENTIONAL SURFACTANTS; THERMODYNAMIC PARAMETERS; ASSOCIATION BEHAVIOR	In the current study, we have examined the interaction amongst an antidepressant drug amitriptyline hydrochloride (AMH) and ethane-1, 2-diyl bis(N,N-dimethyl-N-cetylammoniumacetoxy) dichloride (16-E2-16, a green gemini surfactant) through tensiometric and fluorimetric techniques in aqueous/electrolyte/urea solutions. Significant variations are observed in the various evaluated parameters in the present study. Gemini 16-E2-16 has outstanding surface properties along with a much lower cmc value, demonstrating very little toxicity as well as considerable antimicrobial activity. The cmc values of mixtures decrease through increase in mole fraction (alpha(1)) of 16-E2-16, which specifies the nonideality of the solution mixtures, along with demonstrating the occurrence of mixed micellization too. Negative beta(Rub) values signify on the whole attractive force of interaction between constituents of mixed micelles. Owing to the incidence of electrolyte NaCl (50 mmol.kg(-1)), lowering of the micelles' surface charge happens, resulting in aggregation taking place at lower concentration while the presence of urea (NH2CONH2) halts micellization taking place, which means the cmc value increases in the attendance of urea. The Delta G(m)degrees values for all systems were negative along with the presence of electrolyte/urea. The excess free energy (G(ex)) of studied mixed systems was also estimated and found to be negative for all the systems. Using the fluorescence quenching method, the micelle aggregation number (N-agg) was evaluated and it was found that the contribution of gemini surfactant was always more than that of the AMH and their value enhances in the existence of electrolyte while decreasing in the attendance of NH2CONH2 in the system. In addition, other fluorescence parameters such as micropolarity (I-1/I-3), dielectric constant (D-exp) as well as Stern-Volmer binding constants (K-sv) of mixed systems were evaluated and the results showed the synergistic performance of the AMH + 16-E2-16 mixtures. Along with tensiometric and fluorimetric techniques, FT-IR spectroscopy was also engaged to reveal the interaction among constituents.	[Rub, Malik Abdul] King Abdulaziz Univ, Fac Sci, Chem Dept, Jeddah, Saudi Arabia	King Abdulaziz University	Rub, MA (corresponding author), King Abdulaziz Univ, Fac Sci, Chem Dept, Jeddah, Saudi Arabia.	malikrub@gmail.com	Rub, Malik Abdul/H-6027-2012	Rub, Malik Abdul/0000-0002-4798-5308	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-059-D1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (130-059-D1434). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Al-Muhanna MK, 2015, J CHEM THERMODYN, V89, P112, DOI 10.1016/j.jct.2015.05.007; Ansari WH, 2013, SOFT MATTER, V9, P1478, DOI 10.1039/c2sm26926k; ASAKAWA T, 1995, LANGMUIR, V11, P2376, DOI 10.1021/la00007a010; Attwood D., 1983, SURFACTANT SYSTEMS T; Azum N, 2018, CHINESE J CHEM ENG, V26, P566, DOI 10.1016/j.cjche.2017.09.009; Azum N, 2017, J DISPER SCI TECHNOL, V38, P1785, DOI 10.1080/01932691.2017.1283510; Azum N, 2016, J SOLUTION CHEM, V45, P791, DOI 10.1007/s10953-016-0463-0; Azum N, 2017, J DISPER SCI TECHNOL, V38, P96, DOI 10.1080/01932691.2016.1144197; Bagheri A, 2017, RSC ADV, V7, P18151, DOI 10.1039/c6ra27382c; BRIGANTI G, 1991, J PHYS CHEM-US, V95, P8989, DOI 10.1021/j100175a103; Caetano W, 2000, J COLLOID INTERF SCI, V225, P69, DOI 10.1006/jcis.2000.6720; Camilleri P, 2000, CHEM COMMUN, P1253, DOI 10.1039/b001742f; Ruiz CC, 2011, J COLLOID INTERF SCI, V361, P178, DOI 10.1016/j.jcis.2011.05.019; Chattoraj D.K., 1984, ADSORPTION GIBBSUR; CLINT JH, 1975, J CHEM SOC FARAD T 1, V71, P1327, DOI 10.1039/f19757101327; Dai CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102539; DLUHY RA, 1985, CAN J CHEM, V63, P1925, DOI 10.1139/v85-319; Dong B, 2007, LANGMUIR, V23, P4178, DOI 10.1021/la0633029; Fatma N, 2016, J MOL LIQ, V219, P959, DOI 10.1016/j.molliq.2016.04.038; Fatma N, 2015, COLLOID SURFACE A, V467, P9, DOI 10.1016/j.colsurfa.2014.11.010; Fatma N, 2013, J SURFACTANTS DETERG, V16, P609, DOI 10.1007/s11743-013-1448-2; Faustino CMC, 2014, IND ENG CHEM RES, V53, P10112, DOI 10.1021/ie5003735; Gaikar VG, 2008, J MOL LIQ, V138, P155, DOI 10.1016/j.molliq.2007.10.001; Haque ME, 1996, LANGMUIR, V12, P4084, DOI 10.1021/la9403587; HOLLAND PM, 1983, J PHYS CHEM-US, V87, P1984, DOI 10.1021/j100234a030; Hoque MA, 2017, J SOLUTION CHEM, V46, P682, DOI 10.1007/s10953-017-0594-y; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; Jakubowska A, 2010, J COLLOID INTERF SCI, V346, P398, DOI 10.1016/j.jcis.2010.03.043; Jojart B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102114; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Khan F, 2018, J PHYS ORG CHEM, V31, DOI 10.1002/poc.3812; Khan F, 2016, J MOL LIQ, V222, P1020, DOI 10.1016/j.molliq.2016.07.104; Khan F, 2015, J DISPER SCI TECHNOL, V36, P83, DOI 10.1080/01932691.2013.852105; Kibbey TCG, 1997, ENVIRON SCI TECHNOL, V31, P1171, DOI 10.1021/es960681r; Kral'ova K, 2010, TENSIDE SURFACT DET, V47, P288, DOI 10.3139/113.110079; Kumar D, 2018, J MOL LIQ, V271, P254, DOI 10.1016/j.molliq.2018.08.147; Kumar D, 2018, J MOL LIQ, V250, P329, DOI 10.1016/j.molliq.2017.11.172; Kumar D, 2017, J MOL LIQ, V240, P253, DOI 10.1016/j.molliq.2017.05.088; Kumar D, 2017, J MOL LIQ, V238, P389, DOI 10.1016/j.molliq.2017.05.027; Kumar D, 2015, TENSIDE SURFACT DET, V52, P464, DOI 10.3139/113.110398; Lange KR, 1999, SURFACTANTS: A PRACTICAL HANDBOOK, P144; Mahajan RK, 2012, IND ENG CHEM RES, V51, P3338, DOI 10.1021/ie202463w; Menger FM, 2000, LANGMUIR, V16, P2062, DOI 10.1021/la9910576; MENGER FM, 1993, J AM CHEM SOC, V115, P10083, DOI 10.1021/ja00075a025; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Molla MR, 2017, J MOL LIQ, V238, P62, DOI 10.1016/j.molliq.2017.04.061; Motomura K, 1998, MIXED SURFACTANT SYS; MURANUSHI N, 1980, INT J PHARM, V4, P271; Myers D, 2006, SURFACTANT SCIENCE AND TECHNOLOGY, 3RD EDITION, P1; Olutas EB, 2012, J CHEM THERMODYN, V47, P144, DOI 10.1016/j.jct.2011.10.008; Patil SS, 2012, MOL PHARMACEUT, V9, P318, DOI 10.1021/mp200541r; Pietralik Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144373; Rao KS, 2011, J PHYS CHEM B, V115, P13847, DOI 10.1021/jp2076275; Rodriguez A, 2008, J PHYS CHEM B, V112, P11942, DOI 10.1021/jp802243f; Rohatgi-Mukherjee K.K., 1992, IND J CHEM, V31A, P500; Rosen M. J., 1978, SURFACTANTS INTERFAC, DOI DOI 10.1002/0471670561; ROSEN MJ, 1982, COLLOID SURFACE, V5, P159, DOI 10.1016/0166-6622(82)80071-1; Rosen MJ, COLLOIDS SURF, V13, P201; Rub MA, 2018, J CHEM THERMODYN, V121, P199, DOI 10.1016/j.jct.2018.02.019; Rub MA, 2017, J CHEM ENG DATA, V62, P3216, DOI 10.1021/acs.jced.7b00298; Rub MA, 2017, J PHYS ORG CHEM, V30, DOI 10.1002/poc.3676; Rub MA, 2016, RUSS J PHYS CHEM B+, V10, P1007, DOI 10.1134/S1990793116060257; Rub MA, 2016, J CHEM THERMODYN, V96, P196, DOI 10.1016/j.jct.2016.01.001; Rub MA, 2015, TENSIDE SURFACT DET, V52, P236, DOI 10.3139/113.110371; Rub MA, 2014, J TAIWAN INST CHEM E, V45, P2068, DOI 10.1016/j.jtice.2014.04.024; Rub MA, 2014, J MOL LIQ, V194, P234, DOI 10.1016/j.molliq.2014.02.037; Rub MA, 2013, J MOL STRUCT, V1050, P35, DOI 10.1016/j.molstruc.2013.07.010; SCHOTT H, 1976, J PHARM SCI, V65, P975, DOI 10.1002/jps.2600650706; Schreier S, 2000, BBA-BIOMEMBRANES, V1508, P210, DOI 10.1016/S0304-4157(00)00012-5; Sugihara G., 2003, J OLEO SCI, V52, P449, DOI [10.5650/jos.52.449, DOI 10.5650/JOS.52.449]; Taboada P, 1999, J CHEM ENG DATA, V44, P820, DOI 10.1021/je990060o; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; TURRO NJ, 1978, J AM CHEM SOC, V100, P5951, DOI 10.1021/ja00486a062; TURRO NJ, 1986, J PHYS CHEM-US, V90, P288, DOI 10.1021/j100274a017; UMEMURA J, 1981, J COLLOID INTERF SCI, V83, P558, DOI 10.1016/0021-9797(81)90350-7; Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001; WINNIK FM, 1993, CHEM REV, V93, P587, DOI 10.1021/cr00018a001; Xu DQ, 2016, J SURFACTANTS DETERG, V19, P91, DOI 10.1007/s11743-015-1752-0; YANG PW, 1986, J COLLOID INTERF SCI, V113, P218, DOI 10.1016/0021-9797(86)90222-5; ZANA R, 1993, NATURE, V362, P228, DOI 10.1038/362228a0; Zdziennicka A, 2017, J MOL LIQ, V243, P236, DOI 10.1016/j.molliq.2017.08.042; Zhinong G, 2008, J NAT SCI, V13, P227, DOI DOI 10.1007/S11859-008-0219-9; Zhou Q, 2003, LANGMUIR, V19, P4555, DOI 10.1021/la020789m	83	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211077	10.1371/journal.pone.0211077	http://dx.doi.org/10.1371/journal.pone.0211077			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726255	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000051
J	Xi, YP; Wang, F				Xi, Yanping; Wang, Fei			Extreme pathway analysis reveals the organizing rules of metabolic regulation	PLOS ONE			English	Article							HUMAN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HUMAN TRIFUNCTIONAL ENZYME; ENVIRONMENTAL-CHANGES; ADAPTIVE PREDICTION; ESCHERICHIA-COLI; GENE-EXPRESSION; FLUX; MODELS; NETWORKS; VISFATIN	Cellular systems shift metabolic states by adjusting gene expression and enzyme activities to adapt to physiological and environmental changes. Biochemical and genetic studies are identifying how metabolic regulation affects the selection of metabolic phenotypes. However, how metabolism influences its regulatory architecture still remains unexplored. We present a new method of extreme pathway analysis (the minimal set of conically independent metabolic pathways) to deduce regulatory structures from pure pathway information. Applying our method to metabolic networks of human red blood cells and Escherichia coli, we shed light on how metabolic regulation are organized by showing which reactions within metabolic networks are more prone to transcriptional or allosteric regulation. Applied to a human genome-scale metabolic system, our method detects disease-associated reactions. Thus, our study deepens the understanding of the organizing principle of cellular metabolic regulation and may contribute to metabolic engineering, synthetic biology, and disease treatment.	[Xi, Yanping; Wang, Fei] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China; [Xi, Yanping; Wang, Fei] Fudan Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China; [Xi, Yanping] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, F (corresponding author), Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China.; Wang, F (corresponding author), Fudan Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China.	wangfei@fudan.edu.cn		Xi, Yanping/0000-0002-0689-790X	National Natural Science Foundation of China [61472086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (61472086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2010, J CLIN ONCOL, V28, P614, DOI 10.1200/JCO.2009.23.6406; Arnold W J, 1978, Methods Enzymol, V51, P568; Ates O, 2013, BIOTECHNOL PROGR, V29, P1386, DOI 10.1002/btpr.1823; Bell SL, 2005, BIOINFORMATICS, V21, P1739, DOI 10.1093/bioinformatics/bti228; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Brkic H, 2015, MOL BIOSYST, V11, P898, DOI 10.1039/c4mb00668b; Cakir T, 2004, BIOTECHNOL BIOENG, V86, P251, DOI 10.1002/bit.20020; Cakir T, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-18; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Chiao-Po H, 2009, AUTOPHAGY, V5, P1229, DOI [10.4161/auto.5.8.10275, DOI 10.4161/AUTO.5.8.10275]; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Chubukov V, 2012, P NATL ACAD SCI USA, V109, P5127, DOI 10.1073/pnas.1114235109; COMINGS DE, 1995, GENOMICS, V29, P390, DOI 10.1006/geno.1995.9990; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Crespillo J, 2003, MOL CELL BIOCHEM, V254, P359, DOI 10.1023/A:1027323521969; DECKER RH, 1961, J BIOL CHEM, V236, P3076; Dotsenko V. A., 2014, Biopolymers and Cell, V30, P149, DOI 10.7124/bc.00088E; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Figueiredo JC, 2010, CANCER CAUSE CONTROL, V21, P597, DOI 10.1007/s10552-009-9489-6; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; GILMAN A, 1995, BIOPHYS J, V69, P1321, DOI 10.1016/S0006-3495(95)79999-4; Gonzalez-Gay MA, 2010, CLIN EXP RHEUMATOL, V28, P56; Higuera C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041122; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; HUM DW, 1988, J BIOL CHEM, V263, P15946; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kadoglou NPE, 2010, METABOLISM, V59, P373, DOI 10.1016/j.metabol.2009.08.005; Kaleta C, 2009, GENOME RES, V19, P1872, DOI 10.1101/gr.090639.108; Kim WJ, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600701; Klitgord Niels, 2010, V22, P41; Koh RS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-47; Laura L, 2012, ONCOTARGET, V4, P48; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lim U, 2007, BLOOD, V109, P3050, DOI 10.1182/blood-2006-07-034330; Lim WA, 2013, MOL CELL, V49, P202, DOI 10.1016/j.molcel.2012.12.020; Link H, 2014, CURR OPIN BIOTECH, V29, P8, DOI 10.1016/j.copbio.2014.01.015; Liu F, 2014, TUMOR BIOL, V35, P8685, DOI 10.1007/s13277-014-2111-x; Liu H, 2007, J MOL BIOL, V373, P755, DOI 10.1016/j.jmb.2007.08.043; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Llaneras F, 2007, J THEOR BIOL, V246, P290, DOI 10.1016/j.jtbi.2006.12.029; Lonsdale D, 2007, EVID-BASED COMPL ALT, V4, P247, DOI 10.1093/ecam/nel089; Lubert S, 2007, BIOCHEMISTRY; LUZZATTO L, 1967, BIOCHIM BIOPHYS ACTA, V146, P18, DOI 10.1016/0005-2744(67)90069-1; Machado Daniel, 2015, Metab Eng Commun, V2, P85, DOI 10.1016/j.meteno.2015.04.001; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Marashi SA, 2012, J THEOR BIOL, V302, P62, DOI 10.1016/j.jtbi.2012.02.023; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Mitchell A, 2011, P NATL ACAD SCI USA, V108, P7271, DOI 10.1073/pnas.1019754108; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; MURAKAMI K, 1990, BLOOD, V75, P770; Murakami K, 1997, BLOOD, V89, P762, DOI 10.1182/blood.V89.3.762; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; Orman MA, 2012, METABOLITES, V2, P268, DOI 10.3390/metabo2010268; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010; Papin JA, 2002, GENOME RES, V12, P1889, DOI 10.1101/gr.327702; Paschou P, 2010, CYTOKINE, V51, P25, DOI 10.1016/j.cyto.2010.04.006; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Price ND, 2003, J THEOR BIOL, V225, P185, DOI 10.1016/S0022-5193(03)00237-6; Price ND, 2003, BIOPHYS J, V84, P794, DOI 10.1016/S0006-3495(03)74899-1; Price ND, 2002, BIOPHYS J, V83, P2879, DOI 10.1016/S0006-3495(02)75297-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ranganathan P, 2008, J RHEUMATOL, V35, P572; Rao NA, 2003, BBA-PROTEINS PROTEOM, V1647, P24, DOI 10.1016/S1570-9639(03)00043-8; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rippa M, 1998, BBA-PROTEIN STRUCT M, V1429, P83, DOI 10.1016/S0167-4838(98)00222-2; ROZEN R, 1989, AM J HUM GENET, V44, P781; Saddi-Rosa P, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-21; Sajitz-Hermstein M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003368; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schuster S, 2005, FEBS J, V272, P5278, DOI 10.1111/j.1742-4658.2005.04924.x; Schuster S, 2002, J MATH BIOL, V45, P153, DOI 10.1007/s002850200143; SCHUSTER STEFAN, 1994, J BIOL SYST, V2, P165, DOI [DOI 10.1142/S0218339094000131, 10.1142/S0218339094000131]; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Stanford NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079195; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; STOVER P, 1990, J BIOL CHEM, V265, P14227; TAKEUCHI T, 1986, BIOCHIM BIOPHYS ACTA, V872, P24, DOI 10.1016/0167-4838(86)90143-3; Unluturk U, 2010, CLIN ENDOCRINOL, V72, P469, DOI 10.1111/j.1365-2265.2009.03674.x; van der Straaten RJHM, 2007, PHARMACOGENOMICS, V8, P141, DOI 10.2217/14622416.8.2.141; Warren RB, 2009, BRIT J DERMATOL, V160, P438, DOI 10.1111/j.1365-2133.2008.08898.x; Watkins D, 2011, J MED GENET, V48, P590, DOI 10.1136/jmedgenet-2011-100286; Watson E, 2013, CELL, V153, P253, DOI 10.1016/j.cell.2013.02.050; Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46; Wiback SJ, 2003, J THEOR BIOL, V224, P313, DOI 10.1016/S0022-5193(03)00168-1; Wiback SJ, 2002, BIOPHYS J, V83, P808, DOI 10.1016/S0006-3495(02)75210-7; YOSHIDA A, 1973, BLOOD, V41, P877, DOI 10.1182/blood.V41.6.877.877; Zelezniak A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003572	97	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0210539	10.1371/journal.pone.0210539	http://dx.doi.org/10.1371/journal.pone.0210539			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721240	Green Published, Green Submitted, gold			2022-12-26	WOS:000457746300003
J	Subramaniam, S; Muller, VS; Hering, NA; Mollenkopf, H; Becker, D; Heroven, AK; Dersch, P; Pohlmann, A; Tedin, K; Porwollik, S; McClelland, M; Meyer, TF; Hunke, S				Subramaniam, Sivaraman; Mueller, Volker S.; Hering, Nina A.; Mollenkopf, Hans; Becker, Daniel; Heroven, Ann Kathrin; Dersch, Petra; Pohlmann, Anne; Tedin, Karsten; Porwollik, Steffen; McClelland, Michael; Meyer, Thomas F.; Hunke, Sabine			Contribution of the Cpx envelope stress system to metabolism and virulence regulation in Salmonella enterica serovar Typhimurium	PLOS ONE			English	Article							TWIN-ARGININE TRANSLOCASE; III SECRETION SYSTEM; ESCHERICHIA-COLI; ANTIMICROBIAL PEPTIDES; ELECTRON-ACCEPTOR; SURFACE PROTEASE; GENE-EXPRESSION; IN-VITRO; H-NS; RESISTANCE	The Cpx-envelope stress system regulates the expression of virulence factors in many Gram-negative pathogens. In Salmonella enterica serovar Typhimurium deletion of the sensor kinase CpxA but not of the response regulator CpxR results in the down regulation of the key regulator for invasion, HiIA encoded by the Salmonella pathogenicity island 1 (SPI-1). Here, we provide evidence that cpxA deletion interferes with dephosphorylation of CpxR resulting in increased levels of active CpxR and consequently in misregulation of target genes. 14 potential operons were identified to be under direct control of CpxR. These include the virulence determinants ecotin, the omptin PgtE, and the SPI-2 regulator SsrB. The Tat-system and the PocR regulator that together promote anaerobic respiration of tetrathionate on 1,2-propanediol are also under direct CpxR control. Notably, 1,2-propanediol represses hilA expression. Thus, our work demonstrates for the first time the involvement of the Cpx system in a complex network mediating metabolism and virulence function.	[Subramaniam, Sivaraman; Mueller, Volker S.; Hering, Nina A.; Hunke, Sabine] Humboldt Univ, Dept Microbial Physiol, Berlin, Germany; [Mollenkopf, Hans] Max Planck Inst Infect Biol, Genom Core Facil, Berlin, Germany; [Becker, Daniel; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Heroven, Ann Kathrin; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Infect Biol, Braunschweig, Germany; [Pohlmann, Anne] Humboldt Univ, Dept Microbiol, Berlin, Germany; [Tedin, Karsten] Free Univ Berlin, Inst Microbiol & Epizoot, Ctr Infect Med, Berlin, Germany; [Porwollik, Steffen; McClelland, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Subramaniam, Sivaraman] Tech Univ Dresden, Genom, Biotechnol Ctr, Dresden, Germany; [Hering, Nina A.] Charite, Campus Benjamin Franklin, Dept Gen Visceral & Vasc Surg, Berlin, Germany	Humboldt University of Berlin; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research; Humboldt University of Berlin; Free University of Berlin; University of California System; University of California Irvine; Technische Universitat Dresden; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Subramaniam, S; Hunke, S (corresponding author), Humboldt Univ, Dept Microbial Physiol, Berlin, Germany.; Subramaniam, S (corresponding author), Tech Univ Dresden, Genom, Biotechnol Ctr, Dresden, Germany.	sivaraman.subramaniam@tu-dresden.de; sabine.hunke@hu-berlin.de	Mollenkopf, Hans-Joachim/AAH-2500-2019; Meyer, Thomas F./J-2485-2013	Hering, Nina Alexandra/0000-0001-9751-6967; Meyer, Thomas F./0000-0002-6120-8679; Subramaniam, Sivaraman/0000-0002-5175-5388; McClelland, Michael/0000-0003-1788-9347	Deutsche Forschungsgemeinschaft [Hu1011/2-1, SFB944]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant HU1011/1-3 and DFG-GRK 1121/1 to SS. Funding to SH is gratefully acknowledged by the Deutsche Forschungsgemeinschaft (Hu1011/2-1 and SFB944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILION M, 1993, J BACTERIOL, V175, P7200, DOI 10.1128/JB.175.22.7200-7208.1993; BARRETT EL, 1987, MICROBIOL REV, V51, P192, DOI 10.1128/MMBR.51.2.192-205.1987; Batchelor E, 2005, J BACTERIOL, V187, P5723, DOI 10.1128/JB.187.16.5723-5731.2005; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolivar F, 1992, Biotechnology, V24, P153; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Carlsson KE, 2007, INFECT IMMUN, V75, P3913, DOI 10.1128/IAI.01346-06; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Corbett D, 2007, J BIOL CHEM, V282, P33326, DOI 10.1074/jbc.M703465200; Crouch ML, 2005, MOL MICROBIOL, V56, P789, DOI 10.1111/j.1365-2958.2005.04578.x; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Gerken H, 2010, MOL MICROBIOL, V75, P1033, DOI 10.1111/j.1365-2958.2009.07042.x; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Haiko J, 2010, J BACTERIOL, V192, P4553, DOI 10.1128/JB.00458-10; Haiko J, 2009, INNATE IMMUN-LONDON, V15, P67, DOI 10.1177/1753425909102559; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; HINOJOSALEON M, 1986, BIOCHEM BIOPH RES CO, V136, P577, DOI 10.1016/0006-291X(86)90479-1; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hornschemeyer P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149187; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hritonenko V, 2007, MOL MEMBR BIOL, V24, P395, DOI 10.1080/09687680701443822; Humphreys S, 2004, INFECT IMMUN, V72, P4654, DOI 10.1128/IAI.72.8.4654-4661.2004; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; Karavolos MH, 2011, EMBO REP, V12, P252, DOI 10.1038/embor.2011.4; Kato A, 2008, ADV EXP MED BIOL, V631, P7; Kostakioti M, 2009, MOL MICROBIOL, V73, P1020, DOI 10.1111/j.1365-2958.2009.06826.x; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kukkonen M, 2004, INT J MED MICROBIOL, V294, P7, DOI 10.1016/j.ijmm.2004.01.003; Labandeira-Rey M, 2009, INFECT IMMUN, V77, P3402, DOI 10.1128/IAI.00292-09; Leclerc GJ, 1998, INFECT IMMUN, V66, P682, DOI 10.1128/IAI.66.2.682-691.1998; Lewis C, 2009, MICROBIOL-SGM, V155, P873, DOI 10.1099/mic.0.023754-0; Matsuda K, 2011, VACCINE, V29, P668, DOI 10.1016/j.vaccine.2010.11.039; Mickael CS, 2010, INFECT IMMUN, V78, P3493, DOI 10.1128/IAI.00090-10; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Nakayama S, 2006, J BACTERIOL, V188, P3121, DOI 10.1128/JB.188.8.3121-3125.2006; Nakayama S, 2003, MICROBIOL-SGM, V149, P2809, DOI 10.1099/mic.0.26229-0; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Price-Carter M, 2001, J BACTERIOL, V183, P2463, DOI 10.1128/JB.183.8.2463-2475.2001; Prouty AM, 2002, J BACTERIOL, V184, P1270, DOI 10.1128/JB.184.5.1270-1276.2002; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Ramu P, 2007, FEBS LETT, V581, P1716, DOI 10.1016/j.febslet.2007.03.049; RICHARD C, 1978, ANN BIOL CLIN-PARIS, V36, P407; Ronnebaumer K, 2009, FEMS MICROBIOL LETT, V296, P274, DOI 10.1111/j.1574-6968.2009.01649.x; Roesler U, 2004, VACCINE, V23, P595, DOI 10.1016/j.vaccine.2004.07.013; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101; Rondon MR, 1996, J BACTERIOL, V178, P2196, DOI 10.1128/jb.178.8.2196-2203.1996; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Sambrook J., 1989, MOLECULAR CLONING A; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Slamti L, 2009, J BACTERIOL, V191, P5044, DOI 10.1128/JB.00406-09; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Sonck KAJ, 2009, PROTEOMICS, V9, P565, DOI 10.1002/pmic.200700476; Sosinsky A, 2003, NUCLEIC ACIDS RES, V31, P3589, DOI 10.1093/nar/gkg544; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Surmann K, 2016, MICROBIOLOGYOPEN, V5, P582, DOI 10.1002/mbo3.353; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; Tschauner K, 2014, DYNAMIC INTERACTION, V9, DOI [10.1371/journal.pone.0107383, DOI 10.1371/JOURNAL.PONE.0107383]; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; van Stelten J, 2009, SCIENCE, V325, P753, DOI 10.1126/science.1172221; Vogt SL, 2014, J BACTERIOL, V196, P4229, DOI 10.1128/JB.02138-14; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhou XH, 2011, J BIOL CHEM, V286, P9805, DOI 10.1074/jbc.M110.194092	113	11	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211584	10.1371/journal.pone.0211584	http://dx.doi.org/10.1371/journal.pone.0211584			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716090	gold, Green Published			2022-12-26	WOS:000457744200032
J	Tan, TW; Shih, CD; Concha-Moore, KC; Diri, MM; Hu, B; Marrero, D; Zhou, W; Armstrong, DG				Tan, Tze-Woei; Shih, Chia-Ding; Concha-Moore, Kirsten C.; Diri, Muhanad M.; Hu, Bo; Marrero, David; Zhou, Wei; Armstrong, David G.			Disparities in outcomes of patients admitted with diabetic foot infections	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; PERIPHERAL ARTERIAL-DISEASE; RACIAL DISPARITIES; RACE; VETERANS; REVASCULARIZATION; ISCHEMIA; ULCERS; RATES; PROGNOSIS	Objective The purpose of this study was to evaluate the disparities in the outcomes of White, African American (AA) and non-AA minority (Hispanics and Native Americans (NA)), patients admitted in the hospitals with diabetic foot infections (DFIs). Research design and methods The HCUP-Nationwide Inpatient Sample (2002 to 2015) was queried to identify patients who were admitted to the hospital for management of DFI using ICD-9 codes. Outcomes evaluated included minor and major amputations, open or endovascular revascularization, and hospital length of stay (LOS). Incidence for amputation and open or endovascular revascularization were evaluated over the study period. Multivariable regression analyses were performed to assess the association between race/ethnicity and outcomes. Results There were 150,701 admissions for DFI, including 98,361 Whites, 24,583 AAs, 24,472 Hispanics, and 1,654 Native Americans (NAs) in the study cohort. Overall, 45,278 (30%) underwent a minor amputation, 9,039 (6%) underwent a major amputation, 3,151 underwent an open bypass, and 8,689 had an endovascular procedure. There was a decreasing incidence in major amputations and an increasing incidence of minor amputations over the study period (P <.05). The risks for major amputation were significantly higher (all p<0.05) for AA (OR 1.4, 95%Cl 1.4,1.5), Hispanic (OR 1.3, 95%Cl 1.3,1.4), and NA (OR 1.5, 95%Cl 1.2,1.8) patients with DFIs compared to White patients. Hispanics (OR 1.3, 95%Cl 1.2,1.5) and AAs (OR 1.2, 95%Cl 1.1,1.4) were more likely to receive endovascular intervention or open bypass than Whites (all p<0.05). NA patients with DFI were less likely to receive a revascularization procedure (OR 0.6, 95%Cl 0.3, 0.9, p = 0.03) than Whites. The mean hospital length of stay (LOS) was significantly longer for AAs (9.2 days) and Hispanics (8.6 days) with DFIs compared to Whites (8.1 days, p<0.001). Conclusion Despite a consistent incidence reduction of amputation over the past decade, racial and ethnic minorities including African American, Hispanic, and Native American patients admitted to hospitals with DFIs have a consistently significantly higher risk of major amputation and longer hospital length of stay than their White counterparts. Native Americans were less likely to receive revascularization procedures compared to other minorities despite exhibiting an elevated risk of an amputation. Further study is required to address and limit racial and ethnic disparities and to further promote equity in the treatment and outcomes of these at-risk patients.	[Tan, Tze-Woei; Concha-Moore, Kirsten C.; Diri, Muhanad M.; Marrero, David; Zhou, Wei] Univ Arizona, Coll Med, Tucson, AZ 85721 USA; [Tan, Tze-Woei; Shih, Chia-Ding; Armstrong, David G.] SALSA, Los Angeles, CA 90012 USA; [Shih, Chia-Ding; Armstrong, David G.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Hu, Bo] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA	University of Arizona; University of Southern California; Cleveland Clinic Foundation	Tan, TW (corresponding author), Univ Arizona, Coll Med, Tucson, AZ 85721 USA.; Tan, TW (corresponding author), SALSA, Los Angeles, CA 90012 USA.	ttan@surgery.arizona.edu	Shih, Chia-Ding/CAF-5495-2022; Tan, Tze-Woei/W-3871-2017	Shih, Chia-Ding/0000-0001-9203-1899; Tan, Tze-Woei/0000-0002-6658-9482	NIDDK NIH HHS [P30 DK111022] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Arya S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007425; Blumberg SN, 2014, J DIABETES, V6, P68, DOI 10.1111/1753-0407.12050; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; Brennan MB, 2017, J DIABETES COMPLICAT, V31, P556, DOI 10.1016/j.jdiacomp.2016.11.020; Collins TC, 2002, MED CARE, V40, P106; Durazzo TS, 2013, JAMA SURG, V148, P617, DOI 10.1001/jamasurg.2013.1436; Durham CA, 2010, J VASC SURG, V52, P600, DOI 10.1016/j.jvs.2010.04.011; Eslami MH, 2007, J VASC SURG, V45, P55, DOI 10.1016/j.jvs.2006.09.044; Goodney PP, 2009, J VASC SURG, V50, P54, DOI 10.1016/j.jvs.2009.01.035; GUADAGNOLI E, 1995, ARCH SURG-CHICAGO, V130, P381; Henry AJ, 2011, J VASC SURG, V53, P330, DOI 10.1016/j.jvs.2010.08.077; Hinchliffe RJ, 2016, DIABETES-METAB RES, V32, P136, DOI 10.1002/dmrr.2705; Holman KH, 2011, J VASC SURG, V54, P420, DOI 10.1016/j.jvs.2011.02.035; Huber TS, 1999, J VASC SURG, V30, P417, DOI 10.1016/S0741-5214(99)70068-6; Lefebvre KM, 2015, VASC MED, V20, P51, DOI 10.1177/1358863X14565373; Lefebvre KM, 2011, CLIN ORTHOP RELAT R, V469, P1941, DOI 10.1007/s11999-011-1842-x; Lefebvre KM, 2009, J NATL MED ASSOC, V101, P649, DOI 10.1016/S0027-9684(15)30973-1; Li YF, 2012, DIABETES CARE, V35, P273, DOI 10.2337/dc11-1360; Margolis DJ, 2011, DATA POINTS PUBLICAT; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; MIROWSKY J, 1980, AM J SOCIOL, V86, P479, DOI 10.1086/227277; Mustapha JA, 2017, J RACIAL ETHN HLTH D; Ndosi M, 2018, DIABETIC MED, V35, P78, DOI 10.1111/dme.13537; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Robinson TE, 2016, DIABETIC MED, V33, P55, DOI 10.1111/dme.12807; Rowe VL, 2010, J VASC SURG, V51, p21S, DOI 10.1016/j.jvs.2009.09.066; Schofield CJ, 2009, DIABETIC MED, V26, P773, DOI 10.1111/j.1464-5491.2009.02770.x; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Skrepnek GH, 2014, J VASC SURG, V60, P1255, DOI 10.1016/j.jvs.2014.04.071; Sohn MW, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-27; Tseng CL, 2011, DIABETES CARE, V34, P1157, DOI 10.2337/dc10-1775; TUNIS SR, 1993, ARCH INTERN MED, V153, P991, DOI 10.1001/archinte.153.8.991; Uccioli L, 2010, DIABETES CARE, V33, P977, DOI 10.2337/dc09-0831	36	34	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211481	10.1371/journal.pone.0211481	http://dx.doi.org/10.1371/journal.pone.0211481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716108	Green Submitted, Green Published, gold			2022-12-26	WOS:000457744200026
J	Zhu, XQ; Luo, X; Feng, G; Huang, H; He, YK; Ma, W; Zhang, CQ; Zeng, M; Liu, H				Zhu, Xueqiang; Luo, Xing; Feng, Gang; Huang, Hui; He, Yangke; Ma, Wen; Zhang, Changqing; Zeng, Ming; Liu, Hao			CENPE expression is associated with its DNA methylation status in esophageal adenocarcinoma and independently predicts unfavorable overall survival	PLOS ONE			English	Article							CANCER; PROTEIN; MOTOR	Centrosome-associated protein E (CENPE) is a plus end-directed kinetochore motor protein, which plays a critical role in mitosis. In this in silico study, using data from the Cancer Genome Atlas-Esophageal Carcinoma (TCGA-ESCA), we analyzed the expression profile of CENPE mRNA in esophageal squamous cell carcinoma (ESCC) and adenocarcinoma (EA), its independent prognostic value and the potential mechanisms of its dysregulation in EA. Results showed that both ESCC and EA tissues had significantly elevated CENPE expression compared with their respective adjacent normal tissues. However, Kaplan-Meier survival curves showed that high CENPE was associated with unfavorable OS in EA. Univariate and multivariate analysis confirmed that CENPE expression was an independent indicator of unfavorable OS in EA patients, as a continuous variable (HR: 1.861, 95%CI: 1.235-2.806, p = 0.003) or as categorical variables (HR: 2.550, 95%CI: 1.294-5.025, p = 0.007). However, CENPE expression had no prognostic value in ESCC. Compared with the methylation status in normal samples, 3 CpG sites were hypomethylated (cg27388036, cg27443373, and cg24651824) in EA, among which two sites (cg27443373 and cg24651824) showed moderately negative correlation with CENPE expression. In addition, we also found that although heterozygous loss (-1) was frequent in EA (50/88, 56.8%), it was not necessarily associated with decreased CENPE expression compared with the copy neutral (0) cases. The methylation of the -1 group was significantly lower than that of the +1/0 group (p = 0.04). Based on these findings, we infer that CENPE upregulation in EA might serve as a valuable indicator of unfavorable OS. The methylation status of cg27443373 and cg24651824 might play a critical role in modulating CENPE expression.	[Zhu, Xueqiang; Luo, Xing; Huang, Hui; He, Yangke; Zeng, Ming; Liu, Hao] Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Canc Ctr, Chengdu, Sichuan, Peoples R China; [Zhu, Xueqiang; Luo, Xing; Feng, Gang; Huang, Hui; He, Yangke; Zeng, Ming; Liu, Hao] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China; [Feng, Gang] Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Div Thorac Surg, Dept Surg, Chengdu, Sichuan, Peoples R China; [Ma, Wen; Zhang, Changqing] Gansu Prov Peoples Hosp, Dept Tumor Ctr, Lanzhou, Gansu, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China	Liu, H (corresponding author), Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Canc Ctr, Chengdu, Sichuan, Peoples R China.; Liu, H (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China.	604083933@qq.com			Department of Science and Technology of Sichuan Province [30504010336]; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital [30305031017P]	Department of Science and Technology of Sichuan Province; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital	This work was supported by Department of Science and Technology of Sichuan Province, 30504010336, Ming Zeng; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, 30305031017P, Ming Zeng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Greenawalt DM, 2007, INT J CANCER, V120, P1914, DOI 10.1002/ijc.22501; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; Guo YG, 2012, J CELL BIOL, V198, P205, DOI 10.1083/jcb.201202152; Henderson MC, 2009, MOL CANCER THER, V8, P36, DOI 10.1158/1535-7163.MCT-08-0789; Hou S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.313; Islam F, 2018, METHODS MOL BIOL, V1756, P247, DOI 10.1007/978-1-4939-7734-5_21; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; Kailasam A, 2015, CTS-CLIN TRANSL SCI, V8, P394, DOI 10.1111/cts.12242; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Kung PP, 2014, MOL CANCER THER, V13, P2104, DOI 10.1158/1535-7163.MCT-14-0083-T; Liang Y, 2017, CANCER RES, V77, P5479, DOI 10.1158/0008-5472.CAN-17-0496; Mei LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185636; Olziersky AM, 2017, ADV EXP MED BIOL, V1002, P125, DOI 10.1007/978-3-319-57127-0_6; Rustgi A, 2015, NEW ENGL J MED, V372, P1472, DOI 10.1056/NEJMc1500692; Shiozaki A, 2014, WORLD J GASTROENTERO, V20, P6844, DOI 10.3748/wjg.v20.i22.6844; Su P, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/2968106; Tame MA, 2016, EMBO REP, V17, P317, DOI 10.15252/embr.201541143; Uemura N, 2015, BBA-PROTEINS PROTEOM, V1854, P687, DOI 10.1016/j.bbapap.2014.09.011; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vitre B, 2014, MOL BIOL CELL, V25, P2272, DOI 10.1091/mbc.E14-01-0698; Wood KW, 2008, CLIN CANCER RES, V14, P7588, DOI 10.1158/1078-0432.CCR-07-4443; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5	23	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0207341	10.1371/journal.pone.0207341	http://dx.doi.org/10.1371/journal.pone.0207341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716092	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200002
J	Naha, D; Sathyakumar, S; Dash, S; Chettri, A; Rawat, GS				Naha, Dipanjan; Sathyakumar, S.; Dash, Suraj; Chettri, Abhishek; Rawat, G. S.			Assessment and prediction of spatial patterns of human-elephant conflicts in changing land cover scenarios of a human-dominated landscape in North Bengal	PLOS ONE			English	Article								It is of utmost importance to research on the spatial patterns of human-wildlife conflicts to understand the underlying mechanism of such interactions, i.e. major land use changes and prominent ecological drivers. In the north eastern part of India there has been a disparity between nature, economic development and fragmentation of wildlife habitats leading to intense conflicts between humans and Asian elephants (Elephas maximus) in recent times. Both the elephant and human population have increased in the past few decades with large tracts of forests converted to commercial tea plantations, army camps and human settlements. We analyzed data maintained by the wildlife department on human deaths and injuries caused by elephant attacks between 2006-2016 to understand spatial and temporal patterns of human-elephant conflict, frequency and distribution. The average annual number of human deaths and injuries to elephant attacks between 2006 to 2016 was estimated to be 212 (SE 103) with the highest number of such incidents recorded in 2010-2011. Based on a grid based design of 5 km(2) and 25 km(2) resolution, the main spatial predictors of human-elephant conflicts identified through Maxent presence only models are annual mean precipitation, altitude, distance from protected area, area under forests, tea plantations and agriculture. Major land use changes were assessed for this region from 2008 to 2018 using satellite imageries in Arc GIS and a predicted imagery of 2028 was prepared using Idrisi Selva. Based on the 2018 imagery it was found that forest area had increased by 446 km(2) within 10 years (2008-2018) and the annual rate of change was 12%. Area under agriculture had reduced by 128 km(2) with an annual (-) rate of change of 2.5%. Area under tea plantation declined by 307 km(2) with an annual (-) rate of change of 12% whereas area under human settlements increased by 61 km(2) with an annual (-) rate of change of 44%. Hotspots of human-elephant conflicts were identified in an east west direction primarily around protected areas, tea plantations and along major riverine corridors. During informal interactions with farmers, tea estate labors it was revealed that local community members chased and harassed elephants from agriculture fields, human settlements under the influence of alcohol and thus were primary victims of fatal interactions. Our analytical approach can be replicated for other species in sites with similar issues of human-wildlife conflicts. The hot-spot maps of conflict risk will help in developing appropriate mitigation strategies such as setting up early warning systems, restoration of wildlife corridors especially along dry river beds, using deterrents and barriers for vulnerable. Awareness about alcohol related incidents and basic biology of elephants should be organized regularly involving non-governmental organizations targeting the marginalized farmers and tea estate workers.	[Naha, Dipanjan; Sathyakumar, S.; Dash, Suraj; Chettri, Abhishek] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Rawat, G. S.] Wildlife Inst India, Fac Wildlife Sci, Dehra Dun, Uttarakhand, India	Wildlife Institute of India; Wildlife Institute of India	Sathyakumar, S (corresponding author), Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India.	ssk@wii.gov.in	Fazli, Ghazal/AAE-8320-2022	SATHYAKUMAR, SAMBANDAM/0000-0003-2027-4706	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission for Himalayan Studies (NMHS) [NMHS/LG/2016/009]	Ministry of Environment, Forest and Climate Change, Government of India under the National Mission for Himalayan Studies (NMHS)	This study was funded by the Ministry of Environment, Forest and Climate Change, Government of India under the National Mission for Himalayan Studies (NMHS). The grant number is NMHS/LG/2016/009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua P, 1995, WEEK ELEPHANTS BOMBA; Bhattacharjee A, 2013, HUMAN DIMENSIONS WIL, DOI [10.1371/journal.pone.0177013, DOI 10.1371/JOURNAL.PONE.0177013]; Bist SS, 2002, INDIAN FOR, P128; Chatterjee Piya, 2001, TIME TEA WOMEN LABOR; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162035; Choudhury A, 1999, MAMMAL REV, P29; Chowdhury S, 1998, MANAGEMENT ELEPHANT; Daniel J.C., 2008, EVALUATING POPULATIO; Desai A.A., 2015, HUMAN ELEPHANT CONFL; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Eastman, 2012, IDRISI SELVA TUTORIA, P45; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fernando P., 2008, REV HUMAN ELEP UNPUB; Fick S. E., 2017, INT J CLIMATOLOGY; Foley LS, 2002, THESIS; Gaba KM, 2016, ONLINE DATA RESOURCE; Glimpses of Initiatives taken for Elephant Conservation in India, 2013, GLIMPS IN TAK EL CON; Guha Ramachandra, 2007, INDIA GANDHI HIST WO; Hoare R.E., 2001, DECISION SUPPORT SYS; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Kushwaha SPS, 2004, CURRENT SCI, P87; Lahiri-Choudhury D.K, 1991, ILLUSTRATED ENCY ELE, P166; Lambin EF, 2001, CAUSES LAND USE LAND, DOI [10.1016/S0959-3780(01)00007-3, DOI 10.1016/S0959-3780(01)00007-3]; Lenin J., 2011, ACTION PLAN MITIGATI; Memarian H., 2012, VALIDATION CA MARKOV, DOI [10.4236/jgis.2012.46059, DOI 10.4236/JGIS.2012.46059]; Ministry of Environment, 2017, EL MEN REP; Ministry of Environment Forest and Climate Change, 2017, ALL IND SYNCHR EL PO; Naha D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204528; Nath C.D., 1998, ELEPHANT HUMAN CONFL; Naughton L., 1999, SOCIAL DIMENSIONS HU; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Nelson A., 2003, REV HUMAN ELEPHANT C; Nyhus PJ, 2000, CROP RAIDING ELEPHAN; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Rodriguez E, 2006, PHOTOGRAMMETRIC ENG; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Stewart-Cox B, 2007, MITIGATING HUMAN ELE; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sukumar R., 2003, STUDY ELEPHANTS BUXA; Sukumar R, 2010, CURRENT CONSERVATION, V4, P6; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Tea Board of India, 2017, ANN REPORT; Williams AC, 2001, WILDLIFE SOC B; Yang X, 2014, LAND USE CHANGE MODE, DOI [10.1080/19475705.2014.1001797, DOI 10.1080/19475705.2014.1001797]; Zar JH., 2010, BIOSTAT ANAL, V5th	45	24	25	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0210580	10.1371/journal.pone.0210580	http://dx.doi.org/10.1371/journal.pone.0210580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707690	gold, Green Submitted, Green Published			2022-12-26	WOS:000457742900009
J	Kerie, S; Menberu, M; Geneto, M				Kerie, Sitotaw; Menberu, Melak; Geneto, Mathewos			Metabolic syndrome among residents of Mizan-Aman town, South West Ethiopia, 2017: A cross sectional study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PREVALENCE; POPULATION; ADULTS	Introduction Globally, it is estimated that around 20-25% adult population has metabolic syndrome. Individuals who have metabolic syndrome are up to five times more susceptible for chronic diseases than those who have no metabolic syndrome. In Ethiopia there is no sufficient information regarding the magnitude and factors of metabolic syndrome. The aim of this study is to assess prevalence and associated factors of metabolic syndrome among residents of Mizan-Aman town, South West, Ethiopia. Methods The community based cross-sectional study was held at Mizan-Aman town residents. Systematic random sampling was employed to select each household and lottery method was used to select one individual from the household. Data were cleaned, coded and entered by EPI-INFO version 3.5.4 and were transported to SPSS version 20 for further analysis. To indicate the strength of association, odds ratios (OR) and 95% confidence intervals (95% CI) were used. Results In this study from a total of 558 respondents 534 were completed the interview correctly, which gives a response rate of 95.7%. The overall prevalence of metabolic syndrome was 9.6%. Multivariate logistic regression revealed that physical inactivity [AOR = 2.61, 95% CI (1.22, 5.58)], age from 18 to 28 years [AOR = 0.36, 95% CI (0.14, 0.90)], being male [AOR = 0.46, 95% CI (0.22, 0.96)] and educational status with cannot write and read [AOR = 0.15, 95% CI (0.04,0.53)], from grade 1 to 8 [AOR = 0. 17, (0.11,0.55)], from grade 9 to 12 [AOR = 0.11, (0.03, 0.38)] and from diploma to degree [AOR = 0. 13, (0.01, 0.36)] were significantly associated with metabolic syndrome. Conclusion The prevalence of metabolic syndrome in this study was found to be high. Age, physical activity, educational status and sex were significantly associated with metabolic syndrome. Physical activity was found to be the means of metabolic syndrome prevention.	[Kerie, Sitotaw] Bahir Dar Univ, Dept Nursing, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Menberu, Melak] Bahir Dar Univ, Dept Psychiat, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Geneto, Mathewos] Wachemo Univ, Dept Med, Coll Med & Hlth Sci, Hossana, Ethiopia	Bahir Dar University; Bahir Dar University	Kerie, S (corresponding author), Bahir Dar Univ, Dept Nursing, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	sitkere5@gmail.com			Mizan-Tepiuniversity	Mizan-Tepiuniversity	This research was funded by Mizan-Tepiuniversity. MTU@edu.et.	Arai H, 2006, J ATHEROSCLER THROMB, V13, P202, DOI 10.5551/jat.13.202; Azizi F, 2003, DIABETES RES CLIN PR, V61, P29, DOI 10.1016/S0168-8227(03)00066-4; Chen YC, 2010, J CLIN NURS, V19, P3031, DOI 10.1111/j.1365-2702.2010.03280.x; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duncan Glen E, 2006, Curr Diab Rep, V6, P29, DOI 10.1007/s11892-006-0048-1; Fezeu L, 2007, ATHEROSCLEROSIS, V193, P70, DOI 10.1016/j.atherosclerosis.2006.08.037; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Gyakobo M, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-25; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Kaler SN, 2006, INT J CIRCUMPOL HEAL, V65, P389, DOI 10.3402/ijch.v65i5.18139; Katzmarzyk PT, 2007, CURR CARDIOVASC RISK, V1, P228, DOI 10.1007/s12170-007-0037-1; Kawamoto R, 2007, GERIATR GERONTOL INT, V7, P221, DOI 10.1111/j.1447-0594.2007.00409.x; Kelliny C, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-27; Martin-Cordero L, 2009, EUR J APPL PHYSIOL, V107, P535, DOI 10.1007/s00421-009-1140-4; Mohan, 2006, DIABETES VOICE, V51; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Sanisoglu SY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-92; Scholze J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-529; Sharmin S, 2011, J PHYS CONF SER, V302, DOI 10.1088/1742-6596/302/1/012011; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71; Whelan Deborah M, 2006, Anesthesiol Clin, V24, P599, DOI 10.1016/j.atc.2006.05.008; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210969	10.1371/journal.pone.0210969	http://dx.doi.org/10.1371/journal.pone.0210969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703130	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600026
J	Hsin, KT; Lu, JY; Moller, M; Wang, CN				Hsin, Kuan-Ting; Lu, Jing-Yi; Moller, Michael; Wang, Chun-Neng			Gene duplication and relaxation from selective constraints of GCYC genes correlated with various floral symmetry patterns in Asiatic Gesneriaceae tribe Trichosporeae	PLOS ONE			English	Article							LIKELIHOOD-RATIO TEST; CYC-LIKE GENES; FUNCTIONAL DIVERGENCE; PHYLOGENETIC ANALYSIS; EXPRESSION PATTERNS; CYCLOIDEA EXPRESSION; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; FLOWER SYMMETRY; EVOLUTION	Floral bilateral symmetry is one of the most important acquisitions in flower shape evolution in angiosperms. Members of Gesneriaceae possess predominantly zygomorphic flowers yet natural reversal to actinomorphy have independently evolved multiple times. The development of floral bilateral symmetry relies greatly on the gene CYCLOIDEA (CYC). Our reconstructed GCYC phylogeny indicated at least five GCYC duplication events occurred over the evolutionary history of Gesneriaceae. However, the patterns of GCYC expression following the duplications and the role of natural selection on GCYC copies in relation to floral symmetry remained largely unstudied. The Asiatic tribe Trichosporeae contains most reversals to actinomorphy. We thus investigated shifts in GCYC gene expression among selected zygomorphic species (Hemiboea bicornuta and Lysionotus pauciflorus) and species with reversals to actinomorphy (Conandron ramondioides) by RT-PCR. In the actinomorphic C. ramondioides, none of the three copies of GCYC was found expressed in petals implying that the reversal was a loss-of-function event. On the other hand, both zygomorphic species retained one GCYC1 copy that was expressed in the dorsal petals but each species utilized a different copy (GCYC1C for H. bicornuta and GCYC1D for L. pauciflorus). Together with previously published data, it appeared that GCYC1C and GCYC1D copies diversified their expression in a distinct species-specific pattern. To detect whether the selection signal (.) changed before and after the duplication of GCYC1 in Asiatic Trichosporeae, we reconstructed a GCYC phylogeny using maximum likelihood and Bayesian inference algorithms and examined selection signals using PAML. The PAML analysis detected relaxation from selection right after the GCYC1 duplication (omega(pre-duplication) = 0.2819, omega(post-duplication) = 0.3985) among Asiatic Trichosporeae species. We propose that the selection relaxation after the GCYC1 duplication created an "evolutionary window of flexibility" in which multiple copies were retained with randomly diverged roles for dorsal-specific expressions in association with floral symmetry changes.	[Hsin, Kuan-Ting; Wang, Chun-Neng] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan; [Lu, Jing-Yi; Wang, Chun-Neng] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Moller, Michael] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland	National Taiwan University; National Taiwan University	Wang, CN (corresponding author), Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan.; Wang, CN (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan.	leafy@ntu.edu.tw	; WANG, CHUN-NENG/H-7735-2012	Lu, Jing-Yi/0000-0002-6387-1597; WANG, CHUN-NENG/0000-0003-2583-6544; Hsin, Kuan-Ting/0000-0002-8359-673X	Ministry of Science and Technology (Taiwan) [103-2313-B-002-004-MY3, 106-2621-B-002-002-MY2, 106-2313-B-002 -035 -MY3]; Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, TaiwanMinistry of Science, ICT & Future Planning, Republic of Korea); Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government	Ministry of Science and Technology (Taiwan) to CNW [Grant number: 103-2313-B-002-004-MY3, 106-2621-B-002-002-MY2, and 106-2313-B-002 -035 -MY3] and The Royal Botanic Garden Edinburgh is supported by the Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the Ministry of Science and Technology of Taiwan to CNW [Grant number: 106-2621-B-002-002-MY2 and 106-2313-B-002-035-MY3]. The Royal Botanic Garden Edinburgh is supported by the Rural and Environment Science and Analytical Services division (RESAS) in the Scottish Government to MMO. We thank Dr. Hao-Chih Kuo for providing comments on PAML analyses, and Dr. Zhao-Jun Pan for providing suggestions on RNA extraction and writing comments. Thanks to Mr. Hong-Wen Ma for assisting the field collection, and Mr. Yen-Wei Chou for his help for collecting plant materials and isolating GCYC genes. Collection Permission was granted by Yangmingshan National Park [Permission number: 20151155] for collecting plant species (H. bicornuta and L. pauciflorus). This manuscript was edited by Wallace Academic Editing and word usage suggestions by Kenneth Huang. We thank especially the anonymous reviewers and the editor for their careful reading and many insightful comments and suggestions.	Alhindi T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44948; Almeida J, 1997, DEVELOPMENT, V124, P1387; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bartlett ME, 2011, AM J BOT, V98, P227, DOI 10.3732/ajb.1000246; Bello MA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00589; Bielawski JP, 2003, J MOL EVOL, V59, P121; BURTT B L, 1970, Notes from the Royal Botanic Garden Edinburgh, V30, P1; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Citerne H, 2010, ADV BOT RES, V54, P85, DOI 10.1016/S0065-2296(10)54003-5; Citerne HL, 2000, ANN BOT-LONDON, V86, P167, DOI 10.1006/anbo.2000.1178; Corley SB, 2005, P NATL ACAD SCI USA, V102, P5068, DOI 10.1073/pnas.0501340102; Cronk Q, 1997, TRENDS ECOL EVOL, V12, P85, DOI 10.1016/S0169-5347(97)01028-8; Danisman S, 2013, J EXP BOT, V64, P5673, DOI 10.1093/jxb/ert337; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin Ch., 1868, P411; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du ZY, 2008, J SYST EVOL, V46, P23, DOI 10.3724/SP.J.1002.2008.07059; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endress PK, 1999, INT J PLANT SCI, V160, pS3, DOI 10.1086/314211; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; Force A, 1999, GENETICS, V151, P1531; Gao Q, 2008, DEV GENES EVOL, V218, P341, DOI 10.1007/s00427-008-0227-y; Gu X, 2001, J COMPUT BIOL, V8, P221, DOI 10.1089/10665270152530827; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hileman LC, 2003, MOL BIOL EVOL, V20, P591, DOI 10.1093/molbev/msg063; Hileman LC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0348; Howarth DG, 2006, P NATL ACAD SCI USA, V103, P9101, DOI 10.1073/pnas.0602827103; Howarth DG, 2011, ANN BOT-LONDON, V107, P1521, DOI 10.1093/aob/mcr049; Hsin KT, 2018, BOT STUD, V59, DOI 10.1186/s40529-018-0242-x; Hsu HJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01008; Jabbour F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095727; Liu BL, 2014, J SYST EVOL, V52, P112, DOI 10.1111/jse.12067; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Moller M, 2011, PHYTOTAXA, V23, P1; Moller M, 2011, PLANT SYST EVOL, V292, P223, DOI 10.1007/s00606-010-0413-z; Moller M, 2009, AM J BOT, V96, P989, DOI 10.3732/ajb.0800291; Moller M, 1999, SYST ASSOC SPEC VOL, V57, P375; MOller M, 2003, EDINBURGH J BOT, V60, P425, DOI DOI 10.1017/S0960428603000337; Nielsen R, 1998, GENETICS, V148, P929; Nishii K, 2015, TAXON, V64, P1243, DOI 10.12705/646.8; Ohno S., 1970, P1; OHTA T, 1988, GENETICS, V120, P841; OHTA T, 1988, P NATL ACAD SCI USA, V85, P3509, DOI 10.1073/pnas.85.10.3509; Pang HB, 2010, J SYST EVOL, V48, P309, DOI 10.1111/j.1759-6831.2010.00091.x; Parapunova V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-157; Preston JC, 2011, P NATL ACAD SCI USA, V108, P2343, DOI 10.1073/pnas.1011361108; Preston JC, 2009, TRENDS PLANT SCI, V14, P147, DOI 10.1016/j.tplants.2008.12.005; Ree RH, 2004, MOL BIOL EVOL, V21, P321, DOI 10.1093/molbev/msh022; Ree RH, 1999, SYST BIOL, V48, P633, DOI 10.1080/106351599260201; Reyes E, 2016, TAXON, V65, P945, DOI 10.12705/655.1; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith JF, 2006, PLANT SYST EVOL, V261, P245, DOI 10.1007/s00606-006-0445-6; Smith JF, 2004, MOL PHYLOGENET EVOL, V31, P765, DOI 10.1016/j.ympev.2003.09.012; Song CF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-244; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100; Wang CN, 2004, SYST BOT, V29, P407, DOI 10.1600/036364404774195593; WANG W, 1992, Edinburgh Journal of Botany, V49, P5; Wang YZ, 2011, J SYST EVOL, V49, P50, DOI 10.1111/j.1759-6831.2010.00113.x; Wang YZ, 2010, TAXON, V59, P1044, DOI 10.1002/tax.594005; Weadick CJ, 2012, MOL BIOL EVOL, V29, P1297, DOI 10.1093/molbev/msr311; Weber A, 2004, FA GE VAS P, V7, P63; Weber Anton, 2013, Selbyana, V31, P68; Weber A, 2011, PHYTOTAXA, V23, P49, DOI 10.11646/phytotaxa.23.1.3; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zahn LM, 2005, GENETICS, V169, P2209, DOI 10.1534/genetics.104.037770; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang WH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00302; Zhang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036033; Zhong JS, 2015, NEW PHYTOL, V205, P852, DOI 10.1111/nph.13104; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	77	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210054	10.1371/journal.pone.0210054	http://dx.doi.org/10.1371/journal.pone.0210054			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699126	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600018
J	Liu, S; Liu, XQ; Xiao, YX; Chen, SY; Zhuang, WD				Liu, Shuo; Liu, Xiaoqiang; Xiao, Yingxiu; Chen, Shuying; Zhuang, Weiduan			Prognostic factors associated with survival in patients with anaplastic oligodendroglioma	PLOS ONE			English	Article							MARITAL-STATUS; BRAIN; CLASSIFICATION; IMPACT; TUMORS; IDH1	Anaplastic oligodendroglioma is a rare disease with an inadequately understood prognosis. The aim of this study was to investigate factors associated with survival outcome in anaplastic oligodendroglioma patients. A population-based cohort study was conducted based on the Surveillance, Epidemiology, and End Results program. In total, 1899 patients with a histological diagnosis of anaplastic oligodendroglioma from 1973 to 2015 were included. Mean age at diagnosis was 49.2 years, and 56.19% were male. In our study, 62.40% of patients were married, and 87.05% were white. Most patients (90.42%) were diagnosed with anaplastic oligodendroglioma as their first malignant primary tumor, but 9.58% had a diagnosis of at least one other primary malignancy; 87.89% of patients had received cancer-directed surgery. Patients receiving surgery had a better prognosis for overall survival compared to those not receiving surgery after propensity score matching analysis (p<0.05). The overall 1-, 3-, 5-, and 10-year survival of anaplastic oligodendroglioma was 78.7%, 60%, 50.2%, and 36.2%, respectively. Kaplan-Meier analysis indicated that age, marital status, presence of multiple primary malignancies, and surgical treatment were associated with overall survival, whereas sex and race were not. Moreover, age at diagnosis of 52 years was calculated as an optimal cutoff value to distinguish better and worse overall survival. Multivariate Cox proportional hazard analysis indicated that older age (OR 1.040, 95% CI1.035-1.045), single patients (OR 1.293, 95% CI 1.103-1.515), and presence of multiple primary malignancies (OR 1.501, 95% CI 1.238-1.820) were significantly associated with worse overall survival, whereas surgery (OR 0.584, 95% CI 0.494-0.689) was associated with better overall survival. A nomogram predicting 5-, and 10-year survival probability for anaplastic oligodendroglioma was constructed based on these variables. In conclusion, age, marital status, presence of multiple primary malignancies, and surgical treatment were associated with survival of anaplastic oligodendroglioma.	[Liu, Shuo; Liu, Xiaoqiang; Xiao, Yingxiu; Chen, Shuying; Zhuang, Weiduan] Shantou Univ, Med Coll, Affiliated Hosp 1, Neurol Dept, Shantou, Guangdong, Peoples R China	Shantou University	Zhuang, WD (corresponding author), Shantou Univ, Med Coll, Affiliated Hosp 1, Neurol Dept, Shantou, Guangdong, Peoples R China.	zhuangweiduan@126.com						Abern MR, 2012, UROL ONCOL-SEMIN ORI, V30, P487, DOI 10.1016/j.urolonc.2010.03.005; Allam A, 2000, AM J CLIN ONCOL-CANC, V23, P170, DOI 10.1097/00000421-200004000-00013; Balachandran VP, 2015, LANCET ONCOL, V16, pE173, DOI 10.1016/S1470-2045(14)71116-7; Barnholtz-Sloan JS, 2018, NEUROL CLIN, V36, P395, DOI 10.1016/j.ncl.2018.04.001; Bochner BH, 2006, J CLIN ONCOL, V24, P3967, DOI 10.1200/JCO.2005.05.3884; Boots-Sprenger SHE, 2013, MODERN PATHOL, V26, P922, DOI 10.1038/modpathol.2012.166; Cronin KA, 2014, CANCER-AM CANCER SOC, V120, P3755, DOI 10.1002/cncr.29049; Dubbink HJ, 2016, NEURO-ONCOLOGY, V18, P388, DOI 10.1093/neuonc/nov182; Engelhard HH, 2003, SURG NEUROL, V60, P443, DOI 10.1016/S0090-3019(03)00167-8; Feigenberg Steven J, 2003, Am J Clin Oncol, V26, pe60, DOI 10.1097/00000421-200306000-00031; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; Kang SG, 2005, NEUROL MED-CHIR, V45, P232, DOI 10.2176/nmc.45.232; Khan KA, 2014, JCPSP-J COLL PHYSICI, V24, P935, DOI 12.2014/JCPSP.935939; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MORK SJ, 1985, J NEUROSURG, V63, P881, DOI 10.3171/jns.1985.63.6.0881; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Schiffer D, 1997, CAN J NEUROL SCI, V24, P313, DOI 10.1017/S0317167100032984; SHIMIZU KT, 1993, RADIOLOGY, V186, P569, DOI 10.1148/radiology.186.2.8421767; Shin JY, 2016, J NEURO-ONCOL, V129, P567, DOI 10.1007/s11060-016-2212-z; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211513	10.1371/journal.pone.0211513	http://dx.doi.org/10.1371/journal.pone.0211513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699183	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600083
J	Fernandes, MS; Barbisan, F; Azzolin, VF; do Prado-Lima, PAS; Teixeira, CF; Jung, IED; Assmann, CE; Riffel, RT; Duarte, MMMF; Aguiar-Ribeiro, EM; da Cruz, IBM				Fernandes, Marcelo Soares; Barbisan, Fernanda; Azzolin, Veronica Farina; Schmidt do Prado-Lima, Pedro Antonio; Teixeira, Cibele Ferreira; da Cruz Jung, Ivo Emilio; Assmann, Charles Elias; Riffel, Rogerio Tomasi; Medeiros Frescura Duarte, Marta Maria; Aguiar-Ribeiro, Ednea Maia; Manica da Cruz, Ivana Beatrice			Lithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NAUSEA; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; METABOLIC SYNDROME; CANCER-CELLS; WEIGHT-GAIN; EXPRESSION; RISK; DRUG	Background Olanzapine (OLZ) is a second-generation antipsychotic drug used for treatment of schizophrenia, bipolar disorder, and other neuropsychiatric conditions. Undesirable side effects of OLZ include metabolic alterations associated with chronic oxidative-inflammation events. It is possible that lithium (Li), a mood modulator that exhibits anti-inflammatory properties may attenuate OLZ-induced oxi-inflammatory effects. Methodology To test this hypothesis we activated RAW 264.7 immortalized macrophages with OLZ and evaluated oxidation and inflammation at the gene and protein levels. Li and OLZ concentrations were determined using estimated plasma therapeutic concentrations. Results OLZ triggered a significant increase in macrophage proliferation at 72 h. Higher levels of oxidative markers and proinflammatory cytokines, such as TNF-alpha, IL-1 beta, and IL-6, with a concomitant reduction in IL-10, were observed in OLZ-exposed macrophages. Lithium (Li) exposure triggered a short and attenuated inflammatory response demonstrated by elevation of superoxide anion (SA), reactive oxygen species (ROS), IL-1 beta, and cellular proliferation followed by elevation of anti-inflammatory IL-10 levels. Li treatment of OLZ-supplemented macrophages was able to reverse elevation of oxidative and inflammatory markers and increase IL-10 levels. Conclusions Despite methodological limitations related to in vitro protocols, results suggested that Li may attenuate OLZ-induced oxidative and inflammatory responses that result from metabolic side effects associated with OLZ.	[Fernandes, Marcelo Soares; Teixeira, Cibele Ferreira; da Cruz Jung, Ivo Emilio; Medeiros Frescura Duarte, Marta Maria; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Pharmacol Grad Program, Santa Maria, RS, Brazil; [Fernandes, Marcelo Soares; Riffel, Rogerio Tomasi] Fed Univ Southern Frontier, Passo Fundo, RS, Brazil; [Barbisan, Fernanda; Azzolin, Veronica Farina; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Gerontol Grad Program, Santa Maria, RS, Brazil; [Schmidt do Prado-Lima, Pedro Antonio] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst, Porto Alegre, RS, Brazil; [Assmann, Charles Elias] Univ Fed Santa Maria, Biochem Toxicol Grad Program, Santa Maria, RS, Brazil; [Riffel, Rogerio Tomasi] Hosp Clin Passo Fundo, Passo Fundo, RS, Brazil; [Medeiros Frescura Duarte, Marta Maria] Univ Luterana Brasil, Santa Maria, RS, Brazil; [Aguiar-Ribeiro, Ednea Maia] State Univ Amazonas, Open Univ Third Age, Manaus, AM, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal da Fronteira Sul; Universidade Federal de Santa Maria (UFSM); Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Luterana do Brasil	da Cruz, IBM (corresponding author), Univ Fed Santa Maria, Pharmacol Grad Program, Santa Maria, RS, Brazil.; da Cruz, IBM (corresponding author), Univ Fed Santa Maria, Gerontol Grad Program, Santa Maria, RS, Brazil.	ivana.ufsm@gmail.com	Assmann, Charles/AAM-8039-2021; Barbisan, Fernanda/L-7854-2018; da Cruz, Ivana BM/G-4329-2012; Barbisan, Fernanda/AAS-5551-2020	da Cruz, Ivana BM/0000-0003-3008-6899; Barbisan, Fernanda/0000-0002-2960-7047	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Amazonas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Amparo a Pesquisa do Estado do Amazonas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)" and "Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)" for Brazilian financial support (grants and fellowships).	Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Atkin T, 2017, J CHILD PSYCHOL PSYC, V58, P865, DOI 10.1111/jcpp.12735; Azzolin VF, 2016, TOXICOL IN VITRO, V32, P8, DOI 10.1016/j.tiv.2015.12.001; Baig MR, 2010, J PSYCHIATR PRACT, V16, P325, DOI 10.1097/01.pra.0000388627.36781.6a; Barbisan F, 2018, GENE, V655, P48, DOI 10.1016/j.gene.2018.02.046; Barbisan F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4151594; Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Calevro A, 2018, PSYCHONEUROENDOCRINO, V95, P28, DOI 10.1016/j.psyneuen.2018.05.021; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Contreras-Shannon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059012; Costa F, 2017, ZYGOTE, V25, P111, DOI 10.1017/S0967199416000307; Cui DH, 2018, J CLIN INVEST, V128, P4997, DOI 10.1172/JCI93090; Cruz Jung I, 2016, PSYCHOPHARMACOLOGY, V233, P1715, DOI 10.1007/s00213-015-4079-7; Dale M, 2015, J NEUROPSYCH CLIN N, V27, P262, DOI 10.1176/appi.neuropsych.14100265; Davey KJ, 2012, PSYCHOPHARMACOLOGY, V221, P155, DOI 10.1007/s00213-011-2555-2; de Sousa RT, 2015, PSYCHOPHARMACOLOGY, V232, P245, DOI 10.1007/s00213-014-3655-6; Duarte T, 2018, CYTOKINE, V106, P101, DOI 10.1016/j.cyto.2017.10.017; Farlow MR, 2017, EUR NEUROPSYCHOPHARM, V27, P217, DOI 10.1016/j.euroneuro.2017.01.002; Ferno J, 2015, EUR NEUROPSYCHOPHARM, V25, P923, DOI 10.1016/j.euroneuro.2015.03.002; Finley PR, 2016, CLIN PHARMACOKINET, V55, P925, DOI 10.1007/s40262-016-0370-y; Flank J, 2018, SUPPORT CARE CANCER, V26, P549, DOI 10.1007/s00520-017-3864-8; Fonseka Trehani M, 2016, Mol Neuropsychiatry, V2, P1, DOI 10.1159/000441521; Jeon SW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102174; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Katagiri H, 2012, CURR MED RES OPIN, V28, P701, DOI 10.1185/03007995.2012.666961; Kim HK, 2016, J PSYCHIATR RES, V76, P59, DOI 10.1016/j.jpsychires.2016.02.001; KOMOSSA K, 2010, COCHRANE DB SYST REV, V17; Lindstrom L, 2017, J AFFECT DISORDERS, V213, P138, DOI 10.1016/j.jad.2017.02.012; Machado-Vieira R, 2018, J AFFECT DISORDERS, V233, P92, DOI 10.1016/j.jad.2017.12.026; Mauri MC, 2018, CLIN PHARMACOKINET, V57, P1493, DOI 10.1007/s40262-018-0664-3; Morabito G, 2010, BIOCHIMIE, V92, P1101, DOI 10.1016/j.biochi.2010.04.017; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mostafavi SA, 2017, J CHILD ADOL PSYCHOP, V27, P440, DOI 10.1089/cap.2016.0046; Ozasa R, 2013, CELL STRUCT FUNCT, V38, P183, DOI 10.1247/csf.13012; Pamies A, 2018, ALTEX, V35, P353, DOI [10.14573/altex.1710081, DOI 10.14573/ALTEX.1710081]; Pessina A, 2006, PHARMACOPSYCHIATRY, V39, P160, DOI 10.1055/s-2006-947212; Pessina A, 2006, PHARMACOPSYCHIATRY, V39, P20, DOI 10.1055/s-2006-931475; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Rojo LE, 2015, PHARMACOL RES, V101, P74, DOI 10.1016/j.phrs.2015.07.022; Sanomachi T, 2017, ANTICANCER RES, V37, P6177, DOI 10.21873/anticanres.12067; Sarvari AK, 2014, BIOCHEM BIOPH RES CO, V450, P1383, DOI 10.1016/j.bbrc.2014.07.005; Scaini G, 2018, EUR NEUROPSYCHOPHARM, V28, P369, DOI 10.1016/j.euroneuro.2018.01.004; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Spertus J, 2018, NPJ SCHIZOPHR, V4, DOI 10.1038/s41537-018-0053-9; Stapel B, 2018, J PSYCHIATR RES, V105, P95, DOI 10.1016/j.jpsychires.2018.08.017; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Verdolini N, 2018, ACTA PSYCHIAT SCAND, V138, P196, DOI 10.1111/acps.12896; Victoriano M, 2010, BRAIN RES, V1350, P167, DOI 10.1016/j.brainres.2010.05.060; Wingard L, 2017, J AFFECT DISORDERS, V217, P16, DOI 10.1016/j.jad.2017.03.054; Yoodee J, 2017, CRIT REV ONCOL HEMAT, V112, P113, DOI 10.1016/j.critrevonc.2017.02.017; Zhang QS, 2014, J PSYCHOPHARMACOL, V28, P1161, DOI 10.1177/0269881114555250	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0209223	10.1371/journal.pone.0209223	http://dx.doi.org/10.1371/journal.pone.0209223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695037	Green Submitted, Green Published, gold			2022-12-26	WOS:000457046400006
J	Bono, A; Tencatt, LFC; Alonso, F; Lehmann, AP				Bono, Alessandra; Caserta Tencatt, Luiz Fernando; Alonso, Felipe; Pablo Lehmann, A.			Redescription of Corydoras undulatus Regan, 1912 (Siluriformes: Callichthyidae), with comments on the identity of Corydoras latus Pearson, 1924	PLOS ONE			English	Article							HOMOLOGY; LACEPEDE; PISCES	A redescription of Corydoras undulatus Regan, 1912 is presented. The original description of C. undulatus is very succinct, as is its diagnosis, which is based only on external morphology. Additional information in the scientific literature on this species is scarce. Specimens from the distribution area of this species were analyzed; Parana and Paraguay river basins in Argentina, Uruguay river basin in Argentina, Brazil and Uruguay, and the Laguna dos Patos system in Brazil. Morphological analysis, principal component analysis (PCA), meristic comparison and osteological description were performed. Corydoras undulatus can be distinguished from its congeners mainly by having the following combination of characters: mesethmoid short, with anterior tip short, smaller than 50% of the entire bone length; posterior margin of the pectoral-fin spine with nearly all serrations directed towards origin of spine; pectoral-fin spine with conical serrations; and its peculiar color pattern. The analysis of the material from the different basins did not indicate relevant morphological differences, suggesting that the species presents a wide distribution in La Plata and Laguna dos Patos drainages. The shared geographic distribution between these two systems is also present in other fish species. The current work presents data about the type locality, taxonomy, osteology, distribution and ontogenetic variation of color pattern in C. undulatus. Comments on the identity of a very similar congener, Corydoras latus, will also be provided.	[Bono, Alessandra; Pablo Lehmann, A.] Univ Vale Rio dos Sinos, Lab Ictiol, Sao Leopoldo, RS, Brazil; [Caserta Tencatt, Luiz Fernando] Univ Estadual Mato Grosso Sul, Unidade Univ Coxim, Rua Gen Mendes Moraes, Coxim, MG, Brazil; [Alonso, Felipe] Consejo Nacl Invest Cient & Tecn, IBIGEO, Inst Bio & Geociencias NOA, Rosario Lerma, Salta, Argentina	Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Estadual de Mato Grosso do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lehmann, AP (corresponding author), Univ Vale Rio dos Sinos, Lab Ictiol, Sao Leopoldo, RS, Brazil.	pablole@unisinos.br	Tencatt, Luiz/AAC-3595-2019; Alonso, Felipe/AAA-5717-2020; Albornoz, Pablo Lehmann/I-5602-2012	Alonso, Felipe/0000-0001-7227-2732; Albornoz, Pablo Lehmann/0000-0002-8884-4827	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [483060/2013-5, 141061/2014-6, 304997/2016-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PLA and LFCT are partially funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (grants #483060/2013-5 to PLA and #141061/2014-6 and #304997/2016-1 to LFCT).	Alexandrou MA, 2011, NATURE, V469, P84, DOI 10.1038/nature09660; Aquino AE, 2002, ZOOL ANZ, V241, P223, DOI 10.1078/0044-5231-00071; Arratia G, 1995, J VERTEBR PALEONTOL, V15, P482, DOI 10.1080/02724634.1995.10011243; Britto Marcelo R., 2003, Neotrop. ichthyol., V1, P83, DOI 10.1590/S1679-62252003000200002; Britz M, 2016, NEW SECUR CHALL, P1, DOI 10.1007/978-3-319-39759-7_1; Tencatt LFC, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150063; Espindola VC, 2018, J FISH BIOL, V92, P1463, DOI 10.1111/jfb.13602; Fricke R., 2020, CATALOG FISHES GENER; Huysentruyt F, 2005, CYBIUM, V29, P261; Knaack J., 2002, AQUARISTIK AKTUELL, V2002, P50; Knaack Joachim, 2004, Zoologische Abhandlungen (Dresden), V54, P55; Koerber Stefan, 2011, Ichthyological Contributions of PecesCriollos, V18, P1; Lundberg J. G., 1970, THESIS; MORRIS P.J., 2006, ACSIMAGEBASE DIGITAL; NIJSSEN H, 1980, BIJDR DIERKD, V50, P190; NIJSSEN H, 1970, Beaufortia, V18, P1; Nijssen H, 1986, REV FR AQUARIOL, V12, P65; Nion H, 1994, 1 ENC NAC FAUN AC LI; Regan C. T., 1912, ANN MAGAZINE NATURAL, V10, P209; Reis RE, 1998, ZOOL J LINN SOC-LOND, V124, P105; Reis RE, 2003, CHECK LIST FRESHWATE, P291; Reis Roberto E., 1997, Ichthyological Exploration of Freshwaters, V7, P299; SCHAEFER SA, 1988, J ZOOL, V214, P81, DOI 10.1111/j.1469-7998.1988.tb04988.x; Schaefer SA, 2000, J MORPHOL, V246, P212, DOI 10.1002/1097-4687(200012)246:3<212::AID-JMOR5>3.0.CO;2-S; Spadella MA, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160039; TAYLOR W R, 1985, Cybium, V9, P107; Teixeira de Mello F., 2011, PECES AGUA DULCE URU; Tencatt LF, 2015, NEOTROP ICHTHYOL, V13, P2; TENCATT LF, 2016, NEOTROP ICHTHYOL, V14, P1, DOI DOI 10.1590/1982-0224-20150089; Tencatt LF, 2017, ASPIDORAS IHERING 19; Tencatt LFC, 2013, NEOTROP ICHTHYOL, V11, P257, DOI 10.1590/S1679-62252013000200003	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211352	10.1371/journal.pone.0211352	http://dx.doi.org/10.1371/journal.pone.0211352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689676	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800031
J	Go, MA; Mueller, M; Castanares, ML; Egger, V; Daria, VR				Go, Mary Ann; Mueller, Max; Castanares, Michael Lawrence; Egger, Veronica; Daria, Vincent R.			A compact holographic projector module for high-resolution 3D multi-site two-photon photostimulation	PLOS ONE			English	Article							DENDRITIC SPINES; OPTICAL TWEEZERS; MICROSCOPY; EXCITATION; NETWORK; INTEGRATION; CALCIUM	Patterned two-photon (2P) photolysis via holographic illumination is a powerful method to investigate neuronal function because of its capability to emulate multiple synaptic inputs in three dimensions (3D) simultaneously. However, like any optical system, holographic projectors have a finite space-bandwidth product that restricts the spatial range of patterned illumination or field-of-view (FOV) for a desired resolution. Such trade-off between holographic FOV and resolution restricts the coverage within a limited domain of the neuron's dendritic tree to perform highly resolved patterned 2P photolysis on individual spines. Here, we integrate a holographic projector into a commercial 2P galvanometer-based 2D scanning microscope with an uncaging unit and extend the accessible holographic FOV by using the galvanometer scanning mirrors to reposition the holographic FOV arbitrarily across the imaging FOV. The projector system utilizes the microscope's built-in imaging functions. Stimulation positions can be selected from within an acquired 3D image stack (the volume-of-interest, VOI) and the holographic projector then generates 3D illumination patterns with multiple uncaging foci. The imaging FOV of our system is 800x800 mu m(2) within which a holographic VOI of 70x70x70 mu m(3) can be chosen at arbitrary positions and also moved during experiments without moving the sample. We describe the design and alignment protocol as well as the custom software plugin that controls the 3D positioning of stimulation sites. We demonstrate the neurobiological application of the system by simultaneously uncaging glutamate at multiple spines within dendritic domains and consequently observing summation of postsynaptic potentials at the soma, eventually resulting in action potentials. At the same time, it is possible to perform two-photon Ca2+ imaging in 2D in the dendrite and thus to monitor synaptic Ca2+ entry in selected spines and also local regenerative events such as dendritic action potentials.	[Go, Mary Ann] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England; [Mueller, Max; Egger, Veronica] Univ Regensburg, Inst Zool, Neurophysiol, D-93040 Regensburg, Germany; [Castanares, Michael Lawrence; Daria, Vincent R.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 0200, Australia	Imperial College London; University of Regensburg; Australian National University; John Curtin School of Medical Research	Egger, V (corresponding author), Univ Regensburg, Inst Zool, Neurophysiol, D-93040 Regensburg, Germany.; Daria, VR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 0200, Australia.	veronica.egger@ur.de; vincent.daria@anu.edu.au		Daria, Vincent/0000-0003-4672-5333; Castanares, Michael Lawrence/0000-0002-5937-8273	German Federal Ministry of Education and Research (BMBF) [FKZ 01GQ1502]; Australian Research Council [DP140101555]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Australian Research Council(Australian Research Council)	VE received funding from the German Federal Ministry of Education and Research (BMBF) contract number FKZ 01GQ1502; VD received funding from the Australian Research Council DP140101555.; We thank Dr. Vanessa Rupprecht for initial help with the project. VE acknowledges the funding by the German Federal Ministry of Education and Research (BMBF) contract number FKZ 01GQ1502. VD also acknowledges the partial funding from the Australian Research Council DP140101555.	Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Born M., 1989, PRINCIPLES OPTICS EL; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Bywalez WG, 2015, NEURON, V85, P590, DOI 10.1016/j.neuron.2014.12.051; Choy JMC, 2017, FRONT CELL NEUROSCI, V207, P11; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Dal Maschio M, 2010, OPT EXPRESS, V18, P18720, DOI 10.1364/OE.18.018720; Daria VR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3216581; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Fisher JAN, 2015, ADV EXP MED BIOL, V859, P427, DOI 10.1007/978-3-319-17641-3_17; Go MA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00231; Go MA, 2012, J BIOPHOTONICS, V5, P745, DOI 10.1002/jbio.201100101; Golan L, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066004; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hernandez O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11928; Jerome J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00095; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Liesener J, 2000, OPT COMMUN, V185, P77, DOI 10.1016/S0030-4018(00)00990-1; Lillis KP, 2008, J NEUROSCI METH, V172, P178, DOI 10.1016/j.jneumeth.2008.04.024; Losavio BE, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275468; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Makara JK, 2013, NEURON, V80, P1438, DOI 10.1016/j.neuron.2013.10.033; Nadella KMNS, 2016, NAT METHODS, V13, P1001, DOI [10.1038/NMETH.4033, 10.1038/nmeth.4033]; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Ogden D, 2011, P NATL ACAD SCI USA, V108, P19504, DOI [10.1073/pnas.1109111108, DOI 10.1073/PNAS.1109111108]; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Pegard NC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01031-3; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Tada M, 2014, EUR J NEUROSCI, V39, P1720, DOI 10.1111/ejn.12476; Tanese D, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.3.031211; van der Horst A, 2008, OPT EXPRESS, V16, P20987, DOI 10.1364/OE.16.020987; Yang SJ, 2015, OPT EXPRESS, V23, P32573, DOI 10.1364/OE.23.032573; Yang SG, 2014, P NATL ACAD SCI USA, V111, P12919, DOI 10.1073/pnas.1405468111; Yang S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00127; Yang SG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046002; Yang WJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32671; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210564	10.1371/journal.pone.0210564	http://dx.doi.org/10.1371/journal.pone.0210564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689635	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800007
J	Williams, LA; Casbas-Hernandez, P; Nichols, HB; Tse, CK; Allott, EH; Carey, LA; Olshan, AF; Troester, MA				Williams, Lindsay A.; Casbas-Hernandez, Patricia; Nichols, Hazel B.; Tse, Chiu Kit; Allott, Emma H.; Carey, Lisa A.; Olshan, Andrew F.; Troester, Melissa A.			Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; MOLECULAR SUBTYPES; CIGARETTE-SMOKING; EPIDEMIOLOGY; MAMMOGRAPHY; HISTORY; BIOPSY; COHORT	Purpose Invasive breast cancers are thought to arise from in situ lesions, but some ductal carcinoma in situ (DCIS) are indolent with low likelihood of progressing to invasive carcinoma. Comparison of risk factor associations between DCIS and invasive disease may elucidate which factors influence early versus late stages of carcinogenesis. Therefore, we determined whether there were differences in risk factor profiles for screen-detected DCIS and invasive breast cancer among Luminal A lesions. Methods We conducted a case-control analysis using data from the Carolina Breast Cancer Study (1993-2001). Analyses were restricted to Luminal A tumors and screen-detected tumors among mammography-eligible women, to limit confounding by mode of detection (N = 108 DCIS; N = 203 invasive). Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations between risk factors and lesion type. Results In stratified analyses, we observed qualitative differences in the direction of association for ever smoking, obese BMI, high waist-to-hip-ratio (WHR), and. 10 years of oral contraceptive use between DCIS and invasive disease. Breastfeeding was inversely associated with invasive disease and was not associated with DCIS. Interaction tests for risk factor associations between Luminal A DCIS and invasive breast cancer were not statistically significant (p>0.05). Conclusions Among Luminal A tumors, established breast cancer risk factors may exert stronger effects on progression of early lesions to invasive disease, with lesser effects on risk of DCIS.	[Williams, Lindsay A.; Casbas-Hernandez, Patricia; Nichols, Hazel B.; Tse, Chiu Kit; Olshan, Andrew F.; Troester, Melissa A.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Allott, Emma H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27515 USA; [Carey, Lisa A.; Olshan, Andrew F.; Troester, Melissa A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Troester, Melissa A.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Troester, MA (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.; Troester, MA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Troester, MA (corresponding author), Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA.	troester@unc.edu		Williams, Lindsay/0000-0003-3842-4629	Komen Graduate Training and Disparities Research Grant; Puerto Rico Science, Technology and Research Trust (Science and Technology Grant); National Cancer Institute [U54 CA163071, U54 CA163068, U01 CA179715, U54 CA156733, P30 ES010126, P50 CA058223]; RCMI [G12 MD007579]; NATIONAL CANCER INSTITUTE [P50CA058223, U54CA163071, U01CA179715, U54CA156733, U54CA163068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	Komen Graduate Training and Disparities Research Grant; Puerto Rico Science, Technology and Research Trust (Science and Technology Grant); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RCMI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by: Komen Graduate Training and Disparities Research Grant, Puerto Rico Science, Technology and Research Trust (Science and Technology Grant), the National Cancer Institute (U54 CA163071, U54 CA163068, U01 CA179715, U54 CA156733, P30 ES010126, P50 CA058223), and the RCMI program (G12 MD007579).	ALPERS CE, 1985, HUM PATHOL, V16, P796, DOI 10.1016/S0046-8177(85)80251-3; Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; Anderson WF, 2004, BREAST CANCER RES TR, V88, P149, DOI 10.1007/s10549-004-1483-9; Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P2086, DOI 10.1158/1055-9965.EPI-06-0345; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Butler EN, 2016, CANCER CAUSE CONTROL, V27, P775, DOI 10.1007/s10552-016-0754-1; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Casbas-Hernandez P, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3476; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Cox B, 2013, BREAST, V22, P1041, DOI 10.1016/j.breast.2013.07.046; de Roos MA, 2007, ANN SURG ONCOL, V14, P2097, DOI 10.1245/s10434-007-9395-7; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Furberg H, 2002, CANCER EPIDEM BIOMAR, V11, P829; Gapstur SM, 1999, JAMA-J AM MED ASSOC, V281, P2091, DOI 10.1001/jama.281.22.2091; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P1415, DOI 10.1007/s10552-011-9814-8; Kabat GC, 2010, AM J EPIDEMIOL, V172, P591, DOI 10.1093/aje/kwq159; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kurbel S, 2014, THEOR BIOL MED MODEL, V11, P1, DOI [10.1186/1742-4682-11-1, DOI 10.1186/1742-4682-11-1]; Livasy CA, 2007, HUM PATHOL, V38, P197, DOI 10.1016/j.humpath.2006.08.017; Longnecker MP, 1996, CANCER EPIDEM BIOMAR, V5, P961; Marshall E, 2014, SCIENCE, V343, P1454, DOI 10.1126/science.343.6178.1454; Meeske K, 2004, INT J CANCER, V110, P102, DOI 10.1002/ijc.20072; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Moorman PG, 2001, J NATL MED ASSOC, V93, P329; Nichols HB, 2007, CANCER EPIDEM BIOMAR, V16, P2262, DOI 10.1158/1055-9965.EPI-07-0456; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Park SY, 2016, CARCINOGENESIS, V37, P607, DOI 10.1093/carcin/bgw040; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips LS, 2009, CANCER EPIDEM BIOMAR, V18, P1507, DOI 10.1158/1055-9965.EPI-08-0967; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Reinier KS, 2007, BREAST CANCER RES TR, V103, P343, DOI 10.1007/s10549-006-9375-9; ROSEN P, 1970, CANCER, V26, P944, DOI 10.1002/1097-0142(197010)26:4<944::AID-CNCR2820260432>3.0.CO;2-S; Sisti JS, 2016, INT J CANCER, V138, P2346, DOI 10.1002/ijc.29968; Tamimi RM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2128; Terry MB, 2002, ORAL CONTRACEPTIVE U, P1100; To T, 2014, INT J CANCER, V135, P1646, DOI 10.1002/ijc.28803; Trentham-Dietz A, 2000, CANCER EPIDEM BIOMAR, V9, P697; Trentham-Dietz A, 2007, EPIDEMIOLOGY, V18, P629, DOI 10.1097/EDE.0b013e318127183a; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Weiss HA, 1996, BRIT J CANCER, V73, P1298, DOI 10.1038/bjc.1996.248; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Young Erin, 2009, Tob Induc Dis, V5, P4, DOI 10.1186/1617-9625-5-4; Zhu KM, 2006, PREV MED, V42, P381, DOI 10.1016/j.ypmed.2006.01.020	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211488	10.1371/journal.pone.0211488	http://dx.doi.org/10.1371/journal.pone.0211488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682163	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500172
J	Wang, JL; Dean, DC; Hornicek, FJ; Shi, HR; Duan, ZF				Wang, Jinglu; Dean, Dylan C.; Hornicek, Francis J.; Shi, Huirong; Duan, Zhenfeng			Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer	FASEB JOURNAL			English	Article						LDC000067; transcription; apoptosis	PRECLINICAL MODELS; CELL-CYCLE; TRANSCRIPTION; INHIBITION; EXPRESSION; PHOSPHORYLATION; FLAVOPIRIDOL; STATISTICS; ELONGATION; SYNERGIZES	Despite surgical and chemotherapeutic advances over the past few decades, the prognosis for ovarian cancer remains very poor. Although cyclin-dependent kinase (CDK) 9 has an established pathogenic role in various cancers, its function in ovarian cancer remains poorly defined. The purpose of this study was to evaluate the expression of CDK9 and its therapeutic potential in ovarian cancer. CDK9 expression was determined by immunohistochemistry in a unique ovarian cancer tissue microarray constructed with paired primary, metastatic, and recurrent tumor tissues from 26 ovarian cancer patients. CDK9 was highly expressed in human ovarian cancer cell lines and was also elevated in metastatic and recurrent ovarian tumor tissue compared with patient-matched primary ovarian tumor tissue. In addition, increased CDK9 significantly correlated with poor patient prognosis. Inhibition of CDK9 by small interfering RNA or CDK9 inhibitor functionally suppressed RNA transcription elongation, induced apoptosis, and reduced proliferation of ovarian cancer cells. Inhibition of CDK9 also suppressed ovarian cancer cell spheroid growth, clonogenicity formation, and migration activity. Our results reveal CDK9 as a novel prognostic biomarker and a promising therapeutic target for preventing metastasis and recurrence while also improving the overall clinical outcome for ovarian cancer patients.Wang, J., Dean, D. C., Hornicek, F. J., Shi, H., Duan, Z. Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer.	[Wang, Jinglu; Shi, Huirong; Duan, Zhenfeng] Zhengzhou Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China; [Wang, Jinglu; Dean, Dylan C.; Hornicek, Francis J.; Duan, Zhenfeng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA	Zhengzhou University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shi, HR; Duan, ZF (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.; Duan, ZF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fccshihr@zzu.edu.cn; zduan@mednet.ucla.edu	Duan, Zhenfeng/AAK-5587-2020		National Natural Science Foundation of China [81402266, 81372875]; U.S. National Institutes of Health, National Cancer Institute [CA151452-01]; China Scholarship Council [201607040013]; Gattegno fund; Wechsler fund;  [228282]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); Gattegno fund; Wechsler fund; 	This work was supported, in part, by a Joint Research Fund (228282) devoted to clinical pharmacy and precision medicine (to Z.D.). Support has also been provided by the National Natural Science Foundation of China (Grants 81402266 and 81372875), and Gattegno and Wechsler funds. Z.D. was supported, in part, by the U.S. National Institutes of Health, National Cancer Institute (Grant UO1, CA151452-01). J.W. was supported by a scholarship from the China Scholarship Council (201607040013). The authors declare no conflicts of interest.	Ajiro M, 2018, CLIN CANCER RES, V24, P4518, DOI 10.1158/1078-0432.CCR-17-3119; Albert TK, 2014, BRIT J PHARMACOL, V171, P55, DOI 10.1111/bph.12408; Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070; Bragelmann J, 2017, CELL REP, V20, P2833, DOI 10.1016/j.celrep.2017.08.082; Caracciolo V, 2012, CELL CYCLE, V11, P1202, DOI 10.4161/cc.11.6.19663; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Chen XX, 2015, ONCOTARGET, V6, P14926, DOI 10.18632/oncotarget.3717; De Falco G, 2005, CANCER BIOL THER, V4, P277; Du Bois A, 2005, INT J GYNECOL CANCER, V15, P42, DOI 10.1111/j.1525-1438.2005.15356.x; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gao Y, 2017, CELL ONCOL, V40, P209, DOI 10.1007/s13402-017-0316-x; Greifenberg AK, 2016, CELL REP, V14, P320, DOI 10.1016/j.celrep.2015.12.025; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang CH, 2014, GENE DEV, V28, P1800, DOI 10.1101/gad.244368.114; Kohoutek J, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-19; Kretz AL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694304; Lam F, 2014, ONCOTARGET, V5, P7691, DOI 10.18632/oncotarget.2296; Liu HB, 2005, J CELL PHYSIOL, V203, P251, DOI 10.1002/jcp.20224; Liu XZ, 2016, MOL CANCER THER, V15, P1691, DOI 10.1158/1535-7163.MCT-16-0032; Loschmann N, 2016, ONCOTARGET, V7, P58051, DOI 10.18632/oncotarget.11160; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mitra P, 2016, ONCOTARGET, V7, P9069, DOI 10.18632/oncotarget.6997; Morales F, 2016, CELL CYCLE, V15, P519, DOI 10.1080/15384101.2016.1138186; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prudencio M, 2017, HUM MOL GENET, V26, P3421, DOI 10.1093/hmg/ddx233; Rahaman MH, 2016, ENDOCR-RELAT CANCER, V23, pT211, DOI 10.1530/ERC-16-0299; Rajput S, 2016, ONCOTARGET, V7, P56864, DOI 10.18632/oncotarget.10870; Romano G, 2008, CELL CYCLE, V7, P3664, DOI 10.4161/cc.7.23.7122; Sato S, 2014, THER ADV MED ONCOL, V6, P293, DOI 10.1177/1758834014544891; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shore SM, 2005, GENE, V350, P51, DOI 10.1016/j.gene.2005.01.015; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Su YT, 2018, CLIN CANCER RES, V24, P1124, DOI 10.1158/1078-0432.CCR-17-2032; Walsby E, 2014, ONCOTARGET, V5, P375, DOI 10.18632/oncotarget.1568; Wang JL, 2018, GYNECOL ONCOL, V150, P143, DOI 10.1016/j.ygyno.2018.04.557; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Whittaker SR, 2018, MOL ONCOL, V12, P287, DOI 10.1002/1878-0261.12148; Zhang HH, 2018, CELL, V175, P1244, DOI 10.1016/j.cell.2018.09.051	46	32	34	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5990	6000		10.1096/fj.201801789RR	http://dx.doi.org/10.1096/fj.201801789RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726104	Bronze, Green Published			2022-12-26	WOS:000466932600016
J	Streit, BR; Mattice, JR; Prussia, GA; Peters, JW; DuBois, JL				Streit, Bennett R.; Mattice, Jenna R.; Prussia, Gregory A.; Peters, John W.; DuBois, Jennifer L.			The reactive form of a C-S bond-cleaving, CO2-fixing flavoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin adenine dinucleotide (FAD); microbiology; carbon fixation; oxidase; disulfide; 2-KPCC; C-S bond cleavage; carboxylase; disulfide oxidoreductase; nucleophilic thiolate	GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; CATALYTIC DYAD; PK(A) VALUES; MECHANISM; THIOREDOXIN; DISULFIDE; ENZYME; YEAST; CARBOXYLATION	NADPH:2-ketopropyl-coenzyme M oxidoreductase/carboxylase (2-KPCC) is a bacterial disulfide oxidoreductase (DSOR) that, uniquely in this family, catalyzes CO2 fixation. 2-KPCC differs from other DSORs by having a phenylalanine that replaces a conserved histidine, which in typical DSORs is essential for stabilizing the reduced, reactive form of the active site. Here, using site-directed mutagenesis and stopped-flow kinetics, we examined the reactive form of 2-KPCC and its single turnover reactions with a suicide substrate and CO2. The reductive half-reaction of 2-KPCC was kinetically and spectroscopically similar to that of a typical DSOR, GSH reductase, in which the active-site histidine had been replaced with an alanine. However, the reduced, reactive form of 2-KPCC was distinct from those typical DSORs. In the absence of the histidine, the flavin and disulfide moieties were no longer coupled via a covalent or charge transfer interaction as in typical DSORs. Similar to thioredoxins, the pK(a) between 7.5 and 8.1 that controls reactivity appeared to be due to a single proton shared between the cysteines of the dithiol, which effectively stabilizes the attacking cysteine sulfide and renders it capable of breaking the strong C-S bond of the substrate. The lack of a histidine protected 2-KPCC's reactive intermediate from unwanted protonation; however, without its input as a catalytic acid-base, the oxidative half-reaction where carboxylation takes place was remarkably slow, limiting the overall reaction rate. We conclude that stringent regulation of protons in the DSOR active site supports C-S bond cleavage and selectivity for CO2 fixation.	[Streit, Bennett R.; Mattice, Jenna R.; Prussia, Gregory A.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA; [Prussia, Gregory A.; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA	Montana State University System; Montana State University Bozeman; Washington State University	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA.	jennifer.dubois1@montana.edu		DuBois, Jennifer/0000-0001-5593-3391	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02x04ER15563]; National Science Foundation [MCB1715176]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award DE-FG02x04ER15563 (to J. W. P.). This work was also supported by National Science Foundation Grant MCB1715176 (to J. L. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ARSCOTT LD, 1981, BIOCHEMISTRY-US, V20, P1513, DOI 10.1021/bi00509a016; BASHFORD D, 1993, BIOCHEMISTRY-US, V32, P8045, DOI 10.1021/bi00082a027; BENSON SW, 1978, CHEM REV, V78, P23, DOI 10.1021/cr60311a003; Boyd JM, 2010, J BIOL CHEM, V285, P25232, DOI 10.1074/jbc.M110.144410; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; FOX B, 1982, J BIOL CHEM, V257, P2498; Frey P. A., 2007, ENZYMATIC REACTION M, P387; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HUBER PW, 1980, BIOCHEMISTRY-US, V19, P4568, DOI 10.1021/bi00561a005; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Jursic BS, 1997, INT J QUANTUM CHEM, V62, P291, DOI 10.1002/(SICI)1097-461X(1997)62:3<291::AID-QUA7>3.0.CO;2-R; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P1, DOI 10.1021/bi00594a001; Maung N, 1999, J MOL STRUC-THEOCHEM, V460, P159, DOI 10.1016/S0166-1280(98)00314-5; MILLER SM, 1990, BIOCHEMISTRY-US, V29, P2831, DOI 10.1021/bi00463a028; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; PEARL L, 1984, FEBS LETT, V174, P96, DOI 10.1016/0014-5793(84)81085-6; Prussia GA, 2016, FEBS LETT, V590, P2991, DOI 10.1002/1873-3468.12325; RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043; Sampogna RV, 1996, BIOPHYS J, V71, P1165, DOI 10.1016/S0006-3495(96)79320-7; THORPE C, 1981, BIOCHEMISTRY-US, V20, P1507, DOI 10.1021/bi00509a015; Veine DM, 1998, BIOCHEMISTRY-US, V37, P15575, DOI 10.1021/bi9811314; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268; Westphal AH, 1998, EUR J BIOCHEM, V257, P160, DOI 10.1046/j.1432-1327.1998.2570160.x; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	29	4	4	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5137	5145		10.1074/jbc.RA118.005554	http://dx.doi.org/10.1074/jbc.RA118.005554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30696768	hybrid, Green Published			2022-12-26	WOS:000463985600034
J	Pan, BJ; Vernet, M; Reynolds, RA; Mitchell, BG				Pan, B. Jack; Vernet, Maria; Reynolds, Rick A.; Mitchell, B. Greg			The optical and biological properties of glacial meltwater in an Antarctic fjord	PLOS ONE			English	Article							SUSPENDED SEDIMENT; ICE-SHELF; SEA-ICE; BIOOPTICAL CHARACTERIZATION; LIGHT BACKSCATTERING; COASTAL WATERS; MASS-BALANCE; MELTING ICE; PENINSULA; WEST	As the Western Antarctic Peninsula (WAP) region responds to a warmer climate, the impacts of glacial meltwater on the Southern Ocean are expected to intensify. The Antarctic Peninsula fjord system offers an ideal system to understand meltwater's properties, providing an extreme in the meltwater's spatial gradient from the glacio-marine boundary to the WAP continental shelf. Glacial meltwater discharge in Arctic and Greenland fjords is typically characterized as relatively lower temperature, fresh and with high turbidity. During two cruises conducted in December 2015 and April 2016 in Andvord Bay, we found a water lens of low salinity and low temperature along the glacio-marine interface. Oxygen isotope ratios identified this water lens as a mixture of glacial ice and deep water in Gerlache Strait suggesting this is glacial meltwater. Conventional hydrographic measurements were combined with optical properties to effectively quantify its spatial extent. Fine suspended sediments associated with meltwater (nanoparticles of similar to 5nm) had a significant impact on the underwater light field and enabled the detection of meltwater characteristics and spatial distribution. In this study, we illustrate that glacial meltwater in Andvord Bay alters the inherent and apparent optical properties of the water column, and develop statistical models to predict the meltwater content from hydrographic and optical measurements. The predicted meltwater fraction is in good agreement with in-situ values. These models offer a potential for remote sensing and high-resolution detection of glacial meltwater in Antarctic waters. Furthermore, the possible influence of meltwater on phytoplankton abundance in the surface is highlighted; a significant correlation is found between meltwater fraction and chlorophyll concentration.	[Pan, B. Jack; Vernet, Maria; Mitchell, B. Greg] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Reynolds, Rick A.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Pan, BJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.	b4pan@ucsd.edu	Reynolds, Rick A/C-7470-2014	Reynolds, Rick A/0000-0002-1579-3600	U.S. National Science Foundation [PLR-1443705]; NASA [NNX15AC98G]	U.S. National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This study was supported by the U.S. National Science Foundation grant, award#: PLR-1443705; https://www.nsf.gov/awardsearch/showAward?AWD_ID=1443705 to MV. BGM was supported by NASA Award NNX15AC98G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 1997, QUATERNARY SCI REV, V16, P1017, DOI 10.1016/S0277-3791(97)00034-6; [Anonymous], P NATL ACAD SCI; Aoki S, 2017, J GEOPHYS RES-OCEANS, V122, P6277, DOI 10.1002/2017JC012925; Arendt KE, 2011, J PLANKTON RES, V33, P1526, DOI 10.1093/plankt/fbr054; Arrigo KR, 2017, GEOPHYS RES LETT; Beaird N, 2015, GEOPHYS RES LETT, V42, P7705, DOI 10.1002/2015GL065003; Bohren C. F., 2008, ABSORPTION SCATTERIN, DOI DOI 10.1002/9783527618156; Boss E, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122692; Brito AC, 2015, ESTUAR COAST SHELF S, V167, P86, DOI 10.1016/j.ecss.2015.07.006; Cape M, 2015, JOURNAL OF GEOPHYSIC, V120; Cape MR, 2014, J GEOPHYS RES-OCEANS, V119, P572, DOI 10.1002/2013JC009441; Cape Vernet M, SCAR C 2010; Chu VW, 2009, J GLACIOL, V55, P1072, DOI 10.3189/002214309790794904; Cook S., 2017, LARSEN C ICE SHELF S; Coplen TB, 1995, GEOTHERMICS, V24, P708; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dierssen HM, 2000, J GEOPHYS RES-OCEANS, V105, P26301, DOI 10.1029/1999JC000296; Dierssen HM, 2002, P NATL ACAD SCI USA, V99, P1790, DOI 10.1073/pnas.032206999; Dierssen HM, 2000, P OCEAN OPTICS; Domack E.W., 1990, ANTARCT RES SER, V50, P71, DOI DOI 10.1029/AR050P0071; DOMACK EW, 1994, MAR GEOL, V121, P161, DOI 10.1016/0025-3227(94)90028-0; Doxaran D, 2016, OPT EXPRESS, V24, P3615, DOI 10.1364/OE.24.003615; Ekern L., 2017, THESIS; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Ferreira A, 2018, DEEP-SEA RES PT II, V149, P138, DOI 10.1016/j.dsr2.2017.09.007; GADE HG, 1979, J PHYS OCEANOGR, V9, P189, DOI 10.1175/1520-0485(1979)009<0189:MOIISW>2.0.CO;2; Hernando M, 2015, J EXP MAR BIOL ECOL, V466, P110, DOI 10.1016/j.jembe.2015.02.012; Holinde L, 2016, OCEAN SCI, V12, P117, DOI 10.5194/os-12-117-2016; Holinde L., 2015, OCEAN SCI DISCUSS, V12, P1537; Hudson B, 2014, CRYOSPHERE, V8, P1161, DOI 10.5194/tc-8-1161-2014; Hylander S, 2011, J PLANKTON RES, V33, P1239, DOI 10.1093/plankt/fbr025; ISAO K, 1990, NATURE, V345, P242, DOI 10.1038/345242a0; Jacobs SS, 1985, OCEANOLOGY ANTARCTIC, V43, P59, DOI DOI 10.1029/AR043P0059; Jenkins A, 1999, J PHYS OCEANOGR, V29, P2370, DOI 10.1175/1520-0485(1999)029<2370:TIOMIO>2.0.CO;2; Jenkins A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004449; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; KISHINO M, 1985, B MAR SCI, V37, P634; Knox G.A., 2006, BIOL SO OCEAN, DOI 10.1201/9781420005134; Kong JL, 2015, REMOTE SENS-BASEL, V7, P5373, DOI 10.3390/rs70505373; Maffione RA, 1997, APPL OPTICS, V36, P6057, DOI 10.1364/AO.36.006057; Mankoff KD, 2016, J GEOPHYS RES-OCEANS, V121, P8670, DOI 10.1002/2016JC011764; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Mascarenhas VJ, 2017, J GEOPHYS RES-OCEANS, V122, P3828, DOI 10.1002/2016JC012610; McGrath D, 2010, J GLACIOL, V56, P813, DOI 10.3189/002214310794457227; Meire L, 2017, GLOBAL CHANGE BIOL, V23, P5344, DOI 10.1111/gcb.13801; Meredith MP, 2008, DEEP-SEA RES PT II, V55, P309, DOI 10.1016/j.dsr2.2007.11.005; Meredith MP, 2017, DEEP-SEA RES PT II, V139, P40, DOI 10.1016/j.dsr2.2016.04.019; Mitchell B.G., 2002, OCEAN OPTICS PROTOCO, V3, P231; Mitchell BG, 1998, CAL COOP OCEAN FISH, V39, P133; Mobley C.D.., 1994, LIGHT WATER RAD TRAN; MOREL A, 1991, J MAR RES, V49, P177, DOI 10.1357/002224091784968639; Mortensen J, 2013, J GEOPHYS RES-OCEANS, V118, P1382, DOI 10.1002/jgrc.20134; Motyka RJ, 2003, ANN GLACIOL, V36, P57, DOI 10.3189/172756403781816374; Murray C, 2015, ESTUAR COAST SHELF S, V163, P72, DOI 10.1016/j.ecss.2015.05.041; Park JH, 2007, POLAR BIOL, V30, P199, DOI 10.1007/s00300-006-0173-y; POTTER JR, 1984, J GLACIOL, V30, P161, DOI 10.3189/S002214300000589X; Powell R, 1995, MODERN GLACIOMARINE; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Raiswell R, 2006, GEOCHIM COSMOCHIM AC, V70, P2765, DOI 10.1016/j.gca.2005.12.027; Reynolds RA, 2016, LIMNOL OCEANOGR, V61, P1869, DOI 10.1002/lno.10341; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Schloss Irene, 1997, P135; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Silvano A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9467; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith R.C., 1981, FLUOROMETRIC TECHNIQ; Smith RC, 2001, ANN GLACIOL-SER, V33, P493, DOI 10.3189/172756401781818662; Sravanthi N, 2013, INT J ENVIRON RES, V7, P841; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stramski D, 2004, PROG OCEANOGR, V61, P27, DOI 10.1016/j.pocean.2004.07.001; STRAMSKI D, 1991, PROG OCEANOGR, V28, P343, DOI 10.1016/0079-6611(91)90032-H; Stramski D, 2015, APPL OPTICS, V54, P6763, DOI 10.1364/AO.54.006763; Straneo F, 2015, ANNU REV MAR SCI, V7, P89, DOI 10.1146/annurev-marine-010213-135133; Straneo F, 2011, NAT GEOSCI, V4, P322, DOI [10.1038/ngeo1109, 10.1038/NGEO1109]; Syvitski J, 1987, PROCESSES PRODUCTS; SYVITSKI JPM, 1989, MAR GEOL, V85, P301, DOI 10.1016/0025-3227(89)90158-8; TASSAN S, 1994, APPL OPTICS, V33, P2369, DOI 10.1364/AO.33.002369; Thomas DN, 2011, ENCY SNOW ICE GLACIE, P98; Vaughan DG, 2006, ARCT ANTARCT ALP RES, V38, P147, DOI 10.1657/1523-0430(2006)038[0147:RTIMCO]2.0.CO;2; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vernet M, 2008, DEEP-SEA RES PT II, V55, P2068, DOI 10.1016/j.dsr2.2008.05.021; Weslawski Jan Marcin, 2011, Marine Biodiversity, V41, P71, DOI 10.1007/s12526-010-0073-9; Williams C., 1989, ANTARCTIC J, P116; Zhang XD, 2009, OPT EXPRESS, V17, P5698, DOI 10.1364/OE.17.005698	85	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211107	10.1371/journal.pone.0211107	http://dx.doi.org/10.1371/journal.pone.0211107			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726270	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000053
J	Sieluzycki, C; Maslinski, J; Kaczmarczyk, P; Kubacki, R; Cieslinski, WB; Witkowski, K				Sieluzycki, Cezary; Maslinski, Jaroslaw; Kaczmarczyk, Patryk; Kubacki, Rafal; Cieslinski, Wojciech B.; Witkowski, Kazimierz			Can Kinect aid motor learning in sportsmen? A study for three standing techniques in judo	PLOS ONE			English	Article							PARKINSONS-DISEASE; VIRTUAL-REALITY; VISUAL-SEARCH; VIDEO; DEMONSTRATIONS; PRINCIPLES; SKILL; GAMES	Our objective was to examine how exercises with the second generation of the Microsoft Kinect sensor may aid in the process of motor learning in young judo practitioners. We addressed improvements in spatio-temporal accuracy during execution of three standing techniques in judo, in a simple paradigm designed to study short-term practice effects. Two groups of judokas, 12 athletes each-one aided with Kinect and our dedicated software vs a group of controls-were asked to mimic previously recorded master-level performances of the three techniques, established as benchmarks by a two times world champion in judo. In five training sessions, athletes of the aided group used a virtual-reality setup in which they trained with a virtual representation of the master displayed on a large screen with a simultaneous real-time visualisation of their own movements in the form of an avatar based on body joint localisation, as determined by Kinect, which also measured their performance. The control group used Kinect in the 1st and 5th session, which was necessary for the measurements that constituted the basis for subsequent statistical comparisons, whereas the 2nd, 3rd, and 4th session in this group was guided by a coach, without the use of the Kinect setup. In addition, athletes of the two groups had unrestricted access to a video recording of the master performing the three throws. We found statistically significant improvements (p < 0.05) in the accuracy of executing the three techniques between the 1st and the 5th training session for the aided group but not for the control group. We conclude that incorporating Kinect based exercises into a judo training programme may be a useful means to supporting motor learning, therefore enhancing training efficiency, and thus improving performance.	[Sieluzycki, Cezary] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland; [Sieluzycki, Cezary; Kaczmarczyk, Patryk] Wroclaw Univ Sci & Technol, Fac Comp Sci & Management, Wroclaw, Poland; [Maslinski, Jaroslaw; Kubacki, Rafal; Cieslinski, Wojciech B.; Witkowski, Kazimierz] Univ Sch Phys Educ Wroclaw, Fac Sport Sci, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw University of Science & Technology	Sieluzycki, C (corresponding author), Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland.; Sieluzycki, C (corresponding author), Wroclaw Univ Sci & Technol, Fac Comp Sci & Management, Wroclaw, Poland.	cezary.sieluzycki@pwr.edu.pl	Sielużycki, Cezary/A-6010-2014	Sielużycki, Cezary/0000-0003-1487-1627; Kubacki, Rafal/0000-0002-7904-588X; Cieslinski, Wojciech/0000-0001-8226-607X; Witkowski, Kazimierz/0000-0003-1503-9904	European Commission under the 7th Framework Programme, Coordination and Support Action [316097]; ENGINE -European research centre of Network intelliGence for INnovation Enhancement; Polish Ministry of Science and Higher Education fund; Department of Biomedical Engineering at the Wroclaw University of Science and Technology; Polish Ministry of Science and Higher Education [0011/RS3/2015/53]	European Commission under the 7th Framework Programme, Coordination and Support Action; ENGINE -European research centre of Network intelliGence for INnovation Enhancement; Polish Ministry of Science and Higher Education fund; Department of Biomedical Engineering at the Wroclaw University of Science and Technology; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Cezary Sieluzycki was supported partially by the European Commission under the 7th Framework Programme, Coordination and Support Action, grant agreement number 316097, ENGINE -European research centre of Network intelliGence for INnovation Enhancement, together with the Polish Ministry of Science and Higher Education fund for supporting internationally co-financed projects in 2013-2016, and partially by the statutory funds of the Department of Biomedical Engineering at the Wroclaw University of Science and Technology. Jaroslaw Maslinski, Wojciech B. Cieslinski and Kazimierz Witkowski acknowledge support by the Polish Ministry of Science and Higher Education, grant number 0011/RS3/2015/53. There was no additional external funding received for this study.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Benjaminse A, 2017, J ATHL TRAINING, V52, P993, DOI 10.4085/1062-6050-52.10.11; Bonnechere B, 2017, GAIT POSTURE, V57, P35, DOI 10.1016/j.gaitpost.2017.05.025; Bronner S, 2016, J SCI MED SPORT, V19, P267, DOI 10.1016/j.jsams.2015.03.003; Buszard T, 2016, SPORTS MED, V46, P829, DOI 10.1007/s40279-015-0452-2; Daigo T., 2005, THROWING TECHNIQUES; de Vries AW, 2018, GAIT POSTURE, V59, P111, DOI 10.1016/j.gaitpost.2017.10.006; Mendes FAD, 2012, PHYSIOTHERAPY, V98, P217, DOI 10.1016/j.physio.2012.06.001; Farsi A, 2016, PERCEPT MOTOR SKILL, V123, P477, DOI 10.1177/0031512516662896; Fitzpatrick A, 2018, HUM MOVEMENT SCI, V58, P80, DOI 10.1016/j.humov.2018.01.007; Hodges NJ, 2007, J SPORT SCI, V25, P531, DOI 10.1080/02640410600946860; Hodges NJ, 2003, J MOTOR BEHAV, V35, P247, DOI 10.1080/00222890309602138; Hodges NJ, 2001, RES Q EXERCISE SPORT, V72, P132, DOI 10.1080/02701367.2001.10608943; Horn RR, 2005, J MOTOR BEHAV, V37, P265; Horn RR, 2002, J SPORT SCI, V20, P253, DOI 10.1080/026404102317284808; Ivarsson A, 2013, PSYCHOL SPORT EXERC, V14, P97, DOI 10.1016/j.psychsport.2012.07.007; Johnson TM, 2016, J SCI MED SPORT, V19, P432, DOI 10.1016/j.jsams.2015.05.002; Kano J., 2013, KODOKAN JUDO; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mobini A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0070-0; Motiian S, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0102-9; Otte K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166532; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Pompeu JE, 2014, PHYSIOTHERAPY, V100, P162, DOI 10.1016/j.physio.2013.10.003; Pompeu JE, 2012, PHYSIOTHERAPY, V98, P196, DOI 10.1016/j.physio.2012.06.004; Sacripanti A., 1987, 5 INT S BIOMECHANICS, P181; SAWILOWSKY SS, 1990, REV EDUC RES, V60, P91, DOI 10.3102/00346543060001091; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tupa O, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0092-7; Voyer D, 2017, HUM MOVEMENT SCI, V54, P110, DOI 10.1016/j.humov.2017.04.004; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wolpert DM, 2013, PRINCIPLES NEURAL SC; Woolford K., 2015, P 2 INT WORKSH MOV C P 2 INT WORKSH MOV C, P112, DOI DOI 10.1145/2790994.2791002; Wrisberg C, 2004, MOTOR LEARNING PERFO	36	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210260	10.1371/journal.pone.0210260	http://dx.doi.org/10.1371/journal.pone.0210260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726211	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000017
J	Alali, S; Mereghetti, V; Faoro, F; Bocchi, S; Al Azmeh, F; Montagna, M				Alali, Sumer; Mereghetti, Valeria; Faoro, Franco; Bocchi, Stefano; Al Azmeh, Fawaz; Montagna, Matteo			Thermotolerant isolates of Beauveria bassiana as potential control agent of insect pest in subtropical climates	PLOS ONE			English	Article							ENTOMOPATHOGENIC FUNGI; SEQUENCE ALIGNMENT; TEMPERATURE; IDENTIFICATION; PATHOGENICITY; ADAPTATION	The use of Beauveria bassiana in biological control of agricultural pests is mainly hampered by environmental factors, such as elevated temperatures and low humidity. These limitations, further amplified in a global warming scenario, could nullify biological control strategies based on this fungus. The identification of thermotolerant B. bassiana isolates represents a possible strategy to overcome this problem. In this study, in order to maximize the probability in the isolation of thermotolerant B. bassiana, soil samples and infected insects were collected in warm areas of Syria. The obtained fungal isolates were tested for different biological parameters (i.e., growth rate, sporulation and spore germination) at growing temperatures ranging from 20 degrees C to 35 degrees C. Among these isolates (eight from insects and 11 from soil samples), the five with the highest growth rate, spore production and germination at 30 degrees C were tested for their entomopathogenicity through in vivo assays on Ephestia kuehniella larvae. Insect mortality induced by the five isolates ranged from 31% to 100%. Two isolates, one from Phyllognathus excavatus and one from soil, caused 50% of the larval mortality in less than four days, reaching values exceeding 92% in ten days. These two isolates were molecularly identified as B. bassiana sensu stricto by using three markers (i.e., ITS, Bloc and EF1-alpha). Considering these promising results, further studies are ongoing, testing their efficiency in field conditions as control agents for agricultural insect pests in Mediterranean and Subtropical regions.	[Alali, Sumer; Mereghetti, Valeria; Faoro, Franco; Montagna, Matteo] Univ Milan, Dipartimento Sci Agr & Ambientali, Milan, Italy; [Alali, Sumer; Al Azmeh, Fawaz] Natl Commiss Biotechnol, Damascus, Syria; [Bocchi, Stefano] Univ Milan, Dipartimento Sci & Polit Ambientali, Milan, Italy	University of Milan; University of Milan	Montagna, M (corresponding author), Univ Milan, Dipartimento Sci Agr & Ambientali, Milan, Italy.	matteo.montagna@unimi.it	Faoro, Franco/O-6631-2017; Montagna, Matteo/AAF-8281-2021; Alali, Sumer/AAG-2766-2019	Faoro, Franco/0000-0003-2620-9171; Montagna, Matteo/0000-0003-4465-7146; Alali, Sumer/0000-0002-5191-8298				Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abdulhai M., 2010, Pakistan Journal of Biological Sciences, V13, P1052, DOI 10.3923/pjbs.2010.1052.1056; Abrol DP, 2016, BREEDING OILSEED CROPS FOR SUSTAINABLE PRODUCTION: OPPORTUNITIES AND CONSTRAINTS, P523, DOI 10.1016/B978-0-12-801309-0.00020-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amusa, 2010, FACT REPORTS, V4; Arooni-Hesari M., 2015, Advances in Bioscience and Biotechnology, V6, P501, DOI 10.4236/abb.2015.68052; Barford E., 2013, NATURE, V10, P13644, DOI DOI 10.1038/NATURE.2013.13644; Becker AB, 1993, R VERSION RAY BROWNR; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Castellanos-Moguel Judith, 2013, Rev. Mex. Mic, V38, P23; Cilas C, 2016, CLIMATE CHANGE AGR W, P73, DOI DOI 10.1007/978-94-017-7462-8_6; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Quiroz RD, 2015, CRIT REV BIOTECHNOL, V35, P326, DOI 10.3109/07388551.2013.857292; Diebel J, 2013, J AGROBIOL, V26, P75; DOBERSKI JW, 1980, T BRIT MYCOL SOC, V74, P95, DOI 10.1016/S0007-1536(80)80013-1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ergon A, 2018, EUR J AGRON, V92, P97, DOI 10.1016/j.eja.2017.09.016; Faraji S., 2013, African Journal of Agricultural Research, V8, P4157; Fernandes EKK, 2015, CURR GENET, V61, P427, DOI 10.1007/s00294-015-0492-z; FERRON P, 1978, ANNU REV ENTOMOL, V23, P409, DOI 10.1146/annurev.en.23.010178.002205; Goettel Mark S., 2000, P255; Goettel MS, 1997, MANUAL TECHNIQUES IN, P211; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hiromori H, 2004, APPL ENTOMOL ZOOL, V39, P389, DOI 10.1303/aez.2004.389; Huang B, 2002, MYCOTAXON, V81, P229; Humber RA, 1998, WORKSH JOINTL SPONS; Iglesias A, 2015, AGR WATER MANAGE, V155, P113, DOI 10.1016/j.agwat.2015.03.014; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Koenraadt CJM, 2011, SCIENCE, V332, P175, DOI 10.1126/science.332.6026.175; Kooyman C, 1997, P ROY SOC B-BIOL SCI, V264, P541, DOI 10.1098/rspb.1997.0077; Kryukov VY, 2012, MICROBIOLOGY+, V81, P453, DOI 10.1134/S002626171204011X; Kumar Sarwan, 2017, Journal of Entomology and Zoology Studies, V5, P185; Lacey LA, 1979, MANUAL TECHNIQUES IN, P1; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Meyling NV, 2007, METHODS ISOLATION EN; MILNER RJ, 1991, J INVERTEBR PATHOL, V57, P121, DOI 10.1016/0022-2011(91)90048-U; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Mustafa U., 2010, INT J BIOTECHNOLOGY, V6, P701; ODDS FC, 1991, J MED VET MYCOL, V29, P355; Ortiz-Urquiza A, 2015, APPL MICROBIOL BIOT, V99, P1057, DOI 10.1007/s00253-014-6270-x; Parker BL, 2003, BIOL CONTROL, V27, P260, DOI 10.1016/S1049-9644(03)00017-3; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Safavi Seyed Ali, 2010, Journal of Plant Protection Research, V50, P158, DOI 10.2478/v10045-010-0027-z; SOSAGOMEZ DR, 1994, PESQUI AGROPECU BRAS, V29, P401; StLeger RJ, 1997, MICROBIOL-UK, V143, P1983, DOI 10.1099/00221287-143-6-1983; SUTHERST RW, 1990, SEARCH, V21, P230; Vidal C., 2007, Use of entomopathogenic fungi in biological pest management, P39; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Yeo H, 2003, PEST MANAG SCI, V59, P156, DOI 10.1002/ps.622	54	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211457	10.1371/journal.pone.0211457	http://dx.doi.org/10.1371/journal.pone.0211457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707750	Green Submitted, Green Published, gold			2022-12-26	WOS:000457742900026
J	Dierickx, S; Balen, J; Longman, C; Rahbari, L; Clarke, E; Jarju, B; Coene, G				Dierickx, Susan; Balen, Julie; Longman, Chia; Rahbari, Ladan; Clarke, Ed; Jarju, Bintou; Coene, Gily			We are always desperate and will try anything to conceive': The convoluted and dynamic process of health seeking among women with infertility in the West Coast Region of The Gambia	PLOS ONE			English	Article							PERSPECTIVES; BEHAVIOR; MALARIA; GENDER	Introduction In many Sub-Saharan African countries, women with infertility search relentlessly for treatment. Guided by the Partners for Applied Social Sciences model for health seeking behaviour and access to care research, this study aims to understand the health seeking behaviour of women with infertility in the West Coast region of The Gambia and the influence of aetiological beliefs on health seeking paths. Methodology A qualitative approach was used to generate both primary and secondary data for thematic analysis. The data collection methods included in-depth interviews (36), observations (18), informal conversations (42), group discussion (7) and made use of pile-sorting exercises. Sources of secondary data included government and non-governmental reports and media outputs. Results The health seeking approaches of women living in both rural and urban areas were extremely complex and dynamic, with women reporting that they looked for biomedical treatment as well as seeking indigenous treatment provided by local healers, sacred places and kanyaleng groups. While treatment choice was related to the perceived aetiology of infertility, it was also strongly influenced by the perceived effectiveness of the treatment available and the duration of the fertility problems. Other relevant factors were the affordability, accessibility and availability of treatment and respondents' family and social networks, whereby access to the biomedical health sector was strongly influenced by people's socio-economic background. Conclusion On the basis of this analysis and our wider research in the area, we see a need for health authorities to further invest in providing information and counselling on issues related to infertility prevention and treatment. The availability of locally applicable guidelines for the management of infertility for both men and women at all levels of the health system would facilitate such work. In addition, the public sphere should provide more space for alternative forms of social identity for both men and women.	[Dierickx, Susan; Rahbari, Ladan; Coene, Gily] Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect RHEA, Brussels, Belgium; [Dierickx, Susan; Longman, Chia; Rahbari, Ladan] Univ Ghent, Ctr Res Culture & Gender, Ghent, Belgium; [Balen, Julie] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Clarke, Ed; Jarju, Bintou] London Sch Hyg & Trop Med, Vaccines & Immun Theme, MRC, Unit Gambia, Fajara, Gambia	Vrije Universiteit Brussel; Ghent University; University of Sheffield; University of London; London School of Hygiene & Tropical Medicine	Dierickx, S (corresponding author), Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect RHEA, Brussels, Belgium.; Dierickx, S (corresponding author), Univ Ghent, Ctr Res Culture & Gender, Ghent, Belgium.	Susan.Dierickx@vub.be	Rahbari, Ladan/C-8497-2018	Rahbari, Ladan/0000-0002-3840-708X; Dierickx, Susan/0000-0003-3140-0771; Balen, Julie/0000-0002-4736-8465; Longman, Chia/0000-0002-3919-0353; coene, gily/0000-0002-8158-0718	FWO (Research Foundation-Flanders) [GM274.15N]; Global Minds Fund Operational Grant (VLIR-Ghent University); VLIRUOS; Belgian Department of Development Cooperation; MRC [MC_EX_MR/R006148/1, MC_UP_A900_1115] Funding Source: UKRI	FWO (Research Foundation-Flanders)(FWO); Global Minds Fund Operational Grant (VLIR-Ghent University); VLIRUOS; Belgian Department of Development Cooperation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GC and CL received funding by the FWO (Research Foundation-Flanders) (GM274.15N) (http://www.fwo.be/).SD and CL received funding from the Global Minds Fund Operational Grant (VLIR-Ghent University) with the support of VLIRUOS and the Belgian Department of Development Cooperation (https://www.ugent.be/en/research/funding/devcoop/globalmindsfund.htm).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola O, 2013, NIGERIA AFR HLTH SCI, V13, P1126, DOI DOI 10.4314/AHS.V13I4.37; [Anonymous], 2007, JAMMEHS AIDS CURE RE; [Anonymous], 2009, 3 BATCH 130 PATIENTS; [Anonymous], 2015, PRESIDENT DECLARES B; [Anonymous], 2007, MORE HIV AIDS PATIEN; [Anonymous], 2007, 27 SHORT LISTED HIV; [Anonymous], 2007, PRESIDENT JAMMEH REA; [Anonymous], 2007, GAMBIANS MARCH SOLID; [Anonymous], 2007, 4 BATCH HIV AIDS PAT; [Anonymous], 2007, JAMMEH APPOINTED HON; [Anonymous], 2018, INT CHILDRENS DAY BR; [Anonymous], 2010, PRESIDENT JAMMEHS AI; [Anonymous], 2007, JAMMEHS BREAKTHROUGH; [Anonymous], 2007, PRESIDENT JAMMEH DIS; [Anonymous], 2007, PRESIDENT JAMMEH CUR; [Anonymous], 2007, 27 START HIV AIDS TR; [Anonymous], 2007, PRESIDENT JAMMEH STA; [Anonymous], 2014, GAMBIA DEMOGRAPHIC H; [Anonymous], 2008, PRESIDENT ANNOUNCES; [Anonymous], 2015, PRESIDENT JAMMEH DEC; [Anonymous], 2007, PRESIDENT JAMMEH TRE; [Anonymous], 2015, SKINNY JEANS UNDERWE; [Anonymous], 2013, 261 WOMEN TURN PRESI; [Anonymous], 2007, PRESIDENT JAMMEH ANN; [Anonymous], 2015, 12 BATCH INFERTILE W; Bernard H. R., 2017, RES METHODS ANTHR; Bledsoe Caroline., 2002, CONTINGENT LIVES FER, P285; Ceesay A, 2011, PRESIDENTIAL ALTERNA; Ceesay A, 2010, 6 BATCH HIV AIDS PAT; Ceesay H, 2017, CONSULTATION ISLAM F; Ceesay SM, 2018, THE POINT; Darboe M, 2018, THE VOICE; de Kok BC, 2009, HEALTH-LONDON, V13, P197, DOI 10.1177/1363459308099684; de Kok BC, 2006, CONSTRUCTING INFERTI; de Kok BC, 2013, FAM RELATSH SOC, V2, P23, DOI 10.1332/204674313X664680; Dem F, 2017, THE POINT; Dhont N, 2011, Facts Views Vis Obgyn, V3, P77; Dhont N, 2011, HUM REPROD, V26, P623, DOI 10.1093/humrep/deq373; Dhont N, 2010, HUM REPROD, V25, P2024, DOI 10.1093/humrep/deq161; Dierickx S, 2018, BMC REPROD HEAL REPR, V15, P1; Donkor ES, 2008, AFR J NURS MIDWIFERY, V10, P22; Dyer SJ, 2007, J PSYCHOSOM OBST GYN, V28, P69, DOI 10.1080/01674820701409959; Fehintola AO, 2017, SUDAN J MED SCI, V12, P63, DOI 10.18502/sjms.v12i2.917; Fledderjohann JJ, 2012, HUM REPROD, V27, P1383, DOI 10.1093/humrep/des035; Fledderjohann J, 2016, J BIOSOC SCI, V48, P431, DOI 10.1017/S0021932015000310; Gambie C., 2018, SAFE HAVEN ASS SOUTI; Gerrits T, 1997, PATIENT EDUC COUNS, V31, P39, DOI 10.1016/S0738-3991(97)01018-5; Gijsels M, 2001, WOMEN INFERTILITY SU, P204; Greenhalgh S., 1995, SITUATING FERTILITY, P3, DOI DOI 10.1017/CBO9780511621611.002; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Hausmann-Muela S, 2012, MALAR REP, V2, P17; Hausmann-muela S, 2012, PLOS ONE, V7; HEALTH IS WEALTH, 2007, HLTH IS WEALTH HLTH; Horbst V., 2012, FACTS VIEWS VIS OBGY, V21, P46; Ibisomi L, 2014, CULT HEALTH SEX, V16, P61, DOI 10.1080/13691058.2013.839828; Inhorn M. C., 1995, INFERTILITY PATRIARC; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; INHORN MC, 1994, SOC SCI MED, V39, P459, DOI 10.1016/0277-9536(94)90089-2; Jaiteh F, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1255-0; Jammeh AF, 2016, PRESIDENT JAMMEH CAL; Jammeh YAJJ, 2008, CELEBRATION 1 ANNIVE; Lowe M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163653; MacDouall-Gaya N, 2008, CELEBRATION HIV AIDS; Marong OP, 2013, PRESIDENT JAMMEH HAR; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Mbowe T, 2008, CELEBRATION HIV AIDS; Mbowe T, 2011, PRESIDENTS ALTERNATI; Muela Ribera J., 2013, WOMEN AIDS ACCESS HL, P105; Mumtaz Z, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-3; Nahar Papreen, 2011, Anthropol Med, V18, P327, DOI 10.1080/13648470.2011.615911; Ndow M, 2013, DAILY OBSERVER  0315; Njie A, 2011, PATP DISCHARGES ANOT; Njie A, 2011, PRESIDENTS INFERTILI; Njie A, 2011, COUNTDOWN 4 ANNIVERS; Njie A, 2011, HLTH MINISTRY MICROS; Njie A., 2011, PRESIDENT JAMMEH TAK; Njie M., 2008, SECRETARY STATE HLTH; O'Neill S, 2017, WOMEN STUD INT FORUM, V60, P136, DOI 10.1016/j.wsif.2016.11.003; O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Saine A., 2012, CULTURE CUSTOMS GAMB; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sanneh A, 2008, HEAD PRESIDENTIAL ME; Sanneh S., 2008, HIV AIDS CURED PATIE; Sey O, 2015, MINISTER HLTH SOCIAL, P1; Sundby J, 1997, PATIENT EDUC COUNS, V31, P29, DOI 10.1016/S0738-3991(97)01006-9; Sundby J, 1998, SOC SCI MED, V46, P891, DOI 10.1016/S0277-9536(97)00215-3; Tanner P., 2017, POLITICAL CHANGE PUB; Towns AM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-113; Van der Sijpt E., 2011, AMBIGUOUS AMBITIONS; Veep Kuyateh H., 2018, THE VOICE; Verschuere J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1732-0; Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6; Walraven G, 2016, MENSTRUAL DISORDERS, V33, P261; Witsenburg C, 2016, PLANNED PARENTHOOD C, P1; Witsenburg C, 2016, THE POINT; Wright D. R., 2010, WORLD VERY SMALL PLA	97	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211634	10.1371/journal.pone.0211634	http://dx.doi.org/10.1371/journal.pone.0211634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703136	Green Accepted, Green Published, gold			2022-12-26	WOS:000457301600064
J	Pavlik, V; Sojka, M; Mazurova, M; Velebny, V				Pavlik, Vojtech; Sojka, Martin; Mazurova, Maria; Velebny, Vladimir			Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents	PLOS ONE			English	Article							INHIBITION; MATRIX-METALLOPROTEINASE-9	Objectives The majority of human chronic wounds contain bacterial biofilms, which produce proteases and retard the resolution of inflammation. This in turn leads to elevated patient protease activity. Chronic wounds progressing towards closure show a reduction in proteolytic degradation. Therefore, the modulation of protease activity may lead to the faster healing of chronic wounds. Antimicrobials are used to control biofilm-based infection; however, some of them also exhibit the inhibition of matrix metalloproteinases and bacterial proteases. We investigated the antimicrobial agents used in wound healing for their potential to inhibit bacterial and host proteases relevant to chronic wounds. Methods Using in vitro zymography, we tested the ability of povidone-iodine, silver lactate, chlorhexidine digluconate, and octenidine hydrochloride to inhibit selected human proteases and proteases from Pseudomonas aeruginosa, Staphylococcus aureus, Serratia marcescens, and Serratia liquefaciens. We investigated penetration and skin protease inhibition by means of in situ zymography. Results All the tested antimicrobials inhibited both eukaryotic and prokaryotic proteases in a dose-dependent manner in vitro. The tested compounds were also able to penetrate into skin ex vivo and inhibit the resident proteases. Silver lactate and chlorhexidine digluconate showed an inhibitory effect ex vivo even in partial contact with skin in Franz diffusion cells. Conclusions Our in vitro and ex vivo results suggest that wound healing devices which contain iodine, silver, chlorhexidine, and octenidine may add value to the antibacterial effect and also aid in chronic wound healing. Antiprotease effects should be considered in the design of future antimicrobial wound healing devices.	[Pavlik, Vojtech; Mazurova, Maria; Velebny, Vladimir] Contipro, Cell Physiol Res Grp, Dolni Dobrouc, Czech Republic; [Pavlik, Vojtech] Charles Univ Prague, Med Fac 3, Inst Dermatol, Prague, Czech Republic; [Sojka, Martin] Slovak Med Univ, Fac Med, Inst Microbiol, Bratislava, Slovakia	Charles University Prague; Comenius University Bratislava; Slovak Academy of Sciences; Slovak Medical University Bratislava	Pavlik, V (corresponding author), Contipro, Cell Physiol Res Grp, Dolni Dobrouc, Czech Republic.; Pavlik, V (corresponding author), Charles Univ Prague, Med Fac 3, Inst Dermatol, Prague, Czech Republic.	vojtech.pavlik@contipro.com		Mazurova, Maria/0000-0001-7602-4293; Pavlik, Vojtech/0000-0002-6575-9726; Sojka, Martin/0000-0003-4099-433X	Contipro	Contipro	The work was funded by internal research grant of Contipro. The funder provided support in the form of salaries for authors [VP, MS, MM, VV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BALLINGER PM, 1982, BRIT J PHARMACOL, V77, P147, DOI 10.1111/j.1476-5381.1982.tb09280.x; BEIGHTON D, 1991, J CLIN PERIODONTOL, V18, P85, DOI 10.1111/j.1600-051X.1991.tb01693.x; Eming SA, 2006, J INVEST DERMATOL, V126, P2731, DOI 10.1038/sj.jid.5700474; Gendron R, 1999, CLIN DIAGN LAB IMMUN, V6, P437, DOI 10.1128/CDLI.6.3.437-439.1999; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; HJELJORD LG, 1973, J PERIODONTAL RES, P11, DOI 10.1111/j.1600-0765.1973.tb02158.x; Kloeters O, 2016, INT WOUND J, V13, P1231, DOI 10.1111/iwj.12449; Kodedova M, 2011, BIOTECHNIQUES, V50, P58, DOI 10.2144/000113568; Kucera J, 2014, J MICROBIOL METH, V103, P18, DOI 10.1016/j.mimet.2014.05.008; lukemiller.org, AN GELS W BLOTS IMAG; McCarty SM, 2015, INT WOUND J, V12, P89, DOI 10.1111/iwj.12058; McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370; Mei ML, 2012, DENT MATER, V28, P903, DOI 10.1016/j.dental.2012.04.011; Mirastschijski U, 2002, HUM PATHOL, V33, P355, DOI 10.1053/hupa.2002.32221; R Core Team, 2018, R LANG ENV STAT COMP; RAMACHANDRAN LK, 1956, CHEM REV, V56, P109; Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Shi L, 2010, ADV SKIN WOUND CARE, V23, P456, DOI 10.1097/01.ASW.0000383224.64524.ae; Smejkalova D, 2017, CARBOHYD POLYM, V156, P86, DOI 10.1016/j.carbpol.2016.09.013; Stahl J, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-44; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Tseng KH, 2011, J NANOSCI NANOTECHNO, V11, P1991, DOI 10.1166/jnn.2011.3533	23	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211055	10.1371/journal.pone.0211055	http://dx.doi.org/10.1371/journal.pone.0211055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703114	Green Submitted, gold, Green Published			2022-12-26	WOS:000457301600028
J	Suwannahitatorn, P; Webster, J; Riley, S; Mungthin, M; Donnelly, CA				Suwannahitatorn, Picha; Webster, Joanne; Riley, Steven; Mungthin, Mathirut; Donnelly, Christl A.			Uncooked fish consumption among those at risk of Opisthorchis viverrini infection in central Thailand	PLOS ONE			English	Article								In contrast to northern and northeastern Thailand, central Thailand was believed not to be endemic for Opisthorchis viverrini (OV). Fieldwork conducted in a rural area of central Thailand revealed that the prevalence and incidence were relatively high compared with regional average data. We hypothesized that the behavioural-psycho-social background of the study population might play an important role in the high burden of the infection. As a result, a qualitative study was conducted to highlight potential social determinants of the infection dynamics to gain greater understanding of the risk behaviours and their contexts. A qualitative study using focus group discussion and in-depth interviews was conducted in Na-ngam Village, Chachoengsao Province from 2012-14. Framework analysis was used to explore associations between infection and thematic content. Social influence showed a strong impact on infection dynamics of OV infection. Our results revealed that Koi pla (chopped raw fish salad) remains a popular dish in the community, as the dish itself represents northeastern culture. The cultural norm had been transferred from ancestors to their descendants. Some elders complained that discontinuing the consumption of Koi pla went against old traditions with respect to cultural norms and socialization. In contrast, modern education teaches about hygiene including OV infection risks, and accordingly teenagers and young adults were reported to modify their lifestyles including their eating habits. Children are a potential key to pass knowledge to their parents and school-based education programs can serve as a practical hub for knowledge dissemination. However, health education alone might not lead to behavioural change in other age groups. Therefore, more efforts are needed to support the transformation.	[Suwannahitatorn, Picha; Mungthin, Mathirut] Phramongkutklao Coll Med, Dept Parasitol, Bangkok, Thailand; [Webster, Joanne] Univ London, CEEED, Dept Pathol & Pathogen Biol, Royal Vet Coll, London, England; [Riley, Steven; Donnelly, Christl A.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England	Phramongkutklao College of Medicine; University of London; University of London Royal Veterinary College; Imperial College London; University of Oxford	Suwannahitatorn, P (corresponding author), Phramongkutklao Coll Med, Dept Parasitol, Bangkok, Thailand.	picha.s@pcm.ac.th		Suwannahitatorn, Picha/0000-0001-9043-0108; Webster, Joanne P./0000-0001-8616-4919	Phramongkutklao College of Medicine Research Fund; MRC [MR/R015600/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER	Phramongkutklao College of Medicine Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was fully supported by Phramongkutklao College of Medicine Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RH, 2008, TRENDS PARASITOL, V24, P497, DOI 10.1016/j.pt.2008.08.011; Chai Jong-Yil, 2007, Korean Journal of Parasitology, V45, P213, DOI 10.3347/kjp.2007.45.3.213; Conlan JV, 2011, VET PARASITOL, V182, P22, DOI 10.1016/j.vetpar.2011.07.013; Fried B, 2011, CANCER LETT, V305, P239, DOI 10.1016/j.canlet.2010.07.008; Furst T, 2012, INFECT DIS CLIN N AM, V26, P399, DOI 10.1016/j.idc.2012.03.008; Green J., 2018, QUALITATIVE METHODS, VFourth; Grundy-Warr C, 2012, PARASITOL INT, V61, P65, DOI 10.1016/j.parint.2011.06.015; Jongsuksuntigul P., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P327; Jongsuksuntigul P., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P551; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Jongsuksuntigul P, 2001, J TROP MED PARASITOL, P18; Kaewkes S, 2003, ACTA TROP, V88, P177, DOI 10.1016/j.actatropica.2003.05.001; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P2297, DOI 10.3748/wjg.14.2297; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P666, DOI 10.3748/wjg.14.666; Kaewpitoon N, 2007, WORLD J GASTROENTERO, V13, P1837, DOI 10.3748/wjg.v13.i12.1837; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Lim JH, 2011, KOREAN J RADIOL, V12, P269, DOI 10.3348/kjr.2011.12.3.269; Padchasuwan Natnapa, 2016, Asian Pac J Cancer Prev, V17, P3721; Poomphakwaen K, 2009, RISK FACTORS CHOLANG, P251; Rangsin R, 2009, AM J TROP MED HYG, V81, P152, DOI 10.4269/ajtmh.2009.81.152; Saengsawang P, 2013, ASIAN PAC J CANCER P, V14, P2963, DOI 10.7314/APJCP.2013.14.5.2963; Saengsawang P, 2012, ASIAN PAC J CANCER P, V13, P3399, DOI 10.7314/APJCP.2012.13.7.3399; Sithithaworn P, 2003, ACTA TROP, V88, P187, DOI 10.1016/j.actatropica.2003.02.001; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Smout MJ, 2011, MOL BIOSYST, V7, P1367, DOI 10.1039/c0mb00295j; Songserm N, 2012, CANCER EPIDEMIOL, V36, pE89, DOI 10.1016/j.canep.2011.11.007; Sripa B, 2003, ACTA TROP, V88, P209, DOI 10.1016/j.actatropica.2003.08.002; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2017, PARASITOL INT, V66, P346, DOI 10.1016/j.parint.2016.11.013; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Strandgaard Hanne, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P19; Suwannahitatorn P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-188; Traub RJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000367; Vennervald BJ, 2009, PARASITE IMMUNOL, V31, P686, DOI 10.1111/j.1365-3024.2009.01163.x; Wingood GM, 1997, HLTH BEHAV HLTH ED T, V7, P425, DOI [10.1016/S1047-2797(97)00049-5, DOI 10.1016/S1047-2797(97)00049-5]; Wongratanacheewin S, 2003, ACTA TROP, V88, P195, DOI 10.1016/j.actatropica.2003.02.002; Xayaseng V, 2013, ACTA TROP, V127, P105, DOI 10.1016/j.actatropica.2013.03.016	38	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211540	10.1371/journal.pone.0211540	http://dx.doi.org/10.1371/journal.pone.0211540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703149	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000457301600056
J	Li, B; Hock, A; Wu, RY; Minich, A; Botts, SR; Lee, C; Antounians, L; Miyake, H; Koike, Y; Chen, Y; Zani, A; Sherman, PM; Pierro, A				Li, Bo; Hock, Alison; Wu, Richard Y.; Minich, Adam; Botts, Steven R.; Lee, Carol; Antounians, Lina; Miyake, Hiromu; Koike, Yuhki; Chen, Yong; Zani, Augusto; Sherman, Philip M.; Pierro, Agostino			Bovine milk-derived exosomes enhance goblet cell activity and prevent the development of experimental necrotizing enterocolitis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BREAST-MILK; STEM-CELLS; GROWTH; INJURY; MODELS; GRP94; WNT	Necrotizing enterocolitis (NEC) is characterized by intestinal injury and impaired mucin synthesis. We recently showed that breast milk exosomes from rodents promote intestinal cell viability, epithelial proliferation, and stem cell activity, but whether they also affect mucus production is unknown. Therefore, the aim of this study was to investigate the effects of bovine milk-derived exosomes on goblet cell expression in experimental NEC and delineate potential underlying mechanisms of action. Exosomes were isolated from bovine milk by ultracentrifugation and confirmed by Nanoparticle Tracking Analysis and through the detection of exosome membrane markers. To study the effect on mucin production, human colonic LS174T cells were cultured and exposed to exosomes. Compared to control, exosomes promoted goblet cell expression, as demonstrated by increased mucin production and relative expression levels of goblet cell expression markers trefoil factor 3 (TFF3) and mucin 2 (MUC2). In addition, exosome treatment enhanced the expression of glucose-regulated protein 94 (GRP94), the most abundant intraluminal endoplasmic reticulum (ER) chaperone protein that aids in protein synthesis. Furthermore, experimental NEC was induced in mouse pups by hyperosmolar formula feeding, lipopolysaccharide administration and hypoxia exposure on postnatal days 5-9. Milk exosomes were given with each gavage feed. NEC was associated with ileal morphological injury and reduction in MUC2+ goblet cells and GRP94+ cells per villus. Exosome administration to NEC pups prevented these changes. This research highlights the potential novel application of milk-derived exosomes in preventing the development of NEC in high-risk infants when breast milk is not available.	[Li, Bo; Hock, Alison; Minich, Adam; Lee, Carol; Miyake, Hiromu; Koike, Yuhki; Chen, Yong; Pierro, Agostino] Hosp Sick Children, Translat Med Program, Toronto, ON, Canada; [Li, Bo; Hock, Alison; Minich, Adam; Lee, Carol; Miyake, Hiromu; Koike, Yuhki; Chen, Yong; Zani, Augusto; Pierro, Agostino] Univ Toronto, Hosp Sick Children, Div Gen & Thorac Surg, Toronto, ON, Canada; [Wu, Richard Y.; Botts, Steven R.; Sherman, Philip M.] Hosp Sick Children, Cell Biol Program, Toronto, ON, Canada; [Antounians, Lina; Zani, Augusto] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Sherman, Philip M.] Univ Toronto, Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Pierro, A (corresponding author), Hosp Sick Children, Translat Med Program, Toronto, ON, Canada.; Pierro, A (corresponding author), Univ Toronto, Hosp Sick Children, Div Gen & Thorac Surg, Toronto, ON, Canada.	agostino.pierro@sickkids.ca	Zani, Augusto/AAA-5088-2019; Li, Bo/AAP-6556-2020; Botts, Steven/AAQ-5630-2020	Li, Bo/0000-0002-8298-8344; Botts, Steven/0000-0002-2420-4679; Antounians, Lina/0000-0002-8307-3306; ZANI, AUGUSTO/0000-0003-2283-9846	Canadian Institutes of Health Research (CIHR) Foundation [353857]; Restracomp Fellowship from The Hospital for Sick Children; Thrasher Research Fund [14503]; Vanier Graduate Scholarship from the CIHR; Canada Research Chair in Gastrointestinal Disease; Canadian Institutes of Health Resources	Canadian Institutes of Health Research (CIHR) Foundation(Canadian Institutes of Health Research (CIHR)); Restracomp Fellowship from The Hospital for Sick Children; Thrasher Research Fund; Vanier Graduate Scholarship from the CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Gastrointestinal Disease; Canadian Institutes of Health Resources(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research (CIHR) Foundation Grant 353857 (AP). AP is the Robert M. Filler Chair of Surgery, The Hospital for Sick Children (HSC). BL is the recipient of Restracomp Fellowship from The Hospital for Sick Children and Early Career Award Program grant from Thrasher Research Fund (14503). RYW is the recipient of a Vanier Graduate Scholarship from the CIHR. PMS is the recipient of a Canada Research Chair in Gastrointestinal Disease and Canadian Institutes of Health Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrazi A, 2014, J BIOL CHEM, V289, P9584, DOI 10.1074/jbc.M113.526517; Blackwood Brian P, 2017, J Probiotics Health, V5, DOI 10.4172/2329-8901.1000159; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Cornick S, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.982426; Dharmani P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025058; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Garcia C, 2013, Cell Mol Biol (Noisy-le-grand), V59, P108; Hall NJ, 2013, J PEDIATR SURG, V48, P2359, DOI 10.1016/j.jpedsurg.2013.08.006; Halpern MD, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2014.1000707; Hock A, 2017, J PEDIATR SURG, V52, P755, DOI 10.1016/j.jpedsurg.2017.01.032; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46616; Li B, 2016, J PEDIATR SURG, V51, P1001, DOI 10.1016/j.jpedsurg.2016.02.073; Li B, 2016, J PEDIATR SURG, V51, P775, DOI 10.1016/j.jpedsurg.2016.02.019; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Lu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078491; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McCulloh CJ, 2017, J SURG RES, V214, P278, DOI 10.1016/j.jss.2017.03.026; Paredes PT, 2014, ALLERGY, V69, P463, DOI 10.1111/all.12357; Pipino C, 2018, STEM CELLS DEV, V27, P1587, DOI 10.1089/scd.2018.0114; Quigley MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub2; Quigley M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub3; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; Rasmussen SO, 2016, AM J PHYSIOL-GASTR L, V311, pG480, DOI 10.1152/ajpgi.00139.2016; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wu RY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800658; Xiao S, 2018, ARCH MED RES, V49, P1, DOI 10.1016/j.arcmed.2018.04.003; Zani A, 2016, PEDIATR SURG INT, V32, P65, DOI 10.1007/s00383-015-3813-x; Zani A, 2014, GUT, V63, P300, DOI 10.1136/gutjnl-2012-303735; Zonneveld MI, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24215	34	84	87	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211431	10.1371/journal.pone.0211431	http://dx.doi.org/10.1371/journal.pone.0211431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699187	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600077
J	Cheong, ML; Lai, TH; Wu, WB				Cheong, Mei-Leng; Lai, Tsung-Hsuan; Wu, Wen-Bin			Connective tissue growth factor mediates transforming growth factor beta-induced collagen expression in human endometrial stromal cells	PLOS ONE			English	Article							TGF-BETA; FIBROSIS; CCN2; MYOFIBROBLAST; HSP47	Background Adenomyosis is a medical condition defined by the abnormal presence of endometrial tissue within the myometrium, in which fibrosis occurs with new collagen deposition and myofibroblast differentiation. In this study, the effect of several mediators and growth factors on collagen expression was investigated on human endometrial stromal cells (fibroblasts) derived from adenomyotic endometrium. Experimental approach RT-PCR, Western blot analysis, pharmacological interventions and siRNA interference were applied to primary cultured human endometrial stromal cells (fibroblasts). Immunohistochemistry was used to analyze protein expression in adenomyotic endometrium tissue specimens. Results Of the tested mediators, transforming growth factor beta 1 (TGF beta 1) and its isoforms were effective to induce collagen and connective tissue growth factor (CTGF) expression. Collagen and CTGF induction by TGF beta 1 could be reduced by the inhibitors targeting DNA transcription, protein translation, and Smad2/3 signaling. Interestingly, TGF beta 1 induced Smad2/3 phosphorylation and CTGF mRNA expression, but not collagen mRNA expression, suggesting that TGF beta 1 mediates collagen expression through CTGF induction and Smad2/3 activation. In parallel, TGF beta 1 and CTGF also induced expression of heat shock protein (HSP) 47, a protein required for the synthesis of several types of collagens. However, only CTGF siRNA knockdown, could compromise TGF beta 1-induced collagen expression. Finally, the immunohistochemistry revealed vimentin- and alpha-SMA-positive staining for (myo) fibroblasts, TGF beta 1, collagen, and CTGF in the subepithelial stroma region of human adenomyotic endometria. Conclusion and implications We reveal here that TGF beta 1, collagen, and CTGF are expressed in the stroma of adenomyotic endometria and demonstrate that TGF beta 1 can induce collagen production in endometrium-derived fibroblasts through cellular Smad2/3-dependent signaling pathway and CTGF expression, suggesting that endometrial TGF beta may take part in the pathogenesis of adenomyosis and ectopic endometrium may participate in uterine adenomyosis.	[Cheong, Mei-Leng; Lai, Tsung-Hsuan] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Cheong, Mei-Leng] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan; [Lai, Tsung-Hsuan; Wu, Wen-Bin] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Wu, Wen-Bin] Fu Jen Catholic Univ, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan	Cathay General Hospital; Taipei Medical University; Fu Jen Catholic University; Fu Jen Catholic University	Wu, WB (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.; Wu, WB (corresponding author), Fu Jen Catholic Univ, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan.	wenbin@mail.fju.edu.tw	Wu, Wen-Bin/GLT-4711-2022		Cathay General Hospital, Taipei City, Taiwan [102-CGH-FJU-07]	Cathay General Hospital, Taipei City, Taiwan	The work was supported by the research grant (102-CGH-FJU-07) from Cathay General Hospital, Taipei City, Taiwan to WBW. There was no additional external funding received for this study.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Blaauboer ME, 2013, MATRIX BIOL, V32, P424, DOI 10.1016/j.matbio.2013.04.005; BONGSO A, 1988, HUM REPROD, V3, P705, DOI 10.1093/oxfordjournals.humrep.a136770; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; CAMPBELL ID, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a004994; Ding D, 2015, HUM REPROD, V30, P812, DOI 10.1093/humrep/dev025; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; FUJITA M, 1985, Hokkaido Journal of Medical Science, V60, P602; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Ibrahim MG, 2017, REPROD SCI, V24, P1410, DOI 10.1177/1933719116687855; Ikegami A, 1992, Nihon Sanka Fujinka Gakkai Zasshi, V44, P336; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kishi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189522; Kishi Y, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.027; Lai TH, 2015, INT J NANOMED, V10, P5925, DOI 10.2147/IJN.S88514; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Leppert PC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/783289; Lin CH, 2013, BBA-MOL CELL RES, V1833, P2823, DOI 10.1016/j.bbamcr.2013.07.016; Liu XS, 2016, HUM REPROD, V31, P734, DOI 10.1093/humrep/dew018; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsuzaki S, 2014, HUM REPROD, V29, P1677, DOI 10.1093/humrep/deu123; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Ota H, 1997, J Obstet Gynaecol Res, V23, P485; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ryan ST, 2003, J VASC RES, V40, P37, DOI 10.1159/000068937; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Shen MH, 2016, HUM REPROD, V31, P355, DOI 10.1093/humrep/dev314; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Van Bruaene N, 2012, CLIN EXP ALLERGY, V42, P883, DOI 10.1111/j.1365-2222.2011.03898.x; Vannuccini S, 2017, REPROD BIOMED ONLINE, V35, P592, DOI 10.1016/j.rbmo.2017.06.016; Xiao HB, 2012, AM J PHYSIOL-RENAL, V303, pF757, DOI 10.1152/ajprenal.00470.2011	38	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210765	10.1371/journal.pone.0210765	http://dx.doi.org/10.1371/journal.pone.0210765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695033	Green Submitted, gold, Green Published			2022-12-26	WOS:000457046400013
J	Montanier, N; Bernard, L; Lambert, C; Pereira, B; Desbiez, F; Terral, D; Abergel, A; Bohatier, J; Rosset, E; Schmidt, J; Sautou, V; Hadjadj, S; Batisse-Lignier, M; Tauveron, I; Maqdasy, S; Roche, B				Montanier, Nathanaelle; Bernard, Lise; Lambert, Celine; Pereira, Bruno; Desbiez, Francoise; Terral, Daniel; Abergel, Armand; Bohatier, Jerome; Rosset, Eugenio; Schmidt, Jeannot; Sautou, Valerie; Hadjadj, Samy; Batisse-Lignier, Marie; Tauveron, Igor; Maqdasy, Salwan; Roche, Beatrice			Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; TIGHT GLYCEMIC CONTROL; GLUCOSE CONTROL; HOSPITALIZED-PATIENTS; HYPERGLYCEMIA; PROTOCOL; MORTALITY; MANAGEMENT; HYPOGLYCEMIA; ASSOCIATION	Introduction Insulin infusion is recommended during management of diabetic patients in critical care units to rapidly achieve glycaemic stability and reduce the mortality. The application of an easy-to-use standardized protocol, compatible with the workload is preferred. Glycaemic target must quickly be reached, therefore static algorithms should be replaced by dynamic ones. The dynamic algorithm seems closer to the physiological situation and appreciates insulin sensitivity. However, the protocol must meet both safety and efficiency requirements. Indeed, apprehension from hypoglycaemia is the main deadlock with the dynamic algorithms, thus their application remains limited. In contrary to the critical care units, to date, no prospective study evaluated a dynamic algorithm of insulin infusion in non-critically ill patients. Aim This study primarily aimed to evaluate the efficacy of a dynamic algorithm of intravenous insulin therapy in non-critically-ill patients, and addressed its safety and feasibility in different departments of our university hospital. Methods A "before-after" study was conducted in five hospital departments (endocrinology and four "non-expert" units) comparing a dynamic algorithm (during the "after" period-P2) to the static protocol (the "before" period-P1). Static protocol is based on determining insulin infusion according to an instant blood glycaemia (BG) level at a given time. In the dynamic algorithm, insulin infusion rate is determined according to the rate of change of the BG (the previous and actual BG under a specific insulin infusion rate). Additionally, two distinct glycaemic targets were defined according to the patients' profile: 100-180 mg/dl (5.5-10 mmol/l) for vigorous patients and 140-220 mg/dl (7.8-12.2 mmol/l) for frail ones. Different BG measurements for each patient were collected and recorded in a specific database (e-CRF) in order to analyse the rates of hypo- and hyperglycaemia. A satisfaction survey was also performed. A study approval was obtained from the institutional revision board before starting the study. Results Over 8 months, 72 and 66 patients during P1 and P2 were respectively included. The dynamic algorithm was more efficient, with reduced time to control hyperglycaemia (P1 vs P2:8.3 vs 5.3 hours; HR: 2.02 [1.27; 3.21]; p<0.01), increased the number of in-target BG measurements (P1 vs P2: 37.0% vs 41.8%; p<0.05), and reduced the glycaemic variability related to each patient (P1 vs P2, %CV: 40.9 vs 38.2; p<0.05, Index Correlation Class:0.30 vs 0.14; p<0.05). In patients after the first event of hypoglycemia after having started the infusion, new events were lower (P1 vs P2: 19.4 vs 11.4; p<0.001) thanks to an earlier reaction to hypoglycaemia (8.3% during P1 vs 44.3% during P2; p=0.004). With the dynamic algorithm, the percentage of recurrence of mild hypoglycaemia was significantly lower in frail patients (20.5% vs 10.2%; p<0.001), and in patients managed in the non-expert units (18 vs 7.1%, p<0.001). The % CV was significantly improved in frail patients (36.9%). Mean BG measurements for each patient/day were 5.5 +/- 1.1 during P1 and 6.0 +/- 1.6 during P2 (p=0.6). The threat from hypoglycaemia and the difficulty in using dynamic algorithm are barriers for nurses' adherence. Conclusions This dynamic algorithm for non-critically-ill patients is more efficient and safe than the static protocol, and adapted for frail patients and non-expert units.	[Montanier, Nathanaelle; Desbiez, Francoise; Batisse-Lignier, Marie; Tauveron, Igor; Maqdasy, Salwan; Roche, Beatrice] CHU Clermont Ferrand, Serv Endocrinol Diabetol & Malad Metab, Clermont Ferrand, France; [Bernard, Lise; Sautou, Valerie] CHU Clermont Ferrand, Pole Pharm, Clermont Ferrand, France; [Lambert, Celine; Pereira, Bruno] CHU Clermont Ferrand, DRCI, Clermont Ferrand, France; [Terral, Daniel] CHU Clermont Ferrand, Serv Pediat Gen, Clermont Ferrand, France; [Abergel, Armand] CHU Clermont Ferrand, Serv Med Digest, Clermont Ferrand, France; [Bohatier, Jerome] CHU Clermont Ferrand, Serv Court Sejour Geriatr, Riom, France; [Rosset, Eugenio] CHU Clermont Ferrand, Serv Chirurg Vasc, Clermont Ferrand, France; [Schmidt, Jeannot] CHU Clermont Ferrand, Pole Urgences, Clermont Ferrand, France; [Hadjadj, Samy] CHU Poitiers, Serv Med Interne Endocrinol & Malad Metab, Poitiers, France; [Batisse-Lignier, Marie; Tauveron, Igor; Maqdasy, Salwan] Univ Clermont Auvergne, Lab GReD, UMR, CNRS 6293,INSERM U1103, Clermont Ferrand, France	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Maqdasy, S (corresponding author), CHU Clermont Ferrand, Serv Endocrinol Diabetol & Malad Metab, Clermont Ferrand, France.; Maqdasy, S (corresponding author), Univ Clermont Auvergne, Lab GReD, UMR, CNRS 6293,INSERM U1103, Clermont Ferrand, France.	smaqdasy@chu-clermontferrand.fr		SAUTOU, Valerie/0000-0002-3944-3752; MAQDASY, Salwan/0000-0001-5164-9879; Terral, Daniel/0000-0003-3706-6786				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2009, ANN FR ANESTH, V28, P410, DOI DOI 10.1016/J.ANNFAR.2009.02.020; Balkin M, 2007, DIABETES-METAB RES, V23, P49, DOI 10.1002/dmrr.673; Bernard L, 2016, J EVAL CLIN PRACT, V22, P683, DOI 10.1111/jep.12517; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Clergeau A, 2017, DIABETES TECHNOL THE, V19, P115, DOI 10.1089/dia.2016.0314; DeSantis Anthony J, 2006, Endocr Pract, V12, P491; DHondt NJ, 2008, DIABETES SPECTRUM, V21, P255; Dickerson RN, 2012, NUTRITION, V28, P1008, DOI 10.1016/j.nut.2012.01.010; Egi M, 2016, INTENS CARE MED, V42, P562, DOI 10.1007/s00134-016-4216-8; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Furnary Anthony P, 2004, Endocr Pract, V10 Suppl 2, P21; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Kelly Janet L, 2014, Diabetes Spectr, V27, P218, DOI 10.2337/diaspect.27.3.218; Kelly JL, 2006, SEMIN THORAC CARDIOV, V18, P346, DOI 10.1053/j.semtcvs.2006.06.004; Krikorian A, 2010, CURR OPIN CLIN NUTR, V13, P198, DOI 10.1097/MCO.0b013e32833571db; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2017, ENDOCR PRACT, V23, P318, DOI 10.4158/EP161532.OR; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Ku SY, 2005, JT COMM J QUAL PATIE, V31, P141, DOI 10.1016/S1553-7250(05)31019-1; Lien Lillian F, 2005, Endocr Pract, V11, P240; Malesker MA, 2007, AM J CRIT CARE, V16, P589; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; McCreedy EM, 2018, J AM BOARD FAM MED, V31, P192, DOI 10.3122/jabfm.2018.02.170141; Meijering S, 2006, CRIT CARE, V10, DOI 10.1186/cc3981; Miller I, 2015, J CLIN ENDOCR METAB, V100, pE1428, DOI 10.1210/jc.2015-2312; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Monnier L, 2017, DIABETES CARE, V40, P832, DOI 10.2337/dc16-1769; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P49, DOI 10.1210/jc.2011-2100; Noordzij PG, 2007, EUR J ENDOCRINOL, V156, P137, DOI 10.1530/eje.1.02321; Papak J, 2012, AM J CARDIOL, V110, p24B, DOI 10.1016/j.amjcard.2012.08.034; Passarelli AJ, 2016, DIABETES TECHNOL THE, V18, P93, DOI 10.1089/dia.2015.0046; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Rood E, 2005, J AM MED INFORM ASSN, V12, P172, DOI 10.1197/jamia.M1598; Smiley D, 2010, J HOSP MED, V5, P212, DOI 10.1002/jhm.646; Umpierrez G, 2015, DIABETES CARE, V38, P1665, DOI 10.2337/dc15-0303; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211425	10.1371/journal.pone.0211425	http://dx.doi.org/10.1371/journal.pone.0211425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689675	gold, Green Published, Green Submitted			2022-12-26	WOS:000457041800035
J	Weiland-Brauer, N; Malek, I; Schmitz, RA				Weiland-Braeuer, Nancy; Malek, Irene; Schmitz, Ruth A.			Metagenomic quorum quenching enzymes affect biofilm formation of Candida albicans and Staphylococcus epidermidis	PLOS ONE			English	Article							EXPRESSION; IDENTIFICATION; COLONIZATION; INFECTIONS; INHIBITION; ICA	Biofilm formation in the clinical environment is of increasing concern since a significant part of human infections is associated, and caused by biofilm establishment of (opportunistic) pathogens, for instance Candida albicans and Staphylococcus epidermidis. The rapidly increasing number of antibiotic-resistant biofilms urgently requires the development of novel and effective strategies to prevent biofilm formation ideally targeting a wide range of infectious microorganisms. Both, synthesis of extracellular polymeric substances and quorum sensing are crucial for biofilm formation, and thus potential attractive targets to combat undesirable biofilms. We evaluated the ability of numerous recently identified metagenome-derived bacterial quorum quenching (QQ) proteins to inhibit biofilm formation of C. albicans and S. epidermidis. Here, proteins QQ-5 and QQ-7 interfered with the morphogenesis of C. albicans by inhibiting the yeast-to-hyphae transition, ultimately leading to impaired biofilm formation. Moreover, QQ5 and QQ-7 inhibited biofilm formation of S. epidermidis; in case of QQ7 most likely due to induced expression of the icaR gene encoding the repressor for polysaccharide intercellular adhesin (PIA) synthesis, the main determinant for staphylococcal biofilm formation. Our results indicate that QQ-5 and QQ-7 are attractive potential anti-biofilm agents in the prevention and treatment of C. albicans and S. epidermidis mono-species biofilms, and potentially promising anti-biofilm drugs in also combating multi-species infections.	[Weiland-Braeuer, Nancy; Malek, Irene; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, Kiel, Germany	University of Kiel	Schmitz, RA (corresponding author), Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Weiland-Bräuer, Nancy/ABC-5876-2020	Weiland-Bräuer, Nancy/0000-0001-8284-1222; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	Bundesministerium fur Bildung und Forschung [0315587B]; Deutsche Forschungsgemeinschaft - Exzellenzinitiative "The Future Ocean" [CP1136]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft - Exzellenzinitiative "The Future Ocean"	This research was funded by the Bundesministerium fur Bildung und Forschung, grant number 0315587B, https://www.bmbf.de/, and the Deutsche Forschungsgemeinschaft - Exzellenzinitiative "The Future Ocean", grant number CP1136 to RAS, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; BURCHARD KW, 1983, ARCH SURG-CHICAGO, V118, P217; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870, DOI 10.1128/IAI.55.12.2870-2877.1987; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Deep Antariksh, 2011, J Lab Physicians, V3, P4, DOI 10.4103/0974-2727.78553; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dominguez E. G., 2017, CANDIDA BIOFILM TOLE, P77; Dutronc H, 2010, SCAND J INFECT DIS, V42, P890, DOI 10.3109/00365548.2010.498023; Fetzner S, 2015, J BIOTECHNOL, V201, P2, DOI 10.1016/j.jbiotec.2014.09.001; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Grandclament C, 2016, FEMS MICROBIOL REV; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Kalia V. C., 2015, QUORUM SENSING VS QU, DOI DOI 10.1007/978-81-322-1982-8_26; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Lohse MB, 2018, NAT REV MICROBIOL, V16, P19, DOI 10.1038/nrmicro.2017.107; Lonn-Stensrud J, 2012, FEMS IMMUNOL MED MIC, V65, P326, DOI 10.1111/j.1574-695X.2012.00964.x; MacFaddin JF., 1985, MEDIA ISOLATION CULT, P1; MACK DR, 1995, PEDIATR RES, V37, P75, DOI 10.1203/00006450-199501000-00015; Malek I, 2016, J MATER CHEM B, V4, P5228, DOI 10.1039/c6tb00942e; Naglik JR, 2006, J MED MICROBIOL, V55, P1323, DOI 10.1099/jmm.0.46737-0; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Oduwole KO, 2010, J ORTHOP RES, V28, P1252, DOI 10.1002/jor.21110; Olson ME, 2014, J BACTERIOL; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568; Pujalte MJ, 2005, INT J SYST EVOL MICR, V55, P631, DOI 10.1099/ijs.0.63442-0; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Reiter KC, 2014, INT J ANTIMICROB AG, V43, P248, DOI 10.1016/j.ijantimicag.2013.12.003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Romero Manuel, 2012, Recent Pat Biotechnol, V6, P2; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STEWART PS, 1995, WATER RES, V29, P2006, DOI 10.1016/0043-1354(94)00339-9; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Thein ZM, 2009, MYCOSES, V52, P467, DOI 10.1111/j.1439-0507.2009.01719.x; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Weiland-Brauer N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01098; Weiland-Brauer N, 2015, APPL ENVIRON MICROB, V81, P1477, DOI 10.1128/AEM.03290-14; Weiland-Brauer N, 2017, QUENCHING BACTERIAL; Weiland-Brauer N, QUENCHING BACTERIAL, P62017; Wolfmeier H, 2018, ACS INFECT DIS, V4, P93, DOI 10.1021/acsinfecdis.7b00170; Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006; Xue T, 2015, MICROBES INFECT, V17, P345, DOI 10.1016/j.micinf.2015.01.003	55	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211366	10.1371/journal.pone.0211366	http://dx.doi.org/10.1371/journal.pone.0211366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689669	Green Published, Green Submitted, gold			2022-12-26	WOS:000457041800032
J	Choucair, A; Pham, TH; Omarjee, S; Jacquemetton, J; Kassem, L; Tredan, O; Rambaud, J; Marangoni, E; Corbo, L; Treilleux, I; Le Romancer, M				Choucair, Ali; Thuy Ha Pham; Omarjee, Soleilmane; Jacquemetton, Julien; Kassem, Loay; Tredan, Olivier; Rambaud, Juliette; Marangoni, Elisabetta; Corbo, Laura; Treilleux, Isabelle; Le Romancer, Muriel			The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; METHYLATION; RESISTANCE; EXPRESSION; PROMOTES; CHAIN	Aside from its well-known nuclear routes of signaling, estrogen also mediates its effects through cytoplasmic signaling. Estrogen signaling involves numerous posttranslational modifications of its receptor ER alpha, the best known being phosphorylation. Our research group previously showed that upon estrogen stimulation, ER alpha is methylated on residue R260 and forms the mER alpha/Src/PI3K complex, central to the rapid transduction of nongenomic estrogen signals. Regulation of ER alpha signaling via its phosphorylation by growth factors is well recognized, and we wondered whether they could also trigger ER alpha methylation (mER alpha). Here, we found that IGF-1 treatment of MCF-7 cells induced rapid ER alpha methylation by the arginine methyltransferase PRMT1 and triggered the binding of mER alpha to IGF-1R. Mechanistically, we showed that PRMT1 bound constitutively to IGF-1R and that PRMT1 became activated upon IGF-1 stimulation. Moreover, we found that expression or pharmacological inhibition of PRMT1 impaired mER alpha and IGF-1 signaling. Our findings were substantiated in a cohort of breast tumors in which IGF-1R expression was positively correlated with ER alpha/Src and ER alpha/PI3K expression, hallmarks of nongenomic estrogen signaling, reinforcing the link between IGF-1R and mER alpha. Altogether, these results provide a new insight into ER alpha and IGF-1R interference, and open novel perspectives for combining endocrine therapies with PRMT1 inhibitors in ER alpha-positive tumors.	[Choucair, Ali; Thuy Ha Pham; Omarjee, Soleilmane; Jacquemetton, Julien; Rambaud, Juliette; Corbo, Laura; Treilleux, Isabelle; Le Romancer, Muriel] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Choucair, Ali; Thuy Ha Pham; Omarjee, Soleilmane; Jacquemetton, Julien; Rambaud, Juliette; Corbo, Laura; Treilleux, Isabelle; Le Romancer, Muriel] Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France; [Choucair, Ali; Thuy Ha Pham; Omarjee, Soleilmane; Jacquemetton, Julien; Rambaud, Juliette; Corbo, Laura; Treilleux, Isabelle; Le Romancer, Muriel] Univ Lyon 1, Lyon, France; [Omarjee, Soleilmane] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge CB2 0RE, England; [Kassem, Loay] Cairo Univ, Fac Med, Dept Clin Oncol, Cairo, Egypt; [Tredan, Olivier] Ctr Leon Berard, Dept Oncol, Lyon, France; [Marangoni, Elisabetta] Inst Curie, Translat Res Dept, F-75005 Paris, France; [Treilleux, Isabelle] Ctr Leon Berard, Dept Pathol, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Egyptian Knowledge Bank (EKB); Cairo University; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Leon Berard	Le Romancer, M (corresponding author), Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France.; Le Romancer, M (corresponding author), Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France.; Le Romancer, M (corresponding author), Univ Lyon 1, Lyon, France.	muriel.leromancer@lyon.unicancer.fr	Marangoni, Elisabetta/GSO-3945-2022; Tredan, Olivier/N-9794-2017	Marangoni, Elisabetta/0000-0002-3337-6448; Le Romancer, Muriel/0000-0002-8491-4015; Omarjee, Soleilmane/0000-0001-8686-7286; Jacquemetton, Julien/0000-0003-0513-6604; Tredan, Olivier/0000-0001-5881-9383	Fondation ARC Cancer; DGOS; "la ligue contre le cancer", comity of the Saone-et-Loire; INCA; Ministry of Research; ligue nationale contre le cancer	Fondation ARC Cancer; DGOS; "la ligue contre le cancer", comity of the Saone-et-Loire; INCA(Institut National du Cancer (INCA) France); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); ligue nationale contre le cancer(Ligue nationale contre le cancer)	We thank the Fondation ARC Cancer, the INCA and DGOS and "la ligue contre le cancer", comity of the Saone-et-Loire, the Fondation ARC Cancer and DGOS for JJ, and the Ministry of Research and the ligue nationale contre le cancer for financial support to AC.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bianchini L, 1997, J BIOL CHEM, V272, P271; Bouchekioua-Bouzaghou K, 2014, INT J CANCER, V135, P1307, DOI 10.1002/ijc.28781; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chakraborty AK, 2010, BREAST CANCER RES TR, V120, P327, DOI 10.1007/s10549-009-0382-5; Christopoulos PF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0291-7; Cottu P, 2014, CLIN CANCER RES, V20, P4314, DOI 10.1158/1078-0432.CCR-13-3230; Dupont J, 2003, CELL CYCLE, V2, P270, DOI 10.4161/cc.2.4.408; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Happerfield LC, 1997, J PATHOL, V183, P412; He X, 2010, ONCOGENE, V29, P2238, DOI 10.1038/onc.2009.513; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Herrmann F, 2009, GENES CELLS, V14, P309, DOI 10.1111/j.1365-2443.2008.01266.x; Heskamp S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117745; Infantino S, 2010, J EXP MED, V207, P711, DOI 10.1084/jem.20091303; Ishihara H, 1998, BIOCHEM BIOPH RES CO, V252, P139, DOI 10.1006/bbrc.1998.9621; Jackson JG, 1999, GROWTH HORM IGF RES, V9, P280, DOI 10.1054/ghir.1999.0113; Johnston SRD, 2010, CLIN CANCER RES, V16, P1979, DOI 10.1158/1078-0432.CCR-09-1823; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; La Rosa P, 2012, MOL ENDOCRINOL, V26, P762, DOI 10.1210/me.2011-1208; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Lisztwan J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2113; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; Simpson A, 2017, TARGET ONCOL, V12, P571, DOI 10.1007/s11523-017-0514-5; Soderberg Ola, 2007, Genet Eng (N Y), V28, P85, DOI 10.1007/978-0-387-34504-8_5; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; STEWART AJ, 1992, BRIT J CANCER, V66, P640, DOI 10.1038/bjc.1992.330; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Thordarson G, 2004, BREAST CANCER RES TR, V87, P277, DOI 10.1007/s10549-004-9504-2; Tian J, 2012, J CLIN INVEST, V122, P192, DOI 10.1172/JCI42204; Totta P, 2015, MOL ENDOCRINOL, V29, P739, DOI 10.1210/me.2014-1385; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Yan SC, 2015, ONCOTARGETS THER, V8, P279, DOI 10.2147/OTT.S74774; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhang YH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2883	49	21	21	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4015	4027		10.1038/s41388-019-0694-9	http://dx.doi.org/10.1038/s41388-019-0694-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30692633	Green Published, hybrid			2022-12-26	WOS:000468740200004
J	Xiong, Y; Wu, ZH; Zhang, B; Wang, C; Mao, FY; Liu, X; Hu, KP; Sun, XB; Jin, W; Kuang, SH				Xiong, Yan; Wu, Zihuan; Zhang, Bin; Wang, Chao; Mao, Fengyi; Liu, Xiao; Hu, Keping; Sun, Xiaobo; Jin, Wen; Kuang, Shihuan			Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice	FASEB JOURNAL			English	Article						irisin; WAT; metabolism; Ucp1; beige adipocyte	TYPE-2 DIABETES-MELLITUS; SPIEGELMAN IRISIN ERKS; HUMAN SKELETAL-MUSCLE; MAXIMAL OXYGEN-UPTAKE; INSULIN SENSITIVITY; CIRCULATING IRISIN; GLUCOSE-UPTAKE; WEIGHT-LOSS; OBESITY; FAT	Fibronectin type III domain containing 5 (Fndc5) is a transmembrane protein highly expressed in the skeletal muscle. It was reported that exercise promotes the shedding of the extracellular domain of Fndc5, generating a circulating peptide (irisin) that cross-talks to adipose tissues to convert lipid-storing white adipocytes to energy-catabolizing beige adipocytes. However, the requirement of Fndc5 in mediating the beneficial effect of exercise remains to be determined. Here, we created a mouse model of Fndc5 mutation through transcription activator-like effector nuclease-mediated DNA targeting. The Fndc5 mutant mice have normal skeletal muscle development, growth, regeneration, as well as glucose and lipid metabolism at resting state, even when fed a high-fat diet. In response to running exercise, however, the Fndc5 mutant mice exhibit reduced glucose tolerance and insulin sensitivity and have lower maximal oxygen consumption compared with the exercised wild-type mice. Mechanistically, Fndc5 mutation attenuates exercise-induced browning of white adipose tissue that is crucial for the metabolic benefits of physical activities. These data provide genetic evidence that Fndc5 is dispensable for muscle development and basal metabolism but essential for exercise-induced browning of white adipose tissues in mice.Xiong, Y., Wu, Z., Zhang, B., Wang, C., Mao, F., Liu, X., Hu, K., Sun, X., Jin, W., Kuang, S. Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice.	[Xiong, Yan; Wu, Zihuan; Zhang, Bin; Mao, Fengyi; Hu, Keping; Sun, Xiaobo; Jin, Wen] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Xiong, Yan] Southwest Minzu Univ, Coll Life Sci & Technol, Key Lab Qinghai Tibetan Plateau Anim Genet Resour, Minist Educ, Chengdu, Sichuan, Peoples R China; [Wang, Chao; Mao, Fengyi; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, 270 S Russell St,2070 CRTN, W Lafayette, IN 47907 USA; [Liu, Xiao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Shandong, Peoples R China; [Liu, Xiao] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Southwest Minzu University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences	Jin, W (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, 270 S Russell St,2070 CRTN, W Lafayette, IN 47907 USA.	wjin@implad.ac.cn; skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Kuang, Shihuan/0000-0001-9180-3180	National Natural Science Foundation of China [81471070, 41676152]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-012]; Fundamental Research Funds for the Central Universities [2018NQN34]; U.S. Department of Agriculture [NC1184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); U.S. Department of Agriculture(United States Department of Agriculture (USDA))	The authors thank Pengpeng Zhang, Wenjie Li, and Qing Wang (all of the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences) for discussion and technical support. This work was supported by National Natural Science Foundation of China (81471070, 41676152), the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS; 2016-I2M-1-012), Fundamental Research Funds for the Central Universities (2018NQN34), and the U.S. Department of Agriculture (NC1184). The authors declare no conflicts of interest.	Adachi H, 2007, DIABETES RES CLIN PR, V77, pS258, DOI 10.1016/j.diabres.2007.01.068; Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; BERGH U, 1978, MED SCI SPORT EXER, V10, P151; Biniaminov N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189254; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bosma M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11314; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Burch N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010970; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Colaianni G, 2015, P NATL ACAD SCI USA, V112, pE5763, DOI 10.1073/pnas.1519137112; Rodrigues KCD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00088; Ellefsen S, 2014, EUR J APPL PHYSIOL, V114, P1875, DOI 10.1007/s00421-014-2922-x; Elsen M, 2014, DIABETES, V63, pE16, DOI 10.2337/db14-0776; Elsen M, 2014, J ENDOCRINOL, V222, pR25, DOI 10.1530/JOE-14-0189; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher G, 2017, EUR J APPL PHYSIOL, V117, P1413, DOI 10.1007/s00421-017-3634-9; Fruchter O, 2001, NEW ENGL J MED, V345, P696; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gorgens SW, 2015, PROG MOL BIOL TRANSL, V135, P313, DOI 10.1016/bs.pmbts.2015.07.002; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2014, METABOLISM, V63, P918, DOI 10.1016/j.metabol.2014.04.001; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ikeda S, 2016, BIOCHEM BIOPH RES CO, V473, P947, DOI 10.1016/j.bbrc.2016.03.159; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee HJ, 2015, MOL ENDOCRINOL, V29, P873, DOI 10.1210/me.2014-1353; Lee W, 2018, BIOCHEM BIOPH RES CO, V502, P129, DOI 10.1016/j.bbrc.2018.05.133; Lehr L, 2006, FEBS LETT, V580, P4661, DOI 10.1016/j.febslet.2006.07.037; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin SC, 2004, TRENDS MOL MED, V10, P434, DOI 10.1016/j.molmed.2004.07.005; Liu JJ, 2014, J DIABETES COMPLICAT, V28, P208, DOI 10.1016/j.jdiacomp.2013.09.011; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017; Mann S, 2014, DIABETES-METAB RES, V30, P257, DOI 10.1002/dmrr.2488; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Montero D, 2016, EUR J PREV CARDIOL, V23, P733, DOI 10.1177/2047487315617118; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Reza MM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01131-0; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Ross R, 2003, DIABETES CARE, V26, P944, DOI 10.2337/diacare.26.3.944; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seibaek M, 2003, CLIN CARDIOL, V26, P515, DOI 10.1002/clc.4960261107; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Skorobogatko Y, 2018, P NATL ACAD SCI USA, V115, P7819, DOI 10.1073/pnas.1801050115; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; Spiegelman BM, 2014, DIABETES, V63, pE17, DOI 10.2337/db14-0898; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; van der Zwaard S, 2016, J APPL PHYSIOL, V121, P636, DOI 10.1152/japplphysiol.00355.2016; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2279; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu J, 2014, DIABETES, V63, P381, DOI 10.2337/db13-1586; Wu Z., 2016, CHINESE J COMP MED, V26, P37; Xiong XQ, 2015, BBA-MOL BASIS DIS, V1852, P1867, DOI 10.1016/j.bbadis.2015.06.017; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Zhang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE530, DOI 10.1152/ajpendo.00094.2016; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	78	25	26	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5876	5886		10.1096/fj.201801754RR	http://dx.doi.org/10.1096/fj.201801754RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30721625	Bronze			2022-12-26	WOS:000466932600007
J	Cohen, I; Coban, M; Shahar, A; Sankaran, B; Hockla, A; Lacham, S; Caulfield, TR; Radisky, ES; Papo, N				Cohen, Itay; Coban, Matt; Shahar, Anat; Sankaran, Banumathi; Hockla, Alexandra; Lacham, Shiran; Caulfield, Thomas R.; Radisky, Evette S.; Papo, Niv			Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease inhibitor; proteolysis; serine protease; protein engineering; disulfide; protein structure; molecular dynamics; crystal structure	BIOLOGICAL-ACTIVITY; TRYPSIN-INHIBITORS; POTENT INHIBITORS; DYNAMICS; STABILIZATION; DEGRADATION; VALIDATION; REFINEMENT; MECHANISM; EPI-HNE4	Serine protease inhibitors of the Kunitz-bovine pancreatic trypsin inhibitor (BPTI) family are ubiquitous biological regulators of proteolysis. These small proteins are resistant to proteolysis, but can be slowly cleaved within the protease-binding loop by target proteases, thereby compromising their activity. For the human protease mesotrypsin, this cleavage is especially rapid. Here, we aimed to stabilize the Kunitz domain structure against proteolysis through disulfide engineering. Substitution within the Kunitz inhibitor domain of the amyloid precursor protein (APPI) that incorporated a new disulfide bond between residues 17 and 34 reduced proteolysis by mesotrypsin 74-fold. Similar disulfide engineering of tissue factor pathway inhibitor-1 Kunitz domain 1 ((KD1)TFPI1) and bikunin Kunitz domain 2 ((KD2)bikunin) likewise stabilized these inhibitors against mesotrypsin proteolysis 17- and 6.6-fold, respectively. Crystal structures of disulfide-engineered APPI and (KD1)TFPI1 variants in a complex with mesotrypsin at 1.5 and 2.0 angstrom resolution, respectively, confirmed the formation of well-ordered disulfide bonds positioned to stabilize the binding loop. Long all-atom molecular dynamics simulations of disulfide-engineered Kunitz domains and their complexes with mesotrypsin revealed conformational stabilization of the primed side of the inhibitor-binding loop by the engineered disulfide, along with global suppression of conformational dynamics in the Kunitz domain. Our findings suggest that the Cys-17-Cys-34 disulfide slows proteolysis by dampening conformational fluctuations in the binding loop and minimizing motion at the enzyme-inhibitor interface. The generalizable approach developed here for the stabilization against proteolysis of Kunitz domains, which can serve as important scaffolds for therapeutics, may thus find applications in drug development.	[Cohen, Itay; Lacham, Shiran; Papo, Niv] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Cohen, Itay; Lacham, Shiran; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, POB 653, IL-84105 Beer Sheva, Israel; [Coban, Matt; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA; [Shahar, Anat] NIBN, IL-84105 Beer Sheva, Israel; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Caulfield, Thomas R.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Ben Gurion University; Ben Gurion University; Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Mayo Clinic	Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, POB 653, IL-84105 Beer Sheva, Israel.; Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.; Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, POB 653, IL-84105 Beer Sheva, Israel.	radisky.evette@mayo.edu; papo@bgu.ac.il	Coban, Matt/AAH-7053-2019	Coban, Matt/0000-0001-6396-6759; Caulfield, Thomas/0000-0002-1055-3069; Radisky, Evette/0000-0003-3121-109X	European Research Council [336041]; Prostate Cancer Foundation; Israel Science Foundation (ISF); DKFZ-MOST [GR2495]; National Institutes of Health [R01CA154387]; United States-Israel Binational Science Foundation; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; Israel Science Foundation (ISF)(Israel Science Foundation); DKFZ-MOST; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the European Research Council "Ideas Program" ERC-2013-StG Grant 336041 (to N. P.), a Prostate Cancer Foundation grant (to N. P.), an Israel Science Foundation (ISF) grant (to N. P.), DKFZ-MOST Grant GR2495 (to N. P.), National Institutes of Health Grant R01CA154387 (to E. S. R.), and a United States-Israel Binational Science Foundation grant (to N. P. and E. S. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Caulfield Thomas R, 2011, J Biophys, V2011, P219515, DOI 10.1155/2011/219515; Caulfield TR, 2011, J MOL GRAPH MODEL, V29, P1006, DOI 10.1016/j.jmgm.2011.04.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen I, 2018, BIOCHEM J, V475, P1335, DOI 10.1042/BCJ20180070; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Devy L, 2007, NEOPLASIA, V9, P927, DOI 10.1593/neo.07544; Dockal M, 2014, J BIOL CHEM, V289, P1732, DOI 10.1074/jbc.M113.533836; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Dubois M, 2007, RAPID COMMUN MASS SP, V21, P352, DOI 10.1002/rcm.2844; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guerin ME, 2018, P NATL ACAD SCI USA, V115, P11525, DOI 10.1073/pnas.1803872115; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Jiang S, 2007, ORG LETT, V9, P9, DOI 10.1021/ol0621497; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lehmann A, 2008, EXPERT OPIN BIOL TH, V8, P1187, DOI [10.1517/14712598.8.8.1187, 10.1517/14712598.8.8.1187 ]; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Liu T, 2016, P NATL ACAD SCI USA, V113, P5910, DOI 10.1073/pnas.1605363113; Longhurst H, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00245; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore EJ, 2017, P NATL ACAD SCI USA, V114, P12472, DOI 10.1073/pnas.1708907114; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Puschmann A, 2017, BRAIN, V140, P98, DOI 10.1093/brain/aww261; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHNEIDER SL, 1973, J BIOL CHEM, V248, P7207; Stein R., 2011, KINETICS ENZYME ACTI, P115; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Trivedi M, 2012, INT J PHARMACEUT, V431, P16, DOI 10.1016/j.ijpharm.2012.03.051; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang L, 2011, BIOTECHNOL ADV, V29, P923, DOI 10.1016/j.biotechadv.2011.07.013; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	69	16	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5105	5120		10.1074/jbc.RA118.007292	http://dx.doi.org/10.1074/jbc.RA118.007292			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700553	Green Published, hybrid			2022-12-26	WOS:000463985600032
J	Tan, S; Shan, YL; Lin, YY; Liao, SY; Zhang, BJ; Zeng, Q; Wang, YG; Deng, ZZ; Chen, C; Hu, XQ; Peng, LS; Qiu, W; Lu, ZQ				Tan, Sha; Shan, Yilong; Lin, Yinyao; Liao, Siyuan; Zhang, Bingjun; Zeng, Qin; Wang, Yuge; Deng, Zhezhi; Chen, Chen; Hu, Xueqiang; Peng, Lisheng; Qiu, Wei; Lu, Zhengqi			Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A	FASEB JOURNAL			English	Article						IL-9; ischemic stroke; BBB	MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; NF-KAPPA-B; MEDIATED DISRUPTION; CELLS; INFLAMMATION; PERMEABILITY; MODEL; IL-9; ENCEPHALOMYELITIS	Astrocytes mediate the destruction of the blood-brain barrier (BBB) during ischemic stroke (IS). IL-9 is a pleiotropic cytokine that we previously found to be highly expressed in peripheral blood mononuclear cells from patients with IS, and the presence of IL-9 receptors on astrocytes has been reported in the literature. Here, we detected the effect of IL-9 on astrocytes using an anti-IL-9-neutralizing antibody to treat rats with experimental stroke. Supernatants from astrocytes treated with or without oxygen-glucose deprivation and/or IL-9 were incubated with bEnd.3 cell monolayers after blocking the IL-9 receptor on the endothelium. Immunofluorescence staining and Western blot analyses were conducted to observe the change in tight junction proteins (TJPs) in bEnd.3 cells as well as the level of VEGF-A and possible signal pathways in astrocytes. We also applied middle cerebral artery occlusion (MCAO) models to determine the effect of anti-IL-9-neutralizing antibodies on IS. As a result, astrocyte-conditioned medium treated with IL-9 aggravated the disruption of the BBB accomplished by the degradation of TJPs in endothelial cells. In addition, IL-9 increased the level of VEGF-A in astrocytes, and blocking the effect of VEGF-A reversed the breakdown of the BBB. In the MCAO model, anti-IL-9-neutralizing antibody reduced the infarct volume and BBB destruction. Mechanistically, the anti-IL-9-neutralizing antibody repaired the damaged TJPs (zonula occludens 1, occludin, and claudin-5) and induced a decrease in VEGF-A expression in ischemic lateral brain tissue. In contrast, a local injection of recombinant murine IL-9 to the brain resulted in a marked up-regulation of VEGF-A in the striatum. In conclusion, anti-IL-9-neutralizing antibody can reduce the severity of IS partially by alleviating the destruction of the BBB via down-regulation of astrocyte-derived VEGF-A. This finding suggests that targeting IL-9 or VEGF-A could provide a new direction for the treatment of IS.Tan, S., Shan, Y., Lin, Y., Liao, S., Zhang, B., Zeng, Q., Wang, Y., Deng, Z., Chen, C., Hu, X., Peng, L., Qiu, W., Lu, Z. Neutralization of IL-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A.	[Tan, Sha; Shan, Yilong; Lin, Yinyao; Liao, Siyuan; Zhang, Bingjun; Zeng, Qin; Wang, Yuge; Deng, Zhezhi; Chen, Chen; Hu, Xueqiang; Peng, Lisheng; Qiu, Wei; Lu, Zhengqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, 600 Tianhe Rd, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Qiu, W; Lu, ZQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, 600 Tianhe Rd, Guangzhou, Guangdong, Peoples R China.	qiuwei120@vip.163.com; lzq1828@163.com		Zhang, Bingjun/0000-0002-9641-2485	National Natural Science Foundation of China [81671178]; Natural Science Foundation of Guangdong Province [2017A030311013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Grant 81671178) and the Natural Science Foundation of Guangdong Province (Grant 2017A030311013). The authors declare no conflicts of interest.	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Begum G, 2018, GLIA, V66, P126, DOI 10.1002/glia.23232; Blecharz-Lang KG, 2018, TRANSL STROKE RES, V9, P631, DOI 10.1007/s12975-018-0614-2; Chen XD, 2015, NEUROBIOL DIS, V73, P118, DOI 10.1016/j.nbd.2014.09.007; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; Ding XL, 2015, EXP MOL PATHOL, V99, P570, DOI 10.1016/j.yexmp.2015.07.010; Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230; Elyaman W, 2017, SEMIN IMMUNOPATHOL, V39, P79, DOI 10.1007/s00281-016-0604-y; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Lee H, 2017, ONCOTARGET, V8; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611; Ni YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170346; NISHINO H, 1994, BRAIN RES BULL, V35, P51, DOI 10.1016/0361-9230(94)90215-1; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Park SJ, 2012, INFLAMM RES, V61, P1069, DOI 10.1007/s00011-012-0499-6; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Rost NS, 2018, J CEREBR BLOOD F MET, V38, P75, DOI 10.1177/0271678X17706449; Ruocco G, 2015, CLIN SCI, V129, P291, DOI 10.1042/CS20140608; Seifert HA, 2014, TRANSL STROKE RES, V5, P543, DOI 10.1007/s12975-014-0349-7; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Tan S, 2017, CLIN SCI, V131, P1499, DOI 10.1042/CS20170984; Thirupathi A, 2017, J PHYSIOL BIOCHEM, V73, P487, DOI 10.1007/s13105-017-0576-y; Tian YL, 2016, MOL CELL BIOCHEM, V422, P75, DOI 10.1007/s11010-016-2807-x; Wang W, 2018, MOL MED REP, V17, P3146, DOI 10.3892/mmr.2017.8203; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang Y, 2018, NEUROBIOL DIS, V114, P95, DOI 10.1016/j.nbd.2018.02.012; Yao XH, 2014, IMMUNOLOGY, V143, P396, DOI 10.1111/imm.12322; Yu XF, 2016, CEREBROVASC DIS, V42, P49, DOI 10.1159/000444809; Zhang HM, 2015, CYTOKINE, V76, P549, DOI 10.1016/j.cyto.2015.06.019; Zhang L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0610-y; Zhou Y, 2011, J IMMUNOL, V186, P4415, DOI 10.4049/jimmunol.1003307	45	19	24	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4376	4387		10.1096/fj.201801595RR	http://dx.doi.org/10.1096/fj.201801595RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30694693				2022-12-26	WOS:000459794800102
J	Adablah, JE; Vinson, R; Roper, MG; Bertram, R				Adablah, Joel E.; Vinson, Ryan; Roper, Michael G.; Bertram, Richard			Synchronization of pancreatic islets by periodic or non-periodic muscarinic agonist pulse trains	PLOS ONE			English	Article							PULSATILE INSULIN-SECRETION; INTRAPANCREATIC GANGLIA; NEURAL-CONTROL; YOUNG MICE; IN-VITRO; GLUCOSE; OSCILLATIONS; MECHANISMS; INNERVATION; RAT	Pulsatile insulin secretion into the portal vein from the many pancreatic islets of Langerhans is critical for efficient glucose homeostasis. The islets are themselves endogenous oscillators, but since they are not physically coupled it is not obvious how their oscillations are synchronized across the pancreas. It has been proposed that synchronization of islets is achieved through periodic activity of intrapancreatic ganglia, and indeed there are data supporting this proposal. Postganglionic nerves are cholinergic, and their product, acetylcholine, can influence islet beta-cells through actions on M-3 muscarinic receptors which are coupled to G(q) type G-proteins. In addition, the neurons secrete several peptide hormones that act on beta-cell receptors. The data supporting synchronization via intrapancreatic ganglia are, however, limited. In particular, it has not been shown that trains of muscarinic pulses are effective at synchronizing islets in vitro. Also, if as has been suggested, there is a ganglionic pacemaker driving islets to a preferred frequency, no neural circuitry for this pacemaker has been identified. In this study, both points are addressed using a microfluidic system that allows for the pulsed application of the muscarinic agonist carbachol. We find that murine islets are entrained and synchronized over a wide range of frequencies when the carbachol pulsing is periodic, adding support to the hypothesis that ganglia can synchronize islets in vivo. We also find that islet synchronization is very effective even if the carbachol pulses are applied at random times. This suggests that a neural pacemaker is not needed; all that is required is that islets receive occasional coordinated input from postganglionic neurons. The endogenous rhythmic activity of the islets then sets the frequency of the islet population rhythm, while the input from ganglia acts only to keep the islet oscillators in phase.	[Adablah, Joel E.; Roper, Michael G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Vinson, Ryan; Bertram, Richard] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Mol Biophys, Tallahassee, FL 32306 USA; [Bertram, Richard] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bertram, R (corresponding author), Florida State Univ, Dept Math, Tallahassee, FL 32306 USA.; Bertram, R (corresponding author), Florida State Univ, Program Mol Biophys, Tallahassee, FL 32306 USA.; Bertram, R (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.	bertram@math.fsu.edu	Roper, Michael G./D-2386-2010; Bertram, Richard/ABI-5859-2020	Roper, Michael G./0000-0002-0184-1333; 	National Institutes of Health [R01DK080714]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant to RB and MGR from the National Institutes of Health (R01DK080714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Benninger RKP, 2014, TRENDS ENDOCRIN MET, V25, P399, DOI 10.1016/j.tem.2014.02.005; Bertram R, 2018, DIABETES, V67, P351, DOI 10.2337/dbi17-0004; COUPLAND RE, 1958, J ANAT, V92, P143; Dhumpa R, 2015, INTEGR BIOL-UK, V7, P1061, DOI 10.1039/c5ib00156k; Dhumpa R, 2014, BIOPHYS J, V106, P2275, DOI 10.1016/j.bpj.2014.04.015; Fendler B, 2009, BIOPHYS J, V97, P722, DOI 10.1016/j.bpj.2009.05.016; FUJITA T, 1959, Z ZELLFORSCH MIK ANA, V50, P94, DOI 10.1007/BF00342656; Gilon P, 2002, DIABETES, V51, pS144, DOI 10.2337/diabetes.51.2007.S144; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GOODNER CJ, 1991, AM J PHYSIOL, V260, pE422, DOI 10.1152/ajpendo.1991.260.3.E422; Grapengiesser E, 2004, BIOCHEM PHARMACOL, V68, P667, DOI 10.1016/j.bcp.2004.04.018; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gylfe E, 2012, PANCREAS, V41, P258, DOI 10.1097/MPA.0b013e3182240586; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Hansen KM, 1923, ACTA ENDOCRINOL; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hyrc KB, 2000, CELL CALCIUM, V27, P75, DOI 10.1054/ceca.1999.0092; Inuwa IM, 2005, J ANAT, V206, P185, DOI 10.1111/j.1469-7580.2005.00367.x; Ionescu-Tirgoviste C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14634; Jovic A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001040; KAMEL I, 1979, ACTA ANAT, V104, P237; KING BF, 1989, J PHYSIOL-LONDON, V419, P379, DOI 10.1113/jphysiol.1989.sp017877; KIRCHGESSNER AL, 1991, J COMP NEUROL, V305, P613, DOI 10.1002/cne.903050407; KOMJATI M, 1986, ENDOCRINOLOGY, V118, P312, DOI 10.1210/endo-118-1-312; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; KORSGREN O, 1993, TRANSPLANTATION, V56, P138, DOI 10.1097/00007890-199307000-00026; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; LARSSON LI, 1979, SCAND J GASTROENTERO, V14, P433; Liu MT, 1997, AM J PHYSIOL-GASTR L, V273, pG1273, DOI 10.1152/ajpgi.1997.273.6.G1273; MATTHEWS DR, 1983, DIABETES, V32, P617, DOI 10.2337/diabetes.32.7.617; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; McKenna JP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005143; Merrins MJ, 2016, BIOPHYS J, V110, P691, DOI 10.1016/j.bpj.2015.12.029; MILLER RE, 1981, ENDOCR REV, V2, P471, DOI 10.1210/edrv-2-4-471; Molina J, 2014, DIABETES, V63, P2714, DOI 10.2337/db13-1371; Nunemaker CS, 2006, BIOPHYS J, V91, P2082, DOI 10.1529/biophysj.106.087296; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Persson-Sjogren S, 2001, HISTOCHEM J, V33, P373, DOI 10.1023/A:1012439510709; Pfeuty B, 2011, BIOPHYS J, V100, P2557, DOI 10.1016/j.bpj.2011.04.043; Porksen N, 2002, DIABETOLOGIA, V45, P3, DOI 10.1007/s125-002-8240-x; PORKSEN N, 1994, J CLIN INVEST, V94, P219, DOI 10.1172/JCI117310; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Satin LS, 2015, MOL ASPECTS MED, V42, P61, DOI 10.1016/j.mam.2015.01.003; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; STAGNER J, 1988, LIFE SCI, V43, P929, DOI 10.1016/0024-3205(88)90269-X; STAGNER JI, 1985, AM J PHYSIOL, V248, pE522, DOI 10.1152/ajpendo.1985.248.5.E522; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; STURIS J, 1994, AM J PHYSIOL, V267, pE250, DOI 10.1152/ajpendo.1994.267.2.E250; Tang SC, 2018, DIABETOLOGIA, V61, P168, DOI 10.1007/s00125-017-4409-x; Tang SC, 2018, DIABETOLOGIA, V61, P158, DOI 10.1007/s00125-017-4408-y; TISCORNIA OM, 1977, AM J GASTROENTEROL, V67, P541; Ushiki T, 1997, MICROSC RES TECHNIQ, V37, P399; Wang X, 2014, ANAL METHODS-UK, V6, P3019, DOI 10.1039/c4ay00288a; WOODS SC, 1974, PHYSIOL REV, V54, P596, DOI 10.1152/physrev.1974.54.3.596; Yi L, 2016, ANAL CHEM, V88, P10368, DOI 10.1021/acs.analchem.6b02404; Yi L, 2015, LAB CHIP, V15, P823, DOI 10.1039/c4lc01360c; Zhang M, 2008, BIOPHYS J, V95, P4676, DOI 10.1529/biophysj.107.125088; Zhang XY, 2011, AM J PHYSIOL-ENDOC M, V301, pE742, DOI 10.1152/ajpendo.00248.2011	63	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211832	10.1371/journal.pone.0211832	http://dx.doi.org/10.1371/journal.pone.0211832			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726280	gold, Green Submitted, Green Published			2022-12-26	WOS:000457874000079
J	Echeverria, PC; Bhattacharya, K; Joshi, A; Wang, T; Picard, D				Echeverria, Pablo C.; Bhattacharya, Kaushik; Joshi, Abhinav; Wang, Tai; Picard, Didier			The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity	PLOS ONE			English	Article							CANCER STEM-CELLS; ROUS-SARCOMA-VIRUS; BIOLOGICAL NETWORKS; PROTEOTOXIC STRESS; DRUG-RESISTANCE; PROTEIN; AFFINITY; SPECIFICITY; SELECTIVITY; PRINCIPLES	The molecular chaperone Hsp90 is an essential and highly abundant central node in the interactome of eukaryotic cells. Many of its large number of client proteins are relevant to cancer. A hallmark of Hsp90-dependent proteins is that their accumulation is compromised by Hsp90 inhibitors. Combined with the anecdotal observation that cancer cells may be more sensitive to Hsp90 inhibitors, this has led to clinical trials aiming to develop Hsp90 inhibitors as anti-cancer agents. However, the sensitivity to Hsp90 inhibitors has not been studied in rigorously matched normal versus cancer cells, and despite the discovery of important regulators of Hsp90 activity and inhibitor sensitivity, it has remained unclear, why cancer cells might be more sensitive. To revisit this issue more systematically, we have generated an isogenic pair of normal and oncogenically transformed NIH-3T3 cell lines. Our proteomic analysis of the impact of three chemically different Hsp90 inhibitors shows that these affect a substantial portion of the oncogenic program and that indeed, transformed cells are hypersensitive. Targeting the oncogenic signaling pathway reverses the hypersensitivity, and so do inhibitors of DNA replication, cell growth, translation and energy metabolism. Conversely, stimulating normal cells with growth factors or challenging their proteostasis by overexpressing an aggregation-prone sensitizes them to Hsp90 inhibitors. Thus, the differential sensitivity to Hsp90 inhibitors may not stem from any particular intrinsic difference between normal and cancer cells, but rather from a shift in the balance between cellular quiescence and activity.	[Echeverria, Pablo C.; Bhattacharya, Kaushik; Joshi, Abhinav; Wang, Tai; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland; [Wang, Tai] Mem Sloan Kettering Canc Ctr, Program Chem Biol, 1275 York Ave, New York, NY 10021 USA	University of Geneva; Memorial Sloan Kettering Cancer Center	Picard, D (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland.	didier.picard@unige.ch	Joshi, Abhinav/HCH-8178-2022; Joshi, Abhinav/HCH-8201-2022; Echeverria, Pablo Christian/A-9098-2010	Joshi, Abhinav/0000-0002-1417-6918; Echeverria, Pablo Christian/0000-0003-1367-9692; Wang, Tai/0000-0001-9984-9634	Swiss National Science Foundation (SNF) [316030_145001]; SNF; Canton de Geneve	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF; Canton de Geneve	The Seahorse X-24 instrument was purchased with the R'Equip grant 316030_145001 of the Swiss National Science Foundation (SNF). In addition, this work was supported by a grant from the SNF to DP, and the Canton de Geneve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barluenga S, 2008, ANGEW CHEM INT EDIT, V47, P4432, DOI 10.1002/anie.200800233; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Borel F, 2002, J CELL SCI, V115, P2829; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Calderwood SK, 2016, TRENDS BIOCHEM SCI, V41, P311, DOI 10.1016/j.tibs.2016.01.003; Chen QZ, 2015, J PROTEOMICS, V115, P117, DOI 10.1016/j.jprot.2014.12.008; Chiosis G, 2003, MOL CANCER THER, V2, P123; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Crouch MF, 2000, IMMUNOL CELL BIOL, V78, P408, DOI 10.1046/j.1440-1711.2000.00929.x; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Echeverria PC, 2016, MOL CELL BIOL, V36, P1310, DOI 10.1128/MCB.01099-15; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Farkas Z, 2018, ELIFE, V7, DOI 10.7554/eLife.29845; Fierro-Monti I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080425; Fluegen G, 2017, NAT CELL BIOL, V19, P120, DOI 10.1038/ncb3465; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gligorijevic B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001995; GREIG RG, 1985, P NATL ACAD SCI USA, V82, P3698, DOI 10.1073/pnas.82.11.3698; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haupt A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-38; Houry W.A., 2014, MOL CHAPERONES INTER, P133, DOI DOI 10.1007/978-1-4939-1130-1_6; Immormino RM, 2006, J MED CHEM, V49, P4953, DOI 10.1021/jm060297x; Isaacs J, 2016, ADV CANCER RES, V129, pXIII, DOI 10.1016/S0065-230X(16)30016-1; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Ji H, 2007, ELECTROPHORESIS, V28, P1997, DOI 10.1002/elps.200700009; Joshi S, 2018, NAT REV CANCER, V18, P562, DOI 10.1038/s41568-018-0020-9; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lee CH, 2012, BIOCHIMIE, V94, P1382, DOI 10.1016/j.biochi.2012.02.034; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Massey AJ, 2010, J MED CHEM, V53, P7280, DOI 10.1021/jm100342z; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Nassar D, 2016, ANNU REV PATHOL-MECH, V11, P47, DOI 10.1146/annurev-pathol-012615-044438; Nayar U, 2013, BLOOD, V122, P2837, DOI 10.1182/blood-2013-01-479972; Neckers L, 2018, CELL STRESS CHAPERON, V23, P467, DOI 10.1007/s12192-018-0877-2; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Newman B, 2012, CANCER RES, V72, P4551, DOI 10.1158/0008-5472.CAN-11-3600; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Park KS, 2000, EXP MOL MED, V32, P120, DOI 10.1038/emm.2000.21; Pastorek M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202758; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Prieto-Vila M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122574; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Schell R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001015; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Subramanian C, 2017, NEOPLASIA, V19, P1003, DOI 10.1016/j.neo.2017.09.003; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Takeishi S, 2016, CANCER SCI, V107, P875, DOI 10.1111/cas.12958; TERADA N, 1995, J IMMUNOL, V155, P3418; Wang T, 2014, RSC DRUG DISCOV, V37, P1; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2014, P NATL ACAD SCI USA, V111, P18297, DOI 10.1073/pnas.1421323111; Woodford MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12037; Woodford MR, 2016, CELL REP, V14, P872, DOI 10.1016/j.celrep.2015.12.084; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yang LT, 2013, J PROTEOMICS, V93, P179, DOI 10.1016/j.jprot.2013.04.025; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Yuno A, 2018, METHODS MOL BIOL, V1709, P423, DOI 10.1007/978-1-4939-7477-1_29; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhu DW, 2015, CANCER LETT, V356, P773, DOI 10.1016/j.canlet.2014.10.024; Zong HL, 2015, CELL REP, V13, P2159, DOI 10.1016/j.celrep.2015.10.073	79	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0208287	10.1371/journal.pone.0208287	http://dx.doi.org/10.1371/journal.pone.0208287			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726209	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000005
J	Monroy, C; Shafto, C; Castellanos, I; Bergeson, T; Houston, D				Monroy, Claire; Shafto, Carissa; Castellanos, Irina; Bergeson, Tonya; Houston, Derek			Visual habituation in deaf and hearing infants	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; COCHLEAR IMPLANTS; EXECUTIVE FUNCTION; YOUNG DEAF; CHILDREN; ATTENTION; LANGUAGE; AGE; PERCEPTION; SKILLS	Early cognitive development relies on the sensory experiences that infants acquire as they explore their environment. Atypical experience in one sensory modality from birth may result in fundamental differences in general cognitive abilities. The primary aim of the current study was to compare visual habituation in infants with profound hearing loss, prior to receiving cochlear implants (CIs), and age-matched peers with typical hearing. Two complementary measures of cognitive function and attention maintenance were assessed: the length of time to habituate to a visual stimulus, and look-away rate during habituation. Findings revealed that deaf infants were slower to habituate to a visual stimulus and demonstrated a lower look-away rate than hearing infants. For deaf infants, habituation measures correlated with language outcomes on standardized assessments before cochlear implantation. These findings are consistent with prior evidence suggesting that habituation and look-away rates reflect efficiency of information processing and may suggest that deaf infants take longer to process visual stimuli relative to the hearing infants. Taken together, these findings are consistent with the hypothesis that hearing loss early in infancy influences aspects of general cognitive functioning.	[Monroy, Claire; Castellanos, Irina; Houston, Derek] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Monroy, Claire; Castellanos, Irina; Houston, Derek] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Shafto, Carissa] Insight Data Sci, New York, NY USA; [Bergeson, Tonya] Butler Univ, Dept Commun Sci & Disorders, Indianapolis, IN 46208 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Butler University	Monroy, C (corresponding author), Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA.; Monroy, C (corresponding author), Nationwide Childrens Hosp, Columbus, OH 43205 USA.	Claire.monroy@osumc.edu	Castellanos, Irina/AAD-2560-2020; Castellanos, Irina/AAR-4703-2020; Houston, Derek/AAM-6553-2020	Castellanos, Irina/0000-0002-2955-2875; Monroy, Claire/0000-0002-5044-5185	NIDCD [F31 DC010281, R01 DC006235]	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants from the NIDCD (https://www.nidcd.nih.gov/) to C.L.S. (F31 DC010281) and D.M.H. (R01 DC006235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinger S, 2009, SCAND J PSYCHOL, V50, P371, DOI 10.1111/j.1467-9450.2009.00753.x; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Bahrick LE, 2016, DEV PSYCHOL, V52, P1705, DOI 10.1037/dev0000157; Bavelier D., 2003, CEREBRUM DANA FORUM, P19; Bayley N., 2019, BAYLEY SCALES INFANT; Bharadwaj SV, 2016, INT J PEDIATR OTORHI, V85, P158, DOI 10.1016/j.ijporl.2016.03.036; BORNSTEIN MH, 1986, CHILD DEV, V57, P251, DOI 10.2307/1130581; BORNSTEIN MH, 1986, CHILD DEV, V57, P87, DOI 10.1111/j.1467-8624.1986.tb00009.x; Carpenter M, 1998, JOINT ATTENTION ITS; Cejas I, 2014, J SPEECH LANG HEAR R, V57, P1831, DOI 10.1044/2014_JSLHR-L-13-0262; Cohen L. B., 2004, NEW PROGRAM OBTAININ; COHEN LB, 1993, DEV PSYCHOL, V29, P421, DOI 10.1037/0012-1649.29.3.421; Cohen LB, 1998, INFANT BEHAV DEV, V21, P713, DOI 10.1016/S0163-6383(98)90040-6; Colaizzi J, 2014, INFANCY, V19, P519, DOI 10.1111/infa.12061; Colombo J., 1993, INFANT COGNITION PRE, V5; Colombo J, 2009, NEUROBIOL LEARN MEM, V92, P225, DOI 10.1016/j.nlm.2008.06.002; Conway CM, 2011, DEV NEUROPSYCHOL, V36, P237, DOI 10.1080/87565641.2010.549869; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Conway CM, 2008, ANN NY ACAD SCI, V1145, P113, DOI 10.1196/annals.1416.009; Dye MWG, 2013, SPRINGER HANDB AUDIT, V47, P237, DOI 10.1007/2506_2013_9; Dye MWG, 2014, HEARING RES, V309, P94, DOI 10.1016/j.heares.2013.12.001; Figueras B, 2008, J DEAF STUD DEAF EDU, V13, P362, DOI 10.1093/deafed/enm067; Giraud AL, 2007, RESTOR NEUROL NEUROS, V25, P381; Glick H, 2017, HEARING RES, V343, P191, DOI 10.1016/j.heares.2016.08.012; Hall ML, 2017, J DEAF STUD DEAF EDU, V22, P9, DOI 10.1093/deafed/enw054; Hixson SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152264; Hoffman M, 2018, HEARING RES, V359, P91, DOI 10.1016/j.heares.2018.01.002; Horn DL, 2007, LARYNGOSCOPE, V117, P2017, DOI 10.1097/MLG.0b013e3181271401; Horn DL, 2005, EAR HEARING, V26, P389, DOI 10.1097/00003446-200508000-00003; Houston DM, 2007, INFANCY, V12, P119, DOI 10.1111/j.1532-7078.2007.tb00237.x; Houston DM, 2010, OTOL NEUROTOL, V31, P1248, DOI 10.1097/MAO.0b013e3181f1cc6a; Kavsek M, 2004, J APPL DEV PSYCHOL, V25, P369, DOI 10.1016/j.appdev.2004.04.006; Klein KE, 2019, EAR HEARING, V40, P213, DOI 10.1097/AUD.0000000000000564; Kral A, 2016, LANCET NEUROL, V15, P610, DOI 10.1016/S1474-4422(16)00034-X; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; LEWIS M, 1969, MONOGR SOC RES CHILD, V34, pR1; Lomber SG, 2017, COGNITIVE DEV, V42, P49, DOI 10.1016/j.cogdev.2017.02.007; Meadows-Orland K, 1997, J Deaf Stud Deaf Educ, V2, P26; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MILLER DJ, 1980, INT J BEHAV DEV, V3, P131, DOI 10.1177/016502548000300201; Mitchell TV, 1996, J CLIN CHILD PSYCHOL, V25, P83, DOI 10.1207/s15374424jccp2501_10; Murray MM, 2016, TRENDS NEUROSCI, V39, P567, DOI 10.1016/j.tins.2016.05.003; Pavani F., 2012, NEURAL BASEMULTISE, P421; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; Quittner AL, 2004, ARCH OTOLARYNGOL, V130, P547, DOI 10.1001/archotol.130.5.547; Raudenbush S.W., 2011, HLM 7 HIERARCHICAL L; SAVELSBERGH GJP, 1991, J CHILD PSYCHOL PSYC, V32, P489, DOI 10.1111/j.1469-7610.1991.tb00326.x; Schick B, 2007, CHILD DEV, V78, P376, DOI 10.1111/j.1467-8624.2007.01004.x; Schormans AL, 2017, HEARING RES, V343, P92, DOI 10.1016/j.heares.2016.06.017; Sharma A, 2014, DEV AUDITORY VESTIBU, P315; Smith LB, 1998, DEV PSYCHOL, V34, P840, DOI 10.1037/0012-1649.34.5.840; Suanda SH, 2016, DEV NEUROPSYCHOL, V41, P324, DOI 10.1080/87565641.2016.1256403; Voress J. K., 2013, DEV ASSESSMENT YOUNG, V2nd; Zimmerman I., 2011, PRESCHOOL LANGUAGE S	54	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0209265	10.1371/journal.pone.0209265	http://dx.doi.org/10.1371/journal.pone.0209265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726230	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000007
J	Luna, D; Miranda, M; Minervino, AHH; Pineiro, V; Herrero-Latorre, C; Lopez-Alonso, M				Luna, Diego; Miranda, Marta; Hamad Minervino, Antonio Humberto; Pineiro, Veronica; Herrero-Latorre, Carlos; Lopez-Alonso, Marta			Validation of a simple sample preparation method for multielement analysis of bovine serum	PLOS ONE			English	Article							ICP-MS; BLOOD; PLASMA	Here we propose a single acid digestion (SAD) sample preparation method for ICP-MS analysis of animal serum samples to determine trace element contents. The method was evaluated in comparison with a commonly used procedure involving dilution of samples in an alkaline solution (AKD). In the SAD procedure, aliquots (1 mL) of bovine serum samples were treated at low temperature with a mixture of concentrated nitric acid and hydrogen peroxide. Trace elements (As, B, Ba, Cd, Co, Cr, Cu, Fe, Hg, Li, Mn, Mo, Ni, Pb, Sb, Se, Sr, U, and Zn) were directly determined by ICP-MS analysis of diluted solutions of samples. Both methods were sufficiently sensitive to enable quantification of most trace elements, with the exception of the AKD method for Cd, Hg and Pb. The quality of the data was verified by using certified reference material. Good results were obtained for the SAD procedure and all elements, but recoveries were unacceptable with the AKD procedure for Se (recovery: 57%), Cd (154%) and Fe (139%). Strong associations (R-2>0.90, P = 0.000) between the data obtained by both methods were demonstrated for the elements considered. The proposed SAD sample preparation method produced satisfactory results for determining most toxic and essential trace elements targeted in monitoring studies.	[Luna, Diego; Lopez-Alonso, Marta] Univ Santiago de Compostela, Vet Fac, Dept Anim Pathol, Lugo, Spain; [Luna, Diego] Univ Cent Ecuador, Fac Vet Med, Quito, Ecuador; [Miranda, Marta] Univ Santiago de Compostela, Vet Fac, Dept Anat Anim Prod & Clin Vet Sci, Lugo, Spain; [Hamad Minervino, Antonio Humberto] Fed Univ Western Para UFOPA, Lab Anim Hlth LARSANA, Rua Vera Paz S-N, Santarem, PA, Brazil; [Pineiro, Veronica] Univ Santiago de Compostela, Elemental Anal RIAIDT, Lugo, Spain; [Herrero-Latorre, Carlos] Univ Santiago de Compostela, Fac Ciencias, Dept Quim Anal Nutr & Bromatol, IIAA, Lugo, Spain	Universidade de Santiago de Compostela; Universidad Central del Ecuador; Universidade de Santiago de Compostela; Universidade Federal do Oeste do Para; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Minervino, AHH (corresponding author), Fed Univ Western Para UFOPA, Lab Anim Hlth LARSANA, Rua Vera Paz S-N, Santarem, PA, Brazil.	ah.minervino@gmail.com	López-Alonso, Marta/K-9437-2013; Minervino, Antonio Humberto/G-5512-2011; Miranda, Marta/K-9445-2013; Piñeiro, Veronica/R-4954-2019	López-Alonso, Marta/0000-0001-6426-4273; Minervino, Antonio Humberto/0000-0002-6742-3652; Miranda, Marta/0000-0002-9869-3874; Piñeiro, Veronica/0000-0001-9708-0884; Luna, Diego/0000-0002-6429-9107; Herrero Latorre, Carlos/0000-0002-6217-8141	Federal University of Western Para	Federal University of Western Para	The author(s) received no specific funding for this work. The publication cost was granted by Federal University of Western Para.	[Anonymous], 2014, HDB TOXICOLOGY METAL; AOAC International, 2012, J AOAC Int, V95, P268, DOI 10.5740/jaoacint.11-447; Barany E, 1997, J ANAL ATOM SPECTROM, V12, P1005, DOI 10.1039/a700904f; D'Ilio S, 2010, ANAL METHODS-UK, V2, P2049, DOI 10.1039/c0ay00429d; de Sousa Isadora Karolina Freitas, 2012, Vet Med Int, V2012, P207950, DOI 10.1155/2012/207950; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; Minervino AHH, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8120227; Herdt TH, 2011, VET CLIN N AM-FOOD A, V27, P255, DOI 10.1016/j.cvfa.2011.02.004; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kira CS, 2014, J APPL PHARM SCI, V4, P39, DOI [10.7324/JAPS.2014.40507, DOI 10.7324/JAPS.2014.40507]; Kozlowski H, 2012, COORDIN CHEM REV, V256, P2129, DOI 10.1016/j.ccr.2012.03.013; Lopez-Alonso M, 2017, CHEMOSPHERE, V185, P1048, DOI 10.1016/j.chemosphere.2017.07.112; Lu Y, 2015, CLIN BIOCHEM, V48, P140, DOI 10.1016/j.clinbiochem.2014.12.003; Mehdi Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21040545; Overton TR, 2014, J ANIM SCI, V92, P416, DOI 10.2527/jas.2013-7145; Puls R., 1994, Mineral levels in animal health: diagnostic data.; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306	19	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211859	10.1371/journal.pone.0211859	http://dx.doi.org/10.1371/journal.pone.0211859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721256	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300036
J	Sterkowicz-Przybycien, K; Sterkowicz, S; Biskup, L; Zarow, R; Kryst, L; Ozimek, M				Sterkowicz-Przybycien, Katarzyna; Sterkowicz, Stanislaw; Biskup, Leon; Zarow, Ryszard; Kryst, Lukasz; Ozimek, Mariusz			Somatotype, body composition, and physical fitness in artistic gymnasts depending on age and preferred event	PLOS ONE			English	Article							KRAKOW; ADOLESCENTS; CHILDREN; WEIGHT	In men's artistic gymnastics, results that are particularly appreciated are those obtained in all-around and individual events such as the floor exercise, pommel horse, rings, vault, parallel bars and horizontal bar. However, few studies have explored the dependency of anthropometric characteristics and fitness from age category or the event preferred by gymnasts. Therefore, the aim of this study is to compare the somatic type, body composition and values of some anthropometric and fitness characteristics and indices of gymnasts according to age and preferred event. A total of 53 male gymnasts (19 seniors and 34 juniors) were examined right before the Polish Senior and Junior Championships in Artistic Gymnastics in Warsaw (May 25 to 28, 2017). We examined the characteristics of body length, skeletal system mass, muscle mass, skinfold thickness, and body mass (Tanita S. C.-330S). Body composition (Durnin and Womersley equations), somatotypes (Heath-Carter methodology), handgrip strength (Takei dynamometer), body balance (UPST), the power of the lower limbs (CMJ) were evaluated. Senior gymnasts presented higher than juniors experience, mesomorphy and had higher values in fitness tests of handgrip strength and power of lower limbs (p<0.05). The specialists in floor exercises and vault characterized in higher mesomorphy and lower ectomorphy (p<0.05) and better results of CMJ (p<0.05). We concluded: The seniors demonstrated natural predominance over juniors in several somatic and fitness variables. Detected differences can be useful in the process of identification and development of gymnastic talent. The detected effect of preferred event on certain variables that characterize body build and physical fitness can be useful for choosing a specialization in gymnastic event. A high skill level in all-around events at a national competitive level can be achieved by an athlete characterized by adequate experience, a mesomorphy somatotype component, lower limb index, pelvi-acromial index and relative HGSmax.	[Sterkowicz-Przybycien, Katarzyna; Biskup, Leon] Univ Phys Educ, Inst Sport Sci, Dept Gymnast & Dance, Krakow, Poland; [Sterkowicz, Stanislaw] Univ Phys Educ, Inst Sport Sci, Dept Theory Sport & Kinesiol, Krakow, Poland; [Zarow, Ryszard; Kryst, Lukasz] Univ Phys Educ, Inst Human Physiol, Dept Anthropol, Krakow, Poland; [Ozimek, Mariusz] Univ Phys Educ, Inst Sport Sci, Dept Track End Fields Sports, Krakow, Poland	Institute of Sport - National Research Institute; Institute of Sport - National Research Institute; Institute of Sport - National Research Institute	Sterkowicz-Przybycien, K (corresponding author), Univ Phys Educ, Inst Sport Sci, Dept Gymnast & Dance, Krakow, Poland.	katarzyna.sterkowicz@awf.krakow.pl			University of Physical Education, Cracow, Poland [100/BS/IS/2016]; Bioethics Committee at the Regional Medical Chamber in Cracow, Poland [215/KBL/OIL/2016]	University of Physical Education, Cracow, Poland; Bioethics Committee at the Regional Medical Chamber in Cracow, Poland	This work was supported by project No. 100/BS/IS/2016, Statutory research, URL: awf.krakow.pl; University of Physical Education, Cracow, Poland (K-SP). The authors' institution funded travel and transportation of researcher and devices to the Polish Senior and Junior Championships in Gymnastics (Warsaw, 25-28, May, 2017), supported data collection, and the cost of English editing by American Manuscript Editors (certificate No. 987-894-433-222-929), and cost of agreement of the Bioethics Committee at the Regional Medical Chamber in Cracow, Poland (No. 215/KBL/OIL/2016 as of 12 December 2016).	Almansba R, 2012, ARCH BUDO, V8, P153, DOI 10.12659/AOB.883365; Andreev P., 2015, ACTIVITIES PHYS ED S, V5, P138; [Anonymous], 2017, MENS ARTISTIC GYMNAS; Arkaev L, 2009, CREATE CHAMPIONS THE; Busko K, 2017, BIOMED HUM KINET, V9, P7, DOI 10.1515/bhk-2017-0002; Carter J. E. L., 1990, SOMATOTYPING DEV APP; Carter J. E. L., 2002, HEATH CARTER ANTHROP; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuk J, 2015, SCI GYMNASTICS J, V7, P128; Dallas G, 2014, J SPORT MED PHYS FIT, V54, P683; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Goulding M, 2002, SOMATOTYPE 1 1; GUALDIRUSSO E, 1992, J SPORT MED PHYS FIT, V32, P303; GUALDIRUSSO E, 1993, J SPORT MED PHYS FIT, V33, P282; Hattori K, 1997, AM J HUM BIOL, V9, P573, DOI 10.1002/(SICI)1520-6300(1997)9:5<573::AID-AJHB5>3.0.CO;2-V; Iman R. L., 1974, CANADIAN J STATIST C, V2, P227, DOI DOI 10.2307/3314695; Jemni M, 2000, J STRENGTH COND RES, V14, P389; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kochanowicz A, 2017, SCI GYMNAST J, V9, P5; Kochanowicz A, 2016, J HUM KINET, V53, P33, DOI 10.1515/hukin-2016-0008; Kowal M, 2013, J BIOSOC SCI, V45, P111, DOI 10.1017/S0021932012000284; Kryst L, 2012, J BIOSOC SCI, V44, P495, DOI 10.1017/S0021932011000721; Martin R., 1957, LEHRBUCH ANTHR, V3rd; Miarka B, 2017, MOTOR CONTROL, V21, P390, DOI 10.1123/mc.2016-0007; Ostojic SM, 2006, J STRENGTH COND RES, V20, P740; Pusnik I, 2017, SCI GYMNAST J, V9, P61; Raschka C, 2006, SPORTANTHROPOLOGIE L; Sayers SP, 1999, MED SCI SPORT EXER, V31, P572, DOI 10.1097/00005768-199904000-00013; Soldicaieksic J, 2001, YUGOSLAV J OPERATION, V1, P113; Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8; Sterkowicz K, 2005, REV MACKENZIE EDUCAC, V4, P113; Sterkowicz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155985; Sterkowicz-Przybycien Katarzyna, 2014, Coll Antropol, V38, P511; Suchomel TJ, 2016, SCI GYMNAST J, V8, P15; TOOTHAKER LE, 1994, J EDUC BEHAV STAT, V19, P237, DOI 10.3102/10769986019003237; VALIC A, 2015, 2 INT SCI C ORG P SL, P119; Walaszek R, 2016, J SPORTS MED PHYS FI, V20, P1; Woronkowicz A, 2016, ANTHROPOL ANZ, V73, P125, DOI 10.1127/anthranz/2016/0578	38	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211533	10.1371/journal.pone.0211533	http://dx.doi.org/10.1371/journal.pone.0211533			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2MO	30721273	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300018
J	Trajkovic, K; Valdez, C; Ysselstein, D; Krainc, D				Trajkovic, Katarina; Valdez, Clarissa; Ysselstein, Daniel; Krainc, Dimitri			Fluctuations in cell density alter protein markers of multiple cellular compartments, confounding experimental outcomes	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CONTACT INHIBITION; MAMMALIAN TARGET; HIPPO PATHWAY; CANCER; AUTOPHAGY; FIBROBLASTS; METABOLISM; CONFLUENCE; GROWTH	The life cycle of cultured proliferating cells is characterized by fluctuations in cell population density induced by periodic subculturing. This leads to corresponding changes in micro- and macroenvironment of the cells, accompanied by altered cellular metabolism, growth rate and locomotion. Studying cell density-dependent morphological, physiological and biochemical fluctuations is relevant for understanding basic cellular mechanisms and for uncovering the intrinsic variation of commonly used tissue culture experimental models. Using multiple cell lines, we found that expression levels of the autophagic markers p62 and LC3II, and lysosomal enzyme cathepsin D were altered in highly confluent cells as a consequence of nutrient depletion and cell crowding, which led to inactivation of the mTOR signaling pathway. Furthermore, both Lamp1 and active focal adhesion kinase (FAK) were reduced in high-density cells, while chemical inhibition or deletion of FAK led to alterations in lysosomal and autophagic proteins, as well as in the mTOR signaling. This was accompanied by alterations in the Hippo signaling pathway, while cell cycle checkpoint regulator p-cdc2 remained unaffected in at least one studied cell line. On the other hand, allometric scaling of cellular compartments in growing cell populations resulted in biochemically detectable changes in the plasma membrane proteins Na+K+-ATPase and cadherin, and nuclear proteins HDAC1 and Lamin B1. Finally, we demonstrate how treatment-induced changes in cell density and corresponding modulation of susceptible proteins may lead to ambiguous experimental outcomes, or erroneous interpretation of cell culture data. Together, our data emphasize the need to recognize cell density as an important experimental variable in order to improve scientific rigor of cell culture-based studies.	[Trajkovic, Katarina; Valdez, Clarissa; Ysselstein, Daniel; Krainc, Dimitri] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Trajkovic, K; Krainc, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	katarina.trajkovic@northwestern.edu; dkrainc@nm.org	Trajkovic, Katarina/AAJ-4219-2021	Trajkovic, Katarina/0000-0002-2716-1491; , Clarissa/0000-0002-8602-9706	 [R01NS076054];  [R37NS096241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076054, R37NS096241] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study has been funded by grants R01NS076054 and R37NS096241 awarded to D.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; [Anonymous], 2016, NATURE, V533, P437, DOI 10.1038/533437a; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; Bretou M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aak9573; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cheng ZK, 2017, J BIOL CHEM, V292, P2065, DOI 10.1074/jbc.M116.758268; COCKLE SM, 1982, BIOCHEM J, V208, P795, DOI 10.1042/bj2080795; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; GAL D, 1981, CANCER RES, V41, P473; GRIFFITHS JB, 1972, J CELL SCI, V10, P515; Gu SC, 2013, CELL SIGNAL, V25, P66, DOI 10.1016/j.cellsig.2012.08.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HENDIL KB, 1977, J CELL PHYSIOL, V92, P353, DOI 10.1002/jcp.1040920304; Hu JKH, 2017, CELL STEM CELL, V21, P91, DOI 10.1016/j.stem.2017.03.023; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; KNECHT E, 1984, EXP CELL RES, V154, P224, DOI 10.1016/0014-4827(84)90682-7; Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Muelas MW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21050-4; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Parker DJ, 2015, J CELL SCI, V128, P4171, DOI 10.1242/jcs.172429; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Ren JQ, 2015, CYTOTHERAPY, V17, P897, DOI 10.1016/j.jcyt.2015.03.607; Ruutu M, 2004, ANTICANCER RES, V24, P2627; Sandilands E, 2015, CELL SIGNAL, V27, P1816, DOI 10.1016/j.cellsig.2015.05.017; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schiefermeier N, 2014, J CELL BIOL, V205, P525, DOI 10.1083/jcb.201310043; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Sharifi MN, 2016, CELL REP, V15, P1660, DOI 10.1016/j.celrep.2016.04.065; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Song PP, 2016, J NEUROSCI, V36, P2425, DOI 10.1523/JNEUROSCI.2569-15.2016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trajkovic K, 2017, J NEUROSCI, V37, P9000, DOI 10.1523/JNEUROSCI.0118-17.2017; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211727	10.1371/journal.pone.0211727	http://dx.doi.org/10.1371/journal.pone.0211727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716115	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200042
J	Dangel, ML; Dettmann, JC; Hasselbarth, S; Krogull, M; Schakat, M; Kreikemeyer, B; Fiedler, T				Dangel, Marcel-Lino; Dettmann, Johann-Christoph; Hasselbarth, Steffi; Krogull, Martin; Schakat, Miriam; Kreikemeyer, Bernd; Fiedler, Tomas			The 5 '-nucleotidase S5nA is dispensable for evasion of phagocytosis and biofilm formation in Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; GALLERIA-MELLONELLA; FUNCTIONAL-CHARACTERIZATION; A(2A) RECEPTORS; FCT REGION; ADENOSINE; PATHOGENESIS; PROTEIN; INFLAMMATION; ASSOCIATION	5'-nucleotidases are widespread among all domains of life. The enzymes hydrolyze phosphate residues from nucleotides and nucleotide derivatives. In some pathobiontic bacteria, 5'-nucleotidases contribute to immune evasion by dephosphorylating adenosine mono-, di-, or tri-phosphates, thereby either decreasing the concentration of pro-inflammatory ATP or increasing the concentration of anti-inflammatory adenosine, both acting on purinergic receptors of phagocytic cells. The strict human pathogen Streptococcus pyogenes expresses a surface-associated 5'-nucleotidase (S5nA) under infection conditions that has previously been discussed as a potential virulence factor. Here we show that deletion of the S5nA gene does not significantly affect growth in human blood, evasion of phagocytosis by neutrophils, formation of biofilms and virulence in an infection model with larvae of the greater wax moth Galleria mellonella in S. pyogenes serotypes M6, M18 and M49. Hence, the surface-associated 5'-nucleotidase S5nA seems dispensable for evasion of phagocytosis and biofilm formation in S. pyogenes.	[Dangel, Marcel-Lino; Dettmann, Johann-Christoph; Hasselbarth, Steffi; Krogull, Martin; Schakat, Miriam; Kreikemeyer, Bernd; Fiedler, Tomas] Rostock Univ, Med Ctr, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Dettmann, Johann-Christoph] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Schakat, Miriam] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany	University of Rostock; Miltenyi Biotec; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fiedler, T (corresponding author), Rostock Univ, Med Ctr, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	tomas.fiedler@med.uni-rostock.de		Fiedler, Tomas/0000-0001-6717-1865; Kreikemeyer, Bernd/0000-0001-9527-5098				Baev D, 1999, INFECT IMMUN, V67, P4510, DOI 10.1128/IAI.67.9.4510-4516.1999; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Chalmers C, 2017, J MICROBIOL IMMUNOL; Cook SM, 2013, VIRULENCE, V4, P350, DOI 10.4161/viru.25240; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Fiedler T, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00015; Fiedler T, 2010, FUTURE MICROBIOL, V5, P1675, DOI [10.2217/fmb.10.128, 10.2217/FMB.10.128]; Firon A, 2014, J BIOL CHEM, V289, P5479, DOI 10.1074/jbc.M113.545632; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Koller T, 2008, PROTEOMICS, V8, P140, DOI 10.1002/pmic.200700001; Koller T, 2010, J MED MICROBIOL, V59, P442, DOI 10.1099/jmm.0.013581-0; KOHN J, 1963, J BACTERIOL, V86, P713, DOI 10.1128/JB.86.4.713-716.1963; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; LeMoine O, 1996, J IMMUNOL, V156, P4408; Liu P, 2014, J INFECT DIS, V210, P35, DOI 10.1093/infdis/jiu050; Loh JMS, 2013, VIRULENCE, V4, P419, DOI 10.4161/viru.24930; Ma F, 2017, APPL ENV MICROBIOL, V83; Manetti AGO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013864; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Oehmcke-Hecht S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01841; Olsen RJ, 2011, VIRULENCE, V2, P111, DOI 10.4161/viru.2.2.14338; Pappesch R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12507-z; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Punj V, 2000, INFECT IMMUN, V68, P4930, DOI 10.1128/IAI.68.9.4930-4937.2000; Reid SD, 2002, J BACTERIOL, V184, P6316, DOI 10.1128/JB.184.22.6316-6324.2002; REIS J L, 1950, Biochem J, V2, P21; Santos CA, 2013, MICROB PATHOGENESIS, V59-60, P1, DOI 10.1016/j.micpath.2013.02.007; Severin A, 2007, J BACTERIOL, V189, P1514, DOI 10.1128/JB.01132-06; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Sugareva V, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-34; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Thiel M, 2003, MICROBES INFECT, V5, P515, DOI 10.1016/S1286-4579(03)00068-6; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; Zaborina O, 2000, MICROBIOL-UK, V146, P2521, DOI 10.1099/00221287-146-10-2521; Zheng LS, 2015, J BIOL CHEM, V290, P31126, DOI 10.1074/jbc.M115.677443; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211074	10.1371/journal.pone.0211074	http://dx.doi.org/10.1371/journal.pone.0211074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703118	Green Submitted, gold, Green Published			2022-12-26	WOS:000457301600030
J	Shao, BR; Bjaanaes, MM; Helland, A; Schutte, C; Conrad, T				Shao, Borong; Bjaanaes, Maria Moksnes; Helland, Aslaug; Schuette, Christof; Conrad, Tim			EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; GENE-EXPRESSION; BREAST-CANCER; SIGNATURES; MARKERS; TUMOR; REGULARIZATION; SURVIVAL; MODEL	Various feature selection algorithms have been proposed to identify cancer prognostic biomarkers. In recent years, however, their reproducibility is criticized. The performance of feature selection algorithms is shown to be affected by the datasets, underlying networks and evaluation metrics. One of the causes is the curse of dimensionality, which makes it hard to select the features that generalize well on independent data. Even the integration of biological networks does not mitigate this issue because the networks are large and many of their components are not relevant for the phenotype of interest. With the availability of multi-omics data, integrative approaches are being developed to build more robust predictive models. In this scenario, the higher data dimensions create greater challenges. We proposed a phenotype relevant network-based feature selection (PRNFS) framework and demonstrated its advantages in lung cancer prognosis prediction. We constructed cancer prognosis relevant networks based on epithelial mesenchymal transition (EMT) and integrated them with different types of omics data for feature selection. With less than 2.5% of the total dimensionality, we obtained EMT prognostic signatures that achieved remarkable ;prediction performance (average AUC values >0.8), very significant sample stratifications, and meaningful biological interpretations. In addition to finding EMT signatures from different omics data levels, we combined these single-omics signatures into multi-omics signatures, which improved sample stratifications significantly. Both single- and multi-omics EMT signatures were tested on independent multi-omics lung cancer datasets and significant sample stratifications were obtained.	[Shao, Borong; Schuette, Christof; Conrad, Tim] Zuse Inst Berlin, Berlin, Germany; [Shao, Borong; Schuette, Christof; Conrad, Tim] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Bjaanaes, Maria Moksnes; Helland, Aslaug] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Bjaanaes, Maria Moksnes; Helland, Aslaug] Oslo Univ Hosp, Dept Canc Genet, Oslo, Norway; [Bjaanaes, Maria Moksnes; Helland, Aslaug] Univ Oslo, Dept Clin Med, Oslo, Norway	Zuse Institute Berlin; Free University of Berlin; University of Oslo; University of Oslo; University of Oslo	Shao, BR (corresponding author), Zuse Inst Berlin, Berlin, Germany.; Shao, BR (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany.	borong.shao@gmail.com	Helland, Åslaug/H-3910-2015; Conrad, Tim/N-2742-2014	Helland, Åslaug/0000-0002-5520-0275; Conrad, Tim/0000-0002-5590-5726; Shao, Borong/0000-0003-4670-9229	Federal Ministry of Education and Research of Germany [3FO18501]	Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF))	This study was supported by the Federal Ministry of Education and Research of Germany, grant 3FO18501 (Forschungscampus MODAL) to TC, BS, and CS. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; Allahyar A, 2015, BIOINFORMATICS, V31, P311, DOI 10.1093/bioinformatics/btv255; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bjaanaes MM, 2016, MOL ONCOL, V10, P330, DOI 10.1016/j.molonc.2015.10.021; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; BROAD INSTITUTE TCGA GENOME DATA ANALYSIS CENTER, 2016, 20160128 BROAD I MIT; Chen L, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-161; Chikaish Y, 2011, ANTICANCER RES, V31, P4451; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; COX DR, 1972, J R STAT SOC B, V34, P187; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073074; Cun YP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-69; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Gwinner F, 2017, BIOINFORMATICS, V33, P701, DOI 10.1093/bioinformatics/btw676; Hahsler M, 2005, COMPUTATIONAL ENV MI, DOI [10.1016/j.cell.2011.02.013, DOI 10.1016/J.CELL.2011.02.013]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Howlader Nadia, 2014, Journal of the National Cancer Institute Monographs, P255, DOI 10.1093/jncimonographs/lgu022; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11566; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Li J, 2012, NUCLEIC ACIDS RES, V40, pW123, DOI 10.1093/nar/gks386; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Martinez-Ledesma E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11966; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Mounika Inavolu S, 2017, CPT PHARMACOMETRICS; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Seoane JA, 2014, BIOINFORMATICS, V30, P838, DOI 10.1093/bioinformatics/btt610; Shao B, 2017, GENOMICS COMPUTATION, V3, P57, DOI [10.18547/gcb.2017.vol3.iss3.e57, DOI 10.18547/GCB.2017.VOL3.ISS3.E57]; Shao B, 2016, INT C BIOINF BIOM EN, P135; Shao B., 2018, PHENOTYPE RELEVANT N; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Simon N, 2011, J STAT SOFTW, V39, P1; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staiger Christine, 2013, Frontiers in Genetics, V4, P289, DOI 10.3389/fgene.2013.00289; Staiger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034796; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tang J, 2014, DATA CLASSIFICATION, V2014, P37; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Yang S, 2013, GRAPH EMBEDDING PATT, P27, DOI DOI 10.1007/978-1-4614-4457-2_2; Zhang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002975; Zhang YJ, 2013, INT J DATA MIN BIOIN, V7, P284, DOI 10.1504/IJDMB.2013.053309; Zhao J, 2014, INT BRAZ J UROL, V40, P179, DOI 10.1590/S1677-5538.IBJU.2014.02.07	66	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0204186	10.1371/journal.pone.0204186	http://dx.doi.org/10.1371/journal.pone.0204186			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703089	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600003
J	Takemura, K; Adegoke, O; Suzuki, T; Park, EY				Takemura, Kenshin; Adegoke, Oluwasesan; Suzuki, Tetsuro; Park, Enoch Y.			A localized surface plasmon resonance-amplified immunofluorescence biosensor for ultrasensitive and rapid detection of nonstructural protein 1 of Zika virus	PLOS ONE			English	Article							GOLD NANOPARTICLES; EMERGENCE; HYBRIDS; RNA	Among the members of flaviviruses, the Zika virus (ZIKV) remains a potent infectious disease agent, with its associated pandemic prompting the World Health Organization (WHO) to declare it a global public health concern. Thus, rapid and accurate diagnosis of the ZIKV is needed. In this study, we report a new immunofluorescence biosensor for the detection of nonstructural protein 1 (NS1) of the ZIKV, which operates using the localized surface plasmon resonance (LSPR) signal from plasmonic gold nanoparticles (AuNPs) to amplify the fluorescence intensity signal of quantum dots (QDs) within an antigen-antibody detection process. The LSPR signal from the AuNPs was used to amplify the fluorescence intensity of the QDs. For ultrasensitive, rapid, and quantitative detection of NS1 of the ZIKV, four different thiol-capped AuNPs were investigated. Our biosensor could detect the ZIKV in a wide concentration range from 10-10(7) RNA copies/mL, and we found that the limit of detection (LOD) for the ZIKV followed the order Ab-(L)-cysteine-AuNPs (LOD = 8.2 copies/mL) > Ab-3-mercaptopropionic acid-AuNPs (LOD = 35.0 copies/mL). Immunofluorescence biosensor for NS1 exhibited excellent specificity against other negative control targets and could also detect the ZIKV in human serum.	[Takemura, Kenshin; Park, Enoch Y.] Shizuoka Univ, Biotechnol Lab, Dept Biosci, Grad Sch Sci & Technol,Suruga Ku, Shizuoka, Japan; [Adegoke, Oluwasesan; Park, Enoch Y.] Shizuoka Univ, Biotechnol Lab, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka, Japan; [Adegoke, Oluwasesan] Univ Dundee, Leverhulme Res Ctr Forens Sci, Dundee, Scotland	Shizuoka University; Shizuoka University; Hamamatsu University School of Medicine; University of Dundee	Park, EY (corresponding author), Shizuoka Univ, Biotechnol Lab, Dept Biosci, Grad Sch Sci & Technol,Suruga Ku, Shizuoka, Japan.; Park, EY (corresponding author), Shizuoka Univ, Biotechnol Lab, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka, Japan.	park.enoch@shizuoka.ac.jp	Takemura, Kenshin/AAT-9547-2021; Park, Enoch/AAU-2614-2020	Takemura, Kenshin/0000-0002-7892-8488; Adegoke, Oluwasesan/0000-0002-8087-460X; Park, Enoch Y./0000-0002-7840-1424	Japan Society for the Promotion of Science (JSPS) [P13454]; Bilateral Joint Research Project of the JSPS, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bilateral Joint Research Project of the JSPS, Japan	OA thanks the Japan Society for the Promotion of Science (JSPS) for a postdoctoral fellowship for overseas researchers (P13454). This work was supported partly by the Bilateral Joint Research Project of the JSPS, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke O, 2017, J MATER CHEM B, V5, P3047, DOI 10.1039/c7tb00388a; Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046; Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051; Ahmed SR, 2017, BIOSENS BIOELECTRON, V87, P558, DOI 10.1016/j.bios.2016.08.101; Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316; Bollweg BC, 2018, J PATHOL CLIN RES, V4, P19, DOI 10.1002/cjp2.84; Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chen R, 2010, RARE METALS, V29, P180, DOI 10.1007/s12598-010-0031-5; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Draz MS, 2018, NANOSCALE; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Gebre Y, ASIAN PAC J BIOMED, V6, P815; Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282; Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9; Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lee J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102332; Lee J, 2015, BIOSENS BIOELECTRON, V64, P311, DOI 10.1016/j.bios.2014.09.021; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778; Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1; Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685; Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140; Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213; Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632; Takemura K, 2017, BIOSENS BIOELECTRON, V89, P998, DOI 10.1016/j.bios.2016.10.045; Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010	30	16	16	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211517	10.1371/journal.pone.0211517	http://dx.doi.org/10.1371/journal.pone.0211517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703161	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600053
J	Alves, MI; Macagnan, KL; Piecha, CR; Torres, MM; Perez, IA; Kesserlingh, SM; Rodrigues, RD; de Oliveira, PD; Moreira, AD				Alves, Mariane Igansi; Macagnan, Karine Laste; Piecha, Camila Rios; Torres, Matheus Marques; Perez, Izadora Almeida; Kesserlingh, Sonia Maria; Rodrigues, Rosane da Silva; de Oliveira, Patricia Diaz; Moreira, Angelita da Silveira			Optimization of Ralstonia solanacearum cell growth using a central composite rotational design for the P(3HB) production: Effect of agitation and aeration	PLOS ONE			English	Article							PHB PRODUCTION; POLY(3-HYDROXYBUTYRATE); POLY-3-HYDROXYBUTYRATE; POLYHYDROXYALKANOATES; FERMENTATION; DENSITY	The intracellular accumulation of polyhydroxyalkanoates (PHAs) normally occurs after cell growth, during the second fermentation stage and under nutrient-limited conditions in the presence of a carbon excess. However, some microorganisms are able to accumulate PHAs as poly(3-hydroxybutyrate) [P(3HB)] during the first fermentation stage, the cell growth phase, without nutrient limitation, once they have been reported to utilize type II metabolism during the polymer accumulation phase. This study evaluated the effect of aeration and agitation on cell growth and P(3HB) accumulation in Ralstonia solanacearum RS, performed in a bioreactor for 24h at 32 degrees C. A 2 2 central composite rotational design (CCRD) was used, with agitation (150 to 250 rpm) and aeration (0.3 to 1 vvm) as independent variables and optical density (OD600nm), dry cell weight (DCW), and P(3HB) yield as dependent variables. A significant polymer accumulation, until 70% of P(3HB), was observed, proving that R. solanacearum RS exhibited metabolism type II, regardless of the aeration process. The best results were obtained for 1 vvm and 250 rpm (+1, +1), with values of OD600nm (18.04) and DCW (4.82 g.L-1).	[Alves, Mariane Igansi; de Oliveira, Patricia Diaz; Moreira, Angelita da Silveira] Univ Fed Pelotas, Eliseu Maciel Fac Agron, Dept Food Sci & Technol, Pelotas, RS, Brazil; [Macagnan, Karine Laste; Piecha, Camila Rios; Torres, Matheus Marques; Moreira, Angelita da Silveira] Univ Fed Pelotas, Technol Dev Ctr, Biotechnol, Pelotas, RS, Brazil; [Perez, Izadora Almeida; Rodrigues, Rosane da Silva; de Oliveira, Patricia Diaz; Moreira, Angelita da Silveira] Univ Fed Pelotas, Ctr Chem Pharmaceut & Food Sci, Pelotas, RS, Brazil; [Kesserlingh, Sonia Maria] Co PHB Ind, Serrana, SP, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Moreira, AD (corresponding author), Univ Fed Pelotas, Eliseu Maciel Fac Agron, Dept Food Sci & Technol, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Technol Dev Ctr, Biotechnol, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Ctr Chem Pharmaceut & Food Sci, Pelotas, RS, Brazil.	angelitadasilveiramoreira@gmail.com	Kesserlingh, Sônia/U-1518-2019; Macagnan, Karine Laste/N-9398-2018; Diaz, Patrícia Silva/L-9364-2017; da S. Moreira, Angelita/L-8545-2017	Macagnan, Karine Laste/0000-0002-8643-3397; Diaz, Patrícia Silva/0000-0001-9601-296X; da S. Moreira, Angelita/0000-0001-8711-6521; Kesserlingh, Sonia Maria/0000-0003-4545-835X				AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Alves FG, 2010, APPL BIOCHEM BIOTECH, V160, P1528, DOI 10.1007/s12010-009-8683-z; Alves Mariane I., 2017, IND BIOTECHNOLOGY, V13, P192, DOI [DOI 10.1089/IND.2017.0013, 10.1089/ind.2017.0013]; Alves-Gauterio FG, 2015, REV BRASILEIRA TECNO, V9, P1821; Barros BN, 2001, COMO FAZER EXPT PESQ; BARROS NB, 1995, PLANEJAMENTO OTIMIZA; Brito GF., 2011, REV ELETRON MAT PROC, V6, P127; Burkert JFD, 2005, J CHEM TECHNOL BIOT, V80, P61, DOI 10.1002/jctb.1157; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; Carvell JP, 2006, CYTOTECHNOLOGY, V50, P35, DOI 10.1007/s10616-005-3974-x; Chakraborty P, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/506153; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chioccioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097269; Chisti Y., 2004, HDB MICROALGAL CULTU, P57; Crochemore A. G., 2012, African Journal of Biotechnology, V11, P15144; de Almeida A, 2010, APPL ENVIRON MICROB, V76, P2036, DOI 10.1128/AEM.02706-09; Du GC, 2001, J BIOTECHNOL, V88, P59, DOI 10.1016/S0168-1656(01)00266-8; El-Sayed A.A., 2009, J APPL SCI RES, V5, P556; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Haaland PD, 1989, EXPT DESIGN BIOTECHN; JEANES A, 1974, FOOD TECHNOL-CHICAGO, V28, P34; Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6; Kemavongse K, 2008, WORLD J MICROB BIOT, V24, P2073, DOI 10.1007/s11274-008-9712-8; Khuri AI, 1996, RESPONSE SURFACE DES; Lee SY, 1999, INT J BIOL MACROMOL, V25, P31, DOI 10.1016/S0141-8130(99)00012-4; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Macagnan KL, 2017, QUIM NOVA, V40, P125, DOI 10.21577/0100-4042.20160162; Macagnan KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180563; Franchetti SM, 2006, QUIM NOVA, V29, P811, DOI 10.1590/S0100-40422006000400031; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montoro SR, 2010, POLIMEROS, V20, P19, DOI 10.1590/S0104-14282010005000005; Mozumder MSI, 2015, BIORESOURCE TECHNOL, V191, P213, DOI 10.1016/j.biortech.2015.04.110; National Geographic, WHOPP 91 PLAST ISNT; Park SJ, 2012, BIOTECHNOL ADV, V30, P1196, DOI 10.1016/j.biotechadv.2011.11.007; Pereira D. D., 2001, Revista Cientifica Rural, V6, P22; Prescott L. M., 2003, MICROBIOLOGIE; Ramadas NV, 2010, APPL BIOCHEM BIOTECH, V162, P996, DOI 10.1007/s12010-009-8807-5; RAMSAY J A, 1990, Biotechnology Techniques, V4, P221, DOI 10.1007/BF00158833; Rodrigues AA, 2015, REV BRASILEIRA TECNO, V9, P1771; Rodriguez-Contreras A, 2013, J APPL MICROBIOL, V114, P1378, DOI 10.1111/jam.12151; Rodriguez-Contreras A, 2015, BIOCHEM ENG J, V94, P50, DOI 10.1016/j.bej.2014.11.007; Rosa CFC, 2015, INT J ENG RES APPL, V5, P41; Sathish A, 2014, J POLYM ENVIRON, V22, P272, DOI 10.1007/s10924-014-0647-x; Schaad NW, 2001, LAB GUIDE IDENTIFICA, V3, P373; Squio CR, 2004, QUIM NOVA, V27, P615, DOI 10.1590/S0100-40422004000400016; Tripathi AD, 2013, BIOMASS BIOENERG, V55, P243, DOI 10.1016/j.biombioe.2013.02.017; Wu Q, 2001, ANTON LEEUW INT J G, V80, P111, DOI 10.1023/A:1012222625201; Xiong ZQ, 2008, J BIOSCI BIOENG, V105, P409, DOI 10.1263/jbb.105.409; Zafar M, 2012, J IND MICROBIOL BIOT, V39, P987, DOI 10.1007/s10295-012-1102-4	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211211	10.1371/journal.pone.0211211	http://dx.doi.org/10.1371/journal.pone.0211211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695062	gold, Green Submitted, Green Published			2022-12-26	WOS:000457046400019
J	Nolde, JM; Laupenmuhlen, J; Al-Zubaidi, A; Heldmann, M; Munte, TF; Jauch-Chara, K				Nolde, Janis Marc; Laupenmuehlen, Jana; Al-Zubaidi, Arkan; Heldmann, Marcus; Muente, Thomas F.; Jauch-Chara, Kamila			Endocrine responses and food intake in fasted individuals under the influence of glucose ingestion	PLOS ONE			English	Article							SOLUBLE LEPTIN RECEPTOR; WEIGHT-LOSS; DIETARY-COMPOSITION; ADIPONECTIN LEVELS; CIRCULATING ADIPONECTIN; CALORIC RESTRICTION; ENERGY RESTRICTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; OBESITY	Introduction Different metabolic conditions can affect what and how much we eat. Hormones of glucose metabolism and adipokines such as adiponectin take part in the control of these decisions and energy balance of the body. However, a comprehensive understanding of how these endocrine and metabolic factors influence food intake has not been reached. We hypothesised that the amount of food a person consumes differs substantially after a fasting period even after the energy deficit was partially removed by glucose ingestion and endocrine signals like insulin and C-peptide indicated a high glucose metabolic status. Furthermore, the macronutrient composition of the consumed food and a possible association with adiponectin under the influence of glucose ingestion was assessed. Methods In a within-subject design, 24 healthy males participated in both a fasting (42 h) and control (non-fasting) condition. A total of 20 blood samples from each subject were collected during each condition to assess serum levels of adiponectin, insulin, C-peptide, cortisol and ACTH. At the end of each condition food intake was measured with an ad libitum buffet after the acute energy deficit was compensated using a carbohydrate-rich drink. Results The total amount of caloric intake and single macronutrients was higher after the fasting intervention after replenishment with glucose. All recorded hormone levels, except for adiponectin, were significantly different for at least one of the study intervals. The relative proportions of the macronutrient composition of the consumed food were stable in both conditions under the influence of glucose ingestion. In the non-fasting condition, the relative amount of protein intake correlated with adiponectin levels during the experiment. Discussion and conclusion An anabolic glucose metabolism after glucose ingestion following a fasting intervention did not even out energy ingestion compared to a control group with regular food intake and glucose ingestion. Anorexigenic hormones like insulin in this context were not able despite higher levels than in the control condition to ameliorate the drive for food intake to normal or near normal levels. Relative macronutrient intake remains stable under these varying metabolic conditions and glucose influence. Serum adiponectin levels showed a positive association with the relative protein intake in the non-fasting condition under the influence of glucose although adiponectin levels overall did not differ in between the conditions.	[Nolde, Janis Marc; Al-Zubaidi, Arkan; Heldmann, Marcus; Muente, Thomas F.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Laupenmuehlen, Jana] Univ Lubeck, Dept Psychiat, Lubeck, Germany; [Jauch-Chara, Kamila] Univ Kiel, Dept Psychiat, Kiel, Germany	University of Lubeck; University of Lubeck; University of Kiel	Nolde, JM (corresponding author), Univ Lubeck, Dept Neurol, Lubeck, Germany.; Jauch-Chara, K (corresponding author), Univ Kiel, Dept Psychiat, Kiel, Germany.	janis.m.nolde@gmail.com; kamila.jauch-chara@uksh.de		Al-Zubaidi, Arkan/0000-0002-5893-2527	Deutsche Forschungsgemeinschaft [1957, T-CRC 134]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) (Research Training Group 1957; Adipocyte Brain Crosstalk [KJC, TFM] and T-CRC 134 project C1, Ingestive Behavior (https://sfb134.de/en/team.html) [TFM]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Agus MSD, 2000, AM J CLIN NUTR, V71, P901; Anderlova K, 2006, PHYSIOL RES, V55, P277, DOI 10.33549/physiolres.930779; Anderson ML, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.1.152; Austin J, 2009, HORMONAL REGULATORS, DOI [10.1016/j.appet.2008.09.015, DOI 10.1016/J.APPET.2008.09.015]; BERNARDINI J, 1993, BRAIN RES BULL, V32, P543, DOI 10.1016/0361-9230(93)90305-U; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Blundell JE, 2000, BRIT J NUTR, V83, pS33; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Chowdhury EA, 2016, INT J OBESITY, V40, P305, DOI 10.1038/ijo.2015.154; Clayton DJ, 2016, INT J OBESITY, V40, P1662, DOI 10.1038/ijo.2016.106; Ding Q, 2012, J NUTR BIOCHEM, V23, P867, DOI 10.1016/j.jnutbio.2011.04.011; Dougkas A, 2016, J NUTR, V146, P637, DOI 10.3945/jn.115.217224; Dridi S, 2009, J NUTR BIOCHEM, V20, P831, DOI 10.1016/j.jnutbio.2009.06.003; Dulloo AG, 2012, P NUTR SOC, V71, P379, DOI 10.1017/S0029665112000225; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Frank P, 2013, AM J PHYSIOL-ENDOC M, V304, pE436, DOI 10.1152/ajpendo.00416.2012; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Hall KD, 2017, GASTROENTEROLOGY, V152, P1718, DOI 10.1053/j.gastro.2017.01.052; Hallschmid M, 2010, DIABETES, V59, P1101, DOI 10.2337/db09-1493; Imbeault P, 2004, CLIN ENDOCRINOL, V60, P429, DOI 10.1111/j.1365-2265.2004.01997.x; Imbeault P, 2007, APPL PHYSIOL NUTR ME, V32, P505, DOI 10.1139/H07-017; Jauch-Chara K, 2014, PROG NEUROBIOL, V114, P84, DOI 10.1016/j.pneurobio.2013.12.001; Johnson NA, 2006, EXP PHYSIOL, V91, P693, DOI 10.1113/expphysiol.2006.033399; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3; Kotidis EV, 2006, OBES SURG, V16, P1425, DOI 10.1381/096089206778870058; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Macdonald IA, 2016, EUR J NUTR, V55, pS17, DOI 10.1007/s00394-016-1340-8; Mars M, 2005, AM J CLIN NUTR, V81, P570; McVay MA, 2015, J HUM NUTR DIET, V28, P16, DOI 10.1111/jhn.12188; Merl V, 2005, INT J OBESITY, V29, P998, DOI 10.1038/sj.ijo.0802971; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Rajaie S, 2013, ANN NUTR METAB, V63, P159, DOI 10.1159/000354868; Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z; Shand B, 2006, CLIN CHEM LAB MED, V44, P1264, DOI 10.1515/CCLM.2006.227; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Stimson RH, 2007, J CLIN ENDOCR METAB, V92, P4480, DOI 10.1210/jc.2007-0692; Summer SS, 2011, OBESITY, V19, P2198, DOI 10.1038/oby.2011.60; Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029; van der Klaauw AA, 2015, CELL, V161, P119, DOI 10.1016/j.cell.2015.03.008; Wolfe BE, 2004, CLIN ENDOCRINOL, V61, P332, DOI 10.1111/j.1365-2265.2004.02101.x	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211514	10.1371/journal.pone.0211514	http://dx.doi.org/10.1371/journal.pone.0211514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682147	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500173
J	Soh, YQ; Lim, GPS; Htoon, HM; Gong, X; Mootha, VV; Vithana, EN; Kocaba, V; Mehta, JS				Soh, Yu Qiang; Lim, Gary Peh Swee; Htoon, Hla Myint; Gong, Xin; Mootha, V. Vinod; Vithana, Eranga Nishanthie; Kocaba, Viridiana; Mehta, Jodhbir Singh			Trinucleotide repeat expansion length as a predictor of the clinical progression of Fuchs' Endothelial Corneal Dystrophy	PLOS ONE			English	Article							TCF4 GENE; ASSOCIATION; CTG18.1; SEVERITY; DISEASE	Purpose To determine if CTG18.1 TNR expansion length prognosticates the clinical progression of Fuchs' Endothelial Corneal Dystrophy (FECD). Methods This was a prospective cohort study. A total of 51 patients with newly diagnosed FECD were recruited and followed-up over a period of 12 years, from November 2004 to April 2016. Baseline clinical measurements included central corneal thickness (CCT), endothelial cell density (ECD) and CTG18.1 TNR expansion length from peripheral leukocytes, with yearly repeat measurements of CCT and ECD. A patient was defined to have experienced significant clinical progression and to have developed Threshold Disease if any of these criteria were fulfilled in either eye: a) CCT increased to > 700 mu m, b) ECD decreased to < 700 cells/mm(2), or c) underwent keratoplasty for treatment of FECD. Results Patients were categorized as having at least one allele whose maximum allele length was equal to or greater than 40 repeats (L >= 40, n = 22, 43.1%), or having both alleles shorter than 40 repeats (L< 40). Threshold Disease rates at the 5-year time point were 87.5% for the L >= 40 group and 47.8% for the L<40 group (p = 0.012). This difference narrowed and was no longer statistically significant at the 8-years (92.9% vs 78.9%, p = 0.278) and 10-years (92.9% vs 84.2%, p = 0.426) time points. Conclusions L >= 40 patients are at greater risk of FECD progression and development of Threshold Disease within the first 5 years following diagnosis.	[Soh, Yu Qiang; Lim, Gary Peh Swee; Kocaba, Viridiana; Mehta, Jodhbir Singh] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Soh, Yu Qiang; Mehta, Jodhbir Singh] Singapore Natl Eye Ctr, Singapore, Singapore; [Lim, Gary Peh Swee; Vithana, Eranga Nishanthie; Mehta, Jodhbir Singh] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Htoon, Hla Myint] Singapore Eye Res Inst, Singapore, Singapore; [Gong, Xin; Mootha, V. Vinod] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX USA; [Mootha, V. Vinod] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Mootha, V. Vinod; Vithana, Eranga Nishanthie] Singapore Eye Res Inst, Ocular Genet Res Grp, Singapore, Singapore; [Mehta, Jodhbir Singh] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore; [Mehta, Jodhbir Singh] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.; Mehta, JS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.	jodmehta@gmail.com	Kocaba, Viridiana/A-1871-2016	Kocaba, Viridiana/0000-0002-3044-5057	NMRC/CSA grant - National Medical Research Council, Ministry of Health, Singapore; National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America [R01EY022161]; NATIONAL EYE INSTITUTE [R01EY022161] Funding Source: NIH RePORTER	NMRC/CSA grant - National Medical Research Council, Ministry of Health, Singapore; National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this publication was supported by the NMRC/CSA grant provided by the National Medical Research Council, Ministry of Health, Singapore; and the R01EY022161 (VVM) grant provided by the National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Ang M, 2015, CASE REP OPHTHALMOL, V2015, DOI 10.1155/2015/506251; Chua J, 2014, OPHTHALMOLOGY, V121, P2013, DOI 10.1016/j.ophtha.2014.04.041; Eghrari AO, 2017, CORNEA, V36, P40, DOI 10.1097/ICO.0000000000001049; Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X; Eye Bank Association of America, 2015, 2015 EYE BANK STAT R, P1; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Fujimoto H, 2014, INVEST OPHTH VIS SCI, V55, P5090, DOI 10.1167/iovs.14-14249; Hafezi F, 2010, BRIT J OPHTHALMOL, V94, P660, DOI 10.1136/bjo.2009.162479; Hamzaoglu EC, 2015, OPHTHALMOLOGY, V122, P2193, DOI 10.1016/j.ophtha.2015.07.003; HENTHORN P, 1990, NUCLEIC ACIDS RES, V18, P678, DOI 10.1093/nar/18.3.678; Jirka S, 2015, CURR OPIN NEUROL, V28, P515, DOI 10.1097/WCO.0000000000000235; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kopplin LJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P433, DOI 10.1001/archopthalmol.2011.1626; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Luther M, 2016, KLIN MONATSBL AUGENH, V233, P187, DOI 10.1055/s-0035-1546138; Mahdy MAES, 2012, CLIN OPHTHALMOL, V6, P503, DOI 10.2147/OPTH.S29865; Mootha VV, 2015, INVEST OPHTH VIS SCI, V56, P2003, DOI 10.1167/iovs.14-16222; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Nakano M, 2015, INVEST OPHTH VIS SCI, V56, P4865, DOI 10.1167/iovs.15-17082; Nanda GG, 2014, INVEST OPHTH VIS SCI, V55, P7674, DOI 10.1167/iovs.14-15297; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Soliman AZ, 2015, JAMA OPHTHALMOL, V133, P1386, DOI 10.1001/jamaophthalmol.2015.3430; Urbanek MO, 2016, BBA-MOL BASIS DIS, V1862, P1513, DOI 10.1016/j.bbadis.2016.05.015; Vasanth S, 2015, INVEST OPHTH VIS SCI, V56, P4531, DOI 10.1167/iovs.14-16122; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Wacker K, 2015, OPHTHALMOLOGY, V122, P1645, DOI 10.1016/j.ophtha.2015.05.005; Watanabe S, 2015, OPHTHALMOLOGY, V122, P2103, DOI 10.1016/j.ophtha.2015.06.019; Wieben ED, 2014, INVEST OPHTH VIS SCI, V55, P6101, DOI 10.1167/iovs.14-14958; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; WILSON SE, 1988, CORNEA, V7, P2; Xing C, 2014, INVEST OPHTH VIS SCI, V55, P7073, DOI 10.1167/iovs.14-15390	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210996	10.1371/journal.pone.0210996	http://dx.doi.org/10.1371/journal.pone.0210996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682148	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500087
J	Zhou, F; Gao, S; Han, D; Han, WT; Chen, SJ; Patalano, S; Macoska, JA; He, HSHS; Cai, CM				Zhou, Feng; Gao, Shuai; Han, Dong; Han, Wanting; Chen, Sujun; Patalano, Susan; Macoska, Jill A.; He, Housheng Hansen; Cai, Changmeng			TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells	ONCOGENE			English	Article							SOLUBLE GUANYLATE-CYCLASE; ANDROGEN RECEPTOR; NITRIC-OXIDE; GENE FUSIONS; 5 INHIBITORS; PATHWAY; MIGRATION; EXPRESSION; ANGIOGENESIS; PERMEABILITY	The aberrant activation of the ERG oncogenic pathway due to the TMPRSS2-ERG gene fusion is the major event that contributes to prostate cancer (PCa) development. However, the critical downstream effectors that can be therapeutically targeted remain to be identified. In this study, we have found that the expression of the alpha 1 and beta 1 subunits of soluble guanylyl cyclase (sGC) was directly and specifically regulated by ERG in vitro and in vivo and was significantly associated with TMPRSS2-ERG fusion in clinical PCa cohorts. sGC is the major mediator of nitric oxide (NO)-cGMP signaling in cells that, upon NO binding, catalyzes the synthesis of cGMP and subsequently activates protein kinase G (PKG). We showed that cGMP synthesis was significantly elevated by ERG in PCa cells, leading to increased PKG activity and cell proliferation. Importantly, we also demonstrated that sGC inhibitor treatment repressed tumor growth in TMPRSS2-ERG-positive PCa xenograft models and can act in synergy with a potent AR antagonist, enzalutamide. This study strongly suggests that targeting NO-cGMP signaling pathways may be a novel therapeutic strategy to treat PCa with TMPRSS2-ERG gene fusion.	[Zhou, Feng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Feng; Gao, Shuai; Han, Dong; Han, Wanting; Patalano, Susan; Macoska, Jill A.; Cai, Changmeng] Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; [Zhou, Feng; Gao, Shuai; Han, Dong; Han, Wanting; Patalano, Susan; Macoska, Jill A.; Cai, Changmeng] Dana Farber Harvard Canc Ctr, Boston, MA 02215 USA; [Chen, Sujun; He, Housheng Hansen] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	Zhejiang University; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Cai, CM (corresponding author), Dana Farber Harvard Canc Ctr, Boston, MA 02215 USA.	changmeng.cai@umb.edu	Cai, Changmeng/AAE-6835-2020; Han, Wanting/AEX-5349-2022; Han, Dong/AAG-9502-2021; He, Hansen/ABD-8439-2020; Han, Wanting/GQA-5728-2022	Han, Wanting/0000-0002-2173-3647; Han, Dong/0000-0002-6224-855X; He, Hansen/0000-0003-2898-3363; Macoska, Jill/0000-0001-8471-2221; Gao, Shuai/0000-0002-7304-8801	NIH [R00 CA166507, R01 CA211350, U54 CA156734-06A1]; DOD [W81XWH-15-1-0554, W81XWH-16-1-0445]; Zhejiang Provincial Natural Science Foundation of China [LH19H05001]; NATIONAL CANCER INSTITUTE [U54CA156734, R01CA211350, R00CA166507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from NIH (R00 CA166507 and R01 CA211350 to CC, and U54 CA156734-06A1 to JAM), DOD (W81XWH-15-1-0554 to SG, and W81XWH-16-1-0445 to CC), and the research grant from Zhejiang Provincial Natural Science Foundation of China (LH19H05001 to FZ). We thank Drs. Sen Chen, Steven P. Balk (Beth Israel Deaconess Medical Center), and Eva Corey (Fred Hutchinson Cancer Center) for the support of animal study and Dr. Lirim Shemshedini (University of Toledo) for the advice on manuscript writing.	Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Birdsey GM, 2012, BLOOD, V119, P894, DOI 10.1182/blood-2011-04-350025; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Cai CM, 2012, MOL ENDOCRINOL, V26, P292, DOI 10.1210/me.2010-0394; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chavez AH, 2013, ASIAN J ANDROL, V15, P246, DOI 10.1038/aja.2012.162; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Ciani E, 2002, J NEUROCHEM, V81, P218, DOI 10.1046/j.1471-4159.2002.00857.x; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Dhayade S, 2016, CELL REP, V14, P2599, DOI 10.1016/j.celrep.2016.02.028; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Fajardo AM, 2014, CANCERS, V6, P436, DOI 10.3390/cancers6010436; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064189; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klinger James R, 2017, Am J Cardiol, V120, pS71, DOI 10.1016/j.amjcard.2017.06.012; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Li WQ, 2014, JAMA INTERN MED, V174, P964, DOI 10.1001/jamainternmed.2014.594; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Michl U, 2015, J UROLOGY, V193, P479, DOI 10.1016/j.juro.2014.08.111; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Monica FZ, 2018, NAT REV UROL, V15, P42, DOI 10.1038/nrurol.2017.181; Morbidelli L, 2010, AM J PHYSIOL-REG I, V298, pR824, DOI 10.1152/ajpregu.00222.2009; Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Nikolova-Krstevski V, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-72; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Reffelmann T, 2006, CURR PHARM DESIGN, V12, P3485, DOI 10.2174/138161206778343073; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang XJ, 2017, CANCER CELL, V31, P532, DOI 10.1016/j.ccell.2017.02.017; Wu LT, 2013, CANCER RES, V73, P6068, DOI 10.1158/0008-5472.CAN-13-0882; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zhou J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184088	53	16	16	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4397	4411		10.1038/s41388-019-0730-9	http://dx.doi.org/10.1038/s41388-019-0730-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30718921	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000469339100014
J	Qin, S; Dorschner, RA; Masini, I; Lavoie-Gagne, O; Stahl, PD; Costantini, TW; Baird, A; Eliceiri, BP				Qin, Shu; Dorschner, Robert A.; Masini, Irene; Lavoie-Gagne, Ophelia; Stahl, Philip D.; Costantini, Todd W.; Baird, Andrew; Eliceiri, Brian P.			TBC1D3 regulates the payload and biological activity of extracellular vesicles that mediate tissue repair	FASEB JOURNAL			English	Article						macrophage activation; wound healing; exosome; RabGAP; foreign body response	CELL-DERIVED EXOSOMES; DENDRITIC CELLS; INFLAMMATORY RESPONSE; TRANSFERRIN RECEPTOR; IMMUNE-RESPONSES; IN-VITRO; ANTIGEN; MACROPHAGES; INDUCE; MACROPINOCYTOSIS	Healthy repair of cutaneous injury is a coordinated response of inflammatory cells, secreted factors, and biologically active extracellular vesicles (EVs). Although constitutive release of EVs into biologic fluids is a hallmark of cultured cells and tumors, their payload and biologic activity appears to be tightly regulated. We show that Tre-2/Bub2/Cdc16 (TBC1) domain family member 3 (TBC1D3) drives the release of an EV population that causes a decrease in phosphorylation of the transcription factor signal transducer and activator of transcription 3 in naive recipient cells. To explore the biologic activity of EVs in vivo, we used a mouse model of sterile subcutaneous inflammation to determine the payload and biologic activity of EVs released into the microenvironment by committed myeloid lineages and stroma. Expression of TBC1D3 in macrophages altered the payload of their released EVs, including RNA-binding proteins, molecular motors, and proteins regulating secretory pathways. A wound-healing model demonstrated that closure was delayed by EVs released under the control of TBC1D3. We show that modulating the secretory repertoire of a cell regulates EV payload and biologic activity that affects outcomes in tissue repair and establishes a strategy for modifying EVs mediating specific biologic responses.Qin, S., Dorschner, R. A., Masini, I., Lavoie-Gagne, O., Stahl, P. D., Costantini, T. W., Baird, A., Eliceiri, B. P. TBC1D3 regulates the payload and biological activity of extracellular vesicles that mediate tissue repair.	[Qin, Shu; Dorschner, Robert A.; Masini, Irene; Lavoie-Gagne, Ophelia; Costantini, Todd W.; Baird, Andrew; Eliceiri, Brian P.] Univ Calif San Diego, Dept Surg, 212 Dickinson St,MC8236, La Jolla, CA 92103 USA; [Qin, Shu] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Plast Surg, Shanghai, Peoples R China; [Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	University of California System; University of California San Diego; Shanghai Jiao Tong University; Washington University (WUSTL)	Eliceiri, BP (corresponding author), Univ Calif San Diego, Dept Surg, 212 Dickinson St,MC8236, La Jolla, CA 92103 USA.	beliceiri@ucsd.edu	Lavoie-Gagne, Ophelie/AAG-1784-2021	Lavoie-Gagne, Ophelie/0000-0002-1197-747X; Eliceiri, Brian/0000-0003-1811-1916	U.S. National Institutes of Health, National Institute of General Medical Sciences [1R01GM121530]; UCSD Academic Senate; UCSD Department of Surgery Reinvestment Fund; Shock Society; Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121530] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021724] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCSD Academic Senate; UCSD Department of Surgery Reinvestment Fund; Shock Society; Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Ann-Marie Hageny [University of California-San Diego (UCSD)] for expert technical support, and Dr. Antonio DeMaio (UCSD) for use of the Nanoparticle Tracking Analysis Instrument; Dr. Majid Ghassemian (UCSD Biomolecular and Proteomics Mass Spectrometry Facility) provided expert support and analysis for the proteomics studies; Dr. John Nolan (Scintillon Institute, San Diego, CA, USA) provided expert advice on the design of vesicle flow cytometry assays; Dr. Chen Kong (Washington University) helped with consultation on the molecular biology of TBC1D3; and Dr. Lisa A. Hannan provided expert editorial review of the study. Research was supported by operating grants from the U.S. National Institutes of Health, National Institute of General Medical Sciences (1R01GM121530), the UCSD Academic Senate, the UCSD Department of Surgery Reinvestment Fund, the Shock Society, and the Surgical Infection Society. The authors declare no conflicts of interest.	Abramowicz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205496; Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Baird A, 2016, WOUND REPAIR REGEN, V24, P1004, DOI 10.1111/wrr.12471; Bakhtyar N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0921-2; Bianco Nicole R, 2007, Methods Mol Biol, V380, P443; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Cheng L, 2017, INT J BIOL SCI, V13, P723, DOI 10.7150/ijbs.19642; Choi EW, 2018, EXP DERMATOL, V27, P1170, DOI 10.1111/exd.13451; Colino J, 2007, INFECT IMMUN, V75, P220, DOI 10.1128/IAI.01217-06; Colino J, 2006, J IMMUNOL, V177, P3757, DOI 10.4049/jimmunol.177.6.3757; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Deskins DL, 2012, JOVE-J VIS EXP, V62, P3885; Dorayappan KDP, 2018, ONCOGENE, V37, P3806, DOI 10.1038/s41388-018-0189-0; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Garzetti L, 2014, J LEUKOCYTE BIOL, V95, P817, DOI 10.1189/jlb.0913485; Geiger A, 2015, BIOCHEM BIOPH RES CO, V467, P303, DOI 10.1016/j.bbrc.2015.09.166; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Hao SG, 2006, CELL MOL IMMUNOL, V3, P205; Hao SG, 2007, IMMUNOLOGY, V120, P90, DOI 10.1111/j.1365-2567.2006.02483.x; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Harding CV, 2013, J CELL BIOL, V200, P367, DOI 10.1083/jcb.201212113; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Kim SH, 2006, MOL THER, V13, P289, DOI 10.1016/j.ymthe.2005.09.015; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Kim YJ, 2017, BIOCHEM BIOPH RES CO, V493, P1102, DOI 10.1016/j.bbrc.2017.09.056; Kojima M, 2018, FASEB J, V32, P97, DOI 10.1096/fj.201700488R; Kojima M, 2017, J TRAUMA ACUTE CARE, V82, P42, DOI 10.1097/TA.0000000000001296; Latterich M, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-8; Lee HD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35250; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mittelbrunn M, 2015, TRAFFIC, V16, P327, DOI 10.1111/tra.12258; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nolan JP, 2018, METHODS MOL BIOL, V1678, P79, DOI 10.1007/978-1-4939-7346-0_5; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Patel DB, 2018, BIOTECHNOL ADV, V36, P2051, DOI 10.1016/j.biotechadv.2018.09.001; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pitt JM, 2014, J IMMUNOL, V193, P1006, DOI 10.4049/jimmunol.1400703; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Quah BJC, 2005, BLOOD CELL MOL DIS, V35, P94, DOI 10.1016/j.bcmd.2005.05.002; Rak J, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00021; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P1364, DOI 10.1189/jlb.0208092; Shenoda BB, 2016, CLIN MED INSIGHTS-PA, V9, P1, DOI 10.4137/CPath.S39925; Silva AM, 2017, EUR J PHARM SCI, V98, P86, DOI 10.1016/j.ejps.2016.09.017; Speth JM, 2016, J IMMUNOL, V196, P5112, DOI 10.4049/jimmunol.1502153; Stahl PD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe59; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Truman JP, 2012, IMMUNOLOGY, V136, P30, DOI 10.1111/j.1365-2567.2012.03552.x; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wainszelbaum MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031225; Yang XJ, 2011, J SURG RES, V171, P826, DOI 10.1016/j.jss.2010.05.021; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao H, 2018, DIABETES, V67, P235, DOI 10.2337/db17-0356	74	14	14	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6129	6139		10.1096/fj.201802388R	http://dx.doi.org/10.1096/fj.201802388R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30715917	Green Published, Bronze			2022-12-26	WOS:000466932600027
J	Wang, AJ; Ren, J; Abbadi, A; Wang, AM; Hascall, VC				Wang, Andrew Jun; Ren, Juan; Abbadi, Amina; Wang, Aimin; Hascall, Vincent C.			Heparin affects cytosolic glucose responses of hyperglycemic dividing mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetic nephropathy; inflammation; hyaluronan; glucose transporter type 4 (GLUT4); extracellular matrix; glomerular lesion; glucose uptake; hyperglycemia; kidney disease; mesangial cells	C-FOS INDUCTION; HYALURONAN MATRIX; PROLIFERATION; MICROANALYSIS; INHIBITION; ACTIVATION; EXPRESSION; ADHESIVE; SULFATE	Mesangial expansion underlies diabetic nephropathy, leading to sclerosis and renal failure. The glycosaminoglycan heparin inhibits mesangial cell growth, but the molecular mechanism is unclear. Here, rat mesangial cells (RMCs) were growth-arrested in the G(0)/G(1) phase of cell division, stimulated to divide in normal glucose (5.6 mm) or high glucose (25.6 mm) with or without heparin, and analyzed for glucose uptake. We observed that RMCs entering the G(1) phase in normal glucose with or without heparin rapidly cease glucose uptake. RMCs entering G(1) in high glucose sustained glucose uptake for the first 3 h, and high-glucose exposure of RMCs only in the first 8 h of G(1) induced the formation of an extracellular monocyte-adhesive hyaluronan matrix after cell division was completed. Moreover, a low heparin concentration under high-glucose conditions blocked glucose uptake by 1 h into G(1). Of note, glucose transporter 4 (glut4) localized on the RMC surface at G(0)/G(1) and was internalized into G(1) cells under normal glucose conditions with or without heparin within 30 min. We also noted that, under high-glucose conditions, glut4 remained on the RMC surface for at least 2 h into G(1) and was internalized by 4 h without heparin and within 1 h with heparin. These results provide evidence that the influx of glucose in hyperglycemic dividing RMCs initiates intermediate glucose metabolism, leading to increased cytosolic UDP sugars, and induces abnormal intracellular hyaluronan synthesis during the S phase of cell division.	[Wang, Andrew Jun; Ren, Juan; Abbadi, Amina; Wang, Aimin; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			National Institutes of Health [R01 DK62934, P01 HL107147]; Mizutani Foundation [1000057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 DK62934 (to A. W.) and P01 HL107147 (to V. H. and A. W., Project 1) and by Mizutani Foundation Grant 1000057 (to V. H. and A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babazono T, 1998, DIABETES, V47, P668, DOI 10.2337/diabetes.47.4.668; Blodgett AB, 2011, DIABETES TECHNOL THE, V13, P743, DOI 10.1089/dia.2011.0041; BROSIUS FC, 1992, KIDNEY INT, V42, P1086, DOI 10.1038/ki.1992.391; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CASTELLOT JJ, 1986, AM J PATHOL, V125, P493; CASTELLOT JJ, 1985, AM J PATHOL, V120, P427; COFFEY AK, 1985, AM J PATHOL, V120, P248; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; DIAMOND JR, 1986, RENAL PHYSIOL BIOCH, V9, P366; Dunlop ME, 1996, KIDNEY INT, V50, P40, DOI 10.1038/ki.1996.284; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Kwan J, 2005, KIDNEY INT, V68, P2526, DOI 10.1111/j.1523-1755.2005.00660.x; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mene P, 2001, NEPHROL DIAL TRANSPL, V16, P913, DOI 10.1093/ndt/16.5.913; Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100; NAPARSTEK Y, 1990, ARTHRITIS RHEUM, V33, P1554, DOI 10.1002/art.1780331013; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; Whiteside CI, 2002, AM J PHYSIOL-RENAL, V282, pF975, DOI 10.1152/ajprenal.00014.2002; Wolf G, 1999, KIDNEY INT, V56, P1262, DOI 10.1046/j.1523-1755.1999.00695.x; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Young B., 1992, Journal of the American Society of Nephrology, V3, P770; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139	35	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6591	6597		10.1074/jbc.RA119.007395	http://dx.doi.org/10.1074/jbc.RA119.007395			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30723159	Green Published, hybrid			2022-12-26	WOS:000468402000032
J	Luo, J; Yang, BY; Xin, GW; Sun, MJ; Zhang, BY; Guo, X; Jiang, Q; Zhang, CM				Luo, Jia; Yang, Biying; Xin, Guangwei; Sun, Mengjie; Zhang, Boyan; Guo, Xiao; Jiang, Qing; Zhang, Chuanmao			The microtubule-associated protein EML3 regulates mitotic spindle assembly by recruiting the Augmin complex to spindle microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitotic spindle; microtubule; microtubule-associated protein (MAP); checkpoint control; mitosis; cell division; cytoskeleton; Augmin; chromosome congression; EML3; microtubule nucleation; spindle assembly	PROVIDES INSIGHTS; NUCLEATION; ARCHITECTURE; MITOSIS; PHOSPHORYLATION; ORGANIZATION; CHROMOSOMES; GENERATION; ALIGNMENT; CLATHRIN	In all eukaryotes, a functional mitotic spindle is essential for distributing duplicated chromosomes into daughter cells. Mitotic spindle assembly involves highly ordered arrangement of microtubules (MTs). The Augmin protein complex recruits -tubulin ring complex (-TuRC) to MTs and thereby promotes MT-based MT nucleation and mitotic spindle assembly. However, several factors that may promote Augmin recruitment to MTs remain unknown. Here, we show that echinoderm microtubule-associated protein-like 3 (EML3), an MT-associated protein, facilitates binding between MTs and Augmin/-TuRC and recruiting the latter to MTs for proper mitotic spindle assembly and kinetochore-MT connections. Using immunofluorescence microscopy, live-cell imaging, and immunoprecipitation assays, we found that EML3 recruits Augmin/-TuRC to the MTs to enhance MT-based MT nucleation in both spindle and small acentrosomal asters. We also noted that the EML3-mediated recruitment is controlled by cyclin-dependent kinase 1 (CDK1), which phosphorylated EML3 at Thr-881 and promoted its binding to Augmin/-TuRC. RNAi-mediated EML3 knockdown in HeLa cells reduced spindle localization of Augmin/-TuRC, which resulted in abnormal spindle assembly and caused kinetochore-MT misconnection. The introduction of exogenous WT or a Thr-881 phosphorylation mimic EML3 variant into the EML3 knockdown cells restored normal Augmin/-TuRC localization and spindle assembly. The EML3 knockdown also affected the spindle assembly checkpoint, delaying chromosome congression and cell division. Taken together, our results indicate that EML3 regulates mitotic spindle assembly and the kinetochore-MT connection by regulating MT-based MT nucleation and recruiting Augmin/-TuRC to MTs.	[Luo, Jia; Yang, Biying; Xin, Guangwei; Sun, Mengjie; Zhang, Boyan; Guo, Xiao; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Luo, Jia; Yang, Biying; Xin, Guangwei; Sun, Mengjie; Zhang, Boyan; Guo, Xiao; Jiang, Qing; Zhang, Chuanmao] Peking Univ, State Key Lab Membrane Biol, Coll Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, CM (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn		Guo, Xiao/0000-0002-0533-3547; Zhang, Chuanmao/0000-0003-1359-6475; Zhang, Boyan/0000-0001-7112-9870	National Natural Science Foundation of is China; State Key Basic Research and Development Plan of the Ministry of Science and Technology of China [2016YFA0100501, 31430051, 2016YFA0500201, 31520103906]	National Natural Science Foundation of is China; State Key Basic Research and Development Plan of the Ministry of Science and Technology of China	This work was supported by the National Natural Science Foundation of is China and the State Key Basic Research and Development Plan of the Ministry of Science and Technology of China (Grants 2016YFA0100501, 31430051, 2016YFA0500201, and 31520103906). The authors declare that they have no conflicts of interest with the contents of this article.	Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2011, CELL RES, V21, P1655, DOI 10.1038/cr.2011.106; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Guo YG, 2012, J CELL BIOL, V198, P205, DOI 10.1083/jcb.201202152; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hsia KC, 2014, NAT CELL BIOL, V16, P852, DOI 10.1038/ncb3030; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kamasaki T, 2013, J CELL BIOL, V202, P25, DOI 10.1083/jcb.201304031; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Liu T, 2014, CURR BIOL, V24, P2708, DOI 10.1016/j.cub.2014.09.053; Lu Shan, 2018, Biophys Rep, V4, P68, DOI 10.1007/s41048-018-0050-6; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Masoud K, 2013, PLANT J, V75, P245, DOI 10.1111/tpj.12179; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; Meunier S, 2011, NAT CELL BIOL, V13, P1406, DOI 10.1038/ncb2372; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Song JG, 2018, J CELL BIOL, V217, P2417, DOI 10.1083/jcb.201711090; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Xu X. W., 2016, ELS WILEY ONLINE LIB, DOI [10.1002/9780470015902.a0022518, DOI 10.1002/9780470015902.A0022518]; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	42	4	4	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5643	5656		10.1074/jbc.RA118.007164	http://dx.doi.org/10.1074/jbc.RA118.007164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723163	Green Published, hybrid			2022-12-26	WOS:000464517500032
J	Tong, JS; Tan, LC; Chun, CJ; Im, YJ				Tong, Junsen; Tan, Lingchen; Chun, ChangJu; Im, Young Jun			Structural basis of human ORP1-Rab7 interaction for the late-endosome and lysosome targeting	PLOS ONE			English	Article							OXYSTEROL-BINDING-PROTEIN; PHOSPHATIDYLSERINE TRANSPORT; CONTACT SITES; CHOLESTEROL; RAB7; HOMOLOG; ORP1L; ER; RAB7-RILP-P150(GLUED); EXPRESSION	Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) constitute a family of lipid transfer proteins conserved in eukaryotes. ORP1 transports cholesterol at the interface between the late endosomes/lysosomes (LELs) and the endoplasmic reticulum (ER). ORP1 is targeted to the endosomal membranes by forming a tripartite complex with the LE GTPase Rab7 and its effector RILP (Rab7-interacting lysosomal protein). Here, we determined the crystal structure of human ORP1 ANK domain in complex with the GTP-bound form of Rab7. ORP1 ANK binds to the helix alpha 3 of Rab7 located away from the switching regions, which makes the interaction independent of the nucleotide-binding state of Rab7. Thus, the effector-interacting switch regions of Rab7 are accessible for RILP binding, allowing formation of the ORP1-Rab7-RILP complex. ORP1 ANK binds to Rab7 and the Rab7-RILP complex with similar micro-molar affinities, which is consistent with the independence binding of ORP1 and RILP to Rab7. The structural model of the ORP1-Rab7-RILP complex correlates with the recruitment of ORP1 at the LEL-ER interface and the role in lipid transport and regulation.	[Tong, Junsen; Tan, Lingchen; Chun, ChangJu; Im, Young Jun] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea	Chonnam National University	Im, YJ (corresponding author), Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea.	imyoungjun@jnu.ac.kr			National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2017R1A2B4004914]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (Grant NRF-2017R1A2B4004914 to YJI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Du XM, 2015, CURR OPIN CELL BIOL, V35, P37, DOI 10.1016/j.ceb.2015.04.002; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Koponen A, 2019, BIOCHIMIE, V158, P90, DOI 10.1016/j.biochi.2018.12.013; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lehto M, 2001, J LIPID RES, V42, P1203; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; LI GP, 1993, J BIOL CHEM, V268, P24475; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Ma XL, 2018, J BIOL CHEM, V293, P14155, DOI 10.1074/jbc.RA118.001854; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Manik MK, 2017, STRUCTURE, V25, P617, DOI 10.1016/j.str.2017.02.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Mesmin B, 2016, BBA-MOL CELL BIOL L, V1861, P940, DOI 10.1016/j.bbalip.2016.02.024; Olkkonen Vesa M, 2015, Lipid Insights, V8, P1, DOI 10.4137/LPI.S31726; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Tong J, 2016, BBA-MOL CELL BIOL L, V1861, P928, DOI 10.1016/j.bbalip.2016.01.008; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; von Filseck JM, 2016, BIOCHIMIE, V130, P115, DOI 10.1016/j.biochi.2016.08.001; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Wang H., 2018, MOL CELL; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wijdeven RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11808; Wong LH, 2018, NAT REV MOL CELL BIO; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Zhao KX, 2017, CELL REP, V19, P1807, DOI 10.1016/j.celrep.2017.05.028	41	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211724	10.1371/journal.pone.0211724	http://dx.doi.org/10.1371/journal.pone.0211724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721249	Green Published, Green Submitted, gold			2022-12-26	WOS:000457746300023
J	D'Amato, AR; Puhl, DL; Ziemba, AM; Johnson, CDL; Doedee, J; Bao, J; Gilbert, RJ				D'Amato, Anthony R.; Puhl, Devan L.; Ziemba, Alexis M.; Johnson, Christopher D. L.; Doedee, Janneke; Bao, Jonathan; Gilbert, Ryan J.			Exploring the effects of electrospun fiber surface nanotopography on neurite outgrowth and branching in neuron cultures	PLOS ONE			English	Article							POLYSIALIC ACID; ENGINEERED NANOTOPOGRAPHY; FASCICULATION; MICROFIBERS; NANOFIBERS; AXONIN-1; GUIDANCE; DESIGN; ROLES	Three aligned, electrospun fiber scaffolds with unique surface features were created from poly-L-lactic acid (PLLA). Fibers without surface nanotopography (smooth fibers), fibers with surface divots (shallow pits), and fibers with surface pits (deeper pits) were fabricated, and fiber alignment, diameter, and density were characterized using scanning electron microscopy (SEM). Whole dorsal root ganglia (DRG) were isolated from rats and placed onto uncoated fibers or fibers coated with laminin. On uncoated fibers, neurite outgrowth was restricted by fibers displaying divoted or pitted nanotopography when compared to neurite outgrowth on smooth fibers. However, neurites extending from whole DRG cultured on laminin-coated fibers were not restricted by divoted or pitted surface nanotopography. Thus, neurites extending on laminin-coated fibers were able to extend long neurites even in the presence of surface divots or pits. To further explore this result, individual neurons isolated from dissociated DRG were seeded onto laminin-coated smooth, pitted, or divoted fibers. Interestingly, neurons on pitted or divoted fibers exhibited a 1.5-fold increase in total neurite length, and a 2.3 or 2.7-fold increase in neurite branching compared to neurons on smooth fibers, respectively. Based on these findings, we conclude that fiber roughness in the form of pits or divots can promote extension and branching of long neurites along aligned electrospun fibers in the presence of an extracellular matrix protein coating. Thus, aligned, electrospun fibers can be crafted to not only direct the extension of axons but to induce unique branching morphologies.	[D'Amato, Anthony R.; Puhl, Devan L.; Ziemba, Alexis M.; Johnson, Christopher D. L.; Doedee, Janneke; Bao, Jonathan; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [D'Amato, Anthony R.; Puhl, Devan L.; Ziemba, Alexis M.; Johnson, Christopher D. L.; Doedee, Janneke; Bao, Jonathan; Gilbert, Ryan J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, RJ (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.; Gilbert, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	gilber2@rpi.edu	Ziemba, Alexis/GRJ-4381-2022	Icso, Janneke/0000-0002-2944-1956; Ziemba, Alexis M/0000-0001-8947-9617; Puhl, Devan/0000-0002-8293-3415; Bao, Jonathan/0000-0003-3651-2545	NSF CAREER Award [1105125]; NIH [NS092754]; New York State Spinal Cord Injury Review Board Institutional Support Grant [C32245GG]; New York State Spinal Cord Injury Review Board Pre-doctoral Fellowship [C32631GG]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092754] Funding Source: NIH RePORTER	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Spinal Cord Injury Review Board Institutional Support Grant; New York State Spinal Cord Injury Review Board Pre-doctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the following funding sources: NSF CAREER Award (1105125) to RJG, NIH R01 (NS092754) to RJG, New York State Spinal Cord Injury Review Board Institutional Support Grant (C32245GG) to RJG, and New York State Spinal Cord Injury Review Board Pre-doctoral Fellowship (C32631GG) to ARD. There was no additional external funding received for this study.	Nguyen AT, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/18/183001; Chiono V, 2015, PROG NEUROBIOL, V131, P87, DOI 10.1016/j.pneurobio.2015.06.001; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006; Jiang X, 2014, J TISSUE ENG REGEN M, V8, P377, DOI 10.1002/term.1531; Johnson CD, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aac4de; Kim YP, 2015, J TISSUE ENG REGEN M, V9, P236, DOI 10.1002/term.1626; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Miyajima M, 1997, J CONTROL RELEASE, V49, P207, DOI 10.1016/S0168-3659(97)00081-3; National Spinal Cord Injury Statistical Center, 2018, SPIN CORD INJ FACTS; Neal Rebekah A, 2014, Nanomater Environ, V2, P1; Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204; Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366; Negah SS, 2018, CELL TISSUE RES, V371, P223, DOI 10.1007/s00441-017-2717-6; Passmore Gayle M., 2005, Journal of Pharmacological and Toxicological Methods, V51, P201, DOI 10.1016/j.vascn.2004.08.007; Rocca-Smith JR, 2017, ACS SUSTAIN CHEM ENG, V5, P2751, DOI 10.1021/acssuschemeng.6b03088; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Schaub NJ, 2017, J BIOMAT SCI-POLYM E, V28, P1303, DOI 10.1080/09205063.2017.1321345; Schaub NJ, 2016, J NEUROTRAUM, V33, P1405, DOI 10.1089/neu.2015.4165; Schaub NJ, 2013, ACS APPL MATER INTER, V5, P10173, DOI 10.1021/am402827g; Soliman E, 2018, BIOTECHNOL LETT, V40, P601, DOI 10.1007/s10529-017-2494-z; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Ventre D, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aabeba; Vigani B, 2017, NEURAL REGEN RES, V12, P1786, DOI 10.4103/1673-5374.219029; Voyiadjis AG, 2011, ANN BIOMED ENG, V39, P559, DOI 10.1007/s10439-010-0168-2; Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020; Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Xie JW, 2014, ACS NANO, V8, P1878, DOI 10.1021/nn406363j; Zhang YZ, 2006, NANOTECHNOLOGY, V17, P901, DOI 10.1088/0957-4484/17/3/047; Ziemba AM, 2018, ACS BIOMATER SCI ENG, V4, P1491, DOI 10.1021/acsbiomaterials.8b00013	38	21	21	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211731	10.1371/journal.pone.0211731	http://dx.doi.org/10.1371/journal.pone.0211731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716106	gold, Green Published, Green Submitted			2022-12-26	WOS:000457744200044
J	Kakimoto, PA; Chausse, B; da Silva, CCC; Donato, JP; Kowaltowski, AJ				Kakimoto, Pamela A.; Chausse, Bruno; Caldeira da Silva, Camille C.; Donato Junior, Jose Prime; Kowaltowski, Alicia J.			Resilient hepatic mitochondria! function and lack of iNOS dependence in diet-induced insulin resistance	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; HIGH-FAT DIETS; NITRIC-OXIDE; INDUCED OBESITY; GLUCOSE-INTOLERANCE; LABORATORY RODENTS; REACTIVE OXYGEN; LIVER; MICE; METABOLISM	Obesity-derived inflammation and metabolic dysfunction has been related to the activity of the inducible nitric oxide synthase (iNOS). To understand the interrelation between metabolism, obesity and NO., we evaluated the effects of obesity-induced NO. signaling on liver mitochondrial function. We used mouse strains containing mitochondrial nicotinamide transhydrogenase activity, while prior studies involved a spontaneous mutant of this enzyme, and are, therefore, more prone to oxidative imbalance. Wild-type and iNOS knockout mice were fed a high fat diet for 2, 4 or 8 weeks. iNOS knockout did not protect against diet induced metabolic changes. However, the diet decreased fatty-acid oxidation capacity in liver mitochondria at 4 weeks in both wild-type and knockout groups; this was recovered at 8 weeks. Interestingly, other mitochondrial functional parameters were unchanged, despite significant modifications in insulin resistance in wild type and iNOS knockout animals. Overall, we found two surprising features of obesity-induced metabolic dysfunction: (i) iNOS does not have an essential role in obesity-induced insulin resistance under all experimental conditions and (ii) liver mitochondria are resilient to functional changes in obesity-induced metabolic dysfunction.	[Kakimoto, Pamela A.; Chausse, Bruno; Caldeira da Silva, Camille C.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Donato Junior, Jose Prime] Univ Sao Paulo, Inst Ciencia Biomed, Dept Fisiol & Biofis, Sao Paulo, Brazil; [Chausse, Bruno] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany	Universidade de Sao Paulo; Universidade de Sao Paulo; Ruprecht Karls University Heidelberg	Kakimoto, PA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.	pamela.kakimoto@gmail.com	Donato, Jose/ABB-3686-2020; Kowaltowski, Alicia J/H-8698-2012; Chausse, Bruno/D-7449-2015; Donato, Jose/A-9662-2010	Donato, Jose/0000-0002-4166-7608; 	CNPq; CEPID [2013/07937-8]; FAPESP [DD 2015/25862-0, PD 2015/07670-7, 2017/18972-0]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CEPID; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by CEPID 2013/07937-8, FAPESP DD 2015/25862-0, FAPESP PD 2015/07670-7, FAPESP 2017/18972-0, CAPES and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Belchior T, 2015, MOL NUTR FOOD RES, V59, P957, DOI 10.1002/mnfr.201400914; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cardoso AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077088; Charbonneau A, 2010, DIABETES, V59, P861, DOI 10.2337/db09-1238; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132; Figueira TR, 2013, EXP PHYSIOL, V98, P1643, DOI 10.1113/expphysiol.2013.074682; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Franko A, 2014, J HEPATOL, V60, P816, DOI 10.1016/j.jhep.2013.11.020; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Ha SK, 2010, EXP ANIM TOKYO, V59, P595, DOI 10.1538/expanim.59.595; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Ihrig M, 2001, ATHEROSCLEROSIS, V156, P103, DOI 10.1016/S0021-9150(00)00636-5; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Iwakiri Y, 2015, TRENDS PHARMACOL SCI, V36, P524, DOI 10.1016/j.tips.2015.05.001; Kakimoto PA, 2016, REDOX BIOL, V8, P216, DOI 10.1016/j.redox.2016.01.009; Kanuri BN, 2017, SCI REP-UK, V7, DOI 10.1038/srep41009; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kochhar S. P., 2011, Vegetable oils in food technology: composition, properties and uses, P291; Koliaki C, 2016, ANNU REV NUTR, V36, P337, DOI 10.1146/annurev-nutr-071715-050656; Lai M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.30; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Navarro CDC, 2017, FREE RADICAL BIO MED, V113, P190, DOI 10.1016/j.freeradbiomed.2017.09.026; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Nozaki Y, 2015, BMC GASTROENTEROL, V15, P1, DOI [10.1186/s12876-014-0226-6, DOI 10.1186/S12876-014-0226-6]; Patel RP, 2017, NITRIC OXIDE, DOI [10.1016/B978-0-12-804273-1/00004-1, DOI 10.1016/B978-0-12-804273-1/00004-1]; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Sansbury BE, 2014, FREE RADICAL BIO MED, V73, P383, DOI 10.1016/j.freeradbiomed.2014.05.016; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666; Shiva S, 2017, NITRIC OXIDE: BIOLOGY AND PATHOBIOLOGY, 3RD EDITION, P137, DOI 10.1016/B978-0-12-804273-1.00011-9; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g; Wang Tong, 2011, Vegetable oils in food technology: composition, properties and uses, P59; Weidinger A, 2015, ANTIOXID REDOX SIGN, V22, P572, DOI 10.1089/ars.2014.5996; White PJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE868, DOI 10.1152/ajpendo.00510.2010	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211733	10.1371/journal.pone.0211733	http://dx.doi.org/10.1371/journal.pone.0211733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716103	Green Submitted, gold, Green Published			2022-12-26	WOS:000457744200045
J	Stadlbauer, V; Horvath, A; Komarova, I; Schmerboeck, B; Feldbacher, N; Wurm, S; Klymiuk, I; Durdevic, M; Rainer, F; Blesl, A; Stryeck, S; Madl, T; Stiegler, P; Leber, B				Stadlbauer, Vanessa; Horvath, Angela; Komarova, Irina; Schmerboeck, Bianca; Feldbacher, Nicole; Wurm, Sonja; Klymiuk, Ingeborg; Durdevic, Marija; Rainer, Florian; Blesl, Andreas; Stryeck, Sarah; Madl, Tobias; Stiegler, Philipp; Leber, Bettina			A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers	PLOS ONE			English	Article							PULMONARY INFLAMMATION; ETHANOL INTOXICATION; LIVER; DRINKING; PERMEABILITY; DYSFUNCTION; MECHANISMS; BIOFILM; INJURY; MICE	Alcohol binge drinking is a dangerous drinking habit, associated with neurological problems and inflammation. The impact of a single alcohol binge on innate immunity, gut barrier and gut microbiome was studied. In this cohort study 15 healthy volunteers received 2 ml vodka 40% v/v ethanol/kg body weight. Neutrophil function was studied by flow cytometry; markers of gut permeability and inflammation (lactulose/mannitol/sucrose test, zonulin, calprotectin, diamino-oxidase) were studied with NMR spectroscopy and enzyme-linked immunosorbent assay in urine, stool and serum respectively. Bacterial products in serum were quantified using different reporter cell lines. Gut microbiome composition was studied by 16S rDNA sequencing and bioinformatics analysis. After a single alcohol binge, neutrophils were transiently primed and the response to E.coli stimulation with reactive oxygen species (ROS) production was transiently increased, on the other hand the percentage of neutrophils that did not perform phagocytosis increased. No changes in gut permeability, inflammatory bio-marker, bacterial translocation and microbiome composition could be detected up to 4 hours after a single alcohol binge or on the next day. A single alcohol binge in young, healthy volunteers transiently impacts on neutrophil function. Although the exact biological consequence of this finding is not clear yet, we believe that this strengthens the importance to avoid any alcohol binge drinking, even in young, otherwise healthy persons.	[Stadlbauer, Vanessa; Horvath, Angela; Komarova, Irina; Schmerboeck, Bianca; Feldbacher, Nicole; Wurm, Sonja; Rainer, Florian; Blesl, Andreas] Med Univ Graz, Dept Gastroenterol & Hepatol, Graz, Austria; [Horvath, Angela; Schmerboeck, Bianca; Leber, Bettina] Ctr Biomarker Res Med CBmed, Graz, Austria; [Klymiuk, Ingeborg] Med Univ Graz, Med Res Ctr, Core Facil Mol Biol, Graz, Austria; [Durdevic, Marija] Med Univ Graz, Core Facil Computat Bioanalyt, Graz, Austria; [Stryeck, Sarah; Madl, Tobias] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, Graz, Austria; [Stryeck, Sarah; Madl, Tobias] BioTechMed, Graz, Austria; [Stiegler, Philipp; Leber, Bettina] Med Univ Graz, Dept Transplantat Surg, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Stadlbauer, V (corresponding author), Med Univ Graz, Dept Gastroenterol & Hepatol, Graz, Austria.	vanessa.stadlbauer@medunigraz.at	Klymiuk, Ingeborg/ABG-9952-2021; Balazs, Irina/AAB-5542-2022; Madl, Tobias/B-1682-2012	Balazs, Irina/0000-0003-2026-3521; Madl, Tobias/0000-0002-9725-5231; Stadlbauer, Vanessa/0000-0001-5508-8271; Klymiuk, Ingeborg/0000-0001-8755-0037; Horvath, Angela/0000-0001-7279-0628; Stiegler, Philipp/0000-0002-0952-3030; Leber, Bettina/0000-0002-2101-7560; Stryeck, Sarah/0000-0001-7524-6038	project 3.10 in the Center for Biomarker Research in Medicine, a COMET K1 center; Austrian Research Promotion Agency; Medical University of Graz; Collaborative Research Centre 992 Medical Epigenetics (DFG) [SFB 992/1 2012]; German Federal Ministry of Education and Research (BMBF) [031 A538A/A538C RBC, 031L0101B/031L0101C, 031L0106]; President's International Fellowship Initiative of CAS [2015VBB045]; National Natural Science Foundation of China [31450110423]; Austrian Science Fund [FWF: P28854, I 3792]; Austrian Research Promotion Agency [FFG: 864690]; Integrative Metabolism Research Center Graz; Austrian infrastructure program 2016/2017; BioTechMed/Graz; OMICS center Graz	project 3.10 in the Center for Biomarker Research in Medicine, a COMET K1 center; Austrian Research Promotion Agency; Medical University of Graz; Collaborative Research Centre 992 Medical Epigenetics (DFG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); President's International Fellowship Initiative of CAS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency; Integrative Metabolism Research Center Graz; Austrian infrastructure program 2016/2017; BioTechMed/Graz; OMICS center Graz	The project was funded by project 3.10 in the Center for Biomarker Research in Medicine, a COMET K1 center funded by the Austrian Research Promotion Agency. The company partners involved were Winclove Probiotics B.V., Amsterdam, the Netherlands and Institut Allergosan, Graz, Austria. The study was conducted as an academic study with the Medical University of Graz as sponsor. The companies had not influence on the conduct of the study, the analysis and the interpretation of the results. The Galaxy server, that was used for some calculations is in part funded by Collaborative Research Centre 992 Medical Epigenetics (DFG grant SFB 992/1 2012) and German Federal Ministry of Education and Research (BMBF grants 031 A538A/A538C RBC, 031L0101B/031L0101C de. NBI-epi, 031L0106 de. STAIR (de.NBI)). This work was supported by the President's International Fellowship Initiative of CAS (No. 2015VBB045, to T.M.), the National Natural Science Foundation of China (No. 31450110423, to T.M.), the Austrian Science Fund (FWF: P28854, I 3792 to T.M.), the Austrian Research Promotion Agency (FFG: 864690) the Integrative Metabolism Research Center Graz, the Austrian infrastructure program 2016/2017, BioTechMed/Graz, the OMICS center Graz.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang BX, 2015, HEPATOLOGY, V62, P1070, DOI 10.1002/hep.27921; Connell AM, 2015, PSYCHOL ADDICT BEHAV; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Engen PA, 2015, ALCOHOL RES-CURR REV, V37, P223; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; Hartmann P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00402; Hermens DF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00012; Horvath A, 2016, ALIMENT PHARM THER, V44, P926, DOI 10.1111/apt.13788; Jimenez V, 2017, ALCOHOL, V64, P55, DOI 10.1016/j.alcohol.2017.04.004; Jin LL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006637; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Klymiuk I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02508; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leber B, 2012, EUR J CLIN NUTR, V66, P1110, DOI 10.1038/ejcn.2012.103; Leber B, 2009, WIEN KLIN WOCHENSCHR, V121, P732, DOI 10.1007/s00508-009-1288-2; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Mason-Jones AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121116; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; MATZNER Y, 1982, BLOOD, V60, P822; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; O'Connor RM, 2015, NATURE, V520, P168, DOI 10.1038/520168a; Orio L, 2017, ADDICT BIOL; Pascual M, 2018, J NEUROSCI RES, V96, P765, DOI 10.1002/jnr.24203; Pascual M, 2014, ALCOHOL ALCOHOLISM, V49, P187, DOI 10.1093/alcalc/agt164; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Redelman CV, 2012, FEMS IMMUNOL MED MIC, V66, P411, DOI 10.1111/1574-695X.12005; Shults JA, 2016, J LEUKOCYTE BIOL, V100, P1037, DOI 10.1189/jlb.3MA0316-111R; Shults JA, 2015, ALCOHOL, V49, P713, DOI 10.1016/j.alcohol.2015.06.006; Stadlbauer V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141399; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Tamura DY, 1998, J TRAUMA, V44, P320, DOI 10.1097/00005373-199802000-00015; Tashiro Y, 2014, BIOSCI BIOTECH BIOCH, V78, P178, DOI 10.1080/09168451.2014.877828	35	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211703	10.1371/journal.pone.0211703	http://dx.doi.org/10.1371/journal.pone.0211703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707717	Green Submitted, Green Published, gold			2022-12-26	WOS:000457742900041
J	Wertli, MM; Dangma, TD; Muller, SE; Gort, LM; Klauser, BS; Melzer, L; Held, U; Steurer, J; Hasler, S; Burgstaller, JM				Wertli, Maria M.; Dangma, Tenzin D.; Mueller, Sarah E.; Gort, Laura M.; Klauser, Benjamin S.; Melzer, Lina; Held, Ulrike; Steurer, Johann; Hasler, Susann; Burgstaller, Jakob M.			Non-cardiac chest pain patients in the emergency department: Do physicians have a plan how to diagnose and treat them? A retrospective study	PLOS ONE			English	Article							HEALTH-CARE SEEKING; CHIROPRACTIC TREATMENT; SYMPTOM RESPONSE; SELF-MANAGEMENT; NATURAL-HISTORY; DOUBLE-BLIND; EPIDEMIOLOGY; TRIAL; POPULATION; PREVALENCE	Background Non-cardiac chest pain is common and there is no formal recommendation on what diagnostic tests to use to identify underlying diseases after an acute coronary syndrome has been ruled out. Objective To evaluate the diagnostic tests, treatment recommendations and initiated treatments in patients presenting with non-cardiac chest pain to the emergency department (ED). Methods Single-center, retrospective medical chart review of patients presenting to the ED. Included were all medical records of patients aged 18 years and older presenting to the ED with chest pain and a non-cardiac discharge diagnosis between January 1, 2009 and December 31, 2011. Information on the diagnosis, diagnostic tests performed, treatment initiated and recommendation for further diagnostic testing or treatment were extracted. The primary outcomes of interest were the final diagnosis, diagnostic tests, and treatment recommendations. A formal ACS rule out testing was defined as serial three troponin testing. Results In total, 1341 ED admissions for non-cardiac chest pain (4.2% of all ED admissions) were analyzed. Non-specific chest pain remained the discharge diagnosis in 44.7% (n = 599). Identified underlying diseases included musculoskeletal chest pain (n = 602, 44.9%), pulmonary (n = 30, 2.2%), GI-tract (n = 35, 2.6%), or psychiatric diseases (n = 75, 5.6%). In 81.4% at least one troponin test and in 89% one ECG were performed. A formal ACS rule out troponin testing was performed in 9.2% (GI-tract disease 14.3%, non-specific chest pain 14.0%, pulmonary disease 10.0%, musculoskeletal chest pain 4.7%, and psychiatric disease 4.0%). Most frequently analgesics were prescribed (51%). A diagnostic test with proton pump inhibitor (PPI) was prescribed in 20% (mainly in gastrointestinal diseases). At discharge, over 72 different recommendations were given, ranging from no further measures to extensive cardiac evaluation. Conclusion In this retrospective study, a formal work-up to rule out ACS was found in a minority of patients presenting to the ED with chest pain of non-cardiac origin. A wide variation in diagnostic processes and treatment recommendations reflect the uncertainty of clinicians on how to approach patients after a cardiac cause was considered unlikely. Panic and anxiety disorders were rarely considered and a useful PPI treatment trial to diagnose gastroesophageal reflux disease was infrequently recommended.	[Wertli, Maria M.] Univ Bern, Bern Univ Hosp, Div Gen Internal Med, Bern, Switzerland; [Wertli, Maria M.; Dangma, Tenzin D.; Mueller, Sarah E.; Gort, Laura M.; Klauser, Benjamin S.; Melzer, Lina; Held, Ulrike; Steurer, Johann; Burgstaller, Jakob M.] Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland; [Hasler, Susann] Kantonsspital Winterthur, Dept Gen Internal Med, Outpatient Clin, Winterthur, Switzerland	University of Bern; University Hospital of Bern; University of Zurich	Wertli, MM (corresponding author), Univ Bern, Bern Univ Hosp, Div Gen Internal Med, Bern, Switzerland.; Wertli, MM (corresponding author), Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland.	Maria.Wertli@insel.ch	Held, Ulrike/O-8328-2019; Wertli, Maria/Q-3349-2017	Steurer, Johann/0000-0001-5368-5099; Wertli, Maria/0000-0001-6347-0198; Held, Ulrike/0000-0003-3105-5840				Aikens JE, 1999, J CLIN PSYCHOL MED S, V6, P317, DOI 10.1023/A:1026267113458; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Bautista J, 2004, ALIMENT PHARM THER, V19, P1123, DOI 10.1111/j.1365-2036.2004.01941.x; BEITMAN BD, 1991, JAMA-J AM MED ASSOC, V265, P1545, DOI 10.1001/jama.265.12.1545; Bhuiya Farida A, 2010, NCHS Data Brief, P1; Blatchford O, 1999, BRIT J GEN PRACT, V49, P551; Bosner S, 2010, FAM PRACT, V27, P363, DOI 10.1093/fampra/cmq024; Buntinx F, 2001, FAM PRACT, V18, P586, DOI 10.1093/fampra/18.6.586; Burgstaller JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104722; Cayley WE, 2005, AM FAM PHYSICIAN, V72, P2012; Dickman R, 2005, ALIMENT PHARM THER, V22, P547, DOI 10.1111/j.1365-2036.2005.02620.x; Eslick GD, 2000, MED J AUSTRALIA, V173, P233, DOI 10.5694/j.1326-5377.2000.tb125626.x; Eslick GD, 2004, ALIMENT PHARM THER, V20, P909, DOI 10.1111/j.1365-2036.2004.02175.x; Eslick GD, 2004, GASTROENTEROL CLIN N, V33, P1, DOI 10.1016/S0889-8553(03)00125-0; Eslick GD, 2002, ALIMENT PHARM THERAP, V16, P1217, DOI 10.1046/j.1365-2036.2002.01296.x; Eslick GD, 2008, DM-DIS MON, V54, P593, DOI 10.1016/j.disamonth.2008.06.003; Fass R, 1998, GASTROENTEROLOGY, V115, P42, DOI 10.1016/S0016-5085(98)70363-4; Fass R, 2008, J CLIN GASTROENTEROL, V42, P636, DOI 10.1097/MCG.0b013e3181684c6b; Fass R, 2011, J NEUROGASTROENTEROL, V17, P110, DOI 10.5056/jnm.2011.17.2.110; Fleet R, 2000, J PSYCHOSOM RES, V48, P347, DOI 10.1016/S0022-3999(99)00101-4; Katerndahl DA, 1997, J FAM PRACTICE, V45, P54; Kisely S, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004101.pub2, 10.1002/14651858.CD004408.pub2]; Lehtola V., 2010, INT MUSCULOSKELET ME, V32, P25, DOI [10.1179/175361410X12652805807558, DOI 10.1179/175361410X12652805807558]; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P354; OCKENE IS, 1980, NEW ENGL J MED, V303, P1249, DOI 10.1056/NEJM198011273032201; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Prina LD, 2004, ANN EMERG MED, V43, P59, DOI 10.1016/S0196-0644(03)00601-2; R Core Team, 2021, R LANGUAGE ENV STAT; Ruddox V, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-58; Shimoni Z, 2017, AM J MED, V130, P1205, DOI 10.1016/j.amjmed.2017.03.032; Spalding L, 2003, J ROY SOC MED, V96, P122, DOI 10.1258/jrsm.96.3.122; Stochkendahl MJ, 2012, J MANIP PHYSIOL THER, V35, P254, DOI 10.1016/j.jmpt.2012.04.003; Stochkendahl MJ, 2012, J MANIP PHYSIOL THER, V35, P184, DOI 10.1016/j.jmpt.2012.01.009; Stochkendahl MJ, 2012, J MANIP PHYSIOL THER, V35, P7, DOI 10.1016/j.jmpt.2010.11.004; Visser A, 2015, EMERG MED J, V32, P595, DOI 10.1136/emermed-2014-203798; Wertli MM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-239	37	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211615	10.1371/journal.pone.0211615	http://dx.doi.org/10.1371/journal.pone.0211615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707725	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900037
J	Al Wahaibi, N; Al Lawati, A; Al Ruqeishy, F; Al Khatri, A; Al-Farsi, Y; Juma, TMA; Al Hinai, F; Al-Sibani, N; Mahadevan, S; Al-Adawi, S				Al Wahaibi, Nabila; Al Lawati, Anwaar; Al Ruqeishy, Falaah; Al Khatri, Abdulla; Al-Farsi, Yahya; Juma, Tahira M. A.; Al Hinai, Fatma; Al-Sibani, Nasser; Mahadevan, Sangeetha; Al-Adawi, Samir			The characteristics and patterns of utilization of healthcare services among Omanis with substance use disorders attending therapy for cessation	PLOS ONE			English	Article							DRUG-USE; GLOBAL EPIDEMIOLOGY; UNITED-STATES; CO-INGESTION; INJECT DRUGS; PREVALENCE; ALCOHOL; DEPENDENCE; KNOWLEDGE; PEOPLE	Background It is indicated that Oman is witnessing an increase in issues pertinent to alcohol and psycho-active substance use. Aim The aim of this study was to identify the characteristics of Omanis with substance use disorder attending a specialized hospital in Oman and the pattern of their utilization of healthcare services. A related aim was to ascertain the age group most vulnerable to alcohol and substance use in Oman. Method A cross-sectional study was conducted in a tertiary care center specialized for treatment of those engaging in substance use in Oman. The participants in the study were selected from a convenience sample among patients seeking consultation at the center for alcohol and substance use. A six-part questionnaire was designed to obtain information regarding socio-demographic background, clinical history, healthcare utilization and perceived hurdles to access. Chi-square analyses were used to evaluate the significance of differences among categorical data. Logistic regression modelling was used to obtain measures of association after adjusting for confounding factors. Results Among the patients (n = 293) seeking cessation therapy, 99% were male and less than 30 years of age. Peer influences on the initiation of substance use were significant. Most patients had a history of polysubstance use, including intravenous substance use. Cannabis and alcohol were the first substances consumed by most patients and Hepatitis C and psychiatric disorders were found to be the most common co-morbidities. The participants that reported use of cannabis and benzodiazepines were more likely to perceive "improvement" upon receiving treatment. Conclusion This study indicated that males below 30 years of age with a history of polysubstance use were likely to attend a hospital specialized in treating substance use disorder in Oman. This study identified information regarding socio-demographic background, risk factors and perceived hurdles to healthcare that could serve as groundwork for further studies conducted on newly emerging issues of substance use in Oman.	[Al Wahaibi, Nabila] Minist Hlth, Muscat Governorate, Wadi Kabir Hlth Ctr, Directorate Gen Hlth Serv, Muscat, Oman; [Al Lawati, Anwaar] Minist Hlth, Muscat Governorate, Ruwi Hlth Ctr, Directorate Gen Hlth Serv, Muscat, Oman; [Al Ruqeishy, Falaah] Minist Hlth, Muscat Governorate, Muscat Hlth Ctr, Directorate Gen Hlth Serv, Muscat, Oman; [Al Khatri, Abdulla] Minist Hlth, Al Masarrah Hosp, Muscat, Oman; [Al-Farsi, Yahya] Sultan Qaboos Univ, Dept Family Med & Publ Hlth, Coll Med & Hlth Sci, Muscat, Oman; [Juma, Tahira M. A.; Al Hinai, Fatma] Minist Hlth, Muscat Governorate, Directorate Hlth Serv, Muscat, Oman; [Al-Sibani, Nasser; Mahadevan, Sangeetha; Al-Adawi, Samir] Sultan Qaboos Univ, Dept Behav Med, Coll Med & Hlth Sci, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Al-Adawi, S (corresponding author), Sultan Qaboos Univ, Dept Behav Med, Coll Med & Hlth Sci, Muscat, Oman.	adawi@squ.edu.om	Al-Adawi, Samir/A-9663-2016; Al-Sibani, Nasser/AAS-4038-2020; Al-Farsi, Yahya/AAM-2181-2020	Al-Adawi, Samir/0000-0002-9858-5582; Al-Farsi, Yahya/0000-0002-0302-7132; Mahadevan, Sangeetha/0000-0002-4601-3806				Abdel-Baqui S, 1992, DERASAT NAFSEYAH, V2, P75; Abdelwahab SI, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/604526; Abou-Saleh MT, 2001, SOC PSYCH PSYCH EPID, V36, P20, DOI 10.1007/s001270050286; Al Haremi TZ, 2016, TIMES OF OMAN   1013; Al Mukrashi F, 2015, GULF NEW        1007; Al Reesi H, 2016, TRAFFIC INJ PREV, V17, P480, DOI 10.1080/15389588.2015.1107679; Al-Adawi S, 2017, CRITICAL ISSUES HEAL, P113; Al-Balushi N, 2019, EARLY CHILD DEV CARE, V189, P1515, DOI 10.1080/03004430.2017.1394850; Al-Barwani TA, 2007, MARRIAGE FAM REV, V41, P119, DOI 10.1300/J002v41n01_07; Al-Haddad M. K., 1994, Journal of Communicable Diseases, V26, P127; Al-Harthi A, 1999, THESIS; Al-Kandari FH, 2007, J ADDICT NURS, V18, P31, DOI 10.1080/10884600600995374; Al-Mandhari Ahmed, 2009, Sultan Qaboos Univ Med J, V9, P264; al-Nahedh N, 1999, East Mediterr Health J, V5, P241; Alblooshi H, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0062-5; AlMarri TSK, 2009, INT J PSYCHOL, V44, P222, DOI 10.1080/00207590801888752; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2017, DUBL DRUG POL SUMM R; [Anonymous], SUBST US SO AFR KNOW; [Anonymous], 2018, WORLD POPULATION REV; [Anonymous], 2006, INT ENCY ADOLESCENCE; [Anonymous], HLTH PROM SCH IN OM; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; BILAL AM, 1985, ALCOHOL ALCOHOLISM, V20, P57; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Carra G, 2014, J AFFECT DISORDERS, V167, P125, DOI 10.1016/j.jad.2014.05.066; Chatty D, 2000, INT J MIDDLE E STUD, V32, P241, DOI 10.1017/S0020743800021103; Cheung YW, 2018, QUAL LIFE ASIA, V11, P15, DOI 10.1007/978-981-10-6154-7_2; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Davis SM, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0156-z; Duell N, 2018, J YOUTH ADOLESCENCE, V47, P1052, DOI 10.1007/s10964-017-0752-y; Dwairy M, 1996, CLIN PSYCHOL REV, V16, P231, DOI 10.1016/S0272-7358(96)00011-6; Elarabi H, 2013, J PREV TREAT SUBST U, V1, P76, DOI DOI 10.4038/IJPTSUD.V1I1.5913; Forstenlechner I, 2011, MIDDLE EAST POLICY, V18, P25, DOI 10.1111/j.1475-4967.2011.00508.x; Gielen N, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.17734; Glick P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198435; Goings TC, 2018, J DRUG ISSUES, V48, P90, DOI 10.1177/0022042617731338; Handley T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050928; Hepburn K, 2016, AM J DRUG ALCOHOL AB, P1; Jabeen F, 2018, EQUAL DIVERS INCL, V37, P151, DOI 10.1108/EDI-02-2017-0045; Jaffer Y. A., 2006, Eastern Mediterranean Health Journal, V12, P35; Jayakrishnan B, 2012, Oman Med J, V27, P501, DOI 10.5001/omj.2012.120; Johnston L.D., 2011, MONITORING FUTURE NA; Kalix P, 1996, PHARM WORLD SCI, V18, P69, DOI 10.1007/BF00579708; KANDEL DB, 1991, J YOUTH ADOLESCENCE, V20, P289, DOI 10.1007/BF01537613; Khalifeh MM, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.323; Khantzian EJ, 2013, ADDICTION, V108, P668, DOI 10.1111/add.12004; Kishore V, 2011, DRUG-EDUC PREV POLIC, V18, P60, DOI 10.3109/09687630903501757; Kleinman A., 1988, ILLNESS NARRATIVES; Lander L, 2013, SOC WORK PUBLIC HLTH, V28, P194, DOI 10.1080/19371918.2013.759005; Mackesy-Amiti ME, 2012, DRUG ALCOHOL DEPEN, V124, P70, DOI 10.1016/j.drugalcdep.2011.12.012; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McCabe SE, 2006, J STUD ALCOHOL, V67, P529, DOI 10.15288/jsa.2006.67.529; McCabe SE, 2015, HUM PSYCHOPHARM CLIN, V30, P42, DOI 10.1002/hup.2449; Meier MH, 2018, ADDICTION, V113, P257, DOI 10.1111/add.13946; Nebhinani Naresh, 2013, Ind Psychiatry J, V22, P12, DOI 10.4103/0972-6748.123587; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Njoh J, 1997, J SUBST ABUSE TREAT, V14, P487, DOI 10.1016/S0740-5472(97)85722-4; Noroozi A, 2018, J PSYCHOACTIVE DRUGS, V50, P214, DOI 10.1080/02791072.2018.1425808; Okasha A, 2012, WORLD PSYCHIATRY, V11, P52, DOI 10.1016/j.wpsyc.2012.01.008; Ostergaard MLD, 2017, ADDICTION, V112, P1250, DOI 10.1111/add.13788; Panduranga P, 2013, WORLD J CARDIOL, V5, P397, DOI 10.4330/wjc.v5.i11.397; Peacock A, 2018, ADDICTION, V113, P1905, DOI 10.1111/add.14234; Peck JH, 2018, J CHILD ADOLES SUBST, V27, P11, DOI 10.1080/1067828X.2017.1396516; Quadri MFA, 2014, ASIAN PAC J CANCER P, V15, P1913, DOI 10.7314/APJCP.2014.15.5.1913; Qureshi NA, 1992, ARAB J PSYCHIAT, V2, P98; Rahim S. I. A., 2005, ARAB J PSYCHIAT, V16, P86; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Said AM, 2012, ADDICT DISORD TREAT, V11, P36, DOI 10.1097/ADT.0b013e3182213f0a; Schepis TS, 2016, ADDICT BEHAV, V52, P8, DOI 10.1016/j.addbeh.2015.08.002; Sheikh KA, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-44; Singer M, 2008, INT J DRUG POLICY, V19, P467, DOI 10.1016/j.drugpo.2006.12.007; SOBELL LC, 1995, ADDICT BEHAV, V20, P233, DOI 10.1016/0306-4603(94)00071-9; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Sofuoglu M, 2016, J DUAL DIAGN, V12, P90, DOI 10.1080/15504263.2016.1146383; Storr CL, 2011, DRUG ALCOHOL DEPEN, V117, P7, DOI 10.1016/j.drugalcdep.2010.12.023; Takahashi R, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1344-9; Vega WA, 2002, DRUG ALCOHOL DEPEN, V68, P285, DOI 10.1016/S0376-8716(02)00224-7; Vidourek RA, 2018, J SUBST USE, V23, P136, DOI 10.1080/14659891.2017.1378734; Wallace JM, 2003, ADDICTION, V98, P225, DOI 10.1046/j.1360-0443.2003.00282.x; Wang K, 2018, SUBST USE MISUSE, V53, P859, DOI 10.1080/10826084.2017.1391011; Wells K, 2001, AM J PSYCHIAT, V158, P2027, DOI 10.1176/appi.ajp.158.12.2027; WHO, COUNTR COOP STRAT WH; WIKAN U, 1984, MAN, V19, P635, DOI 10.2307/2802330; Wilkinson John C., 2010, IBADISM ORIGINS EARL; Williams RD, 2018, J COMMUN HEALTH, V43, P406, DOI 10.1007/s10900-017-0438-0; Wippel S., 2016, CONSTRUCTION LOGICS; World Health Organization, 2008, AIMS REPORT MENTAL H; Zaidan ZAJ, 2007, INT J MENT HEALTH AD, V5, P3	91	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210532	10.1371/journal.pone.0210532	http://dx.doi.org/10.1371/journal.pone.0210532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703131	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600021
J	Wang, JB; Fu, XL; Zhang, Z; Li, MH; Cao, HJ; Zhou, XL; Ni, HW				Wang, Jianbo; Fu, Xiaoling; Zhang, Zhen; Li, Maihe; Cao, Hongjie; Zhou, Xiaoliang; Ni, Hongwei			Responses of soil respiration to nitrogen addition in the Sanjiang Plain wetland, northeastern China	PLOS ONE			English	Article							CARBON-DIOXIDE; MICROBIAL RESPIRATION; METHANE EMISSIONS; ROOT RESPIRATION; TROPICAL FOREST; FERTILIZATION; GRASSLAND; TEMPERATURE; DEPOSITION; DYNAMICS	This study was designed to test the hypothesis that nitrogen (N) addition leads to enhanced soil respiration (SR) in nitrogen deficient marsh. Here, we report the response of SR to simulated N deposition in a temperate marsh of northeastern China from June 2009 to September 2011. The experiment included three-levels of N treatment (control: no N addition, Low-N: 4g N m(-2) y(-1), and High-N: 8 g N m(-2) y(-1)). Our study showed various responses of SR to level and duration of N addition. Yearly SR was increased by 11.8%-15.2% (P<0.05) under Low-N addition during the three years, while SR showed a strong increase by 27.5% (P<0.05) in the first year and then decreased by 4.4% (P>0.05) and 15.4% (P<0.05) in the next two years under High-N addition. Soil respiration was positively correlated with soil temperature and negatively correlated with soil water content. High-N treatment reduced soil pH value (P<0.05). The negative response of SR to High-N addition in the following two years may attribute to lower microbial activity, microbial biomass and alteration in the microbial community due to lower soil pH, which consequently leads to decreased SR. Meanwhile, we found root biomass were increased under High-N addition. This implies that the increase of autotrophic respiration was lower than the decline of heterotrophic respiration in the following two years. Our findings suggest complex interactions between N deposition and SR, which is needed to be further investigated in the future studies.	[Wang, Jianbo; Fu, Xiaoling; Cao, Hongjie; Ni, Hongwei] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang, Peoples R China; [Wang, Jianbo] Northeast Forestry Univ, Harbin, Heilongjiang, Peoples R China; [Zhang, Zhen; Li, Maihe] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Li, Maihe] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Jilin, Peoples R China; [Zhou, Xiaoliang] Honghe Natl Nat Reserve, Jiansanjiang, Heilongjiang, Peoples R China	Northeast Forestry University - China; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Ni, HW (corresponding author), Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang, Peoples R China.	nihongwei2000@163.com	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	National Natural Science Foundation of China [31570485, 31170462, 31700424]; National Key R&D Program of China [2016YFC0500405-02]; Special Research of Heilongjiang [ZNJZ2017ZR01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Special Research of Heilongjiang	We gratefully appreciate the Honghe National Nature Reserve for providing the experimental sites. This research was supported by National Natural Science Foundation of China (31570485, 31170462 and 31700424), the National Key R&D Program of China (2016YFC0500405-02), Special Research of Heilongjiang (ZNJZ2017ZR01).	ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Aerts R, 1999, OIKOS, V84, P44, DOI 10.2307/3546865; Al-Kaisi MM, 2008, J ENVIRON QUAL, V37, P325, DOI 10.2134/jeq2007.0240; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Burton AJ, 2002, OECOLOGIA, V131, P559, DOI 10.1007/s00442-002-0931-7; Cao YuSong, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P101; Chu HY, 1984, SOIL BIOL BIOCHEM, V39, P2971; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Ding WX, 2007, SOIL SCI SOC AM J, V71, P944, DOI 10.2136/sssaj2006.0160; Fang C, 2018, AGR FOREST METEOROL, V248, P449, DOI 10.1016/j.agrformet.2017.10.032; Ferrati R, 2005, ECOL MODEL, V186, P3, DOI 10.1016/j.ecolmodel.2005.01.021; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Garcia C, 1997, COMMUN SOIL SCI PLAN, V28, P123, DOI 10.1080/00103629709369777; Giardina CP, 2004, OECOLOGIA, V139, P545, DOI 10.1007/s00442-004-1552-0; Han Y, 2012, J PLANT ECOL-UK, V5, P219, DOI 10.1093/jpe/rtr015; He XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137827; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Li JW, 2018, GCB BIOENERGY, V10, P565, DOI 10.1111/gcbb.12515; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lu SJ, 1998, SOIL BIOL BIOCHEM, V30, P331, DOI 10.1016/S0038-0717(97)00134-X; [雒守华 Luo Shouhua], 2010, [农业环境科学学报, Journal of Agro-Environment Science], V29, P1834; Luo Y, 2010, GCB BIOENERGY, V1, P62; Manninen S, 2016, SCI TOTAL ENVIRON, V571, P314, DOI 10.1016/j.scitotenv.2016.07.152; Micks P, 2004, FOREST ECOL MANAG, V196, P57, DOI 10.1016/j.foreco.2004.03.012; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Ndour NYB, 2008, APPL SOIL ECOL, V38, P51, DOI 10.1016/j.apsoil.2007.09.001; Peng Q, 2011, ENVIRON EARTH SCI, V62, P1163, DOI 10.1007/s12665-010-0605-4; Perakis SS, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00340.1; Phillips RP, 2007, NEW PHYTOL, V176, P655, DOI 10.1111/j.1469-8137.2007.02204.x; Ramirez KS, 2010, SOIL BIOL BIOCHEM, V42, P2336, DOI 10.1016/j.soilbio.2010.08.032; Ren F, 2016, SCI REP-UK, V6, DOI 10.1038/srep34786; Steven DA, 2008, GLOBAL CHANGE BIOL, V14, P1; Sui X, 2017, INT J AGRIC BIOL, V19, P841, DOI [10.17957/ijab/15.0370, 10.17957/IJAB/15.0370]; Sun J, 2013, POL J ECOL, V61, P655; Tao BX, 2013, WETLANDS, V33, P727, DOI 10.1007/s13157-013-0432-y; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Vose JM, 2002, GLOBAL CHANGE BIOL, V8, P182, DOI 10.1046/j.1365-2486.2002.00464.x; Wang JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078393, 10.1371/journal.pone.0073683, 10.1371/journal.pone.0063924, 10.1371/journal.pone.0066563, 10.1371/journal.pone.0070587]; Wei L, 2018, J ARID ENVIRON, V152, P37, DOI 10.1016/j.jaridenv.2018.01.017; Wigand C, 2009, WETLANDS, V29, P952, DOI 10.1672/08-147.1; [徐宏伟 Xu Hongwei], 2005, [生态学报, Acta Ecologica Sinica], V25, P1720; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Xu X, 2015, GLOBAL CHANGE BIOL, V21, P3846, DOI 10.1111/gcb.12940; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Zhang CP, 2015, SOIL SCI PLANT NUTR, V61, P629, DOI 10.1080/00380768.2015.1036307; Zhang Z, 2017, P NATL ACAD SCI USA, V114, P9647, DOI 10.1073/pnas.1618765114; Zhou YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015134; Zhu CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33131	58	9	10	10	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211456	10.1371/journal.pone.0211456	http://dx.doi.org/10.1371/journal.pone.0211456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703158	Green Published, gold			2022-12-26	WOS:000457301600046
J	Buck, C; Loyen, A; Foraita, R; Van Cauwenberg, J; De Craemer, M; Mac Donncha, C; Oppert, JM; Brug, J; Lien, N; Cardon, G; Pigeot, I; Chastin, S				Buck, Christoph; Loyen, Anne; Foraita, Ronja; Van Cauwenberg, Jelle; De Craemer, Marieke; Mac Donncha, Ciaran; Oppert, Jean-Michel; Brug, Johannes; Lien, Nanna; Cardon, Greet; Pigeot, Iris; Chastin, Sebastien		DEDIPAC Consortium	Factors influencing sedentary behaviour: A system based analysis using Bayesian networks within DEDIPAC	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; REDUCE SITTING TIME; ADULTS; ASSOCIATION; INTERVENTIONS; DETERMINANTS; METAANALYSIS; INTEGRATION; STRATEGIES; MORTALITY	Background Decreasing sedentary behaviour (SB) has emerged as a public health priority since prolonged sitting increases the risk of non-communicable diseases. Mostly, the independent association of factors with SB has been investigated, although lifestyle behaviours are conditioned by interdependent factors. Within the DEDIPAC Knowledge Hub, a system of sedentary behaviours (SOS)-framework was created to take interdependency among multiple factors into account. The SOS framework is based on a system approach and was developed by combining evidence synthesis and expert consensus. The present study conducted a Bayesian network analysis to investigate and map the interdependencies between factors associated with SB through the life-course from large scale empirical data. Methods Data from the Eurobarometer survey (80.2, 2013) that included the International physical activity questionnaire (IPAQ) short as well as socio-demographic information and questions on perceived environment, health, and psychosocial information were enriched with macrolevel data from the Eurostat database. Overall, 33 factors were identified aligned to the SOS-framework to represent six clusters on the individual or regional level: 1) physical health and wellbeing, 2) social and cultural context, 3) built and natural environment, 4) psychology and behaviour, 5) institutional and home settings, 6) policy and economics. A Bayesian network analysis was conducted to investigate conditional associations among all factors and to determine their importance within these networks. Bayesian networks were estimated for the complete (23,865 EU-citizens with complete data) sample and for sexand four age-specific subgroups. Distance and centrality were calculated to determine importance of factors within each network around SB. Results In the young (15-25), adult (26-44), and middle-aged (45-64) groups occupational level was directly associated with SB for both, men and women. Consistently, social class and educational level were indirectly associated within male adult groups, while in women factors of the family context were indirectly associated with SB. Only in older adults, factors of the built environment were relevant with regard to SB, while factors of the home and institutional settings were less important compared to younger age groups. Conclusion Factors of the home and institutional settings as well as the social and cultural context were found to be important in the network of associations around SB supporting the priority for future research in these clusters. Particularly, occupational status was found to be the main driver of SB through the life-course. Investigating conditional associations by Bayesian networks gave a better understanding of the complex interplay of factors being associated with SB. This may provide detailed insights in the mechanisms behind the burden of SB to effectively inform policy makers for detailed intervention planning. However, considering the complexity of the issue, there is need for a more comprehensive system of data collection including objective measures of sedentary time.	[Buck, Christoph; Foraita, Ronja; Pigeot, Iris] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Loyen, Anne] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Van Cauwenberg, Jelle] Res Fdn Flanders FWO, Brussels, Belgium; [Van Cauwenberg, Jelle] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [De Craemer, Marieke; Cardon, Greet; Chastin, Sebastien] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Mac Donncha, Ciaran] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Oppert, Jean-Michel] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, ICAN,Dept Nutr, Paris, France; [Brug, Johannes] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands; [Lien, Nanna] Univ Oslo, Dept Nutr, Oslo, Norway; [Pigeot, Iris] Univ Bremen, Fac Math & Comp Sci, Bremen, Germany; [Chastin, Sebastien] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Vrije Universiteit Amsterdam; Ghent University; Ghent University; University of Limerick; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Amsterdam; University of Oslo; University of Bremen; Glasgow Caledonian University	Buck, C (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	buck@leibniz-bips.de	Donncha, Ciaran Mac/I-5861-2014; De Craemer, Marieke/Z-3050-2019; De Craemer, Marieke/P-6072-2016; Brug, Johannes/A-8242-2018; Chastin, Sebastien/ABF-1455-2020; Pigeot, Iris/A-2722-2012	Donncha, Ciaran Mac/0000-0001-7999-4930; De Craemer, Marieke/0000-0002-5220-7850; Brug, Johannes/0000-0002-1904-7349; Chastin, Sebastien/0000-0003-1421-9348; Pigeot, Iris/0000-0001-7483-0726; Buck, Christoph/0000-0003-0261-704X; Cardon, Greet/0000-0003-4983-6557	Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Belgium: Research Foundation - Flanders; France: Institut National de la Recherche Agronomique (INRA); Germany: Federal Ministry of Education and Research [01AE1377]; Ireland: Health Research Board (HRB); The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); Norway: The Research Council of Norway, Division for Society and Health; United Kingdom: The Medical Research Council (MRC); Leibniz Association	Joint Programming Initiative 'Healthy Diet for a Healthy Life'; Belgium: Research Foundation - Flanders; France: Institut National de la Recherche Agronomique (INRA); Germany: Federal Ministry of Education and Research; Ireland: Health Research Board (HRB); The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); Norway: The Research Council of Norway, Division for Society and Health; United Kingdom: The Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leibniz Association	This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agencies supporting this work are (in alphabetical order of participating Member States): Belgium (Authors: JVC MDC GC): Research Foundation - Flanders; France (Author: JMO): Institut National de la Recherche Agronomique (INRA); Germany (Author: CB, RF, IP): Federal Ministry of Education and Research (01AE1377); Ireland (Author: CMD): The Health Research Board (HRB); The Netherlands (Author: AL, JB): The Netherlands Organisation for Health Research and Development (ZonMw); Norway (Author: NL): The Research Council of Norway, Division for Society and Health; The United Kingdom (Author: SC): The Medical Research Council (MRC). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2017, INT J EPIDEMIOL, V46, P1394, DOI 10.1093/ije/dyw317; [Anonymous], START ACTIVE STAY AC; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brug J, 2017, INT J BEHAV NUTR PHY, V14, DOI [10.1186/s12966-017-0609-5, 10.1186/s12966-017-0609-5c]; Buffel T, 2012, INT J LIFELONG EDUC, V31, P13, DOI 10.1080/02601370.2012.636577; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Chastin SFM, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0409-3; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chastin SFM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0292-3; Chastin SFM, 2014, INT J ENV RES PUB HE, V11, P773, DOI 10.3390/ijerph110100773; Chastin SFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082313; Commission European, 2014, 412 COMM EUR; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Daly R, 2011, KNOWL ENG REV, V26, P99, DOI 10.1017/S0269888910000251; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; del Pozo-Cruz J, 2018, AM J PREV MED, V55, P395, DOI 10.1016/j.amepre.2018.04.042; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Fuster-Parra P, 2016, COMPUT METH PROG BIO, V126, P128, DOI 10.1016/j.cmpb.2015.12.010; Garcia LMT, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0553-4; Gardner B, 2016, HEALTH PSYCHOL REV, V10, P89, DOI 10.1080/17437199.2015.1082146; Gheysen F, 2018, CITIES; Hanke M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1677-x; Harding NJ., 2011, APPL BAYESIAN NETWOR; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Kemperman A, 2014, ENVIRON BEHAV, V46, P583, DOI 10.1177/0013916512466662; Kolaczyk ED., 2014, STAT ANAL NETWORK DA; Lakerveld J., 2014, International Journal of Behavioral Nutrition and Physical Activity, V11; Lakerveld J, 2017, PREV MED, V101, P77, DOI 10.1016/j.ypmed.2017.05.015; Lappenschaar M, 2013, ARTIF INTELL MED, V57, P171, DOI 10.1016/j.artmed.2012.12.007; Leask CF, 2015, EUR REV AGING PHYS A, V12, DOI 10.1186/s11556-015-0146-7; Loyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149320; Martin A, 2015, BRIT J SPORT MED, V49, P1056, DOI 10.1136/bjsports-2014-094524; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Patterson R, 2018, EUR J EPIDEMIOL, V33, P811, DOI 10.1007/s10654-018-0380-1; Pigeot I, 2015, J APPL STAT, V42, P2335, DOI 10.1080/02664763.2015.1030368; R Development Core Team, 2014, R LANG ENV STAT COMP; Radermacher W., 2013, EUROPE FIGURES EUROS, VVolume 6; Scutari M., 2009, ARXIV09083817; Scutari M., 2014, BAYESIAN NETWORKS EX; Stierlin AS, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0291-4; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; Van Cauwenberg J, 2014, J AGING PHYS ACTIV, V22, P508, DOI [10.1123/japa.2013-0015, 10.1123/JAPA.2013-0015]; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; World Health Organization, 2011, WHO EUR DAT NUTR OB	49	20	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211546	10.1371/journal.pone.0211546	http://dx.doi.org/10.1371/journal.pone.0211546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699199	gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600086
J	Cadez, N; Bellora, N; Ulloa, R; Hittinger, CT; Libkind, D				Cadez, Neza; Bellora, Nicolas; Ulloa, Ricardo; Hittinger, Chris Todd; Libkind, Diego			Genomic content of a novel yeast species Hanseniaspora gamundiae sp. nov. from fungal stromata (Cyttaria) associated with a unique fermented beverage in Andean Patagonia, Argentina	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE TRANSPORTER; SACCHAROMYCES-CEREVISIAE; SEQUENCE-ANALYSIS; OXIDATIVE STRESS; WINE YEASTS; GENE; PHYLOGENY; DNA; IDENTIFICATION; ALGORITHM	A novel yeast species was isolated from the sugar-rich stromata of Cyttaria hariotii collected from two different Nothofagus tree species in the Andean forests of Patagonia, Argentina. Phylogenetic analyses of the concatenated sequence of the rRNA gene sequences and the protein-coding genes for actin and translational elongation factor-1 alpha indicated that the novel species belongs to the genus Hanseniaspora. De novo genome assembly of the strain CRUB 1928(T) yielded a 10.2-Mbp genome assembly predicted to encode 4452 protein-coding genes. The genome sequence data were compared to the genomes of other Hanseniaspora species using three different methods, an alignment-free distance measure, K-r, and two model-based estimations of DNA-DNA homology values, of which all provided indicative values to delineate species of Hanseniaspora. Given its potential role in a rare indigenous alcoholic beverage in which yeasts ferment sugars extracted from the stromata of Cytarria sp., we searched for the genes that may suggest adaptation of novel Hanseniaspora species to fermenting communities. The SSU1-like gene encoding a sulfite efflux pump, which, among Hanseniaspora, is present only in close relatives to the new species, was detected and analyzed, suggesting that this gene might be one factor that characterizes this novel species. We also discuss several candidate genes that likely underlie the physiological traits used for traditional taxonomic identification. Based on these results, a novel yeast species with the name Hanseniaspora gamundiae sp. nov. is proposed with CRUB 1928(T) (ex-types: ZIM 2545(T) = NRRL Y-63793(T) = PYCC 7262(T); MycoBank number MB 824091) as the type strain. Furthermore, we propose the transfer of the Kloeckera species, K. hatyaiensis, K. lindneri and K. taiwanica to the genus Hanseniaspora as Hanseniaspora hatyaiensis comb. nov. (MB 828569), Hanseniaspora lindneri comb. nov. (MB 828566) and Hanseniaspora taiwanica comb. nov. (MB 828567).	[Cadez, Neza] Univ Ljubljana, Biotech Fac, Jamnikarjeva 101, Ljubljana, Slovenia; [Bellora, Nicolas; Libkind, Diego] Univ Nacl Comahue, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Biodiversidad & Medioambiente, Lab Microbiol Aplicada & Biotecnol, San Carlos De Bariloche, Rio Negro, Argentina; [Ulloa, Ricardo] Univ Nacl Comahue, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest & Desarrollo Ingn Proc, Biotecnol Energias Alternat,Lab Bioproc, Neuquen, Argentina; [Hittinger, Chris Todd] Univ Wisconsin, JF Crow Inst Study Evolut, DOE Great Lakes Bioenergy Res Ctr, Lab Genet,Genome Ctr Wisconsin,Wisconsin Energy I, Madison, WI USA	University of Ljubljana; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional del Comahue; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Libkind, D (corresponding author), Univ Nacl Comahue, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Biodiversidad & Medioambiente, Lab Microbiol Aplicada & Biotecnol, San Carlos De Bariloche, Rio Negro, Argentina.	libkindfd@comahue-conicet.gob.ar	Bellora, Nicolas/E-6356-2014; Cadez, Neza/AFO-6279-2022	Bellora, Nicolas/0000-0001-6637-3465; Cadez, Neza/0000-0002-4987-0539	Slovenian Research Agency [P4-0116, L4-8222, IP-0510]; Universidad Nacional del Comahue [B171, B199]; ANPCyT-FONCyT [PICT 2542]; CONICET [PIP424]; National Science Foundation [DEB-1253634, DEB-1442148]; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-SC0018409, DE-FC02-07ER64494]; Pew Charitable Trusts; Vilas Trust Estate	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Universidad Nacional del Comahue; ANPCyT-FONCyT(ANPCyTFONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Science Foundation(National Science Foundation (NSF)); DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Pew Charitable Trusts; Vilas Trust Estate	This study was supported by funding from the Slovenian Research Agency (P4-0116, L4-8222 and MRIC-UL ZIM, IP-0510), by Universidad Nacional del Comahue (Project B171 and B199), ANPCyT-FONCyT (Project PICT 2542), by CONICET (Project PIP424), by the National Science Foundation under Grant Nos. DEB-1253634 and DEB-1442148, and in part by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-SC0018409 and DE-FC02-07ER64494). CTH is a Pew Scholar in the Biomedical Sciences and Vilas Faculty Early Career Investigator, supported by the Pew Charitable Trusts and the Vilas Trust Estate, respectively.	Abranches J, 2001, MICROBIAL ECOL, V42, P186; Almeida P, 2017, MOL ECOL, V26, P2167, DOI 10.1111/mec.14071; Almeida P, 2015, MOL ECOL, V24, P5412, DOI 10.1111/mec.13341; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bellora N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3244-7; Bleykasten-Grosshans C, 2011, CR BIOL, V334, P679, DOI 10.1016/j.crvi.2011.05.017; Buzzini P, 2017, YEASTS NATURAL ECOSY; Cadez N, 2003, INT J SYST EVOL MICR, V53, P1671, DOI 10.1099/ijs.0.02618-0; Cadez N, 2006, INT J SYST EVOL MICR, V56, P1157, DOI 10.1099/ijs.0.64052-0; Cadez N, 2014, INT J SYST EVOL MICR, V64, P2364, DOI 10.1099/ijs.0.061499-0; Cadez Neza, 2002, FEMS Yeast Research, V1, P279, DOI 10.1111/j.1567-1364.2002.tb00046.x; Chang CF, 2012, INT J SYST EVOL MICR, V62, P1434, DOI 10.1099/ijs.0.034231-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daniel HM, 2014, ANTON LEEUW INT J G, V106, P67, DOI 10.1007/s10482-014-0170-z; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; De Lederkremer RM, 1988, ANALES ACAD CI EXACT, V4, P153; Dietrich FS, 2013, G3-GENES GENOM GENET, V3, P1225, DOI 10.1534/g3.112.002881; DOTT W, 1976, ARCH MICROBIOL, V107, P289, DOI 10.1007/BF00425341; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eizaguirre JI, 2018, ENVIRON MICROBIOL, V20, P3732, DOI 10.1111/1462-2920.14375; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Felder T, 2002, EUKARYOT CELL, V1, P799, DOI 10.1128/EC.1.5.799-810.2002; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI [10.1186/1471-2148-6-6, DOI 10.1186/1471-2148-6-6]; Gamundi IJ, 1989, CIENC INVEST, V43, P4; Gbelska Y, 2006, FEMS YEAST RES, V6, P345, DOI 10.1111/j.1567-1364.2006.00058.x; Giorello FM, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00530-14; Gomes FCO, 2010, FOOD SCI TECHN-HAUPP, P79; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Groenewald M, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy076; Haase MAB, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox019; Hittinger CT, 2015, CURR OPIN GENET DEV, V35, P100, DOI 10.1016/j.gde.2015.10.008; Hittinger CT, 2010, NATURE, V464, P54, DOI 10.1038/nature08791; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jindamorakot S, 2009, FEMS YEAST RES, V9, P1327, DOI 10.1111/j.1567-1364.2009.00568.x; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalac P, 2013, J SCI FOOD AGR, V93, P209, DOI 10.1002/jsfa.5960; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan I.A., 2010, LEUNGS ENCY COMMON N; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov050; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P3, DOI 10.1016/B978-0-444-52149-1.00001-X; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2011, FEMS YEAST RES, V11, P324, DOI 10.1111/j.1567-1364.2011.00718.x; Lam SSTH, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv170; Lee DK, 2018, ANTON LEEUW INT J G, V111, P1935, DOI 10.1007/s10482-018-1084-y; Libkind D, 2007, APPL ENVIRON MICROB, V73, P1120, DOI 10.1128/AEM.01432-06; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Lleixa J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00338; Lopes MR, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow044; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MEYER SA, 1978, A VAN LEEUW J MICROB, V44, P79, DOI 10.1007/BF00400078; Mosbach EW., 1991, MUSEO CHILENO ARTE P; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Opulente DA, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0498-3; Ouoba LII, 2015, INT J SYST EVOL MICR, V65, P3576, DOI 10.1099/ijsem.0.000461; Pardo LO, 2005, CHICHA CHILE PRECOLO; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Peter G., 2017, YEASTS NATURAL ECOSY, P39, DOI DOI 10.1007/978-3-319-61575-2_2; Phaff HJ, 1970, YEASTS TAXONOMIC STU, P209; Pozo MI, 2017, YEASTS NATURAL ECOSY, P73, DOI [10.1007/978-3-319-61575-2_3, DOI 10.1007/978-3-319-61575-2]; Rauhut Doris, 2009, P181, DOI 10.1007/978-3-540-85463-0_10; Riley R, 2016, P NATL ACAD SCI USA, V113, P9882, DOI 10.1073/pnas.1603941113; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Shen XX, 2016, G3-GENES GENOM GENET, V6, P3927, DOI 10.1534/g3.116.034744; SINHA A, 1992, J GEN MICROBIOL, V138, P1865, DOI 10.1099/00221287-138-9-1865; Smit A, 1996, REPEATMASKER OPEN 30; Sternes PR, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01287-16; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Turland N.J., 2018, INT CODE NOMENCLATUR, DOI [10.12705/Code.2018, DOI 10.12705/CODE.2018]; Ulloa José, 2009, Bol. Soc. Argent. Bot., V44, P239; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; Wang CX, 2015, INT J FOOD MICROBIOL, V206, P67, DOI 10.1016/j.ijfoodmicro.2015.04.022; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yoon SH, 2017, ANTON LEEUW INT J G, V110, P1281, DOI 10.1007/s10482-017-0844-4; Yurkov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126996	86	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210792	10.1371/journal.pone.0210792	http://dx.doi.org/10.1371/journal.pone.0210792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699175	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600055
J	Courcoubetis, G; Ali, S; Nuzhdin, SV; Marjoram, P; Haas, S				Courcoubetis, George; Ali, Sammi; Nuzhdin, Sergey V.; Marjoram, Paul; Haas, Stephan			Threshold response to stochasticity in morphogenesis	PLOS ONE			English	Article							COMPOUND EYE; CELL; FURROW; NOTCH	During development of biological organisms, multiple complex structures are formed. In many instances, these structures need to exhibit a high degree of order to be functional, although many of their constituents are intrinsically stochastic. Hence, it has been suggested that biological robustness ultimately must rely on complex gene regulatory networks and clean-up mechanisms. Here we explore developmental processes that have evolved inherent robustness against stochasticity. In the context of the Drosophila eye disc, multiple optical units, ommatidia, develop into crystal-like patterns. During the larva-to-pupa stage of metamorphosis, the centers of the ommatidia are specified initially through the diffusion of morphogens, followed by the specification of R8 cells. Establishing the R8 cell is crucial in setting up the geometric, and functional, relationships of cells within an ommatidium and among neighboring ommatidia. Here we study an PDE mathematical model of these spatio-temporal processes in the presence of parametric stochasticity, defining and applying measures that quantify order within the resulting spatial patterns. We observe a universal sigmoidal response to increasing transcriptional noise. Ordered patterns persist up to a threshold noise level in the model parameters. In accordance with prior qualitative observations, as the noise is further increased past a threshold point of no return, these ordered patterns rapidly become disordered. Such robustness in development allows for the accumulation of genetic variation without any observable changes in phenotype. We argue that the observed sigmoidal dependence introduces robustness allowing for sizable amounts of genetic variation and transcriptional noise to be tolerated in natural populations without resulting in phenotype variation.	[Courcoubetis, George; Haas, Stephan] Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90007 USA; [Ali, Sammi; Nuzhdin, Sergey V.] Univ Southern Calif, Dept Mol & Computat Biol, Los Angeles, CA 90007 USA; [Marjoram, Paul] USC, Keck Sch Med, Dept Preventat Med, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California Keck Hospital	Haas, S (corresponding author), Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90007 USA.; Nuzhdin, SV (corresponding author), Univ Southern Calif, Dept Mol & Computat Biol, Los Angeles, CA 90007 USA.	snuzhdin@usc.edu; shaas@dornsife.usc.edu		Courcoubetis, George/0000-0001-8622-6251; Ali, Sammi/0000-0002-3019-1923	National Institutes of Health [U01GM103804, R01GM102227]; U.S. Department of Energy [ER46240]; NIH [R01GM128193]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM128193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported through grants U01GM103804 and R01GM102227 from the National Institutes of Health (https://www.nih.gov) to Sergey V Nuzhdin and ER46240 from the U.S. Department of Energy (https://www.energy.gov) to Stephan Haas. SA and SVN work is supported by NIH R01GM128193.	Averbukh Inna, 2017, Current Opinion in Systems Biology, V1, P69, DOI 10.1016/j.coisb.2016.12.011; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; Baonza A, 2001, DEVELOPMENT, V128, P3889; Barkai N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001990; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Chowdhury D, 2005, STAT MECH INTERACTIN, P253, DOI [10.1002/3527603158.part3, DOI 10.1002/3527603158.PART3]; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Debye P, 1913, ANN PHYS, V348, P49, DOI DOI 10.1002/ANDP.19133480105; Egami T, 2012, PERGAMON MATER SER, V16, P1; Gavish A, 2016, J BIOL PHYS, V42, P317, DOI 10.1007/s10867-016-9409-4; Gavish A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10461; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Gursky VV, 2012, BIOSYSTEMS, V109, P329, DOI 10.1016/j.biosystems.2012.05.013; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; Jiao Y, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022721; Keller EF, 2002, ANN NY ACAD SCI, V981, P189; Kim S, 2016, BIOPHYS J, V111, P2735, DOI 10.1016/j.bpj.2016.11.004; Kittel C., 2004, INTRO SOLID STATE PH; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; LINDENMEYER PH, 1963, J APPL PHYS, V34, P42, DOI 10.1063/1.1729086; Lubensky DK, 2011, P NATL ACAD SCI USA, V108, P11145, DOI 10.1073/pnas.1015302108; Markov A.A, 1954, T MAT I STEKLOVA, V42, P3; Metzger BPH, 2016, MOL BIOL EVOL, V33, P1131, DOI 10.1093/molbev/msw011; Metzger BPH, 2015, NATURE, V521, P344, DOI 10.1038/nature14244; Okabe A., 2009, SPATIAL TESSELLATION, V501; Rachev S.T., 2013, METHODS DISTANCES TH, P11; Truskett TM, 2000, PHYS REV E, V62, P993, DOI 10.1103/PhysRevE.62.993; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Waller I, 1923, Z PHYS, V17, P398, DOI 10.1007/BF01328696; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOLFF T, 1991, DEVELOPMENT, V113, P825	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210088	10.1371/journal.pone.0210088	http://dx.doi.org/10.1371/journal.pone.0210088			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699125	Green Submitted, gold, Green Published			2022-12-26	WOS:000457155600019
J	Goshu, YA; Yitayew, AE				Goshu, Yitayal Ayalew; Yitayew, Azeb Ewinetu			Prevalence and determinant factors of unintended pregnancy among pregnant women attending antenatal clinics of Addis Zemen hospital	PLOS ONE			English	Article								Introduction Unintended pregnancy is a pregnancy which is not wanted and/or not planed at the time of conception. It has a major consequence on mothers' and newborns' health and its prevalence remains a major health problem in Ethiopia. This study was aimed to assess the prevalence and determinants of unintended pregnancy among pregnant women attending antenatal clinics of Addis Zemen hospital. Methods An institutional-based cross-sectional study was employed in Addis Zemen hospital from April 01 to May 30, 2018. The sampled 398 pregnant mothers were selected by systematic random sampling. The data were collected using a-pretested structured questionnaire via face to face interview and the collected data were analyzedby using SPSS Version-20. The data were summarized with frequency and cross-tabulation. Both binary and multiple logistic regressions were used in order to identify predictor variables using odds ratio at 95% confidence interval. Results All of 398 mothers answered the questionnaire making the response rate 100%. The prevalence of unintended pregnancy was 26.1% (CI; 22.1, 30.4). Women who were multigravid (AOR; 4.7: CI; 2.3, 6.8), women who were multipara (AOR; 2.8: CI; 2.6, 9.7), and women who were from rural (AOR; 2.6: CI; 1.5, 4.6) were more likely experienced unintended pregnancy than their counterparts. Women who were Muslim (AOR; 0.79: CI; 0.6, 0.90) and women who attended secondary education (AOR; 0.58: CI; 0.42, 0.78) were less likely experienced unintended pregnancy. Conclusion and recommendation The prevalence of unintended pregnancy is high in the study area. Educational status, parity, gravity, residence, and religion were the most important predictor variables of unintended pregnancy. Reducing the prevalence of unintended pregnancy especially in the rural area is recommended.	[Goshu, Yitayal Ayalew; Yitayew, Azeb Ewinetu] Debre Tabor Univ, Dept Midwifery, Coll Hlth Sci, Debre Tabor, Ethiopia		Goshu, YA (corresponding author), Debre Tabor Univ, Dept Midwifery, Coll Hlth Sci, Debre Tabor, Ethiopia.	ayalewyitayal@gmail.com	Goshu, Yitayal Ayalew/J-7479-2019	Goshu, Yitayal Ayalew/0000-0002-3760-4903	Debre Tabor University	Debre Tabor University	Firstly, we would like to thanks Debre Tabor University for the approval of the Ethical Clearance, and for its financial support for the study. Our sincere appreciations also go to data collectors and supervisors for their time and honestly collect the required data. Finally, we would like to express our heartfelt thanks to the participants for their willingness to participate in the study, without whom this research would be impossible.	Adebowale Ayo, 2014, AFRICAN POPULATION S, V28, DOI [10.11564/28-0-525, DOI 10.11564/28-0-525]; American Pregnancy Association (APA), 2015, UN PREGN; [Anonymous], 2015, MALAYSIAN J MED BIOL, V2; Assefa N, 2012, REPROD HLTH, V9, P1, DOI [10.1186/1742-4755-9-1, DOI 10.1186/1742-4755-9-1]; Ayalew Y, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0279-4; Ayele M, 2017, J WOMENS HLTH CARE, V6, P408, DOI [10.4172/2167-0420.1000408, DOI 10.4172/2167-0420.1000408]; Cherie A, 2017, J WOMENS HLTH CARE, V6, DOI [10.4172/2167-0420.1000392, DOI 10.4172/2167-0420.1000392]; Dibaba Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-50; Ethiopian Demographic Health and Survey (EDHS), 2016, ETH MIN DEM HLTH SUR; Feyisso M., 2017, J WOMENS HLTH CARE, V6, DOI [10.4172/2167-0420.1000388, DOI 10.4172/2167-0420.1000388]; Geda NR., 2011, J GEOGR REGIONAL PLA, V4, P417; Gerdts C, 2016, WOMEN HEALTH ISS, V26, P55, DOI 10.1016/j.whi.2015.10.001; Melese KG, 2016, OBSTET GYNECOL INT, V2016, DOI 10.1155/2016/4374791; Habte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082987; Hamdela B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039074; Hanson MA, 2015, INT J GYNECOL OBSTET, V131, P40; Jonathan B, 2018, LANCET GLOBAL HLTH; Kibret A., 2015, J WOMENS HLTH CARE, V4, P232; Mohammed F, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0335-1; Moore AM, 2016, INT PERSPECT SEX R H, V42, P111, DOI 10.1363/42e1816; Mosfequr R, 2016, PLOSE ONE, V11, P6; Ndziessi G, 2016, SM J COMMUNITY MED, V2, P1015; Reddy PS, 2017, HUMAN, V7, P51; Tebekaw Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-326; Teshome FT, 2014, SCI J PUBLIC HLTH, V2, P92; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; WHO, 2015, UN PREGN IMPR MAT CH; Worku S, 2006, ETHIOP J HLTH DEV, V20; World Health Organization, 2017, DEPRESSION; Yazdkhasti M, 2015, IRAN J PUBLIC HEALTH, V44, P12	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210206	10.1371/journal.pone.0210206	http://dx.doi.org/10.1371/journal.pone.0210206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699140	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600026
J	Mackenzie-Impoinvil, L; Weedall, GD; Lol, JC; Pinto, J; Vizcaino, L; Dzuris, N; Riveron, J; Padilla, N; Wondji, C; Lenhart, A				Mackenzie-Impoinvil, Lucy; Weedall, Gareth D.; Lol, Juan C.; Pinto, Jesus; Vizcaino, Lucrecia; Dzuris, Nicole; Riveron, Jacob; Padilla, Norma; Wondji, Charles; Lenhart, Audrey			Contrasting patterns of gene expression indicate differing pyrethroid resistance mechanisms across the range of the New World malaria vector Anopheles albimanus	PLOS ONE			English	Article							MICROPLATE ASSAY ANALYSIS; SCALE FIELD TRIAL; INSECTICIDE RESISTANCE; MANAGEMENT STRATEGIES; SEQUENCE ALIGNMENT; GAMBIAE; CYTOCHROME-P450; MOSQUITOS; SUSCEPTIBILITY; VISUALIZATION	Decades of unmanaged insecticide use and routine exposure to agrochemicals have left many populations of malaria vectors in the Americas resistant to multiple classes of insecticides, including pyrethroids. The molecular basis of pyrethroid resistance is relatively uncharacterised in American malaria vectors, preventing the design of suitable resistance management strategies. Using whole transcriptome sequencing, we characterized the mechanisms of pyrethroid resistance in Anopheles albimanus from Peru and Guatemala. An. albimanus were phenotyped as either deltamethrin or alpha-cypermethrin resistant. RNA from 1) resistant, 2) unexposed, and 3) a susceptible laboratory strain of An. albimanus was sequenced and analyzed using RNA-Seq. Expression profiles of the three groups were compared based on the current annotation of the An. albimanus reference genome. Several candidate genes associated with pyrethroid resistance in other malaria vectors were found to be overexpressed in resistant An. albimanus. In addition, gene ontology terms related to serine-type endopeptidase activity, extracellular activity and chitin metabolic process were also commonly overexpressed in the field caught resistant and unexposed samples from both Peru and Guatemala when compared to the susceptible strain. The cytochrome P450 CYP9K1 was overexpressed 14x in deltamethrin and 8x in alpha-cypermethrin-resistant samples from Peru and 2x in deltamethrin-resistant samples from Guatemala, relative to the susceptible laboratory strain. CYP6P5 was overexpressed 68x in deltamethrin-resistant samples from Peru but not in deltamethrin-resistant samples from Guatemala. When comparing overexpressed genes between deltamethrin-resistant and alpha-cypermethrin-resistant samples from Peru, a single P450 gene, CYP4C26, was overexpressed 9.8x (p<0.05) in alpha-cypermethrin-resistant samples. In Peruvian deltamethrin-resistant samples, the knockdown resistance mutation (kdr) variant alleles at position 1014 were rare, with approximately 5% frequency, but in the alpha-cypermethrin-resistant samples, the frequency of these alleles was approximately 15-30%. Functional validation of the candidate genes and the kdr mutation as a resistance marker for alpha-cypermethrin will confirm the role of these mechanisms in conferring pyrethroid resistance.	[Mackenzie-Impoinvil, Lucy; Vizcaino, Lucrecia; Dzuris, Nicole; Lenhart, Audrey] Ctr Dis Control & Prevent, Ctr Global Hlth, Entomol Branch, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Weedall, Gareth D.; Riveron, Jacob; Wondji, Charles] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England; [Weedall, Gareth D.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Lol, Juan C.; Padilla, Norma] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Pinto, Jesus] Inst Nacl Salud Lima, Lima, Peru; [Riveron, Jacob; Wondji, Charles] CRID, Yaounde, Cameroon	Centers for Disease Control & Prevention - USA; Liverpool School of Tropical Medicine; Liverpool John Moores University; Universidad del Valle de Guatemala; Instituto Nacional de Salud - Peru	Lenhart, A (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Entomol Branch, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA.	AJL8@cdc.gov	Wondji, Charles/AAG-1510-2020; Padilla, Norma/AFK-6645-2022; Padilla, Norma/AAG-4945-2022	Lenhart, Audrey/0000-0002-9156-4228; Wondji, Charles S./0000-0003-0791-3673	CDC's Advanced Molecular Detection (AMD) program	CDC's Advanced Molecular Detection (AMD) program	This work was funded by CDC's Advanced Molecular Detection (AMD) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio-Nkondjio C, 2008, T ROY SOC TROP MED H, V102, P352, DOI 10.1016/j.trstmh.2007.12.010; Artemov GN, 2017, G3-GENES GENOM GENET, V7, P155, DOI 10.1534/g3.116.034959; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boonsuepsakul S, 2008, ARCH INSECT BIOCHEM, V69, P13, DOI 10.1002/arch.20248; BREELAND S G, 1970, Bulletin of the World Health Organization, V43, P627; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Brogdon WG, 1999, J ECON ENTOMOL, V92, P298, DOI 10.1093/jee/92.2.298; Brogdon WG, 1999, PESTIC BIOCHEM PHYS, V64, P101, DOI 10.1006/pest.1999.2415; BROGDON WG, 1988, B WORLD HEALTH ORGAN, V66, P339; BROGDON WG, 1988, J AM MOSQUITO CONTR, V4, P152; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chareonviriyaphap T, 1997, J AM MOSQUITO CONTR, V13, P171; Chareonviriyaphap Theeraphap, 1999, Science Asia, V25, P153, DOI 10.2306/scienceasia1513-1874.1999.25.153; Coleman M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1733-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Du W, 2005, INSECT MOL BIOL, V14, P179, DOI 10.1111/j.1365-2583.2005.00544.x; Duangkaew P, 2011, ARCH INSECT BIOCHEM, V76, P236, DOI 10.1002/arch.20413; Dzul FA, 2007, SALUD PUBLICA MEXICO, V49, P302, DOI 10.1590/S0036-36342007000400010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GEORGHIOU GP, 1969, WORLD REV PEST CONTR, V8, P86; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gutierrez LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-259; Hemingway J, 1997, PESTIC SCI, V51, P375, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;375::AID-PS636&gt;3.0.CO;2-K; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Ibrahim SS, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030140; Jones CM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-343; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liebman KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0599-1; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Loaiza JR, 2010, AM J TROP MED HYG, V82, P156, DOI 10.4269/ajtmh.2010.09-0423; Lol JC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-268; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Quinones ML, 2015, AM J TROP MED HYG, V93, P69, DOI 10.4269/ajtmh.14-0844; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Riveron JM, 2017, G3-GENES GENOM GENET, V7, P1819, DOI 10.1534/g3.117.040147; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-33; Rongnoparut P, 2003, J VECTOR ECOL, V28, P150; Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Wilkins RM, 2017, PEST MANAG SCI, V73, P2403, DOI 10.1002/ps.4646; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; World Health Organization, 2012, WHO GLOB MAL PROGR G; World Health Organization, 2017, DEPRESSION; World Health Organization (WHO), 2016, WORLD MAL REP 2016, P186, DOI DOI 10.4135/9781452276151.N221; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103; Zamora Perea Elvira, 2009, Malar J, V8, P208, DOI 10.1186/1475-2875-8-208	68	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210586	10.1371/journal.pone.0210586	http://dx.doi.org/10.1371/journal.pone.0210586			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699158	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600042
J	Zhirnov, AA; Kudryashova, NN; Kudryashova, OB; Korovina, NV; Pavlenko, AA; Titov, SS				Zhirnov, Anatoliy A.; Kudryashova, Nina N.; Kudryashova, Olga B.; Korovina, Nataliya V.; Pavlenko, Anatoliy A.; Titov, Sergey S.			Spores of puffball fungus Lycoperdon pyriforme as a reference standard of stable monodisperse aerosol for calibration of optical instruments	PLOS ONE			English	Article							PARTICLE; GENERATION; EXPOSURE	Advanced air quality control requires real-time monitoring of particulate matter size and concentration, which can only be done using optical instruments. However, such techniques need regular calibration with reference samples. In this study, we suggest that puffball fungus (Lycoperdon pyriforme) spores can be utilized as a reference standard having a monodisperse size distribution. We compare the Lycoperdon pyriforme spores with the other commonly used reference samples, such as Al2O3 powder and polystyrene latex (PSL) microspheres. Here we demonstrate that the puffball spores do not coagulate and, thus, maintain the same particle size in the aerosol state for at least 15 minutes, which is enough for instrument calibration. Moreover, the puffball mushrooms can be stored for several years and no agglomeration of the spores occurs. They are also much cheaper than other calibration samples and no additional devices are needed for aerosol generation since the fungal fruiting body acts as an atomizer itself. The aforementioned features make the fungal spores a highly promising substance for calibration and validation of particle size analyzers, which outperforms the existing, artificially produced particles for aerosol sampling. Furthermore, the L. pyriforme spores are convenient for basic research and development of new optical measurement techniques, taking into account their uniform particle size and absent coagulation in the aerosol.	[Zhirnov, Anatoliy A.; Kudryashova, Olga B.; Korovina, Nataliya V.; Pavlenko, Anatoliy A.; Titov, Sergey S.] RAS, SB, Inst Problems Chem & Energet Technol, Biisk, Russia; [Kudryashova, Nina N.] Moscow Inst Phys & Technol, Life Sci Ctr, Dolgoprudny City, Russia; [Kudryashova, Olga B.] Natl Res Tomsk State Univ, Tomsk, Russia; [Kudryashova, Olga B.] RAS, SB, IPCET, Biisk 659322, Altai Krai, Russia	Institute for Problems of Chemical & Energetic Technologies of the Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; Moscow Institute of Physics & Technology; Tomsk State University; Institute for Problems of Chemical & Energetic Technologies of the Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Kudryashova, OB (corresponding author), RAS, SB, Inst Problems Chem & Energet Technol, Biisk, Russia.; Kudryashova, OB (corresponding author), Natl Res Tomsk State Univ, Tomsk, Russia.; Kudryashova, OB (corresponding author), RAS, SB, IPCET, Biisk 659322, Altai Krai, Russia.	olgakudr@inbox.ru	Жирнов, Анатолий/AAE-7113-2020; Titov, Sergey S/H-9735-2014; Pavlenko, Anatoliy/P-6462-2018; Kudryashova, Olga/AAP-8159-2020; Pavlenko, Anatoliy/H-9704-2014	Titov, Sergey S/0000-0002-5286-173X; Pavlenko, Anatoliy/0000-0002-8103-2578; Kudryashova, Olga/0000-0002-0404-8736; 	Russian Ministry of Education and Science of the Russian Federation [0385-2018-0011]	Russian Ministry of Education and Science of the Russian Federation	The work of AAZ, OBK, NVK, MP and SST was supported by the Russian Ministry of Education and Science of the Russian Federation (mon.gov.ru) grant (state task) No 0385-2018-0011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NNK received no specific funding for this work.	ATKINSON RRL, 2014, THORAX, V281, DOI DOI 10.1136/THORAXJNL-2013-204492; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; BERGLUND RN, 1973, ENVIRON SCI TECHNOL, V7, P147, DOI 10.1021/es60074a001; Chen B., 2001, AIR SAMPLING INSTRUM, P177; CHEN BT, 1984, J AEROSOL SCI, V15, P615, DOI 10.1016/0021-8502(84)90023-5; Dinoi A, 2017, MEASUREMENT, V106, P274, DOI 10.1016/j.measurement.2016.02.019; Duan HX, 2016, AEROSOL SCI TECH, V50, P17, DOI 10.1080/02786826.2015.1123213; Environmental and Industrial science Division RI, 2008, PLOS ONE; FLESCH JP, 1967, AM IND HYG ASSOC J, V28, P507, DOI 10.1080/00028896709342676; Frampton MW, 2016, DOES PARTICLE SIZE M; Gozzi F, 2016, ATMOS POLLUT RES, V7, P228, DOI 10.1016/j.apr.2015.09.007; Haas D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187039; Hinds W.C., 2011, AEROSOL MEASUREMENT, P31; Iida K, 2014, AEROSOL SCI TECH, V48, P789, DOI 10.1080/02786826.2014.930948; International Agency for Research on Cancer, 2011, IARC OUTD AIR POLL L; Jones RM, 2003, AM LAB, V35, P44; Kesavan JS, 2014, AEROSOL SCI TECH, V48, P219, DOI 10.1080/02786826.2013.868594; KLAPPER BF, 1962, APPL MICROBIOL, V10, P487, DOI 10.1128/AEM.10.6.487-491.1962; Kudryashova O., 2012, PHOTODETECTORS; LACEY J, 1988, ANN OCCUP HYG, V32, P515, DOI 10.1093/annhyg/32.4.515; Lakkireddy K, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0326-0; LAX M, 1952, PHYS REV, V85, P621, DOI 10.1103/PhysRev.85.621; LICHTENBELT JW, 1974, J COLLOID INTERF SCI, V49, P281, DOI 10.1016/0021-9797(74)90363-4; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095043, 10.1371/journal.pone.0086026]; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Mitchell J. P., 2000, KONA POWDER PART J, V18, P41, DOI DOI 10.14356/K0NA.2000010; Pope CA, 2016, CIRC RES, V119, P1204, DOI 10.1161/CIRCRESAHA.116.309279; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; ROMAYNOVAS FJ, 1988, AEROSOL SCI TECH, V9, P123; Rosati JA, 2003, AEROSOL SCI TECH, V37, P528, DOI 10.1080/02786820300974; Russian Scientific Research Institute of Metrology D I Mendeleyev (VNIIM), 2003, 1642003 VNIIM GET; Saar M, 2014, AEROBIOLOGIA, V30, P71, DOI 10.1007/s10453-013-9310-6; STAHLHOFEN W, 1975, ATMOS ENVIRON, V9, P851, DOI 10.1016/0004-6981(75)90044-X; Tayali N. E., 1990, Flow Measurement and Instrumentation, V1, P77, DOI 10.1016/0955-5986(90)90032-3; Weichel M, 2003, CLIN EXP ALLERGY, V33, P72, DOI 10.1046/j.1365-2222.2003.01574.x; WHITBY KT, 1968, ATMOS ENVIRON, V2, P103, DOI 10.1016/0004-6981(68)90026-7; Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19; Xu  R., 2001, PARTICLE CHARACTERIZ, V13	38	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210754	10.1371/journal.pone.0210754	http://dx.doi.org/10.1371/journal.pone.0210754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699153	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600052
J	Fuentes-Hurtado, F; Diego-Mas, JA; Naranjo, V; Alcaniz, M				Fuentes-Hurtado, Felix; Diego-Mas, Jose A.; Naranjo, Valery; Alcaniz, Mariano			Automatic classification of human facial features based on their appearance	PLOS ONE			English	Article							LOCAL BINARY PATTERNS; FACE RECOGNITION; DIFFERENT SHAPES; NUMERICAL SURVEY; PROPORTIONS; SOMATOTYPE; EIGENFACES; AVATARS; PARTS	Classification or typology systems used to categorize different human body parts have existed for many years. Nevertheless, there are very few taxonomies of facial features. Ergonomics, forensic anthropology, crime prevention or new human-machine interaction systems and online activities, like e-commerce, e-learning, games, dating or social networks, are fields in which classifications of facial features are useful, for example, to create digital interlocutors that optimize the interactions between human and machines. However, classifying isolated facial features is difficult for human observers. Previous works reported low inter-observer and intra-observer agreement in the evaluation of facial features. This work presents a computer-based procedure to automatically classify facial features based on their global appearance. This procedure deals with the difficulties associated with classifying features using judgements from human observers, and facilitates the development of taxonomies of facial features. Taxonomies obtained through this procedure are presented for eyes, mouths and noses.	[Fuentes-Hurtado, Felix; Diego-Mas, Jose A.; Naranjo, Valery; Alcaniz, Mariano] Univ Politecn Valencia, I3B Inst Res & Innovat Bioengn, Valencia, Spain	Universitat Politecnica de Valencia	Diego-Mas, JA (corresponding author), Univ Politecn Valencia, I3B Inst Res & Innovat Bioengn, Valencia, Spain.	jodiemas@dpi.upv.es	Diego-Mas, Jose A/F-4758-2016; Hurtado, Félix José Fuentes/AAA-8787-2021; Alcañiz, Mariano/CAG-6569-2022	Diego-Mas, Jose A/0000-0002-3698-3411; Hurtado, Félix José Fuentes/0000-0002-4320-245X; Alcañiz, Mariano/0000-0001-9207-0636; Naranjo, Valery/0000-0002-0181-3412				Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Albin-Clark A, 2009, EG UK THEORY PRACT C; Alemany S., 2010, INPR 2010 INT C 3D B, P307; [Anonymous], COMPUTER VISION; Diego-Mas JA, 2015, COMPUT HUM BEHAV, V44, P1, DOI 10.1016/j.chb.2014.11.027; Arslan SG, 2008, AESTHET PLAST SURG, V32, P234, DOI 10.1007/s00266-007-9049-y; Ashraf AB, 2009, IMAGE VISION COMPUT, V27, P1788, DOI 10.1016/j.imavis.2009.05.007; Asmann S, 2007, ANTHR ATLAS MALE FAC; Asthana A, 2014, PROC CVPR IEEE, P1859, DOI 10.1109/CVPR.2014.240; Bag S, 2008, P 2 INT C INF PROC, P198; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Boberg M., 2008, P 3 INT C DIG INT ME, P232, DOI [DOI 10.1145/1413634.1413679, 10.1145/1413634.1413679]; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruce V., 2013, FACE PERCEPTION; Buckingham G, 2006, EVOL HUM BEHAV, V27, P381, DOI 10.1016/j.evolhumbehav.2006.03.001; Carvalho PVR, 2008, DISPLAYS, V29, P273, DOI 10.1016/j.displa.2007.08.010; Chihaoui M, 2016, COMPUTERS, V5, DOI 10.3390/computers5040021; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; DAMASIO AR, 1985, TRENDS NEUROSCI, V8, P132, DOI 10.1016/0166-2236(85)90051-7; DAVIDOFF J, 1990, ACTA PSYCHOL, V73, P225, DOI 10.1016/0001-6918(90)90024-A; Davis A, 2009, J ASSOC INF SYST, V10, P90, DOI 10.17705/1jais.00183; Dharejo FA, 2017, FRONT ARTIF INTEL AP, V296, P429, DOI 10.3233/978-1-61499-785-6-429; Dizaji KG, 2017, IEEE I CONF COMP VIS, P5747, DOI 10.1109/ICCV.2017.612; Donnelly N, 1999, VIS COGN, V6, P319, DOI 10.1080/135062899395000; Doukas C, 2010, IFIP ADV INF COMM TE, V339, P295; Ester M, 1996, COMPUTER LONG BEACH, DOI 10.1.1.71.1980; Fabri M., 2005, VIRTUAL SOC AGENTS, V88, P88; Ferring V, 2008, AM J ORTHOD DENTOFAC, V134, P472, DOI 10.1016/j.ajodo.2007.03.027; Hamerly G, 2004, ADV NEURAL INF PROCE, DOI 10.1.1.9.3574; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Hochscheid H, 2015, ART MAK ANTIQ; Huang PH, 2014, INT C PATT RECOG, P1532, DOI 10.1109/ICPR.2014.272; Jee SC, 2016, INT J IND ERGONOM, V53, P10, DOI 10.1016/j.ergon.2015.10.004; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kim Namsoon, 2014, [Journal of the Korean Society of Clothing and Textiles, 한국의류학회지], V38, P305; Klare B., 2010, BIOMETRICS THEORY AP, P1, DOI [DOI 10.1109/BTAS.2010.5634533, 10.1109/btas.2010.5634533]; Koleva M, 2002, Rev Environ Health, V17, P65; Kong SG, 2005, COMPUT VIS IMAGE UND, V97, P103, DOI 10.1016/j.cviu.2004.04.001; Laurentini A, 2014, COMPUT VIS IMAGE UND, V125, P184, DOI 10.1016/j.cviu.2014.04.006; Li SZ, 2005, HDB FACE RECOGNITION, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Lin YL, 1999, ERGONOMICS, V42, P1311, DOI 10.1080/001401399184965; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Liu L, 2016, INFORM SCIENCES, V358, P56, DOI 10.1016/j.ins.2016.04.021; Ma DS, 2015, BEHAV RES METHODS, V47, P1122, DOI 10.3758/s13428-014-0532-5; Malousaris GG, 2008, J SCI MED SPORT, V11, P337, DOI 10.1016/j.jsams.2006.11.008; Mane DR, 2010, J FORENSIC LEG MED, V17, P421, DOI 10.1016/j.jflm.2010.09.001; Massidda M, 2013, COLLEGIUM ANTROPOL, V37, P853; Meyers E, 2008, INT J COMPUT VISION, V76, P93, DOI 10.1007/s11263-007-0058-8; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Nousi P, 2017, COMMUN COMPUT PHYS, DOI [10.1126/science.aal4230, DOI 10.1126/SCIENCE.AAL4230]; Ohlrogge S, 2009, ANTHR ATLAS MALE FAC; Orvalho V, 2009, STUD HEALTH TECHNOL, V144, P96, DOI 10.3233/978-1-60750-017-9-96; Porter J P, 2001, Arch Facial Plast Surg, V3, P191; PRESTON TA, 1972, ERGONOMICS, V15, P693, DOI 10.1080/00140137208924469; Rhodes G, 2009, BRIT J PSYCHOL, V100, P717, DOI 10.1348/000712608X396503; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Ritz-Timme S, 2011, FORENSIC SCI INT, V207, p239E1, DOI 10.1016/j.forsciint.2011.01.035; Ritz-Timme S, 2011, INT J LEGAL MED, V125, P301, DOI 10.1007/s00414-010-0446-4; Robins G, 1984, GOETTINGER MISZELLEN, P31; Rojas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023323; Sarakon P, 2014, 7 2014 BIOM ENG INT, P1, DOI DOI 10.1109/BMEICON.2014.7017382; Scharff A, 2011, PSYCHON B REV, V18, P713, DOI 10.3758/s13423-011-0101-1; Sheldon W, 1970, ATLAS MEN GUIDE SOMA; Shyam R, 2015, PROCEDIA COMPUT SCI, V48, P666, DOI 10.1016/j.procs.2015.04.150; Siregar STM, 2018, IOP CONF SER-MAT SCI, V308, DOI 10.1088/1757-899X/308/1/012013; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; Sukhija P, 2016, PROCEDIA COMPUT SCI, V85, P410, DOI 10.1016/j.procs.2016.05.183; Sustersic T, 2018, LECT NOTES I COMPUT, DOI [10.1007/978-3-319-74935-8_13, DOI 10.1007/978-3-319-74935-8_13]; Tamir A, 2013, J CRANIOFAC SURG, V24, P1657, DOI 10.1097/SCS.0b013e3182942b77; Tamir A, 2011, J CRANIOFAC SURG, V22, P1104, DOI 10.1097/SCS.0b013e3182108eb3; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Taubert J, 2011, VISION RES, V51, P1273, DOI 10.1016/j.visres.2011.04.002; Tavares G, 2016, COMPUT VIS IMAGE UND, V147, P102, DOI 10.1016/j.cviu.2016.02.001; Todorov A, 2011, SOCIAL NEUROSCIENCE, DOI [10.1093/acprof:oso/9780195316872.003.0004, DOI 10.1093/ACPROF:OSO/9780195316872.003.0004]; Trescak Tomas, 2012, P 18 ACM S VIRT REAL, P1, DOI [10.1145/2407336.2407338, DOI 10.1145/2407336.2407338]; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vanezis P, 1996, J FORENSIC SCI, V41, P786; Vinue G, 2015, COMPUT STAT DATA AN, V87, P102, DOI 10.1016/j.csda.2015.01.018; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Wu J, 2013, MEAS SCI REV, V13, P122, DOI 10.2478/msr-2013-0021; Xie JY, 2016, PR MACH LEARN RES, V48; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x	83	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211314	10.1371/journal.pone.0211314	http://dx.doi.org/10.1371/journal.pone.0211314			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695076	gold, Green Submitted, Green Published			2022-12-26	WOS:000457046400024
J	Ishikawa, T; Yokoyama, H; Matsuura, T; Fujiwara, Y				Ishikawa, Tomoko; Yokoyama, Hiroshi; Matsuura, Tomokazu; Fujiwara, Yoko			Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease	PLOS ONE			English	Article							NATIONAL-HEALTH; FIBROSIS; RECEPTOR; HYALURONAN; NAFLD; STEATOHEPATITIS; INFLAMMATION; PLATELETS; CIRRHOSIS	Liver sinusoidal endothelial cells (LSECs) play a pivotal role in hepatic function and homeostasis. LSEC dysfunction has been recognized to be closely involved in various liver diseases, including non-alcoholic steatohepatitis (NASH), but not much is known about the fate of the scavenger receptors in LSECs during NASH. Fc gamma receptor IIb (Fc gamma RIIb), known as a scavenger receptor, contributes to receptor-mediated endocytosis and immune complexes clearance. In this study, to elucidate the fate of Fc gamma RIIb in the progression of non-alcoholic fatty liver disease (NAFLD), we examined Fc gamma RIIb levels in NAFLD biopsy specimens by immunohistochemistry, and investigated their correlation with the exacerbation of biological indexes and clinicopathological scores of NASH. The Fc gamma RIIb expression levels indicated significant negative correlations with serum levels of blood lipids (triglyceride, total cholesterol, high-density lipoprotein-cholesterol), type 4 collagen and hyaluronic acid, which are involved in hepatic lipid metabolism disorder, fibrosis, and inflammation, respectively. However, there was no significant difference of Fc gamma RIIb expression levels among the pathological grades of NAFLD. During NAFLD progression, inflammation and fibrosis may influence the expression of Fc gamma RIIb and their scavenger functions to maintain hepatic homeostasis.	[Ishikawa, Tomoko; Fujiwara, Yoko] Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan; [Yokoyama, Hiroshi] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Minato Ku, Tokyo, Japan; [Yokoyama, Hiroshi; Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan; [Fujiwara, Yoko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan	Ochanomizu University; Jikei University; Jikei University; Ochanomizu University	Fujiwara, Y (corresponding author), Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan.; Fujiwara, Y (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan.	fujiwara.yoko@ocha.ac.jp		Yokoyama, Hiroshi/0000-0003-4559-030X	Japan Society for the Promotion of Science [15K00810]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grant Number: 15K00810 (https./www.jsps.go.jp/english/index.html) to TI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan A, 2016, HEPATOLOGY, V64, P1774, DOI 10.1002/hep.28526; Colak Y, 2011, HEPATO-GASTROENTEROL, V58, P2087, DOI 10.5754/hge11248; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Duan XY, 2014, CANCER LETT, V345, P230, DOI 10.1016/j.canlet.2013.07.033; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Ganesan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20646; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Geraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Kabbany MN, 2017, AM J GASTROENTEROL, V112, P581, DOI 10.1038/ajg.2017.5; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018; Maslak E, 2015, PHARMACOL REP, V67, P689, DOI 10.1016/j.pharep.2015.04.010; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Ni Y, 2017, WORLD J GASTROENTERO, V23, P7666, DOI 10.3748/wjg.v23.i43.7666; Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Plevris JN, 2000, EUR J GASTROEN HEPAT, V12, P1121, DOI 10.1097/00042737-200012100-00009; Plevris N, 2018, ALIMENT PHARM THER, V48, P423, DOI 10.1111/apt.14897; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; PrabhuDas M, 2014, J IMMUNOL, V192, P1997, DOI 10.4049/jimmunol.1490003; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; SHECHTER I, 1981, J LIPID RES, V22, P63; Smedsrod B, 2009, LIVER INT, V29, P490, DOI 10.1111/j.1478-3231.2009.01979.x; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Stickel F, 2003, EUR J GASTROEN HEPAT, V15, P945, DOI 10.1097/00042737-200309000-00002; Strauss O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44356; Sun Y, 2014, HEPATOL INT, V8, P567, DOI 10.1007/s12072-014-9568-y; Tanigaki K, 2015, CIRC RES, V116, P368, DOI 10.1161/CIRCRESAHA.116.302795; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vilar-Gomez E, 2017, LIVER INT, V37, P1887, DOI 10.1111/liv.13480; Wong RJ, 2017, ALIMENT PHARM THER, V46, P974, DOI 10.1111/apt.14327; Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017; Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6; Xu MX, 2017, BIOSCI TRENDS, V11, P163, DOI 10.5582/bst.2017.01007	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211543	10.1371/journal.pone.0211543	http://dx.doi.org/10.1371/journal.pone.0211543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695042	gold, Green Published, Green Submitted			2022-12-26	WOS:000457046400043
J	Varbanov, HP; Kuttler, F; Banfi, D; Turcatti, G; Dyson, PJ				Varbanov, Hristo P.; Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo; Dyson, Paul J.			Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis	PLOS ONE			English	Article							IN-VITRO; DRUG; CISPLATIN; SPIRONOLACTONE; VORINOSTAT; AURANOFIN; COMPLEXES; RESPONSES; SYNERGY	Drug combinations are extensively used to treat cancer and are often selected according to complementary mechanisms. Here, we describe a cell-based high-throughput screening assay for identification of synergistic combinations between broadly applied platinum-based chemotherapeutics and drugs from a library composed of 1280 chemically and pharmacologically diverse (mostly FDA approved) compounds. The assay was performed on chemoresistant cell lines derived from lung (A549) and pancreatic (PANC-1) carcinoma, where platinum-based combination regimens are currently applied though with limited success. The synergistic combinations identified during the screening were validated by synergy quantification using the combination index method and via high content fluorescent microscopy analysis. New promising synergistic combinations discovered using this approach include compounds currently not used as anticancer drugs, such as cisplatin or carboplatin with hycanthone and cisplatin with spironolactone in pancreatic carcinoma, and carboplatin and deferoxamine in non-small cell lung cancer. Strong synergy between cisplatin or carboplatin and topotecan in PANC-1 cells, compared to A549 cells, suggests that this combination, currently used in lung cancer treatment regimens, could be applied to pancreatic carcinoma as well. Several drugs used to treat diseases other than cancer, including pyrvinium pamoate, auranofin, terfenadine and haloprogin, showed strong cytotoxicity on their own and synergistic interactions with platinum drugs. This study demonstrates that non-obvious drug combinations that would not be selected based on complementary mechanisms can be identified via high-throughput screening.	[Varbanov, Hristo P.; Dyson, Paul J.] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland; [Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo] Ecole Polytech Fed Lausanne, Biomol Screening Facil, Lausanne, Switzerland; [Varbanov, Hristo P.] Karl Franzens Univ Graz, Inst Chem, Graz, Austria	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Graz	Varbanov, HP; Dyson, PJ (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland.; Varbanov, HP (corresponding author), Karl Franzens Univ Graz, Inst Chem, Graz, Austria.	hristo.varbanov@univie.ac.at; paul.dyson@epfl.ch	Varbanov, Hristo P./O-3973-2017; Dyson, Paul/AAB-9075-2019	Varbanov, Hristo P./0000-0003-4450-7332; Dyson, Paul/0000-0003-3117-3249; Kuttler, Fabien/0000-0003-2575-1989	Austrian Science Fund (FWF) [J3577-B13]; BSF-ACCESS screening platform at the EPFL	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); BSF-ACCESS screening platform at the EPFL	H.V. is indebted to the Austrian Science Fund (FWF) for the financial support (Schrodinger fellowship, Project number: J3577-B13). We acknowledge the Swiss National Center for Competence (NCCR) in Chemical Biology for providing access to the chemical libraries and screening facilities.; We acknowledge the BSF-ACCESS screening platform at the EPFL for support, in particular we are thankful to Julien Bortoli Chapalay for dispensing the PCL with the Echo acoustic liquid handler and to Antoine Gibelin for the quality control with LC-MS.	Adhireksan Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14860; Alekseev S, 2014, CHEM BIOL, V21, P398, DOI 10.1016/j.chembiol.2013.12.014; Apps MG, 2015, ENDOCR-RELAT CANCER, V22, pR219, DOI 10.1530/ERC-15-0237; Armstrong-Gordon E, 2018, J CANCER RES CLIN, V144, P1561, DOI 10.1007/s00432-018-2669-6; Bar J, 2016, NEOPLASIA, V18, P525, DOI 10.1016/j.neo.2016.07.004; Barnard C, 2017, JOHNSON MATTHEY TECH, V61, P52, DOI 10.1595/205651317X693624; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Bray F, GLOBOCAN 2012 V1 0; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan E, 2016, RADIOTHER ONCOL, V119, P312, DOI 10.1016/j.radonc.2016.04.013; Cheff DM, 2017, J MED CHEM, V60, P4517, DOI 10.1021/acs.jmedchem.6b01351; Chou T.-C., 2007, COMPUSYN SOFTWARE DR; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cosaert J, 2002, BRIT J CANCER, V87, P825, DOI 10.1038/sj.bjc.6600540; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Greco WR, 1996, J NATL CANCER I, V88, P699, DOI 10.1093/jnci/88.11.699; Hall MD, 2014, CANCER RES, V74, P3913, DOI 10.1158/0008-5472.CAN-14-0247; Herdrich K, 2010, SELECTED SCHEDULES T; Jaramillo ML, 2008, CANCER BIOL THER, V7, P557, DOI 10.4161/cbt.7.4.5533; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klauber N, 1996, CIRCULATION, V94, P2566, DOI 10.1161/01.CIR.94.10.2566; Michaelis M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08202; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Muggia FM, 2015, J CLIN ONCOL, V33, P4219, DOI 10.1200/JCO.2015.60.7481; National Cancer Institute, UND CANC; Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a; Nygren P, 2013, J CANCER RES CLIN, V139, P2133, DOI 10.1007/s00432-013-1539-5; O'Brien A, 2012, ANTICANCER RES, V32, P2679; Oun R, 2018, DALTON T, V47, P6645, DOI 10.1039/c8dt00838h; OuYang PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079000; Pan CH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2888-7; Petersen GH, 2016, J CONTROL RELEASE, V232, P255, DOI 10.1016/j.jconrel.2016.04.028; Pongrakhananon V, 2013, INTECH, P65, DOI [10.5772/55381, DOI 10.5772/55381]; Price P, 2008, TREATMENT OF CANC; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Shahar OD, 2014, NUCLEIC ACIDS RES, V42, P5689, DOI 10.1093/nar/gku217; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Sun YC, 2018, INT J ONCOL, V53, P1237, DOI 10.3892/ijo.2018.4447; Sweetman S.C, 2009, MARTINDALE COMPLETE; Taher MA, 2013, INT J SCI NAT, V4, P683; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; Varbanov HP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171052; Varghese E, 2014, CANCERS, V6, P2243, DOI 10.3390/cancers6042243; Webb JL, 1961, ENZYMES METABOL INH, V1, P66; Weinberg BA, 2015, ONCOLOGY-NY, V29, P809; Wermuth CG, 2004, J MED CHEM, V47, P1303, DOI 10.1021/jm030480f; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; WHO, CANC KEY FACTS; Yi YW, 2011, DNA REPAIR, V10, P1084, DOI 10.1016/j.dnarep.2011.09.008; Yosifov DY, 2011, CANCER CHEMOTH PHARM, V67, P13, DOI 10.1007/s00280-010-1273-5; Schneider NFZ, 2017, MOLECULES, V22, DOI 10.3390/molecules22111932; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	61	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211268	10.1371/journal.pone.0211268	http://dx.doi.org/10.1371/journal.pone.0211268			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695050	gold, Green Published, Green Submitted			2022-12-26	WOS:000457046400022
J	Cano-Rocabayera, O; de Sostoa, A; Padros, F; Cardenas, L; Maceda-Veiga, A				Cano-Rocabayera, Oriol; de Sostoa, Adolfo; Padros, Francesc; Cardenas, Lorena; Maceda-Veiga, Alberto			Ecologically relevant biomarkers reveal that chronic effects of nitrate depend on sex and life stage in the invasive fish Gambusia holbrooki	PLOS ONE			English	Article							FRESH-WATER; WESTERN MOSQUITOFISH; OXYGEN-CONSUMPTION; STABLE-ISOTOPES; TOXICITY; NITRITE; NITROGEN; EXPOSURE; EUTROPHICATION; POPULATION	Agricultural intensification and shifts in precipitation regimes due to global climate change are expected to increase nutrient concentrations in aquatic ecosystems. However, the direct effects of nutrients widely present in wastewaters, such as nitrate, are poorly studied. Here, we use multiple indicators of fish health to experimentally test the effects of three ecologically relevant nitrate concentrations (<10, 50 and 250 mg NO3-/l) on wild-collected mosquitofish (Gambusia holbrooki), a species widely introduced for mosquito biocontrol in often eutrophic waters. Overall, biomarkers (histopathology, feeding assays, growth and caloric content and stable isotopes as indicators of energy content) did not detect overt signs of serious disease in juveniles, males or females of mosquitofish. However, males reduced food intake at the highest nitrate concentration compared to the controls and females. Similarly, juveniles reduced energy reserves without significant changes in growth or food intake. Calorimetry was positively associated with the number of perivisceral fat cells in juveniles, and the growth rate of females was negatively associated with delta N-15 signature in muscle. This study shows that females are more tolerant to nitrate than males and juveniles and illustrates the advantages of combing short- and long-term biomarkers in environmental risk assessment, including when testing for the adequacy of legal thresholds for pollutants.	[Cano-Rocabayera, Oriol; de Sostoa, Adolfo; Cardenas, Lorena; Maceda-Veiga, Alberto] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Inst Res Biodivers IRBio UB, Barcelona, Spain; [Padros, Francesc] Univ Autonoma Barcelona, Servei Diagnost Patol Peixos, Fac Vet, Bellaterra, Spain	University of Barcelona; Autonomous University of Barcelona	Cano-Rocabayera, O (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Inst Res Biodivers IRBio UB, Barcelona, Spain.	canorocabayera@gmail.com	Rocabayera, Oriol Cano/AAI-1851-2019; Maceda-Veiga, Alberto/F-1185-2010	Rocabayera, Oriol Cano/0000-0002-7290-4485; Maceda-Veiga, Alberto/0000-0002-1736-4631	Fundacio Barcelona Zoo [3RB 057]; University of Barcelona (APIF)	Fundacio Barcelona Zoo; University of Barcelona (APIF)	This work was finacially supported by Fundacio Barcelona Zoo (PRIC grant 3RB 057 for labware and analysis costs). OCR received a grant by the University of Barcelona (APIF) during the period 2015-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin S, 2003, TEX J SCI, V55, P255; [Anonymous], 2011, FISH DIS DIAGNOSIS T; Baker JA, 2017, CHEMOSPHERE, V168, P435, DOI 10.1016/j.chemosphere.2016.10.059; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bernier NJ, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P238, DOI 10.1079/9781845935535.0238; Bouraoui F., 2009, JOINT RES CTR SCI TE, VEUR 24002, DOI DOI 10.2788/38971; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Cano-Rocabayera O, 2015, ENVIRON BIOL FISH, V98, P925, DOI 10.1007/s10641-014-0328-6; Catalana de l'Aigua, 2014, INT APPL; CHRISTIANSEN JS, 1991, J EXP ZOOL, V260, P149, DOI 10.1002/jez.1402600203; Colin N, 2016, SCI TOTAL ENVIRON, V540, P307, DOI 10.1016/j.scitotenv.2015.06.099; Coutellec MA, 2011, ECOTOXICOLOGY, V20, P493, DOI 10.1007/s10646-011-0637-x; CRAUN GF, 1981, INT J EPIDEMIOL, V10, P309, DOI 10.1093/ije/10.4.309; Durfort M, 2006, INICIACIO A LES VEGE; Eddy FB, 1987, NITRITE FRESHWATER F, V3, P1, DOI DOI 10.1080/02757548708070832; Edwards TM, 2007, AQUAT TOXICOL, V85, P40, DOI 10.1016/j.aquatox.2007.07.014; Edwards TM, 2018, GEN COMP ENDOCR, V265, P31, DOI 10.1016/j.ygcen.2018.03.021; Ferard J. F., 2013, ENCY AQUATIC ECOTOXI; Field KL, 2004, ANIM BEHAV, V68, P1381, DOI 10.1016/j.anbehav.2003.12.022; Fields S, 2004, ENVIRON HEALTH PERSP, V112, pA556, DOI 10.1289/ehp.112-a556; Focken U, 1998, OECOLOGIA, V115, P337, DOI 10.1007/s004420050525; Fox J., 2019, R COMPANION APPL REG, V.; Freitag AR, 2015, AQUACULTURE, V436, P8, DOI 10.1016/j.aquaculture.2014.10.041; Fryxell DC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1970; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gaye-Siessegger J, 2004, OECOLOGIA, V138, P175, DOI 10.1007/s00442-003-1429-7; Grup de Defensa del Ter, 2018, NITR CONC SPRINGS OS; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; HALLER J, 1995, NEUROSCI BIOBEHAV R, V19, P599, DOI 10.1016/0149-7634(95)00053-4; Hamlin HJ, 2008, AQUACULTURE, V281, P118, DOI 10.1016/j.aquaculture.2008.05.030; Hamlin HJ, 2006, AQUACULTURE, V253, P688, DOI 10.1016/j.aquaculture.2005.08.025; HAYNES JL, 1995, J FISH BIOL, V46, P1026, DOI 10.1111/j.1095-8649.1995.tb01407.x; Honda H., 1993, AQUAC SCI, V41, P19; Hopkins Kevin D., 1992, Journal of the World Aquaculture Society, V23, P173, DOI 10.1111/j.1749-7345.1992.tb00766.x; Hord NG, 2017, FASEB J, V31; Hrubec T., 1996, P AQUACULT ENG SOC, V1, P41; JENSEN FB, 1990, J EXP BIOL, V152, P149; Jensen FB, 1995, NITROGEN METABOLISM, P289; Johansson M, 2001, AQUAT TOXICOL, V54, P1, DOI 10.1016/S0166-445X(00)00182-X; Kestemont P, 2000, FOOD INTAKE IN FISH, P131; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kolkwitz R., 1909, INT REV GES HYDROBIO, V2, P126, DOI DOI 10.1002/IROH.19090020108; LAHTI E, 1985, COMP BIOCHEM PHYS A, V80, P337, DOI 10.1016/0300-9629(85)90047-7; Lall SP, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P202, DOI 10.1079/9781845935535.0202; Lee D. R., 2001, Tradeoffs or synergies? Agricultural intensification, economic development and the environment, DOI 10.1079/9780851994352.0000; Maceda-Veiga A, 2017, SCI TOTAL ENVIRON, V574, P455, DOI 10.1016/j.scitotenv.2016.09.097; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Margalef R, 1983, LIMNOLOGIA; Martin BT, 2017, J ANIM ECOL, V86, P812, DOI 10.1111/1365-2656.12667; MCKIM JM, 1977, J FISH RES BOARD CAN, V34, P1148, DOI 10.1139/f77-172; Moore AP, 2018, ENVIRON POLLUT, V242, P807, DOI 10.1016/j.envpol.2018.07.047; NAKAZAWA T, 1985, JNCI-J NATL CANCER I, V75, P567; Nordlie FG, 1996, J FISH BIOL, V49, P1226; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Panesar NS, 2000, TOXICOL APPL PHARM, V169, P222, DOI 10.1006/taap.2000.9079; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pereira A, 2017, AQUACULTURE, V473, P197, DOI 10.1016/j.aquaculture.2017.02.018; Perkins EJ, 1997, AQUAT TOXICOL, V37, P327, DOI 10.1016/S0166-445X(96)00825-9; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulsen R, 2018, ENVIRON SCI TECHNOL, V52, P3869, DOI 10.1021/acs.est.7b06419; PUCKETT LJ, 1995, ENVIRON SCI TECHNOL, V29, pA408, DOI 10.1021/es00009a001; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; R Core Team, 2018, R LANG ENV STAT COMP; Rodriguez-Estival J, 2010, ENVIRON RES, V110, P469, DOI 10.1016/j.envres.2010.03.008; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Scott G, 2000, ENVIRON TOXICOL CHEM, V19, P2918, DOI [10.1897/1551-5028(2000)019&lt;2918:AACTON&gt;2.0.CO;2, 10.1002/etc.5620191211]; Secondi J, 2013, BEHAV ECOL SOCIOBIOL, V67, P1757, DOI 10.1007/s00265-013-1583-9; Shimura R, 2002, ADV SPACE RES, V30, P803, DOI 10.1016/S0273-1177(02)00399-X; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Smallbone W, 2016, ENVIRON INT, V91, P265, DOI 10.1016/j.envint.2016.03.008; Smith CC, 2006, ANIM BEHAV, V71, P401, DOI 10.1016/j.anbehav.2005.06.003; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Stephenson JF, 2016, ECOL EVOL, V6, P2506, DOI 10.1002/ece3.2049; Stormer J, 1996, CAN J FISH AQUAT SCI, V53, P1943, DOI 10.1139/cjfas-53-9-1943; THURSTON RV, 1981, ENVIRON SCI TECHNOL, V15, P837, DOI 10.1021/es00089a012; U.S. Congress, 1974, 93 C, P93; Vargas MJ, 1996, HYDROBIOLOGIA, V341, P215, DOI 10.1007/BF00014686; Wallace P. D, 1977, Fisheries Res. tech. Rep., VNo. 35, P1; WHO, 2006, GUID DRINK WAT QUAL, V1; Wolf JC, 2015, TOXICOL PATHOL, V43, P297, DOI 10.1177/0192623314540229; Zuur Alain F., 2009, P1	83	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211389	10.1371/journal.pone.0211389	http://dx.doi.org/10.1371/journal.pone.0211389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689670	Green Submitted, Green Published, gold			2022-12-26	WOS:000457041800034
J	Fonseca, DA; Antunes, PE; Antunes, MJ; Cotrim, MD				Fonseca, Diogo A.; Antunes, Pedro E.; Antunes, Manuel J.; Cotrim, Maria Dulce			Histomorphometric analysis of the human internal thoracic artery and relationship with cardiovascular risk factors	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; MAMMARY ARTERY; MYOCARDIAL-INFARCTION; CAROTID WALL; ATHEROSCLEROSIS; STROKE; BYPASS; GENDER; SEX; AGE	In this study, we aimed at performing a histomorphometric analysis of human left internal thoracic artery (ITA) samples as well as at correlating the histomorphometric findings with the clinical profile, including risk factors and medication. Distal segments of ITA were obtained from 54 patients undergoing coronary artery bypass grafting. Histological observation was performed in paraffin-embedded transverse sections of ITA through four staining protocols: hematoxylin-eosin, van Gieson, Masson's trichrome and von Kossa. Morphometric analysis included the intimal width (IW), medial width (MW) and intima/media ratio (IMR). No overt atherosclerotic lesions were observed. Mild calcifications were observed across the vascular wall layers in almost all samples. Multivariable linear regression analysis showed associations between IW and IMR and the following clinical variables: age, gender, kidney function expressed as eGFR and myocardial infarction history. Age (odds ratio = 1.16, P = 0.004), female gender (odds ratio = 11.34, P = 0.011), eGFR (odds ratio = 1.03, P = 0.059) and myocardial infarction history (odds ratio = 4.81, P = 0.040) were identified as the main clinical predictors for intimal hyperplasia. Preatherosclerotic lesions in ITA samples from patients undergoing coronary revascularization were associated not only with classical cardiovascular risk factors such as age and gender, but also with other clinical variables, namely kidney function and myocardial infarction history.	[Fonseca, Diogo A.; Cotrim, Maria Dulce] Univ Coimbra, Fac Pharm, Lab Pharmacol & Pharmaceut Care, Coimbra, Portugal; [Fonseca, Diogo A.; Cotrim, Maria Dulce] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal; [Antunes, Pedro E.; Antunes, Manuel J.] Univ Hosp, Ctr Cardiothorac Surg, Coimbra, Portugal; [Antunes, Pedro E.; Antunes, Manuel J.] Fac Med Coimbra, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Fonseca, DA (corresponding author), Univ Coimbra, Fac Pharm, Lab Pharmacol & Pharmaceut Care, Coimbra, Portugal.; Fonseca, DA (corresponding author), Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal.	diogo.fonseca@ff.uc.pt	Fonseca, Diogo A./AAH-5903-2020; Antunes, Pedro E/E-8968-2013; Antunes, Pedro Engrácia/AAH-9646-2020	Fonseca, Diogo A./0000-0002-8244-139X; Antunes, Pedro E/0000-0002-6607-6978; Antunes, Pedro Engrácia/0000-0002-6607-6978				Bakuy V, 2014, ANN THORAC SURG, V97, P851, DOI 10.1016/j.athoracsur.2013.09.102; Borovic ML, 2013, HISTOL HISTOPATHOL, V28, P1299, DOI 10.14670/HH-28.1299; Borovic ML, 2010, HISTOL HISTOPATHOL, V25, P561, DOI 10.14670/HH-25.561; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Cizek SM, 2007, CARDIOVASC PATHOL, V16, P344, DOI 10.1016/j.carpath.2007.05.007; DIGNAN RJ, 1992, ANN THORAC SURG, V53, P792, DOI 10.1016/0003-4975(92)91438-F; Fonseca DA, 2017, CARDIOVASC TOXICOL, V17, P405, DOI 10.1007/s12012-017-9398-y; Fonseca DA, 2017, CORONARY ARTERY DIS, V28, P518, DOI 10.1097/MCA.0000000000000527; Fonseca DA, 2014, CORONARY ARTERY DIS, V25, P266, DOI 10.1097/MCA.0000000000000097; Grunkemeier GL, 2001, ANN THORAC SURG, V72, P323, DOI 10.1016/S0003-4975(01)02870-3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Iwamoto Y, 2012, ARTERIOSCL THROM VAS, V32, P2295, DOI 10.1161/ATVBAHA.112.249680; Kaufer E, 1997, ANN THORAC SURG, V63, P1118, DOI 10.1016/S0003-4975(96)01393-8; KAY HR, 1976, ANN THORAC SURG, V21, P504, DOI 10.1016/S0003-4975(10)63917-3; Kinoshita T, 2017, J THORAC CARDIOV SUR, V153, P317, DOI 10.1016/j.jtcvs.2016.09.037; Kinoshita T, 2014, EUR J CARDIO-THORAC, V45, P726, DOI 10.1093/ejcts/ezt430; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mannacio V, 2012, ANN THORAC SURG, V94, P1934, DOI 10.1016/j.athoracsur.2012.06.040; Muir AD, 2010, OXID MED CELL LONGEV, V3, P199, DOI 10.4161/oxim.3.3.11757; Nakajima T, 2016, J THORAC CARDIOV SUR, V151, P1704, DOI 10.1016/j.jtcvs.2016.02.018; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLeary DH, 1996, STROKE, V27, P224, DOI 10.1161/01.STR.27.2.224; Omar RZ, 2004, ANN THORAC SURG, V77, P2232, DOI 10.1016/j.athoracsur.2003.10.032; Otsuka F, 2013, ANN CARDIOTHORAC SUR, V2, P519, DOI 10.3978/j.issn.2225-319X.2013.07.06; Ozkan S, 2007, J CARDIAC SURG, V22, P385, DOI 10.1111/j.1540-8191.2007.00431.x; Perrotta I, 2014, ULTRASTRUCT PATHOL, V38, P199, DOI 10.3109/01913123.2013.868568; Qureshi AR, 2015, KIDNEY INT, V88, P1356, DOI 10.1038/ki.2015.194; Reddy S, 2011, CLINICS, V66, P131, DOI 10.1590/S1807-59322011000100023; Ruengsakulrach P, 1999, CIRCULATION, V100, P139; Sahar G, 2015, J THORAC CARDIOV SUR, V149, P1042, DOI 10.1016/j.jtcvs.2014.12.028; Selvin E, 2010, ATHEROSCLEROSIS, V208, P69, DOI 10.1016/j.atherosclerosis.2009.06.025; SISTO T, 1989, ANN THORAC SURG, V47, P884, DOI 10.1016/0003-4975(89)90027-1; Zulli A, 2003, ARTERIOSCL THROM VAS, V23, P1308, DOI 10.1161/01.ATV.0000078902.50489.9B	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211421	10.1371/journal.pone.0211421	http://dx.doi.org/10.1371/journal.pone.0211421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682154	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500168
J	Muench, D; Rezzoug, F; Thomas, SD; Xiao, JJ; Islam, A; Miller, DM; Sedoris, KC				Muench, David; Rezzoug, Francine; Thomas, Shelia D.; Xiao, Jingjing; Islam, Ashraful; Miller, Donald M.; Sedoris, Kara C.			Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells	PLOS ONE			English	Article							G-RICH OLIGONUCLEOTIDES; PROXIMAL PROMOTER; ANTIPROLIFERATIVE ACTIVITY; GENE-TRANSCRIPTION; NUCLEIC-ACIDS; A549 CELLS; DNA; ANGIOGENESIS; EXPRESSION; AUTOPHAGY	Background Vascular endothelial growth factor (VEGF) is commonly overexpressed in a variety of tumor types including lung cancer. As a key regulator of angiogenesis, it promotes tumor survival, growth, and metastasis through the activation of the downstream protein kinase B (AKT) and extracellular signal-regulated kinase (ERK 1/2) activation. The VEGF promoter contains a 36 bp guanine-rich sequence (VEGFq) which is capable of forming quadruplex (fourstranded) DNA. This sequence has been implicated in the down-regulation of both basal and inducible VEGF expression and represents an ideal target for inhibition of VEGF expression. Results Our experiments demonstrate sequence-specific interaction between a G-rich quadruplexforming oligonucleotide encoding a portion of the VEGFq sequence and its double stranded target sequence, suggesting that this G-rich oligonucleotide binds specifically to its complementary C-rich sequence in the genomic VEGF promoter by strand invasion. We show that treatment of A549 non-small lung cancer cells (NSCLC) with this oligonucleotide results in decreased VEGF expression and growth inhibition. The VEGFq oligonucleotide inhibits proliferation and invasion by decreasing VEGF mRNA/protein expression and subsequent ERK 1/2 and AKT activation. Furthermore, the VEGFq oligonucleotide is abundantly taken into cells, localized in the cytoplasm/nucleus, inherently stable in serum and intracellularly, and has no effect on non-transformed cells. Suppression of VEGF expression induces cytoplasmic accumulation of autophagic vacuoles and increased expression of LC3B, suggesting that VEGFq may induce autophagic cell death. Conclusion Our data strongly suggest that the G-rich VEGFq oligonucleotide binds specifically to the Crich strand of the genomic VEGF promoter, via strand invasion, stabilizing the quadruplex structure formed by the genomic G-rich sequence, resulting in transcriptional inhibition. Strand invading oligonucleotides represent a new approach to specifically inhibit VEGF expression that avoids many of the problems which have plagued the therapeutic use of oligonucleotides. This is a novel approach to specific inhibition of gene expression.	[Muench, David] Univ Cincinnati, Dept Immunobiol, Cincinnati, OH USA; [Rezzoug, Francine; Thomas, Shelia D.; Xiao, Jingjing; Miller, Donald M.] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Islam, Ashraful] Univ Tabuk, Fac Med, Tabuk, Saudi Arabia; [Sedoris, Kara C.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA	University System of Ohio; University of Cincinnati; University of Louisville; University of Tabuk; University of Louisville	Miller, DM (corresponding author), Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	donaldmi@ulh.org	Islam, Ashraful/GYR-1579-2022	Islam, Ashraful/0000-0002-1742-6804; Muench, David E./0000-0002-8723-3389	National Institutes of Health [P30GM106396, 1R21CA191663-01A1]; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [R21CA191663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health, grant #: P30GM106396, grant #: 1R21CA191663-01A1, URL: https://www.nih.gov; Helmsley Charitable Trust, grant #: N/A, URL: https://helmsleytrust.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2011, BIOL PHARM BULL, V34, P1264, DOI 10.1248/bpb.34.1264; Adjei AA, 2005, CLIN LUNG CANCER, V7, P221, DOI 10.3816/CLC.2005.n.040; [Anonymous], 2006, CURR PROB CANCER, V30, P7, DOI 10.1016/j.currproblcancer.2005.11.001; Barr MP, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0310-8; Bates Paula J., 2009, V542, P379, DOI 10.1007/978-1-59745-561-9_21; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bikfalvi A, 2002, TRENDS PHARMACOL SCI, V23, P576, DOI 10.1016/S0165-6147(02)02109-0; Blancher C, 2000, CANCER RES, V60, P7106; Brognard J, 2002, CELL DEATH DIFFER, V9, P893, DOI 10.1038/sj.cdd.4401054; Chaires JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115580; Chen ZQ, 1997, CANCER RES, V57, P2013; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; Fontanini G, 2002, BRIT J CANCER, V86, P558, DOI 10.1038/sj.bjc.6600130; Forsha SJ, 2010, OLIGONUCLEOTIDES, V20, P277, DOI 10.1089/oli.2010.0255; Geny S, 2016, NUCLEIC ACIDS RES, V44, P2007, DOI 10.1093/nar/gkw021; Han H, 2001, ANN SURG ONCOL, V8, P72, DOI 10.1245/aso.2001.8.1.72; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; He R, 2003, CANCER GENE THER, V10, P879, DOI 10.1038/sj.cgt.7700645; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Herbst RS, 2005, J CLIN ONCOL, V23, P3243, DOI 10.1200/JCO.2005.18.853; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu PP, 2013, J CANCER RES CLIN, V139, P1157, DOI 10.1007/s00432-013-1425-1; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Islam MA, 2014, J BIOL CHEM, V289, P8521, DOI 10.1074/jbc.M113.505073; Jaboin JJ, 2009, METHOD ENZYMOL, V453, P287, DOI 10.1016/S0076-6879(08)04014-7; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Komi Y, 2010, LAB INVEST, V90, P52, DOI 10.1038/labinvest.2009.110; Kormuth KA, 2016, BIOCHEMISTRY-US, V55, P1749, DOI 10.1021/acs.biochem.6b00026; Ku MJ, 2013, BIOORG MED CHEM LETT, V23, P5609, DOI 10.1016/j.bmcl.2013.08.043; Lee YC, 2010, EUR J PHARMACOL, V632, P23, DOI 10.1016/j.ejphar.2010.01.009; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; MARTINYBARON G, 1995, CURR OPIN BIOTECH, V6, P675, DOI 10.1016/0958-1669(95)80111-1; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Murphy CT, 2014, BIOCHEMISTRY-US, V53, P5315, DOI 10.1021/bi5006859; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Oyaghire SN, 2016, BIOCHEMISTRY-US, V55, P1977, DOI 10.1021/acs.biochem.6b00055; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Rezzoug F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161588; Saintigny P, 2012, DISCOV MED, V13, P287; Schafer G, 2003, J BIOL CHEM, V278, P8190, DOI 10.1074/jbc.M211999200; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Sedoris KC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-157; Shi Q, 2001, CANCER RES, V61, P4143; Shih YW, 2009, J AGR FOOD CHEM, V57, P3490, DOI 10.1021/jf900124r; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Toi M, 2001, LANCET ONCOL, V2, P667, DOI 10.1016/S1470-2045(01)00556-3; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wild R, 2004, INT J CANCER, V110, P343, DOI 10.1002/ijc.20100; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yuan A, 2000, INT J CANCER, V89, P475, DOI 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T	67	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211046	10.1371/journal.pone.0211046	http://dx.doi.org/10.1371/journal.pone.0211046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682194	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500092
J	Nishikawa, Y; Kodama, Y; Shiokawa, M; Matsumori, T; Marui, S; Kuriyama, K; Kuwada, T; Sogabe, Y; Kakiuchi, N; Tomono, T; Mima, A; Morita, T; Ueda, T; Tsuda, M; Yamauchi, Y; Sakuma, Y; Ota, Y; Maruno, T; Uza, N; Uesugi, M; Kageyama, R; Chiba, T; Seno, H				Nishikawa, Yoshihiro; Kodama, Yuzo; Shiokawa, Masahiro; Matsumori, Tomoaki; Marui, Saiko; Kuriyama, Katsutoshi; Kuwada, Takeshi; Sogabe, Yuko; Kakiuchi, Nobuyuki; Tomono, Teruko; Mima, Atsushi; Morita, Toshihiro; Ueda, Tatsuki; Tsuda, Motoyuki; Yamauchi, Yuki; Sakuma, Yojiro; Ota, Yuji; Maruno, Takahisa; Uza, Norimitsu; Uesugi, Motonari; Kageyama, Ryoichiro; Chiba, Tsutomu; Seno, Hiroshi			Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis	ONCOGENE			English	Article							DUCTAL ADENOCARCINOMA; CELL PLASTICITY; BETA-CELL; CANCER; ENDOCRINE; INDUCTION; LINEAGE	Most pancreatic ductal adenocarcinoma (PDAC) develops from pancreatic epithelial cells bearing activating mutant KRAS genes through precancerous lesions, i.e. acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN). During pancreatic tumorigenesis, Hes1 expression starts with the transition from acinar cells to ADM, and continues during PanIN and PDAC formation, but the role of Hes1 in pancreatic tumorigenesis is not fully elucidated. Here we show that Hes1 plays an essential role in the initiation and progression of KRAS-driven pancreatic tumorigenesis. In vitro, activation of MAPK signaling due to EGF or mutant KRAS activation induced sustained Hes1 expression in pancreatic acinar cells. In vivo, acinar cell-specific activation of mutant KRAS by Elastase1-CreERT2;Kras(G12D) induced ADM/PanIN formation with Hes1 expression in mice, and genetic ablation of Hes1 in these mice dramatically suppressed PanIN formation. Gene expression analysis and lineage tracing revealed that Hes1 regulates acinar-to-ductal reprogramming-related genes and, in a Hes1-deficient state, mutant Kras-induced ADM could not progress into PanIN, but re-differentiated into acinar cells. In the Elastase1-CreERT2; Kras(G12D); Trp53(R172H) mouse PDAC model, genetic ablation of Hes1 completely blocked PDAC formation by keeping PanIN lesions in low-grade conditions, in addition to reducing the occurrence of PanIN. Together, these findings indicate that mutant KRAS-induced Hes1 plays an essential role in PDAC initiation and progression by regulating acinar-to-ductal reprogramming-related genes.	[Nishikawa, Yoshihiro; Kodama, Yuzo; Shiokawa, Masahiro; Matsumori, Tomoaki; Marui, Saiko; Kuriyama, Katsutoshi; Kuwada, Takeshi; Sogabe, Yuko; Kakiuchi, Nobuyuki; Tomono, Teruko; Mima, Atsushi; Morita, Toshihiro; Ueda, Tatsuki; Tsuda, Motoyuki; Yamauchi, Yuki; Sakuma, Yojiro; Ota, Yuji; Maruno, Takahisa; Uza, Norimitsu; Chiba, Tsutomu; Seno, Hiroshi] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan; [Kodama, Yuzo] Kobe Univ, Dept Gastroenterol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Uesugi, Motonari; Kageyama, Ryoichiro] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Uji, Kyoto 6110011, Japan; [Kageyama, Ryoichiro] Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kyoto 6068507, Japan; [Chiba, Tsutomu] Kansai Elect Power Hosp, Fukushima Ku, 2-1-7 Fukushima, Osaka 5530003, Japan	Kyoto University; Kobe University; Kyoto University; Kyoto University; Kyoto University	Kodama, Y (corresponding author), Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.; Kodama, Y (corresponding author), Kobe Univ, Dept Gastroenterol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kodamayu@kuhp.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020	Uza, Norimitsu/0000-0002-1334-5740; Nishikawa, Yoshihiro/0000-0002-1113-6937; Morita, Toshihiro/0000-0002-4114-9894	JSPS; MEXT KAKENHI [15J05143, 16K09395, 17H06803]; AMED P-DIRECT Grant [15cm0106120h0002]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED P-DIRECT Grant	This work was supported by the JSPS and MEXT KAKENHI Grant Numbers 15J05143, 16K09395, and 17H06803; AMED P-DIRECT Grant Number 15cm0106120h0002.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hidalgo-Sastre A, 2016, AM J PATHOL, V186, P2934, DOI 10.1016/j.ajpath.2016.07.025; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Horn S, 2012, P NATL ACAD SCI USA, V109, P7356, DOI 10.1073/pnas.1203605109; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawaguchi Y, 2013, J CLIN INVEST, V123, P1881, DOI 10.1172/JCI66022; Kong B, 2018, GUT, V67, P146, DOI 10.1136/gutjnl-2015-310913; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Krah NM, 2015, ELIFE, V4, DOI 10.7554/eLife.07125; Liu ZH, 2015, CANCER BIOL THER, V16, P353, DOI 10.1080/15384047.2015.1016662; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Perron A, 2018, J BIOL CHEM, V293, P8285, DOI 10.1074/jbc.RA118.002316; Rani A, 2016, CYTOKINE GROWTH FACT; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Shih HP, 2012, DEVELOPMENT, V139, P2488, DOI 10.1242/dev.078634; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; Wei DY, 2016, CANCER CELL, V29, P324, DOI 10.1016/j.ccell.2016.02.005; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754	35	19	19	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4283	4296		10.1038/s41388-019-0718-5	http://dx.doi.org/10.1038/s41388-019-0718-5			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30705405	Green Submitted			2022-12-26	WOS:000469339100006
J	Wang, P; Tian, HL; Zhang, JY; Qian, JJ; Li, L; Shi, L; Zhao, Y				Wang, Peng; Tian, Hongling; Zhang, Jiayu; Qian, Juanjuan; Li, Ling; Shi, Lu; Zhao, Yong			Spaceflight/microgravity inhibits the proliferation of hematopoietic stem cells by decreasing Kit-Ras/cAMP-CREB pathway networks as evidenced by RNA-Seq assays	FASEB JOURNAL			English	Article						HSPCs; signaling pathway; SJ-10 satellite; Tianzhou-1 cargo ship	BONE-MARROW; MACROPHAGE POLARIZATION; CYCLE CONTROL; SPACE; MICROGRAVITY; ERYTHROPOIESIS; ASTRONAUTS; EXPRESSION; INDUCTION; ANEMIA	Exposure to spaceflight and microgravity causes physiologic and psychologic changes including bone loss, cardiovascular dysfunction, and immune dysfunction. Anemia and hematopoietic disorders are observed in astronauts after spaceflight. Hematopoietic stem and progenitor cells (HSPCs), which can self-renew and give rise to all blood cells, play vital roles in hematopoiesis and homeostasis; however, the molecular mechanisms responsible for the impacts of microgravity on the proliferation of HSPCs remain unclear. We maintained mouse bone marrow HSPCs in the presence of stem cell factor for 12 d under spaceflight and simulated microgravity conditions, respectively, and analyzed cell proliferation and gene expression. Both spaceflight and simulated microgravity significantly decreased the number of HSPCs, mainly by blocking cell cycle at G(1)/S transition, but did not affect their differentiation abilities. RNA-sequencing data indicated that genes related to cell proliferation were down-regulated, whereas the genes related to cell death were up-regulated under microgravity. Among the gene signatures, we identified that the Kit-Ras/cAMP-cAMP response element-binding protein pathway might be one of the major microgravity-regulated pathways during HSPC proliferation. Furthermore, the quantification of notable genes was validated at the mRNA levels under simulated microgravity condition. Overall, these results would help us to understand the intracellular molecular mechanisms regulating microgravity-inhibited proliferation of HSPCs.Wang, P., Tian, H., Zhang, J., Qian, J., Li, L., Shi, L., Zhao, Y. Spaceflight/microgravity inhibits the proliferation of hematopoietic stem cells by decreasing Kit-Ras/cAMP-CREB pathway networks as evidenced by RNA-Seq assays.	[Wang, Peng; Tian, Hongling; Zhang, Jiayu; Qian, Juanjuan; Li, Ling; Shi, Lu; Zhao, Yong] Chinese Acad Sci, State Key Lab Membrane Biol, Inst Zool, Beijing, Peoples R China; [Zhao, Yong] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Zhang, Jiayu; Zhao, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, L; Zhao, Y (corresponding author), Chinese Acad Sci, Inst Zool, Transplantat Biol Res Div, State Key Lab Membrane Biol, Beichen West Rd 1-5, Beijing 100101, Peoples R China.	shilu@ioz.ac.cn; zhaoy@ioz.ac.cn		wang, peng/0000-0003-1845-7589	Program of National Natural Science Foundation of China [U1738111, 81530049, 31470860]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030301]; Mega-Projects of National Science Research for the 13th Five-Year Plan; China Manned Space Flight Technology Project [TZ-1]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Mega-Projects of National Science Research for the 13th Five-Year Plan; China Manned Space Flight Technology Project	The authors thank Dr. Huiting Su (State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences) for critical reading of the manuscript. This work was supported by grants from the Program of National Natural Science Foundation of China (U1738111 to Y.Z.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA16030301 to Y.Z.), the Mega-Projects of National Science Research for the 13th Five-Year Plan (to L.L.), the Program of National Natural Science Foundation of China (81530049 and 31470860 to Y.Z.), and the China Manned Space Flight Technology Project (TZ-1). The raw RNA-Seq data from this study have been deposited at the Big Data (BIGD) Genome Sequence Archive under accession number CRA001198. The authors declare no conflicts of interest.	Bedessem B, 2014, MATH BIOSCI, V248, P31, DOI 10.1016/j.mbs.2013.11.007; Berridge MJ, 2014, CELL SIGNAL BIOL, V6, P1, DOI DOI 10.1042/CSB0001002; Blaber E, 2014, STEM CELLS DEV, V23, P73, DOI 10.1089/scd.2014.0408; Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69; De Santo NG, 2005, SEMIN NEPHROL, V25, P379, DOI 10.1016/j.semnephrol.2005.05.006; Delp MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep29901; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Domaratskaya EI, 2002, ADV SPACE RES, V30, P771, DOI 10.1016/S0273-1177(02)00394-0; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Graebe A, 2004, J CLIN PHARMACOL, V44, P837, DOI 10.1177/0091270004267193; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Guo Yong, 2016, Chinese Medical Sciences Journal, V31, P100; Hou YZ, 2018, PROTEIN CELL, V9, P1027, DOI 10.1007/s13238-018-0505-z; Hsu P, 2013, CURR OPIN HEMATOL, V20, P289, DOI 10.1097/MOH.0b013e328360ab4d; Hu WR, 2014, MICROGRAVITY SCI TEC, V26, P159, DOI 10.1007/s12217-014-9390-0; LANGE RD, 1994, AVIAT SPACE ENVIR MD, V65, P730; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Li Y, 2018, CELL MOL IMMUNOL, V15, P518, DOI 10.1038/cmi.2017.39; Liang ZF, 2018, AUTOPHAGY, V14, P505, DOI 10.1080/15548627.2017.1376161; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P827, DOI 10.1038/icb.2011.65; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Meng D, 2017, AEROSPACE CHINA, V3, P62; Morettini S, 2008, FRONT BIOSCI-LANDMRK, V13, P5522; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Plett RA, 2001, IN VITRO CELL DEV-AN, V37, P73, DOI 10.1290/1071-2690(2001)037<0073:POHHBM>2.0.CO;2; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sergushichev AA, 2016, NUCLEIC ACIDS RES, V44, pW194, DOI 10.1093/nar/gkw266; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sholl-Franco A, 2010, INT J DEV NEUROSCI, V28, P63, DOI 10.1016/j.ijdevneu.2009.09.004; Sun B, 2018, CELL MOL IMMUNOL, V15, P782, DOI 10.1038/cmi.2017.163; TAVASSOLI M, 1982, BLOOD, V60, P1059; UDDEN MM, 1995, AVIAT SPACE ENVIR MD, V66, P557; VACEK A, 1982, CELL TISSUE KINET, V15, P643, DOI 10.1111/j.1365-2184.1982.tb01070.x; Vajravelu BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140798; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Wakabayashi K, 2017, PHYSIOL PLANTARUM, V161, P285, DOI 10.1111/ppl.12591; Wang CZ, 2015, INFLAMM RES, V64, P303, DOI 10.1007/s00011-015-0811-3; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu XR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00315; Wu XL, 2017, ONCOTARGET, V8, P82968, DOI 10.18632/oncotarget.20897; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zhang C, 2018, FASEB J, V32, P4444, DOI 10.1096/fj.201700208RR; Zhao H., 2016, J SPACE EXPLOR, V5, P101; Zhao QJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00637; Zhao Y, 2018, BLOOD, V131, P1587, DOI 10.1182/blood-2017-04-777128; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	52	14	14	3	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5903	5913		10.1096/fj.201802413R	http://dx.doi.org/10.1096/fj.201802413R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30721627	Green Published			2022-12-26	WOS:000466932600009
J	van Winden, VJC; Damen, MPM; Ummels, R; Bitter, W; Houben, ENG				van Winden, Vincent J. C.; Damen, Merel P. M.; Ummels, Roy; Bitter, Wilbert; Houben, Edith N. G.			Protease domain and transmembrane domain of the type VII secretion mycosin protease determine system-specific functioning in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; protein secretion; serine protease; protein stability; protein complex; Mycobacterium marinum; T7SS; type VII secretion system	TUBERCULOSIS; SUGGESTS; CYTOSOL; MYCP1; BCG	Mycobacteria use type VII secretion systems to secrete proteins across their highly hydrophobic diderm cell envelope. Pathogenic mycobacteria, such as Mycobacterium tuberculosis and Mycobacterium marinum, have up to five of these systems, named ESX-1 to ESX-5. Most of these systems contain a set of five conserved membrane components, of which the four Ecc proteins form the core membrane-embedded secretion complex. The fifth conserved membrane protein, mycosin protease (MycP), is not part of the core complex but is essential for secretion, as it stabilizes this membrane complex. Here we investigated which MycP domains are required for this stabilization by producing hybrid constructs between MycP(1) and MycP(5) in M. marinum and analyzed their effect on ESX-1 and ESX-5 secretion. We found that both the protease and transmembrane domain are required for the ESX system-specific function of mycosins. In addition, we observed that the transmembrane domain strongly affects MycP protein levels. We also show that the extended loops 1 and 2 in the protease domain are probably primarily involved in MycP stability, whereas loop 3 and the MycP(5)-specific loop 5 are dispensable. The atypical propeptide, or N-terminal extension, is required only for MycP stability. Finally, we show that the protease domain of MycP(P1), encoded by the esx-P1 locus on the pRAW plasmid, is functionally redundant to the protease domain of MycP(5). These results provide the first insight into the regions of mycosins involved in interaction with and stabilization of their respective ESX complexes.	[van Winden, Vincent J. C.; Ummels, Roy; Bitter, Wilbert] Vrije Univ Amsterdam, Amsterdam UMC, Dept Med Microbiol & Infect Control, NL-1081 HZ Amsterdam, Netherlands; [Damen, Merel P. M.; Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Sect Mol Microbiol, NL-1081 HZ Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Houben, ENG (corresponding author), Vrije Univ Amsterdam, Sect Mol Microbiol, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	e.n.g.houben@vu.nl	Bitter, Wilbert/ABG-3726-2020; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; Houben, Edith N.G./B-2110-2015	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; Damen, Merel PM/0000-0003-4233-2671	VIDI from the Netherlands Organization of Scientific Research (NWO) [864.12.006]; ALW Open Grant from the Netherlands Organization of Scientific Research (NWO) [ALWOP.319]; CCA from Amsterdam University Medical Center	VIDI from the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ALW Open Grant from the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CCA from Amsterdam University Medical Center	This work was funded by VIDI Grant 864.12.006 (to E. N. G. H.) and ALW Open Grant ALWOP.319 (to M. P. M. D.), both from the Netherlands Organization of Scientific Research (NWO), and by the CCA from Amsterdam University Medical Center (to V. J. C. v. W. and W. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Ates LS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005190; Beckham KSH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.47; Brown GD, 2000, GENE, V254, P147, DOI 10.1016/S0378-1119(00)00277-8; Dumas E, 2016, GENOME BIOL EVOL, V8, P387, DOI 10.1093/gbe/evw001; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Rosenberg OS, 2015, CELL, V161, P501, DOI 10.1016/j.cell.2015.03.040; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Solomonson M, 2013, J BIOL CHEM, V288, P17782, DOI 10.1074/jbc.M113.462036; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun DM, 2013, PROTEIN CELL, V4, P921, DOI 10.1007/s13238-013-3089-7; Ummels R, 2014, MBIO, V5, DOI 10.1128/mBio.01744-14; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Winden VJC, 2016, MBIO, V7, DOI 10.1128/mBio.01471-16; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH004; Wagner' JM, 2016, BMC STRUCT BIOL, V16, DOI [10.1186/s12900-016-0056-6, 10.1186/S12900-016-0056-6]; Wagner JM, 2013, J STRUCT BIOL, V184, P115, DOI 10.1016/j.jsb.2013.09.022	28	9	9	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4806	4814		10.1074/jbc.RA118.007090	http://dx.doi.org/10.1074/jbc.RA118.007090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30692196	Green Published, hybrid			2022-12-26	WOS:000463985600007
J	Lara, P; Tellgren-Roth, A; Behesti, H; Horn, Z; Schiller, N; Enquist, K; Cammenberg, M; Liljenstrom, A; Hatten, ME; von Heijne, G; Nilsson, I				Lara, Patricia; Tellgren-Roth, Asa; Behesti, Hourinaz; Horn, Zachi; Schiller, Nina; Enquist, Karl; Cammenberg, Malin; Liljenstrom, Amanda; Hatten, Mary E.; von Heijne, Gunnar; Nilsson, IngMarie			Murine astrotactins 1 and 2 have a similar membrane topology and mature via endoproteolytic cleavage catalyzed by a signal peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal peptidase; glycosylation; glycosylation inhibitor; cell migration; neuron; Astrotactin; central nervous system; neuronal migration; signal peptidase; topology	AMINO-ACID; IMPORTANT DETERMINANT; PROTEIN; TRANSLOCATION; INSERTION; SEQUON	Astrotactin 1 (Astn1) and Astn2 are membrane proteins that function in glial-guided migration, receptor trafficking, and synaptic plasticity in the brain as well as in planar polarity pathways in the skin. Here we used glycosylation mapping and protease protection approaches to map the topologies of mouse Astn1 and Astn2 in rough microsomal membranes and found that Astn2 has a cleaved N-terminal signal peptide, an N-terminal domain located in the lumen of the rough microsomal membranes (topologically equivalent to the extracellular surface in cells), two transmembrane helices, and a large C-terminal lumenal domain. We also found that Astn1 has the same topology as Astn2, but we did not observe any evidence of signal peptide cleavage in Astn1. Both Astn1 and Astn2 mature through endoproteolytic cleavage in the second transmembrane helix; importantly, we identified the endoprotease responsible for the maturation of Astn1 and Astn2 as the endoplasmic reticulum signal peptidase. Differences in the degree of Astn1 and Astn2 maturation possibly contribute to the higher levels of the C-terminal domain of Astn1 detected on neuronal membranes of the central nervous system. These differences may also explain the distinct cellular functions of Astn1 and Astn2, such as in membrane adhesion, receptor trafficking, and planar polarity signaling.	[Lara, Patricia; Tellgren-Roth, Asa; Schiller, Nina; Enquist, Karl; Cammenberg, Malin; Liljenstrom, Amanda; von Heijne, Gunnar; Nilsson, IngMarie] Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, S-10691 Stockholm, Sweden; [Behesti, Hourinaz; Horn, Zachi; Hatten, Mary E.] Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10065 USA	Stockholm University; Rockefeller University	von Heijne, G; Nilsson, I (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, S-10691 Stockholm, Sweden.	gunnar@dbb.su.se; ingmarie@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; von heijne, gunnar/F-5576-2011	Behesti, Hourinaz/0000-0001-9383-9929; von heijne, gunnar/0000-0002-4490-8569	Knut and Alice Wallenberg Foundation [2012.0282]; Swedish Research Council [621-2014-3713]; Swedish Cancer Foundation [15 0888]; Swedish Foundation for International Cooperation in Research and Higher Education [210/083(12), KU 2003-4674]; Swedish Foundation for Strategic Research [A305:200]; SSF-Infection Biology Grant 2012 [SB12-0026]; Eugene W. Chinery Trust; Renate, Hans, and Maria Hofmann Trust	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); SSF-Infection Biology Grant 2012; Eugene W. Chinery Trust; Renate, Hans, and Maria Hofmann Trust	This work was supported by Knut and Alice Wallenberg Foundation Grant 2012.0282 and the Swedish Research Council Grant 621-2014-3713 (to G. v. H.), Swedish Cancer Foundation Grant 15 0888 (to G. v. H. and I. N.), Swedish Foundation for International Cooperation in Research and Higher Education Grant 210/083(12); KU 2003-4674 (to I. N.), Swedish Foundation for Strategic Research Grant A305:200 and SSF-Infection Biology Grant 2012(SB12-0026 (to I. N.), the Eugene W. Chinery Trust (to M. E. H.), and the Renate, Hans, and Maria Hofmann Trust (to M. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams NC, 2002, DEVELOPMENT, V129, P965; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Behesti H, 2018, P NATL ACAD SCI USA, V115, pE9717, DOI 10.1073/pnas.1809382115; Chang H, 2017, IUBMB LIFE, V69, P572, DOI 10.1002/iub.1641; Chang H, 2017, J BIOL CHEM, V292, P3506, DOI 10.1074/jbc.M116.768077; Chang H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005532; Cuviello F, 2015, FEBS LETT, V589, P3921, DOI 10.1016/j.febslet.2015.10.030; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Green N., 2002, ENZYMES, P57; Horn Z, 2018, P NATL ACAD SCI USA, V115, P10556, DOI 10.1073/pnas.1811100115; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Kapp K., 2009, PROTEIN TRANSPORT EN, P1; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Lara P, 2017, J BIOL CHEM, V292, P11349, DOI 10.1074/jbc.M117.779421; LILJESTROM P, 1991, J VIROL, V65, P147; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Ni T, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160053; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Pene V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175810; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	33	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4538	4545		10.1074/jbc.RA118.007093	http://dx.doi.org/10.1074/jbc.RA118.007093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696770	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000462969500022
J	Qu, BP; Liu, YX; Sun, XY; Li, SY; Wang, XY; Xiong, KY; Yun, BH; Zhang, H				Qu, Bingpeng; Liu, Yuanxin; Sun, Xiangyang; Li, Suyan; Wang, Xinyu; Xiong, Kaiyi; Yun, Binghui; Zhang, Hua			Effect of various mulches on soil physico-Chemical properties and tree growth (Sophora japonica) in urban tree pits	PLOS ONE			English	Article							WATER-USE EFFICIENCY; NUTRIENT AVAILABILITY; LANDSCAPE; MANAGEMENT; IMPACT; MAIZE; STRAW	Mulching is a widely employed soil management practice. The mulches used have variable effects on the soil properties and plant growth. In China, mulches are used to cover bare soil at a few places in landscapes, where most of the soil is uncovered, especially in tree pits. As to improve our understanding on the effect of various mulches on soil properties and tree growth after two years of the treatment justifying its implication in soil fertility and tree growth. A comparison study was conducted to determine the effects of inorganic (cobblestone-CB; water permeable brick-WPB), organic (pine bark-PB; green waste compost-GWC), and living (turf grass-TG) mulches on soil physical and chemical properties at three different depths (0-10 cm, 10-20 cm, and 20-40cm), and on tree growth (Sophora japonica) in urban tree pits. Soil moisture was measured once a month in 2015. The soil samples were collected from the tree pits two years after mulching and used to evaluate the physical and chemical properties. Further, trunk diameter and tree height were determined once a year. During the most months, all types of mulches significantly affected the moisture content of the soil at all the depths analyzed. In July and August, however, the moisture content of PB and TG treated soil decreased when compared with that of unmulched bare soil. Two years after mulching, the bulk density of the soil treated with PB, GWC, and TG was significantly affected at 10-20 cm, with GWC exhibiting a relatively better effect. The treatments with PB, GWC, and TG also improved the total porosity, macroporosity, and microporosity of the soil at lower depths. Further, WPB worsened the bulk density and porosity of the soil, elevating the pH at lower depths. The organic matter, total N, mineral N, available P, and available K contents of the soil at lower depths increased when mulched with organic material. Turf grass significantly increased only the total N and available K at 0-10 and 10-20 cm. There was no significant difference in the soil properties among the treatments at 20-40 cm. Furthermore, the trunk diameter and tree height were not affected by the mulches two years after mulching. In conclusion, organic mulches especially GWC, not only increased soil fertility significantly but improved soil physical characters (0-10 cm depth) comparing to other mulches, are suitable to cover bare soil in urban tree pits.	[Qu, Bingpeng; Liu, Yuanxin; Sun, Xiangyang; Li, Suyan; Wang, Xinyu; Xiong, Kaiyi; Yun, Binghui; Zhang, Hua] Beijing Forestry Univ, Forestry Coll, Beijing, Peoples R China; [Qu, Bingpeng] Tianjin LVYIN Landscape & Ecol Construct Co Ltd, Tianjin, Peoples R China	Beijing Forestry University	Sun, XY; Li, SY (corresponding author), Beijing Forestry Univ, Forestry Coll, Beijing, Peoples R China.	sunxy@bjfu.edu.cn; lisuyan@bjfu.edu.cn	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Municipal Project for Science and Technology of Beijing [Z161100001116061, Z161100001316004]	Municipal Project for Science and Technology of Beijing	This work was supported by the Municipal Project for Science and Technology of Beijing (Z161100001116061 "Research and demonstration of key technologies for improving soil quality of greenbelt and forest land in Beijing", and Z161100001316004).	ASHWORTH S, 1983, HORTSCIENCE, V18, P180; Barajas-Guzman MG, 2006, PLANT SOIL, V287, P347, DOI 10.1007/s11104-006-9082-7; BILLEAUD L A, 1989, Journal of Environmental Horticulture, V7, P155; BOWEN KL, 1995, PLANT DIS, V79, P250, DOI 10.1094/PD-79-0250; Cahill A., 2005, ECOL RESTOR, V23, P212; Chalker-Scott Linda, 2007, Journal of Environmental Horticulture, V25, P239; Cook HF, 2006, SOIL TILL RES, V91, P227, DOI 10.1016/j.still.2005.12.007; EMBRAPA, 1997, MANUAL METODOS ANALI; Ferrini Francesco, 2008, Arboriculture & Urban Forestry, V34, P157; Griffin JJ, 2007, HORTSCIENCE, V42, P267, DOI 10.21273/HORTSCI.42.2.267; Hanada T., 1991, EFFECT MULCHING ROW; Iles Jeffery K., 1999, Journal of Arboriculture, V25, P163; Jafari M, 2012, J FOOD AGRIC ENVIRON, V10, P428; Jim C.Y., 1998, URBAN ECOSYST, V2, P171, DOI [10.1023/A:1009585700191, DOI 10.1023/A:1009585700191]; Jim CY, 1998, LANDSCAPE URBAN PLAN, V40, P235, DOI 10.1016/S0169-2046(97)00117-5; Jordan A, 2010, CATENA, V81, P77, DOI 10.1016/j.catena.2010.01.007; Kader MA, 2017, SOIL TILL RES, V168, P155, DOI 10.1016/j.still.2017.01.001; Kargar M, 2015, URBAN ECOSYST, V18, P921, DOI 10.1007/s11252-015-0439-7; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Koski Ronda, 2004, Journal of Arboriculture, V30, P165; Li SX, 2013, AGR WATER MANAGE, V116, P39, DOI 10.1016/j.agwat.2012.10.004; Liedgens M, 2004, PLANT SOIL, V262, P191, DOI 10.1023/B:PLSO.0000037041.24789.67; Lordan J, 2015, SPAN J AGRIC RES, V13, DOI 10.5424/sjar/2015134-6694; Luo W, 2008, CHEMOSPHERE, V72, P797, DOI 10.1016/j.chemosphere.2008.03.003; Maggard AO, 2012, HORTTECHNOLOGY, V22, P353; Mutetwa M., 2014, J GLOB INNOV AGR SOC, V2, P102, DOI [10.17957/JGIASS/2.3.561, DOI 10.17957/JGIASS/2.3.561]; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; Ni X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158228; Nzeyimana I, 2017, CATENA, V149, P43, DOI 10.1016/j.catena.2016.08.034; Pickering J. S., 2000, Arboricultural Journal, V24, P175; Pinamonti F, 1998, NUTR CYCL AGROECOSYS, V51, P239, DOI 10.1023/A:1009701323580; Qian X, 2015, EUR J SOIL BIOL, V70, P23, DOI 10.1016/j.ejsobi.2015.06.005; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Schmithals A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171533; Sinkeviciene A., 2009, Agronomy Research, V7, P485; Siwek P, 2015, AGROCHIMICA, V59, P108; SKROCH WA, 1986, HORTSCIENCE, V21, P390; Sun JZ, 2006, SOCIOBIOLOGY, V48, P85; Thankamani CK, 2016, SCI HORTIC-AMSTERDAM, V207, P125, DOI 10.1016/j.scienta.2016.05.010; Top GC, METHODS SOIL ANAL 4; Wang H, 2015, AGR WATER MANAGE, V154, P20, DOI 10.1016/j.agwat.2015.02.010; Wu JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142449; Yamanaka T, 2004, AGR WATER MANAGE, V67, P145, DOI 10.1016/j.agwat.2004.01.002; Zhao H, 2014, FIELD CROP RES, V161, P137, DOI 10.1016/j.fcr.2014.02.013	44	30	33	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210777	10.1371/journal.pone.0210777	http://dx.doi.org/10.1371/journal.pone.0210777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726253	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000029
J	Bai, X; Liu, ZZ; Shao, XJ; Wang, D; Dong, EC; Wang, Y; Wu, CI; Yuan, YF; Lu, XM; Li, CY				Bai, Xue; Liu, Zhenzhen; Shao, Xiaojian; Wang, Di; Dong, Encheng; Wang, Yan; Wu, Chung-I; Yuan, Yunfei; Lu, Xuemei; Li, Chunyan			The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma	PLOS ONE			English	Article							CANCER-CELLS; INTRATUMOR HETEROGENEITY; ALPHA-FETOPROTEIN; TUMOR-SUPPRESSOR; MICRORNAS; EVOLUTION; PROLIFERATION; EXPRESSION; GROWTH	Heterogeneity is prevalent in cancer both between and within individuals. Although a few studies have identified several circulating microRNAs (miRNAs) for cancer diagnosis, the complete plasma miRNA profile for hepatocellular carcinoma (HCC) remains undefined, and whether the plasma miRNA profiles are heterogeneous is unknown. Here, we obtained individualized plasma miRNA profiles of both healthy subjects and HCC patients via genome-wide deep sequencing. Compared with the highly stable miRNA profile of the healthy subjects, the profile of the HCC patients was highly variable. Seven miRNAs were optimized as potential plasma-based biomarkers for HCC diagnosis. Combined with the clinical data of The Cancer Genome Atlas (TCGA) cohort, three out of the seven miRNAs were correlated with the survival of the HCC patients. To investigate the effect of cancer cells on the plasma miRNAs profile, we compared the most differentially expressed miRNAs between plasma and tissues. Furthermore, miRNAseq data of HCC patients from TCGA were recruited for comparisons. We found that the differences between plasma and tissue were inconsistent, suggesting that other cells in addition to cancer cells also contribute to plasma miRNAs. Using two HCC cancer cell lines, we examined the levels of seven differentially expressed miRNAs. The reverse direction of certain miRNAs alterations between cancer cells and media further confirmed that miRNAs may be selectively pump out by cancer cells.	[Bai, Xue; Liu, Zhenzhen; Shao, Xiaojian; Wang, Di; Dong, Encheng; Wu, Chung-I; Lu, Xuemei; Li, Chunyan] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing, Peoples R China; [Yuan, Yunfei] Sun Yat Sen Univ, Canc Ctr, Dept Hepatobiliary Oncol, Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Wang, Yan] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Lu, Xuemei] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Shao, Xiaojian] Natl Res Council Canada, Digital Technol, Ottawa, ON, Canada; [Wang, Di] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Sun Yat Sen University; Capital Medical University; Chinese Academy of Sciences; National Research Council Canada; Peking University	Lu, XM; Li, CY (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing, Peoples R China.; Lu, XM (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.	luxm@big.ac.cn; lichunyan@big.ac.cn	dong, wang/T-9093-2019; shao, Xiaojian/AAU-7546-2021; Li, Chunyan/L-5172-2019	shao, Xiaojian/0000-0002-3044-621X; Li, Chunyan/0000-0002-9720-2631; Yuan, Yunfei/0000-0003-2467-3683	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13000000]; National Key Basic Research Program of China (973 Program) [2014CB542006]; Natural Science Foundation of China [31801094]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB13000000 to X.L.), the National Key Basic Research Program of China (973 Program) (2014CB542006 to C.W.), the Natural Science Foundation of China (http://www.nsfc.gov.cn) (91531305 and 31771416 to X.L.), the Natural Science Foundation of China (http://www.nsfc.gov.cn) (31801094 to C.L.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashtari S, 2015, WORLD J HEPATOL, V7, P1708, DOI 10.4254/wjh.v7.i12.1708; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cai H, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317716076; Chen G, 2013, TRENDS MOL MED, V19, P71, DOI 10.1016/j.molmed.2012.10.006; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; Fedele C, 2014, CANCER DISCOV, V4, P146, DOI 10.1158/2159-8290.CD-13-1042; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giannini EG, 2014, CANCER-AM CANCER SOC, V120, P2150, DOI 10.1002/cncr.28706; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Igaz I, 2014, CELL MOL LIFE SCI, V71, P4081, DOI 10.1007/s00018-014-1682-4; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Lim EL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0568-y; Liu HZ, 2016, BIOCHEM BIOPH RES CO, V472, P346, DOI 10.1016/j.bbrc.2016.02.096; Liu JC, 2016, GENE, V592, P308, DOI 10.1016/j.gene.2016.07.034; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng KK, 2008, ARCH SURG-CHICAGO, V143, P68, DOI 10.1001/archsurg.2007.15; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Qin L, 2016, ONCOL REP, V36, P3325, DOI 10.3892/or.2016.5139; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Song Peipei, 2013, Hepatobiliary Surg Nutr, V2, P227, DOI 10.3978/j.issn.2304-3881.2013.08.11; Squadrito ML, 2014, CELL REP, V8, P1432, DOI 10.1016/j.celrep.2014.07.035; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Wang L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0934-3; Wu JC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093806, 10.1371/journal.pone.0090528]; Xing BG, 2016, AM J TRANSL RES, V8, P1082; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yu SH, 2015, J CELL BIOCHEM, V116, P268, DOI 10.1002/jcb.24965; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhou MK, 2015, MOL MED REP, V11, P2947, DOI 10.3892/mmr.2014.3052; Zhou SM, 2016, ONCOL REP, V35, P3453, DOI 10.3892/or.2016.4701	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211581	10.1371/journal.pone.0211581	http://dx.doi.org/10.1371/journal.pone.0211581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721267	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300019
J	Pernold, K; Iannello, F; Low, BE; Rigamonti, M; Rosati, G; Scavizzi, F; Wang, J; Raspa, M; Wiles, MV; Ulfhake, B				Pernold, Karin; Iannello, F.; Low, B. E.; Rigamonti, M.; Rosati, G.; Scavizzi, F.; Wang, J.; Raspa, M.; Wiles, M. V.; Ulfhake, B.			Towards large scale automated cage monitoring - Diurnal rhythm and impact of interventions on in-cage activity of C57BL/6J mice recorded 24/7 with a non-disrupting capacitive-based technique	PLOS ONE			English	Article							BEHAVIOR; CYCLE; PERFORMANCE; STRAINS; POWER	Background and aims Automated recording of laboratory animal's home cage behavior is receiving increasing attention since such non-intruding surveillance will aid in the unbiased understanding of animal cage behavior potentially improving animal experimental reproducibility. Material and methods Here we investigate activity of group held female C57BL/6J mice (mus musculus) housed in standard Individually Ventilated Cages across three test-sites: Consiglio Nazionale delle Ricerche (CNR, Rome, Italy), The Jackson Laboratory (JAX, Bar Harbor, USA) and Karo-linska Insititutet (KI, Stockholm, Sweden). Additionally, comparison of female and male C57BL/6J mice was done at KI. Activity was recorded using a capacitive-based sensor placed non-intrusively on the cage rack under the home cage collecting activity data every 250 msec, 24/7. The data collection was analyzed using non-parametric analysis of variance for longitudinal data comparing sites, weekdays and sex. Results The system detected an increase in activity preceding and peaking around lights-on followed by a decrease to a rest pattern. At lights off, activity increased substantially displaying a distinct temporal variation across this period. We also documented impact on mouse activity that standard animal handling procedures have, e.g. cage-changes, and show that such procedures are stressors impacting in-cage activity. These key observations replicated across the three test-sites, however, it is also clear that, apparently minor local environmental differences generate significant behavioral vari-ances between the sites and within sites across weeks. Comparison of gender revealed differences in activity in the response to cage-change lasting for days in male but not female mice; and apparently also impacting the response to other events such as lights-on in males. Females but not males showed a larger tendency for week-to-week variance in activity possibly reflecting estrous cycling. Conclusions These data demonstrate that home cage monitoring is scalable and run in real time, providing complementary information for animal welfare measures, experimental design and phenotype characterization.	[Pernold, Karin; Wang, J.; Ulfhake, B.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Iannello, F.; Rigamonti, M.; Rosati, G.] Tecniplast SpA, Buguggiate, Va, Italy; [Low, B. E.; Wiles, M. V.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Scavizzi, F.; Raspa, M.] CNR, CNR Campus Int Dev EMMA INFRAFRONTIER IMPC, Rome, Italy	Karolinska Institutet; Jackson Laboratory; Consiglio Nazionale delle Ricerche (CNR)	Ulfhake, B (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	brun.ulfhake@ki.se	RASPA, MARCELLO/AAX-6807-2020; scavizzi, ferdinando/AAX-5443-2021; Ulfhake, Brun/AAG-8969-2020	RASPA, MARCELLO/0000-0002-3437-2430; Ulfhake, Brun/0000-0001-5037-7461; wiles, michael/0000-0002-3620-8386	Infrafrontier-I3 project under EU of the EC FP7 Capacities Specific Programme at CNR Institute of Cell Biology and Neurobiology [312325]; Jackson Laboratory; Karolinska Institutet; Tecniplast SpA	Infrafrontier-I3 project under EU of the EC FP7 Capacities Specific Programme at CNR Institute of Cell Biology and Neurobiology; Jackson Laboratory; Karolinska Institutet(Karolinska Institutet); Tecniplast SpA	The work at CNR was supported by Infrafrontier-I3 project under EU contract Grant Agreement Number 312325 of the EC FP7 Capacities Specific Programme at CNR Institute of Cell Biology and Neurobiology and intramural funding to EM. The work at JAX was funded by The Jackson Laboratory. The work at KI was funded by Karolinska Institutet. DVCTM equipment at CNR, JAX and KI, respectively, was made available by Tecniplast SpA. F. Iannello, M. Rigamonti and G. Rosati are employed by Tecniplast SpA. Tecniplast SpA provided support in the form of salaries for authors FI, MR and GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Aske KC, 2017, EMBO REP, V18, P1490, DOI 10.15252/embr.201744428; Bains RS, 2018, J NEUROSCI METH, V300, P37, DOI 10.1016/j.jneumeth.2017.04.014; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Balci F., 2013, PLOS CURR, V5; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Cressey D, 2015, NATURE, V520, P271, DOI 10.1038/520271a; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; de Visser L, 2005, BEHAV BRAIN RES, V160, P382, DOI 10.1016/j.bbr.2004.12.004; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Giles JM, 2018, J AM ASSOC LAB ANIM; GUTTMAN R, 1975, BEHAV BIOL, V13, P127, DOI 10.1016/S0091-6773(75)90898-6; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Kopp C, 2006, BEHAV BRAIN RES, V167, P165, DOI 10.1016/j.bbr.2005.09.001; Logan S, 2018, GEROSCIENCE, V40, P123, DOI 10.1007/s11357-018-0019-x; Loos M, 2015, MAMM GENOME, V26, P348, DOI 10.1007/s00335-015-9578-7; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; Lutz C, 2018, BRAIN RES, V1693, P1, DOI 10.1016/j.brainres.2018.03.024; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Oakeshott Stephen, 2011, PLoS Curr, V3, pRRN1225, DOI 10.1371/currents.RRN1225; Peters AG, 2002, LAB ANIM-UK, V36, P188, DOI 10.1258/0023677021912334; Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387; Rasheed MZ, 2018, J ENVIRON PATHOL TOX, V37, P139, DOI 10.1615/JEnvironPatholToxicolOncol.2018025666; Reardon S, 2016, NATURE, V530, P264, DOI 10.1038/nature.2016.19335; Richardson CA, 2015, APPL ANIM BEHAV SCI, V163, P19, DOI 10.1016/j.applanim.2014.11.018; Ripperger JA, 2011, FEBS LETT, V585, P1384, DOI 10.1016/j.febslet.2011.02.027; Robinson L, 2018, J NEUROSCI METH, V300, P10, DOI 10.1016/j.jneumeth.2017.11.019; Russell W. M. S, 1959, THE PRINCIPLES OF HU; Tang XD, 2005, PHYSIOL BEHAV, V84, P105, DOI 10.1016/j.physbeh.2004.10.017; Tang XD, 2002, BEHAV BRAIN RES, V136, P555, DOI 10.1016/S0166-4328(02)00228-0; Tankersley CG, 2002, J APPL PHYSIOL, V92, P870; Tucker LB, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00013; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173	36	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211063	10.1371/journal.pone.0211063	http://dx.doi.org/10.1371/journal.pone.0211063			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716111	gold, Green Submitted, Green Published			2022-12-26	WOS:000457744200014
J	Back, M; Hansson, GK				Back, Magnus; Hansson, Goran K.			Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation	FASEB JOURNAL			English	Article						atherosclerosis; leukotrienes; resolvins	ANTIINFLAMMATORY ACTIONS; LIPID MEDIATORS; LEUKOTRIENE	Although a high marine food intake is considered cardioprotective, randomized trials of -3 fatty acids initially generated conflicting results in terms of the role of -3 supplementation in cardiovascular prevention. This work demonstrates the results of the 3 most recent clinical trials with -3 fatty acids are put into the context of possible mechanisms mediating their beneficial cardiovascular effects. In particular, the randomized Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT) showed that icosapent ethyl, which is the ethyl ester form of the -3 fatty acid eicosapentaenoic acid (EPA), induced a significant reduction of cardiovascular events. Importantly, EPA serves as a substrate for the formation of the specialized proresolving mediator resolvin E1 (RvE1), which stimulates the resolution of inflammation. RvE1 reduces atherosclerosis and intimal hyperplasia by means of its specific receptor ERV1/ChemR23. The decreased levels of proinflammatory and proatherosclerotic leukotrienes by -3 fatty acids may further contribute to a beneficial inflammatory balance. Consequently, the Rv/leukotriene ratio is emerging as a marker of nonresolving vascular inflammation. Recent experimental studies have shown that anti-inflammatory and proresolving effects of lipid mediators derived from -3 fatty acids inhibit atherosclerosis independently of cholesterol and triglyceride levels. The results of the 3 most recent clinical trials of -3 fatty acid supplementation indicate an importance of the type and dose of -3 supplementation and highlight the need for risk stratification in the patient selection for -3 supplementation for either primary or secondary prevention of cardiovascular disease.Back, M., Hansson, G. K. Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation.	[Back, Magnus; Hansson, Goran K.] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Back, Magnus] Karolinska Univ Hosp, Div Coronary & Valvular Heart Dis, Theme Heart & Vessels, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Back, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, S1 02, S-17176 Stockholm, Sweden.	magnus.back@ki.se		Hansson, Goran/0000-0003-4148-5190				Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Artiach G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01327; Back M, 2006, ANN MED, V38, P493, DOI 10.1080/07853890600982737; Back M, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0067; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bowman L, 2018, NEW ENGL J MED, V379, P1540, DOI 10.1056/NEJMoa1804989; Hamilton JA, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0696-4; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Kasikara C, 2018, J CLIN INVEST, V128, P2713, DOI 10.1172/JCI97950; Laguna-Fernandez A, 2018, CIRCULATION, V138, P1693, DOI 10.1161/CIRCULATIONAHA.117.032801; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Pirault J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01273; Prescott SM, 2005, NAT MED, V11, P596, DOI 10.1038/nm0605-596; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Thul S, 2017, EUR J PREV CARDIOL, V24, P903, DOI 10.1177/2047487317694464; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011	25	43	43	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					1536	1539		10.1096/fj.201802445R	http://dx.doi.org/10.1096/fj.201802445R			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30703872	Bronze			2022-12-26	WOS:000457296600003
J	Thompson, K; Petkov, S; Zeiter, S; Sprecher, CM; Richards, RG; Moriarty, TF; Eijer, H				Thompson, Keith; Petkov, Stoyan; Zeiter, Stephan; Sprecher, Christoph M.; Richards, R. Geoff; Moriarty, T. Fintan; Eijer, Henk			Intraoperative loading of calcium phosphate-coated implants with gentamicin prevents experimental Staphylococcus aureus infection in vivo	PLOS ONE			English	Article							BONE; HYDROXYAPATITE; RELEASE; OSTEOMYELITIS; PROPHYLAXIS; TITANIUM; VITRO; PROSTHESES; CEFAZOLIN; FIXATION	Orthopedic device-related infection (ODRI) is a potentially devastating complication arising from the colonization of the device with bacteria, such as Staphylococcus aureus. The aim of this study was to determine if intraoperative loading of a clinically approved calcium phosphate (CaP) coating with gentamicin can protect from ODRI in vivo. First, CaP-coated titanium aluminium niobium (TAN) discs were used to investigate the adsorption and release kinetics of gentamicin in vitro. Gentamicin loading and subsequent release from the coating were both rapid, with maximum loading occurring following one second of immersion, and >95% gentamicin released within 15 min in aqueous solution, respectively. Second, efficacy of the gentamicin-loaded CaP coating for preventing ODRI in vivo was investigated using a CaP-coated unicortical TAN screw implanted into the proximal tibia of skeletally mature female Wistar rats, following inoculation of the implant site with S. aureus. Gentamicin-loading prevented ODRI in 7/8 animals, whereas 9/9 of the non-gentamicin treated animals were infected after 7 days. In conclusion, gentamicin can be rapidly and simply loaded onto, and released from, CaP-based implant coatings, and this is an effective strategy for preventing peri-operative S. aureus-induced ODRI in vivo.	[Thompson, Keith; Petkov, Stoyan; Zeiter, Stephan; Sprecher, Christoph M.; Richards, R. Geoff; Moriarty, T. Fintan] AO Res Inst Davos, Davos, Switzerland; [Petkov, Stoyan; Eijer, Henk] Spital Emmental, Burgdorf, Switzerland		Moriarty, TF (corresponding author), AO Res Inst Davos, Davos, Switzerland.	fintan.moriarty@aofoundation.org	Zeiter, Stephan/AAI-1880-2021; Eijer, Henk/R-7313-2019	Zeiter, Stephan/0000-0002-8155-4202; Thompson, Keith/0000-0002-9167-5147	Spital Emmental, Emmental, Switzerland; Spital Emmental	Spital Emmental, Emmental, Switzerland; Spital Emmental	HE was funded by an institutional grant from his employing institution, Spital Emmental, Emmental, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Pamela Furlong, Iris Keller, Christoph Sprecher, Gert-Jan ter Boo, Nora Goudsouzian and Dirk Nehrbass (all from AO Research Institute Davos) for their help and expert technical assistance. DOT GmbH, Rostock, Germany are acknowledged for coating the test materials. This study was funded by institutional grant from Spital Emmental to HE.	Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035; Alt V, 2011, ACTA BIOMATER, V7, P1274, DOI 10.1016/j.actbio.2010.11.012; BARRY AL, 1979, J CLIN MICROBIOL, V10, P885, DOI 10.1128/JCM.10.6.885-889.1979; Bentley KLD, 2017, J BONE MINER RES, V32, P985, DOI 10.1002/jbmr.3055; Campoccia D, 2008, INT J ARTIF ORGANS, V31, P841, DOI 10.1177/039139880803100913; de Mesy Bentley Karen L, 2018, JBJS Case Connect, V8, pe8, DOI 10.2106/JBJS.CC.17.00154; El-Ghannam A, 2005, J BIOMED MATER RES B, V73B, P277, DOI 10.1002/jbm.b.30209; Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135; Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105; HARDY DCR, 1991, J BONE JOINT SURG BR, V73, P732, DOI 10.1302/0301-620X.73B5.1654335; HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005; HILL C, 1981, LANCET, V1, P795; HOFMANN AA, 1993, J ARTHROPLASTY, V8, P157, DOI 10.1016/S0883-5403(06)80056-2; Ince A, 2008, J ARTHROPLASTY, V23, P762, DOI 10.1016/j.arth.2007.06.018; Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083; Li HS, 2010, J ORTHOP RES, V28, P992, DOI 10.1002/jor.21115; Logoluso N, 2016, J Bone Jt Infect, V1, P59, DOI 10.7150/jbji.17586; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; Malizos K, 2017, J ORTHOP TRAUMATOL, V18, P159, DOI 10.1007/s10195-017-0442-2; Morgenstern M, 2016, INJURY, V47, P1427, DOI 10.1016/j.injury.2016.04.027; Moriarty TF, 2016, EFORT OPEN REV, V1, P89, DOI 10.1302/2058-5241.1.000037; Moriarty TF, 2010, INT J ARTIF ORGANS, V33, P667, DOI 10.1177/039139881003300913; MURRAY WR, 1984, CLIN ORTHOP RELAT R, P89; Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885; Reigstad O, 2007, J BIOMED MATER RES B, V83B, P9, DOI 10.1002/jbm.b.30762; Reigstad O, 2011, J BIOMED MATER RES B, V99B, P14, DOI 10.1002/jbm.b.31866; Romano Carlo Luca, 2016, J Bone Jt Infect, V1, P34, DOI 10.7150/jbji.15986; Stadelmann VA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/587857; Stallmann HP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-18; Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011; Teller M, 2007, J BIOMED MATER RES B, V81B, P23, DOI 10.1002/jbm.b.30631; ter Boo GJA, 2016, ACTA BIOMATER, V43, P185, DOI 10.1016/j.actbio.2016.07.029; Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005; Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010; Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233	35	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0210402	10.1371/journal.pone.0210402	http://dx.doi.org/10.1371/journal.pone.0210402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707699	gold, Green Submitted, Green Published			2022-12-26	WOS:000457742900008
J	Robinson-Junker, A; O'Hara, B; Durkes, A; Gaskill, B				Robinson-Junker, Amy; O'Hara, Bruce; Durkes, Abigail; Gaskill, Brianna			Sleeping through anything: The effects of unpredictable disruptions on mouse sleep, healing, and affect	PLOS ONE			English	Article							CIRCADIAN-RHYTHM DISRUPTION; LABORATORY MICE; BODY-TEMPERATURE; SEX-DIFFERENCES; NEST TEST; STRESS; PAIN; FRAGMENTATION; BEHAVIOR; MODEL	Many aspects of the laboratory environment are not tailored to the needs of rodents, which may cause stress. Unpredictable stressors can cause ulcers, prolonged pituitary-adrenal activation, and anhedonia. Similarly, pain has been demonstrated to slow wound healing, and mice experiencing pain exhibit altered behavior. However it is unknown how husbandry, which occurs when the mice are inactive, and lack of analgesia, specifically in a punch biopsy procedure, effects animal physiology, behavior, and welfare, particularly as it relates to sleep fragmentation. We hypothesized that sleep fragmentation, induced by unpredictable husbandry and lack of pain management will slow wound healing. Two main treatments were tested in a factorial design in C57BL/6 mice of both sexes (64 mice total); 1) analgesia (carprofen and saline) and 2) sleep disruptions (random and predictable). Mice were singly housed in a non-invasive sleep monitoring apparatus on arrival (Day -4). Disruption treatments were applied from Day -3 to 2. All mice received a punch biopsy surgery (Day 0) with topical lidocaine gel and their analgesic treatment prior to recovery, and on Days 1 and 2. Nesting behavior was assessed daily and a sugar cereal consumption test, as a measure of anhedonia, was conducted on Days -1 to 2. On Day 3, mice were euthanized and wound tissue and adrenal glands were collected. We found that the disruption predictability had no effect on mouse sleep, wound healing, or adrenal cortex: medulla ratio. It's possible that the disruption period was not long enough to induce chronic stress. However, male mice who received analgesia slept more than their female counterparts; this may be related to sex differences in pain perception. Overall, it does not appear that the predictability of disturbance effects sleep fragmentation or stress responses, indicating that husbandry activities do not need to occur at set predictable times to improve welfare.	[Robinson-Junker, Amy; Durkes, Abigail] Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [O'Hara, Bruce] Univ Kentucky, Dept Biol, Lexington, KY USA; [Gaskill, Brianna] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Robinson-Junker, Amy] Univ Calif San Francisco, Lab Anim Resource Ctr, San Francisco, CA 94143 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Kentucky; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Francisco	Robinson-Junker, A (corresponding author), Purdue Univ, Sch Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; Robinson-Junker, A (corresponding author), Univ Calif San Francisco, Lab Anim Resource Ctr, San Francisco, CA 94143 USA.	amy.robinson.junker@gmail.com		Robinson-Junker, Amy/0000-0002-0961-6317	Universities Federation for Animal Welfare	Universities Federation for Animal Welfare	This project was funded by a 3500 pound small project grant from the Universities Federation for Animal Welfare (https://www.ufaw.org.uk/small-project-and-travel-awards/small-project-and-travel-awards ARJ and BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BB, 1984, PSYCHOL BULL, V96, P45, DOI 10.1037/0033-2909.96.1.45; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert N, 2013, BEHAV BRAIN RES, V252, P347, DOI 10.1016/j.bbr.2013.06.025; [Anonymous], 2008, PHYSL BEHAV ANIMAL S, P72; Ansell DM, 2014, WOUND REPAIR REGEN, V22, P281, DOI 10.1111/wrr.12148; Asarnow LD, 2013, CURR OPIN PSYCHIATR, V26, P566, DOI 10.1097/YCO.0b013e328365a2fa; BADIA P, 1973, J EXP ANAL BEHAV, V20, P47, DOI 10.1901/jeab.1973.20-47; Baud MO, 2015, SLEEP, V38, P567, DOI 10.5665/sleep.4572; Broadbent E, 2003, PSYCHOSOM MED, V65, P865, DOI 10.1097/01.PSY.0000088589.92699.30; Cairns BE, 2009, MATURITAS, V63, P292, DOI 10.1016/j.maturitas.2009.06.004; Carreras A, 2014, SLEEP, V37, P1817, DOI 10.5665/sleep.4178; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Colavito V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00106; Craft RM, 2003, LIFE SCI, V72, P2675, DOI 10.1016/S0024-3205(03)00178-4; Davidson JM, 2001, WOUNDS, V13, P9; DINGES DF, 1987, SLEEP, V10, P313; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; Eng JWL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7426; Ernst K, 2006, PHYSIOL BEHAV, V89, P448, DOI 10.1016/j.physbeh.2006.07.001; Foster RG, 2013, PROG MOL BIOL TRANSL, V119, P325, DOI 10.1016/B978-0-12-396971-2.00011-7; FREEMAN J, 1975, B PSYCHONOMIC SOC, V6, P75; GAMALLO A, 1986, PHYSIOL BEHAV, V36, P217, DOI 10.1016/0031-9384(86)90006-5; Gaskill BN, 2017, LAB ANIMAL, V46, P142, DOI 10.1038/laban.1218; Gaskill BN, 2016, APPL ANIM BEHAV SCI, V180, P140, DOI 10.1016/j.applanim.2016.04.008; Gaskill BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074153; Gaskill BN, 2013, PHYSIOL BEHAV, V110, P87, DOI 10.1016/j.physbeh.2012.12.018; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Grafen A, 2002, MODERN STAT LIFE SCI, Vi-xv, P1; Graham JE, 2006, BRAIN BEHAV IMMUN, V20, P389, DOI 10.1016/j.bbi.2005.11.002; Hakim F, 2015, SLEEP, V38, P31, DOI 10.5665/sleep.4320; Harding K, 2008, J AM ACAD CHILD PSY, V47, P473, DOI 10.1097/01.CHI.0000270812.55636.3b; House SL, 2015, J WOUND OSTOMY CONT, V42, P38, DOI 10.1097/WON.0000000000000080; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Ibironke GF, 2014, NEUROPHYSIOLOGY+, V46, P411, DOI 10.1007/s11062-015-9466-5; Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008; Jirkof P, 2017, LAB ANIMAL, V46, P123, DOI 10.1038/laban.1216; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Jirkof P, 2013, APPL ANIM BEHAV SCI, V148, P209, DOI 10.1016/j.applanim.2013.08.006; Jirkof P, 2013, LAB ANIM-UK, V47, P153, DOI 10.1177/0023677213475603; Jirkof P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00165; Khalyfa A, 2015, SLEEP, V38, P545, DOI 10.5665/sleep.4568; Kokolus KM, 2013, P NATL ACAD SCI USA, V110, P20176, DOI 10.1073/pnas.1304291110; Krohn TC, 2008, SCAND J LAB ANIM SCI, V35, P231; KRONENBERGER JP, 1985, BEHAV PROCESS, V11, P53, DOI 10.1016/0376-6357(85)90102-0; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Landis CA, 1997, RES NURS HEALTH, V20, P259, DOI 10.1002/(SICI)1098-240X(199706)20:3<259::AID-NUR8>3.3.CO;2-7; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Leys LJ, 2012, J AM ASSOC LAB ANIM, V51, P764; Mapplebeck JCS, 2016, PAIN, V157, pS2, DOI 10.1097/j.pain.0000000000000389; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MARTI O, 1993, PSYCHONEUROENDOCRINO, V18, P67, DOI 10.1016/0306-4530(93)90056-Q; Matsuzaki K, 2013, INT WOUND J, V10, P638, DOI 10.1111/j.1742-481X.2012.01038.x; McCoy JG, 2011, NEUROBIOL LEARN MEM, V96, P564, DOI 10.1016/j.nlm.2011.07.004; McGuire L, 2006, ANN BEHAV MED, V31, P165, DOI 10.1207/s15324796abm3102_8; Miyamoto H, 1999, J BIOCHEM, V126, P1175, DOI 10.1093/oxfordjournals.jbchem.a022564; Mogil JS, 2017, LAB ANIMAL, V46, P136, DOI 10.1038/laban.1223; Mogil JS, PROGR BRAIN RES, P186; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Murphy Patricia J., 1996, Physiology and Behavior, V59, P133, DOI 10.1016/0031-9384(95)02036-5; MURPHY PJ, 1994, PHYSIOL BEHAV, V55, P1063, DOI 10.1016/0031-9384(94)90388-3; National Research Council, 2011, GUIDE CARE USE LAB A, DOI [10.1186/1475-925X-7-14, DOI 10.1186/1475-925X-7-14]; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; Padgett DA, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P837; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Patel M, 2008, CRIT CARE NURS Q, V31, P309, DOI 10.1097/01.CNQ.0000336816.89300.41; Prather AA, 2012, SLEEP, V35, P1063, DOI 10.5665/sleep.1990; Prescott MJ, 2017, LAB ANIMAL, V46, P152, DOI 10.1038/laban.1217; Pyter LM, 2014, STRESS, V17, P256, DOI 10.3109/10253890.2014.910761; Robinson-Junker AL, 2018, J AM ASSOC LAB ANIM, V57, P124; Rock ML, 2014, ANIM WELFARE, V23, P381, DOI 10.7120/09627286.23.4.381; Rock ML, 2014, J AM ASSOC LAB ANIM, V53, P24; Sheridan JF, 2004, WORLD J SURG, V28, P327, DOI 10.1007/s00268-003-7404-y; Short M.A., 2014, SLEEP DEPRIVATION DI, DOI [10.1007/978-1-4614-9087-6_2, DOI 10.1007/978-1-4614-9087-6_2, 10.1007/978-146149087-6_2]; Soon K., 2006, WOUNDS UK, V2, P92; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Toth LA, 2013, COMPARATIVE MED, V63, P91; Trammell RA, 2015, COMPARATIVE MED, V65, P173; Trentani A, 2003, NEUROBIOL DIS, V14, P602, DOI 10.1016/j.nbd.2003.08.006; University of Illinois at Chicago Office of Animal Care and Institutional Biosafety, GUID ROD SURG CLASS; University of Pennsylvania Institutional Animal Care and Use Committee, 2014, MOUS AN AN REC; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Woo KY, 2012, ADV SKIN WOUND CARE, V25, P38, DOI 10.1097/01.ASW.0000410689.60105.7d; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003	88	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210620	10.1371/journal.pone.0210620	http://dx.doi.org/10.1371/journal.pone.0210620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703113	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600022
J	Ulrich, S; Grill, E; Flanagin, VL				Ulrich, Susanne; Grill, Eva; Flanagin, Virginia L.			Who gets lost and why: A representative cross-sectional survey on sociodemographic and vestibular determinants of wayfinding strategies	PLOS ONE			English	Article							GENDER-DIFFERENCES; SPATIAL MEMORY; SEX-DIFFERENCES; HIPPOCAMPAL; ANXIETY; GUIDELINES; ATROPHY; VERTIGO; ABILITY; SYSTEM	When we think of our family and friends, we probably know someone who is good at finding their way and someone else that easily gets lost. We still know little about the biological and environmental factors that influence our navigational ability. Here, we investigated the frequency and sociodemographic determinants of wayfinding and their association with vestibular function in a representative cross-sectional sample (N = 783) of the adult German-speaking population. Wayfinding was assessed using the Wayfinding Strategy Scale, a self-report scale that produces two scores for each participant representing to what degree they rely on route-based or orientation (map-based) strategies. We were interested in the following research questions: (1) the frequency and determinants of wayfinding strategies in a population-based representative sample, (2) the relationship between vestibular function and strategy choice and (3) how sociodemographic factors influence general wayfinding ability as measured using a combined score from both strategy scores. Our linear regression models showed that being male, having a higher education, higher age and lower regional urbanization increased orientation strategy scores. Vertigo/dizziness reduced the scores of both the orientation and the route strategies. Using a novel approach, we grouped participants by their combined strategy scores in a multinomial regression model, to see whether individuals prefer one strategy over the other. The majority of individuals reported using either both or no strategy, instead of preferring one strategy over the other. Young age and reduced vestibular function were indicative of using no strategy. In summary, wayfinding ability depends on both biological and environmental factors; all sociodemographic factors except income. Over a third of the population, predominantly under the age of 35, does not successfully use either strategy. This represents a change in our wayfinding skills, which may result from the technological advances in navigational aids over the last few decades.	[Ulrich, Susanne; Grill, Eva] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Grill, Eva; Flanagin, Virginia L.] Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Munich, Germany	University of Munich; University of Munich	Flanagin, VL (corresponding author), Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Munich, Germany.	vflanagin@lrz.uni-muenchen.de	Grill, Eva/AAF-8104-2020	Grill, Eva/0000-0002-0273-7984	German Federal Ministry of Education and Research [01EO1401]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project was supported by funds from the German Federal Ministry of Education and Research (https://www.gesundheitsforschung-bmbf.de/de/integrierte-forschungs-und-behandlungszentren-ifb.php) under the Grant Code 01EO1401 (EG, VLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CA, 2004, CLIN ENDOCRINOL, V60, P653, DOI 10.1111/j.1365-2265.2004.02002.x; [Anonymous], 2014, STICHPROBEN VERFAHRE; [Anonymous], 2010, STAT WISS DEM STAND; Backhaus K., 2016, MULTIVARIATE ANALYSE, V14th rev. ed.; Baltes-Gotz B, LINEARE REGRESSIONSA; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Charleston S, 2008, PERCEPT MOTOR SKILL, V106, P881, DOI 10.2466/PMS.106.3.881-882; Cheema JR, 2014, J MOD APPL STAT METH, V13, P53, DOI 10.22237/jmasm/1414814520; Cohen R., 2015, EXTENSION BUNDLES BM; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; de Rooij NK, 2019, NEUROPSYCHOL REHABIL, V29, P1042, DOI 10.1080/09602011.2017.1347098; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Farr AC, 2012, TRANSPORT REV, V32, P715, DOI 10.1080/01441647.2012.712555; Field A., 2013, SEX DRUGS ROCK N ROL, V4th; Grill E, 2014, J NEUROL, V261, P1492, DOI 10.1007/s00415-014-7367-y; Hale GE, 2009, BEST PRACT RES CL OB, V23, P7, DOI 10.1016/j.bpobgyn.2008.10.001; Harris MA, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00029; Harris MA, 2012, HIPPOCAMPUS, V22, P1770, DOI 10.1002/hipo.22011; Head D, 2010, BEHAV BRAIN RES, V209, P49, DOI 10.1016/j.bbr.2010.01.012; Heckel C, 2014, STICHPROBEN VERFAHRE, P85; Hoffmeyer-Zlotnik Jurgen H. P., 2014, HARMONISING DEMOGRAP; Hufner K, 2007, HIPPOCAMPUS, V17, P471, DOI 10.1002/hipo.20283; Hund A.M., 2006, SPAT COGN COMPUT, VVol. 6, P179, DOI DOI 10.1207/S15427633SCC0603_1; Ishikawa T, 2008, J ENVIRON PSYCHOL, V28, P74, DOI 10.1016/j.jenvp.2007.09.002; Janssen J., 2013, STAT DATENANALYSE SP, V8; Javadi AH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14652; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kremmyda O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00139; Lawton CA, 2002, SEX ROLES, V47, P389, DOI 10.1023/A:1021668724970; Lawton CA, 1996, J ENVIRON PSYCHOL, V16, P137, DOI 10.1006/jevp.1996.0011; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Lawton CA, 2001, SEX ROLES, V44, P321, DOI 10.1023/A:1010981616842; Lawton CA, 1999, SEX ROLES, V40, P73, DOI 10.1023/A:1018830401088; Li RN, 2014, FRONT NEUROENDOCRIN, V35, P385, DOI 10.1016/j.yfrne.2014.01.002; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Meilinger T, 2008, COGNITIVE SCI, V32, P755, DOI 10.1080/03640210802067004; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Neuhauser HK, 2009, NERVENARZT, V80, P887, DOI 10.1007/s00115-009-2738-9; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Olson KE, 2011, AGEING INT, V36, P123, DOI 10.1007/s12126-010-9077-9; Petervari J, 2015, WAYFINDING RESTRUCTU; Popp P, 2017, J NEUROL, V264, P554, DOI 10.1007/s00415-016-8386-7; Prestopnik JL, 2000, J ENVIRON PSYCHOL, V20, P177, DOI 10.1006/jevp.1999.0160; Previc FH, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00046; Previc FH, 2013, MED HYPOTHESES, V80, P360, DOI 10.1016/j.mehy.2012.12.023; Proust-Lima C, 2008, PSYCHOL AGING, V23, P608, DOI 10.1037/a0012838; R Core Team, R LANG ENV STAT COMP; Schendera Christian, 2008, REGRESSIONSANALYSE S; Schmitz S, 1999, SEX ROLES, V41, P71, DOI 10.1023/A:1018837808724; Schmitz S, 1997, J ENVIRON PSYCHOL, V17, P215, DOI 10.1006/jevp.1997.0056; Schneider S. L., 2015, KONZEPTUALISIERUNG E; Semenov YR, 2016, J GERONTOL A-BIOL, V71, P243, DOI 10.1093/gerona/glv069; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Smith PF, 2017, CURR OPIN NEUROL, V30, P84, DOI 10.1097/WCO.0000000000000403; Taillade M, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02034; Torres-Guijarro S, 2017, HIGH EDUC RES DEV, V36, P1072, DOI 10.1080/07294360.2016.1264372; Wiener JM, 2013, J NEUROSCI, V33, P6012, DOI 10.1523/JNEUROSCI.0717-12.2013; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001	66	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0204781	10.1371/journal.pone.0204781	http://dx.doi.org/10.1371/journal.pone.0204781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699119	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600003
J	Hickey, J; Davidsen, J				Hickey, Joseph; Davidsen, Jorn			Self-organization and time-stability of social hierarchies	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DOMINANCE HIERARCHIES; ASSET EXCHANGE; HEALTH; MODEL; WEALTH; DISTRIBUTIONS; INSTABILITY; AGGRESSION; INEQUALITY	The formation and stability of social hierarchies is a question of general relevance. Here, we propose a simple generalized theoretical model for establishing social hierarchy via pairwise interactions between individuals and investigate its stability. In each interaction or fight, the probability of "winning" depends solely on the relative societal status of the participants, and the winner has a gain of status whereas there is an equal loss to the loser. The interactions are characterized by two parameters. The first parameter represents how much can be lost, and the second parameter represents the degree to which even a small difference of status can guarantee a win for the higher-status individual. Depending on the parameters, the resulting status distributions reach either a continuous unimodal form or lead to a totalitarian end state with one high-status individual and all other individuals having status approaching zero. However, we find that in the latter case long-lived intermediary distributions often exist, which can give the illusion of a stable society. As we show, our model allows us to make predictions consistent with animal interaction data and their evolution over a number of years. Moreover, by implementing a simple, but realistic rule that restricts interactions to sufficiently similar-status individuals, the stable or long-lived distributions acquire high-status structure corresponding to a distinct high-status class. Using household income as a proxy for societal status in human societies, we find agreement over their entire range from the low-to-middle-status parts to the characteristic high-status "tail". We discuss how the model provides a conceptual framework for understanding the origin of social hierarchy and the factors which lead to the preservation or deterioration of the societal structure.	[Hickey, Joseph; Davidsen, Jorn] Univ Calgary, Dept Phys & Astron, Complex Sci Grp, Calgary, AB, Canada	University of Calgary	Hickey, J (corresponding author), Univ Calgary, Dept Phys & Astron, Complex Sci Grp, Calgary, AB, Canada.	joseph.hickey@ucalgary.ca		Hickey, Joseph/0000-0002-9373-1181	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	JH was financially supported by the Natural Sciences and Engineering Research Council of Canada through a Canada Graduate Scholarship. JD was financially supported by the Natural Sciences and Engineering Research Council of Canada through a Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9; Baro J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066121; Ben-Naim E, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/11/L11002; Ben-Naim E, 2006, EUR PHYS J B, V49, P531, DOI 10.1140/epjb/e2006-00095-y; Bischoff K, 2014, DIVERS DISPARITIES A; Boghosian B.M., 2016, 1 INT C COMPL INF SY; Boghosian BM, 2016, DESCRIBING REALISTIC, P1; Boghosian BM, 2017, PHYSICA A, V476, P15, DOI 10.1016/j.physa.2017.01.071; Boghosian BM, 2015, J STAT PHYS, V161, P1339, DOI 10.1007/s10955-015-1316-8; BONABEAU E, 1995, PHYSICA A, V217, P373, DOI 10.1016/0378-4371(95)00064-E; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Boyce WT, 2004, ANN NY ACAD SCI, V1036, P47, DOI 10.1196/annals.1330.003; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Capasso M, 2009, ADV COMPLEX SYST, V12, P157, DOI 10.1142/S0219525909002131; Carr J., 2012, DEV STANDARDS COLLEC; Chakrabarti AS., 2010, ECONOMICS, V4, P1, DOI [10.5018/economics-ejournal.ja.2010-4, DOI 10.5018/ECONOMICS-EJOURNAL.JA.2010-4]; Chakraborti A, 2011, QUANT FINANC, V11, P1013, DOI 10.1080/14697688.2010.539249; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Chase ID, 2011, ADV GENET, V75, P51, DOI 10.1016/B978-0-12-380858-5.00001-0; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; Cote S, 2017, J EXP PSYCHOL GEN, V146, P269, DOI 10.1037/xge0000258; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; de Waal F., 2007, CHIMPANZEE POLITICS; Diamond J, 2010, NATURE, V464, P836, DOI 10.1038/464836c; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Ebel Holger, 2002, Complexity, V8, P24, DOI 10.1002/cplx.10066; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Flinn MV, 2012, HUM NATURE-INT BIOS, V23, P68, DOI 10.1007/s12110-012-9135-y; FOURNIER F, 1995, ANIM BEHAV, V49, P1449, DOI 10.1016/0003-3472(95)90066-7; Franz M, 2015, P ROY SOC B-BIOL SCI, V282, P113, DOI 10.1098/rspb.2015.1512; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Gouws EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016606; Graw B, 2007, ANIM BEHAV, V74, P507, DOI 10.1016/j.anbehav.2006.11.021; Guillams B, 2007, ENCY LIFE; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hayes B, 2002, AM SCI, V90, P400, DOI 10.1511/2002.5.400; Hemelrijk CK, 2017, ADV STUD BEHAV, V49, P361, DOI 10.1016/bs.asb.2017.02.005; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hobbes T., 1998, LEVIATHAN; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Iceland J, 2006, SOC PROBL, V53, P248, DOI 10.1525/sp.2006.53.2.248; Ispolatov S, 1998, EUR PHYS J B, V2, P267, DOI 10.1007/s100510050249; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Knobel M, 2008, J NANOSCI NANOTECHNO, V8, P2836, DOI 10.1166/jnn.2008.017; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Kunst JR, 2017, P NATL ACAD SCI USA, V114, P5407, DOI 10.1073/pnas.1616572114; Lagasse P., 2017, COLUMBIA ENCY; LAIDLER KJ, 1972, J CHEM EDUC, V49, P343, DOI 10.1021/ed049p343; Laming D., 2009, INSID PSYCHOL SCI 50; Leymann H., 1996, EUROPEAN J WORK ORG, V5, P165, DOI [10.1080/13594329608414853, DOI 10.1080/13594329608414853]; Lindquist WB, 2009, B MATH BIOL, V71, P556, DOI 10.1007/s11538-008-9371-9; Markov I. V, 2003, CRYSTAL GROWTH BEGIN, DOI [10.1142/5172, DOI 10.1142/5172]; Marmot MG, 2014, SOC HIERARCHY HEAL C; Massey D., 1993, AM APARTHEID SEGREGA; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Odagaki T, 2006, PHYSICA A, V367, P435, DOI 10.1016/j.physa.2005.11.023; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Richmond P., 2013, ECONOPHYSICS PHYS EC, V1st ed; Ruggles S, 2017, NOTE ADJUSTING DOLLA; Ruggles Steven, 2015, INTEGRATED PUBLIC US; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Sanchez-Tojar A, 2018, J ANIM ECOL, V87, P594, DOI 10.1111/1365-2656.12776; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Sapolsky RM, 2011, SCIENCE, V333, P293, DOI 10.1126/science.1209620; SAS Institute Inc, 2000, SAS INSIGHT US GUID; Scheffer M, 2017, P NATL ACAD SCI USA, V114, P13154, DOI 10.1073/pnas.1706412114; Scott J, 1999, BEHAVIOUR, V136, P1283, DOI 10.1163/156853999500721; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Shayo M, 2009, AM POLIT SCI REV, V103, P147, DOI 10.1017/S0003055409090194; Shizuka D, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0080; Silk JB, 2002, EVOL ANTHROPOL, V11, P221, DOI 10.1002/evan.10038; Slanina F., 2013, ESSENTIALS ECONOPHYS; Soteriades ES, 2003, AM J PUBLIC HEALTH, V93, P1155, DOI 10.2105/AJPH.93.7.1155; Statistics Canada, 2001, CENS PUBL US MICR FI; Statistics Canada, 2006, CENS CAN 2001 PUBL U; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Sutton J, 1997, J ECON LIT, V35, P40; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Tsujiguchi M, 2007, PHYSICA A, V375, P317, DOI 10.1016/j.physa.2006.08.026; Wang S. X., 2001, THESIS; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Yakovenko VM, 2009, REV MOD PHYS, V81, P1703, DOI 10.1103/RevModPhys.81.1703	91	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211403	10.1371/journal.pone.0211403	http://dx.doi.org/10.1371/journal.pone.0211403			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695067	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400032
J	Watts, SM; McCarthy, TM; Namgail, T				Watts, Sophie M.; McCarthy, Thomas M.; Namgail, Tsewang			Modelling potential habitat for snow leopards (Panthera uncia) in Ladakh, India	PLOS ONE			English	Article							SPECIES DISTRIBUTION; NATIONAL-PARK; ECOLOGICAL-NICHE; CLIMATE-CHANGE; SAMPLING BIAS; CONSERVATION; SUITABILITY; CARNIVORE; DISTRIBUTIONS; PREY	The snow leopard Panthera uncia is an elusive species inhabiting some of the most remote and inaccessible tracts of Central and South Asia. It is difficult to determine its distribution and density pattern, which are crucial for developing conservation strategies. Several techniques for species detection combining camera traps with remote sensing and geographic information systems have been developed to model the habitat of such cryptic and low-density species in challenging terrains. Utilising presence-only data from camera traps and direct observations, alongside six environmental variables (elevation, aspect, ruggedness, distance to water, land cover, and prey habitat suitability), we assessed snow leopard habitat suitability across Ladakh in northern India. This is the first study to model snow leopard distribution both in India and utilising direct observation data. Results suggested that elevation and ruggedness are the two most influential environmental variables for snow leopard habitat suitability, with highly suitable habitat having an elevation range of 2,800 m to 4,600 m and ruggedness of 450 m to 1,800 m. Our habitat suitability map estimated approximately 12% of Ladakh's geographical area (c. 90,000 km(2)) as highly suitable and 18% as medium suitability. We found that 62.5% of recorded livestock depredation along with over half of all livestock corrals (54%) and homestays (58%) occurred within highly suitable snow leopard habitat. Our habitat suitability model can be used to assist in allocation of conservation resources by targeting construction of livestock corrals to areas of high habitat suitability and promoting ecotourism programs in villages in highly suitable snow leopard habitat.	[Watts, Sophie M.; Namgail, Tsewang] Snow Leopard Conservancy India Trust, Leh, Ladakh, India; [McCarthy, Thomas M.] Panthera, New York, NY USA		Namgail, T (corresponding author), Snow Leopard Conservancy India Trust, Leh, Ladakh, India.	tsewang.namgail@gmail.com	Watts, Sophie/AAW-8692-2020	Watts, Sophie/0000-0002-0760-5526	Winston Cobb Memorial Fellowship from Panthera	Winston Cobb Memorial Fellowship from Panthera	SMW received the Winston Cobb Memorial Fellowship from Panthera. The authors received no specific funding for this work.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Ale SB, 2007, ORYX, V41, P89, DOI 10.1017/S0030605307001585; Alexander JS, 2016, BIOL CONSERV, V197, P27, DOI 10.1016/j.biocon.2016.02.023; Alexander JS, 2016, ORYX, V50, P231, DOI 10.1017/S0030605315001027; Alexander JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155309; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; Aryal A, 2016, ECOL EVOL, V6, P4065, DOI 10.1002/ece3.2196; Aryal A, 2014, SUSTAIN SCI, V9, P321, DOI 10.1007/s11625-014-0246-8; Bai DF, 2018, ZOOL RES, V39, P373, DOI 10.24272/j.issn.2095-8137.2018.057; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Chen P, 2018, TIBET ORYX, V2016, P1; Chundawat R.S., 1999, PLANNING WILDLIFE C; Dearborn KD, 2017, J VEG SCI, V28, P595, DOI 10.1111/jvs.12521; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Ebrahimi A, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-7040-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Erfanian B, 2013, WILDLIFE BIOL, V19, P170, DOI 10.2981/12-045; Farashi A, 2018, MAMMAL RES, V63, P425, DOI 10.1007/s13364-018-0370-4; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forrest JL, 2012, BIOL CONSERV, V150, P129, DOI 10.1016/j.biocon.2012.03.001; FOX JL, 1991, BIOL CONSERV, V55, P283, DOI 10.1016/0006-3207(91)90033-6; Franklin J, 2013, DIVERS DISTRIB, V19, P1217, DOI 10.1111/ddi.12125; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hemery LG, 2016, DIVERS DISTRIB, V22, P1314, DOI 10.1111/ddi.12490; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hussain S, 2003, ORYX, V37, P26, DOI 10.1017/S0030605303000085; Imam E, 2009, ECOL MODEL, V220, P3621, DOI 10.1016/j.ecolmodel.2009.06.044; Jackson R, 1988, P 5 INT SNOW LEOP S, P65; Jackson R., 1984, INT PEDIGREE B SNOW, V4, P43; Jackson R. M., 1996, THESIS U LONDON, P233; Jackson RM, 2016, BIODIVER WORL CONS, P139, DOI 10.1016/B978-0-12-802213-9.00011-0; Jackson RM, 2015, HUM DIMENS WILDL, V20, P310, DOI 10.1080/10871209.2015.1005856; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kittle AM, 2018, BIODIVERS CONSERV, V27, P235, DOI 10.1007/s10531-017-1431-8; Li J., 2012, THESIS, DOI [10.13140/RG.2.2.35552.07685, DOI 10.13140/RG.2.2.35552.07685]; Li J, 2014, BIOL CONSERV, V176, P207, DOI 10.1016/j.biocon.2014.05.025; Li J, 2014, CONSERV BIOL, V28, P87, DOI 10.1111/cobi.12135; Lovari S, 2013, J ZOOL, V291, P127, DOI 10.1111/jzo.12053; Lu CY, 2012, ECOL MODEL, V242, P105, DOI 10.1016/j.ecolmodel.2012.06.002; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy T., 2017, PANTHERA UNCIA IUCN; McCarthy T, 2016, BIODIVER WORL CONS, P23, DOI 10.1016/B978-0-12-802213-9.00003-1; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mohammad G., 2016, SNOW LEOPARDS BIODIV, P179; Molinari-Jobin A, 2018, ANIM CONSERV, V21, P168, DOI 10.1111/acv.12369; Namgail T, 2016, BIODIVER WORL CONS, P164; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Peers MJL, 2014, GLOBAL CHANGE BIOL, V20, P1126, DOI 10.1111/gcb.12469; Phillips S, 2006, AT T RES, V3, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rawat GS, 2005, ARCT ANTARCT ALP RES, V37, P539, DOI 10.1657/1523-0430(2005)037[0539:FADOPC]2.0.CO;2; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Ruiz-Gutierrez V, 2016, METHODS ECOL EVOL, V7, P900, DOI 10.1111/2041-210X.12542; Salas EAL, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00445; Schaller GB., 1977, MOUNTAIN MONARCHS; Sharma RK, 2015, BIOL CONSERV, V190, P8, DOI 10.1016/j.biocon.2015.04.026; Song JW, 2014, SUSTAINABILITY-BASEL, V6, P4059, DOI 10.3390/su6074059; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Wibisono HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198369; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612; Wolf M, 2009, J MAMMAL, V90, P604, DOI 10.1644/08-MAMM-A-002R1.1	71	12	14	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211509	10.1371/journal.pone.0211509	http://dx.doi.org/10.1371/journal.pone.0211509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695083	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400042
J	Tesso, TA; Zheng, AJ; Cai, HY; Liu, GH				Tesso, Tujuba Ayele; Zheng, Aijuan; Cai, Huiyi; Liu, Guohua			Isolation and characterization of two Acinetobacter species able to degrade 3-methylindole	PLOS ONE			English	Article							INDOLIC COMPOUNDS; RING-CLEAVAGE; SKATOLE; BACTERIA; TEMPERATURE; BIOTRANSFORMATION; BIODEGRADATION; OXIDATION; PATHWAY; CULTURE	3-Methylindole (3MI) or Skatole is a volatile lipophilic organic compound produced by anoxic metabolism of L-tryptophan and associated with animal farming and industrial processing wastes. Pure cultures of bacteria capable of utilizing 3MI were isolated from chicken manure using enrichment culture techniques. The bacteria were identified as Acinetobacter toweneri NTA1-2A and Acinetobacter guillouiae TAT1-6A, based on 16S rDNA gene amplicon sequence data. The optimal temperature and pH for degradation of 3MI were established using single factor experiments. Strain tolerance was assessed over a range of initial concentrations of 3MI, and the effects of initial concentration on subsequent microbial 3MI degradation were also measured. During the degradation experiment, concentrations of 3MI were quantified by reverse-phase high-performance liquid chromatography (HPLC). The strains were capable of degrade initial concentrations of 3MI ranging from 65-200 mg/L. The degradation efficiency was >85% in 6 days for both strains when the initial concentration is less than 200 mg/L. The strains were tested for enzymatic activity using 65 mg/L 3MI. The enzyme extracts of NTA1-2A and TAT1-6A from the 3MI medium degraded 71.46% and 60.71% of 3MI respectively, but no appreciable change in 3MI concentration in the control group was witnessed. Our experiment revealed betaine and choline were identified as 3MI degradation metabolites by both strains while nitroso-pyrrolidine and beta-alaninebetaine formed by NTA1-2A and TAT1-6A strains respectively. The NTA1-2A and TAT1-6A strains removed 84.32% and 81.39% 3MI respectively from chicken manure during fermentation in 8 days and showed a statistically significant difference (P < 0.05) compared with the control group. The optimum temperature and pH were 31 degrees C and 6 respectively, for 3MI degradation by A. toweneri NTA1-2A and A. guillouiae TAT1-6A. We concluded that A. toweneri NTA1-2A and A. guillouiae TAT1-6A are potential strains of interest to degrade 3MI and control odorant in poultry and other livestock industries.	[Tesso, Tujuba Ayele; Zheng, Aijuan; Cai, Huiyi; Liu, Guohua] Chinese Acad Agr Sci, Feed Res Inst, Natl Engn Res Ctr Biol Feed, Minist Agr,Key Lab Feed Biotechnol, Beijing, Peoples R China; [Tesso, Tujuba Ayele] Mettu Univ, Fac Nat Sci, Dept Biol, Mettu, Ethiopia	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, GH (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Natl Engn Res Ctr Biol Feed, Minist Agr,Key Lab Feed Biotechnol, Beijing, Peoples R China.	liuguohua@caas.cn			Beijing Innovation Team Program for the poultry industry in Chinese Agriculture Research System	Beijing Innovation Team Program for the poultry industry in Chinese Agriculture Research System	This study was funded by the Beijing Innovation Team Program for the poultry industry in Chinese Agriculture Research System, awarded to Professor Guohua Liu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON ML, 1991, ADV EXP MED BIOL, V283, P245; Arora PK, 2015, J CHEM-NY, V2015, DOI [10.1155/2015/296231, 10.1155/2015/129159]; ARORA PK, 2015, J CHEM-NY, DOI DOI 10.1155/2015/; Attwood G, 2006, J APPL MICROBIOL, V100, P1261, DOI 10.1111/j.1365-2672.2006.02896.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; CARLSON JR, 1972, SCIENCE, V176, P298, DOI 10.1126/science.176.4032.298; Carr BA, 2003, MOL PHARMACOL, V63, P1137, DOI 10.1124/mol.63.5.1137; Carroll NM, 2000, J CLIN MICROBIOL, V38, P1753, DOI 10.1128/JCM.38.5.1753-1757.2000; Deslandes B, 2001, LIVEST PROD SCI, V71, P193, DOI 10.1016/S0301-6226(01)00189-0; Fukuoka K, 2015, BIODEGRADATION, V26, P359, DOI 10.1007/s10532-015-9739-0; Fukuoka K, 2015, INT BIODETER BIODEGR, V97, P13, DOI 10.1016/j.ibiod.2014.11.007; Gu JD, 2002, MAR POLLUT BULL, V45, P379, DOI 10.1016/S0025-326X(02)00091-7; GU JD, 1991, APPL ENVIRON MICROB, V57, P2622, DOI 10.1128/AEM.57.9.2622-2627.1991; GU JD, 1992, APPL ENVIRON MICROB, V58, P2667, DOI 10.1128/AEM.58.8.2667-2669.1992; HAMMOND AC, 1980, VET REC, V107, P344, DOI 10.1136/vr.107.15.344; JENSEN MT, 1995, APPL ENVIRON MICROB, V61, P3180, DOI 10.1128/AEM.61.8.3180-3184.1995; KAMATH AV, 1990, APPL ENVIRON MICROB, V56, P275, DOI 10.1128/AEM.56.1.275-280.1990; Kim MH, 1999, WATER RES, V33, P562, DOI 10.1016/S0043-1354(98)00228-0; Kohda C, 1997, J GEN APPL MICROBIOL, V43, P249, DOI 10.2323/jgam.43.249; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liang C, 2003, BIORESOURCE TECHNOL, V86, P131, DOI 10.1016/S0960-8524(02)00153-0; Liu YJ, 2009, CHEM ECOL, V25, P107, DOI 10.1080/02757540902849278; LUNDSTROM K, 1988, LIVEST PROD SCI, V18, P55, DOI 10.1016/0301-6226(88)90067-X; Madsen EL, 1998, APPL ENVIRON MICROB, V54, P74; Maeng JH, 1996, J BACTERIOL, V178, P3695, DOI 10.1128/jb.178.13.3695-3700.1996; Meng X, 2013, EXP THER MED, V6, P983, DOI 10.3892/etm.2013.1251; Nakai Yutaka, 1999, Animal Science Journal, V70, P32; OCHIAI M, 1986, MUTAT RES, V172, P189, DOI 10.1016/0165-1218(86)90056-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarioglu OF, 2012, INT BIODETER BIODEGR, V71, P67, DOI 10.1016/j.ibiod.2012.04.012; SHANKER R, 1990, MICROBIAL ECOL, V20, P171, DOI 10.1007/BF02543875; Sharma N, 2015, LETT APPL MICROBIOL, V60, P298, DOI 10.1111/lam.12379; Sihag S., 2014, INT J PURE APPL BIOS, V2, P185, DOI DOI 10.1016/S0038-071700219-8; Sundberg C, 2013, WASTE MANAGE, V33, P204, DOI 10.1016/j.wasman.2012.09.017; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tang JC, 2007, J BIOSCI BIOENG, V104, P321, DOI 10.1263/jbb.104.321; Throne-Holst M, 2007, APPL ENVIRON MICROB, V73, P3327, DOI 10.1128/AEM.00064-07; Wang YL, 2005, J BASIC MICROB, V45, P83, DOI 10.1002/jobm.200410446; Whitehead TR, 2008, APPL ENVIRON MICROB, V74, P1950, DOI 10.1128/AEM.02458-07; Yin B, 2006, HUM ECOL RISK ASSESS, V12, P248, DOI 10.1080/10807030500531539; Yin B, 2005, INT BIODETER BIODEGR, V56, P243, DOI 10.1016/j.ibiod.2005.10.001; Yin B, 2006, WATER AIR SOIL POLL, V176, P185, DOI 10.1007/s11270-006-9159-1; YOKOYAMA MT, 1981, APPL ENVIRON MICROB, V41, P71, DOI 10.1128/AEM.41.1.71-76.1981; Yu XQ, 2004, WORLD J MICROB BIOT, V20, P623, DOI 10.1023/B:WIBI.0000043184.30420.20	44	14	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211275	10.1371/journal.pone.0211275	http://dx.doi.org/10.1371/journal.pone.0211275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689668	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800025
J	Galson, SW; Stanifer, JW; Hertz, JT; Temu, G; Thielman, N; Gafaar, T; Staton, CA				Galson, Sophie W.; Stanifer, John W.; Hertz, Julian T.; Temu, Gloria; Thielman, Nathan; Gafaar, Temitope; Staton, Catherine A.			The burden of hypertension in the emergency department and linkage to care: A prospective cohort study in Tanzania	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; SUB-SAHARAN AFRICA; RISK-FACTORS; PREVALENCE; BARRIERS; DISEASE; INCOME	Objectives Globally, hypertension affects one billion people and disproportionately burdens low-and middle-income countries. Despite the high disease burden in sub-Saharan Africa, optimal care models for diagnosing and treating hypertension have not been established. Emergency departments (EDs) are frequently the first biomedical healthcare contact for many people in the region. ED encounters may offer a unique opportunity for identifying high risk patients and linking them to care. Methods Between July 2017 and March 2018, we conducted a prospective cohort study among patients presenting to a tertiary care ED in northern Tanzania. We recruited adult patients with a triage blood pressure. 140/90 mmHg in order to screen for hypertension. We explored knowledge, attitudes and practices for hypertension using a questionnaire, and assessed factors associated with successful follow-up. Hypertension was defined as a single blood pressure measurement. 160/100 mmHg or a three-time average of. 140/90 mmHg. Uncontrolled hypertension was defined as a three-time average measurement of. 160/100 mmHg. Successful follow-up was defined as seeing an outpatient provider within one month of the ED visit. Results We enrolled 598 adults (mean age 59.6 years), of whom 539 (90.1%) completed the study. The majority (78.6%) of participants were aware of having hypertension. Many (223; 37.2%) had uncontrolled hypertension. Overall, only 236 (43.8%) of participants successfully followed-up within one month. Successful follow-up was associated with a greater understanding that hypertension requires lifelong treatment (RR 1.11; 95% CI 1.03,1.21) and inversely associated with greater anxiety about the future (RR 0.80; 95% CI 0.64,0.99). Conclusion In a northern Tanzanian tertiary care ED, the burden of hypertension is high, with few patients receiving optimal outpatient care follow-up. Multi-disciplinary strategies are needed to improve linkage to care for high-risk patients from ED settings.	[Galson, Sophie W.; Hertz, Julian T.; Staton, Catherine A.] Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA; [Galson, Sophie W.; Stanifer, John W.; Hertz, Julian T.; Thielman, Nathan; Gafaar, Temitope; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Stanifer, John W.] Duke Univ, Dept Med, Div Nephrol, Durham, NC USA; [Temu, Gloria] Kilimanjaro Christian Med Coll Hosp, Dept Med, Kilimanjaro, Tanzania; [Thielman, Nathan] Duke Univ, Dept Med, Durham, NC USA; [Staton, Catherine A.] Dept Neurosurg, Div Global Neurosurg & Neurosci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Galson, SW (corresponding author), Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA.; Galson, SW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	sophie.galson@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879; Staton, Catherine/0000-0002-6468-2894; Hertz, Julian/0000-0002-7396-4789	Fogarty International Center [K01 TW010000-01A1]; FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	CAS would like to acknowledge salary support funding from the Fogarty International Center(Staton, K01 TW010000-01A1, https://www.fic.nih.gov/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ajayi IO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3789-z; [Anonymous], 2016, ICHF HLTH INS COV 10; Backer HD, 2003, ANN EMERG MED, V41, P507, DOI 10.1067/mem.2003.151; Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Bitter CC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019024; BONE LR, 1989, AM J EMERG MED, V7, P16, DOI 10.1016/0735-6757(89)90077-6; Boulware LE, 2001, AM J PREV MED, V21, P221, DOI 10.1016/S0749-3797(01)00356-7; Brody A, 2015, ACAD EMERG MED, V22, P632, DOI 10.1111/acem.12660; CHERNOW SM, 1987, ANN EMERG MED, V16, P180, DOI 10.1016/S0196-0644(87)80012-4; Daniel RM, 2012, STAT METHODS MED RES, V21, P243, DOI 10.1177/0962280210394469; Demographic and Health Surveys, 2013, UN REP TANZ HIV AIDS; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Dieterle T, 2005, AM J EMERG MED, V23, P474, DOI 10.1016/j.ajem.2005.02.046; Dutta A., 2015, PROSPECTS SUSTAINABL; Galson SW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018829; Gleason-Comstock J, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0052-3; Katalambula LK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4679-8; Lee S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191738; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martin Alison, 2002, J Health Serv Res Policy, V7, P160, DOI 10.1258/135581902760082463; McNaughton CD, 2015, AM J CARDIOL, V116, P1717, DOI 10.1016/j.amjcard.2015.09.007; Miller AH, 2005, AM J EMERG MED, V23, P423, DOI 10.1016/j.ajem.2005.01.009; Ministry for health community development gender elderly and children, 2013, STAND TREATM GUID NA; Mosha NR, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1321279; Muhamedhussein MS, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/1281384; Naanyu V, 2016, J GEN INTERN MED, V31, P304, DOI 10.1007/s11606-015-3566-1; Pascasie K, 2014, AFR J EMERG MED, V4, P178, DOI 10.1016/j.afjem.2013.10.001; Pastakia SD, 2017, J GEN INTERN MED, V32, P540, DOI 10.1007/s11606-016-3918-5; Prendergast HM, 2015, PUBLIC HEALTH, V129, P604, DOI 10.1016/j.puhe.2015.02.001; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164428; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156336; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121722; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Tan N, 2013, EMERG MED AUSTRALAS, V25, P175, DOI 10.1111/1742-6723.12060; The United Republic of Tanzania, 2013, POPULATION DISTRIBUT; Turin TC, 2013, J AM SOC NEPHROL, V24, P1661, DOI 10.1681/ASN.2012111118; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Vedanthan R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-143; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WHO, 2013, WHO GLOB BRIEF HYP; Xu WX, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h158; Zack RM, 2016, J HYPERTENS, V34, P2353, DOI 10.1097/HJH.0000000000001117	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211287	10.1371/journal.pone.0211287	http://dx.doi.org/10.1371/journal.pone.0211287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682173	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500143
J	Kreis, NN; Steinhauser, K; Ritter, A; Kloble, P; Hoock, SC; Roth, S; Louwen, F; Oswald, F; Yuan, JP				Kreis, Nina-Naomi; Steinhaeuser, Kerstin; Ritter, Andreas; Kloeble, Patricia; Hoock, Samira Catharina; Roth, Susanne; Louwen, Frank; Oswald, Franz; Yuan, Juping			Potential involvement of RITA in the activation of Aurora A at spindle poles during mitosis	ONCOGENE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; MICROTUBULE-ASSOCIATED PROTEIN; CELL LYMPHOMA 6; A KINASE; CENTROSOME AMPLIFICATION; MITOTIC DEFECTS; TPX2; NUCLEATION; TUBULIN; HURP	The mitotic kinase Aurora A is crucial for various mitotic events. Its activation has been intensively investigated and is not yet completely understood. RITA, the RBP-J interacting and tubulin-associated protein, has been shown to modulate microtubule dynamics in mitosis. We asked if RITA could be related to the activation of Aurora A. We show here that RITA is colocalized with Aurora A and its activator TPX2 at spindle poles during mitosis. FLAG-RITA is precipitated with the complex of Aurora A, TPX2 and tubulin. Depletion of RITA increases exclusively active Aurora A and TPX2 at spindle poles in diverse cancer cell lines and in RITA knockout mouse embryonic fibroblasts. The enhanced active Aurora A, its substrate p-TACC3 and TPX2 are restored by adding back of RITA but not its Delta tub mutant with an impaired tubulin-binding capability, indicating that RITA' s role as Aurora A's modulator is mediated through its interaction with tubulin. Also, the mitotic failures in cells depleted of RITA are rescued by the inhibition of Aurora A. RITA itself does not directly interfere with the catalytic activity of Aurora A, instead, affects the microtubule binding of its activator TPX2. Moreover, Aurora A's activation correlates with microtubule stabilization induced by the microtubule stabilizer paclitaxel, implicating that stabilized microtubules caused by RITA depletion could also account for increased active Aurora A. Our data suggest a potential role for RITA in the activation of Aurora A at spindle poles by modulating the microtubule binding of TPX2 and the microtubule stability during mitosis.	[Kreis, Nina-Naomi; Steinhaeuser, Kerstin; Ritter, Andreas; Hoock, Samira Catharina; Roth, Susanne; Louwen, Frank; Yuan, Juping] Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Kloeble, Patricia; Oswald, Franz] Univ Med Ctr Ulm, Ctr Internal Med, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany; [Steinhaeuser, Kerstin] Solvadis Distribut GmbH, Hafen 4, D-64579 Gernsheim, Germany	Goethe University Frankfurt; Ulm University	Yuan, JP (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	yuan@em.uni-frankfurt.de	Ritter, Andreas/AAX-3938-2020; Ritter, Andreas/ABB-6348-2020; Kreis, Nina-Naomi/AAF-5407-2019; Oswald, Franz/AAO-9584-2020	Ritter, Andreas/0000-0002-5955-859X; Kreis, Nina-Naomi/0000-0003-4304-0160; Yuan, Juping/0000-0003-0694-0565	Deutsche Forschungsgemeinschaft [SFB1074/A3, Yu 156/7-1]; BMBF (research nucleus SyStAR); International Graduate School in Molecular Medicine, Ulm [GSC270]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (research nucleus SyStAR)(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine, Ulm	We gratefully thank Ms. Friemel (Frankfurt) and Ms. Schirmer (Ulm) for their technical assistance. The work was partially supported by the Deutsche Forschungsgemeinschaft (SFB1074/A3 to FO, Yu 156/7-1 to JY) and the BMBF (research nucleus SyStAR to FO). PK was supported by the International Graduate School in Molecular Medicine, Ulm (GSC270).	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Burgess SG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005345; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; D'Assoro AB, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00295; Dodson CA, 2012, J BIOL CHEM, V287, P1150, DOI 10.1074/jbc.M111.312090; Ertych N, 2014, NAT CELL BIOL, V16, P779, DOI 10.1038/ncb2994; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Goepfert TM, 2002, CANCER RES, V62, P4115; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hochegger H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120185; Jasmer B, 2017, ONCOTARGET, V8, P108643, DOI 10.18632/oncotarget.20586; Karthigeyan D, 2011, MED RES REV, V31, P757, DOI 10.1002/med.20203; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kreis NN, 2014, ONCOGENE, V33, P5716, DOI 10.1038/onc.2013.518; Kreis NN, 2016, ONCOTARGET, V7, P50215, DOI 10.18632/oncotarget.10330; Kreis NN, 2015, ONCOTARGET, V6, P6611, DOI 10.18632/oncotarget.2844; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Magiera MM, 2013, METHOD CELL BIOL, V115, P247, DOI 10.1016/B978-0-12-407757-7.00016-5; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Muschol-Steinmetz C, 2016, CELL CYCLE, V15, P827, DOI 10.1080/15384101.2016.1149273; Nguyen HL, 1999, J CELL SCI, V112, P1813; Noujaim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086786; Ritter A, 2018, STEM CELL REP, V10, P583, DOI 10.1016/j.stemcr.2017.12.022; Ritter A, 2016, CRIT REV BIOCHEM MOL, V51, P228, DOI 10.1080/10409238.2016.1178705; Ritter A, 2015, CELL CYCLE, V14, P3755, DOI 10.1080/15384101.2015.1068481; Rodel F, 2018, RADIOTHER ONCOL, V126, P214, DOI 10.1016/j.radonc.2017.10.028; Rohena CC, 2013, BIOCHEM PHARMACOL, V85, P1104, DOI 10.1016/j.bcp.2013.01.030; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Sardon T, 2010, EMBO REP, V11, P977, DOI 10.1038/embor.2010.171; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Silva VC, 2013, MOL BIOL CELL, V24, P3819, DOI 10.1091/mbc.E13-02-0108; Steinhauser K, 2017, ONCOGENE, V36, P2146, DOI 10.1038/onc.2016.372; Tang AQ, 2017, ONCOTARGET, V8, P23937, DOI 10.18632/oncotarget.14893; Thakur HC, 2013, BIOL CHEM, V394, P1411, DOI 10.1515/hsz-2013-0184; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Wacker SA, 2011, EMBO J, V30, P43, DOI 10.1038/emboj.2010.289; Wang HH, 2014, BIOCHEM BIOPH RES CO, V454, P71, DOI 10.1016/j.bbrc.2014.10.023; Wang HH, 2012, ONCOL RES, V20, P437, DOI 10.3727/096504013X13685487925059; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wu JM, 2013, P NATL ACAD SCI USA, V110, pE1779, DOI 10.1073/pnas.1220523110; Zhang R, 2017, ELIFE, V6, DOI 10.7554/eLife.30959; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198	57	3	3	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4199	4214		10.1038/s41388-019-0716-7	http://dx.doi.org/10.1038/s41388-019-0716-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30705408				2022-12-26	WOS:000469339100001
J	Perotti, V; Baldassari, P; Molla, A; Nicolini, G; Bersani, I; Grazia, G; Benigni, F; Maurichi, A; Santinami, M; Anichini, A; Mortarini, R				Perotti, Valentina; Baldassari, Paola; Molla, Alessandra; Nicolini, Gabriella; Bersani, Ilaria; Grazia, Giulia; Benigni, Fabio; Maurichi, Andrea; Santinami, Mario; Anichini, Andrea; Mortarini, Roberta			An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; MALIGNANT-MELANOMA; CANCER CELLS; PROGRESSION; METASTASIS; EXPRESSION; BREAST; GROWTH; DIFFERENTIATION	Discovery of new actionable targets and functional networks in melanoma is an urgent need as only a fraction of metastatic patients achieves durable clinical benefit by targeted therapy or immunotherapy approaches. Here we show that NFATc2 expression is associated with an EMT-like transcriptional program and with an invasive melanoma phenotype, as shown by analysis of melanoma cell lines at the mRNA and protein levels, interrogation of the TCGA melanoma dataset and characterization of melanoma lesions by immunohistochemistry. Gene silencing or pharmacological inhibition of NFATc2 downregulated EMT-related genes and AXL, and suppressed c-Myc, FOXM1, and EZH2. Targeting of c-Myc suppressed FOXM1 and EZH2, while targeting of FOXM1 suppressed EZH2. Inhibition of c-Myc, or FOXM1, or EZH2 downregulated EMT-related gene expression, upregulated MITF and suppressed migratory and invasive activity of neoplastic cells. Stable silencing of NFATc2 impaired melanoma cell proliferation in vitro and tumor growth in vivo in SCID mice. In NFATc2(+) EZH2(+) melanoma cell lines pharmacological co-targeting of NFATc2 and EZH2 exerted strong anti-proliferative and proapoptotic activity, irrespective of BRAF or NRAS mutations and of BRAF inhibitor resistance. These results provide preclinical evidence for a role of NFATc2 in shaping the EMT-like melanoma phenotype and reveal a targetable vulnerability associated with NFATc2 and EZH2 expression in melanoma cells belonging to different mutational subsets.	[Perotti, Valentina; Baldassari, Paola; Molla, Alessandra; Nicolini, Gabriella; Bersani, Ilaria; Grazia, Giulia; Anichini, Andrea; Mortarini, Roberta] Dept Res, Human Tumors Immunobiol Unit, Milan, Italy; [Benigni, Fabio] HuMabs Biomed, Subsidiary Vir Biotechnol, Bellinzona, Switzerland; [Maurichi, Andrea; Santinami, Mario] Fdn IRCCS, Dept Surg, Melanoma & Sarcoma Unit, Ist Nazl Tumori, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Mortarini, R (corresponding author), Dept Res, Human Tumors Immunobiol Unit, Milan, Italy.	roberta.mortarini@istitutotumori.mi.it	Maurichi, Andrea/E-7030-2017; Maurichi, Andrea/AAX-5020-2020; Santinami, Mario/I-3795-2017; Anichini, Andrea/K-1434-2016; Perotti, Valentina/C-1049-2017	Maurichi, Andrea/0000-0002-6503-5373; Maurichi, Andrea/0000-0002-6503-5373; Santinami, Mario/0000-0001-8436-4757; Anichini, Andrea/0000-0001-5096-5538; Perotti, Valentina/0000-0003-4506-2363	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.) [IG15860]	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.), grant IG15860 to RM.	Anichini A, 2006, CANCER RES, V66, P6405, DOI 10.1158/0008-5472.CAN-06-0854; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Baumgart S, 2016, MOL CANCER THER, V15, P491, DOI 10.1158/1535-7163.MCT-15-0309; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Caballero FJ, 2007, BIOCHEM PHARMACOL, V73, P1013, DOI 10.1016/j.bcp.2006.12.001; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciuffreda L, 2009, NEOPLASIA, V11, P720, DOI 10.1593/neo.09398; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eriksson J, 2016, ONCOTARGET, V7, P15065, DOI 10.18632/oncotarget.7604; Garay T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117021; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Izumi H, 2015, SURG TODAY, V45, P487, DOI 10.1007/s00595-015-1126-2; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kreiseder B, 2013, INT J CANCER, V132, P521, DOI 10.1002/ijc.27698; Kudo-Saito C, 2013, CANCER RES, V73, P6185, DOI 10.1158/0008-5472.CAN-13-1364; Liu L, 2016, BJU INT, V117, P351, DOI 10.1111/bju.12702; Lu J, 2015, MOL MED REP, V12, P2668, DOI 10.3892/mmr.2015.3752; Mahmoud F, 2016, CANCER BIOL THER, V17, P579, DOI 10.1080/15384047.2016.1167291; Mann KM, 2004, J CELL BIOL, V165, P483, DOI 10.1083/jcb.200402105; Paluncic J, 2016, BBA-MOL CELL RES, V1863, P770, DOI 10.1016/j.bbamcr.2016.01.025; Parvani JG, 2015, CANCER RES, V75, P2316, DOI 10.1158/0008-5472.CAN-14-3485; Pearlman RL, 2017, CANCER LETT, V391, P125, DOI 10.1016/j.canlet.2017.01.029; Penna I, 2016, ONCOTARGET, V7, P3947, DOI 10.18632/oncotarget.6600; Peres J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-117; Perotti V, 2016, ONCOGENE, V35, P2862, DOI 10.1038/onc.2015.355; Perotti V, 2012, J INVEST DERMATOL, V132, P2652, DOI 10.1038/jid.2012.179; Rai K, 2015, CANCER DISCOV, V5, P1314, DOI 10.1158/2159-8290.CD-15-0493; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Rastelli L, 2011, INT J ONCOL, V39, P401, DOI 10.3892/ijo.2011.1040; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schech AJ, 2013, MOL CANCER THER, V12, P1356, DOI 10.1158/1535-7163.MCT-12-0304; Sensi M, 2011, J INVEST DERMATOL, V131, P2448, DOI 10.1038/jid.2011.218; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Singh SK, 2011, J BIOL CHEM, V286, P28761, DOI 10.1074/jbc.M110.197533; Tian L, 2016, INT J ONCOL, V48, P783, DOI 10.3892/ijo.2015.3282; Tiffen JC, 2015, ONCOTARGET, V6, P27023, DOI 10.18632/oncotarget.4809; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Wang B, 2012, BIOCHEM BIOPH RES CO, V417, P601, DOI 10.1016/j.bbrc.2011.12.014; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Xu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059412; Yamamoto K, 2014, MOL CELL, V53, P904, DOI 10.1016/j.molcel.2014.02.028; Yang KK, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0158-1; Yin LL, 2015, J INVEST DERMATOL, V135, P2455, DOI 10.1038/jid.2015.179; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007	50	21	22	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4384	4396		10.1038/s41388-019-0729-2	http://dx.doi.org/10.1038/s41388-019-0729-2			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30710146	Green Published, hybrid			2022-12-26	WOS:000469339100013
J	Rosenfeld, YBZ; Krumbein, M; Yeffet, A; Schiffmann, N; Mishalian, I; Pikarsky, E; Oberman, F; Fridlender, Z; Yisraeli, JK				Rosenfeld, Yifat Bar-Zakay; Krumbein, Miriam; Yeffet, Avner; Schiffmann, Nathan; Mishalian, Inbal; Pikarsky, Eli; Oberman, Froma; Fridlender, Zvi; Yisraeli, Joel K.			VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice	ONCOGENE			English	Article							BREAST-CANCER CELLS; MESSENGER-RNA; BINDING-PROTEIN; PANCREATIC-CANCER; STEM-CELLS; CRD-BP; EXPRESSION; PROMOTE; GROWTH; IGF2BP1	The VICKZ (Igf2bp) family of RNA binding proteins regulate RNA function at many levels, including intracellular RNA localization, RNA stability, and translational control. One or more of the three VICKZ paralogs are upregulated in many different types of cancers. Here, we show how VICKZ1 enhances, and dominant negative VICKZ1 inhibits, cell migration, growth in soft agar, and wound healing in a mouse lung adenocarcinoma cell line containing a constitutively active, mutant Kras. Similarly, modulation of VICKZ1 activity promotes or inhibits metastases upon implantation of these cells into syngeneic mice. To test these effects in a genetic model system, we generated a mouse with an inducible VICKZ1 transgene and found that isolated overexpression of VICKZ1 in the lungs had no noticeable effect on morphology. Although directed overexpression of mutant Kras in the lungs led to the formation of small adenomas, concurrent overexpression of VICKZ1 remarkably accelerated tumor growth and formation of pulmonary adenocarcinomas. VICKZ1-containing ribonucleoprotein complexes are highly enriched in Kras mRNA in lung adenocarcinoma cells, and Kras signaling is enhanced in these cells by overexpression of VICKZ1. Analysis of lung carcinoma patients reveals that elevated VICKZ1 expression correlates with lower overall survival; this reduction is dramatically enhanced in those patients bearing a mutant Kras gene. Our study reveals that RNA binding proteins of the VICKZ family can synergize with Kras to influence signaling and oncogenic activity.	[Rosenfeld, Yifat Bar-Zakay; Krumbein, Miriam; Yeffet, Avner; Schiffmann, Nathan; Oberman, Froma; Yisraeli, Joel K.] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Mishalian, Inbal; Fridlender, Zvi] Hadassah Hebrew Univ Med Ctr, Inst Pulm Med, POB 12000, IL-91120 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Yisraeli, JK (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	joely@ekmd.huji.ac.il	Yisraeli, Joel/S-2031-2019; pikarsky, eli/GXV-7099-2022	Yisraeli, Joel/0000-0001-6538-6686; pikarsky, eli/0000-0003-4186-7105	Israel Science Foundation; Israel Cancer Research Fund; Eliahu Penn Foundation (JKY)	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Eliahu Penn Foundation (JKY)	This research was supported by the Israel Science Foundation, the Israel Cancer Research Fund, and the Eliahu Penn Foundation (JKY).	Barghash A, 2016, ONCOTARGET, V7, P49743, DOI 10.18632/oncotarget.10439; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Busch B, 2016, NUCLEIC ACIDS RES, V44, P3845, DOI 10.1093/nar/gkw099; Carmel MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136408; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Conway AE, 2016, CELL REP, V15, P666, DOI 10.1016/j.celrep.2016.03.052; Dai N, 2015, CELL METAB, V21, P609, DOI 10.1016/j.cmet.2015.03.006; Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Davidson B, 2014, HUM PATHOL, V45, P1520, DOI 10.1016/j.humpath.2014.03.005; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Degrauwe N, 2016, CELL REP, V15, P1634, DOI 10.1016/j.celrep.2016.04.086; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gong Y, 2014, ADV ANAT PATHOL, V21, P191, DOI 10.1097/PAP.0000000000000021; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Gu W, 2009, J CELL SCI, V122, P1895, DOI 10.1242/jcs.045278; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Ioannidis P, 2004, CANCER LETT, V209, P245, DOI 10.1016/j.canlet.2003.12.015; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; JnBaptiste CK, 2017, GENE DEV, V31, P674, DOI 10.1101/gad.296301.117; Kalous A, 2014, DEV NEUROBIOL, V74, P303, DOI 10.1002/dneu.22110; Kato T, 2007, CLIN CANCER RES, V13, P434, DOI 10.1158/1078-0432.CCR-06-1297; Khan P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2078-7; Kim HY, 2018, CANCER LETT, V415, P30, DOI 10.1016/j.canlet.2017.11.039; Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033; Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500; LEADER M, 1986, HISTOPATHOLOGY, V10, P1315, DOI 10.1111/j.1365-2559.1986.tb02574.x; Maizels Y, 2015, J CELL SCI, V128, P1922, DOI 10.1242/jcs.163972; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Mueller S, 2018, NATURE, V554, P62, DOI 10.1038/nature25459; Muller S, 2018, NUCLEIC ACIDS RES, V46, P6285, DOI 10.1093/nar/gky229; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi Felicite K, 2010, Genes Cancer, V1, P1074, DOI 10.1177/1947601910395581; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Nwokafor CU, 2016, ONCOTARGET, V7, P72662, DOI 10.18632/oncotarget.12083; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Samanta S, 2013, J BIOL CHEM, V288, P12569, DOI 10.1074/jbc.C112.442319; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Stoskus M, 2016, BLOOD CELL MOL DIS, V57, P30, DOI 10.1016/j.bcmd.2015.11.006; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Timar J, 2014, CURR OPIN ONCOL, V26, P138, DOI 10.1097/CCO.0000000000000051; Uekita T, 2014, MOL CANCER RES, V12, P1449, DOI 10.1158/1541-7786.MCR-13-0587; Vainer G, 2008, J PATHOL, V215, P445, DOI 10.1002/path.2376; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wang GL, 2016, ONCOTARGET, V7, P15690, DOI 10.18632/oncotarget.7464; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang JH, 2015, ONCOL LETT, V9, P1927, DOI 10.3892/ol.2015.2910	55	16	16	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4169	4181		10.1038/s41388-019-0715-8	http://dx.doi.org/10.1038/s41388-019-0715-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30700831				2022-12-26	WOS:000468740200014
J	Zhou, XL; Zhu, CY; Wu, ZG; Guo, X; Zou, W				Zhou, Xiao-Lei; Zhu, Chong-Yue; Wu, Zhi-Gang; Guo, Xin; Zou, Wei			The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NRF2; PROMOTE PROLIFERATION; FACTOR SP1; MIGRATION; PROTEIN; PATHWAY; DYSREGULATION; DEGRADATION; MECHANISMS; MUTATIONS	The nuclear factor E2-related factor 2 (NRF2)-Kelch-like ECH-associated protein 1 (KEAP1) signaling cascades is a key transcriptional pathway governing cellular oxidative stress and tumor development. Mammalian hepatitis B X-interacting protein (HBXIP) has critical roles in modulating cancer malignance and tumor progression. However, whether HBXIP interacts with KEAP1 and NRF2 is unclear. Here, we found that HBXIP can effectually compete with NRF2 for binding with KEAP1 protein via its highly conserved GLNLG motif. The HBXIP-mediated reduction in NRF2-KEAP1 complexes promotes NRF2 accumulation and nuclear entry, which facilities the activation of antioxidant response element (ARE)dependent signaling cascades, thereby reducing the accumulation of endogenous cellular reactive oxygen species (ROS). We also found a strong positive correlation between HBXIP expression and NRF2 expression in breast cancer cells, tissue microarrays and clinical breast cancer tissues. Furthermore, this positive correlation was further confirmed via analysis of 1905 clinical cases of breast carcinoma provided by the cancer genomics database cBioPortal. Strikingly, disrupting the HBXIP-KEAP1 axis via mutating the GLNLG motif of HBXIP leads to potent inhibition of the malignancy of breast carcinoma both in vivo and in vitro. Our findings broaden our understanding of HBXIP as a modulation factor of cellular oxidative stress and address a novel regulatory mechanism governing redox homeostasis and the progression of breast carcinoma.	[Zhou, Xiao-Lei; Zhu, Chong-Yue; Wu, Zhi-Gang; Zou, Wei] Hebei Univ Sci & Technol, Publ R&D Ctr Biomanufacture, Shijiazhuang 050018, Hebei, Peoples R China; [Guo, Xin] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Pathol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan	Hebei University of Science & Technology; Kagoshima University	Zhou, XL (corresponding author), Hebei Univ Sci & Technol, Publ R&D Ctr Biomanufacture, Shijiazhuang 050018, Hebei, Peoples R China.	foxlei@live.cn			National Natural Scientific Foundation [81602428]; Colleges and Universities in Hebei Province Science and Technology Research Project [QN2016020]; Science and Technology Research and Developmental Guidance Program of Shijiazhuang City [171201073 A]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Colleges and Universities in Hebei Province Science and Technology Research Project; Science and Technology Research and Developmental Guidance Program of Shijiazhuang City	This project was supported by grants from the National Natural Scientific Foundation (No. 81602428), the Colleges and Universities in Hebei Province Science and Technology Research Project (No. QN2016020), and the Science and Technology Research and Developmental Guidance Program of Shijiazhuang City (No. 171201073 A)	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bauer AK, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/746432; Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Leinonen HM, 2015, BIOCHEM SOC T, V43, P645, DOI 10.1042/BST20150048; Li H, 2018, J BIOL CHEM, V293, P2053, DOI 10.1074/jbc.M117.809582; Li H, 2015, J BIOL CHEM, V290, P22649, DOI 10.1074/jbc.M115.658468; Li LL, 2015, BIOCHEM BIOPH RES CO, V458, P720, DOI 10.1016/j.bbrc.2015.02.036; Li YH, 2014, CANCER LETT, V355, P288, DOI 10.1016/j.canlet.2014.09.047; Liu BW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0577-5; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Onodera Y, 2014, ENDOCR-RELAT CANCER, V21, P241, DOI 10.1530/ERC-13-0234; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Shi H, 2016, BIOCHEM BIOPH RES CO, V471, P89, DOI 10.1016/j.bbrc.2016.01.174; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Torrente L, 2017, ONCOGENE, V36, P6204, DOI 10.1038/onc.2017.221; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Xu FQ, 2013, CANCER LETT, V333, P124, DOI 10.1016/j.canlet.2013.01.029; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhang YY, 2013, BIOCHEM BIOPH RES CO, V434, P305, DOI 10.1016/j.bbrc.2013.02.123; Zhao Y, 2016, CANCER RES, V76, P4696, DOI 10.1158/0008-5472.CAN-15-1734; Zhou XL, 2018, ACTA PHARMACOL SIN, V39, P459, DOI 10.1038/aps.2017.157; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	45	23	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4028	4046		10.1038/s41388-019-0698-5	http://dx.doi.org/10.1038/s41388-019-0698-5			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30692632				2022-12-26	WOS:000468740200005
J	Ikeno, S; Nakano, N; Sano, K; Minowa, T; Sato, W; Akatsu, R; Sakata, N; Hanagata, N; Fujii, M; Itoh, F; Itoh, S				Ikeno, Souichi; Nakano, Naoko; Sano, Keigo; Minowa, Takashi; Sato, Wataru; Akatsu, Ryosuke; Sakata, Nobuo; Hanagata, Nobutaka; Fujii, Makiko; Itoh, Fumiko; Itoh, Susumu			PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-beta (TGF-beta) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); receptor protein serine; threonine kinase; signal transduction; SMAD transcription factor; transforming growth factor (TGF-); tumor; transcription; cell signaling; PDZK1-interacting protein 1 (PDZK1IP1); Smad4	FUNCTIONAL-CHARACTERIZATION; FAMILY-MEMBERS; MAP17; IDENTIFICATION; ACTIVATOR; APOPTOSIS; PROMOTER; ELEMENTS; PATHWAY; COMPLEX	Transforming growth factor (TGF)-beta signaling in humans is stringently regulated to prevent excessive TGF-beta signaling. In tumors, TGF-beta signaling can both negatively and positively regulate tumorigenesis dependent on tumor type, but the reason for these opposite effects is unclear. TGF-beta signaling is mainly mediated via the Smad-dependent pathway, and herein we found that PDZK1-interacting protein 1 (PDZK1IP1) interacts with Smad4. PDZK1IP1 inhibited both the TGF-beta and the bone morphogenetic protein (BMP) pathways without affecting receptor-regulated Smad (R-Smad) phosphorylation. Rather than targeting R-Smad phosphorylation, PDZK1IP1 could interfere with TGF-beta- and BMP-induced R-Smad/Smad4 complex formation. Of note, PDZK1IP1 retained Smad4 in the cytoplasm of TGF-beta-stimulated cells. To pinpoint PDZK1IP1's functional domain, we created several PDZK1IP1 variants and found that its middle region, from Phe(40) to Ala(49), plays a key role in its Smad4-regulating activity. PDZK1IP1 knockdown enhanced the expression of the TGF-beta target genes Smad7 and prostate transmembrane protein androgen-induced (TMEPAI) upon TGF-beta stimulation. In contrast, PDZK1IP1 overexpression suppressed TGF-beta-induced reporter activities, cell migration, and cell growth inhibition. In a xenograft tumor model in which TGF-beta was previously shown to elicit tumor-promoting effects, PDZK1IP1 gain of function decreased tumor size and increased survival rates. Taken together, these findings indicate that PDZK1IP1 interacts with Smad4 and thereby suppresses the TGF-beta signaling pathway.	[Ikeno, Souichi; Nakano, Naoko; Sano, Keigo; Sato, Wataru; Akatsu, Ryosuke; Sakata, Nobuo; Itoh, Susumu] Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan; [Minowa, Takashi; Hanagata, Nobutaka] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki 3050047, Japan; [Fujii, Makiko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Hiroshima 7348553, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 1920392, Japan	Showa Pharmaceutical University; National Institute for Materials Science; Hiroshima University; Tokyo University of Pharmacy & Life Sciences	Itoh, S (corresponding author), Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	sitoh@ac.shoyaku.ac.jp	Sakata, Nobuo/L-9753-2015	Sakata, Nobuo/0000-0001-9967-8409; Hanagata, Nobutaka/0000-0001-6079-3426; Itoh, Fumiko/0000-0002-6134-5331	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [15K18866]; Takeda Science Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Vehicle Racing Commemorative Foundation; Mitsubishi Foundation; Science Research Promotion Fund; Research Foundation for Pharmaceutical Sciences; MEXT [S1311012]; Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Vehicle Racing Commemorative Foundation; Mitsubishi Foundation; Science Research Promotion Fund; Research Foundation for Pharmaceutical Sciences; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Young Scientists (B) 15K18866 (to N. N.) and the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) (to S. Itoh) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); the Takeda Science Foundation (to S. Itoh); the Daiichi-Sankyo Foundation of Life Science (to S. Itoh); the Naito Foundation (to S. Itoh); the Vehicle Racing Commemorative Foundation (to S. Itoh); the Mitsubishi Foundation (to S. Itoh); the Science Research Promotion Fund (S. Itoh); the Research Foundation for Pharmaceutical Sciences (to N. N.); the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Grant S1311012) (to N. N. and S. Itoh); and a grant-in-aid for young scientists of Showa Pharmaceutical University (to S. Ikeno and N. N.). This work was also supported by the Joint Usage/Research Program of the Medical Research Institute, Tokyo Medical and Dental University and by the Core-to-Core program "Cooperative International Framework in TGF-beta Family Signaling" of the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blasco T, 2003, AM J PHYSIOL-RENAL, V285, pF799, DOI 10.1152/ajprenal.00149.2003; Carnero A, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00112; Coady MJ, 2017, AM J PHYSIOL-RENAL, V313, pF467, DOI 10.1152/ajprenal.00628.2016; Coady MJ, 2017, J AM SOC NEPHROL, V28, P85, DOI 10.1681/ASN.2015111282; de Miguel-Luken MJ, 2015, ONCOTARGET, V6, P12625, DOI 10.18632/oncotarget.3470; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ferrer I, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0871-7; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Guijarro MV, 2007, J CELL BIOCHEM, V101, P112, DOI 10.1002/jcb.21163; Guijarro MV, 2007, CARCINOGENESIS, V28, P2443, DOI 10.1093/carcin/bgm154; Guijarro MV, 2007, CARCINOGENESIS, V28, P2096, DOI 10.1093/carcin/bgm124; Guijarro MV, 2007, CARCINOGENESIS, V28, P1646, DOI 10.1093/carcin/bgm083; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Itoh S, 2018, J BIOCHEM, V164, P195, DOI 10.1093/jb/mvy059; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Jaeger C, 2000, J INVEST DERMATOL, V115, P375, DOI 10.1046/j.1523-1747.2000.00071.x; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kocher O, 1996, AM J PATHOL, V149, P493; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Garcia-Heredia JM, 2017, CLIN CANCER RES, V23, P3871, DOI 10.1158/1078-0432.CCR-16-2358; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moses HL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021865; Nakano N, 2017, J BIOL CHEM, V292, P4099, DOI 10.1074/jbc.M116.769109; Nakano N, 2014, J BIOL CHEM, V289, P12680, DOI 10.1074/jbc.M114.558981; Nakano N, 2010, J BIOL CHEM, V285, P38023, DOI 10.1074/jbc.M110.132209; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pribanic S, 2003, AM J PHYSIOL-RENAL, V285, pF784, DOI 10.1152/ajprenal.00109.2003; Seoane J, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022277; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Zhao M, 2018, INT J BIOL SCI, V14, P111, DOI 10.7150/ijbs.23230; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	46	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4966	4980		10.1074/jbc.RA118.004153	http://dx.doi.org/10.1074/jbc.RA118.004153			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718277	Green Published, hybrid			2022-12-26	WOS:000463985600021
J	Pontejo, SM; Sanchez, C; Ruiz-Arguello, B; Alcami, A				Pontejo, Sergio M.; Sanchez, Carolina; Ruiz-Arguello, Begona; Alcami, Antonio			Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); receptor; viral immunology; inflammation; autoimmune disease; decoy receptor	PRELIGAND ASSEMBLY DOMAIN; LYMPHOTOXIN-BETA-RECEPTOR; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; FACTOR AGENTS; FACTOR-ALPHA; LT-ALPHA; DISTINCT; APOPTOSIS; HOMOLOG	Etanercept is a soluble form of the tumor necrosis factor receptor 2 (TNFR2) that inhibits pathological tumor necrosis factor (TNF) responses in rheumatoid arthritis and other inflammatory diseases. However, besides TNF, etanercept also blocks lymphotoxin-alpha (LT alpha), which has no clear therapeutic value and might aggravate some of the adverse effects associated with etanercept. Poxviruses encode soluble TNFR2 homologs, termed viral TNF decoy receptors (vTNFRs), that display unique specificity properties. For instance, cytokine response modifier D (CrmD) inhibits mouse and human TNF and mouse LT alpha, but it is inactive against human LT alpha. Here, we analyzed the molecular basis of these immunomodulatory activities in the ectromelia virus-encoded CrmD. We found that the overall molecular mechanism to bind TNF and LT alpha from mouse and human origin is fairly conserved in CrmD and dominated by a groove under its 50s loop. However, other ligand-specific binding determinants optimize CrmD for the inhibition of mouse ligands, especially mouse TNF. Moreover, we show that the inability of CrmD to inhibit human LT alpha is caused by a Glu-Phe-Glu motif in its 90s loop. Importantly, transfer of this motif to etanercept diminished its anti-LT alpha activity in >60-fold while weakening its TNF-inhibitory capacity in 3-fold. This new etanercept variant could potentially be used in the clinic as a safer alternative to conventional etanercept. This work is the most detailed study of the vTNFR-ligand interactions to date and illustrates that a better knowledge of vTNFRs can provide valuable information to improve current anti-TNF therapies.	[Pontejo, Sergio M.; Sanchez, Carolina; Ruiz-Arguello, Begona; Alcami, Antonio] CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Pontejo, Sergio M.; Sanchez, Carolina; Ruiz-Arguello, Begona; Alcami, Antonio] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Ruiz-Arguello, Begona] Progenika Biopharma, Derio 48160, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Alcami, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain.	aalcami@cbm.csic.es	Pontejo, Sergio M./AAN-6403-2020; Alcami, Antonio/F-8512-2015	Pontejo, Sergio M./0000-0002-7756-9831; Alcami, Antonio/0000-0002-3333-6016; Sanchez Fernandez, Carolina/0000-0002-5183-8167	Spanish Ministry of Economy and Competitiveness [SAF2012-38957, SAF2015-67485-R]; European Union (European Regional Development Fund); Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union (European Regional Development Fund)(European Commission); Consejo Superior de Investigaciones Cientificas	This work was supported by Spanish Ministry of Economy and Competitiveness Grants SAF2012-38957 and SAF2015-67485-R and the European Union (European Regional Development Fund). S. M. Pontejo, C. Sanchez, and A. Alcami are inventors of a patent application on the potential use of the variant form of etanercept, but there is no company involved or development of this reagent as a drug so far.r Recipient of a Junta para la Ampliacion de Estudios Ph.D. studentship from Consejo Superior de Investigaciones Cientificas.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alejo A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04098-8; Alejo A, 2011, ADV EXP MED BIOL, V691, P203, DOI 10.1007/978-1-4419-6612-4_21; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chan FKM, 2000, ANN RHEUM DIS, V59, P50, DOI 10.1136/ard.59.suppl_1.i50; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Cunnion KM, 1999, MOL GENET METAB, V67, P278, DOI 10.1006/mgme.1999.2878; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Fellermann K, 2013, DIGEST DIS, V31, P374, DOI 10.1159/000354703; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; GOH CR, 1991, PROTEIN ENG, V4, P785; Graham SC, 2007, J MOL BIOL, V372, P660, DOI 10.1016/j.jmb.2007.06.082; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Kennedy WP, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0467-3; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Loparev VN, 1998, P NATL ACAD SCI USA, V95, P3786, DOI 10.1073/pnas.95.7.3786; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Mitoma H, 2018, CYTOKINE, V101, P56, DOI 10.1016/j.cyto.2016.08.014; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murray KM, 1997, ANN PHARMACOTHER, V31, P1335, DOI 10.1177/106002809703101111; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Neregard P, 2014, SCAND J RHEUMATOL, V43, P85, DOI 10.3109/03009742.2013.834964; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Orlinick JR, 1997, J BIOL CHEM, V272, P28889, DOI 10.1074/jbc.272.46.28889; Pontejo SM, 2015, J BIOL CHEM, V290, P15973, DOI 10.1074/jbc.M115.650119; Reading PC, 2002, VIROLOGY, V292, P285, DOI 10.1006/viro.2001.1236; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Saraiva M, 2001, J VIROL, V75, P226, DOI 10.1128/JVI.75.1.226-233.2001; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schreiber M, 1997, J VIROL, V71, P2171, DOI 10.1128/JVI.71.3.2171-2181.1997; Schreiber M, 1996, J IMMUNOL, V157, P4486; Sedger LM, 2006, J VIROL, V80, P9300, DOI 10.1128/JVI.02449-05; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Smith CA, 1996, VIROLOGY, V223, P132, DOI 10.1006/viro.1996.0462; Smulski CR, 2013, J BIOL CHEM, V288, P10914, DOI 10.1074/jbc.M112.427583; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Willrich MAV, 2015, TRANSL RES, V165, P270, DOI 10.1016/j.trsl.2014.09.006; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; YAMAGISHI J, 1990, PROTEIN ENG, V3, P713, DOI 10.1093/protein/3.8.713; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004; Zhan CY, 2009, BIOCHEMISTRY-US, V48, P7636, DOI 10.1021/bi900031w; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	62	9	11	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5214	5227		10.1074/jbc.RA118.005828	http://dx.doi.org/10.1074/jbc.RA118.005828			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723161	hybrid, Green Published			2022-12-26	WOS:000463985600045
J	Dhom-Lemos, L; Viana, AG; Cunha, JLR; Cardoso, MS; Mendes, TAO; Pinheiro, GRG; Siqueira, WF; Lobo, FP; Teles, LF; Bueno, LL; Guimaraes-Carvalho, SF; Bartholomeu, DC; Fujiwara, RT				Dhom-Lemos, Lucas; Viana, Agostinho Goncalves; Reis Cunha, Joao Luis; Cardoso, Mariana Santos; Oliveira Mendes, Tiago Antonio; Gomide Pinheiro, Guilherme Rafael; Siqueira, Williane Fernanda; Lobo, Francisco Pereira; Teles, Leandro Freitas; Bueno, Lilian Lacerda; Guimaraes-Carvalho, Silvio Fernando; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio			Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TEST; CANINE LEISHMANIASIS; K-39 ANTIGEN; PROTEINS; EXPRESSION; CLONING; QUANTIFICATION; IDENTIFICATION; PERFORMANCE; CHAGASI	Visceral leishmaniasis (VL) or kala-azar, the most severe form of leishmaniasis, can lead to death if not properly diagnosed and treated. Correct identification of infected patients and reservoirs is vital for controlling the spread of leishmaniasis. Current diagnostic kits for leishmaniasis show high sensitivity and specificity, but can also result in false negatives and cross reactions with related parasitic infections. New diagnostic methods with greater accuracy are urgently needed for diagnosis of leishmaniasis. In this study, we aimed to uncover a new highly effective antigen for the diagnosis of visceral leishmaniasis in dogs and humans, aiming to improve the accuracy compared with those of current methods of diagnosis. Initially, in-silico epitope prediction analyses identified several potential B-cell epitopes in the repetitive region of Leishmania infantum kinesin, which co-localized with predicted structural disordered regions, suggesting high potential for antigenicity. Based on this analysis, 8.5 genomic motifs, which encode the repetitive sequence of 39 degenerate amino acids, were selected for recombinant expression. BLASTn analysis of this repetitive region indicated that it is absent in the T. cruzi parasite, which is closely related to Leishmania, indicating the specificity of this region. This potentially antigenic protein, named recombinant kinesin degenerated derived repeat (rKDDR), was recombinantly expressed in Escherichia coli BL21-Star using the pET28a-TEV expression vector. We then evaluated the performance of rKDDR in correctly diagnosing Leishmania infection and compared this new assay with currently used diagnostic tests for leishmaniasis. rKDDR showed greater sensitivity and specificity in correctly diagnosing leishmaniasis both in human (sensitivity 92.86% and specificity 100%) and canine (sensitivity 88.54% and specificity 97.30%) sera compared with those of rK39 (human: sensitivity 90.48% and specificity 97.92%; canine: sensitivity 78.13% and specificity 90.09%). In addition, the rKDDR-ELISA outperformed the EIE-LVC kit, which is the serologic kit recommended by the Brazilian Ministry of Health for the diagnosis of canine visceral leishmaniasis. These results indicate that rKDDR is a highly promising candidate for diagnosis of visceral leishmaniasis, and is more accurate than the currently used gold-standard antigens.	[Dhom-Lemos, Lucas; Viana, Agostinho Goncalves; Reis Cunha, Joao Luis; Cardoso, Mariana Santos; Oliveira Mendes, Tiago Antonio; Gomide Pinheiro, Guilherme Rafael; Siqueira, Williane Fernanda; Lobo, Francisco Pereira; Bueno, Lilian Lacerda; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Teles, Leandro Freitas; Guimaraes-Carvalho, Silvio Fernando] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Programa Posgrad Ciencias Saude, Montes Claros, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros	Fujiwara, RT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.	fujiwara@icb.ufmg.br	Mendes, Tiago/AAG-1709-2021; Lobo, Francisco Pereira/AAG-3118-2021; Pinheiro, Guilherme Rafael Gomide/AAP-7531-2021; Reis-Cunha, João/AAX-6470-2020; Viana, Agostinho AGV Gonçalves/C-8281-2014; Fujiwara, Ricardo Toshio/J-7579-2012; Bartholomeu, Daniella C./J-4714-2015; Bueno, Lilian/AAQ-1939-2020	Mendes, Tiago/0000-0002-5569-4893; Lobo, Francisco Pereira/0000-0002-9671-9313; Pinheiro, Guilherme Rafael Gomide/0000-0002-8343-8344; Reis-Cunha, João/0000-0003-1034-0992; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Bartholomeu, Daniella C./0000-0003-0974-7357; Bueno, Lilian/0000-0003-3510-4590; Siqueira, Williane Fernanda/0000-0001-8307-5961				Abass E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116408; Abass E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002322; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Alves Waneska Alexandre, 2004, Cad. Saúde Pública, V20, P259, DOI 10.1590/S0102-311X2004000100043; Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239; Carvalho SFG, 2003, AM J TROP MED HYG, V68, P321; COPPEL RL, 1984, NATURE, V310, P789, DOI 10.1038/310789a0; COWMAN AF, 1985, CELL, V40, P775, DOI 10.1016/0092-8674(85)90337-X; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Dantas-Torres F, 2006, REV SOC BRAS MED TRO, V39, P352, DOI 10.1590/S0037-86822006000400007; Dantas-Torres F, 2006, VET PARASITOL, V140, P54, DOI 10.1016/j.vetpar.2006.03.008; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dubessay P, 2006, MOL MICROBIOL, V59, P1162, DOI 10.1111/j.1365-2958.2005.05013.x; Fernandez-Robledo JA, 2010, TRENDS PARASITOL, V26, P244, DOI 10.1016/j.pt.2010.02.004; FLEISS JL, 1972, ARCH GEN PSYCHIAT, V26, P168; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Goto Y, 2006, INFECT IMMUN, V74, P3939, DOI 10.1128/IAI.00101-06; Goto Y, 2014, AM J TROP MED HYG, V91, P912, DOI 10.4269/ajtmh.14-0260; Goto Y, 2010, INFECT IMMUN, V78, P2138, DOI 10.1128/IAI.01102-09; IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6; Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; Kiros YK, 2017, BMC RES NOTES, V10, P1, DOI [10.1186/s13104-016-2345-3, DOI 10.1186/S13104-016-2345-3]; KOENEN M, 1984, NATURE, V311, P382, DOI 10.1038/311382a0; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Maalej IA, 2003, AM J TROP MED HYG, V68, P312, DOI 10.4269/ajtmh.2003.68.312; MAGALHAES P A, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P197; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Menezes-Souza D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099216; Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; Ministerio da Saude. Ministerio da Saude, 2010, B EPIDEMIOLOGICO, V2, P11; Moura AS, 2013, REV SOC BRAS MED TRO, V46, P589, DOI 10.1590/0037-8682-0145-2013; Thuy N, 2012, PARASITOL RES, V110, P733, DOI 10.1007/s00436-011-2632-9; QU JQ, 1994, T ROY SOC TROP MED H, V88, P543, DOI 10.1016/0035-9203(94)90154-6; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Sarkari B, 2018, IRAN J PARASITOL, V13, P331; Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4; Singh DP, 2010, J HEALTH POPUL NUTR, V28, P281; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Sivakumar R, 2006, PROTEIN EXPRES PURIF, V46, P156, DOI 10.1016/j.pep.2005.07.027; Nguyen TT, 2014, VET PARASITOL, V201, P18, DOI 10.1016/j.vetpar.2014.01.009; Valiente-Gabioud AA, 2011, EXP PARASITOL, V127, P672, DOI 10.1016/j.exppara.2010.11.011; Veeken H, 2003, TROP MED INT HEALTH, V8, P164, DOI 10.1046/j.1365-3156.2003.00996.x; Venturin GL, 2015, PARASITE IMMUNOL, V37, P670, DOI 10.1111/pim.12281; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211719	10.1371/journal.pone.0211719	http://dx.doi.org/10.1371/journal.pone.0211719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703138	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600065
J	Choi, MJ; Noh, JY; Cheong, HJ; Kim, WJ; Kim, MJ; Jang, YS; Lee, SN; Choi, EH; Lee, HJ; Song, JY				Choi, Min Joo; Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Kim, Min Ja; Jang, Ye Seul; Lee, Saem Na; Choi, Eun Hwa; Lee, Hoan Jong; Song, Joon Young			Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir	PLOS ONE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; PCV7 VACCINATION; ADULT PATIENTS; UNITED-STATES; SEROTYPE; PREVALENCE	Despite the availability of a pneumococcal National Immunization Program, which provides free PPSV23 vaccination for older adults aged >= 65 years in South Korea, pneumococcal pneumonia remains one of the most common respiratory infections, with increasing antimicrobial resistance. From January to December in 2015, all pneumococcal isolates were collected from a 1,050-bed teaching hospital in South Korea. All isolates were analyzed for serotype, genotype, and antimicrobial susceptibility. Demographic, clinical and microbiological data were compared between ceftriaxone susceptible and non-susceptible cases. Among 92 microbiologically identified pneumococcal isolates, ceftriaxone non-susceptible pneumococci (CNSP) accounted for 32 cases (34.8%). Some of these cases also showed levofloxacin resistance (25%, 8/32 isolates) and all CNSP cases were multidrug resistant. Compared to patients with ceftriaxone susceptible pneumococci (CSP), long-term care facility residents (odds ratio [OR] 7.0, 95% confidence interval [CI] 0.8-62.1) and patients with chronic lung (OR 4.1, 95% CI 1.1-15.0) and renal diseases (OR 9.1, 95% CI 1.2-70.5) were more common among those with CNSP on multivariate analysis. PPSV23-unique serotypes not included in PCV13 were more common in CNSP than in CSP (34.4% versus 13.3%, p = 0.02). Regarding genotypes, ST320 (10 cases), ST166 (7 cases) and ST8279 (3 cases) were dominant in CNSP, and ST8279 was only detected in previous long-term care facility residents. Clonal expansion and spread of CNSP strains should be monitored among patients with chronic lung/renal diseases and residents of long-term care facilities.	[Choi, Min Joo; Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Kim, Min Ja; Jang, Ye Seul; Lee, Saem Na; Song, Joon Young] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Song, JY (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.	infection@korea.ac.kr		KIM, MIN JA/0000-0002-2125-7521; Song, Joon Young/0000-0002-0148-7194; Cheong, Hee Jin/0000-0002-2532-1463	Korea University	Korea University	This work was supported by a Korea University grant.	Amsden GW, 2001, ANN PHARMACOTHER, V35, P480, DOI 10.1345/aph.10080; APPELBAUM PC, 1987, EUR J CLIN MICROBIOL, V6, P367, DOI 10.1007/BF02013089; Australian Government Department of Health, PNEUM DIS; Baek JY, 2016, INFECT GENET EVOL, V38, P122, DOI 10.1016/j.meegid.2015.12.018; Baek JY, 2011, DIAGN MICR INFEC DIS, V69, P370, DOI 10.1016/j.diagmicrobio.2010.10.019; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Brown SM, 2009, CRIT CARE MED, V37, P3010, DOI 10.1097/CCM.0b013e3181b030d9; Centers for Disease Control and Prevention, 2016, ACT BACT COR SURV AB, VVolume 2016; Centers for Disease Control and Prevention, 2017, PNEUM DIS; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P60; Cho SY, 2014, EMERG INFECT DIS, V20, P869, DOI 10.3201/eid2005.131371; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; HANSMAN D, 1967, LANCET, V2, P264; Harbarth S, 2002, EMERG INFECT DIS, V8, P1460, DOI 10.3201/eid0812.010533; Heo JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194598; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Huang SY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1042-5; Jochems SP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006665; Kang CI, 2013, INFECTION, V41, P151, DOI 10.1007/s15010-012-0299-5; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Korea Centers for Disease Control and Prevention, PED VACC RAT 2017; Korea Centers for Disease Control and Prevention, 2016, NAT IMM PROGR PNEUM; Lee HY, 2018, J MICROBIOL IMMUNOL, V51, P500, DOI 10.1016/j.jmii.2016.12.004; Lee S, 2010, MICROB DRUG RESIST, V16, P135, DOI 10.1089/mdr.2009.0114; Metlay JP, 2000, CLIN INFECT DIS, V30, P520, DOI 10.1086/313716; National Health Service, 2016, NHS VACC SCHED; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Pallares R, 2002, AM J MED, V113, P120, DOI 10.1016/S0002-9343(02)01162-2; Park M, 2016, EMERG INFECT DIS, V22, P1978, DOI 10.3201/eid2211.151450; Patel J.B., 2015, PERFORMANCE STANDARD; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ramos V, 2014, VACCINE, V32, P755, DOI 10.1016/j.vaccine.2013.12.024; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Seok H, 2018, MICROB DRUG RESIST, V24, P1412, DOI 10.1089/mdr.2017.0416; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Shukla SD, 2015, EXPERT REV RESP MED, V9, P473, DOI 10.1586/17476348.2015.1070673; Song JH, 2009, INFECT CHEMOTHER, V41, P133, DOI 10.3947/ic.2009.41.3.133; Song JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-202; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Torumkuney D, 2016, J Antimicrob Chemother, V71 Suppl 1, pi3, DOI 10.1093/jac/dkw073; Yin JK, 2017, MED J AUSTRALIA, V207, P396, DOI 10.5694/mja16.01102; Yoo KH, 2013, J KOREAN MED SCI, V28, P888, DOI 10.3346/jkms.2013.28.6.888; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534; [No title captured]	48	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210520	10.1371/journal.pone.0210520	http://dx.doi.org/10.1371/journal.pone.0210520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699137	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600039
J	Daou, N; Wang, YG; Levdikov, VM; Nandakumar, M; Livny, J; Bouillaut, L; Blagova, E; Zhang, KS; Belitsky, BR; Rhee, K; Wilkinson, AJ; Sun, XM; Sonenshein, AL				Daou, Nadine; Wang, Yuanguo; Levdikov, Vladimir M.; Nandakumar, Madhumitha; Livny, Jonathan; Bouillaut, Laurent; Blagova, Elena; Zhang, Keshan; Belitsky, Boris R.; Rhee, Kyu; Wilkinson, Anthony J.; Sun, Xingmin; Sonenshein, Abraham L.			Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027	PLOS ONE			English	Article							BACILLUS-SUBTILIS SPORULATION; GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; TOXIN PRODUCTION; SIGMA-FACTOR; DEPENDENT REGULATION; STRINGENT RESPONSE; RNA-POLYMERASE; FATTY-ACIDS; AMINO-ACID	Toxin synthesis and endospore formation are two of the most critical factors that determine the outcome of infection by Clostridioides difficile. The two major toxins, TcdA and TcdB, are the principal factors causing damage to the host. Spores are the infectious form of C. difficile, permit survival of the bacterium during antibiotic treatment and are the predominant cell form that leads to recurrent infection. Toxin production and sporulation have their own specific mechanisms of regulation, but they share negative regulation by the global regulatory protein CodY. Determining the extent of such regulation and its detailed mechanism is important for understanding the linkage between two apparently independent biological phenomena and raises the possibility of creating new ways of limiting infection. The work described here shows that a codY null mutant of a hypervirulent (ribotype 027) strain is even more virulent than its parent in a mouse model of infection and that the mutant expresses most sporulation genes prematurely during exponential growth phase. Moreover, examining the expression patterns of mutants producing CodY proteins with different levels of residual activity revealed that expression of the toxin genes is dependent on total CodY inactivation, whereas most sporulation genes are turned on when CodY activity is only partially diminished. These results suggest that, in wild-type cells undergoing nutrient limitation, sporulation genes can be turned on before the toxin genes.	[Daou, Nadine; Bouillaut, Laurent; Belitsky, Boris R.; Sonenshein, Abraham L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Wang, Yuanguo; Zhang, Keshan] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA USA; [Levdikov, Vladimir M.; Blagova, Elena; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York, N Yorkshire, England; [Nandakumar, Madhumitha; Rhee, Kyu] Weill Cornell Med Coll, Div Infect Dis, Dept Med, New York, NY USA; [Livny, Jonathan] Broad Inst MIT & Harvard, Cambridge, MA USA; [Wang, Yuanguo; Sun, Xingmin] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA; [Daou, Nadine] Axcella Hlth Inc, Cambridge, MA USA; [Nandakumar, Madhumitha] Seres Therapeut, Cambridge, MA USA; [Bouillaut, Laurent] ConsortiaTX Inc, Woburn, MA USA; [Zhang, Keshan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	Tufts University; Tufts University; University of York - UK; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; State University System of Florida; University of South Florida; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Sonenshein, AL (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	linc.sonenshein@tufts.edu	Levdikov, Vladimir/AAA-6139-2022	Levdikov, Vladimir/0000-0003-3041-1049	US National Institutes of Health; National Institute of General Medical Sciences [R01 GM042219]; National Institute of Diabetes and Digestive and Kidney Diseases [K0 DK092352]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092352] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All research reported in this manuscript was funded by grants from the US National Institutes of Health. The funder provided support in the form of salaries for most of the authors and the purchase of materials and supplies, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the 'author contributions' section. Some of the authors are now employees of commercial organizations, but at the time that they contributed to the research described in this manuscript they were university employees. R01 GM042219, National Institute of General Medical Sciences (ALS, AJW, KR). K0 DK092352, National Institute of Diabetes and Digestive and Kidney Diseases (XS).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Belitsky BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005600; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bilverstone TW, 2017, ANAEROBE; Bordeleau E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002039; Bouillaut L, 2015, RES MICROBIOL, V166, P375, DOI 10.1016/j.resmic.2014.10.002; Bouillaut Laurent, 2011, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09a02s20; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Brinsmade SR, 2014, P NATL ACAD SCI USA, V111, P8227, DOI 10.1073/pnas.1321308111; Brinsmade SR, 2011, J BACTERIOL, V193, P5637, DOI 10.1128/JB.05510-11; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chateau A, 2013, J BACTERIOL, V195, P1204, DOI 10.1128/JB.02041-12; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Chu M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005946; Darkoh C, 2015, MBIO, V6, DOI 10.1128/mBio.02569-14; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; Dembek M, 2015, MBIO, V6, DOI 10.1128/mBio.02383-14; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; Dubois T, 2013, MOL MICROBIOL, V88, P48, DOI 10.1111/mmi.12168; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Edwards AN, 2016, MOL MICROBIOL, V100, P954, DOI 10.1111/mmi.13361; El Meouche I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083748; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Feng LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep21241; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Friggen AH, 2016, ACS SYNTH BIOL; Girinathan BP, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00383-16; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Han AR, 2016, NUCLEIC ACIDS RES, V44, P9483, DOI 10.1093/nar/gkw775; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Hensbergen PJ, 2015, FEBS LETT, V589, P3952, DOI 10.1016/j.febslet.2015.10.027; Ho TD, 2014, INFECT IMMUN, V82, P2345, DOI 10.1128/IAI.01483-13; Ibberson CB, 2014, INFECT IMMUN, V82, P4253, DOI 10.1128/IAI.01710-14; Ihekwaba AEC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005205; Janoir C, 2016, ANAEROBE, V37, P13, DOI 10.1016/j.anaerobe.2015.10.009; KANEDA T, 1967, J BACTERIOL, V93, P894, DOI 10.1128/JB.93.3.894-903.1967; KANEDA T, 1971, BIOCHEMISTRY-US, V10, P340, DOI 10.1021/bi00778a022; Kovacs-Simon A, 2014, J INFECT DIS, V210, P274, DOI 10.1093/infdis/jiu070; Kreth J, 2011, J BACTERIOL, V193, P4153, DOI 10.1128/JB.00061-11; Lemos JA, 2008, J BACTERIOL, V190, P5291, DOI 10.1128/JB.00288-08; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Levdikov VM, 2017, J BIOL CHEM, V292, P2714, DOI 10.1074/jbc.M116.754309; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li J, 2017, INFECT IMMUN, V85; Li JH, 2013, MBIO, V4, DOI 10.1128/mBio.00770-13; Lindback T, 2012, ENVIRON MICROBIOL, V14, P2233, DOI 10.1111/j.1462-2920.2012.02766.x; Livny J, 2014, NUCLEIC ACIDS RES, V42, P12212, DOI 10.1093/nar/gku891; Lobel L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002887; LYERLY DM, 1982, INFECT IMMUN, V35, P1147, DOI 10.1128/IAI.35.3.1147-1150.1982; Lyon SA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005758; Mackin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079666; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Manganelli R, 1998, FEMS MICROBIOL LETT, V168, P259, DOI 10.1111/j.1574-6968.1998.tb13282.x; Mani N, 2002, J BACTERIOL, V184, P5971, DOI 10.1128/JB.184.21.5971-5978.2002; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; McBride SM, 2011, MICROBIOL-SGM, V157, P1457, DOI 10.1099/mic.0.045997-0; McBride SM, 2011, INFECT IMMUN, V79, P167, DOI 10.1128/IAI.00731-10; McKee RW, 2013, J BACTERIOL, V195, P5174, DOI 10.1128/JB.00501-13; Miller JH, 1972, EXPT MOL GENETICS, Vxvi; Montgomery CP, 2012, INFECT IMMUN, V80, P2382, DOI 10.1128/IAI.06172-11; Mooyottu S, 2014, INT J MOL SCI, V15, P4415, DOI 10.3390/ijms15034415; MULLANY P, 1991, FEMS MICROBIOL LETT, V79, P191, DOI 10.1016/0378-1097(91)90084-N; Nawrocki KL, 2018, ENVIRON MICROBIOL, V20, P1419, DOI 10.1111/1462-2920.14048; Nawrocki KL, 2016, J BACTERIOL, V198, P2113, DOI 10.1128/JB.00220-16; OCHI K, 1981, J BIOL CHEM, V256, P6866; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Pesek JJ, 2009, J SEP SCI, V32, P2200, DOI 10.1002/jssc.200900270; Pettit LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-160; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pishdadian K, 2015, MOL MICROBIOL, V95, P189, DOI 10.1111/mmi.12856; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; PREDICH M, 1992, J BACTERIOL, V174, P2771, DOI 10.1128/JB.174.9.2771-2778.1992; Prevention CfDCa, 2013, ANT RES THREATS US 2; Purcell EB, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00347-17; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Richardson AR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0004-2014; Rivera FE, 2012, PROTEOMICS, V12, P263, DOI 10.1002/pmic.201100298; Rosenbusch KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048608; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shields K, 2015, ANAEROBE, V34, P59, DOI 10.1016/j.anaerobe.2015.04.012; SIRANOSIAN KJ, 1994, J BACTERIOL, V176, P3812, DOI 10.1128/JB.176.12.3812-3815.1994; Smits WK, 2013, VIRULENCE, V4, P592, DOI 10.4161/viru.26297; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; STRAGIER P, 1990, MOL MICROBIOL, V4, P1801, DOI 10.1111/j.1365-2958.1990.tb02028.x; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Waters NR, 2016, MOL MICROBIOL, V101, P495, DOI 10.1111/mmi.13404; Willing SE, 2015, MOL MICROBIOL, V96, P596, DOI 10.1111/mmi.12958; WU JJ, 1991, GENE, V101, P113, DOI 10.1016/0378-1119(91)90231-Y; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zhang Z, 2014, APPL ENVIRON MICROB, V80, P7651, DOI 10.1128/AEM.02838-14	108	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0206896	10.1371/journal.pone.0206896	http://dx.doi.org/10.1371/journal.pone.0206896			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699117	gold, Green Accepted, Green Published			2022-12-26	WOS:000457155600005
J	Iglesias-Carres, L; Mas-Capdevila, A; Bravo, FI; Aragones, G; Muguerza, B; Arola-Arnal, A				Iglesias-Carres, Lisard; Mas-Capdevila, Anna; Bravo, Francisca I.; Aragones, Gerard; Muguerza, Begona; Arola-Arnal, Anna			Optimization of a polyphenol extraction method for sweet orange pulp (Citrus sinensis L.) to identify phenolic compounds consumed from sweet oranges	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; BIOACTIVE COMPOUNDS; SOLVENT-EXTRACTION; GENE-EXPRESSION; BY-PRODUCTS; VITAMIN-C; FLAVONOIDS; FRUITS; JUICE; STORAGE	The consumption of sweet oranges has been linked to several health benefits, many of which are attributed to hesperidin, a flavanone that is present in high amounts in these fruits. However, other phenolic compounds can contribute to the bioactivity of sweet orange. To link those effects to their phenolic profile, the complete characterization of the phenolic profile is mandatory. Although many studies have profiled the phenolic composition of orange juices, their pulps, which retain phenolic compounds, are overlooked. This fact is particularly relevant because dietary guidelines recommend the consumption of whole fruits. Therefore, this study aimed to develop a specific method for the optimal extraction of phenolics from orange pulp and to use this method to characterize these fruits grown at different locations by HPLC-ESI-MS/MS. The extraction conditions that reported the highest total polyphenol content (TPC) and hesperidin contents were 20 mL/g, 55 degrees C, and 90% methanol. The extraction time and number of sequential steps were further evaluated and optimized as 20 min and two extraction steps, respectively. Although lower extraction rates were achieved when using ethanol as the extraction solvent, high TPC and hesperidin yields were obtained, suggesting the potential use of this methodology to produce phenolic-rich extracts for the food industry. By applying the optimized methodology and analyzing the extracts by HPLC-ESI-MS/MS, geographic cultivation regions were demonstrated to affect the phenolic profiles of oranges. In short, we developed a quick, easy-to-perform methodology that can be used to extract orange phenolics from pulp for their identification and quantification and to evaluate the factors that affect the phenolic profile in sweet orange pulps.	[Iglesias-Carres, Lisard; Mas-Capdevila, Anna; Bravo, Francisca I.; Aragones, Gerard; Muguerza, Begona; Arola-Arnal, Anna] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Nutrigen Res Grp, Tarragona, Spain; [Muguerza, Begona] Eurecat, Ctr Tecnol Catalunya, Technol Unit Nutr & Hlth, Reus, Spain	Universitat Rovira i Virgili	Muguerza, B (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Nutrigen Res Grp, Tarragona, Spain.; Muguerza, B (corresponding author), Eurecat, Ctr Tecnol Catalunya, Technol Unit Nutr & Hlth, Reus, Spain.	begona.muguerza@urv.cat	Arola-Arnal, Anna/C-2087-2015; Aragonès, Gerard/AAJ-9150-2021; Bravo, Francisca Isabel/L-4409-2019; Carres, Lisard Iglesias/AAK-5962-2021; Aragones, Gerard/F-9673-2016; Muguerza, Begoña/C-6704-2015; Muguerza, Begoña/AAT-3544-2021	Arola-Arnal, Anna/0000-0001-6529-1345; Aragonès, Gerard/0000-0001-8657-5726; Bravo, Francisca Isabel/0000-0002-6468-3088; Carres, Lisard Iglesias/0000-0003-0768-0611; Aragones, Gerard/0000-0001-8657-5726; Muguerza, Begoña/0000-0001-7384-8588; Muguerza, Begoña/0000-0001-7384-8588; Mas-Capdevila, Anna/0000-0002-0416-7102	NUTRISALT;  [AGL2013-49500-EXP];  [AGL2016-77105-R];  [2015PMF-PIPF-50];  [2015PMF-PIPF-51]	NUTRISALT; ; ; ; 	This work was supported by: AGL2013-49500-EXP (http://www.idi.mineco.gob.es/stfls/eSede/Ficheros/2014/Anexo_Preseleccion_Propuesta_Resolucion_Provisional_Proyectos_Explora_2013.pdf): AGL2016-77105-R (http://www.idi.mineco.gob.es/stfls/MICINN/Ayudas/PE_2013_2016/PE_Promocion_e_Incorporacion_Talento_y_su_Empleabilidad/FICHEROS/SE_Formacion/Ayudas_contratos_predoctorales_formacion_doctores_2017/PROYECTOS_RETOS_EXCELENCIA_2017.pdf); NUTRISALT (http://municat.gencat.cat/web/.content/Article/ajuts?feder/feder2014/documents?Resolucion-provisional-signada.pdf); 2015PMF-PIPF-50 (http://www.urv.cat/media/upload//arxius/recerca_innovacio/programes/urv/programa-MF/2015/PIPF/1a%20edicio/2015PMF_relacio_places_concedides.pdf); 2015PMF-PIPF-51 (http://www.urv.cat/media/upload//arxius/recerca_innovacio/programes/urv/programa-MF/2015/PIPF/1a%20edicio/2015PMF_relacio_places_concedides.pdf).	Abad-Garcia B, 2014, EUR FOOD RES TECHNOL, V238, P803, DOI 10.1007/s00217-014-2160-9; Al-Juhaimi FV, 2014, PAK J BOT, V46, P1459; Amarowicz R, 2009, MOL NUTR FOOD RES, V53, pS151, DOI 10.1002/mnfr.200700486; Amenta M, 2015, FOOD RES INT, V74, P250, DOI 10.1016/j.foodres.2015.04.040; Arboit M, 2010, RENEW ENERG, V35, P1551, DOI 10.1016/j.renene.2009.11.027; Assefa AD, 2017, J FOOD MEAS CHARACT, V11, P364, DOI 10.1007/s11694-016-9405-1; Cacace JE, 2003, J FOOD ENG, V59, P379, DOI 10.1016/S0260-8774(02)00497-1; Borges GDC, 2011, FOOD RES INT, V44, P708, DOI 10.1016/j.foodres.2010.12.025; Cano A, 2008, J FOOD COMPOS ANAL, V21, P377, DOI 10.1016/j.jfca.2008.03.005; Canterino S, 2012, J FOOD QUALITY, V35, P108, DOI 10.1111/j.1745-4557.2012.00435.x; Chan S. W., 2009, INT FOOD RES J, V2, P203; Corrales M, 2008, INNOV FOOD SCI EMERG, V9, P85, DOI 10.1016/j.ifset.2007.06.002; De Ancos B, 2017, FOOD CHEM, V225, P114, DOI 10.1016/j.foodchem.2016.12.098; DeSalvo KB, 2016, JAMA-J AM MED ASSOC, V315, P457, DOI 10.1001/jama.2015.18396; Faller ALK, 2010, J FOOD COMPOS ANAL, V23, P561, DOI 10.1016/j.jfca.2010.01.003; Galili S, 2014, POLYPHENOLS IN PLANTS: ISOLATION, PURIFICATION AND EXTRACT PREPARATION, P305, DOI 10.1016/B978-0-12-397934-6.00016-4; Garau MC, 2007, FOOD CHEM, V104, P1014, DOI 10.1016/j.foodchem.2007.01.009; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Hernandez-Carranza P, 2016, J FOOD PROCESS PRES, V40, P103, DOI 10.1111/jfpp.12588; Inoue T, 2010, FOOD CHEM, V123, P542, DOI 10.1016/j.foodchem.2010.04.051; Justesen U, 1998, J CHROMATOGR A, V799, P101, DOI 10.1016/S0021-9673(97)01061-3; Karoui IJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/345415; Kelebek H, 2009, MICROCHEM J, V91, P187, DOI 10.1016/j.microc.2008.10.008; Kelebek H, 2011, J SCI FOOD AGR, V91, P1855, DOI 10.1002/jsfa.4396; Khan MK, 2014, J FOOD COMPOS ANAL, V33, P85, DOI 10.1016/j.jfca.2013.11.004; Klimczak I, 2007, J FOOD COMPOS ANAL, V20, P313, DOI 10.1016/j.jfca.2006.02.012; Li BB, 2006, SEP PURIF TECHNOL, V48, P182, DOI 10.1016/j.seppur.2005.07.005; Li W, 2012, FOOD CHEM, V130, P1044, DOI 10.1016/j.foodchem.2011.07.129; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Liu LX, 2008, J CHEM ENG DATA, V53, P1649, DOI 10.1021/je800078j; Liu Y, 2013, IND CROP PROD, V49, P837, DOI 10.1016/j.indcrop.2013.07.023; Lovdal T, 2010, PHYTOCHEMISTRY, V71, P605, DOI 10.1016/j.phytochem.2009.12.014; Magwaza LS, 2016, FOOD SCI NUTR, V4, P4, DOI 10.1002/fsn3.210; Mane C, 2007, J AGR FOOD CHEM, V55, P7224, DOI 10.1021/jf071301w; Martinez-Gil AM, 2018, J SCI FOOD AGR, V98, P274, DOI 10.1002/jsfa.8468; Mattila P, 2000, J AGR FOOD CHEM, V48, P5834, DOI 10.1021/jf000661f; Morand C, 2011, AM J CLIN NUTR, V93, P73, DOI 10.3945/ajcn.110.004945; Moriguchi T, 2001, PHYSIOL PLANTARUM, V111, P66, DOI 10.1034/j.1399-3054.2001.1110109.x; Mphahlele RR, 2014, SCI HORTIC-AMSTERDAM, V179, P36, DOI 10.1016/j.scienta.2014.09.007; Nenadis N, 2003, J AM OIL CHEM SOC, V80, P451, DOI 10.1007/s11746-003-0719-8; Papoutsis K, 2016, FOOD SCI BIOTECHNOL, V25, P971, DOI 10.1007/s10068-016-0158-8; Pompeu DR, 2009, BIORESOURCE TECHNOL, V100, P6076, DOI 10.1016/j.biortech.2009.03.083; Richa Kushwaha, 2011, International Journal of ChemTech Research, V3, P1033; Sicari V, 2016, INT J FOOD PROP, V19, P1962, DOI 10.1080/10942912.2015.1089893; Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008; Stewart AJ, 2000, J AGR FOOD CHEM, V48, P2663, DOI 10.1021/jf000070p; Stinco CM, 2015, J FOOD COMPOS ANAL, V37, P1, DOI 10.1016/j.jfca.2014.09.006; Tabaraki R, 2011, ULTRASON SONOCHEM, V18, P1279, DOI 10.1016/j.ultsonch.2011.05.004; Tiwari U, 2013, FOOD RES INT, V50, P497, DOI 10.1016/j.foodres.2011.09.007; Wani S. M., 2017, Journal of the Saudi Society of Agricultural Sciences, V16, P119, DOI 10.1016/j.jssas.2015.03.006; Yang L, 2010, J SEP SCI, V33, P1349, DOI 10.1002/jssc.200900776; Yang L, 2009, J SEP SCI, V32, P1437, DOI 10.1002/jssc.200800744; Yi L, 2017, PHYTOCHEMISTRY REV; Zhang MX, 2014, MOLECULES, V19, P17314, DOI 10.3390/molecules191117314	54	29	30	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211267	10.1371/journal.pone.0211267	http://dx.doi.org/10.1371/journal.pone.0211267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699169	gold, Green Submitted, Green Published			2022-12-26	WOS:000457155600070
J	Tang, CX; Luan, L; Zhang, L; Wang, Y; Liu, XF; Wang, J; Xiong, Y; Wang, D; Huang, LY; Gao, DS				Tang, Chuan-Xi; Luan, Lan; Zhang, Lin; Wang, Yue; Liu, Xin-Feng; Wang, Jie; Xiong, Ye; Wang, Dan; Huang, Lin-Yan; Gao, Dian-Shuai			Golgin-160 and GMAP210 play an important role in U251 cells migration and invasion initiated by GDNF	PLOS ONE			English	Article							MICROTUBULE NUCLEATION; MEMBRANE TRAFFICKING; POLARIZATION; FIBROBLASTS; CENTROSOME; APPARATUS; PLATFORM; RECEPTOR; GROWTH; EDGE	Gliomas are the most common malignant tumors of the brain and are characteristic of severe migration and invasion. Glial cell line-derived neurotrophic factor (GDNF) promotes glioma development process. However, the regulatory mechanisms of promoting occurrence and development of glioma have not yet been clearly elucidated. In the present study, the mechanism by which GDNF promotes glioma cell migration and invasion through regulating the dispersion and location of the Golgi apparatus (GA) is described. Following GDNF treatment, a change in the volume and position of GA was observed. The stack area of the GA was enlarged and it was more concentrated near the nucleus. Golgin-160 and Golgi microtubule-associated protein 210 (GMAP210) were identified as target molecules regulating GA positioning. In the absence of either golgin-160 or GMAP210 using lentivirus, the migration and invasion of U251 cells were decreased, while it was increased following GDNF. It was also found that the GA was decreased in size and dispersed following golgin-160 or GMAP210 knockdown, as determined by GA green fluorescence assay. Once GDNF was added, the above phenomenon would be twisted, and the concentrated location and volume of the GA was restored. In combination, the present data suggested that the regulation of the position and size of the GA by golgin-160 and GMAP210 play an important role in U251 cell migration and invasion.	[Tang, Chuan-Xi; Wang, Yue; Wang, Jie; Xiong, Ye; Gao, Dian-Shuai] Xuzhou Med Univ, Xuzhou Key Lab Neurobiol, Dept Neurobiol & Anat, Xuzhou, Jiangsu, Peoples R China; [Luan, Lan; Zhang, Lin] Xuzhou Med Univ, Sch Nursing, Xuzhou, Jiangsu, Peoples R China; [Liu, Xin-Feng] Xuzhou Med Univ, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China; [Wang, Dan] Xuzhou Med Univ, Sch Med Informat, Xuzhou, Jiangsu, Peoples R China; [Huang, Lin-Yan] Xuzhou Med Univ, Sch Med Technol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Gao, DS (corresponding author), Xuzhou Med Univ, Xuzhou Key Lab Neurobiol, Dept Neurobiol & Anat, Xuzhou, Jiangsu, Peoples R China.	gds@xzhmu.edu.cn		Gao, DianShuai/0000-0001-8567-0238	National Natural Science Research Foundation of China [81372698, 81402918]; Jiangsu University Natural Science Foundation [17KJB310015]	National Natural Science Research Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University Natural Science Foundation	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by the National Natural Science Research Foundation of China (grant Nos. 81372698, 81402918) and Jiangsu University Natural Science Foundation funded project (17KJB310015. Dan Wang: Funding, Lin-Yan Huang: Funding, experimental guidance, Dian-Shuai Gao: Funding, project supervision, study conception and design.	BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; CHAKRABORTY M, 1992, CELL MOL NEUROBIOL, V12, P589, DOI 10.1007/BF00711238; Cuccioli V, 2015, HIPPOCAMPUS, V25, P486, DOI 10.1002/hipo.22386; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Darido C, 2013, ADV WOUND CARE, V2, P87, DOI 10.1089/wound.2011.0352; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Ghezali G, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.155275; Gilbert CE, 2014, INT J MOL SCI, V15, P2929, DOI 10.3390/ijms15022929; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; Iochmann S, 2009, CLIN EXP METASTAS, V26, P457, DOI 10.1007/s10585-009-9245-z; Kim MS, 2015, BIOCHEM BIOPH RES CO, V460, P255, DOI 10.1016/j.bbrc.2015.03.021; Kimura M, 2018, EXP CELL RES, V367, P73, DOI 10.1016/j.yexcr.2018.03.024; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Millarte V, 2012, SCI WORLD J, DOI 10.1100/2012/498278; Ong ST, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00397; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Petry S, 2015, NAT CELL BIOL, V17, P1089, DOI 10.1038/ncb3220; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Procter DJ, 2018, DEV CELL, V45, P83, DOI 10.1016/j.devcel.2018.03.010; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roboti P, 2015, J CELL SCI, V128, P1595, DOI 10.1242/jcs.166710; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Xiong Y, 2017, ONCOTARGET, V8, P24902, DOI 10.18632/oncotarget.15302; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yang ZK, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa7677; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zhu RJ, 2018, SEMIN CELL DEV BIOL, V82, P41, DOI 10.1016/j.semcdb.2017.11.006	36	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211501	10.1371/journal.pone.0211501	http://dx.doi.org/10.1371/journal.pone.0211501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695072	gold, Green Published, Green Submitted			2022-12-26	WOS:000457046400039
J	Straatmann, VS; Almquist, YB; Oliveira, AJ; Veiga, GV; Rostila, M; Lopes, CS				Straatmann, Viviane S.; Almquist, Ylva B.; Oliveira, Aldair J.; Veiga, Gloria V.; Rostila, Mikael; Lopes, Claudia S.			Stability and bidirectional relationship between physical activity and sedentary behaviours in Brazilian adolescents: Longitudinal findings from a school cohort study	PLOS ONE			English	Article							CHILDHOOD; TRACKING; TIME; ASSOCIATION; ADULTHOOD; PROGRESS; CHILDREN; TRENDS; YOUTH	Purpose We investigated the stability, correlations and bidirectional relationship of light physical activities (PA), moderate and vigorous PA (MVPA), television viewing (TV) and video game/computer use (VG) in Brazilian adolescents. Methods Adolescent Nutritional Assessment Longitudinal Study-ELANA is a middle school cohort study conducted in Rio de Janeiro-Brazil in 2010-2012. Self-reported data on PA (International Physical Activity Questionnaire-IPAQ) and screen activities were obtained from 810 adolescents (mean ages of 10.9 years old (SD 0.78) for girls; 11 years old (SD 0.85) for boys) to perform autoregressive cross-lagged structural equation models in two time points for PA and three time points for screen activities. Results There was no significant stability of light PA and MVPA for boys and girls. Moderate stability of screen activities were found for both genders, with a significant coefficient of TV for boys (T1-T2:0.29; T2-T3:0.27 p<0.001); and VG for boys (T1-T2:0.33; T2-T3:0.35 p<0.001) and girls (T1-T2:0.26; T2-T3:0.37 p<0.01). Significant lagged effects were obtained only among girls:light PA had effect on VG (-0.10 p<0.01), as well as in the opposite direction of TV on light PA (-0.03 p<0.01) and TV on MVPA (-0.11 p<0.01). Conclusion The light PA, MVPA and screen activities (among girls) did not demonstrate stability over time. A warning scenario was suggested by the stability of high amounts of screen activities among boys over time. Screen activities had bidirectional association with light PA and MVPA among girls over time.	[Straatmann, Viviane S.] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Straatmann, Viviane S.] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Almquist, Ylva B.; Rostila, Mikael] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden; [Oliveira, Aldair J.] UFRRJ, Lab Social Dimens Appl Phys Act & Sport LABSAFE, Seropedica, Brazil; [Veiga, Gloria V.] Fed Univ Rio de Janeiro UFRJ, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil; [Lopes, Claudia S.] State Univ Rio de Janeiro UERJ, Inst Social Med, Rio De Janeiro, Brazil	University of Liverpool; Karolinska Institutet; Stockholm University; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Straatmann, VS (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.; Straatmann, VS (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	v.schultz-straatmann@liv.ac.uk; gveiga@nutricao.ufrj.br	J Oliveira, Aldair/AAE-7422-2022; de Souza Lopes, Claudia/H-9150-2013	J Oliveira, Aldair/0000-0002-2714-0615; de Souza Lopes, Claudia/0000-0002-0401-689X; Straatmann, Viviane/0000-0003-2355-1174	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq) [47667/2011-9]; Research Support Foundation of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro- FAPERJ) [E26/110.626/2011, E-26/110.774/2013, E26/110.847/2009]; Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES) [23038.007702/2011-5]	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro- FAPERJ); Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The ELANA was supported by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq) (grant 47667/2011-9), the Research Support Foundation of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro- FAPERJ) (grants E26/110. 847/2009, E26/110.626/2011 and E-26/110.774/2013) and Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES) (grant 23038.007702/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associac Brasileira de Empresas de Pesquisa, 2008, COD GUIAS ABEP CRIT; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Bucksch J, 2016, J ADOLESCENT HEALTH, V58, P417, DOI 10.1016/j.jadohealth.2015.11.014; Chaput JP, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.14; Currie C, 2008, HLTH POLICY CHILDREN, V5, P206; Ferrari GLD, 2015, J PEDIAT-BRAZIL, V91, P574, DOI 10.1016/j.jped.2015.01.009; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Ekelund U, 2016, LANCET, V388, pE6; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Epstein LH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-13; Epstein LH, 2005, ANN BEHAV MED, V29, P200, DOI 10.1207/s15324796abm2903_6; Gordon CC, 1988, ANTHR STAND REF MANU, P3; Guedes Dartagnan Pinto, 2005, Rev Bras Med Esporte, V11, P151, DOI 10.1590/S1517-86922005000200011; Guerra PH, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006307; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; IPAQ, 2005, GUIDELINES DATA PROC; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Junior GC, 2016, REV BRAS CIENC ESPOR, V38, P179; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kwon S, 2015, JAMA PEDIATR, V169, P666, DOI 10.1001/jamapediatrics.2015.0327; Laird Y, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0405-7; Ling JY, 2014, AM J HEALTH BEHAV, V38, P881, DOI 10.5993/AJHB.38.6.10; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Pearson N, 2014, OBES REV, V15, P666, DOI 10.1111/obr.12188; Rauner A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1731-4; Raustorp A, 2018, J PHYS ACT HEALTH, V15, P7, DOI 10.1123/jpah.2017-0146; Saito MI, 1984, PEDIATRICA, V6, P111; Sturm R, 2004, AM J PREV MED, V27, P126, DOI 10.1016/j.amepre.2004.06.013; Szwarcwald Célia Landmann, 2005, Rev. Bras. Saude Mater. Infant., V5, ps11, DOI 10.1590/S1519-38292005000500002; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Taveras EM, 2007, PEDIATRICS, V119, pE314, DOI 10.1542/peds.2005-2974; Telama R, 2014, MED SCI SPORT EXER, V46, P955, DOI 10.1249/MSS.0000000000000181; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; van den Eijnden RJJM, 2008, DEV PSYCHOL, V44, P655, DOI 10.1037/0012-1649.44.3.655; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Young DR, 2018, J ADOLESCENT HEALTH, V63, P466, DOI 10.1016/j.jadohealth.2018.05.023; Yvonne Laird, 2018, J QUAL STUD HLTH WEL, V13, P1	46	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211470	10.1371/journal.pone.0211470	http://dx.doi.org/10.1371/journal.pone.0211470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682158	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500171
J	Jiang, EH; Xu, Z; Wang, M; Yan, TL; Huang, CM; Zhou, XC; Liu, Q; Wang, L; Chen, Y; Wang, H; Liu, K; Shao, Z; Shang, ZJ				Jiang, Erhui; Xu, Zhi; Wang, Meng; Yan, Tinglin; Huang, Chunming; Zhou, Xiaocheng; Liu, Qing; Wang, Lin; Chen, Yang; Wang, Hui; Liu, Ke; Shao, Zhe; Shang, Zhengjun			Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma	FASEB JOURNAL			English	Article						OSCC; reverse Warburg effect; metabolism; tumor-stroma interaction; tumor microenvironment	CANCER-ASSOCIATED FIBROBLASTS; EXTRACELLULAR VESICLES; PANCREATIC-CANCER; MEMBRANE MICROVESICLES; EMERGING ROLE; STROMA; MICROENVIRONMENT; COMMUNICATION; METABOLISM; CONVERSION	Metabolic reprogramming is a hallmark of cancer. Stromal cells could function as providers of energy metabolites for tumor cells by undergoing the "reverse Warburg effect," but the mechanism has not been fully elucidated. The interaction between the tumoral microvesicles (TMVs) and stroma in the tumor microenvironment plays a critical role in facilitating cancer progression. In this study, we demonstrated a novel mechanism for the TMV-mediated glycometabolic reprogramming of stromal cells. After being incubated with TMVs, normal human gingival fibroblasts exhibited a phenotype switch to cancer-associated fibroblasts and underwent a degradation of caveolin 1 (CAV1) through the ERK1/2-activation pathway. CAV1 degradation further induced the metabolic switch to aerobic glycolysis in the fibroblasts. The microvesicle-activated fibroblasts absorbed more glucose and produced more lactate. The migration and invasion of oral squamous cell carcinoma (OSCC) were promoted after being cocultured with the activated fibroblasts. Fibroblast-cancer cell glycometabolic coupling ring mediated by monocarboxylate transporter (MCT) 4 and MCT1 was then proved in the tumor microenvironment. Results indicated a mechanism for tumor progression by the crosstalk between tumor cells and stromal cells through the reverse Warburg effect via TMVs, thereby identifying potential targets for OSCC prevention and treatment.	[Jiang, Erhui; Yan, Tinglin; Huang, Chunming; Zhou, Xiaocheng; Liu, Qing; Wang, Lin; Chen, Yang; Wang, Hui; Liu, Ke; Shao, Zhe; Shang, Zhengjun] Minist Educ KLOBME, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan, Hubei, Peoples R China; [Jiang, Erhui; Yan, Tinglin; Huang, Chunming; Zhou, Xiaocheng; Liu, Qing; Wang, Lin; Chen, Yang; Wang, Hui; Liu, Ke; Shao, Zhe; Shang, Zhengjun] Minist Educ KLOBME, Key Lab Oral Biomed Engn, Wuhan, Hubei, Peoples R China; [Xu, Zhi] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Stomatol, Wuhan, Hubei, Peoples R China; [Wang, Meng] Shandong Univ, Sch Stomatol, Shandong Prov Key Lab Oral Tissue Regenerat, Jinan, Shandong, Peoples R China; [Liu, Ke; Shao, Zhe; Shang, Zhengjun] Wuhan Univ, Sch Stomatol, Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Oncol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Shandong University; Wuhan University	Shao, Z; Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol,Minist Educ KLOBME, Dept Oral & Maxillofacial Head & Neck Oncol, State Key Lab Breeding Base Basic Sci Stomatol Hu, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.; Shao, Z; Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol,Minist Educ KLOBME, Dept Oral & Maxillofacial Head & Neck Oncol, Key Lab Oral Biomed Engn, 237 Luoyu Rd, Wuhan 430079, Hubei, Peoples R China.	shaozhe@whu.edu.cn; shangzhengjun@whu.edu.cn		Jiang, Erhui/0000-0003-4668-026X; shang, zhengjun/0000-0002-4884-8129	National Natural Science Foundation of China [81672666, 81372879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Xiaoxuan Wang (Wuhan University) and Xiaoping Zhao (Huazhong University of Science and Technology) for their kind help in the experimental research. The authors thank Pei Zhang (Wuhan Institute of Virology, Wuhan, China), for help with producing transmission electron microscopy micrographs. This study was supported by the National Natural Science Foundation of China (Grants 81672666, 81372879 to Z. Shang). The authors declare no conflicts of interest.	Achreja A, 2017, METAB ENG, V43, P156, DOI 10.1016/j.ymben.2017.01.001; Almangush A, 2018, HISTOPATHOLOGY, V72, P1128, DOI 10.1111/his.13481; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Chen G, 2015, ANGEW CHEM INT EDIT, V54, P1036, DOI 10.1002/anie.201410223; Chiarugi P, 2016, CANCER LETT, V380, P272, DOI 10.1016/j.canlet.2015.10.027; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Corbet C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03525-0; Crewe C, 2018, CELL, V175, P695, DOI 10.1016/j.cell.2018.09.005; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Leef G, 2013, ORAL ONCOL, V49, P381, DOI 10.1016/j.oraloncology.2012.12.014; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Milani G, 2017, MOL CANCER RES, V15, P683, DOI 10.1158/1541-7786.MCR-16-0307; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Moore C, 2017, INT J CANCER, V141, P428, DOI 10.1002/ijc.30672; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; NAITO S, 1986, CANCER RES, V46, P4109; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Nwosu ZC, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0558-7; Orr B, 2012, ONCOGENE, V31, P1130, DOI 10.1038/onc.2011.312; Pang WJ, 2015, CANCER SCI, V106, P1362, DOI 10.1111/cas.12747; Patel BB, 2017, EXP CELL RES, V352, P20, DOI 10.1016/j.yexcr.2017.01.013; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pertega-Gomes N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-352; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Shan T, 2017, ONCOL REP, V37, P1971, DOI 10.3892/or.2017.5479; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Sung MS, 2018, SMALL, V14, DOI 10.1002/smll.201802358; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Wang X, 2016, BIOMATERIALS, V83, P207, DOI 10.1016/j.biomaterials.2016.01.001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Yang ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145807; Yogev O, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006524; Zhan HX, 2017, CANCER LETT, V392, P83, DOI 10.1016/j.canlet.2017.01.041; Zhang J, 2013, PHARMACOL THERAPEUT, V137, P200, DOI 10.1016/j.pharmthera.2012.10.003; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250; Zhao XP, 2015, CANCER LETT, V360, P125, DOI 10.1016/j.canlet.2015.01.032; Zhou XC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0911-3	49	38	40	1	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5690	5703		10.1096/fj.201802226R	http://dx.doi.org/10.1096/fj.201802226R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698991	Bronze			2022-12-26	WOS:000462888500084
J	Liang, XL; Jin, YM; Wang, H; Meng, XL; Tan, ZZ; Huang, T; Fan, SR				Liang, Xiaoling; Jin, Yimei; Wang, Hao; Meng, Xinlu; Tan, Zhongzhou; Huang, Tao; Fan, Shangrong			Transgelin 2 is required for embryo implantation by promoting actin polymerization	FASEB JOURNAL			English	Article						TAGLN2; blastocyst implantation; cell migration; cell invasion	LASER CAPTURE MICRODISSECTION; ADHESION MOLECULES; TROPHOBLAST; IDENTIFICATION; CYTOSKELETON; ADHESIVENESS; BIOMARKER; PROTEIN; WINDOW; TAGLN2	Infertility has been a great challenge in reproductive medicine. At least 40% of human pregnancy losses are clinically unrecognized and occur because of embryo implantation failure. Identification of the proteins and biochemical factors involved in embryo implantation and that are essential for crosstalk between the embryo and uterus can further increase female fertility rates. The actin cytoskeleton and actin-binding proteins (ABPs) are of great importance for cell morphology and rearrangement, which is crucial for trophoblast adhesion and invasion. However, the research on ABPs in embryo implantation is insufficient. In this report, we found that transgelin (TAGLN)2 is highly expressed in mouse blastocyst trophoblasts. Notably, inhibition of mouse blastocyst trophoblast TAGLN2 by lentivirus-mediated RNA interference significantly impaired embryo adhesion and implantation ability. Further in vitro experiments demonstrated that TAGLN2 knockdown with small interfering RNA observably decreased the invasion and migration abilities of human trophoblast cells. Immunofluorescence colocalization and microscale thermophoresis analysis showed that TAGLN2 directly binds to actin. In addition, knockdown of TAGLN2 in trophoblast cells resulted in a remarkable reduction in F-actin rather than G-actin. Our findings reveal an unidentified role of TAGLN2 in regulation of trophoblast invasion and adhesion by promoting actin polymerization.	[Liang, Xiaoling; Wang, Hao; Fan, Shangrong] Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, 1120 Lianhua Rd, Shenzhen 518036, Peoples R China; [Liang, Xiaoling; Fan, Shangrong] Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China; [Jin, Yimei; Meng, Xinlu] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing, Peoples R China; [Tan, Zhongzhou; Huang, Tao] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University	Fan, SR (corresponding author), Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, 1120 Lianhua Rd, Shenzhen 518036, Peoples R China.	fanshangrong@163.com		Jin, Yimei/0000-0001-7599-7042; meng, xin lu/0000-0003-3731-9536; Liang, Xiaoling/0000-0002-9436-8476	Shenzhen Science and Technology Plan [JCYJ20160428175005906]	Shenzhen Science and Technology Plan	The authors are grateful to Prof. Mo Li and Dr. Bingteng Xie (both from the Center for Reproductive Medicine, Peking University Third Hospital) for the insightful comments and suggestions on the manuscript. This research was supported by the Shenzhen Science and Technology Plan (Grant JCYJ20160428175005906 to S. Fan). The authors declare no conflicts of interest.	Aplin JD, 2017, J CELL SCI, V130, P15, DOI 10.1242/jcs.175943; Armant DR, 2011, CELL CYCLE, V10, P574, DOI 10.4161/cc.10.4.14846; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Dvorakova M, 2016, J PROTEOMICS, V132, P103, DOI 10.1016/j.jprot.2015.11.025; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; Forti G, 1998, J CLIN ENDOCR METAB, V83, P4177, DOI 10.1210/jc.83.12.4177; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Han MZ, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0619-9; Heneweer C, 2002, MOL HUM REPROD, V8, P1014, DOI 10.1093/molehr/8.11.1014; Hill JJ, 2011, J PROTEOME RES, V10, P2479, DOI 10.1021/pr101267k; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huang QJ, 2008, J CANCER RES CLIN, V134, P1219, DOI 10.1007/s00432-008-0398-y; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Jauniaux E, 2005, PLACENTA, V26, P114, DOI 10.1016/j.placenta.2004.05.011; Kim HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09144-x; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Pei J, 2018, EUR REV MED PHARMACO, V22, P307, DOI 10.26355/eurrev_201801_14173; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Singh H, 2009, J ANAT, V215, P3, DOI 10.1111/j.1469-7580.2008.01034.x; Thie M, 1997, MOL HUM REPROD, V3, P275, DOI 10.1093/molehr/3.4.275; van Mourik MSM, 2009, J LEUKOCYTE BIOL, V85, P4, DOI 10.1189/jlb.0708395; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Xie BT, 2018, CELL RES, V28, P462, DOI 10.1038/s41422-018-0009-7; Yekani F, 2018, J CELL PHYSIOL, V233, P9070, DOI 10.1002/jcp.26879; Zhang HJ, 2018, ONCOL LETT, V16, P6355, DOI 10.3892/ol.2018.9436; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x	40	19	20	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5667	5675		10.1096/fj.201802158RRR	http://dx.doi.org/10.1096/fj.201802158RRR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702937	Bronze			2022-12-26	WOS:000462888500082
J	Zhang, X; Zhang, SN; Zhang, L; Lu, JX; Zhao, CY; Luo, F; Li, D; Li, XM; Liu, C				Zhang, Xiang; Zhang, Shengnan; Zhang, Li; Lu, Jinxia; Zhao, Chunyu; Luo, Feng; Li, Dan; Li, Xueming; Liu, Cong			Heat shock protein 104 (HSP104) chaperones soluble Tau via a mechanism distinct from its disaggregase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; heat shock protein (HSP); amyloid; protein aggregation; Tau protein (Tau); holdase; HSP104; protein fibrils	N-TERMINAL DOMAIN; PLASTICITY; REVEALS; PROPAGATION; PRIONS; SYSTEM; MODEL; MOTIF	Heat shock protein 104 (HSP104) is a conserved AAA+ protein disaggregase, can disassemble the toxic aggregates formed by different amyloid proteins, and is protective in various animal models associated with amyloid-related diseases. Extensive studies have attempted to elucidate how HSP104 disassembles the aggregated form of clients. Here, we found that HSP104 exhibits a potent holdase activity that does not require energy, prevents the soluble form of amyloid clients from aggregating, and differs from HSP104's disaggregase activity. Using cryo-EM, NMR, and additional biophysical approaches, we found that HSP104 utilizes its small subdomain of nucleotide-binding domain 2 (ssNBD2) to capture the soluble amyloid client (K19 of Tau) independent of its ATP hydrolysis activity. Our results indicate that HSP104 utilizes two fundamental distinct mechanisms to chaperone different forms of amyloid client and highlight the important yet previously unappreciated function of ssNBD2 in chaperoning amyloid client and thereby preventing pathological aggregation.	[Zhang, Xiang; Zhang, Shengnan; Zhao, Chunyu; Luo, Feng; Liu, Cong] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 Qiuyue Rd, Shanghai 201210, Peoples R China; [Zhang, Li; Li, Xueming] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Lu, Jinxia; Li, Dan] Shanghai Jiao Tong Univ, Bio X Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Zhang, Xiang; Zhao, Chunyu; Luo, Feng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Tsinghua University; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, C (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 Qiuyue Rd, Shanghai 201210, Peoples R China.; Li, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.	lixueming@tsinghua.edu.cn; liulab@sioc.ac.cn		liu, cong/0000-0003-3425-6672	National Natural Science Foundation of China [31470748]; Major State Basic Research Development Program [2016YFA0501902]; Chinese Academy of Sciences; "1000 Talents Plan" of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); "1000 Talents Plan" of China	This work was supported by National Natural Science Foundation of China Grant 31470748), Major State Basic Research Development Program Grant 2016YFA0501902, and funds from the Chinese Academy of Sciences, and the "1000 Talents Plan" of China. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cushman-Nick M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003781; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heuck A, 2016, ELIFE, V5, DOI 10.7554/eLife.21516; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; Koldewey P, 2016, CELL, V166, P369, DOI 10.1016/j.cell.2016.05.054; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Landau M, 2017, J BIOL CHEM, V292, P16380, DOI 10.1074/jbc.H117.780528; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Liu ZY, 2017, PROTEIN PEPTIDE LETT, V24, P315, DOI 10.2174/0929866524666170206122616; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Sweeny EA, 2011, JOVE-J VIS EXP, DOI 10.3791/3190; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Xu LA, 2018, CELL MOL LIFE SCI, V75, P1445, DOI 10.1007/s00018-017-2698-3; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zhao ML, 2016, J MOL BIOL, V428, P1912, DOI 10.1016/j.jmb.2015.10.026; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	61	12	13	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4956	4965		10.1074/jbc.RA118.005980	http://dx.doi.org/10.1074/jbc.RA118.005980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718279	Green Published, hybrid			2022-12-26	WOS:000463985600020
J	Amor, JM; Newman, R; Jensen, WF; Rundquist, BC; Walter, WD; Boulanger, JR				Amor, Jacqueline M.; Newman, Robert; Jensen, William F.; Rundquist, Bradley C.; Walter, W. David; Boulanger, Jason R.			Seasonal home ranges and habitat selection of three elk (Cervus elaphus) herds in North Dakota	PLOS ONE			English	Article							ROCKY-MOUNTAIN ELK; FEMALE ELK; MOVEMENTS; POPULATIONS; RESPONSES; PATTERNS; UNGULATE; BEHAVIOR; FOREST; SPACE	Changes in land use have resulted in range shifts of many wildlife species, including those entering novel environments, resulting in the critical need to understand their spatial ecology to inform ecosystem effects and management decisions. Dispersing elk (Cervus elaphus) were colonizing areas of suitable habitat in the Northern Great Plains, USA, resulting in crop depredation complaints in these areas. Although state resource managers had little information on these elk herds, limited evidence suggested temporal movements into Canada. We collected and analyzed essential information on home range and habitat selection for 3 elk herds residing in North Dakota. We captured 5 adult female elk in each study area, affixed global positioning system collars, and monitored them for 1 year (2016-2017). We estimated diel period, seasonal, and hunting season home ranges using Brownian Bridge Movement Models for each individual. We analyzed habitat selection using multinomial logit models to test for differences in use of land classes, and for departures from proportionate use based on random sampling; our predictor variables included individual elk, diel period, and season. Home ranges differed between the 3 herds, seasons, and diel period; gun and winter season home ranges were both larger than in summer, as was night when compared with day. Female elk generally restricted themselves to cover during the day and entered open areas at night and during winter months. Our results also suggest that elk in our study areas tended to seek more cover, and in the case of our Turtle Mountain study area, some cross into Canada during gun season. Our study provides a better understanding of the spatial ecology of elk in the Northern Great Plains while highlighting the need for enhanced international cooperative management efforts.	[Amor, Jacqueline M.; Rundquist, Bradley C.] Univ North Dakota, Dept Geog, Grand Forks, ND USA; [Newman, Robert; Boulanger, Jason R.] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Jensen, William F.] North Dakota Game & Fish Dept, Bismarck, ND USA; [Walter, W. David] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Amor, Jacqueline M.] US Forest Serv, Oroville, CA USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); United States Forest Service	Boulanger, JR (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.	jason.boulanger@und.edu		Boulanger, Jason/0000-0002-7602-3124; Walter, David/0000-0003-3068-1073	Federal Aid in Wildlife Restoration Project [W-67-R-58, C-XI]; University of North Dakota, College of Arts and Sciences; North Dakota EPSCoR through National Science Foundation [11A-135466]; North Dakota EPSCoR through North Dakota EPSCoR State funds	Federal Aid in Wildlife Restoration Project; University of North Dakota, College of Arts and Sciences; North Dakota EPSCoR through National Science Foundation; North Dakota EPSCoR through North Dakota EPSCoR State funds	JRB received the following awards. This research was funded by Federal Aid in Wildlife Restoration Project No. W-67-R-58 (Study No. C-XI) and administered by North Dakota Game and Fish Department (littps://gf.nd.gov/), and University of North Dakota, College of Arts and Sciences (littps://arts-sciences.und.edu/). Additional financial support was received from North Dakota EPSCoR (https://www.ndepscor.ndus.edu/) through National Science Foundation (https://www.nsf.gov/) grant 11A-135466 and through North Dakota EPSCoR State funds. North Dakota Game and Fish Department had a role in study design, data collection, decision to publish, and preparation of the manuscript. The remaining funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020; Allen AM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1524; Amor JM, 2017, THESIS; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; [Anonymous], [No title captured]; Beall RC, 1974, THESIS; Beck JL, 2013, WEST N AM NATURALIST, V73, P442, DOI 10.3398/064.073.0414; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brough AM, 2017, FOREST ECOL MANAG, V389, P220, DOI 10.1016/j.foreco.2016.11.034; Bullard F, 1999, THESIS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chiu CH, 2014, WEATHER CLIM SOC, V6, P22, DOI 10.1175/WCAS-D-13-00023.1; Christianson DA, 2007, J WILDLIFE MANAGE, V71, P164, DOI 10.2193/2005-575; CONGALTON RG, 1983, PHOTOGRAMM ENG REM S, V49, P69; Conner MM, 2001, J WILDLIFE MANAGE, V65, P926, DOI 10.2307/3803041; Cook JG, 2004, TRANS N AM WILDL NAT, V69, P708; DeVore RM., 2014, THESIS; Devore RM, 2016, J WILDLIFE MANAGE, V80, P479, DOI 10.1002/jwmg.1040; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fox J, 2018, J STAT SOFTW, V87, P1, DOI 10.18637/jss.v087.i09; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Hegel TA, 2009, J ENVIRON MANAGE, V90, P222, DOI 10.1016/j.jenvman.2007.09.005; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hudson R. J., 2002, N AM ELK ECOLOGY MAN; Irby LR, 2002, J ENVIRON MANAGE, V64, P153, DOI 10.1006/jema.2001.0514; IRWIN LL, 1983, J WILDLIFE MANAGE, V47, P664, DOI 10.2307/3808602; JENKINS KJ, 1987, CAN J ZOOL, V65, P1397, DOI 10.1139/z87-220; Jensen JR., 2004, INTRO DIGITAL IMAGE, V3; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Keller BJ, 2015, MAMMAL REV, V45, P146, DOI 10.1111/mam.12041; Kneib T, 2011, ENVIRON ECOL STAT, V18, P1, DOI 10.1007/s10651-009-0115-2; Knight R. R., 1970, WILDLIFE MONOGR, V23, P3; Knue J, 1991, BIG GAME N DAKOTA; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Lone K, 2017, OIKOS, V126, P624, DOI 10.1111/oik.03486; Manly BF, 2002, RESOURCE SELECTION A, P1, DOI [10.1007/0-306-48151-0_1, DOI 10.1007/0-306-48151-0_1]; Maskey J., 2008, THESIS; McCracken Marti L., 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P268, DOI 10.2307/1400582; McNairn H, 2009, ISPRS J PHOTOGRAMM, V64, P434, DOI 10.1016/j.isprsjprs.2008.07.006; Merkle JA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0456; Muller A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177431; Newman DR, 2018, GEOMORPHOLOGY, V312, P40, DOI 10.1016/j.geomorph.2018.04.003; Osborn RG, 1997, DIET N DAKOTA ELK DE, P13; Ranglack DH, 2017, J WILDLIFE MANAGE, V81, P778, DOI 10.1002/jwmg.21258; Richard JH, 2014, BEHAV ECOL SOCIOBIOL, V68, P1639, DOI 10.1007/s00265-014-1772-1; ROBBINS CT, 1981, J WILDLIFE MANAGE, V45, P172, DOI 10.2307/3807885; Sawyer H, 2007, J WILDLIFE MANAGE, V71, P868, DOI 10.2193/2006-131; Seabloom R., 2011, MAMMALS N DAKOTA; Seidel DP, 2016, OIKOS, V125, P39, DOI 10.1111/oik.02005; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smith J, 2017, A245 N DAK STAT GAM; Smith J, 2016, A235 N DAK GAM FISH; Strassler A, 1996, ECOLOGY NO BADLANDS; Sullivan M.G., 1988, THESIS; Sunde P, 2009, WILDLIFE BIOL, V15, P454, DOI 10.2981/09-012; Thurfjell H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178082; Unsworth JW, 1998, J WILDLIFE MANAGE, V62, P1255, DOI 10.2307/3801989; Venables WN., 2002, MODERN APPL STAT S 4; Vore JM, 2001, WILDLIFE SOC B, V29, P720; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; Walter WD, 2010, WILDLIFE RES, V37, P630, DOI 10.1071/WR10021; Walter WD, 2016, MANUAL APPL SPATIAL; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; Westfall J., 1989, THESIS; Wilckens DT, 2016, J MAMMAL, V97, P373, DOI 10.1093/jmammal/gyv183; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Yott A, 2011, RESTOR ECOL, V19, P70, DOI 10.1111/j.1526-100X.2009.00639.x; Zuur Alain F., 2009, P1	71	2	3	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211650	10.1371/journal.pone.0211650	http://dx.doi.org/10.1371/journal.pone.0211650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716128	Green Published, gold			2022-12-26	WOS:000457744200037
J	Bobardt, M; Kuo, J; Chatterji, U; Chanda, S; Little, SJ; Wiedemann, N; Vuagniaux, G; Gallay, PA				Bobardt, Michael; Kuo, Joseph; Chatterji, Udayan; Chanda, Sumit; Little, Susan J.; Wiedemann, Norbert; Vuagniaux, Gregoire; Gallay, Philippe A.			The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; SMAC MIMETICS; IN-VITRO; INFECTION; TRANSCRIPTION; ACTIVATION; POTENT; MICE; RECONSTITUTION	Antiretroviral therapy (ART) suppresses HIV replication, but does not cure the infection because replication-competent virus persists within latently infected CD4+ T cells throughout years of therapy. These reservoirs contain integrated HIV-1 genomes and can resupply active virus. Thus, the development of strategies to eliminate the reservoir of latently infected cells is a research priority of global significance. In this study, we tested efficacy of a new inhibitor of apoptosis protein antagonist (IAPa) called Debio 1143 at reversing HIV latency and investigated its mechanisms of action. Debio 1143 activates HIV transcription via NF-kB signaling by degrading the ubiquitin ligase baculoviral IAP repeat-containing 2 (BIRC2), a repressor of the non-canonical NF-kB pathway. Debio 1143-induced BIRC2 degradation results in the accumulation of NF-KB-inducing kinase (NIK) and proteolytic cleavage of p100 into p52, leading to nuclear translocation of p52 and RELB. Debio 1143 greatly enhances the binding of RELB to the HIV-1 LTR. These data indicate that Debio 1143 activates the non-canonical NF-kB signaling pathway by promoting the binding of RELB:p52 complexes to the HIV-1 LTR, resulting in the activation of the LTR-dependent HIV-1 transcription. Importantly, Debio 1143 reverses viral latency in HIV-1 latent T cell lines. Using knockdown (siRNA BIRC2), knockout (CRIPSR NIK) and proteasome machinery neutralization (MG132) approaches, we found that Debio 1143-mediated HIV latency reversal is BIRC2 degradation- and NIK stabilization-dependent. Debio 1143 also reverses HIV-1 latency in resting CD4+ T cells derived from ART-treated patients or HIV-1-infected humanized mice under ART. Interestingly, daily oral administration of Debio 1143 in cancer patients at well-tolerated doses elicited BIRC2 target engagement in PBMCs and induced a moderate increase in cytokines and chemokines mechanistically related to NF-kB signaling. In conclusion, we provide strong evidences that the IAPa Debio 1143, by initially activating the non-canonical NF-kB signaling and subsequently reactivating HIV-1 transcription, represents a new attractive viral latency reversal agent (LRA).	[Bobardt, Michael; Kuo, Joseph; Chatterji, Udayan; Gallay, Philippe A.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Chanda, Sumit] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Little, Susan J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Wiedemann, Norbert; Vuagniaux, Gregoire] Debiopharm Int SA, Lausanne, Switzerland	Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Debiopharm	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	gallay@scripps.edu	Little, Susan/AAA-6116-2019		Debiopharm International; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, R01AI125365] Funding Source: NIH RePORTER	Debiopharm International; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Author PAG received funding from Debiopharm International. Authors NW and GV receive support in the form of salary from Debiopharm International. The funder contributed to study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Baba M, 2000, AIDS RES HUM RETROV, V16, P935, DOI 10.1089/08892220050058344; Bai LC, 2014, PHARMACOL THERAPEUT, V144, P82, DOI 10.1016/j.pharmthera.2014.05.007; Barton K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12731; Beans EJ, 2013, P NATL ACAD SCI USA, V110, P11698, DOI 10.1073/pnas.1302634110; Benetatos CA, 2014, MOL CANCER THER, V13, P867, DOI 10.1158/1535-7163.MCT-13-0798; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Britanova LV, 2008, BIOCHEM BIOPH RES CO, V365, P583, DOI 10.1016/j.bbrc.2007.10.200; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Cai Q, 2011, J MED CHEM, V54, P2714, DOI 10.1021/jm101505d; CANN AJ, 1990, J VIROL, V64, P4735, DOI 10.1128/JVI.64.10.4735-4742.1990; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Dai Y, 2009, AM J TRANSL RES, V1, P1; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Dubrez L, 2013, ONCOTARGETS THER, V6, P1285, DOI 10.2147/OTT.S33375; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Flygare JA, 2012, J MED CHEM, V55, P4101, DOI 10.1021/jm300060k; Fulda S, 2014, CLIN CANCER RES, V20, P289, DOI 10.1158/1078-0432.CCR-13-0227; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gallay Philippe A, 2018, Open Virol J, V12, P1, DOI 10.2174/1874357901812010001; Gallay PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184303; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hurwitz HI, 2015, CANCER CHEMOTH PHARM, V75, P851, DOI 10.1007/s00280-015-2709-8; Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kovochich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018270; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Marsden MD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006575; Marsden Matthew D, 2015, For Immunopathol Dis Therap, V6, P91; Marsden MD, 2015, CELL HOST MICROBE, V17, P141, DOI 10.1016/j.chom.2015.01.008; Marsden MD, 2013, BIOORG MED CHEM LETT, V23, P4003, DOI 10.1016/j.bmcl.2013.05.032; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Oberoi-Khanuja TK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.311; Pache L, 2015, CELL HOST MICROBE, V18, P345, DOI 10.1016/j.chom.2015.08.009; Paiva C, 2017, ONCOTARGET, V8, P21128, DOI 10.18632/oncotarget.15050; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Perez M, 2010, CURR HIV RES, V8, P418, DOI 10.2174/157016210793499312; Philchenkov Alex, 2016, Critical Reviews in Oncogenesis, V21, P185, DOI 10.1615/CritRevOncog.2016017032; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tsai P, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0268-7; UNAIDS, 2016, UNAIDS 2016 GLOB FAC; Veazey RS, 2016, ANTIMICROB AGENTS CH, V60, P693, DOI 10.1128/AAC.01925-15; Verhagen AM, 2001, GENOME BIOL, V2; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2013, DRUG DISCOV TODAY, V18, P541, DOI 10.1016/j.drudis.2012.12.008	65	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211746	10.1371/journal.pone.0211746	http://dx.doi.org/10.1371/journal.pone.0211746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716099	gold, Green Submitted, Green Published			2022-12-26	WOS:000457744200047
J	Garcia, M; Eckermann, P; Haefele, S; Satija, S; Sznajder, B; Timmins, A; Baumann, U; Wolters, P; Mather, DE; Fleury, D				Garcia, Melissa; Eckermann, Paul; Haefele, Stephan; Satija, Sanjiv; Sznajder, Beata; Timmins, Andy; Baumann, Ute; Wolters, Petra; Mather, Diane E.; Fleury, Delphine			Genome-wide association mapping of grain yield in a diverse collection of spring wheat (Triticum aestivum L.) evaluated in southern Australia	PLOS ONE			English	Article							BREAD WHEAT; GENETIC DISSECTION; COMPLEX TRAITS; DROUGHT; TOLERANCE; DESIGN; QTL	Wheat landraces, wild relatives and other 'exotic' accessions are important sources of new favorable alleles. The use of those exotic alleles is facilitated by having access to information on the association of specific genomic regions with desirable traits. Here, we conducted a genome-wide association study (GWAS) using a wheat panel that includes landraces, synthetic hexaploids and other exotic wheat accessions to identify loci that contribute to increases in grain yield in southern Australia. The 568 accessions were grown in the field during the 2014 and 2015 seasons and measured for plant height, maturity, spike length, spike number, grain yield, plant biomass, HI and TGW. We used the 90K SNP array and two GWAS approaches (GAPIT and QTCAT) to identify loci associated with the different traits. We identified 17 loci with GAPIT and 25 with QTCAT. Ten of these loci were associated with known genes that are routinely employed in marker assisted selection such as Ppd-D1 for maturity and Rht-D1 for plant height and seven of those were detected with both methods. We identified one locus for yield per se in 2014 on chromosome 6B with QTCAT and three in 2015, on chromosomes 4B and 5A with GAPIT and 6B with QTCAT. The 6B loci corresponded to the same region in both years. The favorable haplotypes for yield at the 5A and 6B loci are widespread in Australian accessions with 112 out of 153 carrying the favorable haplotype at the 5A locus and 136 out of 146 carrying the favorable haplotype at the 6A locus, while the favorable haplotype at 4B is only present in 65 out of 149 Australian accessions. The low number of yield QTL in our study corroborate with other GWAS for yield in wheat, where most of the identified loci have very small effects.	[Garcia, Melissa; Eckermann, Paul; Haefele, Stephan; Satija, Sanjiv; Sznajder, Beata; Timmins, Andy; Baumann, Ute; Mather, Diane E.; Fleury, Delphine] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Garcia, Melissa; Eckermann, Paul; Haefele, Stephan; Satija, Sanjiv; Sznajder, Beata; Timmins, Andy; Baumann, Ute; Mather, Diane E.; Fleury, Delphine] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Haefele, Stephan] Rothamsted Res, Harpenden, Herts, England; [Wolters, Petra] Corteva Agrisci, New Holland, PA USA	University of Adelaide; University of Adelaide; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Garcia, M (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.; Garcia, M (corresponding author), Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Glen Osmond, SA, Australia.	Melissa.garcia@adelaide.edu.au	Garcia, Melissa/W-3469-2019; Haefele, Stephan M/E-1256-2017; Fleury, Delphine L/G-4464-2010; Mather, Diane/A-1857-2009	Garcia, Melissa/0000-0001-9825-273X; Haefele, Stephan M/0000-0003-0389-8373; Fleury, Delphine L/0000-0002-7077-4103; Mather, Diane/0000-0001-7506-2589	DuPont Pioneer; Australian Research Council Industrial Transformation Research Hub for Genetic Diversity and Molecular Breeding for Wheat in a Hot and Dry Climate [IH130200027]; BBSRC [BBS/E/C/000I0310] Funding Source: UKRI	DuPont Pioneer; Australian Research Council Industrial Transformation Research Hub for Genetic Diversity and Molecular Breeding for Wheat in a Hot and Dry Climate(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank DuPont Pioneer and the Australian Research Council Industrial Transformation Research Hub for Genetic Diversity and Molecular Breeding for Wheat in a Hot and Dry Climate (project number IH130200027) for financial support. Corteva AgriscienceTM provided support in form of salaries for authors (PW) and genotyping of the accessions used in this study but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexander DH, 2013, ADMIXTURE 1 21 SOFTW; Ankerst M, P ACM SIGMOD 99 INT; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Butler D.G., 2009, TECHNICAL REPORT; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Curtis T, 2014, ANN APPL BIOL, V164, P354, DOI 10.1111/aab.12108; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Edwards D, 2012, PLANT BIOTECHNOL J, V10, P703, DOI 10.1111/j.1467-7652.2012.00717.x; Edwards J. E., 2012, THESIS; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Gilmour A. R., 1997, Breeding ... responding to client needs. Association for the Advancement of Animal Breeding and Genetics. Proceedings of the Twelfth Conference, Dubbo, NSW, Australia 6th-10th April 1997: Part 1., P386; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; He S, 2017, THEOR APPL GENET, V130, P635, DOI 10.1007/s00122-016-2840-x; Huang BE, 2015, THEOR APPL GENET, V128, P999, DOI 10.1007/s00122-015-2506-0; Izirrari R, 2017, LOWERING GWAS THRESH; Joukhadar R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02115; Klasen JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13299; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu J, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-017-0759-9; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Millet EJ, 2016, PLANT PHYSIOL, V172, P749, DOI 10.1104/pp.16.00621; Mo Y, 2018, THEOR APPL GENET, V131, P2021, DOI 10.1007/s00122-018-3130-6; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Porter JR, CLIMATE CHANGE 2014; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Primary Industry and Regions SA (PIRSA), 2018, CROP AND PASTURE REP; Pritchard JK, 2000, GENETICS, V155, P945; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rebetzke GJ, 2013, FUNCT PLANT BIOL, V40, P14, DOI 10.1071/FP12184; Singh R, 2016, PLANT SCI, V242, P278, DOI 10.1016/j.plantsci.2015.08.008; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Tabas-Madrid D, 2018, PLANT CELL ENVIRON, V41, P1806, DOI 10.1111/pce.13189; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tricker PJ, 2018, J EXP BOT, V69, P3195, DOI 10.1093/jxb/ery081; Tyagi S, 2014, MOL BREEDING, V34, P167, DOI 10.1007/s11032-014-0027-1; United States Department of Agriculture Foreign Agricultural Service, 2018, GRAINS WORLD MARK TR; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	55	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211730	10.1371/journal.pone.0211730	http://dx.doi.org/10.1371/journal.pone.0211730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716107	gold, Green Published, Green Submitted			2022-12-26	WOS:000457744200043
J	Wu, Y; Chen, CH; Tsuang, FY; Lin, YC; Chiang, CJ; Kuo, YJ				Wu, Yueh; Chen, Chia-Hsien; Tsuang, Fon-Yih; Lin, Yi-Cheng; Chiang, Chang-Jung; Kuo, Yi-Jie			The stability of long-segment and short segment fixation for treating severe burst fractures at the thoracolumbar junction in osteoporotic bone: A finite element analysis	PLOS ONE			English	Article							PEDICLE INSTRUMENTATION; DYNAMIC STABILIZATION; LUMBAR; SPINE; BIOMECHANICS; BEHAVIOR; SCREWS; MODEL; DISC	The majority of compressive vertebral fractures in osteoporotic bone occur at the level of the thoracolumbar junction. Immediate decompression is often required in order to reduce the extent of neurological damage. This study evaluated four fixation methods for decompression in patients with thoracolumbar burst fractures, and presented the most suitable method for osteoporotic patients. A finite element model of a T7-L5 spinal segment was created and subjected to an L1 corpectomy to simulate a serious burst fracture. Five models were tested: a) intact spine; 2) two segment fixation (TSF), 3) up-three segment fixation (UTSF), below three segment fixation (BTSF), and four segment fixation (FSF). The ROM, stiffness and compression ratio of the fractured vertebra were recorded under various loading conditions. The results of this study showed that the ROM of the FSF model was the lowest, and the ROMs of UTSF and BTSF models were similar but still greater than the TSF model. Decreasing the BMD to simulate osteoporotic bone resulted in a ROM for the four instrumented models that was higher than the normal bone model. Of all models, the FSF model had the highest stiffness at T12-L2 in extension and lateral bending. Similarly, the compression ratio of the FSF model at L1 was also higher than the other instrumented models. In conclusion, FSF fixation is suggested for patients with osteoporotic thoracolumbar burst fractures. For patients with normal bone quality, both UTSF and BTSF fixation provide an acceptable stiffness in extension and lateral bending, as well as a favorable compression ratio at L1.	[Wu, Yueh; Kuo, Yi-Jie] Taipei Med Univ, Taipei Municipal Wanfang Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Chen, Chia-Hsien; Lin, Yi-Cheng; Chiang, Chang-Jung] Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan; [Chen, Chia-Hsien; Chiang, Chang-Jung; Kuo, Yi-Jie] Taipei Med Univ, Sch Med, Dept Orthoped Surg, Coll Med, Taipei, Taiwan; [Chen, Chia-Hsien] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Kuo, YJ (corresponding author), Taipei Med Univ, Taipei Municipal Wanfang Hosp, Dept Orthoped Surg, Taipei, Taiwan.; Kuo, YJ (corresponding author), Taipei Med Univ, Sch Med, Dept Orthoped Surg, Coll Med, Taipei, Taiwan.	dr.benkuo5@gmail.com		Tsuang, Fon-Yih/0000-0001-5797-1885; Chiang, Chang-Jung/0000-0002-2269-8337				Alpantaki K, 2010, ORTHOPEDICS, V33, P422, DOI 10.3928/01477447-20100429-24; Altay M, 2007, EUR SPINE J, V16, P1145, DOI 10.1007/s00586-007-0310-5; Anekstein Y, 2007, J SPINAL DISORD TECH, V20, P72, DOI 10.1097/01.bsd.0000211240.98963.f6; Ayberk G, 2008, NEUROL MED-CHIR, V48, P8, DOI 10.2176/nmc.48.8; Bess S, 2017, J NEUROSURG-SPINE, V26, P125, DOI 10.3171/2016.6.SPINE151477; Bowden AE, 2008, CLIN BIOMECH, V23, P536, DOI 10.1016/j.clinbiomech.2007.12.010; Canbek Umut, 2014, Eur J Orthop Surg Traumatol, V24, P459, DOI 10.1007/s00590-013-1326-7; CARL AL, 1992, SPINE, V17, pS317; Chiba M, 1996, SPINE, V21, P288, DOI 10.1097/00007632-199602010-00006; Crawford NR, 1997, SPINE, V22, P559, DOI 10.1097/00007632-199703010-00020; Dai JH, 2015, INT J CLIN EXP MED, V8, P11125; EBELKE DK, 1991, SPINE, V16, pS428; Eldin MMM, 2014, ASIAN SPINE J, V8, P281, DOI 10.4184/asj.2014.8.3.281; Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; GERTZBEIN SD, 1992, SPINE, V17, P528, DOI 10.1097/00007632-199205000-00010; GOEL VK, 1995, SPINE, V20, P689, DOI 10.1097/00007632-199503150-00010; Goto Keisuke, 2003, J Orthop Sci, V8, P577, DOI 10.1007/s00776-003-0675-1; Ha KY, 2013, ASIAN SPINE J, V7, P294, DOI 10.4184/asj.2013.7.4.294; Hitchon PW, 2006, J NEUROSURG-SPINE, V5, P117, DOI 10.3171/spi.2006.5.2.117; Hongo M, 2009, EUR SPINE J, V18, P1213, DOI 10.1007/s00586-009-0999-4; Kifune M, 1997, J SPINAL DISORD, V10, P457; Li CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099156; Li J, 2017, INT J CLIN EXP MED, V10; Liao JC, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1623-0; Liu S, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-83; MCLAIN RF, 1993, J BONE JOINT SURG AM, V75A, P162, DOI 10.2106/00004623-199302000-00002; Mikles MR, 2004, J AM ACAD ORTHOP SUR, V12, P424, DOI 10.5435/00124635-200411000-00007; Modi Hitesh N, 2009, J Orthop Surg Res, V4, P28, DOI 10.1186/1749-799X-4-28; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Nieuwenhuijse MJ, 2011, SPINE J, V11, P839, DOI 10.1016/j.spinee.2011.07.027; Niosi CA, 2006, EUR SPINE J, V15, P913, DOI 10.1007/s00586-005-0948-9; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; Parker JW, 2000, SPINE, V25, P1157, DOI 10.1097/00007632-200005010-00018; Perez-Orribo L, 2013, SPINE, V38, P635, DOI 10.1097/BRS.0b013e318279a95e; Schilling C, 2011, EUR SPINE J, V20, P297, DOI 10.1007/s00586-010-1620-6; Schmidt H, 2007, CLIN BIOMECH, V22, P377, DOI 10.1016/j.clinbiomech.2006.11.008; Schmoelz W, 2003, J SPINAL DISORD TECH, V16, P418, DOI 10.1097/00024720-200308000-00015; Schroeder GD, 2015, GLOB SPINE J, V5, P339, DOI 10.1055/s-0035-1549035; Schulze M, 2017, J ORTHOP RES, V35, P167, DOI 10.1002/jor.23237; Serin E., 2004, EUR J ORTHOP SURG TR, V14, P1, DOI [DOI 10.1007/S00590-003-0110-5, 10.1007/s00590-003-0110-5]; Ugras AA, 2012, ACTA ORTHOP BELG, V78, P87; 이윤수, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V37, P416	43	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211676	10.1371/journal.pone.0211676	http://dx.doi.org/10.1371/journal.pone.0211676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716122	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200040
J	Gutmans, DS; Whittaker, SBM; Asiani, K; Atkinson, RA; Oregioni, A; Pfuhl, M				Gutmans, Daniel S.; Whittaker, Sara B-M; Asiani, Karishma; Atkinson, R. Andrew; Oregioni, Alain; Pfuhl, Mark			Controlling the dynamics of the Nek2 leucine zipper by engineering of "kinetic" disulphide bonds	PLOS ONE			English	Article							BACKBONE DYNAMICS; PHAGE-T4 LYSOZYME; CHEMICAL-EXCHANGE; NMR-SPECTROSCOPY; PROTEIN; STABILITY; HELIX; KINASE; SHIFTS	Nek2 is a dimeric serine/threonine protein kinase that belongs to the family of NIMA-related kinases (Neks). Its N-terminal catalytic domain and its C-terminal regulatory region are bridged by a leucine zipper, which plays an important role in the activation of Nek2's catalytic activity. Unusual conformational dynamics on the intermediary/slow timescale has thwarted all attempts so far to determine the structure of the Nek2 leucine zipper by means of X-ray crystallography and Nuclear Magnetic Resonance (NMR). Disulfide engineering, the strategic placement of non-native disulfide bonds into flexible regions flanking the coiled coil, was used to modulate the conformational exchange dynamics of this important dimerization domain. The resulting reduction in exchange rate leads to substantial improvements of important features in NMR spectra, such as line width, coherence transfer leakage and relaxation. These effects were comprehensively analyzed for the wild type protein, two single disulfide bond-bearing mutants and another double disulfide bonds-carrying mutant. Furthermore, exchange kinetics were measured across a wide temperature range, allowing for a detailed analysis of activation energy (Delta G(double dagger)) and maximal rate constant (k'(ex)). For one mutant carrying a disulfide bond at its C-terminus, a full backbone NMR assignment could be obtained for both conformers, demonstrating the benefits of the disulfide engineering. Our study demonstrates the first successful application of 'kinetic' disulfide bonds for the purpose of controlling the adverse effects of protein dynamics. Firstly, this provides a promising, robust platform for the full structural and functional investigation of the Nek2 leucine zipper in the future. Secondly, this work broadens the toolbox of protein engineering by disulfide bonds through the addition of a kinetic option in addition to the well-established thermodynamic uses of disulfide bonds.	[Gutmans, Daniel S.; Asiani, Karishma; Atkinson, R. Andrew; Pfuhl, Mark] Kings Coll London, Randall Ctr, London, England; [Gutmans, Daniel S.; Asiani, Karishma; Atkinson, R. Andrew; Pfuhl, Mark] Kings Coll London, Sch Cardiovasc Med & Sci, London, England; [Whittaker, Sara B-M] Univ Birmingham, Inst Canc & Genom Sci, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England; [Oregioni, Alain] Francis Crick Inst, MRC, Biomol NMR Ctr, London, England	University of London; King's College London; University of London; King's College London; University of Birmingham; Francis Crick Institute	Gutmans, DS; Pfuhl, M (corresponding author), Kings Coll London, Randall Ctr, London, England.; Gutmans, DS; Pfuhl, M (corresponding author), Kings Coll London, Sch Cardiovasc Med & Sci, London, England.	daniel.gutmans@kcl.ac.uk; mark.pfuhl@kcl.ac.uk	Atkinson, Robert Andrew/ABE-8068-2020	Atkinson, Robert Andrew/0000-0002-3645-9492; Oregioni, Alain/0000-0003-2462-3870	Swiss National Science Foundation; Dr. Arnold U. und Susanne Huggenberger-Bischoff Stiftung zur Krebsforschung, Zurich, Switzerland (2016); Madeleine und Albert Erlanger-Wyler-Stiftung, Zurich (2017); Dr. Hans Altschuler Stiftung, St. Gallen, Switzerland (2017); Jetty, Aron and Simon Blum Foundation, Zurich, Switzerland (2017); MRC [MC_U117533887] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Dr. Arnold U. und Susanne Huggenberger-Bischoff Stiftung zur Krebsforschung, Zurich, Switzerland (2016); Madeleine und Albert Erlanger-Wyler-Stiftung, Zurich (2017); Dr. Hans Altschuler Stiftung, St. Gallen, Switzerland (2017); Jetty, Aron and Simon Blum Foundation, Zurich, Switzerland (2017); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DG acknowledges funding from the Swiss National Science Foundation (doc.mobility fellowship, 2015-2016), the Dr. Arnold U. und Susanne Huggenberger-Bischoff Stiftung zur Krebsforschung, Zurich, Switzerland (2016), the Madeleine und Albert Erlanger-Wyler-Stiftung, Zurich (2017), the Dr. Hans Altschuler Stiftung, St. Gallen, Switzerland (2017) and the Jetty, Aron and Simon Blum Foundation, Zurich, Switzerland (2017).	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Asakawa N, 1992, J AM CHENICAL SOC; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Croasdale R, 2011, J BIOL CHEM, V286, P27537, DOI 10.1074/jbc.M110.196972; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; ENGLANDER SW, 1987, BIOCHEMISTRY-US, V26, P5953, DOI 10.1021/bi00393a001; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Fribolin H, 2013, EIN ZWEIDIMENSIONALE; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Fry AM, 1997, METHOD ENZYMOL, V283, P270; Guo Y, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4984818; Gutfreund H, 1995, KINETICS LIFE SCI; KOHN WD, 1995, PROTEIN SCI, V4, P237; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Mackay JP, 1996, BIOCHEMISTRY-US, V35, P4867, DOI 10.1021/bi952761y; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Moleschi KJ, 2015, J AM CHEM SOC, V137, P10777, DOI 10.1021/jacs.5b06557; Newell NE, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0671-4; Oki M., 1985, APPL DYNAMIC NMR SPE; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PJURA PE, 1990, BIOCHEMISTRY-US, V29, P2592, DOI 10.1021/bi00462a023; Pontiggia F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8284; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Rodriguez JC, 2004, J BIOMOL NMR, V30, P155, DOI 10.1023/B:JNMR.0000048857.44219.c3; Sandstrom J., 1982, DYNAMIC NMR SPECTROS; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Seifert MHJ, 2003, BIOCHEMISTRY-US, V42, P2500, DOI 10.1021/bi026481b; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Stewart CM, 2016, P NATL ACAD SCI USA, V113, P9515, DOI 10.1073/pnas.1606160113; Tsunoda N, 2008, CANC SCI ENGLAND, V100, P111; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WILLIAMSON MP, 1990, BIOPOLYMERS, V29, P1428; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Yang LQ, 2014, J BIOMOL STRUCT DYN, V32, P372, DOI 10.1080/07391102.2013.770372; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0210352	10.1371/journal.pone.0210352	http://dx.doi.org/10.1371/journal.pone.0210352			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707691	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900007
J	Cui, JR; O'Connell, CM; Costa, A; Pan, Y; Smyth, JA; Verardi, PH; Burgess, DJ; Van Kruiningen, HJ; Garmendia, AE				Cui, Junru; O'Connell, Caitlin M.; Costa, Antonio; Pan, Yan; Smyth, Joan A.; Verardi, Paulo H.; Burgess, Diane J.; Van Kruiningen, Herbert J.; Garmendia, Antonio E.			A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFN gamma responses against several genotype 2 strains	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; CELLULAR IMMUNE-RESPONSES; ENVELOPE GENES; NORTH-AMERICAN; EXPRESSING GP5; DNA; PROTEINS; EPITOPES; DISEASE; GLYCOPROTEIN-5	Porcine reproductive and respiratory syndrome virus (PRRSV), is a highly mutable RNA virus that affects swine worldwide and its control is very challenging due to its formidable heterogeneity in the field. In the present study, DNA vaccines constructed with PRRSV GP5-Mosaic sequences were complexed to cationic liposomes and administered to experimental pigs by intradermal and intramuscular injection, followed by three boosters 14, 28 and 42 days later. The GP5-Mosaic vaccine thus formulated was immunogenic and induced protection from challenge in vaccinated pigs comparable to that induced by a wild type (VR2332) GP5 DNA vaccine (GP5-WT). Periodic sampling of blood and testing of vaccine-induced responses followed. Interferon-gamma (IFN-gamma) mRNA expression by virus-stimulated peripheral blood mononuclear cells (PBMCs) of GP5-Mosaic-vaccinated pigs was significantly higher compared to pigs vaccinated with either GP5-WT or empty vector at 21, 35 and 48 days after vaccination. Cross-reactive cellular responses were also demonstrated in GP5-Mosaic vaccinated pigs after stimulation of PBMCs with divergent strains of PRRSV. Thus, significantly higher levels of IFN-gamma mRNA were detected when PBMCs from GP5-Mosaic-vaccinated pigs were stimulated by four Genotype 2 strains (VR2332, NADC9, NADC30 and SDSU73), which have at least 10% difference in GP5 amino acid sequences, while such responses were recorded only upon VR2332 stimulation in GP5-WT-vaccinated pigs. In addition, the levels of virus-specific neutralizing antibodies were higher in GP5-Mosaic or GP5-WT vaccinated pigs than those in vector-control pigs. The experimental pigs vaccinated with either the GP5-Mosaic vaccine or the GP5-WT vaccine were partially protected from challenge with VR2332, as measured by significantly lower viral loads in sera and tissues and lower lung lesion scores than the vector control group. These data demonstrate that the GP5-Mosaic vaccine can induce cross-reactive cellular responses to diverse strains, neutralizing antibodies, and protection in pigs.	[Cui, Junru; O'Connell, Caitlin M.; Smyth, Joan A.; Verardi, Paulo H.; Van Kruiningen, Herbert J.; Garmendia, Antonio E.] Univ Connecticut, Coll Agr Hlth & Nat Resources, Dept Pathobiol & Vet Sci, Storrs, CT 06269 USA; [Costa, Antonio; Burgess, Diane J.] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT USA; [Pan, Yan] Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & New Technol, Nanning, Guangxi, Peoples R China	University of Connecticut; University of Connecticut; Guangxi Veterinary Research Institute	Garmendia, AE (corresponding author), Univ Connecticut, Coll Agr Hlth & Nat Resources, Dept Pathobiol & Vet Sci, Storrs, CT 06269 USA.	antonio.garmendia@uconn.edu		Smyth, Joan/0000-0002-8879-6474	USDA/NIFA [2011 67015-30176, NC229]	USDA/NIFA(United States Department of Agriculture (USDA))	This work was supported by funds from USDA/NIFA Grant Number 2011 67015-30176 and NC229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiee A, 2012, EXP PARASITOL, V132, P403, DOI 10.1016/j.exppara.2012.09.001; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Botner A, 1997, VET MICROBIOL, V55, P295, DOI 10.1016/S0378-1135(96)01333-8; Bu J, 2003, COMP IMMUNOL MICROB, V26, P175, DOI 10.1016/S0147-9571(02)00050-4; Cao QM, 2018, J VIROL, V92, DOI [10.1128/JVI.00007-18, 10.1128/jvi.00007-18]; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Cui J., 2016, Vaccine Reports, V6, P77, DOI 10.1016/j.vacrep.2016.11.003; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Diaz I, 2009, VACCINE, V27, P5603, DOI 10.1016/j.vaccine.2009.07.029; DONE SH, 1995, VET REC, V136, P32, DOI 10.1136/vr.136.2.32; Ferrari L, 2018, VET MICROBIOL, V216, P85, DOI 10.1016/j.vetmic.2018.02.001; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Halbur PG, 1996, J VET DIAGN INVEST, V8, P11, DOI 10.1177/104063879600800103; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Jeong J, 2018, TRANSBOUND EMERG DIS, P1; Jiang WM, 2008, VIRUS RES, V136, P50, DOI 10.1016/j.virusres.2008.04.016; Jiang YB, 2006, VACCINE, V24, P2869, DOI 10.1016/j.vaccine.2005.12.049; Jiang YB, 2007, VACCINE, V25, P547, DOI 10.1016/j.vaccine.2006.07.032; Kim HK, 2009, J VET SCI, V10, P121, DOI 10.4142/jvs.2009.10.2.121; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kita Y, 2005, VACCINE, V23, P2132, DOI 10.1016/j.vaccine.2005.01.057; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mateu E, 2003, J GEN VIROL, V84, P529, DOI 10.1099/vir.0.18478-0; Meulenberg JJM, 2000, VET RES, V31, P11, DOI 10.1051/vetres:2000054; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Nan YC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01635; Ndhlovu ZM, 2011, J IMMUNOL, V186, P6914, DOI 10.4049/jimmunol.1004231; Nedumpun T, 2018, VET MICROBIOL, V216, P13, DOI 10.1016/j.vetmic.2018.01.014; Ni YY, 2013, J VIROL, V87, P304, DOI 10.1128/JVI.01789-12; Okada M, 2007, VACCINE, V25, P2990, DOI 10.1016/j.vaccine.2007.01.014; REED L. J., 1938, AMER JOUR HYG, V27, P493; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Shen GS, 2007, VACCINE, V25, P4193, DOI 10.1016/j.vaccine.2007.03.010; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Thurmond J, 2008, BIOINFORMATICS, V24, P1639, DOI 10.1093/bioinformatics/btn251; Tian DB, 2015, VIROLOGY, V485, P402, DOI 10.1016/j.virol.2015.08.021; Varona S, 2011, IND ENG CHEM RES, V50, P2088, DOI 10.1021/ie102016r; Vashisht K, 2008, VACCINE, V26, P4747, DOI 10.1016/j.vaccine.2008.06.047; Vu HLX, 2015, J VIROL, V89, P12070, DOI 10.1128/JVI.01657-15; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Yan J, 2007, MOL THER, V15, P411, DOI 10.1038/sj.mt.6300036; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066645; Zhou L, 2012, VIROLOGY, V434, P96, DOI 10.1016/j.virol.2012.09.005	46	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0208801	10.1371/journal.pone.0208801	http://dx.doi.org/10.1371/journal.pone.0208801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703122	gold, Green Submitted, Green Published			2022-12-26	WOS:000457301600008
J	Dotinga, BM; de Winter, AF; Bocca-Tjeertes, IFA; Kerstjens, JM; Reijneveld, SA; Bos, AF				Dotinga, Baukje M.; de Winter, Andrea F.; Bocca-Tjeertes, Inger F. A.; Kerstjens, Jorien M.; Reijneveld, Sijmen A.; Bos, Arend F.			Longitudinal growth and emotional and behavioral problems at age 7 in moderate and late preterms	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DIFFICULTIES QUESTIONNAIRE; CHILDREN BORN; PSYCHOSOCIAL PROBLEMS; SOCIOECONOMIC-STATUS; BRAIN-DEVELOPMENT; PRESCHOOL-AGE; SCHOOL-AGE; INFANTS; HEALTH	Objectives Moderately and late preterm children (MLPs, 32.0-36.9 weeks gestational age) have a greater risk of poorer growth. This seems to be associated with poorer neuropsychological functioning. Evidence is limited on whether this also holds for emotional and behavioral (EB) problems. Therefore, we assessed whether longitudinal growth from birth until age 7 was associated with EB problems at age 7 in MLPs. Study design This study was part of the Longitudinal Preterm Outcome Project, a prospective cohort study. Data on growth (height, weight, head circumference, and extent of catch-up growth) were obtained from assessments from birth until age 7. EB problems were assessed at age 7 with the Child Behavior Checklist. We assessed whether growth and EB problems were associated using logistic regression analyses, adjusting for multiple birth, parity, and socioeconomic status. Results We included 248 MLPs. Median gestational age was 34 weeks (interquartile range: 33-35 weeks). Mean birth weight was 2.2 kg (standard deviation: 0.5 kg). Postnatal growth measures were below the Dutch reference norm. EB problems were more prevalent in MLPs than in the general Dutch population. Generally, we found no associations between growth and EB problems; odds ratios ranged from 0.20 to 2.72. Conclusions In MLPs, postnatal growth from birth until age 7 was not associated with EB problems at age 7. Poorer growth thus seems to relate to neuropsychological problems, but not to EB problems. This suggests that the etiologies of these problems differ at least partially.	[Dotinga, Baukje M.; Bocca-Tjeertes, Inger F. A.; Kerstjens, Jorien M.; Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol,Dept Pediat, Groningen, Netherlands; [de Winter, Andrea F.; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands	University of Groningen; University of Groningen	Dotinga, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol,Dept Pediat, Groningen, Netherlands.	b.m.dotinga@umcg.nl		Reijneveld, Sijmen/0000-0002-1206-7523; Dotinga, Baukje/0000-0003-4371-4081	research foundation of the Beatrix Children's Hospital; Cornelia Foundation for the Handicapped Child; A. Bulk-Child Preventive Child Health Care research fund; Dutch Brain Foundation; FrieslandCampina; Friso Infant Nutrition; Pfizer Europe; Junior Scientific Masterclass of the University of Groningen	research foundation of the Beatrix Children's Hospital; Cornelia Foundation for the Handicapped Child; A. Bulk-Child Preventive Child Health Care research fund; Dutch Brain Foundation; FrieslandCampina; Friso Infant Nutrition; Pfizer Europe; Junior Scientific Masterclass of the University of Groningen	The LOLLIPOP study has been supported by grants from the research foundation of the Beatrix Children's Hospital, the Cornelia Foundation for the Handicapped Child, the A. Bulk-Child Preventive Child Health Care research fund, the Dutch Brain Foundation, and unrestricted investigator initiated research grants from FrieslandCampina, Friso Infant Nutrition, and Pfizer Europe. Baukje M. Dotinga received financial support from the Junior Scientific Masterclass of the University of Groningen. The funders had no role at any stage of the project including the decision to submit the manuscript.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC; [Anonymous], 1991, MANUAL ASEBA SCH AGE; Arpi E, 2013, DEV MED CHILD NEUROL, V55, P788, DOI 10.1111/dmcn.12142; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Bocca-Tjeertes IFA, 2011, PEDIATRICS, V128, pE1187, DOI 10.1542/peds.2010-3781; Bosquet M, 2006, DEV PSYCHOPATHOL, V18, P517, DOI 10.1017/S0954579406060275; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brugman E, 2001, ARCH PEDIAT ADOL MED, V155, P462, DOI 10.1001/archpedi.155.4.462; Casey PH, 2006, PEDIATRICS, V118, P1078, DOI 10.1542/peds.2006-0361; Clouchoux C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.002; Crone MR, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0867-9; Cserjesi R, 2012, PEDIATRICS, V130, pE838, DOI 10.1542/peds.2011-2079; Cusick SE, 2016, J PEDIATR-US, V175, P16, DOI 10.1016/j.jpeds.2016.05.013; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; de Jong M, 2012, SEMIN FETAL NEONAT M, V17, P163, DOI 10.1016/j.siny.2012.02.003; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Dotinga BM, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3638; Embleton ND, 2013, WORLD REV NUTR DIET, V106, P26, DOI 10.1159/000342553; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Groen-Blokhuis MM, 2011, J AM ACAD CHILD PSY, V50, P1247, DOI 10.1016/j.jaac.2011.09.007; Gutierrez E, 2015, ACTA PAEDIATR, V104, P974, DOI DOI 10.1111/APA.13128; Hayward C, 1998, J AM ACAD CHILD PSY, V37, P1308, DOI 10.1097/00004583-199812000-00015; Hornman J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2255; Huang C, 2013, INT J EPIDEMIOL, V42, P160, DOI 10.1093/ije/dys207; Huddy CLJ, 2001, ARCH DIS CHILD-FETAL, V85, pF23, DOI 10.1136/fn.85.1.F23; Huhtala M, 2014, EARLY HUM DEV, V90, P119, DOI 10.1016/j.earlhumdev.2013.12.009; Kelly CE, 2016, BRAIN IMAGING BEHAV, V10, P41, DOI 10.1007/s11682-015-9361-0; Kerstjens JM, 2011, J PEDIATR-US, V159, P92, DOI 10.1016/j.jpeds.2010.12.041; Keunen K, 2015, PEDIATR RES, V77, P148, DOI 10.1038/pr.2014.171; KLOOSTERMAN GJ, 1970, INT J GYNECOL OBSTET, V8, P895, DOI DOI 10.1002/J.1879-3479.1970.TB00313.X; Kovacs M, 1998, J CHILD PSYCHOL PSYC, V39, P47, DOI 10.1017/S0021963097001765; Kroes M, 2002, J AM ACAD CHILD PSY, V41, P955, DOI 10.1097/00004583-200208000-00014; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; Levit-Binnun N, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-26; McLeod KR, 2014, NEUROIMAGE-CLIN, V4, P566, DOI 10.1016/j.nicl.2014.03.010; Messerschmidt A, 2008, EUR J PEDIATR, V167, P1141, DOI 10.1007/s00431-007-0647-0; Murray E, 2016, J EPIDEMIOL COMMUN H, V70, P704, DOI 10.1136/jech-2015-206222; Newman DL, 1996, J CONSULT CLIN PSYCH, V64, P552, DOI 10.1037/0022-006X.64.3.552; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Potijk MR, 2016, ARCH DIS CHILD, V101, P217, DOI 10.1136/archdischild-2015-308958; Potijk MR, 2015, EUR CHILD ADOLES PSY, V24, P787, DOI 10.1007/s00787-014-0623-y; Potijk MR, 2012, ARCH DIS CHILD, V97, P112, DOI 10.1136/adc.2011.300131; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; Sammallahti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137092; Stathis SL, 1999, DEV MED CHILD NEUROL, V41, P375, DOI 10.1017/S0012162299000833; Stone Lisanne L, 2015, BMC Psychol, V3, P4, DOI 10.1186/s40359-015-0061-8; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Uljas H, 1999, DEV MED CHILD NEUROL, V41, P412, DOI 10.1017/S0012162299000882; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; Zeijl E CM, 2005, KINDEREN NEDERLAND	56	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211427	10.1371/journal.pone.0211427	http://dx.doi.org/10.1371/journal.pone.0211427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703154	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600040
J	Grand, TS; Basarir, H; Jackson, LJ				Grand, Tobias Sydendal; Basarir, Hasan; Jackson, Louise J.			The cost-effectiveness of oral contraceptives compared to 'no hormonal treatment' for endometriosis-related pain: An economic evaluation	PLOS ONE			English	Article							QUALITY-OF-LIFE; ESHRE GUIDELINE; PELVIC PAIN; WOMEN; DIENOGEST; DYSMENORRHEA; DIAGNOSIS; ANALOGS; BURDEN	Objective To develop a preliminary cost-effectiveness model that compares oral contraceptives and 'no hormonal treatment' for the treatment of endometriosis-related pain. Methods A de novo preliminary state transition (Markov) model was developed. The model was informed by systematic literature review and expert opinion. The uncertainty around the results was assessed both by deterministic and probabilistic sensitivity analyses. The economic evaluation was conducted from National Health Service (NHS) England perspective. The main outcome measure was incremental cost per quality-adjusted life year (QALY), with cost-effectiveness plane and cost-effectiveness acceptability curves presented for alternative willingness-to-pay thresholds. Results Oral contraceptives dominated 'no hormonal treatment' and provided more QALYs at a lower cost than 'no hormonal treatment', with a cost-effectiveness probability of 98%. A one-way sensitivity analysis excluding general practitioner consultations showed that oral contraceptives were still cost-effective. Conclusions The analyses showed that oral contraceptives could be an effective option for the treatment of endometriosis, as this treatment was shown to provide a higher level of QALYs at a lower cost, compared to 'no hormonal treatment'. The results are subject to considerable parameter uncertainty as a range of assumptions were required as part of the modelling process.	[Grand, Tobias Sydendal; Jackson, Louise J.] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Basarir, Hasan] RTI Hlth Solut, Manchester, England	University of Birmingham; Research Triangle Institute	Jackson, LJ (corresponding author), Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England.	L.Jackson.1@bham.ac.uk	Basarir, Hasan/K-8532-2019	Basarir, Hasan/0000-0002-3202-4563; Grand, Tobias Sydendal/0000-0002-7058-916X; Jackson, Louise/0000-0001-8492-0020	RTI Health Solutions, Greater Manchester, United Kingdom; University of Birmingham, Fredrik Andersson	RTI Health Solutions, Greater Manchester, United Kingdom; University of Birmingham, Fredrik Andersson	RTI Health Solutions, Greater Manchester, United Kingdom provided support in the form of a salary for one author [HB] during the drafting of the paper, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.; TS Grand would like to acknowledge the support from Ferring pharmaceuticals during his master's degree in health economics and health policy from the University of Birmingham, Fredrik Andersson for supporting research in endometriosis-related pain, and Roberto Palencia for the daily support and sharing of expertise.	Alton V, 2006, INT J TECHNOL ASSESS, V22, P512, DOI 10.1017/S0266462306051452; Ara R, 2008, VALUE HEALTH, V11, P1131, DOI 10.1111/j.1524-4733.2008.00352.x; Arakawa I, 2015, VALUE HEALTH, V18, pA736, DOI 10.1016/j.jval.2015.09.2824; Araujo D, 2009, VALUE HEALTH, V12, pA164, DOI 10.1016/S1098-3015(10)73883-3; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Briggs A, 2006, DECISION MODELLING H; British National Formulary, 2016, MEDICINESCOMPLETE; Canis M, 1997, FERTIL STERIL, V67, P817; CRD, 2009, SYSTEMATIC REV; Curtis L, 2015, UNIT COSTS HLTH SOCI; Davis L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001019.pub2; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dunselman G, 2013, HUM REPROD, V28, P86; Gao X, 2006, CURR MED RES OPIN, V22, P1787, DOI 10.1185/030079906X121084; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Hadfield R, 1996, HUM REPROD, V11, P878; Higgins J., 2009, COCHRANE HDB SYSTEMA; Jia SZ, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-29; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P370, DOI 10.1016/j.jclinepi.2009.08.005; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Lukac M, 2011, VALUE HEALTH, V14, pA403, DOI 10.1016/j.jval.2011.08.934; Lukac M, 2011, VALUE HEALTH, V14, pA109, DOI 10.1016/j.jval.2011.02.606; Marmarali B, 2012, VALUE HEALTH, V15, pA537, DOI 10.1016/j.jval.2012.08.1882; Morotti M, 2012, ARCH GYNECOL OBSTET, V286, P1571, DOI 10.1007/s00404-012-2473-5; Morris DE, 2014, ENVIRON MODELL SOFTW, V52, P1, DOI 10.1016/j.envsoft.2013.10.010; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; NICE, 2014, DEVELOPING NICE GUID; NICE, 2017, END DIAGN MAN; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Prast J, 2013, J ENDOMETRIOSIS, V5, pS63; Roberts T, 2002, BJOG-INT J OBSTET GY, V109, P44, DOI 10.1016/S1470-0328(02)00223-9; Sanghera S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010580; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Simoens S, 2011, VALUE HEALTH, V14, pA401, DOI 10.1016/j.jval.2011.08.924; Unsal A, 2010, UPSALA J MED SCI, V115, P138, DOI 10.3109/03009730903457218; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Yasui T, 2011, MATURITAS, V69, P279, DOI 10.1016/j.maturitas.2011.04.009	37	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210089	10.1371/journal.pone.0210089	http://dx.doi.org/10.1371/journal.pone.0210089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699134	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600020
J	Calvete, CL; Martho, KF; Felizardo, G; Paes, A; Nunes, JM; Ferreira, CO; Vallim, MA; Pascon, RC				Calvete, Crislaine Lambiase; Martho, Kevin Felipe; Felizardo, Gabrielle; Paes, Alexandre; Nunes, Joao Miguel; Ferreira, Camila Oliveira; Vallim, Marcelo A.; Pascon, Renata C.			Amino acid permeases in Cryptococcus neoformans are required for high temperature growth and virulence; and are regulated by Ras signaling	PLOS ONE			English	Article							GENE-EXPRESSION; METABOLISM; MECHANISMS; PATHWAY; BIOSYNTHESIS; RESISTANCE; MENINGITIS; ADAPTATION; SYNTHASE; HOMOLOG	Cryptococcosis is an Invasive Fungal Infection (IFI) caused by Cryptococcus neoformans, mainly in immunocompromised patients. Therapeutic failure due to pathogen drug resistance, treatment inconstancy and few antifungal options is a problem. The study of amino acid biosynthesis and uptake represents an opportunity to explore possible development of novel antifungals. C. neoformans has 10 amino acids permeases, two of them (Aap3 and Aap7) not expressed at the conditions tested, and five were studied previously (Aap2, Aap4, Aap5, Mup1 and Mup3). Our previous results showed that Aap4 and Aap5 are major permeases with overlapping functions. The aap4 Delta/aap5 Delta double mutant fails to grow in amino acids as sole nitrogen source and is avirulent in animal model. Here, we deleted the remaining amino acid permeases (AAP1, AAP6, AAP8) that showed gene expression modulation by nutritional condition and created a double mutant (aap1 Delta/aap2 Delta). We studied the virulence attributes of these mutants and explored the regulatory mechanism behind amino acid uptake in C. neoformans. The aap1 Delta/aap2 Delta strain had reduced growth at 37 degrees C in L-amino acids, reduced capsule production and was hypovirulent in the Galleria mellonella animal model. Our data, along with previous studies, (i) complement the analysis for all 10 amino acid permeases mutants, (ii) corroborate the idea that these transporters behave as global permeases, (iii) are required during heat and nutritional stress, and (iv) are important for virulence. Our study also indicates a new possible link between Ras1 signaling and amino acids uptake.	[Calvete, Crislaine Lambiase] Univ Sao Paulo, Biotechnol Grad Program, Sao Paulo, SP, Brazil; [Calvete, Crislaine Lambiase; Martho, Kevin Felipe; Felizardo, Gabrielle; Paes, Alexandre; Nunes, Joao Miguel; Ferreira, Camila Oliveira; Vallim, Marcelo A.; Pascon, Renata C.] Univ Fed Sao Paulo, Dept Biol Sci, Campus Diadema, Diadema, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Pascon, RC (corresponding author), Univ Fed Sao Paulo, Dept Biol Sci, Campus Diadema, Diadema, SP, Brazil.	renata.pascon@gmail.com	Alves Nunes, João Miguel/ABC-1125-2021; Pascon, Renata/E-1494-2012; Vallim, Marcelo/J-2624-2013	Alves Nunes, João Miguel/0000-0001-7733-4349; Pascon, Renata/0000-0001-9902-9396; Vallim, Marcelo/0000-0002-6929-0566	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/14542-8, 2015/04400-9, 2016/23890-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grants 2016/14542-8 to Dr. Renata C Pascon, 2015/04400-9 to Dr Marcelo Afonso Vallim, 2016/23890-0 to Joao Miguel Nunes), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (awarded to Ms Crislaine Lambiase Calvete and Kevin Felipe Martho). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abdallah Q, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00234-16; Alspaugh JA, 2015, FUNGAL GENET BIOL, V78, P55, DOI 10.1016/j.fgb.2014.09.004; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Amich J, 2016, CURR OPIN MICROBIOL, V32, P151, DOI 10.1016/j.mib.2016.06.003; Ballou ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003687; Casadevall A, 1998, MED MYCOL, V36, P95; Casadevall A, 2003, TRENDS MICROBIOL, V11, P157, DOI 10.1016/S0966-842X(03)00008-8; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Coelho C, 2014, ADV APPL MICROBIOL, V87, P1, DOI 10.1016/B978-0-12-800261-2.00001-3; Coelho C, 2014, ANNU REV PATHOL-MECH, V9, P219, DOI 10.1146/annurev-pathol-012513-104653; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Martho KFC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163919; de Aguiar PADF, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759013, 10.1590/S1678-9946201759013]; Do E, 2016, BIOCHEM BIOPH RES CO, V477, P706, DOI 10.1016/j.bbrc.2016.06.123; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; Fu JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003335; Garcia-Rodas R, 2012, FEMS IMMUNOL MED MIC, V64, P147, DOI 10.1111/j.1574-695X.2011.00871.x; Gournas C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051398; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Janbon G, 2004, FEMS YEAST RES, V4, P765, DOI 10.1016/j.femsyr.2004.04.003; Jauniaux JC, 1990, FEBS J, V190, P39; Jung KW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7757; Kim Min Su, 2012, Methods Mol Biol, V845, P67, DOI 10.1007/978-1-61779-539-8_5; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2004, EUKARYOT CELL, V3, P752, DOI 10.1128/EC.3.3.752-763.2004; Kingsbury JM, 2008, MICROBIOL-SGM, V154, P2767, DOI 10.1099/mic.0.2008/019729-0; Kingsbury JM, 2010, EUKARYOT CELL, V9, P729, DOI 10.1128/EC.00045-10; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Kraidlova L, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00284-16; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu TB, 2012, VIRULENCE, V3, P173, DOI 10.4161/viru.18685; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mourad A, 2018, J FUNGI, V4, DOI 10.3390/jof4030079; Mourad A, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170391; Mourad A, 2018, J ANTIMICROB CHEMOTH, V73, pi26, DOI 10.1093/jac/dkx446; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nazi I, 2007, ANTIMICROB AGENTS CH, V51, P1731, DOI 10.1128/AAC.01400-06; Nichols CB, 2007, MOL MICROBIOL, V63, P1118, DOI 10.1111/j.1365-2958.2006.05566.x; Nichols CB, 2015, EUKARYOT CELL, V14, P626, DOI 10.1128/EC.00010-15; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Pentland DR, 2018, MICROB CELL, V5, P63, DOI 10.15698/mic2018.02.612; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Phadke SS, 2013, EUKARYOT CELL, V12, P1155, DOI 10.1128/EC.00147-13; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Ramachandra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092734; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rhodes J, 2017, G3-GENES GENOM GENET, V7, P1165, DOI 10.1534/g3.116.037499; Fernandes JDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132369; Schneider RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043773; Schrevens S, 2018, MOL MICROBIOL, V109, P415, DOI 10.1111/mmi.14065; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Vallim MA, 2004, MICROBIOL-SGM, V150, P1925, DOI 10.1099/mic.0.27030-0; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Velez N, 2016, MEM I OSWALDO CRUZ, V111, P642, DOI 10.1590/0074-02760160201; Waugh MS, 2003, FUNGAL GENET BIOL, V38, P110, DOI 10.1016/S1087-1845(02)00518-2; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Yang ZH, 2002, MICROBIOL-SGM, V148, P2617, DOI 10.1099/00221287-148-8-2617; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	82	7	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211393	10.1371/journal.pone.0211393	http://dx.doi.org/10.1371/journal.pone.0211393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682168	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500165
J	Guerra, J; Mogollon, D; Gonzalez, D; Sanchez, R; Rueda, ZV; Parra-Lopez, CA; Murcia, MI				Guerra, Julio; Mogollon, Daniel; Gonzalez, Deccy; Sanchez, Ricardo; Vanessa Rueda, Zulma; Parra-Lopez, Carlos A.; Isabel Murcia, Martha			Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; PULMONARY TUBERCULOSIS; PREVALENCE; INFECTION; SITUATION; DIAGNOSIS; TIME; TB	Introduction Active tuberculosis (TB) and latent tuberculosis infection (LTBI) are a public health threat in prisons around the world. The objectives of the study were to estimate the prevalence of LTBI and TB as well as to investigate TB transmission inside one prison, in Colombia. Methods A Cross-sectional study was conducted in inmates who agreed to participate. Inmates with respiratory symptoms (RS) of any duration underwent to medical evaluation and three sputum samples were taken for smear microscopy and culture for TB diagnosis. Drug susceptibility was analyzed using BACTEC MGIT 960 and GenoType MTBDRplus. Molecular genotyping of Mycobacterium tuberculosis isolates was performed by 24-Locus MIRU-VNTR and spoligotyping. LTBI was evaluated according to the result of the tuberculin skin test (TST). Close contact investigation was conducted inside the prison for inmates that shared the cell with the index TB case. Results Among 301/2,020 (15%) inmates with RS of any duration, 8% were diagnosed with active TB. The prevalence of active TB was 1,026 cases/100,000 inmates. We isolated M. tuberculosis in 19/24 (79%) TB cases, 94.7% were susceptible to first line drugs and only one was monoresistant to isoniazid. The most prevalent sub-lineage was Haarlem (68.4%), followed by LAM (26.3%) and T superfamily (5.3%). 24-Locus MIRU-VNTR typing results alone or in combination with spoligotyping identified three clusters containing two isolates each. Two clusters corresponded to inmates that shared the same cell, but each one was located in different blocks of the prison. Inmates from the last cluster were in the same block in nearby cells. TST reading was performed in 95.6% inmates, and 67.6% had a positive reaction. Conclusions The prevalence of LTBI and TB was higher in prison than in the general population. Molecular genotyping suggests that TB in this prison is mainly caused by strains imported by inmates or endogenous reactivation.	[Guerra, Julio; Mogollon, Daniel; Parra-Lopez, Carlos A.; Isabel Murcia, Martha] Univ Nacl Colombia, Grp MICOBAC UN, Fac Med, Dept Microbiol, Bogota, Colombia; [Gonzalez, Deccy] Secretaria Salud Cundinamarca, Programa TB & Lepra, Bogota, Colombia; [Sanchez, Ricardo] Univ Nacl Colombia, Fac Med, Dept Psiquiatria, Bogota, Colombia; [Vanessa Rueda, Zulma] Univ Pontificia Bolivariana, Fac Med, Medellin, Antioquia, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Pontificia Bolivariana	Murcia, MI (corresponding author), Univ Nacl Colombia, Grp MICOBAC UN, Fac Med, Dept Microbiol, Bogota, Colombia.	mimurciaa@unal.edu.co	Rueda, Zulma Vanessa/AAH-4650-2019	Rueda, Zulma Vanessa/0000-0001-6342-1812	Sanatorio Agua de Dios, a social support entity of the state [30.09.48.296]; Universidad Nacional de Colombia -Facultad de Medicina, sede Bogota [30.09.48.296]; Secretaria de Salud de Cundinamarca, Bogota, DC [1347]	Sanatorio Agua de Dios, a social support entity of the state; Universidad Nacional de Colombia -Facultad de Medicina, sede Bogota; Secretaria de Salud de Cundinamarca, Bogota, DC	This work was supported by the inter-administrative cooperation agreement no. 30.09.48.296 between Sanatorio Agua de Dios, a social support entity of the state and Universidad Nacional de Colombia -Facultad de Medicina, sede Bogota. Sanatorio Agua de Dios obtained the funding for this project from Secretaria de Salud de Cundinamarca, Bogota, DC; through inter-administrative cooperation agreement no. 1347 in 2013.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Abrahao RMCM, 2006, INT J TUBERC LUNG D, V10, P203; Al-Darraji HAA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-22; [Anonymous], 2010, TREATM TUB GUID; [Anonymous], 2015, 007 MIN SAL PROT SOC; [Anonymous], WHO VACC PREV DIS MO; [Anonymous], 2004, GUID APPL GEN TUB PR; [Anonymous], 2012, TUB GEN; [Anonymous], 2018, ESQ VAUN; [Anonymous], 2012, TUB SKIN TEST TB; Arbelaez MP, 2004, INT J HEALTH PLAN M, V19, pS25, DOI 10.1002/hpm.775; Arroyave L, 2017, EPIDEMIOL INFECT, V145, P2491, DOI 10.1017/S0950268817001558; Arroyave L, 2019, J IMMIGR MINOR HEALT, V21, P578, DOI 10.1007/s10903-018-0746-1; Assefzadeh M, 2009, East Mediterr Health J, V15, P258; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; BD, 2016, BACTEC MGIT 960 SIRE; Bone A., 2000, TUBERCULOSIS CONTROL; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Castaneda-Hernandez DM, 2013, TUBERCULOSIS, V93, P275, DOI 10.1016/j.tube.2013.02.001; Center FJCNT, 2008, TUB CONT INV JAIL FA; Chee CBE, 2005, INT J TUBERC LUNG D, V9, P1248; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Chigbu LN, 2010, J HEALTH POPUL NUTR, V28, P327; Couvin D, 2014, EUROREFERENCE CAHIER, V2014, P36; Dara M, 2009, GUIDELINES CONTROL T; Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029; de Miranda SS, 2011, MEM I OSWALDO CRUZ, V106, P267, DOI 10.1590/S0074-02762011000300003; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fuge Terefe G, 2016, BMC Res Notes, V9, P201, DOI 10.1186/s13104-016-2005-7; Gómez Ingrid T, 2015, Rev. salud pública, V17, P97, DOI 10.15446/rsap.v17n1.50937; Huerga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051336; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Instituto Nacional do Cancer, 2018, INF EV TUB COL 2017, P1; Jagielski T, 2016, CLIN MICROBIOL REV, V29, P239, DOI 10.1128/CMR.00055-15; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Kuhleis D, 2012, MEM I OSWALDO CRUZ, V107, P909, DOI 10.1590/S0074-02762012000700012; Lobato MN, 2005, INT J TUBERC LUNG D, V9, P1179; Maggard KR, 2015, B WORLD HEALTH ORGAN, V93, P93, DOI 10.2471/BLT.14.135285; Mancuso JD, 2017, CHEST, V152, P282, DOI 10.1016/j.chest.2017.01.001; Medeiros TF, 2018, INFECT GENET EVOL, V58, P34, DOI 10.1016/j.meegid.2017.12.010; Lemos ACM, 2009, J BRAS PNEUMOL, V35, P63, DOI 10.1590/S1806-37132009000100009; Moreira-Oliveira MS, 2008, BRAZ J INFECT DIS, V12, P487, DOI 10.1590/S1413-86702008000600009; Murcia MPLCA, 2012, TUBERCULOSIS PRISON; Nogueira PA, 2012, REV SAUDE PUBL, V46, P119, DOI 10.1590/S0034-89102011005000080; Nyasulu Peter, 2015, Tuberc Res Treat, V2015, P752709, DOI 10.1155/2015/752709; Ongen Gul, 2013, Tuberk Toraks, V61, P21; Prisons FBo, 2010, MAN TUB CLIN PRACT G; Puerto G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124308; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Research IfCP, 2017, WORLD PRIS BRIEF DAT; Rueda Z, 2013, THESIS, P77; Rueda ZV, 2014, INT J TUBERC LUNG D, V18, P1166, DOI 10.5588/ijtld.14.0179; Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633; Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8; ScreenItalia, 2016, HIV 1 2 O RAP TEST C; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Rueda ZV, 2015, INT J INFECT DIS, V33, P82, DOI 10.1016/j.ijid.2015.01.004; Rueda ZV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080592; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2013, SYST SCREEN ACT TUB	68	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209895	10.1371/journal.pone.0209895	http://dx.doi.org/10.1371/journal.pone.0209895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682199	gold, Green Submitted, Green Published			2022-12-26	WOS:000457037500017
J	Lin, T; Lin, TC; McGrail, DJ; Bhupal, PK; Ku, YH; Zhang, W; Meng, LJ; Lin, SY; Peng, G; Tsai, RYL				Lin, Tao; Lin, Tsung-Chin; McGrail, Daniel J.; Bhupal, Parnit K.; Ku, Yi-Hsuan; Zhang, Wen; Meng, Lingjun; Lin, Shiaw-Yih; Peng, Guang; Tsai, Robert Y. L.			Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression	ONCOGENE			English	Article							STEM-CELLS; SOMATIC MUTATIONS; SELF-RENEWAL; REPAIR; DAMAGE; REPLICATION; INHIBITION; EXPRESSION; LANDSCAPE; MAINTAINS	A defective homologous recombination (HR) repair program increases tumor incidence as well as providing a survival advantage in patients with breast and ovarian cancers. Here we hypothesize that the tumor-promoting side of genome maintenance programs may be contributed by a self-renewal protein, nucleostemin (NS). To address this issue, we established its functional importance in mammary tumor progression in mice and showed that mammary tumor cells become highly susceptible to replicative DNA damage following NS depletion and are protected from hydroxyurea-induced damage by NS overexpression. Breast cancer cells with basal-like characters display more reliance on NS for genome maintenance than those with luminal characters. Mechanistically, NS-deficient cells demonstrate a significantly reduced HR repair activity. TCGA analyses of human breast cancers revealed that NS is co-enriched positively with HR repair proteins and that high NS expression correlates with low HR defects and predicts poor progression-free survival and resistance to knockdown of cell-cycle checkpoint genes in triple-negative/basal-like breast cancers. This work indicates that NS constitutes a tumor-promoting genome maintenance program required for mammary tumor progression.	[Lin, Tao; Lin, Tsung-Chin; Bhupal, Parnit K.; Ku, Yi-Hsuan; Zhang, Wen; Meng, Lingjun; Tsai, Robert Y. L.] Texas A&M Univ, Inst Biosci & Technol, Houston, TX 77030 USA; [McGrail, Daniel J.; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Tsai, Robert Y. L.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station	Tsai, RYL (corresponding author), Texas A&M Univ, Inst Biosci & Technol, Houston, TX 77030 USA.; Tsai, RYL (corresponding author), Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	rtsai@ibt.tamhsc.edu	McGrail, Daniel/F-3967-2014	McGrail, Daniel/0000-0002-6669-6069; Tsai, Robert/0000-0002-8357-0812	NCI-PHS grants [R01 CA113750, R03 CA201988, R21AG052006]; National Science Council Postdoctoral Fellowship (ROC); G. Komen [PDF17483544]; CPRIT [RP140456]; NATIONAL CANCER INSTITUTE [R03CA201988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG052006] Funding Source: NIH RePORTER	NCI-PHS grants; National Science Council Postdoctoral Fellowship (ROC); G. Komen; CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Margie Moczygemba at the IBT Flow Cytometry Core for her help in cell cycle analysis. This work was supported by NCI-PHS grants (R01 CA113750, R03 CA201988, R21AG052006) to RYT, National Science Council Postdoctoral Fellowship (ROC) to TCL, G. Komen PDF17483544 to DJM, and CPRIT RP140456 to GP.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; ETIENNE MC, 1989, BRIT J CANCER, V60, P30, DOI 10.1038/bjc.1989.214; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Hsu JK, 2012, J CELL BIOL, V197, P613, DOI 10.1083/jcb.201109038; Huang G, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.60; Knijnenburg TA, 2018, CELL REP, V23, P239, DOI 10.1016/j.celrep.2018.03.076; Kobayashi T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-215; Konstantinopoulos PA, 2015, CANCER DISCOV, V5, P1137, DOI 10.1158/2159-8290.CD-15-0714; Lin T, 2014, J CELL SCI, V127, P2302, DOI 10.1242/jcs.143842; Lin T, 2013, HEPATOLOGY, V58, P2176, DOI 10.1002/hep.26600; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; LOEB LA, 1974, CANCER RES, V34, P2311; Meng LJ, 2013, P NATL ACAD SCI USA, V110, P11415, DOI 10.1073/pnas.1301672110; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Peng G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4361; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Qu J, 2012, J CELL BIOL, V197, P731, DOI 10.1083/jcb.201103071; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Tsai RYL, 2016, CELL MOL LIFE SCI, V73, P1803, DOI 10.1007/s00018-016-2152-y; Tsai RYL, 2014, J CELL SCI, V127, P3885, DOI 10.1242/jcs.154054; Tsai RYL, 2011, PROTEIN REV, V15, P301, DOI 10.1007/978-1-4614-0514-6_13; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Watkins JA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3670; Wiedemeyer WR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00034; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Zwolinska AK, 2012, ONCOGENE, V31, P3311, DOI 10.1038/onc.2011.507; 2010, CELL CYCLE, V9, P3227, DOI DOI 10.4161/CC.9.16.12605	47	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3919	3931		10.1038/s41388-019-0710-0	http://dx.doi.org/10.1038/s41388-019-0710-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30692636	Green Accepted			2022-12-26	WOS:000468035600011
J	Jeeva, S; Mir, S; Velasquez, A; Ragan, J; Leka, A; Wu, S; Sevarany, AT; Royster, AD; Almeida, NA; Chan, F; O'Brien, L; Mir, MA				Jeeva, Subbiah; Mir, Sheema; Velasquez, Adrain; Ragan, Jacquelyn; Leka, Aljona; Wu, Sharon; Sevarany, Ariga Tahmasian; Royster, Austin D.; Almeida, Nicholas A.; Chan, Fion; O'Brien, Lea; Mir, Mohammad Ayoub			Crimean-Congo hemorrhagic fever virus nucleocapsid protein harbors distinct RNA-binding sites in the stalk and head domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; virology; viral protein; RNA-protein interaction; viral polymerase; C-C chemokine receptor type 5 (CCR5); CCHF; nucleocapsid	NUCLEOPROTEIN REVEALS; ENCAPSIDATION; INSIGHTS	Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne Nairovirus that causes severe hemorrhagic fever with a mortality rate of up to 30% in certain outbreaks worldwide. The virus has wide endemic distribution. There is no effective antiviral therapeutic or FDA approved vaccine for this zoonotic viral illness. The multifunctional CCHFV nucleocapsid protein (N protein) plays a crucial role in the establishment of viral infection and is an important structural component of the virion. Here we show that CCHFV N protein has a distant RNA-binding site in the stalk domain that specifically recognizes the vRNA panhandle, formed by the base pairing of complementary nucleotides at the 5' and 3' termini of the vRNA genome. Using multiple approaches, including filter-bonding analysis, GFP reporter assay, and biolayer interferometry we observed an N protein-panhandle interaction both in vitro and in vivo. The purified WT CCHFV N protein and the stalk domain also recognize the vRNA panhandle of hazara virus, another Nairovirus in the family Bunyaviridae, demonstrating the genus-specific nature of N protein-panhandle interaction. Another RNA-binding site was identified at the head domain of CCHFV N protein that nonspecifically recognizes the single strand RNA (ssRNA) of viral or nonviral origin. Expression of CCHFV N protein stalk domain active in panhandle binding, dramatically inhibited the hazara virus replication in cell culture, illustrating the role of N protein-panhandle interaction in Nairovirus replication. Our findings reveal the stalk domain of N protein as a potential target in therapeutic interventions to manage CCHFV disease.	[Jeeva, Subbiah; Ragan, Jacquelyn; Mir, Mohammad Ayoub] Western Univ Hlth Sci, Pomona, CA 91766 USA; [Mir, Sheema] Appl BioCode, Santa Fe Springs, CA 90670 USA; [Velasquez, Adrain; Leka, Aljona; Wu, Sharon; Sevarany, Ariga Tahmasian; Royster, Austin D.; Almeida, Nicholas A.; Chan, Fion; O'Brien, Lea] Calif State Polytech Univ Pomona, Coll Sci, Pomona, CA 91766 USA	Western University of Health Sciences; California State University System; California State Polytechnic University Pomona	Mir, MA (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.	mmir@westernu.edu		Mir, Sheema/0000-0001-7279-8734	National Institutes of Health [1R15AI126395-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI126395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1R15AI126395-01A1 (to M. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksoy D, 2018, AGRI, V30, P12, DOI 10.5505/agri.2017.76259; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Elliot R.M., 2000, VIRUS TAXONOMY, P599; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ergonul O, 2008, ANTIVIR RES, V78, P125, DOI 10.1016/j.antiviral.2007.11.002; Flick R, 2005, CURR MOL MED, V5, P753, DOI 10.2174/156652405774962335; Flick R, 2002, J VIROL, V76, P10849, DOI 10.1128/JVI.76.21.10849-10860.2002; Ganaie SS, 2014, BIOCHEM J, V464, P109, DOI 10.1042/BJ20140449; Ghaemi Z, 2017, J PHYS CHEM B, V121, P8437, DOI 10.1021/acs.jpcb.7b04318; Gunes Turabi, 2006, Mikrobiyoloji Bulteni, V40, P279; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Hussein ITM, 2012, J VIROL, V86, P7520, DOI 10.1128/JVI.07204-11; Jeeva S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184935; Jeeva S, 2017, J VIROL, V91, DOI [10.1128/JVI.00636-17, 10.1128/jvi.00636-17]; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Koksal I, 2014, EPIDEMIOL INFECT, V142, P239, DOI 10.1017/S0950268813001155; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Macleod JML, 2015, J GEN VIROL, V96, P524, DOI 10.1099/vir.0.071332-0; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mourya DT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001653; Olal D, 2014, NUCLEIC ACIDS RES, V42, P6025, DOI 10.1093/nar/gku229; Oncu Serkan, 2013, Virologica Sinica, V28, P193, DOI 10.1007/s12250-013-3327-4; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Salim NN, 2016, J BIOL CHEM, V291, P24702, DOI 10.1074/jbc.M116.750729; Sargianou M, 2013, EXPERT REV ANTI-INFE, V11, P897, DOI 10.1586/14787210.2013.827890; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; Swanepoel R., 1994, INFECT DIS LIVESTOCK, P723; Uyar Y, 2010, MIKROBIYOL BUL, V44, P57; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	37	8	8	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5023	5037		10.1074/jbc.RA118.004976	http://dx.doi.org/10.1074/jbc.RA118.004976			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723154	Green Published, hybrid			2022-12-26	WOS:000463985600025
J	Agudelo, M; Rodriguez, CA; Zuluaga, AF; Vesga, O				Agudelo, Maria; Rodriguez, Carlos A.; Zuluaga, Andres F.; Vesga, Omar			Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin	PLOS ONE			English	Article							THERAPEUTIC EQUIVALENCE; MEMBRANE DIPEPTIDASE; IN-VIVO; STABILITY; BIOEQUIVALENCE; SUBPOPULATIONS; IDENTIFICATION; SUBSTITUTION; ANTIBIOTICS; INFECTIONS	Background We demonstrated therapeutic nonequivalence of "bioequivalent" generics for meropenem, but there is no data with generics of other carbapenems. Methods One generic product of imipenem-cilastatin was compared with the innovator in terms of in vitro susceptibility testing, pharmaceutical equivalence, pharmacokinetic (PK) and pharmacodynamic (PD) equivalence in the neutropenic mouse thigh, lung and brain infection models. Both pharmaceutical forms were then subjected to analytical chemistry assays (LC/MS). Results and conclusion The generic product had 30% lower concentration of cilastatin compared with the innovator of imipenem-cilastatin. Regarding the active pharmaceutical ingredient (imipenem), we found no differences in MIC, MBC, concentration or potency or AUC, confirming equivalence in terms of in vitro activity. However, the generic failed therapeutic equivalence in all three animal models. Its E-max against S. aureus in the thigh model was consistently lower, killing from 0.1 to 7.3 million less microorganisms per gram in 24 hours than the innovator (P = 0.003). Against K. pneumoniae in the lung model, the generic exhibited a conspicuous Eagle effect fitting a Gaussian equation instead of the expected sigmoid curve of the Hill model. In the brain infection model with P. aeruginosa, the generic failed when bacterial growth was >4 log(10) CFU/g in 24 hours, but not if it was less than 2.5 log(10) CFU/g. These large differences in the PD profile cannot be explained by the lower concentration of cilastatin, and rather suggested a failure attributable to the imipenem constituent of the generic product. Analytical chemistry assays confirmed that, besides having 30% less cilastatin, the generic imipenem was more acidic, less stable, and exhibited four different degradation masses that were absent in the innovator.	[Agudelo, Maria; Rodriguez, Carlos A.; Zuluaga, Andres F.; Vesga, Omar] Univ Antioquia UdeA, Med Sch, GRIPE Grp Invest Problemas Enfermedades Infeccios, Medellin, Colombia; [Agudelo, Maria; Vesga, Omar] Hosp Univ San Vicente Fdn, Infect Dis Unit, Medellin, Colombia; [Rodriguez, Carlos A.; Zuluaga, Andres F.] Univ Antioquia UdeA, Med Sch, CIEMTO Ctr Informac Medicamentos & Tox, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Vesga, O (corresponding author), Univ Antioquia UdeA, Med Sch, GRIPE Grp Invest Problemas Enfermedades Infeccios, Medellin, Colombia.; Vesga, O (corresponding author), Hosp Univ San Vicente Fdn, Infect Dis Unit, Medellin, Colombia.	omar.vesga@udea.edu.co	Zuluaga, Andres F./K-7366-2016; Rodriguez, Carlos A./P-8324-2019	Zuluaga, Andres F./0000-0001-5656-4153; Rodriguez, Carlos A./0000-0002-4042-4313	University of Antioquia's Research Committee (CODI); University of Antioquia's Sustainability Strategy 2012-2013; Fundacion Cientifica Rodrigo Vesga-Meneses	University of Antioquia's Research Committee (CODI); University of Antioquia's Sustainability Strategy 2012-2013; Fundacion Cientifica Rodrigo Vesga-Meneses	This project was financed by the University of Antioquia's Research Committee (CODI), the University of Antioquia's Sustainability Strategy 2012-2013, and Fundacion Cientifica Rodrigo Vesga-Meneses. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agudelo M, 2014, ANTIMICROB AGENTS CH, V58, P1005, DOI 10.1128/AAC.00350-13; Agudelo M, 2012, ANTIMICROB AGENTS CH, V56, P2659, DOI 10.1128/AAC.06012-11; Agudelo M, 2015, INT J ANTIMICROB AG, V45, P161, DOI 10.1016/j.ijantimicag.2014.10.014; Alliance for Human Research Protection, 2005, FORM FDA COMM SAYS F; BENNETT JV, 1966, APPL MICROBIOL, V14, P170, DOI 10.1128/AEM.14.2.170-177.1966; Christopoulos A, 2001, J PHARMACOL EXP THER, V298, P1260; Cielecka-Piontek J, 2011, CURR PHARM ANAL, V7, P213, DOI 10.2174/157341211797457989; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUSC; Cummings JA, 2010, BIOCHEMISTRY-US, V49, P611, DOI 10.1021/bi901935y; EAGLE H, 1948, J EXP MED, V88, P99, DOI 10.1084/jem.88.1.99; Fujimura S, 2012, J INFECT CHEMOTHER, V18, P421, DOI 10.1007/s10156-012-0437-0; FUKASAWA M, 1992, ANTIMICROB AGENTS CH, V36, P1577, DOI 10.1128/AAC.36.7.1577; Generic Pharmaceutical Association, 2014, GEN DRUG SAV US 6 AN; Glantz SA., 2002, PRIMER BIOSTATISTICS, P230; Gonzalez JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141872; JACOBS RF, 1986, ANTIMICROB AGENTS CH, V29, P670, DOI 10.1128/AAC.29.4.670; Kera Y, 1999, COMP BIOCHEM PHYS B, V123, P53, DOI 10.1016/S0305-0491(99)00039-5; KEYNAN S, 1995, ANTIMICROB AGENTS CH, V39, P1629, DOI 10.1128/AAC.39.7.1629; Louie A, 2010, ANTIMICROB AGENTS CH, V54, P2638, DOI 10.1128/AAC.01721-09; Mastoraki E, 2008, J INFECTION, V56, P35, DOI 10.1016/j.jinf.2007.09.011; Merck, 2015, PRIM PROD MON IM CIL; Meredith PA, 2009, CURR MED RES OPIN, V25, P2179, DOI 10.1185/03007990903116867; MYERS CM, 1984, ANTIMICROB AGENTS CH, V26, P78, DOI 10.1128/AAC.26.1.78; Neely MN, 2012, THER DRUG MONIT, V34, P467, DOI 10.1097/FTD.0b013e31825c4ba6; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; PATAMASUCON P, 1982, ANTIMICROB AGENTS CH, V21, P390, DOI 10.1128/AAC.21.3.390; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez CA, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0155806, DOI 10.1371/journal.pone.0155806]; Rodriguez CA, 2017, INT J ANTIMICROB AG, V49, P189, DOI 10.1016/j.ijantimicag.2016.10.011; Rodriguez CA, 2015, ANTIMICROB AGENTS CH, V59, P53, DOI 10.1128/AAC.03633-14; Rodriguez CA, 2012, ANTIMICROB AGENTS CH, V56, P243, DOI 10.1128/AAC.05129-11; Rodriguez CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-153; Rodriguez CA, 2009, J INFECTION, V59, P277, DOI 10.1016/j.jinf.2009.08.005; Unites States Pharmacopoeia (USP), 2005, US PHARM MON DEV ANT, V27, P1110; Vesga O, 2010, ANTIMICROB AGENTS CH, V54, P3271, DOI 10.1128/AAC.01044-09; Wargo MJ, 2009, MICROBIOL-SGM, V155, P2411, DOI 10.1099/mic.0.028787-0; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Xia M, 2009, J PHARMACEUT BIOMED, V49, P937, DOI 10.1016/j.jpba.2009.02.002; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55; Zuluaga Andres F, 2015, BMC Res Notes, V8, P546, DOI 10.1186/s13104-015-1507-z; Zuluaga AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010744; Zuluaga Andres F, 2009, BMC Clin Pharmacol, V9, P1, DOI 10.1186/1472-6904-9-1	43	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211096	10.1371/journal.pone.0211096	http://dx.doi.org/10.1371/journal.pone.0211096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726248	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000052
J	Bvochora, T; Satyanarayana, S; Takarinda, KC; Bara, H; Chonzi, P; Komtenza, B; Duri, C; Apollo, T				Bvochora, Talent; Satyanarayana, Srinath; Takarinda, Kudakwashe C.; Bara, Hilda; Chonzi, Prosper; Komtenza, Brian; Duri, Clemence; Apollo, Tsitsi			Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY	Background In people living with HIV (PLHIV) who are on anti-retroviral therapy (ART), it is essential to identify persons with high blood viral loads (VLs) (>= 1000 copies/ml), provide enhanced adherence counselling (EAC) for 3 months and assess for VL suppression (< 1000 copies/ml). Objective Our study objectives were to determine the proportion who had a high viral load in those people who underwent viral load testing between 1 August 2016-31 July 2017 at Wilkins Hospital, Harare, Zimbabwe. Of those with high viral load to assess; a) the proportion who enrolled for EAC, the demographic and clinical characteristics associated with enrolment for EAC and, b) the proportion who achieved viral load suppression and demographic, clinical characteristics associated with viral load suppression. Design Retrospective cohort study using routinely collected programme data. Data was collected from PLHIV who were on ART and had a high viral load from 1 August 2016 to 31 July 2017. Results Of 5,573 PLHIV on ART between 1 August 2016 and 31 July 2017, 4787 (85.9%) had undergone VL testing and 646 (13.5%) had high VLs. Of these 646, only 489 (75.7%) were enrolled for EAC, of whom 444 (69%) underwent a repeat VL test at. 3 months with 201 (31.2%) achieving VL suppression. The clinical characteristics that were independently associated with higher probability of VL suppression were: a) undergoing 3 sessions of EAC; b) being on 2nd line ART. Initial VL levels >5,000 copies/ml were associated with lower probability of viral suppression. Conclusion The routine VL testing levels were high, but there were major programmatic gaps in enrolling PLHIV with high VLs into EAC and achieving VL suppression. The full potential of EAC on achieving viral load suppression has not been achieved in this setting. The reasons for these gaps need to be assessed in future research studies and addressed by suitable changes in policies/practices.	[Bvochora, Talent; Bara, Hilda; Chonzi, Prosper; Duri, Clemence] City Harare Hlth Serv Dept, Harare, Zimbabwe; [Satyanarayana, Srinath; Takarinda, Kudakwashe C.] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France; [Takarinda, Kudakwashe C.; Komtenza, Brian; Apollo, Tsitsi] Minist Hlth & Child Care, Govt Zimbabwe, AIDS & TB Unit, Harare, Zimbabwe		Bvochora, T (corresponding author), City Harare Hlth Serv Dept, Harare, Zimbabwe.	tbvochora@yahoo.com		Bvochora, Talent/0000-0003-4520-4130; Satyanarayana, Srinath/0000-0002-5420-2551	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch (Luxembourg); United States Agency for International Development (USAID) through Challenge TB; Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); National AIDS Council Zimbabwe	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch (Luxembourg); United States Agency for International Development (USAID) through Challenge TB(United States Agency for International Development (USAID)); Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); National AIDS Council Zimbabwe	This study was funded by: the United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch (Luxembourg); the United States Agency for International Development (USAID) through Challenge TB; The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) and the National AIDS Council Zimbabwe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, SUCC CHALL IMPL RO 1; Bonner K, 2013, J ACQ IMMUN DEF SYND, V6464, P74; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Davey DJ, 2017, FACTORS ASS UNSUPPRE; Fox MP, 2016, TROP MED INT HEALTH, V21, P1131, DOI 10.1111/tmi.12741; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Garone DB, 2013, S AFRICAN MED J, V14; Gupta RK, 2018, LANCET INFECT DIS, V18, P346, DOI [10.1016/s1473-3099(17)30702-8, 10.1016/S1473-3099(17)30702-8]; ICAP CU, 2016, ZIMB POP BAS HIV IMP; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; National Zimbabwe Statistics Agency, 2012, ZIMB POP CENS RES 20; UNAIDS, 2016, UNAIDS HIV DAT; USAIDS, 2017, 90 90 90 AMB TREATM; WHO, 2016, WHO TECH REP SER, V997, P1	16	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211326	10.1371/journal.pone.0211326	http://dx.doi.org/10.1371/journal.pone.0211326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721229	Green Published, gold, Green Submitted			2022-12-26	WOS:000457746300011
J	Rakszegi, M; Darko, E; Lovegrove, A; Molnar, I; Lang, L; Bedo, Z; Molnar-Lang, M; Shewry, P				Rakszegi, Marianna; Darko, Eva; Lovegrove, Alison; Molnar, Istva; Lang, Laszlo; Bedo, Zoltan; Molnar-Lang, Marta; Shewry, Peter			Drought stress affects the protein and dietary fiber content of wholemeal wheat flour in wheat/Aegilops addition lines	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNITS; BETA-GLUCAN CONTENT; END-USE QUALITY; HEAT-STRESS; AEGILOPS-BIUNCIALIS; DEVELOPING GRAINS; MALTING QUALITY; COMMON WHEAT; BARLEY; IDENTIFICATION	Wild relatives of wheat, such as Aegilops spp. are potential sources of genes conferring tolerance to drought stress. As drought stress affects seed composition, the main goal of the present study was to determine the effects of drought stress on the content and composition of the grain storage protein (gliadin (Gli), glutenin (Glu), unextractable polymeric proteins (UPP%) and dietary fiber (arabinoxylan, beta-glucan) components of hexaploid bread wheat (T. aestivum) lines containing added chromosomes from Ae. biuncialis or Ae. geniculata. Both Aegilops parents have higher contents of protein and beta-glucan and higher proportions of water-soluble arabinoxylans (determined as pentosans) than wheat when grown under both well-watered and drought stress conditions. In general, drought stress resulted in increased contents of protein and total pentosans in the addition lines, while the beta-glucan content decreased in many of the addition lines. The differences found between the wheat/Aegilops addition lines and wheat parents under well-watered conditions were also manifested under drought stress conditions: Namely, elevated beta-glucan content was found in addition lines containing chromosomes 5U(g), 7U(g) and 7M(b), while chromosomes 1U(b) and 1M(g) affected the proportion of polymeric proteins (determined as Glu/Gli and UPP%, respectively) under both well-watered and drought stress conditions. Furthermore, the addition of chromosome 6M(g) decreased the WE-pentosan content under both conditions. The grain composition of the Aegilops accessions was more stable under drought stress than that of wheat, and wheat lines with the added Aegilops chromosomes 2M(g) and 5M(g) also had more stable grain protein and pentosan contents. The negative effects of drought stress on both the physical and compositional properties of wheat were also reduced by the addition of these. These results suggest that the stability of the grain composition could be improved under drought stress conditions by the intraspecific hybridization of wheat with its wild relatives.	[Rakszegi, Marianna; Darko, Eva; Molnar, Istva; Lang, Laszlo; Bedo, Zoltan; Molnar-Lang, Marta] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Martonvasar, Hungary; [Lovegrove, Alison; Shewry, Peter] Rothamsted Res, Dept Plant Sci, Harpenden, Herts, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Rakszegi, M (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Martonvasar, Hungary.	rakszegi.mariann@agrar.mta.hu	Darkó, Éva/AAR-8167-2021; Molnar, istvan/L-9779-2019; Rakszegi, Marianna/B-2904-2013	Molnar, Istvan/0000-0002-7167-9319; Rakszegi, Marianna/0000-0003-0798-8974	Hungarian National Research Fund [K112226, K116277, K112169]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Marie Curie Fellowship [H2020-MSCA-IF-2016-746253]; Biotechnology and Biological Sciences Research Council [BBS/E/C/000I0250];  [TAMOP-4.2.2. A-11/1/KONV-2012-0008]; BBSRC [BBS/E/C/000I0250, BB/L025108/1] Funding Source: UKRI	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Marie Curie Fellowship(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by project No TAMOP-4.2.2. A-11/1/KONV-2012-0008, by the Hungarian National Research Fund [K112226, K116277, K112169], by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (MR) and Marie Curie Fellowship (H2020-MSCA-IF-2016-746253) (IM). The work at Rothamsted forms part of the Designing Future Wheat (DFW) strategic programme (BBS/E/C/000I0250) funded by the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC International,, 1995, 322301 AACC INT; Alvarez JB, 2018, THEOR APPL GENET, V131, P225, DOI 10.1007/s00122-017-3042-x; Andersson AAM, 2008, J AGR FOOD CHEM, V56, P9767, DOI 10.1021/jf802037f; [Anonymous], 1986, 6367486 MSZ HUNG STA; Ashraf M, 2014, CRIT REV FOOD SCI, V54, P1576, DOI 10.1080/10408398.2011.644354; Balla K, 2011, CZECH J FOOD SCI, V29, P117, DOI 10.17221/227/2010-CJFS; Bandou H, 2009, PLANT SYST EVOL, V277, P85, DOI 10.1007/s00606-008-0106-z; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; BATEY IL, 1991, CEREAL CHEM, V68, P207; Begcy K, 2015, PLANT SCI, V240, P109, DOI 10.1016/j.plantsci.2015.08.024; Bennett D, 2013, PRIVACY SOLUTIONS AND SECURITY FRAMEWORKS IN INFORMATION PROTECTION, P1, DOI 10.4018/978-1-4666-2050-6.ch001; Blum A., 1988, PLANT BREEDING STRES, DOI 10.1201/9781351075718; BLUMENTHAL C, 1994, AUST J PLANT PHYSIOL, V21, P901, DOI 10.1071/PP9940901; BLUMENTHAL C, 1995, CEREAL CHEM, V72, P539; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chapman SC, 2012, CROP PASTURE SCI, V63, P251, DOI 10.1071/CP11303; Coles GD, 1997, J CEREAL SCI, V26, P47, DOI 10.1006/jcrs.1996.0102; COLES GD, 1991, J CEREAL SCI, V14, P161, DOI 10.1016/S0733-5210(09)80137-9; Dai ZM, 2016, PLANT SOIL ENVIRON, V62, P53, DOI 10.17221/728/2015-PSE; Danilova TV, 2018, THEOR APPL GENET, V131, P377, DOI 10.1007/s00122-017-3008-z; DENYER K, 1994, AUST J PLANT PHYSIOL, V21, P783, DOI 10.1071/PP9940783; DOUGLAS SG, 1981, FOOD CHEM, V7, P139, DOI 10.1016/0308-8146(81)90059-5; FINCHER GB, 1975, J I BREWING, V81, P116, DOI 10.1002/j.2050-0416.1975.tb03672.x; Finnie SM, 2006, CEREAL CHEM, V83, P617, DOI 10.1094/CC-83-0617; Flagella Z, 2010, EUR J AGRON, V33, P197, DOI 10.1016/j.eja.2010.05.006; Garg M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162350; Gebruers K, 2010, J AGR FOOD CHEM, V58, P9353, DOI 10.1021/jf100447g; Gong WP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01743; Guler M, 2003, FIELD CROP RES, V84, P335, DOI 10.1016/S0378-4290(03)00100-X; GUPTA RB, 1992, CEREAL CHEM, V69, P125; HONG BH, 1989, CEREAL CHEM, V66, P369; *INT ASS CER SCI T, 1995, 1052 ICC INT ASS CER; International Association for Cereal Science and Technology ICC 166, 1998, 166 ICC INT ASS CER; Izydorczyk MS, 2008, FOOD RES INT, V41, P850, DOI 10.1016/j.foodres.2008.04.001; Jiang D, 2009, J AGRON CROP SCI, V195, P89, DOI 10.1111/j.1439-037X.2008.00353.x; Kilian B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P1, DOI 10.1007/978-3-642-14228-4_1; Kozub NA, 2011, RUSS J GENET+, V47, P1078, DOI 10.1134/S1022795411090092; Laurentin AM, 2003, NUTR BULL, V28, P69; Li GR, 2016, PLANTA, V244, P865, DOI 10.1007/s00425-016-2554-y; Li QF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165957; Li YF, 2013, J CEREAL SCI, V57, P73, DOI 10.1016/j.jcs.2012.09.014; MACNICOL PK, 1993, J CEREAL SCI, V18, P61, DOI 10.1006/jcrs.1993.1034; Medouri A, 2015, CEREAL RES COMMUN, V43, P272, DOI 10.1556/CRC.2014.0042; Millet E, 2014, EUPHYTICA, V195, P69, DOI 10.1007/s10681-013-0975-2; Molnar-Lang M., 2002, Acta Agronomica Hungarica, V50, P303, DOI 10.1556/AAgr.50.2002.3.8; MORGAN AG, 1981, J SCI FOOD AGR, V32, P339, DOI 10.1002/jsfa.2740320405; NARASIMHALU P, 1995, CAN J PLANT SCI, V75, P371, DOI 10.4141/cjps95-062; Nilssen AK, 2008, J CEREAL SCI, V48, P670; Ordaz-Ortiz JJ, 2005, J AGR FOOD CHEM, V53, P8349, DOI 10.1021/jf050755v; Ordaz-Ortiz JJ, 2005, J CEREAL SCI, V42, P119, DOI 10.1016/j.jcs.2005.02.004; Ordaz-Ortiz JJ, 2004, CARBOHYD POLYM, V57, P425, DOI 10.1016/j.carbpol.2004.05.016; Rakszegi M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01529; Rakszegi M, 2014, CARBOHYD POLYM, V102, P557, DOI 10.1016/j.carbpol.2013.12.005; Ren TH, 2016, GENOME, V59, P1076, DOI 10.1139/gen-2016-0112; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Saulnier L, 2009, J CEREAL SCI, V50, P312, DOI 10.1016/j.jcs.2009.05.003; Savin R, 1997, AUST J AGR RES, V48, P615, DOI 10.1071/A96064; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Schneider A, 2016, THEOR APPL GENET, V129, P1045, DOI 10.1007/s00122-016-2682-6; Shamsi K, 2011, AFR J BIOTECHNOL, V10, P2708; Shewry PR, 2008, J AGR FOOD CHEM, V56, P9777, DOI 10.1021/jf801880d; Swanston JS, 1997, CEREAL CHEM, V74, P456, DOI 10.1094/CCHEM.1997.74.4.456; Szakacs E, 2016, J CEREAL SCI, V71, P204, DOI 10.1016/j.jcs.2016.08.019; Toole GA, 2007, PLANTA, V225, P1393, DOI 10.1007/s00425-006-0448-0; Toole GA, 2010, PLANTA, V232, P677, DOI 10.1007/s00425-010-1199-5; Triboi E, 2003, J EXP BOT, V54, P1731, DOI 10.1093/jxb/erg183; Virk DS, 2009, EXP AGR, V45, P77, DOI 10.1017/S0014479708007047; Wang YJ, 2015, GENET RESOUR CROP EV, V62, P1085, DOI 10.1007/s10722-015-0217-7; Xie WL, 2008, EUPHYTICA, V164, P603, DOI 10.1007/s10681-008-9703-8; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang J, 2015, THEOR APPL GENET, V128, P1827, DOI 10.1007/s00122-015-2550-9; Zhang XX, 2013, J CEREAL SCI, V57, P134, DOI 10.1016/j.jcs.2012.10.010; Zhou JP, 2014, GENET MOL RES, V13, P660, DOI 10.4238/2014.January.28.11; Zhou JX, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0134-x	75	16	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211892	10.1371/journal.pone.0211892	http://dx.doi.org/10.1371/journal.pone.0211892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721262	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000457746300039
J	Chiarelli, N; Carini, G; Zoppi, N; Ritelli, M; Colombi, M				Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Ritelli, Marco; Colombi, Marina			Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients' skin fibroblasts	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; EXTRACELLULAR-MATRIX; V COLLAGEN; ENDOPLASMIC-RETICULUM; INTEGRIN; OSTEOPONTIN; PERIOSTIN; AUTOPHAGY; COL5A1; COMPLEMENT	Classical Ehlers-Danlos syndrome (cEDS) is a dominant inherited connective tissue disorder mainly caused by mutations in the COL5A1 and COL5A2 genes encoding type V collagen (COLLV), which is a fibrillar COLL widely distributed in a variety of connective tissues. cEDS patients suffer from skin hyperextensibility, abnormal wound healing/atrophic scars, and joint hypermobility. Most of the causative variants result in a non-functional COL5A1 allele and COLLV haploinsufficiency, whilst COL5A2 mutations affect its structural integrity. To shed light into disease mechanisms involved in cEDS, we performed gene expression profiling in skin fibroblasts from four patients harboring haploinsufficient and structural mutations in both disease genes. Transcriptome profiling revealed significant changes in the expression levels of different extracellular matrix (ECM)-related genes, such as SPP1, POSTN, EDIL3, IGFBP2, and C3, which encode both matricellular and soluble proteins that are mainly involved in cell proliferation and migration, and cutaneous wound healing. These gene expression changes are consistent with our previous protein findings on in vitro fibroblasts from other cEDS patients, which exhibited reduced migration and poor wound repair owing to COLLV disorganization, altered deposition of fibronectin into ECM, and an abnormal integrin pattern. Microarray analysis also indicated the decreased expression of DNAJB7, VIPAS39, CCPG1, ATG10, SVIP, which encode molecular chaperones facilitating protein folding, enzymes regulating post-Golgi COLLs processing, and proteins acting as cargo receptors required for endoplasmic reticulum (ER) proteostasis and implicated in the autophagy process. Patients' cells also showed altered mRNA levels of many cell cycle regulating genes including CCNE2, KIF4A, MKI67, DTL, and DDIAS. Protein studies showed that aberrant COLLV expression causes the disassembly of itself and many structural ECM constituents including COLLI, COLLIII, fibronectin, and fibrillins. Our findings provide the first molecular evidence of significant gene expression changes in cEDS skin fibroblasts highlighting that defective ECM remodeling, ER homeostasis and autophagy might play a role in the pathogenesis of this connective tissue disorder.	[Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Ritelli, Marco; Colombi, Marina] Univ Brescia, Div Biol & Genet, Dept Mol & Translat Med, Brescia, Italy	University of Brescia	Colombi, M (corresponding author), Univ Brescia, Div Biol & Genet, Dept Mol & Translat Med, Brescia, Italy.	marina.colombi@unibs.it	Chiarelli, Nicola/T-4923-2019; Carini, Giulia/AAA-8800-2022	Carini, Giulia/0000-0001-8096-9417; Colombi, Marina/0000-0002-3105-5990; ZOPPI, Nicoletta/0000-0003-0197-8927; Chiarelli, Nicola/0000-0002-1760-5079; RITELLI, Marco/0000-0002-7025-2495				Ailane S, 2013, EUR J NEUROSCI, V38, P2468, DOI 10.1111/ejn.12231; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Banushi B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12111; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besio R, 2018, BBA-MOL BASIS DIS, V1864, P1642, DOI 10.1016/j.bbadis.2018.02.002; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bowen JM, 2017, AM J MED GENET C, V175, P27, DOI 10.1002/ajmg.c.31548; Brandt K, 2015, GROWTH HORM IGF RES, V25, P34, DOI 10.1016/j.ghir.2014.11.001; Cazander G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534291; Chiarelli N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191220; Chiarelli N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161347; Colombi M, 2017, CLIN GENET, V92, P624, DOI 10.1111/cge.13052; Colombi M, 2017, AM J MED GENET A, V173, P524, DOI 10.1002/ajmg.a.38035; De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x; DeNigris J, 2016, CONNECT TISSUE RES, V57, P1, DOI 10.3109/03008207.2015.1081901; Egbert M, 2014, J DERMATOL SCI, V73, P40, DOI 10.1016/j.jdermsci.2013.08.010; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Giacomassi C, 2017, J INVEST DERMATOL, V137, P760, DOI 10.1016/j.jid.2016.11.011; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Im JY, 2018, ONCOGENE, V37, P1251, DOI 10.1038/s41388-017-0025-y; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Liaw L, 1998, J CLIN INVEST, V101, P1468; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Mak KM, 2016, ANAT REC, V299, P613, DOI 10.1002/ar.23330; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Melnyk Armin, 2015, Subcell Biochem, V78, P179, DOI 10.1007/978-3-319-11731-7_9; Mendes KN, 2010, INT J ONCOL, V37, P143, DOI 10.3892/ijo_00000662; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Niyibizi C, 2000, KNEE SURG SPORT TR A, V8, P281, DOI 10.1007/s001670000134; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Olczyk P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/747584; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Park AC, 2017, AM J PATHOL, V187, P2300, DOI 10.1016/j.ajpath.2017.06.006; Rafail S, 2015, J IMMUNOL, V194, P1285, DOI 10.4049/jimmunol.1402354; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritelli M, 2015, MOLEC GENET METAB RE, V2, P1, DOI 10.1016/j.ymgmr.2014.11.005; Ritelli M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-58; Rogerson C, 2018, BBA-MOL BASIS DIS, V1864, P1609, DOI 10.1016/j.bbadis.2018.01.028; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; Settembre C, 2018, MATRIX BIOL, V71-72, P283, DOI 10.1016/j.matbio.2018.06.001; Shen W, 2017, MOL MED REP, V16, P4054, DOI 10.3892/mmr.2017.7122; Shimomura T, 2003, CONNECT TISSUE RES, V44, P167, DOI 10.1080/03008200390215872; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Symoens S, 2012, HUM MUTAT, V33, P1485, DOI 10.1002/humu.22137; Symoens S, 2009, HUM MUTAT, V30, pE395, DOI 10.1002/humu.20887; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Viglio S, 2008, J INVEST DERMATOL, V128, P1915, DOI 10.1038/jid.2008.33; Walker JT, 2016, CELL TISSUE RES, V365, P453, DOI 10.1007/s00441-016-2426-6; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024478; Wang Z, 2012, SURGERY, V151, P296, DOI 10.1016/j.surg.2011.07.013; Wang Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156412; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009; Wu MH, 2012, J INVEST DERMATOL, V132, P1605, DOI 10.1038/jid.2012.32; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang H, 2014, CELL PHYSIOL BIOCHEM, V33, P991, DOI 10.1159/000358670; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200; Zoppi N, 2008, BBA-MOL CELL RES, V1783, P1177, DOI 10.1016/j.bbamcr.2008.03.003; Zoppi N, 2018, BBA-MOL BASIS DIS, V1864, P1010, DOI 10.1016/j.bbadis.2018.01.005; Zoppi N, 2015, HUM MOL GENET, V24, P6769, DOI 10.1093/hmg/ddv382; Zoppi N, 2012, BBA-GEN SUBJECTS, V1820, P1576, DOI 10.1016/j.bbagen.2012.06.004	86	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211647	10.1371/journal.pone.0211647	http://dx.doi.org/10.1371/journal.pone.0211647			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716086	gold, Green Submitted, Green Published			2022-12-26	WOS:000457744200036
J	Hewins, DB; Lee, H; Barnes, PW; McDowell, NG; Pockman, WT; Rahn, T; Throop, HL				Hewins, Daniel B.; Lee, Hanna; Barnes, Paul W.; McDowell, Nathan G.; Pockman, William T.; Rahn, Thom; Throop, Heather L.			Early exposure to UV radiation overshadowed by precipitation and litter quality as drivers of decomposition in the northern Chihuahuan Desert	PLOS ONE			English	Article							B RADIATION; ABIOTIC DEGRADATION; LIGNIN CONTROL; PHOTODEGRADATION; TERRESTRIAL; CLIMATE; MODEL; GRASSLAND; GRADIENT; NITROGEN	Dryland ecosystems cover nearly 45% of the Earth's land area and account for large proportions of terrestrial net primary production and carbon pools. However, predicting rates of plant litter decomposition in these vast ecosystems has proven challenging due to their distinctly dry and often hot climate regimes, and potentially unique physical drivers of decomposition. In this study, we elucidated the role of photopriming, i.e. exposure of standing dead leaf litter to solar radiation prior to litter drop that would chemically change litter and enhance biotic decay of fallen litter. We exposed litter substrates to three different UV radiation treatments simulating three-months of UV radiation exposure in southern New Mexico: no light, UVA+UVB+Visible, and UVA+Visible. There were three litter types: mesquite leaflets (Prosopis glandulosa, litter with high nitrogen (N) concentration), filter paper (pure cellulose), and basswood (Tilia spp, high lignin concentration). We deployed the photoprimed litter in the field within a large scale precipitation manipulation experiment: similar to 50% precipitation reduction, similar to 150% precipitation addition, and ambient control. Our results revealed the importance of litter substrate, particularly N content, for overall decomposition in drylands, as neither filter paper nor basswood exhibited measurable mass loss over the course of the year-long study, while high N-containing mesquite litter exhibited potential mass loss. We saw no effect of photopriming on subsequent microbial decay. We did observe a precipitation effect on mesquite where the rate of decay was more rapid in ambient and precipitation addition treatments than in the drought treatment. Overall, we found that precipitation and N played a critical role in litter mass loss. In contrast, photopriming had no detected effects on mass loss over the course of our year-long study. These results underpin the importance of biotic-driven decomposition, even in the presence of photopriming, for understanding litter decomposition and biogeochemical cycles in drylands.	[Hewins, Daniel B.] Rhode Isl Coll, Biol Dept, Providence, RI 02908 USA; [Lee, Hanna] Bjerknes Ctr Climate Res, NORCE Norwegian Res Ctr, Bergen, Norway; [Barnes, Paul W.] Loyola Univ, Dept Biol Sci, New Orleans, LA 70118 USA; [McDowell, Nathan G.] Pacific Northwest Natl Lab, Richland, WA USA; [Pockman, William T.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Rahn, Thom] Los Alamos Natl Lab, Earth & Environm Sci Div, Los Alamos, NM USA; [Throop, Heather L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Throop, Heather L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Bjerknes Centre for Climate Research; Norwegian Research Centre (NORCE); United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Lee, H (corresponding author), Bjerknes Ctr Climate Res, NORCE Norwegian Res Ctr, Bergen, Norway.	hale@norceresearch.no	Throop, Heather L./D-6391-2012	Throop, Heather L./0000-0002-7963-4342; Lee, Hanna/0000-0002-2003-4377	US Natural Science Foundation [DEB 0953864]; New Mexico State University - Los Alamos National Lab Collaborative Grant; Pacific Northwest National Laboratory LDRD	US Natural Science Foundation; New Mexico State University - Los Alamos National Lab Collaborative Grant; Pacific Northwest National Laboratory LDRD	This work was supported by US Natural Science Foundation DEB 0953864 (Dr. Heather L Throop); New Mexico State University - Los Alamos National Lab Collaborative Grant (Dr. Heather L Throop and Dr. Thom Rahn), and Pacific Northwest National Laboratory LDRD (Dr. Nathan G McDowell).	Adair EC, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1892; Adair EC, 2010, ECOLOGY, V91, P1225, DOI 10.1890/09-0430.1; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Almagro M, 2015, SOIL BIOL BIOCHEM, V90, P214, DOI 10.1016/j.soilbio.2015.08.006; Araujo PI, 2015, J ECOL, V103, P1408, DOI 10.1111/1365-2745.12433; Ault TR, 2014, J CLIMATE, V27, P7529, DOI 10.1175/JCLI-D-12-00282.1; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2016, P NATL ACAD SCI USA, V113, P4392, DOI 10.1073/pnas.1516157113; Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Baker NR, 2015, ECOLOGY, V96, P1994, DOI 10.1890/14-1482.1; Barnes P. W., 2015, PROG BOT, V76, P273, DOI DOI 10.1007/978-3-319-08807-5_11; Barnes PW, 2012, ECOSYSTEMS, V15, P311, DOI 10.1007/s10021-011-9511-1; Barnes PW, 2009, COMP BIOCHEM PHYS A, V153A, pS201, DOI 10.1016/j.cbpa.2009.04.459; BARNES PW, 1993, CROP SCI, V33, P1041, DOI 10.2135/cropsci1993.0011183X003300050033x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gallo ME, 2009, SOIL BIOL BIOCHEM, V41, P1433, DOI 10.1016/j.soilbio.2009.03.025; GEHRKE C, 1995, OIKOS, V72, P213, DOI 10.2307/3546223; Gliksman D, 2017, GLOBAL CHANGE BIOL, V23, P1564, DOI 10.1111/gcb.13465; Hewins DB, 2017, PLANT ECOL, V218, P459, DOI 10.1007/s11258-017-0703-4; Hewins DB, 2016, J ARID ENVIRON, V129, P111, DOI 10.1016/j.jaridenv.2016.02.014; Hewins DB, 2013, ECOSYSTEMS, V16, P183, DOI 10.1007/s10021-012-9604-5; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Huang G, 2017, SCI TOTAL ENVIRON, V601, P784, DOI 10.1016/j.scitotenv.2017.05.213; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/nclimate2837, 10.1038/NCLIMATE2837]; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; King JY, 2012, BIOGEOCHEMISTRY, V111, P57, DOI 10.1007/s10533-012-9737-9; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Lee H, 2012, BIOGEOSCIENCES, V9, P4411, DOI 10.5194/bg-9-4411-2012; Lee H, 2014, SOIL BIOL BIOCHEM, V72, P123, DOI 10.1016/j.soilbio.2014.01.027; Lee H, 2012, GLOBAL CHANGE BIOL, V18, P1185, DOI 10.1111/j.1365-2486.2011.02579.x; Li J, 2007, BIOGEOCHEMISTRY, V85, P317, DOI 10.1007/s10533-007-9142-y; Lin Y, 2018, SCI TOTAL ENVIRON, V615, P838, DOI 10.1016/j.scitotenv.2017.09.239; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; Pangle R. E., 2012, Ecosphere, V3, part28; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Plaut JA, 2012, PLANT CELL ENVIRON, V35, P1601, DOI 10.1111/j.1365-3040.2012.02512.x; Pravalie R, 2016, EARTH-SCI REV, V161, P259, DOI 10.1016/j.earscirev.2016.08.003; R Core Team, 2021, R LANGUAGE ENV STAT; Rozema J, 1997, PLANT ECOL, V128, P284; Ryel RJ, 2010, UV RADIATION IN GLOBAL CLIMATE CHANGE, P370; Schlesinger W.H., 2013, BIOGEOCHEMISTRY; Song XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068858; Throop HL, 2007, ECOL APPL, V17, P1809, DOI 10.1890/06-0889.1; Throop Heather L., 2009, V70, P171, DOI 10.1007/978-3-540-68421-3_8; WHITFORD WG, 1981, ECOLOGY, V62, P275, DOI 10.2307/1936687	50	6	6	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0210470	10.1371/journal.pone.0210470	http://dx.doi.org/10.1371/journal.pone.0210470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716078	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200011
J	Lange, F; Wesslau, K; Porath, K; Hornschemeyer, J; Bergner, C; Krause, BJ; Mullins, CS; Linnebacher, M; Kohling, R; Kirschstein, T				Lange, Falko; Wesslau, Konrad; Porath, Katrin; Hoernschemeyer, Julia; Bergner, Carina; Krause, Bernd Joachim; Mullins, Christina Susanne; Linnebacher, Michael; Koehling, Ruediger; Kirschstein, Timo			AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro	PLOS ONE			English	Article							VALPROIC ACID; ANTIEPILEPTIC DRUGS; BRAIN-TUMORS; GLIOMA-CELLS; SEIZURES; LEVETIRACETAM; TEMOZOLOMIDE; EPILEPSY; METABOLISM; INHIBITION	Epileptic seizures are frequent in patients with glioblastoma, and anticonvulsive treatment is often necessary. While clinical guidelines recommend all approved anticonvulsants, so far it is still unclear which of the available drugs is the best therapeutic option for treating glioma-associated seizures, also in view of possible anti-tumorigenic effects. In our study, we employed four patient-derived low-passage cell lines of glioblastoma and three cell lines of brain metastases, and challenged these cultures with four anticonvulsants with different mechanisms of action: levetiracetam, valproic acid, carbamazepine and perampanel. Cell proliferation was determined by bromodeoxyuridine incorporation. To further analyze the effects of perampanel, apoptosis induction was measured by caspase 3/7 activation. Glutamate release was quantified and glucose uptake was determined using F-18-fluorodeoxyglucose. Real-time polymerase chain reaction was employed to assess the expression of genes associated with glutamate release and uptake in brain tumor cells. Of the four anticonvulsants, only perampanel showed systematic inhibitory effects on cell proliferation, whereas all other anticonvulsants failed to inhibit glioma and metastasis cell growth in vitro. Metastasis cells were much more resistant to perampanel than glioblastoma cell lines. Glucose uptake was attenuated in all glioblastoma cells after perampanel exposure, whereas cell death via apoptosis was not induced. Extracellular glutamate levels were found to be significantly higher in glioblastoma cell lines as compared to metastasis cell lines, but could be reduced by perampanel exposure. Incubation with perampanel up-regulated glutamine synthetase expression in glioblastoma cells, whereas treatment with valproic acid and levetiracetam downregulated excitatory amino acid transporter-2 expression. Overall, our data suggest that perampanel acts as an anticonvulsive drug and additionally mediated antitumorigenic effects.	[Lange, Falko; Wesslau, Konrad; Porath, Katrin; Hoernschemeyer, Julia; Koehling, Ruediger; Kirschstein, Timo] Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, Rostock, Germany; [Lange, Falko; Krause, Bernd Joachim; Koehling, Ruediger; Kirschstein, Timo] Univ Rostock, Ctr Transdisciplinary Neurosci Rostock, Rostock, Germany; [Bergner, Carina; Krause, Bernd Joachim] Rostock Univ, Med Ctr, Dept Nucl Med, Rostock, Germany; [Mullins, Christina Susanne; Linnebacher, Michael] Univ Rostock, Med Ctr, Dept Surg, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Lange, F (corresponding author), Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, Rostock, Germany.; Lange, F (corresponding author), Univ Rostock, Ctr Transdisciplinary Neurosci Rostock, Rostock, Germany.	falko.lange@uni-rostock.de	Linnebacher, Michael/AAT-3763-2021; Mullins, Christina/ABG-4821-2021	Linnebacher, Michael/0000-0001-8054-1402; Mullins, Christina/0000-0003-2296-2027; Lange, Falko/0000-0001-8782-5205; Bergner, Carina/0000-0001-7346-8067	University Medicine Rostock FORUN Program [889010]; Damp Stiftung [:2016-20]	University Medicine Rostock FORUN Program; Damp Stiftung	This work was supported by a grant from the University Medicine Rostock FORUN Program to F.L. (Project no.: 889010) and a grant by the Damp Stiftung (Project no.:2016-20) to F.L. and T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2016, NEURO-ONCOLOGY, V18, P160, DOI 10.1093/neuonc/nov125; Armstrong TS, 2016, NEURO-ONCOLOGY, V18, P779, DOI 10.1093/neuonc/nov269; Bobustuc GC, 2010, NEURO-ONCOLOGY, V12, P917, DOI 10.1093/neuonc/noq044; Boot A, 2016, ONCOTARGET, V7, P14499, DOI 10.18632/oncotarget.7391; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Camphausen K, 2005, INT J CANCER, V114, P380, DOI 10.1002/ijc.20774; Chaichana KL, 2009, J NEUROSURG, V111, P282, DOI 10.3171/2009.2.JNS081132; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; de Groot JF, 2005, CANCER RES, V65, P1934, DOI 10.1158/0008-5472.CAN-04-3626; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; De Groot JF, 2008, J NEURO-ONCOL, V88, P121, DOI 10.1007/s11060-008-9552-2; de Groot M, 2012, BRAIN, V135, P1002, DOI 10.1093/brain/awr310; Eckert M, 2017, CELL PHYSIOL BIOCHEM, V44, P1591, DOI 10.1159/000485753; Englot Dario J, 2016, Handb Clin Neurol, V134, P267, DOI 10.1016/B978-0-12-802997-8.00016-5; Gefroh-Grimes HA, 2016, ACTA NEUROL SCAND, V133, P4, DOI 10.1111/ane.12437; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Hanada T, 2011, EPILEPSIA, V52, P1331, DOI 10.1111/j.1528-1167.2011.03109.x; Happold C, 2016, J CLIN ONCOL, V34, P731, DOI 10.1200/JCO.2015.63.6563; Hoja S, 2016, ONCOTARGET, V7, P62989, DOI 10.18632/oncotarget.11379; Hosein AN, 2015, J NEURO-ONCOL, V122, P263, DOI 10.1007/s11060-014-1713-x; Huberfeld G, 2016, NAT REV NEUROL, V12, P204, DOI 10.1038/nrneurol.2016.26; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Iwamoto FM, 2010, CANCER-AM CANCER SOC, V116, P1776, DOI 10.1002/cncr.24957; Izumoto S, 2018, ANTICANCER RES, V38, P4361, DOI 10.21873/anticanres.12737; Kim YH, 2015, CANCER-AM CANCER SOC, V121, P2926, DOI 10.1002/cncr.29439; Lange F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/568693; Lee CY, 2016, J NEURO-ONCOL, V127, P445, DOI 10.1007/s11060-016-2056-6; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Mai WX, 2017, NAT MED, V23, P1342, DOI 10.1038/nm.4418; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Marutani A, 2017, NEUROCHEM J+, V11, P43, DOI 10.1134/S1819712416040073; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mullins CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071070; Mullins CS, 2013, J CANC SCI THER, V5; Niu H-X, 2017, CELL MOL NEUROBIOL; Pacheco-Dominguez RL, 2008, EXP EYE RES, V86, P207, DOI 10.1016/j.exer.2007.10.011; Patsalos PN, 2015, EPILEPSIA, V56, P12, DOI 10.1111/epi.12865; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Rosche J, 2015, FORTSCHR NEUROL PSYC, V83, P286, DOI 10.1055/s-0034-1399459; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P19, DOI 10.1111/ane.12100; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; Ryu CH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/987495; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; Sizoo EM, 2010, NEURO-ONCOLOGY, V12, P1162, DOI 10.1093/neuonc/nop045; Sorensen MF, 2018, J NEURO-ONCOL, V138, P49, DOI 10.1007/s11060-018-2785-9; Stepulak A, 2007, CANCER BIOL THER, V6, P1908, DOI 10.4161/cbt.6.12.4965; Strickland M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00043; Thotala D, 2015, ONCOTARGET, V6, P35004, DOI 10.18632/oncotarget.5253; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Tseng JH, 2017, ONCOTARGET, V8, P14666, DOI 10.18632/oncotarget.14716; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Vecht C, 2017, J NEUROONCOL; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weller M, 2012, LANCET ONCOL, V13, pE375, DOI 10.1016/S1470-2045(12)70266-8; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yuen TI, 2012, NEUROLOGY, V79, P883, DOI 10.1212/WNL.0b013e318266fa89	61	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211644	10.1371/journal.pone.0211644	http://dx.doi.org/10.1371/journal.pone.0211644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716120	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200035
J	Carey, MR; Callaghan, BC; Kerber, KA; Skolarus, LE; Burke, JF				Carey, Matthew R.; Callaghan, Brian C.; Kerber, Kevin A.; Skolarus, Lesli E.; Burke, James F.			Impact of early headache neuroimaging on time to malignant brain tumor diagnosis: A retrospective cohort study	PLOS ONE			English	Article							INCIDENTAL FINDINGS; COST; EPIDEMIOLOGY; TESTS; MRI	Background Neuroimaging for headaches is both common and costly. While the costs are well quantified, little is known about the benefit in terms of diagnosing pathology. Our objective was to determine the role of early neuroimaging in the identification of malignant brain tumors in individuals presenting to healthcare providers with headaches. Methods This was a retrospective cohort study using administrative claims data (2001-2014) from a US insurer. Individuals were included if they had an outpatient visit for headaches and excluded for prior headache visits, other neurologic conditions, neuroimaging within the previous year, and cancer. The exposure was early neuroimaging, defined as neuroimaging within 30 days of the first headache visit. A propensity score-matched group that did not undergo early neuroimaging was then created. The primary outcome was frequency of malignant brain tumor diagnoses and median time to diagnosis within the first year after the incident headache visit. The secondary outcome was frequency of incidental findings. Results 22.2% of 180,623 individuals had early neuroimaging. In the following year, malignant brain tumors were found in 0.28% (0.23-0.34%) of the early neuroimaging group and 0.04% (0.02-0.06%) of the referent group (P<0.001). Median time to diagnosis in the early neuroimaging group was 8 (3-19) days versus 72 (39-189) days for the referent group (P<0.001). Likely incidental findings were discovered in 3.17% (3.00-3.34%) of the early neuroimaging group and 0.66% (0.58-0.74%) of the referent group (P<0.001). Conclusions Malignant brain tumors in individuals presenting with an incident headache diagnosis are rare and early neuroimaging leads to a small reduction in the time to diagnosis.	[Carey, Matthew R.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Callaghan, Brian C.; Kerber, Kevin A.; Skolarus, Lesli E.; Burke, James F.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carey, MR (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.	mrcarey@med.umich.edu	Carey, Matthew/ABF-3674-2020	Carey, Matthew/0000-0002-5838-8437	University of Michigan Summer Biosciences Research Program (SBRP); American Academy of Neurology; National Institutes of Health [R01MD00887, R01MD011516, U01MD010579]; Impeto Medical Inc.; National Institute on Minority Health and Health Disparities [U01MD010579, R01MD011516] Funding Source: NIH RePORTER	University of Michigan Summer Biosciences Research Program (SBRP); American Academy of Neurology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Impeto Medical Inc.; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was conducted with financial support from the University of Michigan Summer Biosciences Research Program (SBRP) and American Academy of Neurology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Chun Chieh Lin for her comments on the data management process. This research was conducted with financial support from the University of Michigan Summer Biosciences Research Program (SBRP) and American Academy of Neurology, neither of which played a role in this project or the decision to submit this manuscript. MRC is a former Business Analyst at McKinsey & Company and current External Adviser to McKinsey & Company's Healthcare Systems & Services Practice; BCC receives research support from Impeto Medical Inc., performs medical consultations for Advance Medical, consults for a PCORI grant, consults for the Immune Tolerance Network, and performs medical legal consultations; LES receives funding from National Institutes of Health (R01MD00887, R01MD011516, U01MD010579), and she has consulted for Bracket Global; KAK and JFB has no relevant financial disclosures. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Data are available upon request only.	Afra D, 2002, LANCET, V359, P1011; [Anonymous], 2017, RES 1973 2014; [Anonymous], 2017, CHOOS WIS ACR IM UNC; [Anonymous], 2015, CLINF DAT MART; Bernstein JA, 2013, J ALLER CL IMM-PRACT, V1, P242, DOI 10.1016/j.jaip.2013.03.014; Burke JF, 2013, ANN NEUROL, V73, P679, DOI 10.1002/ana.23865; Callaghan BC, 2015, CEPHALALGIA; Callaghan BC, 2014, JAMA INTERN MED, V174, P819, DOI 10.1001/jamainternmed.2014.173; Chamoun R, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11220; Clarke CE, 2010, J NEUROL, V257, P1274, DOI 10.1007/s00415-010-5506-7; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Fox BD, 2011, NEUROSURG CLIN N AM, V22, P1, DOI 10.1016/j.nec.2010.08.007; Goadsby P, 2004, BMJ-BRIT MED J, V329, P469, DOI 10.1136/bmj.329.7464.469; Hawasli AH, 2015, NEUROSURGERY, V76, P1, DOI 10.1227/NEU.0000000000000560; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945; Meisel K, 2017, J AM GERIATR SOC, V65, P1848, DOI 10.1111/jgs.14908; Mennini FS, 2008, J HEADACHE PAIN, V9, P199, DOI 10.1007/s10194-008-0051-9; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Nathan JK, 2017, J NEUROONCOLOGY; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Robbins MS, 2010, SEMIN NEUROL, V30, P107, DOI 10.1055/s-0030-1249220; Schafer AM, 2011, HEADACHE, V51, P985, DOI 10.1111/j.1526-4610.2011.01905.x; Sharma A, 2013, AM J ROENTGENOL, V201, pW75, DOI 10.2214/AJR.12.10238; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Whiteley W. N., 2009, BMJ, P339	30	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211599	10.1371/journal.pone.0211599	http://dx.doi.org/10.1371/journal.pone.0211599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707721	Green Submitted, Green Published, gold			2022-12-26	WOS:000457742900036
J	Maan, HS; Dhole, TN; Chowdhary, R				Maan, Harjeet Singh; Dhole, Tapan N.; Chowdhary, Rashmi			Identification and characterization of nonpolio enterovirus associated with nonpolio-acute flaccid paralysis in polio endemic state of Uttar Pradesh, Northern India	PLOS ONE			English	Article							ENVIRONMENTAL SURVEILLANCE; HIGH-FREQUENCY; RT-PCR; DIVERSITY; ENCEPHALITIS; ERADICATION; SEROTYPES; CHILDREN; VACCINE; AREA	Despite polio eradication, nonpolio enterovirus (NPEV) detection amid polio surveillance, which is considered to have implications in paralysis, requires attention. The attributes of NPEV infections in nonpolio-AFP (NPAFP) cases from Uttar Pradesh (UP), India, remain undetermined and are thus investigated. A total of 1839 stool samples collected from patients with acute flaccid paralysis (AFP) from UP, India, between January 2010 and October 2011 were analyzed as per the WHO algorithm. A total of 359 NPAFP cases yielded NPEVs, which were subjected to microneutralization assay, partial VP1 gene-based molecular serotyping and phylogenetic analysis. Demographic and clinical-epidemiological features were also ascertained. Echoviruses (29%) and Coxsackievirus (CV)-B (17%) were the most common viruses identified by the microneutralization assay. The molecular genotyping characterized the NPEVs into 34 different serotypes, corresponding to Enterovirus (EV)-A (1.6%), EV-B (94%) and EV-C (5.3%) species. The rarely described EV serotypes, such as EV-C95, CV-A20, EV-C105, EV-B75, EV-B101, and EV-B107, were also identified. NPEV-associated AFP was more prevalent in younger male children, peaked in the monsoon months and was predominantly found in the central part of the state. The NPEV strains isolated in the study exhibited genetic diversity from those isolated in other countries. These form part of a different cluster or subcluster existing in cocirculation, limited to India only. This study augments the understanding of epidemiological features and demonstrates the extensive diversity exhibited by the NPEV strains in NPAFP cases from the polio-endemic region. It also underscores the need or effective long-term strategies to monitor NPEV circulation and its associated health risks in the post-polio eradication era.	[Maan, Harjeet Singh; Dhole, Tapan N.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Microbiol, Lucknow, Uttar Pradesh, India; [Chowdhary, Rashmi] All India Inst Med Sci, Dept Biochem, Bhopal, India; [Maan, Harjeet Singh] Gandhi Med Coll, GMC Campus Dept Microbiol, State Virol Lab, Bhopal, Madhya Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; All India Institute of Medical Sciences (AIIMS) Bhopal	Dhole, TN (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Microbiol, Lucknow, Uttar Pradesh, India.	tapandhole321@yahoo.in			Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Government of India, New Delhi, India [80/719/2011-ECD-1]	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Government of India, New Delhi, India	This work was supported partially by a grant-in-aid from Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, Government of India, New Delhi, India (Ref no. 80/719/2011-ECD-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab Jalaa, 2011, Morbidity and Mortality Weekly Report, V60, P1482; Angez M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17456; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P153; Apostol LN, 2012, J MED VIROL, V84, P624, DOI 10.1002/jmv.23242; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P778; Chowdhary R, 2008, J MED VIROL, V80, P1477, DOI 10.1002/jmv.21230; daSilva EE, 1996, EMERG INFECT DIS, V2, P231, DOI 10.3201/eid0203.960312; Dhole TN, 2009, J PAEDIATR CHILD H, V45, P409, DOI 10.1111/j.1440-1754.2009.01529.x; Horner LM, 2015, EMERG INFECT DIS, V21, P1858, DOI 10.3201/eid2110.150759; Jorba J, 2016, MMWR-MORBID MORTAL W, V65, P763, DOI 10.15585/mmwr.mm6530a3; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Kapoor Amit, 2001, Indian Journal of Pediatrics, V68, P927, DOI 10.1007/BF02722583; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kumar A, 2013, J INFECT DEV COUNTR, V7, P475, DOI 10.3855/jidc.2413; Kumar A, 2012, J CLIN MICROBIOL, V50, P3509, DOI 10.1128/JCM.01483-12; Kumar A, 2011, J CLIN VIROL, V51, P142, DOI 10.1016/j.jcv.2011.02.011; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Maan HS, 2013, EMERG INFECT DIS, V19, P293, DOI 10.3201/eid1902.111832; Macesic N, 2015, OPEN FORUM INFECT DI; Muir P, 1998, CLIN MICROBIOL REV, V11, P202, DOI 10.1128/CMR.11.1.202; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Odoom JK, 2012, PAN AFR MED J, V12; Pallansch M., 2007, FIELDS VIROL, P839; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; Saeed M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-6; Shaukat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080040; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shukla D, 2013, J MED VIROL, V85, P505, DOI 10.1002/jmv.23441; Silva PA, 2008, J VIROL METHODS, V148, P260, DOI 10.1016/j.jviromet.2007.10.008; Todd A, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/wpsar.2014.5.4.003, 10.2471/WPSAR.2014.5.4.003]; World Health Organization, 2004, POL LAB MAN, V4th; Zhang YW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10909	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0208902	10.1371/journal.pone.0208902	http://dx.doi.org/10.1371/journal.pone.0208902			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699113	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600008
J	Migueis, GD; da Silva, RH; Damasceno, GA; Neto, GG				Migueis, Graciela da Silva; da Silva, Rosa Helena; Damasceno Junior, Geraldo Alves; Guarim-Neto, Germano			Plants used by the rural community of Bananal, Mato Grosso, Brazil: Aspects of popular knowledge	PLOS ONE			English	Article							MART. EX HAYNE; MEDICINAL-PLANTS; ETHNOBOTANICAL SURVEY; STRYCHNOS-PSEUDOQUINA; HOME GARDENS; LAMIACEAE; DESERT; AREA	Studies in rural communities are important to maintain popular knowledge between generations, as well as to identify new species for pharmaceutical production. Thus, the objectives of this study were to determine which plant species the rural community of Bananal, Mato Grosso, Brazil, uses by calculating the levels of fidelity and concordance regarding species uses among residents and to determine if there is a relationship between the number of known useful plants and levels of education, age, and residence time. Ethnobotanical data was collected from residents of the community through semi-structured interviews in January/December/2016. Species diversity was calculated using Shannon-Wiener, Level of Fidelity (LF), Correction Factor, and the Percentage of Agreement regarding the Main Uses (AMU). Statistical tests were performed using generalized linear models (GLM) in the R environment. The plant use indications were grouped according to the International Classification of Diseases and Related Health Problems (ICD 10). We found 152 species belonging to 130 genera and 67 families. The most frequently used plant parts were leaves, and decoction was the most frequent preparation mode. Strychnos pseudoquina was the species with the highest amount of use indications. The diversity index was 4.5 nats/ind(-1). The body system with the most citations was the code XVIII of ICD 10, corresponding to the species: alfavaca, mentraste, terramicina, angelim, fedegoso. Medicinal species with AMU values higher than 25% were: Strychnos pseudoquina, Plectranthus barbatus, Citrus sinensis cv. pera, Cymbopogon citratus. There was a relationship between the number of useful plants and the residence time of the participants. The Bananal community revealed high species richness and the relationship of knowledge showed that the older the residents and the longer their residence time in the community, the more knowledge they acquired.	[Migueis, Graciela da Silva] Univ Fed Mato Grosso, Inst Ciencias Exatas & Nat, Rondonopolis, MG, Brazil; [da Silva, Rosa Helena; Damasceno Junior, Geraldo Alves] Univ Fed Mato Grosso do Sul, Inst Biociencias, Campo Grande, MS, Brazil; [Guarim-Neto, Germano] Univ Fed Mato Grosso, Inst Biociencias, Cuiaba, MG, Brazil	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso	Migueis, GD (corresponding author), Univ Fed Mato Grosso, Inst Ciencias Exatas & Nat, Rondonopolis, MG, Brazil.	gmigueis@yahoo.com.br	Damasceno Junior, Geraldo/ABG-2834-2021	Silva, Rosa Helena/0000-0003-2691-9130; Migueis, Graciela/0000-0001-7287-6026	Foundation for Research Support of the State of Mato Grosso (FAPEMAT)	Foundation for Research Support of the State of Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	The research obtained support from the Foundation for Research Support of the State of Mato Grosso (FAPEMAT).; The authors thank the Federal University of Mato Grosso (UFMT), to the course of Powders graduation in Biotechnology and Biodiversity of the Rede Pro-Centro-Oeste, the Foundation of support the Research of the State of Mato Grosso for (FAPEMAT) the offered support, to the Community Agent of Health for his disposition in accompanying the visits for the interviews and to the community's of the Bananal community residents for they share their knowledge.	Abbas Z, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0172-9; Ahmad KS, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0196-1; Amaral Cleomara Nunes do, 2008, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V3, P329; Amorozo Maria Christina de Mello, 2002, Acta Bot. Bras., V16, P189, DOI 10.1590/S0102-33062002000200006; Andenberg AA, 2007, FAMILIES GENERA VASC, VVIII; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Apostolides N.A., 2017, J ECOSYST ECOGRAPHY, V7, P10, DOI DOI 10.4172/2157-7625.1000245; Aziz MA, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-017-0204-5; Aziz MA, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0126-7; Badke Marcio Rossato, 2011, Esc. Anna Nery, V15, P132; Bidak LM, 2015, GLOB ECOL CONSERV, V3, P433, DOI 10.1016/j.gecco.2015.02.001; Boff L, 2016, J APPL MICROBIOL, V121, P1519, DOI 10.1111/jam.13279; Boniface PK, 2017, J ETHNOPHARMACOL, V206, P193, DOI 10.1016/j.jep.2017.05.024; Bortolotto IM, 2017, REG ENVIRON CHANGE, V17, P1329, DOI 10.1007/s10113-016-1088-y; Bortolotto IM, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0026-2; Bussmann RW, 2018, ECON BOT, V72, P357, DOI 10.1007/s12231-018-9420-8; Byg A, 2001, BIODIVERS CONSERV, V10, P951, DOI 10.1023/A:1016640713643; Camara-Leret R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085794; Chahad AM, 2015, J ALTERN COMPLEM MED, V21, P569, DOI 10.1089/acm.2014.0243; Conde BE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187599; Corrigan BM, 2011, S AFR J BOT, V77, P346, DOI 10.1016/j.sajb.2010.09.017; Bieski IGC, 2015, J ETHNOPHARMACOL, V173, P383, DOI 10.1016/j.jep.2015.07.025; Bieski IGC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/272749; Costa M. C. C. D., 2006, Revista Brasileira de Plantas Medicinais, V8, P81; Culida de Oliveira T.A., 2007, REV ELETRONICA ENFER, V9, P93; da Costa IBC, 2017, B LATINOAM CARIBE PL, V16, P53; da Cunha SA, 2011, ACTA BOT BRAS, V25, P685, DOI 10.1590/S0102-33062011000300022; de Albuquerque UP, 2004, METODOS TECNICAS PES, P139; Dimech GS, 2013, SCI WORLD J, DOI 10.1155/2013/862763; dos Santos RT, 2012, QUIM NOVA, V35, P2229, DOI 10.1590/S0100-40422012001100025; Egea T, 2015, J ETHNOPHARMACOL, V175, P241, DOI 10.1016/j.jep.2015.08.053; Farias KD, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/1919474; Faruque MO, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00040; Freitas AVL, 2014, J GLOBAL BIOSCIENCES, V3, P749; FRIEDMAN J, 1986, J ETHNOPHARMACOL, V16, P275, DOI 10.1016/0378-8741(86)90094-2; Gonzalez JA, 2010, J ETHNOPHARMACOL, V131, P343, DOI 10.1016/j.jep.2010.07.022; Guarrera PM, 2015, ETHNOBIOL LETT, V6, P119, DOI 10.14237/ebl.6.1.2015.288; Jost X, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0128-5; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kiraithe MN, 2016, J ETHNOPHARMACOL, V178, P266, DOI 10.1016/j.jep.2015.12.013; Kulshrestha P., 2018, INT J ACAD RES DEV, V3, P52; Kunwar RM, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0242-7; Lage PS, 2015, PARASITOL RES, V114, P4625, DOI 10.1007/s00436-015-4708-4; Lage PS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/304354; Lautenschlager T, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0238-3; Licata M, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-015-0074-7; Lima LMdeS, 2007, THESIS, DOI [10.11606/T.8.2007.tde-101020077-152602, DOI 10.11606/T.8.2007.TDE-101020077-152602]; Liporacci H.S.N, 2013, Rev. bras. plantas med., V15, P529, DOI 10.1590/S1516-05722013000400009; Liporacci Heitor S.N., 2017, Rodriguésia, V68, P1225, DOI 10.1590/2175-7860201768407; Lumpert M, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0144-0; Maciel Márcia Regina Antunes, 2006, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V1, P61; Martins JLR, 2015, FUND CLIN PHARMACOL, V29, P238, DOI 10.1111/fcp.12113; Mbunde MVN, 2017, J INTERCULT ETHNOPHA, V6, P84, DOI 10.5455/jice.20161222103956; Megersa M, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-68; MESSIAS M.C.T.B., 2015, Rev. bras. plantas med., V17, P76, DOI 10.1590/1983-084X/12_139; Meyer L., 2012, REV BRASILEIRA BIOCI, V10, P258; MONTELES R, 2007, REV BIOLOGIA CIENCIA, V7, P38; Moura Flávia de Barros Prado, 2007, Biota Neotrop., V7, P119, DOI 10.1590/S1676-06032007000300014; Murad W, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-77; Neto F.R.G, 2014, Rev. bras. plantas med., V16, P856, DOI 10.1590/1983-084X/11_207; NICOLETTI M, 1984, J NAT PROD, V47, P953, DOI 10.1021/np50036a007; Orsi PR, 2014, J ETHNOPHARMACOL, V151, P380, DOI 10.1016/j.jep.2013.10.056; Orsi PR, 2012, J ETHNOPHARMACOL, V143, P81, DOI 10.1016/j.jep.2012.06.001; Pasa Maria Corette, 2010, Interações (Campo Grande), V11, P195, DOI 10.1590/S1518-70122010000200008; Pasquini MW, 2018, ECON BOT, V72, P278, DOI 10.1007/s12231-018-9422-6; Pott VJ., 1994, PLANTAS PANTANAL; Prefeitura Municipal de Rondonopolis, 2010, PREF ROND MT AP PEQ; Premamalini P., 2017, INT J ADV HERBAL SCI, V3, P67, DOI [10.23953/cloud.ijahst.327, DOI 10.23953/CLOUD.IJAHST.327]; Ramos U.F., 2011, INFARMA, V24, P10; Randrianarivony TN, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0147-x; Rankoana SA, 2015, AFRICAN J PHYS HLTH, V1, P773; Reyes-Garcia V, 2014, GLOBAL ENVIRON CHANG, V24, P223, DOI 10.1016/j.gloenvcha.2013.11.022; Ribeiro RV, 2017, J ETHNOPHARMACOL, V205, P69, DOI 10.1016/j.jep.2017.04.023; Rossato SC, 1999, ECON BOT, V53, P387, DOI 10.1007/BF02866716; Ruzza DAC, 2014, ENCICLOPEDIA BIOSFER, V10, P3332; Saraiva ME, 2015, J ETHNOPHARMACOL, V171, P141, DOI 10.1016/j.jep.2015.05.034; Sarandy MM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9538351; Saravanan Kasilingam, 2017, INT J ADV HERBAL SCI, V3, P49, DOI [10.23953/cloud.ijahst. 315, DOI 10.23953/CLOUD.IJAHST.315]; Shaheen H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183956; Silva JS, 2012, REV CIENCIAS AGROAMB, V10, P9; Singh A, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0178-3; Souza M, 2013, BIODIVERSIDADE, V12, P138; Stevens PF, 2017, BOT J LINN SOC, V181, P1; de Jesus NZT, 2009, REV BRAS FARMACOGN, V19, P130, DOI 10.1590/S0102-695X2009000100023; Tibiri A, 2015, J ALTERN COMPLEM MED, V21, P294, DOI 10.1089/acm.2014.0016; Tuasha N, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0213-z; Umair M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177912; Veiga Junior VF, 2008, BRAZILIAN J PHARMACO, V18, P308, DOI [10.1590/S0102-695X2008000200027, DOI 10.1590/S0102-695X2008000200027]; Veiga VF, 2005, QUIM NOVA, V28, P519, DOI 10.1590/S0100-40422005000300026; Verma Raj Kumar, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS460, DOI 10.12980/APJTB.4.2014C1067; VIEIRA L.S, 2015, Rev. bras. plantas med., V17, P1061, DOI 10.1590/1983-084X/15_009; Weckerle CS, 2006, ECON BOT, V60, P3, DOI 10.1663/0013-0001(2006)60[3:PKOTSI]2.0.CO;2; Wilson E.O., 1988, P3; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	94	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210488	10.1371/journal.pone.0210488	http://dx.doi.org/10.1371/journal.pone.0210488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699133	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600036
J	Ali, SA; Niu, B; Cheah, KSE; Alman, B				Ali, Shabana Amanda; Niu, Ben; Cheah, Kathryn S. E.; Alman, Benjamin			Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes	PLOS ONE			English	Article							CHONDROSARCOMA CELLS; HEDGEHOG PATHWAY; READ ALIGNMENT; EXPRESSION; INHIBITOR; CARTILAGE; RECEPTOR; ELEMENTS; ENCODE	Excessive Hedgehog (Hh) signaling in chondrocytes is sufficient to cause formation of enchondroma-like lesions which can progress to chondrosarcoma. To elucidate potential underlying mechanisms, we identified GLI1 and GLI2 target genes in human chondrosarcoma. Using chromatin immunoprecipitation (ChIP) sequencing and microarray data, in silico analyses were conducted to identify and characterize unique and overlapping GLI1 and GLI2 binding regions in neoplastic chondrocytes. After overlaying microarray data from human chondrosarcoma, 204 upregulated and 106 downregulated genes were identified as Hh-responsive Gli binding targets. After overlaying published Gli ChIP-on-chip data from mouse, 48 genes were identified as potential direct downstream targets of Hedgehog signaling with shared GLI binding regions in evolutionarily conserved DNA elements. Among these was BMP2, pointing to potential cross-talk between TGF beta signaling and Hh signaling. Our identification of potential target genes that are unique and common to GLI1 and GLI2 in neoplastic chondrocytes contributes to elucidating potential pathways through which Hh signaling impacts cartilage tumor biology.	[Ali, Shabana Amanda] Krembil Res Inst, Genet & Dev, Toronto, ON, Canada; [Niu, Ben; Cheah, Kathryn S. E.] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Alman, Benjamin] Duke Univ, Dept Orthopaed Surg, Durham, NC 27708 USA	Krembil Research Institute; University of Hong Kong; Duke University	Alman, B (corresponding author), Duke Univ, Dept Orthopaed Surg, Durham, NC 27708 USA.	ben.alman@duke.edu		Ali, Shabana/0000-0002-4339-9467	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01 AR066765]; Hong Kong Research Grants Council [T12-708/12N]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066765] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research contributions by B.A. and S.A.A. in this publication were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number: R01 AR066765. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Research contributions by K.S.E.C. and B.N. are supported by Hong Kong Research Grants Council project no: T12-708/12N.	Ali SA, 2016, ARTHRITIS RHEUMATOL, V68, P127, DOI 10.1002/art.39337; Ali SA, 2012, ANAL BIOCHEM, V429, P39, DOI 10.1016/j.ab.2012.06.028; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Boeuf S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-488; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Campbell VT, 2014, MOL CANCER THER, V13, P1259, DOI 10.1158/1535-7163.MCT-13-0731; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jamil N, 2010, INT J EXP PATHOL, V91, P387, DOI 10.1111/j.1365-2613.2010.00749.x; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.33; Koers-Wunrau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070709; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Onishi Anne C., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/381564; Park HL, 2000, DEVELOPMENT, V127, P1593; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Shi Y, 2015, P NATL ACAD SCI USA, V112, P4678, DOI 10.1073/pnas.1502301112; Tan ZJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007346; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang C, 2018, ELIFE, V7, DOI 10.7554/eLife.37673; Wang JY, 2015, ONCOTARGET, V6, P20636, DOI 10.18632/oncotarget.4114; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211333	10.1371/journal.pone.0211333	http://dx.doi.org/10.1371/journal.pone.0211333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695055	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400025
J	Nickels, S; Hopf, S; Pfeiffer, N; Schuster, AK				Nickels, Stefan; Hopf, Susanne; Pfeiffer, Norbert; Schuster, Alexander K.			Myopia is associated with education: Results from NHANES 1999-2008	PLOS ONE			English	Article							REFRACTIVE ERRORS; RISK-FACTORS; ASIAN POPULATION; UNITED-STATES; PREVALENCE; PARAMETERS; LEVEL; EPIDEMIOLOGY; METAANALYSIS; BLINDNESS	Purpose Myopia is increasing worldwide and possibly linked to education. In this study, we analyse the association of myopia and education in the U.S. and investigate its age-dependency. Methods We conducted a secondary data analysis using the public use files from the cross-sectional study National Health and Nutrition Examination Survey of the period from 1999 to 2008. 19,756 participants aged 20 to 85 years were included with data on education and ophthalmic parameters (distance visual acuity, objective refraction and keratometry). Spherical equivalent, astigmatism, corneal power and corneal astigmatism were evaluated for an association with education using linear regression analysis with adjustment of potential confounders. Results Analysis revealed an association between spherical equivalent and educational level in the univariate analysis (P <.001), and in the adjusted model (P <.001). Subjects who attend school to less than 9th grade had a mean spherical equivalent of 0.34 D, subjects with 9-11th grade -0.14 D, subjects that finished high school -0.33 D, subjects with partial college education -0.70 D, subjects that graduated from college or a higher formal education -1.22 D. Subjects that graduated from college or above were -1.47 D more myopic compared to subjects that completed less than 9 th grade school in the adjusted analyses. Astigmatism and corneal curvature was not associated with education. Conclusions Myopia is associated with higher education in the U. S. Our analysis shows that corneal curvature does not contribute to this association, therefore axial elongation or lens power are likely to contribute to myopia.	[Nickels, Stefan; Schuster, Alexander K.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Ctr Ophthalm Epidemiol & Healthcare Res, Mainz, Germany; [Hopf, Susanne; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Schuster, AK (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Ctr Ophthalm Epidemiol & Healthcare Res, Mainz, Germany.	alexander.schuster@uni-mainz.de	Pfeiffer, Norbert/AAO-7586-2020	Pfeiffer, Norbert/0000-0002-5766-2617; Hopf, Susanne/0000-0002-7989-9420				Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Cheng CY, 2003, INVEST OPHTH VIS SCI, V44, P4630, DOI 10.1167/iovs.03-0169; Cumberland PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139780; Dandona R, 1999, INVEST OPHTH VIS SCI, V40, P2810; Eong K. G. Au, 1993, Singapore Medical Journal, V34, P489; Fan Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11008; Fan Q, 2014, HUM MOL GENET, V23, P546, DOI 10.1093/hmg/ddt431; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Guggenheim JA, 2015, MOL VIS, V21, P621; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Hashemi H, 2016, OPHTHAL PHYSL OPT, V36, P671, DOI 10.1111/opo.12317; Holladay JT, 1997, J REFRACT SURG, V13, P388; Hwang HS, 2018, ACTA OPHTHALMOLOGICA; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Jacobsen N, 2007, ACTA OPHTHALMOL SCAN, V85, P165, DOI 10.1111/j.1600-0420.2006.00789.x; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Jonas JB, 2016, CORNEA, V35, P1333, DOI 10.1097/ICO.0000000000000854; Jonas JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154554; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kinge B, 1999, ACTA OPHTHALMOL SCAN, V77, P648, DOI 10.1034/j.1600-0420.1999.770608.x; Lee KE, 1960, ARCH OPHTHALMOL-CHIC, VIll, P127; Li SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134514; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P103, DOI 10.1167/iovs.09-3553; Mirshahi A, 2016, INVEST OPHTH VIS SCI, V57, P5230, DOI 10.1167/iovs.16-19507; Mirshahi A, 2014, OPHTHALMOLOGY, V121, P2047, DOI 10.1016/j.ophtha.2014.04.017; Morgan IG, 2018, PROG RETIN EYE RES, V62, P134, DOI 10.1016/j.preteyeres.2017.09.004; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2017, PHOTOCH PHOTOBIO SCI, V16, P426, DOI 10.1039/c6pp00292g; Pan CW, 2013, AM J OPHTHALMOL, V155, P1129, DOI 10.1016/j.ajo.2013.01.009; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P2590, DOI 10.1167/iovs.13-11725; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Rim Tyler Hyungtaek, 2016, Korean J Ophthalmol, V30, P214, DOI 10.3341/kjo.2016.30.3.214; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2007, OPHTHAL PHYSL OPT, V27, P126, DOI 10.1111/j.1475-1313.2006.00455.x; Saw SM, 2004, INVEST OPHTH VIS SCI, V45, P2943, DOI 10.1167/iovs.03-1296; Scragg R, 2008, AM J EPIDEMIOL, V168; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Varma R, 2017, AM J OPHTHALMOL, V175, P201, DOI 10.1016/j.ajo.2016.10.002; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Won SJ, 2010, J ADV ACAD, V21, P628, DOI 10.1177/1932202X1002100404; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P721, DOI 10.1007/s00417-009-1233-0	54	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211196	10.1371/journal.pone.0211196	http://dx.doi.org/10.1371/journal.pone.0211196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695049	Green Published, gold, Green Submitted			2022-12-26	WOS:000457046400017
J	Patel, BB; Lebensohn, AM; Pusapati, GV; Carette, JE; Salzman, J; Rohatgi, R				Patel, Bhaven B.; Lebensohn, Andres M.; Pusapati, Ganesh V.; Carette, Jan E.; Salzman, Julia; Rohatgi, Rajat			Discovery of gene regulatory elements through a new bioinformatics analysis of haploid genetic screens	PLOS ONE			English	Article							SEQUENCE-SPECIFIC CONTROL; CRISPR; TRANSCRIPTION	The systematic identification of regulatory elements that control gene expression remains a challenge. Genetic screens that use untargeted mutagenesis have the potential to identify protein-coding genes, non-coding RNAs and regulatory elements, but their analysis has mainly focused on identifying the former two. To identify regulatory elements, we conducted a new bioinformatics analysis of insertional mutagenesis screens interrogating WNT signaling in haploid human cells. We searched for specific patterns of retroviral gene trap integrations (used as mutagens in haploid screens) in short genomic intervals overlapping with introns and regions upstream of genes. We uncovered atypical patterns of gene trap insertions that were not predicted to disrupt coding sequences, but caused changes in the expression of two key regulators of WNT signaling, suggesting the presence of cis-regulatory elements. Our methodology extends the scope of haploid genetic screens by enabling the identification of regulatory elements that control gene expression.	[Patel, Bhaven B.; Lebensohn, Andres M.; Pusapati, Ganesh V.; Salzman, Julia; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Patel, Bhaven B.; Lebensohn, Andres M.; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Carette, Jan E.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA; [Salzman, Julia] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Lebensohn, Andres M.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Stanford University; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lebensohn, AM; Salzman, J; Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.; Lebensohn, AM; Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.; Salzman, J (corresponding author), Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA.; Lebensohn, AM (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	andres.lebensohn@nih.gov; julia.salzman@stanford.edu; rrohatgi@stanford.edu		Pusapati, Ganesh/0000-0002-1406-2566; Carette, Jan/0000-0002-5187-8070; Patel, Bhaven/0000-0002-1746-3277	National Cancer Institute [R00 CA168987-03]; National Institute of General Medical Sciences [R01 GM116847]; Joint Initiative for Metrology in Biology seed grant; National Science Foundation CAREER Award; McCormick-Gabilan Fellowship; Baxter Family Fellowship; National Institutes of Health [DP2 AI104557, DP2 GM105448, R35 GM118082]; Stanford Cancer Institute; Stanford Bio-X Undergraduate Summer Research Program; Stanford University Office of Undergraduate Advising and Research; Stanford Dean's Postdoctoral Fellowship; Stanford Cancer Biology Program Training Grant; Novartis from the Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE [R00CA168987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118082, R01GM116847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Joint Initiative for Metrology in Biology seed grant; National Science Foundation CAREER Award(National Science Foundation (NSF)); McCormick-Gabilan Fellowship; Baxter Family Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Cancer Institute; Stanford Bio-X Undergraduate Summer Research Program; Stanford University Office of Undergraduate Advising and Research; Stanford Dean's Postdoctoral Fellowship; Stanford Cancer Biology Program Training Grant; Novartis from the Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a National Cancer Institute (https://www.cancer.gov) grant R00 CA168987-03, a National Institute of General Medical Sciences (https.//www.nigms.nih.gov) grant R01 GM116847, a Joint Initiative for Metrology in Biology (http://jimb.stanford.edu) seed grant, a National Science Foundation (https://www.nsf.gov) CAREER Award, a McCormick-Gabilan Fellowship and a Baxter Family Fellowship (all to JS), by National Institutes of Health (https://www.nih.gov) grants DP2 AI104557 (JEC), DP2 GM105448 (RR), R35 GM118082 (RR) and by startup funds from the Stanford Cancer Institute (RR). BBP was supported by the Stanford Bio-X Undergraduate Summer Research Program and a Major Grant from the Stanford University Office of Undergraduate Advising and Research. AM L was supported by the Stanford Dean's Postdoctoral Fellowship, the Stanford Cancer Biology Program Training Grant and the Novartis sponsored Fellowship from the Helen Hay Whitney Foundation (http://hhwf.org).JEC is a David and Lucile Packard Foundation (https://www.packard.org) fellow, JS is an Alfred P. Sloan Foundation (https://sloan.org) fellow in Computational & Evolutionary Molecular Biology, and RR is a Josephine Q. Berry Faculty Scholar in Cancer Research at Stanford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2018, NAT METHODS, V15, P505, DOI 10.1038/s41592-018-0014-2; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2017, NAT GENET; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lebensohn AM, 2016, ELIFE, V5, DOI 10.7554/eLife.21459; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Pellicelli M, 2018, BBA-GENE REGUL MECH, V1861, P61, DOI 10.1016/j.bbagrm.2018.01.008; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Vrljicak P, 2016, G3-GENES GENOM GENET, V6, P805, DOI 10.1534/g3.115.026849; Wright JB, 2016, TRENDS GENET, V32, P526, DOI 10.1016/j.tig.2016.06.004; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0198463	10.1371/journal.pone.0198463	http://dx.doi.org/10.1371/journal.pone.0198463			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695034	Green Submitted, Green Published, gold			2022-12-26	WOS:000457046400001
J	Cao, J; Zhu, Z; Wang, H; Nichols, TC; Lui, GYL; Deng, SB; Rejto, PA; VanArsdale, T; Hardwick, JS; Weinrich, SL; Wei, P				Cao, Joan; Zhu, Zhou; Wang, Hui; Nichols, Timothy C.; Lui, Goldie Y. L.; Deng, Shibing; Rejto, Paul A.; VanArsdale, Todd; Hardwick, James S.; Weinrich, Scott L.; Wei, Ping			Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer	ONCOGENE			English	Article							DEPENDENT KINASE 4/6; BREAST-CANCER; EXPRESSION; ANGIOGENESIS; PHOSPHORYLATION; TRANSCRIPTION; REPLICATION; SENSITIVITY; DISRUPTION; RECEPTOR	The CDK4/6 inhibitor palbociclib reduces tumor growth by decreasing retinoblastoma (RB) protein phosphorylation and inducing cell cycle arrest at the G1/S phase transition. Palbociclib in combination with anti-hormonal therapy brings significant benefit to breast cancer patients. In this study, novel combination approaches and underlying molecular/cellular mechanisms for palbociclib were explored in squamous cell lung cancer (SqCLC), the second most common subtype of non-small cell lung cancer. While approximate 20% lung patients benefit from immunotherapy, most SqCLC patients who receive platinum-doublet chemotherapy as first-line treatment, which often includes a taxane, are still in need of more effective combination therapies. Our results demonstrated enhanced cytotoxicity and anti-tumor effect with palbociclib plus taxanes at clinically achievable doses in multiple SqCLC models with diverse cancer genetic backgrounds. Comprehensive gene expression analysis revealed a sustained disruption of pRB-E2F signaling by combination that was accompanied with enhanced regulation of pleiotropic biological effects. These included several novel mechanisms such as abrogation of G2/M and mitotic spindle assembly checkpoints, as well as impaired induction of hypoxia-inducible factor 1 alpha (HIF-1 alpha). The decrease in HIF-1 alpha modulated a couple key angiogenic and anti-angiogenic factors, resulting in an enhanced anti-angiogenic effect. This preclinical work suggests a new therapeutic opportunity for palbociclib in lung and other cancers currently treated with taxane based chemotherapy as standard of care.	[Cao, Joan; Zhu, Zhou; Rejto, Paul A.; Hardwick, James S.; Weinrich, Scott L.; Wei, Ping] Pfizer Inc, Oncol Translat Res, San Diego, CA 92121 USA; [Wang, Hui] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Nichols, Timothy C.] Pfizer Inc, Drug Safety Res & Dev, San Diego, CA 92121 USA; [Lui, Goldie Y. L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Deng, Shibing] Pfizer Inc, La Jolla Labs, Biostat, San Diego, CA 92121 USA; [VanArsdale, Todd] Pfizer Inc, Tumor Cell Biol Oncol Res & Dev, San Diego, CA 92121 USA	Pfizer; Novartis; Pfizer; Fred Hutchinson Cancer Center; Pfizer; Pfizer	Wei, P (corresponding author), Pfizer Inc, Oncol Translat Res, San Diego, CA 92121 USA.	ping.wei@pfizer.com	Lui, Goldie/J-7874-2019	Lui, Goldie/0000-0003-2741-6025				Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Bakker WJ, 2013, TRANSCR-AUSTIN, V4, P62, DOI 10.4161/trns.23680; Bertoli C, 2016, CELL REP, V15, P1412, DOI 10.1016/j.celrep.2016.04.036; Bocci G, 2013, ANGIOGENESIS, V16, P481, DOI 10.1007/s10456-013-9334-0; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Bretz F, 2011, MULTIPLE COMP USING, DOI DOI 10.1201/9781420010909; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Budde A, 2005, ONCOGENE, V24, P1802, DOI 10.1038/sj.onc.1208369; Dean JL, 2012, J BIOL CHEM, V287, P29075, DOI 10.1074/jbc.M112.365494; Deville JL, 2010, EXPERT OPIN THER TAR, V14, P1059, DOI 10.1517/14728222.2010.522328; Dhillon S, 2015, DRUGS, V75, P543, DOI 10.1007/s40265-015-0379-9; Dominguez-Brauer C, 2015, MOL CELL, V60, P524, DOI 10.1016/j.molcel.2015.11.006; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Ferrara R, 2016, EXPERT OPIN PHARMACO, V17, P1113, DOI 10.1517/14656566.2016.1157581; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gong XQ, 2017, CANCER CELL, V32, P761, DOI 10.1016/j.ccell.2017.11.006; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Newcomb EW, 2005, NEURO-ONCOLOGY, V7, P225, DOI 10.1215/S1152851704000997; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Oh E, 2016, SCI REP, V6, P1; Raspe E, 2017, EMBO MOL MED, V9, P1052, DOI 10.15252/emmm.201607084; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schaal C, 2014, ADV CANCER RES, V121, P147, DOI 10.1016/B978-0-12-800249-0.00004-4; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Socinski MA, 2014, CURR ONCOL, V21, pE691, DOI 10.3747/co.21.1997; Spilker ME, 2017, CLIN CANCER RES, V23, P1080, DOI 10.1158/1078-0432.CCR-16-1164; Stetler-Stevenson WG, 2005, TRENDS MOL MED, V11, P97, DOI 10.1016/j.molmed.2005.01.007; Subramaniam D, 2012, MOL CANCER THER, V11, P1598, DOI 10.1158/1535-7163.MCT-12-0102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Syed YY, 2017, DRUGS, V77, P799, DOI 10.1007/s40265-017-0742-0; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; VanArsdale T, 2015, CLIN CANCER RES, V21, P2905, DOI 10.1158/1078-0432.CCR-14-0816; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Witkiewicz AK, 2012, CLIN CANCER RES, V18, P5110, DOI 10.1158/1078-0432.CCR-12-0903; Zhang XH, 2013, CANCER BIOL THER, V14, P597, DOI 10.4161/cbt.24592	53	19	19	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4125	4141		10.1038/s41388-019-0708-7	http://dx.doi.org/10.1038/s41388-019-0708-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30700828				2022-12-26	WOS:000468740200011
J	Kim, BR; Park, SH; Jeong, YA; Na, YJ; Kim, JL; Jo, MJ; Jeong, S; Yun, HK; Oh, SC; Lee, DH				Kim, Bo Ram; Park, Seong Hye; Jeong, Yoon A.; Na, Yoo Jin; Kim, Jung Lim; Jo, Min Jee; Jeong, Soyeon; Yun, Hye Kyeong; Oh, Sang Cheul; Lee, Dae-Hee			RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEATH RECEPTOR 5; LIGAND (TRAIL)-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR RUNX3; NF-KAPPA-B; ER STRESS; MEDIATED APOPTOSIS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; GASTRIC-CANCER	RUNX3 is frequently inactivated by DNA hypermethylation in numerous cancers. Here, we show that RUNX3 has an important role in modulating apoptosis in immediate response to tumor necrosis factor-related apoptosis-including ligand (TRAIL). Importantly, no combined effect of TRAIL and RUNX3 was observed in non-cancerous cells. We investigated the expression of the death receptors (DRs) DR4 and DR5, which are related to TRAIL resistance. Overexpression of RUNX3 increased DR5 expression via induction of the reactive oxygen species (ROS)-endoplasmic reticulum (ER) stress-effector CHOP. Reduction of DR5 markedly decreased apoptosis enhanced by the combined therapy of TRAIL and RUNX3. Interestingly, RUNX3 induced reactive oxygen species production by inhibiting SOD3 transcription via binding to the Superoxide dismutase 3 (SOD3) promoter. Additionally, the combined effect of TRAIL and RUNX3 decreased tumor growth in xenograft models. Our results demonstrate a direct role for RUNX3 in TRAIL-induced apoptosis via activation of DR5 and provide further support for RUNX3 as an anti-tumor.	[Kim, Bo Ram; Kim, Jung Lim; Jeong, Soyeon; Oh, Sang Cheul; Lee, Dae-Hee] Korea Univ, Coll Med, Guro Hosp, Dept Oncol, Seoul, South Korea; [Park, Seong Hye; Jeong, Yoon A.; Na, Yoo Jin; Jo, Min Jee; Yun, Hye Kyeong] Korea Univ, Grad Sch Med, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Oh, SC; Lee, DH (corresponding author), Korea Univ, Coll Med, Guro Hosp, Dept Oncol, Seoul, South Korea.	sachoh@korea.ac.kr; neogene@korea.ac.kr			National Research Foundation (NRF) of Korea [NRF-2017R1A6A3A11030765]; Korea University Grant; project for cooperative R&D between Industry, Academy, and Research Institute [Co558375]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korea University Grant; project for cooperative R&D between Industry, Academy, and Research Institute	This work was supported by a National Research Foundation (NRF) of Korea grant funded the Korean government (MSIP) [NRF-2017R1A6A3A11030765] and was supported by Korea University Grant and was supported by project for cooperative R&D between Industry, Academy, and Research Institute funded Korea ministry of SMES and Startups in 2018 [Grants No. Co558375].	Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Dufour F, 2017, ONCOTARGET, V8, P9974, DOI 10.18632/oncotarget.14285; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Fritsche H, 2015, ONCOTARGET, V6, P9502, DOI 10.18632/oncotarget.3321; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gan HC, 2016, AM J PHYSIOL-LUNG C, V311, pL1101, DOI 10.1152/ajplung.00278.2016; Gan HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17916; Giambra V, 2012, NAT MED, V18, P1693, DOI 10.1038/nm.2960; Glab JA, 2017, CELL DEATH DIFFER, V24, P944, DOI 10.1038/cdd.2017.53; Guha P, 2017, ONCOTARGET, V8, P68191, DOI 10.18632/oncotarget.19277; Harashima N, 2017, ONCOTARGET, V8, P42887, DOI 10.18632/oncotarget.17157; Hartwig T, 2017, MOL CELL, V65, P730, DOI 10.1016/j.molcel.2017.01.021; He K, 2016, ONCOGENE, V35, P148, DOI 10.1038/onc.2015.79; He L, 2013, MOL CARCINOGEN, V52, P85, DOI 10.1002/mc.21831; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Iurlaro R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00479-16; Jiang YN, 2017, MOL IMMUNOL, V82, P123, DOI 10.1016/j.molimm.2016.12.023; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; Kandasamy K, 2002, CANCER RES, V62, P4929; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Kapur A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27530; Kim BR, 2016, ONCOL REP, V36, P2601, DOI 10.3892/or.2016.5086; Kim BR, 2017, ONCOTARGET, V8; Kodach LL, 2010, CARCINOGENESIS, V31, P1567, DOI 10.1093/carcin/bgq147; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee DH, 2016, J CELL BIOCHEM, V117, P1078, DOI 10.1002/jcb.25289; Lee DH, 2014, TOXICOL APPL PHARM, V279, P253, DOI 10.1016/j.taap.2014.06.030; Lee DH, 2009, BRIT J PHARMACOL, V157, P1189, DOI 10.1111/j.1476-5381.2009.00245.x; Lee JH, 2011, CLIN EXP DERMATOL, V36, P769, DOI 10.1111/j.1365-2230.2011.04069.x; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li TL, 2015, J BIOL CHEM, V290, P11108, DOI 10.1074/jbc.M115.645333; Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265; Liu ZX, 2016, CHEM RES TOXICOL, V29, P1510, DOI 10.1021/acs.chemrestox.6b00181; Lotem J, 2015, BBA-REV CANCER, V1855, P131, DOI 10.1016/j.bbcan.2015.01.004; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Ma ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35196; Na YJ, 2017, INT J BIOCHEM CELL B, V89, P147, DOI 10.1016/j.biocel.2017.06.010; Pal S, 2016, CANCER MICROENVIRON, V9, P77, DOI 10.1007/s12307-016-0184-3; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Park SH, 2016, ONCOTARGET, V7, P59503, DOI 10.18632/oncotarget.11147; Prasad S, 2014, TRENDS PHARMACOL SCI, V35, P520, DOI 10.1016/j.tips.2014.07.004; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shi K, 2017, THERANOSTICS, V7, P4480, DOI 10.7150/thno.21707; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; Toscano F, 2008, ONCOGENE, V27, P4161, DOI 10.1038/onc.2008.52; von Karstedt S, 2015, CANCER CELL, V27, P561, DOI 10.1016/j.ccell.2015.02.014; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Waki T, 2003, CANCER SCI, V94, P360, DOI 10.1111/j.1349-7006.2003.tb01447.x; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Yang F, 2010, CELL DEATH DIFFER, V17, P1354, DOI 10.1038/cdd.2010.29; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; ZLOTORYNSKI E, 2014, NAT REV MOL CELL BIO, V15, P498	61	18	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3903	3918		10.1038/s41388-019-0693-x	http://dx.doi.org/10.1038/s41388-019-0693-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30692634				2022-12-26	WOS:000468035600010
J	Tauber, D; Parker, R				Tauber, Devin; Parker, Roy			15-Deoxy-(12,14)-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2 and activates the integrated stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostaglandin; eukaryotic initiation factor 2 (eIF2); stress granule; stress response; neuroinflammation; proteasome	UNFOLDED PROTEIN RESPONSE; TRANSGENIC MOUSE MODEL; GRANULES; INHIBITION; SUPPRESSION; TRIAL; TRANSLATION; NEURONS; MEMORY; RNA	Stress granules (SGs) are cytoplasmic RNA-protein aggregates formed in response to inhibition of translation initiation. SGs contribute to the stress response and are implicated in a variety of diseases, including cancer and some forms of neurodegeneration. Neurodegenerative diseases often involve chronic phosphorylation of eukaryotic initiation factor 2 (eIF2), with deletions of eIF2 kinases or treatment with eIF2 kinase inhibitors being protective in some animal models of disease. However, how and why the integrated stress response (ISR) is activated in different forms of neurodegeneration remains unclear. Because neuroinflammation is common to many neurodegenerative diseases, we hypothesized that inflammatory factors contribute to ISR activation in a cell-nonautonomous manner. Using fluorescence microscopy and immunoblotting, we show here that the endogenously produced product of inflammation, 15-deoxy-(12,14)-prostaglandin J2 (15-d-PGJ2), triggers eIF2 phosphorylation, thereby activating the ISR, repressing bulk translation, and triggering SG formation. Our findings define a mechanism by which inflammation activates the ISR in a cell-nonautonomous manner and suggest that inhibition of 15-d-PGJ2 production might be a useful therapeutic strategy in some neuroinflammatory contexts.	[Tauber, Devin; Parker, Roy] Univ Colorado, Dept Biochem, 596 UCB, Boulder, CO 80309 USA; [Parker, Roy] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute	Parker, R (corresponding author), Univ Colorado, Dept Biochem, 596 UCB, Boulder, CO 80309 USA.	roy.parker@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Tauber, Devin/0000-0002-8521-1573	National Institutes of Health [R01GM45443, T32GM008758]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM45443 (to R.P.) and T32GM008758 (to D.T.) and the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Ansari MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27611; Aulas A, 2017, J CELL SCI, V130, P927, DOI 10.1242/jcs.199240; Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Campo PA, 2002, CELL GROWTH DIFFER, V13, P409; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Lima IVD, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/946813; DeGracia DJ, 2007, NEUROSCIENCE, V146, P562, DOI 10.1016/j.neuroscience.2007.01.050; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Figueiredo-Pereira ME, 2016, ANN NY ACAD SCI, V1363, P125, DOI 10.1111/nyas.12987; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Grabocka E, 2016, CELL, V167, P1803, DOI 10.1016/j.cell.2016.11.035; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Marcone S, 2013, PROTEOMICS, V13, P2135, DOI 10.1002/pmic.201200289; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Moon SL, 2018, TRENDS MOL MED, V24, P575, DOI 10.1016/j.molmed.2018.04.001; Myeku N, 2018, TRENDS MOL MED, V24, P18, DOI 10.1016/j.molmed.2017.11.006; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; Pompl PN, 2003, FASEB J, V17, P725, DOI 10.1096/fj.02-0876fje; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Tsai JC, 2018, SCIENCE, V359, P1483, DOI 10.1126/science.aaq0939; Wu CT, 2011, FREE RADICAL BIO MED, V51, P671, DOI 10.1016/j.freeradbiomed.2011.04.038; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	42	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6344	6352		10.1074/jbc.RA118.007138	http://dx.doi.org/10.1074/jbc.RA118.007138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30723157	Green Published, hybrid			2022-12-26	WOS:000468402000012
J	Davis, DL; Gable, K; Suemitsu, J; Dunn, TM; Wattenberg, BW				Davis, Deanna L.; Gable, Kenneth; Suemitsu, John; Dunn, Teresa M.; Wattenberg, Binks W.			The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: Reconstitution of SPT regulation in isolated membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; homeostasis; endoplasmic reticulum (ER); lipid metabolism; lipid signaling; cell signaling; phytoceramide; sphingomyelin; sphingosine	SPHINGOLIPID BIOSYNTHESIS; PROTEINS MEDIATE; ORM; SPHINGOSINE; DIHYDROCERAMIDE; CHOLESTEROL; HOMEOSTASIS; BIOPHYSICS; EXPRESSION; SUBUNITS	Sphingolipids compose a lipid family critical for membrane structure as well as intra- and intercellular signaling. De novo sphingolipid biosynthesis is initiated by the enzyme serine palmitoyltransferase (SPT), which resides in the endoplasmic reticulum (ER) membrane. In both yeast and mammalian species, SPT activity is homeostatically regulated through small ER membrane proteins, the Orms in yeast and the ORMDLs in mammalian cells. These proteins form stable complexes with SPT. In yeast, the homeostatic regulation of SPT relies, at least in part, on phosphorylation of the Orms. However, this does not appear to be the case for the mammalian ORMDLs. Here, we accomplished a cell-free reconstitution of the sphingolipid regulation of the ORMDL-SPT complex to probe the underlying regulatory mechanism. Sphingolipid and ORMDL-dependent regulation of SPT was demonstrated in isolated membranes, essentially free of cytosol. This suggests that this regulation does not require soluble cytosolic proteins or small molecules such as ATP. We found that this system is particularly responsive to the pro-apoptotic sphingolipid ceramide and that this response is strictly stereospecific, indicating that ceramide regulates the ORMDL-SPT complex via a specific binding interaction. Yeast membranes harboring the Orm-SPT system also directly responded to sphingolipid, suggesting that yeast cells have, in addition to Orm phosphorylation, an additional Orm-dependent SPT regulatory mechanism. Our results indicate that ORMDL/Orm-mediated regulation of SPT involves a direct interaction of sphingolipid with the membrane-bound components of the SPT-regulatory apparatus.	[Davis, Deanna L.; Suemitsu, John; Wattenberg, Binks W.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Gable, Kenneth; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Wattenberg, Binks W.] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40202 USA	Virginia Commonwealth University; Uniformed Services University of the Health Sciences - USA; University of Louisville	Wattenberg, BW (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	brian.wattenberg@vcuhealth.org			Bridge Grant from the University of Louisville School of Medicine; James Graham Brown Cancer Center; National Institutes of Health [R01HL131340]; National Institutes of Health, Department of Defense Grant [HL14-007.001/BIO-71-8822]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131340] Funding Source: NIH RePORTER	Bridge Grant from the University of Louisville School of Medicine; James Graham Brown Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Department of Defense Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Bridge Grant from the University of Louisville School of Medicine (to B. W.), the James Graham Brown Cancer Center (to B. W.), National Institutes of Health Grant R01HL131340 (to B. W.), and National Institutes of Health, Department of Defense Grant HL14-007.001/BIO-71-8822 (to T. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barenholz Y, 2004, SUB CELL BIOCHEM, V37, P167; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cai L, 2016, J LIPID RES, V57, P1412, DOI 10.1194/jlr.M065920; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Davis Deanna, 2018, Advances in Biological Regulation, V70, P3, DOI 10.1016/j.jbior.2018.08.002; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Gupta SD, 2015, J BIOL CHEM, V290, P90, DOI 10.1074/jbc.M114.588236; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Han GS, 2019, BBA-MOL CELL BIOL L, V1864, P245, DOI 10.1016/j.bbalip.2018.11.007; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Harrison PJ, 2018, NAT PROD REP, V35, P921, DOI 10.1039/c8np00019k; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Liu LK, 2017, J CELL BIOL, V216, P131, DOI 10.1083/jcb.201606059; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; MANDON EC, 1991, EUR J BIOCHEM, V198, P667, DOI 10.1111/j.1432-1033.1991.tb16065.x; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow D, 2015, J LIPID RES, V56, P898, DOI 10.1194/jlr.M057539; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Wang S, 2015, P NATL ACAD SCI USA, V112, P3728, DOI 10.1073/pnas.1422455112; Wang XH, 2017, INT J BIOCHEM CELL B, V87, P8, DOI 10.1016/j.biocel.2017.03.007	39	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5146	5156		10.1074/jbc.RA118.007291	http://dx.doi.org/10.1074/jbc.RA118.007291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700557	Green Published, hybrid			2022-12-26	WOS:000463985600035
J	Seneque, E; Lesimple, C; Morisset, S; Hausberger, M				Seneque, Emilie; Lesimple, Clemence; Morisset, Stephane; Hausberger, Martine			Could posture reflect welfare state? A study using geometric morphometrics in riding school horses	PLOS ONE			English	Article							BACK; BEHAVIOR; PAIN; RESPONSES; MANAGEMENT; MOVEMENTS; WALKING; SPORT; IMAGE; DOGS	Despite the fact that animal posture is known to reflect emotional state, the presence of chronic postures associated with poor welfare has not been investigated with an objective tool for measuring, quantifying and comparing postures. The use of morphometric geometrics )GM) to describe horse posture )profile of the dorsum) has shown to be an effective method of distinguishing populations that are known to differ in terms of welfare states. Here we investigated photographs of 85 riding school horses differing in terms of welfare state, in order to determine if a specific posture )modelled by GM) is associated with altered welfare. The welfare state was estimated with the prevalence of stereotypic or abnormal repetitive behaviours, depressed-like posture and the ear positions. ANOVA results show that horses with stereotypic or abnormal behaviour, and to a lesser degree horses with depressed-like postures, tend to have a flatter, or even hollow, dorsal profile, especially at the neck and croup levels. These altered profiles could represent an additional indicator of poor welfare, easy to use in the field or by owners.	[Seneque, Emilie; Lesimple, Clemence; Hausberger, Martine] Univ Caen Normandie, Univ Rennes, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie; Universite de Rennes	Lesimple, C (corresponding author), Univ Caen Normandie, Univ Rennes, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	lesimple.c@gmail.com	Morisset, Stéphane/B-9629-2019	Morisset, Stéphane/0000-0002-7747-113X; Seneque, Emilie/0000-0003-0574-2129; /0000-0003-0664-1151	University of Rennes 1; Centre National de la Recherche Scientifique (CNRS); Groupement d'Interet Scientifique "Cerveau -Comportement -Societe" (GIS CCS); Caisse Centrale de la Mutualite Agricole (MSA; Clemence Lesimple PhD grant)	University of Rennes 1; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Groupement d'Interet Scientifique "Cerveau -Comportement -Societe" (GIS CCS); Caisse Centrale de la Mutualite Agricole (MSA; Clemence Lesimple PhD grant)	This work was funded by the University of Rennes 1, the Centre National de la Recherche Scientifique (CNRS), the Groupement d'Interet Scientifique "Cerveau -Comportement -Societe" (GIS CCS) and the Caisse Centrale de la Mutualite Agricole (MSA; Clemence Lesimple PhD grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Bookstein F L, 1997, Med Image Anal, V1, P225; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Burn CC, 2010, APPL ANIM BEHAV SCI, V126, P109, DOI 10.1016/j.applanim.2010.06.007; Bussieres G, 2008, RES VET SCI, V85, P294, DOI 10.1016/j.rvsc.2007.10.011; Cauvin E, 1997, IN PRACTICE, V19, P522; Chabchoub A, 2004, REV MED VET-TOULOUSE, V155, P31; Cook WR, 2003, PFERDEHEILKUNDE, V19, P75, DOI 10.21836/PEM20030111; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Cooper JJ, 2005, LIVEST PROD SCI, V92, P177, DOI 10.1016/j.livprodsci.2004.11.017; Darwin C., 1872, EXPRESSION EMOTIONS, V526; DAVIES WG, 1978, ANIM BEHAV, V26, P381, DOI 10.1016/0003-3472(78)90056-8; Dyson S, 2003, EQUINE VET J, V35, P240, DOI 10.2746/042516403776148255; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2015, APPL ANIM BEHAV SCI, V162, P26, DOI 10.1016/j.applanim.2014.11.007; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Gleerup KB, 2015, APPL ANIM BEHAV SCI, V171, P25, DOI 10.1016/j.applanim.2015.08.023; Graubner C, 2011, VET J, V188, P178, DOI 10.1016/j.tvjl.2010.04.029; Gregoire J, 2013, ANIMAL, V7, P1163, DOI 10.1017/S1751731113000098; Greve L, 2014, EQUINE VET J, P687; Hausberger A, 2002, APPL ANIM BEHAV SCI, V76, P339, DOI 10.1016/S0168-1591(02)00016-3; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Head M. J., 2012, Veterinary Nursing Journal, V27, P288, DOI 10.1111/j.2045-0648.2012.00202.x; Henry S, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1429-1; Huzzey JM, 2005, J DAIRY SCI, V88, P2454, DOI 10.3168/jds.S0022-0302(05)72923-4; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; KILEYWORTHINGTON M, 1976, BEHAVIOUR, V56, P69, DOI 10.1163/156853976X00307; KOMERS PE, 1992, Z SAUGETIERKD, V57, P343; Krawczel PD, 2008, J DAIRY SCI, V91, P1903, DOI 10.3168/jds.2007-0520; Lepicard EM, 2003, PSYCHIAT RES, V118, P273, DOI 10.1016/S0165-1781(03)00069-6; Lesimple C, 2016, APPL ANIM BEHAV SCI, V181, P105, DOI 10.1016/j.applanim.2016.04.015; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00021; Lesimple C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-209; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Lesimple C, 2011, APPL ANIM BEHAV SCI, V129, P92, DOI 10.1016/j.applanim.2010.11.005; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Martin BB, 1999, VET CLIN N AM-EQUINE, V15, P61; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; McAfee LM, 2002, APPL ANIM BEHAV SCI, V78, P159, DOI 10.1016/S0168-1591(02)00086-2; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Mills DS, 2005, APPL ANIM BEHAV SCI, V91, P155, DOI 10.1016/j.applanim.2004.08.027; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moe RO, 2006, APPL ANIM BEHAV SCI, V101, P362, DOI 10.1016/j.applanim.2006.02.004; Molony V, 2002, APPL ANIM BEHAV SCI, V76, P215, DOI 10.1016/S0168-1591(02)00014-X; Murphy S, 2004, APPL ERGON, V35, P113, DOI 10.1016/j.apergo.2004.01.001; NICOL CJ, 2000, RECENT ADV COMPANION; Parker M, 2008, APPL ANIM BEHAV SCI, V114, P206, DOI 10.1016/j.applanim.2008.02.003; Paull DR, 2007, AUST VET J, V85, P98, DOI 10.1111/j.1751-0813.2007.00115.x; Pawluski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182257; Peham C, 2006, J BIOMECH, V39, P2845, DOI 10.1016/j.jbiomech.2005.09.019; Popescu S, 2013, J EQUINE VET SCI, V33, P1, DOI 10.1016/j.jevs.2012.04.001; Poursaberi A, 2010, COMPUT ELECTRON AGR, V74, P110, DOI 10.1016/j.compag.2010.07.004; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Ridgway K, 1999, VET CLIN N AM-EQUINE, V15, P263; Rochais C, 2016, BEHAV PROCESS, V124, P93, DOI 10.1016/j.beproc.2015.12.010; SAINSBURY P, 1954, J NEUROL NEUROSUR PS, V17, P216, DOI 10.1136/jnnp.17.3.216; Schilder MBH, 2004, APPL ANIM BEHAV SCI, V85, P319, DOI 10.1016/j.applanim.2003.10.004; Seneque E, PLOS ONE; STOKES ALLEN W., 1962, BEHAVIOUR, V19, P118, DOI 10.1163/156853961X00222; Tallet C, 2016, APPL ANIM BEHAV SCI, V174, P32, DOI 10.1016/j.applanim.2015.10.008; van der Sluijs JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123274; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Wallin L, 2000, LIVEST PROD SCI, V63, P275, DOI 10.1016/S0301-6226(99)00126-8; Waring GH, 2003, HORSE BEHAV NORWICH; Wennerstrand J, 2004, EQUINE VET J, V36, P707, DOI 10.2746/0425164044848226; WILSON RH, 1974, ANIM BEHAV, V22, P75, DOI 10.1016/S0003-3472(74)80055-2; Wolff A, 1997, BEHAV PROCESS, V40, P209, DOI 10.1016/S0376-6357(97)00784-5; Xin H, 1999, J ANIM SCI, V77, P1; Zimmerman M, 2012, EQUINE VET J, V44, P178, DOI 10.1111/j.2042-3306.2011.00373.x	82	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211852	10.1371/journal.pone.0211852	http://dx.doi.org/10.1371/journal.pone.0211852			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2MO	30721258	Green Published, Green Submitted, gold			2022-12-26	WOS:000457746300035
J	Dong, M; Zhou, XM; Ku, WZ; Xu, ZG				Dong Meng; Zhou Xiaomei; Ku Wenzhen; Xu, Zhenggang			Detecting useful genetic markers and reconstructing the phylogeny of an important medicinal resource plant, Artemisia selengensis, based on chloroplast genomics	PLOS ONE			English	Article							TRANSCRIPTION MAP; INVERTED REPEAT; SEQUENCE; DNA; EVOLUTION; NUCLEAR; DIVERSIFICATION; ORGANIZATION; ANNOTATION; INVERSIONS	Artemisia selengenesis is not only a health food, but also a well-known traditional Chinese medicine. Only a fraction of the chloroplast (cp) genome data of Artemisia has been reported and chloroplast genomic materials have been widely used in genomic evolution studies, molecular marker development, and phylogenetic analysis of the genus Artemisia, which makes evolutionary studies, genetic improvement, and phylogenetic identification very difficult. In this study, the complete chloroplast genome of A. selengensis was compared with that of other species within Artemisia and phylogenetic analyses was conducted with other genera in the Asteraceae family. The results showed that A. selengensis is an AT-rich species and has a typical quadripartite structure that is 151,215 bp in length. Comparative genome analyses demonstrated that the available chloroplast genomes of species of Artemisia were well conserved in terms of genomic length, GC contents, and gene organization and order. However, some differences, which may indicate evolutionary events, were found, such as a re-inversion event within the Artemisia genus, an unequal duplicate phenomenon of the ycf1 gene because of the expansion and contraction of the IR region, and the fast-evolving regions. Repeated sequences analysis showed that Artemisia chloroplast genomes presented a highly similar pattern of SSR or LDR distribution. A total of 257 SSRs and 42 LDRs were identified in the A. selengensis chloroplast genome. The phylogenetic analysis showed that A. selengensis was sister to A. gmelinii. The findings of this study will be valuable in further studies to understand the genetic diversity and evolutionary history of Asteraceae.	[Dong Meng; Zhou Xiaomei; Ku Wenzhen; Xu, Zhenggang] Hunan City Univ, Coll Mat & Chem Engn, Yiyang, Hunan, Peoples R China; [Dong Meng; Zhou Xiaomei; Xu, Zhenggang] Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China	Hunan City University; Central South University of Forestry & Technology	Xu, ZG (corresponding author), Hunan City Univ, Coll Mat & Chem Engn, Yiyang, Hunan, Peoples R China.; Xu, ZG (corresponding author), Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China.	rssq198677@163.com	Zhenggang, Xu/ABE-9095-2020	Zhenggang, Xu/0000-0002-7401-5163	Natural Science Foundation of Hunan Province [2016JJ4015]; Key Technology RAMP;D Program of Hunan Province [2016TP2007, 2016NK2148, 2016TP1014]	Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Key Technology RAMP;D Program of Hunan Province	This work was supported by the Natural Science Foundation of Hunan Province (2016JJ4015 to DM) and the Key Technology R&D Program of Hunan Province under Grant (2016TP2007, 2016NK2148, 2016TP1014 to DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2017, FASTQC QUALITY CONTR; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Curci PL, 2016, MOL ECOL RESOUR, V16, P562, DOI 10.1111/1755-0998.12457; Curci PL, 2015, MITOCHONDR DNA, P1, DOI [10.3109/19401736.2015.1013392, DOI 10.3109/19401736.2015.1013392]; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dhingra V, 1999, LIFE SCI, V66, P279, DOI 10.1016/S0024-3205(99)00356-2; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; Fu ZX, 2016, J SYST EVOL, V54, P416, DOI 10.1111/jse.12216; Haghighi AR, 2014, BIOLOGIA, V69, P834, DOI 10.2478/s11756-014-0379-3; Jansen, 2005, CHLOROPLAST GENOMES, DOI 10.1079/9780851999043.0045; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kanamoto H, 2004, PLANT CELL PHYSIOL, V45, pS39; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keller J, 2017, DNA RES, V24, P343, DOI 10.1093/dnares/dsx006; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koo Kyoung Ah, 1994, Archives of Pharmacal Research (Seoul), V17, P371, DOI 10.1007/BF02974179; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee JH, 2009, BIOL PHARM BULL, V32, P1912, DOI 10.1248/bpb.32.1912; Lee YS, 2016, MITOCHONDRIAL DNA B, V1, P410, DOI 10.1080/23802359.2016.1176880; Lee YS, 2016, MITOCHONDRIAL DNA B, V1, P376, DOI 10.1080/23802359.2016.1155426; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057533; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lu C, 2015, MITOCHONDR DNA, P1; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mahmood T, 2011, ARCH BIOL SCI, V63, P661, DOI 10.2298/ABS1103661M; Malagon F., 1997, Parassitologia (Rome), V39, P3; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Newton P, 1999, ANNU REV MED, V50, P179, DOI 10.1146/annurev.med.50.1.179; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; PALMER JD, 1988, CURR GENET, V14, P65, DOI 10.1007/BF00405856; PALMER JD, 1987, P NATL ACAD SCI USA, V84, P769, DOI 10.1073/pnas.84.3.769; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; Panero JL, 2002, P BIOL SOC WASH, V115, P909; Panero JL, 2014, MOL PHYLOGENET EVOL, V80, P43, DOI 10.1016/j.ympev.2014.07.012; Pellicer J, 2011, TAXON, V60, P691, DOI 10.1002/tax.603006; Peng J, 2018, MITOCHONDRIAL DNA B, V3, P909, DOI 10.1080/23802359.2018.1501322; Saina JK, 2018, GENETICA, V146, P101, DOI 10.1007/s10709-017-0003-x; Salih RHM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168008; Shen XF, 2017, MOLECULES, V22, DOI 10.3390/molecules22081330; Shi F, 2010, MOLECULES, V15, P4934, DOI 10.3390/molecules15074934; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tu YY, 2016, ANGEW CHEM INT EDIT, V55, P10210, DOI 10.1002/anie.201601967; Turuspekov Yerlan, 2018, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V72, P29, DOI 10.1515/prolas-2017-0068; Vargas OM, 2017, NEW PHYTOL, V214, P1736, DOI 10.1111/nph.14530; Walker JF, 2015, AM J BOT, V102, P1751, DOI 10.3732/ajb.1500299; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Won SY, 2018, MITOCHONDRIAL DNA B, V3, P549, DOI 10.1080/23802359.2018.1468225; WOODBURY NW, 1988, CURR GENET, V14, P75, DOI 10.1007/BF00405857; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Yang G, 2017, PLANT BIOLOGY, V19, P268, DOI 10.1111/plb.12524; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoon HS, 2006, J APPL PHYCOL, V18, P475, DOI 10.1007/s10811-006-9054-6; Zhang W, 2017, MITOCHONDRIAL DNA B, V2, P843, DOI 10.1080/23802359.2017.1407687; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	65	18	18	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211340	10.1371/journal.pone.0211340	http://dx.doi.org/10.1371/journal.pone.0211340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716116	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200019
J	Humphrey, JM; Al-Absi, ES; Hamdan, MM; Okasha, SS; Al-Trmanini, DM; El-Dous, HG; Dargham, SR; Schieffelin, J; Abu-Raddad, LJ; Nasrallah, GK				Humphrey, John M.; Al-Absi, Enas S.; Hamdan, Munia M.; Okasha, Sara S.; Al-Trmanini, Diyna M.; El-Dous, Hend G.; Dargham, Soha R.; Schieffelin, John; Abu-Raddad, Laith J.; Nasrallah, Gheyath K.			Dengue and chikungunya seroprevalence among Qatari nationals and immigrants residing in Qatar	PLOS ONE			English	Article							BLOOD-DONORS; VIRUS-INFECTION; MIDDLE-EAST; AEDES-ALBOPICTUS; SOUTH KORDOFAN; YELLOW-FEVER; AL-HUDAYDAH; OUTBREAK; YEMEN; ARBOVIRUSES	The objective of this study is to characterize the seroprevalence of anti-dengue (DENV) and anti-chikungunya (CHIKV) antibodies among blood donors residing in Qatar who are Middle East and North Africa (MENA) nationals and non-nationals. Sera were collected from adult blood donors in Qatar from 2013 to 2016 and tested for anti-DENV and anti-CHIKV IgG using commercial microplate enzyme-linked immunosorbent assays. Age-specific seroprevalence was summarized by region/nationality: Asia (India, Philippines), Middle East (Iran, Jordan, Lebanon, Pakistan, Palestine, Syria, Yemen), North Africa (Egypt, Sudan), Qatar. The adjusted odds of anti-DENV and anti-CHIKV IgG seropositivity was estimated by logistic regression. Among 1,992 serum samples tested, Asian nationals had higher adjusted odds of being seropositive for anti-DENV antibodies compared to nationals of the Middle East (aOR 0.05, 95% CI 0.04-0.07), North Africa (aOR 0.14, 95% CI 0.10-0.20), and Qatar (aOR 0.01, 95% CI 0.01-0.03). Asian nationals also had higher adjusted odds of being seropositive for anti-CHIKV antibodies compared to those from the Middle East (aOR 0.14, 95% CI 0.07-0.27), North Africa (aOR 0.50, 95% CI 0.26-0.96), and Qatar (aOR 0.38, 95% CI 0.15-0.96). The adjusted odds of being anti-DENV seropositive was higher among anti-CHIKV seropositive adults, and vice versa (aOR 1.94, 95% CI 1.09-3.44), suggesting co-circulation of these viruses. DENV and CHIKV exposure is lower in Qatar and MENA nationals compared to Asian nationals suggesting a lower burden of DENV and CHIKV disease in the MENA. Antibodies to both viruses were detected in nationals from most MENA countries, supporting the need to better understand the regional epidemiology of these viruses.	[Humphrey, John M.] Indiana Univ, Dept Med, Div Infect Dis, Indianapolis, IN USA; [Al-Absi, Enas S.; Hamdan, Munia M.; Okasha, Sara S.; Al-Trmanini, Diyna M.; El-Dous, Hend G.; Nasrallah, Gheyath K.] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar; [Al-Absi, Enas S.; Hamdan, Munia M.; Okasha, Sara S.; Al-Trmanini, Diyna M.; El-Dous, Hend G.; Nasrallah, Gheyath K.] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Dargham, Soha R.; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Weill Cornell Med Qatar, Doha, Qatar; [Schieffelin, John] Tulane Univ, Sch Med, Dept Pediat, Infect Dis Sect, New Orleans, LA 70112 USA; [Abu-Raddad, Laith J.] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med, New York, NY 10021 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Qatar University; Qatar University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Tulane University; Cornell University	Humphrey, JM (corresponding author), Indiana Univ, Dept Med, Div Infect Dis, Indianapolis, IN USA.; Nasrallah, GK (corresponding author), Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar.; Nasrallah, GK (corresponding author), Qatar Univ, Biomed Res Ctr, Doha, Qatar.	humphrjm@iu.edu; gheyath.nasrallah@qu.edu.qa	Nasrallah, Gheyath K/H-7949-2019; Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Hamdan, Munia/0000-0002-2629-9448; Humphrey, john/0000-0003-3156-1065; Dargham, Soha/0000-0003-2695-6564; Nasrallah, Gheyath/0000-0001-9252-1038	Qatar University [QUST-1-CHS-2018-3/4]; Qatar National Research Fund [UREP19-013-3-001]	Qatar University(Qatar National Research Fund (QNRF)); Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported by Qatar University student grants [QUST-1-CHS-2018-3/4, received by ESA, MMH, SSO, DMA, HGE] and the Qatar National Research Fund [UREP19-013-3-001, received by LJA and GKN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozeid S, 2018, LANCET INFECT DIS, V18, P142, DOI 10.1016/S1473-3099(18)30018-5; Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; AbuOdeh R, 2015, J MED VIROL, V87, P1184, DOI 10.1002/jmv.24146; AbuOdeh RO, 2015, J MED VIROL, V87, P2074, DOI 10.1002/jmv.24289; Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153; Adawi SHAA, 2012, INT J TROPICAL DIS H, V2, P301, DOI [10.9734/IJTDH/2012/2660, DOI 10.9734/IJTDH/2012/2660]; Aghaie A, 2014, TRANSFUS APHER SCI, V50, P59, DOI 10.1016/j.transci.2013.07.034; Al-Qahtani AA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0664-6; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; Ashshi AM, 2015, BLOOD TRANSFUS-ITALY, V13, P135, DOI 10.2450/2014.0134-14; Assir MZK, 2014, INT J INFECT DIS, V18, P41, DOI 10.1016/j.ijid.2013.09.007; Aziz AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-258; Barakat AM, 2016, AM J TROP MED HYG, V94, P794, DOI 10.4269/ajtmh.15-0622; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bin Ghouth AS, 2012, AM J TROP MED HYG, V86, P1072, DOI 10.4269/ajtmh.2012.11-0723; Bravo L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003027; Busch MP, 2016, J INFECT DIS, V214, P49, DOI 10.1093/infdis/jiw122; Chinikar S, 2013, TRAVEL MED INFECT DI, V11, P166, DOI 10.1016/j.tmaid.2012.10.001; Dargham SR, 2018, SEX TRANSM DIS, V45, P482, DOI [10.1097/OLQ.0000000000000791, 10.1097/olq.0000000000000791]; DARWISH MA, 1975, AM J TROP MED HYG, V24, P981, DOI 10.4269/ajtmh.1975.24.981; DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2; De Bel-Air F., 2014, DEMOGRAPHY MIGRATION; Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0; Ergunay K, 2010, MIKROBIYOL BUL, V44, P415; Euroimmun, 2016, ANT VIR ELISA IGG; Euroimmun, 2017, ELISA; Forshey BM, 2016, J INFECT DIS, V214, P979, DOI 10.1093/infdis/jiw102; Garabedian G A, 1971, J Med Liban, V24, P339; Gould LH, 2008, T ROY SOC TROP MED H, V102, P1247, DOI 10.1016/j.trstmh.2008.04.014; Haddad N, 2007, J AM MOSQUITO CONTR, V23, P226, DOI 10.2987/8756-971X(2007)23[226:POAAIL]2.0.CO;2; Harfouche M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187177; Hatem J, 1972, J Med Liban, V25, P151; Himatt S, 2015, J INFECT PUBLIC HLTH; Hisam A, 2014, J PAK MED ASSOC, V64, P247; Humphrey JM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005707; Humphrey JM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005194; Ibrahim S H, 1974, J Egypt Public Health Assoc, V49, P77; Ibrahim S H, 1973, J Egypt Public Health Assoc, V48, P308; Ibrahim SA, 2002, TROP MED INT HEALTH, V7, P442, DOI 10.1046/j.1365-3156.2002.00884.x; Ijaz T, 2014, INT J INFECT DIS, V21, P136, DOI 10.1016/j.ijid.2014.03.708; Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505; Kidwai AA, 2010, J PAK MED ASSOC, V60, P936; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Madani TA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-136; Mahmud S, 2018, J MED VIROL, V90, P131, DOI 10.1002/jmv.24921; Malik Amal, 2011, J Infect Public Health, V4, P1, DOI 10.1016/j.jiph.2010.08.001; Malik MR, 2014, J EPIDEMIOL GLOB HEA, V4, P203, DOI 10.1016/j.jegh.2014.01.004; MOHAMMED YS, 1970, J HYG-CAMB, V68, P491, DOI 10.1017/S002217240004239X; Mumtaz GR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001663; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Nasrallah GK, 2018, J MED VIROL, V90, P184, DOI 10.1002/jmv.24916; Nasrallah GK, 2017, TRANSFUSION, V57, P1801, DOI 10.1111/trf.14116; NovaTec Immunodiagnostica GmbH, 2018, DENG VIR IGG; Obaidat MM, 2018, T ROY SOC TROP MED H, V112, P279, DOI 10.1093/trstmh/try055; Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269; ProMED-mail, 2015, PROMED MAIL     1025; Qassem MAM, 2014, INT J INFECT DIS, V21, P457, DOI 10.1016/j.ijid.2014.03.1364; Qatar Ministry of Development Planning and Statistics. Qatar's Fourth National Human Development Report, 2015, QAT 4 NAT HUM DEV RE; Ranjan P, 2016, J CLIN DIAGN RES, V10, pDC8, DOI 10.7860/JCDR/2016/21262.8711; Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615; Saidi S., 1971, PAHLAVI MED J, V2, P485; SALIM AR, 1973, T ROY SOC TROP MED H, V67, P206, DOI 10.1016/0035-9203(73)90145-4; Soghaier MA, 2014, J INFECT PUBLIC HEAL, V7, P54, DOI 10.1016/j.jiph.2013.07.008; Tezcan S, 2014, MIKROBIYOL BUL, V48, P606, DOI 10.5578/mb.8301; The World Bank Group, 2018, CLIM CHANG KNOWL POR; Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337; Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; WOODRUFF PWR, 1988, T ROY SOC TROP MED H, V82, P761, DOI 10.1016/0035-9203(88)90229-5; World Health Organization, DENG FEV EGYPT2015; World Health Organization Regional Office for the Eastern Mediterranean, 2016, WKLY EPI MONITOR, V9; World Health Organization Regional Office for the Eastern Mediterranean, 2013, WKLY EPI MONITOR, V6; World Health Organization Regional Office for the Eastern Mediterranean, 2010, DENG FEV YEM, V3; World Health Organization Regional Office for the Eastern Mediterranean, 2010, DENG FEV SUD CAS CON, V3; World Health Organization Regional Office for the Eastern Mediterranean, 2017, WKLY EPI MONITOR, V10	75	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211574	10.1371/journal.pone.0211574	http://dx.doi.org/10.1371/journal.pone.0211574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703150	Green Published, gold			2022-12-26	WOS:000457301600059
J	Suzuki, Y; Suzuki, T; Awai, K; Shioi, Y				Suzuki, Yuya; Suzuki, Tomohiro; Awai, Koichiro; Shioi, Yuzo			Isolation and characterization of a tandem-repeated cysteine protease from the symbiotic dinoflagellate Symbiodinium sp. KB8	PLOS ONE			English	Article							CELL-DEATH	A cysteine protease belonging to peptidase C1A superfamily from the eukaryotic, symbiotic dinoflagellate, Symbiodinium sp. strain KB8, was characterized. The protease was purified to near homogeneity (566-fold) by (NH4)(2)SO4 fractionation, ultrafiltration, and column chromatography using a fluorescent peptide, butyloxycarbonyl-Val-Leu-Lys-4-methylcoumaryl-7-amide (Boc-VLK-MCA), as a substrate for assay purposes. The enzyme was termed VLKP (VLK protease), and its activity was strongly inhibited by cysteine protease inhibitors and activated by reducing agents. Based on the results for the amino acid sequence determined by liquid chromatography-coupled tandem mass spectrometry, a cDNA encoding VLKP was synthesized. VLKP was classified into the peptidase C1A superfamily of cysteine proteases (C1AP). The predicted amino acid sequence of VLKP indicated a tandem array of highly conserved precursors of C1AP with a molecular mass of approximately 71 kDa. The results of gel-filtration chromatography and SDS-PAGE suggested that VLKP exists as a monomer of 31-32 kDa, indicating that the tandem array is likely divided into two mass-equivalent halves that undergo equivalent posttranslational modifications. The VLKP precursor contains an inhibitor prodomain that might become activated after acidic autoprocessing at approximately pH 4. Both purified and recombinant VLKPs had a similar substrate specificity and kinetic parameters for common C1AP substrates. Most C1APs reside in acidic organelles such as the vacuole and lysosomes, and indeed VLKP was most active at pH 4.5. Since VLKP exhibited maximum activity during the late logarithmic growth phase, these attributes suggest that, VLKP is involved in the metabolism of proteins in acidic organelles.	[Suzuki, Yuya; Awai, Koichiro; Shioi, Yuzo] Shizuoka Univ, Grad Sch Sci, Shizuoka, Japan; [Suzuki, Tomohiro] Shizuoka Univ, Res Inst Green Sci & Technol, Shizuoka, Japan; [Awai, Koichiro] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka, Japan; [Awai, Koichiro] JST, PRESTO, Kawaguchi, Saitama, Japan; [Suzuki, Tomohiro] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan	Shizuoka University; Shizuoka University; Shizuoka University; Japan Science & Technology Agency (JST); Utsunomiya University	Awai, K (corresponding author), Shizuoka Univ, Grad Sch Sci, Shizuoka, Japan.; Awai, K (corresponding author), Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka, Japan.; Awai, K (corresponding author), JST, PRESTO, Kawaguchi, Saitama, Japan.	awai.koichiro@shizuoka.ac.jp	; Awai, Koichiro/B-5119-2010	Suzuki, Tomohiro/0000-0002-2444-5288; Awai, Koichiro/0000-0002-1731-7499	Precursory Research for Embryonic Science and Technology program of the Japanese Science and Technology Agency	Precursory Research for Embryonic Science and Technology program of the Japanese Science and Technology Agency	This work was supported in part by the Precursory Research for Embryonic Science and Technology program of the Japanese Science and Technology Agency to KA, and there was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Cizelj I, 2011, MICROBIOL-SGM, V157, P362, DOI 10.1099/mic.0.045641-0; Diaz-Mendoza M, 2014, J EXP BOT, V65, P3825, DOI 10.1093/jxb/eru043; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Groeme R, 2016, J BIOL CHEM, V291, P13076, DOI 10.1074/jbc.M115.702001; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jinka R, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-28; Karim W, 2015, J MAR SCI ENG, V3, P368, DOI 10.3390/jmse3020368; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; Ogata M, 2010, CARBOHYD RES, V345, P2623, DOI 10.1016/j.carres.2010.10.015; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Shin SP, 2014, PARASITOL INT, V63, P359, DOI 10.1016/j.parint.2013.12.007; Shinzato C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085182; Tajima T, 2011, PHYSIOL PLANTARUM, V141, P97, DOI 10.1111/j.1399-3054.2010.01425.x; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Usui M, 2007, PHYSIOL PLANTARUM, V131, P519, DOI 10.1111/j.1399-3054.2007.00981.x; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Vardi A, 1999, CURR BIOL, V9, P1061, DOI 10.1016/S0960-9822(99)80459-X; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Watanabe Y, 2009, PLANT SCI, V176, P264, DOI 10.1016/j.plantsci.2008.11.002; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211534	10.1371/journal.pone.0211534	http://dx.doi.org/10.1371/journal.pone.0211534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703144	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600054
J	Singh, T; Iijima, M; Yasumoto, K; Sakai, K				Singh, Tanya; Iijima, Mariko; Yasumoto, Ko; Sakai, Kazuhiko			Effects of moderate thermal anomalies on Acropora corals around Sesoko Island, Okinawa	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MASS-TRANSFER; SCLERACTINIAN CORALS; PARTIAL MORTALITY; STRESS; TEMPERATURE; MOOREA; IMPACT; CONSERVATION; CONSEQUENCES	Over the past several decades, coral reef ecosystems have experienced recurring bleaching events. These events were predominantly caused by thermal anomalies, which vary widely in terms of severity and spatio-temporal distribution. Acropora corals, highly prominent contributors to the structural complexity of Pacific coral reefs, are sensitive to thermal stress. Response of Acropora corals to extremely high temperature has been well documented. However, studies on the effects of moderately high temperature on Acropora corals are limited. In the summer of 2016, a moderate coral bleaching event due to moderately high temperature was observed around Sesoko Island, Okinawa, Japan. The objective of this study was to examine thermal tolerance patterns of Acropora corals, across reefs with low to moderate thermal exposure (degree heating weeks similar to 2-5 degrees C week). Field surveys on permanent plots were conducted from October 2015 to April 2017 to compare the population dynamics of adult Acropora corals 6 months before and after the bleaching events around Sesoko Island. Variability in thermal stress response was driven primarily by the degree of thermal stress. Wave action and turbidity may have mediated the thermal stress. Tabular and digitate coral morphologies were the most tolerant and susceptible to thermal stress, respectively. Growth inhibition after bleaching was more pronounced in the larger digitate and corymbose coral morphologies. This study indicates that Acropora populations around Sesoko Island can tolerate short-term, moderate thermal challenges.	[Singh, Tanya] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa, Japan; [Iijima, Mariko; Yasumoto, Ko] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa, Japan; [Sakai, Kazuhiko] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa, Japan	University of the Ryukyus; Kitasato University; University of the Ryukyus	Singh, T (corresponding author), Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa, Japan.	tsingh138@gmail.com	Iijima, Mariko/AAH-8548-2019	Iijima, Mariko/0000-0002-5491-9309; Sakai, Kazuhiko/0000-0003-1905-5952; Singh, Tanya/0000-0001-8104-0597	JSPS KAKENHI [15H04326]; University of the Ryukyus President's Research Award for Leading Scientists	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); University of the Ryukyus President's Research Award for Leading Scientists	This study was partly supported by JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/index.html; grant number 15H04326), and University of the Ryukyus President's Research Award for Leading Scientists. (http://www.res.lab.u-ryukyu.ac.jp/project_list.html; no specific grant number) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bena C, 2004, B MAR SCI, V75, P115; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Edmunds PJ, 2016, J EXP BIOL, V219, P3896, DOI 10.1242/jeb.146381; Eriksson Hampus, 2012, Western Indian Ocean Journal of Marine Science, V11, P113; Fox J., 2019, R COMPANION APPL REG, V.; Gates RD, 1999, AM ZOOL, V39, P30; GLEASON MG, 1993, CORAL REEFS, V12, P193, DOI 10.1007/BF00334479; GLYNN PW, 1983, ENVIRON CONSERV, V10, P149, DOI 10.1017/S0376892900012248; GLYNN PW, 1985, DIS AQUAT ORGAN, V1, P29, DOI 10.3354/dao001029; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Harborne AR, 2017, ANNU REV MAR SCI, V9, P445, DOI 10.1146/annurev-marine-010816-060551; HARRIOTT VJ, 1995, MAR ECOL PROG SER, V123, P155, DOI 10.3354/meps123155; HAYES RL, 1990, CORAL REEFS, V8, P203, DOI 10.1007/BF00265012; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hoogenboom MO, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00376; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hughes TP, 2018, NATURE, V556, P492, DOI 10.1038/s41586-018-0041-2; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Hutchings Pat, 2013, Pacific Conservation Biology, V19, P409; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kayanne Hajime, 2017, Galaxea - Tokyo, V19, P17; Kennedy EV, 2018, MAR FRESHWATER RES, V69, P191, DOI 10.1071/MF16317; Kitada Y, 2008, CHEMOSPHERE, V71, P2082, DOI 10.1016/j.chemosphere.2008.01.025; Kumagai NH, 2018, PEERJ, V6, DOI 10.7717/peerj.4382; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenihan HS, 2008, MAR ECOL PROG SER, V370, P127, DOI 10.3354/meps07622; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Liu G, 2006, P 10 INT COR REEF S; Liu G., 2003, EOS T AM GEOPHYS UN, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001, DOI 10.1029/2003EO150001]; Liu G, 2013, 143 NESDIS NOAA, P41; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2016, TRENDS ECOL EVOL, V31, P419, DOI 10.1016/j.tree.2016.02.012; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mazerolle M.J., 2017, R PACKAGE VERS, V2, P1, DOI DOI 10.1515/pacres-2017-0001; MEESTERS EH, 1993, MAR ECOL PROG SER, V96, P189, DOI 10.3354/meps096189; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Mizerek TL, 2018, CORAL REEFS, V37, P791, DOI 10.1007/s00338-018-1702-1; Morgan KM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00224; Muko S, 2013, CORAL REEFS, V32, P269, DOI 10.1007/s00338-012-0967-z; Nakamura T, 2003, MAR ECOL PROG SER, V256, P287, DOI 10.3354/meps256287; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; NOAA Coral Reef Watch, 2000, NOAA COR REEF WATCH; Omori M, 2001, LIMNOL OCEANOGR, V46, P704, DOI 10.4319/lo.2001.46.3.0704; PATTERSON MR, 1992, SCIENCE, V255, P1421, DOI 10.1126/science.255.5050.1421; Penin L, 2007, CR BIOL, V330, P171, DOI 10.1016/j.crvi.2006.12.003; Penin L, 2013, ENVIRON MONIT ASSESS, V185, P5031, DOI 10.1007/s10661-012-2923-3; Pinheiro J., 2021, CRAN, V3, P1; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1134, DOI 10.4319/lo.2006.51.2.1134; Roth L, 2010, MAR ECOL PROG SER, V411, P73, DOI 10.3354/meps08640; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shenkar N, 2005, MAR ECOL PROG SER, V294, P181, DOI 10.3354/meps294181; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Smith TB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00107.1; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; Suzuki G, 2016, CORAL REEFS, V35, P1419, DOI 10.1007/s00338-016-1484-2; Terashima H, 2002, GALAXEA, V4, P43, DOI DOI 10.3755/JCRS.2002.43; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; van Woesik R, 2012, CORAL REEFS, V31, P633, DOI 10.1007/s00338-012-0911-2; Vega-Rodriguez M, 2015, MAR ECOL PROG SER, V528, P173, DOI 10.3354/meps11268; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Ward S, 2000, P 9 INT COR REEF S, V2, P1123; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wellington G.M., 2001, EOS T AM GEOPHYS UN, V82, P1, DOI [10.1038/srep08402, DOI 10.1038/SREP08402]; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; West K, 2001, MAR POLLUT BULL, V42, P864, DOI 10.1016/S0025-326X(01)00040-6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winter A, 1998, CORAL REEFS, V17, P377, DOI 10.1007/s003380050143; Zuur A. F., 2013, BEGINNERS GUIDE GLM; Zuur Alain F., 2009, P1	84	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210795	10.1371/journal.pone.0210795	http://dx.doi.org/10.1371/journal.pone.0210795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699163	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600056
J	Zybailov, BL; Glazko, GV; Rahmatallah, Y; Andreyev, DS; McElroy, T; Karaduta, O; Byrum, SD; Orr, L; Tackett, AJ; Mackintosh, SG; Edmondson, RD; Kieffer, DA; Martin, RJ; Adams, SH; Vaziri, ND; Arthur, JM				Zybailov, Boris L.; Glazko, Galina V.; Rahmatallah, Yasir; Andreyev, Dmitri S.; McElroy, Taylor; Karaduta, Oleg; Byrum, Stephanie D.; Orr, Lisa; Tackett, Alan J.; Mackintosh, Samuel G.; Edmondson, Ricky D.; Kieffer, Dorothy A.; Martin, R. J.; Adams, Sean H.; Vaziri, Nosratola D.; Arthur, John M.			Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; INTESTINAL MICROBIOTA; GUT; QUANTIFICATION; VISUALIZATION; EXPRESSION; BUTYRATE; HOST	Background Resistant starch is a prebiotic metabolized by the gut bacteria. It has been shown to attenuate chronic kidney disease (CKD) progression in rats. Previous studies employed taxonomic analysis using 16S rRNA sequencing and untargeted metabolomics profiling. Here we expand these studies by metaproteomics, gaining new insight into the host-microbiome interaction. Methods Differences between cecum contents in CKD rats fed a diet containing resistant starch with those fed a diet containing digestible starch were examined by comparative metaproteomics analysis. Taxonomic information was obtained using unique protein sequences. Our methodology results in quantitative data covering both host and bacterial proteins. Results 5,834 proteins were quantified, with 947 proteins originating from the host organism. Taxonomic information derived from metaproteomics data surpassed previous 16S RNA analysis, and reached species resolutions for moderately abundant taxonomic groups. In particular, the Ruminococcaceae family becomes well resolved-with butyrate producers and amylolytic species such as R. bromii clearly visible and significantly higher while fibrolytic species such as R. flavefaciens are significantly lower with resistant starch feeding. The observed changes in protein patterns are consistent with fiber-associated improvement in CKD phenotype. Several known host CKD-associated proteins and biomarkers of impaired kidney function were significantly reduced with resistant starch supplementation. Data are available via ProteomeXchange with identifier PXD008845. Conclusions Metaproteomics analysis of cecum contents of CKD rats with and without resistant starch supplementation reveals changes within gut microbiota at unprecedented resolution, providing both functional and taxonomic information. Proteins and organisms differentially abundant with RS supplementation point toward a shift from mucin degraders to butyrate producers.	[Zybailov, Boris L.; Andreyev, Dmitri S.; McElroy, Taylor; Karaduta, Oleg; Byrum, Stephanie D.; Orr, Lisa; Tackett, Alan J.; Mackintosh, Samuel G.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Glazko, Galina V.; Rahmatallah, Yasir] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Tackett, Alan J.; Mackintosh, Samuel G.; Edmondson, Ricky D.] Univ Arkansas Med Sci, Prote Core Facil, Little Rock, AR 72205 USA; [Kieffer, Dorothy A.; Martin, R. J.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Adams, Sean H.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Vaziri, Nosratola D.] Univ Calif Irvine, Div Nephrol, Irvine, CA USA; [Arthur, John M.] Univ Arkansas Med Sci, Div Nephrol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Davis; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Irvine; University of Arkansas System; University of Arkansas Medical Sciences	Zybailov, BL (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.; Arthur, JM (corresponding author), Univ Arkansas Med Sci, Div Nephrol, Little Rock, AR 72205 USA.	blzybaylov@uams.edu; JMArthur@uams.edu	; ADAMS, SEAN/N-9262-2018	Arthur, John/0000-0003-4342-4762; Mcelroy, Taylor/0000-0002-4924-9283; ADAMS, SEAN/0000-0002-9515-2319; Rahmatallah, Yasir/0000-0002-8176-6328; Zybailov, Boris/0000-0003-2432-9145	Center for Translational Pediatric Research (CPTR) NIH Center of Biomedical Research Excellence [P20GM121293, R01 DK101034]; T32 training award - National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000002, TL1 TR000133]; Danish Council for Strategic Research Project [10-093526]; USDA-ARS Projects [2032-51530-022-00D, 6026-51000-010-05S]; NIH IDeA Networks of Biomedical Research Excellence (INBRE) grant [P20 GM103429]; Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121293, P20GM103429] Funding Source: NIH RePORTER	Center for Translational Pediatric Research (CPTR) NIH Center of Biomedical Research Excellence; T32 training award - National Center for Advancing Translational Sciences, National Institutes of Health; Danish Council for Strategic Research Project; USDA-ARS Projects; NIH IDeA Networks of Biomedical Research Excellence (INBRE) grant; Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was supported by Center for Translational Pediatric Research (CPTR) NIH Center of Biomedical Research Excellence award P20GM121293 (to Alan Tackett) and R01 DK101034 (to John Arthur). It was also supported in part by a T32 training award (to D. A. Kieffer) funded by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR000002 and linked award TL1 TR000133. Additional funding was provided by the Danish Council for Strategic Research Project 10-093526, USDA-ARS Projects 2032-51530-022-00D and 6026-51000-010-05S, the NIH IDeA Networks of Biomedical Research Excellence (INBRE) grant P20 GM103429 (to Lawrence Cornett) and in part by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000.	Arvaniti E, 2016, BBA-MOL BASIS DIS, V1862, P1774, DOI 10.1016/j.bbadis.2016.06.013; Arvaniti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26235; Avraham R, 2016, NAT PROTOC, V11, P1477, DOI 10.1038/nprot.2016.090; Bhensdadia NM, 2013, KIDNEY INT, V83, P1136, DOI 10.1038/ki.2013.57; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Esnaola M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-254; Fedorova LV, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-209; Fernandes M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40367; Fritz KS, 2013, FREE RADICAL BIO MED, V59, P85, DOI 10.1016/j.freeradbiomed.2012.06.025; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Herrmann E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01331; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jacobasch G, 1999, INT J COLORECTAL DIS, V14, P201, DOI 10.1007/s003840050212; Khosroshahi HT, 2018, HEMODIAL INT, V22, P492, DOI 10.1111/hdi.12653; Kieffer DA, 2016, AM J PHYSIOL-RENAL, V310, pF857, DOI 10.1152/ajprenal.00513.2015; Kleessen B, 1997, J ANIM SCI, V75, P2453; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luczak M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-25; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Mesuere B, 2015, PROTEOMICS, V15, P1437, DOI 10.1002/pmic.201400361; Mesuere B, 2012, J PROTEOME RES, V11, P5773, DOI 10.1021/pr300576s; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Ravcheev DA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00111; Reznichenko A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036512; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shiraishi T, 2014, AM J PHYSIOL-RENAL, V307, pF1313, DOI 10.1152/ajprenal.00521.2014; Spurney RF, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00181; Su M, 2013, AM J PHYSIOL-RENAL, V305, pF520, DOI 10.1152/ajprenal.00570.2012; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Toden S, 2007, CARCINOGENESIS, V28, P2355, DOI 10.1093/carcin/bgm216; Toden S, 2007, CANCER BIOL THER, V6, P253, DOI 10.4161/cbt.6.2.3627; Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5; Vanhoutvin SALW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006759; Vaziri ND, 2016, NEPHROL DIAL TRANSPL, V31, P737, DOI 10.1093/ndt/gfv095; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Y, 2016, BIOINFORMATICS, V32, P3469, DOI 10.1093/bioinformatics/btw507; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Xie JX, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00097; Xu F, 2009, DIABETES, V58, pA3, DOI 10.2337/db08-1637; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Young W, 2012, APPL ENVIRON MICROB, V78, P6656, DOI 10.1128/AEM.01536-12; Ze XL, 2015, MBIO, V6, DOI 10.1128/mBio.01058-15; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	61	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0199274	10.1371/journal.pone.0199274	http://dx.doi.org/10.1371/journal.pone.0199274			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699108	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600001
J	Horstman, AMH; Backx, EMP; Smeets, JSJ; Marzuca-Nassr, GN; van Kranenburg, J; de Boer, D; Dolmans, J; Snijders, T; Verdijk, LB; de Groot, LCPGM; van Loon, LJC				Horstman, Astrid M. H.; Backx, Evelien M. P.; Smeets, Joey S. J.; Marzuca-Nassr, Gabriel N.; van Kranenburg, Janneau; de Boer, Douwe; Dolmans, John; Snijders, Tim; Verdijk, Lex B.; de Groot, Lisette C. P. G. M.; van Loon, Luc J. C.			Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SKELETAL-MUSCLE; ANABOLIC-STEROIDS; LEG IMMOBILIZATION; OLDER-ADULTS; BED-REST; MASS; STRENGTH; HEALTHY; 19-NORTESTOSTERONE	Background A few days of bed rest or immobilization following injury, disease, or surgery can lead to considerable loss of skeletal muscle mass and strength. It has been speculated that such short, successive periods of muscle disuse may be largely responsible for the age-related loss of muscle mass throughout the lifespan. Objective To assess whether a single intramuscular injection of nandrolone decanoate prior to immobilization can attenuate the loss of muscle mass and strength in vivo in humans. Design, setting and participants Thirty healthy (22 +/- 1 years) men were subjected to 7 days of one-legged knee immobilization by means of a full leg cast with (NAD, n = 15) or without (CON, n = 15) prior intramuscular nandrolone decanoate injection (200 mg). Measures Before and immediately after immobilization, quadriceps muscle cross-sectional area (CSA) (by means of single-slice computed tomography (CT) scans of the upper leg) and one-legged knee extension strength (one-repetition maximum [1-RM]) were assessed for both legs. Furthermore, muscle biopsies from the immobilized leg were taken before and after immobilization to assess type I and type II muscle fiber cross-sectional area. Results Quadriceps muscle CSA decreased during immobilization in both CON and NAD (-6 +/- 1% and -6 +/- 1%, respectively; main effect of time P< 0.01), with no differences between the groups (time x treatment interaction, P = 0.59). Leg muscle strength declined following immobilization (-6 +/- 2% in CON and -7 +/- 3% in NAD; main effect of time, P< 0.05), with no differences between groups (time x treatment interaction, P = 0.55). Conclusions This is the first study to report that nandrolone decanoate administration does not preserve skeletal muscle mass and strength during a short period of leg immobilization in vivo in humans.	[Horstman, Astrid M. H.; Backx, Evelien M. P.; Smeets, Joey S. J.; Marzuca-Nassr, Gabriel N.; van Kranenburg, Janneau; Snijders, Tim; Verdijk, Lex B.; van Loon, Luc J. C.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Med Ctr, Maastricht, Netherlands; [Backx, Evelien M. P.; de Groot, Lisette C. P. G. M.] Wageningen Univ, Dept Human Nutr, Wageningen, Netherlands; [de Boer, Douwe] Maastricht Univ, Dept Clin Chem, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands; [Dolmans, John] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Wageningen University & Research; Maastricht University; Maastricht University	van Loon, LJC (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Med Ctr, Maastricht, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; Verdijk, Lex B/H-4468-2016; Marzuca-Nassr, Gabriel/S-5901-2019; van Loon, Luc J C/G-5920-2010	van Loon, Luc J.C./0000-0002-6768-9231; Verdijk, Lex B/0000-0002-9196-8767; van Loon, Luc J C/0000-0002-6768-9231; Smeets, Joey/0000-0003-2877-0114; de Groot, Lisette/0000-0003-2778-2789				Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Backx EMP, 2017, SPORTS MED, V47, P1661, DOI 10.1007/s40279-016-0670-2; Bagchus WM, 2005, J CLIN ENDOCR METAB, V90, P2624, DOI 10.1210/jc.2004-1526; Batterham MJ, 2001, INT J ANDROL, V24, P232, DOI 10.1046/j.1365-2605.2001.00291.x; BELKIEN L, 1985, J STEROID BIOCHEM, V22, P623, DOI 10.1016/0022-4731(85)90215-8; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Biolo G, 2007, AM J CLIN NUTR, V86, P366, DOI 10.1093/ajcn/86.2.366; CHRISTENSEN T, 1982, BRIT J SURG, V69, P417, DOI 10.1002/bjs.1800690721; Creutzberg EC, 2003, CHEST, V124, P1733, DOI 10.1378/chest.124.5.1733; DEITRICK JE, 1948, B NEW YORK ACAD MED, V24, P364; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Dirks ML, 2015, CLIN SCI, V128, P357, DOI 10.1042/CS20140447; Dirks ML, 2014, J NUTR, V144, P1196, DOI 10.3945/jn.114.194217; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Fisher SR, 2010, ARCH INTERN MED, V170, P1942, DOI 10.1001/archinternmed.2010.422; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2010, CURR OPIN CLIN NUTR, V13, P630, DOI 10.1097/MCO.0b013e32833f1ae5; Gold J, 1996, AIDS, V10, P745, DOI 10.1097/00002030-199606001-00008; HARUNA Y, 1994, ACTA PHYSIOL SCAND, V150, P43; HASSAGER C, 1989, MATURITAS, V11, P305, DOI 10.1016/0378-5122(89)90027-3; Hohmann E, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-93; Johansen KL, 1999, JAMA-J AM MED ASSOC, V281, P1275, DOI 10.1001/jama.281.14.1275; Liu XH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13520; Minto CF, 1997, J PHARMACOL EXP THER, V281, P93; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Qin WP, 2015, MOL CELL ENDOCRINOL, V399, P336, DOI 10.1016/j.mce.2014.09.025; REZNIK Y, 1987, J CLIN ENDOCR METAB, V64, P1086, DOI 10.1210/jcem-64-5-1086; Sattler FR, 1999, J CLIN ENDOCR METAB, V84, P1268, DOI 10.1210/jc.84.4.1268; SCHOLS AMWJ, 1995, AM J RESP CRIT CARE, V152, P1268, DOI 10.1164/ajrccm.152.4.7551381; Schroeder ET, 2003, AM J PHYSIOL-ENDOC M, V285, pE16, DOI 10.1152/ajpendo.00032.2003; Singh GKS, 2014, J CLIN ENDOCR METAB, V99, P2592, DOI 10.1210/jc.2014-1243; Stein TP, 1999, NUTRITION, V15, P656, DOI 10.1016/S0899-9007(99)00120-3; Storer TW, 2005, J CLIN ENDOCR METAB, V90, P4474, DOI 10.1210/jc.2005-0275; Strandberg Soren, 2010, BMC Med Imaging, V10, P18, DOI 10.1186/1471-2342-10-18; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; Suetta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051238; TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001; Urban Randall J, 2014, Trans Am Clin Climatol Assoc, V125, P27; Velema MS, 2012, CURR OPIN PULM MED, V18, P118, DOI 10.1097/MCP.0b013e32834e9001; Verdijk LB, 2009, J SPORT SCI, V27, P59, DOI 10.1080/02640410802428089; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wall BT, 2014, SPORTS MED, V44, pS185, DOI 10.1007/s40279-014-0258-7; Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003; Wall BT, 2013, NUTR REV, V71, P195, DOI 10.1111/nure.12019; WIJNAND HP, 1985, ACTA ENDOCRINOL-COP, V110, P19, DOI 10.1530/acta.0.109S00019; Wright TJ, 2018, J CACHEXIA SARCOPENI, V9, P482, DOI 10.1002/jcsm.12295	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210823	10.1371/journal.pone.0210823	http://dx.doi.org/10.1371/journal.pone.0210823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689637	Green Submitted, Green Published, gold			2022-12-26	WOS:000457041800011
J	Mori, N; Mochizuki, T; Yamazaki, F; Takei, S; Mano, H; Matsugi, T; Setou, M				Mori, Naoto; Mochizuki, Takaharu; Yamazaki, Fumiyoshi; Takei, Shiro; Mano, Hidetoshi; Matsugi, Takeshi; Setou, Mitsutoshi			MALDI imaging mass spectrometry revealed atropine distribution in the ocular tissues and its transit from anterior to posterior regions in the whole-eye of rabbit after topical administration	PLOS ONE			English	Article							DRUG-DELIVERY; CHEMISTRY; DIAGNOSIS; BRAIN	It is essential to elucidate drug distribution in the ocular tissues and drug transit in the eye for ophthalmic pharmaceutical manufacturers. Atropine is a reversible muscarinic receptor used to treat various diseases. However, its distribution in ocular tissues is still incompletely understood. Matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) evaluates drug distribution in biological samples. However, there have been few investigations of drug distribution in ocular tissues, including whole-eye segments. In the present study, we explored the spatial distribution of atropine in the whole-eye segment by MALDI-IMS, and then evaluated the changes in atropine level along the anterior-posterior and superior-inferior axes. A 1% atropine solution was administered to a rabbit and after 30 min, its eye was enucleated, sectioned, and analyzed by MALDI-IMS. Atropine accumulated primarily in the tear menisci but was found at substantially lower concentrations in the tissue surrounding the conjunctival sacs. Relative differences in atropine levels between the anterior and posterior regions provided insights into the post-instillation behavior of atropine. Atropine signal intensities differed among corneal layers and between the superior and inferior eyeball regions. Differences in signal intensity among tissues indicated that the drug migrated to the posterior regions via a periocular-scleral route. Line scan analysis elucidated atropine transit from the anterior to the posterior region. This information is useful for atropine delivery in the ocular tissues and indicates that MALDI-IMS is effective for revealing drug distribution in whole-eye sections.	[Mori, Naoto; Mochizuki, Takaharu; Mano, Hidetoshi; Matsugi, Takeshi] Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma, Nara, Japan; [Yamazaki, Fumiyoshi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan; [Yamazaki, Fumiyoshi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Hamamatsu, Shizuoka, Japan; [Takei, Shiro] Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Lab Fish Biol, Kasugai, Aichi, Japan; [Setou, Mitsutoshi] Preeminent Med Photon Educ & Res Ctr, Inst Med Photon Res, Dept Syst Mol Anat, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China	Santen Pharmaceutical Co Ltd; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Chubu University; University of Hong Kong	Mori, N (corresponding author), Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma, Nara, Japan.	naoto.mori@santen.com		Mori, Naoto/0000-0001-6454-0418	MEXT/JSPS KAKENHI [JP15H05898B1]; Imaging Platform - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; AMED [JP18gm0910004]; Santen Pharmaceutical Co. Ltd.	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Imaging Platform - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; AMED(Japan Agency for Medical Research and Development (AMED)); Santen Pharmaceutical Co. Ltd.	This study was supported by MEXT/JSPS KAKENHI Grant Number JP15H05898B1; Imaging Platform supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; and AMED under Grant Number JP18gm0910004. Santen Pharmaceutical Co. Ltd. provided support in the form of salaries for NM, T. Mochizuki, HM, and T. Matsugi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal RV, 2010, INDIAN J OPHTHALMOL, V58, P11, DOI 10.4103/0301-4738.58468; Asano N, 2017, BIOL PHARM BULL, V40, P1586, DOI 10.1248/bpb.b17-00288; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Brignole-Baudouin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050180; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Chia A, 2016, OPHTHALMOLOGY, V123, P391, DOI 10.1016/j.ophtha.2015.07.004; Chumbley CW, 2016, ANAL CHEM, V88, P2392, DOI 10.1021/acs.analchem.5b04409; Clark TY, 2015, J OCUL PHARMACOL TH, V31, P541, DOI 10.1089/jop.2015.0043; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Crouch RK, 2015, PROG MOL BIOL TRANSL, V134, P449, DOI 10.1016/bs.pmbts.2015.06.005; Fraunfelder F T, 1976, Trans Am Ophthalmol Soc, V74, P457; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goodwin RJA, 2016, J BIOMOL SCREEN, V21, P187, DOI 10.1177/1087057115623740; GREENSTEIN SH, 1984, B NEW YORK ACAD MED, V60, P961; Greer T, 2011, J PROTEOMICS, V74, P2617, DOI 10.1016/j.jprot.2011.03.032; Grove KJ, 2017, SLAS DISCOV, V22, P1239, DOI 10.1177/2472555217724780; Harrison PK, 2006, N-S ARCH PHARMACOL, V373, P230, DOI 10.1007/s00210-006-0054-5; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; HOLLY FJ, 1985, T OPHTHAL SOC UK, V104, P374; Kallback P, 2012, J PROTEOMICS, V75, P4941, DOI 10.1016/j.jprot.2012.07.034; LIEBL H, 1967, J APPL PHYS, V38, P5277, DOI 10.1063/1.1709314; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; MEISNER D, 1989, INT J PHARM, V55, P105, DOI 10.1016/0378-5173(89)90030-6; Mitchelson Frederick, 2012, Handb Exp Pharmacol, P263, DOI 10.1007/978-3-642-23274-9_12; Mizuno K, 2009, INVEST OPHTH VIS SCI, V50, P2839, DOI 10.1167/iovs.08-2922; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j; Prausnitz MR, 1998, J PHARM SCI, V87, P1479, DOI 10.1021/js9802594; Shen MX, 2009, INVEST OPHTH VIS SCI, V50, P2722, DOI 10.1167/iovs.08-2704; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugiura Y, 2010, J NEUROIMMUNE PHARM, V5, P31, DOI 10.1007/s11481-009-9162-6; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Tahara K, 2017, ASIAN J PHARM SCI, V12, P394, DOI 10.1016/j.ajps.2017.03.002; Takai N, 2012, RAPID COMMUN MASS SP, V26, P1549, DOI 10.1002/rcm.6256; Tigges M, 1999, OPTOMETRY VISION SCI, V76, P397, DOI 10.1097/00006324-199906000-00020; Uchida A, 2007, AM J OPHTHALMOL, V144, P232, DOI 10.1016/j.ajo.2007.04.006; Zaima N, 2011, ATHEROSCLEROSIS, V217, P427, DOI 10.1016/j.atherosclerosis.2011.03.044	37	8	8	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211376	10.1371/journal.pone.0211376	http://dx.doi.org/10.1371/journal.pone.0211376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682156	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500159
J	Quesada, JIP; Kerr, ZY; Bertucci, WM; Carpes, FP				Priego Quesada, Jose Ignacio; Kerr, Zachary Y.; Bertucci, William M.; Carpes, Felipe P.			A retrospective international study on factors associated with injury, discomfort and pain perception among cyclists	PLOS ONE			English	Article							OVERUSE INJURIES; SPORTS INJURIES; COMFORT; RELIABILITY; EXERCISE; LEVEL; RISK; EPIDEMIOLOGY; TOLERANCE; STATEMENT	Although cycling has been associated with overuse/fatigue and acute injuries, there is lack of information regarding associated risk factors and prevention factors. The objective of the study was to determine the factors associated with injury, and perceptions of discomfort and pain in cyclists. A total of 739 cyclists completed an online questionnaire between February and October 2016. The questionnaire acquired information on participant demographics, characteristics related to cycling profile and fitness training, bike components and cycling posture, self-reported perceptions of comfort and pain, and injuries sustained in the last 12 months. Logistic regression models estimated odds ratios (OR) and 95% confidence intervals (95% CI) that examined factors associated with reporting overuse/fatigue injury, acute injury, body discomfort, saddle discomfort, and pain while cycling. Odds of reporting an overuse/fatigue injury increased when the cyclists complemented training with running (OR = 1.74; 95% CI = 1.03-2.91) or swimming (OR = 2.17; 95% CI = 1.19-3.88), and with reported pain while cycling (OR = 1.17; 95% CI = 1.05-3.69) and not cycling (OR = 1.76; 95% CI = 1.07-2.90). Odds of reporting an acute injury increased when biking to work (OR = 1.79; 95% CI = 1.07-2.86), and decreased with increased average cycling speed (1-km/h decrease OR = 0.93; 95% CI = 0.88-0.97), and compared to low-end bike, with the use of mid-range (OR = 0.25; 95% CI = 0.09-0.72) and high-end bike (OR = 0.34; 95% CI = 0.13-0.96). Although body discomfort was only associated with saddle discomfort and the presence of pain during cycling, saddle discomfort was also associated with biking to work (OR = 0.46; 95% CI = 0.22-0.88). Finally, pain perception was associated with a number of factors such as ride to work, core training, cycling experience, saddle discomfort, pain while not cycling. Numerous factors are associated with injury, and perceptions of discomfort and pain in cyclists. Such factors should be considered when developing training routines, bicycle maintenance best practices, and injury prevention programs.	[Priego Quesada, Jose Ignacio] Univ Valencia, Dept Phys Educ & Sports, Res Grp Sports Biomech GIBD, Valencia, Spain; [Priego Quesada, Jose Ignacio] Univ Valencia, Dept Physiol, Biophys & Med Phys Grp, Valencia, Spain; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Bertucci, William M.] Univ Reims, UFR STAPS, Lab Performance Hlth Metrol & Soc, PSMS,EA 7507, Reims, France; [Carpes, Felipe P.] Fed Univ Pampa, Lab Neuromech, Appl Neuromech Res Grp, Uruguaiana, Brazil	University of Valencia; University of Valencia; University of North Carolina; University of North Carolina Chapel Hill; Universite de Reims Champagne-Ardenne; Universidade Federal do Pampa	Quesada, JIP (corresponding author), Univ Valencia, Dept Phys Educ & Sports, Res Grp Sports Biomech GIBD, Valencia, Spain.; Quesada, JIP (corresponding author), Univ Valencia, Dept Physiol, Biophys & Med Phys Grp, Valencia, Spain.	j.priego.gibd@gmail.com	Priego-Quesada, Jose Ignacio/D-3424-2013; Carpes, Felipe P/A-1069-2010	Priego-Quesada, Jose Ignacio/0000-0002-0375-1454; Carpes, Felipe P/0000-0001-8923-4855				Abt JP, 2007, J STRENGTH COND RES, V21, P1300; Aldred R, 2018, ACCIDENT ANAL PREV, V117, P75, DOI 10.1016/j.aap.2018.03.003; Assa T, 2019, EUR J PAIN, V23, P686, DOI 10.1002/ejp.1335; Astokorki AHY, 2017, SCAND J MED SCI SPOR, V27, P309, DOI 10.1111/sms.12659; Ayachi FS, 2015, APPL ERGON, V46, P124, DOI 10.1016/j.apergo.2014.07.010; Barrios C, 2015, INT J SPORTS MED, V36, P241, DOI 10.1055/s-0034-1389983; Bini R. R., 2012, J SCI CYCLING, V1, P9; Bini RR, 2014, BIOMECHANICS CYCLING, P55, DOI [10.1007/978-3-319-05539-8_6, DOI 10.1007/978-3-319-05539-8_6]; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Calleja-Gonzalez J, 2018, J EXERC REHABIL, V14, P545, DOI 10.12965/jer.1836244.122; Candotti CT, 2007, SPORT BIOMECH, V6, P31, DOI 10.1080/14763140601058490; Chapman AR, 2007, EXP BRAIN RES, V181, P503, DOI 10.1007/s00221-007-0949-5; Chen C, 2017, ACCIDENT ANAL PREV, V108, P234, DOI 10.1016/j.aap.2017.09.001; Chen YL, 2014, APPL ERGON, V45, P1181, DOI 10.1016/j.apergo.2014.02.006; Choi S, 2011, TEXT RES J, V81, P81, DOI 10.1177/0040517510377822; Chu CH, 2010, COMPUT IND, V61, P541, DOI 10.1016/j.compind.2010.03.004; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Clarsen B, 2010, AM J SPORT MED, V38, P2494, DOI 10.1177/0363546510376816; Dahlquist M, 2015, CLIN J SPORT MED, V25, P88, DOI 10.1097/JSM.0000000000000111; De Bernardo N, 2012, J SPORT SCI, V30, P1047, DOI 10.1080/02640414.2012.687112; De Vera MA, 2010, AM J EPIDEMIOL, V172, P1190, DOI 10.1093/aje/kwq273; Decock M, 2016, BRIT J SPORT MED, V50, P669, DOI 10.1136/bjsports-2015-095612; Dettori NJ, 2006, SPORTS MED, V36, P7, DOI 10.2165/00007256-200636010-00002; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hakansson S, 2018, EUR J PAIN, V22, P1813, DOI 10.1002/ejp.1277; Hermans TJN, 2016, J SEX MED, V13, P40, DOI 10.1016/j.jsxm.2015.11.004; Jones MD, 2014, MED SCI SPORT EXER, V46, P1640, DOI 10.1249/MSS.0000000000000273; Kinchington M, 2010, J SPORT SCI MED, V9, P652; Lam WK, 2011, FOOTWEAR SCI, V3, P151, DOI 10.1080/19424280.2011.630680; Liu Z, 2014, INT J CLOTH SCI TECH, V26, P118, DOI 10.1108/IJCST-02-2013-0009; Min-Chi Chiu, 2013, Human Interface and the Management of Information. Information and Interaction Design. 15th International Conference, HCI International 2013. Proceedings: LNCS 8016, P12, DOI 10.1007/978-3-642-39209-2_2; Munera M, 2015, P I MECH ENG P-J SPO, V229, P231, DOI 10.1177/1754337115579606; Munera M, 2015, MECH IND, V16, DOI 10.1051/meca/2015028; Nigg BM, 2015, BRIT J SPORT MED, V49, P1290, DOI 10.1136/bjsports-2015-095054; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Oser SM, 2013, PRIMARY CARE, V40, P969, DOI 10.1016/j.pop.2013.08.011; Paungmali A, 2017, PAIN PRACT, V17, P1008, DOI 10.1111/papr.12552; Pavelka E, 1998, BICYCLING MAGAZINES; Quesada JIP, 2017, J SPORT SCI, V35, P1459, DOI 10.1080/02640414.2016.1215496; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos-Ortega J, 2014, CLIN J SPORT MED, V24, P251, DOI 10.1097/JSM.0000000000000027; Rankin KM, 2008, CANCER EPIDEM BIOMAR, V17, P2639, DOI 10.1158/1055-9965.EPI-08-0304; Roi GS, 2014, ACCIDENT ANAL PREV, V73, P170, DOI 10.1016/j.aap.2014.08.010; Rose C, 2017, INT J SPORTS MED, V38, P1049, DOI 10.1055/s-0043-114861; Scheepers S, 2016, IMAGING TRIATHLON IN, P557, DOI [10.1007/978-3-319-14307-1_21, DOI 10.1007/978-3-319-14307-1_21]; Silberman MR, 2013, CURR SPORT MED REP, V12, P337, DOI 10.1249/JSR.0b013e3182a4bab7; Sondergaard KHE, 2010, J BIOMECH, V43, P1997, DOI 10.1016/j.jbiomech.2010.03.009; Springer BA, 2013, PHYS THER SPORT, V14, P77, DOI 10.1016/j.ptsp.2012.11.001; Stanley J, 2015, INT J SPORT PHYSIOL, V10, P528, DOI 10.1123/ijspp.2014-0196; Taylor N, 2013, AUSTR J PARAMED, V10; Townes DA, 2005, WILD ENVIRON MED, V16, P125, DOI 10.1580/1080-6032(2005)16[125:IAIDAM]2.0.CO;2; Trofaier ML, 2016, INT UROGYNECOL J, V27, P513, DOI 10.1007/s00192-015-2803-9; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Verma R, 2016, J ELECTROMYOGR KINES, V27, P78, DOI 10.1016/j.jelekin.2016.02.003; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zwingenberger S, 2014, J SPORT SCI, V32, P583, DOI 10.1080/02640414.2013.843018	57	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211197	10.1371/journal.pone.0211197	http://dx.doi.org/10.1371/journal.pone.0211197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682136	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500122
J	Blijlevens, M; van der Meulen-Muileman, IH; de Menezes, RX; Smit, EF; van Beusechem, VW				Blijlevens, Maxime; van der Meulen-Muileman, Ida H.; de Menezes, Renee X.; Smit, Egbert F.; van Beusechem, Victor W.			High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome	ONCOGENE			English	Article							FALSE DISCOVERY RATE; PHASE-I; ORGANIZATION; MACHINERY; E7107; CORE	Novel therapeutic strategies for non-small-cell lung cancer (NSCLC) are urgently needed. RNA splicing, orchestrated by the spliceosome, is deregulated in many forms of cancer, including NSCLC. Here, we performed high-throughput screening with a small interfering RNA library targeting all annotated human spliceosome proteins to identify cancer-selective lethal targets in the RNA splicing machinery. Silencing of several spliceosome proteins reduced cell viability in a panel of NSCLC cell lines, but not in non-malignant lung fibroblasts and epithelial cells. Interestingly, the cancer-selective lethal target set comprised all seven Sm proteins that, together with small nuclear RNA, form the core structure of most spliceosome subunits. Interfering with Sm protein expression induced apoptosis in NSCLC cells, but not in non-malignant cells. In silico analysis revealed that Sm proteins are frequently upregulated in NSCLC. For several Sm proteins, increased expression showed a positive correlation with disease severity. Together, our results suggest that the Sm proteins represent particularly useful novel targets for selective treatment of NSCLC.	[Blijlevens, Maxime; van der Meulen-Muileman, Ida H.; van Beusechem, Victor W.] Vrije Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Med Oncol, Boelelaan 1118, Amsterdam, Netherlands; [de Menezes, Renee X.] Vrije Univ Amsterdam, Amsterdam UMC, Netherlands Bioinformat Ctr, Epidemiol & Biostat, Boelelaan 1118, Amsterdam, Netherlands; [Smit, Egbert F.] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute	van Beusechem, VW (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Med Oncol, Boelelaan 1118, Amsterdam, Netherlands.	vw.vanbeusechem@vumc.nl	Menezes, Renee/L-2182-2019	Smit, Egbert/0000-0002-7329-6995	Walter Bruckerhoff Stiftung; Stichting VUmc-CCA	Walter Bruckerhoff Stiftung; Stichting VUmc-CCA	This work was supported by Walter Bruckerhoff Stiftung and Stichting VUmc-CCA.	[Anonymous], 2014, R LANG ENV STAT COMP; Bachas C, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2306-z; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Citterio L, 1999, BIOCHEM BIOPH RES CO, V266, P110, DOI 10.1006/bbrc.1999.1769; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; Effenberger KA., 2017, WILEY INTERDISCIP RE, V8, P1; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao Y, 2013, ACS CHEM BIOL, V8, P895, DOI 10.1021/cb300602j; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Quidville V, 2013, CANCER RES, V73, P2247, DOI 10.1158/0008-5472.CAN-12-2501; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Siebring-van Olst E, 2017, MOL ONCOL, V11, P534, DOI 10.1002/1878-0261.12052; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Webb TR, 2013, DRUG DISCOV TODAY, V18, P43, DOI 10.1016/j.drudis.2012.07.013; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295	34	12	12	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4142	4153		10.1038/s41388-019-0711-z	http://dx.doi.org/10.1038/s41388-019-0711-z			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30705407				2022-12-26	WOS:000468740200012
J	Zhang, SP; Guo, XW; Wu, HG; Sun, Y; Ma, XJ; Li, JK; Xu, Q; Wu, CX; Li, QW; Jiang, CZ; Li, WZ; Ho, MS; Lv, ZW; Xue, L				Zhang, Shiping; Guo, Xiaowei; Wu, Honggui; Sun, Ying; Ma, Xianjue; Li, Jikai; Xu, Qian; Wu, Chenxi; Li, Qiwen; Jiang, Cizhong; Li, Wenzhe; Ho, Margaret S.; Lv, Zhongwei; Xue, Lei			Wingless modulates activator protein-1-mediated tumor invasion	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LONG-RANGE ACTION; BETA-CATENIN; ONCOGENIC RAS; CELL-DEATH; DROSOPHILA; MIGRATION; GROWTH; CANCER; PROLIFERATION	Metastasis begins with a subset of local tumor cells acquiring the potential to invade into surrounding tissues, and remains to be a major obstacle for cancer treatments. More than 90% of cancer patients died from tumor metastasis, instead of primary tumor growth. The canonical Wnt/beta-catenin pathway plays essential roles in promoting tumor formation, yet its function in regulating tumor metastasis and the underlying mechanisms remain controversial. Here we employed well-established Drosophila tumor models to investigate the regulating mechanism of Wingless (Wg) pathway in tumor invasion. Our results showed that Wg signaling is necessary and sufficient for cell polarity disruption-induced cell migration and molecular changes reminiscent of epithelial-mesenchymal transition (EMT). Moreover, reducing Wg signaling suppressed lgl(-/-)/Ras(V12)-induced tumor invasion, and cooperation between Arm and Ras(V12) is sufficient to induce tumor invasion. Mechanistically, we found that cell polarity disruption activates JNK signaling, which in turn upregulate wg expression through transcription factor activator protein-1 (AP-1). We identified a consensus AP-1 binding site located in the 2nd intron of wg, and confirmed that it is essential for AP-1 induced wg transcription both in vitro and in vivo. Lastly, we confirmed that the transcriptional activation of WNT by AP-1 is conserved in human cancer cells. These evidences reveal a positive role of Wnt/beta-catenin pathway in tumor invasion, and provide a conserved mechanism that connects JNK and Wnt signaling in regulating tumor progression.	[Zhang, Shiping; Guo, Xiaowei; Wu, Honggui; Sun, Ying; Ma, Xianjue; Li, Jikai; Wu, Chenxi; Li, Qiwen; Jiang, Cizhong; Li, Wenzhe; Lv, Zhongwei; Xue, Lei] Tongji Univ, Shanghai Peoples Hosp 10, Shanghai Key Lab Signaling & Dis Res, Inst Intervent Vessel,Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China; [Zhang, Shiping; Ho, Margaret S.] ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China; [Ma, Xianjue] Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06519 USA; [Xu, Qian] Fujian Univ Tradit Chinese Med, Inst Integrated Chinese & Western Med, 1 Qiu Yang Rd, Fuzhou 350122, Fujian, Peoples R China; [Wu, Chenxi] North China Univ Sci & Technol, Coll Tradit Chinese Med, 21 Bohai Rd, Tangshan 063210, Peoples R China; [Xue, Lei] Zhuhai Peoples Hosp, Ctr Intervent Radiol, Zhuhai 519000, Peoples R China	Tongji University; ShanghaiTech University; Howard Hughes Medical Institute; Yale University; Fujian University of Traditional Chinese Medicine; North China University of Science & Technology	Xue, L (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Shanghai Key Lab Signaling & Dis Res, Inst Intervent Vessel,Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.; Xue, L (corresponding author), Zhuhai Peoples Hosp, Ctr Intervent Radiol, Zhuhai 519000, Peoples R China.	lei.xue@tongji.edu.cn	Ho, Margaret/K-6310-2017	Ho, Margaret/0000-0002-2387-7564; Ma, Xianjue/0000-0003-4360-3947	National Natural Science Foundation of China [31571516, 31701278, 31771595]; Shanghai Committee of Science and Technology [18430711600, 18140900400, 09DZ2260100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Center, Fly Stocks of National Institute of Genetics, the Core Facility of Drosophila Resource and Technology at SIBCB of CAS, Developmental Studies Hybridoma Bank, Dr. Jose ' Carlos Pastor-Pareja and Dr. Haiyun Song for fly stocks and antibodies. We thank Drs. Zhihua Liu, Ru Zhang, Fan Zhang and Jian Fei for cell lines and plasmids. We thank Dr. Mark Peifer and other lab members for discussion and critical comments. This work is founded by National Natural Science Foundation of China (31571516, 31701278 and 31771595), and Shanghai Committee of Science and Technology (18430711600, 18140900400, 09DZ2260100).	Agnes F, 1999, DEVELOPMENT, V126, P5453; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arozarena I, 2011, ONCOGENE, V30, P4531, DOI 10.1038/onc.2011.162; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hunter Kent W, 2008, Breast Cancer Res, V10 Suppl 1, pS2, DOI 10.1186/bcr1988; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jung A, 2001, AM J PATHOL, V159, P1613, DOI 10.1016/S0002-9440(10)63007-6; Jung HY, 2015, CLIN CANCER RES, V21, P962, DOI 10.1158/1078-0432.CCR-13-3173; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Ma X, 2016, ONCOGENE, V35, P846, DOI 10.1038/onc.2015.137; Ma X, 2014, CELL DEATH DIFFER, V21, P407, DOI 10.1038/cdd.2013.154; Ma X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.392; Ma XJ, 2017, P NATL ACAD SCI USA, V114, P1934, DOI 10.1073/pnas.1621359114; Ma XJ, 2013, DEV BIOL, V380, P211, DOI 10.1016/j.ydbio.2013.05.013; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Millar JBA, 2002, GENOME BIOL, V3; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Swarup S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007930; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Ulivieri A, 2008, J PATHOL, V215, P87, DOI 10.1002/path.2331; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang AL, 2014, MOL CELL BIOCHEM, V395, P211, DOI 10.1007/s11010-014-2127-y; Wang X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.196; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yamben IF, 2013, DEV BIOL, V384, P41, DOI 10.1016/j.ydbio.2013.09.027; Yang JB, 2015, INT J CLIN EXP PATHO, V8, P11837; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.85; Zhang SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep22348; Zhao M, 2008, GENETICS, V178, P1947, DOI 10.1534/genetics.108.086983; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	56	15	15	2	29	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3871	3885		10.1038/s41388-018-0629-x	http://dx.doi.org/10.1038/s41388-018-0629-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30683884				2022-12-26	WOS:000468035600008
J	Steinbusch, MMF; Caron, MMJ; Surtel, DAM; van den Akker, GGH; van Dijk, PJ; Friedrich, F; Zabel, B; van Rhijn, LW; Peffers, MJ; Welting, TJM				Steinbusch, Mandy M. F.; Caron, Marjolein M. J.; Surtel, Don A. M.; van den Akker, Guus G. H.; van Dijk, Paul J.; Friedrich, Franziska; Zabel, Bernhard; van Rhijn, Lodewijk W.; Peffers, Mandy J.; Welting, Tim J. M.			The antiviral protein viperin regulates chondrogenic differentiation via CXCL10 protein secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cartilage biology; chondrogenesis; small nucleolar RNA (snoRNA); transforming growth factor beta (TGF-B); chemokine; secretion; C-X-C motif chemokine ligand 10; cartilage-hair hypoplasia; chondrogenic differentiation; RMRP snoRNA; viperin	INTERFERON-INDUCIBLE PROTEIN; MESENCHYMAL STEM-CELLS; RNASE MRP; GENE-EXPRESSION; MESSENGER-RNA; GROWTH-FACTOR; INHIBITION; GAMMA; ACTIVATION; MUTATIONS	Viperin (also known as radical SAM domain-containing 2 (RSAD2)) is an interferon-inducible and evolutionary conserved protein that participates in the cell's innate immune response against a number of viruses. Viperin mRNA is a substrate for endoribonucleolytic cleavage by RNase mitochondrial RNA processing (MRP) and mutations in the RNase MRP small nucleolar RNA (snoRNA) subunit of the RNase MRP complex cause cartilage-hair hypoplasia (CHH), a human developmental condition characterized by metaphyseal chondrodysplasia and severe dwarfism. It is unknown how CHH-pathogenic mutations in RNase MRP snoRNA interfere with skeletal development, and aberrant processing of RNase MRP substrate RNAs is thought to be involved. We hypothesized that viperin plays a role in chondrogenic differentiation. Using immunohistochemistry, real-time quantitative PCR, immunoblotting, ELISA, siRNA-mediated gene silencing, plasmid-mediated gene overexpression, label-free MS proteomics, and promoter reporter bioluminescence assays, we discovered here that viperin is expressed in differentiating chondrocytic cells and regulates their protein secretion and the outcome of chondrogenic differentiation by influencing transforming growth factor beta (TGF-beta)/SMAD family 2/3 (SMAD2/3) activity via C-X-C motif chemokine ligand 10 (CXCL10). Of note, we observed disturbances in this viperin-CXCL10-TGF-beta/SMAD2/3 axis in CHH chondrocytic cells. Our results indicate that the antiviral protein viperin controls chondrogenic differentiation by influencing secretion of soluble proteins and identify a molecular route that may explain impaired chondrogenic differentiation of cells from individuals with CHH.	[Steinbusch, Mandy M. F.; Caron, Marjolein M. J.; Surtel, Don A. M.; van den Akker, Guus G. H.; van Rhijn, Lodewijk W.; Welting, Tim J. M.] Maastricht Univ, Dept Orthoped Surg, Lab Expt Orthoped, NL-6202 AZ Maastricht, Netherlands; [van Dijk, Paul J.] Maastricht Univ, Dept Anat & Embryol, NL-6202 AZ Maastricht, Netherlands; [Friedrich, Franziska] Univ Freiburg, Univ Heart Ctr Freiburg, Fac Med, Inst Expt Cardiovasc Med, D-79110 Freiburg, Germany; [Zabel, Bernhard] Otto van Guericke Univ Magdeburg, Med Fac, D-39106 Magdeburg, Germany; [Peffers, Mandy J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	Maastricht University; Maastricht University; Universitats Herzzentrum Freiburg; University of Freiburg; Otto von Guericke University; University of Liverpool	Welting, TJM (corresponding author), Maastricht Univ, Med Ctr, Dept Orthopaed Surg, POB 5800, NL-6202 AZ Maastricht, Netherlands.	t.welting@maastrichtuniversity.nl	van den Akker, Guus/AAD-9536-2019; Peffers, Mandy Jayne/AAV-9411-2020	Peffers, Mandy Jayne/0000-0001-6979-0440	Netherlands Organisation for Scientific Research [DN 82-304]; Deutsche Forschungsgemeinschaft; Dutch Arthritis Association [LLP14]; Wellcome Trust Clinical Intermediate Fellowship Grant [107471]; MRC [MR/P020941/1] Funding Source: UKRI	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch Arthritis Association; Wellcome Trust Clinical Intermediate Fellowship Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Bilateral Cooperation Grant DN 82-304 from The Netherlands Organisation for Scientific Research and the Deutsche Forschungsgemeinschaft and by Dutch Arthritis Association Grant LLP14. This work is also supported in part by a Wellcome Trust Clinical Intermediate Fellowship Grant 107471 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Amanatullah DF, 2014, J TISSUE ENG REGEN M, V8, P505, DOI 10.1002/term.1543; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Cristino S, 2008, TISSUE ENG PT A, V14, P97, DOI 10.1089/ten.a.2007.0121; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Goldfarbi KC, 2017, GENE DEV, V31, P59, DOI 10.1101/gad.286963.116; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; Grewal TS, 2000, FASEB J, V14, P523, DOI 10.1096/fasebj.14.3.523; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Kong L, 2008, CELL MOL LIFE SCI, V65, P3494, DOI 10.1007/s00018-008-8342-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27105; Makitie O, 1998, EUR J PEDIATR, V157, P816, DOI 10.1007/s004310050943; Makitie O, 1993, GENEREVIEWS; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Mattijssen S, 2011, CELL MOL LIFE SCI, V68, P2469, DOI 10.1007/s00018-010-0568-3; Morimoto H, 2013, CELL TISSUE RES, V351, P41, DOI 10.1007/s00441-012-1521-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Osawa A, 2006, GENOMICS, V88, P52, DOI 10.1016/j.ygeno.2006.02.013; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Peffers MJ, 2014, J BIOL CHEM, V289, P25867, DOI 10.1074/jbc.M114.566554; Peffers MJ, 2013, INT J MOL SCI, V14, P20658, DOI 10.3390/ijms141020658; Qiu LQ, 2009, BLOOD, V113, P3520, DOI 10.1182/blood-2008-07-171942; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Satish L, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0119-8; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Shahabuddin S, 2006, AM J PHYSIOL-CELL PH, V291, pC34, DOI 10.1152/ajpcell.00441.2005; Steinbusch MMF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06809-5; Thorpe CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20455; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; van Beuningen HM, 2014, TISSUE ENG PT A, V20, P2243, DOI [10.1089/ten.tea.2013.0553, 10.1089/ten.TEA.2013.0553]; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yu JSL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8212; Zhang Y, 2008, CELL DEATH DIFFER, V15, P1760, DOI 10.1038/cdd.2008.112	47	9	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5121	5136		10.1074/jbc.RA119.007356	http://dx.doi.org/10.1074/jbc.RA119.007356			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718282	Green Published, hybrid			2022-12-26	WOS:000463985600033
J	Wang, ZG; Khor, S; Cai, DS				Wang, Zhouguang; Khor, Sinan; Cai, Dongsheng			Age-dependent decline of hypothalamic HIF2 alpha in response to insulin and its contribution to advanced age-associated metabolic disorders in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia-inducible factor (HIF); insulin resistance; obesity; aging; hypothalamus; cell signaling; diabetes	HYPOXIA-INDUCIBLE FACTOR-1; BETA/NF-KAPPA-B; FOOD-INTAKE; STEM-CELLS; PROOPIOMELANOCORTIN DEFICIENCY; BODY-WEIGHT; OBESITY; GLUCOSE; ENERGY; BINDING	Hypoxia-inducible factor-2 alpha (HIF2 alpha) is a nuclear transcription factor that plays a critical role in cell survival including metabolic adaptation under hypoxia as well as normoxia, but whether HIF2 alpha contributes to the control of whole-body metabolic balance is unclear. In this study, we found that the hypothalamic HIF2 alpha protein level rapidly increases in young mice that are centrally stimulated with insulin. However, this insulin-induced HIF2 alpha up-regulation is substantially attenuated in mice of advanced age. This attenuation is comparable with the effect of high-calorie feeding in young mice. Of note, unlike high-calorie feeding conditions, age-dependent HIF2 alpha attenuation occurs without impaired activation of the hypothalamic IR/IRS-2/AKT/FOXO1 pathway in response to insulin. Molecular and physiological analyses revealed that hypothalamic HIF2 alpha contributes to the action of central insulin in regulation of proopiomelanocortin (Pomc) gene expression and food intake. HIF2 alpha knockout in POMC neurons led to age-dependent excess weight gain and fat increase, a phenotype that was associated with a mild degree of glucose intolerance and insulin resistance. In conclusion, hypothalamic HIF2 alpha responds to insulin, and the up-regulation is involved in adaptive metabolic regulation as age increases, whereas impairment of HIF2 alpha in the hypothalamus contributes to weight gain and glucose disorders in age-dependent manners.	[Wang, Zhouguang; Khor, Sinan; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging Res, Diabet Res Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Wang, Zhouguang/F-7918-2017	Wang, Zhouguang/0000-0001-9903-0362	National Institutes of Health [RO1 DK 099136, AG 031774]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants RO1 DK 099136 and AG 031774. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bento CF, 2011, DIABETOLOGIA, V54, P1946, DOI 10.1007/s00125-011-2191-8; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Coll AP, 2013, CURR OPIN PHARMACOL, V13, P970, DOI 10.1016/j.coph.2013.09.010; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Garcia-San Frutos M, 2007, ENDOCRINOLOGY, V148, P5238, DOI 10.1210/en.2007-0543; Grillo CA, 2007, PHYSIOL BEHAV, V92, P691, DOI 10.1016/j.physbeh.2007.05.043; He X, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011152; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lai TW, 2012, J MOL CELL BIOL, V4, P184, DOI 10.1093/jmcb/mjs009; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Ropelle ER, 2009, J PHYSIOL-LONDON, V587, P2341, DOI 10.1113/jphysiol.2009.170050; Sartorius T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126804; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282; Zhang YL, 2017, CELL METAB, V25, P1091, DOI 10.1016/j.cmet.2017.04.002	36	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4946	4955		10.1074/jbc.RA118.005429	http://dx.doi.org/10.1074/jbc.RA118.005429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30709906	Green Published, hybrid			2022-12-26	WOS:000463985600019
J	Du, LJ; Yang, F; Fang, HS; Sun, HY; Chen, Y; Xu, Y; Li, H; Zheng, L; Zhou, BBS				Du, Lijuan; Yang, Fan; Fang, Houshun; Sun, Huiying; Chen, Yao; Xu, Yan; Li, Hui; Zheng, Liang; Zhou, Bin-Bing S.			AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells	FASEB JOURNAL			English	Article						cell cycle; apoptosis; nucleotide imbalances	ACTIVATED PROTEIN-KINASE; ADENOSINE-REGULATING AGENT; DOUBLE-STRAND BREAKS; CYCLE REGULATION; CANCER CELLS; APOPTOSIS; AMPK; ACADESINE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE-1-BETA-D-RIBOFURANOSIDE; MAINTENANCE	It has been shown that 5-amino-4-imidazolecarboxamide riboside (AICAr) can inhibit cell proliferation and induce apoptosis in childhood acute lymphoblastic leukemia (ALL) cells. Although AICAr could regulate cellular energy metabolism by activating AMPK, the cytotoxic mechanisms of AICAr are still unclear. Here, we knocked out TP53 or PRKAA1 gene (encoding AMPK1) in NALM-6 and Reh cells by using the clustered regularly interspaced short palindromic repeats/Cas9 system and found that AICAr-induced proliferation inhibition was independent of AMPK activation but dependent on p53. Liquid chromatography-mass spectrometry analysis of nucleotide metabolites indicated that AICAr caused an increase in adenosine triphosphate, deoxyadenosine triphosphate, and deoxyguanosine triphosphate levels by up-regulating purine biosynthesis, while AICAr led to a decrease in cytidine triphosphate, uridine triphosphate, deoxycytidine triphosphate, and deoxythymidine triphosphate levels because of reduced phosphoribosyl pyrophosphate production, which consequently impaired the pyrimidine biosynthesis. Ribonucleoside triphosphate (NTP) pool imbalances suppressed the rRNA transcription efficiency. Furthermore, deoxy-ribonucleoside triphosphate (dNTP) pool imbalances induced DNA replication stress and DNA double-strand breaks, followed by cell cycle arrest and apoptosis in ALL cells. Exogenous uridine could rebalance the NTP and dNTP pools by supplementing pyrimidine and then attenuate AICAr-induced cytotoxicity. Our data indicate that RNA transcription inhibition and DNA replication stress induced by NTP and dNTP pool imbalances might play a key role in AICAr-mediated cytotoxic effects on ALL cells, suggesting a potential clinical application of AICAr in future ALL therapy.Du, L., Yang, F., Fang, H., Sun, H., Chen, Y., Xu, Y., Li, H., Zheng, L., Zhou, B.-B. S. AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells.	[Du, Lijuan; Yang, Fan; Fang, Houshun; Sun, Huiying; Chen, Yao; Xu, Yan; Li, Hui; Zheng, Liang; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Minist Hlth, Key Lab Pediat Hematol & Oncol, 1678 Dongfang Rd, Shanghai 200127, Peoples R China; [Du, Lijuan; Yang, Fan; Fang, Houshun; Sun, Huiying; Chen, Yao; Xu, Yan; Li, Hui; Zheng, Liang; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Pediat Translat Med Inst, 1678 Dongfang Rd, Shanghai 200127, Peoples R China; [Li, Hui; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Sch Basic Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China; [Li, Hui; Zhou, Bin-Bing S.] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Translat Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, F; Zhou, BBS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Minist Hlth, Key Lab Pediat Hematol & Oncol, 1678 Dongfang Rd, Shanghai 200127, Peoples R China.; Yang, F; Zhou, BBS (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Pediat Translat Med Inst, 1678 Dongfang Rd, Shanghai 200127, Peoples R China.	yangfan@nibs.ac.cn; binbing_s_zhou@yahoo.com		Zheng, Liang/0000-0002-5346-4111; Du, Lijuan/0000-0001-6792-3684	National Natural Science Foundation of China [31530017, 81372349, 81800145]; National Basic Research Program of China (973 Program) [2015CB553904]; Science and Technology Commission of Shanghai Municipality [13431900502, 16XD1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank Dr. Renate Kirschner-Schwabe (Charite-Universitatsmedizin Berlin, Berlin, Germany) for kindly providing the ALL cell lines, Malwine Pogodzinski (Charite-Universitatsmedizin Berlin) for sequencing the TP53 gene in all the ALL cell lines, Fangfei Wei and N. Cauwenberghs (both from University of Leuven, Leuven, Belgium) for reviewing the manuscript, and Shanghai ChemPartner and Wuhan Metware for LC-MS services. This work was supported by grants from the National Natural Science Foundation of China (31530017 and 81372349 to B.-B.S.Z., and 81800145 to F.Y.), the National Basic Research Program of China (973 Program 2015CB553904 to B.-B.S.Z.), and the Science and Technology Commission of Shanghai Municipality (13431900502 and 16XD1402100 to B.-B.S.Z.). The authors declare no conflicts of interest.	Adachi S, 2011, BIOCHEM BIOPH RES CO, V414, P53, DOI 10.1016/j.bbrc.2011.09.020; Ahmad MF, 2013, PROG MOL BIOL TRANSL, V117, P389, DOI 10.1016/B978-0-12-386931-9.00014-3; Bardeleben C, 2013, MOL CANCER THER, V12, P1310, DOI 10.1158/1535-7163.MCT-12-1042; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Ceschin J, 2014, J BIOL CHEM, V289, P16844, DOI 10.1074/jbc.M114.551192; Chabosseau P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1363; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cui CH, 2004, BIOTECHNIQUES, V36, P134, DOI 10.2144/04361RR04; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; Drew BG, 2008, EXPERT OPIN PHARMACO, V9, P2137, DOI [10.1517/14656566.9.12.2137, 10.1517/14656566.9.12.2137 ]; Esparza Samuel D, 2005, MedGenMed, V7, P23; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; HIROTA Y, 1989, CANCER RES, V49, P915; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Ma HQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04227; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; Morishita M, 2017, INT J ONCOL, V50, P23, DOI 10.3892/ijo.2016.3775; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Newman MF, 2012, JAMA-J AM MED ASSOC, V308, P157, DOI 10.1001/jama.2012.7633; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Schmiegelow K, 2014, J PEDIAT HEMATOL ONC, V36, P503, DOI 10.1097/MPH.0000000000000206; Schwab RAV, 2011, JOVE-J VIS EXP, DOI 10.3791/3255; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Van Den Neste E, 2013, CANCER CHEMOTH PHARM, V71, P581, DOI 10.1007/s00280-012-2033-5; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Yang F., 2017, ONCOTARGET, V9, P2268; YOSHIOKA A, 1987, BIOCHEM BIOPH RES CO, V146, P258, DOI 10.1016/0006-291X(87)90719-4	39	10	10	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4525	4537		10.1096/fj.201801559RR	http://dx.doi.org/10.1096/fj.201801559RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30702927	Bronze			2022-12-26	WOS:000459794800113
J	Kim, HW; Lee, HY; Kim, SE; Ahn, HY; Kim, YH; Lee, YJ				Kim, Hae Won; Lee, Hyang Yuol; Kim, Seong Eun; Ahn, Hye Young; Kim, Yeon Hee; Lee, Young Jin			Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea	PLOS ONE			English	Article							HPV VACCINE UPTAKE; GENERAL-PRACTITIONERS; HEALTH BELIEFS; HESITANCY; KNOWLEDGE; ATTITUDES; ACCEPTABILITY; PREDICTORS; BARRIERS; BOYS	Background In June 2016, the Republic of Korea included free human papillomavirus (HPV) vaccinations for all 12-year-old girls in its national immunization program. Purpose This study investigated perceptions of nurses on HPV vaccination and their intent to vaccinate preteens at the best ages. Methods Recruited for the survey were 514 health teachers (181, 35.2%), public health nurses (168, 32.7%), and clinical nurses (165, 32.1%). Factor-analysis was conducted to validate the Vaccine-Hesitancy Scale for Korean nurses. Related variables associated with vaccine-acceptance were examined using the Kruskal-Wallis test and Spearman's rho coefficients, due to lack of normalization. Results Factor-analysis results showed that two factors of positive acceptance (7 items) and negative acceptance (3 items) accounted for 67.46% of the total variance, and explained 47.4% and 20.1%, respectively. Nurses who positively accepted HPV vaccine differed significantly in agreement to vaccinate girls or boys. For the proper vaccination age, a significant difference emerged between answers for girls and vaccine-acceptance scores, whereas no difference emerged between answers for boys and the scores. The vaccinated status of respondents significantly related to higher HPV vaccine acceptance, although age, religion, marital status, education, and working duration did not. Conclusions This study showed that vaccine-acceptance levels reflect nurses' attitudes and opinions about HPV vaccination for girls and boys.	[Kim, Hae Won; Lee, Hyang Yuol] Seoul Natl Univ, Coll Nursing, Res Inst Nursing Sci, Seoul, South Korea; [Kim, Hae Won; Lee, Young Jin] Seoul Natl Univ, Coll Nursing, Seoul, South Korea; [Kim, Seong Eun] Woosuk Univ, Dept Nursing, Jeollabuk Do, South Korea; [Ahn, Hye Young] Eulji Univ, Coll Nursing, Daejeon, South Korea; [Kim, Yeon Hee] Asan Med Ctr, Dept Nursing, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Woosuk University; Eulji University; University of Ulsan; Asan Medical Center	Lee, HY (corresponding author), Seoul Natl Univ, Coll Nursing, Res Inst Nursing Sci, Seoul, South Korea.	hyangyuol.lee@gmail.com	kim, hae won/E-9905-2015	kim, hae won/0000-0002-6730-1575	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning [2015-R1-A1-A3A0-4001267]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning	Hae Won Kim received a research grant of the Basic Science Research Program through the National Research Foundation of Korea(NRF), which funded by the Ministry of Science, ICT & Future Planning (grant number: 2015-R1-A1-A3A0-4001267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2488; Bratic JS, 2016, CURR OPIN PEDIATR, V28, P407, DOI 10.1097/MOP.0000000000000353; Bruno DM, 2014, VACCINE, V32, P4149, DOI 10.1016/j.vaccine.2014.05.058; Centers for Disease Control and Prevention, HPV VACC IS CAN PREV; Centers for Disease Control and Prevention, HPV ASSOCIATED CANCE; Collange F, 2016, VACCINE, V34, P762, DOI 10.1016/j.vaccine.2015.12.054; Dorell CG, 2011, PEDIATRICS, V128, P830, DOI 10.1542/peds.2011-0950; Dube E, 2016, CAN MED ASSOC J, V188, pE17, DOI 10.1503/cmaj.150707; Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039; Giambi C, 2018, VACCINE, V36, P779, DOI 10.1016/j.vaccine.2017.12.074; Gilkey MB, 2016, VACCINE, V34, P1187, DOI 10.1016/j.vaccine.2016.01.023; Gorjana R, 2017, PREV MED, V95, P26, DOI 10.1016/j.ypmed.2016.11.019; Grandahl M, 2019, HUM VACC IMMUNOTHER, V15, P1794, DOI 10.1080/21645515.2018.1551670; Grandahl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175883; Handler NS, 2015, J AM ACAD DERMATOL, V73, P759, DOI 10.1016/j.jaad.2015.05.041; Hoefer L, 2018, HUM VACC IMMUNOTHER, V14, P134, DOI 10.1080/21645515.2017.1379640; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Killian M, 2016, EUR J CLIN MICROBIOL, V35, P1837, DOI 10.1007/s10096-016-2735-4; Kim HW, 2013, ASIA-PAC J PUBLIC HE, V25, P248, DOI 10.1177/1010539512444307; Kim HW, 2012, VACCINE, V30, P5327, DOI 10.1016/j.vaccine.2012.06.040; Kim HW, 2009, P 19 WORLD C SEX HLT, P284; Korean Centers for Disease Control and Prevention, EARL PREV ANSW YOUNG; Korean Centers for Disease Control and Prevention, FREE HPV VACC IS AV; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; McRee AL, 2014, J PEDIATR HEALTH CAR, V28, P541, DOI 10.1016/j.pedhc.2014.05.003; Morrone T, 2017, HUM VACC IMMUNOTHER, V13, P1921, DOI 10.1080/21645515.2017.1313940; Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271; Nilsen K, 2017, SCAND J PRIM HEALTH, V35, P387, DOI 10.1080/02813432.2017.1358433; Oh JK, 2018, CANCER RES TREAT, V50, P436, DOI 10.4143/crt.2017.174; Perez MRO, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0034-9; 이은주, 2011, Asian Oncology Nursing, V11, P65; Perkins RB, 2015, VACCINE, V33, P1223, DOI 10.1016/j.vaccine.2014.11.021; Reiter PL, 2013, AM J PUBLIC HEALTH, V103, P1419, DOI 10.2105/AJPH.2012.301189; Rosen BL, 2017, PSYCHOL HEALTH MED, V22, P535, DOI 10.1080/13548506.2016.1173710; Rosen BL, 2016, J SCH NURS, V32, P138, DOI 10.1177/1059840515583312; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Scott K, 2016, J COMMUN HEALTH, V41, P197, DOI 10.1007/s10900-015-0069-2; Sung T., 2007, EASY STAT ANAL USING; Vorsters A, 2018, VACCINE, V36, P5219, DOI 10.1016/j.vaccine.2018.06.066; White Leah, 2016, Pediatr Nurs, V42, P21; World Health Organization, VACC NAT IMM PROGR U	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211475	10.1371/journal.pone.0211475	http://dx.doi.org/10.1371/journal.pone.0211475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726267	gold, Green Submitted, Green Published			2022-12-26	WOS:000457874000067
J	Miehls, SM; Holbrook, CM; Marsden, JE				Miehls, Scott M.; Holbrook, Christopher M.; Marsden, J. Ellen			Diel activity of newly metamorphosed juvenile sea lamprey (Petromyzon marinus)	PLOS ONE			English	Article							SALMON SALMO-SALAR; ATLANTIC SALMON; MIGRATORY BEHAVIOR; LAMPETRA-FLUVIATILIS; PACIFIC LAMPREY; RIVER; SMOLTS; TEMPERATURE; WATER; MANAGEMENT	Timing of activity, especially for juvenile anadromous fishes undertaking long migrations can be critical for survival. River-resident larval sea lamprey metamorphose into juveniles and migrate from their larval stream habitats in fall through spring, but diel timing of this migratory behavior is not well understood. Diel activity was determined for newly metamorphosed sea lamprey using day/night net sampling and passive integrated transponder (PIT) telemetry in two natural streams and PIT telemetry in an artificial stream. Downstream migration was primarily nocturnal in all studies. All but one of 372 sea lamprey were captured during night sampling in the day/night net collections and all detections (N = 56) for the in-stream PIT telemetry occurred within a few hours after sunset. Most (81% of 48) tagged lamprey moved downstream during the first night following release and moved at speeds consistent with observed water velocities. During long-term observation of behavior in the artificial stream most sea lamprey movement occurred during the night with limited occurrence of movement during daylight hours. Understanding seasonal and diel timing of downstream migration behavior may allow more effective management of sea lamprey for both conservation and control.	[Miehls, Scott M.; Holbrook, Christopher M.] US Geol Survey, Great Lakes Sci Ctr, Hammond Bay Biol Stn, Millersburg, MI 49759 USA; [Marsden, J. Ellen] Univ Vermont, Rubenstein Ecosyst Sci Lab, Burlington, VT USA	United States Department of the Interior; United States Geological Survey; University of Vermont	Miehls, SM (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Hammond Bay Biol Stn, Millersburg, MI 49759 USA.	smiehls@usgs.gov		Miehls, Scott/0000-0002-5546-1854	Great Lakes Fishery Commission	Great Lakes Fishery Commission	Funding was provided by the Great Lakes Fishery Commission and the Lake Champlain Sea Lamprey Alternative Control Workgroup to SMM and JEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], T AM FISH SOC; Applegate V. C., 1950, 55 US DEP INT FISH W; Applegate V.C., 1961, DOWNSTREAM MOVEMENT; Binder TR, 2013, CAN J ZOOL, V91, P635, DOI 10.1139/cjz-2013-0041; Binder TR, 2008, CAN J FISH AQUAT SCI, V65, P1113, DOI 10.1139/F08-070; Bracken FSA, 2013, RIVER RES APPL, V29, P1073, DOI 10.1002/rra.2596; Chapman ED, 2013, ENVIRON BIOL FISH, V96, P273, DOI 10.1007/s10641-012-0001-x; Christie GC, 2003, J GREAT LAKES RES, V29, P1, DOI 10.1016/S0380-1330(03)70474-2; Clemens BJ, 2010, FISHERIES, V35, P580, DOI 10.1577/1548-8446-35.12.580; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dainys J, 2017, ENVIRON BIOL FISH, P1; Dauble DD, 2006, ENVIRON BIOL FISH, V75, P167, DOI 10.1007/s10641-005-4698-7; Dawson HA, 2015, FISH FISH SER, V37, P75, DOI 10.1007/978-94-017-9306-3_3; Dingle H, 1996, BIOL LIFE MOVE; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; GODIN JGJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P359, DOI 10.1007/BF00197006; GODIN JGJ, 1988, CAN J ZOOL, V66, P2360, DOI 10.1139/z88-350; Goodman D. H., 2015, CANADIAN J FISHERIES, V72, P1; Hanson L.H., 1989, North American Journal of Fisheries Management, V9, P327, DOI 10.1577/1548-8675(1989)009<0327:DMORMS>2.3.CO;2; Hardisty M.W., 2006, LAMPREYS LIFE JAWS; Hollander M., 1973, NONPARAMETRIC STAT M, P115; Johnson GE, 2006, REV FISH SCI, V14, P213, DOI 10.1080/10641260600864023; Johnson NS, 2014, RIVER RES APPL, V30, P1146, DOI 10.1002/rra.2703; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Katopodis C., 1994, SEA LAMPREY BARRIERS; Kujawa R, 2018, AQUACULT INT, V26, P27, DOI 10.1007/s10499-017-0190-6; LABAR GW, 1978, J CONSEIL, V38, P257; Lacroix GL, 1996, J FISH BIOL, V49, P1086; Lampman R, 2016, JAWLESS FISHES WORLD; Lucas MC, 2007, 256 SCOTT NAT HER; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Manion P. J., 1978, 30 GREAT LAK FISH 2; Manion P.J., 1971, BIOL LARVAL SEA LAMP; McCormick SD, 1998, CAN J FISH AQUAT SCI, V55, P77, DOI 10.1139/d98-011; Mesa M.G., 2015, SYNTHESIS JUVENILE L; Moore A, 1998, HYDROBIOLOGIA, V372, P295; MOORE A, 1995, CAN J FISH AQUAT SCI, V52, P1923, DOI 10.1139/f95-784; Moser ML, 2015, REV FISH BIOL FISHER, V25, P103, DOI 10.1007/s11160-014-9372-8; Pavlov DS, 2017, BIOL BULL+, V44, P290, DOI 10.1134/S1062359017030062; Pohlert T., 2014, PAIRWISE MULTIPLE CO; Potter I.C., 1982, BIOL LAMPREYS, P137; POTTER IC, 1973, J ZOOL, V169, P365; POTTER IC, 1970, J ZOOL, V161, P487; POTTER IC, 1980, CAN J FISH AQUAT SCI, V37, P1641, DOI 10.1139/f80-212; Quintella BR, 2005, J FISH BIOL, V66, P97, DOI 10.1111/j.0022-1112.2005.00584.x; Silva S, 2013, HYDROBIOLOGIA, V700, P277, DOI 10.1007/s10750-012-1237-3; Simard L.G., 2017, ANIM BIOTELEM, V5, P18, DOI [10.1186/s40317-017-0133-z, DOI 10.1186/S40317-017-0133-Z]; Sotola VA, 2018, J GREAT LAKES RES, V44, P491, DOI 10.1016/j.jglr.2018.03.004; Spence BC, 2010, CAN J FISH AQUAT SCI, V67, P1316, DOI 10.1139/F10-060; Sutphin ZA, 2010, NORTHWEST SCI, V84, P196, DOI 10.3955/046.084.0209; Thorstad EB, 2004, ENVIRON BIOL FISH, V71, P305, DOI 10.1007/s10641-004-1264-7; Trancart T, 2013, ENDANGER SPECIES RES, V21, P181, DOI 10.3354/esr00517; Zydlewski GB, 2005, CAN J FISH AQUAT SCI, V62, P68, DOI 10.1139/F04-179	53	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211687	10.1371/journal.pone.0211687	http://dx.doi.org/10.1371/journal.pone.0211687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726289	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000072
J	Parthipan, A; Banerjee, I; Humphreys, K; Asch, SM; Curtin, C; Carroll, I; Hernandez-Boussard, T				Parthipan, Arjun; Banerjee, Imon; Humphreys, Keith; Asch, Steven M.; Curtin, Catherine; Carroll, Ian; Hernandez-Boussard, Tina			Predicting inadequate postoperative pain management in depressed patients: A machine learning approach	PLOS ONE			English	Article							ANTECEDENT RISK-FACTOR; DRUG-INTERACTIONS; CYP2D6; PHARMACOKINETICS; MORPHINE; ONSET	Widely-prescribed prodrug opioids (e.g., hydrocodone) require conversion by liver enzyme CYP-2D6 to exert their analgesic effects. The most commonly prescribed antidepressant, selective serotonin reuptake inhibitors (SSRIs), inhibits CYP-2D6 activity and therefore may reduce the effectiveness of prodrug opioids. We used a machine learning approach to identify patients prescribed a combination of SSRIs and prodrug opioids postoperatively and to examine the effect of this combination on postoperative pain control. Using EHR data from an academic medical center, we identified patients receiving surgery over a 9-year period. We developed and validated natural language processing (NLP) algorithms to extract depression-related information (diagnosis, SSRI use, symptoms) from structured and unstructured data elements. The primary outcome was the difference between preoperative pain score and postoperative pain at discharge, 3-week and 8-week time points. We developed computational models to predict the increase or decrease in the postoperative pain across the 3 time points by using the patient's EHR data (e.g. medications, vitals, demographics) captured before surgery. We evaluate the generalizability of the model using 10-fold cross-validation method where the holdout test method is repeated 10 times and mean area-under-the-curve (AUC) is considered as evaluation metrics for the prediction performance. We identified 4,306 surgical patients with symptoms of depression. A total of 14.1% were prescribed both an SSRI and a prodrug opioid, 29.4% were prescribed an SSRI and a non-prodrug opioid, 18.6% were prescribed a prodrug opioid but were not on SSRIs, and 37.5% were prescribed a non-prodrug opioid but were not on SSRIs. Our NLP algorithm identified depression with a F1 score of 0.95 against manual annotation of 300 randomly sampled clinical notes. On average, patients receiving prodrug opioids had lower average pain scores (p<0.05), with the exception of the SSRI+ group at 3-weeks postoperative follow-up. However, SSRI+/Prodrug+ had significantly worse pain control at discharge, 3 and 8-week follow-up (p < .01) compared to SSRI+/Prodrug- patients, whereas there was no difference in pain control among the SSRI- patients by prodrug opioid (p>0.05). The machine learning algorithm accurately predicted the increase or decrease of the discharge, 3-week and 8-week follow-up pain scores when compared to the pre-operative pain score using 10-fold cross validation (mean area under the receiver operating characteristic curve 0.87, 0.81, and 0.69, respectively). Preoperative pain, surgery type, and opioid tolerance were the strongest predictors of postoperative pain control. We provide the first direct clinical evidence that the known ability of SSRIs to inhibit prodrug opioid effectiveness is associated with worse pain control among depressed patients. Current prescribing patterns indicate that prescribers may not account for this interaction when choosing an opioid. The study results imply that prescribers might instead choose direct acting opioids (e.g. oxycodone or morphine) in depressed patients on SSRIs.	[Parthipan, Arjun] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Banerjee, Imon; Hernandez-Boussard, Tina] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Humphreys, Keith] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Humphreys, Keith; Asch, Steven M.] VA Palo Alto Ctr Innovat Implementat, Palo Alto, CA USA; [Asch, Steven M.; Hernandez-Boussard, Tina] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Curtin, Catherine] VA Palo Alto Healthcare Syst, Dept Surg, Palo Alto, CA USA; [Curtin, Catherine; Hernandez-Boussard, Tina] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Carroll, Ian] Stanford Univ, Dept Anesthesiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Hernandez-Boussard, T (corresponding author), Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA.; Hernandez-Boussard, T (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.; Hernandez-Boussard, T (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	boussard@stanford.edu		Hernandez-Boussard, Tina/0000-0001-6553-3455	Agency for Healthcare Research and Quality [R01HS024096]; Senior Research Career Scientist Award from the Veterans Affairs Health Services Research and Development Service; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024096] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Senior Research Career Scientist Award from the Veterans Affairs Health Services Research and Development Service; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant number R01HS024096 from the Agency for Healthcare Research and Quality to TH. Dr. Humphreys was supported by a Senior Research Career Scientist Award from the Veterans Affairs Health Services Research and Development Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality or the Veterans Health Administration.	Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Armstrong SC, 2003, PSYCHOSOMATICS, V44, P167, DOI 10.1176/appi.psy.44.2.167; Barrett N, 2009, ST HEAL T, V143, P441, DOI 10.3233/978-1-58603-979-0-441; Carroll LJ, 2004, PAIN, V107, P134, DOI 10.1016/j.pain.2003.10.009; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Currie SR, 2005, PSYCHOL MED, V35, P1275, DOI 10.1017/S0033291705004952; Enggaard TP, 2006, ANESTH ANALG, V102, P146, DOI 10.1213/01.ane.0000189613.61910.32; Gawande AA, 2017, ANN SURG, V265, P693, DOI 10.1097/SLA.0000000000002133; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gregory KB, 2019, BIOMETRICS, V75, P13, DOI 10.1111/biom.12973; Heiskanen T, 1998, CLIN PHARMACOL THER, V64, P603, DOI 10.1016/S0009-9236(98)90051-0; Hsu YW, 2005, ANESTHESIOLOGY, V103, P613, DOI 10.1097/00000542-200509000-00026; Huang S, 2018, BIOMETRICS, V74, P1045, DOI 10.1111/biom.12868; Humphreys K, 2017, LANCET, V390, P437, DOI 10.1016/S0140-6736(17)31918-9; Kalkman CJ, 2003, PAIN, V105, P415, DOI 10.1016/S0304-3959(03)00252-5; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Larson SL, 2004, PSYCHOL MED, V34, P211, DOI 10.1017/S0033291703001041; Leppert W, 2011, PHARMACOLOGY, V87, P274, DOI 10.1159/000326085; Monte AA, 2014, ACAD EMERG MED, V21, P879, DOI 10.1111/acem.12431; Nielsen S, 2016, PHARMACOEPIDEM DR S, V25, P733, DOI 10.1002/pds.3945; Phillips DM, 2000, JAMA-J AM MED ASSOC, V284, P428, DOI 10.1001/jama.284.4.428; Samer CF, 2010, BRIT J PHARMACOL, V160, P907, DOI 10.1111/j.1476-5381.2010.00673.x; Tedesco D, 2017, HEALTH AFFAIR, V36, P1748, DOI 10.1377/hlthaff.2017.0260; Toblin RL, 2010, J CLIN PSYCHIAT, V71, P491, DOI 10.4088/JCP.09m05567blu; Waljee JF, 2017, ANN SURG, V265, P728, DOI 10.1097/SLA.0000000000001904; Wynn GH, 2005, PSYCHOSOMATICS, V46, P79, DOI 10.1176/appi.psy.46.1.79	26	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210575	10.1371/journal.pone.0210575	http://dx.doi.org/10.1371/journal.pone.0210575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726237	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000021
J	Haines, N; Southward, MW; Cheavens, JS; Beauchaine, T; Ahn, WY				Haines, Nathaniel; Southward, Matthew W.; Cheavens, Jennifer S.; Beauchaine, Theodore; Ahn, Woo-Young			Using computer-vision and machine learning to automate facial coding of positive and negative affect intensity	PLOS ONE			English	Article							EMOTIONAL EXPRESSION; ELECTROMYOGRAPHIC ACTIVITY; BEHAVIORAL MARKERS; BASIC EMOTIONS; VALENCE; RECOGNITION; VALIDATION; SMILE	Facial expressions are fundamental to interpersonal communication, including social interaction, and allow people of different ages, cultures, and languages to quickly and reliably convey emotional information. Historically, facial expression research has followed from discrete emotion theories, which posit a limited number of distinct affective states that are represented with specific patterns of facial action. Much less work has focused on dimensional features of emotion, particularly positive and negative affect intensity. This is likely, in part, because achieving inter-rater reliability for facial action and affect intensity ratings is painstaking and labor-intensive. We use computer-vision and machine learning (CVML) to identify patterns of facial actions in 4,648 video recordings of 125 human participants, which show strong correspondences to positive and negative affect intensity ratings obtained from highly trained coders. Our results show that CVML can both (1) determine the importance of different facial actions that human coders use to derive positive and negative affective ratings when combined with interpretable machine learning methods, and (2) efficiently automate positive and negative affect intensity coding on large facial expression databases. Further, we show that CVML can be applied to individual human judges to infer which facial actions they use to generate perceptual emotion ratings from facial expressions.	[Haines, Nathaniel; Southward, Matthew W.; Cheavens, Jennifer S.; Beauchaine, Theodore] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Ahn, Woo-Young] Seoul Natl Univ, Dept Psychol, Seoul, South Korea	University System of Ohio; Ohio State University; Seoul National University (SNU)	Ahn, WY (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.	wahn55@snu.ac.kr	Southward, Matt/AAX-3746-2020; Beauchaine, Theodore P/CAF-4478-2022	Southward, Matt/0000-0002-5888-2769; Haines, Nathaniel/0000-0001-6654-9010				Ahn WY, 2016, CURR OPIN BEHAV SCI, V11, P1, DOI 10.1016/j.cobeha.2016.02.001; Ahn WY, 2016, DRUG ALCOHOL DEPEN, V161, P247, DOI 10.1016/j.drugalcdep.2016.02.008; Ahn WY, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00034; Ahn WY, 2017, EASYML EASILY BUILD; Amirian M, 2016, PROCEEDINGS OF THE 6TH INTERNATIONAL WORKSHOP ON AUDIO/VISUAL EMOTION CHALLENGE (AVEC'16), P67, DOI 10.1145/2988257.2988260; Bailenson JN, 2008, INT J HUM-COMPUT ST, V66, P303, DOI 10.1016/j.ijhcs.2007.10.011; Baltrusaitis T, 2016, IEEE WINT CONF APPL; Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; Bartlett MS, 1999, PSYCHOPHYSIOLOGY, V36, P253, DOI 10.1017/S0048577299971664; Belsky J, 1996, DEV PSYCHOL, V32, P289, DOI 10.1037/0012-1649.32.2.289; Bonanno GA, 2004, PSYCHOL SCI, V15, P482, DOI 10.1111/j.0956-7976.2004.00705.x; Boukricha H., 2009, 2009 3 INT C AFFECTI, P1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BROWN SL, 1980, BIOL PSYCHOL, V11, P49, DOI 10.1016/0301-0511(80)90026-5; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Celani G, 1999, J AUTISM DEV DISORD, V29, P57, DOI 10.1023/A:1025970600181; Cohn J. F., 2005, NEW HDB METHODS NONV, P9; Del Libano M, 2018, ACTA PSYCHOL, V187, P19, DOI 10.1016/j.actpsy.2018.04.019; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 2005, WHAT FACE REVEALS BA, DOI DOI 10.1093/ACPROF:OSO/9780195179644.001.0001; Erickson K, 2003, BRAIN COGNITION, V52, P52, DOI 10.1016/S0278-2626(03)00008-3; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; Greenwell BM., 2018, SIMPLE EFFECTIVE MOD; Gunes Hatice, 2010, International Journal of Strategic Synthetic Emotions, V1, P68, DOI 10.4018/jse.2010101605; Haamer E, 2018, REV EMOTION RECOGNIT; Haines N, REGRET INDUCES UNPUB; Hammal Z, 2015, 2015 ACM INT C MULT; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561; Keltner D., 2000, HDB EMOTIONS, P236; Korb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099194; Kossaifi J, 2017, IMAGE VISION COMPUT, V65, P23, DOI 10.1016/j.imavis.2017.02.001; Kotsia I, 2007, IEEE T IMAGE PROCESS, V16, P172, DOI 10.1109/TIP.2006.884954; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang PJ, 1995, INT AFFECTIVE PICTUR; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Lewinski P, 2014, J NEUROSCI PSYCHOL E, V7, P227, DOI 10.1037/npe0000028; Littlewort G., 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P298, DOI 10.1109/FG.2011.5771414; Martinez AM, 2017, CURR OPIN PSYCHOL, V17, P27, DOI 10.1016/j.copsyc.2017.06.009; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Messinger DS, 2012, EMOTION, V12, P430, DOI 10.1037/a0026498; Mollahosseini Ali, 2017, IEEE T AFFECT COMPUT, DOI 10.1109/TAFFC.2016.2582490; Nicolaou MA, 2011, IEEE T AFFECT COMPUT, V2, P92, DOI 10.1109/T-AFFC.2011.9; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Pu XR, 2015, NEUROCOMPUTING, V168, P1173, DOI 10.1016/j.neucom.2015.05.005; Reed LI, 2014, PSYCHOL SCI, V25, P1511, DOI 10.1177/0956797614531027; Reed LI, 2012, EVOL HUM BEHAV, V33, P200, DOI 10.1016/j.evolhumbehav.2011.09.003; Ringeval F., 2015, P 5 INT WORKSH AUD V, P3, DOI [10.1145/2808196.2811642, DOI 10.1145/2808196.2811642]; Rosenthal Robert, 2005, P NEW HDB METHODS NO, P199; RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570; Sikka K, 2015, PEDIATRICS, V136, pE124, DOI 10.1542/peds.2015-0029; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Southward MW, 2017, J SOC CLIN PSYCHOL, V36, P142, DOI 10.1521/jscp.2017.36.2.142; Srinivasan R, 2016, J NEUROSCI, V36, P4434, DOI 10.1523/JNEUROSCI.1704-15.2016; Stockli S, 2018, BEHAV RES METHODS, V50, P1446, DOI 10.3758/s13428-017-0996-1; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	62	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211735	10.1371/journal.pone.0211735	http://dx.doi.org/10.1371/journal.pone.0211735			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2MO	30721270	Green Published, Green Submitted, gold			2022-12-26	WOS:000457746300024
J	Xu, WJ; Huang, QY; Stabach, J; Buho, H; Leimgruber, P				Xu, Wenjing; Huang, Qiongyu; Stabach, Jared; Buho, Hoshino; Leimgruber, Peter			Railway underpass location affects migration distance in Tibetan antelope (Pantholops hodgsonii)	PLOS ONE			English	Article							NATIONAL NATURE-RESERVE; MITIGATION; WILDLIFE; CONNECTIVITY; PATTERNS; IMPACTS	Wildlife crossings are designed to mitigate barrier effects of transportation infrastructure on wildlife movement. Most efforts in evaluating crossing efficiency focus on counting animal use. However, crossings placed at suboptimal locations may alter animals' natural movement pattern and decrease population fitness, which cannot be reflected solely by counts of animal use. The long-distance migration of Tibetan antelope (Pantholops hodgsonii) is directly affected by the Qinghai-Tibet Railway (QTR). Using the Wubei wildlife underpass along the QTR, we evaluated how underpass placement affects migration routes and decreases movement efficiency. We calculated the net-squared displacement of each animal to identify migration segments (wintering, calving, and migrating) based on Argos tracking data. We used two corridor modeling methods to identify optimal routes that theoretically require less energy to travel between seasonal habitats. We calculated the distance from actual migration routes recorded by Argos to the modelled optimal routes. We found that antelopes stray farther away from the optimal routes as they approach Wubei, indicating that animals have to deviate from their optimal migration pathway to access the railway underpass. On average, antelopes prolong their migration distance by 86.19 km (SEM = 17.29 km) in order to access the underpass. Our study suggests crossing location can affect animal migrations even if structures facilitate animal crossing. To better conserve long-distance migrations, long-term studies using tracking data which evaluate optimal migration routes are needed. We suggest considering the location and structural characteristics in designing and improving wildlife crossings, which do not only facilitate utilization, but also optimize animal movement processes such as migration.	[Xu, Wenjing; Huang, Qiongyu; Stabach, Jared; Leimgruber, Peter] Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [Buho, Hoshino] Rakuno Gakuen Univ, Dept Environm & Symbiot Sci, Environm Remote Sensing Lab, Ebetsu, Hokkaido, Japan; [Xu, Wenjing] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Rakuno Gakuen University; University of California System; University of California Berkeley	Xu, WJ (corresponding author), Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA.; Buho, H (corresponding author), Rakuno Gakuen Univ, Dept Environm & Symbiot Sci, Environm Remote Sensing Lab, Ebetsu, Hokkaido, Japan.; Xu, WJ (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	wenjing.xu@berkeley.edu; aosier@rakuno.ac.jp	Stabach, Jared/AEX-9187-2022; Hoshino, Buho/A-1281-2017; Leimgruber, Peter/O-1304-2015; Xu, Wenjing/AAQ-3611-2021	Stabach, Jared/0000-0002-7896-1237; Hoshino, Buho/0000-0002-5909-7869; Leimgruber, Peter/0000-0002-3682-0153; Huang, Qiongyu/0000-0002-1450-3587; Xu, Wenjing/0000-0001-5657-2364	Japan Society for the Promotion of Science [19255005]; Smithsonian Graduate Student Fellowship	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smithsonian Graduate Student Fellowship	Animal capture and collaring was funded by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (KAKENHI), Grant ID 19255005. The leading author of this manuscript, Xu, received the Smithsonian Graduate Student Fellowship, which allows her to conduct this study during her residence at the Smithsonian Conservation Biology Institute. There was no additional external funding received for this study.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Ament R, 2008, ENVIRON MANAGE, V42, P480, DOI 10.1007/s00267-008-9112-8; Baxter-Gilbert JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120537; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bolger DT, 2008, ECOL LETT, V11, P63; Bu Q, 2013, RAILW OCCUP SAF HEAL, V3, P111; Buho H, 2011, ADV SPACE RES, V48, P43, DOI 10.1016/j.asr.2011.02.015; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Clevenger AP, 2005, GAIA, V14, P124, DOI 10.14512/gaia.14.2.12; Cui X, 2009, CLIM CHANG, V94, P41; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hoshino B, 2012, J RAKUNO GAKUEN U, V37, P61; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Leslie David M. Jr., 2008, Mammalian Species, P1, DOI 10.1644/817.1; Li Y, 2008, CHINA RAILW SCI, V4, P127; Manayeva K, 2012, J RAKUNO GAKUEN U, V36, P339; Manayeva K., 2014, MIGRATION PATTERNS H; Manly BFL., 2007, RESOURCE SELECTION A; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Middleton AD, 2013, ECOLOGY, V94, P1245, DOI 10.1890/11-2298.1; Murray Martyn G., 1995, P231; Olson K.A., 2009, MONGOLIAN J BIOL S, V7, P45; Peaden JM, 2015, WILDLIFE RES, V42, P650, DOI 10.1071/WR15082; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R Core Team, 2021, R LANGUAGE ENV STAT; Rytwinski T, 2015, J ENVIRON MANAGE, V154, P48, DOI 10.1016/j.jenvman.2015.01.048; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; SCHALLER GB, 1991, APPL ANIM BEHAV SCI, V29, P361, DOI 10.1016/0168-1591(91)90261-U; Schaller GB., 1998, WILDLIFE TIBETAN STE; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Singh N, 2016, PLOS ONE, V11, P1; Stabach JA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1428; Su XK, 2015, J NAT CONSERV, V28, P119, DOI 10.1016/j.jnc.2015.09.008; Taylor BD, 2010, WILDLIFE RES, V37, P320, DOI 10.1071/WR09171; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; van der Ree R, 2009, ECOL SOCEITY, V16; van der Ree R, 2015, HANDBOOK OF ROAD ECOLOGY, P71; Xia L, 2007, ORYX, V41, P352, DOI 10.1017/S0030605307000116; Yang QS, 2008, NATURE, V452, P810, DOI 10.1038/452810c; Yu HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41212; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zhao HD, 2014, ECOL RES, V29, P1065, DOI 10.1007/s11284-014-1193-7	46	11	12	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211798	10.1371/journal.pone.0211798	http://dx.doi.org/10.1371/journal.pone.0211798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716135	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200050
J	Muhsen, M; Protschka, M; Schneider, LE; Muller, U; Kohler, G; Magin, TM; Buttner, M; Alber, G; Siegemund, S				Muhsen, Mahmod; Protschka, Martina; Schneider, Laura E.; Mueller, Uwe; Koehler, Gabriele; Magin, Thomas M.; Buettner, Mathias; Alber, Gottfried; Siegemund, Sabine			Orf virus (ORFV) infection in a three-dimensional human skin model: Characteristic cellular alterations and interference with keratinocyte differentiation	PLOS ONE			English	Article							PARAPOXVIRUS-OVIS; TERMINAL DIFFERENTIATION; PROTEIN FUNCTION; GENE-EXPRESSION; VEGF-E; CELLS; PATHOGENESIS; PROLIFERATION; INTERLEUKIN-6; KERATIN-10	ORF virus (ORFV) is the causative agent of contagious ecthyma, a pustular dermatitis of small ruminants and humans. Even though the development of lesions caused by ORFV was extensively studied in animals, only limited knowledge exists about the lesion development in human skin. The aim of the present study was to evaluate a three-dimensional (3D) organotypic culture (OTC) as a human skin model for ORFV infection considering lesion development, replication of the virus, viral gene transcription and modulation of differentiation of human keratinocytes by ORFV. ORFV infection of OTC was performed using the ORFV isolate B029 derived from a human patient. The OTC sections showed a similar structure of stratified epidermal keratinocytes as human foreskin and a similar expression profile of the differentiation markers keratin 1 (K1), K10, and loricrin. Upon ORFV infection, OTCs exhibited histological cytopathic changes including hyperkeratosis and ballooning degeneration of the keratinocytes. ORFV persisted for 10 days and was located in keratinocytes of the outer epidermal layers. ORFV-specific early, intermediate and late genes were transcribed, but limited viral spread and restricted cell infection were noticed. ORFV infection resulted in downregulation of K1, K10, and loricrin at the transcriptional level without affecting proliferation as shown by PCNA or Ki-67 expression. In conclusion, OTC provides a suitable model to study the interaction of virus with human keratinocytes in a similar structural setting as human skin and reveals that ORFV infection downregulates several differentiation markers in the epidermis of the human skin, a hitherto unknown feature of dermal ORFV infection in man.	[Muhsen, Mahmod; Protschka, Martina; Schneider, Laura E.; Mueller, Uwe; Buettner, Mathias; Alber, Gottfried; Siegemund, Sabine] Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, Leipzig, Germany; [Koehler, Gabriele] Klinikum Fulda gAG, Inst Pathol, Fulda, Germany; [Magin, Thomas M.] Univ Leipzig, Div Cell & Dev Biol, Inst Biol, Leipzig, Germany; [Siegemund, Sabine] IDT Biol GmbH, Dessau Rosslau, Germany	Leipzig University; Klinikum Fulda; Leipzig University; IDT Biologika	Alber, G (corresponding author), Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, Leipzig, Germany.	alber@rz.uni-leipzig.de		Alber, Gottfried/0000-0001-7475-4858; Muller, Uwe/0000-0003-1502-9271	Leipzig University; Hanns Seidel Foundation, Germany; Philipp Schwartz Initiative	Leipzig University; Hanns Seidel Foundation, Germany; Philipp Schwartz Initiative	This study was supported by Leipzig University. LS was funded by the PhD program from the Hanns Seidel Foundation, Germany (no grant number is available) (URL: https://www.hss.de/stipendium/auswahlverfahren/promotionsfoerderung/). MM received a fellowship from the Philipp Schwartz Initiative, which was launched by the Alexander von Humboldt Foundation together with the German Federal Foreign Office (no grant number is available). URL://www.humboldt-foundation.de/web/philipp-schwartz-initiative.html. The commercial affiliation of GK (Klinikum Fulda gAG) and SS (IDT Biologika GmbH) did not play a role in the study. Both commercial companies did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution section.	Alkharsah KR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061642; Anacker D, 2012, JOVE-J VIS EXP, DOI 10.3791/3668; Anziliero D, 2014, BRAZ J MED BIOL RES, V47, P110, DOI 10.1590/1414-431X20133358; Arin MJ, 2011, BRIT J DERMATOL, V164, P442, DOI 10.1111/j.1365-2133.2010.10096.x; Arnette C, 2016, METHOD ENZYMOL, V569, P287, DOI 10.1016/bs.mie.2015.07.015; Avci O, 2016, J VET MED SCI, V78, P129, DOI 10.1292/jvms.15-0231; Bayer-Garner IB, 2005, J CUTAN PATHOL, V32, P28, DOI 10.1111/j.0303-6987.2005.00254.x; Bennett JR, 2016, VIRUS RES, V213, P230, DOI 10.1016/j.virusres.2015.12.015; Bodaan CJ, 2016, WOUND REPAIR REGEN, V24, P966, DOI 10.1111/wrr.12488; Buttner M, 2002, J VET MED B, V49, P7, DOI 10.1046/j.1439-0450.2002.00539.x; Callegaro CF, 2009, J CUTAN PATHOL, V36, P1279, DOI 10.1111/j.1600-0560.2009.01288.x; Cargnelutti JF, 2011, MICROB PATHOGENESIS, V50, P56, DOI 10.1016/j.micpath.2010.08.004; Chavez-Alvarez S, 2016, J AM ACAD DERMATOL, V74, pE95, DOI 10.1016/j.jaad.2015.10.047; Chen DX, 2017, ONCOTARGET, V8, P58668, DOI 10.18632/oncotarget.17417; CHIN JC, 1995, VET MICROBIOL, V46, P327, DOI 10.1016/0378-1135(95)99034-O; Choi M, 2017, BIOMOL THER, V25, P296, DOI 10.4062/biomolther.2017.043; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Dal Pozzo F, 2005, ANTIMICROB AGENTS CH, V49, P4843, DOI 10.1128/AAC.49.12.4843-4852.2005; Dal Pozzo F, 2011, J CLIN MICROBIOL, V49, P4397, DOI 10.1128/JCM.05281-11; Deane D, 2000, J VIROL, V74, P1313, DOI 10.1128/JVI.74.3.1313-1320.2000; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Ertekin SS, 2017, CUTIS, V99, pE19; Fleming SB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00046; Fleming SB, 2015, VIRUSES-BASEL, V7, P1505, DOI 10.3390/v7031505; Friebe A, 2004, J VIROL, V78, P9400, DOI 10.1128/JVI.78.17.9400-9411.2004; Friederichs S, 2015, J GEN VIROL, V96, P1446, DOI 10.1099/vir.0.000080; Friederichs S, 2014, VIRUS RES, V181, P11, DOI 10.1016/j.virusres.2013.12.015; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Gunther T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03997-y; Haddock ES, 2017, PEDIATR DERMATOL, V34, pE337, DOI 10.1111/pde.13259; Haig DM, 1997, COMP IMMUNOL MICROB, V20, P197, DOI 10.1016/S0147-9571(96)00045-8; Haig DM, 1998, VET RES, V29, P311; Harvey R, 2015, VIRUS RES, V208, P180, DOI 10.1016/j.virusres.2015.06.014; Herder V, 2011, VET DERMATOL, V22, P220, DOI 10.1111/j.1365-3164.2010.00947.x; Iizuka H, 2004, J DERMATOL, V31, P271, DOI 10.1111/j.1346-8138.2004.tb00672.x; Ishida-Yamamoto A, 2003, J DERMATOL SCI, V31, P3, DOI 10.1016/S0923-1811(02)00143-3; Jenkinson David McEWAN, 1990, Vet Dermatol, V1, P189, DOI 10.1111/j.1365-3164.1990.tb00099.x; Jiang M, 2017, EXP CELL RES, V360, P310, DOI 10.1016/j.yexcr.2017.09.021; Krause KA, 2018, STATPEARLS KOILOCYTO; Kumar V, 2016, J CELL BIOL, V212, P877, DOI 10.1083/jcb.20140414703042016c; Kumar V, 2015, J CELL BIOL, V211, P1057, DOI 10.1083/jcb.201404147; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Lear A, 1996, EUR J DERMATOL, V6, P135; Melo TC, 2015, GENET MOL RES, V14, P16712, DOI 10.4238/2015.December.11.19; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Natal E., 2012, SCREENING METHODS PR; Okeke MI, 2006, J GEN VIROL, V87, P21, DOI 10.1099/vir.0.81479-0; Porter RM, 1998, J INVEST DERMATOL, V110, P951, DOI 10.1046/j.1523-1747.1998.00218.x; Ran ML, 2015, JAMA DERMATOL, V151, P1032, DOI 10.1001/jamadermatol.2015.0760; Reichelt J, 2004, EUR J CELL BIOL, V83, P747, DOI 10.1078/0171-9335-00429; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Reijnders CMA, 2015, TISSUE ENG PT A, V21, P2448, DOI [10.1089/ten.tea.2015.0139, 10.1089/ten.TEA.2015.0139]; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Saalbach A, 2016, AM J PATHOL, V186, P639, DOI 10.1016/j.ajpath.2015.10.030; Sancho MC, 2002, J VIROL, V76, P8318, DOI 10.1128/JVI.76.16.8318-8334.2002; Scagliarini A, 2005, VET RES COMMUN, V29, P245, DOI 10.1007/s11259-005-0053-x; Son ED, 2014, J DERMATOL SCI, V74, P64, DOI 10.1016/j.jdermsci.2013.12.004; Strudwick XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123651; Sugawara T, 2001, CYTOKINE, V15, P328, DOI 10.1006/cyto.2001.0946; Tamosiunaite A, 2016, J COMP PATHOL, V155, P55, DOI 10.1016/j.jcpa.2016.05.001; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Veraldi S, 2014, INFECTION, V42, P767, DOI 10.1007/s15010-014-0591-7; von Buttlar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106188; Wise LM, 2012, CELL MICROBIOL, V14, P1376, DOI 10.1111/j.1462-5822.2012.01802.x; Wood AR, 2003, J GEN VIROL, V84, P2993, DOI 10.1099/vir.0.19455-0; Yogisharadhya R, 2018, GENE, V663, P72, DOI 10.1016/j.gene.2018.04.026; Zhao K, 2010, VET MICROBIOL, V142, P408, DOI 10.1016/j.vetmic.2009.10.006	70	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210504	10.1371/journal.pone.0210504	http://dx.doi.org/10.1371/journal.pone.0210504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699132	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600038
J	Sotomayor, MA; Reyes, JK; Restrepo, L; Dominguez-Borbor, C; Maldonado, M; Bayot, B				Sotomayor, Maria Auxiliadora; Reyes, Jessica Karina; Restrepo, Leda; Dominguez-Borbor, Cristobal; Maldonado, Martha; Bayot, Bonny			Efficacy assessment of commercially available natural products and antibiotics, commonly used for mitigation of pathogenic Vibrio outbreaks in Ecuadorian Penaeus (Litopenaeus) vannamei hatcheries	PLOS ONE			English	Article							OREGANO ESSENTIAL OIL; PACIFIC WHITE SHRIMP; IN-VITRO SUSCEPTIBILITY; ORIGANUM-VULGARE; ORGANIC-ACIDS; CHEMICAL-COMPOSITION; ENHANCED RESISTANCE; PROBIOTIC BACTERIA; IMMUNE-RESPONSE; GUT MICROBIOTA	Bacterial diseases cause high mortality in Penaeus (Litopenaeus) vannamei postlarvae. Therefore, appropriate application of efficient therapeutic products is of vital importance for disease control. This study evaluated through in vitro analyses the antimicrobial effectiveness of commercial therapeutic products used for P. vannamei bacterial diseases and antibiotics against pathogenic Vibrio strains circulating in Ecuadorian hatcheries. Twenty strains were isolated from 31 larvae samples with high bacterial counts from 10 hatcheries collected during mortality events. The strains virulence was verified through challenge tests with Artemia franciscana nauplii and P. vannamei postlarvae. Through 16S rRNA sequence analysis, strains showed a great similarity to the Vibrio sequences reported as pathogens, with 95% belonging to the Harveyi clade. Through antibiograms and minimal inhibitory concentration (MIC) in vitro tests we found that furazolidone, ciprofloxacin, chloramphenicol, norfloxacin, nalidixic acid, florfenicol, fosfomycin and enrofloxacin inhibited the growth of all or most of the strains. Less efficient antibiotics were penicillin, oxytetracycline and tetracycline. A multiple antibiotic resistance (MAR) index of 0.23 showed some level of resistance to antibiotics, with two MAR prevalent patterns (Penicillin-Oxytetracycline and Penicillin-Oxytetracycline-Tetracycline). From a total of 16 natural products (five probiotics, nine organic acids and two essential oils), only three (one probiotic, one organic acid and one essential oil) were effective to control most of the strains. Shrimp producers can apply relatively simple in vitro analyses, such as those employed in this study, to help take adequate management decisions to reduce the impact of bacterial diseases and increase profit.	[Sotomayor, Maria Auxiliadora; Reyes, Jessica Karina; Restrepo, Leda; Dominguez-Borbor, Cristobal; Maldonado, Martha; Bayot, Bonny] ESPOL, CENAIM Escuela Super Politecn Litoral, Ctr Nacl Acuicultura & Invest Marinas, Guayaquil, Ecuador; [Reyes, Jessica Karina] Univ Estatal Peninsula Santa Elena, UPSE, FCM, Via Santa Elena La Libertad, La Libertad, Ecuador; [Bayot, Bonny] ESPOL, Escuela Super Politecn Litoral, FIMCBOR, Fac Ingn Maritima Ciencias Biol Ocean & Recursos, Guayaquil, Ecuador	Escuela Superior Politecnica del Litoral; Escuela Superior Politecnica del Litoral	Sotomayor, MA; Bayot, B (corresponding author), ESPOL, CENAIM Escuela Super Politecn Litoral, Ctr Nacl Acuicultura & Invest Marinas, Guayaquil, Ecuador.; Bayot, B (corresponding author), ESPOL, Escuela Super Politecn Litoral, FIMCBOR, Fac Ingn Maritima Ciencias Biol Ocean & Recursos, Guayaquil, Ecuador.	masotomayor@espol.edu.ec; bbayot@espol.edu.ec	Domínguez Borbor, Cristóbal Leonardo/AHA-5185-2022	Domínguez Borbor, Cristóbal Leonardo/0000-0003-3204-3569; , Jessica Karina Reyes/0000-0003-3987-9465; Bayot, Bonny/0000-0003-1917-8557	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT [PIC-14-CENAIM-003]	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT	This study was funded by the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT (www.educacionsuperior.gob.ec) in the framework of the PIC-14-CENAIM-003 Project Desarrollo e implementacion de metodos de control y prevencion de enfermedades en especies acuaticas de uso comercial y uso potencial en maricultura y repoblacion (Grant to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2013, BIOLOGIA, V68, P1017, DOI 10.2478/s11756-013-0251-x; Al-Sagheer AA, 2018, AQUACULT NUTR, V24, P1006, DOI 10.1111/anu.12637; Anuta JD, 2011, J WORLD AQUACULT SOC, V42, P834, DOI 10.1111/j.1749-7345.2011.00519.x; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Barman Prasenjit, 2017, Acta Biologica Szegediensis, V61, P35; Baruah K, 2017, CELL STRESS CHAPERON, V22, P377, DOI 10.1007/s12192-017-0775-z; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Chen H, 2018, J HAZARD MATER, V343, P140, DOI 10.1016/j.jhazmat.2017.09.017; CLSI, 2015, M100S25 CLSI; da Silva BC, 2013, AQUACULTURE, V384, P104, DOI 10.1016/j.aquaculture.2012.12.017; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Defoirdt T, 2005, ENVIRON MICROBIOL, V7, P1239, DOI 10.1111/j.1462-2920.2005.00807.x; Defoirdt T, 2006, AQUACULTURE, V261, P804, DOI 10.1016/j.aquaculture.2006.06.038; Defoirdt T, 2009, BIOTECHNOL ADV, V27, P680, DOI 10.1016/j.biotechadv.2009.04.026; Dominguez-Borbor C, 2018, METHODSX, V5, P90, DOI 10.1016/j.mex.2018.01.010; FAO, 2002, STATE WORLD FISH AQU, P74; Figiel A, 2010, J FOOD ENG, V98, P240, DOI 10.1016/j.jfoodeng.2010.01.002; Garriques D, 1995, WORLD AQ M, P1; Gracia-Valenzuela MH, 2014, ARCH BIOL SCI, V66, P1367, DOI 10.2298/ABS1404367G; Gullian M, 2004, AQUACULTURE, V233, P1, DOI 10.1016/j.aquaculture.2003.09.013; Haldar S, 2011, MICROBIOL-SGM, V157, P179, DOI 10.1099/mic.0.041475-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hameed A.S. Sahul, 1995, Journal of the World Aquaculture Society, V26, P315, DOI 10.1111/j.1749-7345.1995.tb00260.x; Hasan Md Abdur Razzak, 2017, Dhaka University Journal of Biological Sciences, V26, P45; Hassaan MS, 2018, AQUACULT NUTR, V24, P83, DOI 10.1111/anu.12536; Kara K, 2018, J APPL ANIM RES, V46, P178, DOI 10.1080/09712119.2017.1284073; Karunasagar I, 1998, FISH PATHOL, V33, P413, DOI 10.3147/jsfp.33.413; KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3; Kerekes EB, 2013, J APPL MICROBIOL, V115, P933, DOI 10.1111/jam.12289; Kordali S, 2008, BIORESOURCE TECHNOL, V99, P8788, DOI 10.1016/j.biortech.2008.04.048; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Le Groumellec M., 1995, DIS ASIAN AQUACULTUR, P163; Liu X, 2017, ENVIRON POLLUT, V223, P161, DOI 10.1016/j.envpol.2017.01.003; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Balcazar JL, 2007, J INVERTEBR PATHOL, V96, P147, DOI 10.1016/j.jip.2007.04.008; Maisak H., 1995, DIS ASIAN AQUACULTUR, P309; Manzanares D. L., 2015, AES Bioflux, V7, P468; Mine S, 2011, CURR MICROBIOL, V63, P1, DOI 10.1007/s00284-011-9932-2; Mirbakhsh M, 2014, IRAN J FISH SCI, V13, P384; Mohney Leone L., 1992, Journal of Aquatic Animal Health, V4, P257, DOI 10.1577/1548-8667(1992)004&lt;0257:SATIIV&gt;2.3.CO;2; Moriarty DJW, 1998, AQUACULTURE, V164, P351, DOI 10.1016/S0044-8486(98)00199-9; NCCLS, 2004, PERFORMANCE STANDARD; Newaj-Fyzul A, 2014, AQUACULTURE, V431, P1, DOI 10.1016/j.aquaculture.2013.08.026; Ng WK, 2017, INT AQUAT RES, V9, P293, DOI 10.1007/s40071-017-0177-y; Ng WK, 2015, AQUACULTURE, V449, P69, DOI 10.1016/j.aquaculture.2015.02.006; R Core Team, 2018, R LANG ENV STAT COMP; Reboucas RH, 2011, ENVIRON RES, V111, P21, DOI 10.1016/j.envres.2010.09.012; Robertson PAW, 1998, DIS AQUAT ORGAN, V32, P151, DOI 10.3354/dao032151; Rodgers CJ, 2011, REV SCI TECH OIE, V30, P241; Rodrigues de Menezes Francisca Gleire, 2013, Arquivos de Ciencias do Mar, V46, P84; Rodriguez J, 2007, AQUACULTURE, V273, P405, DOI 10.1016/j.aquaculture.2007.10.042; Roque A, 2001, INT J ANTIMICROB AG, V17, P383, DOI 10.1016/S0924-8579(01)00308-9; Russo M, 1998, J AGR FOOD CHEM, V46, P3741, DOI 10.1021/jf980087w; Ruwandeepika HAD, 2012, REV AQUACULT, V4, P59, DOI 10.1111/j.1753-5131.2012.01061.x; Salem A. M., 2012, World Journal of Dairy & Food Sciences, V7, P41; Sarter S, 2011, VECTOR-BORNE ZOONOT, V11, P433, DOI 10.1089/vbz.2010.0069; Silvester R, 2017, CURR SCI INDIA, V112, P1749, DOI 10.18520/cs/v112/i08/1749-1755; Morales-Covarrubias MS, 2012, REV CIENT-FAC CIEN V, V22, P72; Soto-Rodriguez S, 2006, AQUACULTURE, V255, P48, DOI 10.1016/j.aquaculture.2005.11.035; Soto-Rodriguez SA, 2006, AQUACULTURE, V258, P109, DOI 10.1016/j.aquaculture.2006.04.035; Szabo MA, 2010, PHYTOTHER RES, V24, P782, DOI 10.1002/ptr.3010; Teixeira B, 2013, J SCI FOOD AGR, V93, P2707, DOI 10.1002/jsfa.6089; Tendencia EA, 2001, AQUACULTURE, V195, P193, DOI 10.1016/S0044-8486(00)00570-6; Tipmongkolsilp N., 2006, Thai Journal of Veterinary Medicine, V36, P39; Vandenberghe J, 1998, AQUACULTURE, V169, P121, DOI 10.1016/S0044-8486(98)00319-6; Vandenberghe J, 1999, APPL ENVIRON MICROB, V65, P2592; Vaseeharan B, 2005, INT J ANTIMICROB AG, V26, P285, DOI 10.1016/j.ijantimicag.2005.07.005; Vazquez JA, 2005, AQUACULTURE, V245, P149, DOI 10.1016/j.aquaculture.2004.12.008; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Webster LF, 2004, J EXP MAR BIOL ECOL, V298, P179, DOI 10.1016/S0022-0981(03)00358-7; Williams Rodney R., 1992, Journal of Aquatic Animal Health, V4, P262, DOI 10.1577/1548-8667(1992)004&lt;0262:SATITT&gt;2.3.CO;2; Zhang YB, 2011, MAR POLLUT BULL, V62, P2299, DOI 10.1016/j.marpolbul.2011.08.048; Zherdmant MT, 1997, PANORAMA ACUICOLA, V2, P28; Zidour M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01919	75	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210478	10.1371/journal.pone.0210478	http://dx.doi.org/10.1371/journal.pone.0210478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699138	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600035
J	Yue, YJ; Zhou, L; Zhu, AX; Ye, XY				Yue, Yaojie; Zhou, Lan; Zhu, A-xing; Ye, Xinyue			Vulnerability of cotton subjected to hail damage	PLOS ONE			English	Article							SIMULATED HAIL; CLIMATE-CHANGE; YIELD; WEATHER; LOSSES; GROWTH; HAZARD; IMPACT; TREND; CHINA	This paper establishes the quantitative relationships between hail fall parameters and crop damages by examining the impacts of 49 hail hazard scenarios on cotton in the bud stage and boll stage. This study utilizes simulated cotton hail hazard to analyze the following data: hail size, hail fall density, and crop damages (i.e., defoliation rate, branch breaking rate, and the fruit falling rate). The results are as follows: 1) cotton vulnerability increased via an increase in crop damages as the hail hazard magnitude increased; 2) crop damages exhibit significant logistic relationships with hail diameter and hail fall density, and the fit was better at the bud stage than at the boll stage; 3) cotton is more vulnerable to hail hazard at the bud stage than at the boll stage, and the bud stage is a critical period for cotton hail disaster prevention and mitigation; and 4) damages to cotton plant at the bud stage and boll stage were less sensitive to hail size from hail fall density. Thus, we suggest that hail diameter can be used as the priority indicator to predict hail-induced crop damages. These results provide a sound basis for developing a comprehensive evaluation of hail damage in cotton, which is crucial for promoting sustainable cotton production. We recommend that the impacts of hail-induced crop damages on yield and fiber quality need to be addressed further in future studies.	[Yue, Yaojie] Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing, Peoples R China; [Yue, Yaojie] Beijing Normal Univ, Sch Geog, Fac Geog Sci, Beijing, Peoples R China; [Zhou, Lan] Jiangxia Jinkou High Sch, Wuhan, Hubei, Peoples R China; [Zhu, A-xing] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Zhu, A-xing] Nanjing Normal Univ, Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China; [Zhu, A-xing] Nanjing Normal Univ, Sch Geog, Nanjing, Jiangsu, Peoples R China; [Ye, Xinyue] New Jersey Inst Technol, Dept Informat, Urban Informat & Spatial Comp Lab, Newark, NJ 07102 USA	Beijing Normal University; Beijing Normal University; University of Wisconsin System; University of Wisconsin Madison; Nanjing Normal University; Nanjing Normal University; New Jersey Institute of Technology	Yue, YJ (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Environm Change & Nat Disaster, Beijing, Peoples R China.; Yue, YJ (corresponding author), Beijing Normal Univ, Sch Geog, Fac Geog Sci, Beijing, Peoples R China.	yjyue@bnu.edu.cn	Yue, Yaojie/AAF-2489-2019; Ye, Xinyue/A-7677-2011	Yue, Yaojie/0000-0001-5198-1281; Ye, Xinyue/0000-0001-8838-9476	National Natural Science Foundation of China [41271515]; National Key Research and Development Program of China from the Ministry of Science and Technology of China [2016YFA0602402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China from the Ministry of Science and Technology of China	This research is financially supported by Yaojie Yue who received the funding from the National Natural Science Foundation of China, http./www.nsfc.gov.cn/, grant number 41271515, and the National Key Research and Development Program of China from the Ministry of Science and Technology of China, http://www.most.gov.cn, grant number 2016YFA0602402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLO ME, 1994, HORTSCIENCE, V29, P1465, DOI 10.21273/HORTSCI.29.12.1465; Botzen WJW, 2010, RESOUR ENERGY ECON, V32, P341, DOI 10.1016/j.reseneeco.2009.10.004; Brimelow JC, 2017, NAT CLIM CHANGE, V7, P516, DOI [10.1038/NCLIMATE3321, 10.1038/nclimate3321]; Bueckert RA, 2011, CAN J PLANT SCI, V91, P117, DOI 10.4141/CJPS10125; Changnon S. A.  Jr., 1971, Journal of Applied Meteorology, V10, P270, DOI 10.1175/1520-0450(1971)010<0270:HCRTCD>2.0.CO;2; CHANGNON SA, 1978, SCIENCE, V200, P387, DOI 10.1126/science.200.4340.387; Changnon SA, 2009, CLIMATIC CHANGE, V96, P161, DOI 10.1007/s10584-009-9597-z; Conley SP, 2009, AGRON J, V101, P120, DOI 10.2134/agronj2008.0123; Duan Y., 2009, HAIL DISASTER; Fell R, 2008, ENG GEOL, V102, P85, DOI 10.1016/j.enggeo.2008.03.022; Fuchs S, 2012, NAT HAZARDS, V64, P2129, DOI 10.1007/s11069-011-0081-5; Gall M, 2011, SUSTAINABILITY-BASEL, V3, P2157, DOI 10.3390/su3112157; Garcia RR, 1976, RELATIONSHIPS CROP D; Guo YC, 1999, CHINAS AGR DISASTER; Hoogewind KA, 2017, J CLIMATE, V30, P10081, DOI 10.1175/JCLI-D-16-0885.1; Hu Guofang, 2015, Journal of Natural Disasters, V24, P139, DOI 10.13577/j.jnd.2015.0516; IEC (International Electrotechnical Commission), 2005, IEC612152005 IDT; Irigoyen I, 2011, AM J POTATO RES, V88, P82, DOI 10.1007/s12230-010-9166-z; ISDR (International Strategy for Disaster Reduction), 2002, LIV RISK GLOB REV DI; KATZ RW, 1981, AGR METEOROL, V24, P29, DOI 10.1016/0002-1571(81)90031-5; Lane HC., 1959, BULLETIN, V934; Lang SW, 2007, BEIJING AGR, V10, P6; Lei TT, 2004, ANN BOT-LONDON, V94, P179, DOI 10.1093/aob/mch125; Lei YS, 1978, INTRO TO HAIL; Lemons H, 1942, ECON GEOGR, V18, P363, DOI 10.2307/141444; Li CS., 1993, COTTON HAIL DISASTER; Li M. Z., 2006, ANHUI AGR SCI, V34, P649; Li MX, 2016, J CLIMATE, V29, P7027, DOI 10.1175/JCLI-D-15-0500.1; Li XY, 1993, J NATURAL DISASTERS, V2, P47; Papathoma-Kohle M, 2011, NAT HAZARDS, V58, P645, DOI 10.1007/s11069-010-9632-4; Pavek MJ, 2018, AM J POTATO RES, V95, P33, DOI 10.1007/s12230-017-9612-2; QIN DH, 2007, J NAT DIS, V16, P46, DOI DOI 10.3969/J.ISSN.1004-4574.2007.Z1.013; Sanchez JL, 1996, J APPL METEOROL, V35, P1535, DOI 10.1175/1520-0450(1996)035<1535:CDTHSF>2.0.CO;2; Schiesser HH, 1990, ATMOS RES, V25, P559, DOI 10.1016/0169-8095(90)90038-E; Seino H., 1980, Journal of Agricultural Meteorology, V36, P81, DOI 10.2480/agrmet.36.81; Seino H, 1985, J AGR METEOROL, V40, DOI [10.2480/agrmet.40.361, DOI 10.2480/AGRMET.40.361]; Shan YC, 1998, METEOROLOGICAL MONTH, V24, P49; Shi P.J., 2011, ATLAS NATURAL DISAST; Sij JW, 2005, AGRON J, V97, P1636, DOI 10.2134/agronj2004.0283; Skripnikova K, 2014, ATMOS RES, V144, P175, DOI 10.1016/j.atmosres.2013.06.002; SMITH CW, 1981, AGRON J, V73, P597, DOI 10.2134/agronj1981.00021962007300040007x; [孙宏勇 SUN HongYong], 2006, [中国生态农业学报, Chinese journal of eco-agriculture], V14, P173; UNDRO, 1982, NAT DIS VULN AN; Velten S, 2015, SUSTAINABILITY-BASEL, V7, P7833, DOI 10.3390/su7067833; WANG L, 2016, SUSTAINABILITY-BASEL, V8, DOI DOI 10.3390/SU8030218; WILLE MJ, 1992, AM POTATO J, V69, P705, DOI 10.1007/BF02853814; Wilson LJ, 2003, CROP SCI, V43, P2125, DOI 10.2135/cropsci2003.2125; Yu S-X, 2012, J SHENYANG AGR U, V14, P3; [岳耀杰 Yue Yaojie], 2015, [灾害学, Journal of Catastrophology], V30, P102; Yue YJ, 2015, [China, Chinese patent], Patent No. [ZL201120558289.0, ZL201120558289]; Yue YJ, 2013, [China, Chinese patent], Patent No. [ZL201210038963.1, ZL201210038963]; Zhang QH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42310; [赵金涛 Zhao Jintao], 2015, [中国农业气象, Chinese Journal of Agrometeorology], V36, P083; Zhao JT, 2011, CHINESE COTTON HAILS; Zhao XW, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010233; Zhou JF, 2016, COMPUT ELECTRON AGR, V127, P406, DOI 10.1016/j.compag.2016.06.019; [周兰 Zhou Lan], 2014, [中国农业气象, Chinese Journal of Agrometeorology], V35, P330; Zou T, 2018, GEOPHYS RES LETT, V45, P4485, DOI 10.1029/2018GL077069	58	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210787	10.1371/journal.pone.0210787	http://dx.doi.org/10.1371/journal.pone.0210787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699171	gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600054
J	Bubak, AN; Watt, MJ; Renner, KJ; Luman, AA; Costabile, JD; Sanders, EJ; Grace, JL; Swallow, JG				Bubak, Andrew N.; Watt, Michael J.; Renner, Kenneth J.; Luman, Abigail A.; Costabile, Jamie D.; Sanders, Erin J.; Grace, Jaime L.; Swallow, John G.			Sex differences in aggression: Differential roles of 5-HT2, neuropeptide F and tachykinin	PLOS ONE			English	Article							STALK-EYED FLIES; SUBSTANCE-P; DROSOPHILA-MELANOGASTER; SEROTONIN SYNTHESIS; SOCIAL-ISOLATION; RECEPTORS; BEHAVIOR; NEURONS; BRAIN; HYPOTHALAMUS	Despite the conserved function of aggression across taxa in obtaining critical resources such as food and mates, serotonin's (5-HT) modulatory role on aggressive behavior appears to be largely inhibitory for vertebrates but stimulatory for invertebrates. However, critical gaps exist in our knowledge of invertebrates that need to be addressed before definitively stating opposing roles for 5-HT and aggression. Specifically, the role of 5-HT receptor subtypes are largely unknown, as is the potential interactive role of 5-HT with other neurochemical systems known to play a critical role in aggression. Similarly, the influence of these systems in driving sex differences in aggressive behavior of invertebrates is not well understood. Here, we investigated these questions by employing complementary approaches in a novel invertebrate model of aggression, the stalk-eyed fly. A combination of altered social conditions, pharmacological manipulation and 5-HT2 receptor knockdown by siRNA revealed an inhibitory role of this receptor subtype on aggression. Additionally, we provide evidence for 5-HT2's involvement in regulating neuropeptide F activity, a suspected inhibitor of aggression. However, this function appears to be stage-specific, altering only the initiation stage of aggressive conflicts. Alternatively, pharmacologically increasing systemic concentrations of 5-HT significantly elevated the expression of the neuropeptide tachykinin, which did not affect contest initiation but instead promoted escalation via production of high intensity aggressive behaviors. Notably, these effects were limited solely to males, with female aggression and neuropeptide expression remaining unaltered by any manipulation that affected 5-HT. Together, these results demonstrate a more nuanced role for 5-HT in modulating aggression in invertebrates, revealing an important interactive role with neuropeptides that is more reminiscent of vertebrates. The sex-differences described here also provide valuable insight into the evolutionary contexts of this complex behavior.	[Bubak, Andrew N.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Watt, Michael J.] Univ South Dakota, Ctr Brain & Behav Res, Basic Biomed Sci, Vermillion, SD 57069 USA; [Renner, Kenneth J.] Univ South Dakota, Biol Dept, Vermillion, SD 57069 USA; [Luman, Abigail A.; Costabile, Jamie D.; Sanders, Erin J.; Swallow, John G.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Grace, Jaime L.] Bradley Univ, Dept Biol, Peoria, IL 61625 USA; [Watt, Michael J.] Univ Otago, Dept Anat, Dunedin, New Zealand	University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Dakota; University of South Dakota; University of Colorado System; University of Colorado Denver; Bradley University; University of Otago	Swallow, JG (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	john.swallow@ucdenver.edu	Bubak, Andrew/GLR-6501-2022; Grace, Jaime/I-4407-2014	Watt, Michael/0000-0003-1164-1367; Grace, Jaime/0000-0002-8563-9182; Swallow, John/0000-0001-7107-8866	National Science Foundation [IOS 1256898, 1656465, IOS 1257679]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation grants IOS 1256898 and 1656465 (to JGS) and IOS 1257679 (to MJW), https://www.nsf.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-khairulla H, 2003, J INSECT BEHAV, V16, P679, DOI 10.1023/B:JOIR.0000007703.84691.ad; Alekseyenko OV, 2014, CURR BIOL, V24, P2700, DOI 10.1016/j.cub.2014.09.051; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Antonsen BL, 1997, J COMP PHYSIOL A, V181, P501, DOI 10.1007/s003590050134; Aoki M, 2016, EUR J NEUROSCI, V43, P1219, DOI 10.1111/ejn.13233; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; BAKER KG, 1991, NEUROSCIENCE, V42, P757, DOI 10.1016/0306-4522(91)90043-N; Bath E, 2015, ECOL EVOL, V5, P1826, DOI 10.1002/ece3.1467; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Boyan G, 2010, CELL TISSUE RES, V340, P13, DOI 10.1007/s00441-009-0922-7; Boyer C, 2007, BRAIN RES, V1133, P53, DOI 10.1016/j.brainres.2006.11.042; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Bubak AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166417; Bubak AN, 2016, CURR ZOOL, V62, P257, DOI 10.1093/cz/zow040; Bubak AN, 2015, BEHAV BRAIN RES, V292, P521, DOI 10.1016/j.bbr.2015.07.028; Bubak AN, 2014, CURR ZOOL, V60, P778, DOI 10.1093/czoolo/60.6.778; Bubak AN, 2014, BEHAV BRAIN RES, V259, P137, DOI 10.1016/j.bbr.2013.10.050; Bubak AN, 2013, J NEUROSCI METH, V219, P124, DOI 10.1016/j.jneumeth.2013.07.006; BURKHARDT D, 1983, J COMP PHYSIOL, V151, P407, DOI 10.1007/BF00605457; CHAMBERLAIN SC, 1986, J COMP NEUROL, V251, P363, DOI 10.1002/cne.902510307; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Dierick HA, 2013, NAT GENET, V39, P678; Dryden S, 1996, NEUROSCIENCE, V72, P557, DOI 10.1016/0306-4522(95)00566-8; Dryden S, 1996, BRAIN RES, V724, P232, DOI 10.1016/0006-8993(96)00329-0; Dyakonova VE, 2013, J COMP PHYSIOL A, V199, P601, DOI 10.1007/s00359-013-0804-z; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; Egge AR, 2011, BEHAV ECOL SOCIOBIOL, V65, P369, DOI 10.1007/s00265-010-1054-5; Ferrari PF, 2005, EUR J PHARMACOL, V526, P259, DOI 10.1016/j.ejphar.2005.10.002; Glass JD, 2000, BRAIN RES, V859, P224, DOI 10.1016/S0006-8993(00)01963-6; Grignaschi G, 1996, BRAIN RES, V708, P173, DOI 10.1016/0006-8993(95)01373-3; Halasz J, 2009, EUR J PHARMACOL, V611, P35, DOI 10.1016/j.ejphar.2009.03.050; Herbert Z, 2010, J MORPHOL, V271, P1509, DOI 10.1002/jmor.10895; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P60, DOI 10.1159/000113355; Ignell R, 2001, CELL TISSUE RES, V306, P143, DOI 10.1007/s004410100434; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Juarez P, 2013, BEHAV BRAIN RES, V256, P354, DOI 10.1016/j.bbr.2013.07.044; Karl T, 2004, P NATL ACAD SCI USA, V101, P12742, DOI 10.1073/pnas.0404085101; Katsouni E, 2009, PEPTIDES, V30, P1586, DOI 10.1016/j.peptides.2009.05.001; Langworthy K, 1997, CELL TISSUE RES, V288, P191, DOI 10.1007/s004410050806; Lihoreau M, 2009, BEHAV PROCESS, V82, P81, DOI 10.1016/j.beproc.2009.03.008; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Maejima T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00040; Mann J. John, 1995, P1919; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Martin CA, 2014, NEUROCHEM INT, V73, P71, DOI 10.1016/j.neuint.2014.03.015; Momohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074489; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; OSBORNE NN, 1982, SCIENCE, V216, P409, DOI 10.1126/science.6176023; Panksepp JB, 2003, MICROSC RES TECHNIQ, V60, P360, DOI 10.1002/jemt.10274; Rehm KJ, 2008, J NEUROSCI, V28, P9828, DOI 10.1523/JNEUROSCI.2328-08.2008; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smialowska M, 2001, NEUROPEPTIDES, V35, P82, DOI 10.1054/npep.2001.0849; Stevenson PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074965; Summers CH, 2006, J EXP BIOL, V209, P4581, DOI 10.1242/jeb.02565; Szczuka A, 2013, ACTA NEUROBIOL EXP, V73, P495; Takahashi Aki, 2012, Curr Top Behav Neurosci, V12, P73; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; Ueda A, 2009, J NEUROGENET, V23, P378, DOI 10.3109/01677060903063026; Vleugels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065052; WILKINSON GS, 1993, GENET RES, V62, P213, DOI 10.1017/S001667230003192X; Wongwitdecha N, 1996, BEHAV BRAIN RES, V75, P27, DOI 10.1016/0166-4328(96)00181-7	69	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0203980	10.1371/journal.pone.0203980	http://dx.doi.org/10.1371/journal.pone.0203980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695038	Green Submitted, gold, Green Published			2022-12-26	WOS:000457046400003
J	Ozaki, Y; Yamada, H; Kikuchi, H; Hirotsu, A; Murakami, T; Matsumoto, T; Kawabata, T; Hiramatsu, Y; Kamiya, K; Yamauchi, T; Goto, K; Ueda, Y; Okazaki, S; Kitagawa, M; Takeuchi, H; Konno, H				Ozaki, Yusuke; Yamada, Hidenao; Kikuchi, Hirotoshi; Hirotsu, Amane; Murakami, Tomohiro; Matsumoto, Tomohiro; Kawabata, Toshiki; Hiramatsu, Yoshihiro; Kamiya, Kinji; Yamauchi, Toyohiko; Goto, Kentaro; Ueda, Yukio; Okazaki, Shigetoshi; Kitagawa, Masatoshi; Takeuchi, Hiroya; Konno, Hiroyuki			Label-free classification of cells based on supervised machine learning of subcellular structures	PLOS ONE			English	Article							QUANTITATIVE PHASE; REFRACTIVE-INDEX; LIGHT-SCATTERING; MICROSCOPY; CANCER; BLOOD; PROGRESSION; IMAGES	It is demonstrated that cells can be classified by pattern recognition of the subcellular structure of non-stained live cells, and the pattern recognition was performed by machine learning. Human white blood cells and five types of cancer cell lines were imaged by quantitative phase microscopy, which provides morphological information without staining quantitatively in terms of optical thickness of cells. Subcellular features were then extracted from the obtained images as training data sets for the machine learning. The built classifier successfully classified WBCs from cell lines (area under ROC curve = 0.996). This label-free, non-cytotoxic cell classification based on the subcellular structure of QPM images has the potential to serve as an automated diagnosis of single cells.	[Ozaki, Yusuke; Kikuchi, Hirotoshi; Hirotsu, Amane; Murakami, Tomohiro; Matsumoto, Tomohiro; Kawabata, Toshiki; Hiramatsu, Yoshihiro; Kamiya, Kinji; Takeuchi, Hiroya] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka, Japan; [Yamada, Hidenao; Yamauchi, Toyohiko; Goto, Kentaro; Ueda, Yukio] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Okazaki, Shigetoshi] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Inst Med Photon Res, Dept Med Spect, Hamamatsu, Shizuoka, Japan; [Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Mol Biol, Hamamatsu, Shizuoka, Japan; [Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Lab Anim Facil & Serv, Hamamatsu, Shizuoka, Japan; [Konno, Hiroyuki] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu Photonics; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Yamada, H (corresponding author), Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan.	iwai@crl.hpk.co.jp		Hiramatsu, Yoshihiro/0000-0003-1448-1610; Kikuchi, Hirotoshi/0000-0002-1776-1020; Yamada, Hidenao/0000-0001-7091-9053	 [15K10132];  [26461974];  [15H04929]	; ; 	This work was supported in part by Grants-in-Aid for Scientific Research in Japan 15K10132 (H. Kikuchi), 26461974 (T. Kawabata), and 15H04929 (H. Konno), URL: https//www.jsps.go.jp/english/e-grants/index.html.; This work was supported in part by Grants-in-Aid for Scientific Research in Japan 15K10132 (H. Kikuchi), 26461974 (T. Kawabata), and 15H04929 (H. Konno).	Bayramoglu N, 2014, INT C PATT RECOG, P3345, DOI 10.1109/ICPR.2014.576; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bhaskar D, 2017, MORPHOLOGY BASED CEL, DOI [10.14288/1.0345604, DOI 10.14288/1.0345604]; Blasi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10256; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brauer J, 2016, HOG DESCRIPTOR COMPU; Chalut KJ, 2009, CANCER RES, V69, P1199, DOI 10.1158/0008-5472.CAN-08-3079; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19757; Cibas E.S., 2019, CYTOLOGY DIAGNOSTIC; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Diaz G, 1996, COMPUT METH PROG BIO, V49, P1, DOI 10.1016/0169-2607(95)01688-0; Drezek R, 2003, J BIOMED OPT, V8, P7, DOI 10.1117/1.1528950; Dunn A K, 1997, J Biomed Opt, V2, P262, DOI 10.1117/12.275219; Essa E, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2916; Essa E, 2015, IEEE ENG MED BIO, P3865, DOI 10.1109/EMBC.2015.7319237; Gero E, 1987, IMMUNOLOGICAL APPROA, P95; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Gschwendtner A, 1999, MODERN PATHOL, V12, P806; Iwai H, 2004, OPT LETT, V29, P2399, DOI 10.1364/OL.29.002399; Iwai H, 2014, OPT COMMUN, V319, P159, DOI 10.1016/j.optcom.2014.01.013; Jiang YY, 2017, LAB CHIP, V17, P2426, DOI 10.1039/c7lc00396j; Jo Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700606; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kandel ME, 2017, REAL TIME HALO CORRE, DOI [10.1101/227025, DOI 10.1101/227025]; Kang MS, 2012, PROC SPIE, V8227, DOI 10.1117/12.908070; Kasprowicz R, 2017, INT J BIOCHEM CELL B, V84, P89, DOI 10.1016/j.biocel.2017.01.004; Kim GB, 2018, J DIGIT IMAGING, V31, P415, DOI 10.1007/s10278-017-0028-9; Kobayashi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12378-4; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Mahjoubfar A, 2013, BIOMED OPT EXPRESS, V4, P1618, DOI 10.1364/BOE.4.001618; Martin A.F., 1997, P EUR 97 RHOD GREEC, V4, P1899; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mualla F, 2013, IEEE T MED IMAGING, V32, P2274, DOI 10.1109/TMI.2013.2280380; Neumann D, 2017, IEEE INT VEH SYM, P773, DOI 10.1109/IVS.2017.7995810; Nguyen TH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44034; Ozaki Ryota, 2013, Journal of the Japan Society for Precision Engineering, V79, P1074; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pan J, 2009, P MICR IM AN APPL BI; Park HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163045; Roitshtain D, 2017, CYTOM PART A, V91A, P482, DOI 10.1002/cyto.a.23100; Scholkopf B., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P252; Schurmann M, 2016, J BIOPHOTONICS, V9, P1068, DOI 10.1002/jbio.201500273; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Theriault DH, 2012, MACH VISION APPL, V23, P659, DOI 10.1007/s00138-011-0345-9; Xu MJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005746; Yamauchi T, 2008, OPT EXPRESS, V16, P12227, DOI 10.1364/OE.16.012227; Yamauchi T, 2018, PROC SPIE, V10503, DOI 10.1117/12.2289473; Yamauchi T, 2011, OPT EXPRESS, V19, P5536, DOI 10.1364/OE.19.005536; Yin ZZ, 2012, MED IMAGE ANAL, V16, P1047, DOI 10.1016/j.media.2011.12.006; Yoon J, 2015, BIOMED OPT EXPRESS, V6, P3865, DOI 10.1364/BOE.6.003865; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454	56	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211347	10.1371/journal.pone.0211347	http://dx.doi.org/10.1371/journal.pone.0211347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695059	Green Published, gold			2022-12-26	WOS:000457046400027
J	Lin, LT; Chen, JT; Tai, MC; Chen, YH; Chen, CL; Pao, SI; Hsu, CR; Liang, CM				Lin, Le-Tien; Chen, Jiann-Torng; Tai, Ming-Cheng; Chen, Yi-Hao; Chen, Ching-Long; Pao, Shu-I; Hsu, Cherng Ru; Liang, Chang-Min			Protective effects of hypercapnic acidosis on Ischemia-reperfusion-induced retinal injury	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROGRAMMED CELL-DEATH; HEAT-SHOCK PROTEINS; OXIDATIVE-STRESS; CARBON-DIOXIDE; SIGNALING PATHWAYS; KAPPA-B; APOPTOSIS; GLUCOSAMINE; INFLAMMATION	Ischemia-reperfusion (I/R) injury is associated with numerous retinal diseases, such as diabetic retinopathy, acute glaucoma, and other vascular retinopathies. Hypercapnic acidosis (HCA) has a protective effect on lung, myocardial, and central nervous system ischemic injury models. However, no study has evaluated its protective effects in an experimental retinal I/R injury model. In this study, retinal I/R injury was induced in Sprague Dawley rats by elevating the intraocular pressure to 110 mmHg for 60 minutes. HCA was induced before and after the injury. After 24 hours, the terminal dUTP nick end labeling assay was performed. Moreover, the ratios of cleaved caspase-3/total caspase-3, phosphorylated I kappa B/I kappa B, and phosphorylated p38 were measured through Western blotting. After 7 days, the rats' aqueous humor was analyzed. In addition, electroretinography and retinal thickness measurement were performed in the rats. Moreover, the retinal neural cell line RGC-5 was exposed to 500 mu M H2O2 for 24 hours to induce a sustained oxidative stress in vitro. The effects of HCA were evaluated by comparing oxidative stress, MAPK signals, NF-kappa B signals, survival rates, and apoptosis rates in the RGC-5 cells before and after H2O2 exposure. We further investigated whether the potent I/R-protective heat shock protein (HSP) 32 contribute to protective effects of HCA. Our results indicated that HCA has protective effects against retinal I/R injury both in vivo and in vitro, at multiple levels, including antiapoptotic, anti-inflammatory, antioxidative, and functional retinal cell protection. Further research clarifying the role of HCA in retinal I/R injury prevention and treatment is warranted.	[Lin, Le-Tien] Natl Def Med Ctr, Triserv Gen Hosp, Songshan Branch, Dept Ophthalmol, Taipei, Taiwan; [Lin, Le-Tien; Chen, Jiann-Torng; Chen, Yi-Hao; Chen, Ching-Long; Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Jiann-Torng; Tai, Ming-Cheng; Chen, Yi-Hao; Chen, Ching-Long; Pao, Shu-I; Hsu, Cherng Ru; Liang, Chang-Min] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chen, JT; Chen, YH; Liang, CM (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, JT; Chen, YH; Liang, CM (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Liang, CM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	jt66chen@gmail.com; doc30879@ndmctsgh.edu.tw; doc30875@mail.ndmctsgh.edu.tw		Hsu, Cherng-Ru/0000-0002-4390-0389	Ministry of Science and Technology, Taiwan [105-2314-B-016-042]; National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan [TSGHSB10711]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan	This study was funded by the Ministry of Science and Technology, Taiwan to CML (grant no. 105-2314-B-016-042) and National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan to LTL and SIP (grant no. TSGHSB10711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; ANDERSON DR, 1975, ARCH OPHTHALMOL-CHIC, V93, P267; Chang YH, 2008, INVEST OPHTH VIS SCI, V49, P5441, DOI 10.1167/iovs.08-1784; Chen L, 2015, OPHTHALMIC RES, V54, P157, DOI 10.1159/000439026; Chen YJ, 2015, INVEST OPHTH VIS SCI, V56, P1506, DOI 10.1167/iovs.14-15726; Chonghaile MN, 2008, ANESTHESIOLOGY, V109, P837, DOI 10.1097/ALN.0b013e3181895fb7; Duan HJ, 2016, J SURG RES, V203, P6, DOI 10.1016/j.jss.2016.01.035; Fujita R, 2009, CELL DEATH DIFFER, V16, P349, DOI 10.1038/cdd.2008.159; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; HANGAI M, 1995, INVEST OPHTH VIS SCI, V36, P571; Hartsock MJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54065; Huang CK, 2013, MOL VIS, V19, P1422; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kanski JJ, 2011, CLIN OPHTHALMOLOGY S; KENNEDY TP, 1989, J CLIN INVEST, V83, P1326, DOI 10.1172/JCI114019; Kerr NM, 2012, EXP NEUROL, V234, P144, DOI 10.1016/j.expneurol.2011.12.027; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Li AM, 2010, CHINESE MED J-PEKING, V123, P2254, DOI 10.3760/cma.j.issn.0366-6999.2010.16.018; Li L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4985323; MAINES MD, 1986, J BIOL CHEM, V261, P411; Masterson C, 2016, CRIT CARE MED, V44, pe207, DOI 10.1097/CCM.0000000000001376; McLarty JL, 2013, LIFE SCI, V92, P621, DOI 10.1016/j.lfs.2012.08.006; Meldrum DR, 1998, SURGERY, V124, P291, DOI 10.1067/msy.1998.90570; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; Moynagh PN, 2003, J ENDOCRINOL, V179, P139, DOI 10.1677/joe.0.1790139; Napankangas JP, 2012, J MOL CELL CARDIOL, V53, P906, DOI 10.1016/j.yjmcc.2012.09.011; Nardelli LM, 2015, RESP PHYSIOL NEUROBI, V205, P1, DOI 10.1016/j.resp.2014.09.007; NOMURA F, 1994, CIRCULATION, V90, P321; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pan HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096190; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; RABACCHI SA, 1994, J NEUROSCI, V14, P5292; Sirieix D, 1997, AM J RESP CRIT CARE, V155, P957, DOI 10.1164/ajrccm.155.3.9117032; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sucher R, 2009, TRANSPL INT, V22, P922, DOI 10.1111/j.1432-2277.2009.00883.x; SZABO ME, 1991, OPHTHALMIC RES, V23, P225, DOI 10.1159/000267107; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tong NT, 2012, J OCUL PHARMACOL TH, V28, P459, DOI 10.1089/jop.2011.0218; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; VANNUCCI RC, 1995, PEDIATRICS, V95, P868; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wu SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069530	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211185	10.1371/journal.pone.0211185	http://dx.doi.org/10.1371/journal.pone.0211185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682118	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500118
J	Borges, DGL; Echeverria, JT; de Oliveira, TL; Heckler, RP; de Freitas, MG; Damasceno, GA; Carollo, CA; Borges, FD				Lino Borges, Dyego Goncalves; Echeverria, Jessica Teles; de Oliveira, Tamires Lima; Heckler, Rafael Pereira; de Freitas, Mariana Green; Damasceno-Junior, Geraldo Alves; Carollo, Carlos Alexandre; Borges, Fernando de Almeida			Discovery of potential ovicidal natural products using metabolomics	PLOS ONE			English	Article							IN-VITRO ACTIVITY; HAEMONCHUS-CONTORTUS; GASTROINTESTINAL NEMATODES; ANTHELMINTIC RESISTANCE; LARVICIDAL ACTIVITY; BEEF-CATTLE; IMPACT; HELMINTHS; EXTRACTS; SHEEP	Plant extracts are a potential source of new compounds for nematode control and may be an excellent alternative for the control gastrointestinal nematodes that are resistant to conventional anthelmintics. However, research involving natural products is a complex process. The main challenge is the identification of bioactive compounds. Online analytical techniques with universal detectors, such as high-performance liquid chromatographymass spectrometry (HPLC-MS), together with metabolomics could enable the fast, accurate evaluation of a massive amount of data, constituting a viable option for the identification of active compounds in plant extracts. This study focused on the evaluation of the ovicidal activity of ethanol extracts from 17 plants collected from the Pantanal wetland in the state of Mato Grosso do Sul, Brazil, against eggs of Haemonchus placei using the egg hatchability test. The ethanol extracts were obtained using accelerated solvent extraction. The data on ovicidal activity, mass spectrometry and metabolomics were evaluated using HPLC-DAD-MS, partial least squares regression analysis (PLS-DA) and a correlation map (univariate correlation analyses) to detect compounds that have a positive correlation with biological activity. Among the ten metabolites with the best correlation coefficients, six were phenylpropanoids, two were triterpene saponins, one was a brevipolide, and one was a flavonoid. Combinations of metabolites with high ovicidal action were also identified, such as phenylpropanoids combined with the triterpene saponins and the flavonoid, flavonoids combined with iridoid and phenylpropanoids, and saponins combined with phenylpropanoid. The positive correlation between classes of compounds in plants belonging to different genera and biological activity (as previously identified in the literature) reinforces the robustness of the statistical data and demonstrates the efficacy of this method for the selection of bioactive compounds without the need for isolation and reevaluation. The proposed method also enables the determination of synergism among the classes, which would be impracticable using traditional methods. The present investigation demonstrates that the metabolomic technique was efficient at detecting secondary metabolites with ovicidal activity against H. placei. Thus, the use of metabolomics can be a tool to accelerate and simplify bioprospecting research with plant extracts in veterinary parasitology.	[Lino Borges, Dyego Goncalves; Echeverria, Jessica Teles; de Oliveira, Tamires Lima; Heckler, Rafael Pereira; de Freitas, Mariana Green; Borges, Fernando de Almeida] Univ Fed Mato Grosso do Sul, Sch Vet Med & Anim Sci, Campo Grande, MS, Brazil; [Damasceno-Junior, Geraldo Alves] Univ Fed Mato Grosso do Sul, Inst Biosci, Campo Grande, MS, Brazil; [Carollo, Carlos Alexandre] Univ Fed Mato Grosso do Sul, Sch Pharmaceut Sci Food & Nutr, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Borges, DGL (corresponding author), Univ Fed Mato Grosso do Sul, Sch Vet Med & Anim Sci, Campo Grande, MS, Brazil.	dyegogborges@hotmail.com	Damasceno Junior, Geraldo/ABG-2834-2021; Borges, Fernando/T-6717-2019	Borges, Fernando/0000-0002-8888-6269; Echeverria, Jessica/0000-0002-7500-1230	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors declare that we have received financial support from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES), in the form of a master's degree post-graduate scholarship; of the Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), that made available of funds to purchase equipment used in the metabolomics studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentieri MP, 2008, EUR J PLANT PATHOL, V120, P189, DOI 10.1007/s10658-007-9207-8; Ayouni K, 2016, IND CROP PROD, V88, P65, DOI 10.1016/j.indcrop.2016.01.001; Bizimenyera ES, 2006, VET PARASITOL, V142, P336, DOI 10.1016/j.vetpar.2006.06.013; Borges FA, 2013, TROP ANIM HEALTH PRO, V45, P723, DOI 10.1007/s11250-012-0280-4; Botura MB, 2013, VET PARASITOL, V192, P211, DOI 10.1016/j.vetpar.2012.10.012; Castillo-Mitre GF, 2017, J ETHNOPHARMACOL, V204, P125, DOI 10.1016/j.jep.2017.04.010; Chassagne F, 2018, FITOTERAPIA, V127, P226, DOI 10.1016/j.fitote.2018.02.021; COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U; D'Addabbo T, 2011, PHYTOCHEM REV, V10, P503, DOI 10.1007/s11101-010-9180-2; Dembogurski DSD, 2018, FOOD RES INT, V111, P661, DOI 10.1016/j.foodres.2018.05.033; Dimander SO, 2000, VET PARASITOL, V90, P271, DOI 10.1016/S0304-4017(00)00256-9; Durmic Z, 2012, ANIM FEED SCI TECH, V176, P150, DOI 10.1016/j.anifeedsci.2012.07.018; Engstrom MT, 2016, J AGR FOOD CHEM, V64, P840, DOI 10.1021/acs.jafc.5b05691; Feboli A, 2016, VET PARASITOL, V226, P65, DOI 10.1016/j.vetpar.2016.06.030; Feliz DC, 2011, THESIS, P41; Gaudencio SP, 2015, NAT PROD REP, V32, P779, DOI 10.1039/c4np00134f; GENNARI SM, 1991, VET PARASITOL, V38, P163, DOI 10.1016/0304-4017(91)90126-G; Gustine DL, 2010, STRATEGY DETECTING N; Hoste H, 2011, VET PARASITOL, V180, P144, DOI 10.1016/j.vetpar.2011.05.035; Diaz GJ, 2017, MICROB PATHOGENESIS, V109, P162, DOI 10.1016/j.micpath.2017.05.048; Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Lino Borges Dyego Goncalves, 2016, Nematoda, V3, pe92016, DOI 10.4322/nematoda.00916; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Mengistu G, 2017, VET PARASITOL, V237, P110, DOI 10.1016/j.vetpar.2016.12.020; Molento MB, 2011, VET PARASITOL, V180, P126, DOI 10.1016/j.vetpar.2011.05.033; Mondal H, 2015, PAK VET J, V35, P58; Morais-Costa F, 2015, TROP ANIM HEALTH PRO, V47, P1321, DOI 10.1007/s11250-015-0866-8; Ramos F, 2016, INT J PARASITOL-DRUG, V6, P93, DOI 10.1016/j.ijpddr.2016.02.002; Ribeiro WLC, 2017, SMALL RUMINANT RES, V153, P146, DOI 10.1016/j.smallrumres.2017.06.001; Sandoval-Castro CA, 2012, ANIM FEED SCI TECH, V176, P192, DOI 10.1016/j.anifeedsci.2012.07.023; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Titman CM, 2009, MOL BIOSYST, V5, P1913, DOI 10.1039/b907754e; Van Wyk IC, 2014, PARASITOLOGY, V141, P374, DOI 10.1017/S0031182013001625; WHITLOCK H. V., 1950, JOUR HELMINTHOL, V24, P47, DOI 10.1017/S0022149X00019106; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Lopes WDZ, 2014, RES VET SCI, V96, P133, DOI 10.1016/j.rvsc.2013.11.001	38	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211237	10.1371/journal.pone.0211237	http://dx.doi.org/10.1371/journal.pone.0211237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682122	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500132
J	Ogundijo, OE; Zhu, KY; Wang, XD; Anastassiou, D				Ogundijo, Oyetunji E.; Zhu, Kaiyi; Wang, Xiaodong; Anastassiou, Dimitris			A sequential Monte Carlo algorithm for inference of subclonal structure in cancer	PLOS ONE			English	Article							SOMATIC MUTATIONS; EVOLUTION; MODEL; HETEROGENEITY; LANDSCAPE; PATTERNS; PATHWAY; PIK3CA	Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referred to as subclones, each of which is characterized by a distinct profile of genomic variations such as somatic mutations. Inferring the underlying clonal landscape has become an important topic in that it can help in understanding cancer development and progression, and thereby help in improving treatment. We describe a novel state-space model, based on the feature allocation framework and an efficient sequential Monte Carlo (SMC) algorithm, using the somatic mutation data obtained from tumor samples to estimate the number of subclones, as well as their characterization. Our approach, by design, is capable of handling any number of mutations. Via extensive simulations, our method exhibits high accuracy, in most cases, and compares favorably with existing methods. Moreover, we demonstrated the validity of our method through analyzing real tumor samples from patients from multiple cancer types (breast, prostate, and lung). Our results reveal driver mutation events specific to cancer types, and indicate clonal expansion by manual phylogenetic analysis. MATLAB code and datasets are available to download at: https://github.com/moyanre/tumor_clones.	[Ogundijo, Oyetunji E.; Zhu, Kaiyi; Wang, Xiaodong; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Zhu, Kaiyi; Anastassiou, Dimitris] Columbia Univ, Dept Syst Biol, New York, NY USA	Columbia University; Columbia University	Wang, XD (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	xw2008@columbia.edu	Zhu, Kaiyi/CAF-9654-2022					Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Doucet A., 2001, SEQUENTIAL MONTE CAR; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hughes AEO, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004462; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Lee J, 2016, STAT ANAL HIGH DIMEN, P211; Lee T, 2016, J PATHOL TRANSL MED, V50, P197, DOI 10.4132/jptm.2016.03.09; Li P, 2004, IEE P-CONTR THEOR AP, V151, P727, DOI 10.1049/ip-cta:20041008; Li P, 2003, EUR CONTR C ECC 2003, P2384; Marass F, 2016, ANN APPL STAT, V10, P2377, DOI 10.1214/16-AOAS986; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ogundijo OE, 2018, PEERJ, V6, DOI 10.7717/peerj.4838; Ogundijo OE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186167; Ogundijo OE, 2017, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0055-8; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Rudolph M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2626-1; Sarkka S, 2013, BAYESIAN FILTERING S; Sengupta S, 2015, BIOCOMPUT-PAC SYM, P467; Tserga A, 2016, VIRCHOWS ARCH, V469, P35, DOI 10.1007/s00428-016-1938-5; Unni AM, 2015, ELIFE, V4, DOI 10.7554/eLife.06907; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Wood F., 2007, P 19 INT C NEUR INF, P1513; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yuan K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0592-6; Zare H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003703	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211213	10.1371/journal.pone.0211213	http://dx.doi.org/10.1371/journal.pone.0211213			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682127	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500126
J	Zhao, YF; Qiao, SP; Hou, XL; Tian, H; Deng, S; Ye, KR; Nie, YZ; Chen, XB; Yan, HJ; Tian, WM				Zhao, Yufang; Qiao, Shupei; Hou, Xiaolu; Tian, Hui; Deng, Shuai; Ye, Kangruo; Nie, Yongzhan; Chen, Xiongbiao; Yan, Hongji; Tian, Weiming			Bioengineered tumor microenvironments with naked mole rats high-molecular-weight hyaluronan induces apoptosis in breast cancer cells	ONCOGENE			English	Article							CD44; RESISTANCE; HAS2; P53; INVASION; GROWTH	The naked mole rat (nmr) is cancer resistant due to the abundant production of extremely high-molecular-weight hyaluronan (EHMW-HA). However, whether EHMW-HA has similar anti-cancer effects in mice and humans remains to be determined. The present study used breast cancer cells to clarify the effect of EHMW-HA on breast cancer. First, the overexpression of nmrHas2 in 4T1 and BT549 cell lines in both two-dimensional (2D) and three-dimensional (3D) models to mimic tumor microenvironment was established. The 4T1/BT549-nmrHas2 cells could secrete EHMW-HA (with a molecular weight of up to 6 MDa), which was similar to that found in the naked mole rat. Second, EHMW-HA altering tumor microenvironment in both 2D monolayers and 3D spheroids significantly enhanced apoptosis, inhibiting the proliferation of 4T1 and BT549 cells. The prominent anticancer effects of EHMW-HA on the cancer-cell apoptosis phenotype were further confirmed by inhibiting tumor formation in nude mice. Finally, EHMW-HA significantly induced higher p53 protein expression, which enhanced pro-apoptotic proteins p21 and Bax in breast cancer cells; this is in contrast with the triggering of hypersensitivity of the naked mole rat cells to early contact inhibition (ECI). These results have important implications for the design of therapeutic approaches based on the application of EHMW-HA.	[Zhao, Yufang; Qiao, Shupei; Hou, Xiaolu; Tian, Hui; Deng, Shuai; Ye, Kangruo; Tian, Weiming] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China; [Zhao, Yufang] Harbin Inst Technol, Res Ctr Basic Space Sci, Space Environm Stimulat & Res Interface, Harbin 150080, Heilongjiang, Peoples R China; [Nie, Yongzhan] Fourth Mil Med Univ, State Key Lab Canc Biol, Harbin 150080, Heilongjiang, Peoples R China; [Nie, Yongzhan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Harbin 150080, Heilongjiang, Peoples R China; [Chen, Xiongbiao] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A2, Canada; [Yan, Hongji] AlbaNova Univ Ctr, Sch Engn Sci Chem Biotechnol & Hlth, KTHRoyal Inst Technol, Dept Chem,Div Glycosci, S-10691 Stockholm, Sweden	Harbin Institute of Technology; Harbin Institute of Technology; Air Force Military Medical University; Air Force Military Medical University; University of Saskatchewan; Royal Institute of Technology	Tian, WM (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China.	tianweiming@hit.edu.cn	Yan, Hongji/AAL-7040-2021	Tian, Weiming/0000-0003-4958-4118; DENG, Shuai/0000-0001-7622-2097; Chen, Xiongbiao (Daniel)/0000-0002-4716-549X; /0000-0001-7257-5522	National Natural Science Foundation of China [51773050, 81770923]; Opening Foundation of the State Key Laboratory of Cancer Biology [CBSKL201106]; Heilongjiang Postdoctoral Fund [LBH-Z18068]; China Postdoctoral Science Foundation [2018M641837]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of the State Key Laboratory of Cancer Biology; Heilongjiang Postdoctoral Fund; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National Natural Science Foundation of China (Grant No.: 51773050 and 81770923), the Opening Foundation of the State Key Laboratory of Cancer Biology (CBSKL201106), and the author was supported by the Heilongjiang Postdoctoral Fund (No. LBH-Z18068) and a general financial grant from the China Postdoctoral Science Foundation (No. 2018M641837).	Beasley KL, 2009, FACIAL PLAST SURG, V25, P86, DOI 10.1055/s-0029-1220647; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Brown TJ, 2008, CURR PHARM BIOTECHNO, V9, P253, DOI 10.2174/138920108785161514; Carvalho MP, 2016, CARBOHYD POLYM, V150, P139, DOI 10.1016/j.carbpol.2016.05.005; COOPER EH, 1988, BRIT J CANCER, V58, P668, DOI 10.1038/bjc.1988.283; Fuchs K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.364; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GILLI R, 1994, CARBOHYD RES, V263, P315, DOI 10.1016/0008-6215(94)00147-2; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Goldsworthy TL, 1996, MUTAT RES-REV GENET, V365, P71, DOI 10.1016/S0165-1110(96)90013-5; Heldin P, 2013, J BIOCHEM, V154, P395, DOI 10.1093/jb/mvt085; Huang Z, 2014, INFLAMM CELL SIGNAL, V1; Karbownik MS, 2013, PHARMACOL REP, V65, P1056, DOI 10.1016/S1734-1140(13)71465-8; Kultti Anne, 2012, Cancers (Basel), V4, P873, DOI 10.3390/cancers4030873; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429; Lee YJ, 2016, ACTA PHARMACOL SIN, V37, P664, DOI 10.1038/aps.2015.151; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Miyawaki S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11471; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nikitovic D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/929531; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Seluanov A, 2018, NAT REV CANCER, V18, P433, DOI 10.1038/s41568-018-0004-9; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; Thanos CD, 2016, NOVEL IMMUNOTHERAPEU, P249; Tian X, 2015, P NATL ACAD SCI USA, V112, P1053, DOI 10.1073/pnas.1418203112; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Wu M, 2015, FASEB J, V29, P1290, DOI 10.1096/fj.14-259978; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Zhao Y, 2018, P NATL ACAD SCI USA, V115, P1801, DOI 10.1073/pnas.1721160115; Zhao YF, 2017, ACS APPL MATER INTER, V9, P9327, DOI 10.1021/acsami.6b15187	43	13	14	1	72	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4297	4309		10.1038/s41388-019-0719-4	http://dx.doi.org/10.1038/s41388-019-0719-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30700830				2022-12-26	WOS:000469339100007
J	Deng, WT; Fernandez, A; McLaughlin, SL; Klinke, DJ				Deng, Wentao; Fernandez, Audry; McLaughlin, Sarah L.; Klinke, David J.			WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanoma; metastasis; invasion; epithelial-mesenchymal transition (EMT); tumor microenvironment; cancer; Wnt signaling; AKT signaling; secreted protein; WNT1-inducible signaling pathway protein 1 (WISP1; CCN4)	INDUCED SECRETED PROTEIN-1; SQUAMOUS-CELL CARCINOMA; TISSUE GROWTH-FACTOR; CCN FAMILY; STROMAL FIBROBLASTS; EXPRESSION; CANCER; WISP-1; ACTIVATION; REGULATOR	Besides intrinsic changes, malignant cells also release soluble signals that reshape their microenvironment. Among these signals is WNT1-inducible signaling pathway protein 1 (WISP1), a secreted matricellular protein whose expression is elevated in several cancers, including melanoma, and is associated with reduced survival of patients diagnosed with primary melanoma. Here, we found that WISP1 knockout increases cell proliferation and represses wound healing, migration, and invasion of mouse and human melanoma cells in multiple in vitro assays. Metastasis assays revealed that WISP1 knockout represses tumor metastasis of B16F10 and YUMM1.7 melanoma cells in both C57BL/6Ncrl and NOD-scid IL2R(null) (NSG) mice. WT B16F10 cells having an invasion phenotype in a transwell assay possessed a gene expression signature similar to that observed in the epithelial-mesenchymal transition (EMT), including E-cadherin repression and fibronectin and N-cadherin induction. Upon WISP1 knockout, expression of these EMT signature genes went in the opposite direction in both mouse and human cell lines, and EMT-associated gene expression was restored upon exposure to media containing WISP1 or to recombinant WISP1 protein. In vivo, Wisp1 knockout-associated metastasis repression was reversed by the reintroduction of either WISP1 or snail family transcriptional repressor 1 (SNAI1). Experiments testing EMT gene activation and inhibition with recombinant WISP1 or kinase inhibitors in B16F10 and YUMM1.7 cells suggested that WISP1 activates AKT Ser/Thr kinase and that MEK/ERK signaling pathways shift melanoma cells from proliferation to invasion. Our results indicate that WISP1 present within the tumor microenvironment stimulates melanoma invasion and metastasis by promoting an EMT-like process.	[Deng, Wentao; Fernandez, Audry; Klinke, David J.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26505 USA; [Deng, Wentao; Fernandez, Audry; McLaughlin, Sarah L.; Klinke, David J.] West Virginia Univ, Canc Inst, Morgantown, WV 26505 USA; [McLaughlin, Sarah L.] West Virginia Univ, Anim Models & Imaging Facil, Morgantown, WV 26505 USA; [Klinke, David J.] West Virginia Univ, Dept Chem & Biomed Engn, Morgantown, WV 26505 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Klinke, DJ (corresponding author), West Virginia Univ, Dept Chem & Biomed Engn, POB 6102, Morgantown, WV 26506 USA.	david.klinke@mail.wvu.edu		Klinke, David/0000-0003-3299-4938; Fernandez Gomez, Audry/0000-0002-3436-625X; McLaughlin, Sarah/0000-0002-8413-3585	National Science Foundation [CBET-1644932]; NCI, National Institutes of Health [R01CA193473]; NATIONAL CANCER INSTITUTE [R01CA193473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488, U54GM104942] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant CBET-1644932 (to D. J. K.) and NCI, National Institutes of Health, Grant R01CA193473 (to D. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aladowicz E, 2013, FUTURE ONCOL, V9, P713, DOI [10.2217/fon.13.9, 10.2217/FON.13.9]; Bedogni B, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12194; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chiang KC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08686; Chuang JY, 2015, ONCOTARGET, V6, P4239, DOI 10.18632/oncotarget.2978; Chuang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078022; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Deng WT, 2017, ANALYST, V142, P2945, DOI 10.1039/c7an00623c; Deng WT, 2015, J CELL SCI, V128, P1123, DOI 10.1242/jcs.162164; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Golan T, 2015, MOL CELL, V59, P664, DOI 10.1016/j.molcel.2015.06.028; Gurbuz I, 2015, INT J BIOCHEM CELL B, V62, P142, DOI 10.1016/j.biocel.2015.03.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Herlyn M, 2010, J INVEST DERMATOL, V130, P911, DOI 10.1038/jid.2009.441; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Howard JD, 2013, PIGM CELL MELANOMA R, V26, P697, DOI 10.1111/pcmr.12131; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Jia SQ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699755; Jing D, 2017, INT J ONCOL, V51, P1261, DOI 10.3892/ijo.2017.4119; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392; Klinke DJ, 2015, MOL BIOL CELL, V26, P4135, DOI 10.1091/mbc.E15-02-0083; Klinke DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003409; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kulkarni YM, 2012, INTEGR BIOL-UK, V4, P925, DOI 10.1039/c2ib20053h; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lau LF, 2016, J CELL COMMUN SIGNAL, V10, P121, DOI 10.1007/s12079-016-0324-z; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu YD, 2018, INT IMMUNOPHARMACOL, V59, P375, DOI 10.1016/j.intimp.2018.04.033; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lu S, 2016, EUR J PHARMACOL, V788, P90, DOI 10.1016/j.ejphar.2016.06.027; Maeda A, 2015, J BIOL CHEM, V290, P14004, DOI 10.1074/jbc.M114.628818; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Nagai Y, 2011, ANTICANCER RES, V31, P991; Ono M, 2018, MATRIX BIOL, V68-69, P533, DOI 10.1016/j.matbio.2018.01.004; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P625, DOI 10.1007/s12079-018-0491-1; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schlegelmilch K, 2014, GENE, V551, P243, DOI 10.1016/j.gene.2014.09.002; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Shao HW, 2016, ONCOTARGET, V7, P79248, DOI 10.18632/oncotarget.13021; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spranger S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086862; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stephens S, 2015, J CELL COMMUN SIGNAL, V9, P63, DOI 10.1007/s12079-015-0267-9; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tanaka S, 2003, HEPATOLOGY, V37, P1122, DOI 10.1053/jhep.2003.50187; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vandamme N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00352; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Webster MR, 2015, BBA-REV CANCER, V1856, P244, DOI 10.1016/j.bbcan.2015.10.002; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wu CL, 2013, CELL SIGNAL, V25, P2812, DOI 10.1016/j.cellsig.2013.09.005; Xu LF, 2000, GENE DEV, V14, P585; Xue GD, 2016, CANCER TREAT REV, V49, P1, DOI 10.1016/j.ctrv.2016.06.009; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshioka Y, 2016, BONE, V83, P162, DOI 10.1016/j.bone.2015.11.007; Zhang HF, 2015, ONCOTARGET, V6, P6218, DOI 10.18632/oncotarget.3358; Zhang XQ, 2015, AM J CANCER RES, V5, P2344; Zhou LL, 2015, J CANCER, V6, P717, DOI 10.7150/jca.10865	77	26	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5261	5280		10.1074/jbc.RA118.006122	http://dx.doi.org/10.1074/jbc.RA118.006122			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723155	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000464517500003
J	Zhang, QM; Xiao, KH; Paredes, JM; Mamonova, T; Sneddon, WB; Liu, HD; Wang, DW; Li, S; McGarvey, JC; Uehling, D; Al-awar, R; Joseph, B; Jean-Alphonse, F; Orte, A; Friedman, PA				Zhang, Qiangmin; Xiao, Kunhong; Paredes, Jose M.; Mamonova, Tatyana; Sneddon, W. Bruce; Liu, Hongda; Wang, Dawei; Li, Sheng; McGarvey, Jennifer C.; Uehling, David; Al-awar, Rima; Joseph, Babu; Jean-Alphonse, Frederic; Orte, Angel; Friedman, Peter A.			Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PDZ domain; protein-protein interaction; protein phosphorylation; phosphoprotein phosphatase 1 (PP1); hydrogen-deuterium exchange; structural biology; NHERF1; NPT2A; phosphate transport	RENAL PROXIMAL TUBULES; POSTTRANSLATIONAL MODIFICATIONS; FACTOR-I; PROTEIN PHOSPHATASE-1; INTRINSIC DISORDER; STRUCTURAL BASIS; RECEPTOR; BINDING; EBP50; IIA	Na+-H+ exchanger regulatory factor-1 (NHERF1) is a PDZ protein that scaffolds membrane proteins, including sodium-phosphate co-transport protein 2A (NPT2A) at the plasma membrane. NHERF1 is a phosphoprotein with 40 Ser and Thr residues. Here, using tandem MS analysis, we characterized the sites of parathyroid hormone (PTH)-induced NHERF1 phosphorylation and identified 10 high-confidence phosphorylation sites. Ala replacement at Ser(46), Ser(162), Ser(181), Ser(269), Ser(280), Ser(291), Thr(293), Ser(299), and Ser(302) did not affect phosphate uptake, but S290A substitution abolished PTH-dependent phosphate transport. Unexpectedly, Ser(290) was rapidly dephosphorylated and rephosphorylated after PTH stimulation, and we found that protein phosphatase 1 (PP1), which binds NHERF1 through a conserved VxF/W PP1 motif, dephosphorylates Ser(290). Mutating (VPF259)-V-257 eliminated PP1 binding and blunted dephosphorylation. Tautomycetin blocked PP1 activity and abrogated PTH-sensitive phosphate transport. Using fluorescence lifetime imaging (FLIM), we observed that PTH paradoxically and transiently elevates intracellular phosphate. Added phosphate blocked PP1-mediated Ser(290) dephosphorylation of recombinant NHERF1. Hydrogen-deuterium exchange MS revealed that -sheets in NHERF1's PDZ2 domain display lower deuterium uptake than those in the structurally similar PDZ1, implying that PDZ1 is more cloistered. Dephosphorylated NHERF1 exhibited faster exchange at C-terminal residues suggesting that NHERF1 dephosphorylation precedes Ser(290) rephosphorylation. Our results show that PP1 and NHERF1 form a holoenzyme and that a multiprotein kinase cascade involving G protein-coupled receptor kinase 6A controls the Ser(290) phosphorylation status of NHERF1 and regulates PTH-sensitive, NPT2A-mediated phosphate uptake. These findings reveal how reversible phosphorylation modifies protein conformation and function and the biochemical mechanisms underlying PTH control of phosphate transport.	[Zhang, Qiangmin; Xiao, Kunhong; Mamonova, Tatyana; Sneddon, W. Bruce; Liu, Hongda; Wang, Dawei; McGarvey, Jennifer C.; Jean-Alphonse, Frederic; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Xiao, Kunhong] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Xiao, Kunhong] Univ Pittsburgh, Sch Med, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15261 USA; [Paredes, Jose M.; Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Uehling, David; Al-awar, Rima; Joseph, Babu] Ontario Inst Canc Res, Dept Drug Discovery, Toronto, ON M5G 0A3, Canada; [McGarvey, Jennifer C.] Sosei Heptares, Steinmetz Bldg,Granta Pk, Great Abington CB21 6GP, Cambs, England; [Jean-Alphonse, Frederic] INRA, Unite Physiol Reprod & Comportements PRC, UMR85, Biol & Bioinformat Syst Signalisat BIOS Grp, Nouzilly, France; [Jean-Alphonse, Frederic] CNRS, UMR7247, Nouzilly, France; [Jean-Alphonse, Frederic] Univ Tours, Tours, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Granada; University of California System; University of California San Diego; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Heptares Therapeutics Ltd.; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1356 Thomas E Starzl Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Orte, Angel/J-4810-2012; Xiao, Kunhong/AAG-4275-2020; M.Paredes, Jose/M-3494-2014	Orte, Angel/0000-0003-1905-4183; Xiao, Kunhong/0000-0002-1069-1226; M.Paredes, Jose/0000-0002-3252-9174; Liu, Hongda/0000-0002-5977-9130; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825	National Institutes of Health [DK105811, DK111427]; Spanish Ministry of Economy and Competitiveness [CTQ2014-56370-R]; Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811, R01DK111427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness(Spanish Government); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF)(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Awards DK105811 and DK111427 (to P. A. F.), Spanish Ministry of Economy and Competitiveness Grant CTQ2014-56370-R, the Agencia Estatal de Investigacion (AEI), and the European Regional Development Fund (ERDF) (to A. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews LD, 2014, BIOCHEMISTRY-US, V53, P6811, DOI 10.1021/bi500765p; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Bacic D, 2004, KIDNEY INT, V66, pS5, DOI 10.1111/j.1523-1755.2004.09102.x; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bertolotti A, 2018, BIOCHEM J, V475, P3707, DOI 10.1042/BCJ20170726; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; BIBER J, 1990, METHOD ENZYMOL, V191, P494; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Broadbent D, 2017, ADV IMMUNOL, V136, P353, DOI 10.1016/bs.ai.2017.05.008; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Centonze M, 2018, TRANSL ONCOL, V11, P374, DOI 10.1016/j.tranon.2018.01.006; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; Choy MS, 2017, J AM CHEM SOC, V139, P17703, DOI 10.1021/jacs.7b09368; Clinkenbeard EL, 2017, BONE, V102, P31, DOI 10.1016/j.bone.2017.01.034; Courbebaisse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034764; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Eisinger ML, 2017, P NATL ACAD SCI USA, V114, P11691, DOI 10.1073/pnas.1703422114; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GESEK FA, 1992, J CLIN INVEST, V90, P749, DOI 10.1172/JCI115947; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Herrero-Foncubierta P, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010161; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jiang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081904; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Khajeh JA, 2014, J MOL BIOL, V426, P2755, DOI 10.1016/j.jmb.2014.05.011; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kremer KN, 2015, J BIOL CHEM, V290, P29478, DOI 10.1074/jbc.M115.668160; Kumar GS, 2016, ELIFE, V5, DOI 10.7554/eLife.16539; Lederer E, 2019, PFLUG ARCH EUR J PHY, V471, P137, DOI 10.1007/s00424-018-2246-5; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Lim H, 2016, ONCOTARGET, V7, P10283, DOI 10.18632/oncotarget.7184; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mamonova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129554; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; McWhirter C, 2008, J AM CHEM SOC, V130, P13673, DOI 10.1021/ja803612z; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Naderi ASA, 2010, NAT REV NEPHROL, V6, P657, DOI 10.1038/nrneph.2010.121; Nagai S, 2011, J BIOL CHEM, V286, P1618, DOI 10.1074/jbc.M110.198416; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Normanno D, 2017, ELIFE, V6, DOI 10.7554/eLife.22900; Paredes JM, 2013, J PHYS CHEM B, V117, P8143, DOI 10.1021/jp405041c; Park JY, 2015, BIOCHEM CELL BIOL, V93, P290, DOI 10.1139/bcb-2014-0145; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pfister MF, 1997, J BIOL CHEM, V272, P20125, DOI 10.1074/jbc.272.32.20125; Pfister MF, 1998, P NATL ACAD SCI USA, V95, P1909, DOI 10.1073/pnas.95.4.1909; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Roy SJ, 2013, MOL ENDOCRINOL, V27, P1245, DOI 10.1210/me.2013-1091; Rubino R, 2014, PFLUG ARCH EUR J PHY, V466, P2269, DOI 10.1007/s00424-014-1474-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Sneddon WB, 2016, J BIOL CHEM, V291, P18632, DOI 10.1074/jbc.M116.744052; Song GJ, 2015, J BIOL CHEM, V290, P2879, DOI 10.1074/jbc.M114.609768; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun CY, 2013, MOL CELLS, V36, P47, DOI 10.1007/s10059-013-0014-0; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang B, 2013, BONE, V52, P268, DOI 10.1016/j.bone.2012.10.001; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2009, AM J PHYSIOL-RENAL, V297, pF1560, DOI 10.1152/ajprenal.90657.2008; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Xiao KH, 2018, NAT PROTOC, V13, P1403, DOI 10.1038/nprot.2018.037; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01247; Zhang QM, 2018, J BIOL CHEM, V293, P5556, DOI 10.1074/jbc.RA118.001737; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	105	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4546	4571		10.1074/jbc.RA119.007421	http://dx.doi.org/10.1074/jbc.RA119.007421			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696771	Green Published, hybrid			2022-12-26	WOS:000462969500023
J	Stephenson, E; Estrada, S; Meng, X; Ourada, J; Muszynski, MG; Habben, JE; Danilevskaya, ON				Stephenson, Elizabeth; Estrada, Stacey; Meng, Xin; Ourada, Jesse; Muszynski, Michael G.; Habben, Jeffrey E.; Danilevskaya, Olga N.			Over-expression of the photoperiod response regulator ZmCCT10 modifies plant architecture, flowering time and inflorescence morphology in maize	PLOS ONE			English	Article							BOX TRANSCRIPTION FACTOR; VEGETATIVE PHASE-CHANGE; SPIKELET MERISTEM IDENTITY; CRITICAL DAY LENGTH; POSTDOMESTICATION SPREAD; REPRODUCTIVE DEVELOPMENT; NATURAL VARIATION; FLORAL INDUCTION; GENE-EXPRESSION; CELL FATE	Maize originated as a tropical plant that required short days to transition from vegetative to reproductive development. ZmCCT10 [CO, CONSTANS, CO-LIKE and TIMING OF CAB1 (CCT) transcription factor family] is a regulator of photoperiod response and was identified as a major QTL controlling photoperiod sensitivity in maize. We modulated expression of ZmCCT10 in transgenic maize using two constitutive promoters with different expression levels. Transgenic plants over expressing ZmCCT10 with either promoter were delayed in their transition from vegetative to reproductive development but were not affected in their switch from juvenile-to-adult vegetative growth. Strikingly, transgenic plants containing the stronger expressing construct had a prolonged period of vegetative growth accompanied with dramatic modifications to plant architecture that impacted both vegetative and reproductive traits. These plants did not produce ears, but tassels were heavily branched. In more than half of the transgenic plants, tassels were converted into a branched leafy structure resembling phyllody, often composed of vegetative plantlets. Analysis of expression modules controlling the floral transition and meristem identity linked these networks to photoperiod dependent regulation, whereas phase change modules appeared to be photoperiod independent. Results from this study clarified the influence of the photoperiod pathway on vegetative and reproductive development and allowed for the fine-tuning of the maize flowering time model.	[Stephenson, Elizabeth; Estrada, Stacey; Meng, Xin; Ourada, Jesse; Habben, Jeffrey E.; Danilevskaya, Olga N.] CORTEVA Agrisci, Agr Div DowDuPont, Johnston, IA 50313 USA; [Muszynski, Michael G.] Univ Hawaii Manoa, Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Estrada, Stacey] ARS, USDA, Plant Intro Res Unit, Ames, IA USA; [Meng, Xin] Syngenta Crop, Slater, IA USA	University of Hawaii System; University of Hawaii Manoa; United States Department of Agriculture (USDA); Syngenta	Danilevskaya, ON (corresponding author), CORTEVA Agrisci, Agr Div DowDuPont, Johnston, IA 50313 USA.	o.danilevskaya@gmail.com	Muszynski, Michael G./L-2843-2016	Muszynski, Michael G./0000-0002-0817-7594				Abedon BG, 1966, J HERED, V87, P219; Abendroth LJ, 2011, CORN GROWTH DEV, DOI [10.1242/dev.058578, DOI 10.1242/DEV.058578]; Alter P, 2016, PLANT PHYSIOL, V172, P389, DOI 10.1104/pp.16.00285; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Bomblies K, 2003, DEVELOPMENT, V130, P2385, DOI 10.1242/dev.00457; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Chuck GS, 2014, P NATL ACAD SCI USA, V111, P18775, DOI 10.1073/pnas.1407401112; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Coles ND, 2010, GENETICS, V184, P799, DOI 10.1534/genetics.109.110304; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Danilevskaya ON, 2011, PLANT SIGNAL BEHAV, V6, P1267, DOI 10.4161/psb.6.9.16423; Danilevskaya ON, 2010, PLANT PHYSIOL, V153, P238, DOI 10.1104/pp.110.154211; Diehn S, 2012, United States Patent, Patent No. [US 8,338,662 B, 8338662B]; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Dong ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043450; DUDLEY M, 1993, GENETICS, V133, P389; EVANS MMS, 1994, DEVELOPMENT, V120, P1971; EVANS MMS, 1995, PLANT PHYSIOL, V108, P475, DOI 10.1104/pp.108.2.475; Gallavotti A, 2008, P NATL ACAD SCI USA, V105, P15196, DOI 10.1073/pnas.0805596105; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gallavotti A, 2010, DEVELOPMENT, V137, P2849, DOI 10.1242/dev.051748; Galli M, 2015, P NATL ACAD SCI USA, V112, P13372, DOI 10.1073/pnas.1516473112; Guo L, 2018, CURR BIOL, V28, P3005, DOI 10.1016/j.cub.2018.07.029; Ha CM, 2010, CURR TOP DEV BIOL, V91, P103, DOI 10.1016/S0070-2153(10)91004-1; Huang C, 2018, P NATL ACAD SCI USA, V115, pE334, DOI 10.1073/pnas.1718058115; Hultquist JF, 2008, PLANTA, V229, P99, DOI 10.1007/s00425-008-0813-2; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Itoh H, 2013, MOL PLANT, V6, P635, DOI 10.1093/mp/sst022; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; JOHNSON DQ, 1982, CROP SCI, V22, P805, DOI 10.2135/cropsci1982.0011183X002200040025x; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kobayashi K, 2010, PLANT CELL PHYSIOL, V51, P47, DOI 10.1093/pcp/pcp166; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lazakis CM, 2011, J EXP BOT, V62, P4833, DOI 10.1093/jxb/err129; Lee YS, 2015, J PLANT BIOL, V58, P353, DOI 10.1007/s12374-015-0425-x; Li CX, 2015, PLANT J, V84, P70, DOI 10.1111/tpj.12960; Liang YM, 2019, NEW PHYTOL, V221, P2335, DOI 10.1111/nph.15512; Mascheretti I, 2015, PLANT PHYSIOL, V168, P1351, DOI 10.1104/pp.15.00535; Matsubara K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00193; MCELROY D, 1994, TRENDS BIOTECHNOL, V12, P62, DOI 10.1016/0167-7799(94)90102-3; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; McSteen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001479; Mena M, 1995, PLANT J, V8, P845, DOI 10.1046/j.1365-313X.1995.8060845.x; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; Minow MAA, 2018, J EXP BOT, V69, P2937, DOI 10.1093/jxb/ery110; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Murphy RL, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0040; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Phillips KA, 2011, PLANT CELL, V23, P550, DOI 10.1105/tpc.110.075267; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Poethig RS, 2013, CURR TOP DEV BIOL, V105, P125, DOI 10.1016/B978-0-12-396968-2.00005-1; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Shi J, 2015, PLANT PHYSIOL, V169, P266, DOI 10.1104/pp.15.00780; Song YH, 2015, ANNU REV PLANT BIOL, V66, P441, DOI 10.1146/annurev-arplant-043014-115555; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Taoka K, 2013, TRENDS PLANT SCI, V18, P287, DOI 10.1016/j.tplants.2013.02.002; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Teichmann T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00233; Teotia S, 2015, MOL PLANT, V8, P359, DOI 10.1016/j.molp.2014.12.018; Troyer AF, 2001, TEMPERATE CORN BACKG; TSUJI H, 2010, CURR OPIN PLANT BIOL, V14, P1; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Weng XY, 2014, PLANT PHYSIOL, V164, P735, DOI 10.1104/pp.113.231308; Woods DP, 2016, PLANT PHYSIOL, V170, P2124, DOI 10.1104/pp.15.01279; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yan WH, 2013, CELL RES, V23, P969, DOI 10.1038/cr.2013.43; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Yang SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105352; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhao SZ, 2014, INT J MOL SCI, V15, P19987, DOI 10.3390/ijms151119987; Zheng XM, 2016, J INTEGR PLANT BIOL, V58, P540, DOI 10.1111/jipb.12383	97	18	20	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0203728	10.1371/journal.pone.0203728	http://dx.doi.org/10.1371/journal.pone.0203728			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726207	gold, Green Published, Green Submitted			2022-12-26	WOS:000457874000002
J	Thompson, SL; Dulawa, SC				Thompson, Summer L.; Dulawa, Stephanie C.			Dissecting the roles of beta-arrestin2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; 5-HT1B RECEPTOR; SUMATRIPTAN CHALLENGE; REPETITIVE BEHAVIORS; MODULATION; SENSITIZATION; PINDOLOL; MORPHINE; PLACEBO; COCAINE	Serotonin-1B receptors (5-HT1BRs) modulate perseverative behaviors and prepulse inhibition (PPI) in humans and mice. These inhibitory G-protein-coupled receptors signal through a canonical G-protein-coupled pathway that is modulated by GSK-3 beta, and a noncanonical pathway mediated by the adaptor protein beta-arrestin2 (Arrb2). Given the development of biased ligands that differentially affect canonical versus noncanonical signaling, we examined which signaling pathway mediates 5-HT1BR agonist-induced locomotor perseveration and PPI deficits, behavioral phenotypes observed in both obsessive-compulsive disorder (OCD) and autism spectrum disorder (ASD). To assess the role of canonical 5-HT1BR signaling, mice received acute pretreatment with a GSK-3 inhibitor (SB216763 or AR-A014418) and acute treatment with the 5-HT1A/1B receptor agonist RU24969 prior to assessing perseverative locomotor behavior in the open field, and PPI. To determine the role of noncanonical 5-HT1BR signaling, Arrb2 wild-type (WT), heterozygous (HT), and knockout (KO) mice received acute RU24969 treatment prior to behavioral testing. GSK-3 inhibition increased locomotor perseveration overall, and also failed to influence the RU24969-induced perseverative locomotor pattern in the open field. Yet, GSK-3 inhibition modestly reduced RU24969-induced PPI deficits. On the other hand, Arrb2 HT and KO mice showed reduced locomotion and no changes in perseveration overall, in addition to modest reductions in RU24969-induced locomotion and PPI deficits. In conclusion, our data do not support use of either GSK-3 inhibitors or beta-arrestin2 inhibition in treatment of perseverative behaviors.	[Thompson, Summer L.; Dulawa, Stephanie C.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Thompson, Summer L.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Thompson, Summer L.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University of California System; University of California San Diego; University of Chicago; Yale University	Dulawa, SC (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	sdulawa@ucsd.edu		Thompson, Summer/0000-0003-1922-1201	Brain Research Foundation; NARSAD Independent Investigator Award;  [T32 GM07839];  [T32 DA07255]	Brain Research Foundation; NARSAD Independent Investigator Award(NARSAD); ; 	This work was funded by Brain Research Foundation (https://www.thebrf.org/) to SCD, a NARSAD Independent Investigator Award (https://www.bbrfoundation.org/) to SCD, a generous gift from the Norton Gerali Foundation (SCD), and training grants: T32 GM07839 (SLT) and T32 DA07255 (SLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; Amar S, 2004, GENES BRAIN BEHAV, V3, P178, DOI 10.1111/j.1601-183x.2004.00065.x; An XL, 2011, EXP ANIM TOKYO, V60, P111, DOI 10.1538/expanim.60.111; [Anonymous], 2013, DIAGNOSTIC STAT MANU, V5; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; Bourin M, 1998, PSYCHOPHARMACOLOGY, V136, P226, DOI 10.1007/s002130050560; Castanon N, 2000, PHARMACOL BIOCHEM BE, V67, P559, DOI 10.1016/S0091-3057(00)00389-0; Chan MH, 2012, SCHIZOPHR RES, V136, P96, DOI 10.1016/j.schres.2012.01.024; CHEETHAM SC, 1993, BRIT J PHARMACOL, V110, P1621, DOI 10.1111/j.1476-5381.1993.tb14010.x; Chen L, 2011, MOL PHARMACOL, V79, P974, DOI 10.1124/mol.111.071092; Chen LG, 2009, MOL PHARMACOL, V76, P1150, DOI 10.1124/mol.109.056994; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Correll JA, 2009, SYNAPSE, V63, P510, DOI 10.1002/syn.20625; Dannon PN, 2000, EUR NEUROPSYCHOPHARM, V10, P165, DOI 10.1016/S0924-977X(00)00065-1; Dawson LA, 2000, NEUROPHARMACOLOGY, V39, P1044, DOI 10.1016/S0028-3908(99)00192-6; Dayton A, 2016, HYPERTENSION, V68, P1139, DOI 10.1161/HYPERTENSIONAHA.116.08207; Enman NM, 2012, BEHAV BRAIN RES, V231, P217, DOI 10.1016/j.bbr.2012.03.027; Giles H, 1996, BRIT J PHARMACOL, V117, P1119, DOI 10.1111/j.1476-5381.1996.tb16705.x; GOODMAN WK, 1990, ARCH GEN PSYCHIAT, V47, P577; GORDON CT, 1993, ARCH GEN PSYCHIAT, V50, P441; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Gross-Isseroff R, 2004, NEUROPSYCHOBIOLOGY, V50, P200, DOI 10.1159/000079970; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Hartig PR, 1996, TRENDS PHARMACOL SCI, V17, P103, DOI 10.1016/0165-6147(96)30002-3; Ho EV, 2016, PSYCHOPHARMACOLOGY, V233, P57, DOI 10.1007/s00213-015-4086-8; Hollander E, 2000, NEUROPSYCHOPHARMACOL, V22, P163, DOI 10.1016/S0893-133X(99)00121-9; Kalinichev M, 2011, INT J NEUROPSYCHOPH, V14, P1051, DOI 10.1017/S1461145710001495; Kantak PA, 2014, BEHAV PHARMACOL, V25, P71, DOI 10.1097/FBP.0000000000000013; Kapfhamer D, 2010, J NEUROSCI, V30, P8830, DOI 10.1523/JNEUROSCI.1292-10.2010; Koran LM, 2001, EUR NEUROPSYCHOPHARM, V11, P169, DOI 10.1016/S0924-977X(01)00082-7; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin SL, 2002, BRIT J PHARMACOL, V136, P1072, DOI 10.1038/sj.bjp.0704809; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; PAULUS MP, 1991, PSYCHOPHARMACOLOGY, V104, P6, DOI 10.1007/BF02244547; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pittenger C, 2016, J AFFECT DISORDERS, V196, P87, DOI 10.1016/j.jad.2016.02.021; Pizarro M, 2014, EXPERT OPIN PHARMACO, V15, P1391, DOI 10.1517/14656566.2014.914493; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Ravier MA, 2014, DIABETOLOGIA, V57, P532, DOI 10.1007/s00125-013-3130-7; Rodriguez D, 2014, STRUCTURE, V22, P1140, DOI 10.1016/j.str.2014.05.017; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Shanahan NA, 2011, BIOL PSYCHIAT, V70, P1039, DOI 10.1016/j.biopsych.2011.07.032; Shanahan NA, 2009, BIOL PSYCHIAT, V65, P401, DOI 10.1016/j.biopsych.2008.09.026; Soorya L, 2008, CHILD ADOL PSYCH CL, V17, P753, DOI 10.1016/j.chc.2008.06.003; Stein DJ, 1999, PROG NEURO-PSYCHOPH, V23, P1079, DOI 10.1016/S0278-5846(99)00051-2; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Woehrle NS, 2013, PSYCHOPHARMACOLOGY, V227, P545, DOI 10.1007/s00213-013-2985-0; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042; Zhou WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043262	55	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211239	10.1371/journal.pone.0211239	http://dx.doi.org/10.1371/journal.pone.0211239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721232	Green Published, gold, Green Submitted			2022-12-26	WOS:000457746300010
J	Zainabadi, K; Dhayabaran, V; Moideen, K; Krishnaswamy, P				Zainabadi, Kayvan; Dhayabaran, Vaigundan; Moideen, Kutty; Krishnaswamy, Patnam			An efficient and cost-effective method for purification of small sized DNAs and RNAs from human urine	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; NUCLEIC-ACIDS; CLINICAL-SAMPLES; DIAGNOSIS; PCR; BIOMARKERS; VIRUS; IDENTIFICATION; PROTOCOLS	Urine holds great promise as a non-invasive sampling method for molecular diagnostics. The cell-free nucleic acids of urine however are small, labile, and difficult to purify. Here an efficient method for the purification of these nucleic acids is presented. An empirically derived protocol was devised by first identifying conditions that allowed recovery of a 100 base pair (bp) DNA, followed by optimization using a quantitative polymerase chain reaction (qPCR) assay. The resulting method efficiently purifies both small sized DNAs and RNAs from urine, which when combined with quantitative reverse transcription PCR (qRTPCR), demonstrably improves detection sensitivity. Fractionation experiments reveal that nucleic acids in urine exist both in the cell-free and cellular fraction, roughly in equal proportion. Consistent with previous studies, amplicons > 180bp show a marked loss in PCR sensitivity for cell-free nucleic acids. Finally, the lysis buffer developed here also doubles as an effective preservative, protecting against nucleic acid degradation for at least two weeks under simulated field conditions. With this method, volumes of up to 25ml of whole urine can be purified in a high-throughput and cost-effective manner. Coupled with its ability to purify both DNA and RNA, the described method may have broad applicability for improving the diagnostic utility of urine, particularly for the detection of low abundant targets.	[Zainabadi, Kayvan; Dhayabaran, Vaigundan; Moideen, Kutty; Krishnaswamy, Patnam] Sri Devaraj Urs Acad Higher Educ & Res, Dept Cell Biol & Mol Genet, Genom & Cent Res Lab, Tamaka, Kolar, India; [Zainabadi, Kayvan] Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India; [Zainabadi, Kayvan] Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA	Indian Institute of Science (IISC) - Bangalore; Cornell University	Zainabadi, K (corresponding author), Sri Devaraj Urs Acad Higher Educ & Res, Dept Cell Biol & Mol Genet, Genom & Cent Res Lab, Tamaka, Kolar, India.; Zainabadi, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India.; Zainabadi, K (corresponding author), Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA.	kayvan@alum.mit.edu		Dhayabaran, vaigundan/0000-0001-8821-6276; P.R., Krishnaswamy/0000-0001-7627-8568				Aceti A, 1999, THORAX, V54, P145, DOI 10.1136/thx.54.2.145; Adams M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1038-z; Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boom R, 1999, J CLIN MICROBIOL, V37, P615, DOI 10.1128/JCM.37.3.615-619.1999; Bryzgunova OE, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-3-48-54; Center for Disease Control and Prevention Interim Guidance for Zika Virus Testing of Urine-United States, 2016, MMWRMORB MORTAL WKLY, V2016, P65; Chan KCA, 2008, CLIN CANCER RES, V14, P4809, DOI 10.1158/1078-0432.CCR-08-1112; Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67; Chen S, 2017, CLIN TRANSL ONCOL, V19, P332, DOI 10.1007/s12094-016-1534-9; Chiu L, 2015, J BONE ONCOL, V4, P18, DOI 10.1016/j.jbo.2015.01.002; DEMMLER GJ, 1988, J INFECT DIS, V158, P1177, DOI 10.1093/infdis/158.6.1177; El Bali Latifa, 2014, J Biomol Tech, V25, P96, DOI 10.7171/jbt.14-2504-002; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Franovic A, 2017, J THORAC DIS, V9, pS1323, DOI 10.21037/jtd.2017.06.144; Gopinath K, 2009, INT J INFECT DIS, V13, P374, DOI 10.1016/j.ijid.2008.07.022; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Heydari AA, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.9311; Janvier F, 2016, EMERG INFECT DIS, V22, P292, DOI 10.3201/eid2202.151395; Kafwabulula M, 2002, INT J TUBERC LUNG D, V6, P732; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; LIOU TC, 1992, J MED VIROL, V37, P197, DOI 10.1002/jmv.1890370309; da Silva MAL, 2014, REV SOC BRAS MED TRO, V47, P193, DOI 10.1590/0037-8682-0233-2013; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9; OLIVE DM, 1989, J MED VIROL, V29, P232, DOI 10.1002/jmv.1890290403; PATHAK N, 2014, BMJ BRIT MED J, V349; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966; Pinto GG, 2013, J VIROL METHODS, V188, P94, DOI 10.1016/j.jviromet.2012.12.006; Schmidt B, 2005, CLIN CHEM, V51, P1561, DOI 10.1373/clinchem.2005.051003; Sechi LA, 1997, MOL CELL PROBE, V11, P281, DOI 10.1006/mcpr.1997.0119; Serdyuk OI, 2001, B EXP BIOL MED+, V131, P283, DOI 10.1023/A:1017624120807; Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011; Southern TR, 2015, J CLIN MICROBIOL, V53, P2956, DOI 10.1128/JCM.01317-15; Streleckiene G, 2018, BIOTECHNIQUES, V64, P225, DOI 10.2144/btn-2018-0003; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Su Ying-Hsiu, 2005, Cancer Biomarkers, V1, P177; Torrea G, 2005, J MED MICROBIOL, V54, P39, DOI 10.1099/jmm.0.45688-0; Tuuminen T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00045; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; VANEYS GJJM, 1989, J CLIN MICROBIOL, V27, P2258, DOI 10.1128/JCM.27.10.2258-2262.1989; Vorsters A, 2014, EUR J CLIN MICROBIOL, V33, P2005, DOI 10.1007/s10096-014-2147-2; Warren AD, 2014, P NATL ACAD SCI USA, V111, P3671, DOI 10.1073/pnas.1314651111; Warton K, 2018, CANC GENET; Zainabadi K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2025-3; Zou LL, 2015, ADV EXP MED BIOL, V845, P31, DOI 10.1007/978-94-017-9523-4_4	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0210813	10.1371/journal.pone.0210813	http://dx.doi.org/10.1371/journal.pone.0210813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721243	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000457746300007
J	Limkakeng, AT; Henao, R; Voora, D; O'Connell, T; Griffin, M; Tsalik, EL; Shah, S; Woods, CW; Ginsburg, GS				Limkakeng, Alexander T., Jr.; Henao, Ricardo; Voora, Deepak; O'Connell, Thomas; Griffin, Michelle; Tsalik, Ephraim L.; Shah, Svati; Woods, Christopher W.; Ginsburg, Geoffrey S.			Pilot study of myocardial ischemia-induced metabolomic changes in emergency department patients undergoing stress testing	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR EVENTS; CHEST-PAIN; BIOMARKERS; SIGNATURE; ELEVATION; PATTERNS; HUMANS; BLOOD; RISK	Background The heart is a metabolically active organ, and plasma acylcarnitines are associated with long-term risk for myocardial infarction. We hypothesized that myocardial ischemia from cardiac stress testing will produce dynamic changes in acylcarnitine and amino acid levels compared to levels seen in matched control patients with normal stress tests. Methods We analyzed targeted metabolomic profiles in a pilot study of 20 case patients with inducible ischemia on stress testing from an existing prospectively collected repository of 357 consecutive patients presenting with symptoms of Acute Coronary Syndrome (ACS) in an Emergency Department (ED) observation unit between November 2012 and September 2014. We selected 20 controls matched on age, sex, and body-mass index (BMI). A peripheral blood sample was drawn <1 hour before stress testing and 2 hours after stress testing on each patient. We assayed 60 select acylcarnitines and amino acids by tandem mass spec-trometry (MS/MS) using a Quattro Micro instrument (Waters Corporation, Milford, MA). Metabolite values were log transformed for skew. We then performed bivariable analysis for stress test outcome and both individual timepoint metabolite concentrations and stress-delta metabolite ratios (T2/T0). False discovery rates (FDR) were calculated for 60 metabolites while controlling for age, sex, and BMI. We built multivariable regularized linear models to predict stress test outcome from metabolomics data at times 0, 2 hours, and log ratio between these two. We used leave-one-out cross-validation to estimate the performance characteristics of the model. Results Nine of our 20 case subjects were male. Cases' average age was 55.8, with an average BMI 29.5. Bivariable analysis identified 5 metabolites associated with positive stress tests (FDR < 0.2): alanine, C14:1-OH, C16:1, C18:2, C20:4. The multivariable regularized linear models built on T0 and T2 had Area Under the ROC Curve (AUC-ROC) between 0.5 and 0.55, however, the log(T2/T0) model yielded 0.625 AUC, with 65% sensitivity and 60% specificity. The top metabolites selected by the model were: Ala, Arg, C12-OH/C10-DC, C14:1-OH, C16:1, C18:2, C18:1, C20:4 and C18:1-DC. Conclusions Stress-delta metabolite analysis of patients undergoing stress testing is feasible. Future studies with a larger sample size are warranted.	[Limkakeng, Alexander T., Jr.; Griffin, Michelle] Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA; [Henao, Ricardo; Voora, Deepak; Tsalik, Ephraim L.; Shah, Svati; Woods, Christopher W.; Ginsburg, Geoffrey S.] Duke Univ, Ctr Appl Genom & Precis Med, Durham, NC USA; [Voora, Deepak; Shah, Svati; Ginsburg, Geoffrey S.] Duke Univ, Dept Med, Div Cardiol, Durham, NC USA; [O'Connell, Thomas] Indiana Univ, Indianapolis, IN 46204 USA; [Tsalik, Ephraim L.] Durham Vet Affairs Med Ctr, Emergency Med Serv, Durham, NC USA; [Tsalik, Ephraim L.; Woods, Christopher W.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC USA	Duke University; Duke University; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Limkakeng, AT (corresponding author), Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA.	alexander.limkakeng@duke.edu		Limkakeng, Alexander T./0000-0002-9822-5595; Tsalik, Ephraim/0000-0002-6417-2042; Henao, Ricardo/0000-0003-4980-845X	ENABLE grant from the Duke Private Diagnostic Clinics; Abbott Laboratories; Roche International; Siemens Healthcare Diagnostics	ENABLE grant from the Duke Private Diagnostic Clinics; Abbott Laboratories(Abbott Laboratories); Roche International; Siemens Healthcare Diagnostics	This study was made possible by an ENABLE grant from the Duke Private Diagnostic Clinics and Duke University. The study authors retained rights to data and decision of whether to publish. Dr. Tsalik works at the Durham VA Hospital but is not a government employee. Dr. Shah and Dr. Ginsburg report having an unrelated unlicensed patent on a metabolomic finding, "Predicting coronary artery disease and risk of cardiovascular events", patent application number #20160195543. Dr. Ginsburg also serves on the Scientific Advisory Board for CardioDx and has received research funding from Abbott Laboratories but is not an employee. Dr. Limkakeng has received research grants from Roche International, Abbott Laboratories, and Siemens Healthcare Diagnostics but is not an employee. None of these entities provided funding for this study. They provided support in the form of salaries for authors GG and ATL, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep36359; Barderas MG, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/790132; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Bodi V, 2013, J CARDIOVASC TRANSL, V6, P808, DOI 10.1007/s12265-013-9505-9; DeFilippis AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175591; DeRatt BN, 2017, J NUTR, V147, P1658, DOI 10.3945/jn.117.254029; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Ely S, 2013, J EMERG MED, V44, P306, DOI 10.1016/j.jemermed.2012.07.048; Foy AJ, 2015, JAMA INTERN MED, V175, P428, DOI 10.1001/jamainternmed.2014.7657; Gao XQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12254-1; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heather LC, 2013, J MOL CELL CARDIOL, V55, P2, DOI 10.1016/j.yjmcc.2012.12.001; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Limkakeng AT, 2017, J APPL LAB MED, V1, P532, DOI 10.1373/jalm.2016.021667; Makam AN, 2015, JAMA INTERN MED, V175, P67, DOI 10.1001/jamainternmed.2014.5830; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Niska R, 2010, NATL HOSP AMBULATORY; Park HJ, 2015, ONCOTARGET, V6, P12970, DOI 10.18632/oncotarget.4001; R Core Team, 2013, R LANG ENV STAT COMP; Rizza S, 2014, ATHEROSCLEROSIS, V232, P260, DOI 10.1016/j.atherosclerosis.2013.10.029; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Shah AA, 2012, J THORAC CARDIOV SUR, V143, P873, DOI 10.1016/j.jtcvs.2011.09.070; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Yin XJ, 2017, METALLOMICS, V9, P734, DOI 10.1039/c7mt00071e	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211762	10.1371/journal.pone.0211762	http://dx.doi.org/10.1371/journal.pone.0211762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707740	gold, Green Published			2022-12-26	WOS:000457742900048
J	Nganje, CN; Haynes, SA; Qabar, CM; Lent, RC; Ghanem, ENB; Shainheit, MG				Nganje, Charmaine N.; Haynes, Scott A.; Qabar, Christine M.; Lent, Rachel C.; Ghanem, Elsa N. Bou; Shainheit, Mara G.			PepN is a non-essential, cell wall-localized protein that contributes to neutrophil elastase-mediated killing of Streptococcus pneumoniae	PLOS ONE			English	Article							CHEDIAK-HIGASHI-SYNDROME; CATHEPSIN-G; VIRULENCE FACTORS; ESCHERICHIA-COLI; AMINOPEPTIDASE-N; HOST; GENE; PURIFICATION; RESISTANCE; COLONIZATION	Streptococcus pneumoniae (Spn) is an asymptomatic colonizer of the human nasopharynx but can also cause disease in the inner ear, meninges, lung and blood. Although various mechanisms contribute to the effective clearance of Spn, opsonophagocytosis by neutrophils is perhaps most critical. Upon phagocytosis, Spn is exposed to various degradative molecules, including a family of neutrophil serine proteases (NSPs) that are stored within intracellular granules. Despite the critical importance of NSPs in killing Spn, the bacterial proteins that are degraded by NSPs leading to Spn death are still unknown. In this report, we identify a 90kDa protein in a purified cell wall (CW) preparation, aminopeptidase N (PepN) that is degraded by the NSP neutrophil elastase (NE). Since PepN lacked a canonical signal sequence or LPxTG motif, we created a mutant expressing a FLAG tagged version of the protein and confirmed its localization to the CW compartment. We determined that not only is PepN a CW-localized protein, but also is a substrate of NE in the context of intact Spn cells. Furthermore, in comparison to wild-type TIGR4 Spn, a mutant strain lacking PepN demonstrated a significant hyper-resistance phenotype in vitro in the presence of purified NE as well as in opsonophagocytic assays with purified human neutrophils ex vivo. Taken together, this is the first study to demonstrate that PepN is a CW-localized protein and a substrate of NE that contributes to the effective killing of Spn by NSPs and human neutrophils.	[Nganje, Charmaine N.; Haynes, Scott A.; Qabar, Christine M.; Lent, Rachel C.; Shainheit, Mara G.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA; [Ghanem, Elsa N. Bou] Univ Buffalo, Sch Med, Dept Microbiol & Immunol, Buffalo, NY USA	University System of Maryland; Towson University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shainheit, MG (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD 21252 USA.	mshainheit@towson.edu		Qabar, Christine/0000-0002-8345-9225	Jess and Mildred Fisher College of Science and Mathematics at Towson University; Department of Biological Sciences	Jess and Mildred Fisher College of Science and Mathematics at Towson University; Department of Biological Sciences	This project was funded by Undergraduate Research Awards provided by the Jess and Mildred Fisher College of Science and Mathematics at Towson University and funds provided by the Department of Biological Sciences. We thank Dr. A. L. Sonenshein for providing the anti-CodY antibody and Dr. John Leong for sharing additional reagents needed for PMN experiments. We also thank Dr. Neil Greene for helpful discussions and for critically reading our manuscript and Ross Tomaino for help with the mass spectrometry analysis.	ANDERSSON C, 1992, CURR MICROBIOL, V25, P261, DOI 10.1007/BF01575859; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Blevins LK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01610; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; Chavagnat F, 1999, APPL ENVIRON MICROB, V65, P3001; Dalia AB, 2014, P NATL ACAD SCI USA, V111, P8937, DOI 10.1073/pnas.1406478111; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Dallaire F, 2001, J INFECT DIS, V184, P292, DOI 10.1086/322021; Domon H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38013; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; Ghanem ENB, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00161; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Hahn I, 2011, INFECT IMMUN, V79, P4893, DOI 10.1128/IAI.05593-11; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hazenbos WLW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003653; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hurley BP, 2004, J IMMUNOL, V173, P5712, DOI 10.4049/jimmunol.173.9.5712; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; MIDWINTER RG, 1994, J APPL BACTERIOL, V77, P288, DOI 10.1111/j.1365-2672.1994.tb03076.x; Mitchell TJ, 2000, RES MICROBIOL, V151, P413, DOI 10.1016/S0923-2508(00)00175-3; Moorthy AN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00056; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Plumptre CD, 2013, INFECT IMMUN, V81, P3644, DOI 10.1128/IAI.00562-13; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; ROOT RK, 1972, J CLIN INVEST, V51, P649, DOI 10.1172/JCI106854; SALLES C, 1992, NUCLEIC ACIDS RES, V20, P6103, DOI 10.1093/nar/20.22.6103; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shapiro SD, 2002, AM J RESP CELL MOL, V26, P266, DOI 10.1165/ajrcmb.26.3.f233; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; van der Windt D, 2012, FEMS IMMUNOL MED MIC, V66, P445, DOI 10.1111/j.1574-695X.2012.01028.x; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; WHO, 2017, PNEUM DIS; WOODRUFF WA, 1986, J BACTERIOL, V167, P473, DOI 10.1128/jb.167.2.473-479.1986; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Zar JH., 2010, BIOSTAT ANAL, V5th	54	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211632	10.1371/journal.pone.0211632	http://dx.doi.org/10.1371/journal.pone.0211632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707714	gold, Green Published, Green Submitted			2022-12-26	WOS:000457742900038
J	Alhaddad, H; Maraqa, T; Alabdulghafour, S; Alaskar, H; Alaqeely, R; Almathen, F; Alhajeri, BH				Alhaddad, Hasan; Maraqa, Tasneem; Alabdulghafour, Suha; Alaskar, Huda; Alaqeely, Randa; Almathen, Faisal; Alhajeri, Bader H.			Quality and quantity of dromedary camel DNA sampled from whole-blood, saliva, and tail-hair	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GULF	Camels are livestock with unique adaptations to hot-arid regions. To effectively study camel traits, a biobank of camel DNA specimens with associated biological information is needed. We examined whole-blood, saliva (buccal swabs), and tail-hair follicle samples to determine which is the best source for establishing a DNA biobank. We inspected five amounts of each of whole-blood, buccal swabs, and tail-hair follicles in nine camels, both qualitatively via gel electrophoresis and quantitatively using a NanoDrop spectrophotometer. We also tested the effects of long term-storage on the quality and quantity of DNA, and measured the rate of degradation, by analyzing three buccal swab samples and 30 tail-hair follicles over a period of nine months. Good quality DNA, in the form of visible large size DNA bands, was extracted from all three sources, for all five amounts. The five volumes of whole-blood samples (20-100 mu l) provided similar to 0.4-3.6 mu g, the five quantities of buccal swabs (1-5) produced similar to 0.1-12 mu g, while the five amounts of tail-hair follicles (10-50) resulted in similar to 0.7-25 mu g. No differences in the rate of degradation of buccal swab and tail-hair follicle DNA were detected, but there was clearly greater deterioration in the quality of DNA extracted from buccal swabs when compared to tail-hair follicles. We recommend using tail-hair samples for camel DNA biobanking, because it resulted in both an adequate quality and quantity of DNA, along with its ease of collection, transportation, and storage. Compared to its success in studies of other domesticated animals, we anticipate that using similar to 50 tail-hair follicles will provide sufficient DNA for sequencing or SNP genotyping.	[Alhaddad, Hasan; Maraqa, Tasneem; Alabdulghafour, Suha; Alaskar, Huda; Alaqeely, Randa; Alhajeri, Bader H.] Kuwait Univ, Dept Biol Sci, Safat, Kuwait; [Almathen, Faisal] King Faisal Univ, Coll Vet Med, Dept Vet Publ Hlth & Anim Husb, Al Hasa, Saudi Arabia; [Almathen, Faisal] King Faisal Univ, Camel Res Ctr, Al Hasa, Saudi Arabia	Kuwait University; King Faisal University; King Faisal University	Alhaddad, H (corresponding author), Kuwait Univ, Dept Biol Sci, Safat, Kuwait.	hhalhaddad@gmail.com	Alhajeri, Bader/J-8119-2019	Alhajeri, Bader/0000-0002-4071-0301; Alhaddad, Hasan/0000-0001-7904-2913; Almathen, Faisal/0000-0001-6970-9155; Alaqeely, Randa/0000-0001-6049-4784; Alaskar, Huda/0000-0002-5330-4919	Kuwait University Research Sector [SL09/16]	Kuwait University Research Sector	The authors hereby acknowledge the support of the Kuwait University Research Sector in granting the research project (SL09/16), and in facilitating its implementation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu shulukh E, 2017, NOVA J MED BIOL SCI, V6; Al-Swailem AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010720; Alhaddad H, 2018, ECOL EVOL, V8, P10266, DOI 10.1002/ece3.4503; Almathen F, 2018, J HERED, V109, P700, DOI 10.1093/jhered/esy024; Almathen F, 2016, P NATL ACAD SCI USA, V113, P6707, DOI 10.1073/pnas.1519508113; [Anonymous], 2016, MASONS WORLD ENCY LI; Blackburn HD, 2018, ANNU REV ANIM BIOSCI, V6, P69, DOI 10.1146/annurev-animal-030117-014603; Bruinsma Fiona J, 2018, BMC Res Notes, V11, P8, DOI 10.1186/s13104-017-3110-y; Burger PA, 2016, TROP ANIM HEALTH PRO, V48, P905, DOI 10.1007/s11250-016-1032-7; Desjardins P., 2010, JOVE-J VIS EXP, V45, P2565, DOI DOI 10.3791/2565; Do DN, 2017, J DAIRY SCI, V100, P1955, DOI 10.3168/jds.2016-11910; Dorshorst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128969; FARAH Z, 1993, J DAIRY RES, V60, P603, DOI 10.1017/S0022029900027953; Faye B, 2016, TROP ANIM HEALTH PRO, V48, P689, DOI 10.1007/s11250-016-0995-8; Faye B, 2014, ANTHROPOZOOLOGICA, V49, P167, DOI 10.5252/az2014n2a01; Fitak RR, 2016, MOL ECOL RESOUR, V16, P314, DOI 10.1111/1755-0998.12443; Gandolfi B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25438-0; Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171; Groeneveld LF, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002523; Hammond A., 2007, ODDLY ENOUGH; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Holl H, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030102; Kadim IT, 2008, MEAT SCI, V80, P555, DOI 10.1016/j.meatsci.2008.02.010; Kagunyu AW, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-25; Khalaf S, 1999, ANTHROPOS, V94, P85; Khalaf S, 2000, ETHNOLOGY, V39, P243, DOI 10.2307/3774109; Livy A, 2012, INDIAN J CLIN BIOCHE, V27, P28, DOI 10.1007/s12291-011-0154-y; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mburu DN, 2003, ANIM GENET, V34, P26, DOI 10.1046/j.1365-2052.2003.00937.x; Menzi F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28438; Neary MT, 2014, J ANIM SCI, V92, P3811, DOI 10.2527/jas.2013-7445; Nedel F, 2009, J APPL ORAL SCI, V17, P113, DOI 10.1590/S1678-77572009000200008; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Omrani AS, 2015, PATHOG GLOB HEALTH, V109, P354, DOI 10.1080/20477724.2015.1122852; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; PERK K, 1963, NATURE, V200, P272, DOI 10.1038/200272a0; R Core Team, 2013, R LANG ENV STAT COMP; Ramadan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191119; Schaefer RJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3943-8; SCHMIDTNIELSEN B, 1956, AM J PHYSIOL, V185, P185, DOI 10.1152/ajplegacy.1956.185.1.185; SCHMIDTNIELSEN K, 1959, SCI AM, V201, P140, DOI 10.1038/scientificamerican1259-140; SCHMIDTNIELSEN K, 1981, PROC R SOC SER B-BIO, V211, P305, DOI 10.1098/rspb.1981.0009; SCHMIDTNIELSEN K, 1957, AM J PHYSIOL, V188, P103, DOI 10.1152/ajplegacy.1956.188.1.103; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938; Teague M., 2009, NATL GEOGRAPHIC; THOMSON DM, 1992, CLIN CHIM ACTA, V207, P169, DOI 10.1016/0009-8981(92)90116-8; Woo JG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-79; Wu HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5515; YAGIL R, 1974, AM J PHYSIOL, V226, P298, DOI 10.1152/ajplegacy.1974.226.2.298; Yokoyama JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010809; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	52	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211743	10.1371/journal.pone.0211743	http://dx.doi.org/10.1371/journal.pone.0211743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703133	gold, Green Submitted, Green Published			2022-12-26	WOS:000457301600066
J	de Sousa, TLW; Ostoli, TLVD; Sperandio, EF; Arantes, RL; Gagliardi, ARD; Romiti, M; da Silva, RP; Dourado, VZ				Wanderley de Sousa, Thiago Luis; Valentim di Paschoale Ostoli, Thatiane Lopes; Sperandio, Evandro Fornias; Arantes, Rodolfo Leite; de Toledo Gagliardi, Antonio Ricardo; Romiti, Marcello; da Silva, Rodrigo Pereira; Dourado, Victor Zuniga			Dose-response relationship between very vigorous physical activity and cardiovascular health assessed by heart rate variability in adults: Cross-sectional results from the EPIMOV study	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; ATRIAL-FIBRILLATION; VENTRICULAR DYSFUNCTION; PROGNOSTIC VALUE; EXERCISE; RISK; MORTALITY; FITNESS	The minimum amount of physical activity needed to obtain health benefits has been widely determined. Unlikely, the impact of extreme amounts of very vigorous physical activity (VVPA, >= 8 metabolic equivalents) to the heart remains controversial. We aimed to evaluate the dose-response relationship between VVPA and heart rate variability (HRV) in adults. We selected 1040 asymptomatic individuals (60% women, 42 +/- 15 years, 28 +/- 6 kg/m(2)) from the Epidemiology and Human Movement Study (EPIMOV). Participants remained in the supine position for 10 min, and we selected an intermediate 5-min window for HRV analysis. The standard deviation of the RR intervals, root mean square of RR intervals, successive RR intervals that differ > 50 ms, powers of the low-and high-frequency bands and Poincare plot standard deviations were quantified. Participants used a triaxial accelerometer (Actigraph GT3x+) above the dominant hip for 4-7 consecutive days for quantifying their physical activity. We also evaluated the maximum oxygen uptake ((V) over dotO(2max)) during an exercise test. We stratified participants into five groups according to the VVPA in min/week (group 1, <= 1.50; 2, 1.51-3.16; 3, 3.17-3.54; 4, 3.55-20.75; and 5, > 20.75). The linear trends of the HRV through the quintiles of VVPA were investigated. We used logarithmic transformations to compare the five groups adjusted for age, sex, cardiovascular risk, and (V) over dotO(2max). We found a better HRV with increased VVPA for all HRV indices studied (p trend < 0.05). However, group 5 did not differ from group 4 (p > 0.05) for none of the indices. We conclude that there is an incremental benefit of VVPA on HRV of asymptomatic adults. Since we found neither additional benefits nor the harmful impact of amounts of VVPA as high as 22 min/week on HRV, our results should not discourage asymptomatic adults to perform VVPA.	[Wanderley de Sousa, Thiago Luis; Valentim di Paschoale Ostoli, Thatiane Lopes; Sperandio, Evandro Fornias; da Silva, Rodrigo Pereira; Dourado, Victor Zuniga] Fed Univ Sao Paulo UNIFESP, Dept Human Movement Sci, Sao Paulo, Brazil; [Arantes, Rodolfo Leite; de Toledo Gagliardi, Antonio Ricardo; Romiti, Marcello] Angiocorpore Inst Cardiovasc Med, Sao Paulo, Brazil; [Dourado, Victor Zuniga] Harvard TH Chan Sch Publ Hlth, Lown Scholars Program, Boston, MA 02115 USA	Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard T.H. Chan School of Public Health	Dourado, VZ (corresponding author), Fed Univ Sao Paulo UNIFESP, Dept Human Movement Sci, Sao Paulo, Brazil.; Dourado, VZ (corresponding author), Harvard TH Chan Sch Publ Hlth, Lown Scholars Program, Boston, MA 02115 USA.	vzdourado@yahoo.com.br	Dourado, Victor/E-6784-2012; Sperandio, Evandro/K-5155-2015	Dourado, Victor/0000-0002-6222-3555; Sperandio, Evandro/0000-0002-8580-458X	Sao Paulo Research Foundation (FAPESP) [2011/07282-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07282-6]; Angiocorpore Institute of Cardiovascular Medicine	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Angiocorpore Institute of Cardiovascular Medicine	This paper was supported by Grant number 2011/07282-6, Sao Paulo Research Foundation (FAPESP), www.fapesp.br, to Dourado VZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was made possible by the financial support of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2011/07282-6. The authors would like to thank the Angiocorpore Institute of Cardiovascular Medicine for their support and partnership.	Abdulla J, 2009, EUROPACE, V11, P1156, DOI 10.1093/europace/eup197; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Baumert M, 2006, CLIN J SPORT MED, V16, P412, DOI 10.1097/01.jsm.0000244610.34594.07; BERNARDI L, 1990, CARDIOVASC RES, V24, P969, DOI 10.1093/cvr/24.12.969; Boveda S, 2001, J INTERV CARD ELECTR, V5, P181, DOI 10.1023/A:1011485609838; Camm AJ, 1996, EUR HEART J, V17, P354; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Culver BH, 2017, AM J RESP CRIT CARE, V196, P1463, DOI 10.1164/rccm.201710-1981ST; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Drca N, 2014, HEART, V100, P1037, DOI 10.1136/heartjnl-2013-305304; Dutra SGV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077092; Ector J, 2007, EUR HEART J, V28, P345, DOI 10.1093/eurheartj/ehl468; Elliott AD, 2018, CLIN CARDIOL, V41, P843, DOI 10.1002/clc.22967; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Guo Y, 2015, J CLIN NEUROPHYSIOL, V32, P516, DOI 10.1097/WNP.0000000000000210; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; Istenes I, 2014, DIABETES-METAB RES, V30, P305, DOI 10.1002/dmrr.2496; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Koenig J, 2016, NEUROSCI BIOBEHAV R, V64, P288, DOI 10.1016/j.neubiorev.2016.03.007; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Lavie CJ, 2015, CURR SPORT MED REP, V14, P104, DOI 10.1249/JSR.0000000000000134; Liu GZ, 2014, AUSTRALAS PHYS ENG S, V37, P567, DOI 10.1007/s13246-014-0281-x; Melillo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118504; Merghani A, 2016, TRENDS CARDIOVAS MED, V26, P232, DOI 10.1016/j.tcm.2015.06.005; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Mont L, 2002, EUR HEART J, V23, P477, DOI 10.1053/euhj.2001.2802; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; O'Keefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Poirier P, 2014, CIRCULATION, V129, P2085, DOI 10.1161/CIRCULATIONAHA.114.009778; Scherr J, 2011, MED SCI SPORT EXER, V43, P1819, DOI 10.1249/MSS.0b013e31821b12eb; Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023; Sessa F, 2018, AGING-US, V10, P166, DOI 10.18632/aging.101386; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Song T, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-59; Tegegne BS, 2018, HEART RHYTHM, V15, P1552, DOI 10.1016/j.hrthm.2018.05.006; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; Wasserman K., 2012, PRINCIPLES EXERCISE, V1, P8	45	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210216	10.1371/journal.pone.0210216	http://dx.doi.org/10.1371/journal.pone.0210216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703127	Green Submitted, Green Published, gold			2022-12-26	WOS:000457301600014
J	Pechtl, J; Land, A				Pechtl, Joachim; Land, Alexander			Tree rings as a proxy for seasonal precipitation variability and Early Neolithic settlement dynamics in Bavaria, Germany	PLOS ONE			English	Article							CENTRAL-EUROPE; DENDROCLIMATOLOGY; RECORD; MODEL; OAK	Studying the dynamic of Neolithic settlement on a local scale and its connection to climate variability is often difficult due to missing on-site climate reconstructions from natural archives. Here we bring together archaeological settlement data and a regional climate reconstruction from precipitation-sensitive trees. Both archives hold information about regional settlement dynamics and hydroclimate variability spanning the time of the first farming communities, the so called Linearbandkeramik (LBK) in Bavaria, Germany. Precipitation-sensitive tree-ring series from subfossil oak are used to develop a spring-summer precipitation reconstruction (5700-4800 B.C.E.) representative for southern Germany. Early Neolithic settlement data from Bavaria, mainly for the duration of the LBK settlement activities, are critically evaluated and compared to this unique regional hydroclimate reconstruction as well as to reconstructions of Greenland temperature, summer sea surface temperature, delta O-18 and global solar irradiance to investigate the potential impact of climate on Neolithic settlers and their settlement dynamic during the LBK. Our hydroclimate reconstruction demonstrates an extraordinarily high frequency of severe dry and wet springsummer seasons during the entire LBK, with particularly high year-to-year variability from 5400 to 5101 B.C.E. and with lower fluctuations until 4801 B.C.E. A significant influence of regional climate on the dynamic of the LBK is possible (e.g. around 4960 B.C.E.), but should be interpreted very carefully due to asynchronous trends in settlement dynamics. Thus, we conclude that even when a climate proxy such as tree rings that has excellent spatio-temporal resolution is available, it remains difficult to establish potential connections between the settlement dynamic of the LBK and climate variability.	[Pechtl, Joachim] Kelten Romer Museum Manching, Manching, Germany; [Land, Alexander] Univ Hohenheim, Inst Bot 210a, Stuttgart, Germany; [Land, Alexander] Univ Appl Forest Sci, Rottenburg, Germany	University Hohenheim	Land, A (corresponding author), Univ Hohenheim, Inst Bot 210a, Stuttgart, Germany.; Land, A (corresponding author), Univ Appl Forest Sci, Rottenburg, Germany.	alexander.land@uni-hohenheim.de						Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Amkreutz L., 2016, SOMETHING OUT ORDINA; Asam Tanja, 2006, Anthropologischer Anzeiger, V64, P1; Banffy E, 2016, SCHRIFTEN BODENDENKM, V11, P73; Baum T, 2016, COMPUT SOC SCI, P255, DOI 10.1007/978-3-319-31481-5_9; BECKER B, 1993, RADIOCARBON, V35, P201, DOI 10.1017/S0033822200013898; Bleicher N., 2011, STRATEGIEN ZUM UBERL, P67; Bogaard A., 2017, NEOLITHIC EUROPE PAP, P120, DOI [10.2307/j.ctvh1dgtm.15, DOI 10.2307/J.CTVH1DGTM.15]; Bogaard A, 2016, GERMANIA, V94, P1; Bowles S, 2011, P NATL ACAD SCI USA, V108, P4760, DOI 10.1073/pnas.1010733108; Briffa K.R., 1990, METHODS DENDROCHRONO, P137, DOI DOI 10.1007/978-94-015-7879-0; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Buntgen U, 2010, QUATERNARY SCI REV, V29, P1005, DOI 10.1016/j.quascirev.2010.01.003; Cook E.R., 2005, PROGRAM ARSTAN TREE; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; Drangmeister H, 2011, PFLANZENSCHUTZ OKO L; Engelhardt B, 2006, ARCHAOLOGIE BAYERN F, P54; Engelhardt B, 1981, MATERIALHEFTE BAYERI, V42; Friedrich M, 2004, RADIOCARBON, V46, P1111, DOI 10.1017/S003382220003304X; Friedrichs DA, 2009, TREE PHYSIOL, V29, P39, DOI 10.1093/treephys/tpn003; Frohlich N, 2018, GERMANIA, V95, P43; Galeta P, 2009, DOC PRAEHIST, V36, P139, DOI 10.4312/dp.36.8; Gillis RE, 2017, P ROYAL SOC BIOL SCI, V284; Gronenborn D., 2012, ARBEITS FORSCHUNGS S, P241; Haack F, 2016, 4000 JAHRE PFAHLBAUT, P301; Hinz M., 2012, JOURN NEOL ARCH, DOI [10.12766/jna.2012.65, DOI 10.12766/JNA.2012.65]; Hofmann D., 2013, TRACKING NEOLITHIC H, P197, DOI [10.1007/978-1-4614-5289-8_9, DOI 10.1007/978-1-4614-5289-8_9]; Jeunesse C., 2009, KRISEN KULTURWANDEL, V10, P241; Jiang H, 2015, GEOLOGY, V43, P203, DOI 10.1130/G36377.1; Kalis AJ, 2003, QUATERNARY SCI REV, V22, P33, DOI 10.1016/S0277-3791(02)00181-6; Kerig T, 2010, MICHELSBERGER KULTUR, P236; Khoury W, 1989, THESIS; KlooSS S, 2011, UNIVERSITATSFORSCHUN, V203, P235; Korber-Grohne U., 1994, NUTZPFLANZEN DEUTSCH; Kreuz A, 2005, VEG HIST ARCHAEOBOT, V14, P237, DOI 10.1007/s00334-005-0080-0; Kreuz A, 2011, VEG HIST ARCHAEOBOT, V20, P333, DOI 10.1007/s00334-011-0294-2; Land A, 2018, TREE RINGS PROXY SEA; Land A, 2015, 2200 BC CLIMATIC BRE, P595; Land A, 2018, RECONSTRUCTION HYDRO; Land A, 2017, DENDROCHRONOLOGIA, V45, P156, DOI 10.1016/j.dendro.2017.08.005; Lenneis E., 2017, ERSTE BAUERNDORFER A, P202; Leopold M, 2011, QUATERN INT, V243, P293, DOI 10.1016/j.quaint.2010.11.021; Link T., 2014, VEROFFENTLICHUNGEN L, V60; Luning J., 1988, JB ROMISCH GERMANISC, V35, P27; Luning J., 1997, DTSCH AGRARGESCHICHT, P15; Meier-Arendt W., 1966, VEROFFENTLICHUNGEN A, V3; Mischka C, 2014, RHEINISCHE AUSGRABUN, V69, P175; Munster A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194862; Parkhomenko P., 2013, GAGARIN 1 SPACE; Pavlu I., 1986, PAMATKY ARCHEOL, V77, P288; Pechtl J, 2009, THESIS; Pechtl J., 2011, 20 FINES TRANSIRE JA, V20, P53; Pechtl J, 2015, OXFORD HDB NEOLITHIC, P556; Pechtl J., 2018, VORTR 35 NIED ARCH, V36, P29; Pechtl J., 2017, ARCHAOLOGIE DEUTSCHL, V6, P8; Pechtl J., 2011, FOKUS JUNGSTEINZEIT, P37; Pechtl J., 2009, FINES TRANSIRE JAHRG, V18, P79; Peters M, 2014, INT ARCHAOLOGIE STUD, V35, P37; Petrasch J, 2010, RGZM TAGUNG, V4, P351; Pinto JG, 2012, CLIM RES, V54, P1, DOI 10.3354/cr01111; Riedhammer K, 2017, THESIS; Rosch M, 2016, 4000 JAHRE PFAHLBAUT, P304; Rybnicek M, 2018, DENDROCHRONOLOGIA, V50, P98, DOI 10.1016/j.dendro.2018.06.003; Salque M, 2012, ANTHROPOZOOLOGICA, V47, P45, DOI 10.5252/az2012n2a4; Schier W, 1990, MATERIALHEFTE BAYERI, V60; Schmidt B, 1998, MATERIALIEN BODENKEN, V11, P279; Schmotz K, 2004, VORTR 22 NIED ARCH, P331; Schmotz K., 1989, MATERIALHEFTE BAYERI, V58; Schonbein J., 2015, INTEGRATED ANAL INTE, P127; Schroder N., 2004, J TRANSDISCIPL ENV S, V3, P1602; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Spatz H, 1996, MATERIALHEFTE ARCHAO, V37; Steinhilber F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040142; Stephan E, 2016, 4000 JAHRE PFAHLBAUT, P332; Strien H.-C., 2000, UNIVERSITATSFORSCHUN, V69; Strien H.-Ch., 2018, WESTEXPANSION REGION; Strien H-C, 2017, DOC PRAEH, V44, P272; Tegel W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051374; von Grafenstein U, 1999, SCIENCE, V284, P1654, DOI 10.1126/science.284.5420.1654; Watkins T, 2007, VOR 12 000 JAHREN AN, P37; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Willmott CJ, 2009, ATMOS ENVIRON, V43, P749, DOI 10.1016/j.atmosenv.2008.10.005	83	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210438	10.1371/journal.pone.0210438	http://dx.doi.org/10.1371/journal.pone.0210438			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699136	gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600034
J	Shibasaki, H; Imamura, M; Arima, S; Tanihata, J; Kuraoka, M; Matsuzaka, Y; Uchiumi, F; Tanuma, S; Takeda, S				Shibasaki, Hiroyuki; Imamura, Michihiro; Arima, Sayuri; Tanihata, Jun; Kuraoka, Mutsuki; Matsuzaka, Yasunari; Uchiumi, Fumiaki; Tanuma, Sei-ichi; Takeda, Shin'ichi			Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model	PLOS ONE			English	Article							SKELETAL-MUSCLE; MRF4 PROMOTER; BIOMARKERS; EXPRESSION; GENE; PCR	MicroRNAs (miRNAs) are non-coding small RNAs that regulate gene expression at the post-transcriptional level. Several miRNAs are exclusively expressed in skeletal muscle and participate in the regulation of muscle differentiation by interacting with myogenic factors. These miRNAs can be found at high levels in the serum of patients and animal models for Duchenne muscular dystrophy, which is expected to be useful as biomarkers for their clinical conditions. By miRNA microarray analysis, we identified miR-188 as a novel miRNA that is elevated in the serum of the muscular dystrophy dog model, CXMDJ. miR-188 was not muscle-specific miRNA, but its expression was up-regulated in skeletal muscles associated with muscle regeneration induced by cardiotoxin-injection in normal dogs and mice. Manipulation of miR-188 expression using antisense oligo and mimic oligo RNAs alters the mRNA expression of the myogenic regulatory factors, MRF4 and MEF2C. Our results suggest that miR-188 is a new player that participates in the gene regulation process of muscle differentiation and that it may serve as a serum biomarker reflecting skeletal muscle regeneration.	[Shibasaki, Hiroyuki; Imamura, Michihiro; Arima, Sayuri; Tanihata, Jun; Kuraoka, Mutsuki; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Dept Mol Therapy, Natl Inst Neurosci, Kodaira, Tokyo, Japan; [Shibasaki, Hiroyuki; Uchiumi, Fumiaki] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Gene Regulat, Noda, Chiba, Japan; [Tanihata, Jun] Jikei Univ, Sch Med, Dept Cell Physiol, Minato Ku, Tokyo, Japan; [Kuraoka, Mutsuki] Nippon Vet & Life Sci Univ, Lab Expt Anim Sci, Musashino, Tokyo, Japan; [Matsuzaka, Yasunari] Meiji Pharmaceut Univ, Dept Med Mol Informat, Tokyo, Japan; [Tanuma, Sei-ichi] Tokyo Univ Sci, Res Inst Sci & Technol, Dept Genom Med Sci, Org Res Adv, Noda, Chiba, Japan	National Center for Neurology & Psychiatry - Japan; Tokyo University of Science; Jikei University; Nippon Veterinary & Life Science University; Meiji Pharmaceutical University; Tokyo University of Science	Takeda, S (corresponding author), Natl Ctr Neurol & Psychiat, Dept Mol Therapy, Natl Inst Neurosci, Kodaira, Tokyo, Japan.	takeda@ncnp.go.jp	Kuraoka, Mutsuki/AAB-5760-2022		Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP [28-6]; Japan Agency for Medical Research and Development (AMED) [17ek0109154h0003]	Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP 28-6 to ST and Japan Agency for Medical Research and Development (AMED) 17ek0109154h0003 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; BLACK BL, 1995, J BIOL CHEM, V270, P2889, DOI 10.1074/jbc.270.7.2889; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Chen X, 2017, ONCOTARGET, V8, P112152, DOI 10.18632/oncotarget.22899; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Imamura M, 2016, J BIOCHEM, V159, P171, DOI 10.1093/jb/mvv084; Jeanson-Leh L, 2014, AM J PATHOL, V184, P2885, DOI 10.1016/j.ajpath.2014.07.021; Kuraoka M, 2016, AM J PATHOL, V186, P1302, DOI 10.1016/j.ajpath.2016.01.002; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llano-Diez M, 2017, NEUROMUSCULAR DISORD, V27, P15, DOI 10.1016/j.nmd.2016.11.003; Mizbani A, 2016, DEVELOPMENT, V143, P4137, DOI 10.1242/dev.136051; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Xue M, 2018, INT J BIOL SCI, V14, P1545, DOI 10.7150/ijbs.24032	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211597	10.1371/journal.pone.0211597	http://dx.doi.org/10.1371/journal.pone.0211597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699200	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600087
J	Tanaka, H; Li, G; Uchida, Y; Nakamura, M; Ikeda, T; Liu, H				Tanaka, Hiroto; Li, Gen; Uchida, Yusuke; Nakamura, Masashi; Ikeda, Teruaki; Liu, Hao			Measurement of time-varying kinematics of a dolphin in burst accelerating swimming	PLOS ONE			English	Article							HYDROMECHANICS; PERFORMANCE	Dolphins are well known as excellent swimmers for being capable of efficient cruising and sharp acceleration. While studies of the thrust production and power consumption of dolphin swimming have been the main subject for decades, time-varying acceleration process during successive fluke beats still remains poorly understood. In this study, we quantified the time-varying kinematics of a dolphin (Lagenorhynchus obliquidens) by directly recording its burst-accelerating swimming before vertical jump in an aquarium with two synchronized high-speed video cameras. We tracked the three-dimensional trajectories of its beak, body sides, and fluke. We found that dolphin could quickly accelerate from 5.0 m s(-1) to 8.7 m s(-1) merely by 5 strokes (i.e. 2.5 fluke beats) in 0.7 seconds. During the strokes, it was further found that the dolphin demonstrated a great acceleration in downstroke but less acceleration or even a slight deceleration in upstroke. Hydrodynamic forces and thrust power for each stroke were further estimated based on the equation of body motion and a static hydrodynamic model. The drag coefficient of the dolphin was estimated through computational fluid dynamics (CFD) modeling of the steady flows around a realistic geometric model based on 3-D scan data. The thrust and thrust power were then calculated by combining the body kinematics and the drag coefficient, resulting in a maximum stroke-averaged thrust and power-to-mass ratio of 1.3 x 10(3) N and 90 W kg(-1) at downstroke, and 3.3 x 10(2) N and 19 W kg(-1) at upstroke, respectively. Our results point out the importance of asymmetric kinematics in burst acceleration of dolphin, which may be a useful mechanism for biomimetic design of high-performance underwater robots.	[Tanaka, Hiroto] Tokyo Inst Technol, Sch Engn, Tokyo, Japan; [Li, Gen] Japan Agcy Marine Earth Sci & Technol, Yokohama Inst Earth Sci, Yokohama, Japan; [Uchida, Yusuke; Nakamura, Masashi; Ikeda, Teruaki; Liu, Hao] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Ikeda, Teruaki] Teral Inc, Fukuyama, Hiroshima, Japan	Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Chiba University	Tanaka, H (corresponding author), Tokyo Inst Technol, Sch Engn, Tokyo, Japan.; Liu, H (corresponding author), Chiba Univ, Grad Sch Engn, Chiba, Japan.	tanaka.h.cb@m.titech.ac.jp; hliu@chiba-u.jp	Tanaka, Hiroto/F-7786-2011; Li/O-7610-2019	Tanaka, Hiroto/0000-0003-4233-8918; Li/0000-0002-4423-3266; Liu, Hao/0000-0002-8687-3237	JSPS [JP18H05468, JP24120007, JP17K17641]; "Program to Promote the Tenure Track System" of the Ministry of Education, Culture, Sports, Science Technology; Teral Inc.	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "Program to Promote the Tenure Track System" of the Ministry of Education, Culture, Sports, Science Technology; Teral Inc.	This study was supported in part by JSPS KAKENHI Grant Number JP18H05468 (HT), JP24120007 (HL), JP17K17641 (GL), and "Program to Promote the Tenure Track System" of the Ministry of Education, Culture, Sports, Science & Technology (HT). Teral Inc. provided support in the form of salaries for TI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author contributions' section.	Abe K, 2009, TURBULENCE ENG HDB, P276; Aleyev Y.G, 1977, NEKTON; Aleyev Yu.G., 1974, Voprosy Ikhtiologii, V14, P173; Alfonsi G, 2009, APPL MECH REV, V62, DOI 10.1115/1.3124648; Argyropoulos CD, 2015, APPL MATH MODEL, V39, P693, DOI 10.1016/j.apm.2014.07.001; Brennen C.E., 1982, REV ADDED MASS FLUID, P50; CHOPRA MG, 1977, J FLUID MECH, V79, P49, DOI 10.1017/S0022112077000032; Fish F. E., 1999, TECHNICAL REPORT; Fish FE, 1998, J EXP BIOL, V201, P2867; Fish FE, 2006, BIOINSPIR BIOMIM, V1, pR17, DOI 10.1088/1748-3182/1/2/R01; Fish FE, 2014, J EXP BIOL, V217, P252, DOI 10.1242/jeb.087924; Gray J, 1936, J EXP BIOL, V13, P192; Isogai K, 2014, T JPN SOC AERONAUT S, V57, P21, DOI 10.2322/tjsass.57.21; KAYAN VP, 1974, BIONIKA, V8, P31; Kwon A., 1999, ISBS C P ARCHIVE; LANG TG, 1966, SCIENCE, V151, P588, DOI 10.1126/science.151.3710.588; LANG TG, 1966, SCIENCE, V152, P531, DOI 10.1126/science.152.3721.531; Lang TG, 1963, 3063 NOTS TP; LIGHTHILL MJ, 1971, PROC R SOC SER B-BIO, V179, P125, DOI 10.1098/rspb.1971.0085; LIGHTHILL MJ, 1969, ANNU REV FLUID MECH, V1, P413, DOI 10.1146/annurev.fl.01.010169.002213; Nakashima M, 2004, BIO-MECHANISMS OF SWIMMING AND FLYING, P79; PARRY DA, 1949, J EXP BIOL, V26, P24; Purves P.E., 1975, Aquatic Mamm, V3, P5; Ren G, 2015, ROBOT AUTON SYST, V74, P184, DOI 10.1016/j.robot.2015.07.014; RIDGWAY SH, 1966, SCIENCE, V151, P456, DOI 10.1126/science.151.3709.456; Riedeberger D., 2012, HIGH PERFORMANCE COM, V32, P379; Rohr JJ, 2002, MAR MAMMAL SCI, V18, P1, DOI 10.1111/j.1748-7692.2002.tb01014.x; Roper DT, 2011, P I MECH ENG M-J ENG, V225, P77, DOI 10.1177/1475090210397438; Shirakura M, 1969, FLUID MECH; VIDELER J, 1985, J EXP BIOL, V119, P265; Wang YL, 2015, J MAR ENG TECHNOL, V14, P44, DOI 10.1080/20464177.2015.1022383; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; Yates G.T., 1983, P177; Yu JZ, 2016, IEEE-ASME T MECH, V21, P2307, DOI 10.1109/TMECH.2016.2572720; Yu JZ, 2009, ADV ROBOTICS, V23, P1299, DOI 10.1163/156855309X462592	35	10	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210860	10.1371/journal.pone.0210860	http://dx.doi.org/10.1371/journal.pone.0210860			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699184	Green Submitted, gold, Green Published			2022-12-26	WOS:000457155600060
J	Yang, SW; Cho, SH; Kang, YS; Park, SH; Sohn, IS; Kwon, HS; Hwang, HS				Yang, Seung Woo; Cho, Soo Hyun; Kang, Young Sun; Park, Seung Hwa; Sohn, In Sook; Kwon, Han Sung; Hwang, Han Sung			Usefulness of uterine artery Doppler velocimetry as a predictor for hypertensive disorders in pregnancy in women with prehypertension before 20 weeks gestation	PLOS ONE			English	Article							BLOOD-PRESSURE; BIOCHEMICAL MARKERS; PREECLAMPSIA; RISK	Hypertensive disorders of pregnancy (HDP) is major complication of maternal-fetal outcomes in obstetric field. Although HDP is mainly defined by high blood pressure, the information about the relationship between prehypertension (preHTN, 120-139mmHg and 80-89mmHg) and HDP development is limited. The objective of this study is to determine the usefulness of preHTN before 20 weeks gestation and uterine artery (UtA) Doppler velocimetry as a predictor of HDP. A total of 2039 singleton pregnant women who had received continuous prenatal care were included in this study. The participants were classified into 2 groups based on the highest blood pressure (BP) under 20 gestational weeks as defined by the Joint National Committee 7: Normotensive (n = 1816) and preHTN pregnant women (n = 223). All preHTN pregnant women were assessed using UtA Doppler velocimetry, and the numbers of preHTN assessments were recorded. The risk of HDP was assessed in the PreHTN groups through patient history and Doppler velocimetry. Compared to normotensive patients, a total of 223 preHTN patients had a higher risk of preeclampsia (OR: 2.3; CI: 1.2-4.3), gestational hypertension (OR: 3.3; CI: 2.0-5.4) and any HDP (OR: 3.0; CI: 2.0-4.5). In the preHTN group, 134 (60.1%) patients had preHTN measured at least twice and 89 (39.9%) patients had preHTN. The results showed that two or more preHTN measurements have high sensitivity for predicting HDP (OR: 1.9; CI: 1.0-3.1; sensitivity: 83.8%; specificity: 47.2%). Additionally, the combination of abnormal UtA Doppler velocimetry results and at least two preHTN measurements showed a high accuracy in predicting HDP (OR: 2.9; CI: 1.1-4.1; sensitivity: 67.6%; specificity: 98.4%). In conclusion, close BP monitoring and recording of every preHTN event are important for pregnant women with preHTN history, and UtA Doppler examination in those women during the 2nd trimester can be a further aid in determining the risk of HDP.	[Yang, Seung Woo; Cho, Soo Hyun; Sohn, In Sook; Kwon, Han Sung; Hwang, Han Sung] Konkuk Univ, Sch Med, Res Inst Med Sci, Div Maternal & Fetal Med,Dept Obstet & Gynecol, Seoul, South Korea; [Yang, Seung Woo; Park, Seung Hwa] Konkuk Univ, Sch Med, Dept Anat, Seoul, South Korea; [Kang, Young Sun] Konkuk Univ, Dept Biomed Sci & Technol, Seoul, South Korea; [Kang, Young Sun] Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University	Hwang, HS (corresponding author), Konkuk Univ, Sch Med, Res Inst Med Sci, Div Maternal & Fetal Med,Dept Obstet & Gynecol, Seoul, South Korea.	hwanghs@kuh.ac.kr		Yang, Seung woo/0000-0001-8727-7528; Kwon, Han-Sung/0000-0002-4449-0481; Hwang, Han Sung/0000-0003-0622-0701	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [S201803S00049]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1713]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT & Future Planning [NRF-2017R1C1B2010487]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (S201803S00049), Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant number: HI17C1713) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017R1C1B2010487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Akolekar R, 2011, PRENATAL DIAG, V31, P66, DOI 10.1002/pd.2660; Antsaklis A, 2000, ULTRASOUND OBST GYN, V16, P635, DOI 10.1046/j.1469-0705.2000.00288.x; Black MH, 2015, J HYPERTENS, V33, P1860, DOI 10.1097/HJH.0000000000000646; Callen P, 2007, ULTRASONOGRAPHY OBST, P799; Caradeux J, 2013, PRENATAL DIAG, V33, P732, DOI 10.1002/pd.4113; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; Coleman MAG, 2000, ULTRASOUND OBST GYN, V15, P7, DOI 10.1046/j.1469-0705.2000.00014.x; Friedman E A, 1976, Perspect Nephrol Hypertens, V5, P13; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Huppertz B, 2007, PLACENTA, V28, pS94, DOI 10.1016/j.placenta.2007.01.015; Hwang HS, 2010, J PERINAT MED, V38, P467, DOI [10.1515/JPM.2010.047, 10.1515/jpm.2010.047]; JACOBSON SL, 1990, AM J OBSTET GYNECOL, V162, P110, DOI 10.1016/0002-9378(90)90832-R; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; Lee Seung Mi, 2016, Obstet Gynecol Sci, V59, P463, DOI 10.5468/ogs.2016.59.6.463; Macdonald-Wallis C, 2011, J HYPERTENS, V29, P1703, DOI 10.1097/HJH.0b013e328349eec6; MOUTQUIN JM, 1985, AM J OBSTET GYNECOL, V151, P191, DOI 10.1016/0002-9378(85)90010-9; Onwudiwe N, 2008, ULTRASOUND OBST GYN, V32, P877, DOI 10.1002/uog.6124; Papageorghiou AT, 2004, BEST PRACT RES CL OB, V18, P383, DOI 10.1016/j.bpobgyn.2004.02.003; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Poon LCY, 2010, ULTRASOUND OBST GYN, V35, P662, DOI 10.1002/uog.7628; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rosner JY, 2017, AM J PERINAT, V34, P117, DOI 10.1055/s-0036-1584542; Rosner JY, 2017, J MATERN-FETAL NEO M, V12, P1; Scandiuzzi Rosiane Maciel, 2016, Obstet Gynecol Sci, V59, P347, DOI 10.5468/ogs.2016.59.5.347; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876	28	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210566	10.1371/journal.pone.0210566	http://dx.doi.org/10.1371/journal.pone.0210566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699135	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600041
J	Song, TT; Li, KT; Wu, T; Wang, Y; Zhang, XZ; Xu, XF; Yao, YC; Han, ZH				Song, Tingting; Li, Keting; Wu, Ting; Wang, Yi; Zhang, Xinzhong; Xu, Xuefeng; Yao, Yuncong; Han, Zhenhai			Identification of new regulators through transcriptome analysis that regulate anthocyanin biosynthesis in apple leaves at low temperatures	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; FREEZING TOLERANCE; COLD TOLERANCE; GENE-EXPRESSION; RED COLORATION; COLORFUL MODEL; R2R3 MYB; UV-B; ACCUMULATION; STRESS	Anthocyanin pigments play many roles in plants, including providing protection against biotic and abiotic stresses. To identify new regulatory genes in apple (Malus domestica) that may be involved in regulating low temperature induced anthocyanin biosynthesis, we performed RNA-seq analysis of leaves from the 'Gala' apple cultivar following exposure to a low temperature (16 degrees C). A visible red color appeared on the upper leaves and the anthocyanin content increased significantly after the low temperature treatment. Genes from the flavonoid biosynthesis pathway were significantly enriched among the differentially expressed genes, and the expression of several transcription factors was shown by WGCNA (weighted gene co-expression network analysis) to correlate with anthocyanin accumulation, including members of the MYB, MADS, WRKY, WD40, Zinc Finger and HB-ZIP families. Three MYB transcription factors (MdMYB12, MdMYB22 and MdMYB114), which had several CBF/DREB response elements in their promoters, were significantly induced by low temperature exposure and their expression also correlated highly with anthocyanin accumulation. We hypothesize that they may act as regulators of anthocyanin biosynthesis and be regulated by CBF/DREB transcription factors in apple leaves under low temperature conditions. The analyses presented here provide insights into the molecular mechanisms underlying anthocyanin accumulation during low temperature exposure.	[Song, Tingting; Li, Keting; Wu, Ting; Wang, Yi; Zhang, Xinzhong; Xu, Xuefeng; Han, Zhenhai] China Agr Univ, Coll Hort, Beijing, Peoples R China; [Song, Tingting; Yao, Yuncong] Beijing Univ Agr, Plant Sci & Technol Coll, Beijing, Peoples R China; [Wu, Ting; Wang, Yi; Zhang, Xinzhong; Xu, Xuefeng; Yao, Yuncong; Han, Zhenhai] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China	China Agricultural University; Beijing University of Agriculture	Han, ZH (corresponding author), China Agr Univ, Coll Hort, Beijing, Peoples R China.; Han, ZH (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China.	rschan@cau.edu.cn			National Natural Science Foundation of China [31772263]; Beijing Municipal Commission of Education Supporting Plan for Cultivating High Level Teachers in Colleges and Universities in Beijing [5045243001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education Supporting Plan for Cultivating High Level Teachers in Colleges and Universities in Beijing	Financial support was provided by the 'National Natural Science Foundation of China' (31772263), and 'Beijing Municipal Commission of Education Supporting Plan for Cultivating High Level Teachers in Colleges and Universities in Beijing' (5045243001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; An JP, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.23; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andino GK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3130-3; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Beck EH, 2004, J BIOSCIENCES, V29, P449, DOI 10.1007/BF02712118; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cabello JV, 2012, PLANT J, V69, P141, DOI 10.1111/j.1365-313X.2011.04778.x; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; Crifo T, 2011, GENE, V476, P1, DOI 10.1016/j.gene.2011.02.005; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Gu XB, 2015, PLANT PHYSIOL BIOCH, V89, P31, DOI 10.1016/j.plaphy.2015.02.004; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hutcheson DA, 2005, DEVELOPMENT, V132, P829, DOI 10.1242/dev.01653; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jin YM, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/5480617; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kim JH, 2013, J PLANT PHYSIOL, V170, P1461, DOI 10.1016/j.jplph.2013.05.011; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Korn M, 2008, PLANT CELL ENVIRON, V31, P813, DOI 10.1111/j.1365-3040.2008.01800.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HG, 2015, PLANT J, V82, P962, DOI 10.1111/tpj.12866; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Lv Y, 2017, PLANT PHYSIOL, V173, P1475, DOI 10.1104/pp.16.01725; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marczak L, 2008, RAPID COMMUN MASS SP, V22, P3949, DOI 10.1002/rcm.3819; Middleton E, 1986, FLAVONOIDS ADV RES 1, V1993, P619; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Revilla E, 2000, J CHROMATOGR A, V881, P461, DOI 10.1016/S0021-9673(00)00269-7; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schulz E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34027; Shen JZ, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-017-0010-1; Shvarts M, 1997, PHYSIOL PLANTARUM, V99, P67, DOI 10.1034/j.1399-3054.1997.990110.x; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tian J, 2015, HORTSCIENCE, V50, P640, DOI 10.21273/HORTSCI.50.5.640; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang N, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0084-4; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Xu HF, 2018, BIOCHEM BIOPH RES CO, V500, P405, DOI 10.1016/j.bbrc.2018.04.088; Yamane T, 2006, AM J ENOL VITICULT, V57, P54; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Zhan JP, 2015, PLANT CELL, V27, P513, DOI 10.1105/tpc.114.135657; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V108, P478, DOI 10.1016/j.plaphy.2016.08.013; Zhou LJ, 2017, PLANT CELL ENVIRON, V40, P2068, DOI 10.1111/pce.12978	77	25	26	17	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210672	10.1371/journal.pone.0210672	http://dx.doi.org/10.1371/journal.pone.0210672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695036	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400012
J	Amado, E; Muth, G; Arechaga, I; Cabezon, E				Amado, Eric; Muth, Guenther; Arechaga, Ignacio; Cabezon, Elena			The FtsK-like motor TraB is a DNA-dependent ATPase that forms higher-order assemblies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; bacterial conjugation; ATPase; G-quadruplex; antibiotics; DNA segregation; DNA translocation; DNA-dependent ATPase; FtsK-like ATPase; Streptomyces; DNA translocase; conjugal plasmid transfer; motor protein; TRS sequence	DIRECTIONAL TRANSLOCATION; CHROMOSOME SEGREGATION; BACTERIAL CONJUGATION; SINGLE-MOLECULE; CELL-DIVISION; PROTEIN; MECHANISM; TRWB; STREPTOMYCES; SPOIIIE	TraB is an FtsK-like DNA translocase responsible for conjugative plasmid transfer in mycelial Streptomyces. Unlike other conjugative systems, which depend on a type IV secretion system, Streptomyces requires only TraB protein to transfer the plasmid as dsDNA. The gamma-domain of this protein specifically binds to repeated 8-bp motifs on the plasmid sequence, following a mechanism that is reminiscent of the FtsK/SpoIIIE chromosome segregation system. In this work, we purified and characterized the enzymatic activity of TraB, revealing that it is a DNA-dependent ATPase that is highly stimulated by dsDNA substrates. Interestingly, we found that unlike the SpoIIIE protein, the gamma-domain of TraB does not confer sequence-specific ATPase stimulation. We also found that TraB binds G-quadruplex DNA structures with higher affinity than TraB-recognition sequences (TRSs). An EM-based structural analysis revealed that TraB tends to assemble as large complexes comprising four TraB hexamers, which might be a prerequisite for DNA translocation across cell membranes. In summary, our findings shed light on the molecular mechanism used by the DNA-translocating motor TraB, which may be shared by other membrane-associated machineries involved in DNA binding and translocation.	[Amado, Eric; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Dept Biol Mol, Santander, Spain; [Amado, Eric; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Inst Biomed Biotecnol Cantabria IBBTEC, Santander, Spain; [Muth, Guenther] Eberhard Karls Univ Tuebingen, Interfakultaeres Inst Mikrobiol & Infekt Med Tueb, Mikrobiol Biotechnol, D-72074 Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Dept Biol Mol, Santander, Spain.; Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Inst Biomed Biotecnol Cantabria IBBTEC, Santander, Spain.	arechagai@unican.es; cabezone@unican.es	Cabezon, Elena/K-5874-2014	Cabezon, Elena/0000-0002-6177-5016	Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2016-78521-R]; Deutsche Forschungsgemeinschaft [SFB766]	Spanish Ministerio de Economia y Competitividad (MINECO); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Spanish Ministerio de Economia y Competitividad (MINECO) Grants BFU2016-78521-R (to E. C. and I. A.) and Deutsche Forschungsgemeinschaft SFB766 (to G. M). The authors declare that they have no conflicts of interest with the contents of this article.	Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; Berezuk AM, 2014, J BIOL CHEM, V289, P23287, DOI 10.1074/jbc.M114.569624; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Cabezon E, 2015, FEMS MICROBIOL REV, V39, P81, DOI 10.1111/1574-6976.12085; Cabezon E, 2012, CURR OPIN BIOTECH, V23, P537, DOI 10.1016/j.copbio.2011.11.031; Cattoni DI, 2014, NUCLEIC ACIDS RES, V42, P2624, DOI 10.1093/nar/gkt1231; Cattoni DI, 2013, EMBO REP, V14, P473, DOI 10.1038/embor.2013.39; Chara O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23400-8; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Demarre G, 2013, ADV EXP MED BIOL, V973, P245, DOI 10.1007/978-1-4614-5037-5_12; Diagne CT, 2014, NUCLEIC ACIDS RES, V42, P1721, DOI 10.1093/nar/gkt1024; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Franco B, 2003, PLASMID, V50, P242, DOI 10.1016/S0147-619X(03)00063-5; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Graham JE, 2010, P NATL ACAD SCI USA, V107, P20263, DOI 10.1073/pnas.1007518107; Grainge I, 2008, CURR BIOL, V18, pR871, DOI 10.1016/j.cub.2008.07.047; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kosono S, 1996, MOL MICROBIOL, V19, P397, DOI 10.1046/j.1365-2958.1996.379909.x; Lee JY, 2012, P NATL ACAD SCI USA, V109, P6531, DOI 10.1073/pnas.1201613109; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Matilla I, 2010, J BIOL CHEM, V285, P17537, DOI 10.1074/jbc.M109.084137; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Pena A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413849; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Possoz C, 2001, MOL MICROBIOL, V42, P159, DOI 10.1046/j.1365-2958.2001.02618.x; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Reuther J, 2006, MOL MICROBIOL, V61, P436, DOI 10.1111/j.1365-2958.2006.05258.x; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Vogelmann J, 2011, EMBO J, V30, P2246, DOI 10.1038/emboj.2011.121; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zawadzki P, 2013, P NATL ACAD SCI USA, V110, P17302, DOI 10.1073/pnas.1311065110; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	45	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5050	5059		10.1074/jbc.RA119.007459	http://dx.doi.org/10.1074/jbc.RA119.007459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723158	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000463985600027
J	Hawse, WF; Cattley, RT				Hawse, William F.; Cattley, Richard T.			T cells transduce T-cell receptor signal strength by generating different phosphatidylinositols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell receptor (TCR); phosphatase and tensin homolog (PTEN); phosphatidylinositol signaling; signal transduction; T-cell; T helper cells; cell differentiation; AKT; T regulatory cell	FOCAL ADHESION KINASE; PROTEIN-KINASE; ACTIVATION; TCR; AKT; PHOSPHORYLATION; COMPLEX; BINDING; 4,5-BISPHOSPHATE; RICTOR	T-cell receptor (TCR) signaling strength is a dominant factor regulating T-cell differentiation, thymic development, and cytokine signaling. The molecular mechanisms by which TCR signal strength is transduced to downstream signaling networks remains ill-defined. Using computational modeling, biochemical assays, and imaging flow cytometry, we found here that TCR signal strength differentially generates phosphatidylinositol species. Weak TCR signals generated elevated phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and reduced phosphatidylinositol (3,4,5)-trisphosphate (PIP3) levels, whereas strong TCR signals reduced PI(4,5)P2 and elevated PIP3 levels. A proteomics screen revealed that focal adhesion kinase bound PI(4,5)P2, biochemical assays disclosed that focal adhesion kinase is preferentially activated by weak TCR signals and is required for optimal Treg induction, and further biochemical experiments revealed how TCR signaling strength regulates AKT activation. Low PIP3 levels generated by weak TCR signals were sufficient to activate phosphoinositide-dependent kinase-1 to phosphorylate AKT on Thr-308 but insufficient to activate mTOR complex 2 (mTORC2), whereas elevated PIP3 levels generated by a strong TCR signal were required to activate mTORC2 to phosphorylate Ser-473 on AKT. Our results provide support for a model that links TCR signaling to mTORC2 activation via phosphoinositide 3-kinase signaling. Together, the findings in this work establish that T cells measure TCR signal strength by generating different levels of phosphatidylinositol species that engage alternate signaling networks to control cell fate decisions.	[Hawse, William F.; Cattley, Richard T.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hawse, WF (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.	whawse@pitt.edu			Competitive Medical Research Fund grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology	Competitive Medical Research Fund grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology	This work was supported by a Competitive Medical Research Fund grant from the University of Pittsburgh Medical Center (to W. F. H.) and startup funds generously provided by the University of Pittsburgh Department of Immunology (to W. F. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed F, 2009, J IMMUNOL METHODS, V347, P79, DOI 10.1016/j.jim.2009.05.014; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Burton TJ, 2012, J CLIN ENDOCR METAB, V97, P100, DOI 10.1210/jc.2011-1537; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; Chouaki-Benmansour N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23109-8; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Gawden-Bone CM, 2018, IMMUNITY, V49, P427, DOI 10.1016/j.immuni.2018.08.017; Gokhale NA, 2013, BIOCHEM J, V453, P413, DOI 10.1042/BJ20121528; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gross C, 2015, CELL REP, V11, P727, DOI 10.1016/j.celrep.2015.03.060; Hashimoto-Tane A, 2016, J EXP MED, V213, P1609, DOI 10.1084/jem.20151088; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; Malek M, 2017, MOL CELL, V68, P566, DOI 10.1016/j.molcel.2017.09.024; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Osborne SL, 2001, J CELL SCI, V114, P2501; Raab M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16001; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Sobol M, 2013, NUCLEUS-PHILA, V4, P478, DOI 10.4161/nucl.27154; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner MS, 2014, DIABETOLOGIA, V57, P1428, DOI 10.1007/s00125-014-3233-9; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; WARD SG, 1992, EUR J IMMUNOL, V22, P45, DOI 10.1002/eji.1830220108; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Waugh Mark G., 2009, V462, P279, DOI 10.1007/978-1-60327-115-8_19; Yildirim S, 2013, J CELL SCI, V126, P2730, DOI 10.1242/jcs.123661; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454	58	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4793	4805		10.1074/jbc.RA118.006524	http://dx.doi.org/10.1074/jbc.RA118.006524			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30692200	hybrid, Green Published			2022-12-26	WOS:000463985600006
J	Andrew, RJ; De Rossi, P; Nguyen, P; Kowalski, HR; Recupero, AJ; Guerbette, T; Krause, SV; Rice, RC; Laury-Kleintop, L; Wagner, SL; Thinakaran, G				Andrew, Robert J.; De Rossi, Pierre; Nguyen, Phuong; Kowalski, Haley R.; Recupero, Aleksandra J.; Guerbette, Thomas; Krause, Sofia V.; Rice, Richard C.; Laury-Kleintop, Lisa; Wagner, Steven L.; Thinakaran, Gopal			Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); beta-amyloid (AB); beta-secretase 1 (BACE1); pathogenesis; 5XFAD; APP; BACE1; BIN1; GWAS; amphiphysin; neurodegeneration; endocytosis; secretase; amyloid	PRECURSOR PROTEIN; AMPHIPHYSIN FAMILY; BETA; ENDOCYTOSIS; BACE1; MICE; TRAFFICKING; APP; RECEPTOR; ASSOCIATION	Alzheimer's disease (AD) is pathologically characterized by the deposition of the -amyloid (A) peptide in senile plaques in the brain, leading to neuronal dysfunction and eventual decline in cognitive function. Genome-wide association studies have identified the bridging integrator 1 (BIN1) gene within the second most significant susceptibility locus for late-onset AD. BIN1 is a member of the amphiphysin family of proteins and has reported roles in the generation of membrane curvature and endocytosis. Endocytic dysfunction is a pathological feature of AD, and endocytosis of the amyloid precursor protein is an important step in its subsequent cleavage by -secretase (BACE1). In vitro evidence implicates BIN1 in endosomal sorting of BACE1 and A generation in neurons, but a role for BIN1 in this process in vivo is yet to be described. Here, using biochemical and immunohistochemistry analyses we report that a 50% global reduction of BIN1 protein levels resulting from a single Bin1 allele deletion in mice does not change BACE1 levels or localization in vivo, nor does this reduction alter the production of endogenous murine A in nontransgenic mice. Furthermore, we found that reduction of BIN1 levels in the 5XFAD mouse model of amyloidosis does not alter A deposition nor behavioral deficits associated with cerebral amyloid burden. Finally, a conditional BIN1 knockout in excitatory neurons did not alter BACE1, APP, C-terminal fragments derived from BACE1 cleavage of APP, or endogenous A levels. These results indicate that BIN1 function does not regulate A generation in vivo.	[Andrew, Robert J.; De Rossi, Pierre; Kowalski, Haley R.; Recupero, Aleksandra J.; Guerbette, Thomas; Krause, Sofia V.; Rice, Richard C.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Nguyen, Phuong; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Laury-Kleintop, Lisa] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Wagner, Steven L.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of California System; University of California San Diego; Lankenau Medical Center; Lankenau Institute for Medical Research; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Chicago; University of Chicago	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.; Thinakaran, G (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Thinakaran, G (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	gopal@uchicago.edu	Guerbette, Thomas/AGR-6964-2022; GUERBETTE, Thomas/AAL-6542-2020	Recupero, Aleksandra/0000-0002-3321-4385; Kowalski, Haley/0000-0003-3530-5579; De Rossi, Pierre/0000-0002-2356-4269	 [S10OD010649]; NATIONAL INSTITUTE ON AGING [RF1AG056061, RF1AG054223] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the University of Chicago Grossman Institute for Neuroscience for shared equipment support. Confocal imaging was performed at the Integrated Microscopy Core Facility at the University of Chicago (supported by grant S10OD010649).	Adams SL, 2016, J NEUROPATH EXP NEUR, V75, P779, DOI 10.1093/jnen/nlw056; Andersen OM, 2016, ACTA NEUROPATHOL, V132, P653, DOI 10.1007/s00401-016-1615-4; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andrew RJ, 2017, P NATL ACAD SCI USA, V114, pE9665, DOI 10.1073/pnas.1708568114; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Buggia-Prevot V, 2013, CELL REP, V5, P1552, DOI 10.1016/j.celrep.2013.12.006; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; De Rossi P, 2016, MOL PSYCHIATR, V21, P1768, DOI 10.1038/mp.2015.195; De Rossi P, 2019, BRAIN PATHOL, V29, P485, DOI 10.1111/bpa.12687; De Rossi Pierre, 2017, Matters (Zur), V2017, DOI 10.19185/matters.201611000018; De Rossi P, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0124-1; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Giannoni P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00096; Glennon EBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078806; Gong P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-87; Gu LH, 2018, BRAIN RES BULL, V137, P285, DOI 10.1016/j.brainresbull.2017.12.013; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Holler CJ, 2014, J ALZHEIMERS DIS, V42, P1221, DOI 10.3233/JAD-132450; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Malki I, 2017, FEBS J, V284, P3218, DOI 10.1111/febs.14185; Miyagawa T, 2016, HUM MOL GENET, V25, P2948, DOI 10.1093/hmg/ddw146; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ou-Yang MH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-134; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Tan MS, 2013, TRENDS MOL MED, V19, P594, DOI 10.1016/j.molmed.2013.06.004; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Veeraraghavalu K, 2014, J NEUROSCI, V34, P3668, DOI 10.1523/JNEUROSCI.5079-13.2014; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884	59	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4477	4487		10.1074/jbc.RA118.006379	http://dx.doi.org/10.1074/jbc.RA118.006379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30692199	Green Published, hybrid			2022-12-26	WOS:000462969500016
J	Van Laar, R; Lincoln, M; Fereday, S				Van Laar, Ryan; Lincoln, Mitchel; Fereday, Sian			Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma	PLOS ONE			English	Article							GENE-EXPRESSION; METASTATIC MELANOMA; SURVIVAL; NUMBER; CANCER	Background Histopathologic examination of melanocytic neoplasms can be challenging and subjective, with no specific circulating or tissue-based biomarkers currently available. Recently, a circulating 38-microRNA profile of melanoma (Mel38) was described. In this study, Mel38 expression and its impact on downstream mRNA regulation in solid tissue is examined. Methods Mel38 was applied to archival, clinically-annotated, solid-tissue genomic datasets representing benign naevi, primary and metastatic melanoma. Statistical analysis of the signature in relation to disease status, patient outcome and molecular pathways was performed. Results Mel38 is able to stratify genomic data from solid tissue biopsies on the basis of disease status and differences in melanoma-specific survival. Experimentally-verified messenger-RNA targets of Mel38 also exhibit prognostic expression patterns and represent key molecular pathways and events in melanoma development and progression. Conclusion The Mel38 microRNA profile may have diagnostic and prognostic utility in solid tissue as well as being a robust circulating biomarker of melanoma.	[Van Laar, Ryan; Lincoln, Mitchel; Fereday, Sian] Geneseq Biosci, Melbourne, Vic, Australia		Van Laar, R (corresponding author), Geneseq Biosci, Melbourne, Vic, Australia.	rvanlaar@geneseq.com.au		Fereday, Sian/0000-0002-8559-8579; van Laar, Ryan/0000-0003-2828-4175				Baade PD, 2008, ARCH DERMATOL, V144, P1468, DOI 10.1001/archderm.144.11.1468; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cirenajwis H, 2015, ONCOTARGET, V6, P12297, DOI 10.18632/oncotarget.3655; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmore JG, 2017, BMJ-BRIT MED J, P357; Ferlay J, 2018, CANCER INCIDENCE AND; Gerami P, 2014, AM J SURG PATHOL, V38, P934, DOI 10.1097/PAS.0000000000000198; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jayawardana K, 2015, INT J CANCER, V136, P863, DOI 10.1002/ijc.29047; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Sidhu S, 2012, CLIN EXP DERMATOL, V37, P6, DOI 10.1111/j.1365-2230.2011.04148.x; Sundarbose K, 2013, DIAGNOSTICS, V3, P84, DOI 10.3390/diagnostics3010084; Van Laar R, 2018, BRIT J CANCER, V118, P857, DOI 10.1038/bjc.2017.477; van Laar RK, 2019, MELANOMA RES, V29, P19, DOI 10.1097/CMR.0000000000000492; Wahie S, 2007, ARCH DERMATOL, V143, P1267, DOI 10.1001/archderm.143.10.1267; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211504	10.1371/journal.pone.0211504	http://dx.doi.org/10.1371/journal.pone.0211504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721246	Green Submitted, Green Published, gold			2022-12-26	WOS:000457746300017
J	Jakob, U				Jakob, Ursula			Capturing A beta 42 aggregation in the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ALZHEIMERS-DISEASE; MUTATION	Novel imaging techniques with ever-increasing resolution are invaluable tools for the study of protein deposition, as they allow the self-assembly of proteins to be directly investigated in living cells. For the first time, the acceleration in A beta 42 aggregation induced by the Arctic mutation was monitored in cells, revealing a number of distinct morphologies that form sequentially. This approach will help discriminate the impacts of mutations on amyloid protein processing, A beta aggregation propensity, and other mechanistic outcomes.						Cecchi, Cristina/0000-0001-8387-7737; Bemporad, Francesco/0000-0002-0643-6249				Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Golde TE, 2018, SCIENCE, V362, P1250, DOI 10.1126/science.aau0437; Lu M, 2019, J BIOL CHEM, V294, P1478, DOI 10.1074/jbc.RA118.004511; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Willig KI, 2014, CURR OPIN CHEM BIOL, V20, P16, DOI 10.1016/j.cbpa.2014.03.021	10	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1488	1489		10.1074/jbc.H119.007392	http://dx.doi.org/10.1074/jbc.H119.007392			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710006	Green Published, hybrid			2022-12-26	WOS:000457879200005
J	Bourgeois, S; Kaden, J; Senn, H; Bunnefeld, N; Jeffery, KJ; Akomo-Okoue, EF; Ogden, R; McEwing, R				Bourgeois, Stephanie; Kaden, Jenny; Senn, Helen; Bunnefeld, Nils; Jeffery, Kathryn J.; Akomo-Okoue, Etienne F.; Ogden, Rob; McEwing, Ross			Improving cost-efficiency of faecal genotyping: New tools for elephant species	PLOS ONE			English	Article							POPULATION-SIZE ESTIMATION; DNA AMPLIFICATION SUCCESS; POLYMERASE-CHAIN-REACTION; PRESERVATION METHODS; GENETIC DIVERSITY; FOREST ELEPHANTS; PCR SUCCESS; NUCLEAR-DNA; SAMPLE AGE; FECES	Despite the critical need for non-invasive tools to improve monitoring of wildlife populations, especially for endangered and elusive species, faecal genetic sampling has not been adopted as regular practice, largely because of the associated technical challenges and cost. Substantial work needs to be undertaken to refine sample collection and preparation methods in order to improve sample set quality and provide cost-efficient tools that can effectively support wildlife management. In this study, we collected an extensive set of forest elephant (Loxodonta cyclotis) faecal samples throughout Gabon, Central Africa, and prepared them for genotyping using 107 single-nucleotide polymorphism assays. We developed a new quantitative polymerase chain reaction (PCR) assay targeting a 130-bp nuclear DNA fragment and demonstrated its suitability for degraded samples in all three elephant species. Using this assay to compare the efficacy of two sampling methods for faecal DNA recovery, we found that sampling the whole surface of a dung pile with a swab stored in a small tube of lysis buffer was a convenient method producing high extraction success and DNA yield. We modelled the influence of faecal quality and storage time on DNA concentration in order to provide recommendations for optimized collection and storage. The maximum storage time to ensure 75% success was two months for samples collected within 24 hours after defecation and extended to four months for samples collected within one hour. Lastly, the real-time quantitative PCR assay allowed us to predict genotyping success and pre-screen DNA samples, thus further increasing the cost-efficiency of our approach. We recommend combining the validation of an efficient sampling method, the build of in-country DNA extraction capacity for reduced storage time and the development of species-specific quantitative PCR assays in order to increase the cost-efficiency of routine non-invasive DNA analyses and expand the use of next-generation markers to non-invasive samples.	[Bourgeois, Stephanie; Jeffery, Kathryn J.] Agence Natl Parcs Nationaux, Libreville, Gabon; [Bourgeois, Stephanie; Kaden, Jenny; Senn, Helen] RZSS Edinburgh Zoo, Royal Zool Soc Scotland, WildGenes Lab, Edinburgh, Midlothian, Scotland; [Bourgeois, Stephanie; Bunnefeld, Nils; Jeffery, Kathryn J.] Univ Stirling, Biol & Environm Sci, Fac Nat Sci, Stirling, Scotland; [Jeffery, Kathryn J.; Akomo-Okoue, Etienne F.] Inst Rech Ecol Trop, Libreville, Gabon; [Ogden, Rob; McEwing, Ross] TRACE Wildlife Forens Network, Edinburgh, Midlothian, Scotland	University of Stirling	Bourgeois, S (corresponding author), Agence Natl Parcs Nationaux, Libreville, Gabon.; Bourgeois, S (corresponding author), RZSS Edinburgh Zoo, Royal Zool Soc Scotland, WildGenes Lab, Edinburgh, Midlothian, Scotland.; Bourgeois, S (corresponding author), Univ Stirling, Biol & Environm Sci, Fac Nat Sci, Stirling, Scotland.	stephbourgeois_@hotmail.com			European Union [FED/2013/332-349]	European Union(European Commission)	Funds for the project were provided by CEEAC under the ECOFAC V Programme (Fragile ecosystems of Central Africa) funded by the European Union (contract no FED/2013/332-349).	Akomo-Okoue EF, 2015, MAMMAL RES, V60, P375, DOI 10.1007/s13364-015-0233-1; [Anonymous], 2021, LANG ENV STAT COMP; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Arandjelovic M, 2018, AM J PRIMATOL, V80, DOI 10.1002/ajp.22743; Ball MC, 2007, CONSERV GENET, V8, P577, DOI 10.1007/s10592-006-9193-y; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bourgeois S, 2018, ECOL EVOL, V8, P2207, DOI 10.1002/ece3.3854; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; Burham K. P., 2002, MODEL SELECTION MULT; Campbell NR, 2009, CONSERV GENET, V10, P779, DOI 10.1007/s10592-008-9661-7; Chiou KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20427-9; Costa V, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-016-1058-1; Cullingham CI, 2010, J WILDLIFE MANAGE, V74, P849, DOI 10.2193/2008-292; Ebert C, 2012, WILDLIFE BIOL, V18, P142, DOI 10.2981/11-002; Eggert LS, 2014, CONSERV BIOL, V28, P107, DOI 10.1111/cobi.12161; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Fabbri E, 2012, ARCH BIOL SCI, V64, P321, DOI 10.2298/ABS1201321F; Fernando P, 2003, J HERED, V94, P115, DOI 10.1093/jhered/esg022; Fitak RR, 2016, J FISH WILDL MANAG, V7, P13, DOI 10.3996/112014-JFWM-080; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frantzen MAJ, 1998, MOL ECOL, V7, P1423, DOI 10.1046/j.1365-294x.1998.00449.x; Goossens B, 2016, BIOL CONSERV, V196, P80, DOI 10.1016/j.biocon.2016.02.008; Gray TNE, 2014, CONSERV GENET, V15, P803, DOI 10.1007/s10592-014-0579-y; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Hausknecht R, 2010, J WILDLIFE MANAGE, V74, P1904, DOI 10.2193/2009-421; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Hedges S., 2006, DUNG SURVEY STANDARD; Hedges S, 2013, BIOL CONSERV, V159, P101, DOI 10.1016/j.biocon.2012.12.010; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; Jeffery KJ, 2007, BIOL J LINN SOC, V91, P281, DOI 10.1111/j.1095-8312.2007.00792.x; Johnson WE, 2016, TROPICAL CONSERVATIO, P226; Kanthaswamy S, 2012, FORENSIC SCI INT-GEN, V6, P290, DOI 10.1016/j.fsigen.2011.06.005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Lampa S, 2008, CONSERV GENET, V9, P201, DOI 10.1007/s10592-007-9328-9; Lampa S, 2013, J WILDLIFE MANAGE, V77, P1490, DOI 10.1002/jwmg.604; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Matheson C.D., 2010, OPEN ENZYME INHIB J, V3, P38, DOI [10.2174/1874940201003010038, DOI 10.2174/1874940201003010038]; Maudet C, 2004, MOL ECOL NOTES, V4, P772, DOI 10.1111/j.1471-8286.2004.00787.x; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Monteiro L, 2001, J MICROBIOL METH, V45, P89, DOI 10.1016/S0167-7012(01)00225-1; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murphy MA, 2002, CONSERV GENET, V3, P435, DOI 10.1023/A:1020503330767; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Ng J, 2014, J FOOD SCI TECH MYS, V51, P4060, DOI 10.1007/s13197-012-0893-7; Norman AJ, 2015, ECOL EVOL, V5, P3056, DOI 10.1002/ece3.1588; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Nussberger B, 2014, EUR J WILDLIFE RES, V60, P405, DOI 10.1007/s10344-014-0806-3; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Pakstis AJ, 2010, HUM GENET, V127, P315, DOI 10.1007/s00439-009-0771-1; Panasci M, 2011, J WILDLIFE MANAGE, V75, P1616, DOI 10.1002/jwmg.221; Perry GH, 2010, MOL ECOL, V19, P5332, DOI 10.1111/j.1365-294X.2010.04888.x; Piggott MP, 2004, WILDLIFE RES, V31, P485, DOI 10.1071/WR03096; Poulsen JR, 2017, CURR BIOL, V27, pR134, DOI 10.1016/j.cub.2017.01.023; Quasim S, 2018, MAMMAL RES, V63, P387, DOI 10.1007/s13364-018-0369-x; Ramon-Laca A, 2015, WILDLIFE BIOL, V21, P195, DOI 10.2981/wlb.00096; Ranade K, 2001, GENOME RES, V11, P1262; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046732; Renan S, 2012, MOL ECOL RESOUR, V12, P1040, DOI 10.1111/j.1755-0998.2012.03170.x; Rodgers TW, 2013, EUR J WILDLIFE RES, V59, P1, DOI 10.1007/s10344-012-0675-6; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutledge LY, 2009, J WILDLIFE MANAGE, V73, P1430, DOI 10.2193/2008-492; Santini A, 2007, MOL ECOL NOTES, V7, P955, DOI 10.1111/j.1471-8286.2007.01829.x; Sarre SD, 2009, WILDLIFE RES, V36, P70, DOI 10.1071/WR08066; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Schultz AJ, 2018, ECOL EVOL, V8, P3139, DOI 10.1002/ece3.3765; Schuttler SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088074; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Skaug H., 2016, GLMMADMB GEN LINEAR; Soto-Calderon ID, 2009, MOL ECOL RESOUR, V9, P471, DOI 10.1111/j.1755-0998.2008.02462.x; Stenglein JL, 2010, MOL ECOL RESOUR, V10, P109, DOI 10.1111/j.1755-0998.2009.02670.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Vigilant L, 2002, EVOL ANTHROPOL, V11, P162, DOI 10.1002/evan.10082; von Thaden A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10647-w; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wultsch C, 2015, WILDLIFE SOC B, V39, P403, DOI 10.1002/wsb.540; Zuur Alain F., 2009, P1	82	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210811	10.1371/journal.pone.0210811	http://dx.doi.org/10.1371/journal.pone.0210811			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699177	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600057
J	Davidson, J; Thompson, A; Logan, M; Schaffelke, B				Davidson, Johnston; Thompson, Angus; Logan, Murray; Schaffelke, Britta			High spatio-temporal variability in Acroporidae settlement to inshore reefs of the Great Barrier Reef	PLOS ONE			English	Article							CORAL-REEFS; SCLERACTINIAN CORAL; SUSPENDED SEDIMENTS; TERRESTRIAL RUNOFF; LARVAL SETTLEMENT; WATER CLARITY; PHASE-SHIFTS; RECRUITMENT; PATTERNS; SURVIVAL	Recovery of coral reefs after disturbance relies heavily on replenishment through successful larval settlement and their subsequent survival. As part of an integrated study to determine the potential effects of water quality changes on the resilience of inshore coral communities, scleractinian coral settlement was monitored between 2006 and 2012 at 12 reefs within the inshore Great Barrier Reef. Settlement patterns were only analysed for the family Acroporidae, which represented the majority (84%) of settled larvae. Settlement of Acroporidae to terracotta tiles averaged 0.11 cm(-2), representing 34 +/- 31.01 (mean +/- SD) spat per tile, indicating an abundant supply of competent larvae to the study reefs. Settlement was highly variable among reefs and between years. Differences in settlement among locations partly corresponded to the local cover of adult Acroporidae, while substantial reductions in Acroporidae cover caused by tropical cyclones and floods resulted in a clear reduction in settlement. Much of the observed variability remained unexplained, although likely included variability in both connectivity to, and the fecundity of, adult Acroporidae. The responsiveness of settlement patterns to the decline in Acroporidae cover across all four regions indicates the importance of supply and connectivity, and the vulnerability towards region-wide disturbance. High spatial and temporal variability, in addition to the resource-intensive nature of sampling with settlement tiles, highlights the logistical difficulty of determining coral settlement over large spatial and temporal scales.	[Davidson, Johnston; Thompson, Angus; Logan, Murray; Schaffelke, Britta] Australian Inst Marine Sci, Townsville, Qld, Australia	Australian Institute of Marine Science	Davidson, J (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	j.davidson@aims.gov.au		Logan, Murray/0000-0001-5102-3972	Australian Government's Reef Rescue initiative; Australian Government's Caring for our Country Program; Australian Institute of Marine Science	Australian Government's Reef Rescue initiative(Australian Government); Australian Government's Caring for our Country Program(Australian Government); Australian Institute of Marine Science	This study was carried out as part of a larger monitoring program on the Great Barrier Reef. The Reef Rescue Marine Monitoring Program (MMP) was developed by the Great Barrier Reef Marine Park Authority and funded by the Australian Government's Reef Rescue initiative. A summary of the MMP's overall goals and objectives, and a description of the sub-programs are available at http://www.gbrmpa.gov.au/about-the-reef/how-the-reefs-managed/science-and-research/our-monitoring-and-assessment-programs/reef-rescue-marine-monitoring-program and http://e-atlas.org.au/rrmmp. The Reef Rescue initiative had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We especially thank Steve Neale for significant contributions to the early years of this study. We also thank Paul Costello, Charlotte Johansson, Damian Thomson, Aaron Anderson and Joe Gioffre for invaluable field and laboratory assistance, and the crew of the RV Cape Ferguson for logistical support. This project was supported by the Great Barrier Reef Marine Park Authority, through funding from the Australian Government's Caring for our Country Program, and by the Australian Institute of Marine Science.	Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; [Anonymous], REEF RESCUE MARINE M; [Anonymous], 2013, REEF WATER QUALITY P, P34; [Anonymous], 1985, MARINE ECOLOGY PROGR, P289; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Atrigenio MP, 1996, J EXP MAR BIOL ECOL, V203, P179, DOI 10.1016/0022-0981(95)02527-8; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; Babcock R, 1985, P 5 INT COR REEF S, V4, P355; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Babock R.C., 1988, P635; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2012, 12 INT COR REEF S CA, P5; Baird AH, 2009, GALAXEA, P101; Baird AH, 1997, P 8 INT COR REEF S P, V2, P1207; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burke L., 2011, REEFS RISK REVISITED; Chin A, 2011, STATUS CORAL REEFS P, P260; CONNELL JH, 1985, J EXP MAR BIOL ECOL, V93, P11, DOI 10.1016/0022-0981(85)90146-7; Cooper T, 2007, CORAL BASED INDICATO, P29; Davies SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072830; dela Cruz DW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14546-y; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Done T, 2007, CORAL REEFS, V26, P789, DOI 10.1007/s00338-007-0265-3; Doropoulos C, 2018, CORAL REEFS, V37, P25, DOI 10.1007/s00338-017-1629-y; Doropoulos C, 2016, ECOL MONOGR, V86, P20, DOI 10.1890/15-0668.1; Elmer F, 2018, CORAL REEFS, V37, P397, DOI 10.1007/s00338-018-1665-2; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Erwin P., 2008, P 11 INT COR REEF S, P1219; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2016, ESTUAR COAST SHELF S, V173, pA1, DOI 10.1016/j.ecss.2016.03.001; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Fabricius KE, 2013, ESTUAR COAST SHELF S, V116, P57, DOI 10.1016/j.ecss.2012.03.010; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2000, ESTUAR COAST SHELF S, V50, P115, DOI 10.1006/ecss.1999.0538; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Figueiredo J, 2013, ECOLOGY, V94, P650, DOI 10.1890/12-0767.1; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Graham JE, 2013, MAR BIOL, V160, P2561, DOI 10.1007/s00227-013-2248-y; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HARRIOTT VJ, 1987, MAR ECOL PROG SER, V37, P201, DOI 10.3354/meps037201; HARRIOTT VJ, 1988, AUST J MAR FRESH RES, V39, P409; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hock K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003355; HODGSON G, 1990, CORAL REEFS, V9, P41, DOI 10.1007/BF00686720; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2015, NAT CLIM CHANGE, V5, P508, DOI 10.1038/nclimate2604; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Humanes A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44101; Humanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161616; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jones AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084739; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones R, 2015, MAR POLLUT BULL, V100, P13, DOI 10.1016/j.marpolbul.2015.08.021; Jonker M., 2008, LONG TERM MONITORING; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Lukoschek V, 2016, MOL ECOL, V25, P3065, DOI 10.1111/mec.13649; Lukoschek V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065363; MAIDA M, 1995, MAR ECOL PROG SER, V121, P191, DOI 10.3354/meps121191; Markey KL, 2007, MAR ECOL PROG SER, V330, P127, DOI 10.3354/meps330127; Munday PL, 2009, CORAL REEFS, V28, P379, DOI 10.1007/s00338-008-0461-9; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Negri AP, 2011, ECOLOGICAL IMPACT TO; Orpin AR, 2012, CONT SHELF RES, V47, P55, DOI 10.1016/j.csr.2012.06.013; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Perez K, 2014, PEERJ, V2, DOI 10.7717/peerj.387; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ricardo GF, 2017, SCI TOTAL ENVIRON, V609, P277, DOI 10.1016/j.scitotenv.2017.07.153; Ricardo GF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18084; RICHMOND RH, 1993, AM ZOOL, V33, P524; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; SAMMARCO PW, 1988, SCIENCE, V239, P1422, DOI 10.1126/science.239.4846.1422; Schaffelke B, 2009, REEF RESCUE MARINE M, P146; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; TE FT, 1992, CORAL REEFS, V11, P131, DOI 10.1007/BF00255466; Tebben J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10803; Thompson A, 2014, MARINE MONITORING PR, P146; Thompson A, 2017, MARINE MONITORING PR, P133; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Wallace CC, 1985, P 5 INT COR REEF S, V4, P385; Ward S., 2002, P1123; Ward S, 2000, J EXP MAR BIOL ECOL, V246, P179, DOI 10.1016/S0022-0981(99)00182-3; Waterhouse J, 2017, MARINE MONITORING PR; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wilkinson CR, 2002, STATUS CORAL REEFS W, P379; WOLANSKI E, 1989, CONT SHELF RES, V9, P479, DOI 10.1016/0278-4343(89)90011-3; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2012, MGCV PACKAGE MIXED G	105	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0209771	10.1371/journal.pone.0209771	http://dx.doi.org/10.1371/journal.pone.0209771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699141	gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600014
J	Kawakita, A; Sato, AAW; Salazar, JRL; Kato, M				Kawakita, Atsushi; Wong Sato, Akira A.; Llacsahuanga Salazar, Juana R.; Kato, Makoto			Leafflower-leafflower moth mutualism in the Neotropics: Successful transoceanic dispersal from the Old World to the New World by actively-pollinating leafflower moths	PLOS ONE			English	Article							PHYLLANTHUS PHYLLANTHACEAE; TAXONOMIC REVISION; EPICEPHALA MOTHS; DIVERSITY; EVOLUTION; ISLANDS; EUPHORBIACEAE; ASSOCIATION; MADAGASCAR; TREE	In the Old World tropics, several hundred species of leafflowers (Phyllanthus sensu lato; Phyllanthaceae) are engaged in obligate mutualisms with species-specific leafflower moths (Epicephala; Gracillariidae) whose adults actively pollinate flowers and larvae consume the resulting seeds. Considerable diversity of Phyllanthus also exists in the New World, but whether any New World Phyllanthus is pollinated by Epicephala is unknown. We studied the pollination biology of four woody Phyllanthus species occurring in Peru over a period of four years, and found that each species is associated with a species-specific, seed-eating Epicephala moth, here described as new species. Another Epicephala species found associated with herbaceous Phyllanthus is also described. This is the first description of Epicephala from the New World. Field-collected female moths of the four Epicephala species associated with woody Phyllanthus all carried pollen on the proboscises, and active pollination behavior was observed in at least two species. Thus, Epicephala moths also pollinate New World Phyllanthus. However, not all of these Epicephala species may be mutualistic with their hosts, because we occasionally observed females laying eggs in developing fruits without pollinating. Also, the flowers of some Phyllanthus species were visited by pollen-bearing thrips or gall midges, which potentially acted as co-pollinators or primary pollinators. Phylogenetic analysis showed that the New World Epicephala associated with woody Phyllanthus are nested within lineages of Old World active pollinators. Thus, actively-pollinating Epicephala moths, which originated in the Old World, successfully colonized the New World probably across the Pacific and established mutualisms with resident Phyllanthus species, although whether any of the relationships are obligate requires further study. There is likely a major radiation of Epicephala still to be found in the New World.	[Kawakita, Atsushi] Univ Tokyo, Grad Sch Sci, Bot Gardens, Tokyo, Japan; [Wong Sato, Akira A.; Llacsahuanga Salazar, Juana R.] Natl Agr Univ La Molina, Fac Forestry Sci, Lima, Peru; [Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	University of Tokyo; University Nacional Agraria La Molina; Kyoto University	Kawakita, A (corresponding author), Univ Tokyo, Grad Sch Sci, Bot Gardens, Tokyo, Japan.	kawakita@ns.bg.s.u-tokyo.ac.jp	Sato, Akira Armando Wong/ABB-6008-2020	Sato, Akira Armando Wong/0000-0002-3617-8121; Kawakita, Atsushi/0000-0002-4864-7423	Japan Ministry of Education, Culture, Science, Sports, and Technology [15370012, 18207002, 22247003, 22405009, 15H02420, 15H04421]	Japan Ministry of Education, Culture, Science, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Japan Ministry of Education, Culture, Science, Sports, and Technology Grants-in-Aid for Scientific Research (awarded to MK) No. 15370012, 18207002, 22247003, 22405009, and 15H02420 and Japan Ministry of Education, Culture, Science, Sports, and Technology Grants-in-Aid for Scientific Research (awarded to AK) No. 15H04421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Govaerts R, 2000, WORLD CHECKLIST BIBL; Hembry DH, 2012, BIOL LETTERS, V8, P258, DOI 10.1098/rsbl.2011.0771; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kathriarachchi H, 2006, AM J BOT, V93, P637, DOI 10.3732/ajb.93.4.637; Kato M, 2017, ECOL RES MONOGR, P1, DOI 10.1007/978-4-431-56532-1; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kato M, 2017, ECOL RES MONOGR, P63, DOI 10.1007/978-4-431-56532-1_3; Kawakita A, 2004, EVOLUTION, V58, P2201; Kawakita A, 2004, AM J BOT, V91, P410, DOI 10.3732/ajb.91.3.410; Kawakita A, 2006, ZOOKEYS, V568, P87; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kawakita A, 2006, MOL ECOL, V15, P3567, DOI 10.1111/j.1365-294X.2006.03037.x; Kawakita A, 2017, ECOL RES MONOGR, P117, DOI 10.1007/978-4-431-56532-1_5; Kawakita A, 2017, ECOL RES MONOGR, P81, DOI 10.1007/978-4-431-56532-1_4; Kawakita A, 2015, BIOL J LINN SOC, V116, P507, DOI 10.1111/bij.12633; Kawakita A, 2010, PLANT SPEC BIOL, V25, P3, DOI 10.1111/j.1442-1984.2009.00266.x; Kjellberg F, 2001, P ROY SOC B-BIOL SCI, V268, P1113, DOI 10.1098/rspb.2001.1633; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Pellmyr O, 2002, P NATL ACAD SCI USA, V99, P5498, DOI 10.1073/pnas.072588699; Ralimanana H, 2013, KEW BULL, V68, P535, DOI 10.1007/s12225-013-9485-6; Ralimanana Helene, 2011, Kew Bulletin, V66, P331; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Webster GL, 2002, BOT J LINN SOC, V138, P325, DOI 10.1046/j.1095-8339.2002.00009.x; Webster Grady L., 2003, Lundellia, P19	27	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210727	10.1371/journal.pone.0210727	http://dx.doi.org/10.1371/journal.pone.0210727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699166	gold, Green Published, Green Submitted			2022-12-26	WOS:000457155600047
J	Nutahara, E; Abe, E; Uno, S; Ishibashi, Y; Watanabe, T; Hayashi, M; Okino, N; Ito, M				Nutahara, Eri; Abe, Eriko; Uno, Shinya; Ishibashi, Yohei; Watanabe, Takashi; Hayashi, Masahiro; Okino, Nozomu; Ito, Makoto			The glycerol-3-phosphate acyltransferase PLAT2 functions in the generation of DHA-rich glycerolipids in Aurantiochytrium limacinum F26-b	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TRANSGENE EXPRESSION; TRANSFORMATION; BIOSYNTHESIS; DISEASE; PHOSPHATIDYLCHOLINE; THRAUSTOCHYTRIDS; ENZYMES; SYSTEM; HEALTH	Thraustochytrids possess docosahexaenoic acid (DHA, 22:6n-3) as acyl chain(s) of triacylglycerol (TG) and phosphatidylcholine (PC), some of which contain multiple DHAs. However, little is known about how these DHA-rich glycerolipids are produced in thraustochytrids. In this study, we identified PLAT2 in Aurantiochytrium limacinum F26-b as a glycerol-3-phosphate (G3P) acyltransferase (GPAT) by heterologous expression of the gene in budding yeast. Subsequently, we found that GPAT activity was reduced by disruption of the PLAT2 gene in A. limacinum, resulting in a decrease in DHA-containing lysophosphatidic acid (LPA 22:6). Conversely, overexpression of PLAT2 increased both GPAT activity and LPA 22:6. These results indicate that PLAT2 is a GPAT that transfers DHA to G3P in vivo as well as in vitro. Overexpression of the PLAT2 gene increased the production of a two DHA-containing diacylglycerol (DG 44:12), followed by an increase in the three DHA-containing TG (TG 66:18), two-DHA-containing TG (TG 60:12), and two DHA-containing PC (PC 44:12). However, overexpression of PLAT2 did not increase DHA-free DG (DG32:0), which was preferentially converted to three 16:0-containing TG (TG 48:0) but not two 16:0-containing PC (PC 32:0). Collectively, we revealed that DHA-rich glycerolipids are produced from a precursor, LPA 22:6, which is generated by incorporating DHA to G3P by PLAT2 in the A. limacinum.	[Nutahara, Eri; Abe, Eriko; Uno, Shinya; Ishibashi, Yohei; Watanabe, Takashi; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Nishi Ku, Fukuoka, Fukuoka, Japan; [Hayashi, Masahiro] Univ Miyazaki, Fac Agr, Dept Marine Biol & Environm Sci, 1-1 Gakuen Kibanadai Nishi, Miyazaki, Japan; [Ito, Makoto] Kyushu Univ, Innovat Bioarchitecture Ctr, Nishi Ku, Fukuoka, Fukuoka, Japan	Kyushu University; University of Miyazaki; Kyushu University	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Nishi Ku, Fukuoka, Fukuoka, Japan.; Ito, M (corresponding author), Kyushu Univ, Innovat Bioarchitecture Ctr, Nishi Ku, Fukuoka, Fukuoka, Japan.	makotoi@agr.kyushu-u.ac.jp	Okino, Nozomu/AAY-2635-2021; Ito, Makoto/Q-6164-2019	ito, Makoto/0000-0003-3159-7818	Japanese Ministry of Education, Culture, Science, and Technology [15H04488]; Science and Technology Research Promotion Program for Agriculture, Fisheries and Food Industry, Japan [26050A]	Japanese Ministry of Education, Culture, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Fisheries and Food Industry, Japan	Japanese Ministry of Education, Culture, Science, and Technology (15H04488) The Science and Technology Research Promotion Program for Agriculture, Fisheries and Food Industry, Japan (26050A). Funder plays any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe E, 2006, J BIOCHEM, V140, P247, DOI 10.1093/jb/mvj145; Abe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102377; Adachi T, 2017, J OLEO SCI, V66, P791, DOI 10.5650/jos.ess17084; Chen X, 2011, PLANT SIGNAL BEHAV, V6, P1695, DOI 10.4161/psb.6.11.17777; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Dellero Y, 2018, ALGAL RES, V35, P125, DOI 10.1016/j.algal.2018.08.018; Dellero Y, 2018, ENVIRON MICROBIOL, V20, P3057, DOI 10.1111/1462-2920.14346; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gupta Adarsha, 2012, Biotechnol Adv, V30, P1733, DOI 10.1016/j.biotechadv.2012.02.014; Harayama T, 2009, J LIPID RES, V50, P1824, DOI 10.1194/jlr.M800500-JLR200; Hong WK, 2013, BIOPROC BIOSYST ENG, V36, P1191, DOI 10.1007/s00449-012-0846-6; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kobayashi T, 2011, APPL ENVIRON MICROB, V77, P3870, DOI 10.1128/AEM.02664-10; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JW, 2013, J CHROMATOGR A, V1279, P98, DOI 10.1016/j.chroma.2013.01.020; Lenihan-Geels G, 2013, NUTRIENTS, V5, P1301, DOI 10.3390/nu5041301; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Li HY, 2014, MAR DRUGS, V12, P153, DOI 10.3390/md12010153; Liang Y, 2016, MAR DRUGS, V14, DOI 10.3390/md14010010; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Matsuda T, 2012, J LIPID RES, V53, P2806, DOI 10.1194/jlr.M024935ERR; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nagano N, 2011, J OLEO SCI, V60, P475, DOI 10.5650/jos.60.475; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Okazaki K, 2006, PLANT PHYSIOL, V141, P546, DOI 10.1104/pp.105.075796; RACENIS PV, 1992, J BACTERIOL, V174, P5702, DOI 10.1128/JB.174.17.5702-5710.1992; Raghukumar S, 2008, MAR BIOTECHNOL, V10, P631, DOI 10.1007/s10126-008-9135-4; Sakaguchi K, 2012, APPL ENVIRON MICROB, V78, P3193, DOI 10.1128/AEM.07129-11; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Song ZQ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4904-6; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Watanabe T, 2017, J LIPID RES, V58, P2334, DOI 10.1194/jlr.M079897; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Yu ET, 2009, J APPL PHYCOL, V21, P669, DOI 10.1007/s10811-008-9400-y; Zhang CY, 2013, J EXP BOT, V64, P3189, DOI 10.1093/jxb/ert156	44	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211164	10.1371/journal.pone.0211164	http://dx.doi.org/10.1371/journal.pone.0211164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699157	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600065
J	Yu, J; Hu, QW; Tang, DL; Zhao, H; Chen, PM				Yu, Jing; Hu, Qiwei; Tang, Danling; Zhao, Hui; Chen, Pimao			Response of Sthenoteuthis oualaniensis to marine environmental changes in the north-central South China Sea based on satellite and in situ observations	PLOS ONE			English	Article							DOSIDICUS-GIGAS CEPHALOPODA; PURPLEBACK FLYING SQUID; DAYA BAY; BIOLOGY; OMMASTREPHIDAE; CATCH; MODEL	In the South China Sea (SCS), Sthenoteuthis oualaniensis (S. oualaniensis) generally has the highest stock density in spring and occupies an important position in fisheries. The responses of S. oualaniensis to marine environments in the north-central SCS in spring (March to May) from 2006 to 2010 were analyzed using satellite and in situ observations, with generalized additive models (GAMs). A high proportion variation in catch per unit effort (CPUE) was explained by environmental variables, including sea surface temperature (SST; explaining 13.8%) and the interaction between SST and chlorophyll a (Chl-a) concentration (explaining 16.9%). SSTs within the range of 24-28 degrees C and Chl-a concentrations within 0.10-0.35 mg/m(3) had positive effects on S. oualaniensis CPUE, and SST within 28-29.5 degrees C and Chl-a concentrations within 0.05-0.20 mg/m(3) had negative effects. In addition, the response time of the maximum standardized catch per unit effort (SCPUE) in May to the maximum Chl-a in March was approximately six ten-day time step. The higher Chl-a and smaller stock size of S. oualaniensis in early March 2008 were partly associated with climatic anomalies caused by La Nina in spring and the limitation of S. oualaniensisby low temperature in 2008. The findings in this study can help better protect and manage S. oualaniensis resources in the SCS.	[Yu, Jing; Hu, Qiwei; Chen, Pimao] Chinese Acad Fishery Sci, Guangdong Prov Key Lab Fishery Ecol & Environm, Sci Observing & Expt Stn South China Sea Fishery, Minist Agr & Rural Affairs,South China Sea Fisher, Guangzhou, Guangdong, Peoples R China; [Tang, Danling] Chinese Acad Sci, South China Sea Inst Oceanog, Key Lab Ocean Remote Sensing, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Zhao, Hui] Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang, Peoples R China	Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Guangdong Ocean University	Yu, J (corresponding author), Chinese Acad Fishery Sci, Guangdong Prov Key Lab Fishery Ecol & Environm, Sci Observing & Expt Stn South China Sea Fishery, Minist Agr & Rural Affairs,South China Sea Fisher, Guangzhou, Guangdong, Peoples R China.	yujing@scsfri.ac.cn			Central Public-interest Scientific Institution Basal Research Fund, CAFS [2018HY-ZD0104]; National Key R&D Program of China [2018YFD0900901]; Natural Science Foundation of Guangdong Province, China [2018A030313120]; International Scientific & Technological Cooperation Project of Department of Education of Guangdong Province, China [2015KGJHZ017]; National Natural Science Foundation of China [41376125]; State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences [LTO1806]	Central Public-interest Scientific Institution Basal Research Fund, CAFS; National Key R&D Program of China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); International Scientific & Technological Cooperation Project of Department of Education of Guangdong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences	This study was supported by the following funds: (1) Central Public-interest Scientific Institution Basal Research Fund, CAFS (2018HY-ZD0104), (2) National Key R&D Program of China (2018YFD0900901), (3) Natural Science Foundation of Guangdong Province, China (2018A030313120), (4) International Scientific & Technological Cooperation Project of Department of Education of Guangdong Province, China (2015KGJHZ017), (5) National Natural Science Foundation of China (grants 41376125), (6) State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences (LTO1806).	ARKHIPKIN A, 1992, J EXP MAR BIOL ECOL, V163, P261, DOI 10.1016/0022-0981(92)90054-E; Bacha M, 2017, FISH OCEANOGR, V8, P12; Bacha M, 2017, FISH OCEANOGR, V26, P282, DOI 10.1111/fog.12192; Basir S, 2000, BIOL FEATURE OCEANIC, P135; Bower JR, 1999, MAR ECOL PROG SER, V185, P203, DOI 10.3354/meps185203; Burnham KP, 2002, J WILDLIFE MANAGE, V67, P175, DOI DOI 10.2307/2669574; Campbell RA, 2004, FISH RES, V70, P209, DOI 10.1016/j.fishres.2004.08.026; Chen XJ, 2007, ICES J MAR SCI, V64, P1152, DOI 10.1093/icesjms/fsm103; Chen XJ, 2007, FISH RES, V83, P98, DOI 10.1016/j.fishres.2006.09.005; Diekman R, 2002, BERICHTE I MEERESKUN, V326, P1; Fan Jiang-tao, 2013, Guangdong Agricultural Sciences, V40, P122; Fan JT, 2016, S CHINA FISHERIES SC, V12, P7; Fu DY, 2017, GEOMAT NAT HAZ RISK, V8, P1034, DOI 10.1080/19475705.2017.1292559; GAVARIS S, 1980, CAN J FISH AQUAT SCI, V37, P2272, DOI 10.1139/f80-273; Hinton M. G., 2004, ICCAT COL VOL SCI PA, V56, P169; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; [胡启伟 Hu Qiwei], 2016, [海洋学报, Acta Oceanologica Sinica], V38, P66; Kang L, 2016, MAR FISH, V12, P64; Klemas V, 2013, FISH RES, V148, P124, DOI 10.1016/j.fishres.2012.02.027; Kuo NJ, 2004, REMOTE SENS ENVIRON, V89, P106, DOI 10.1016/j.rse.2003.10.009; Li Bin, 2016, Nanfang Shuichan, V12, P28; [林东明 Lin Dongming], 2006, [海洋科学进展, Advances in Marine Science], V24, P546; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Nateewathana A., 2000, P 3 TECHN SEM MAR FI, P76; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Qian W.G., 2006, MAR FISH, V28, P265; Siriraksophon S., 2000, P 3 TECHN SEM MAR FI, P101; Su Li, 2016, Nanfang Shuichan, V12, P96; Tafur R, 2001, FISH RES, V54, P33, DOI 10.1016/S0165-7836(01)00379-4; Tang DL, 2018, CHINA SCI B, V63, DOI [10.1360/N972017-00440, DOI 10.1360/N972017-00440]; Tian SQ, 2006, B OCEANOL LIMN, P51; Wang JJ, 2014, DEEP-SEA RES PT II, V101, P120, DOI 10.1016/j.dsr2.2013.09.020; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worms J., 1983, FAO Fisheries Technical Paper, V231, P1; Yan H., 2012, HIGH RESOLUTION CLIM, P25; [晏磊 Yan Lei], 2016, [中国水产科学, Journal of Fishery Sciences of China], V23, P469; [颜云榕 Yan Yunrong], 2012, [海洋与湖沼, Oceanologia et Limnologia Sinica], V43, P1177; [杨德康 Yang Dekang], 2002, [上海水产大学学报, Journal of Shanghai fisheries university], V11, P176; [杨晓明 YANG Xiaoming], 2006, [水产学报, Journal of Fisheries of China], V30, P669; Ye HJ, 2018, INT J REMOTE SENS, V39, P4360, DOI 10.1080/01431161.2017.1399479; YOUNG R E, 1990, Pacific Science, V44, P71; Yu J, 2017, HAIYANG XUEBAO, V39, P72, DOI [10.3969/j.issn.0253-4193.2017.06.007, DOI 10.3969/J.ISSN.0253-4193.2017.06.007]; Yu J, 2007, TERR ATMOS OCEAN SCI, V18, P1011, DOI 10.3319/TAO.2007.18.5.1011(Oc); Yu J, 2015, ADV SPACE RES, V55, P2315, DOI 10.1016/j.asr.2015.02.001; Yu J, 2010, TERR ATMOS OCEAN SCI, V21, P393, DOI 10.3319/TAO.2009.05.26.01(Oc); Yu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122997; [张培群 Zhang Peiqun], 2009, [气象, Meteorological Monthly], V35, P112; Zhang YM, 2013, J GUANGDONG OCEAN U, V13, P56; Zhang ZM, 2001, NINO NINA EVENTS THE, P20; Ziegler PE, 2003, FISH RES, V61, P107, DOI 10.1016/S0165-7836(02)00240-0	50	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211474	10.1371/journal.pone.0211474	http://dx.doi.org/10.1371/journal.pone.0211474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695066	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400036
J	Marcelo, C; Warwick, M; Marcelo, C; Qayyum, R				Marcelo, Carolyn; Warwick, Melissa; Marcelo, Catherine; Qayyum, Rehan			The association between urinary genistein levels and mortality among adults in the United States	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BREAST-CANCER SURVIVAL; CARDIOVASCULAR-DISEASE; FLAVONOID INTAKE; HEART-DISEASE; SOY; RISK; HEALTH; ISOFLAVONES; PHYTOESTROGENS	Background Current research on the relationship between phytoestrogens and mortality has been inconclusive. We explored the relationship between genistein, a phytoestrogen, and mortality in a large cohort representative of the United States population. Methods Data were analyzed from the National Health and Nutrition Examination Survey (NHANES) from 1999-2010. Normalized urinary genistein (nUG) was analyzed as a log-transformed continuous variable and in quartiles. Mortality data were obtained from the National Death Index and matched to the NHANES participants. Survival analyses were conducted using the Kaplan-Meier analysis. Cox proportional hazard models were constructed for all-cause and cause-specific mortality without and with adjustment for potential confounding variables. Results Of 11,497 participants, 944 died during the 64,443 person-years follow-up. The all-cause mortality rate was significantly lower in the lowest quartile compared to the highest quartile (incidence rate ratio = 2.14, 95% CI = 1.76 to 2.60). Compared to the lowest quartile, the highest quartile had significantly higher adjusted all-cause (HR = 1.57, 95% CI = 1.23 to 2.00), cardiovascular (HR = 1.67, 95% CI = 1.04 to 2.68), and other-cause (HR = 1.85, 95% CI = 1.33 to 2.57) mortality. Conclusion We found that high urinary genistein levels were associated with increased risk of all-cause, cardiovascular, and other-cause mortality. This is contrary to popular opinion on the health benefits of genistein and needs further research.	[Marcelo, Carolyn; Warwick, Melissa; Marcelo, Catherine; Qayyum, Rehan] Virginia Commonwealth Univ, Sch Med, Div Hosp Med, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Marcelo, C (corresponding author), Virginia Commonwealth Univ, Sch Med, Div Hosp Med, Dept Internal Med, Richmond, VA 23284 USA.	carolyn.marcelo@vcuhealth.org		Qayyum, Rehan/0000-0003-3086-8014				Anderson D, 1997, TERATOGEN CARCIN MUT, V17, P29, DOI 10.1002/(SICI)1520-6866(1997)17:1<29::AID-TCM5>3.0.CO;2-H; Arai Y, 2000, J Epidemiol, V10, P127; Baechler SA, 2016, TOXICOL LETT, V243, P88, DOI 10.1016/j.toxlet.2015.12.009; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Boos G, 2000, TOXICOL LETT, V116, P7, DOI 10.1016/S0378-4274(00)00192-2; Caan BJ, 2011, CANCER EPIDEM BIOMAR, V20, P854, DOI 10.1158/1055-9965.EPI-10-1041; Chavez-Suarez KM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101078; Di Virgilio AL, 2004, TOXICOL LETT, V151, P151, DOI 10.1016/j.toxlet.2004.04.005; Fink BN, 2007, CANCER EPIDEM BIOMAR, V16, P2285, DOI 10.1158/1055-9965.EPI-07-0245; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; Grace PB, 2004, CANCER EPIDEM BIOMAR, V13, P698; Guglielmini P, 2012, BREAST CANCER RES TR, V132, P661, DOI 10.1007/s10549-011-1881-8; Kang XM, 2010, CAN MED ASSOC J, V182, P1857, DOI 10.1503/cmaj.091298; Kim Y, 2017, CLIN NUTR ESPEN, V20, P68, DOI 10.1016/j.clnesp.2017.03.004; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; Kokubo Y, 2007, CIRCULATION, V116, P2553, DOI 10.1161/CIRCULATIONAHA.106.683755; Kyro C, 2015, BREAST CANCER RES TR, V154, P389, DOI 10.1007/s10549-015-3595-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Milder IEJ, 2006, AM J CLIN NUTR, V84, P400; Nagata C, 2002, AM J EPIDEMIOL, V156, P824, DOI 10.1093/aje/kwf118; Nagata C, 2000, INT J EPIDEMIOL, V29, P832, DOI 10.1093/ije/29.5.832; Olsen A, 2011, BREAST CANCER RES TR, V128, P883, DOI 10.1007/s10549-011-1397-2; Pool-Zobel BL, 2000, CARCINOGENESIS, V21, P1247, DOI 10.1093/carcin/21.6.1247; Reger MK, 2016, EUR J NUTR, V55, P1029, DOI 10.1007/s00394-015-0917-y; Rienks J, 2017, NUTR REV, V75, P616, DOI 10.1093/nutrit/nux021; Rietjens IMCM, 2017, BRIT J PHARMACOL, V174, P1263, DOI 10.1111/bph.13622; Seibold P, 2014, INT J CANCER, V135, P923, DOI 10.1002/ijc.28729; Talaei M, 2014, J NUTR, V144, P921, DOI 10.3945/jn.114.190454; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; THOMAS LJ, 1975, T AM SOC ART INT ORG, V21, P516; Vanharanta M, 2003, ARCH INTERN MED, V163, P1099, DOI 10.1001/archinte.163.9.1099; Yang Z, 2012, ANTI-CANCER AGENT ME, V12, P1264, DOI 10.2174/187152012803833107; Yellayi S, 2003, J ENDOCRINOL, V176, P267, DOI 10.1677/joe.0.1760267; Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199; Zhang FF, 2017, CANCER-AM CANCER SOC, V123, P2070, DOI 10.1002/cncr.30615; Zhang YF, 2012, ASIAN PAC J CANCER P, V13, P479, DOI 10.7314/APJCP.2012.13.2.479	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211368	10.1371/journal.pone.0211368	http://dx.doi.org/10.1371/journal.pone.0211368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682197	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500156
J	Li, MN; Liu, YK; Wei, YM; Wu, CC; Meng, HB; Niu, WH; Zhou, Y; Wang, HR; Wen, QY; Fan, SQ; Li, Z; Li, XY; Zhou, JD; Cao, K; Xiong, W; Zeng, ZY; Li, XL; Qiu, YZ; Li, GY; Zhou, M				Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Wang, Heran; Wen, Qiuyuan; Fan, Songqing; Li, Zheng; Li, Xiayu; Zhou, Jianda; Cao, Ke; Xiong, Wei; Zeng, Zhaoyang; Li, Xiaoling; Qiu, Yuanzheng; Li, Guiyuan; Zhou, Ming			Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor; transcription regulation; proliferation; cell cycle; apoptosis; tumor suppressor gene; c-Myc; microRNA 141; nasopharyngeal carcinoma (NPC); Yin Yang 1 (YY1)	YIN YANG 1; CANCER; EXPRESSION; MECHANISM; PROVIDES; DOMAIN; GENE; BRD7; MAX	Yin Yang 1 (YY1) is a zinc-finger protein that plays critical roles in various biological processes by interacting with DNA and numerous protein partners. YY1 has been reported to play dual biological functions as either an oncogene or tumor suppressor in the development and progression of multiple cancers, but its role in human nasopharyngeal carcinoma (NPC) has not yet been revealed. In this study, we found that YY1 overexpression significantly inhibits cell proliferation and cell-cycle progression from G(1) to S and promotes apoptosis in NPC cells. Moreover, we identified YY1 as a component of the c-Myc complex and observed that ectopic expression of YY1 inhibits c-Myc transcriptional activity, as well as the promoter activity and expression of the c-Myc target gene microRNA-141 (miR-141). Furthermore, restoring miR-141 expression could at least partially reverse the inhibitory effect of YY1 on cell proliferation and tumor growth and on the expression of some critical c-Myc targets, such as PTEN/AKT pathway components both in vitro and in vivo. We also found that YY1 expression is reduced in NPC tissues, negatively correlates with miR-141 expression and clinical stages in NPC patients, and positively correlates with survival prognosis. Our results reveal a previously unappreciated mechanism in which the YY1/c-Myc/miR-141 axis plays a critical role in NPC progression and may provide some potential and valuable targets for the diagnosis and treatment of NPC.	[Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Wang, Heran; Li, Guiyuan; Zhou, Ming] Cent S Univ, Hunan Canc Hosp, Changsha 410013, Hunan, Peoples R China; [Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Wang, Heran; Li, Guiyuan; Zhou, Ming] Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha 410013, Hunan, Peoples R China; [Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Li, Zheng; Xiong, Wei; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Zhou, Ming] Cent S Univ, Key Lab Carcinogenesis, Chinese Minist Hlth, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China; [Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Li, Zheng; Xiong, Wei; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Zhou, Ming] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Wen, Qiuyuan; Fan, Songqing] Cent S Univ, XiangYa Hosp 2, Changsha 410011, Hunan, Peoples R China; [Qiu, Yuanzheng] Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha 410008, Hunan, Peoples R China; [Li, Zheng] Cent S Univ, High Resolut Mass Spectrometry Lab, Adv Res Ctr, Changsha 410013, Hunan, Peoples R China; [Li, Xiayu; Zhou, Jianda; Cao, Ke] Cent S Univ, XiangYa Hosp 3, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Zhou, M (corresponding author), Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha 410013, Hunan, Peoples R China.	zhouming2001@163.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; wu, Xianrui/AAM-6540-2021	wu, Xianrui/0000-0003-4803-5934	National Natural Science Foundation of China [81772990, 81572748]; "111" Project [111-2-12]; Central South University Graduate Research and Innovation Project [2018zzts823, 2018zzts233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" Project(Ministry of Education, China - 111 Project); Central South University Graduate Research and Innovation Project	This work was supported by National Natural Science Foundation of China Grants 81772990 and 81572748, the "111" Project Grant 111-2-12, and the Central South University Graduate Research and Innovation Project Grants 2018zzts823 and 2018zzts233. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Beaulieu ME, 2013, METHODS MOL BIOL, V1012, P7, DOI 10.1007/978-1-62703-429-6_2; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Khachigian LM, 2018, INT J CANCER, V143, P460, DOI 10.1002/ijc.31255; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; Lee MH, 2012, ONCOGENE, V31, P116, DOI 10.1038/onc.2011.217; Liu HY, 2006, DNA CELL BIOL, V25, P346, DOI 10.1089/dna.2006.25.346; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Liu Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.64; Liu YK, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0734-2; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Masmoudi A, 2007, CANCER TREAT REV, V33, P499, DOI 10.1016/j.ctrv.2007.04.007; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nair SK, 2006, CURR TOP MICROBIOL, V302, P123; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Niu ZX, 2015, ACTA BIOCH BIOPH SIN, V47, P183, DOI 10.1093/abbs/gmu129; Pan JJ, 2016, CANCER-AM CANCER SOC, V122, P546, DOI 10.1002/cncr.29795; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Shen Y, 2017, EXP HEMATOL, V53, P16, DOI 10.1016/j.exphem.2017.04.009; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638; Trop-Steinberg S, 2018, AM J MED SCI, V355, P67, DOI 10.1016/j.amjms.2017.06.007; Wen QY, 2015, INT J CLIN EXP PATHO, V8, P8236; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Yu X, 2016, AM J TRANSL RES, V8, P742; Yue M, 2017, CELL REP, V21, P3819, DOI 10.1016/j.celrep.2017.12.002; Zhang JJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-130; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163; Zhao R, 2017, CELL MOL IMMUNOL, V14, P830, DOI 10.1038/cmi.2016.31	38	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6172	6187		10.1074/jbc.RA118.006281	http://dx.doi.org/10.1074/jbc.RA118.006281			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30718276	Green Published, hybrid			2022-12-26	WOS:000465077500044
J	Lu, CY; Shi, X; Allen, A; Baez-Nieto, D; Nikish, A; Sanjana, NE; Pan, JQ				Lu, Congyi; Shi, Xi; Allen, Andrew; Baez-Nieto, David; Nikish, Alexandria; Sanjana, Neville E.; Pan, Jen Q.			Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons	FASEB JOURNAL			English	Article						neurogenin; induced neuronal network; GABAergic; SCN2A	AUTISM SPECTRUM DISORDER; CODING MUTATIONS; EPILEPSY; SPECIFICATION; GENERATION; INDUCTION; MOUSE; LHX5	Overexpression of mouse neurogenin (Neurog)2 alone or in combination with mouse Neurog2/1 in human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) can rapidly produce high-yield excitatory neurons. Here, we report a detailed characterization of human neuronal networks induced by the expression of human NEUROG2 together with human NEUROG2/1 in hESCs using molecular, cellular, and electrophysiological measurements over 60 d after induction. Both excitatory synaptic transmission and network firing activity increased over time. Strikingly, inhibitory synaptic transmission and GABAergic cells were identified from NEUROG2/1 induced neurons (iNs). To illustrate the application of such iNs, we demonstrated that the heterozygous knock out of SCN2A, whose loss-of-function mutation is strongly implicated in autism risk, led to a dramatic reduction in network activity in the NEUROG2/1 iNs. Our findings not only extend our understanding of the NEUROG2/1-induced human neuronal network but also substantiate NEUROG2/1 iNs as an in vitro system for modeling neuronal and functional deficits on a human genetic background.	[Lu, Congyi; Shi, Xi; Allen, Andrew; Baez-Nieto, David; Pan, Jen Q.] Broad Inst, Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 01720 USA; [Lu, Congyi; Sanjana, Neville E.] New York Genome Ctr, New York, NY USA; [Lu, Congyi; Shi, Xi] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nikish, Alexandria] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lu, Congyi; Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); New York University	Pan, JQ (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 01720 USA.	jpan@broadinstitute.org		Nikish, Alexandria/0000-0001-7320-4897; Allen, Andrew/0000-0002-7232-2143	Stanley Center for Psychiatric Research; U.S. National Institutes of Health, National Institute of Mental Health [R21 MH099448-02, R01 MH115045-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP2HG010099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH115045] Funding Source: NIH RePORTER	Stanley Center for Psychiatric Research; U.S. National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Wenting Wang (Institute of Neuroscience, Fourth Military Medical University, Xi'an, China) for his advice on electrophysiological experiments, Dr. Qian Chen (McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA), and Rhiannon Macrae (Broad Institute, Cambridge, MA, USA) for help with the manuscript. This work was supported by funding from the Stanley Center for Psychiatric Research, and U.S. National Institutes of Health, National Institute of Mental Health Grants R21 MH099448-02 (to J.Q.) and R01 MH115045-01 (to J.Q.). The authors declare no conflicts of interest.	Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Ben-Shalom R, 2017, BIOL PSYCHIAT, V82, P224, DOI 10.1016/j.biopsych.2017.01.009; Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P241, DOI 10.1007/s13311-012-0118-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Frega M, 2017, JOVE-J VIS EXP, DOI 10.3791/54900; Gascon S, 2017, CELL STEM CELL, V21, P18, DOI 10.1016/j.stem.2017.06.011; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Hafezparast M, 2002, LANCET NEUROL, V1, P215, DOI 10.1016/S1474-4422(02)00100-X; Hibaoui Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00267; Ho SM, 2016, METHODS, V101, P113, DOI 10.1016/j.ymeth.2015.11.019; Howell KB, 2015, NEUROLOGY, V85, P958, DOI 10.1212/WNL.0000000000001926; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Lam RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169506; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lu C, 2016, MOL PSYCHIATR, V21, P159, DOI 10.1038/mp.2015.173; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; OGIWARA I, 2018, BIOL, V1, DOI DOI 10.1038/S42003-018-0099-2; Peters D.T., 2008, STEMBOOK; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schwarz N, 2016, J NEUROL, V263, P334, DOI 10.1007/s00415-015-7984-0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu R, 2007, MOL CELL NEUROSCI, V35, P292, DOI 10.1016/j.mcn.2007.03.003; Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/NMETH.4291, 10.1038/nmeth.4291]; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	40	14	14	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5287	5299		10.1096/fj.201801110RR	http://dx.doi.org/10.1096/fj.201801110RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698461	Bronze, Green Published			2022-12-26	WOS:000462888500053
J	Schnell, L; Felix, I; Muller, B; Sadi, M; von Bank, F; Papatheodorou, P; Popoff, MR; Aktories, K; Waltenberger, E; Benz, R; Weichbrodt, C; Fauler, M; Frick, M; Barth, H				Schnell, Leonie; Felix, Ina; Mueller, Bastian; Sadi, Mirko; von Bank, Franziska; Papatheodorou, Panagiotis; Popoff, Michel R.; Aktories, Klaus; Waltenberger, Eva; Benz, Roland; Weichbrodt, Conrad; Fauler, Michael; Frick, Manfred; Barth, Holger			Revisiting an old antibiotic: bacitracin neutralizes binary bacterial toxins and protects cells from intoxication	FASEB JOURNAL			English	Article						bacterial binary AB-toxins; anthrax toxin; toxin inhibitor	BOTULINUM C2 TOXIN; LIPID BILAYER-MEMBRANES; PERFRINGENS IOTA-TOXIN; DIPHTHERIA-TOXIN; ANTHRAX LETHAL; ADP-RIBOSYLATION; CHANNEL FUNCTION; TYROSINE GLYCOSYLATION; BINDING-KINETICS; CLOSTRIDIUM	The antibiotic bacitracin (Bac) inhibits cell wall synthesis of gram-positive bacteria. Here, we discovered a totally different activity of Bac: the neutralization of bacterial exotoxins. Bac prevented intoxication of mammalian cells with the binary enterotoxins Clostridiumbotulinum C2, C. perfringens iota, C. difficile transferase (CDT), and Bacillus anthracis lethal toxin. The transport (B) subunits of these toxins deliver their respective enzyme (A) subunits into cells. Following endocytosis, the B subunits form pores in membranes of endosomes, which mediate translocation of the A subunits into the cytosol. Bac inhibited formation of such B pores in lipid bilayers in vitro and in living cells, thereby preventing translocation of the A subunit into the cytosol. Bac preserved the epithelial integrity of toxin-treated CaCo-2 monolayers, a model for the human gut epithelium. In conclusion, Bac should be discussed as a therapeutic option against infections with medically relevant toxin-producing bacteria, including C. difficile and B. anthracis, because it inhibits bacterial growth and neutralizes the secreted toxins.	[Schnell, Leonie; Felix, Ina; Mueller, Bastian; Sadi, Mirko; von Bank, Franziska; Papatheodorou, Panagiotis; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Popoff, Michel R.] Inst Pasteur, Dept Anaerob Bacteria, Paris, France; [Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Freiburg, Germany; [Waltenberger, Eva; Benz, Roland] Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany; [Weichbrodt, Conrad] Nanion Technol, Munich, Germany; [Fauler, Michael; Frick, Manfred] Univ Ulm, Inst Gen Physiol, Ulm, Germany	Ulm University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Freiburg; Jacobs University; Ulm University	Barth, H (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	holger.barth@uni-ulm.de	Aktories, Klaus/CAJ-5682-2022; Frick, Manfred/E-1374-2012	Aktories, Klaus/0000-0002-5397-0436; Frick, Manfred/0000-0002-4763-1104; Papatheodorou, Panagiotis/0000-0003-3571-695X	German Research Foundation (DFG) [316249678-CRC, 1279]; PharmCompNet Baden-Wurttemberg (project Barth); IGradU	German Research Foundation (DFG)(German Research Foundation (DFG)); PharmCompNet Baden-Wurttemberg (project Barth); IGradU	The work was supported by the German Research Foundation (DFG) project number 316249678-CRC (Collaborative Research Center) 1279/project C02 and the PharmCompNet Baden-Wurttemberg (project Barth). L.S. and B.M. are members of the International Graduate School in Molecular Medicine Ulm (IGradU) and thank the IGradU for the support. The authors declare no conflicts of interest.	AKTORIES K, 1992, MOL MICROBIOL, V6, P2905, DOI 10.1111/j.1365-2958.1992.tb01749.x; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Angeles DC, 2005, BIOCHEM BIOPH RES CO, V327, P361, DOI 10.1016/j.bbrc.2004.11.167; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; Beitzinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066099; Beitzinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046964; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; Benz R, 2017, CURR TOP MICROBIOL, V406, P229, DOI 10.1007/82_2017_17; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Bronnhuber A, 2014, TOXICOLOGY, V316, P25, DOI 10.1016/j.tox.2013.12.006; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dickerhof N, 2011, FEBS J, V278, P2034, DOI 10.1111/j.1742-4658.2011.08119.x; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Ernst K, 2017, CURR TOP MICROBIOL, V406, P163, DOI 10.1007/82_2016_14; Ernst K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02882-y; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; FALNES PO, 1992, J BIOL CHEM, V267, P12284; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Gatsogiannis C, 2013, NATURE, V495, P520, DOI 10.1038/nature11987; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; IKAI Y, 1995, J ANTIBIOT, V48, P233, DOI 10.7164/antibiotics.48.233; Jank T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8807; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Knapp O, 2016, BBA-BIOMEMBRANES, V1858, P512, DOI 10.1016/j.bbamem.2015.08.006; Kreidler AM, 2017, ARCH TOXICOL, V91, P1431, DOI 10.1007/s00204-016-1716-9; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; LEPPLA SH, 1991, METHOD ENZYMOL, V195, P153; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Ming LJ, 2002, J INORG BIOCHEM, V91, P46, DOI 10.1016/S0162-0134(02)00464-6; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; Nestorovich EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023927; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; OHISHI I, 1980, INFECT IMMUN, V30, P668; OHISHI I, 1986, BIOCHEM BIOPH RES CO, V136, P802, DOI 10.1016/0006-291X(86)90511-5; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; ROTH RA, 1981, BIOCHEM BIOPH RES CO, V98, P431, DOI 10.1016/0006-291X(81)90858-5; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; SCHERING B, 1988, EUR J BIOCHEM, V171, P225, DOI 10.1111/j.1432-1033.1988.tb13780.x; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Schnell L, 2016, TOXICON, V116, P23, DOI 10.1016/j.toxicon.2015.04.012; Stiles BG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00011; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	65	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5755	5771		10.1096/fj.201802453R	http://dx.doi.org/10.1096/fj.201802453R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30699302	Bronze			2022-12-26	WOS:000462888500089
J	van der Wijk, AE; Wisniewska-Kruk, J; Vogels, IMC; van Veen, HA; Ip, WF; van der Wel, NN; van Noorden, CJF; Schlingemann, RO; Klaassen, I				van der Wijk, Anne-Eva; Wisniewska-Kruk, Joanna; Vogels, Ilse M. C.; van Veen, Henk A.; Ip, Wing Fung; van der Wel, Nicole N.; van Noorden, Cornelis J. F.; Schlingemann, Reinier O.; Klaassen, Ingeborg			Expression patterns of endothelial permeability pathways in the development of the blood-retinal barrier in mice	FASEB JOURNAL			English	Article						tight junctions; transcellular permeability; VEGF signaling	VESICLE-ASSOCIATED PROTEIN; HUMAN DIABETIC-RETINOPATHY; ANTIGEN PAL-E; VASCULAR DEVELOPMENT; GENE-EXPRESSION; UP-REGULATION; BRAIN-TUMOR; VEGF-A; ANGIOGENESIS; MARKER	Insight into the molecular and cellular processes in blood-retinal barrier (BRB) development, including the contribution of paracellular and transcellular pathways, is still incomplete but may help to understand the inverse process of BRB loss in pathologic eye conditions. In this comprehensive observational study, we describe in detail the formation of the BRB at the molecular level in physiologic conditions, using mice from postnatal day (P)3 to P25. Our data indicate that immature blood vessels already have tight junctions at P5, before the formation of a functional BRB. Expression of the endothelial cell-specific protein plasmalemma vesicle-associated protein (PLVAP), which is known to be involved in transcellular transport and associated with BRB permeability, decreased during development and was absent when a functional barrier was formed. Moreover, we show that PLVAP deficiency causes a transient delay in retinal vascular development and changes in mRNA expression levels of endothelial permeability pathway proteins.	[van der Wijk, Anne-Eva; Wisniewska-Kruk, Joanna; Vogels, Ilse M. C.; Ip, Wing Fung; van Noorden, Cornelis J. F.; Schlingemann, Reinier O.; Klaassen, Ingeborg] Univ Amsterdam, Dept Ophthalmol, Amsterdam UMC,Canc Ctr Amsterdam, Ocular Angiogenesis Grp,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [van der Wijk, Anne-Eva; Wisniewska-Kruk, Joanna; Vogels, Ilse M. C.; Ip, Wing Fung; van Noorden, Cornelis J. F.; Schlingemann, Reinier O.; Klaassen, Ingeborg] Univ Amsterdam, Dept Med Biol, Amsterdam UMC,Canc Ctr Amsterdam, Ocular Angiogenesis Grp,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [van Veen, Henk A.; van der Wel, Nicole N.] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Electron Microscopy Ctr Amsterdam, Amsterdam, Netherlands; [van Noorden, Cornelis J. F.] Univ Amsterdam, Dept Med Biol, Amsterdam UMC, Cellular Imaging Core Facil, Amsterdam, Netherlands; [van Noorden, Cornelis J. F.] Natl Inst Biol, Dept Genet Toxicol & Tumor Biol, Ljubljana, Slovenia; [Schlingemann, Reinier O.] Univ Lausanne, Jules Gonin Eye Hosp, Dept Ophthalmol, Lausanne, Switzerland	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; National Institute of Biology - Slovenia; University of Lausanne	Klaassen, I (corresponding author), Amsterdam UMC, Ocular Angiogenesis Grp, Dept Med Biol, Meibergdreef 15,Room L3-154, NL-1105 AZ Amsterdam, Netherlands.	i.klaassen@amc.uva.nl	Van Der Wel, Nicole/AAE-7569-2020	van der Wijk, Anne-Eva/0000-0002-7436-5323; Klaassen, Ingeborg/0000-0003-1695-9403; van der Wel, Nicole/0000-0001-6392-3417	U.S. National Institutes of Health [032525-UCD]; Diabetes Fonds (Dutch Diabetes Fund) [2014.00.1784]; Landelijke Stichting voor Blinden en Slechtzienden; Novartis Fonds; St. MD Fonds [UitZicht 2014-33]; Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen [B20140050]; Stichting Blindenhulp	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Fonds (Dutch Diabetes Fund); Landelijke Stichting voor Blinden en Slechtzienden; Novartis Fonds; St. MD Fonds; Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp	In memory of the authors' dear friend and colleague, Joanna Wisniewska-Kruk (1986-2016), who will always be remembered with a smile. The authors thank Dr. R. A. Hoebe of the Cellular Imaging Core Facility (University of Amsterdam, Amsterdam, The Netherlands) for his advice with respect to quantification of vascular density and help with making the supplemental video and Dr. A. Jonker (Department of Medical Biology, AMC, Amsterdam, The Netherlands) for designing the ImageJ macro to determine the length of the vascular sprouting front. The mouse strain used for this research project, B6; 129S5-Plvap<SUP>tm1Lex</SUP>/Mmucd, identification number 032525-UCD, was obtained from the Mutant Mouse Regional Resource Center (MMRRC), a U.S. National Institutes of Health-funded strain repository, and was donated to the MMRRC by Genentech. This study was made possible by the financial support of the Diabetes Fonds (Dutch Diabetes Fund, Grant 2014.00.1784) and by the following foundations: Landelijke Stichting voor Blinden en Slechtzienden, Novartis Fonds, and St. MD Fonds, which contributed through UitZicht (Grant UitZicht 2014-33); the Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen (Grant B20140050); and Stichting Blindenhulp. This study was published with the help of Edmond en Marianne Blaauw Fonds voor Oogheelkunde. The funding organizations had no role in the design or conduct of this research. They provided unrestricted grants. The authors declare no conflicts of interest.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-279; Chow BW, 2017, NEURON, V93, P1325, DOI 10.1016/j.neuron.2017.02.043; Elkadri A, 2015, CELL MOL GASTROENTER, V1, P381, DOI 10.1016/j.jcmgh.2015.05.001; Felinski EA, 2005, CURR EYE RES, V30, P949, DOI 10.1080/02713680500263598; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gardner TW, 1996, BIOCHEM J, V320, P717, DOI 10.1042/bj3200717; Gariano RF, 2003, PROG RETIN EYE RES, V22, P295, DOI 10.1016/S1350-9462(02)00062-9; Gerhardt H, 2005, EXP SUPPL, V94, P3; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3; Hofman P, 2001, OPHTHALMIC RES, V33, P156, DOI 10.1159/000055663; Hofman P, 2000, CURR EYE RES, V21, P637, DOI 10.1076/0271-3683(200008)21:2;1-V;FT637; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Kowluru RA, 1998, DIABETES, V47, P464, DOI 10.2337/diabetes.47.3.464; Kremer C, 1997, CANCER RES, V57, P3852; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LEENSTRA S, 1993, CANCER, V72, P3061, DOI 10.1002/1097-0142(19931115)72:10<3061::AID-CNCR2820721031>3.0.CO;2-6; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Luo Y, 2011, INVEST OPHTH VIS SCI, V52, P7556, DOI 10.1167/iovs.11-7185; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Niemela H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254; RISAU W, 1990, TRENDS NEUROSCI, V13, P174, DOI 10.1016/0166-2236(90)90043-A; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Schlingemann R., 1988, ANN NY ACAD SCI, V529, P111; SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71; Schlingemann RO, 1997, OPHTHALMIC RES, V29, P130, DOI 10.1159/000268007; Schlingemann RO, 1999, DIABETOLOGIA, V42, P596, DOI 10.1007/s001250051200; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2004, AM J PHYSIOL-HEART C, V286, pH1347, DOI 10.1152/ajpheart.00909.2003; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Umans RA, 2017, DEV BIOL, V425, P101, DOI 10.1016/j.ydbio.2017.03.017; van der Wijk AE, 2018, TISSUE CELL, V52, P42, DOI 10.1016/j.tice.2018.03.010; Wisniewska-Kruk J, 2016, AM J PATHOL, V186, P1044, DOI 10.1016/j.ajpath.2015.11.019; Witmer AN, 2002, INVEST OPHTH VIS SCI, V43, P849; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	51	8	8	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5320	5333		10.1096/fj.201801499RRR	http://dx.doi.org/10.1096/fj.201801499RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30698992	hybrid, Green Published			2022-12-26	WOS:000462888500056
J	Park, J; Selvam, B; Sanematsu, K; Shigemura, N; Shukla, D; Procko, E				Park, Jihye; Selvam, Balaji; Sanematsu, Keisuke; Shigemura, Noriatsu; Shukla, Diwakar; Procko, Erik			Structural architecture of a dimeric class C GPCR based on co-trafficking of sweet taste receptor subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); membrane trafficking; dimerization; directed evolution; molecular modeling; structural model; mutagenesis; deep mutational scan	EVOLUTIONARY CONSERVATION; HEPTAHELICAL DOMAIN; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; HUMAN T1R3; GLUTAMATE; ACTIVATION; EXPRESSION; IDENTIFICATION	Class C G protein-coupled receptors (GPCRs) are obligatory dimers that are particularly important for neuronal responses to endogenous and environmental stimuli. Ligand recognition through large extracellular domains leads to the reorganization of transmembrane regions to activate G protein signaling. Although structures of individual domains are known, the complete architecture of a class C GPCR and the mechanism of interdomain coupling during receptor activation are unclear. By screening a mutagenesis library of the human class C sweet taste receptor subunit T1R2, we enhanced surface expression and identified a dibasic intracellular retention motif that modulates surface expression and co-trafficking with its heterodimeric partner T1R3. Using a highly expressed T1R2 variant, dimerization sites along the entire subunit within all the structural domains were identified by a comprehensive mutational scan for co-trafficking with T1R3 in human cells. The data further reveal that the C terminus of the extracellular cysteine-rich domain needs to be properly folded for T1R3 dimerization and co-trafficking, but not for surface expression of T1R2 alone. These results guided the modeling of the T1R2-T1R3 dimer in living cells, which predicts a twisted arrangement of domains around the central axis, and a continuous folded structure between transmembrane domain loops and the cysteine-rich domains. These insights have implications for how conformational changes between domains are coupled within class C GPCRs.	[Park, Jihye; Procko, Erik] Univ Illinois, Dept Biochem, 315 Roger Adams Lab,600 South Mathews Ave, Urbana, IL 61801 USA; [Selvam, Balaji; Shukla, Diwakar] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Sanematsu, Keisuke; Shigemura, Noriatsu] Kyushu Univ, Res & Dev Ctr 5 Sense Devices, Sect Oral Neurosci, Grad Sch Dent Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Sanematsu, Keisuke; Shigemura, Noriatsu] Kyushu Univ, Res & Dev Ctr 5 Sense Devices, Div Sensory Physiol Med Applicat Sensing, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Kyushu University; Kyushu University	Procko, E (corresponding author), Univ Illinois, Dept Biochem, 315 Roger Adams Lab,600 South Mathews Ave, Urbana, IL 61801 USA.	procko@illinois.edu	Shukla, Diwakar/GRY-2518-2022	Shukla, Diwakar/0000-0003-4079-5381; Selvam, Balaji/0000-0002-7677-290X; Procko, Erik/0000-0002-0028-490X; Shigemura, Noriatsu/0000-0002-3061-6362	National Institutes of Health NIMH [R21MH113155]; JSPS KAKENHI [JP18K09523]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH113155] Funding Source: NIH RePORTER	National Institutes of Health NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health NIMH Award R21MH113155 (to E.P.) for development of deep mutational scanning in human cells and in part by JSPS KAKENHI Grant JP18K09523 (to K.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Ashikawa Y, 2011, PROTEIN SCI, V20, P1720, DOI 10.1002/pro.707; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Case DA, 2014, AMBER 14; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cheron JB, 2017, PROTEINS, V85, P332, DOI 10.1002/prot.25228; Christopher JA, 2015, J MED CHEM, V58, P6653, DOI 10.1021/acs.jmedchem.5b00892; Chun L, 2012, ACTA PHARMACOL SIN, V33, P312, DOI 10.1038/aps.2011.186; Cvicek V, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004805; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Gacasan SB, 2017, AIMS BIOPHYS, V4, P491, DOI 10.3934/biophy.2017.3.491; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Heredia JD, 2018, J IMMUNOL, V200, P3825, DOI 10.4049/jimmunol.1800343; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleffner R, 2017, BIOINFORMATICS, V33, P2765, DOI 10.1093/bioinformatics/btx283; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Koizumi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12947; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Leach K, 2017, PHARMACOL RES, V116, P105, DOI 10.1016/j.phrs.2016.12.006; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Levitz J, 2016, NEURON, V92, P143, DOI 10.1016/j.neuron.2016.08.036; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Maillet EL, 2015, CHEM SENSES, V40, P577, DOI 10.1093/chemse/bjv045; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Morini G, 2005, J MED CHEM, V48, P5520, DOI 10.1021/jm0503345; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nango E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25745; Nasrallah C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22729-4; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Norskov-Lauritsen L, 2015, FEBS LETT, V589, P588, DOI 10.1016/j.febslet.2015.01.019; Nuemket N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15530; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 2007, J BIOL CHEM, V282, P5310, DOI 10.1074/jbc.M609610200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanematsu K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22807; Sanematsu K, 2014, J BIOL CHEM, V289, P25711, DOI 10.1074/jbc.M114.560409; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Shimizu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100425; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Walters DE, 2006, J AGR FOOD CHEM, V54, P10129, DOI 10.1021/jf062359y; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Woo CH, 2015, MOL BIOL CELL, V26, P4280, DOI 10.1091/mbc.E15-06-0361; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Xue L, 2015, NAT CHEM BIOL, V11, P134, DOI [10.1038/nchembio.1711, 10.1038/NCHEMBIO.1711]; Yamniuk AP, 2016, J MOL BIOL, V428, P2860, DOI 10.1016/j.jmb.2016.05.014; Zhang C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600241; Zhang XJC, 2014, PROTEIN CELL, V5, P492, DOI 10.1007/s13238-014-0062-z	77	23	23	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4759	4774		10.1074/jbc.RA118.006173	http://dx.doi.org/10.1074/jbc.RA118.006173			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723160	hybrid, Green Published			2022-12-26	WOS:000463985600003
J	Tong, HC; Wang, XH; Dong, YZ; Hu, QQ; Zhao, ZY; Zhu, Y; Dong, LX; Bai, F; Dong, XZ				Tong, Huichun; Wang, Xinhui; Dong, Yuzhu; Hu, Qingqing; Zhao, Ziyi; Zhu, Yun; Dong, Linxuan; Bai, Fan; Dong, Xiuzhu			A Streptococcus aquaporin acts as peroxiporin for efflux of cellular hydrogen peroxide and alleviation of oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; hydrogen peroxide; oxidative stress; transcription regulation; bacteria; Streptococcus; H2O2 detoxification; H2O2-facilitator; H2O2-induced expression	PLASMA-MEMBRANE AQUAPORINS; WATER CHANNELS; LACTIC-ACID; OLIGOFERMENTANS; TRANSPORT; H2O2; RECONSTITUTION; PERMEABILITY; FACILITATE; GLYCEROL	Aquaporins (AQPs) are transmembrane proteins widely distributed in various organisms, and they facilitate bidirectional diffusion of water and uncharged solutes. The catalase-negative bacterium Streptococcus oligofermentans produces the highest H2O2 levels reported to date, which has to be exported to avoid oxidative stress. Here, we report that a S. oligofermentans aquaporin functions as a peroxiporin facilitating bidirectional transmembrane H2O2 transport. Knockout of this aquaporin homolog, So-AqpA, reduced H2O2 export by approximate to 50% and increased endogenous H2O2 retention, as indicated by the cellular H2O2 reporter HyPer. Heterologous expression of So-aqpA accelerated exogenous H2O2 influx into Saccharomyces cerevisiae and Escherichia coli cells, indicating that So-AqpA acts as an H2O2-transferring aquaporin. Alanine substitution revealed Phe-40 as a key residue for So-AqpA-mediated H2O2 transport. Northern blotting, qPCR, and luciferase reporter assays disclosed that H2O2 induces a >10-fold expression of So-aqpA. Super-resolution imaging showed that H2O2 treatment increases So-AqpA protein molecules per cell by 1.6- to 3-fold. Inactivation of two redox-regulatory transcriptional repressors, PerR and MntR, reduced H2O2-induced So-aqpA expression to 1.8- and 4-fold, respectively. Electrophoretic mobility shift assays determined that MntR, but not PerR, binds to the So-aqpA promoter, indicating that MntR directly regulates H2O2-induced So-aqpA expression. Importantly, So-aqpA deletion decreased oxic growth and intraspecies competition and diminished the competitive advantages of S. oligofermentans over the caries pathogen Streptococcus mutans. Of note, So-aqpA orthologs with the functionally important Phe-40 are present in all streptococci. Our work has uncovered an intrinsic, H2O2-inducible bacterial peroxiporin that has a key physiological role in H2O2 detoxification in S. oligofermentans.	[Tong, Huichun; Wang, Xinhui; Dong, Yuzhu; Hu, Qingqing; Dong, Linxuan; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Tong, Huichun; Wang, Xinhui; Dong, Yuzhu; Hu, Qingqing; Dong, Xiuzhu] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Zhao, Ziyi; Zhu, Yun; Bai, Fan] Peking Univ, Sch Life Sci, Biomed Pioneering Innovat Ctr BIOPIC, 5 Yiheyuan Rd, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Tong, HC; Dong, XZ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China.; Tong, HC; Dong, XZ (corresponding author), Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China.	tonghuichun@im.ac.cn; dongxz@im.ac.cn	ZHAO, ZIYI/AAG-5359-2022; Dong, Xiuzhu/EBF-2196-2022; ZHAO, ZIYI/AFK-7002-2022	ZHAO, ZIYI/0000-0002-0811-2782; Dong, Xiuzhu/0000-0002-6926-5459; ZHAO, ZIYI/0000-0002-0811-2782	National Natural Science Foundation of China [31370098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China Grant No. 31370098. The authors declare that they have no conflicts of interest with the contents of this article.	Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; Al Ghouleh I, 2013, CARDIOVASC RES, V97, P134, DOI 10.1093/cvr/cvs295; Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bi CS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00412; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Bienert GP, 2013, BIOCHEM J, V454, P559, DOI 10.1042/BJ20130388; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Calamita G, 2000, MOL MICROBIOL, V37, P254, DOI 10.1046/j.1365-2958.2000.02016.x; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Calamita G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00851; Chen ZY, 2017, J BIOL CHEM, V292, P5519, DOI 10.1074/jbc.M116.764126; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lim JB, 2014, J MICROBIOL METH, V106, P33, DOI 10.1016/j.mimet.2014.07.038; Liu L, 2012, APPL ENVIRON MICROB, V78, P2120, DOI 10.1128/AEM.07539-11; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Medrano-Fernandez I, 2016, ANTIOXID REDOX SIGN, V24, P1031, DOI 10.1089/ars.2016.6636; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mosca AF, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110207; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rodrigues C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122090; Rodrigues O, 2017, P NATL ACAD SCI USA, V114, P9200, DOI 10.1073/pnas.1704754114; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; Verdoucq L, 2008, BIOCHEM J, V415, P409, DOI 10.1042/BJ20080275; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Wang XH, 2014, APPL ENVIRON MICROB, V80, P2351, DOI 10.1128/AEM.00064-14; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang YB, 2012, BIOPHYS CHEM, V160, P69, DOI 10.1016/j.bpc.2011.07.006	49	12	12	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4583	4595		10.1074/jbc.RA118.006877	http://dx.doi.org/10.1074/jbc.RA118.006877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30705089	hybrid, Green Published			2022-12-26	WOS:000462969500025
J	Accioly, T; Sousa, JO; Moreau, PA; Lecuru, C; Silva, BDB; Roy, M; Gardes, M; Baseia, IG; Martin, MP				Accioly, Thiago; Sousa, Julieth O.; Moreau, Pierre-Arthur; Lecuru, Christophe; Silva, Bianca D. B.; Roy, Melanie; Gardes, Monique; Baseia, Iuri G.; Martin, Maria P.			Hidden fungal diversity from the Neotropics: Geastrum hirsutum, G. schweinitzii (Basidiomycota, Geastrales) and their allies	PLOS ONE			English	Article							GUIANA SHIELD; CONSERVATION; BIODIVERSITY; AMAZONIA; RECORDS; DELIMITATION; TAXONOMY	Taxonomy of Geastrum species in the neotropics has been subject to divergent opinions among specialists. In our study, type collections were reassessed and compared with recent collections in order to delimit species in Geastrum, sect. Myceliostroma, subsect. Epigaea. A thorough review of morphologic features combined with barcode and phylogenetic analyses (ITS and LSU nrDNA) revealed six new species (G. neoamericanum, G. rubellum, G. brunneocapillatum, G. baculicrystallum, G. rubropusillum and G. courtecuissei). In additon, the presence of hairs on the exoperidium, a commonly used feature to diagnose Geastrum species, proved to be ineffective because it is a derived character within subsect. Epigaea.	[Accioly, Thiago; Sousa, Julieth O.] Univ Fed Rio Grande do Norte, Programa Posgrad Sistemat & Evolucao, Natal, RN, Brazil; [Moreau, Pierre-Arthur] Univ Lille, UFR Pharm, IMPECS EA4483, Lille, France; [Lecuru, Christophe] Univ Lille, UFR Pharm, Herbarium LIP, Lille, France; [Silva, Bianca D. B.] Univ Fed Bahia, Inst Biol, Dept Bot, Salvador, BA, Brazil; [Roy, Melanie; Gardes, Monique] Univ Toulouse 3 Paul Sabatier, Lab Evolut & Diversite Biol EDB UMR5174, Toulouse, France; [Baseia, Iuri G.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Natal, RN, Brazil; [Martin, Maria P.] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain	Universidade Federal do Rio Grande do Norte; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universidade Federal da Bahia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidade Federal do Rio Grande do Norte; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Martin, MP (corresponding author), Real Jardin Bot CSIC, Dept Micol, Madrid, Spain.	maripaz@rjb.csic.es	Sousa, Julieth/AAR-1504-2021; Martín, María/HDL-9512-2022; MOREAU, PIERRE-ARTHUR/AAP-8248-2020; Martín, María/H-8069-2012	Martín, María/0000-0002-1235-4418; Silva, Bianca/0000-0002-8920-0652; Moreau, Pierre-Arthur/0000-0003-4783-3643; Sousa, Julieth/0000-0002-9874-5419; Accioly, Thiago/0000-0002-5880-9174	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil) [PVE/407474/2013-7]; French Laboratory of Excellence Labex TULIP [ANR-10-LABX-41, ANR-11-IDEX-0002-02]; French Laboratory of Excellence Labex CEBA [ANR-10-LABX-25-01]; National Forest Office (ONF, France); program ANR E-TRICEL (National Research Agency, France); DREAL Martinique (France); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); French Laboratory of Excellence Labex TULIP; French Laboratory of Excellence Labex CEBA; National Forest Office (ONF, France); program ANR E-TRICEL (National Research Agency, France)(French National Research Agency (ANR)); DREAL Martinique (France); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: (TA and JS) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) for the PhD scholarships awarded to Thiago Accioly and Julieth Sousa (PDSE-2017); (IGB and MPM) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil, Projeto Pesquisador Visitante Especial PVE/407474/2013-7, Maria P. Martin and Iuri G. Baseia); (PAM, MR and MG) The French Laboratories of Excellence Labex TULIP (ANR-10-LABX-41; ANR-11-IDEX-0002-02) and Labex CEBA (ANR-10-LABX-25-01), the National Forest Office (ONF, France), the program ANR E-TRICEL (National Research Agency, France) and the DREAL Martinique (France) provided financial support for this study. The authors would like to express their thanks to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) for the PhD scholarships awarded to Thiago Accioly and Julieth Sousa (PDSE-2017); to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil, Projeto Pesquisador Visitante Especial PVE/407474/2013-7, Maria P. Martin and Iuri G. Baseia). The authors are also thank Donis Alfredo for the photos from Kew ' s collections, Dr. Clark Ovrebo for the collection UFRN-Fungos 2851 from Costa Rica, Angelia Ottoni for the collection UFRN-Fungos 2844 from Acre state, Brazil, Marian Glenn for English revision, the curators of herbaria K, LIP and PC for having made collections available to them, Jean-Louis Cheype, Regis Courtecuisse, Francois Hairie, Jean-Pierre Fiard and Melanie Roy for providing interesting material from French West Indies. We are grateful to Sophie Manzi for help with molecular labwork, and we also thank Jonathan Dubousquet and Morgan Ada who have contributed to this work by conducting some DNA extractions and amplifications at the laboratory EDB. The French Laboratories of Excellence Labex TULIP (ANR-10-LABX-41; ANR-11-IDEX-0002-02) and Labex CEBA (ANR-10-LABX-25-01), the National Forest Office (ONF, France), the program ANR E-TRICEL (National Research Agency, France) and the DREAL Martinique (France) provided financial support for this study.	[Anonymous], 2002, ATLAS DE LOS COLORES; da Silva BDB, 2011, MYCOTAXON, V118, P355, DOI 10.5248/118.355; Baseia IG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167879; Bates ST, 2004, THESIS; Cabral TS, 2017, MYCOSCIENCE, V58, P344, DOI 10.1016/j.myc.2017.03.004; Cabral TS, 2014, PHYTOTAXA, V183, P239, DOI 10.11646/phytotaxa.183.4.3; Calonge FD., 1998, FLORA MICOLOGICA IBE, V3, P271; Calonge Francisco D., 2005, Anales del Jardin Botanico de Madrid, V62, P23; Zamora JC, 2016, PHYTOTAXA, V277, P297, DOI 10.11646/phytotaxa.277.3.10; Zamora JC, 2014, TAXON, V63, P477, DOI 10.12705/633.36; CRACRAFT J, 1988, SYST ZOOL, V37, P221, DOI 10.2307/2992369; Crous PW, 2018, PERSOONIA, V40, P240, DOI 10.3767/persoonia.2018.40.10; Crous PW, 2017, PERSOONIA, V39, P270, DOI 10.3767/persoonia.2017.39.11; Crous PW, 2016, PERSOONIA, V37, P218, DOI 10.3767/003158516X694499; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Fouquet A, 2012, SYST BIOL, V61, P461, DOI 10.1093/sysbio/syr130; Hawksworth D. L., 2001, International Journal of Medicinal Mushrooms, V3, P333, DOI 10.1615/IntJMedMushr.v3.i4.50; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Caffot MLH, 2016, MYCOSCIENCE, V57, P157, DOI 10.1016/j.myc.2015.08.004; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Juen L, 2012, BIODIVERS CONSERV, V21, P3507, DOI 10.1007/s10531-012-0377-0; Kasuya T, 2012, MYCOSCIENCE, V53, P411, DOI 10.1007/s10267-012-0186-z; KORNERUP A., 1967, Methuen handbook of colour.; Korshunova T, 2017, ZOOL SCR, V46, P683, DOI 10.1111/zsc.12253; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Martin M. P., 2018, Fungal Systematics and Evolution, V2, P57, DOI 10.3114/fuse.2018.02.05; Morawetz W, 2007, TAXON, V56, P1245, DOI 10.2307/25065916; Morrone J. J., 2001, THESIS, V3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naka LN, 2011, J BIOGEOGR, V38, P681, DOI 10.1111/j.1365-2699.2010.02443.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PONCE de LEON PATRICK, 1968, FIELDIANA BOT, V31, P303; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Silva BDB, 2015, MYCOSPHERE, V6, P459, DOI 10.5943/mycosphere/6/4/7; Sodhi NS, 2010, CONSERVATION BIOLOGY FOR ALL, P1; Sousa JO, 2015, MYCOSPHERE, V6, P501, DOI 10.5943/mycosphere/6/4/12; Sousa JD, 2014, MYCOTAXON, V129, P169, DOI 10.5248/129.169; Sousa JO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177873; Sunhede S., 1989, SYN FUNGORUM, V1, P534; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Trierveiler-Pereira L, 2012, PHYTOTAXA, V61, P37, DOI 10.11646/phytotaxa.61.1.3; Uehling JK, 2012, FUNGAL BIOL-UK, V116, P1263, DOI 10.1016/j.funbio.2012.09.004; Vondrak J, 2009, LICHENOLOGIST, V41, P571, DOI 10.1017/S0024282909008317; Wurdack KJ, 2017, PHYTOKEYS, P117, DOI 10.3897/phytokeys.86.14761; Zamora JC, 2015, PERSOONIA, V34, P130, DOI 10.3767/003158515X687443	49	14	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211388	10.1371/journal.pone.0211388	http://dx.doi.org/10.1371/journal.pone.0211388			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726262	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000065
J	Germer, S; Kleidon, A				Germer, Sonja; Kleidon, Axel			Have wind turbines in Germany generated electricity as would be expected from the prevailing wind conditions in 2000-2014?	PLOS ONE			English	Article							PERFORMANCE DECLINE; FARM; EFFICIENCY; ENERGY; WAKES	The planning of the energy transition from fossil fuels to renewables requires estimates for how much electricity wind turbines can generate from the prevailing atmospheric conditions. Here, we estimate monthly ideal wind energy generation from datasets of wind speeds, air density and installed wind turbines in Germany and compare these to reported actual yields. Both yields were used in a statistical model to identify and quantify factors that reduced actual compared to ideal yields. The installed capacity within the region had no significant influence. Turbine age and park size resulted in significant yield reductions. Predicted yields increased from 9.1 TWh/a in 2000 to 58.9 TWh/a in 2014 resulting from an increase in installed capacity from 5.7 GW to 37.6 GW, which agrees very well with reported estimates for Germany. The age effect, which includes turbine aging and possibly other external effects, lowered yields from 3.6 to 6.7% from 2000 to 2014. The effect of park size decreased annual yields by 1.9% throughout this period. However, actual monthly yields represent on average only 73.7% of the ideal yields, with unknown causes. We conclude that the combination of ideal yields predicted from wind conditions with observed yields is suitable to derive realistic estimates of wind energy generation as well as realistic resource potentials.	[Germer, Sonja; Kleidon, Axel] Max Planck Inst Biogeochem, Biospher Theory & Modelling Grp, Jena, Germany; [Germer, Sonja] Leibniz Inst Agr Engn & Bioecon, Potsdam, Germany	Max Planck Society; Leibniz Institut fur Agrartechnik und Biookonomie (ATB)	Germer, S (corresponding author), Max Planck Inst Biogeochem, Biospher Theory & Modelling Grp, Jena, Germany.; Germer, S (corresponding author), Leibniz Inst Agr Engn & Bioecon, Potsdam, Germany.	sonja@germerweb.com	Germer, Sonja/B-2601-2009	Germer, Sonja/0000-0002-2715-008X				AGEE-Stat, 2017, ZEITR ENTW ERN EN DE; Barthelmie RJ, 2013, APPL ENERG, V104, P834, DOI 10.1016/j.apenergy.2012.12.013; Barthelmie RJ, 2010, WIND ENERGY, V13, P573, DOI 10.1002/we.408; Barthelmie RJ, 2013, P IEEE, V101, P1010, DOI 10.1109/JPROC.2012.2204029; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BDB, 2016, BETR DAT; BEYER HG, 1994, J WIND ENG IND AEROD, V51, P303, DOI 10.1016/0167-6105(94)90065-5; Boccard N, 2009, ENERG POLICY, V37, P2679, DOI 10.1016/j.enpol.2009.02.046; Bollmeyer C, 2015, Q J ROY METEOR SOC, V141, P1, DOI 10.1002/qj.2486; Borsche M., 2016, ADV SCI RES, V13, P151, DOI [DOI 10.5194/asr-13-151-2016, 10.5194/asr-13-151-2016]; Carrillo C, 2013, RENEW SUST ENERG REV, V21, P572, DOI 10.1016/j.rser.2013.01.012; Delisle B, 2017, GYNAKOL PRAX, V42, P21; Emeis S, 2016, J PHYS CONF SER, V753, DOI 10.1088/1742-6596/753/9/092014; ENTSOE, 2015, YEARL STAT AD RETR 2, P66; European-Commission, 2012, EN ROADM 2050; GWEC GWEC, 2015, GLOB WIND 2015 REP A, P73; Jacobson MZ, 2012, P NATL ACAD SCI USA, V109, P15679, DOI 10.1073/pnas.1208993109; Kusiak A, 2010, RENEW ENERG, V35, P685, DOI 10.1016/j.renene.2009.08.019; McVicar TR, 2012, J HYDROL, V416, P182, DOI 10.1016/j.jhydrol.2011.10.024; Miller LM, 2011, EARTH SYST DYNAM, V2, P1, DOI 10.5194/esd-2-1-2011; Miller LM, 2016, P NATL ACAD SCI USA, V113, P13570, DOI 10.1073/pnas.1602253113; Miller LM, 2015, P NATL ACAD SCI USA, V112, P11169, DOI 10.1073/pnas.1408251112; Olauson J, 2017, WIND ENERGY, V20, P2049, DOI 10.1002/we.2132; Pieralli S, 2015, ENERGY, V90, P429, DOI 10.1016/j.energy.2015.07.055; R Core Team, 2021, R LANGUAGE ENV STAT; R Studio Team, 2016, RSTUDIO INT DEV ENV; REN21, 2016, REN 2016 GLOB STAT R; Staffell I, 2014, RENEW ENERG, V66, P775, DOI 10.1016/j.renene.2013.10.041; TheWindPowerNet, 2017, GERM COUNTR ONL ACC; Tobin I, 2015, CLIMATIC CHANGE, V128, P99, DOI 10.1007/s10584-014-1291-0; Vautard R, 2010, NAT GEOSCI, V3, P756, DOI [10.1038/ngeo979, 10.1038/NGEO979]	31	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211028	10.1371/journal.pone.0211028	http://dx.doi.org/10.1371/journal.pone.0211028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726244	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000045
J	Rastogi, S; Shah, S; Kumar, R; Vashisth, D; Akhtar, MQ; Kumar, A; Dwivedi, UN; Shasany, AK				Rastogi, Shubhra; Shah, Saumya; Kumar, Ritesh; Vashisth, Divya; Akhtar, Md Qussen; Kumar, Ajay; Dwivedi, Upendra Nath; Shasany, Ajit Kumar			Ocimum metabolomics in response to abiotic stresses: Cold, flood, drought and salinity	PLOS ONE			English	Article							PLANT-RESPONSES; MACROPHOMINA-PHASEOLINA; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; ESSENTIAL OIL; TOLERANCE; SALT; PROTEINS; GENOME; BASIL	Ocimum tenuiflorum is a widely used medicinal plant since ancient times and still continues to be irreplaceable due to its properties. The plant has been explored chemically and pharmacologically, however, the molecular studies have been started lately. In an attempt to get a comprehensive overview of the abiotic stress response in O. tenuiflorum, de novo transcriptome sequencing of plant leaves under the cold, drought, flood and salinity stresses was carried out. A comparative differential gene expression (DGE) study was carried out between the common transcripts in each stress with respect to the control. KEGG pathway analysis and gene ontology (GO) enrichment studies exhibited several modifications in metabolic pathways as the result of four abiotic stresses. Besides this, a comparative metabolite profiling of stress and control samples was performed. Among the cold, drought, flood and salinity stresses, the plant was most susceptible to the cold stress. Severe treatments of all these abiotic stresses also decreased eugenol which is the main secondary metabolite present in the O. tenuiflorum plant. This investigation presents a comprehensive analysis of the abiotic stress effects in O. tenuiflorum. Current study provides an insight to the status of pathway genes' expression that help synthesizing economically valuable phenylpropanoids and terpenoids related to the adaptation of the plant. This study identified several putative abiotic stress tolerant genes which can be utilized to either breed stress tolerant O. tenuiflorum through pyramiding or generating transgenic plants.	[Rastogi, Shubhra; Dwivedi, Upendra Nath] Univ Lucknow, Dept Biochem, Lucknow, Uttar Pradesh, India; [Shah, Saumya; Kumar, Ritesh; Vashisth, Divya; Akhtar, Md Qussen; Kumar, Ajay; Shasany, Ajit Kumar] Cent Inst Med & Aromat Plants, CSIR, Biotechnol Div, Lucknow, Uttar Pradesh, India	Lucknow University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Shasany, AK (corresponding author), Cent Inst Med & Aromat Plants, CSIR, Biotechnol Div, Lucknow, Uttar Pradesh, India.	ak.shasany@cimap.res.in	KUMAR, RITESH/AAT-4590-2020; Dwivedi, Upendra/AAM-7657-2021	KUMAR, RITESH/0000-0002-0055-6784; Dwivedi, Upendra/0000-0002-4053-2795; Akhtar, Md Qussen/0000-0002-5564-9961; Shah, Saumya/0000-0001-9569-2844	Science and Engineering Research Board [YSS/2014/001011]; Science and Engineering Research Board, New Delhi Eurofins Genomics India Pvt. Ltd (Bangalore, India) [YSS/2014/001011]	Science and Engineering Research Board; Science and Engineering Research Board, New Delhi Eurofins Genomics India Pvt. Ltd (Bangalore, India)	SR received Start Up Research Grant (Grant number-YSS/2014/001011) by Science and Engineering Research Board to conduct this study (http://www.serbonline.in/SERB/HomePage.do).SR designed, conceived, conducted the research plans and wrote the manuscript. SR, SS, RK, DV, MQA, AK performed the abiotic stress experiments and bioinformatics analysis. AKS and UND gave directions and suggestions for implementation of the experiments. All the authors have read and approved the final manuscript.; Science and Engineering Research Board, New Delhi is acknowledged for fund (Grant number-YSS/2014/001011) and Dept. of Biochemistry, University of Lucknow for laboratory space. Director, CSIR-CIMAP and CSIR Aroma Mission (HCP-0007) are also deeply acknowledged for providing laboratory facilities and instrumentation for smooth conduction of experiments. Eurofins Genomics India Pvt. Ltd (Bangalore, India) is acknowledged for NGS.	Akhtar MQ, 2017, PHYSIOL PLANTARUM, V160, P128, DOI 10.1111/ppl.12550; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Armstrong W., 2002, PLANT ROOTS HIDDEN H, P729, DOI [10.1201/9780203909423, DOI 10.1201/9780203909423.CH42]; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bai JH, 2016, J SCI FOOD AGR, V96, P3867, DOI 10.1002/jsfa.7583; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; Barnawal D, 2012, PLANT PHYSIOL BIOCH, V58, P227, DOI 10.1016/j.plaphy.2012.07.008; Barrett-Lennard EG, 2003, PLANT SOIL, V253, P35, DOI 10.1023/A:1024574622669; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein N, 2010, ANN APPL BIOL, V156, P167, DOI 10.1111/j.1744-7348.2009.00376.x; Bettaieb I, 2011, ACTA PHYSIOL PLANT, V33, P1103, DOI 10.1007/s11738-010-0638-z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bond DM, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0141-7; Bouchabke-Coussa O, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-125; Cao XF, 2016, BIOTECHNOL BIOTEC EQ, V30, P227, DOI 10.1080/13102818.2015.1136237; Chakhchar A, 2015, J PLANT INTERACT, V10, P252, DOI 10.1080/17429145.2015.1068386; Chauhan B. S., 2013, American Journal of Plant Sciences, V4, P989, DOI 10.4236/ajps.2013.45122; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; CHRISTIE PJ, 1994, PLANTA, V194, P541, DOI 10.1007/BF00714468; Daneshmand F, 2010, ACTA PHYSIOL PLANT, V32, P91, DOI 10.1007/s11738-009-0384-2; Dev N, 2011, J SCI RES, V3, P197, DOI [10.3329/jsr.v3i1.5409, DOI 10.3329/JSR.V3I1.5409]; DIOURTE M, 1995, PLANT PATHOL, V44, P196, DOI 10.1111/j.1365-3059.1995.tb02729.x; Ekren S, 2012, AGR WATER MANAGE, V109, P155, DOI 10.1016/j.agwat.2012.03.004; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Ghanbari A., 2013, International Journal of AgriScience, V3, P308; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gujjar Ranjit Singh, 2014, Indian Journal of Plant Physiology, V19, P306, DOI 10.1007/s40502-014-0121-8; Gupta B, 2013, PLANT BIOCH PHYSL, V1, pe108, DOI [10.4172/2329-9029.1000e108, DOI 10.4172/2329-9029.100, DOI 10.4172/2329-9029.1000E108]; Han YH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110300; Hao CC, 2013, AUSTRALAS PLANT PATH, V42, P393, DOI 10.1007/s13313-013-0202-6; Jha SK, 2016, CURR GENOMICS, V17, P315, DOI 10.2174/1389202917666160331202125; Jibran R, 2015, J EXP BOT, V66, P6849, DOI 10.1093/jxb/erv390; JOSHI R, 2016, FRONT PLANT SCI, V7, P1029, DOI DOI 10.3389/FPLS.2016.01029; Kavar T, 2008, MOL BREEDING, V21, P159, DOI 10.1007/s11032-007-9116-8; Khalid K. A., 2006, International Agrophysics, V20, P289; Komatsu S, 2014, MOL BIOL REP, V41, P1127, DOI 10.1007/s11033-013-2959-7; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061155; Li L, 2014, PHYSIOL MOL BIOL PLA, V20, P161, DOI 10.1007/s12298-014-0228-4; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-153; Liao YR, 2017, BIOTECHNOL BIOTEC EQ, V31, P51, DOI 10.1080/13102818.2016.1242377; Liu X, 2018, J EXP BOT, V69, P3949, DOI 10.1093/jxb/ery214; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mandoulakani BA, 2017, PHYTOCHEMISTRY, V139, P1, DOI 10.1016/j.phytochem.2017.03.006; Mayek-Perez N, 2002, PHYSIOL MOL PLANT P, V60, P185, DOI 10.1006/pmpp.2001.0388; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Munir S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31772; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Nanjo Y, 2013, J PROTEOME RES, V12, P4785, DOI 10.1021/pr4002349; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Oshino T, 2007, MOL GENET GENOMICS, V278, P31, DOI 10.1007/s00438-007-0229-x; Pandey V, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1150400; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Qin J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-409; Rai V, 2004, PLANT SCI, V167, P1159, DOI 10.1016/j.plantsci.2004.06.016; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Rastogi S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-588; Rastogi S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1640-z; Rastogi S, 2013, PLANT CELL PHYSIOL, V54, P1238, DOI 10.1093/pcp/pct073; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rubio-Cabetas MJ, 2018, J PLANT PHYSIOL, V228, P134, DOI 10.1016/j.jplph.2018.06.004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Selmar D, 2013, PLANT CELL PHYSIOL, V54, P817, DOI 10.1093/pcp/pct054; Shao HH, 2014, GENET MOL RES, V13, P10852, DOI 10.4238/2014.December.19.6; Shekoofeh E., 2012, African Journal of Biotechnology, V11, P2223; Solecka D, 1997, ACTA PHYSIOL PLANT, V19, P257, DOI 10.1007/s11738-997-0001-1; Sormani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028070; Tan XL, 2014, PROTEIN J, V33, P18, DOI 10.1007/s10930-013-9532-z; Taochy C, 2015, PLANT J, V83, P466, DOI 10.1111/tpj.12901; Maldonado-Calderon MT, 2012, PLANT SCI, V185, P208, DOI 10.1016/j.plantsci.2011.10.013; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Vashisth D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21598-1; Venkatakrishnan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057283; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wakasa Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-101; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wang SH, 2009, PLANT CELL PHYSIOL, V50, P1721, DOI 10.1093/pcp/pcp105; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Wu J, 2016, PLANT PATHOLOGY J, V32, P552, DOI 10.5423/PPJ.OA.06.2016.0141; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu ZZ, 2010, PLANT SIGNAL BEHAV, V5, P649, DOI 10.4161/psb.5.6.11398; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yang L, 2017, BIOL PLANTARUM, V61, P641, DOI 10.1007/s10535-017-0724-9; Yin XJ, 2015, J PROTEOMICS, V119, P183, DOI 10.1016/j.jprot.2015.02.004; Yu F, 2012, P NATL ACAD SCI USA, V109, P14693, DOI 10.1073/pnas.1212547109; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhan XQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2507-7; Zhang ZZ, 2014, BIOSCI BIOTECH BIOCH, V78, P1337, DOI 10.1080/09168451.2014.923292; Zhou XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115485; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	102	29	30	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210903	10.1371/journal.pone.0210903	http://dx.doi.org/10.1371/journal.pone.0210903			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726239	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000036
J	Surowka, G; Ogorzalek, M				Surowka, Grzegorz; Ogorzalek, Maciej			Resolution invariant wavelet features of melanoma studied by SVM classifiers	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS; CLASSIFICATION; DERMOSCOPY; MACHINE; SUPPORT	This article refers to the Computer Aided Diagnosis of the melanoma skin cancer. We derive wavelet-based features of melanoma from the dermoscopic images of pigmental skin lesions and apply binary C-SVM classifiers to discriminate malignant melanoma from dysplastic nevus. The aim of this research is to select the most efficient model of the SVM classifier for various image resolutions and to search for the best resolution-invariant wavelet bases. We show AUC as a function of the wavelet number and SVM kernels optimized by the Bayesian search for two independent data sets. Our results are compatible with the previous experiments to discriminate melanoma in dermoscopy images with ensembling and feed-forward neural networks.	[Surowka, Grzegorz; Ogorzalek, Maciej] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Krakow, Poland	Jagiellonian University	Surowka, G (corresponding author), Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Krakow, Poland.	grzegorz.surowka@uj.edu.pl		Ogorzalek, Maciej/0000-0003-3314-269X				Abbas Q, 2013, PATTERN RECOGN, V46, P86, DOI 10.1016/j.patcog.2012.07.027; Alquran H, 2017, IEEE JORDAN CONF APP; Amelard R, 2015, IEEE T BIO-MED ENG, V62, P820, DOI 10.1109/TBME.2014.2365518; Arrangoiz R, 2016, J CANC TREAT RES, V4, P1, DOI [10.11648/jjctr.20160401.11, DOI 10.11648/j.jctr.20160401.11]; Ashtami K, 2018, INT J RES APPL SCI E, V6; Barata C, 2014, IEEE SYST J, V8, P965, DOI 10.1109/JSYST.2013.2271540; Breiman L., 1996, BAGGING PREDICTORS M, P24; Celebi ME, 2007, COMPUT MED IMAG GRAP, V31, P362, DOI 10.1016/j.compmedimag.2007.01.003; Choudhury D, 2015, ANNU IEEE IND CONF; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini N, 2000, INTRO SUPPORT VECTOR; d'Amico M, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1155; Dreiseitl S, 2001, J BIOMED INFORM, V34, P28, DOI 10.1006/jbin.2001.10004; Garnavi R, 2012, IEEE T INF TECHNOL B, V16, P1239, DOI 10.1109/TITB.2012.2212282; Gautam D, 2015, ANNU IEEE IND CONF; Gilmore S, 2010, EXP DERMATOL, V19, P830, DOI 10.1111/j.1600-0625.2010.01112.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hof C, 2001, P SOC PHOTO-OPT INS, V4474, P9, DOI 10.1117/12.448645; Johr RH, 2002, CLIN DERMATOL, V20, P240, DOI 10.1016/S0738-081X(02)00236-5; Kassianos AP, 2015, BRIT J DERMATOL, V172, P1507, DOI 10.1111/bjd.13665; Khaled M, 2014, CISP 14 BMEI 14; Kuncheva L., 2014, COMBINING PATTERN CL; Maglogiannis I, 2006, LECT NOTES COMPUT SC, V3955, P214; Maglogiannis I, 2015, COMPUT METH PROG BIO, V118, P124, DOI 10.1016/j.cmpb.2014.12.001; Maglogiannis I, 2009, IEEE T INF TECHNOL B, V13, P721, DOI 10.1109/TITB.2009.2017529; Mahmoud K, 2011, 11 INT C HYBR INT SY, P680; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Masood A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/323268; Masood A, 2014, LECT NOTES COMPUT SC, V8835, P101, DOI 10.1007/978-3-319-12640-1_13; Maurya R, 2014, INT C COMP SUST GLOB; Mirzaalian H., 2012, 2012 IEEE Workshop on Mathematical Methods in Biomedical Image Analysis (MMBIA), P97, DOI 10.1109/MMBIA.2012.6164758; Mishra N. K., 2016, ARXIV160107843; Nayak J., 2015, INT J DATABASE THEOR, V8, P169, DOI [10.14257/ijdta.2015.8.1.18, DOI 10.14257/IJDTA.2015.8.1.18]; Oliveira RB, 2018, NEURAL COMPUT APPL, V29, P613, DOI 10.1007/s00521-016-2482-6; Patwardhan SV, 2003, COMPUT METH PROG BIO, V72, P223, DOI 10.1016/S0169-2607(02)00147-5; Rahman M, 2008, P 8 IEEE INT C BIOIN, P1, DOI DOI 10.1109/GLOCOM.2008.ECP.461; Rastgoo M, 2016, BIOSTEC 3 INT C BIOI; Rosado B, 2003, ARCH DERMATOL, V139, P361, DOI 10.1001/archderm.139.3.361; Satheesha T, 2012, INT J ADV TECHNOLOGY, V2; Sikorski J., 2004, PROCEEDINGS OF STUDE; Stanganelli I, 2005, ANTICANCER RES, V25, P4577; Stefanowski J, 2008, LECT NOTES COMPUT SC, V5182, P283, DOI 10.1007/978-3-540-85836-2_27; Surowka G., 2016, SCHEDAE INFORM, V25, P189; Surowka G, 2013, J THEORETICAL APPL C, V7, P7; Surowka G., 2006, BIOALGORITHMS MED SY, V2, P43; Surowka G, 2007, P EMBC07 LYON; Surowka G, 2016, LECT NOTES ARTIF INT, V9692, P655, DOI 10.1007/978-3-319-39378-0_56; Takruri M, 2014, AUTOMATIC RECOGNITIO	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211318	10.1371/journal.pone.0211318	http://dx.doi.org/10.1371/journal.pone.0211318			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726260	Green Submitted, gold, Green Published			2022-12-26	WOS:000457874000064
J	Pawlik, A; Ruminowicz-Stefaniuk, M; Frac, M; Mazur, A; Wielbo, J; Janusz, G				Pawlik, Anna; Ruminowicz-Stefaniuk, Marta; Frac, Magdalena; Mazur, Andrzej; Wielbo, Jerzy; Janusz, Grzegorz			The wood decay fungus Cerrena unicolor adjusts its metabolism to grow on various types of wood and light conditions	PLOS ONE			English	Article							CELLOBIOSE DEHYDROGENASE; PHENOTYPE MICROARRAYS; BROWN-ROT; DEGRADATION; LACCASE; DIVERSITY; MECHANISMS; ENZYMES	Cerrena unicolor is a wood-degrading basidiomycete with ecological and biotechnological importance. Comprehensive Biolog-based analysis was performed to assess the metabolic capabilities and sensitivity to chemicals of C. unicolor FCL139 growing in various sawdust substrates and light conditions. The metabolic preferences of the fungus towards utilization of specific substrates were shown to be correlated with the sawdust medium applied for fungus growth and the light conditions. The highest catabolic activity of C. unicolor was observed after fungus precultivation on birch and ash sawdust media. The fungus growing in the dark showed the highest metabolic activity which was indicated by capacity to utilize a broad spectrum of compounds and the decomposition of 74/95 of the carbon sources. In all the culture light conditions, p-hydroxyphenylacetic acid was the most readily metabolized compound. The greatest tolerance to chemicals was also observed during C. unicolor growth in darkness. The fungus was the most sensitive to nitrogen compounds and antibiotics, but more resistant to chelators. Comparative analysis of C. unicolor and selected wood-decay fungi from different taxonomic and ecological groups revealed average catabolic activity of the fungus. However, C. unicolor showed outstanding capabilities to catabolize salicin and arbutin. The obtained picture of C. unicolor metabolism showed that the fungus abilities to decompose woody plant material are influenced by various environmental factors.	[Pawlik, Anna; Ruminowicz-Stefaniuk, Marta; Janusz, Grzegorz] Marie Curie Sklodowska Univ, Dept Biochem, Lublin, Poland; [Frac, Magdalena] Polish Acad Sci, Inst Agrophys, Lublin, Poland; [Mazur, Andrzej; Wielbo, Jerzy] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Lublin, Poland	Maria Curie-Sklodowska University; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Maria Curie-Sklodowska University	Pawlik, A (corresponding author), Marie Curie Sklodowska Univ, Dept Biochem, Lublin, Poland.	anna.pawlik@poczta.umcs.lublin.pl	Wielbo, Jerzy/AAJ-1366-2020; Janusz, Grzegorz/D-4491-2013	Wielbo, Jerzy/0000-0001-9075-6132; Janusz, Grzegorz/0000-0002-2046-2806; Frac, Magdalena/0000-0001-9437-3139; Mazur, Andrzej/0000-0002-3503-7642; Ruminowicz-Stefaniuk, Marta/0000-0003-0384-747X; Pawlik, Anna/0000-0002-2991-758X	National Science Centre (Poland) [DEC-2014/15/B/NZ9/01990, DEC-2013/09/B/NZ9/01829]	National Science Centre (Poland)	This work was financially supported by the National Science Centre (Poland) based on the decision number DEC-2014/15/B/NZ9/01990 and DEC-2013/09/B/NZ9/01829 (GJ). https://ncn.gov.pl/.The Biolog analyses were performed using equipment purchased within the EU Operational Programme Eastern Poland 2007-2013 - Regional Laboratory of Renewable Energy, IA PAS. http://www.polskawschodnia.gov.pl/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes V, 2006, J CHEM TECHNOL BIOT, V81, P413, DOI 10.1002/jctb.1417; Atanasova L, 2010, J ZHEJIANG UNIV-SC B, V11, P151, DOI 10.1631/jzus.B1000007; Baldrian P, 2003, ENZYME MICROB TECH, V32, P78, DOI 10.1016/S0141-0229(02)00245-4; Belova OV, 2014, APPL BIOCHEM MICRO+, V50, P148, DOI 10.1134/S0003683814020057; Blanchette R. A, 1989, BIOL DEGRADATION WOO, P141; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Cragg SM, 2015, CURR OPIN CHEM BIOL, V29, P108, DOI 10.1016/j.cbpa.2015.10.018; Druzhinina IS, 2006, APPL ENVIRON MICROB, V72, P2126, DOI 10.1128/AEM.72.3.2126-2133.2006; ENEBAK SA, 1989, CAN J FOREST RES, V19, P225, DOI 10.1139/x89-031; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; Fuller KK, 2016, ADV GENET, V96, P1, DOI 10.1016/bs.adgen.2016.08.002; Green F, 1996, RECENT RES DEV PLANT, V1, P83; Gupte M, 2002, APPL MICROBIOL BIOT, V58, P46, DOI 10.1007/s002530100822; HARTIGAN JA, 1975, ANN STAT, V3, P573, DOI 10.1214/aos/1176343123; Hibi M, 2012, BIOCATAL AGRIC BIOTE, V1, P220, DOI 10.1016/j.bcab.2012.03.003; HILL EP, 1976, J GEN MICROBIOL, V95, P39, DOI 10.1099/00221287-95-1-39; Hori C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004759; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Janusz G, 2007, WORLD J MICROB BIOT, V23, P1459, DOI 10.1007/s11274-007-9390-y; Janusz G, 2018, MICROBIOL RES, V207, P256, DOI 10.1016/j.micres.2017.12.007; Janusz G, 2017, FEMS MICROBIOL REV, V41, P941, DOI 10.1093/femsre/fux049; Janusz G, 2016, ACTA BIOCHIM POL, V63, P223, DOI 10.18388/abp.2015_1235; Janusz G, 2015, WORLD J MICROB BIOT, V31, P121, DOI 10.1007/s11274-014-1769-y; Kachlishvili E, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-463; Karmakar M, 2013, APPL BIOCHEM MICRO+, V49, P395, DOI 10.1134/S0003683813040078; Ko KS, 1999, FEMS MICROBIOL LETT, V170, P181, DOI 10.1111/j.1574-6968.1999.tb13372.x; Krieglsteiner G.J., 2000, GROSSPILZE BADEN WUR; Kubicek C. P., 1987, BIOCHEM SOC SYMP, V54, P113; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; LINDEBERG G, 1952, PHYSIOL PLANTARUM, V5, P100, DOI 10.1111/j.1399-3054.1952.tb08234.x; Matuszewska A, 2016, ONCOL LETT, V11, P2009, DOI 10.3892/ol.2016.4220; Mester T, 2004, MYCOTA, V2, P355; Mizerska-Dudka M, 2015, INT J BIOL MACROMOL, V79, P459, DOI 10.1016/j.ijbiomac.2015.05.015; Monroy AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182530; Nagy LG, 2017, MOL BIOL EVOL, V34, P35, DOI 10.1093/molbev/msw238; Pawlik A, 2015, ACTA BIOCHIM POL, V62, P683, DOI 10.18388/abp.2015_1102; Pinzari F, 2016, RES MICROBIOL, V167, P710, DOI 10.1016/j.resmic.2016.05.008; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Robertson JB, 2013, P NATL ACAD SCI USA, V110, P21130, DOI 10.1073/pnas.1313369110; Roody W.C., 2003, MUSHROOMS W VIRGINIA; Schmoll M, 2011, ADV APPL MICROBIOL, V76, P27, DOI 10.1016/B978-0-12-387048-3.00002-7; Sulej J, 2015, APPL BIOCHEM BIOTECH, V176, P1638, DOI 10.1007/s12010-015-1667-2; Talbot NJ, 1996, FUNGAL GENET BIOL, V20, P254, DOI 10.1006/fgbi.1996.0040; Tisch D, 2010, APPL MICROBIOL BIOT, V85, P1259, DOI 10.1007/s00253-009-2320-1; Tryon R. C, 1939, CLUSTER ANAL CORRELA; WILDMAN HG, 1995, CAN J BOT, V73, pS907, DOI 10.1139/b95-338; Zhang H, 2017, P BIOCH, V66, P222	47	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211744	10.1371/journal.pone.0211744	http://dx.doi.org/10.1371/journal.pone.0211744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721259	Green Published, Green Submitted, gold			2022-12-26	WOS:000457746300026
J	Cetina-Heredia, P; Roughan, M; Liggins, G; Coleman, MA; Jeffs, A				Cetina-Heredia, Paulina; Roughan, Moninya; Liggins, Geoffrey; Coleman, Melinda A.; Jeffs, Andrew			Mesoscale circulation determines broad spatio-temporal settlement patterns of lobster	PLOS ONE			English	Article							WESTERN ROCK LOBSTER; EAST AUSTRALIAN CURRENT; NEW-SOUTH-WALES; JASUS-EDWARDSII; PANULIRUS-CYGNUS; SPINY LOBSTER; VERTICAL-DISTRIBUTION; PUERULUS SETTLEMENT; DIURNAL MIGRATION; LARVAL TRANSPORT	The influence of physical oceanographic processes on the dispersal of larvae is critical for understanding the ecology of species and for anticipating settlement into fisheries to aid long-term sustainable harvest. This study examines the mechanisms by which ocean currents shape larval dispersal and supply to the continental shelf-break, and the extent to which circulation determines settlement patterns using Sagmariasus verreauxi (Eastern Rock Lobster, ERL) as a model species. Despite the large range of factors that can impact larval dispersal, we show that within a Western Boundary Current system, mesoscale circulation explains broad spatio-temporal patterns of observed settlement including inter-annual and decadal variability along 500 km of coastline. To discern links between ocean circulation and settlement, we correlate a unique 21-year dataset of observed lobster settlement (i.e., early juvenile & pueruli abundance), with simulated larval settlement. Simulations use outputs of an eddy-resolving, data-assimilated, hydrodynamic model, incorporating ERL spawning strategy and larval duration. The latitude where the East Australian Current (EAC) deflects east and separates from the continent determines the limit between regions of low and high ERL settlement. We found that years with a persistent EAC flow have low settlement while years when mesoscale eddies prevail have high settlement; in fact, mesoscale eddies facilitate the transport of larvae to the continental shelf-break from offshore. Proxies for settlement based on circulation features observed with satellites could therefore be useful in predicting broadscale patterns of settlement orders of magnitudes to guide harvest limits.	[Cetina-Heredia, Paulina; Roughan, Moninya] UNSW Australia, Sch Math & Stat, Reg & Coastal Oceanog Lab, Sydney, NSW, Australia; [Liggins, Geoffrey] NSW Fisheries, Dept Primary Ind, Sydney, NSW, Australia; [Coleman, Melinda A.] NSW Fisheries, Dept Primary Ind, Coffs Harbour, NSW, Australia; [Coleman, Melinda A.] Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Jeffs, Andrew] Univ Auckland, Inst Marine Sci, Auckland, New Zealand; [Jeffs, Andrew] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	University of New South Wales Sydney; NSW Department of Primary Industries; NSW Department of Primary Industries; Southern Cross University; University of Auckland; University of Auckland	Cetina-Heredia, P (corresponding author), UNSW Australia, Sch Math & Stat, Reg & Coastal Oceanog Lab, Sydney, NSW, Australia.	p.cetinaheredia@unsw.edu.au	Roughan, Moninya/B-5563-2009; Jeffs, Andrew G/D-9474-2012	Roughan, Moninya/0000-0003-3825-7533; 	Australian Research Council [LP150100064]; OECD Co-operative Research Programme Fellowship; NSW Department of Primary Industries	Australian Research Council(Australian Research Council); OECD Co-operative Research Programme Fellowship; NSW Department of Primary Industries	The research was supported by the Australian Research Council Linkage Project No. LP150100064 to MR, MAC, AJ and GL, and an OECD Co-operative Research Programme Fellowship to AJ. The NSW Department of Primary Industries supports the Linkage grant and the collection of the lobster settlement data.; The NSW Department of Primary Industries and shareholders in the NSW Rock Lobster Fishery. The research was supported by the Australian Research Council Linkage Project No. LP150100064 to MR, MAC, AJ and GL, and an OECD Co-operative Research Programme Fellowship to AJ. This research is a contribution to the Worldwide Universities Network project; Ocean Eddies in a Changing Climate: Understanding the Impact of Coastal Climates and Fisheries Production.	Adcroft A, 1997, MON WEATHER REV, V125, P2293, DOI 10.1175/1520-0493(1997)125<2293:ROTBSC>2.0.CO;2; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Booth J D., 2017, DISTRIBUTION PHYLLOS; Bradford RW, 2005, NEW ZEAL J MAR FRESH, V39, P593, DOI 10.1080/00288330.2005.9517338; BREEN PA, 1989, NEW ZEAL J MAR FRESH, V23, P519, DOI 10.1080/00288330.1989.9516387; Briones-Fourzan P, 2008, LIMNOL OCEANOGR, V53, P970, DOI 10.4319/lo.2008.53.3.0970; Bull CYS, 2017, J GEOPHYS RES-OCEANS, V122, P9980, DOI 10.1002/2017JC013311; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Butler MJ, 2007, LOBSTERS BIOL MANAGE, P263; CAPUTI N, 1995, CRUSTACEANA, V68, P213, DOI 10.1163/156854095X01376; Caputi N, 2008, FISH OCEANOGR, V17, P147, DOI 10.1111/j.1365-2419.2008.00471.x; Cetina-Heredia P, 2014, J GEOPHYS RES-OCEANS, V119, P4351, DOI 10.1002/2014JC010071; Cetina-Heredia P, 2015, GLOBAL CHANGE BIOL, V21, P4377, DOI 10.1111/gcb.13063; Chiswell S, MAR ECOL PROG SER, V183, P227; Coleman MA, 2017, GLOBAL CHANGE BIOL, V23, P3533, DOI 10.1111/gcb.13634; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; de Lestang S, 2015, ICES J MAR SCI, V72, P49, DOI 10.1093/icesjms/fsu177; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V139, P33; Ehrhardt NM, 2010, FISH OCEANOGR, V19, P434, DOI 10.1111/j.1365-2419.2010.00555.x; Everett JD, 2017, FISH OCEANOGR, V26, P513, DOI 10.1111/fog.12213; Feng M, 2011, CAN J FISH AQUAT SCI, V68, P1182, DOI 10.1139/F2011-065; Fitzgibbon Q, 2014, THERMAL TOLERANCE NE, P173; Funes-Rodriguez R, 2015, T AM FISH SOC, V144, P1192, DOI 10.1080/00028487.2015.1083474; Gardner C, 2001, MAR FRESHWATER RES, V52, P1271, DOI 10.1071/MF01032; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; Griffin DA, 2001, MAR FRESHWATER RES, V52, P1187, DOI 10.1071/MF01181; Harrison CS, 2014, LIMNOL OCEANOGR FLUI, V4, P50, DOI DOI 10.1215/21573689-2689820; Hinojosa IA, 2017, FISH OCEANOGR, V26, P49, DOI 10.1111/fog.12185; Incze LS, 2000, FISH OCEANOGR, V9, P99, DOI 10.1046/j.1365-2419.2000.00125.x; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Jeffs AG, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P259; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; LEE TN, 1994, B MAR SCI, V54, P621; Liggins GW., 2016, E ROCK LOBSTER SAGMA; Lindo-Atichati D, 2012, MAR ECOL PROG SER, V463, P245, DOI 10.3354/meps09860; Linnane A, 2014, ICES J MAR SCI, V71, P528, DOI 10.1093/icesjms/fst176; Linnane A, 2010, FISH RES, V105, P163, DOI 10.1016/j.fishres.2010.04.001; Linnane A, 2010, FISH OCEANOGR, V19, P290, DOI 10.1111/j.1365-2419.2010.00544.x; Liu YG, 2007, J ATMOS OCEAN TECH, V24, P2093, DOI 10.1175/2007JTECHO511.1; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Monroy P, 2017, ICES J MAR SCI, V74, P1763, DOI 10.1093/icesjms/fsw235; Montgomery S S, 2003, EFFECTS MOON PHASE S, P847; Montgomery SS, 2005, NEW ZEAL J MAR FRESH, V39, P619, DOI 10.1080/00288330.2005.9517340; Montgomery SS, 2013, MAR BIOL RES, V9, P104, DOI 10.1080/17451000.2012.727436; Mullaney TJ, 2013, LIMNOL OCEANOGR, V58, P1546, DOI 10.4319/lo.2013.58.5.1546; Nakata H, 2000, ICES J MAR SCI, V57, P143, DOI 10.1006/jmsc.1999.0565; Oke PR, 2013, OCEAN MODEL, V67, P52, DOI 10.1016/j.ocemod.2013.03.008; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; Paris CB, 2002, DEEP-SEA RES PT I, V49, P1363, DOI 10.1016/S0967-0637(02)00033-X; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; Penn JW, 2015, ICES J MAR SCI, V72, P22, DOI 10.1093/icesjms/fsv057; Phillips BF, 2007, LOBSTERS BIOL MANAGE, P231; Provost EJ, 2017, GLOBAL CHANGE BIOL, V23, P353, DOI 10.1111/gcb.13414; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; RIMMER DW, 1979, MAR BIOL, V54, P109, DOI 10.1007/BF00386590; Roughan M, 2017, J GEOPHYS RES-OCEANS, V122, P2494, DOI 10.1002/2016JC012241; Roughan M, 2011, DEEP-SEA RES PT II, V58, P628, DOI 10.1016/j.dsr2.2010.06.004; Rykova T, 2017, OCEAN MODEL, V114, P1, DOI 10.1016/j.ocemod.2017.03.013; Schaeffer A, 2014, J GEOPHYS RES-OCEANS, V119, P4922, DOI 10.1002/2013JC009735; Simons RD, 2015, DEEP-SEA RES PT I, V100, P34, DOI 10.1016/j.dsr.2015.02.002; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; Sloyan BM, 2016, J PHYS OCEANOGR, V46, P993, DOI 10.1175/JPO-D-15-0052.1; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Wahle R, 1991, RECRUITMENT HABITATS, P231; Wahle RA, 1997, J EXP MAR BIOL ECOL, V217, P179, DOI 10.1016/S0022-0981(97)00055-5; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]; Wilkin JL, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003590; Woodings LN, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3443-7; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Yeung C, 2001, INFLUENCE COASTAL ED, P1217	72	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211722	10.1371/journal.pone.0211722	http://dx.doi.org/10.1371/journal.pone.0211722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707747	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900043
J	Khalil, Y; Flower, K; Siddique, KHM; Ward, P				Khalil, Yaseen; Flower, Ken; Siddique, Kadambot H. M.; Ward, Phil			Rainfall affects leaching of pre-emergent herbicide from wheat residue into the soil	PLOS ONE			English	Article							CONSERVATION AGRICULTURE; CROP RESIDUES; METOLACHLOR; VOLATILIZATION; MOISTURE; MULCH; TEMPERATURE; DISSIPATION; TRIFLURALIN; DEGRADATION	No-tillage with stubble retention is a widely used cropping system for its conservation and yield benefits. The no-tillage farming system in southern Australia relies heavily on herbicides for weed management, but heavy crop residues may have a negative impact on the activity of pre-emergent herbicides applied. Any herbicide intercepted by the crop residue may not reach the soil surface without timely rainfall and may dissipate due to volatilisation, photo-degradation and/ or microbial activity. Two experiments were carried out to investigate the interception of prosulfocarb, pyroxasulfone, and trifluralin herbicides by wheat residue and retention following simulated rainfall. For the first experiment, there were four simulated rainfall amounts (0, 5, 10, and 20 mm), three intensities (5, 10, and 20 mm h(-1)) and five application times (immediately after spraying herbicide, 6 h, 1, 7, and 14 days after spraying). In the second experiment, 20 mm of rainfall was applied at 10 mm h(-1) in either 4 x 5 mm rainfall events over two days, 2 x 10 mm rainfall events over one day, or a single 20 mm rainfall event, with a no-rainfall control treatment. Bioassays were used to assess the herbicide activity/availability in the soil and remaining on the residue, using cucumber (Cucumis sativus L.) and Italian ryegrass (Lolium multiflorum Lam.) as indicator plants. At higher rainfall amounts, most of the herbicide leached from the stubble into the soil soon after application; more so with rain in one event rather than multiple events. However, the intensity of rainfall had no effect. Pyroxasulfone leached easily from the residue to the soil to potentially offer good weed control, prosulfocarb had an intermediary leaching effect, while only a small amount of trifluralin leached from stubble after rain. Therefore, in no-tillage situations with large amounts of crop residue present on the soil surface, herbicides that leach easily from the residue should be considered, like pyroxasulfone.	[Khalil, Yaseen; Flower, Ken; Siddique, Kadambot H. M.; Ward, Phil] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia; [Khalil, Yaseen; Flower, Ken; Siddique, Kadambot H. M.] Univ Western Australia, Inst Agr, Perth, WA, Australia; [Ward, Phil] CSIRO, Wembley, WA, Australia	University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Khalil, Y (corresponding author), Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia.; Khalil, Y (corresponding author), Univ Western Australia, Inst Agr, Perth, WA, Australia.	yaseen.khalil@uwa.edu.au	Siddique, Kadambot H.M./B-3462-2011; Flower, Ken/H-1748-2012; Ward, Phil/A-2623-2008	Siddique, Kadambot H.M./0000-0001-6097-4235; Ward, Phil/0000-0002-1748-1133; Flower, Kenneth/0000-0002-7477-9921; Khalil, Yaseen/0000-0002-4156-2486	Australian Centre for International Agricultural Research/John Allwright Fellowship; University of Western Australia (UWA) Institute of Agriculture; UWA School of Agriculture and Environment; Australian Herbicide Resistance Initiative; Syngenta Australia	Australian Centre for International Agricultural Research/John Allwright Fellowship(Australian Ctr Intl Agr Res); University of Western Australia (UWA) Institute of Agriculture; UWA School of Agriculture and Environment; Australian Herbicide Resistance Initiative; Syngenta Australia(Syngenta)	Australian Centre for International Agricultural Research/John Allwright Fellowship for providing the PhD scholarship, The University of Western Australia (UWA) Institute of Agriculture, the UWA School of Agriculture and Environment and Faculty of Science for providing the operation fund and experimentation facilities, Australian Herbicide Resistance Initiative and Syngenta Australia for their support and providing herbicides. The Faculty of Science for awarding Scholarship for International Research Fees and Underwood PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam S, 2015, PEST MANAG SCI, V71, P278, DOI 10.1002/ps.3803; BANKS PA, 1986, WEED SCI, V34, P607, DOI 10.1017/S0043174500067527; BANKS PA, 1982, WEED SCI, V30, P164, DOI 10.1017/S0043174500062263; Bedos C, 2006, ENVIRON POLLUT, V144, P958, DOI 10.1016/j.envpol.2006.01.043; Beulke S, 2002, PEST MANAG SCI, V58, P45, DOI 10.1002/ps.419; Boutsalis P, 2014, WEED TECHNOL, V28, P332, DOI 10.1614/WT-D-13-00094.1; Carbonari CA, 2016, WEED SCI, V64, P201, DOI 10.1614/WS-D-14-00171.1; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Congreve M, 2015, PREEM HERB AUSTR; Coppens F, 2006, EUR J SOIL SCI, V57, P894, DOI 10.1111/j.1365-2389.2006.00783.x; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; EDWARDS WM, 1992, SOIL SCI SOC AM J, V56, P52, DOI 10.2136/sssaj1992.03615995005600010008x; Fletcher AL, 2015, AGR SYST, V136, P114, DOI 10.1016/j.agsy.2015.03.004; Gaston LA, 2001, SOIL SCI, V166, P681, DOI 10.1097/00010694-200110000-00004; Gennari M, 2002, J ENVIRON SCI HEAL B, V37, P297, DOI 10.1081/PFC-120004471; GHADIRI H, 1984, WEED SCI, V32, P24, DOI 10.1017/S0043174500058458; Granovsky AV, SOIL TILLAGE RES; GRASS B, 1994, CHEMOSPHERE, V28, P491, DOI 10.1016/0045-6535(94)90293-3; Harries M, 2015, CROP PASTURE SCI, V66, P634, DOI 10.1071/CP14221; Haskins B., 2012, USING PREEMERGENT HE; Hermsmeier LF, 1963, CONSTRUCTION OPERATI; Isensee AR, CHEMOSPHERE; Issa S, 2005, PEST MANAG SCI, V61, P126, DOI 10.1002/ps.951; Kassam A, 2012, FIELD CROP RES, V132, P7, DOI 10.1016/j.fcr.2012.02.023; Khalil Y, 2018, CROP PASTURE SCI, V69, P606, DOI 10.1071/CP18026; Kleemann S, 2015, SEEDING SYSTEMS PREE; Lamoreaux RJ, 1993, BRIGHT CROP PROT C W; Lewis KA, 2015, HERTFORDSHIRE; MCDOWELL LL, 1985, T ASAE, V28, P1896; MEYER L. D., 1960, Soil Science Society of America. Proceedings, V24, P319; Nichols V, 2015, FIELD CROP RES, V183, P56, DOI 10.1016/j.fcr.2015.07.012; Payne R.W., 2009, GENSTAT WINDOWS, V12nd; Prueger JH, 1999, J ENVIRON QUAL, V28, P75, DOI 10.2134/jeq1999.00472425002800010008x; Rainbow R, 2011, RAINFED FARMING SYST, P991, DOI [10.1007/978-1-4020-9132-2_39, DOI 10.1007/978-1-4020-9132-2_39]; Rayment G.E., 2011, SOIL CHEM METHODS; REDDY KN, 1995, J AGR FOOD CHEM, V43, P2752, DOI 10.1021/jf00058a038; Rodrigues B. N., 1993, Planta Daninha, V11, P21, DOI 10.1590/S0100-83581993000100004; Rusinamhodzi L, 2011, AGRON SUSTAIN DEV, V31, P657, DOI 10.1007/s13593-011-0040-2; Selim HM, 2003, J ENVIRON QUAL, V32, P1445, DOI 10.2134/jeq2003.1445; Serraj R, 2012, FIELD CROP RES, V132, P1, DOI 10.1016/j.fcr.2012.03.002; Shaner DL, 2013, INTERACTIONS HERBICI; Singh N, 2002, CHEMOSPHERE, V47, P409, DOI 10.1016/S0045-6535(01)00322-8; Somasegaran P., 1985, METHODS LEGUME RHIZO; Taylor-Lovell S, 2002, J AGR FOOD CHEM, V50, P5626, DOI 10.1021/jf011486l; Unger P. W., 1994, MANAGING AGR RESIDUE; Verhulst N, 2010, ADV SOIL SCI-SER, P137; Watts DW, 1996, SOIL TILL RES, V39, P241, DOI 10.1016/S0167-1987(96)01058-6; Westra EP, 2014, WEED TECHNOL, V28, P72, DOI 10.1614/WT-D-13-00047.1; Williams J. L. Jr., 1978, ASA [American Society of Agronomy] Special Publication, P165; WILLIS GH, 1987, REV ENVIRON CONTAM T, V100, P23; WILLIS GH, 1992, J AGR FOOD CHEM, V40, P1086, DOI 10.1021/jf00018a036; Zhou M, 2003, VADOSE ZONE J, V2, P231, DOI 10.2113/2.2.231	52	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0210219	10.1371/journal.pone.0210219	http://dx.doi.org/10.1371/journal.pone.0210219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707698	gold, Green Published, Green Submitted			2022-12-26	WOS:000457742900005
J	Menec, VH; Newall, NE; Mackenzie, CS; Shooshtari, S; Nowicki, S				Menec, Verena H.; Newall, Nancy E.; Mackenzie, Corey S.; Shooshtari, Shahin; Nowicki, Scott			Examining individual and geographic factors associated with social isolation and loneliness using Canadian Longitudinal Study on Aging (CLSA) data	PLOS ONE			English	Article							OLDER-ADULTS; RISK-FACTORS; COGNITIVE FUNCTION; FOLLOW-UP; HEALTH; MEN; PREDICTORS; PEOPLE; AGE; DISADVANTAGE	Background A large body of research shows that social isolation and loneliness have detrimental health consequences. Identifying individuals at risk of social isolation or loneliness is, therefore, important. The objective of this study was to examine personal (e.g., sex, income) and geographic (rural/urban and sociodemographic) factors and their association with social isolation and loneliness in a national sample of Canadians aged 45 to 85 years. Methods The study involved cross-sectional analyses of baseline data from the Canadian Longitudinal Study on Aging that were linked to 2016 census data at the Forward Sortation Area (FSA) level. Multilevel logistic regression analyses were conducted to examine the association between personal factors and geographic factors and social isolation and loneliness for the total sample, and women and men, respectively. Results The prevalence of social isolation and loneliness was 5.1% and 10.2%, respectively, but varied substantially across personal characteristics. Personal characteristics (age, sex, education, income, functional impairment, chronic diseases) were significantly related to both social isolation and loneliness, although some differences emerged in the direction of the relationships for the two measures. Associations also differed somewhat for women versus men. Associations between some geographic factors emerged for social isolation, but not loneliness. Living in an urban core was related to increased odds of social isolation, an effect that was no longer significant when FSA-level factors were controlled for. FSAs with a higher percentage of 65+ year old residents with low income were consistently associated with higher odds of social isolation. Conclusion The findings indicate that socially isolated individuals are, to some extent, clustered into areas with a high proportion of low-income older adults, suggesting that support and resources could be targeted at these areas. For loneliness, the focus may be less on where people live, but rather on personal characteristics that place individuals at risk.	[Menec, Verena H.; Shooshtari, Shahin; Nowicki, Scott] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Newall, Nancy E.] Brandon Univ, Dept Psychol, Brandon, MB, Canada; [Mackenzie, Corey S.] Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada	University of Manitoba; Brandon University; University of Manitoba	Menec, VH (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.	verena.menec@umanitoba.ca			Government of Canada through the Canadian Institutes of Health Research (CIHR) [LSA 9447]; Canada Foundation for Innovation; CIHR [373098]; CLSA [170303]	Government of Canada through the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); CLSA	This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 9447 and the Canada Foundation for Innovation. This research has been conducted using the CLSA Baseline Tracking Dataset 3.2, Baseline Comprehensive Dataset 3.1, under Application Number 170303. The CLSA is led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland. The analyses presented in this paper were funded by a CIHR grant (#373098) to VHM.; This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 9447 and the Canada Foundation for Innovation. This research has been conducted using the CLSA Baseline Tracking Dataset 3.2, Baseline Comprehensive Dataset 3.1, under Application Number 170303. The CLSA is led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland.; The analyses presented in this paper were funded by a CIHR grant (#373098).	Anderson K, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0684-6; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Antonucci TC, 2014, GERONTOLOGIST, V54, P82, DOI 10.1093/geront/gnt118; Avlund K, 2008, EUR J AGEING, V5, P191, DOI 10.1007/s10433-008-0086-4; Barlow MA, 2015, HEALTH PSYCHOL, V34, P870, DOI 10.1037/hea0000182; Beutel ME, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1262-x; Boss L, 2015, INT PSYCHOGERIATR, V27, P541, DOI 10.1017/S1041610214002749; Brown EG, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13031; Burr JA, 2013, J AGING HEALTH, V25, P191, DOI 10.1177/0898264312464497; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616; Child ST, 2019, AGING MENT HEALTH, V23, P196, DOI 10.1080/13607863.2017.1399345; Cloutier-Fisher D, 2009, GENDER PLACE CULT, V16, P181, DOI 10.1080/09663690902795787; CLSA, 2017, DAT SUPP MAT FORW SO; Cohen-Mansfield J, 2016, INT PSYCHOGERIATR, V28, P557, DOI 10.1017/S1041610215001532; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; Coyle CE, 2017, J AGING HEALTH, V29, P128, DOI 10.1177/0898264315624909; Cudjoe TKM, 2020, J GERONTOL B-PSYCHOL, V75, P107, DOI 10.1093/geronb/gby037; Dahlberg L, 2015, AGING MENT HEALTH, V19, P409, DOI 10.1080/13607863.2014.944091; de Jong Gierveld J., 1998, REV CLIN GERONTOLOGY, V8, P73, DOI DOI 10.1017/S0959259898008090; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; DEJONGGIERVELD J, 1987, J PERS SOC PSYCHOL, V53, P119, DOI 10.1037/0022-3514.53.1.119; Dickens AP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-647; du Plessis V., 2002, AGR RURAL WORKING PA; Dykstra PA, 2009, EUR J AGEING, V6, P91, DOI 10.1007/s10433-009-0110-3; Ferreira-Alves J, 2014, ARCH GERONTOL GERIAT, V59, P613, DOI 10.1016/j.archger.2014.06.010; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Finlay JM, 2018, SOC SCI MED, V208, P25, DOI 10.1016/j.socscimed.2018.05.010; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gierveld JD, 2015, CAN J AGING, V34, P125, DOI 10.1017/S0714980815000070; Goodman A., 2015, HIDDEN CITIZENS CAN; Grenade L, 2008, AUST HEALTH REV, V32, P468, DOI 10.1071/AH080468; Harasemiw O, 2019, AGING MENT HEALTH, V23, P1413, DOI 10.1080/13607863.2018.1495176; Harasemiw O, 2018, RES AGING, V40, P715, DOI 10.1177/0164027517734587; Havens B, 2004, CAN J AGING, V23, P129, DOI 10.1353/cja.2004.0022; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Ibrahim R, 2013, PSYCHOGERIATRICS, V13, P71, DOI 10.1111/psyg.12000; Jang YR, 2016, J AGING HEALTH, V28, P3, DOI 10.1177/0898264315584578; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kirkland SA, 2015, CAN J AGING, V34, P366, DOI 10.1017/S071498081500029X; Kobayashi KM, 2009, J AGING HEALTH, V21, P374, DOI 10.1177/0898264308329022; Lang FR, 2002, PSYCHOL AGING, V17, P125, DOI 10.1037//0882-7974.17.1.125; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Lundholm E, 2015, J POPUL AGEING, V8, P173, DOI 10.1007/s12062-015-9117-z; Marr E, 2015, J RURAL COMMUNITY D, V10, P100; Martin-Matthews A, 2011, CAN J AGING, V30, P339, DOI 10.1017/S0714980811000201; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Menec V, 2015, J AGING SOC POLICY, V27, P173, DOI 10.1080/08959420.2014.995044; Menec VH, 2011, CAN J AGING, V30, P479, DOI 10.1017/S0714980811000237; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Mistry R, 2001, INT J GERIATR PSYCH, V16, P950, DOI 10.1002/gps.447; Newall N, 2015, J AGING HEALTH, V27, P500, DOI 10.1177/0898264314552420; Nicolaisen M, 2014, AGING MENT HEALTH, V18, P194, DOI 10.1080/13607863.2013.821457; Novek S, 2014, AGEING SOC, V34, P1052, DOI 10.1017/S0144686X1200150X; Paul C, 2003, EUR PSYCHOL, V8, P160, DOI 10.1027//1016-9040.8.3.160; Peplau L.A., 1982, LONELINESS SOURCEBOO, DOI DOI 10.2307/2068915; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Rafnsson S. B, 2017, J GERONTOL B-PSYCHOL, DOI [10.1093/geronb/gbx087, DOI 10.1093/GERONB/GBX087]; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; Routasalo PE, 2006, GERONTOLOGY, V52, P181, DOI 10.1159/000091828; Savikko N, 2005, ARCH GERONTOL GERIAT, V41, P223, DOI 10.1016/j.archger.2005.03.002; Scharf T, 2008, EUR J AGEING, V5, P103, DOI 10.1007/s10433-008-0080-x; Shankar A, 2013, PSYCHOSOM MED, V75, P161, DOI 10.1097/PSY.0b013e31827f09cd; Statistics Canada, 2017, POSTAL CODEOM CONVER; Statistics Canada, 2015, LOW INC CUT OFFS; Statistics Canada, 2017, POP CTR RUR AR CLASS; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Thapa DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205665; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; WHO, 2007, GLOB AG FRIENDL CIT; Winterton R, 2011, RURAL SOC, V20, P187, DOI 10.5172/rsj.20.2.187	73	70	71	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211143	10.1371/journal.pone.0211143	http://dx.doi.org/10.1371/journal.pone.0211143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2LM	30707719	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900018
J	Zhang, J; Liu, L; Tao, J; Song, YL; Fan, YM; Gou, ML; Xu, JG				Zhang, Jing; Liu, Lin; Tao, Jie; Song, Yanlin; Fan, Yimeng; Gou, Maling; Xu, Jianguo			Prognostic role of early D-dimer level in patients with acute ischemic stroke	PLOS ONE			English	Article							DEGRADATION-PRODUCT D; HEMOSTATIC BIOMARKERS; PLASMINOGEN-ACTIVATOR; RISK; MORTALITY; BURDEN	Object The purpose of our study was to assess the prognostic role of early D-dimer level in patients with acute ischemic stroke (AIS). Methods The included patients' D-dimer levels have to be tested within 24 hours from stroke onset. Poor functional outcome was defined as modified Rankin Scale (mRS) >= 3. The endpoints included recurrence on 5-day diffusion-weighted imaging, 30-day mRS >= 3, 30-day mortality and 90-day mRS >= 3. Regarding to each endpoint, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the prognostic role of D-dimer in patients with AIS. Results A total of 2,479 patients were included. The results showed that elevated D-dimer levels were associated with recurrence on 5-day diffusion-weighted imaging (OR = 2.28, 95% CI = 1.32-3.95), 30-day mRS >= 3 (OR = 1.59, 95% CI = 1.37-1.85), 30-day mortality (OR = 1.92, 95% CI = 1.27-2.90) and 90-day mRS >= 3 (OR = 1.61, 95% CI = 1.05-2.46). Conclusions In conclusion, for patients with AIS, higher D-dimer level within 24 hours from stroke onset was associated with recurrence on 5-day diffusion-weighted imaging, mortality at 30 days, and poor functional outcome at both 30 days and 90 days. However, more studies are warranted to clarify this issue.	[Zhang, Jing; Song, Yanlin; Fan, Yimeng; Xu, Jianguo] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Zhang, Jing; Song, Yanlin; Fan, Yimeng; Xu, Jianguo] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China; [Liu, Lin] Neijiang Hosp Tradit Chinese Med, Dept Neurosurg, Neijiang, Sichuan, Peoples R China; [Tao, Jie; Gou, Maling] Sichuan Univ, West China Hosp, Ctr Canc, Dept Biotherapy, Chengdu, Sichuan, Peoples R China; [Tao, Jie; Gou, Maling] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Xu, JG (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.; Xu, JG (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Sichuan, Peoples R China.	jianguo_1229@126.com						Abdel Ghani AA, 2011, EGYPT J NEUROL PSYCH, V48, P215, DOI DOI 10.4103/1110-1083.192656; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Barber M, 2006, STROKE, V37, P1113, DOI 10.1161/01.STR.0000209240.63821.1a; Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Csala M, 1998, SCAND J IMMUNOL, V48, P269; Dougu N, 2011, J CLIN NEUROL, V7, P197, DOI 10.3988/jcn.2011.7.4.197; FISHER M, 1990, ARCH NEUROL-CHICAGO, V47, P1075, DOI 10.1001/archneur.1990.00530100037011; Goldenberg NA, 2013, J PEDIATR-US, V162, P1041, DOI 10.1016/j.jpeds.2012.11.035; Haapaniemi E, 2009, ACTA NEUROL SCAND, V119, P141, DOI 10.1111/j.1600-0404.2008.01081.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu PJ, 2016, CEREBROVASC DIS, V42, P117, DOI 10.1159/000445037; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kang DW, 2009, STROKE, V40, P1653, DOI 10.1161/STROKEAHA.108.539429; Lai PT, 2012, J CHIN MED ASSOC, V75, P513, DOI 10.1016/j.jcma.2012.07.005; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Park SY, 2013, CRIT CARE, V17, DOI 10.1186/cc12564; Rallidis LS, 2008, ACTA NEUROL SCAND, V117, P415, DOI 10.1111/j.1600-0404.2007.00971.x; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Shibazaki K, 2009, INTERNAL MED, V48, P1601, DOI 10.2169/internalmedicine.48.2166; Sienkiewicz-Jarosz H, 2009, NEUROL NEUROCHIR POL, V43, P126; Specogna AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096743; Squizzato A, 2006, BLOOD COAGUL FIBRIN, V17, P303, DOI 10.1097/01.mbc.0000224850.57872.d0; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Ustundag M, 2010, NOBEL MED, V6, P37; Urbach H, 2002, NEURORADIOLOGY, V44, P695, DOI 10.1007/s00234-002-0762-6; Wang J, 2016, J STROKE CEREBROVASC, V25, P2011, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.031; Wannamethee SG, 2012, STROKE, V43, P1206, DOI 10.1161/STROKEAHA.111.636373; Welsh P, 2009, CEREBROVASC DIS, V27, P247, DOI 10.1159/000196823; Whiteley W, 2012, STROKE, V43, P86, DOI 10.1161/STROKEAHA.111.634089; Yang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089756; Yew KS, 2015, AM FAM PHYSICIAN, V91, P528	33	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211458	10.1371/journal.pone.0211458	http://dx.doi.org/10.1371/journal.pone.0211458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707716	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900027
J	Xi, JX; Zhao, WZ				Xi, Jinxiang; Zhao, Weizhong			Correlating exhaled aerosol images to small airway obstructive diseases: A study with dynamic mode decomposition and machine learning	PLOS ONE			English	Article							CANCER-DIAGNOSIS; DEPOSITION; REDUCTION; NANOPARTICLE; TRANSPORT; PATTERNS; BEHAVIOR; GROWTH; TUMOR	Background Exhaled aerosols from lungs have unique patterns, and their variation can be correlated to the underlying lung structure and associated abnormities. However, it is challenging to characterize such aerosol patterns and differentiate their difference because of their complexity. This challenge is even greater for small airway diseases, where the disturbance signals are weak. Objectives and methods The objective of this study is exploiting different feature extraction algorithms to develop a practical classifier to diagnose obstructive lung diseases using exhaled aerosol images. These include proper orthogonal decomposition (POD), principal component analysis (PCA), dynamic mode decomposition (DMD), and DMD with control (DMDC). Aerosol images were generated via physiology-based simulations in one normal and four diseased airway models in G7-9 bronchioles. The image data were classified using both the support vector machine (SVM) and random forest (RF) algorithms. The effectiveness of different features was evaluated by classification accuracy and misclassification rate. Findings Results show a significantly higher performance using dynamic feature extractions (DMD and DMDC) than static algorithms (POD and PCA). Adding the control variables to DMD further improved classification accuracy. Comparing the classification methods, RF persistently outperformed SVM for all types of features considered. While the performance of RF constantly increased with the number of features retained, the performance of SVM peaked at 50 and decreased thereafter. The 5-class classification accuracy was 94.8% using the DMDC-RF model and 93.0% using the DMD-RF model, both of which were higher than 87.0% in the previous study that used fractal dimension features. Conclusion Considering that disease progression is inherently a dynamic process, DMD(C)-based feature extraction preserves temporal information and is preferred over POD and PCA. Compared with hand-crafted features like fractals, feature extraction by DMD and DMDC is automatic and more accurate.	[Xi, Jinxiang] Calif Baptist Univ, Dept Biomed Engn, Riverside, CA 92504 USA; [Xi, Jinxiang] Calif Baptist Univ, Dept Aerosp & Mech Engn, Riverside, CA 92504 USA; [Zhao, Weizhong] Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA	California Baptist University; California Baptist University; US Food & Drug Administration (FDA)	Xi, JX (corresponding author), Calif Baptist Univ, Dept Biomed Engn, Riverside, CA 92504 USA.; Xi, JX (corresponding author), Calif Baptist Univ, Dept Aerosp & Mech Engn, Riverside, CA 92504 USA.	jxi@calbaptist.edu	Xi, Jinxiang/Y-1161-2019					Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Akervik E, 2007, J FLUID MECH, V579, P305, DOI 10.1017/S0022112007005492; [Anonymous], 1994, Ann ICRP, V24, P1; Berg EJ, 2010, J BIOMECH, V43, P1039, DOI 10.1016/j.jbiomech.2009.12.019; Berger E, 2015, ADV ROBOTICS, V29, P331, DOI 10.1080/01691864.2014.981292; BERKOOZ G, 1993, ANNU REV FLUID MECH, V25, P539, DOI 10.1146/annurev.fl.25.010193.002543; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Boyle KR, 2006, IEEE T ANTENN PROPAG, V54, P231, DOI 10.1109/TAP.2005.861537; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brunton BW, 2016, J NEUROSCI METH, V258, P1, DOI 10.1016/j.jneumeth.2015.10.010; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Erichson NB, 2019, J REAL-TIME IMAGE PR, V16, P1479, DOI 10.1007/s11554-016-0655-2; HEISTRACHER T, 1995, J AEROSOL SCI, V26, P497, DOI 10.1016/0021-8502(94)00113-D; Hemon P, 2007, J WIND ENG IND AEROD, V95, P21, DOI 10.1016/j.jweia.2006.04.003; Hua JC, 2016, PHYSICA A, V448, P172, DOI 10.1016/j.physa.2015.12.059; Kim JW, 2013, INT J NUMER METH BIO, V29, P17, DOI 10.1002/cnm.2490; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Longest PW, 2007, J AEROSOL SCI, V38, P111, DOI 10.1016/j.jaerosci.2006.09.007; Mann J, 2016, QUANT FINANC, V16, P1643, DOI 10.1080/14697688.2016.1170194; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Proctor JL, 2016, SIAM J APPL DYN SYST, V15, P142, DOI 10.1137/15M1013857; Proctor JL, 2015, INT HEALTH, V7, P139, DOI 10.1093/inthealth/ihv009; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Richard L, 2018, SPACE WEATHER, V16, P569, DOI [10.1029/2018SW001840, DOI 10.1029/2018SW001840]; Rowley CW, 2009, J FLUID MECH, V641, P115, DOI 10.1017/S0022112009992059; Rowley CW, 2005, INT J BIFURCAT CHAOS, V15, P997, DOI 10.1142/S0218127405012429; Schmid P, 2011, THEOR COMP FLUID DYN, V25, P249, DOI 10.1007/s00162-010-0203-9; Sharma H, 2017, COMPUT MED IMAG GRAP, V61, P2, DOI 10.1016/j.compmedimag.2017.06.001; Si XHA, 2013, RESP PHYSIOL NEUROBI, V186, P22, DOI 10.1016/j.resp.2012.12.005; Susuki Y, 2011, IEEE T POWER SYST, V26, P1894, DOI 10.1109/TPWRS.2010.2103369; Suzuki K, 2017, RADIOL PHYS TECHNOL, V10, P257, DOI 10.1007/s12194-017-0406-5; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; Tu J.H., 2014, J COMPUT DYN, V1, P391, DOI [10.3934/jcd.2014.1.391, DOI 10.3934/JCD.2014.1.391]; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; Wilcox DC, 2008, AIAA J, V46, P2823, DOI 10.2514/1.36541; WILSON TA, 1967, NATURE, V213, P668, DOI 10.1038/213668a0; Longest PW, 2007, AEROSOL SCI TECH, V41, P380, DOI 10.1080/02786820701203223; Xi J, 2015, J AEROSOL SCI; Xi JX, 2008, J APPL PHYSIOL, V104, P1761, DOI 10.1152/japplphysiol.01233.2007; Xi JX, 2007, ANN BIOMED ENG, V35, P560, DOI 10.1007/s10439-006-9245-y; Xi JX, 2017, COMPUT BIOL MED, V87, P57, DOI 10.1016/j.compbiomed.2017.05.019; Xi JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139511; Xi JX, 2015, THERANOSTICS, V5, P443, DOI 10.7150/thno.11107; Xi JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104682; Xi JX, 2013, J AEROSOL SCI, V64, P24, DOI 10.1016/j.jaerosci.2013.06.003; Xi JX, 2009, AEROSOL SCI TECH, V43, P808, DOI 10.1080/02786820902950887; Yamashita R, 2018, INSIGHTS IMAGING, V9, P611, DOI [10.1007/s13244-018-0639-9, 10.1007/978-3-319-98666-1_1]; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Zhao WZ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S11-S11; Zhou MG, 2012, CLIN CHIM ACTA, V413, P1770, DOI 10.1016/j.cca.2012.07.006; Zou W, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S15	55	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211413	10.1371/journal.pone.0211413	http://dx.doi.org/10.1371/journal.pone.0211413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703132	gold, Green Submitted, Green Published			2022-12-26	WOS:000457301600039
J	Varghese, JS; Swaminathan, S; Kurpad, AV; Thomas, T				Varghese, Jithin Sam; Swaminathan, Sumathi; Kurpad, Anura V.; Thomas, Tinku			Demand and supply factors of iron-folic acid supplementation and its association with anaemia in North Indian pregnant women	PLOS ONE			English	Article							ENVIRONMENTAL ENTERIC DYSFUNCTION; DETERMINANTS	Anaemia prevalence in pregnant women of India declined from 57.9% to 50.3% from National Family Health Survey (NFHS)-3 to NFHS-4. However, over the course of that decade, the uptake of iron and folic acid (IFA) supplementation for 100 days of pregnancy improved by only 15%. To understand demand side risk factors of anaemia specifically related to IFA intake, an in-depth survey was conducted on pregnant women (n = 436) in 50 villages and wards of Sirohi district of Rajasthan, India. At the demand side, consistent IFA consumption in the previous trimester was inversely and strongly associated with anaemia (OR: 0.26, 95% CI: 0.12, 0.55). Reasons for inconsistent consumption included not registering to antenatal clinic, not receiving IFA tablets from the health worker and perceived lack of need. At the supply side, an analysis of IFA stock data at various levels of the health care (n = 168) providers from primary to tertiary levels showed that 14 out of 52 villages surveyed did not have access to IFA tablets. The closest availability of an IFA tablet for 16 villages, was more than 5 km away. To improve the uptake of IFA supplementation and thereby reduce iron deficiency anaemia in pregnant women, a constant supply of IFA at the village or sub-centre level, where frontline workers can promote uptake, should be ensured.	[Varghese, Jithin Sam; Swaminathan, Sumathi; Kurpad, Anura V.] St Johns Res Inst, Div Nutr, Bangalore, Karnataka, India; [Kurpad, Anura V.] St Johns Med Coll, Dept Physiol, Bangalore, Karnataka, India; [Thomas, Tinku] St Johns Med Coll, Dept Biostat, Bangalore, Karnataka, India	St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College	Thomas, T (corresponding author), St Johns Med Coll, Dept Biostat, Bangalore, Karnataka, India.	tinku.sarah@sjri.res.in	Varghese, Jithin Sam/GQA-5392-2022; Swaminathan, Sumathi/AGI-7678-2022	Thomas, Tinku/0000-0002-1786-6076; Varghese, Jithin Sam/0000-0003-3825-9897	Tata Trusts (RAPID MCN Study)	Tata Trusts (RAPID MCN Study)	This work was supported by Tata Trusts (RAPID MCN Study), www.tatatrusts.org.	Al Hasan SM, 2016, BMC NUTR, V2, P24, DOI [DOI 10.1186/S40795-016-0064-8, 10.1186/s40795-016-0064-8]; Anand T, 2014, NUTRITION, V30, P764, DOI 10.1016/j.nut.2013.11.022; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Government of India O of the RG& CC, 2011, CENS IND 2011 MET DA; Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S; International Institute for Population Sciences (IIPS) and ICF, 2017, NAT FAM HLTH SURV 4; Kapil Umesh, 2014, Natl Med J India, V27, P27; Lumley, 2021, ANAL COMPLEX SURVEY; Mariani R, 2009, MEDITERR J HEMATOL I, V1, DOI [10.4084/MMID.2009.006, 10.4084/MJHID.2009.006]; Mbuya MNN, 2016, MATERN CHILD NUTR, V12, P106, DOI 10.1111/mcn.12220; Mejia-Guevara I, 2015, J S ASIAN DEV, V10, P168, DOI 10.1177/0973174115588841; Mithra P, 2013, Afr Health Sci, V13, P880, DOI 10.4314/ahs.v13i4.3; Mukherjee MB, 1997, AM J HEMATOL, V55, P104, DOI 10.1002/(SICI)1096-8652(199706)55:2<104::AID-AJH9>3.0.CO;2-X; Musoke D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.36; National Imagery and Mapping Agency G and GD, 1984, TECHNICAL REPORT; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; NORDENBERG D, 1990, JAMA-J AM MED ASSOC, V264, P1556, DOI 10.1001/jama.264.12.1556; Ostlin O P., 2008, GLOB PUBLIC HLTH, V3; Pappagallo S, 1996, B WORLD HEALTH ORGAN, V74, P25; Petry N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110693; Prendergast AJ, 2015, CLIN INFECT DIS, V61, pS726, DOI 10.1093/cid/civ848; Puthuchira Ravi R, 2014, J SEX TRANSM DIS, V2014; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Rammohan A, 2012, ISRN PUBLIC HLTH, V2012, P1, DOI DOI 10.5402/2012/765476; Schultink W., 1996, FOOD NUTR B, V17; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Stuart Gillespie JK, 1991, 9 NUTR POL, V7, P21; Subramoney S, 2008, NICOTINE TOB RES, V10, P917, DOI 10.1080/14622200802027206; Thankachan P, 2008, AM J CLIN NUTR, V87, P881, DOI 10.1093/ajcn/87.4.881; Thankachan P, 2007, FOOD NUTR BULL, V28, P328, DOI 10.1177/156482650702800309; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 2015, GLOB PREV AN 2011	36	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210634	10.1371/journal.pone.0210634	http://dx.doi.org/10.1371/journal.pone.0210634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699167	gold, Green Submitted, Green Published			2022-12-26	WOS:000457155600044
J	Morales-Cano, D; Callejo, M; Barreira, B; Mondejar-Parreno, G; Esquivel-Ruiz, S; Ramos, S; Martin, MA; Cogolludo, A; Moreno, L; Perez-Vizcaino, F				Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Ramos, Sonia; Angeles Martin, Maria; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco			Elevated pulmonary arterial pressure in Zucker diabetic fatty rats	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; KV7 CHANNELS; HYPERTENSION; INSULIN; OBESITY; LEPTIN; ASSOCIATION; ACTIVATION; EXPRESSION; GUIDELINES	Diabetes is a very strong predictor of chronic systemic vascular diseases and acute cardiovascular events. Recently, associations between metabolic disorders and pulmonary hypertension have also been reported in both humans and animal models. In order to get some further insight into the relationship of pulmonary hypertension with obesity, insulin resistance and hyperglycemia, herein we have used the Zucker diabetic fatty rats (ZDF/clr-lepr fa) at 20 weeks fed a standard diet and compared to their lean Zucker littermates (ZL). ZDF rats were obese, had elevated plasma glucose levels and insulin resistance, i.e. a clinically relevant model of type 2 diabetes. They presented elevated systolic, diastolic and mean pulmonary arterial pressures and a parallel increase in the Fulton index. Systemic arterial pressures were also increased but the left ventricle plus septum weight was similar in both groups and the heart rate was reduced. Wall media thickening was observed in the small pulmonary arteries from the ZDF rats. Isolated pulmonary arteries mounted in a wire myograph showed similar vasoconstrictor responses to phenylephrine and 5-HT and similar responses to the endothelium-dependent vasodilator acetylcholine. However, the iNOS inhibitor 1400W enhanced the vasoconstrictor responses in ZDF but not in ZL rats. The protein expression of eNOS and iNOS was not significantly different in the lungs of the two groups. The lung expression of Bmpr2 mRNA was downregulated. However, the mRNA expression of Kcna5, Kcnk3, Kcnq1, Kcnq4 or Kcnq5, which encode for the potassium channels Kv1.5, TASK-1, Kv7.1, Kv7.4 and Kv7.5, respectively, was similar in ZL and ZDF rats. In conclusion, ZDF rats show increased pulmonary arterial pressure, right ventricular hypertrophy, pulmonary arterial medial thickening and downregulated lung Bmpr2 despite leptin resistance. These changes were mild but are consistent with the view that diabetes is a risk factor for pulmonary hypertension.	[Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco] Univ Complutense Madrid, Sch Med, Dept Pharmacol & Toxicol, Madrid, Spain; [Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco] Ciber Enfermedades Resp Ciberes, Madrid, Spain; [Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco] IISGM, Madrid, Spain; [Ramos, Sonia; Angeles Martin, Maria] CSIC, Inst Food Sci & Technol & Nutr ICTAN, Dept Metab & Nutr, Madrid, Spain; [Angeles Martin, Maria] Ciber Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Perez-Vizcaino, F (corresponding author), Univ Complutense Madrid, Sch Med, Dept Pharmacol & Toxicol, Madrid, Spain.; Perez-Vizcaino, F (corresponding author), Ciber Enfermedades Resp Ciberes, Madrid, Spain.; Perez-Vizcaino, F (corresponding author), IISGM, Madrid, Spain.	fperez@med.ucm.es	Cano, Daniel Morales/A-3550-2017; Perez-Vizcaino, Francisco/A-9735-2011; Martín, María/HDL-9512-2022; Moreno, Laura/A-9433-2010; Ramos, Sonia/K-4594-2012; Martín, Maria Angeles/C-5768-2014; Cogolludo, Angel/A-6129-2011	Cano, Daniel Morales/0000-0002-1692-4633; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Moreno, Laura/0000-0001-9028-2299; Ramos, Sonia/0000-0003-2649-2616; Martín, Maria Angeles/0000-0001-8173-4521; Mondejar Parreno, Gema/0000-0001-9514-8961; Barreira, Bianca/0000-0002-0338-8456	Ministerio de Economia y Competitividad (Mineco) [SAF2016-77222-R, AGL2015-67087-R]; Instituto de Salud Carlos III [PI15/01100]; European Union (Fondo Europeo de Desarrollo Regional FEDER); Universidad Complutense; Ciberes; Fundacion Contra la Hipertension Pulmonar (Enpathy); FPU grant from Ministerio de Educacion	Ministerio de Economia y Competitividad (Mineco); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union (Fondo Europeo de Desarrollo Regional FEDER)(European Commission); Universidad Complutense; Ciberes; Fundacion Contra la Hipertension Pulmonar (Enpathy); FPU grant from Ministerio de Educacion(German Research Foundation (DFG))	This study was supported by grants from Ministerio de Economia y Competitividad (Mineco, https://sede.micinn.gob.es SAF2016-77222-R to FPV and AC and AGL2015-67087-R to SR and MAM), Instituto de Salud Carlos III (www.isciii.es, PI15/01100 to LM), with funds from the European Union (Fondo Europeo de Desarrollo Regional FEDER). M.C., G.M-P. and S.E-R. are funded by Universidad Complutense (www.ucm.es) and Ciberes (www.Ciberes.org) grant with funds from Fundacion Contra la Hipertension Pulmonar (Enpathy, www.fchp.es) and a FPU grant from Ministerio de Educacion (www.mecd.gob.es), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951; Austin ED, 2014, CIRC RES, V115, P189, DOI 10.1161/CIRCRESAHA.115.303404; Benson L, 2014, PULM CIRC, V4, P311, DOI 10.1086/675994; Briancon-Marjollet A, 2016, EXP PHYSIOL, V101, P1432, DOI 10.1113/EP085783; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Corpe C, 2001, DIGESTION, V63, P116, DOI 10.1159/000051879; Corsetti JP, 2000, ATHEROSCLEROSIS, V148, P231, DOI 10.1016/S0021-9150(99)00265-8; Cui RZ, 2011, STROKE, V42, P2611, DOI 10.1161/STROKEAHA.111.614313; Ferreira L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/592760; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Huertas A, 2015, EUR RESPIR J, V45, P1066, DOI 10.1183/09031936.00193014; Huertas A, 2012, EUR RESPIR J, V40, P895, DOI 10.1183/09031936.00159911; Irwin DC, 2014, PULM CIRC, V4, P638, DOI 10.1086/678510; Kawaguchi M, 1999, EUR J ENDOCRINOL, V140, P341, DOI 10.1530/eje.0.1400341; Lesniewski LA, 2008, AM J PHYSIOL-HEART C, V294, pH1840, DOI 10.1152/ajpheart.00692.2007; Lopez-Lopez JG, 2008, AM J PHYSIOL-LUNG C, V295, pL727, DOI 10.1152/ajplung.90354.2008; Lopez-Lopez JG, 2011, J PHARMACOL EXP THER, V338, P400, DOI 10.1124/jpet.111.179515; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Mondejar-Parreno G, 2019, J PHYSIOL-LONDON, V597, P1185, DOI 10.1113/JP276054; Moral-Sanz J, 2014, CURR VASC PHARMACOL, V12, P473, DOI 10.2174/1570161112666140423222808; Moral-Sanz J, 2012, EXP PHYSIOL, V97, P676, DOI 10.1113/expphysiol.2011.062257; Moral-Sanz J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-51; Morales-Cano D, 2016, CLIN SCI, V130, P1823, DOI 10.1042/CS20160141; Morales-Cano D, 2015, CARDIOVASC RES, V106, P98, DOI 10.1093/cvr/cvv020; Morales-Cano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114492; Movahed MR, 2005, CHEST, V128, P3568, DOI 10.1016/S0012-3692(15)52932-2; Robbins IM, 2009, CHEST, V136, P31, DOI 10.1378/chest.08-2008; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Schleinitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016155; Segersvaerd R, 2008, OBESITY, V16, P23, DOI 10.1038/oby.2007.27; Tan Y, 2017, WORLD J GASTROENTERO, V23, P3805, DOI 10.3748/wjg.v23.i21.3805; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wong YY, 2011, EUR J HEART FAIL, V13, P1290, DOI 10.1093/eurjhf/hfr140; Yeh CH, 2009, HORM METAB RES, V41, P605, DOI 10.1055/s-0029-1220736; Zafrir B, 2013, RESP MED, V107, P139, DOI 10.1016/j.rmed.2012.10.019; Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508; Zimmet PZ, 2016, DIABETES CARE, V39, P878, DOI 10.2337/dc16-0273	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211281	10.1371/journal.pone.0211281	http://dx.doi.org/10.1371/journal.pone.0211281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689673	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800027
J	Porcacchia, P; de Toledo, PA; Rodriguez-Baena, A; Martin-Rodriguez, JF; Palomar, FJ; Vargas-Gonzalez, L; Jesus, S; Koch, G; Mir, P				Porcacchia, Paolo; Alvarez de Toledo, Paloma; Rodriguez-Baena, Antonio; Francisco Martin-Rodriguez, Juan; Palomar, Francisco J.; Vargas-Gonzalez, Laura; Jesus, Silvia; Koch, Giacomo; Mir, Pablo			Abnormal cerebellar connectivity and plasticity in isolated cervical dystonia	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA BURST STIMULATION; MOTOR CORTEX; SECONDARY; CIRCUIT; BRAIN; TASK	There is increasing evidence that supports the role of the cerebellum in the pathophysiology of dystonia. We used transcranial magnetic stimulation to test the hypothesis that patients with cervical dystonia may have a disrupted cerebellar cortical connectivity at rest, and that cerebellar plasticity is altered too. We enrolled 12 patients with isolated cervical dystonia and 13 controls. A paired-pulse transcranial magnetic stimulation protocol was applied over the right cerebellum and the left primary motor area. Changes in the amplitude of motor evoked potentials were analysed. Continuous and intermittent Theta Burst Stimulation over the cerebellum was also applied. The effects of these repetitive protocols on cortical excitability, on intra-cortical circuits and on cerebellar cortical inhibition were analysed. In healthy subjects, but not in dystonic patients, a conditioning stimulus over the cerebellum was able to inhibit the amplitude of the motor evoked potentials from primary motor cortex. In healthy subjects continuous and intermittent cerebellar Theta Burst Stimulation were able to decrease and increase respectively motor cortex excitability. Continuous Theta Burst Stimulation was able to abolish the cerebellar cortical inhibition observed in basal condition. These effects were not observed in patients with cervical dystonia. Cerebellar cortical connectivity and cerebellar plasticity is altered at rest in patients with cervical dystonia.	[Porcacchia, Paolo; Alvarez de Toledo, Paloma; Rodriguez-Baena, Antonio; Francisco Martin-Rodriguez, Juan; Palomar, Francisco J.; Vargas-Gonzalez, Laura; Jesus, Silvia; Mir, Pablo] Univ Seville, Unidad Trastornos Movimiento, Serv Neurol & Neurofisiol Clin, Inst Biomed Sevilla,Hosp Univ Virgen Rocio,CSIC, Seville, Spain; [Porcacchia, Paolo; Palomar, Francisco J.] Hosp Univ Virgen Rocio, Serv Neurol & Neurofisiol Clin, Unidad Neurofisiol Clin, Seville, Spain; [Koch, Giacomo] Univ Roma Tor Vergata, Dipartimento Neurosci, Clin Neurol, Rome, Italy; [Mir, Pablo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; University of Rome Tor Vergata; CIBERNED	Mir, P (corresponding author), Univ Seville, Unidad Trastornos Movimiento, Serv Neurol & Neurofisiol Clin, Inst Biomed Sevilla,Hosp Univ Virgen Rocio,CSIC, Seville, Spain.; Mir, P (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain.	pmir@us.es	Mir, Pablo/C-8662-2013; Termine, Cristinano/AAB-8366-2022; Palomar, Francisco J/N-3089-2018	Mir, Pablo/0000-0003-1656-302X; Martin Rodriguez, Juan Francisco/0000-0003-1392-8775; Porcacchia, Paolo/0000-0003-3879-286X; KOch, Giacomo/0000-0001-6155-9439; Palomar, Francisco J/0000-0002-6541-8243	Ministerio de Economia y Competitividad de Espana [SAF2007-60700]; Instituto de Salud Carlos III [CP08/00174, PI10/01674, PI13/01461]; Consejeria de Economia, Innovacion, Ciencia y Empresa de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471/2013]; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; Jaques and Gloria Gossweiler Foundation	Ministerio de Economia y Competitividad de Espana(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Economia, Innovacion, Ciencia y Empresa de la Junta de Andalucia; Consejeria de Salud y Bienestar Social de la Junta de Andalucia; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Jaques and Gloria Gossweiler Foundation	This research was supported by grants from the Ministerio de Economia y Competitividad de Espana (SAF2007-60700), the Instituto de Salud Carlos III (CP08/00174, PI10/01674, PI13/01461), the Consejeria de Economia, Innovacion, Ciencia y Empresa de la Junta de Andalucia (CVI-02526, CTS-7685), the Consejeria de Salud y Bienestar Social de la Junta de Andalucia (PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471/2013), the Sociedad Andaluza de Neurologia, the Fundacion Alicia Koplowitz, the Fundacion Mutua Madrilena and the Jaques and Gloria Gossweiler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio S, 2014, MOVEMENT DISORD, V29, P1185, DOI 10.1002/mds.25888; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Brighina F, 2009, EXP BRAIN RES, V192, P651, DOI 10.1007/s00221-008-1572-9; Carbon M, 2010, BRAIN, V133, P690, DOI 10.1093/brain/awq017; Carrillo F, 2013, BRAIN STIMUL, V6, P582, DOI 10.1016/j.brs.2012.12.004; Chen CH, 2014, NAT NEUROSCI, V17, P1767, DOI 10.1038/nn.3868; Chen G, 2009, J NEUROPHYSIOL, V101, P234, DOI 10.1152/jn.90829.2008; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Di Lorenzo F, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00002; Draganski B, 2003, NEUROLOGY, V61, P1228, DOI 10.1212/01.WNL.0000094240.93745.83; Filip P, 2017, MOVEMENT DISORD, V32, P757, DOI 10.1002/mds.26930; Hoffland BS, 2013, EUR J NEUROSCI, V38, P2166, DOI 10.1111/ejn.12186; Hubsch C, 2013, BRAIN, V136, P2050, DOI 10.1093/brain/awt147; Koch G, 2014, BRAIN STIMUL, V7, P564, DOI 10.1016/j.brs.2014.05.002; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; Kojovic M, 2013, BRAIN, V136, P2038, DOI 10.1093/brain/awt150; LeDoux MS, 2003, MOVEMENT DISORD, V18, P60, DOI 10.1002/mds.10301; Munchau A, 1999, J NEUROL, V246, P840, DOI 10.1007/s004150050465; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Popa T, 2010, BRAIN STIMUL, V3, P161, DOI 10.1016/j.brs.2009.10.001; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Sadnicka A, 2015, EUR J NEUROL, V22, P762, DOI 10.1111/ene.12521; Sadnicka A, 2014, MOVEMENT DISORD, V29, P1304, DOI 10.1002/mds.25881; Siebner HR, 1999, NEUROLOGY, V52, P529, DOI 10.1212/WNL.52.3.529; Song CH, 2014, NEUROBIOL DIS, V62, P372, DOI 10.1016/j.nbd.2013.10.003; Teo JTH, 2009, J NEUROL NEUROSUR PS, V80, P80, DOI 10.1136/jnnp.2008.144626; Torriero S, 2011, J COGNITIVE NEUROSCI, V23, P338, DOI 10.1162/jocn.2010.21471; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211367	10.1371/journal.pone.0211367	http://dx.doi.org/10.1371/journal.pone.0211367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682155	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500155
J	Geng, J; Wei, MZ; Yuan, X; Liu, ZQ; Wang, XX; Zhang, DM; Luo, L; Wu, JC; Guo, WJ; Qin, ZH				Geng, Ji; Wei, Mingzhen; Yuan, Xiao; Liu, Ziqi; Wang, Xinxin; Zhang, Dingmei; Luo, Li; Wu, Junchao; Guo, Wenjie; Qin, Zheng-Hong			TIGAR regulates mitochondrial functions through SIRT1-PGC1 pathway and translocation of TIGAR into mitochondria in skeletal muscle	FASEB JOURNAL			English	Article						exhaustive exercise; type IIA fiber; mitochondrial content	GENE-EXPRESSION; TP53-INDUCED GLYCOLYSIS; EXERCISE PERFORMANCE; APOPTOSIS REGULATOR; ENERGY-PRODUCTION; S-SULFHYDRATION; ATP SYNTHASE; RESISTANCE; LOCALIZATION; FATIGUE	TP53-induced glycolysis and apoptosis regulator (TIGAR), a glycolytic inhibitor, plays vital roles in regulating cellular metabolism and oxidative stress. However, the role of highly expressed TIGAR in skeletal muscle remains unexplored. In the present study, TIGAR levels varied in different skeletal muscles and fibers. An exhaustive swimming test with a load corresponding to 5% of body weight was utilized in mice to assess the effects of TIGAR on exercise-induced fatigue and muscle damage. The running time and metabolic indicators were significantly greater in wild-type (WT) mice compared with TIGAR knockout (KO) mice. Poor exercise capacity was accompanied by decreased type IIA fibers in TIGAR KO mice. Decreased mitochondrial number and mitochondrial oxidative phosphorylation were observed more in TIGAR KO mice than in WT mice, which were involved in sirtuin 1 (SIRT1)-mediated deacetylation of peroxisome proliferator-activated receptor coactivator 1 (PGC1), and resveratrol treatment in TIGAR KO mice can increase mitochondrial content and exercise time. Much more TIGAR was also detected in mitochondria during exhaustive exercise. In addition, TIGAR, rather than mitochondria-targeted TIGAR achieved by in vitro plasmid transfection, promoted SIRT1-PGC1 pathway. Glutathione S-transferase-TIGAR pull-down assay followed by liquid chromatography mass spectrometry found that TIGAR interacted with ATP synthase F1 subunit (ATP5A1), and its binding to ATP5A1 increased during exhaustive exercise. Overexpression of mitochondrial-TIGAR enhanced ATP generation, maintained mitochondrial membrane potential and reduced mitochondrial oxidative stress under hypoxia condition. Taken together, our results uncovered a novel role for TIGAR in mitochondrial regulation in fast-twitch oxidative skeletal muscle through SIRT1-PGC1 and translocation into mitochondria, which contribute to the increase in exercise endurance of mice.Geng, J., Wei, M., Yuan, X., Liu, Z., Wang, X., Zhang, D., Luo, L., Wu, J., Guo, W., Qin, Z.-H. TIGAR regulates mitochondrial functions through SIRT1-PGC1 pathway and translocation of TIGAR into mitochondria in skeletal muscle.	[Geng, Ji; Wei, Mingzhen; Liu, Ziqi; Wang, Xinxin; Zhang, Dingmei; Wu, Junchao; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; [Geng, Ji; Wei, Mingzhen; Liu, Ziqi; Wang, Xinxin; Zhang, Dingmei; Wu, Junchao; Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Lab Aging & Nervous Dis, Suzhou, Peoples R China; [Luo, Li] Soochow Univ, Sch Phys Educ & Sports Sci, Suzhou, Peoples R China; [Yuan, Xiao] Soochow Univ, Affiliated Hosp 1, Pathol Dept, Suzhou, Peoples R China; [Guo, Wenjie] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Nanjing University	Qin, ZH (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Med Coll, 199 Renai Rd, Suzhou 215123, Peoples R China.	qinzhenhong@suda.edu.cn	Zhang, Dingmei/ABC-7476-2020; Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Geng, Ji/0000-0002-6055-7156	National Natural Science Foundation of China [81730092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 81730092 to Z.-H.Q.). The authors declare no conflicts of interest.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; BANGSBO J, 1990, J PHYSIOL-LONDON, V422, P539, DOI 10.1113/jphysiol.1990.sp018000; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Cannavino J, 2015, J PHYSIOL-LONDON, V593, P1981, DOI 10.1113/jphysiol.2014.286740; Cao LJ, 2015, NEUROSCI BULL, V31, P527, DOI 10.1007/s12264-015-1538-4; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chamari K, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0012-1; Chen JY, 2018, NEUROPHARMACOLOGY, V131, P377, DOI 10.1016/j.neuropharm.2018.01.012; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; Feng J, 2018, ONCOL LETT, V15, P155, DOI 10.3892/ol.2017.7303; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Geng J, 2018, FREE RADICAL RES, V52, P1240, DOI 10.1080/10715762.2018.1489133; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; Iizuka K, 2014, ANN CLIN LAB SCI, V44, P272; Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; JANSSON E, 1983, HISTOCHEMISTRY, V78, P121, DOI 10.1007/BF00491118; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Ko YH, 2016, J BIOL CHEM, V291, P26291, DOI 10.1074/jbc.M116.740209; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lee P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.205; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li M, 2014, J NEUROSCI, V34, P7458, DOI 10.1523/JNEUROSCI.4655-13.2014; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu JB, 2018, HUM PATHOL, V77, P54, DOI 10.1016/j.humpath.2017.12.029; Ma T, 2017, BIOCHEM PHARMACOL, V143, P90, DOI 10.1016/j.bcp.2017.07.018; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Modis K, 2016, PHARMACOL RES, V113, P116, DOI 10.1016/j.phrs.2016.08.023; Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364; Murton AJ, 2014, J APPL PHYSIOL, V116, P113, DOI 10.1152/japplphysiol.00426.2013; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni R, 2016, DIABETES, V65, P255, DOI 10.2337/db15-0963; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qi ZT, 2011, FREE RADICAL BIO MED, V50, P794, DOI 10.1016/j.freeradbiomed.2010.12.022; Qian SX, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0360-4; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schiller D, 2008, MOL CELL BIOL, V28, P4424, DOI 10.1128/MCB.00007-08; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Tajsharghi H, 2010, BRAIN, V133, P1451, DOI 10.1093/brain/awq083; Takeda K, 2011, J NUTR SCI VITAMINOL, V57, P246, DOI 10.3177/jnsv.57.246; TESCH PA, 1986, EUR J APPL PHYSIOL, V55, P362, DOI 10.1007/BF00422734; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Wang CN, 2018, MOL CELL ENDOCRINOL, V474, P65, DOI 10.1016/j.mce.2018.02.011; Wang CK, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12440; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wu RE, 2013, MOLECULES, V18, P4689, DOI 10.3390/molecules18044689; Yu HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09853; Yuan LS, 2018, ONCOL REP, V39, P525, DOI 10.3892/or.2017.6132; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zhou H, 2017, BIOINFORMATICS, V33, P843, DOI 10.1093/bioinformatics/btw723; Zhou JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27096	69	17	17	7	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6082	6098		10.1096/fj.201802209R	http://dx.doi.org/10.1096/fj.201802209R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30726106	Bronze			2022-12-26	WOS:000466932600024
J	Close, AF; Dadheech, N; Villela, BS; Rouillard, C; Buteau, J				Close, Anne-Francoise; Dadheech, Nidheesh; Villela, Barbara Scoralick; Rouillard, Claude; Buteau, Jean			The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of beta-cell mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-cell; diabetes; apoptosis; nuclear receptor; cytokine; pancreas; insulin; Nr4a	SKELETAL-MUSCLE; NGFI-B; NUR77; EXPRESSION; NOR-1; METABOLISM; KINASE; PATHOGENESIS; ACTIVATION; PATHWAYS	The Nr4a subfamily of nuclear receptor comprises three members in mammalian cells: Nur77/Nr4a1, Nurr1/Nr4a2, and Nor1/Nr4a3. Nr4a proteins play key roles in the regulation of glucose homeostasis in peripheral metabolic tissues. However, their biological functions in -cells remain relatively uncharacterized. Here we sought to investigate the potential role of Nor1 in the regulation of -cell mass and, in particular, beta-cell survival/apoptosis. We used histological analysis to examine the consequences of genetic deletion of either Nur77 and Nor1 on beta-cell mass, investigated the expression patterns of Nr4as in human islets and INS cells and performed gain- and loss-of-function experiments to further characterize the role of Nor1 in beta-cell apoptosis. Surprisingly, Nor1 knockout mice displayed increased beta-cell mass, whereas mice with genetic deletion of Nur77 did not exhibit any significant differences compared with their WT littermates. The increase in beta-cell mass in Nor1 knockout mice was accompanied by improved glucose tolerance. A gene expression study performed in both human islets and INS cells revealed that Nor1 expression is significantly increased by pro-inflammatory cytokines and, to a lesser extent, by elevated concentrations of glucose. Nor1 overexpression in both INS and human islet cells caused apoptosis, whereas siRNA-mediated Nor1 knockdown prevented cytokine-induced beta-cell death. Finally, Nor1 expression was up-regulated in islets of individuals with type 2 diabetes. Altogether, our results uncover that Nor1 negatively regulates beta-cell mass. Nor1 represents a promising molecular target in diabetes treatment to prevent beta-cell destruction.	[Close, Anne-Francoise; Dadheech, Nidheesh; Villela, Barbara Scoralick; Buteau, Jean] Univ Alberta, Dept AFNS, Edmonton, AB T6G 2E1, Canada; [Close, Anne-Francoise; Dadheech, Nidheesh; Villela, Barbara Scoralick; Buteau, Jean] Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada; [Rouillard, Claude] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ G1V 4G2, Canada; [Rouillard, Claude] CHU Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada	University of Alberta; Laval University; Laval University	Buteau, J (corresponding author), Univ Alberta, 5-126 Li Ka Shing Ctr, Edmonton, AB T6G 2E1, Canada.	jbuteau@ualberta.ca	Close, Anne-Françoise/GWZ-2344-2022; Rouillard, Claude/G-9127-2017; Dadheech, Nidheesh/E-3142-2017	Rouillard, Claude/0000-0003-4210-9330; Dadheech, Nidheesh/0000-0002-7155-0486	Alberta Diabetes Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Wallonie-Bruxelles International; Alberta Innovates Health Solutions; Canadian Institutes of Health Research New Investigator Award	Alberta Diabetes Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wallonie-Bruxelles International; Alberta Innovates Health Solutions; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by the Alberta Diabetes Foundation, the Canadian Institutes of Health Research, and the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from Wallonie-Bruxelles International and Alberta Innovates Health Solutions.; Supported by a Canadian Institutes of Health Research New Investigator Award.	Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Auwerx J, 1999, CELL, V97, P161; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Close AF, 2013, DIABETES METAB, V39, P478, DOI 10.1016/j.diabet.2013.07.005; Diaz MB, 2006, CELL METAB, V4, P339, DOI 10.1016/j.cmet.2006.10.005; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gao WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091462; Gissendanner CR, 2008, DEV BIOL, V313, P767, DOI 10.1016/j.ydbio.2007.11.014; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kanzleiter T, 2009, BBA-MOL BASIS DIS, V1792, P777, DOI 10.1016/j.bbadis.2009.05.002; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; Lammi J, 2008, MOL CELL ENDOCRINOL, V295, P87, DOI 10.1016/j.mce.2008.08.023; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Levesque D., 2009, HDB NEUROPSYCHIATRIC, P195; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Maira M, 1999, MOL CELL BIOL, V19, P7549; Meier JJ, 2012, DIABETOLOGIA, V55, P1346, DOI 10.1007/s00125-012-2466-8; Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008; Nonogaki K, 2009, BIOCHEM BIOPH RES CO, V386, P311, DOI 10.1016/j.bbrc.2009.06.023; Ordelheide AM, 2013, MOL METAB, V2, P243, DOI 10.1016/j.molmet.2013.06.003; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Tessem JS, 2014, P NATL ACAD SCI USA, V111, P5242, DOI 10.1073/pnas.1320953111; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Veum VL, 2012, INT J OBESITY, V36, P1195, DOI 10.1038/ijo.2011.240; Volakakis N, 2006, J MOL ENDOCRINOL, V37, P317, DOI 10.1677/jme.1.02106; Weyrich P, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-77; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967	43	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4889	4897		10.1074/jbc.RA118.005135	http://dx.doi.org/10.1074/jbc.RA118.005135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30696767	hybrid, Green Published			2022-12-26	WOS:000463985600014
J	Frossi, B; Antoniali, G; Yu, KF; Akhtar, N; Kaplan, MH; Kelley, MR; Tell, G; Pucillo, CEM				Frossi, Barbara; Antoniali, Giulia; Yu, Kefei; Akhtar, Nahid; Kaplan, Mark H.; Kelley, Mark R.; Tell, Gianluca; Pucillo, Carlo E. M.			Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA endonuclease; DNA transcription; immunoglobulin A (IgA); immunology; apurinic; apyrimidinic endonuclease 1 (APE1); base excision repair (BER); class switch recombination; immunoglobulin A (IgA); redox-inhibitor	BASE EXCISION-REPAIR; DNA-REPAIR; ENDOTHELIAL-CELLS; AP ENDONUCLEASE; ENZYME HAP1; IMMUNOGLOBULIN; APE1/REF-1; CANCER; IDENTIFICATION; EXPRESSION	The base excision repair (BER) pathway is an important DNA repair pathway and is essential for immune responses. In fact, it regulates both the antigen-stimulated somatic hypermutation (SHM) process and plays a central function in the process of class switch recombination (CSR). For both processes, a central role for apurinic/apyrimidinic endonuclease 1 (APE1) has been demonstrated. APE1 acts also as a master regulator of gene expression through its redox activity. APE1's redox activity stimulates the DNA-binding activity of several transcription factors, including NF-kappa B and a few others involved in inflammation and in immune responses. Therefore, it is possible that APE1 has a role in regulating the CSR through its function as a redox coactivator. The present study was undertaken to address this question. Using the CSR-competent mouse B-cell line CH12F3 and a combination of specific inhibitors of APE1's redox (APX3330) and repair (compound 3) activities, APE1-deficient or -reconstituted cell lines expressing redox-deficient or endonuclease-deficient proteins, and APX3330-treated mice, we determined the contributions of both endonuclease and redox functions of APE1 in CSR. We found that APE1's endonuclease activity is essential for IgA-class switch recombination. We provide evidence that the redox function of APE1 appears to play a role in regulating CSR through the interleukin-6 signaling pathway and in proper IgA expression. Our results shed light on APE1's redox function in the control of cancer growth through modulation of the IgA CSR process.	[Frossi, Barbara; Pucillo, Carlo E. M.] Univ Udine, Dept Med, Lab Immunol, Piazzale M Kolbe 4, I-33100 Udine, Italy; [Antoniali, Giulia; Tell, Gianluca] Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy; [Yu, Kefei] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Akhtar, Nahid; Kaplan, Mark H.; Kelley, Mark R.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA	University of Udine; University of Udine; Michigan State University; Indiana University System; Indiana University Bloomington	Pucillo, CEM (corresponding author), Univ Udine, Dept Med, Lab Immunol, Piazzale M Kolbe 4, I-33100 Udine, Italy.; Tell, G (corresponding author), Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy.	gianluca.tell@uniud.it; carlo.pucillo@uniud.it	Frossi, Barbara/AFL-0800-2022; Antoniali, Giulia/AAA-1637-2021; Pucillo, Carlo/A-5515-2008	Frossi, Barbara/0000-0001-9855-2396; Antoniali, Giulia/0000-0002-2639-1893; Pucillo, Carlo/0000-0002-4872-6156; Yu, Kefei/0000-0002-3870-2812; Tell, Gianluca/0000-0001-8845-6448; Kaplan, Mark/0000-0002-2923-8245	Associazione Italiana per la Ricerca sul Cancro [IG19862]; National Institutes of Health [R01CA205166, R01CA167291]; NATIONAL CANCER INSTITUTE [R01CA167291, R01CA205166] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG19862 (to G. T.), by National Institutes of Health Grants R01CA205166 and R01CA167291 (to M. R. K.), and by funds granted the Earl and Betty Herr Professor in Pediatric Oncology Research and the Riley Children's Foundation (to M. R. K.). Mark R. Kelley is Chief Scientific Officer of Apexian Pharmaceuticals, the biotech company that has licensed APX3330 used in these studies. Apexian Pharmaceuticals had neither control nor oversight of the studies, interpretation, or presentation of the data in this manuscript. They did not have to approve the manuscript in any way prior to its submission. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Antoniali G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00842-8; Antoniali G, 2014, MOL BIOL CELL, V25, P532, DOI 10.1091/mbc.E13-05-0286; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; Biswas A, 2015, AM J PHYSIOL-CELL PH, V309, pC296, DOI 10.1152/ajpcell.00022.2015; Cesaratto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070909; Georgiadis M., 2012, BIOORG MED CHEM; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Guan ZJ, 2005, ARTERIOSCL THROM VAS, V25, P96, DOI 10.1161/01.ATV.0000150418.14698.75; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Jiang SJ, 2015, INT J ONCOL, V47, P610, DOI 10.3892/ijo.2015.3048; Kelley MR, 2016, J PHARMACOL EXP THER, V359, P300, DOI 10.1124/jpet.116.235283; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; LEE YTN, 1977, J SURG ONCOL, V9, P179, DOI 10.1002/jso.2930090212; Logsdon DP, 2016, MOL CANCER THER, V15, P2722, DOI 10.1158/1535-7163.MCT-16-0253; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Mantha AK, 2014, MITOCHONDRION, V16, P38, DOI 10.1016/j.mito.2013.10.007; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Montaldi AP, 2015, MUTAT RES-GEN TOX EN, V793, P19, DOI 10.1016/j.mrgentox.2015.06.001; Nath S, 2017, CELL SIGNAL, V39, P18, DOI 10.1016/j.cellsig.2017.07.019; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; Poletto M, 2016, MOL CARCINOGEN, V55, P688, DOI 10.1002/mc.22313; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; ROBERTS MM, 1975, CANCER, V36, P221, DOI 10.1002/1097-0142(197507)36:1<221::AID-CNCR2820360124>3.0.CO;2-P; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tell G, 2015, ONCOTARGET, V6, P584, DOI 10.18632/oncotarget.2705; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Vuong BQ, 2013, NAT IMMUNOL, V14, P1183, DOI 10.1038/ni.2732; Vuong BQ, 2012, SEMIN IMMUNOL, V24, P264, DOI 10.1016/j.smim.2012.05.006; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Welinder C, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00143; Wilson DM, 2010, CELL MOL LIFE SCI, V67, P3621, DOI 10.1007/s00018-010-0488-2; Xie JY, 2010, CL LYMPH MYELOM LEUK, V10, P385, DOI 10.3816/CLML.2010.n.072; Xu JL, 2014, P NATL ACAD SCI USA, V111, P17242, DOI 10.1073/pnas.1420221111; Zaky A, 2018, EXP NEUROL, V307, P1, DOI 10.1016/j.expneurol.2018.05.014; Zhang J, 2013, BIOCHEMISTRY-US, V52, P2955, DOI 10.1021/bi400179m	42	13	13	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5198	5207		10.1074/jbc.RA118.006601	http://dx.doi.org/10.1074/jbc.RA118.006601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30705092	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000463985600039
J	Rivero-Rios, P; Romo-Lozano, M; Madero-Perez, J; Thomas, AP; Biosa, A; Greggio, E; Hilfiker, S				Rivero-Rios, Pilar; Romo-Lozano, Maria; Madero-Perez, Jesus; Thomas, Andrew P.; Biosa, Alice; Greggio, Elisa; Hilfiker, Sabine			The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leucine-rich repeat kinase 2 (LRRK2); Rab; receptor endocytosis; lysosome; receptor recycling; GTPase; neurodegeneration; Parkinson disease; early recycling compartment; endolysosome; protein homeostasis; RAB7A; RAB8A	PARKINSONS-DISEASE; ACTIVATING PROTEIN; REGULATES AUTOPHAGY; PATHOGENIC LRRK2; ALPHA-SYNUCLEIN; RECEPTOR; MUTATIONS; BINDING; ENDOSOMES; HOMOLOG	Mutations in the gene encoding for leucine-rich repeat kinase 2 (LRRK2) are a common cause of hereditary Parkinson's disease. LRRK2 regulates various intracellular vesicular trafficking pathways, including endolysosomal degradative events such as epidermal growth factor receptor (EGFR) degradation. Recent studies have revealed that a subset of RAB proteins involved in secretory and endocytic recycling are LRRK2 kinase substrates in vivo. However, the effects of LRRK2-mediated phosphorylation of these substrates on membrane trafficking remain unknown. Here, using an array of immunofluorescence and pulldown assays, we report that expression of active or phosphodeficient RAB8A variants rescues the G2019S LRRK2-mediated effects on endolysosomal membrane trafficking. Similarly, up-regulation of the RAB11-Rabin8-RAB8A cascade, which activates RAB8A, also reverted these trafficking deficits. Loss of RAB8A mimicked the effects of G2019S LRRK2 on endolysosomal trafficking and decreased RAB7A activity. Expression of pathogenic G2019S LRRK2 or loss of RAB8A interfered with EGFR degradation by causing its accumulation in a RAB4-positive endocytic compartment, which was accompanied by a deficit in EGFR recycling and was rescued upon expression of active RAB7A. Dominant-negative RAB7A expression resulted in similar deficits in EGF degradation, accumulation in a RAB4 compartment, and deficits in EGFR recycling, which were all rescued upon expression of active RAB8A. Taken together, these findings suggest that, by impairing RAB8A function, pathogenic G2019S LRRK2 deregulates endolysosomal transport and endocytic recycling events.	[Rivero-Rios, Pilar; Romo-Lozano, Maria; Madero-Perez, Jesus; Hilfiker, Sabine] CSIC, Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18016, Spain; [Thomas, Andrew P.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Biosa, Alice; Greggio, Elisa] Univ Padua, Dept Biol, I-35121 Padua, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Padua	Hilfiker, S (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18016, Spain.	sabine.hilfiker@ipb.csic.es	Biosa, Alice/AAC-2574-2022; Perez, Jesus Madero/AAB-2430-2021; Hilfiker, Sabine/L-6369-2014	Perez, Jesus Madero/0000-0002-3473-6011; Hilfiker, Sabine/0000-0002-5167-7682; Rivero-Rios, Pilar/0000-0001-9398-2995; Romo-Lozano, Maria/0000-0002-1508-7634	Michael J. Fox Foundation tk; Fonds Europeen de Developpement Economique et Regional (FEDER); Spanish Ministry of Economy and Competitiveness (MINECO) Grant [SAF2017-89402-R]; Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Spain); 4for Parkinson's Research	Michael J. Fox Foundation tk; Fonds Europeen de Developpement Economique et Regional (FEDER); Spanish Ministry of Economy and Competitiveness (MINECO) Grant; Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Spain)(BBVA Foundation); 4for Parkinson's Research(Parkinson's UK)	This work was supported by funding from the Michael J. Fox Foundation tk; 4for Parkinson's Research, Fonds Europeen de Developpement Economique et Regional (FEDER), Spanish Ministry of Economy and Competitiveness (MINECO) Grant SAF2017-89402-R, and the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Spain). The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Braun AC, 2015, J CELL SCI, V128, P1386, DOI 10.1242/jcs.163857; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; Chamberland JP, 2016, J CELL SCI, V129, P2625, DOI 10.1242/jcs.173708; Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cookson MR, 2016, BIOCHEM SOC T, V44, P1603, DOI 10.1042/BST20160228; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Devergne O, 2017, CELL REP, V18, P1831, DOI 10.1016/j.celrep.2017.02.002; Dhekne HS, 2018, ELIFE, V7, DOI 10.7554/eLife.40202; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gomez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Goueli BS, 2012, P NATL ACAD SCI USA, V109, P15787, DOI 10.1073/pnas.1204540109; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Henry AG, 2015, HUM MOL GENET, V24, P6013, DOI 10.1093/hmg/ddv314; Hockey LN, 2015, J CELL SCI, V128, P232, DOI 10.1242/jcs.164152; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Jimenez-Orgaz A, 2018, EMBO J, V37, P235, DOI 10.15252/embj.201797128; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim MJ, 2017, HUM MOL GENET, V26, P729, DOI 10.1093/hmg/ddw413; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Madero-Perez J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0235-y; Madero-Perez J, 2017, BIOCHEM SOC T, V45, P147, DOI 10.1042/BST20160392; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ritter B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001670; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schapansky J, 2018, NEUROBIOL DIS, V111, P26, DOI 10.1016/j.nbd.2017.12.005; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Soukup SF, 2016, NEURON, V92, P829, DOI 10.1016/j.neuron.2016.09.037; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Steger M, 2017, ELIFE, V6, DOI 10.7554/eLife.31012; Toyofuku T, 2015, MOL CELL BIOL, V35, P3044, DOI 10.1128/MCB.00085-15; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Yasuda S, 2016, J CELL SCI, V129, P329, DOI 10.1242/jcs.178095; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	72	39	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4738	4758		10.1074/jbc.RA118.005008	http://dx.doi.org/10.1074/jbc.RA118.005008			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30709905	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000463985600002
J	Sandoval, JE; Huang, YH; Muise, A; Goodell, MA; Reich, NO				Sandoval, Jonathan E.; Huang, Yung-Hsin; Muise, Abigail; Goodell, Margaret A.; Reich, Norbert O.			Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mutation; enzyme kinetics; epigenetics; DNA methyltransferase; DNA methylation; DNA binding protein	CPG ISLAND HYPERMETHYLATION; EMBRYONIC STEM-CELLS; METHYLATION PATTERNS; TUMOR-SUPPRESSOR; BINDING PROTEIN; SITE; HYPOMETHYLATION; MAINTENANCE; MECHANISM; SUGGESTS	Eukaryotic DNA methylation prevents genomic instability by regulating the expression of oncogenes and tumor-suppressor genes. The negative effects of dysregulated DNA methylation are highlighted by a strong correlation between mutations in the de novo DNA methyltransferase gene DNA methyltransferase 3 (DNMT3A) and poor prognoses among acute myeloid leukemia (AML) patients. We show here that clinically observed DNMT3A mutations dramatically alter enzymatic activity, including mutations that lead to 6-fold hypermethylation and 3-fold hypomethylation of the human cyclin-dependent kinase inhibitor 2B (CDKN2B or p15) gene promoter. Our results provide insights into the clinically observed heterogeneity of p15 methylation in AML. Cytogenetically normal AML (CN-AML) constitutes 40-50% of all AML cases and is the most epigenetically diverse AML subtype with pronounced changes in non-CpG DNA methylation. We identified a subset of DNMT3A mutations that enhance the enzyme's ability to perform non-CpG methylation by 2-8-fold. Many of these mutations mapped to DNMT3A regions known to interact with proteins that themselves contribute to AML, such as thymine DNA glycosylase (TDG). Using functional mapping of TDG-DNMT3A interactions, we provide evidence that TDG and DNMT3-like (DNMT3L) bind distinct regions of DNMT3A. Furthermore, DNMT3A mutations caused diverse changes in the ability of TDG and DNMT3L to affect DNMT3A function. Cell-based studies of one of these DNMT3A mutations (S714C) replicated the enzymatic studies and revealed that it causes dramatic losses of genome-wide methylation. In summary, mutations in DNMT3A lead to diverse levels of activity, interactions with epigenetic machinery components and cellular changes.	[Sandoval, Jonathan E.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Sandoval, Jonathan E.; Muise, Abigail] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu		Huang, Yung-Hsin/0000-0002-5180-934X; sandoval, jonathan/0000-0003-1986-0804	National Science Foundation [1808775]; National Institutes of Health [CA183252, DK092883-01, CA222736]; NATIONAL CANCER INSTITUTE [F99CA222736, K00CA222736, R01CA183252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Science Foundation Grant 1808775 (to N. R.) and National Institutes of Health Grants CA183252, DK092883-01, and CA222736 (to M. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggerholm A, 1999, CANCER RES, V59, P436; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, BLOOD, V94, P2445, DOI 10.1182/blood.V94.7.2445.419k19_2445_2451; Chen D, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0072-9; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen WJ, 2007, J BIOL CHEM, V282, P11365, DOI 10.1074/jbc.M700186200; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Esposito MT, 2014, CHROMOSOMA, V123, P545, DOI 10.1007/s00412-014-0482-9; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Galonska C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02708-5; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Gu TP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1464-7; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hata K, 2002, DEVELOPMENT, V129, P1983; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Hou HA, 2016, EXPERT REV HEMATOL, V9, P447, DOI 10.1586/17474086.2016.1144469; Huang YH, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1306-z; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lei Y, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1566-2; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Melnick AM, 2010, BEST PRACT RES CL HA, V23, P463, DOI 10.1016/j.beha.2010.09.017; Shiba N, 2012, BRIT J HAEMATOL, V156, P413, DOI 10.1111/j.1365-2141.2011.08879.x; PEDRALINOY G, 1986, J BIOL CHEM, V261, P7600; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Qu Y, 2014, EPIGENETICS-US, V9, P1108, DOI 10.4161/epi.29315; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rau RE, 2016, BLOOD, V128, P971, DOI 10.1182/blood-2015-11-684225; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Santini V, 2001, ANN INTERN MED, V134, P573, DOI 10.7326/0003-4819-134-7-200104030-00011; Schuermann D, 2016, NUCLEIC ACIDS RES, V44, P2187, DOI 10.1093/nar/gkv1520; Spencer DH, 2017, CELL, V168, P801, DOI 10.1016/j.cell.2017.01.021; Stegelmann F, 2011, LEUKEMIA, V25, P1217, DOI 10.1038/leu.2011.77; Stirzaker C, 2017, ONCOGENE, V36, P1328, DOI 10.1038/onc.2016.297; Su JZ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1492-3; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262	54	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4898	4910		10.1074/jbc.RA118.006795	http://dx.doi.org/10.1074/jbc.RA118.006795			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30705090	Green Published, hybrid			2022-12-26	WOS:000463985600015
J	Mahmood, Z; Enocsson, H; Back, M; Chung, RWS; Lundberg, AK; Jonasson, L				Mahmood, Zeid; Enocsson, Helena; Back, Maria; Chung, Rosanna W. S.; Lundberg, Anna K.; Jonasson, Lena			Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease	PLOS ONE			English	Article							CLINICAL-EVIDENCE; STRESS; INFLAMMATION; BIOMARKERS; MARKERS	Background Low-grade systemic inflammation is a predictor of recurrent cardiac events in patients with coronary artery disease (CAD). Plasma proteins such as matrix metalloproteinase (MMP)-9 and myeloperoxidase (MPO) have been shown to reflect basal as well as stress-induced inflammation in CAD. Measurements of MMP-9 and MPO in saliva might pose several advantages. Therefore, we investigated whether salivary levels of MMP-9 and MPO corresponded to plasma levels in patients with coronary artery disease (CAD), both at rest and after acute physical exercise. Methods A bicycle ergometer test was used as a model for stress-induced inflammation. Twenty-three CAD patients performed the test on two occasions 3-6 months apart. Whole unstimulated saliva was collected before, directly after and 30 min after exercise while plasma was collected before and after 30 min. MMP-9 and MPO in saliva and plasma were determined by Luminex. Results MMP-9 and MPO levels were 2- to 4-fold higher in saliva than in plasma. Amongst the saliva samples, and also to a great extent amongst the plasma samples, the levels of both types of protein showed strong intercorrelations between the levels at rest and after exercise during the two visits. However, there were no (or weak) correlations between salivary and plasma MMP-9 and none between salivary and plasma MPO. Conclusion We conclude that salivary diagnostics cannot be used to assess systemic levels of MMP-9 and MPO in CAD patients, neither at rest nor after acute physical exercise.	[Mahmood, Zeid; Chung, Rosanna W. S.; Lundberg, Anna K.; Jonasson, Lena] Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Enocsson, Helena] Linkoping Univ, Dept Clin & Expt Med, Div Neuro & Inflammat Sci, Linkoping, Sweden; [Back, Maria] Linkoping Univ, Fac Hlth Sci, Div Physiotherapy, Dept Med & Hlth Sci, Linkoping, Sweden; [Back, Maria] Sahlgrens Univ Hosp, Dept Occupat Therapy & Physiotherapy, Gothenburg, Sweden	Linkoping University; Linkoping University; Linkoping University; Sahlgrenska University Hospital	Jonasson, L (corresponding author), Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	lena.jonasson@liu.se		Back, Maria/0000-0002-6031-7478; Jonasson, Lena/0000-0002-0586-6618	Heart Lung Foundation, Sweden [20150648]; Swedish Research Council, Sweden [2014-2479]	Heart Lung Foundation, Sweden(Swedish Heart-Lung Foundation); Swedish Research Council, Sweden(Swedish Research Council)	L.J. was funded by the Heart Lung Foundation, Sweden (Grant number: 20150648, www.hjart-lungfonden.se) and Swedish Research Council, Sweden (Reference number: 2014-2479, www.vr.se).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, World Health Organ Tech Rep Ser, V388, P1; Borg G., 1998, BORGS PERCEIVED EXER; Chen F, 2005, INT J MOL MED, V15, P57; Davis JA, 2007, J PHYSIOL SCI, V57, P95, DOI 10.2170/physiolsci.RP014406; Fingleton B, 2004, CLIN CANCER RES, V10, P7865, DOI 10.1158/1078-0432.CCR-04-1252; Floriano PN, 2009, CLIN CHEM, V55, P1530, DOI 10.1373/clinchem.2008.117713; Foley JD, 2012, OR SURG OR MED OR PA, V114, P616, DOI 10.1016/j.oooo.2012.05.024; Garvin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138290; Gohel V, 2018, CLIN CHEM LAB MED, V56, P1432, DOI 10.1515/cclm-2017-1018; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Hellmark M, 2017, EUROPEAN J CARDIOVAS, DOI [10.1177/1609406915624574, DOI 10.1177/1609406915624574]; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Javaid Mohammad A, 2016, J Oral Biol Craniofac Res, V6, P66, DOI 10.1016/j.jobcr.2015.08.006; Jonsson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105572; Khurshid Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060846; Kop WJ, 2008, AM J CARDIOL, V101, P767, DOI 10.1016/j.amjcard.2007.11.006; Kop WJ, 2003, BRAIN BEHAV IMMUN, V17, P233, DOI 10.1016/S0889-1591(03)00051-5; Labat C, 2013, J HYPERTENS, V31, P2251, DOI 10.1097/HJH.0b013e328363dccc; Lundberg AK, 2016, PSYCHONEUROENDOCRINO, V73, P117, DOI 10.1016/j.psyneuen.2016.07.219; Meschiari CA, 2013, CLIN CHIM ACTA, V421, P140, DOI 10.1016/j.cca.2013.03.008; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Nijm J, 2007, J INTERN MED, V262, P375, DOI 10.1111/j.1365-2796.2007.01817.x; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Rathnayake N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126370; Ridker PM, 2016, EUR HEART J, V37, P1720, DOI 10.1093/eurheartj/ehw024; Ruparelia N, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.185; Ryden L, 2016, CIRCULATION, V133, P576, DOI 10.1161/CIRCULATIONAHA.115.020324; Sahibzada HA, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7020021; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Steinhubl SR, 2007, VASC MED, V12, P113, DOI 10.1177/1358863X07077462; Tang WHW, 2011, CLIN CHEM, V57, P33, DOI 10.1373/clinchem.2010.152827; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; van Zanten JJCSV, 2005, ANN RHEUM DIS, V64, P1299, DOI 10.1136/ard.2004.03215; Virtanen E, 2017, CLIN EXP DENT RES, V3, P165, DOI 10.1002/cre2.76; Zalli A, 2014, P NATL ACAD SCI USA, V111, P4519, DOI 10.1073/pnas.1322145111	35	1	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0207166	10.1371/journal.pone.0207166	http://dx.doi.org/10.1371/journal.pone.0207166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726210	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000004
J	Pi, YL; Wu, XH; Wang, FJ; Liu, K; Wu, Y; Zhu, H; Zhang, J				Pi, Yan-Ling; Wu, Xu-Heng; Wang, Feng-Juan; Liu, Ke; Wu, Yin; Zhu, Hua; Zhang, Jian			Motor skill learning induces brain network plasticity: A diffusion-tensor imaging study	PLOS ONE			English	Article							SEMANTIC MEMORY; DEFAULT-MODE; ANATOMICAL NETWORKS; ALZHEIMERS-DISEASE; SUPPLEMENTARY; ORGANIZATION; ACTIVATIONS; INFERIOR; COMPLEX; CORTEX	Motor skills and the acquisition of brain plasticity are important topics in current research. The development of non-invasive white matter imaging technology, such as diffusion-tensor imaging and the introduction of graph theory make it possible to study the effects of learning skills on the connection patterns of brain networks. However, few studies have characterized the brain network topological features of motor skill learning, especially open skill. Given the need to interact with environmental changes in real time, we hypothesized that the brain network of high-level open-skilled athletes had higher transmission efficiency and stronger interaction in attention, visual and sensorimotor networks. We selected 21 high-level basketball players and 25 ordinary individuals as control subjects, collected their DTI data, built a network of brain structures, and used graph theory to analyze and compare the network properties of the two groups at global and regional levels. In addition, we conducted a correlation analysis on the training years of high-level athletes and brain network nodal parameters on the regional level to assess the relationship between brain network topological characteristics and skills learning. We found that on the global-level, the brain network of high-level basketball players had a shorter path length, small-worldness, and higher global efficiency. On the regional level, the brain nodes of the high-level athletes had nodal parameters that were significantly higher than those of control groups, and were mainly distributed in the visual network, the default mode network, and the attention network. The changes in brain node parameters were significantly related to the number of training years.	[Pi, Yan-Ling; Liu, Ke] Shanghai Punan Hosp Pudong New Dist, Shanghai, Peoples R China; [Wu, Xu-Heng; Wu, Yin; Zhu, Hua; Zhang, Jian] Shanghai Univ Sport, Minist Educ, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China; [Wang, Feng-Juan] Tianjin Univ Sport, Phys Educ & Educ Sci Dept, Tianjin, Peoples R China	Shanghai University of Sport; Tianjin University of Sport	Zhu, H; Zhang, J (corresponding author), Shanghai Univ Sport, Minist Educ, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China.	15201775972@163.com; zhangjian@sus.edu.cn		Zhang, Jian/0000-0003-3838-7389	National Natural Science Foundation of China [31371056, 31470051, 31701041]; Shanghai Municipal Commission of Health and Family Planning - China [ZHYY-ZXYJHZX-2-22]; Shanghai City Committee of Science and Technology Key Project [17080503200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning - China; Shanghai City Committee of Science and Technology Key Project	The present study was funded by the National Natural Science Foundation of China (no. 31371056, no. 31470051, no. 31701041 to JZ), Shanghai Municipal Commission of Health and Family Planning - China (ZHYY-ZXYJHZX-2-22 to JZ), the Shanghai City Committee of Science and Technology Key Project (no. 17080503200 to JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andersson J, 2007, TR07JA2 FMRIB U OXF, V2, P1; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang YM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00035; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gentile AM., 1972, QUEST, V17, P3, DOI [10.1080/00336297.1972.10519717, DOI 10.1080/00336297.1972.10519717]; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Huijbers W, 2012, NEUROPSYCHOLOGIA, V50, P3764, DOI 10.1016/j.neuropsychologia.2012.08.021; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim J, 2008, NEUROSCI LETT, V445, P236, DOI 10.1016/j.neulet.2008.09.018; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; MCGUIRE PK, 1995, LANCET, V346, P596, DOI 10.1016/S0140-6736(95)91435-8; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Ojemann GA, 2002, NAT NEUROSCI, V5, P64, DOI 10.1038/nn785; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Rombouts SARB, 2000, AM J NEURORADIOL, V21, P1869; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SAINTCYR JA, 1990, J COMP NEUROL, V298, P129, DOI 10.1002/cne.902980202; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Visser M, 2010, NEUROPSYCHOLOGIA, V48, P1689, DOI 10.1016/j.neuropsychologia.2010.02.016; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	75	21	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210015	10.1371/journal.pone.0210015	http://dx.doi.org/10.1371/journal.pone.0210015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK4EL	30726222	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000012
J	Ahmed, G; Thakur, AK; Pushpanjali; Snehil; Chaturvedi, SK; Shivam, P; Jamal, F; Singh, MK; Bimal, S; Singh, SK; Choudhary, SK; Das, P; Narayan, S				Ahmed, Ghufran; Thakur, Ajit K.; Pushpanjali; Snehil; Chaturvedi, Sanjay K.; Shivam, Pushkar; Jamal, Fauzia; Singh, Manish K.; Bimal, Sanjiva; Singh, Subhankar K.; Choudhary, Sunil K.; Das, Pradeep; Narayan, Shyam			Modulation of the immune response and infection pattern to Leishmania donovani in visceral leishmaniasis due to arsenic exposure: An in vitro study	PLOS ONE			English	Article							ANTIMONIAL DRUGS; RESISTANCE; CYTOKINE; PROTEIN; IDENTIFICATION; METABOLISM; MECHANISM; REDUCTASE; ANTIGEN; DEATH	The arsenic contamination of ground water in visceral leishmaniasis (VL) endemic areas in Bihar, India leads to human exposure through drinking water. Possibly, the consumed arsenic (As) accumulates in the tissues of VL patients, who subsequently internalize intracellular amastigotes to confer resistance against chemotherapy to the parasite, leading to modulation in the host's immune response. This hypothesis appears to be consistent with the in vitro findings that in arsenic-exposed parasites, the mitochondrial membrane potential became depolarized, whereas the reduced thiol and lactate production was overexpressed with enhanced glucose consumption; therefore, the reduced thiol possibly supports an immunosuppressive state in the host cells. This observation was well supported by the down-regulated expression of pro-inflammatory cytokines (IL-2, IL-12, IFN-gamma, and TNF-alpha) with a suppressed anti-leishmanial function of macrophage (NO, ROS). In contrast, the pathophysiological mechanism of VL has received ample support by the promotion of Th2 cytokines (IL-4 and IL-10) in the presence of arsenic-exposed Leishmania parasites (Ld(AS)). Dysfunction of mitochondria and the overexpression of lactate production raise the possibility of the Warburg effect being operative through the up-regulation of glucose consumption by parasites to enhance the energy production, possibly augmenting virulence. Therefore, we surmise from our data that arsenic exposure to Leishmania donovani modulates the immune response and infection pattern by impairing parasite function, which may affect the anti-leishmanial effect in VL.	[Ahmed, Ghufran; Thakur, Ajit K.; Pushpanjali; Snehil; Chaturvedi, Sanjay K.; Shivam, Pushkar; Jamal, Fauzia; Singh, Manish K.; Singh, Subhankar K.; Narayan, Shyam] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Microbiol, Patna, Bihar, India; [Bimal, Sanjiva] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Immunol, Patna, Bihar, India; [Choudhary, Sunil K.] Tilka Manjhi Bhagalpur Univ, Univ Dept Bot, Bhagalpur, Bihar, India; [Das, Pradeep] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Mol Biol, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Narayan, S (corresponding author), Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Microbiol, Patna, Bihar, India.	drshyamnarayan@rediffmail.com	SINGH, MANISH/GVT-5584-2022; Singh, Shubankar/AAT-5366-2020	Jamal, Fauzia/0000-0002-3072-7783; SINGH, SHUBHANKAR/0000-0003-0292-6483	parent institute Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, of Indian Council of Medical Research (ICMR) India [INT-114-BAS/2015]; Department of Biotechnology (DBT) India [DBT/JRF/13/AL/185/2315]	parent institute Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, of Indian Council of Medical Research (ICMR) India; Department of Biotechnology (DBT) India(Department of Biotechnology (DBT) India)	The authors are grateful to the parent institute Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, of Indian Council of Medical Research (ICMR) India, for their financial support to this intramural project (No. INT-114-BAS/2015) and Department of Biotechnology (DBT) India, for the Student Fellowship (Ref. Letter No. DBT/JRF/13/AL/185/2315) to Ghufran Ahmed.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amit A, 2017, J BIOMOL STRUCT DYN, V35, P128, DOI 10.1080/07391102.2015.1134349; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Baiocco P, 2009, J MED CHEM, V52, P2603, DOI 10.1021/jm900185q; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Banerjee S, 2015, FISH SHELLFISH IMMUN, V44, P43, DOI 10.1016/j.fsi.2015.01.029; Bergquist ER, 2009, J ORGANOMET CHEM, V694, P973, DOI 10.1016/j.jorganchem.2008.12.028; Bottrel RLA, 2001, INFECT IMMUN, V69, P3232, DOI 10.1128/IAI.69.5.3232-3239.2001; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73; Das M, 2013, FEBS J, V280, P4807, DOI 10.1111/febs.12449; Das S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005060; Denton H, 2004, BIOCHEM J, V381, P405, DOI 10.1042/BJ20040283; DEY S, 1994, MOL BIOCHEM PARASIT, V67, P49, DOI 10.1016/0166-6851(94)90095-7; Dutta A, 2007, J MED MICROBIOL, V56, P629, DOI 10.1099/jmm.0.47039-0; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh AK, 2015, FASEB J, V29, P2081, DOI 10.1096/fj.14-258624; Heaney CD, 2015, ENVIRON RES, V142, P273, DOI 10.1016/j.envres.2015.07.004; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hosseini MJ, 2013, IRAN J PHARM RES, V12, P119; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Leta S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003131; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Luz AL, 2016, TOXICOL SCI, V152, P349, DOI 10.1093/toxsci/kfw093; Maciaszczyk-Dziubinska E, 2012, INT J MOL SCI, V13, P3527, DOI 10.3390/ijms13033527; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Miller WH, 2002, CANCER RES, V62, P3893; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Perry MR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003518; Perry MR, 2013, P NATL ACAD SCI USA, V110, P19932, DOI 10.1073/pnas.1311535110; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Pushpanjali, 2016, CYTOKINE, V86, P79, DOI 10.1016/j.cyto.2016.07.017; Robey RB, 2015, CARCINOGENESIS, V36, pS203, DOI 10.1093/carcin/bgv037; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Saha JC, 1999, CRIT REV ENV SCI TEC, V29, P281, DOI 10.1080/10643389991259227; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; Soto-Pena GA, 2006, FASEB J, V20, P779, DOI 10.1096/fj.05-4860fje; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09; World Health Organization, 2015, VISC LEISHM CONTR ST; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099657; Zhao F, 2013, TOXICOL APPL PHARM, V271, P72, DOI 10.1016/j.taap.2013.04.020; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0210737	10.1371/journal.pone.0210737	http://dx.doi.org/10.1371/journal.pone.0210737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721235	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300005
J	Mores, R				Mores, Robert			Further empirical data for torsion on bowed strings	PLOS ONE			English	Article							VIOLIN BOW; CONTACT AREA; MECHANICS; FORCE; SYNCHRONIZATION; MOTION	Research on bowed string motion focuses on transverse waves rather than on torsional waves. These are believed to play only a minor role for stabilizing vibrations and no role for perception. Here, torsion is measured on both sides of the bow contact point for a variety of bridge-bow distances on a cello string. Every periodic string release is preceeded by a reverse torsional motion independent from bowing position or dynamics. Transverse and torsional motions are coupled and there are cases of stabilization, but also cases of perturbation or surrender. Structural and timing analyses of torsional waves suggest that the earlier concepts of differential slipping can be essentially confirmed while the concept of Schelleng ripples cannot be confirmed and the concept of subharmonics is under question.	[Mores, Robert] Hamburg Univ Appl Sci, Fac Design Media & Informat, Hamburg, Germany	Hochschule Angewandte Wissenschaft Hamburg	Mores, R (corresponding author), Hamburg Univ Appl Sci, Fac Design Media & Informat, Hamburg, Germany.	robert.mores@haw-hamburg.de						Abel M, 2006, J ACOUST SOC AM, V119, P2467, DOI 10.1121/1.2170441; Bader R., 2013, NONLINEARITIES SYNCH; Cremer L., 1984, PHYS VIOLIN, V2nd; Fischer JL, 2016, J ACOUST SOC AM, V140, P2344, DOI 10.1121/1.4964135; FRIEDLANDER FG, 1953, P CAMB PHILOS SOC, V49, P516, DOI 10.1017/S0305004100028681; Galluzzo PM, 2017, ACTA ACUST UNITED AC, V103, P1080, DOI 10.3813/AAA.919136; GILLAN FS, 1989, J SOUND VIB, V130, P347, DOI 10.1016/0022-460X(89)90562-2; Gough CE, 2012, J ACOUST SOC AM, V131, P4152, DOI 10.1121/1.3699172; Guettler K, 2002, ACTA ACUST UNITED AC, V88, P970; Guettler K., 1994, J CATGUT ACOUSTICAL, V2, P8; Isvan OK, 2002, Patent US, Patent No. 6392137; LAWERGREN B, 1983, J ACOUST SOC AM, V73, P2174, DOI 10.1121/1.389541; Mansour H, 2016, ACTA ACUST UNITED AC, V102, P1094, DOI 10.3813/AAA.919026; MCINTYRE ME, 1981, ACUSTICA, V49, P13; MCINTYRE ME, 1979, ACUSTICA, V43, P93; MCINTYRE ME, 1983, J ACOUST SOC AM, V74, P1325, DOI 10.1121/1.390157; Mores R, 2017, J ACOUST SOC AM, V142, P728, DOI 10.1121/1.4996141; Mores R, 2016, J ACOUST SOC AM, V140, P1162, DOI 10.1121/1.4960626; Pitteroff R, 1998, ACUSTICA, V84, P543; Pitteroff R, 1998, ACUSTICA, V84, P929; Pitteroff R, 1998, ACUSTICA, V84, P744; SCHELLENG JC, 1973, J ACOUST SOC AM, V53, P26, DOI 10.1121/1.1913322; Schoonderwaldt E, 2008, ACTA ACUST UNITED AC, V94, P604, DOI 10.3813/AAA.918070; Smith JH, 2000, J MECH PHYS SOLIDS, V48, P1633, DOI 10.1016/S0022-5096(99)00067-8; Trendelenburg F, 1938, AKUST Z, V3, P7; WOODHOUSE J, 1994, ACUSTICA, V80, P58; Woodhouse J, 2000, J ACOUST SOC AM, V108, P357, DOI 10.1121/1.429529; Woodhouse J, 1999, ACUSTICA, V85, P734	28	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211217	10.1371/journal.pone.0211217	http://dx.doi.org/10.1371/journal.pone.0211217			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716095	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200016
J	Ren, S; Chen, X; Wang, ZL; Zhao, R; Wang, JH; Cui, WJ; Wang, ZQ				Ren, Shuai; Chen, Xiao; Wang, Zhonglan; Zhao, Rui; Wang, Jianhua; Cui, Wenjing; Wang, Zhongqiu			Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE; GRADE; CT; NEOPLASMS; CARCINOMA; PREDICTION; ACCURACY; FEATURES; MDCT	Hypovascular pancreatic neuroendocrine tumors (hypo-PNETs) are often misdiagnosed as pancreatic ductal adenocarcinoma (PDAC). However, the treatment options and prognosis of PNETs and PDAC are substantially different. This retrospective study differentiated hypo-PNETs from PDAC using contrast-enhanced CT (CE-CT). Clinical data and CE-CT findings, including tumor location, size, boundary, pancreatic duct dilatation, local invasion or metastases, tumor contrast enhancement, and tumor-to-pancreas enhancement ratio, were compared between 39 PDACs and 18 hypo-PNETs. At CT imaging, hypo-PNETs showed a higher frequency of a well-defined margin and lower frequencies of pancreatic duct dilatation and local invasion or metastasis when compared with PDAC (p < 0.05 for all). The mean attenuation of hypo-PNETs at the arterial and portal venous phase was significantly higher than that of PDAC (p < 0.001, p = 0.003, respectively). Similar results were observed in tumor-to-pancreas enhancement ratio. Tumor attenuation and tumor-to-pancreas enhancement ratio at the arterial phase showed the largest area under the curve (AUC) of 0.888 and 0.812 with 83.3-88.9% of sensitivity and 61.6-77.0% of specificity. Pancreatic duct dilatation, local invasion or metastasis, and tumor attenuation at the portal venous phase also showed acceptable AUC (0.703-0.748). Thus CE-CT features, especially the enhancement degree at the arterial phases, may be useful for differentiating hypo-PNETs from PDAC using CE-CT.	[Ren, Shuai; Chen, Xiao; Wang, Zhonglan; Zhao, Rui; Wang, Jianhua; Cui, Wenjing; Wang, Zhongqiu] Nanjing Univ Chinese Med, Dept Radiol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Dept Radiol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.	zhqwang001@126.com	Ren, Shuai/A-5350-2019	Ren, Shuai/0000-0003-4902-6298	National Natural Science foundation of China [81771899]; Key Program of Research and Development of Jiangsu Province [BE2017772]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Research and Development of Jiangsu Province	This study was funded by the National Natural Science foundation of China (81771899) to ZQW and the Key Program of Research and Development of Jiangsu Province (BE2017772) to ZQW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basturk O, 2015, AM J SURG PATHOL, V39, P683, DOI 10.1097/PAS.0000000000000408; Baur ADJ, 2016, ACTA RADIOL, V57, P260, DOI 10.1177/0284185115579932; Belousova E, 2017, CLIN RADIOL, V72, P150, DOI 10.1016/j.crad.2016.10.021; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Boutsen L, 2018, NEUROENDOCRINOLOGY, V106, P158, DOI 10.1159/000477213; Canellas R, 2018, AM J ROENTGENOL, V210, P341, DOI 10.2214/AJR.17.18417; Choi TW, 2018, ACTA RADIOL, V59, P383, DOI 10.1177/0284185117725367; Cloyd JM, 2015, WORLD J GASTROENTERO, V21, P9512, DOI 10.3748/wjg.v21.i32.9512; Ehehalt F, 2009, ONCOLOGIST, V14, P456, DOI 10.1634/theoncologist.2008-0259; Guo C, 2018, CANC IMAGING, V18, P1; Guo CG, 2017, ONCOTARGET, V8, P42962, DOI 10.18632/oncotarget.17309; Hill JS, 2009, CANCER-AM CANCER SOC, V115, P741, DOI 10.1002/cncr.24065; Jeon SK, 2017, RADIOLOGY, V284, P77, DOI 10.1148/radiol.2016160586; Jilesen APJ, 2016, CLIN RADIOL, V71, P537, DOI 10.1016/j.crad.2016.01.015; Kang J, 2018, J GASTROEN HEPATOL, V33, P1677, DOI 10.1111/jgh.14139; Kim DW, 2015, EUR RADIOL, V25, P1375, DOI 10.1007/s00330-014-3532-z; Kim JH, 2016, EUR RADIOL, V26, P1338, DOI 10.1007/s00330-015-3941-7; Kimura T, 2016, CLIN J GASTROENTEROL, V9, P261, DOI 10.1007/s12328-016-0655-6; Lewis RB, 2010, RADIOGRAPHICS, V30, P1445, DOI 10.1148/rg.306105523; Lotfalizadeh E, 2017, EUR RADIOL, V27, P1748, DOI 10.1007/s00330-016-4539-4; Milione M, 2017, NEUROENDOCRINOLOGY, V104, P85, DOI 10.1159/000445165; Noone TC, 2005, BEST PRACT RES CL EN, V19, P195, DOI 10.1016/j.beem.2004.11.013; Poultsides GA, 2012, ANN SURG ONCOL, V19, P2295, DOI 10.1245/s10434-012-2305-7; Rha SE, 2007, EUR J RADIOL, V62, P371, DOI 10.1016/j.ejrad.2007.02.036; Tummala P, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.15; Worhunsky DJ, 2014, HPB, V16, P304, DOI 10.1111/hpb.12139; Yamada S, 2016, PANCREAS, V45, P198, DOI 10.1097/MPA.0000000000000443	27	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211566	10.1371/journal.pone.0211566	http://dx.doi.org/10.1371/journal.pone.0211566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707733	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900031
J	Kidzinski, L; Delp, S; Schwartz, M				Kidzinski, Lukasz; Delp, Scott; Schwartz, Michael			Automatic real-time gait event detection in children using deep neural networks	PLOS ONE			English	Article							TREADMILL; WALKING; KINEMATICS	Annotation of foot-contact and foot-off events is the initial step in post-processing for most quantitative gait analysis workflows. If clean force plate strikes are present, the events can be automatically detected. Otherwise, annotation of gait events is performed manually, since reliable automatic tools are not available. Automatic annotation methods have been proposed for normal gait, but are usually based on heuristics of the coordinates and velocities of motion capture markers placed on the feet. These heuristics do not generalize to pathological gait due to greater variability in kinematics and anatomy of patients, as well as the presence of assistive devices. In this paper, we use a data-driven approach to predict foot-contact and foot-off events from kinematic and marker time series in children with normal and pathological gait. Through analysis of 9092 gait cycle measurements we build a predictive model using Long Short-Term Memory (LSTM) artificial neural networks. The best-performing model identifies foot-contact and foot-off events with an average error of 10 and 13 milliseconds respectively, outperforming popular heuristic-based approaches. We conclude that the accuracy of our approach is sufficient for most clinical and research applications in the pediatric population. Moreover, the LSTM architecture enables real-time predictions, enabling applications for real-time control of active assistive devices, orthoses, or prostheses. We provide the model, usage examples, and the training code in an open-source package.	[Kidzinski, Lukasz; Delp, Scott] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Schwartz, Michael] Gillette Childrens Specialty Healthcare, St Paul, MN USA; [Schwartz, Michael] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Schwartz, Michael] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kidzinski, L (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	lukasz.kidzinski@stanford.edu		Delp, Scott/0000-0002-9643-7551; Schwartz, Michael/0000-0003-3388-7413	Mobilize Center, National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence [U54EB020405]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020405] Funding Source: NIH RePORTER	Mobilize Center, National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was funded by the Mobilize Center, National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence supported through Grant U54EB020405.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Appelboom G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-28; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Billauer E., 2008, PEAKDET PEAK DETECTI; Bruening DA, 2014, COMP AUTOMATED EVENT; Caderby T, 2013, GAIT POSTURE, V37, P463, DOI 10.1016/j.gaitpost.2012.08.011; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Fellin RE, 2010, J SCI MED SPORT, V13, P646, DOI 10.1016/j.jsams.2010.03.006; Fourati H, 2015, IEEE T INSTRUM MEAS, V64, P221, DOI 10.1109/TIM.2014.2335912; Ghoussayni S, 2004, GAIT POSTURE, V20, P266, DOI 10.1016/j.gaitpost.2003.10.001; Goodfellow I, 2016, DEEP LEARNING, V1; Hannink J, 2018, IEEE J BIOMED HEALTH, V22, P354, DOI 10.1109/JBHI.2017.2679486; Hannink J, 2017, IEEE J BIOMED HEALTH, V21, P85, DOI 10.1109/JBHI.2016.2636456; Henrich N, 2004, J ACOUST SOC AM, V115, P1321, DOI 10.1121/1.1646401; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hreljac A, 2000, J BIOMECH, V33, P783, DOI 10.1016/S0021-9290(00)00014-2; Hsue B.-J., 2007, J BIOMECHANICS, V40, pS529, DOI [10.1016/s0021-9290(07)70519-5, DOI 10.1016/S0021-9290(07)70519-5]; Jasiewicz JM, 2006, GAIT POSTURE, V24, P502, DOI 10.1016/j.gaitpost.2005.12.017; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Karcnik T, 2003, MED BIOL ENG COMPUT, V41, P509, DOI 10.1007/BF02345310; Kuo YL, 2009, GAIT POSTURE, V29, P304, DOI 10.1016/j.gaitpost.2008.09.014; Lambrecht S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040671; Lauer RT, 2005, IEEE T BIO-MED ENG, V52, P1532, DOI 10.1109/TBME.2005.851527; Mannini A, 2014, IEEE J BIOMED HEALTH, V18, P1122, DOI 10.1109/JBHI.2013.2293887; Miller A, 2009, GAIT POSTURE, V29, P542, DOI 10.1016/j.gaitpost.2008.12.003; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Olsen E, 2012, SENSORS-BASEL, V12, P8145, DOI 10.3390/s120608145; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Schache AG, 2001, CLIN BIOMECH, V16, P667, DOI 10.1016/S0268-0033(01)00061-4; Skelly MM, 2001, IEEE T NEUR SYS REH, V9, P59, DOI 10.1109/7333.918277; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; vanRossum G., 1995, PYTHON TUTORIAL; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	36	46	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211466	10.1371/journal.pone.0211466	http://dx.doi.org/10.1371/journal.pone.0211466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703141	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600048
J	Park, K; Jung, Y; Son, T; Cho, YJ; Jeon, NL; Kim, W; Kim, HY				Park, Keunhwan; Jung, Yeonsu; Son, Taeho; Cho, Young-Jae; Jeon, Noo Li; Kim, Wonjung; Kim, Ho-Young			Optimal diameter reduction ratio of acinar airways in human lungs	PLOS ONE			English	Article							GAS-DIFFUSION; DESIGN; TRANSPORT; SYSTEM; MODEL	In the airway network of a human lung, the airway diameter gradually decreases through multiple branching. The diameter reduction ratio of the conducting airways that transport gases without gas exchange is 0.79, but this reduction ratio changes to 0.94 in acinar airways beyond transitional bronchioles. While the reduction in the conducting airways was previously rationalized on the basis of Murray's law, our understanding of the design principle behind the acinar airways has been far from clear. Here we elucidate that the change in gas transfer mode is responsible for the transition in the diameter reduction ratio. The oxygen transfer rate per unit surface area is maximized at the observed geometry of acinar airways, which suggests the minimum cost for the construction and maintenance of the acinar airways. The results revitalize and extend the framework of Murray's law over an entire human lung.	[Park, Keunhwan; Son, Taeho] Seoul Natl Univ, Inst Adv Machines & Design, Seoul, South Korea; [Park, Keunhwan] Tech Univ Denmark, Dept Phys, Lyngby, Denmark; [Jung, Yeonsu; Jeon, Noo Li; Kim, Ho-Young] Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea; [Cho, Young-Jae] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seongnam, South Korea; [Kim, Wonjung] Sogang Univ, Dept Mech Engn, Seoul, South Korea	Seoul National University (SNU); Technical University of Denmark; Seoul National University (SNU); Seoul National University (SNU); Sogang University	Kim, HY (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Engn, Seoul, South Korea.; Kim, W (corresponding author), Sogang Univ, Dept Mech Engn, Seoul, South Korea.	wonjungkim@sogang.ac.kr; hyk@snu.ac.kr	Cho, Young-Jae/D-5528-2012; Park, Keunhwan/H-9311-2018; Jung, Yeonsu/D-2126-2019	Cho, Young-Jae/0000-0001-6943-4462; Park, Keunhwan/0000-0003-1013-5382; Jung, Yeonsu/0000-0001-7920-3844; Son, Taeho/0000-0002-7217-817X; Kim, Ho-Young/0000-0002-6813-2398	National Research Foundation of Korea via SNU IAMD [2018052541]; Korea Health Industry Development Institute [HI14C0746]	National Research Foundation of Korea via SNU IAMD(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	H.-Y. Kim was supported by the National Research Foundation of Korea (grant no. 2018052541) via SNU IAMD. W. Kim was supported by the Korea Health Industry Development Institute (grant no. HI14C0746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejan A., 2008, DESIGN CONSTRUCTAL T; Bejan A., 2000, SHAPE STRUCTURE ENG; Fan R, 2015, RSC ADV, V5, P90596, DOI 10.1039/c5ra20265e; Felici M, 2003, J APPL PHYSIOL, V94, P2010, DOI 10.1152/japplphysiol.00913.2002; Finlay WH, 2000, AM J RESP CRIT CARE, V161, P91, DOI 10.1164/ajrccm.161.1.9812094; Florens M, 2011, J APPL PHYSIOL, V110, P756, DOI 10.1152/japplphysiol.00984.2010; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; Grebenkov DS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.050602; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; HORSFIELD K, 1982, J APPL PHYSIOL, V52, P21, DOI 10.1152/jappl.1982.52.1.21; Hou C, 2005, MATH BIOSCI INTERAC, P17, DOI 10.1007/3-7643-7412-8_2; Hou C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000902; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Mauroy B, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016007; McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Noblin X, 2008, P NATL ACAD SCI USA, V105, P9140, DOI 10.1073/pnas.0709194105; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Park K, 2014, P NATL ACAD SCI USA, V111, P8067, DOI 10.1073/pnas.1403621111; Park SJ, 2016, SCIENCE, V353, P158, DOI 10.1126/science.aaf4292; Price CA, 2012, ECOL LETT, V15, P87, DOI 10.1111/j.1461-0248.2011.01712.x; RODRIGUEZ M, 1987, AM J ANAT, V180, P143, DOI 10.1002/aja.1001800204; Sapoval B, 2013, FRACTALS, V21, DOI 10.1142/S0218348X13500242; Sapoval B, 2002, P NATL ACAD SCI USA, V99, P10411, DOI 10.1073/pnas.122352499; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Weibel ER, 2005, RESP PHYSIOL NEUROBI, V148, P3, DOI 10.1016/j.resp.2005.03.005; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; West J.B., 2012, RESP PHYSL ESSENTIAL; YU CP, 1978, POWDER TECHNOL, V21, P55, DOI 10.1016/0032-5910(78)80107-7; Zheng XF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14921	34	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0204191	10.1371/journal.pone.0204191	http://dx.doi.org/10.1371/journal.pone.0204191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703086	Green Submitted, Green Published, gold			2022-12-26	WOS:000457301600004
J	Franceschini, S; Tancioni, L; Lorenzoni, M; Mattei, F; Scardi, M				Franceschini, Simone; Tancioni, Lorenzo; Lorenzoni, Massimo; Mattei, Francesco; Scardi, Michele			An ecologically constrained procedure for sensitivity analysis of Artificial Neural Networks and other empirical models	PLOS ONE			English	Article							FRESH-WATER FISH; SPECIES RICHNESS; ASSEMBLAGES; VARIABLES; RIVER; CONVERGENCE; ECOSYSTEMS; DIVERSITY; COMMUNITY; PATTERNS	Sensitivity analysis applied to Artificial Neural Networks (ANNs) as well as to other types of empirical ecological models allows assessing the importance of environmental predictive variables in affecting species distribution or other target variables. However, approaches that only consider values of the environmental variables that are likely to be observed in real-world conditions, given the underlying ecological relationships with other variables, have not yet been proposed. Here, a constrained sensitivity analysis procedure is presented, which evaluates the importance of the environmental variables considering only their plausible changes, thereby exploring only ecological meaningful scenarios. To demonstrate the procedure, we applied it to an ANN model predicting fish species richness, as identifying relationships between environmental variables and fish species occurrence in river ecosystems is a recurring topic in freshwater ecology. Results showed that several environmental variables played a less relevant role in driving the model output when that sensitivity analysis allowed them to vary only within an ecologically meaningful range of values, i.e. avoiding values that the model would never handle in its practical applications. By comparing percent changes in MSE between constrained and unconstrained sensitivity analysis, the relative importance of environmental variables was found to be different, with habitat descriptors and urbanization factors that played a more relevant role according to the constrained procedure. The ecologically constrained procedure can be applied to any sensitivity analysis method for ANNs, but obviously it can also be applied to other types of empirical ecological models.	[Franceschini, Simone; Tancioni, Lorenzo; Mattei, Francesco; Scardi, Michele] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Lorenzoni, Massimo] Dept Chem Biol & Biotechnol, Perugia, Italy	University of Rome Tor Vergata	Franceschini, S (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	smn.franceschini@gmail.com		Franceschini, Simone/0000-0001-9725-4346; lorenzoni, massimo/0000-0002-8548-9487; Mattei, Francesco/0000-0003-0660-5310				Albaret JJ, 2004, AQUAT LIVING RESOUR, V17, P35, DOI 10.1051/alr:2004001; [Anonymous], H2O R INT H2O VERS 3; Bellman R., 1957, DYNAMIC PROGRAMMING; Carosi A, 2015, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2015018; Cunico AM, 2011, ECOL INDIC, V11, P1354, DOI 10.1016/j.ecolind.2011.02.009; Cushing, 2001, STREAMS THEIR ECOLOG; Dimopoulos I, 1999, ECOL MODEL, V120, P157, DOI 10.1016/S0304-3800(99)00099-X; DIMOPOULOS Y, 1995, NEURAL PROCESS LETT, V2, P1, DOI 10.1007/BF02309007; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Ferreira FC., 2007, Braz. J. Biol., V67, P23, DOI 10.1590/S1519-69842007000100004; Franceschini S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22761-4; Garson G.D., 1991, AI EXPERT, V6, P46; Gevrey M., 2005, P54, DOI 10.1007/3-540-26894-4_6; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Gevrey M, 2006, ECOL MODEL, V195, P43, DOI 10.1016/j.ecolmodel.2005.11.008; Giller P.S., 1998, BIOL HABITATS SERIES, P1; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hoeinghaus DJ, 2007, J BIOGEOGR, V34, P324, DOI 10.1111/j.1365-2699.2006.01587.x; Ibarra AA, 2005, ECOL FRESHW FISH, V14, P233, DOI 10.1111/j.1600-0633.2005.00096.x; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Joy M.K., 2005, P76, DOI 10.1007/3-540-26894-4_8; Joy MK, 2004, FRESHWATER BIOL, V49, P1036, DOI 10.1111/j.1365-2427.2004.01248.x; Joy MK, 2002, FRESHWATER BIOL, V47, P2261, DOI 10.1046/j.1365-2427.2002.00954.x; Lamouroux N, 2002, ECOLOGY, V83, P1792, DOI 10.2307/3071765; Larsen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051115; Lecours V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167128; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Lek S, 2000, ENVIRONM SCI, P3; Lek S, 1996, AQUAT LIVING RESOUR, V9, P23, DOI 10.1051/alr:1996004; Lek S, 2005, MODELLING COMMUNITY; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Lu M, 2001, J COMPUT CIVIL ENG, V15, P299, DOI 10.1061/(ASCE)0887-3801(2001)15:4(299); Mattei F, 2018, ECOL MODEL, V382, P51, DOI 10.1016/j.ecolmodel.2018.05.003; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; Morrison G, 2001, WATER SA, V27, P475; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Nourani V, 2012, ADV ENG SOFTW, V47, P127, DOI 10.1016/j.advengsoft.2011.12.014; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Olaya-Marin EJ, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013052; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Olden JD, 2002, ECOL MODEL, V154, P135, DOI 10.1016/S0304-3800(02)00064-9; Olden JD, 2001, T AM FISH SOC, V130, P878, DOI 10.1577/1548-8659(2001)130<0878:FHRILG>2.0.CO;2; Ozesmi SL, 2006, ECOL MODEL, V195, P83, DOI 10.1016/j.ecolmodel.2005.11.012; Postel S., 2012, RIVERS LIFE MANAGING; R Core Team, 2018, R LANG ENV STAT COMP; Radinger J, 2016, GLOBAL CHANGE BIOL, V22, P1505, DOI 10.1111/gcb.13183; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Scardi M, 2001, ECOL MODEL, V146, P33, DOI 10.1016/S0304-3800(01)00294-0; Scardi M, 1999, ECOL MODEL, V120, P213, DOI 10.1016/S0304-3800(99)00103-9; Scardi M, 2007, PROTOCOLLO CAMPIONAM; Schwartzman G.L., 1987, ECOLOGICAL SIMULATIO; Tancioni S, 2012, CARTA BIODIVERSITA I; Teresa FB, 2012, ECOL FRESHW FISH, V21, P433, DOI 10.1111/j.1600-0633.2012.00562.x; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Vega M, 1998, WATER RES, V32, P3581, DOI 10.1016/S0043-1354(98)00138-9	55	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211445	10.1371/journal.pone.0211445	http://dx.doi.org/10.1371/journal.pone.0211445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699204	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600078
J	Tian, L; Zhao, XY; Liu, HH; Ku, LX; Wang, SX; Han, ZP; Wu, LC; Shi, Y; Song, XH; Chen, YH				Tian, Lei; Zhao, Xiyong; Liu, Haohao; Ku, Lixia; Wang, Shunxi; Han, Zanping; Wu, Liancheng; Shi, Yong; Song, Xiaoheng; Chen, Yanhui			Alternative splicing of ZmCCA1 mediates drought response in tropical maize	PLOS ONE			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; TRANSCRIPTION FACTOR GENES; MESSENGER-RNA; ARABIDOPSIS; CLOCK; EXPRESSION; LINKING; CORE	The circadian clock regulates numerous biological processes in plants, especially development and stress responses. CIRCADIAN CLOCK-ASSOCIATED 1 (CCA1) is one of the core components of the day-night rhythm response and is reportedly associated with ambient temperature in Arabidopsis thaliana. However, it remains unknown if alternative splicing of ZmCCA1 is modulated by external stress in maize, such as drought stress and photoperiod. Here, we identified three ZmCCA1 splice variants in the tropical maize line CML288, which are predicted to encode three different protein isoforms, i.e., ZmCCA1.1, ZmCCA1.2, and ZmCCA1.3, which all retain the MYB domain. In maize, the expression levels of ZmCCA1 splice variants were influenced by photoperiod, tissue type, and drought stress. In transgenic A. thaliana, ZmCCA1.1 may be more effective than ZmCCA1.3 in increasing drought tolerance while ZmCCA1.2 may have only a small effect on tolerance to drought stress. Additionally, although CCA1 genes have been found in many plant species, alternative CCA1 splicing events are known to occur in species-specific ways. Our study provides new sight to explore the function of ZmCCA1 splice variants' response to abiotic stress, and clarify the linkage between circadian clock and environmental stress in maize.	[Tian, Lei; Liu, Haohao; Ku, Lixia; Wang, Shunxi; Wu, Liancheng; Shi, Yong; Song, Xiaoheng; Chen, Yanhui] Henan Agr Univ, Natl Key Lab wheat & Maize Crop Sci, Coll Agron, Zhengzhou, Henan, Peoples R China; [Zhao, Xiyong] Anhui Acad Agr Sci, Peanut Res Lab, Crop Res Inst, Hefei, Anhui, Peoples R China; [Han, Zanping] Henan Univ Sci & Technol, Coll Agron, Luoyang, Peoples R China	Henan Agricultural University; Anhui Academy of Agricultural Sciences; Henan University of Science & Technology	Wu, LC; Chen, YH (corresponding author), Henan Agr Univ, Natl Key Lab wheat & Maize Crop Sci, Coll Agron, Zhengzhou, Henan, Peoples R China.	wuliancheng998@163.com; chy9953@163.com		Tian, Lei/0000-0001-5374-0641	Major Science and Technology Projects of Henan Province [161100110500]	Major Science and Technology Projects of Henan Province	This work was funded by the Major Science and Technology Projects of Henan Province (grant no. 161100110500 to Yanhui Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Bartok O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0011; Chang CY, 2014, PLANT PHYSIOL, V165, P826, DOI 10.1104/pp.113.230540; Chen YQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8526104; Cheng Q, 2015, PLANT BIOLOGY, V17, P419, DOI 10.1111/plb.12267; Clough S, 1999, FLORAL DIP SIMPLIFIE, V16; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gao F, 2017, J PLANT PHYSIOL, V214, P81, DOI 10.1016/j.jplph.2017.04.007; Hradilova J, 2007, BIOL PLANTARUM, V51, P257, DOI 10.1007/s10535-007-0051-7; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Karousis ED, 2016, WIRES RNA, V7, P661, DOI 10.1002/wrna.1357; Keller M, 2017, DNA RES, V24, P205, DOI 10.1093/dnares/dsw051; Ku LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0930-1; Kwon YJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-136; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Li C, 2017, GENE, V619, P44, DOI 10.1016/j.gene.2017.04.001; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Liu Z, 2017, PLANT BIOTECHNOLOGY; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; Mei WB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00694; Min XJ, 2017, COMPREHENSIVE CATALO; MUCHOW RC, 1989, FIELD CROP RES, V20, P221, DOI 10.1016/0378-4290(89)90081-6; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Park MJ, 2012, PLANT SIGNAL BEHAV, V7, P1194, DOI 10.4161/psb.21300; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Qin ZR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14320; Ryu JY, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1093715; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Seo PJ, 2012, PLANT CELL, V24, P2427, DOI 10.1105/tpc.112.098723; Seo PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1303; Sureshkumar S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.55, 10.1038/nplants.2016.55]; Wang CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011396; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Wang XT, 2011, PLANT CELL REP, V30, P1261, DOI 10.1007/s00299-011-1036-8; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wei XM, 2011, AFR J AGR RES, V6, P4871; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Yu HQ, 2017, PLANT GROWTH REGUL, V81, P385, DOI 10.1007/s10725-016-0215-6; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhao XY, 2014, MOL BREEDING, V34, P1413, DOI 10.1007/s11032-014-0125-0; Zhu GZ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4449-8	45	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211623	10.1371/journal.pone.0211623	http://dx.doi.org/10.1371/journal.pone.0211623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699185	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600088
J	Bigaut, K; Achard, S; Hemmert, C; Baloglu, S; Kremer, L; Collongues, N; De Seze, J; Kremer, S				Bigaut, Kevin; Achard, Sophie; Hemmert, Celine; Baloglu, Seyyid; Kremer, Laurent; Collongues, Nicolas; De Seze, Jerome; Kremer, Stephane			Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; WHITE	Background The relation between brain functional connectivity of patients with neuromyelitis optica spectrum disorder (NMOSD) and the degree of disability remains unclear. Objective Compare brain functional connectivity of patients with NMOSD to healthy subjects in resting-state functional MRI (rs-fMRI). Methods We compared the rs-fMRI connectivity in 12 NMOSD patients with 20 healthy subjects matched for age and sex. Graph theory analysis was used to quantify the role of each node using a set of metrics: degree, global efficiency, clustering and modularity. To summarize the abnormal connectivity profile of brain regions in patients compared to healthy subjects, we defined a hub disruption index k. Results Concerning the global organization of networks in NMOSD, a small-world topology was preserved without significant modification concerning all average metrics. However, visual networks and the sensorimotor network showed decreased connectivity with high interindividual variability. The hub disruption index. was correlated to the Expanded Disability Status Scale (EDSS). Conclusion These results demonstrate a correlation between disability according to the EDSS and neuronal reorganization using the rs-fMRI graph methodology. The conservation of a normal global topological structure despite local modifications in functional connectivity seems to show brain plasticity in response to the disability.	[Bigaut, Kevin; Kremer, Laurent; Collongues, Nicolas; De Seze, Jerome] Hop Univ Strasbourg, Dept Neurol, Strasbourg, France; [Achard, Sophie] CNRS, Grenoble Image Parole Signal Automat, Grenoble, France; [Hemmert, Celine] Grp Hosp Reg Mulhouse Sud Alsace, Dept Radiol, Mulhouse, France; [Baloglu, Seyyid; Kremer, Stephane] Hop Univ Strasbourg, Dept Radiol, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kremer, S (corresponding author), Hop Univ Strasbourg, Dept Radiol, Strasbourg, France.	stephane.kremer@chru-strasbourg.fr	Bigaut, Kévin/ABE-2734-2021; Kremer, Laurent/M-7449-2016	Bigaut, Kevin/0000-0002-5176-580X; Kremer, Laurent/0000-0002-7246-2533				Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; de Kouchkovsky I, 2016, J NEUROL, V263, P1146, DOI 10.1007/s00415-016-8118-z; Dogonowski AM, 2013, ACTA NEUROL SCAND, V128, P328, DOI 10.1111/ane.12121; Fleischer V, 2019, NEUROSCIENCE, V403, P35, DOI 10.1016/j.neuroscience.2017.10.033; Fleischer V, 2017, MULT SCLER J, V23, P432, DOI 10.1177/1352458516651503; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Kim HJ, 2015, NEUROLOGY, V84, P1165, DOI 10.1212/WNL.0000000000001367; Koubiyr I, 2020, MULT SCLER J, V26, P188, DOI 10.1177/1352458518813108; Kremer S, 2015, JAMA NEUROL, V72, P815, DOI 10.1001/jamaneurol.2015.0248; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liu H, 2016, NEUROPSYCH DIS TREAT, V12, P3031, DOI 10.2147/NDT.S120909; Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002; Muthuraman M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.7016.00014, 10.3389/fnins.2016.00014]; Ridley BGY, 2015, NEUROIMAGE, V118, P39, DOI 10.1016/j.neuroimage.2015.05.096; Termenon M, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00084; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075	22	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211465	10.1371/journal.pone.0211465	http://dx.doi.org/10.1371/journal.pone.0211465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695058	Green Published, gold			2022-12-26	WOS:000457046400035
J	Lee, YJ; Shu, MS; Kim, JY; Kim, YH; Sim, KH; Sung, WJ; Eun, JR				Lee, Youn Ju; Shu, Mi-Sun; Kim, Jong-Yeon; Kim, Yun-Hye; Sim, Kyeong Hwa; Sung, Woo Jung; Eun, Jong Ryeol			Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway	PLOS ONE			English	Article							PHOSPHODIESTERASE-3 INHIBITOR CILOSTAZOL; ETHANOL-INDUCED DAMAGE; INDUCED LIVER-INJURY; OXIDATIVE STRESS; RAT-LIVER; KINASE; EXPRESSION; METFORMIN; AUTOPHAGY; DYSFUNCTION	Alcoholic liver disease (ALD) is a worldwide health problem and hepatocyte apoptosis has been associated with the development/progression of ALD. However, no definite effective pharmacotherapy for ALD is currently available. Cilostazol, a selective type III phosphodiesterase inhibitor has been shown to protect hepatocytes from ethanol-induced apoptosis. In the present study, the underlying mechanisms for the protective effects of cilostazol were examined. Primary rat hepatocytes were treated with ethanol in the presence or absence of cilostazol. Cell viability and intracellular cAMP were measured. Apoptosis was detected by Hoechst staining, TUNEL assay, and caspase-3 activity assay. The roles of cAMP and AMP-activated protein kinase (AMPK) pathways in the action of CTZ were explored using pharmacological inhibitors and siRNAs. Liver from mice received ethanol (5g/kg body weight) by oral gavage following cilostazol treatment intraperitoneally was obtained for measurement of apoptosis and activation of AMPK pathway. Cilostazol inhibited ethanolinduced hepatocyte apoptosis and potentiated the increases in cAMP level induced by forskolin. However, the anti-apoptotic effect of cilostazol was not reversed by an inhibitor of adenylyl cyclase. Interestingly, cilostazol activated AMPK and increased the level of LC3-II, a marker of autophagy. The inhibition of AMPK abolished the effects of cilostazol on LC3-II expression and apoptosis. Moreover, the inhibition of LKB1 and CaMKK2, upstream kinases of AMPK, dampened cilostazol-inhibited apoptosis as well as AMPK activation. In conclusion, cilostazol protected hepatocytes from apoptosis induced by ethanol mainly via AMPK pathway which is regulated by both LKB1 and CaMKK2. Our results suggest that cilostazol may have potential as a promising therapeutic drug for treatment of ALD.	[Lee, Youn Ju; Shu, Mi-Sun; Sim, Kyeong Hwa] Catholic Univ Daegu, Sch Med, Dept Pharmacol, Daegu, South Korea; [Kim, Jong-Yeon; Kim, Yun-Hye] Yeungnam Univ, Sch Med, Dept Physiol, Daegu, South Korea; [Sung, Woo Jung] Catholic Univ Daegu, Sch Med, Dept Pathol, Daegu, South Korea; [Eun, Jong Ryeol] Hanyang Univ, Myongj Hosp, Dept Internal Med, Coll Med, Goyang, South Korea	Catholic University of Daegu; Yeungnam University; Catholic University of Daegu; Hanyang University	Eun, JR (corresponding author), Hanyang Univ, Myongj Hosp, Dept Internal Med, Coll Med, Goyang, South Korea.	dreundavis@gmail.com		Eun, Jong Ryeol/0000-0002-8583-0737	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0069506]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (no. 2009-0069506).	Arsene D, 2016, HEPATOL INT, V10, P538, DOI 10.1007/s12072-015-9701-6; Avila DV, 2016, J PATHOL, V240, P96, DOI 10.1002/path.4760; Bai T, 2016, PHARMACOL RES, V105, P1, DOI 10.1016/j.phrs.2015.12.022; Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570; Bhattacharjee R, 2012, BIOCHEM BIOPH RES CO, V423, P85, DOI 10.1016/j.bbrc.2012.05.087; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Cai L, 2015, BIOCHEM BIOPH RES CO, V465, P381, DOI 10.1016/j.bbrc.2015.08.009; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chattipakorn SC, 2014, J GERIATR CARDIOL, V11, P151, DOI 10.3969/j.issn.1671-5411.2014.02.014; Choi BK, 2015, PHYTOTHER RES, V29, P1577, DOI 10.1002/ptr.5415; Fuest M, 2012, HEPATOLOGY, V55, P408, DOI 10.1002/hep.24699; Fujii T, 2017, J SURG RES, V213, P207, DOI 10.1016/j.jss.2017.02.020; Gobejishvili L, 2006, AM J PHYSIOL-GASTR L, V291, pG681, DOI 10.1152/ajpgi.00098.2006; Guo XL, 2016, EUR J PHARMACOL, V791, P578, DOI 10.1016/j.ejphar.2016.09.031; Hashimoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132835; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Ishii H, 2015, J CARDIOL, V66, P97, DOI 10.1016/j.jjcc.2015.03.011; Jang JY, 2018, CLIN MOL HEPATOL, V24, P93, DOI 10.3350/cmh.2017.0079; Jeon BH, 2015, METABOLISM, V64, P1444, DOI 10.1016/j.metabol.2015.07.014; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Kim HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep31169; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Lee HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134486; Mandal S, 2014, ALCOHOL, V48, P123, DOI 10.1016/j.alcohol.2013.11.005; Mandal S, 2013, FOOD CHEM TOXICOL, V59, P236, DOI 10.1016/j.fct.2013.05.056; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506; Noh BK, 2011, BIOCHEM BIOPH RES CO, V414, P361, DOI 10.1016/j.bbrc.2011.09.077; Park SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160620; Park WS, 2010, INT IMMUNOPHARMACOL, V10, P1077, DOI 10.1016/j.intimp.2010.06.008; Ratchford EV, 2017, J VASC SURG, V66, P275, DOI 10.1016/j.jvs.2017.02.040; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Singal AK, 2014, CLIN GASTROENTEROL H, V12, P555, DOI 10.1016/j.cgh.2013.06.013; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tanano I, 2013, INVEST OPHTH VIS SCI, V54, P1443, DOI 10.1167/iovs.12-10115; Tseng SY, 2016, J VASC SURG, V63, P1051, DOI 10.1016/j.jvs.2014.10.103; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; von Heesen M, 2015, LIVER TRANSPLANT, V21, P792, DOI 10.1002/lt.24114; Weng YI, 2000, EUR J PHARMACOL, V398, P323, DOI 10.1016/S0014-2999(00)00313-7; Wu DF, 2013, REDOX BIOL, V1, P552, DOI 10.1016/j.redox.2013.10.008; Xie XH, 2018, CELL STRESS CHAPERON, V23, P203, DOI 10.1007/s12192-017-0828-3; Yang LL, 2012, FREE RADICAL BIO MED, V53, P1170, DOI 10.1016/j.freeradbiomed.2012.06.029; Zhang M, 2017, AM J TRANSL RES, V9, P823	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211415	10.1371/journal.pone.0211415	http://dx.doi.org/10.1371/journal.pone.0211415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695051	Green Submitted, Green Published, gold			2022-12-26	WOS:000457046400033
J	Kim, Y; Lee, D; Lee, J; Lee, S; Lawler, S				Kim, Yangjin; Lee, Donggu; Lee, Junho; Lee, Seongwon; Lawler, Sean			Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model	PLOS ONE			English	Article							ANTITUMOR IMMUNE-RESPONSES; COLONY-STIMULATING FACTOR; NATURAL-KILLER-CELLS; TGF-BETA; LYMPHOCYTE RATIO; INTERFERON-BETA; T-CELLS; BREAST-CANCER; IN-VITRO; BONE-MARROW	Neutrophils display rapid and potent innate immune responses in various diseases. Tumor-associated neutrophils (TANs) however either induce or overcome immunosuppressive functions of the tumor microenvironment through complex tumor-stroma crosstalk. We developed a mathematical model to address the question of how phenotypic alterations between tumor suppressive N1 TANS, and tumor promoting N2 TANs affect nonlinear tumor growth in a complex tumor microenvironment. The model provides a visual display of the complex behavior of populations of TANs and tumors in response to various TGF-beta and IFN-beta stimuli. In addition, the effect of anti-tumor drug administration is incorporated in the model in an effort to achieve optimal anti-tumor efficacy. The simulation results from the mathematical model were in good agreement with experimental data. We found that the N2-to-N1 ratio (N21R) index is positively correlated with aggressive tumor growth, suggesting that this may be a good prognostic factor. We also found that the antitumor efficacy increases when the relative ratio (Dap) of delayed apoptotic cell death of N1 and N2 TANs is either very small or relatively large, providing a basis for therapeutically targeting prometastatic N2 TANs.	[Kim, Yangjin; Lee, Donggu; Lee, Junho] Konkuk Univ, Dept Math, Seoul, South Korea; [Kim, Yangjin] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Lee, Seongwon] Natl Inst Math Sci, Div Math Models, Daejeon, South Korea; [Lawler, Sean] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [Lawler, Sean] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Konkuk University; University System of Ohio; Ohio State University; National Institute for Mathematical Sciences (NIMS), Republic of Korea; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul, South Korea.; Kim, Y (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014	Kim, Yangjin/0000-0002-8905-8481	Konkuk University	Konkuk University	This work was supported by Konkuk University 2015 Research fund (www.konkuk.ac.kr, Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported by Konkuk University in 2015 (Yangjin Kim).	Abulaiti A, 2013, LUNG CANCER, V82, P204, DOI 10.1016/j.lungcan.2013.08.008; Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Aktas ON, 2018, J CANCER RES CLIN, V144, P997, DOI 10.1007/s00432-018-2635-3; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Andzinski L, 2016, INT J CANCER, V138, P1982, DOI 10.1002/ijc.29945; Andzinski L, 2015, INT J CANCER, V136, P572, DOI 10.1002/ijc.28957; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Arelaki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154484; Atzpodien J, 2008, CANCER BIOTHER RADIO, V23, P129, DOI 10.1089/cbr.2007.0429; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Bajetta E, 2008, NAT CLIN PRACT ONCOL, V5, P4, DOI 10.1038/ncponc1007; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bellocq A, 1998, AM J PATHOL, V152, P83; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Brockwell NK, 2017, CANCER IMMUNOL RES, V5, P871, DOI 10.1158/2326-6066.CIR-17-0150; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Calone I., 2012, Experimental Oncology, V34, P9; CARTWRIGHT GE, 1964, BLOOD, V24, P780, DOI 10.1182/blood.V24.6.780.780; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02537-y; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chiantore MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036909; Choe C, 2015, ONCOTARGETS THER, V8, P3665, DOI 10.2147/OTT.S89659; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cools-Lartigue J, 2014, CELL MOL LIFE SCI, V71, P4179, DOI 10.1007/s00018-014-1683-3; Corwin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079115; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; CRESTANI B, 1994, J CLIN INVEST, V94, P731, DOI 10.1172/JCI117392; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dale DC, 1998, TRANSFUSION, V38, P713, DOI 10.1046/j.1537-2995.1998.38898375509.x; de Kleijn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072249; Demers M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22946; Demidenko E., 2013, WILEY SERIES; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Doherty MR, 2018, DNA CELL BIOL, V37, P513, DOI 10.1089/dna.2018.4247; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Enderling H, 2006, J THEOR BIOL, V241, P158, DOI 10.1016/j.jtbi.2005.11.015; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Ghosh D, 2016, CURR CANCER THER REV, V12, P237, DOI 10.2174/1573394713666170316124158; Gong L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-154; Gordon-Weeks AN, 2017, HEPATOLOGY, V65, P1920, DOI 10.1002/hep.29088; Granot Z, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/701067; Granot Z, 2015, CANCER RES, V75, P4441, DOI 10.1158/0008-5472.CAN-15-1502; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Grimes M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq1087; Hagerling C, 2016, SEMIN IMMUNOL, V28, P197, DOI 10.1016/j.smim.2016.02.003; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hattar K, 2014, CANCER IMMUNOL IMMUN, V63, P1297, DOI 10.1007/s00262-014-1606-z; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Horie M, 2012, BIOCHEM BIOPH RES CO, V423, P158, DOI 10.1016/j.bbrc.2012.05.104; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Huang HL, 2012, ACTA BIOCH BIOPH SIN, V44, P737, DOI 10.1093/abbs/gms060; Huang QT, 2017, ONCOTARGET, V8, P16755, DOI 10.18632/oncotarget.15157; Huang SY, 2011, CANCER PREV RES, V4, P666, DOI 10.1158/1940-6207.CAPR-10-0235; Ibrahim SA, 2017, J IMMUNOL S, V198; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2018, P NATL ACAD SCI USA, V115, P4927, DOI 10.1073/pnas.1715295115; Kim Y, 2017, IEEE T BIO-MED ENG, V64, P519, DOI 10.1109/TBME.2016.2637828; Kim Y, 2015, MATH BIOSCI ENG, V12, P1141, DOI 10.3934/mbe.2015.12.1141; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114370; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102499; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kingwell E, 2014, J NEUROL NEUROSUR PS, V85, P1096, DOI 10.1136/jnnp-2013-307238; Kinoshita T, 2013, CANCER SCI, V104, P409, DOI 10.1111/cas.12099; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Kirkwood JM, 2008, NAT CLIN PRACT ONCOL, V5, P2, DOI 10.1038/ncponc1004; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Kuijpers T, 2012, CELL MOL LIFE SCI, V69, P7, DOI 10.1007/s00018-011-0834-z; Gabelloni ML, 2013, SEMIN IMMUNOPATHOL, V35, P423, DOI 10.1007/s00281-013-0364-x; Lee B, 2017, SCI REP-UK, V7, DOI 10.1038/srep39498; Lens MB, 2002, J CLIN ONCOL, V20, P1818, DOI 10.1200/JCO.2002.07.070; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Liang W, 2016, CANCER IMMUNOL RES, V4, P83, DOI 10.1158/2326-6066.CIR-15-0313; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7; Liu XM, 2017, ONCOTARGET, V8, P50209, DOI 10.18632/oncotarget.16854; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Madar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061353; Maeda S, 2014, J BIOL CHEM, V289, P23786, DOI 10.1074/jbc.M114.551879; Maini P, 2010, P INT C MATH IND; Malietzis G, 2014, ANN SURG ONCOL, V21, P3938, DOI 10.1245/s10434-014-3815-2; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; McKenna SD, 2004, J INTERF CYTOK RES, V24, P119, DOI 10.1089/107999004322813363; Mitselou A, 2010, HISTOL HISTOPATHOL, V25, P1257, DOI 10.14670/HH-25.1257; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Moroy G, 2012, ANTI-CANCER AGENT ME, V12, P565, DOI 10.2174/187152012800617696; Ni XY, 2012, ONCOL REP, V28, P615, DOI 10.3892/or.2012.1822; Oh SS, 2012, INT J MOL MED, V29, P1153, DOI 10.3892/ijmm.2012.936; Ohshio Y, 2013, ONCOL REP, V30, P1000, DOI 10.3892/or.2013.2505; Okada Y, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0040-y; Park MY, 2010, CANCER GENE THER, V17, P356, DOI 10.1038/cgt.2009.78; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Patel MR, 2015, ONCOTARGET, V6, P33165, DOI 10.18632/oncotarget.5320; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pistelli M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1204-2; Catani JPP, 2016, TRANSL ONCOL, V9, P565, DOI 10.1016/j.tranon.2016.09.011; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Price TH, 1996, BLOOD, V88, P335; PRICE TH, 1977, J CLIN INVEST, V59, P475, DOI 10.1172/JCI108662; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qu J, 2017, ONCOTARGET, V9, P10147, DOI [10.18632/oncotarget, DOI 10.18632/ONCOTARGET]; Revels SL, 2018, J THORAC DIS, V10, P617, DOI 10.21037/jtd.2018.01.105; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rogge L, 1998, J IMMUNOL, V161, P6567; Romani L, 1997, J IMMUNOL, V158, P5349; ROSENSHEIN MS, 1979, J CLIN INVEST, V64, P580, DOI 10.1172/JCI109496; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Saha S, 2016, CANCER CELL, V30, P11, DOI 10.1016/j.ccell.2016.06.016; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salmon P, 1996, J INTERF CYTOK RES, V16, P759, DOI 10.1089/jir.1996.16.759; Sangaletti S, 2014, CANCER DISCOV, V4, P110, DOI 10.1158/2159-8290.CD-13-0276; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schaaf MB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0061-0; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Serizawa M, 2013, J THORAC ONCOL, V8, P259, DOI 10.1097/JTO.0b013e318279e942; Shaul ME, 2018, FEBS J, V285, P4316, DOI 10.1111/febs.14524; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Shen L, 2007, CLIN EXP IMMUNOL, V149, P155, DOI 10.1111/j.1365-2249.2007.03376.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shih CS, 2009, NEUROMOL MED, V11, P43, DOI 10.1007/s12017-009-8059-0; Shimizu K, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0710-7; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; STEINBACH KH, 1979, BLUT, V39, P27, DOI 10.1007/BF01008072; Stratigos M, 2016, TRANSL LUNG CANCER R, V5, P389, DOI 10.21037/tlcr.2016.08.04; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swierczak A, 2015, CANCER METAST REV, V34, P735, DOI 10.1007/s10555-015-9594-9; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeshima T, 2016, P NATL ACAD SCI USA, V113, P11300, DOI 10.1073/pnas.1613187113; Tao LL, 2017, ONCOL LETT, V14, P2611, DOI 10.3892/ol.2017.6497; Tavakoli Maryam, 2012, Mater Sociomed, V24, P203, DOI 10.5455/msm.2012.24.203-205; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Tohme S, 2016, CANCER RES, V76, P1367, DOI 10.1158/0008-5472.CAN-15-1591; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tuting T, 2016, SCIENCE, V352, P145, DOI 10.1126/science.aaf7300; Uribe-Querol E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/983698; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Wakabayashi T, 2008, J GENE MED, V10, P329, DOI 10.1002/jgm.1160; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang RF, 2006, SEMIN IMMUNOL, V18, P136, DOI 10.1016/j.smim.2006.01.008; Wang RF, 2006, SEMIN CANCER BIOL, V16, P73, DOI 10.1016/j.semcancer.2005.07.009; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weis JA, 2017, COMPUT METHOD APPL M, V314, P494, DOI 10.1016/j.cma.2016.08.024; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; Wheatley K, 2003, CANCER TREAT REV, V29, P241, DOI 10.1016/S0305-7372(03)00074-4; Xu YF, 2013, P NATL ACAD SCI USA, V110, P7726, DOI 10.1073/pnas.1302906110; Yan B, 2013, J IMMUNOL, V190, P5882, DOI 10.4049/jimmunol.1201881; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Yuan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14273; Zeren S, 2015, INT SURG, V100, P1185, DOI 10.9738/INTSURG-D-15-00044.1; Zhang FL, 2009, IMMUNOLOGY, V128, pe905, DOI 10.1111/j.1365-2567.2009.03104.x; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	191	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211041	10.1371/journal.pone.0211041	http://dx.doi.org/10.1371/journal.pone.0211041			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689655	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800019
J	ul Haq, I; Abd-Alla, A; Tomas, US; Meza, JS; Bourtzis, K; Caceres, C				ul Haq, Ihsan; Abd-Alla, Adly; Tomas, Ulysses Sto; Salvador Meza, Jose; Bourtzis, Kostas; Caceres, Carlos			Cryopreservation of the Mediterranean fruit fly (Diptera: Tephritidae) VIENNA 8 genetic sexing strain: No effect on large scale production of high quality sterile males for SIT applications	PLOS ONE			English	Article							CERATITIS-CAPITATA; INSECT TECHNIQUE; FLIES; ERADICATION; DOMESTICATION; ATTRACTANTS; SUPPRESSION	The sterile insect technique (SIT) integrated in area-wide integrated pest management (AW-IPM) programmes is being used for the successful management of the Mediterranean fruit fly Ceratitis capitata (Wiedemann) (Diptera: Tephritidae) which is a horticultural pest of economic importance in tropical and subtropical countries. All programmes with an SIT component are using the VIENNA genetic sexing strains (GSS), mainly the VIENNA 8 GSS, which have been developed by applying classical genetic approaches. The VIENNA 8 GSS carries two selectable markers, the white pupae and the temperature sensitive lethal genes, which allows the production and release of only males thus increasing the biological efficiency and cost effectiveness of SIT applications. However, mass rearing may affect quality traits of the GSS, in which case replenishment of the colony with wild flies is recommended, a process which is tedious and time consuming. We previously reported the development of a cryopreservation protocol for the VIENNA 8(D53+) strain. In the present study, we report on the evaluation of the cryopreserved strain VIENNA 8(D53+)/Cryo-228L, reared under semi mass rearing conditions, for production parameters, quality control indices and mating competitiveness of males, in a comparative way with the non-cryopreserved VIENNA 8(D53+) strain, against wild type males. The VIENNA 8(D53+) and VIENNA 8(D53+)/Cryo-228L strains were similar for production parameters viz. egg production, pupal production, pupal recovery, and quality control indices like fly emergence, sex ratio and flight ability. Males from both strains were equally competitive with males of the wild type strain in achieving mating with wild type females under field cage conditions. Results are discussed in the context of cryopreservation as a potential backup strategy for refreshing the mass rearing colony with biological material from a cryopreserved stock.	[ul Haq, Ihsan; Abd-Alla, Adly; Tomas, Ulysses Sto; Salvador Meza, Jose; Bourtzis, Kostas; Caceres, Carlos] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria; [ul Haq, Ihsan] Natl Agr Res Ctr, Pk Rd, Islamabad, Pakistan; [Salvador Meza, Jose] SAGARPA IICA, Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; National Agricultural Research Council - Pakistan	ul Haq, I (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria.; ul Haq, I (corresponding author), Natl Agr Res Ctr, Pk Rd, Islamabad, Pakistan.	imihsan@yahoo.com	Meza Hernández, José Salvador/B-6203-2015; Hernández, José Salvador Meza/AAS-2085-2021	Meza Hernández, José Salvador/0000-0001-5178-419X; Hernández, José Salvador Meza/0000-0001-5178-419X; ABD-ALLA, Adly/0000-0001-7540-4462				Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Augustinos AA, 2017, ENTOMOL EXP APPL, V164, P305, DOI 10.1111/eea.12612; Augustinos AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160232; BUSCHPETERSEN E, 1989, ENTOMOL EXP APPL, V51, P241, DOI 10.1007/BF00347887; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; Fischer K., 2000, J ECON ENTOMOL, V91, P1406; Fischer K., 1998, J ECON ENTOMOL, V93, P394; Fisher K., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P543; Franz G, 1996, FRUIT FLY PESTS, P185; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gilchrist AS, 2012, J ECON ENTOMOL, V105, P1051, DOI 10.1603/EC11421; HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Hendrichs J., 2009, ENCY INSECTS, V2nd ed., P953, DOI DOI 10.1016/B978-0-12-374144-8.00252-6; HOOPER GHS, 1987, ENTOMOL EXP APPL, V44, P161, DOI 10.1007/BF00367625; Ito Y., 2003, Journal of Asia-Pacific Entomology, V6, P119, DOI 10.1016/S1226-8615(08)60177-6; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Leopold R.A., 1991, P379; Leopold RA, 2001, ANN ENTOMOL SOC AM, V94, P695, DOI 10.1603/0013-8746(2001)094[0695:COEOTN]2.0.CO;2; Leopold RA, 2010, ANN ENTOMOL SOC AM, V103, P264, DOI 10.1603/AN09094; Liquido N. J., 1991, MISCELLANEOUS PUBLIC, V77; MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231; Ott RL, 2001, INTRO STAT METHODS D; Rajamohan A, 2007, CRYOBIOLOGY, V54, P44, DOI 10.1016/j.cryobiol.2006.10.192; Rajamohan A, 2003, CRYOLETTERS, V24, P125; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; ROBINSON AS, 1982, GENETICA, V58, P229, DOI 10.1007/BF00128017; ROBINSON AS, 1999, TRENDS ENTOMOL, V2, P81; Roessler Y., 1989, WORLD CROP PESTS FRU, V3, P329; STEINER LF, 1961, J ECON ENTOMOL, V54, P30, DOI 10.1093/jee/54.1.30; VARGAS RI, 1986, J ECON ENTOMOL, V79, P864, DOI 10.1093/jee/79.3.864; Yuval B, 2010, J APPL ENTOMOL, V135, P1; Zygouridis NE, 2014, J APPL ENTOMOL, V138, P423, DOI 10.1111/jen.12042	37	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211259	10.1371/journal.pone.0211259	http://dx.doi.org/10.1371/journal.pone.0211259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682129	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500136
J	Castagnoli, L; Cancila, V; Cordoba-Romero, SL; Faraci, S; Talarico, G; Belmonte, B; Iorio, MV; Milani, M; Volpari, T; Chiodoni, C; Hidalgo-Miranda, A; Tagliabue, E; Tripodo, C; Sangaletti, S; Di Nicola, M; Pupa, SM				Castagnoli, Lorenzo; Cancila, Valeria; Cordoba-Romero, Sandra L.; Faraci, Simona; Talarico, Giovanna; Belmonte, Beatrice; Iorio, Marilena V.; Milani, Matteo; Volpari, Tatiana; Chiodoni, Claudia; Hidalgo-Miranda, Alfredo; Tagliabue, Elda; Tripodo, Claudio; Sangaletti, Sabina; Di Nicola, Massimo; Pupa, Serenella M.			WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer	ONCOGENE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PROGNOSTIC VALUE; PATHWAY; STABILIZATION; ONTOLOGY	Triple-negative breast cancers (TNBCs) are characterized by a poor prognosis and lack of targeted treatments, and thus, new therapeutic strategies are urgently needed. Inhibitors against programmed death-1 (PD-1)/PD-1 ligand (PD-L1) have shown significant efficacy in various solid cancers, but their activity against TNBCs remains limited. Here, we report that human TNBCs molecularly stratified for high levels of PD-L1 (PD-L1(High)) showed significantly enriched expression of immune and cancer stemness pathways compared with those with low PD-L1 expression (PD-L1(Low)). In addition, the PD-L1(High) cases were significantly associated with a high stemness score (SSHigh) signature. TNBC cell lines gated for aldehyde dehydrogenase (ALDH) and CD44 stemness markers exhibited increased levels of PD-L1 versus their ALDH-negative and CD44(Low) counterparts, and PD-L1(High) cells generated significantly more mammospheres than PD-L1(Low) cells. Murine mammary SCA-1-positive tumor cells with PD-L1(High) expression generated tumors in vivo with higher efficacy than PD-L1(Low) cells. Furthermore, treatment of TNBC cells with selective WNT inhibitors or activators downregulated or upregulated PD-L1 expression, respectively, implying a functional cross-talk between WNT activity and PD-L1 expression. Remarkably, human TNBC samples contained tumor elements co-expressing PD-L1 with ALDH1A1 and/or CD44v6. Additionally, both PD-L1-/SCA1-positive and ALDH1A1-positive tumor elements were found in close contact with CD3-, and PD-1-positive T cells in murine and human tumor samples. Overall, our study suggests that PD-L1-positive tumor elements with a stemness phenotype may participate in the complex dynamics of TNBC-related immune evasion, which might be targeted through WNT signaling inhibition.	[Castagnoli, Lorenzo; Cordoba-Romero, Sandra L.; Faraci, Simona; Iorio, Marilena V.; Tagliabue, Elda; Pupa, Serenella M.] Fdn IRCCS Ist Nazl Tumori Milano, Dept Res, Mol Targeting Unit, Milan, Italy; [Cancila, Valeria; Belmonte, Beatrice; Tripodo, Claudio] Univ Palermo, Sch Med, Dept Hlth Sci, Tumor Immunol Unit,Human Pathol Sect, Palermo, Italy; [Talarico, Giovanna; Milani, Matteo; Chiodoni, Claudia; Sangaletti, Sabina] Fdn IRCCS Ist Nazl Tumori Milano, Dept Res, Mol Immunol Unit, Milan, Italy; [Volpari, Tatiana; Di Nicola, Massimo] Fdn IRCCS Ist Nazl Tumori Milano, Dept Med Oncol & Hematol, Unit Immunotherapy & Anticanc Innovat Therapeut, Milan, Italy; [Hidalgo-Miranda, Alfredo] Natl Inst Genom Med, Canc Genom Lab, Mexico City, DF, Mexico	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Palermo; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Instituto Nacional de Medicina Genomica	Pupa, SM (corresponding author), Fdn IRCCS Ist Nazl Tumori Milano, Dept Res, Mol Targeting Unit, Milan, Italy.; Di Nicola, M (corresponding author), Fdn IRCCS Ist Nazl Tumori Milano, Dept Med Oncol & Hematol, Unit Immunotherapy & Anticanc Innovat Therapeut, Milan, Italy.	massimo.dinicola@istitutotumori.mi.it; serenella.pupa@istitutotumori.mi.it	Talarico, Giovanna/AAB-2251-2019; Cancila, Valeria/AAJ-3041-2021; Pupa, Serenella/K-6388-2016; Iorio, Marilena V/K-5446-2016; Castagnoli, Lorenzo/J-1893-2014; Cancila, Valeria/AIE-4354-2022; Tripodo, Claudio/AAB-6004-2022; Sangaletti, Sabina/AAB-5873-2019; Milani, Matteo/AAC-1988-2020; Hidalgo-Miranda, Alfredo/B-2123-2010; Romero, Sandra/A-2246-2014; Tagliabue, Elda/B-9377-2017; Chiodoni, Claudia/C-2172-2017	Talarico, Giovanna/0000-0001-5051-6468; Pupa, Serenella/0000-0002-4592-6830; Iorio, Marilena V/0000-0002-6058-1527; Castagnoli, Lorenzo/0000-0002-0220-6497; Cancila, Valeria/0000-0002-9502-1191; Tripodo, Claudio/0000-0002-0821-6231; Sangaletti, Sabina/0000-0001-7047-287X; Milani, Matteo/0000-0002-9127-9523; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Romero, Sandra/0000-0002-5591-696X; Tagliabue, Elda/0000-0001-9877-2903; Chiodoni, Claudia/0000-0002-7644-9969; Belmonte, Beatrice/0000-0001-9668-0925	Associazione Italiana Ricerca Cancro (AIRC) [16918]; Mexican National Council of Science and Technology [CVU 363453]	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Mexican National Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by grants from Ricerca Strategica Istituzionale call 2016 to M. Di Nicola and the Associazione Italiana Ricerca Cancro (AIRC) 16918 to S.M. Pupa. S.L. Cordoba-Romero received the Postdoctoral fellowship "Estancias Posdoctorales en el Extranjero Vinculadas a la Consolidacion de Grupos de Investigatiocion y Fortalecimiento del Posgrado Nacional" from the Mexican National Council of Science and Technology (CVU 363453).	Abramson VG, 2015, CANCER-AM CANCER SOC, V121, P8, DOI 10.1002/cncr.28914; Adams S, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-P2-11-06; Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Almozyan S, 2017, INT J CANCER, V141, P1402, DOI 10.1002/ijc.30834; Alsuliman A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0421-2; Annett S, 2018, PHARMACOL THERAPEUT, V187, P13, DOI 10.1016/j.pharmthera.2018.02.001; Ascierto PA, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1309-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bruttel VS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00360; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Dey N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-537; Emens LA, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2859; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Guastella D, 2016, J VIS COMMUN IMAGE R, V36, P149, DOI 10.1016/j.jvcir.2016.01.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04313-6; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jang GB, 2015, SCI REP-UK, V5, DOI 10.1038/srep12465; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee Y, 2016, CLIN CANCER RES, V22, P3571, DOI 10.1158/1078-0432.CCR-15-2665; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Li CW, 2018, CANCER CELL, V33, P187, DOI 10.1016/j.ccell.2018.01.009; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; McCloskey CW, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00053; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Mohammed MK, 2016, GENES DIS, V3, P11, DOI 10.1016/j.gendis.2015.12.004; Muenst S, 2015, EXPERT OPIN THER TAR, V19, P201, DOI 10.1517/14728222.2014.980235; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pohl SG, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.14; Polonia A, 2017, J CLIN PATHOL, V70, P860, DOI 10.1136/jclinpath-2016-203990; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sangaletti S, 2016, CELL REP, V17, P233, DOI 10.1016/j.celrep.2016.08.075; Sciortino G, 2016, IMAGE ANAL STEREOL, V35, P105, DOI 10.5566/ias.1352; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai D, 2015, ONCOLOGIST, V20, P1189, DOI 10.1634/theoncologist.2015-0057; Vareki SM, 2017, CRIT REV ONCOL HEMAT, V116, P116, DOI 10.1016/j.critrevonc.2017.06.001; Xu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117097; Yam C, 2017, ONCOLOGIST, V22, P1086, DOI 10.1634/theoncologist.2017-0095; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	49	102	105	5	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4047	4060		10.1038/s41388-019-0700-2	http://dx.doi.org/10.1038/s41388-019-0700-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30705400	Green Published, hybrid			2022-12-26	WOS:000468740200006
J	Llanos, S; Megias, D; Blanco-Aparicio, C; Hernandez-Encinas, E; Rovira, M; Pietrocola, F; Serrano, M				Llanos, Susana; Megias, Diego; Blanco-Aparicio, Carmen; Hernandez-Encinas, Elena; Rovira, Miguel; Pietrocola, Federico; Serrano, Manuel			Lysosomal trapping of palbociclib and its functional implications	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; INDUCED SENESCENCE; DRUGS; RESISTANCE; RADIATION; HEAD; PROLIFERATION; SENSITIVITY; INHIBITION; MECHANISMS	Palbociclib is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6) approved for the treatment of some cancers. The main mechanism of action of palbociclib is to induce cell cycle arrest and senescence on responsive cells. Here, we report that palbociclib concentrates in intracellular acidic vesicles, where it can be readily observed due to its intrinsic fluorescence, and it is released from these vesicles upon dilution or washing out of the extracellular medium. This reversible storage of drugs into acidic vesicles is generally known as lysosomal trapping and, based on this, we uncover novel properties of palbociclib. In particular, a short exposure of cells to palbociclib is sufficient to produce a stable cell-cycle arrest and long-term senescence. Moreover, after washing out the drug, palbociclib-treated cells release the drug to the medium and this conditioned medium is active on susceptible cells. Interestingly, cancer cells resistant to palbociclib also accumulate and release the drug producing paracrine senescence on susceptible cells. Finally, other lysosomotropic drugs, such as chloroquine, interfere with the accumulation of palbociclib into lysosomes, thereby reducing the minimal dose of palbociclib required for cell-cycle arrest and senescence. In summary, lysosomal trapping explains the prolonged temporal activity of palbociclib, the paracrine activity of exposed cells, and the cooperation with lysosomotropic drugs. These are important features that may help to improve the therapeutic dosing and efficacy of palbociclib. Finally, two other clinically approved CDK4/6 inhibitors, ribociclib and abemaciclib, present a similar behavior as palbociclib, suggesting that lysosomal trapping is a property common to all three clinically-approved CDK4/6 inhibitors.	[Llanos, Susana; Megias, Diego; Blanco-Aparicio, Carmen; Hernandez-Encinas, Elena; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Rovira, Miguel; Pietrocola, Federico; Serrano, Manuel] BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Serrano, Manuel] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Llanos, S; Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.; Serrano, M (corresponding author), BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Serrano, M (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.	sllanos@cnio.es; manuel.serrano@irbbarcelona.org	Megías, Diego/L-6008-2014; Pietrocola, Federico/AAW-9621-2020; , Susana/AAA-9282-2019; Serrano, Manuel/H-2634-2015; Blanco-Aparicio, Carmen/I-3162-2015	Pietrocola, Federico/0000-0002-2930-234X; Serrano, Manuel/0000-0001-7177-9312; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Megias, Diego/0000-0003-0755-0518; Rovira, Miguel/0000-0002-1391-8465; Llanos, Susana/0000-0002-8555-9326	"la Caixa"-Severo Ochoa PhD scholarship; EMBO Long-Term Postdoctoral Fellowship [ALTF 358-2017]; CNIO; IRB; Spanish Ministry of Economy (MINECO, SAF); European Research Council (ERC); Botin Foundation; Banco Santander (Santander Universities Global Division); "la Caixa" Foundation; MINECO	"la Caixa"-Severo Ochoa PhD scholarship; EMBO Long-Term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); CNIO; IRB; Spanish Ministry of Economy (MINECO, SAF); European Research Council (ERC)(European Research Council (ERC)European Commission); Botin Foundation; Banco Santander (Santander Universities Global Division); "la Caixa" Foundation(La Caixa Foundation); MINECO(Spanish Government)	M.R. was holder of a "la Caixa"-Severo Ochoa PhD scholarship. F.P. is supported by EMBO Long-Term Postdoctoral Fellowship (ALTF 358-2017). Work in the laboratory of M.S. was funded by the CNIO and the IRB, and by grants from the Spanish Ministry of Economy (MINECO, SAF), the European Research Council (ERC Advanced Grant), the Botin Foundation and Banco Santander (Santander Universities Global Division), and by "la Caixa" Foundation. CNIO and IRB Barcelona are recipients of a Severo Ochoa Award of Excellence from the MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Beaver JA, 2015, CLIN CANCER RES, V21, P4760, DOI 10.1158/1078-0432.CCR-15-1185; Chen F, 2017, ANTI-CANCER AGENT ME, V17, P1; Chen L, 2017, BRIT J PHARMACOL, V174, P2427, DOI 10.1111/bph.13836; Daniel WA, 2003, PROG NEURO-PSYCHOPH, V27, P65, DOI 10.1016/S0278-5846(02)00317-2; Daniel WA, 1997, PHARMACOL TOXICOL, V80, P62, DOI 10.1111/j.1600-0773.1997.tb00285.x; Daniel WA, 1999, EUR NEUROPSYCHOPHARM, V9, P483, DOI 10.1016/S0924-977X(99)00034-6; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Goldman SDB, 2009, BIOANALYSIS, V1, P1445, DOI 10.4155/BIO.09.128; GRENMAN R, 1991, CANCER, V67, P2741, DOI 10.1002/1097-0142(19910601)67:11<2741::AID-CNCR2820671105>3.0.CO;2-S; Hay T, 2009, DRUG METAB DISPOS, V37, P1864, DOI 10.1124/dmd.109.027888; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054; Knas M, 2012, FOLIA HISTOCHEM CYTO, V50, P220, DOI 10.5603/FHC.2012.0031; Kurz DJ, 2000, J CELL SCI, V113, P3613; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Leontieva OV, 2015, ONCOTARGET, V6, P23238, DOI 10.18632/oncotarget.4836; Leontieva OV, 2013, CELL CYCLE, V12, P3063, DOI 10.4161/cc.26130; LI WW, 1995, P NATL ACAD SCI USA, V92, P10436, DOI 10.1073/pnas.92.22.10436; MACINTYRE AC, 1988, BIOPHARM DRUG DISPOS, V9, P513, DOI 10.1002/bod.2510090602; Massaro RR, 2017, PHARMACOL RES, V119, P242, DOI 10.1016/j.phrs.2017.02.013; Miettinen TP, 2018, EMBO J, V37, DOI 10.15252/embj.201798359; Mok CC, 2017, EXPERT REV CLIN IMMU, V13, P35, DOI 10.1080/1744666X.2016.1212659; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Murayama N, 2006, J PHARM SCI-US, V95, P1763, DOI 10.1002/jps.20530; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ndolo RA, 2010, J PHARMACOL EXP THER, V333, P120, DOI 10.1124/jpet.109.160226; Palmgren JJ, 2006, EUR J PHARM BIOPHARM, V64, P369, DOI 10.1016/j.ejpb.2006.06.005; PEKKOLAHEINO K, 1994, ARCH OTOLARYNGOL, V120, P750; PEKKOLAHEINO K, 1995, J CANCER RES CLIN, V121, P452, DOI 10.1007/BF01218360; Pierzynska-Mach A, 2014, CYTOM PART A, V85A, P729, DOI 10.1002/cyto.a.22495; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Robinson TJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078641; Servomaa K, 1996, CELL PROLIFERAT, V29, P219, DOI 10.1046/j.1365-2184.1996.01009.x; Valenzuela CA, 2017, EXP CELL RES, V360, P390, DOI 10.1016/j.yexcr.2017.09.031; VanArsdale T, 2015, CLIN CANCER RES, V21, P2905, DOI 10.1158/1078-0432.CCR-14-0816; Verhaegen M, 2012, ONCOGENE, V31, P828, DOI 10.1038/onc.2011.277; Vijayaraghavan S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15916; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Zhitomirsky B, 2016, DRUG RESIST UPDATE, V24, P23, DOI 10.1016/j.drup.2015.11.004; 2009, METHOD ENZYMOL, V452, P181, DOI DOI 10.1016/S0076-6879(08)03612-4; 2012, EXPERT OPIN DRUG MET, V8, P943, DOI DOI 10.1517/17425255.2012.691165	49	37	37	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3886	3902		10.1038/s41388-019-0695-8	http://dx.doi.org/10.1038/s41388-019-0695-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30692638	Green Published, hybrid			2022-12-26	WOS:000468035600009
J	Bourkas, MEC; Arshad, H; Al-Azzawi, ZAM; Halgas, O; Shikiya, RA; Mehrabian, M; Schmitt-Ulms, G; Bartz, JC; Watts, JC				Bourkas, Matthew E. C.; Arshad, Hamza; Al-Azzawi, Zaid A. M.; Halgas, Ondrej; Shikiya, Ronald A.; Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold; Bartz, Jason C.; Watts, Joel C.			Engineering a murine cell line for the stable propagation of hamster prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; cell culture; neurodegeneration; protein aggregation; CRISPR; Cas; neuron; bovine spongiform encephalopathy; Creutzfeldt-Jakob disease; heterologous system	TRANSMISSIBLE MINK ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; SPONGIFORM ENCEPHALOPATHY; SCRAPIE INFECTION; MOUSE SCRAPIE; PROTEIN; STRAINS; PRP; CONVERSION	Prions are infectious protein aggregates that cause several fatal neurodegenerative diseases. Prion research has been hindered by a lack of cellular paradigms for studying the replication of prions from different species. Although hamster prions have been widely used to study prion replication in animals and within in vitro amplification systems, they have proved challenging to propagate in cultured cells. Because the murine catecholaminergic cell line CAD5 is susceptible to a diverse range of mouse prion strains, we hypothesized that it might also be capable of propagating nonmouse prions. Here, using CRISPR/Cas9-mediated genome engineering, we demonstrate that CAD5 cells lacking endogenous mouse PrP expression (CAD5-PrP-/- cells) can be chronically infected with hamster prions following stable expression of hamster PrP. When exposed to the 263K, HY, or 139H hamster prion strains, these cells stably propagated high levels of protease-resistant PrP. Hamster prion replication required absence of mouse PrP, and hamster PrP inhibited the propagation of mouse prions. Cellular homogenates from 263K-infected cells exhibited prion seeding activity in the RT-QuIC assay and were infectious to naive cells expressing hamster PrP. Interestingly, murine N2a neuroblastoma cells ablated for endogenous PrP expression were susceptible to mouse prions, but not hamster prions upon expression of cognate PrP, suggesting that CAD5 cells either possess cellular factors that enhance or lack factors that restrict the diversity of prion strains that can be propagated. We conclude that transfected CAD5-PrP-/- cells may be a useful tool for assessing the biology of prion strains and dissecting the mechanism of prion replication.	[Bourkas, Matthew E. C.; Arshad, Hamza; Al-Azzawi, Zaid A. M.; Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold; Watts, Joel C.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 0S8, Canada; [Bourkas, Matthew E. C.; Arshad, Hamza; Al-Azzawi, Zaid A. M.; Halgas, Ondrej; Watts, Joel C.] Univ Toronto, Dept Biochem, Toronto, ON M5T 0S8, Canada; [Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 0S8, Canada; [Shikiya, Ronald A.; Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Toronto; University of Toronto; University of Toronto; Creighton University	Watts, JC (corresponding author), Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.	joel.watts@utoronto.ca		Halgas, Ondrej/0000-0002-2858-9123; Watts, Joel/0000-0002-2604-2925; Bartz, Jason/0000-0003-4081-7886	Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05112]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2015-05112 (to J. C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bardelli M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007335; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghodrati F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26685-x; Giles K, 2016, J PHARMACOL EXP THER, V358, P537, DOI 10.1124/jpet.116.235556; Giles K, 2015, J PHARMACOL EXP THER, V355, P2, DOI 10.1124/jpet.115.224659; Grassmann A, 2013, VIRUSES-BASEL, V5, P374, DOI 10.3390/v5010374; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; Herva ME, 2012, PRION, V6, P371, DOI 10.4161/pri.20198; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Krejciova Z, 2017, J EXP MED, V214, P3481, DOI 10.1084/jem.20161547; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lu D, 2013, J PHARMACOL EXP THER, V347, P325, DOI 10.1124/jpet.113.205799; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marbiah MM, 2014, EMBO J, V33, P1527, DOI 10.15252/embj.201387150; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Moudjou M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29116; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Oelschlegel AM, 2012, J VIROL, V86, P5297, DOI 10.1128/JVI.00181-12; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Qi YP, 1997, J NEUROSCI, V17, P1217; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Schatzl HM, 1997, J VIROL, V71, P8821; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shikiya RA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006298; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SURI C, 1993, J NEUROSCI, V13, P1280; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Watts JC, 2018, ACTA NEUROPATHOL, V135, P159, DOI 10.1007/s00401-017-1790-y; Watts JC, 2014, J BIOL CHEM, V289, P19841, DOI 10.1074/jbc.R114.550707; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998	74	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4911	4923		10.1074/jbc.RA118.007135	http://dx.doi.org/10.1074/jbc.RA118.007135			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30705093	Green Published, hybrid			2022-12-26	WOS:000463985600016
J	Gourinchas, G; Vide, U; Winkler, A				Gourinchas, Geoffrey; Vide, Ursula; Winkler, Andreas			Influence of the N-terminal segment and the PHY-tongue element on light-regulation in bacteriophytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; signal transduction; photobiology; cyclic di-GMP (c-di-GMP); ultraviolet-visible spectroscopy (UV-visible spectroscopy); protein engineering; bilin; diguanylate cyclase; GGDEF; phytochrome	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BACTERIAL PHYTOCHROMES; PR STATES; PLANT; CHROMOPHORE; REVEALS; DOMAIN; PFR; PHOTOCONVERSION	Photoreceptors enable the integration of ambient light stimuli to trigger lifestyle adaptations via modulation of central metabolite levels involved in diverse regulatory processes. Red light-sensing bacteriophytochromes are attractive targets for the development of innovative optogenetic tools because of their natural modularity of coupling with diverse functionalities and the natural availability of the light-absorbing biliverdin chromophore in animal tissues. However, a rational design of such tools is complicated by the poor understanding of molecular mechanisms of light signal transduction over long distancesfrom the site of photon absorption to the active site of downstream enzymatic effectors. Here we show how swapping structural elements between two bacteriophytochrome homologs provides additional insight into light signal integration and effector regulation, involving a fine-tuned interplay of important structural elements of the sensor, as well as the sensor-effector linker. Facilitated by the availability of structural information of inhibited and activated full-length structures of one of the two homologs (Idiomarina species A28L phytochrome-activated diguanylyl cyclase (IsPadC)) and characteristic differences in photoresponses of the two homologs, we identify an important cross-talk between the N-terminal segment, containing the covalent attachment site of the chromophore, and the PHY-tongue region. Moreover, we highlight how these elements influence the dynamic range of photoactivation and how activation can be improved to light/dark ratios of approximate to 800-fold by reducing basal dark-state activities at the same time as increasing conversion in the light state. This will enable future optimization of optogenetic tools aiming at a direct allosteric regulation of enzymatic effectors.	[Gourinchas, Geoffrey; Vide, Ursula; Winkler, Andreas] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Winkler, Andreas] BioTechMed Graz, A-8010 Graz, Austria	Graz University of Technology	Winkler, A (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	andreas.winkler@TUGraz.at	Gourinchas, Geoffrey/AAF-7377-2021; Gourinchas, Geoffrey/D-1277-2017	Winkler, Andreas/0000-0001-6221-9671; Gourinchas, Geoffrey/0000-0003-2543-3518	NAWI Graz; Austrian Science Fund through the Ph.D. program "DK Molecular Enzymology"; Austrian Science Fund (FWF) [P27124]	NAWI Graz; Austrian Science Fund through the Ph.D. program "DK Molecular Enzymology"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by NAWI Graz, by the Austrian Science Fund through the Ph.D. program "DK Molecular Enzymology" (to G. G.), and by the Austrian Science Fund (FWF): P27124 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders K, 2015, CURR OPIN STRUC BIOL, V35, P7, DOI 10.1016/j.sbi.2015.07.005; Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Antoniani D, 2010, APPL MICROBIOL BIOT, V85, P1095, DOI 10.1007/s00253-009-2199-x; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bellini D, 2012, STRUCTURE, V20, P1436, DOI 10.1016/j.str.2012.06.002; Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Buhrke D, 2018, CHEMPHYSCHEM, V19, P566, DOI 10.1002/cphc.201701311; Burgie ES, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14037-0; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chernov KG, 2017, CHEM REV, V117, P6423, DOI 10.1021/acs.chemrev.6b00700; CHERRY JR, 1992, P NATL ACAD SCI USA, V89, P5039, DOI 10.1073/pnas.89.11.5039; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; Engelhard C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01497-7; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Etzl S, 2018, J BIOL CHEM, V293, P9078, DOI 10.1074/jbc.RA118.003069; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Gourinchas G, 2018, ELIFE, V7, DOI 10.7554/eLife.34815; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Heintzen C., 2012, WILEY INTERDISCIP RE, V1, P411, DOI DOI 10.1002/WMTS.36; Hennig L, 2001, J BIOL CHEM, V276, P7913, DOI 10.1074/jbc.M009793200; Otero LH, 2016, J MOL BIOL, V428, P3702, DOI 10.1016/j.jmb.2016.04.012; Ihalainen JA, 2018, J AM CHEM SOC, V140, P12396, DOI 10.1021/jacs.8b04659; Jordan ET, 1997, PLANT PHYSIOL, V115, P693, DOI 10.1104/pp.115.2.693; Kikis EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000352; Klose C, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.90, 10.1038/nplants.2015.90]; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Losi A, 2017, PHOTOCHEM PHOTOBIOL, V93, P141, DOI 10.1111/php.12674; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Murgida DH, 2007, BIOPHYS J, V93, P2410, DOI 10.1529/biophysj.107.108092; Nagano S, 2016, J PLANT RES, V129, P123, DOI 10.1007/s10265-016-0789-0; Piatkevich KD, 2013, CHEM SOC REV, V42, P3441, DOI 10.1039/c3cs35458j; Reichhart E, 2016, ANGEW CHEM INT EDIT, V55, P6339, DOI 10.1002/anie.201601736; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Salewski J, 2013, J BIOL CHEM, V288, P16800, DOI 10.1074/jbc.M113.457531; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07392-7; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00498; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Zienicke Benjamin, 2013, J Biol Chem, V288, P31738, DOI 10.1074/jbc.M113.479535	58	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4498	4510		10.1074/jbc.RA118.007260	http://dx.doi.org/10.1074/jbc.RA118.007260			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30683693	Green Published, hybrid			2022-12-26	WOS:000462969500018
J	Gunderson, AJ; Yamazaki, T; McCarty, K; Phillips, M; Alice, A; Bambina, S; Zebertavage, L; Friedman, D; Cottam, B; Newell, P; Gough, MJ; Crittenden, MR; Van der Veken, P; Young, KH				Gunderson, Andrew J.; Yamazaki, Tomoko; McCarty, Kayla; Phillips, Michaela; Alice, Alejandro; Bambina, Shelly; Zebertavage, Lauren; Friedman, David; Cottam, Benjamin; Newell, Pippa; Gough, Michael J.; Crittenden, Marka R.; Van der Veken, Pieter; Young, Kristina H.			Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; CD8(+) T-CELLS; STROMAL CELLS; CANCER; EXPRESSION; THERAPY; FAP; IMMUNOTHERAPY; INHIBITORS; IMMUNITY	Pancreatic ductal adenocarcinoma (PDAC) is characterized by a fibrotic stroma with a poor lymphocyte infiltrate, in part driven by cancer-associated fibroblasts (CAFs). CAFs, which express fibroblast activation protein (FAP), contribute to immune escape via exclusion of anti-tumor CD8(+) T cells from cancer cells, upregulation of immune checkpoint ligand expression, immunosuppressive cytokine production, and polarization of tumor infiltrating inflammatory cells. FAP is a post-proline peptidase selectively expressed during tissue remodeling and repair, such as with wound healing, and in the tumor microenvironment by cancer-associated fibroblasts. We targeted FAP function using a novel small molecule inhibitor, UAMC-1110, and mice with germline knockout of FAP and concomitant knock-in of E. coli beta-galactosidase. We depleted CAFs by adoptive transfer of anti-beta gal T cells into the FAP knockout animals. Established syngeneic pancreatic tumors in immune competent mice were targeted with these 3 strategies, followed by focal radiotherapy to the tumor. FAP loss was associated with improved antigen-specific tumor T cell infiltrate and enhanced collagen deposition. However, FAP targeting alone or with tumor-directed radiation did not improve survival even when combined with anti-PD1 therapy. Targeting of CAFs alone or in combination with radiation did not improve survival. We conclude that targeting FAP and CAFs in combination with radiation is capable of enhancing anti-tumor T cell infiltrate and function, but does not result in sufficient tumor clearance to extend survival.	[Gunderson, Andrew J.; Yamazaki, Tomoko; McCarty, Kayla; Phillips, Michaela; Alice, Alejandro; Bambina, Shelly; Zebertavage, Lauren; Friedman, David; Cottam, Benjamin; Newell, Pippa; Gough, Michael J.; Crittenden, Marka R.; Young, Kristina H.] Providence Canc Inst, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Newell, Pippa] Oregon Clin, Gastrointestinal & Minimally Invas Surg, Portland, OR USA; [Crittenden, Marka R.; Young, Kristina H.] Oregon Clin, Radiat Oncol, Portland, OR 97220 USA; [Van der Veken, Pieter] UA, Dept Pharmaceut Sci, Med Chem UAMC, Antwerp, Belgium	University of Antwerp	Young, KH (corresponding author), Providence Canc Inst, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA.; Young, KH (corresponding author), Oregon Clin, Radiat Oncol, Portland, OR 97220 USA.	kristina.young@providence.org	Gough, Michael/AAY-3419-2020; Van der Veken, Pieter/P-5819-2016	Gough, Michael/0000-0002-5575-0074; Van der Veken, Pieter/0000-0003-1208-3571; Friedman, David/0000-0002-1295-1562	American Society of Clinical Oncologists Young Investigator Award; Collins Medical Trust; Radiologic Society of North America Research Seed Grant	American Society of Clinical Oncologists Young Investigator Award; Collins Medical Trust; Radiologic Society of North America Research Seed Grant	This work was supported by American Society of Clinical Oncologists Young Investigator Award: https://www.conquer.org/young-investigator-award Radiologic Society of North America Research Seed Grant: https://www.rsna.org/en/research/funding-opportunities/research-grants/research-seed-grant, Collins Medical Trust: http://www.collinsmedicaltrust.org.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Cremasco V, 2018, CANCER IMMUNOL RES, V6, P1472, DOI 10.1158/2326-6066.CIR-18-0098; Crittenden MR, 2016, ONCOTARGET, V7, P78653, DOI 10.18632/oncotarget.11823; Crittenden MR, 2014, RADIAT RES, V182, P182, DOI 10.1667/RR13493.1; Crittenden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069527; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Fearon DT, 2014, CANCER IMMUNOL RES, V2, P187, DOI 10.1158/2326-6066.CIR-14-0002; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Formenti SC, 2018, CLIN CANCER RES, DOI [10.1158/1078-0432, DOI 10.1158/1078-0432]; Ganss R, 2002, CANCER RES, V62, P1462; Gottschalk S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082658; Gough MJ, 2010, J IMMUNOTHER, V33, P798, DOI 10.1097/CJI.0b013e3181ee7095; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hawinkels LJAC, 2014, ONCOGENE, V33, P97, DOI 10.1038/onc.2012.536; Jansen K, 2014, J MED CHEM, V57, P3053, DOI 10.1021/jm500031w; Jansen K, 2013, ACS MED CHEM LETT, V4, P491, DOI 10.1021/ml300410d; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Juillerat-Jeanneret L, 2017, EXPERT OPIN THER TAR, V21, P977, DOI 10.1080/14728222.2017.1370455; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kunk PR, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0119-z; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lo A, 2015, CANCER RES, V75, P2800, DOI 10.1158/0008-5472.CAN-14-3041; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Lykidis D, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm433; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Masso-Valles D, 2015, CANCER RES, V75, P1675, DOI 10.1158/0008-5472.CAN-14-2852; Mazur A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150287; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Niedermeyer J, 2001, INT J DEV BIOL, V45, P445; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; PRIEBE TS, 1992, CANCER CHEMOTH PHARM, V29, P485, DOI 10.1007/BF00684853; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Young KH, 2014, CANCER IMMUNOL RES, V2, P1011, DOI 10.1158/2326-6066.CIR-13-0207; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056; Zhang Y, 2016, ONCOTARGET, V7, P23282, DOI 10.18632/oncotarget.7818; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	42	36	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0211117	10.1371/journal.pone.0211117	http://dx.doi.org/10.1371/journal.pone.0211117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726287	Green Published, Green Submitted, gold			2022-12-26	WOS:000457874000054
J	Yang, S; Xue, S; Kang, WW; Qian, ZX; Yi, ZL				Yang, Sai; Xue, Shuai; Kang, Weiwei; Qian, Zhuxi; Yi, Zili			Genetic diversity and population structure of Miscanthus lutarioriparius, an endemic plant of China	PLOS ONE			English	Article							CODON TARGETED SCOT; SINENSIS; ENERGY; LAND; ISSR; DNA; MARKERS; FLOW; CROP; US	Miscanthus lutarioriparius is a native perennial Miscanthus species of China, which is currently used as raw material of papermaking and bioenergy crop. It also has been considered as a promising eco-bioindustrial plant, which can offer raw material and gene for the biomass industry. However, lack of germplasm resources and genetic diversity information of M. lutarioriparius have become the bottleneck that prevents the stable and further development of the biomass industry. In the present study, genetic diversity of 153 M. lutarioriparius individuals nine populations was studied using 27 Start Codon Targeted (SCoT) markers. High polymorphic bands (97.67%), polymorphic information content (0.26) and allele number (1.88) showed SCoT as a reliable marker system for genetic analysis in M. lutarioriparius. At the species, the percentage of polymorphic loci [PPL] was 97.2%, Nei's gene diversity [H] was 0.36, Shannon index [I] was 0.54 and Expected Heterozygosity [He] was 0.56. Genetic variation within populations (84.91%) was higher than among populations (15.09%) based on analysis of molecular variance (AMOVA). Moderate level of genetic differentiation was found in M. lutarioriparius populations (F-st = 0.15), which is further confirmed by STRUCTURE, principal coordinates analysis (PCoA) and an unweighted pair group method with arithmetic mean (UPGMA) analysis that could reveal a clear separation between groups of the north and south of Yangtze River. The gene flow of the populations within the respective south and north of Yangtze River area was higher, but lower between the areas. There was no obvious correlation between genetic distance and geographic distance. The breeding systems, geographical isolation and fragmented habitat of M. lutarioriparius may be due to the high level of genetic diversity, moderate genetic differentiation, and the population, structure. The study further suggests some measure for conservation of genetic resources and provides the genetic basis for improving the efficiency of breeding based on the results of diversity analysis.	[Yang, Sai; Xue, Shuai; Kang, Weiwei; Yi, Zili] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Yang, Sai; Qian, Zhuxi] Hunan Agr Univ, Orient Sci & Technol Coll, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Agricultural University	Yi, ZL (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	yizili889@163.com	Xue, Shuai/AAX-7888-2021	Xue, Shuai/0000-0002-4397-1013	Undergraduate Research Learning and Innovative Experimental Program of Hunan Province [DFCXS201603]; Hundred-Youth Scheme of Hunan Province [5404921]	Undergraduate Research Learning and Innovative Experimental Program of Hunan Province; Hundred-Youth Scheme of Hunan Province	This research was supported by the Undergraduate Research Learning and Innovative Experimental Program of Hunan Province (No. DFCXS201603) and Hundred-Youth Scheme of Hunan Province (No. 5404921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani L, 2014, GENE, V552, P176, DOI 10.1016/j.gene.2014.09.034; Alzagameem A, 2018, LIGNOCELLULOSIC BIOM; An G-H, 2010, SOIL SCI PLANT NUTR, V54, P517, DOI [10.1111/j.1747.0765.2008.00267.x, DOI 10.1111/J.1747.0765.2008.00267.X]; Andrew L, 2005, ECOLOGICAL GENETICS; Ayala F, 1984, MODERN GENETICS, DOI [10.1016/j.gene.2014.09.034, DOI 10.1016/J.GENE.2014.09.034]; Basch G, 2002, REV CIENCIAS AGRARIA, V36, P469; Borba EL, 2001, ANN BOT-LONDON, V88, P89, DOI 10.1006/anbo.2001.1435; Brosse N, 2012, BIOFUEL BIOPROD BIOR, V6, P580, DOI 10.1002/bbb.1353; Chen S, 2006, FLORA CHINA, V12, P165; Chen X, 2009, STUDY VARIATION PATT; Christian DG, 2001, MISCANTHUS ENERGY FI; Clark LV, 2015, J EXP BOT, V66, P4213, DOI 10.1093/jxb/eru511; Clark LV, 2014, ANN BOT-LONDON, V114, P97, DOI 10.1093/aob/mcu084; Clifton-Brown JC, 2004, GLOBAL CHANGE BIOL, V10, P509, DOI 10.1111/j.1529-8817.2003.00749.x; Clifton-Brown JC, 2011, DEV MISCANTHUS BIOEN, P301; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El Hage R, 2009, POLYM DEGRAD STABIL, V94, P1632, DOI 10.1016/j.polymdegradstab.2009.07.007; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ezaki B, 2008, PLANT CELL REP, V27, P951, DOI 10.1007/s00299-007-0503-8; Feng SG, 2015, GENE, V567, P182, DOI 10.1016/j.gene.2015.04.076; Fernando AL, 2004, MATER SCI FORUM, V455-456, P437, DOI 10.4028/www.scientific.net/MSF.455-456.437; George S, 2009, AM J BOT, V96, P2022, DOI 10.3732/ajb.0800368; Godt MJW, 1996, CONSERV BIOL, V10, P796, DOI 10.1046/j.1523-1739.1996.10030796.x; Gorji AM, 2012, AM J POTATO RES, V89, P453, DOI 10.1007/s12230-012-9268-x; Gorji AM, 2011, AM J POTATO RES, V88, P226, DOI 10.1007/s12230-011-9187-2; Greef JM, 1997, GENET RESOUR CROP EV, V44, P185, DOI 10.1023/A:1008693214629; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Hodkinson TR, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300042; Huang CL, 2014, PLANT J, V80, P834, DOI 10.1111/tpj.12676; Huang LK, 2014, GENET RESOUR CROP EV, V61, P1047, DOI 10.1007/s10722-014-0107-4; Jiang QiaoQiao, 2011, Agricultural Science & Technology - Hunan, V12, P1594; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2006, AGR ECOSYST ENVIRON, V112, P335, DOI 10.1016/j.agee.2005.08.003; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Lewandowski I, 2003, HARVEST TIME AFFECTS, P603; Li C, 2016, FUEL, V179, P267, DOI 10.1016/j.fuel.2016.03.087; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Luo C, 2014, GENE, V548, P182, DOI 10.1016/j.gene.2014.07.024; Mccalmont JP, 2017, GCB BIOENERGY, V9, P710, DOI 10.1111/gcbb.12380; Nie G, 2014, MOLECULES, V19, P12881, DOI 10.3390/molecules190812881; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pinheiro LR, 2012, PLANT SYST EVOL, V298, P1815, DOI 10.1007/s00606-012-0682-9; Pritchard JK, 2000, GENETICS, V155, P945; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharmin SA, 2012, PLANT SCI, V187, P113, DOI 10.1016/j.plantsci.2012.02.002; Shekhawat JK, 2018, IND CROP PROD, V122, P202, DOI 10.1016/j.indcrop.2018.05.074; Singh SK, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-016-1092-x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Still S., 2010, HORTSCIENCE PUBLICAT, V45, P604; Sun M, 1996, CONSERV BIOL, V10, P785, DOI 10.1046/j.1523-1739.1996.10030785.x; Tang J, 2015, PLANTA, V242, P985, DOI 10.1007/s00425-015-2335-z; Van der Weijde T, 2017, GCB BIOENERGY, V9, P176, DOI 10.1111/gcbb.12355; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xi Q., 2000, INVESTIGATION DISTRI; Xu WZ, 2013, BIOCHEM SYST ECOL, V48, P174, DOI 10.1016/j.bse.2012.11.024; Xue S, 2016, RENEW SUST ENERG REV, V54, P932, DOI 10.1016/j.rser.2015.10.040; Yan J, 2016, GCB BIOENERGY, V8, P764, DOI 10.1111/gcbb.12278; Yan J, 2015, GCB BIOENERGY, V7, P207, DOI 10.1111/gcbb.12118; Yook MJ, 2014, BIOMASS BIOENERG, V66, P81, DOI 10.1016/j.biombioe.2014.01.025; Yu HH, 2011, BIOCHEM SYST ECOL, V39, P71, DOI 10.1016/j.bse.2010.12.003; Zapater M, 2017, BIOENERG RES, V10, P115, DOI 10.1007/s12155-016-9781-8; Zhang JC, 2015, MOLECULES, V20, P5987, DOI 10.3390/molecules20045987; Zhang QX, 2013, BIOCHEM SYST ECOL, V48, P248, DOI 10.1016/j.bse.2012.12.024; Zhang Y, 2016, HEREDITAS, V153, DOI 10.1186/s41065-016-0007-z; Zhao H, 2014, GCB BIOENERGY, V6, P768, DOI 10.1111/gcbb.12115; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075672; Zhao XF, 2012, INT J MOL SCI, V13, P4396, DOI 10.3390/ijms13044396; Zhao YL, 2017, GCB BIOENERGY, V9, P965, DOI 10.1111/gcbb.12404	77	17	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211471	10.1371/journal.pone.0211471	http://dx.doi.org/10.1371/journal.pone.0211471			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707722	Green Submitted, Green Published, gold			2022-12-26	WOS:000457742900028
J	Nguyen, KA; Peer, N; de Villiers, A; Mukasa, B; Matsha, TE; Mills, EJ; Kengne, AP				Nguyen, Kim A.; Peer, Nasheeta; de Villiers, Anniza; Mukasa, Barbara; Matsha, Tandi E.; Mills, Edward J.; Kengne, Andre P.			Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans	PLOS ONE			English	Article							A1C	Background Glycated haemoglobin (HbA1c) test has been increasingly promoted as an alternative to fasting plasma glucose (FPG) or oral glucose tolerance test (OGTT) to diagnose dysglycaemia but its performance in HIV-infected Africans has yet to be established. This study aimed to assess the diagnostic accuracy of HbA1c for dysglycaemia including FPG-defined and OGTT-defined dysglycaemia, and OGTT-defined diabetes in HIV-infected Africans, and the effect of HbA1c-predicted dysglycaemia on Joint Interim Statement (JIS)-based prevalent metabolic syndrome (MS). Methods A cross-sectional study included HIV-positive patients recruited across public healthcare facilities in the Western Cape. The recommended HbA1c cut-points were tested alongside the optimal cut-points obtained from receiver operating characteristic curve analyses, while the agreement between the MS criteria were assessed using kappa statistic. Results 748 participants (157 men), median age 38 years, 93% on anti-retroviral drugs were included. The optimal HbA1c cut-points of 5.75% (39.3 mmol/mol) showed 54% sensitivity, 84% specificity for FPG-defined dysglycaemia, and 52% sensitivity, 85% specificity for OGTT-defined dysglycaemia. The HbA1c value of 5.85% (40.4 mmol/mol) (63% sensitivity, 99% specificity) was optimal for diabetes. The internationally advocated cut-point of 6.5% (48 mmol/mol) had 37% sensitivity and 99% specificity for diabetes, while HbA1c >= 5.7%(>= 39 mmol/mol) yielded similar performance with the study-specific cut-point for any dysglycaemia. MS prevalence by the JIS criteria (28.2%) increased to 29.7% when using HbA1c >= 5.75% (>= 39.3 mmol/mol) and to 32.9% with HbA1c >= 5.7% (>= 39 mmol/mol); agreement between the original and modified criteria was generally good. Conclusions This study agrees with the internationally recommended HbA1c cut-point for detecting dysglycaemia, but not for diabetes in HIV-infected Africans. In line with previous studies in general African populations, our findings suggest that similar factors interfere with HbA1c values regardless of HIV infection status. Replacing FPG-based with HbA1c-predicted dysglycaemia in the JIS criteria to diagnose MS is feasible in HIV-infected Africans.	[Nguyen, Kim A.; Peer, Nasheeta; de Villiers, Anniza; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Nguyen, Kim A.; Peer, Nasheeta; Kengne, Andre P.] Univ Cape Town, Dept Med, Fac Hlth Sci, Cape Town, South Africa; [Nguyen, Kim A.] Stellenbosch Univ, Ctr Evidence Based Hlth Care, Div Epidemiol & Biostat, Fac Med & Hlth Sci, Cape Town, South Africa; [Mukasa, Barbara] United Nations Populat Fund UNFPA, Mildmay, Uganda; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Dept Biomed Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa; [Mills, Edward J.] Global Evaluat Sci, Vancouver, BC, Canada	South African Medical Research Council; University of Cape Town; Stellenbosch University; United Nations Population Fund; Cape Peninsula University of Technology	Nguyen, KA (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.; Nguyen, KA (corresponding author), Univ Cape Town, Dept Med, Fac Hlth Sci, Cape Town, South Africa.; Nguyen, KA (corresponding author), Stellenbosch Univ, Ctr Evidence Based Hlth Care, Div Epidemiol & Biostat, Fac Med & Hlth Sci, Cape Town, South Africa.	kimn@sun.ac.za	Kengne, Andre Pascal/ABB-3696-2020; De Villiers, Anniza/GQB-3288-2022	Peer, Nasheeta/0000-0003-2131-8344; Kengne, Andre Pascal/0000-0002-5183-131X	Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative; NRF; Yeoman Bequest Bursary through the University of Cape Town	Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative; NRF; Yeoman Bequest Bursary through the University of Cape Town	Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative funded this study. NRF Innovation Doctoral Research Scholarship, Doctoral Scholarship and Yeoman Bequest Bursary through the University of Cape Town supported KAN. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Global Evaluation Science provided support in the form of salary for EJM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contribution' section.	Africa SS, 2016, MIDYEAR POPULATION E; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; BRYANT Systems, 2015, BRYANT RES SYSTEMS W; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Diop ME, 2006, AIDS RES HUM RETROV, V22, P1242, DOI 10.1089/aid.2006.22.1242; Eckhardt BJ, 2012, AIDS PATIENT CARE ST, V26, P197, DOI 10.1089/apc.2011.0379; English E, 2015, DIABETOLOGIA, V58, P1409, DOI 10.1007/s00125-015-3599-3; Hare MJL, 2012, J INTERN MED, V271, P227, DOI 10.1111/j.1365-2796.2012.02513.x; Kim PS, 2009, DIABETES CARE, V32, P1591, DOI 10.2337/dc09-0177; Levitt NS, 2000, DIABETIC MED, V17, P381, DOI 10.1046/j.1464-5491.2000.00264.x; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nguyen KA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060299; Slama L, 2014, J ANTIMICROB CHEMOTH, V69, P3360, DOI 10.1093/jac/dku295; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zemlin AE, 2015, CLIN CHIM ACTA, V448, P215, DOI 10.1016/j.cca.2015.06.019; Zemlin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022558	18	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211483	10.1371/journal.pone.0211483	http://dx.doi.org/10.1371/journal.pone.0211483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703147	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600051
J	Martins, MVA; Hohenegger, J; Frontalini, F; Dias, JMA; Geraldes, MC; Rocha, F				Alves Martins, Maria Virginia; Hohenegger, Johann; Frontalini, Fabrizio; Alveirinho Dias, Joao Manuel; Geraldes, Mauro Cesar; Rocha, Fernando			Dissimilarity between living and dead benthic foraminiferal assemblages in the Aveiro Continental Shelf (Portugal)	PLOS ONE			English	Article							SEDIMENTARY PROCESSES; SPECIES COMPOSITION; EASTERN BOUNDARY; ATLANTIC COAST; SEA; DIVERSITY; MARGIN; VARIABILITY; PATTERNS; LAGOON	This study compares living (LA) and dead (DA) benthic foraminiferal assemblages and identifies different factors that possibly cause differences in the distribution of both assemblages in the Aveiro Continental Shelf (Portugal). A total of 44 sediment samples was collected during summers of 1994 and 1995 along transects (east-west direction) and between 10 and 200 m water depth. Complex statistical analyses allow us to compare the abundance and composition of the LAs and DAs in function of depth, grain-size and total organic matter in all studied stations even in those where the numbers of individuals were rare in one or both assemblages. The highest densities and diversities of the LAs are found in the middle continental shelf on gravel deposits (coarse and very coarse sands) mostly due to the substrate stability, reduced deposition of fine sedimentary particles, availability of organic matter with high quality related to oceanic primary productivity likely induced by upwelling events, and oxygenated porewaters conditions. The DAs have, in general, higher densities and diversities than the LAs. In the outer continental shelf, the dissimilarity between both assemblages is higher due to the accumulation of tests, low dilution by sedimentary particles and scarcity of living foraminifera. Based on the comparison of LAs and DAs and considering the characteristics of the study area and the species ecology, it has been possible to understand the cause of temporal deviation between the LAs and DAs of benthic foraminifera. This deviation is much more pronounced in the inner shelf where the energy of the waves and the currents induce very dynamic sedimentary processes preventing the development of large LAs and the preservation of DAs. Some deviation also occurs in the middle shelf due to the seasonal loss of empty tests. The most well-preserved time-averaged DAs were found in the outer continental shelf.	[Alves Martins, Maria Virginia; Geraldes, Mauro Cesar] Univ Estado Rio de Janeiro, Fac Geol, Dept Estratig & Paleontol, Rio De Janeiro, Brazil; [Alves Martins, Maria Virginia; Rocha, Fernando] Univ Aveiro, GeoBioTec, Dept Geociencias, Aveiro, Portugal; [Hohenegger, Johann] Univ Wien, Inst Palaontol, Vienna, Austria; [Frontalini, Fabrizio] Univ Urbino Carlo Bo, Dipartimento Sci Pure & Applicate DiSPeA, Urbino, Italy; [Alveirinho Dias, Joao Manuel] Univ Algarve, CIMA, Campus Gambelas, Faro, Portugal	Universidade do Estado do Rio de Janeiro; Universidade de Aveiro; University of Vienna; University of Urbino; Universidade do Algarve	Martins, MVA (corresponding author), Univ Estado Rio de Janeiro, Fac Geol, Dept Estratig & Paleontol, Rio De Janeiro, Brazil.; Martins, MVA (corresponding author), Univ Aveiro, GeoBioTec, Dept Geociencias, Aveiro, Portugal.	virginia.martins@ua.pt	Frontalini, Fabrizio/C-4819-2008; Alves Martins, Maria Virginia/AAD-3531-2021; Martins, Maria Virginia Alves/O-2893-2013; Rocha, Fernando/A-4532-2009	Frontalini, Fabrizio/0000-0002-0425-9306; Alves Martins, Maria Virginia/0000-0001-8348-8862; Martins, Maria Virginia Alves/0000-0001-8348-8862; Rocha, Fernando/0000-0002-3636-3933	Universidade de Aveiro; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [UID/GEO/04035/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CnPQ, Brazil [301588/2016-3]	Universidade de Aveiro(European Commission); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CnPQ, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Universidade de Aveiro and by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through the strategic project UID/GEO/04035/2013. The first author received a research grant (reference number: 301588/2016-3) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CnPQ, Brazil.	Abrantes I., 1994, GAIA, V8, P97; Abrantes M.I, 2005, THESIS; Abrantes MIRR, 1994, THESIS; ALAVI SN, 1988, MAR MICROPALEONTOL, V13, P213, DOI 10.1016/0377-8398(88)90004-7; Altenbach A. V., 1988, REV PALEOBIOL, V2, P719; Altenbach AV, 1999, J FORAMIN RES, V29, P173; Martins MVA, 2017, J SEDIMENT ENVIRON, V2, P9, DOI 10.12957/jse.2017.28041; Martins MVA, 2016, PALAEOGEOGR PALAEOCL, V455, P16, DOI 10.1016/j.palaeo.2016.05.003; Martins MVA, 2016, MAR POLLUT BULL, V105, P161, DOI 10.1016/j.marpolbul.2016.02.032; Martins MVA, 2015, MAR ENVIRON RES, V109, P52, DOI 10.1016/j.marenvres.2015.06.006; Antia A, 1999, OMEXII II 2 ANN SCI, P249; Antia AN, 2001, DEEP-SEA RES PT II, V48, P3083, DOI 10.1016/S0967-0645(01)00033-9; Boltovskoy E, 1957, BERNARDINO RIVADAVIA, V6, P1; BUZAS MA, 1969, SCIENCE, V163, P72, DOI 10.1126/science.163.3862.72; Buzas MA, 2002, J FORAMIN RES, V32, P68, DOI 10.2113/0320068; Caruso A, 2011, CHEM ECOL, V27, P9, DOI 10.1080/02757540.2010.529076; Carvalho FP, 1990, 2 C QUAL AMB LISB, pA143; Carvalho RAC, 1991, SEM ZON COST PROBL A, P184; Cascalho J., 2000, THESIS; CHAO A, 1984, SCAND J STAT, V11, P265; Colom G., 1974, PATRONO J DELACIERVA, V38; Coppa M. Grazia, 1995, Revista Espanola de Paleontologia, V10, P161; CORLISS BH, 1985, NATURE, V314, P435, DOI 10.1038/314435a0; CORLISS BH, 1988, GEOLOGY, V16, P716, DOI 10.1130/0091-7613(1988)016<0716:MPONSD>2.3.CO;2; Debenay J.-P., 1987, Revue de Paleobiologie, V6, P213; Debenay Jean-Pierre, 1993, Revue de Paleobiologie, V12, P265; Debenay JP, 2001, MAR MICROPALEONTOL, V43, P75, DOI 10.1016/S0377-8398(01)00023-8; DEBENAY JP, 1990, J FORAMIN RES, V20, P267, DOI 10.2113/gsjfr.20.3.267; Dessandier PA, 2018, MAR MICROPALEONTOL, V140, P1, DOI 10.1016/j.marmicro.2018.01.001; Dias J. M. A, 1987, THESIS; DIAS JMA, 1992, J COASTAL RES, V8, P641; Dias JMA, 2002, PROG OCEANOGR, V52, P215, DOI 10.1016/S0079-6611(02)00007-1; Dias JMA, 2002, PROG OCEANOGR, V52, P249, DOI 10.1016/S0079-6611(02)00009-5; DIAS JMA, 1984, CONT SHELF RES, V3, P147, DOI 10.1016/0278-4343(84)90004-9; Dias JMA, 1983, B SOC GEOL PORTUGAL, VXXIV, P31; Dias JMA, 1980, B SOC GEOL PORTUGAL, V22, P181; Dias JMA, 1985, 1 REUNIAO QUATERNARI, VI, P281; Dijkstra N, 2017, MAR POLLUT BULL, V114, P384, DOI 10.1016/j.marpolbul.2016.09.053; Dimiza Margarita D., 2016, Revue de Micropaleontologie, V59, P19, DOI 10.1016/j.revmic.2015.10.002; Diz P, 2004, J FORAMIN RES, V34, P258, DOI 10.2113/34.4.258; Ernst SR, 2002, GEOL ULTRAIECTINA, V220; Fatela F, 1989, MEMOIRE PRESENTEE U; Ferreira O, 1993, THESIS; Fiuza A., 1984, THESIS; FIUZA AFD, 1982, OCEANOL ACTA, V5, P31; Fiuza AFG, 1983, COASTAL UPWELLING A, P85; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Fraga F., 1981, COASTAL UPWELLING, P176, DOI [10.1029/co001p0176, DOI 10.1029/C0001P0176, DOI 10.1029/CO001P0176]; Frontalini F, 2008, ESTUAR COAST SHELF S, V76, P404, DOI 10.1016/j.ecss.2007.07.024; FROUIN R, 1990, J GEOPHYS RES-OCEANS, V95, P679, DOI 10.1029/JC095iC01p00679; Goineau A, 2015, MAR MICROPALEONTOL, V119, P17, DOI 10.1016/j.marmicro.2015.07.002; GOODAY AJ, 1993, MAR MICROPALEONTOL, V22, P187, DOI 10.1016/0377-8398(93)90043-W; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; HAYNES R, 1993, J GEOPHYS RES-OCEANS, V98, P22681, DOI 10.1029/93JC02016; HAYNES R, 1990, J GEOPHYS RES-OCEANS, V95, P11425, DOI 10.1029/JC095iC07p11425; Hayward B.W., 1993, TANE, V34, P79; Hayward Bruce W., 1994, Journal of Micropalaeontology, V13, P103; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hohenegger J, 2018, MICROPALEONTOLOGY, V64, P255; Huthnance JM, 2002, J MARINE SYST, V32, P107, DOI 10.1016/S0924-7963(02)00034-9; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost Lou, 2011, P66; Jouanneau JM, 2002, PROG OCEANOGR, V52, P261, DOI 10.1016/S0079-6611(02)00010-1; Kidwell SM, 2013, PNAS, V112, P4922; Kidwell SM, 2008, LETHAIA, V41, P199, DOI 10.1111/j.1502-3931.2007.00050.x; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Kidwell SM, 2013, ANNU REV ECOL EVOL S, V44, P539, DOI 10.1146/annurev-ecolsys-110512-135838; LEVY A, 1993, MICROPALEONTOLOGY, V39, P75, DOI 10.2307/1485977; LEVY A, 1995, MEM I GEOL MM PORT, V32, P116; Li ZY, 2014, QUATERN INT, V349, P113, DOI 10.1016/j.quaint.2014.05.019; Lorenzo LM, 2005, J MARINE SYST, V54, P157, DOI 10.1016/j.jmarsys.2004.07.010; MagalhAes F., 1999, THESIS; Magurran A.E., 2011, BIOL DIVERSITY; Martins M.V.A., 2016, J SEDIMENT ENV, V1, P411, DOI [10.12957/jse.2016.26875, DOI 10.12957/JSE.2016.26875]; Martins MVA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137250; Martins V, 2012, ESTUAR COAST SHELF S, V102, P48, DOI 10.1016/j.ecss.2012.03.004; Martins V, 2012, J MARINE SYST, V96-97, P48, DOI 10.1016/j.jmarsys.2012.02.001; Martins VA, 2013, MAR POLLUT BULL, V70, P18, DOI 10.1016/j.marpolbul.2013.02.003; Maze JP, 1997, DEEP-SEA RES PT I, V44, P1543, DOI 10.1016/S0967-0637(97)00038-1; MCCARTNEY MS, 1982, J PHYS OCEANOGR, V12, P1169, DOI 10.1175/1520-0485(1982)012<1169:TSMWOT>2.0.CO;2; Mendes I, 2004, MAR MICROPALEONTOL, V51, P171, DOI 10.1016/j.marmicro.2003.11.001; Mendes I, 2012, J FORAMIN RES, V42, P18; Monteiro JH, 1982, ARTISTS ARTISANS DEL, P89; MOUGENOT D, 1980, ANN I OCEANOGR PARIS, V56, P85; Murray J.W., 1971, ATLAS BRIT RECENT FO; Murray J. W., 1991, ECOLOGY PALAEOECOLOG; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Oliveira A, 2002, PROG OCEANOGR, V52, P233, DOI 10.1016/S0079-6611(02)00008-3; Oliveira A, 2002, PROG OCEANOGR, V52, P195, DOI 10.1016/S0079-6611(02)00006-X; ORLOCI L, 1966, J ECOL, V54, P193, DOI 10.2307/2257667; Parker FL., 1958, SEDIMENT CORES MEDIT, V4, P219; Peliz A, 2002, J MARINE SYST, V35, P61, DOI 10.1016/S0924-7963(02)00076-3; Pereira AR, 1992, LINHA ACCDE GEOGRAFI, V30; Ribeiro A, 1988, RELATORIO EXECUCAO P; Rodrigues A., 2001, THESIS; Rodrigues Ana Maria J., 1993, Netherlands Journal of Aquatic Ecology, V27, P449, DOI 10.1007/BF02334806; Samir AM, 2000, J FORAMIN RES, V30, P83, DOI 10.2113/0300083; Sanchez-Vidal A, 2004, J MARINE SYST, V52, P89, DOI 10.1016/j.jmarsys.2004.01.010; Schmidt S, 2002, J MARINE SYST, V32, P3, DOI 10.1016/S0924-7963(02)00027-1; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; SENGUPTA BK, 1993, MAR MICROPALEONTOL, V20, P183, DOI 10.1016/0377-8398(93)90032-S; Sgarrella Franca, 1993, Bollettino della Societa Paleontologica Italiana, V32, P145; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; STIGTER HC, 1998, J FORAMIN RES, V28, P40; Taborda R, 1992, GEONOVAS, V3, P117; Taborda R, 1999, THESIS; Tang Y., 2018, BIOGEOSCIENCES DISCU, DOI [10.5194/bg-2018-309, DOI 10.5194/BG-2018-309]; Tomasovych A, 2016, TERRA NOVA, V28, P271, DOI 10.1111/ter.12218; Tomasovych A, 2010, PALEOBIOLOGY, V36, P672, DOI 10.1666/08092.1; Tomasovych A, 2009, PALEOBIOLOGY, V35, P94, DOI 10.1666/08024.1; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; van der Zwaan G.J., 1991, Geological Society Special Publication, V58, P65, DOI 10.1144/GSL.SP.1991.058.01.05; Van der Zwaan G.J., 1982, UTRECHT MICROPALEONT, V25; VANNEY JR, 1990, OCEANOL ACTA, V13, P1; Vanney JR, 1981, MEM SERV GEOL PORTUG, V28; Vitorino J, 2002, PROG OCEANOGR, V52, P155, DOI 10.1016/S0079-6611(02)00004-6; Vitorino J, 2000, 3 S IB ATL MARG FAR, P279; Vitorino J.P.N., 1989, ANAIS I HIDROGRAFICO, V10, P25; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; WOOSTER WS, 1976, J MAR RES, V34, P131	121	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0209066	10.1371/journal.pone.0209066	http://dx.doi.org/10.1371/journal.pone.0209066			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699123	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600010
J	Chignola, R; Sega, M; Molesini, B; Baruzzi, A; Stella, S; Milotti, E				Chignola, Roberto; Sega, Michela; Molesini, Barbara; Baruzzi, Anna; Stella, Sabrina; Milotti, Edoardo			Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein	PLOS ONE			English	Article							RETROVIRUS-LIKE PARTICLES; LINE; RADIOTHERAPY; EXPRESSION	It is generally accepted that radiotherapy must target clonogenic cells, i.e., those cells in a tumour that have self-renewing potential. Focussing on isolated clonogenic cells, however, may lead to an underestimate or even to an outright neglect of the importance of biological mechanisms that regulate tumour cell sensitivity to radiation. We develop a new statistical and experimental approach to quantify the effects of radiation on cell populations as a whole. In our experiments, we change the proximity relationships of the cells by culturing them in wells with different shapes, and we find that the radiosensitivity of T47D human breast carcinoma cells in tight clusters is different from that of isolated cells. Molecular analyses show that T47D cells express a Syncytin-1 homologous protein (SyHP). We observe that SyHP translocates to the external surface of the plasma membrane of cells killed by radiation treatment. The data support the fundamental role of SyHP in the formation of intercellular cytoplasmic bridges and in the enhanced radioresistance of surviving cells. We conclude that complex and unexpected biological mechanisms of tumour radioresistance take place at the cell population level. These mechanisms may significantly bias our estimates of the radiosensitivity of breast carcinomas in vivo and thereby affect treatment plans, and they call for further investigations.	[Chignola, Roberto; Sega, Michela; Molesini, Barbara] Univ Verona, Dept Biotechnol, Str Le Grazie 15, Verona, Italy; [Baruzzi, Anna] Univ Verona, Dept Med, Piazzale L Scuro 10, Verona, Italy; [Stella, Sabrina; Milotti, Edoardo] Univ Trieste, Dept Phys, Via Valerio 2, Trieste, Italy; [Sega, Michela] GlaxoSmithKline, Via Alessandro Fleming 2, Verona, Italy; [Baruzzi, Anna] Don Bosco Inst, Stradone Provolo 16, Verona, Italy; [Stella, Sabrina] Modefinance Srl, AREA Sci Pk,Padriciano 99, Trieste, Italy	University of Verona; University of Verona; University of Trieste; GlaxoSmithKline	Chignola, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, Verona, Italy.	roberto.chignola@univr.it	Milotti, Edoardo/AAA-7076-2020	CHIGNOLA, Roberto/0000-0001-6981-6890; MOLESINI, Barbara/0000-0002-4324-4908	University of Verona	University of Verona	This work has been supported by grants from the University of Verona, Basic Research Program 2015 (RATs 2015, RC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baruzzi A, 2015, J IMMUNOL, V195, P4900, DOI 10.4049/jimmunol.1500579; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Brenner DJ, 2008, SEMIN RADIAT ONCOL, V18, P234, DOI 10.1016/j.semradonc.2008.04.004; CARLSSON J, 1983, ADV EXP MED BIOL, V159, P399; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Erenpreisa JA, 2000, CELL BIOL INT, V24, P635, DOI 10.1006/cbir.2000.0558; Erenpreisa J, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-92; FAFF O, 1992, J GEN VIROL, V73, P1087, DOI 10.1099/0022-1317-73-5-1087; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gucalp Ayca, 2014, F1000Prime Rep, V6, P66, DOI 10.12703/P6-66; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Illidge TM, 2000, CELL BIOL INT, V24, P621, DOI 10.1006/cbir.2000.0557; Ivanov A, 2003, J CELL SCI, V116, P4095, DOI 10.1242/jcs.00740; Larsen JM, 2009, CANCER LETT, V280, P44, DOI 10.1016/j.canlet.2009.02.008; Larsson LI, 2007, HUM PATHOL, V38, P726, DOI 10.1016/j.humpath.2006.10.018; Lavaille C, 2016, PHIL T R SOC B, V368; Milotti E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00990; NEDERMAN T, 1984, RECENT RESULTS CANC, V95, P84; Ozyigit G, 2014, WORLD J CLIN ONCOL, V5, P425, DOI 10.5306/wjco.v5.i3.425; Patience C, 1996, J VIROL, V70, P2654, DOI 10.1128/JVI.70.4.2654-2657.1996; SEGEV N, 1985, P NATL ACAD SCI USA, V82, P1531, DOI 10.1073/pnas.82.5.1531; SEIFARTH W, 1995, J VIROL, V69, P6408, DOI 10.1128/JVI.69.10.6408-6416.1995; Shah R, 2014, WORLD J CLIN ONCOL, V5, P283, DOI 10.5306/wjco.v5.i3.283; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thompson RF, 2014, ADV EXP MED BIOL, V772, P147, DOI 10.1007/978-1-4614-5915-6_7; Tubiana M, 2008, NAT REV CANCER, V8, DOI 10.1038/nrc2419-c1; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Waldmann H., 1979, LIMITING DILUTION AN	30	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0206713	10.1371/journal.pone.0206713	http://dx.doi.org/10.1371/journal.pone.0206713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699112	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600004
J	Donohue, SE; Weinhold, S; Schoenfeld, MA; Quiroga, RQ; Hopf, JM				Donohue, Sarah E.; Weinhold, Steffi; Schoenfeld, Mircea A.; Quiroga, Rodrigo Quian; Hopf, Jens-Max			A neural hallmark of auditory implicit learning is altered in older adults	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SERIAL PATTERNS; AGE-DIFFERENCES; SEQUENCE; EXPLICIT; YOUNG	Temporal regularities in the environment are often learned implicitly. In an auditory target-detection paradigm using EEG, Jongsma and colleagues (2006) showed that the neural response to these implicit regularities results in a reduction of the P-3-N-2 complex. Here, we utilized the same paradigm, this time in both young and old participants, to determine if this EEG signature of implicit learning was altered with age. Behaviorally, both groups of participants showed similar benefits for the presence of temporal regularity, with faster and more accurate responses given when the auditory targets were presented in a temporally regular vs. random pattern. In the brain, the younger adults showed the expected decrease in amplitude of this complex for regular compared to irregular trials. Older adults, in contrast, showed no difference in the amplitude of the P-3-N-2 complex between the irregular and regular condition. These data suggest that, although auditory implicit learning may be behaviorally spared in aging, older adults are not using the same neural substrates as younger adults to achieve this.	[Donohue, Sarah E.; Schoenfeld, Mircea A.; Hopf, Jens-Max] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Donohue, Sarah E.; Weinhold, Steffi; Schoenfeld, Mircea A.; Hopf, Jens-Max] Leibniz Inst Neurobiol, Magdeburg, Germany; [Schoenfeld, Mircea A.] Kliniken Schmieder Heidelberg, Heidelberg, Germany; [Quiroga, Rodrigo Quian] Univ Leicester, Leicester, Leics, England	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); University of Leicester	Hopf, JM (corresponding author), Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany.; Hopf, JM (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	jens-max.hopf@med.ovgu.de	Schoenfeld, Ariel/O-7513-2019	Schoenfeld, Ariel/0000-0001-9003-4092	Deutsche Forschungsgemeinschaft/ Sonderforschungsbereich [779, TP A1, TP A14N]	Deutsche Forschungsgemeinschaft/ Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by: Deutsche Forschungsgemeinschaft / Sonderforschungsbereich 779, Projects TP A1 to JMH and MAS; and Deutsche Forschungsgemeinschaft / Sonderforschungsbereich 779, Projects TP A14N to SED and MAS.	Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; CHERRY KE, 1995, PSYCHOL AGING, V10, P379, DOI 10.1037/0882-7974.10.3.379; Cock J, 2007, PSYCHOL RES-PSYCH FO, V71, P140, DOI 10.1007/s00426-005-0005-7; Curran T, 1997, PSYCHOL RES-PSYCH FO, V60, P24, DOI 10.1007/BF00419678; Dennis NA, 2006, EXP BRAIN RES, V175, P153, DOI 10.1007/s00221-006-0534-3; Dennis Nancy A, 2011, Neurobiol Aging, V32, DOI 10.1016/j.neurobiolaging.2010.04.004; Eimer M, 1996, J EXP PSYCHOL LEARN, V22, P970, DOI 10.1037/0278-7393.22.4.970; Ferdinand NK, 2017, DEV PSYCHOL, V53, P597, DOI 10.1037/dev0000262; Ferdinand NK, 2010, COGN TECHNOL, P55, DOI 10.1007/978-3-540-89408-7_4; Foster CM, 2017, MEMORY, V25, P187, DOI 10.1080/09658211.2016.1148739; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Goschke T, 2012, COGNITIVE PSYCHOL, V65, P284, DOI 10.1016/j.cogpsych.2012.04.002; HARRINGTON DL, 1992, PSYCHOL AGING, V7, P425, DOI 10.1037/0882-7974.7.3.425; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Howard JH, 2008, J EXP PSYCHOL LEARN, V34, P1139, DOI 10.1037/a0012797; Howard JH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00817; Howard JH, 2004, NEUROPSYCHOLOGY, V18, P124, DOI 10.1037/0894-4105.18.1.124; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Jongsma MLA, 2006, CLIN NEUROPHYSIOL, V117, P1957, DOI 10.1016/j.clinph.2006.05.012; Kopp B, 2000, BIOL PSYCHOL, V51, P223, DOI 10.1016/S0301-0511(99)00039-3; Mayr U, 1996, J EXP PSYCHOL LEARN, V22, P350, DOI 10.1037/0278-7393.22.2.350; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OKADA YC, 1983, ELECTROEN CLIN NEURO, V55, P417, DOI 10.1016/0013-4694(83)90130-X; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Repp B, 2003, PSYCHOL RES, V68, P1, DOI [10.1007/s00426-003-0132-y, DOI 10.1007/S00426-003-0132-Y]; Rieckmann A, 2009, NEUROPSYCHOL REV, V19, P490, DOI 10.1007/s11065-009-9117-y; RITTER W, 1984, ANN NY ACAD SCI, V425, P24, DOI 10.1111/j.1749-6632.1984.tb23521.x; Russeler J, 2003, COGNITIVE BRAIN RES, V15, P116, DOI 10.1016/S0926-6410(02)00145-3; Salthouse TA, 1999, AGING NEUROPSYCHOL C, V6, P1, DOI 10.1076/anec.6.1.1.789; Simon JR, 2012, J COGNITIVE NEUROSCI, V24, P451, DOI 10.1162/jocn_a_00116; Simon JR, 2011, J GERONTOL B-PSYCHOL, V66, P32, DOI 10.1093/geronb/gbq066; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; Weiermann B, 2012, J COGN PSYCHOL, V24, P468, DOI 10.1080/20445911.2011.653339; Weiermann B, 2012, COGNITION, V123, P380, DOI 10.1016/j.cognition.2012.02.010; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047	37	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211468	10.1371/journal.pone.0211468	http://dx.doi.org/10.1371/journal.pone.0211468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699188	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600080
J	Verbeek, E; Colditz, I; Blache, D; Lee, C				Verbeek, Else; Colditz, Ian; Blache, Dominique; Lee, Caroline			Chronic stress influences attentional and judgement bias and the activity of the HPA axis in sheep	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; LONG-TERM EXPOSURE; COGNITIVE BIAS; INDUCED HYPERTHERMIA; SELECTIVE ATTENTION; ALLOSTATIC LOAD; EMOTIONAL STATE; ANIMAL-WELFARE; LAYING HENS; DEPRESSION	Introduction Environmental challenges are part of everyday life for most domestic animals. However, very little is known about how animals cope emotionally and physiologically with cumulative challenges. This experiment aimed to determine the impact of long-term exposure to environmental challenges on the affective state and hypothalamic-pituitary-adrenal (HPA) axis responses to a subsequent additional acute shearing challenge. Methods Sheep were exposed to either a long-term environmental challenge (rest disruption and individual housing) in order to induce chronic stress (chronic stress group) or control conditions (group housing in a field with low stress handling and daily feed rewards, control group). Judgement and attention bias were assessed as measures of the emotional state following several days of the challenge or control treatment (pre-shearing tests). In addition, the responsiveness of the HPA-axis was evaluated using a combined Corticotropin Releasing Hormone and Arginine Vasopressin (CRH/AVP) challenge. Finally, all animals were exposed to an acute shearing challenge, then judgement bias (post-shearing test), HPA-axis and internal body temperature responses were determined. Results In the pre-shearing judgement bias test, the chronic stress group slightly increased optimism compared to the control treatment. In the attention bias test, the chronic stress group showed reduced vigilance behaviour towards a predator threat and a quicker approach to the food compared to the control treatment. The chronic stress group also had lower plasma ACTH concentrations in response to the CRH/AVP challenge compared to the control group, no differences in cortisol concentrations were found. In the post-shearing judgement bias test, differences in optimism were no longer evident between the chronic stress and control groups. Plasma ACTH concentrations and body temperatures showed a greater increase in response to shearing in the chronic stress group compared to the control group. Conclusion Our results suggest that long-term exposure to challenges biased cognitive measures of the affective state towards an increased expectation of a reward and reduced attention towards a threat. The exaggerated ACTH responses in the chronic stress group may be indicative of HPA-axis dysregulation. Despite a period of challenge exposure in the chronic stress group, judgement bias responses to the shearing challenge were similar in the chronic stress and control groups; the reasons for this need further investigation. The altered affective state together with signs of HPA-axis dysregulation may indicate an increased risk of compromised welfare in animals exposed to long-term environmental challenges.	[Verbeek, Else; Colditz, Ian; Lee, Caroline] CSIRO, Agr & Food, Locked Bag 1, Armidale, NSW, Australia; [Blache, Dominique] Univ Western Australia, Sch Agr & Environm, Crawley, WA, Australia; [Blache, Dominique] Univ Western Australia, Inst Agr, Crawley, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia	Verbeek, E (corresponding author), CSIRO, Agr & Food, Locked Bag 1, Armidale, NSW, Australia.	else.verbeek@slu.se	Colditz, Ian G/A-1289-2008; Blache, Dominique/H-4991-2014; Lee, Caroline/B-9427-2008	Colditz, Ian G/0000-0001-9497-5148; Blache, Dominique/0000-0003-3476-3068; Lee, Caroline/0000-0003-1900-635X; Verbeek, Else/0000-0002-1223-3480	Office of the Chief Executive Postdoctoral Fellowship Award; Commonwealth Scientific and Industry Research Organization	Office of the Chief Executive Postdoctoral Fellowship Award; Commonwealth Scientific and Industry Research Organization	This work was supported by an Office of the Chief Executive Postdoctoral Fellowship Award, awarded by the Commonwealth Scientific and Industry Research Organization to CL, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; APPLE JK, 1993, J ANIM SCI, V71, P71, DOI 10.2527/1993.71171x; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Asher L., 2016, BIOL LETT, V12, P11; Balbo M, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/759234; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; BAZELY DR, 1989, APPL ANIM BEHAV SCI, V23, P293, DOI 10.1016/0168-1591(89)90098-1; Beauchaine TP, 2011, DEV PSYCHOPATHOL, V23, P975, DOI 10.1017/S0954579411000459; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Blache D, 2017, WOODHEAD PUBL FOOD S, P73, DOI 10.1016/B978-0-08-100718-1.00005-4; Bolker Ben, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Breuer K, 2003, APPL ANIM BEHAV SCI, V84, P3, DOI 10.1016/S0168-1591(03)00146-1; Brilot BO, 2012, BIOL LETTERS, V8, P379, DOI 10.1098/rsbl.2011.1200; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Checkley S, 1996, BRIT MED BULL, V52, P597; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Dallman MF, 2007, EXP NEUROL, V206, P179, DOI 10.1016/j.expneurol.2007.06.002; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; de Bruijn R, 2017, J EXP ZOOL PART A, V327, P493, DOI 10.1002/jez.2134; de Haas EN, 2017, BEHAV PROCESS, V134, P37, DOI 10.1016/j.beproc.2016.11.001; Destrez A, 2013, ANIMAL, V7, P476, DOI 10.1017/S1751731112001796; Destrez A, 2014, APPL ANIM BEHAV SCI, V154, P30, DOI 10.1016/j.applanim.2014.01.005; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Doyle RE, 2011, PHYSIOL BEHAV, V102, P503, DOI 10.1016/j.physbeh.2011.01.001; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Ellenbogen MA, 2002, PSYCHOPHYSIOLOGY, V39, P723, DOI 10.1111/1469-8986.3960723; Fisher AD, 2002, LIVEST PROD SCI, V73, P255, DOI 10.1016/S0301-6226(01)00246-9; Freymond SB, 2014, APPL ANIM BEHAV SCI, V158, P34, DOI 10.1016/j.applanim.2014.06.006; GRANDIN T, 1989, APPL ANIM BEHAV SCI, V23, P257, DOI 10.1016/0168-1591(89)90116-0; Guldimann K, 2015, BRAIN COGNITION, V93, P35, DOI 10.1016/j.bandc.2014.11.004; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; HARGREAVES AL, 1990, APPL ANIM BEHAV SCI, V26, P91, DOI 10.1016/0168-1591(90)90090-Z; Hemsworth PH, 1999, APPL ANIM BEHAV SCI, V65, P43, DOI 10.1016/S0168-1591(99)00047-7; Hernandez CE, 2010, PHYSIOL BEHAV, V101, P588, DOI 10.1016/j.physbeh.2010.08.020; Hernandez CE, 2015, APPL ANIM BEHAV SCI, V163, P135, DOI 10.1016/j.applanim.2014.12.002; Kamal A, 2010, EXP BRAIN RES, V201, P641, DOI 10.1007/s00221-009-2083-z; Kamil B., MULTIMODEL INFERENCE; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Lee C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0977; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; MCCABE SB, 1995, J ABNORM PSYCHOL, V104, P241, DOI 10.1037/0021-843X.104.1.241; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Muehlemann T, 2011, NEUROIMAGE, V54, P1625, DOI 10.1016/j.neuroimage.2010.08.079; Novati A, 2008, SLEEP, V31, P1579, DOI 10.1093/sleep/31.11.1579; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olivier B, 2003, EUR J PHARMACOL, V463, P117, DOI 10.1016/S0014-2999(03)01326-8; Otovic P, 2015, ALTEX-ALTERN ANIM EX, V32, P41, DOI 10.14573/altex.1406161; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Paull DR, 2007, AUST VET J, V85, P98, DOI 10.1111/j.1751-0813.2007.00115.x; Reefmann N, 2012, APPL ANIM BEHAV SCI, V136, P146, DOI 10.1016/j.applanim.2011.12.007; Roelofs S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00119; Sanger ME, 2011, APPL ANIM BEHAV SCI, V131, P94, DOI 10.1016/j.applanim.2011.02.001; Siegel EH, 2018, PSYCHOL SCI, V29, P496, DOI 10.1177/0956797617741718; Siegel EH, 2011, EMOTION, V11, P1006, DOI 10.1037/a0024590; Sloboda DM, 2007, AM J PHYSIOL-ENDOC M, V292, pE61, DOI 10.1152/ajpendo.00270.2006; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Van Der Harst JE, 2003, ANIM BEHAV, V66, P493, DOI 10.1006/anbe.2003.2201; Van der Horst JE, 2007, ANIM WELFARE, V16, P67; Verbeek E, 2014, APPL ANIM BEHAV SCI, DOI [10.1016/j.applanim.2013.12.011, DOI 10.1016/J.APPLANIM.2013.12.011]; Verbeek E, 2014, APPL ANIM BEHAV SCI, V154, P39, DOI 10.1016/j.applanim.2014.02.011; Verbeek E, 2014, PHYSIOL BEHAV, V123, P67, DOI 10.1016/j.physbeh.2013.09.017; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Vogeli S, 2014, BEHAV BRAIN RES, V267, P144, DOI 10.1016/j.bbr.2014.03.036; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Wichman A, 2012, APPL ANIM BEHAV SCI, V140, P62, DOI 10.1016/j.applanim.2012.05.006	83	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211363	10.1371/journal.pone.0211363	http://dx.doi.org/10.1371/journal.pone.0211363			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699168	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600071
J	Wu, D; Zou, CX; Cao, W; Xiao, T; Gong, GL				Wu, Dan; Zou, Changxin; Cao, Wei; Xiao, Tong; Gong, Guoli			Ecosystem services changes between 2000 and 2015 in the Loess Plateau, China: A response to ecological restoration	PLOS ONE			English	Article							SOIL-EROSION; WIND EROSION; PATTERNS; CROPLAND; PROGRAM; FOREST; AREAS	The Loess Plateau of China is one of the most severe soil and water loss areas in the world. Since 1999, the Grain to Green Program (GTGP) has been implemented in the region. This study aimed to analyze spatial and temporal variations of ecosystem services from 2000 to 2015 to assess the effects of the GTGP, including carbon sequestration, water regulation, soil conservation and sand fixation. During the study period, the area of forest land and grassland significantly expanded, while the area of farmland decreased sharply. Ecosystem services showed an overall improvement with localized deterioration. Carbon sequestration, water regulation and soil conservation increased substantially. Sand fixation showed a decreasing trend mainly because of decreased wind speeds. There were synergies between carbon sequestration and water regulation, and tradeoffs between soil conservation and sand fixation. It was concluded that ecological projects have contributed significantly to the rehabilitation of the fragile ecosystems of this region. To make these projects more successful and sustainable, long-term management procedures are necessary to maintain and consolidate the improvements.	[Wu, Dan; Zou, Changxin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Cao, Wei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China; [Xiao, Tong] Minist Environm Protect, Satellite Environm Ctr, Beijing, Peoples R China; [Gong, Guoli] Shanxi Acad Environm Planning, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Cao, W (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China.	caowei@igsnrr.ac.cn			National Key R&D Program of China [2017YFC0506404, 2017YFC0506606]; National Natural Science Foundation of China [41501117]; basic research funding for the central level scientific research institutes, Nanjing Institute of Environmental Sciences, Ministry of Environmental Protection, China [GYZX170306]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); basic research funding for the central level scientific research institutes, Nanjing Institute of Environmental Sciences, Ministry of Environmental Protection, China	This research was funded by National Key R&D Program of China (2017YFC0506404, 2017YFC0506606), National Natural Science Foundation of China (41501117) and basic research funding for the central level scientific research institutes, Nanjing Institute of Environmental Sciences, Ministry of Environmental Protection, China (GYZX170306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Chen YP, 2015, NAT GEOSCI, V8, P739, DOI 10.1038/ngeo2544; Costanza R., 1997, WORLD ENV, V387, P3, DOI [10.1038/387253a0, DOI 10.1038/387253A0]; Costanza R, 2017, ECOSYST SERV, V28, P1, DOI 10.1016/j.ecoser.2017.09.008; Fang HY, 2011, AFR J MICROBIOL RES, V5, P1414; Feng XM, 2012, HYDROL EARTH SYST SC, V16, P4161; Fryrear DW, 2000, J SOIL WATER CONSERV, V55, P183; Fu B.J., 2012, CHIN J NAT MED-CHINA, V34, P261; [巩国丽 Gong Guoli], 2014, [地理科学进展, Progress in Geography], V33, P825; Gong ZN, 2017, J GEOGR SCI, V27, P143, DOI 10.1007/s11442-017-1369-5; Halle S, 2007, RESTOR ECOL, V15, P358, DOI 10.1111/j.1526-100X.2007.00226.x; Heinsch F. A, 2003, USERS GUIDE VERSION; Hu YunFeng, 2017, Journal of Resources and Ecology, V8, P352, DOI 10.5814/j.issn.1674-764x.2017.04.006; Huang L, 2012, RENEW SUST ENERG REV, V16, P1291, DOI 10.1016/j.rser.2011.10.004; Jiang C, 2016, ECOL ENG, V93, P24, DOI 10.1016/j.ecoleng.2016.05.011; Joshi A.K., 2018, PROC NATL ACAD SCI I, P1, DOI [10.1007/s40011-018-0969-x, DOI 10.1007/S40011-018-0969-X]; Kim JK, 2014, QUATERN INT, V344, P75, DOI 10.1016/j.quaint.2014.07.036; Kinnell PI, 2010, EARTH SURF PROCESSES, V33, P1627; Li BY, 2018, ECOL INDIC, V84, P837, DOI 10.1016/j.ecolind.2017.10.001; Li YR, 2014, LAND USE POLICY, V39, P188, DOI 10.1016/j.landusepol.2014.02.016; Li Z, 2015, GEOMORPHOLOGY, V228, P462, DOI 10.1016/j.geomorph.2014.10.005; Liu J.H., 2013, J MT SCI-ENGL, V27, P113; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JY, 2014, J GEOGR SCI, V24, P195, DOI 10.1007/s11442-014-1082-6; Liu Y, 2012, GEOMORPHOLOGY, V138, P404, DOI 10.1016/j.geomorph.2011.10.009; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Qiu GY, 2011, J ENVIRON QUAL, V40, P1745, DOI 10.2134/jeq2010.0263; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Renard K. G., 1997, AGR HDB; Rustomji P., 2008, WATER RESOUR RES, V44, P148; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Sun WY, 2013, J GEOGR SCI, V23, P1091, DOI 10.1007/s11442-013-1065-z; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang S, 2004, FOREST POLICY ECON, V6, P71, DOI 10.1016/S1389-9341(02)00078-3; Wei LN, 2013, CHINA SCIENCEPAPER, V8, P377; Xu J., 2002, INT ECON REV, V3, P56; Xu JT, 2006, ECOL ECON, V57, P595, DOI 10.1016/j.ecolecon.2005.05.008; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Yin RS, 2010, ENVIRON MANAGE, V45, P429, DOI 10.1007/s00267-009-9373-x; Zhang BQ, 2016, SCI TOTAL ENVIRON, V539, P436, DOI 10.1016/j.scitotenv.2015.08.132; Zhang HY, 2018, ECOL ENG, V116, P67, DOI 10.1016/j.ecoleng.2018.02.028; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; [赵安周 Zhao Anzhou], 2017, [自然资源学报, Journal of Natural Resources], V32, P449; [赵同谦 Zhao Tongqian], 2004, [自然资源学报, Journal of Natural Resources], V19, P480; Zhou Y., 1999, J MT SCI-ENGL, V17, P324	49	23	23	14	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0209483	10.1371/journal.pone.0209483	http://dx.doi.org/10.1371/journal.pone.0209483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689646	gold, Green Published, Green Submitted			2022-12-26	WOS:000457041800002
J	Duarte, LN; Coelho, FJRC; Oliveira, V; Cleary, DFR; Martins, P; Gomes, NCM				Duarte, Leticia N.; Coelho, Francisco J. R. C.; Oliveira, Vanessa; Cleary, Daniel F. R.; Martins, Patricia; Gomes, Newton C. M.			Characterization of bacterioplankton communities from a hatchery recirculating aquaculture system (RAS) for juvenile sole (Solea senegalensis) production	PLOS ONE			English	Article							LIVE FEED; SP NOV.; WATER; BACTERIUM; PROBIOTICS; PATHOGEN; SURVIVAL; CULTURE; SEA	There is a growing consensus that future technological developments of aquaculture systems should account for the structure and function of microbial communities in the whole system and not only in fish guts. In this study, we aimed to investigate the composition of bacterioplankton communities of a hatchery recirculating aquaculture system (RAS) used for the production of Senegalese sole (Solea senegalensis) juveniles. To this end, we used a 16S rRNA gene based denaturing gradient gel electrophoresis (DGGE) and pyrosequencing analyses to characterize the bacterioplankton communities of the RAS and its water supply. Overall, the most abundant orders were Alteromonadales, Rhodobacterales, Oceanospirillales, Vibrionales, Flavobacteriales, Lactobacillales, Thiotrichales, Burkholderiales and Bdellovibrionales. Although we found a clear distinction between the RAS and the water supply bacterioplankton communities, most of the abundant OTUs (>= 50 sequences) in the hatchery RAS were also present in the water supply. These included OTUs related to Pseudoalteromonas genus and the Roseobacter clade, which are known to comprise bacterial members with activity against Vibrio fish pathogens. Overall, in contrast to previous findings for sole grow-out RAS, our results suggest that the water supply may influence the bacterioplankton community structure of sole hatchery RAS. Further studies are needed to investigate the effect of aquaculture practices on RAS bacterioplankton communities and identification of the key drivers of their structure and diversity.	[Gomes, Newton C. M.] Univ Aveiro, Dept Biol, Aveiro, Portugal; Univ Aveiro, CESAM, Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Gomes, NCM (corresponding author), Univ Aveiro, Dept Biol, Aveiro, Portugal.	gomesncm@ua.pt	Martins, Patricia/W-8942-2019; Cleary, Daniel/ABA-9393-2021; Gomes, Newton Carlos Marcial/AAV-4603-2021; Oliveira, Vanessa/K-4593-2014; Martins, Paulo N./AAO-5680-2021; Gomes, Newton Carlos Marcial/K-3211-2015; Coelho, Francisco JRC/M-3561-2018; Gomes, Newton CM/F-7430-2012	Martins, Patricia/0000-0002-3815-7922; Cleary, Daniel/0000-0002-6143-3390; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Oliveira, Vanessa/0000-0003-4223-0851; Martins, Paulo N./0000-0001-9333-0233; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Coelho, Francisco JRC/0000-0001-7638-8628; Gomes, Newton CM/0000-0003-1934-0091	CNPq, National Council of Scientific and Technological Development - Brazil; CAPES on CsF Program [BEX 1287-13-3]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/92366/2013, SFRH/BPD/101919/2014]; project AQUASAFE - PROMAR (Operational Programme for Fisheries) [PROMAR 31-03-05-FEP-0016]; AquaHeal - MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF) [MAR-02.01.01-FEAMP-0031]; CESAM [UID/AMB/50017]; FCT/MEC; FEDER; FEDER, within the Compete 2020	CNPq, National Council of Scientific and Technological Development - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES on CsF Program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); project AQUASAFE - PROMAR (Operational Programme for Fisheries); AquaHeal - MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF); CESAM; FCT/MEC; FEDER(European Commission); FEDER, within the Compete 2020	Leticia N. Duarte was supported by the CNPq, National Council of Scientific and Technological Development - Brazil and CAPES on CsF Program (BEX 1287-13-3). Francisco J.R.C. Coelho (SFRH/BPD/92366/2013) and Vanessa Oliveira (SFRH/BPD/101919/2014) were supported by postdoctoral scholarships financed by the Portuguese Foundation for Science and Technology (FCT). This study has been carried out with the financial support of the project AQUASAFE (PROMAR 31-03-05-FEP-0016) funded by PROMAR (Operational Programme for Fisheries) and AquaHeal (MAR-02.01.01-FEAMP-0031) funded by MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF). We are also grateful for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ricardo Calado for helpful discussions. Leticia N. Duarte was supported by the CNPq, National Council of Scientific and Technological Development-Brazil and CAPES on CsF Program (BEX 1287-13-3). Francisco J.R.C. Coelho (SFRH/BPD/92366/2013) and Vanessa Oliveira (SFRH/BPD/101919/2014) were supported by postdoctoral scholarships financed by the Portuguese Foundation for Science and Technology (FCT). This study has been carried out with the financial support of the project AQUASAFE (PROMAR 31-03-05-FEP-0016) funded by PROMAR (Operational Programme for Fisheries) and AquaHeal (MAR-02.01.01-FEAMP-0031) funded by MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF). We are also grateful for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020.	Actis LA, 2011, FISH DIS DISORDERS, V3, DOI 10.1079/9781845935542.0000; [Anonymous], 2009, POPUL DEV REV, V35, P837; Attramadal KJK, 2014, AQUACULTURE, V432, P483, DOI 10.1016/j.aquaculture.2014.05.052; Auclair J, 2010, ISME J, V4, P1302, DOI 10.1038/ismej.2010.47; Birkbeck TH, 2011, J FISH DIS, V34, P173, DOI 10.1111/j.1365-2761.2010.01226.x; Blancheton JP, 2013, AQUACULT ENG, V53, P30, DOI 10.1016/j.aquaeng.2012.11.009; Bourne DG, 2004, AQUACULTURE, V242, P31, DOI 10.1016/j.aquaculture.2004.08.047; Bowman J.P., 2005, BERGEYS MANUAL SYSTE, P443; Bregnballe J., 2015, GUIDE RECIRCULATION; Byun SO, 2009, ANAL BIOCHEM, V385, P174, DOI 10.1016/j.ab.2008.10.024; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Cleary DFR, 2015, COMPOSITION PREDICTE, DOI [10.1007/s10482-014-0375-1, DOI 10.1007/S10482-014-0375-1]; Coelho FJRC, 2015, GLOBAL CHANGE BIOL, V21, P1871, DOI 10.1111/gcb.12801; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Emami K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00104; FAO, 2016, CONTRIBUTING FOOD SE; Garrity GM, 2005, BERGEYS MANUAL SYSTE, DOI [10.1007/978-0-387-29298-7_2, DOI 10.1007/978-0-387-29298-7_2]; Giatsis C, 2015, SCI REP-UK, V5, DOI 10.1038/srep18206; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gomes NCM, 2008, FEMS MICROBIOLOGY EC, DOI [10.1111/j.15746941.2008.00519.x, DOI 10.1111/J.15746941.2008.00519.X]; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Howell B., 2009, AQUACULTURE EUROPE, V34, P24; Ishimaru K, 1996, INT J SYST BACTERIOL, V46, P155, DOI 10.1099/00207713-46-1-155; Kandel PP, 2014, FEMS MICROBIOL ECOL, V89, P149, DOI 10.1111/1574-6941.12342; Kasai H, 2002, FISHERIES SCI, V68, P821, DOI 10.2331/fishsci.68.sup1_821; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Kesarcodi-Watson A, 2012, AQUACULTURE, V344, P29, DOI 10.1016/j.aquaculture.2012.02.029; Kim HS, 2016, INT J SYST EVOL MICR, V66, P3293, DOI 10.1099/ijsem.0.001188; Kreitmann L, 2015, EMERG INFECT DIS, V21, P2260, DOI 10.3201/eid2112.150615; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Labatut RA, 2004, AQUACULT ENG, V32, P113, DOI 10.1016/j.aquaeng.2004.05.008; Lee DE, 2016, J MICROBIOL, V54, P296, DOI 10.1007/s12275-016-5571-4; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; Martins P, 2018, AQUACULTURE, DOI [10.1016/j.aquaculture.2018.02.049, DOI 10.1016/J.AQUACULTURE.2018.02.049]; Martins P, 2015, AQUACULTURE, V435, P137, DOI 10.1016/j.aquaculture.2014.09.028; Martins P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080847; Matos A, 2011, AQUAC RES, V42, P1308, DOI 10.1111/j.1365-2109.2010.02719.x; McIntosh D, 2008, AQUACULTURE, V275, P42, DOI 10.1016/j.aquaculture.2007.12.021; Merrifield DL, 2014, AQUACULTURE NUTRITION: GUT HEALTH, PROBIOTICS AND PREBIOTICS, P185; Moriarty DJW, 1997, AQUACULTURE, V151, P333, DOI 10.1016/S0044-8486(96)01487-1; Nocker A, 2004, APPL ENVIRON MICROB, V70, P6834, DOI 10.1128/AEM.70.11.6834-6845.2004; NSW Government Department of Primary Industries, 2016, OZ REC AQ SYST; Nubel U, 1996, J BACTERIOL, V178, P5636; Oksanen J, 2011, VEGAN ECOLOGICAL DIV; Powell A, 2015, AQUACULT ENG, V64, P20, DOI 10.1016/j.aquaeng.2014.11.005; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Ramachandran K., 2016, BENEFICIAL MICROBES; Richards GP, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00175-17; Rodrigues S, 2015, PROBIOTICS ANTIMICRO, V7, P45, DOI 10.1007/s12602-014-9173-3; Rud I, 2017, AQUACULT ENG, V78, P50, DOI 10.1016/j.aquaeng.2016.10.003; Salvesen I, 1999, AQUACULTURE, V175, P337, DOI 10.1016/S0044-8486(99)00110-6; SCHOEFFIELD AJ, 1990, APPL ENVIRON MICROB, V56, P230, DOI 10.1128/AEM.56.1.230-236.1990; Sharifah E.N., 2012, AQUAC SCI, V60, P39, DOI [10.11233/aquaculturesci.60.39, DOI 10.11233/AQUACULTURESCI.60.39]; Skjermo J, 2015, AQUACULTURE, V438, P17, DOI 10.1016/j.aquaculture.2014.12.027; SOROKIN DY, 1995, MICROBIOLOGY+, V64, P295; Tal Y, 2009, AQUACULTURE, V286, P28, DOI 10.1016/j.aquaculture.2008.08.043; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Valladao GMR, 2015, J VET PHARMACOL THER, V38, P417, DOI 10.1111/jvp.12202; Voget S, 2015, ISME J, V9, P371, DOI 10.1038/ismej.2014.134; Wang Y, 2009, PLOS ONE, DOI [10.1371/journal.pone.007401, DOI 10.1371/JOURNAL.PONE.007401]; Wang Y, 2012, ANTON LEEUW INT J G, V101, P787, DOI 10.1007/s10482-011-9693-8; Wawrik B, 2012, FEMS MICROBIOL ECOL, V79, P400, DOI 10.1111/j.1574-6941.2011.01226.x; Webster NS, 2006, ENVIRON MICROBIOL, V8, P1177, DOI 10.1111/j.1462-2920.2006.01007.x; Welsh RM, 2016, ISME J, V10, P1540, DOI 10.1038/ismej.2015.219; Wesseling W, 2015, AQUACULTURE, V446, P57, DOI 10.1016/j.aquaculture.2015.04.017; Zhang DC, 2008, INT J SYST EVOL MICR, V58, P1384, DOI 10.1099/ijs.0.65708-0	72	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211209	10.1371/journal.pone.0211209	http://dx.doi.org/10.1371/journal.pone.0211209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682196	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500124
J	Mullers, Y; Meiser, I; Stracke, F; Riemann, I; Lautenschlager, F; Neubauer, JC; Zimmermann, H				Muellers, Yannik; Meiser, Ina; Stracke, Frank; Riemann, Iris; Lautenschlaeger, Franziska; Neubauer, Julia C.; Zimmermann, Heiko			Quantitative analysis of F-actin alterations in adherent human mesenchymal stem cells: Influence of slow-freezing and vitrification-based cryopreservation	PLOS ONE			English	Article							MEMBRANE-CYTOSKELETON COMPLEX; CELLULAR ADHESION; TISSUE-CULTURE; STROMAL CELLS; APOPTOSIS; SHOCK; DIFFERENTIATION; ORGANIZATION; MORPHOLOGY; MICROSCOPY	Cryopreservation is an essential tool to meet the increasing demand for stem cells in medical applications. To ensure maintenance of cell function upon thawing, the preservation of the actin cytoskeleton is crucial, but so far there is little quantitative data on the influence of cryopreservation on cytoskeletal structures. For this reason, our study aims to quantitatively describe cryopreservation induced alterations to F-actin in adherent human mesenchymal stem cells, as a basic model for biomedical applications. Here we have characterised the actin cytoskeleton on single-cell level by calculating the circular standard deviation of filament orientation, F-actin content, and average filament length. Cryo-induced alterations of these parameters in identical cells pre and post cryopreservation provide the basis of our investigation. Differences between the impact of slow-freezing and vitrification are qualitatively analyzed and highlighted. Our analysis is supported by live cryo imaging of the actin cytoskeleton via two photon microscopy. We found similar actin alterations in slow-frozen and vitrified cells including buckling of actin filaments, reduction of F-actin content and filament shortening. These alterations indicate limited functionality of the respective cells. However, there are substantial differences in the frequency and time dependence of F-actin disruptions among the applied cryopreservation strategies; immediately after thawing, cytoskeletal structures show least disruption after slow freezing at a rate of 1 degrees C/min. As post-thaw recovery progresses, the ratio of cells with actin disruptions increases, particularly in slow frozen cells. After 120 min of recovery the proportion of cells with an intact actin cytoskeleton is higher in vitrified than in slow frozen cells. Freezing at 10 degrees C/min is associated with a high ratio of impaired cells throughout the post-thawing culture.	[Muellers, Yannik; Meiser, Ina; Stracke, Frank; Riemann, Iris; Neubauer, Julia C.; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn IBMT, Dept Cryo & Stem Cell Technol, Joseph Von Fraunhofer Weg 1, Sulzbach, Germany; [Lautenschlaeger, Franziska] Leibniz Inst New Mat, Div Cytoskeletal Fibers, Campus D2 2, Saarbrucken, Germany; [Lautenschlaeger, Franziska] Saarland Univ, Chair Expt Phys, Saarbrucken, Germany; [Neubauer, Julia C.] Fraunhofer Project Ctr Stem Cell Proc Engn, Neunerpl 2, Wurzburg, Germany; [Zimmermann, Heiko] Saarland Univ, Chair Mol & Cellular Biotechnol, Saarbrucken, Germany; [Zimmermann, Heiko] Univ Catolica Norte, Fac Marine Sci, Coquimbo, Chile	Fraunhofer Gesellschaft; Leibniz Institut fur Neue Materialien (INM); Saarland University; Saarland University; Universidad Catolica del Norte	Zimmermann, H (corresponding author), Fraunhofer Inst Biomed Engn IBMT, Dept Cryo & Stem Cell Technol, Joseph Von Fraunhofer Weg 1, Sulzbach, Germany.; Zimmermann, H (corresponding author), Saarland Univ, Chair Mol & Cellular Biotechnol, Saarbrucken, Germany.; Zimmermann, H (corresponding author), Univ Catolica Norte, Fac Marine Sci, Coquimbo, Chile.	heiko.zimmermann@ibmt.fraunhofer.de	; Lautenschlager, Franziska/L-3484-2016	Neubauer, Julia/0000-0001-6876-1453; Lautenschlager, Franziska/0000-0001-8263-3386; Zimmermann, Heiko/0000-0001-8595-1304				Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; Beier AF, 2013, CRYOBIOLOGY, V66, P8, DOI 10.1016/j.cryobiol.2012.10.001; Beier AFJ, 2011, CRYOBIOLOGY, V63, P175, DOI 10.1016/j.cryobiol.2011.06.003; Beil M, 2005, J MICROSC-OXFORD, V220, P84, DOI 10.1111/j.1365-2818.2005.01505.x; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906; Cancer W, 2016, STEM CELLS, V34, P2429, DOI [10.1002/stem.2415, DOI 10.1002/STEM.2415]; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chinnadurai R, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.003; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doerr Daniel, 2009, Biotechnology Journal, V4, P1215, DOI 10.1002/biot.200800212; Eltzner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126346; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fahy GM, 2015, METHODS MOL BIOL, V1257, P21, DOI 10.1007/978-1-4939-2193-5_2; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Genesca M, 2006, APOPTOSIS, V11, P563, DOI 10.1007/s10495-006-4937-1; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623; Katkov I., 2011, STEM CELLS INT, V2011, P1; Katsen-Globa A, 2014, J MATER SCI-MATER M, V25, P857, DOI 10.1007/s10856-013-5108-x; Keung E, 2013, STEM CELLS, V30, P804; LAMPUGNANI MG, 1987, EXP CELL RES, V172, P385, DOI 10.1016/0014-4827(87)90396-X; Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; Mardones R, 2017, J HIP PRESERV SURG, V4, P159, DOI 10.1093/jhps/hnx011; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mullins PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063141; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Pollock K, 2017, J TISSUE ENG REGEN M, V11, P2806, DOI 10.1002/term.2175; Pollock K, 2015, CYTOTHERAPY, V17, P38, DOI 10.1016/j.jcyt.2014.06.008; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Ragoonanan V, 2013, CRYOBIOLOGY, V66, P96, DOI 10.1016/j.cryobiol.2012.10.008; Ragoonanan V, 2010, CRYOBIOLOGY, V61, P335, DOI 10.1016/j.cryobiol.2010.10.160; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Valojerdi MR, 2009, J ASSIST REPROD GEN, V26, P347, DOI 10.1007/s10815-009-9318-6; VINCENT C, 1990, MOL REPROD DEV, V26, P227, DOI 10.1002/mrd.1080260306; WEISS L, 1972, EXP CELL RES, V74, P21, DOI 10.1016/0014-4827(72)90477-6; Wesley-Smith J, 2015, ANN BOT-LONDON, V115, P991, DOI 10.1093/aob/mcv009; Wu YN, 2015, CRYOLETTERS, V36, P325; Xu X, 2012, J BIOTECHNOL, V162, P224, DOI 10.1016/j.jbiotec.2012.09.004; Xu X, 2010, BIOTECHNOL PROGR, V26, P781, DOI 10.1002/btpr.358; Yousaf MN, 2001, ANGEW CHEM INT EDIT, V40, P1093, DOI 10.1002/1521-3773(20010316)40:6<1093::AID-ANIE10930>3.3.CO;2-H	60	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211382	10.1371/journal.pone.0211382	http://dx.doi.org/10.1371/journal.pone.0211382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682146	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500162
J	Wang, MX; Ferreira, RB; Law, ME; Davis, BJ; Yaaghubi, E; Ghilardi, AF; Sharma, A; Avery, BA; Rodriguez, E; Chiang, CW; Narayan, S; Heldermon, CD; Castellano, RK; Law, BK				Wang, Mengxiong; Ferreira, Renan B.; Law, Mary E.; Davis, Bradley J.; Yaaghubi, Elham; Ghilardi, Amanda F.; Sharma, Abhisheak; Avery, Bonnie A.; Rodriguez, Edgardo; Chiang, Chi-Wu; Narayan, Satya; Heldermon, Coy D.; Castellano, Ronald K.; Law, Brian K.			A novel proteotoxic combination therapy for EGFR+ and HER2+cancers	ONCOGENE			English	Article							UNFOLDED PROTEIN RESPONSE; CYCLOSPORINE-A; EXTRACELLULAR REGION; ORGANIC DISULFIDES; CRYSTAL-STRUCTURE; ER STRESS; CANCER; GROWTH; CELLS; SUBSTANCES	While HER2 and EGFR are overexpressed in breast cancers and multiple other types of tumors, the use of EGFR and/or HER2 inhibitors have failed to cure many cancer patients, largely because cancers acquire resistance to HER2/EGFR-specific drugs. Cancers that overexpress the HER-family proteins EGFR, HER2, and HER3 are uniquely sensitive to agents that disrupt HER2 and EGFR protein folding. We previously showed that disruption of disulfide bond formation by Disulfide Disrupting Agents (DDAs) kills HER2/EGFR overexpressing cells through multiple mechanisms. Herein, we show that interference with proline isomerization in HER2/EGFR overexpressing cells also induces cancer cell death. The peptidyl-prolyl isomerase inhibitor Cyclosporine A (CsA) selectively kills EGFR+ or HER2+ breast cancer cells in vitro by activating caspase-dependent apoptotic pathways. Further, CsA synergizes with the DDA tcyDTDO to kill HER2/EGFR overexpressing cells in vitro and the two agents cooperate to kill HER2+ tumors in vivo. There is a critical need for novel strategies to target HER2+ and EGFR+ cancers that are resistant to currently available mechanism-based agents. Drugs that target HER2/EGFR protein folding, including DDAs and CsA, have the potential to kill cancers that overexpress EGFR or HER2 through the induction of proteostatic synthetic lethality.	[Wang, Mengxiong; Law, Mary E.; Davis, Bradley J.; Rodriguez, Edgardo; Law, Brian K.] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Ferreira, Renan B.; Yaaghubi, Elham; Ghilardi, Amanda F.; Castellano, Ronald K.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Sharma, Abhisheak; Avery, Bonnie A.] Univ Florida, Dept Pharmaceut, Gainesville, FL 32610 USA; [Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Chiang, Chi-Wu] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan; [Narayan, Satya] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Narayan, Satya; Heldermon, Coy D.; Castellano, Ronald K.; Law, Brian K.] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL 32610 USA; [Heldermon, Coy D.] Univ Florida, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Cheng Kung University; National Cheng Kung University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Law, BK (corresponding author), Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA.; Castellano, RK (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.; Castellano, RK; Law, BK (corresponding author), Univ Florida, UF Hlth Canc Ctr, Gainesville, FL 32610 USA.	castellano@chem.ufl.edu; bklaw@ufl.edu	Ferreira, Renan/O-4919-2019; Sharma, Abhisheak/H-9327-2019; Sharma, Abhisheak/V-8401-2017; Castellano, Ronald/AAY-3252-2020	Ferreira, Renan/0000-0001-5205-659X; Sharma, Abhisheak/0000-0003-0553-4039; Castellano, Ronald/0000-0003-4322-9932; Wang, Mengxiong/0000-0002-8290-151X; Yaaghubi, Elham/0000-0003-1821-1052; Heldermon, Coy/0000-0002-2148-2868	Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program [W81XWH-15-1-0199, W81XWH-15-1-0200]; Florida Breast Cancer Foundation; Ocala Royal Dames for Cancer Research; Florida Department of Health Bankhead-Coley Program [4BF03]; UF-Health Cancer Center pilot project award; University of Florida; Collaboration of Scientists for Critical Research in Biomedicine (CSCRB, Inc.)	Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program; Florida Breast Cancer Foundation; Ocala Royal Dames for Cancer Research; Florida Department of Health Bankhead-Coley Program; UF-Health Cancer Center pilot project award; University of Florida(University of Florida); Collaboration of Scientists for Critical Research in Biomedicine (CSCRB, Inc.)	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program under Award Nos. W81XWH-15-1-0199 (BL) and W81XWH-15-1-0200 (RC). These studies were supported in part by grants from the Florida Breast Cancer Foundation (BL and RC), The Ocala Royal Dames for Cancer Research (BL), the Florida Department of Health Bankhead-Coley Program (4BF03, BL), the Collaboration of Scientists for Critical Research in Biomedicine (CSCRB, Inc., BL), and a UF-Health Cancer Center pilot project award (BL, RC, and CH). RF is grateful to the University of Florida for a Graduate School Fellowship.	Ahmed-Belkacem A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12777; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; BASS SW, 1980, J ORG CHEM, V45, P710, DOI 10.1021/jo01292a032; Chlebowski RT, 2013, JNCI-J NATL CANCER I, V105, P526, DOI 10.1093/jnci/djt043; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; Dunyak BM, 2016, J MED CHEM, V59, P9622, DOI 10.1021/acs.jmedchem.6b00411; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Feng XL, 2014, EXP HEMATOL, V42, P172, DOI 10.1016/j.exphem.2013.11.010; Ferreira RB, 2017, ONCOTARGET, V8, P28971, DOI 10.18632/oncotarget.15952; Ferreira RB, 2015, ONCOTARGET, V6, P10445, DOI 10.18632/oncotarget.3398; FIELD L, 1972, J MED CHEM, V15, P312, DOI 10.1021/jm00273a024; Garg AD, 2014, PHOTOCH PHOTOBIO SCI, V13, P474, DOI 10.1039/c3pp50333j; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GOETHALS EJ, 1969, B SOC CHIM BELG, V78, P191; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hartman DA, 2003, CURR PROTOC PHARM, V7, P6; Hysing Jan, 2011, Tidsskr Nor Laegeforen, V131, P2239, DOI 10.4045/tidsskr.10.0862; IYER RP, 1990, J AM CHEM SOC, V112, P1253, DOI 10.1021/ja00159a059; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kopper L, 2008, PATHOL ONCOL RES, V14, P1, DOI 10.1007/s12253-008-9018-z; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Law ME, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0741-1; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Neckers L, 2000, Breast Dis, V11, P49; Ni SS, 2009, J MED CHEM, V52, P5295, DOI 10.1021/jm9008295; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robinson PJ, 2017, J BIOL CHEM, V292, P6978, DOI 10.1074/jbc.M117.780742; SHIMIZU T, 1989, IMMUNOBIOLOGY, V178, P401, DOI 10.1016/S0171-2985(89)80062-2; Singh N, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6922; SRIVASTAVA PK, 1972, J ORG CHEM, V37, P4196, DOI 10.1021/jo00798a055; Stocki P, 2014, J BIOL CHEM, V289, P23086, DOI 10.1074/jbc.M114.570911; Takenokuchi M, 2015, ANTICANCER RES, V35, P3307; Theuerkorn M, 2011, CURR OPIN PHARMACOL, V11, P281, DOI 10.1016/j.coph.2011.03.007; Vekaria PH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00181; Wang MX, 2018, CRIT REV ONCOL HEMAT, V127, P66, DOI 10.1016/j.critrevonc.2018.05.003; Werneck MBF, 2012, CELL CYCLE, V11, P3997, DOI 10.4161/cc.22222	43	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 30	2019	38	22					4264	4282		10.1038/s41388-019-0717-6	http://dx.doi.org/10.1038/s41388-019-0717-6			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IA1RB	30718919				2022-12-26	WOS:000469339100005
J	Moss, DL; Park, HW; Mettu, RR; Landry, SJ				Moss, Daniel L.; Park, Hee-Won; Mettu, Ramgopal R.; Landry, Samuel J.			Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen processing; T-helper cells; T cell; antigen presentation; antibody; protein structure; protein stability; proteomics; proteolysis; cancer; CD4+T cells; deimmunization; immunotoxin; vaccine	CLASS-I; 3-DIMENSIONAL STRUCTURE; FLANKING REGION; NEURAL-NETWORKS; GERMINAL CENTER; PEPTIDES; IMMUNODOMINANCE; IMMUNOGENICITY; IDENTIFICATION; SELECTION	Effective adaptive immune responses depend on activation of CD4+ T cells via the presentation of antigen peptides in the context of major histocompatibility complex (MHC) class II. The structure of an antigen strongly influences its processing within the endolysosome and potentially controls the identity of peptides that are presented to T cells. A recombinant immunotoxin, comprising exotoxin A domain III (PE-III) from Pseudomonas aeruginosa and a cancer-specific antibody fragment, has been developed to manage cancer, but its effectiveness is limited by the induction of neutralizing antibodies. Here, we observed that this immunogenicity is substantially reduced by substituting six residues within PE-III. Although these substitutions targeted T-cell epitopes, we demonstrate that reduced conformational stability and protease resistance were responsible for the reduced antibody titer. Analysis of mouse T-cell responses coupled with biophysical studies on single-substitution versions of PE-III suggested that modest but comprehensible changes in T-cell priming can dramatically perturb antibody production. The most strongly responsive PE-III epitope was well-predicted by a structure-based algorithm. In summary, single-residue substitutions can drastically alter the processing and immunogenicity of PE-III but have only modest effects on CD4+ T-cell priming in mice. Our findings highlight the importance of structure-based processing constraints for accurate epitope prediction.	[Moss, Daniel L.; Park, Hee-Won; Landry, Samuel J.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Mettu, Ramgopal R.] Tulane Univ, Dept Comp Sci, New Orleans, LA 70118 USA	Tulane University; Tulane University	Landry, SJ (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	landry@tulane.edu	Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543; Moss, Daniel/0000-0001-7639-7276	National Institutes of Health [P20 RR018766, P20 GM103514, P30 GM103514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jessie Guidry for assisting with the proteomics work. Proteomics work was supported by National Institutes of Health Grants P20 RR018766, P20 GM103514, and P30 GM103514 and a special appropriation from the Louisiana State University School of Medicine Office of the Dean.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BOND JS, 1980, BIOCHEM J, V189, P17, DOI 10.1042/bj1890017; Carmicle S, 2002, J BIOL CHEM, V277, P155, DOI 10.1074/jbc.M107624200; Carmicle S, 2007, MOL IMMUNOL, V44, P1159, DOI 10.1016/j.molimm.2006.06.014; CHAUDHARY VK, 1988, NATURE, V335, P369, DOI 10.1038/335369a0; Dai GX, 2002, J BIOL CHEM, V277, P161, DOI 10.1074/jbc.M102259200; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fraternali F, 1996, J MOL BIOL, V256, P939, DOI 10.1006/jmbi.1996.0139; Friedman David B, 2007, Methods Mol Biol, V367, P219; Gebreselassie D, 2006, HUM IMMUNOL, V67, P894, DOI 10.1016/j.humimm.2006.08.294; Gelder C, 1998, INT IMMUNOL, V10, P211, DOI 10.1093/intimm/10.2.211; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hassan C, 2014, J PROTEOMICS, V109, P240, DOI 10.1016/j.jprot.2014.07.009; Hilser VJ, 2014, METHODS MOL BIOL, V1084, P255, DOI 10.1007/978-1-62703-658-0_14; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karunakaran KP, 2017, J PROTEOME RES, V16, P298, DOI 10.1021/acs.jproteome.6b00926; Karunakaran KP, 2015, VACCINE, V33, P2159, DOI 10.1016/j.vaccine.2015.02.055; Kim J, 1997, J IMMUNOL, V159, P335; KONDO T, 1988, J BIOL CHEM, V263, P9470; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kreitman RJ, 1997, BLOOD, V90, P252; Landry SJ, 1997, IMMUNOL TODAY, V18, P527, DOI 10.1016/S0167-5699(97)01152-3; Latek RR, 1999, IMMUNOL REV, V172, P209, DOI 10.1111/j.1600-065X.1999.tb01367.x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Ma CL, 1999, J IMMUNOL, V163, P6413; Machado Y, 2016, J ALLERGY CLIN IMMUN, V137, P1525, DOI 10.1016/j.jaci.2015.09.026; Manyusa S, 1999, BIOCHEMISTRY-US, V38, P9533, DOI 10.1021/bi990550d; Mazor R, 2017, CELL MOL IMMUNOL, V14, P432, DOI 10.1038/cmi.2015.91; Mazor R, 2016, IMMUNOL REV, V270, P152, DOI 10.1111/imr.12390; Mazor R, 2014, P NATL ACAD SCI USA, V111, P8571, DOI 10.1073/pnas.1405153111; Mazor R, 2012, P NATL ACAD SCI USA, V109, pE3597, DOI 10.1073/pnas.1218138109; Mettu RR, 2016, J IMMUNOL METHODS, V432, P72, DOI 10.1016/j.jim.2016.02.013; Mirano-Bascos D, 2008, EUR J IMMUNOL, V38, P1231, DOI 10.1002/eji.200738011; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen HNP, 2015, VACCINE, V33, P2887, DOI 10.1016/j.vaccine.2015.04.082; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Norton EB, 2015, VACCINE, V33, P1909, DOI 10.1016/j.vaccine.2015.02.069; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Phelps RG, 1998, J BIOL CHEM, V273, P11440, DOI 10.1074/jbc.273.19.11440; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; So T, 1997, J BIOL CHEM, V272, P32136, DOI 10.1074/jbc.272.51.32136; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252	60	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4667	4681		10.1074/jbc.RA118.006704	http://dx.doi.org/10.1074/jbc.RA118.006704			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30683694	Green Published, hybrid			2022-12-26	WOS:000462969500032
J	Lee, S; Lee, YN; Chinsamy, A; Lu, JC; Barsbold, R; Tsogtbaatar, K				Lee, Sungjin; Lee, Yuong-Nam; Chinsamy, Anusuya; Lu, Junchang; Barsbold, Rinchen; Tsogtbaatar, Khishigjav			A new baby oviraptorid dinosaur (Dinosauria: Theropoda) from the Upper Cretaceous Nemegt Formation of Mongolia	PLOS ONE			English	Article							GOBI DESERT; PARK FORMATION; CAENAGNATHID DINOSAURIA; ALBERTA; CHINA; DIVERSITY; SPECIMENS; TURNOVER; INSIGHTS; BEARING	Recent discoveries of new oviraptorosaurs revealed their high diversity from the Cretaceous Period in Asia and North America. Particularly, at the family level, oviraptorids are among the most diverse theropod dinosaurs in the Late Cretaceous of Mongolia and China. A new oviraptorid dinosaur Gobiraptor minutus gen. et sp. nov. from the Upper Cretaceous Nemegt Formation is described here based on a single holotype specimen that includes incomplete cranial and postcranial elements. The most prominent characters of Gobiraptor are its thickened rostrodorsal end of the mandibular symphysis and a rudimentary lingual shelf on each side of the dentary. Each lingual shelf is lined with small occlusal foramina and demarcated by a weakly developed lingual ridge. This mandibular morphology of Gobiraptor is unique among oviraptorids and likely to be linked to a specialized diet that probably included hard materials, such as seeds or bivalves. The osteohistology of the femur of the holotype specimen indicates that the individual was fairly young at the time of its death. Phylogenetic analysis recovers Gobiraptor as a derived oviraptorid close to three taxa from the Ganzhou region in southern China, but rather distantly related to other Nemegt oviraptorids which, as the results of recent studies, are also not closely related to each other. Gobiraptor increases diversity of oviraptorids in the Nemegt Formation and its presence confirms the successful adaptation of oviraptorids to a mesic environment.	[Lee, Sungjin; Lee, Yuong-Nam] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Chinsamy, Anusuya] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa; [Lu, Junchang] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Barsbold, Rinchen; Tsogtbaatar, Khishigjav] Mongolian Acad Sci, Inst Paleontol & Geol, Ulaanbaatar, Mongolia	Seoul National University (SNU); University of Cape Town; Chinese Academy of Geological Sciences; Mongolian Academy of Sciences	Lee, YN (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	ynlee@snu.ac.kr		Chinsamy-Turan, Anusuya/0000-0002-9786-5080; Lee, Sungjin/0000-0001-5117-8552	National Research Foundation of Korea [2016R1A2B2015012]; University of Cape Town's, URC grant	National Research Foundation of Korea(National Research Foundation of Korea); University of Cape Town's, URC grant	Funding for this project was granted by the National Research Foundation of Korea (grant number 2016R1A2B2015012) (to Y-NL), and the University of Cape Town's, URC grant to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks go to all members of Korea-Mongolia International Dinosaur Expedition (KID) in 2008. The KID expedition was supported by a grant to the corresponding author from Hwaseong City, Gyeonggi Province, South Korea. We thank Do Kwon Kim for help with fossil preparation and Jin-Young Park for valuable comments on the manuscript. Su-Hwan Kim and Noeheon Kim also helped making and improving the quality of figures with technical assistance. The Willi Hennig Society provided TNT version 1.5. We also thank two reviewers (Federico Agnolin and Gregory Funston) and the academic editor (Alex Hubbe) for their constructive comments and suggestions which greatly improved the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], [No title captured]; [Anonymous], 1970, PALAENTOL POL; Balanoff AM, 2012, B AM MUS NAT HIST, P1; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1986, P210; BARSBOLD R, 1976, DOKL AKAD NAUK SSSR+, V226, P685; Barsbold R., 1977, T JOINT SOVIET MONGO, V4, P37; Barsbold R., 1997, ENCY DINOSAURS, P505; Barsbold R., 1981, T SOVMESTNAYA SOVETS, V15, P28; Bell PR, 2015, CRETACEOUS RES, V52, P101, DOI 10.1016/j.cretres.2014.09.006; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; Currie P.J., 1990, P245; Currie PJ, 2016, ACTA PALAEONTOL POL, V61, P143, DOI 10.4202/app.00130.2014; CURRIE PJ, 1989, CAN J EARTH SCI, V26, P1319, DOI 10.1139/e89-111; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Eberth DA, 2018, PALAEOGEOGR PALAEOCL, V494, P29, DOI 10.1016/j.palaeo.2017.11.018; Eberth David A., 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P1; Elzanowski A, 1999, SM C PALEOB, P311; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; Funston GF, 2018, PALAEOGEOGR PALAEOCL, V494, P101, DOI 10.1016/j.palaeo.2017.10.023; Funston GF, 2018, DATA BRIEF, V16, P660, DOI 10.1016/j.dib.2017.11.086; Funston GF, 2015, CRETACEOUS RES, V54, P179, DOI 10.1016/j.cretres.2014.12.002; Funston GF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35782; Funston GF, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1160910; Funston GF, 2016, ACTA PALAEONTOL POL, V61, P159, DOI 10.4202/app.00129.2014; Funston GF, 2014, CAN J EARTH SCI, V51, P156, DOI 10.1139/cjes-2013-0186; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gilmore C. W., 1924, Canada Geol Survey Bull, V38, P1; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; GRADZINSKI R, 1977, Acta Geologica Polonica, V27, P281; GRADZINSKI R, 1974, SEDIMENT GEOL, V12, P249, DOI 10.1016/0037-0738(74)90021-9; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; [Ji Qiang 季强], 2012, [地质通报, Geological Bulletin of China], V31, P2102; Khand Yo., 2000, Developments in Palaeontology and Stratigraphy, V17, P49; Kurzanov S. M., 1981, JOINT SOVIET MONGOLI, V15, P39, DOI DOI 10.1371/J0URNAL.P0NE.0022916; Lamanna MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092022; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P23, DOI 10.3374/014.054.0102; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Lu Junchang, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P51; Lu Junchang, 2004, Bulletin of the National Science Museum Series C (Geology & Paleontology), V30, P95; Lu Junchang, 2003, Journal of Vertebrate Paleontology, V22, P871; Lu JC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05016-6; Lu JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35780; Lu JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11490; Lu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080557; Lu JC, 2013, NATURWISSENSCHAFTEN, V100, P165, DOI 10.1007/s00114-012-1007-0; Lyson TR, 2011, P ROY SOC B-BIOL SCI, V278, P1158, DOI 10.1098/rspb.2010.1444; Ma WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15709-7; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Mallon JC, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.904323; Mallon JC, 2014, PALAEOGEOGR PALAEOCL, V394, P29, DOI 10.1016/j.palaeo.2013.11.014; Mallon JC, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-14; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Maryanska T, 1997, ACTA PALAEONTOL POL, V42, P361; Nixon K.C., 2002, WINCLADA VER 1 00 08; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; Norell MA, 2018, AM MUS NOVIT, P1; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; OSMOLSKA H, 1981, Palaeontologia Polonica, P79; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Rinchen Barsbold., 1983, T JT SOV PALEONTOL E, V19, P5; Smith D., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V186, P365; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; STERNBERG R. M., 1940, JOUR PALEONTOL, V14, P81; Sues HD, 2015, CRETACEOUS RES, V54, P50, DOI 10.1016/j.cretres.2014.12.001; Sullivan R.M, 2011, NEW MEXICO MUSEUM NA, V53, P418; Tsuihiji T, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1347177; Tsuihiji T, 2016, CRETACEOUS RES, V63, P148, DOI 10.1016/j.cretres.2016.03.007; Tsuihiji T, 2015, CRETACEOUS RES, V56, P60, DOI 10.1016/j.cretres.2015.03.007; Wang S, 2013, ZOOTAXA, V3640, P242, DOI 10.11646/zootaxa.3640.2.7; Watabe Mahito, 2010, Hayashibara Museum of Natural Sciences Research Bulletin, V3, P41; Wei XF, 2013, ACTA GEOL SIN-ENGL, V87, P899, DOI 10.1111/1755-6724.12098; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2010, Vertebrata Palasiatica, V48, P11; Yu YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23252-2; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108	90	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210867	10.1371/journal.pone.0210867	http://dx.doi.org/10.1371/journal.pone.0210867			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726228	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000033
J	Shenge, JA; Odaibo, GN; Olaleye, DO				Shenge, Juliet A.; Odaibo, Georgina N.; Olaleye, David O.			Phylogenetic analysis of hepatitis C virus among HIV/HCV co-infected patients in Nigeria	PLOS ONE			English	Article							COINFECTION; PREVALENCE; GENOTYPES; EVOLUTION; HISTORY	Hepatitis C virus (HCV) infection has been associated with liver disease including liver cirrhosis and hepatocellular carcinoma (HCC) in chronically-infected persons. However, in HIV/HCV co-infected patients, increased rate of progression to cirrhosis and HCC has been reported. Limited information exists regarding genetic variants of HCV circulating among co-infected patients, which could be important in the design of broadly protective vaccine and management of the disease. Here, we determined the genotypes of HCV isolates circulating among HIV/HCV co-infected patients in Ibadan, southwestern Nigeria. One hundred and twenty-five HIV/HCV IgM positive samples obtained from HIV laboratory, University of Ibadan were used for this study. HCV NS5B gene was amplified using polymerase chain reaction (PCR). The amplified NS5B gene was sequenced using gene specific primers. Twenty isolates were amplified, out of which 13 were successfully sequenced. Phylogenetic analysis of the 13 sequenced isolates showed three HCV subtypes 1a, 3a and 5a belonging to genotypes 1, 3 and 5 respectively. Ten isolates (77%) belong to subtype 5a, followed by 2 isolates (15%) subtype 1a and 1 isolate (8%) was subtype 3a. The predominant HCV genotype was 5, followed by genotype 1 (subtype 1a). The findings, as well as the observed mutations in NS5B gene, indicate the need for screening and monitoring of HIV/HCV co-infected patients. Further study to determine the phylogeny of isolates circulating in other parts of Nigeria will be carried out.	[Shenge, Juliet A.; Odaibo, Georgina N.; Olaleye, David O.] Univ Ibadan, Dept Virol, Coll Med, Ibadan, Nigeria	University of Ibadan	Shenge, JA (corresponding author), Univ Ibadan, Dept Virol, Coll Med, Ibadan, Nigeria.	jadamma@yahoo.com	Shenge, Juliet Adamma/AAW-3412-2020		Medical Education Partnership Initiative Nigeria (MEPIN) through National Institute of Health (NIH) USA - Fogarty International Centre; office of AIDS Research and National Human Genome Research Institute of NIH; Health Resources and Services Administration (HRSA); Office of the U.S. Global AIDS Coordinator [R24TW008878]	Medical Education Partnership Initiative Nigeria (MEPIN) through National Institute of Health (NIH) USA - Fogarty International Centre; office of AIDS Research and National Human Genome Research Institute of NIH; Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Office of the U.S. Global AIDS Coordinator	This study was supported by Medical Education Partnership Initiative Nigeria (MEPIN) through National Institute of Health (NIH) USA grant funded by Fogarty International Centre, the office of AIDS Research and National Human Genome Research Institute of NIH, the Health Resources and Services Administration (HRSA) and the Office of the U.S. Global AIDS Coordinator under award number R24TW008878' to JAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewole OO, 2009, J INFECT DEV COUNTR, V3, P369, DOI 10.3855/jidc.245; Agwale SM, 2004, J CLIN VIROL, V31, pS3, DOI 10.1016/j.jcv.2004.09.001; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Balogun TM, NIG QJ HOSP MED, V20, P117; Codes L, 2003, BRAZ J INFECT DIS, P7; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; Dhawan VK, MEDSCAPE, P1; Forbi JC, 2012, J GEN VIROL, V93, P1410, DOI 10.1099/vir.0.042184-0; Gededzha MP, 2012, J MED VIROL, V84, P601, DOI 10.1002/jmv.23215; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kato Nobuyuki, 2000, Microbial and Comparative Genomics, V5, P129, DOI 10.1089/omi.1.2000.5.129; Kazmierczak J, 2014, ARCH IMMUNOL THER EX, V62, P145, DOI 10.1007/s00005-013-0257-7; Kumar S, 2015, MEGA 7 MOL EVOLUTION; Laraba A, 2010, INTERNET J GASTROENT; Le Guillou-Guillemette H, 2007, WORLD J GASTROENTERO, V13, P2416, DOI 10.3748/wjg.v13.i17.2416; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mora N, 2016, BMC INFECT DIS, P160; Mukherjee S., 2012, MEDSCAPE; Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14; Mustapha SK, 2007, INTERNET J ONCOLOGY, P2; Naamani KAI, 2013, CAN J GASTROENTEROL, V27; Nwankiti OO, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-110; Ohno O., 2007, J CLIN MICROBIOL, V35, P201; Okwuraiwe A. P., 2012, NIGERIAN J GASTROENT, V4; Oni AO, 1996, J MED VIROL, V49, P178, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;178::AID-JMV4&gt;3.0.CO;2-1; Otegbayo JA, 2008, ANN HEPATOL, V7, P152, DOI 10.1016/S1665-2681(19)31872-1; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Ramia S, 2006, INT J INFECT DIS, V10, P272, DOI 10.1016/j.ijid.2005.07.008; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Rodriguez-Torres M, 2009, 60 ANN M AM ASS STUD; Rohrbach J, 2010, GUT, V59, P1252, DOI 10.1136/gut.2009.205971; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sajadi MM, 2010, AIDS, V24, P1689, DOI 10.1097/QAD.0b013e32833a2a32; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Shenge J A, 2018, Arch Basic Appl Med, V6, P79; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; World Health Organization, VIR HEP FACTSH 2012; World Health Organization, 2016, MOR 2 MILL PEOPL COI	50	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210724	10.1371/journal.pone.0210724	http://dx.doi.org/10.1371/journal.pone.0210724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726229	Green Submitted, Green Published, gold			2022-12-26	WOS:000457874000028
J	Cardoso, MS; Bento, GA; de Almeida, LV; de Castro, JC; Reis-Cunha, JL; Barbosa, VD; de Souza, CF; Brazil, RP; Valdivia, HO; Bartholomeu, DC				Cardoso, Mariana Santos; Bento, Gabrielle Ariadine; de Almeida, Laila Viana; de Castro, Joseane Camilla; Reis-Cunha, Joao Luis; Barbosa, Vanessa de Araujo; de Souza, Cristian Ferreira; Brazil, Reginaldo Pecanha; Oswaldo Valdivia, Hugo; Bartholomeu, Daniella Castanheira			Detection of multiple circulating Leishmania species in Lutzomyia longipalpis in the city of Governador Valadares, southeastern Brazil	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; SAND FLIES DIPTERA; POLYMERASE-CHAIN-REACTION; CUTANEOUS LEISHMANIASIS; MINAS-GERAIS; AREA; DNA; PSYCHODIDAE; DIAGNOSIS; VECTORS	Leishmaniasis encompasses a group of diverse clinical diseases caused by protozoan parasites of the Leishmania genus. This disease is a major public health problem in the New World affecting people exposed in endemic regions. The city of Governador Valadares (Minas Gerais/Brazil) is a re-emerging area for visceral leishmaniasis, with 191 human cases reported from 2008 to 2017 and a lethality rate of 14.7%. The transmission of the parasite occurs intensely in this region with up to 22% of domestic dogs with positive serology for the visceral form. Lu. longipalpis is one of the most abundant sand fly species in this area. Despite this scenario, so far there is no information regarding the circulating Leishmania species in the insect vector Lutzomyia longipalpis in this focus. We collected 616 female Lutzomyia longipalpis sand flies between January and September 2015 in the Vila Parque Ibituruna neighborhood (Governador Valadares/MG), which is located on a transitional area between the sylvatic and urban environments with residences built near a preserved area. After DNA extraction of individual sand flies, the natural Leishmania infections in Lu. longipalpis were detected by conventional PCR, using primers derived from kDNA sequences, specific for L. (Leishmania) or L. (Viannia) subgenus. The sensitivity of these PCR reactions was 0.1 pg of DNA for each Leishmania subgenus and the total infection rate of 16.2% (100 positive specimens). Species-specific PCR detected the presence of multiple Leishmania species in infected Lu. longipalpis specimens in Governador Valadares, including L. amazonensis (n = 3), L. infantum (n = 28), L. (Viannia) spp. (n = 20), coinfections with L. infantum and L. (Viannia) spp. (n = 5), and L. (Leishmania) spp (n = 44). Our results demonstrate that multiple Leishmania species circulate in Lu. longipalpis in Governador Valadares and reveal a potential increasing risk of transmission of the different circulating parasite species. This information reinforces the need for epidemiological and entomological surveillance in this endemic focus, and the development of effective control strategies against leishmaniasis.	[Cardoso, Mariana Santos; Bento, Gabrielle Ariadine; de Almeida, Laila Viana; de Castro, Joseane Camilla; Reis-Cunha, Joao Luis; Bartholomeu, Daniella Castanheira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Barbosa, Vanessa de Araujo; de Souza, Cristian Ferreira; Brazil, Reginaldo Pecanha] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Oswaldo Valdivia, Hugo] US Naval Med Res Unit 6, Dept Parasitol, Lima, Peru	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6)	Bartholomeu, DC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	daniella@icb.ufmg.br	Reis-Cunha, João/AAX-6470-2020; Brazil, Reginaldo Peçanha/AAF-6777-2019; Bartholomeu, Daniella C./J-4714-2015	Reis-Cunha, João/0000-0003-1034-0992; Bartholomeu, Daniella C./0000-0003-0974-7357; Valdivia, Hugo/0000-0003-2159-5667; Souza, Cristian/0000-0003-4274-3278	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [FAPEMIG APQ-02803-15]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES 051/2013]; Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais; CNPq; CAPES	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	DCB has been supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG APQ-02803-15), http://www.fapemig.br; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES 051/2013), http://www.capes.gov.br; Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais. DCB and RPB are research fellows of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). MSC and LVA have a scholarship from CNPq. GAB, JCC and JLRC have a scholarship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; Barata RA, 2004, MEM I OSWALDO CRUZ, V99, P481, DOI 10.1590/S0074-02762004000500004; Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083; Barata RA, 2011, REV SOC BRAS MED TRO, V44, P136, DOI 10.1590/S0037-86822011005000003; Barbosa V. C., 2016, THESIS; de Lima ECB, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759048, 10.1590/s1678-9946201759048]; Bray DP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002723; Brazil R.P., 2015, ENTOMOLOGY ORNITHOLO, V04, P4, DOI [10.4172/2161, DOI 10.1089/VBZ.2007.0180.V, DOI 10.4172/2161-0983.1000144]; Brazil RP, 2013, REV SOC BRAS MED TRO, V46, P263, DOI 10.1590/0037-8682-0101-2013; Coelho LIC, 2011, PARASITOL RES, V108, P671, DOI 10.1007/s00436-010-2139-9; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; DASILVA ALFF, 1990, MEM I OSWALDO CRUZ, V85, P453, DOI 10.1590/S0074-02761990000400010; DATASUS, VISC LEISHM CAS CONF; DATASUS, AM CUT LEISHM CAS CO; Leal GGD, 2018, PREV VET MED, V150, P1, DOI 10.1016/j.prevetmed.2017.11.022; de Oliveira Joao Paulo C, 2007, Kinetoplastid Biol Dis, V6, P5; de Souza NA, 2017, MEM I OSWALDO CRUZ, V112, P161, DOI 10.1590/0074-02760160463; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dias ES, 2011, VET PARASITOL, V176, P101, DOI 10.1016/j.vetpar.2010.11.014; Feliciangeli MD, 1999, PARASITE, V6, P113, DOI 10.1051/parasite/1999062113; Flórez Mónica, 2006, Biomed., V26, P109; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Ghasemloo Hadi, 2016, Pak J Biol Sci, V19, P136, DOI 10.3923/pjbs.2016.136.142; GONTIJO CMF, 1995, MEM I OSWALDO CRUZ, V90, P367, DOI 10.1590/S0074-02761995000300011; (IBGE) IBdGeE, POP CIT GOV VAL MIN; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LEPONT F, 1985, T ROY SOC TROP MED H, V79, P227, DOI 10.1016/0035-9203(85)90341-4; Lidani K. C. F., 2017, VISCERAL LEISHMANIAS, DOI [10.5772/65787, DOI 10.5772/65787]; LOPEZ M, 1993, AM J TROP MED HYG, V49, P348, DOI 10.4269/ajtmh.1993.49.348; Savani ESMM, 2009, VET PARASITOL, V160, P18, DOI 10.1016/j.vetpar.2008.10.090; Michalsky EM, 2009, MEM I OSWALDO CRUZ, V104, P56, DOI 10.1590/S0074-02762009000100009; Moya SL, 2017, ACTA TROP, V172, P122, DOI 10.1016/j.actatropica.2017.05.004; Paiva BR, 2010, ACTA TROP, V115, P126, DOI 10.1016/j.actatropica.2010.02.013; Pereira AA, 2018, J MED ENTOMOL, V55, P989, DOI 10.1093/jme/tjy014; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Ranasinghe S, 2015, MEM I OSWALDO CRUZ, V110, P1017, DOI 10.1590/0074-02760150286; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; Reguera RM, 2016, VET PARASITOL, V227, P98, DOI 10.1016/j.vetpar.2016.07.011; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Saraiva L, 2017, MEM I OSWALDO CRUZ, V112, P309, DOI 10.1590/0074-02760160438; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Seccombe A.K, 1993, CATALOGUE OLD WORLD; SHAW J, 2003, FLEBOTOMINEOS BRASIL, P337; Teodoro U, 2004, BRAZ ARCH BIOL TECHN, V47, P205, DOI 10.1590/S1516-89132004000200007; Tonelli GB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178628; Valdivia HO, 2017, SCI REP-UK, V7, DOI 10.1038/srep40804; WALTERS LL, 1993, J MED ENTOMOL, V30, P699, DOI 10.1093/jmedent/30.4.699; World Health Organization (WHO), LEISHMANIASIS; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zorrilla V, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006029	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211831	10.1371/journal.pone.0211831	http://dx.doi.org/10.1371/journal.pone.0211831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721272	Green Submitted, gold, Green Published			2022-12-26	WOS:000457746300032
J	Rodil, IF; Attard, KM; Norkko, J; Glud, RN; Norkko, A				Rodil, Ivan F.; Attard, Karl M.; Norkko, Joanna; Glud, Ronnie N.; Norkko, Alf			Towards a sampling design for characterizing habitat-specific benthic biodiversity related to oxygen flux dynamics using Aquatic Eddy Covariance	PLOS ONE			English	Article							ECOSYSTEM METABOLISM; COMMUNITY METABOLISM; PERMEABLE SEDIMENTS; DISSOLVED-OXYGEN; CARBON FLUXES; EXCHANGE; GROWTH; LIGHT; FLOW; MICROPHYTOBENTHOS	The Aquatic Eddy Covariance (AEC) technique has emerged as an important method to quantify in situ seafloor metabolism over large areas of heterogeneous benthic communities, enabling cross-habitat comparisons of seafloor productivity. However, the lack of a corresponding sampling protocol to perform biodiversity comparisons across habitats is impeding a full assessment of marine ecosystem metabolism. Here, we study a range of coastal benthic habitats, from rocky-bed communities defined by either perennial macroalgae or blue mussel beds to soft-sediment communities comprised of either seagrass, patches of different macrophyte species or bare sand. We estimated that the maximum contribution to the AEC metabolic flux can be found for a seafloor area of approximately 80 m(2) with a 5 meter upstream distance of the instrument across all the habitats. We conducted a sampling approach to characterize and quantify the dominant features of biodiversity (i.e., community biomass) within the main seafloor area of maximum metabolic contribution (i.e., gross primary production and community respiration) measured by the AEC. We documented a high biomass contribution of the macroalgal Fucus vesiculosus, the seagrass Zostera marina and the macroinvertebrate Mytilus edulis to the net ecosystem metabolism of the habitats. We also documented a significant role of the bare sediments for primary productivity compared to vegetated canopies of the soft sediments. The AEC also provided insight into dynamic short-term drivers of productivity such as PAR availability and water flow velocity for the productivity estimate. We regard this study as an important step forward, setting a framework for upcoming research focusing on linking biodiversity metrics and AEC flux measurements across habitats.	[Rodil, Ivan F.; Attard, Karl M.; Norkko, Joanna; Norkko, Alf] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Rodil, Ivan F.; Norkko, Alf] Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden; [Attard, Karl M.; Glud, Ronnie N.] Univ Southern Denmark, Odense, Denmark; [Glud, Ronnie N.] Tech Univ Marine Sci & Technol, Tokyo, Japan	University of Helsinki; Stockholm University; University of Southern Denmark	Rodil, IF (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.; Rodil, IF (corresponding author), Stockholm Univ, Baltic Sea Ctr, Stockholm, Sweden.	ivan.rodil@helsinki.fi	Norkko, Alf/L-8736-2019; Rodil, Iván F./I-5305-2013; Attard, Karl/AAO-8314-2021; Attard, Karl Michael/ABE-6044-2021	Norkko, Alf/0000-0002-9741-4458; Rodil, Iván F./0000-0001-6375-1598; Attard, Karl Michael/0000-0002-8009-5462; Glud, Ronnie N./0000-0002-7069-893X; Norkko, Joanna/0000-0001-9885-8408	Academy of Finland [294853]; University of Helsinki; Walter and Andree de Nottbeck Foundation; European Commission through ATLAS [678760]; FINMARI (Finnish Marine Research Infrastructure network, The Academy of Finland) [283417]	Academy of Finland(Academy of Finland); University of Helsinki; Walter and Andree de Nottbeck Foundation; European Commission through ATLAS; FINMARI (Finnish Marine Research Infrastructure network, The Academy of Finland)	This study was funded by the Academy of Finland, University of Helsinki and Walter and Andree de Nottbeck Foundation. The Walter and Andree de Nottbeck Foundation supported this work through a postdoctoral fellowship to KMA and through a senior research fellowship to RNG. Further funding for this project was provided by research grants from The Academy of Finland (project ID 294853) and the European Commission through ATLAS (project ID 678760). This study has utilized research infrastructure facilities provided by FINMARI (Finnish Marine Research Infrastructure network, The Academy of Finland, project ID 283417).	Anderson M.J., 2008, PERMANOVA FRIMER GUI; Apostolaki ET, 2010, ECOSYSTEMS, V13, P459, DOI 10.1007/s10021-010-9330-9; Attard KM, 2019, LIMNOL OCEANOGR, V64, P149, DOI 10.1002/lno.11026; Attard KM, 2015, MAR ECOL PROG SER, V535, P99, DOI 10.3354/meps11413; Attard KM, 2014, LIMNOL OCEANOGR, V59, P1555, DOI 10.4319/lo.2014.59.5.1555; Berg P, 2003, MAR ECOL PROG SER, V261, P75, DOI 10.3354/meps261075; Berg P, 2007, LIMNOL OCEANOGR, V52, P1672, DOI 10.4319/lo.2007.52.4.1672; Berg P, 2013, LIMNOL OCEANOGR, V58, P1329, DOI 10.4319/lo.2013.58.4.1329; Berg P, 2008, OCEANOGRAPHY, V21, P164, DOI 10.5670/oceanog.2008.13; Binzer T, 2005, AQUAT BOT, V83, P239, DOI 10.1016/j.aquabot.2005.07.001; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722, DOI 10.4319/lo.2006.51.6.2722; Bordeyne F, 2017, LIMNOL OCEANOGR, V62, P2418, DOI 10.1002/lno.10574; Bordeyne F, 2015, MAR BIOL, V162, P2119, DOI 10.1007/s00227-015-2741-6; Brey T., 2001, POPULATION DYNAMICS; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Delgard ML, 2016, MAR ECOL PROG SER, V543, P55, DOI 10.3354/meps11570; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Gammal J, 2019, ECOSYSTEMS, V22, P137, DOI 10.1007/s10021-018-0258-9; Glud RN, 2002, MAR ECOL PROG SER, V238, P15, DOI 10.3354/meps238015; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Glud RN, 2014, LIMNOL OCEANOGR, V59, P1097, DOI 10.4319/lo.2014.59.4.1097; Glud RN, 2010, MAR ECOL PROG SER, V417, P1, DOI 10.3354/meps08795; Gorley C.K., 2006, GETTING STARTED PRIM; Hume AC, 2011, LIMNOL OCEANOGR, V56, P86, DOI 10.4319/lo.2011.56.1.0086; Kautsky H., 1989, Contributions from the Asko Laboratory University of Stockholm, P1; Kiirikki M, 1997, SARSIA, V82, P259, DOI 10.1080/00364827.1997.10413653; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; Koch EW, 1999, MAR ECOL PROG SER, V184, P63, DOI 10.3354/meps184063; Koopmans D., 2018, BIOGEOSCI DISCUSS, DOI [10.5194/bg-2018-199, DOI 10.5194/BG-2018-199]; Landes A, 2015, J SHELLFISH RES, V34, P373, DOI 10.2983/035.034.0220; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10349; Long MH, 2015, MAR ECOL PROG SER, V529, P75, DOI 10.3354/meps11314; Long MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058581; Longphuirt SN, 2007, ESTUAR COAST SHELF S, V74, P367, DOI 10.1016/j.ecss.2007.04.025; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; McGinnis DF, 2014, J GEOPHYS RES-OCEANS, V119, P6918, DOI 10.1002/2014JC010303; McGinnis DF, 2011, LIMNOL OCEANOGR-METH, V9, P340, DOI 10.4319/lom.2011.9.340; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Micallef A, 2012, CONT SHELF RES, V39-40, P14, DOI 10.1016/j.csr.2012.03.008; Migne A, 2015, MAR BIOL, V162, P449, DOI 10.1007/s00227-014-2592-6; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Ouisse V, 2010, HYDROBIOLOGIA, V649, P3, DOI 10.1007/s10750-010-0254-3; Peralta G, 2006, MAR ECOL PROG SER, V327, P135, DOI 10.3354/meps327135; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Reidenbach M.A., 2013, LIMNOL OCEANOGR FLUI, V3, P225, DOI 10.1215/21573689-2395266; Rheuban JE, 2014, MAR ECOL PROG SER, V507, P1, DOI 10.3354/meps10843; Rheuban JE, 2014, LIMNOL OCEANOGR, V59, P1376, DOI 10.4319/lo.2014.59.4.1376; Rheuban JE, 2013, LIMNOL OCEANOGR-METH, V11, P351, DOI 10.4319/lom.2013.11.351; Robert K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09382-z; Rovelli L, 2017, LIMNOL OCEANOGR, V62, pS381, DOI 10.1002/lno.10619; Rovelli L, 2015, MAR ECOL PROG SER, V525, P97, DOI 10.3354/meps11211; Rumohr H, 1987, BALTIC MAR BIOL PUBL, V9, P56; Snelgrove PVR, 2014, TRENDS ECOL EVOL, V29, P398, DOI 10.1016/j.tree.2014.05.002; Tagliarolo M, 2012, AQUAT BIOL, V17, P167, DOI 10.3354/ab00464; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Thorngren L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187870; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Villas A, 2011, ECOL APPL, V21, P2172, DOI 10.1890/10-1473.1; Westerbom M, 2008, MAR BIOL, V153, P1153, DOI 10.1007/s00227-007-0886-7	64	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211673	10.1371/journal.pone.0211673	http://dx.doi.org/10.1371/journal.pone.0211673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716124	Green Submitted, Green Published, gold			2022-12-26	WOS:000457744200038
J	Xing, YW; Liu, JP; Lu, FG; Wang, L; Li, Y; Ouyang, CH				Xing, Yawei; Liu, Jianping; Lu, Fanggen; Wang, Li; Li, Ying; Ouyang, Chunhui			Dynamic distribution of gallbladder microbiota in rabbit at different ages and health states	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; LISTERIA-MONOCYTOGENES; BACTERIAL COMMUNITY; GUT MICROBIOTA; BILE-ACIDS; DIVERSITY; DISEASE	The internal environment of the gallbladder has been considered extremely unfavorable for bacterial growth, and the microbial profile of the gallbladder still unknown. By high-throughput sequencing of the bacterial 16S rRNA gene, we studied the microbial profile of the gallbladder from healthy rabbits before and after weaning. Moreover, we investigated the difference of microbiota between the gallbladder and gut. Our results showed that the gallbladder was dominantly populated by Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria in the phylum throughout the developmental stages of rabbits. The adult rabbits showed higher species richness and exhibited higher bacterial diversity than rabbits before weaning based on the results of alpha diversity. Beta diversity analyses indicated differences in the bacterial community composition between different developmental stages. In the comparison of the gallbladder and feces, Firmicutes and Bacteroidetes were dominant in the phylum, as they were present in about 61% and 21% of the feces, respectively. Conversely, in the gallbladder, Firmicutes was the most dominant (about 41%), and Bacteroidetes and Proteobacteria were present in about 16% and 22% of the gallbladder, respectively. The Unweighted UniFrac Principal Coordinate Analysis results illustrated samples clustered into 2 categories: the gallbladder and feces. Our study might provide a foundation for knowledge on gallbladder microbiota for the first time and a basis for further studies on gallbladder and intestinal health.	[Xing, Yawei; Liu, Jianping; Lu, Fanggen; Wang, Li; Li, Ying; Ouyang, Chunhui] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China	Central South University	Ouyang, CH (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China.	doctoroych@csu.edu.cn		Xing, Ya-wei/0000-0002-7564-2302	National Natural Science Foundation of China [81470801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China No.81470801. Fanggen Lu received this award. The URL is http://www.nsfc.gov.cn/.The sponsor played a role in the study design and review.	Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bauer TM, 2001, AM J GASTROENTEROL, V96, P2962, DOI 10.1111/j.1572-0241.2001.04668.x; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dowd GC, 2011, INFECT IMMUN, V79, P369, DOI 10.1128/IAI.00330-10; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fremont-Rahl JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070657; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Gutierrez-Diaz I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091307; Hardy J, 2006, INFECT IMMUN, V74, P1819, DOI 10.1128/IAI.74.3.1819-1827.2006; Hardy J, 2004, SCIENCE, V303, P851, DOI 10.1126/science.1092712; Hazrah P, 2004, HPB (Oxford), V6, P28, DOI 10.1080/13651820310025192; Hofmann AF, 2006, P NATL ACAD SCI USA, V103, P4333, DOI 10.1073/pnas.0600780103; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Kohl KD, 2014, ENVIRON MICROBIOL, V16, P2869, DOI 10.1111/1462-2920.12376; Kook PH, 2010, J VET INTERN MED, V24, P224, DOI 10.1111/j.1939-1676.2009.0413.x; Kurdi P, 2006, J BACTERIOL, V188, P1979, DOI 10.1128/JB.188.5.1979-1986.2006; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu JP, 2016, WORLD J GASTROENTERO, V22, P7353, DOI 10.3748/wjg.v22.i32.7353; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Sanchez B, 2005, J BACTERIOL, V187, P5799, DOI 10.1128/JB.187.16.5799-5808.2005; Sheh A, 2013, GUT MICROBES, V4, P505, DOI 10.4161/gmic.26205; SWIDSINSKI A, 1995, GASTROENTEROLOGY, V108, P860, DOI 10.1016/0016-5085(95)90461-1; Walker MM, 2014, ALIMENT PHARM THER, V39, P767, DOI 10.1111/apt.12666; WETTER LA, 1994, LANCET, V343, P444, DOI 10.1016/S0140-6736(94)92691-3; Wu T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-669; Wu Y, 2019, APPL MICROBIOL BIOT, V103, P1231, DOI 10.1007/s00253-018-9494-3; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yang I, 2013, FEMS MICROBIOL REV, V37, P736, DOI 10.1111/1574-6976.12027; Zhang YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187940; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441	46	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211828	10.1371/journal.pone.0211828	http://dx.doi.org/10.1371/journal.pone.0211828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716131	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200052
J	Ota, H; Ito-Matsuoka, Y; Matsui, Y				Ota, Hiromitsu; Ito-Matsuoka, Yumi; Matsui, Yasuhisa			Identification of the X-linked germ cell specific miRNAs (XmiRs) and their functions	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; BETA-CATENIN; SELF-RENEWAL; MICRORNAS; DIFFERENTIATION; PROLIFERATION; MECHANISMS; EXPRESSION; EFFICIENT; RNA	MicroRNAs (miRNAs) play a critical role in multiple aspects of biology. Dicer, an RNase III endonuclease, is essential for the biogenesis of miRNAs, and the germ cell-specific Dicer1 knockout mouse shows severe defects in gametogenesis. How miRNAs regulate germ cell development is still not fully understood. In this study, we identified germ cell-specific miRNAs (miR-741-3p, miR-871-3p, miR-880-3p) by analyzing published RNA-seq data of mouse. These miRNA genes are contiguously located on the X chromosome near other miRNA genes. We named them X chromosome-linked miRNAs (XmiRs). To elucidate the functions of XmiRs, we generated knockout mice of these miRNA genes using the CRISPR/Cas9-mediated genome editing system. Although no histological abnormalities were observed in testes of F0 mice in which each miRNA gene was disrupted, a deletion covering miR-871 and miR-880 or covering all XmiRs (Delta XmiRs) resulted in arrested spermatogenesis in meiosis in a few seminiferous tubules, indicating their redundant functions in spermatogenesis. Among candidate targets of XmiRs, we found increased expression of a gene encoding a WNT receptor, FZD4, in Delta XmiRs testis compared with that in wildtype testis. miR-871-3p and miR-880-3p repressed the expression of Fzd4 via the 3'-untranslated region of its mRNA. In addition, downstream genes of the WNT/beta-catenin pathway were upregulated in Delta XmiRs testis. We also found that miR-871, miR-880, and Fzd4 were expressed in spermatogonia, spermatocytes and spermatids, and overexpression of miR-871 and miR-880 in germ stem cells in culture repressed their increase in number and Fzd4 expression. Previous studies indicated that the WNT/beta-catenin pathway enhances and represses proliferation and differentiation of spermatogonia, respectively, and our results consistently showed that stable beta-catenin enhanced GSC number. In addition, stable beta-catenin partially rescued reduced GSC number by overexpression of miR-871 and miR-880. The results together suggest that miR-871 and miR-880 cooperatively regulate the WNT/beta-catenin pathway during testicular germ cell development.	[Ota, Hiromitsu; Ito-Matsuoka, Yumi; Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Ota, Hiromitsu; Matsui, Yasuhisa] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chuo Ku, Tokyo, Japan; [Matsui, Yasuhisa] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Matsui, Y (corresponding author), Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chuo Ku, Tokyo, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.	yasuhisa.matsui.d3@tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Ministry of Education, Culture, Sports, Science and Technology of Japan [JP16K20908]; KAKENHI in the Innovative Areas, "Mechanisms regulating gamete formation in animals" from MEXT [16H06530]; AMED-CREST from the Japan Agency for Medical Research and Development [JP17gm0510017h]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI in the Innovative Areas, "Mechanisms regulating gamete formation in animals" from MEXT; AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	H.O. was supported by a Grant-in-Aid (KAKENHI) for Young Scientists (B) (grant #JP16K20908) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/en/index.htm).Y.M.was supported by KAKENHI in the Innovative Areas, "Mechanisms regulating gamete formation in animals" (grant #16H06530) from MEXT, and by AMED-CREST (grant #JP17gm0510017h) from the Japan Agency for Medical Research and Development8https://www.amed.go.jp/en/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Chang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028039; Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cui N, 2016, J CELL MOL MED, V20, P1503, DOI 10.1111/jcmm.12838; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forte E, 2015, J VIROL, V89, P2333, DOI 10.1128/JVI.03317-14; Garcia-Lopez J, 2015, RNA, V21, P946, DOI 10.1261/rna.048215.114; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; He ZP, 2013, STEM CELLS, V31, P2205, DOI 10.1002/stem.1474; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Huszar JM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103747; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Kerr GE, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.112.105809; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kumar M, 2016, ONCOTARGET, V7, P85709, DOI 10.18632/oncotarget.13920; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu DK, 2012, BIOCHEM BIOPH RES CO, V422, P114, DOI 10.1016/j.bbrc.2012.04.118; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marco A, 2013, NUCLEIC ACIDS RES, V41, P7745, DOI 10.1093/nar/gkt534; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513; REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873; Reza AMT, 2019, BIOL REV, V94, P415, DOI 10.1111/brv.12459; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014; Royo H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005461; Soma K, 2006, GENE EXPR PATTERNS, V6, P325, DOI 10.1016/j.modgep.2005.06.013; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sosa E, 2015, DEVELOPMENT, V142, P3791, DOI 10.1242/dev.127191; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Takase HM, 2016, P NATL ACAD SCI USA, V113, pE1489, DOI 10.1073/pnas.1601461113; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Wang YR, 2016, MOL BIOL EVOL, V33, P2232, DOI 10.1093/molbev/msw089; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yang QE, 2013, DEVELOPMENT, V140, P280, DOI 10.1242/dev.087403; Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705; Yeh JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040002; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu M, 2014, J CELL BIOCHEM, V115, P232, DOI 10.1002/jcb.24655; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zhao BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-488	81	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211739	10.1371/journal.pone.0211739	http://dx.doi.org/10.1371/journal.pone.0211739			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707741	gold, Green Published, Green Submitted			2022-12-26	WOS:000457742900045
J	Bo, ZY; Wan, Y; Meng, SS; Lin, TF; Kuang, WH; Jiang, LJ; Qiu, PY				Bo, Zhenyan; Wan, Yang; Meng, Steven Siyao; Lin, Tengfei; Kuang, Weihong; Jiang, Lijun; Qiu, Peiyuan			The temporal trend and distribution characteristics in mortality of Alzheimer's disease and other forms of dementia in China: Based on the National Mortality Surveillance System (NMS) from 2009 to 2015	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; DEVELOPING-COUNTRIES; ENTERIC VIRUSES; PREVALENCE; SHANGHAI; IMPACT; OLDER; SUBTYPES; PEOPLE; BURDEN	Background China is experiencing rapid age, which will lead to increasing burden of age-related diseases, such as Alzheimer disease and other forms of dementia. Objectives The aim of this study was to 1) Explore the temporal trend of mortality of Alzheimer disease (AD) and other forms of dementia in China and 2) Analyze its geographic variations and urban-rural differences and calculate the years of life lost (YLLs) from AD and other forms of dementia. Data and methods Data were extracted from the National Mortality Surveillance System (NMS). Age-standardized mortalities were calculated with the Western Grade 26 Standard Life List, and the YLLs were calculated using the DALY template provided by the WHO / World Bank global burden of disease (GBD) Working Group. The trends in crude and age-standardized mortality of AD and other forms of dementia were examined using Cochran-Armitage trend test. Results In China, the crude mortality from AD and other forms of dementia increased from 2009 to 2015, but the age-standardized mortality decreased. The YLLs of AD and other forms of dementia increased during the study period. The age-standardized mortality in the east was higher than those in the west and middle regions, and the age-standardized mortality in rural areas was higher than that in urban areas. Conclusion In China, the age-standardized mortality of AD and other forms of dementia decreased from 2009 to 2015. However, the disease burden from AD and other forms of dementia is becoming heavier due to increasing elderly population. Moreover, there were geographic variations and urban-rural differences in mortality of AD and other forms of dementia in China.	[Bo, Zhenyan; Wan, Yang; Qiu, Peiyuan] Sichuan Univ, West China Sch Publ Hlth, West China Teaching Hosp 4, Chengdu, Sichuan, Peoples R China; [Meng, Steven Siyao] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14627 USA; [Lin, Tengfei] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Kuang, Weihong; Jiang, Lijun] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; University of Rochester; China Agricultural University; Sichuan University	Qiu, PY (corresponding author), Sichuan Univ, West China Sch Publ Hlth, West China Teaching Hosp 4, Chengdu, Sichuan, Peoples R China.	qiupeiyuan@scu.edu.cn	lin, tengfei/GXV-4968-2022	lin, tengfei/0000-0001-5282-6945				[Anonymous], 2010, DIS SURVEILLANCE, V25, P239; Banerjee TK, 2017, INT J GERIATR PSYCH, V32, P605, DOI 10.1002/gps.4499; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; Bertrand I, 2012, J APPL MICROBIOL, V112, P1059, DOI 10.1111/j.1365-2672.2012.05267.x; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen RL, 2012, INT J GERIATR PSYCH, V27, P692, DOI 10.1002/gps.2767; Dai ZC ZX, 2005, GUIDEBOOK DIS SURVEI, P57, DOI [10.2471/BLT.15.153148, DOI 10.2471/BLT.15.153148]; Dong MJ, 2007, AGE AGEING, V36, P619, DOI 10.1093/ageing/afm128; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Gao MY, 2017, AGE AGEING, V46, P787, DOI 10.1093/ageing/afx038; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P1, DOI 10.1016/j.jalz.2013.01.012; Keogh-Brown MR, 2016, EBIOMEDICINE, V4, P184, DOI 10.1016/j.ebiom.2015.12.019; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Li S, 2007, ACTA PSYCHIAT SCAND, V115, P73, DOI 10.1111/j.1600-0447.2006.00859.x; Li YC, 2013, B WORLD HEALTH ORGAN, V91, P650, DOI 10.2471/BLT.13.117549; Liu L, 2003, DEMENT GERIATR COGN, V15, P226, DOI 10.1159/000068784; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075918; Manton K C, 2005, Adv Gerontol, V16, P30; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Morampudi S, 2017, CANCER BIOL MED, V14, P74, DOI 10.20892/j.issn.2095-3941.2016.0030; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Sabat SR, 2009, LANCET, V374, P1805, DOI 10.1016/S0140-6736(09)62037-7; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Suh GH, 2001, ACTA PSYCHIAT SCAND, V104, P4, DOI 10.1034/j.1600-0447.2001.00210.x; Wang G, 2008, J ALZHEIMERS DIS, V15, P109; World Health Organization, DALY CALC TEMPL; World Health Organization, 1992, INT STAT CLASS DIS R; Wu YT, 2015, INT J GERIATR PSYCH, V30, P793, DOI 10.1002/gps.4297; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang G, 1992, Zhonghua Liu Xing Bing Xue Za Zhi, V13, P197; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yin P, 2016, ALZ DIS ASSOC DIS, V30, P348, DOI 10.1097/WAD.0000000000000147; Yu R, 2012, INT J ALZHEIMERS DIS, V2012, DOI [10.1155/2012/406852, DOI 10.1155/2012/406852]; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447	38	6	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210621	10.1371/journal.pone.0210621	http://dx.doi.org/10.1371/journal.pone.0210621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703120	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600023
J	Ganesan, K; Kulandaisamy, A; Priya, SB; Gromiha, MM				Ganesan, Kaliappan; Kulandaisamy, A.; Priya, S. Binny; Gromiha, M. Michael			HuVarBase: A human variant database with comprehensive information at gene and protein levels	PLOS ONE			English	Article							ACCESS	Human variant databases could be better exploited if the variant data available in multiple resources is integrated in a single comprehensive resource along with sequence and structural features. Such integration would improve the analyses of variants for disease prediction, prevention or treatment. The HuVarBase (HUmanVARiantdataBASE) assimilates publicly available human variant data at protein level and gene level into a comprehensive resource. Protein level data such as amino acid sequence, secondary structure of the mutant residue, domain, function, subcellular location and post-translational modification are integrated with gene level data such as gene name, chromosome number & genome position, DNA mutation, mutation type origin and rs ID number. Disease class has been added for the disease causing variants. The database is publicly available at https://www.iitm.ac.in/bioinfo/huvarbase. A total of 774,863 variant records, integrated in the HuVarBase, can be searched with options to display, visualize and download the results.	[Ganesan, Kaliappan; Kulandaisamy, A.; Priya, S. Binny; Gromiha, M. Michael] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Chennai, Tamil Nadu, India; [Gromiha, M. Michael] Tokyo Inst Technol, Inst Innovat Res, Adv Computat Drug Discovery Unit ACDD, Midori Ku, Yokohama, Kanagawa, Japan	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Tokyo Institute of Technology	Ganesan, K; Gromiha, MM (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch BioSci, Dept Biotechnol, Chennai, Tamil Nadu, India.; Gromiha, MM (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Adv Computat Drug Discovery Unit ACDD, Midori Ku, Yokohama, Kanagawa, Japan.	kganeshnew@gmail.com; gromiha@iitm.ac.in	Priya, Binny/AAI-8313-2021; arulsamy, kulandaisamy/AAX-2889-2021	arulsamy, kulandaisamy/0000-0002-3367-2669; S, Binny Priya/0000-0003-1872-2020; Ganesan, Kaliappan/0000-0002-6108-4100	Department of Biotechnology, Government of India [BT/PR16710/BID/7/680/2016]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This project work was partially supported by the Department of Biotechnology, Government of India to MMG (No. BT/PR16710/BID/7/680/2016). There was no additional external funding received for this study.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Burley SK, 2018, PROTEIN SCI, V27, P316, DOI 10.1002/pro.3331; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gaudet P, 2017, NUCLEIC ACIDS RES, V45, pD177, DOI 10.1093/nar/gkw1062; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Gosalia N, 2017, NUCLEIC ACIDS RES, V45, P10393, DOI 10.1093/nar/gkx730; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kulandaisamy A, 2018, BIOINFORMATICS, V34, P2325, DOI 10.1093/bioinformatics/bty054; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lewis Janine, 2017, Transl Sci Rare Dis, V2, P77, DOI 10.3233/TRD-170011; Li JC, 2018, NUCLEIC ACIDS RES, V46, pD1039, DOI 10.1093/nar/gkx1039; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Pundir S, 2017, METHODS MOL BIOL, V1558, P41, DOI 10.1007/978-1-4939-6783-4_2; Ritter DI, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0367-z; Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173; Savige J, 2014, PEDIATR NEPHROL, V29, P971, DOI 10.1007/s00467-013-2486-8; Shen JD, 2017, BIOINFORMATICS, V33, P2784, DOI 10.1093/bioinformatics/btx274; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singhal A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005017; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Thangam M, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav092; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258	23	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210475	10.1371/journal.pone.0210475	http://dx.doi.org/10.1371/journal.pone.0210475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703169	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600018
J	Lamanna, C; Hachhethu, K; Chesterman, S; Singhal, G; Mwongela, B; Ng'endo, M; Passeri, S; Farhikhtah, A; Kadiyala, S; Bauer, JM; Rosenstock, TS				Lamanna, Christine; Hachhethu, Kusum; Chesterman, Sabrina; Singhal, Gaurav; Mwongela, Beatrice; Ng'endo, Mary; Passeri, Silvia; Farhikhtah, Arghanoon; Kadiyala, Suneetha; Bauer, Jean-Martin; Rosenstock, Todd S.			Strengths and limitations of computer assisted telephone interviews (CATI) for nutrition data collection in rural Kenya	PLOS ONE			English	Article							SOCIAL-DESIRABILITY BIAS; CHILD UNDERNUTRITION; HEALTH; INTERVENTIONS; AFRICA; VALIDITY; LANDLINE; PROGRESS; POVERTY; IMPACT	Despite progress in fighting undernutrition, Africa has the highest rates of undernutrition globally, exacerbated by drought and conflict. Mobile phones are emerging as a tool for rapid, cost effective data collection at scale in Africa, as mobile phone subscriptions and phone ownership increase at the highest rates globally. To assess the feasibility and biases of collecting nutrition data via computer assisted telephone interviews (CATI) to mobile phones, we measured Minimum Dietary Diversity for Women (MDD-W) and Minimum Acceptable Diet for Infants and Young Children (MAD) using a one-week test-retest study on 1,821 households in Kenya. Accuracy and bias were assessed by comparing individual scores and population prevalence of undernutrition collected via CATI with data collected via traditional face-to-face (F2F) surveys. We were able to reach 75% (n = 1366) of study participants via CATI. Women's reported nutrition scores did not change with mode for MDD-W, but children's nutrition scores were significantly higher when measured via CATI for both the dietary diversity (mean increase of 0.45 food groups, 95% confidence interval 0.34-0.56) and meal frequency (mean increase of 0.75 meals per day, 95% confidence interval 0.53-0.96) components of MAD. This resulted in a 17% higher inferred prevalence of adequate diets for infants and young children via CATI. Women without mobile-phone access were younger and had fewer assets than women with access, but only marginally lower dietary diversity, resulting in a small non-coverage bias of 1-7% due to exclusion of participants without mobile phones. Thus, collecting nutrition data from rural women in Africa with mobile phones may result in 0% (no change) to as much as 25% higher nutrition estimates than collecting that information in face-to-face interviews.	[Lamanna, Christine; Chesterman, Sabrina; Ng'endo, Mary] World Agroforestry Ctr, Nairobi, Kenya; [Hachhethu, Kusum; Singhal, Gaurav; Passeri, Silvia; Bauer, Jean-Martin] United Nations World Food Programme, Vulnerabil Anal & Mapping Unit, Rome, Italy; [Hachhethu, Kusum; Passeri, Silvia; Farhikhtah, Arghanoon] United Nations World Food Programme, Div Nutr, Rome, Italy; [Chesterman, Sabrina; Kadiyala, Suneetha] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Mwongela, Beatrice] United Nations World Food Programme, Kenya Country Off, Nairobi, Kenya; [Bauer, Jean-Martin] United Nations World Food Programme, Brazzaville, Rep Congo; [Rosenstock, Todd S.] CGIAR Res Program Climate Change Agr & Food Secur, Kinshasa, DEM REP CONGO; [Rosenstock, Todd S.] World Agroforestry Ctr, Kinshasa, DEM REP CONGO	CGIAR; World Agroforestry (ICRAF); University of London; London School of Hygiene & Tropical Medicine; CGIAR	Lamanna, C (corresponding author), World Agroforestry Ctr, Nairobi, Kenya.	c.lamanna@cgiar.org	McIntyre, Lauren/AAC-8416-2020	Ng'endo Kanui, Mary/0000-0002-6349-5325; Kadiyala, Suneetha/0000-0002-9101-1471	UKAID funded Innovative Methods and Metrics for Agriculture and Nutrition Actions IMMANA [1.99]; USAID Office of Food for Peace; CGIAR Research Program on Climate Change, Agriculture and Food Security research project Partnerships for Scaling Climate-Smart Agriculture (P4S); CGIAR Trust Fund; London School of Hygiene and Tropical Medicine	UKAID funded Innovative Methods and Metrics for Agriculture and Nutrition Actions IMMANA(CGIAR); USAID Office of Food for Peace(United States Agency for International Development (USAID)); CGIAR Research Program on Climate Change, Agriculture and Food Security research project Partnerships for Scaling Climate-Smart Agriculture (P4S)(CGIAR); CGIAR Trust Fund(CGIAR); London School of Hygiene and Tropical Medicine	This work was supported by UKAID funded Innovative Methods and Metrics for Agriculture and Nutrition Actions IMMANA (http://immana.lcirah.ac.uk/) grant #1.99 to the World Agroforestry Centre (TS Rosenstock) and the London School of Hygiene and Tropical Medicine (S Kadiyala). The United Nations World Food Programme mVAM and Nutrition units were supported in part by funding from the USAID Office of Food for Peace (www.usaid.gov) (JM Bauer). The CGIAR Research Program on Climate Change, Agriculture and Food Security research project Partnerships for Scaling Climate-Smart Agriculture (P4S) (TS Rosenstock) provided additional support. CCAFS is supported by the CGIAR Trust Fund and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors. The views expressed in this document cannot be taken to reflect the official opinions of these organizations.	Aker JC, 2010, J ECON PERSPECT, V24, P207, DOI 10.1257/jep.24.3.207; [Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; Aranda-Jan CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-188; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Ballivian A, 2013, MOBILE RES METHODS O, DOI [10.5334/bar.c, DOI 10.5334/BAR.C]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Brunette W., 2013, P 14 WORKSH MOB COMP, DOI 10.1145/2444776.2444790; Chakraborty D, 2013, P 3 ACM S COMP DEV; Dabalen A, 2016, MOBILE PHONE PANEL S; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher RJ, 2000, PSYCHOL MARKET, V17, P105, DOI 10.1002/(SICI)1520-6793(200002)17:2<105::AID-MAR3>3.0.CO;2-9; Food and Agriculture Organization of the United Nations, 2016, MIN DIET DIV WOM GUI; Gibson DG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7428; Greenleaf AR, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7331; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; GSMA, 2016, MOB EC AFR 2016; GSMA, 2015, BRIDG GEND GAP MOB A; GSMA Intelligence, 2017, MOB EC 2017; Haddad L, 2016, NATURE, V540, P30, DOI 10.1038/540030a; Hammond J, 2017, AGR SYST, V151, P225, DOI 10.1016/j.agsy.2016.05.003; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Hoogeveen J, 2014, CAN J DEV STUD, V35, P186, DOI 10.1080/02255189.2014.876390; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Jaetzold R, 2005, FARM MANAGEMENT HDB, VI; Janevic MR, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0093-3; Keeter S, 2006, PUBLIC OPIN QUART, V70, P88, DOI 10.1093/poq/nfj008; Kenya National Bureau of Statistics, 2014, EC SURV 2014; Kenya National Bureau of Statistics, 2015, KEN DEM HLTH SURV 20; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; Langhaug LF, 2011, SEX TRANSM INFECT, V87, P165, DOI 10.1136/sti.2009.037374; Link MW, 2007, PUBLIC OPIN QUART, V71, P814, DOI 10.1093/poq/nfm051; Livingston M, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-41; Lupu N, 2018, ANNU REV POLIT SCI, V21, P195, DOI 10.1146/annurev-polisci-052115-021432; Mavletova A., 2015, MOBILE RES METHODS O; Mock N, 2016, PROCEDIA ENGINEER, V159, P217, DOI 10.1016/j.proeng.2016.08.164; Morrow N, 2016, PROCEDIA ENGINEER, V159, P210, DOI 10.1016/j.proeng.2016.08.163; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; Panel Global, 2015, IMPR METR DAT AR NEE; Pascoe SJS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074977; Perrier T, 2015, P 2015 ANN S COMP DE, P13, DOI [10.1145/2830629.2830645, DOI 10.1145/2830629.2830645]; R Core Team, 2013, R LANG ENV STAT COMP; Rosenstock TS, 2017, CURR OPIN ENV SUST, V26-27, P54, DOI 10.1016/j.cosust.2017.02.010; Rosskam E, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7593; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Schreiner M., 2011, KENYA PROGR OUT POVE; Shepherd K, 2015, NATURE, V523, P152, DOI 10.1038/523152a; Stewart O, 2009, P COMP ADV TECHN ED; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tran MC, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3663; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; West BT, 2017, J SURV STAT METHODOL, V5, P175, DOI 10.1093/jssam/smw024; Zuur Alain F., 2009, P1	60	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210050	10.1371/journal.pone.0210050	http://dx.doi.org/10.1371/journal.pone.0210050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ4PJ	30699207	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000457155600017
J	Campbell, CL; Saavedra-Rodriguez, K; Kubik, TD; Lenhart, A; Lozano-Fuentes, S; Black, WC				Campbell, Corey L.; Saavedra-Rodriguez, Karla; Kubik, Tristan D.; Lenhart, Audrey; Lozano-Fuentes, Saul; Black, William C.			Vgsc-interacting proteins are genetically associated with pyrethroid resistance in Aedes aegypti 1	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; MOSQUITO AEDES-AEGYPTI; INSECTICIDE RESISTANCE; MEMBRANE SKELETON; SYNAPTOTAGMIN-I; MESSENGER-RNA; DROSOPHILA; EXPRESSION; ANKYRIN; PUMILIO	Association mapping of factors that condition pyrethroid resistance in Aedes aegypti has consistently identified genes in multiple functional groups. Toward better understanding of the mechanisms involved, we examined high throughput sequencing data (HTS) from two Aedes aegypti aegypti collections from Merida, Yucatan, Mexico treated with either permethrin or deltamethrin. Exome capture enrichment for coding regions and the AaegL5 annotation were used to identify genes statistically associated with resistance. The frequencies of single nucleotide polymorphisms (SNPs) were compared between resistant and susceptible mosquito pools using a contingency chi(2) analysis. The -log(10)(chi(2) p value) was calculated at each SNP site, with a weighted average determined from all sites in each gene. Genes with -log(10)(chi(2) p value). 4.0 and present among all 3 treatment groups were subjected to gene set enrichment analysis (GSEA). We found that several functional groups were enriched compared to all coding genes. These categories were transport, signal transduction and metabolism, in order from highest to lowest statistical significance. Strikingly, 21 genes with demonstrated association to synaptic function were identified. In the high association group (n = 1,053 genes), several genes were identified that also genetically or physically interact with the voltage-gated sodium channel (VGSC). These genes were eg., CHARLATAN (CHL), a transcriptional regulator, several ankyrin-domain proteins, PUMILIO (PUM), a translational repressor, and NEDD4 (E3 ubiquitin-protein ligase). There were 13 genes that ranked among the top 10%: these included VGSC; CINGULIN, a predicted neuronal gap junction protein, and the aedine ortholog of NERVY (NVY), a transcriptional regulator. Silencing of CHL and NVY followed by standard permethrin bottle bioassays validated their association with permethrin resistance. Importantly, VGSC levels were also reduced about 50% in chl- or nvy-dsRNA treated mosquitoes. These results are consistent with the contribution of a variety of neuronal pathways to pyrethroid resistance in Ae. aegypti.	[Campbell, Corey L.; Saavedra-Rodriguez, Karla; Kubik, Tristan D.; Lozano-Fuentes, Saul; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lenhart, Audrey] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA USA	Colorado State University; Centers for Disease Control & Prevention - USA	Campbell, CL (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	corey.campbell@colostate.edu	; Lozano, Saul/H-4324-2011	Lenhart, Audrey/0000-0002-9156-4228; Saavedra-Rodriguez, Karla/0000-0001-8511-3327; Campbell, Corey L./0000-0002-6384-1259; Lozano, Saul/0000-0003-1517-6853	National Institutes of Health (NIH) [R01A10833680]; NIH/National Institute of Allergy and Infectious Diseases [RO1AI121211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121211] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) R01A10833680 and NIH/National Institute of Allergy and Infectious Diseases (RO1AI121211) awards to WCB4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2014, DEVELOPMENT, V141, P4716, DOI 10.1242/dev.113308; Arora D, 2016, LIFE SCI, V160, P72, DOI 10.1016/j.lfs.2016.04.025; Badiou A, 2008, ECOTOX ENVIRON SAFE, V69, P246, DOI 10.1016/j.ecoenv.2006.11.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Black W. C. IV, 1997, The molecular biology of insect disease vectors: a methods manual., P361; Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0; Breckenridge CB, 2009, NEUROTOXICOLOGY, V30, pS17, DOI 10.1016/j.neuro.2009.09.002; Brinzer RA, 2015, INSECT BIOCHEM MOLEC, V67, P74, DOI 10.1016/j.ibmb.2015.09.009; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Campbell CL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4348-4; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chen ML, 2017, INSECT BIOCHEM MOLEC, V82, P1, DOI 10.1016/j.ibmb.2017.01.007; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; CORRIGAN JJ, 1963, J INSECT PHYSIOL, V9, P1, DOI 10.1016/0022-1910(63)90079-9; Cui F, 2015, PESTIC BIOCHEM PHYS, V121, P88, DOI 10.1016/j.pestbp.2014.12.016; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Dickson LB, 2017, G3-GENES GENOM GENET, V7, P571, DOI 10.1534/g3.116.036053; Driscoll HE, 2013, J NEUROSCI, V33, P9644, DOI 10.1523/JNEUROSCI.0921-13.2013; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; FEINSTEIN PG, 1995, GENETICS, V140, P573; FENG GL, 1992, PESTIC BIOCHEM PHYS, V42, P64, DOI 10.1016/0048-3575(92)90074-A; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Julio AHF, 2017, COMP BIOCHEM PHYS C, V195, P27, DOI 10.1016/j.cbpc.2017.01.011; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; Fontaine A, 2017, GENOME BIOL EVOL, V9, P2322, DOI 10.1093/gbe/evx171; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673; GANETZKY B, 1986, ANNU REV GENET, V20, P13; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771; Hamid PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189680; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harms E, 2000, GENETICS, V155, P1831; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; He J, 2016, P NATL ACAD SCI USA, V113, P6029, DOI 10.1073/pnas.1605707113; Howlett IC, 2013, G3-GENES GENOM GENET, V3, P1399, DOI 10.1534/g3.113.006130; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jenson LJ, 2016, PESTIC BIOCHEM PHYS, V130, P59, DOI 10.1016/j.pestbp.2015.11.012; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17772; Lin WH, 2017, DIS MODEL MECH, V10, P141, DOI 10.1242/dmm.027045; Lorono-Pino MA, 2004, AM J TROP MED HYG, V71, P485; Lynn BD, 2012, J MEMBRANE BIOL, V245, P303, DOI 10.1007/s00232-012-9451-5; Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014; MANSINGH AJAL, 1965, J INSECT PHYSIOL, V11, P1389, DOI 10.1016/0022-1910(65)90176-9; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z; Mee CJ, 2004, J NEUROSCI, V24, P8695, DOI 10.1523/JNEUROSCI.2282-04.2004; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Nix P, 2014, J NEUROSCI, V34, P629, DOI 10.1523/JNEUROSCI.3859-13.2014; NOM, 2010, NOM032SSA22010; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Otali D, 2014, B ENTOMOL RES, V104, P323, DOI 10.1017/S0007485314000091; Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0; Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277; Sampo B, 2000, P NATL ACAD SCI USA, V97, P3666, DOI 10.1073/pnas.97.7.3666; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Streit AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148461; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terhzaz S, 2015, INSECT BIOCHEM MOLEC, V67, P38, DOI 10.1016/j.ibmb.2015.06.002; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; Wongtrakul J, 2010, J MED ENTOMOL, V47, P162, DOI 10.1603/ME09132; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yan Y, 2011, TOXICOL LETT, V201, P258, DOI 10.1016/j.toxlet.2011.01.009; ZERBA E, 1988, PARASITOL TODAY, V4, pS3, DOI 10.1016/0169-4758(88)90079-8; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024; Zhang YV, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00207; Zhao LM, 2009, J MED ENTOMOL, V46, P1361, DOI 10.1603/033.046.0615	98	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211497	10.1371/journal.pone.0211497	http://dx.doi.org/10.1371/journal.pone.0211497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695054	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400038
J	Ivic, I; Balasko, M; Fulop, BD; Hashimoto, H; Toth, G; Tamas, A; Juhasz, T; Koller, A; Reglodi, D; Solymar, M				Ivic, Ivan; Balasko, Marta; Fulop, Balazs D.; Hashimoto, Hitoshi; Toth, Gabor; Tamas, Andrea; Juhasz, Tamas; Koller, Akos; Reglodi, Dora; Solymar, Margit			VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; CEREBRAL-ARTERIES; PHARMACOLOGICAL CHARACTERIZATION; PITUITARY; VIP; NEUROPEPTIDE; EXPRESSION; CORONARY; HORMONE	Background PACAP and VIP are closely related neuropeptides with wide distribution and potent effect in the vasculature. We previously reported vasomotor activity in peripheral vasculature of male wild type (WT) and PACAP-deficient (KO) mice. However, female vascular responses are still unexplored. We hypothesized that PACAP-like activity is maintained in female PACAP KO mice and the mechanism through which it is regulated differs from that of male PACAP KO animals. Methods We investigated the vasomotor effects of VIP and PACAP isoforms and their selective blockers in WT and PACAP KO female mice in carotid and femoral arteries. The expression and level of different PACAP receptors in the vessels were measured by RT-PCR and Western blot. Results In both carotid and femoral arteries of WT mice, PACAP1-38, PACAP1-27 or VIP induced relaxation, without pronounced differences between them. Reduced relaxation was recorded only in the carotid arteries of KO mice as compared to their WT controls. The specific VPAC1R antagonist completely blocked the PACAP/VIP-induced relaxation in both arteries of all mice, while PAC1R antagonist affected relaxation only in their femoral arteries. Conclusion In female WT mice, VPAC1 receptors appear to play a dominant role in PACAP-induced vasorelaxation both in carotid and in femoral arteries. In the PACAP KO group PAC1R activation exerts vasorelaxation in the femoral arteries but in carotid arteries there is no significant effect of the activation of this receptor. In the background of this regional difference, decreased PAC1R and increased VPAC1R availability in the carotid arteries was found.	[Ivic, Ivan; Fulop, Balazs D.; Tamas, Andrea; Reglodi, Dora] Univ Pecs, Med Sch, MTA PTE PACAP Res Grp, Dept Anat, Pecs, Hungary; [Ivic, Ivan] Univ JJ Strossmayer, Med Sch Osijek, Dept Physiol & Immunol, Osijek, Croatia; [Balasko, Marta; Solymar, Margit] Univ Pecs, Inst Translat Med, Med Sch, Pecs, Hungary; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, Inst Databil Sci, Div Biosci, Suita, Osaka, Japan; [Toth, Gabor] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Juhasz, Tamas] Univ Debrecen, Dept Anat Histol & Embryol, Fac Med, Debrecen, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Koller, Akos] Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary; [Koller, Akos] Univ Phys Educ, Inst Nat Sci, Res Grp Sportgenet & Sportgerontol, Budapest, Hungary	University of Pecs; University of JJ Strossmayer Osijek; University of Pecs; Osaka University; Osaka University; Osaka University; Szeged University; University of Debrecen; New York Medical College; University of Pecs; University of Physical Education	Solymar, M (corresponding author), Univ Pecs, Inst Translat Med, Med Sch, Pecs, Hungary.	margit.solymar@aok.pte.hu	Juhasz, Tamas/M-6878-2019; Hashimoto, Hitoshi/D-1209-2010; Ákos, Koller/Q-4672-2019	Juhasz, Tamas/0000-0003-0489-5676; Hashimoto, Hitoshi/0000-0001-6548-4016; Solymar, Margit/0000-0001-6667-6263	Operative Program for the Development of Human Resources [EFOP-3.6.3-VEKOP-16-15 2017-00008, EFOP-3.6.3-VEKOP-16-2017-00009]; Hungarian National Science Research Fund (OTKA) [K115874, K104984, K119759, KTIA_13_NAP-A-III/5, GINOP-2.3.2-15-2016-00050 "PEPSYS", EFOP-3.6.1.-16-2016-00004]; "Comprehensive Development for Implementing Smart Specialization Strategies" at the University of Pecs; Janos Bolyai Scholarship; New National Excellence Program of the Ministry of Human Capacities [UNKP-16-4-IV]; University of Pecs Medical School [PTE-AOK-KA-2015-14]; MTA-TKI; FP7 Marie Sklodowska Curie project-Small Artery Remodeling (SmART) ITN; JSPS KAKENHI [JP26293020, JP17H03989]; SRPBS; Brain/MINDS from AMED; Hungarian Academy of Science; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]; Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary [20765-3/2018/FEKUTSTRAT];  [OTKA K108444]	Operative Program for the Development of Human Resources; Hungarian National Science Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Comprehensive Development for Implementing Smart Specialization Strategies" at the University of Pecs; Janos Bolyai Scholarship(Hungarian Academy of Sciences); New National Excellence Program of the Ministry of Human Capacities; University of Pecs Medical School; MTA-TKI; FP7 Marie Sklodowska Curie project-Small Artery Remodeling (SmART) ITN; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SRPBS; Brain/MINDS from AMED; Hungarian Academy of Science(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary; 	This work was supported by the Operative Program for the Development of Human Resources EFOP-3.6.3-VEKOP-16-15 2017-00008 "The role of neuro-inflammation in neurodegeneration: from molecules to clinics" and EFOP-3.6.3-VEKOP-16-2017-00009 and the Hungarian National Science Research Fund (OTKA) K115874, K104984, K119759, KTIA_13_NAP-A-III/5, GINOP-2.3.2-15-2016-00050 "PEPSYS", EFOP-3.6.1.-16-2016-00004, "Comprehensive Development for Implementing Smart Specialization Strategies" at the University of Pecs (D.R., A.T.), OTKA K108444 (A.K.); Janos Bolyai Scholarship (A.T., T.J.) and New Excellence Program (A.T., T.J), UNKP-16-4-IV, New National Excellence Program of the Ministry of Human Capacities (A. T.), University of Pecs Medical School PTE-AOK-KA-2015-14 (M. S.); MTA-TKI (D.R., T.A.) and FP7 Marie Sklodowska Curie project-Small Artery Remodeling (SmART) ITN (I.I, A.K.), in part by JSPS KAKENHI Grant Numbers JP26293020 (H.H.), JP17H03989 (H.H.); and the SRPBS and Brain/MINDS from AMED (H.H.), Magyary Zoltan Funds by Hungarian Academy of Science and the European Union and the State of Hungary (T.J.), co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program" (T.J.). Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the 20765-3/2018/FEKUTSTRAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; Almli LM, 2013, AM J MED GENET B, V162B, P262, DOI 10.1002/ajmg.b.32145; ANZAI M, 1995, EUR J PHARMACOL, V285, P173, DOI 10.1016/0014-2999(95)00404-9; Banki E, 2015, J GERONTOL A-BIOL, V70, P665, DOI 10.1093/gerona/glu116; Baun M, 2011, EUR J PHARMACOL, V670, P186, DOI 10.1016/j.ejphar.2011.08.016; BROYART JP, 1981, J CLIN ENDOCR METAB, V52, P715, DOI 10.1210/jcem-52-4-715; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175; CARDELL LO, 1991, REGUL PEPTIDES, V36, P379, DOI 10.1016/0167-0115(91)90071-N; Chan KY, 2011, CEPHALALGIA, V31, P181, DOI 10.1177/0333102410375624; CHARTREL N, 1991, ENDOCRINOLOGY, V129, P3367, DOI 10.1210/endo-129-6-3367; CHENG DY, 1993, EUR J PHARMACOL, V243, P79, DOI 10.1016/0014-2999(93)90170-M; Dalsgaard T, 2003, REGUL PEPTIDES, V110, P179, DOI 10.1016/S0167-0115(02)00205-7; Erdling A, 2013, NEUROPEPTIDES, V47, P85, DOI 10.1016/j.npep.2012.12.005; Fahrenkrug J, 2000, J CEREBR BLOOD F MET, V20, P1205, DOI 10.1097/00004647-200008000-00006; Farkas J, 2017, J MOL NEUROSCI, V61, P468, DOI 10.1007/s12031-017-0887-z; Fulop B, 2018, J MOL NEUROSCI, P1; Hoover DB, 2009, J PHARMACOL EXP THER, V331, P197, DOI 10.1124/jpet.109.155747; Hoyle CHV, 1998, REGUL PEPTIDES, V73, P1, DOI 10.1016/S0167-0115(97)01073-2; HUANG M, 1993, PEPTIDES, V14, P755, DOI 10.1016/0196-9781(93)90109-T; Ivic I, 2017, J VASC RES, V54, P180, DOI 10.1159/000457798; Ivic I, 2017, J GERONTOL A-BIOL, V72, P481, DOI 10.1093/gerona/glw085; Jackson DN, 2005, J PHYSIOL-LONDON, V562, P285, DOI 10.1113/jphysiol.2004.076141; Jozsa R, 2005, PEPTIDES, V26, P2344, DOI 10.1016/j.peptides.2005.03.054; Karacay B, 2001, J MOL NEUROSCI, V17, P311, DOI 10.1385/JMN:17:3:311; Kiss P, 2007, GEN COMP ENDOCR, V152, P225, DOI 10.1016/j.ygcen.2006.12.012; Knutsson M, 2002, NEUROREPORT, V13, P507, DOI 10.1097/00001756-200203250-00030; Koide M, 2014, J MOL NEUROSCI, V54, P443, DOI 10.1007/s12031-014-0301-z; Kovacs-Valasek A, 2017, NEUROSCIENCE, V348, P1, DOI 10.1016/j.neuroscience.2017.02.003; KOVES K, 1991, NEUROENDOCRINOLOGY, V54, P159, DOI 10.1159/000125864; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; LAM KSL, 1990, BRAIN RES, V526, P135, DOI 10.1016/0006-8993(90)90259-E; Laughlin MH, 1985, J APPL PHYSIOL, V2001, P90; LEGRADI G, 1994, NEUROSCI LETT, V176, P193, DOI 10.1016/0304-3940(94)90080-9; Lutz EM, 1999, BRIT J PHARMACOL, V128, P934, DOI 10.1038/sj.bjp.0702872; Markovics A, 2012, NEUROBIOL DIS, V45, P633, DOI 10.1016/j.nbd.2011.10.010; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Mercer KB, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.241; MINKES RK, 1992, AM J PHYSIOL, V263, pH1659, DOI 10.1152/ajpheart.1992.263.6.H1659; Mori H, 2010, CIRC J, V74, P1183, DOI 10.1253/circj.CJ-09-1024; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nakamachi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12034; NANDHA KA, 1991, J ENDOCRINOL, V129, P69, DOI 10.1677/joe.0.1290069; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Reglodi D, 2018, J PATHOLOGY; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; ROSSASCUITTO NT, 1993, PEDIATR RES, V34, P323, DOI 10.1203/00006450-199309000-00017; Rubio-Beltran E, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0893-8; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Syed AU, 2012, J MOL NEUROSCI, V48, P574, DOI 10.1007/s12031-012-9851-0; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Vamos Z, 2014, J MOL NEUROSCI, V54, P535, DOI 10.1007/s12031-014-0349-9; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vollesen A.L.H., 2018, NEUROTHERAPEUTICS, P1, DOI DOI 10.1007/S13311-018-0604-9; Zagami AS, 2014, ANN CLIN TRANSL NEUR, V1, P1036, DOI 10.1002/acn3.113	57	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211433	10.1371/journal.pone.0211433	http://dx.doi.org/10.1371/journal.pone.0211433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682157	gold, Green Accepted, Green Published			2022-12-26	WOS:000457037500170
J	Pereira, F; Rettel, M; Stein, F; Savitski, MM; Collinson, I; Romisch, K				Pereira, Fabio; Rettel, Mandy; Stein, Frank; Savitski, Mikhail M.; Collinson, Ian; Roemisch, Karin			Effect of Sec61 interaction with Mpd1 on endoplasmic reticulum-associated degradation	PLOS ONE			English	Article							MISFOLDED SECRETORY PROTEIN; QUALITY-CONTROL; MEMBRANE-PROTEINS; TRANSLOCATION; GENE; ERAD; CHANNEL; EXPRESSION; TRANSPORT; EXPORT	Proteins that misfold in the endoplasmic reticulum (ER) are transported back to the cytosol for ER-associated degradation (ERAD). The Sec61 channel is one of the candidates for the retrograde transport conduit. Channel opening from the ER lumen must be triggered by ERAD factors and substrates. Here we aimed to identify new lumenal interaction partners of the Sec61 channel by chemical crosslinking and mass spectrometry. In addition to known Sec61 interactors we detected ERAD factors including Cue1, Ubc6, Ubc7, Asi3, and Mpd1. We show that the CPY* ERAD factor Mpd1 binds to the lumenal Sec61 hinge region. Deletion of the Mpd1 binding site reduced the interaction between both proteins and caused an ERAD defect specific for CPY* without affecting protein import into the ER or ERAD of other substrates. Our data suggest that Mpd1 binding to Sec61 is a prerequisite for CPY* ERAD and confirm a role of Sec61 in ERAD of misfolded secretory proteins.	[Pereira, Fabio; Roemisch, Karin] Saarland Univ, Fac Nat Sci & Technol, Saarbrucken, Germany; [Rettel, Mandy; Stein, Frank; Savitski, Mikhail M.] EMBL, Prote Core Facil, Heidelberg, Germany; [Collinson, Ian] Univ Bristol, Sch Biochem, Bristol, Avon, England	Saarland University; European Molecular Biology Laboratory (EMBL); University of Bristol	Romisch, K (corresponding author), Saarland Univ, Fac Nat Sci & Technol, Saarbrucken, Germany.	k.roemisch@mx.uni-saarland.de	Römisch, Karin/AAO-1210-2021	Römisch, Karin/0000-0003-0415-6558; Collinson, Ian/0000-0002-3931-0503; Stein, Frank/0000-0001-9695-1692	Saarland University; BBSRC [BB/M003604/1, BB/N015126/1]	Saarland University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	KR received core funding from the Saarland University; IC received funding from the BBSRC, BB/M003604/1 and BB/N015126/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, IN VITRO MUTAGENESIS, P177; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Braunstein I, 2015, MOL BIOL CELL, V26, P3719, DOI 10.1091/mbc.E15-02-0085; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Gatto L, 2012, BIOINFORMATICS, V28, P288, DOI 10.1093/bioinformatics/btr645; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUBER W, 2002, BIOINFORMATICS S1, V18; Jadhav B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10133; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kaiser ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117260; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; MEHNERT M, 2013, CELL, V16, P77, DOI DOI 10.1038/; Neal S, 2018, MOL CELL, V69, P306, DOI 10.1016/j.molcel.2017.12.012; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Pilla E, 2017, ANNU REV CELL DEV BI, V33, P439, DOI 10.1146/annurev-cellbio-111315-125334; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1999, J CELL SCI, V112, P4123; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romisch K, 2017, TRENDS BIOCHEM SCI, V42, P171, DOI 10.1016/j.tibs.2016.10.005; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Scheper W, 2003, J BIOL CHEM, V278, P37998, DOI 10.1074/jbc.M300176200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Servas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082058; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tretter T, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-56; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vitu E, 2008, J MOL BIOL, V384, P631, DOI 10.1016/j.jmb.2008.09.052; Voorhees R, 2016, STRUCTURE MAMMALIAN; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545	48	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211180	10.1371/journal.pone.0211180	http://dx.doi.org/10.1371/journal.pone.0211180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682149	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500117
J	Bialas, J; Boehm, AN; Catone, N; Aichem, A; Groettrup, M				Bialas, Johanna; Boehm, Annika N.; Catone, Nicola; Aichem, Annette; Groettrup, Marcus			The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin thioesterase (OTUB1); ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); proteasome; enzyme activity; FAT10; inflammation; ubiquitin-like protein; USE1	PROTEIN FAT10; IDENTIFICATION; SPECIFICITY; SUBSTRATE; BINDING; INHIBITION; ACTIVATION; MECHANISM; OTUBAIN-1; INTERACTS	The deubiquitylation of target proteins is mediated by deubiquitylating enzymes (DUB) such as OTUB1, which plays an important role in immune response, cell cycle progression, and DNA repair. Within these processes, OTUB1 reduces the ubiquitylation of target proteins in two distinct ways, either by using its catalytic DUB activity or in a noncatalytic manner by inhibiting the E2-conjugating enzyme. Here, we show that the ubiquitin-like modifier FAT10 regulates OTUB1 stability and functionality in different ways. Covalent FAT10ylation of OTUB1 resulted in its proteasomal degradation, whereas a noncovalent interaction stabilized OTUB1. We provide evidence that OTUB1 interacts directly with FAT10 and the E2-conjugating enzyme USE1. This interaction strongly stimulated OTUB1 DUB activity toward Lys-48-linked diubiquitin. Furthermore, the noncovalent interaction between FAT10 and OTUB1 not only enhanced its isopeptidase activity toward Lys-48-linked ubiquitin moieties but also strengthened its noncatalytic activity in reducing Lys-63 polyubiquitylation of its target protein TRAF3 (TNF receptor-associated factor 3). Additionally, the cellular clearance of overall polyubiquitylation by OTUB1 was strongly stimulated through the presence of FAT10. The addition of FAT10 also led to an increased interaction between OTUB1 and its cognate E2 UbcH5B, implying a function of FAT10 in the inhibition of polyubiquitylation. Overall, these data indicate that FAT10 not only plays a role in covalent modification, leading its substrates to proteasomal degradation, but also regulates the stability and functionality of target proteins by interacting in a noncovalent manner. FAT10 is thereby able to exert a major influence on ubiquitylation processes.	[Bialas, Johanna; Boehm, Annika N.; Aichem, Annette; Groettrup, Marcus] Univ Konstanz, Div Immunol, Dept Biol, D-78464 Constance, Germany; [Bialas, Johanna; Boehm, Annika N.; Catone, Nicola; Aichem, Annette; Groettrup, Marcus] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Boehm, Annika N.] Univ Konstanz, Grad Sch Biol Sci, Constance, Germany	University of Konstanz; University of Konstanz	Aichem, A (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland.	Annette.Aichem@bitg.ch	Groettrup, Marcus/AAT-2623-2020	Groettrup, Marcus/0000-0002-5423-6399	German Research Foundation (DFG) Collaborative Research Center [SFB969, 1029]; Velux Foundation; Graduate School Chemical Biology at the University of Konstanz	German Research Foundation (DFG) Collaborative Research Center(German Research Foundation (DFG)); Velux Foundation(Velux Fonden); Graduate School Chemical Biology at the University of Konstanz	This work was supported by the German Research Foundation (DFG) Collaborative Research Center SFB969, project C01 (to M. G.) and by Grant 1029 from the Velux Foundation (to A. A. and M. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a stipend from the Graduate School Chemical Biology at the University of Konstanz.	Aichem A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05776-3; Aichem A, 2016, INT J BIOCHEM CELL B, V79, P451, DOI 10.1016/j.biocel.2016.07.001; Aichem A, 2014, FEBS J, V281, P1848, DOI 10.1111/febs.12745; Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aichem A, 2012, METHODS MOL BIOL, V832, P125, DOI 10.1007/978-1-61779-474-2_7; Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bialas J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120329; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Herrador A, 2013, J BIOL CHEM, V288, P16206, DOI 10.1074/jbc.C113.452250; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nguyen NTH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23377; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Peng YY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004041; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schelpe J, 2016, J BIOL CHEM, V291, P630, DOI 10.1074/jbc.M115.671545; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Theng SS, 2014, P NATL ACAD SCI USA, V111, pE5282, DOI 10.1073/pnas.1403383111; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Zhang YL, 2016, J IMMUNOL, V197, P824, DOI 10.4049/jimmunol.1501563; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	50	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4315	4330		10.1074/jbc.RA118.005406	http://dx.doi.org/10.1074/jbc.RA118.005406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30718280	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000462969500004
J	Chernyavsky, A; Amber, KT; Agnoletti, AF; Wang, C; Grando, SA				Chernyavsky, Alex; Amber, Kyle T.; Agnoletti, Arianna F.; Wang, Candice; Grando, Sergei A.			Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; antibody; antigen; pemphigus; apoptosis; acantholysis; cell-cell detachment; immune dysfunction; keratinocyte; non-desmoglein pemphigus antibodies	CELL-DEATH; ANTIMITOCHONDRIAL AUTOANTIBODIES; INTRACELLULAR CALCIUM; SIGNALING PATHWAYS; CLINICAL PHENOTYPE; DESMOCOLLIN 3; CROSS-TALK; DISEASE; ATP2C1; GOLGI	Pemphigus vulgaris (PV) is a potentially lethal mucocutaneous blistering disease characterized by IgG autoantibodies (AuAbs) binding to epidermal keratinocytes and inducing this devastating disease. Here, we observed that non-desmoglein (Dsg) AuAbs in the sera of patients with Dsg1/3 AuAb-negative acute PV are pathogenic, because IgGs from these individuals induced skin blistering in neonatal mice caused by suprabasal acantholysis. Serum levels of AuAbs to desmocollin 3 (Dsc3), M3 muscarinic acetylcholine receptor (M3AR), and secretory pathway Ca2+/Mn2+-ATPase isoform 1 (SPCA1) correlated with the disease stage of PV. Moreover, AuAb absorption on recombinant Dsc3, M3AR, or SPCA1 both prevented skin blistering in the passive transfer of AuAbs model of PV in BALB/c mice and significantly decreased the extent of acantholysis in a neonatal mouse skin explant model. Although acantholytic activities of each of these immunoaffinity-purified AuAbs could not induce a PV-like phenotype, their mixture produced a synergistic effect manifested by a positive Nikolskiy sign in the skin of neonatal mice. The downstream signaling of all pathogenic non-Dsg AuAbs involved p38 mitogen-activated protein kinase (MAPK)-mediated phosphorylation and elevation of cytochrome c release and caspase 9 activity. Anti-Dsc3 and anti-SPCA1 AuAbs also activated SRC proto-oncogene, nonreceptor tyrosine kinase (SRC). Of note, although a constellation of non-Dsg AuAbs apparently disrupted epidermal integrity, elimination of a single pathogenic AuAb could prevent keratinocyte detachment and blistering. Therefore, anti-Dsg1/3 AuAb-free PV can be a model for elucidating the roles of non-Dsg antigen-specific AuAbs in the physiological regulation of keratinocyte cell-cell adhesion and blister development.	[Chernyavsky, Alex; Amber, Kyle T.; Agnoletti, Arianna F.; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Amber, Kyle T.] Univ Illinois, Dept Dermatol, Chicago, IL 60607 USA; [Agnoletti, Arianna F.] San Martino Policlin Hosp, DISSAL Sect Dermatol, I-16132 Genoa, Italy; [Wang, Candice] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University of Health Sciences	Grando, SA (corresponding author), Univ Calif Irvine, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu		Grando, Sergei/0000-0001-5769-8938	International Pemphigus and Pemphigoid Foundation; Department of Dermatology of University of California-Irvine	International Pemphigus and Pemphigoid Foundation; Department of Dermatology of University of California-Irvine	This work was supported, in part, by a research grant from the International Pemphigus and Pemphigoid Foundation (to K. T. A.) and internal funds from the Department of Dermatology of University of California-Irvine. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AR, 2016, EXP DERMATOL, V25, P839, DOI 10.1111/exd.13106; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; Amber KT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01190; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Belloni-Fortina A, 2009, CLIN DEV IMMUNOL, P1, DOI 10.1155/2009/187864; Carraro M, 2016, CELL CALCIUM, V60, P102, DOI 10.1016/j.ceca.2016.03.005; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chen YM, 2015, J BIOL CHEM, V290, P23826, DOI 10.1074/jbc.M115.668061; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cozzani E, 2013, EUR J DERMATOL, V23, P40, DOI 10.1684/ejd.2012.1903; Di Zenzo G, 2016, SEMIN IMMUNOPATHOL, V38, P57, DOI 10.1007/s00281-015-0541-1; Didier K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00541; DMOCHOWSKI M, 1995, BRIT J DERMATOL, V133, P519, DOI 10.1111/j.1365-2133.1995.tb02698.x; DMOCHOWSKI M, 1993, J INVEST DERMATOL, V100, P380, DOI 10.1111/1523-1747.ep12471934; Espana A, 2013, EXP DERMATOL, V22, P125, DOI 10.1111/exd.12088; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Giurdanella F, 2016, BRIT J DERMATOL, V175, P185, DOI 10.1111/bjd.14408; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando SA, 2019, INT J DERMATOL, V58, P114, DOI 10.1111/ijd.14143; Grando Sergei A, 2012, Handb Exp Pharmacol, P429, DOI 10.1007/978-3-642-23274-9_18; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Hirata Y, 2004, BRAIN RES, V1021, P241, DOI 10.1016/j.brainres.2004.06.064; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Jamora MJJ, 2003, J AM ACAD DERMATOL, V48, P976, DOI 10.1067/mjd.2003.438; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kalantari-Dehaghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057587; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Lehotsky J, 2009, GEN PHYSIOL BIOPHYS, V28, pF104; Madala Jayakiran, 2017, J Oral Maxillofac Pathol, V21, P260, DOI 10.4103/jomfp.JOMFP_143_17; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Mao XM, 2010, AM J PATHOL, V177, P2724, DOI 10.2353/ajpath.2010.100483; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Rafei D, 2011, AM J PATHOL, V178, P718, DOI 10.1016/j.ajpath.2010.10.016; Sajda T, 2015, J INVEST DERMATOL, V135, pS12; Sajda T, 2014, J INVEST DERMATOL, V134, pS13; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Sardana K, 2013, BRIT J DERMATOL, V168, P669, DOI 10.1111/bjd.12012; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Sharma VK, 2006, INT J DERMATOL, V45, P518, DOI 10.1111/j.1365-4632.2006.02593.x; Shull GE, 2011, BIOFACTORS, V37, P150, DOI 10.1002/biof.141; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Zagorodniuk I, 2005, INT J DERMATOL, V44, P541, DOI 10.1111/j.1365-4632.2004.02541.x	56	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4520	4528		10.1074/jbc.RA118.006743	http://dx.doi.org/10.1074/jbc.RA118.006743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30692201	hybrid, Green Published			2022-12-26	WOS:000462969500020
J	Rossi, L; Romero, AM; Milder, M; de Klerck, E; Breedveld, S; Heijmen, B				Rossi, Linda; Romero, Alejandra Mendez; Milder, Maaike; de Klerck, Erik; Breedveld, Sebastiaan; Heijmen, Ben			Individualized automated planning for dose bath reduction in robotic radiosurgery for benign tumors	PLOS ONE			English	Article							STEREOTACTIC RADIOSURGERY; VESTIBULAR SCHWANNOMAS; ARC THERAPY; NERVOUS-SYSTEM; BEAM ANGLE; RADIOTHERAPY; OPTIMIZATION; BRAIN; IMRT; GENERATION	Object To explore the use of automated planning in robotic radiosurgery of benign vestibular schwannoma (VS) tumors for dose reduction outside the planning target volume (PTV) to potentially reduce risk of secondary tumor induction. Methods A system for automated planning (AUTOplans) for VS patients was set up. The goal of AUTO-planning was to reduce the dose bath, including the occurrence of high dose spikes leaking from the PTV into normal tissues, without worsening PTV coverage, OAR doses, or treatment time. For 20 VS patients treated with 1x12 Gy, the AUTOplan was compared with the plan generated with conventional, manual trial-and-error planning (MANplan). Results With equal PTV coverage, AUTOplans showed clinically negligible differences with MAN-plans in OAR sparing (largest mean difference for all OARs: Delta D2% = 0.2 Gy). AUTOplan dose distributions were more compact: mean/maximum reductions of 23.6/53.8% and 9.6/28.5% in patient volumes receiving more than 1 or 6 Gy, respectively (p<0.001). AUTOplans also showed smaller dose spikes with mean/maximum reductions of 22.8/37.2% and 14.2/40.4% in D2% for shells at 1 and 7 cm distance from the PTV, respectively (p<0.001). Conclusion Automated planning for benign VS tumors highly outperformed manual planning with respect to the dose bath outside the PTV, without deteriorating PTV coverage or OAR sparing, or significantly increasing treatment time.	[Rossi, Linda; Romero, Alejandra Mendez; Milder, Maaike; de Klerck, Erik; Breedveld, Sebastiaan; Heijmen, Ben] Erasmus MC, Canc Inst, Dept Radiat Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Rossi, L (corresponding author), Erasmus MC, Canc Inst, Dept Radiat Oncol, Rotterdam, Netherlands.	l.rossi@erasmusmc.nl		Rossi, Linda/0000-0002-3705-2504	Accuray Inc, Sunnyvale, USA	Accuray Inc, Sunnyvale, USA	This work was in part funded by a research grant of Accuray Inc, Sunnyvale, USA. Erasmus MC Cancer Institute also has research collaboration with Elekta AB Stockholm, Sweden. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Arthurs BJ, 2011, NEUROSURG REV, V34, P265, DOI 10.1007/s10143-011-0307-8; Boylan C, 2014, J APPL CLIN MED PHYS, V15, P213, DOI 10.1120/jacmp.v15i1.4530; Braunstein S, 2018, CANCER MANAG RES, V10, P3733, DOI 10.2147/CMAR.S140764; Breedveld S, 2012, MED PHYS, V39, P951, DOI 10.1118/1.3676689; Cozzi L, 2008, RADIOTHER ONCOL, V89, P180, DOI 10.1016/j.radonc.2008.06.013; Dutta D, 2012, J NEURO-ONCOL, V106, P637, DOI 10.1007/s11060-011-0703-5; Echner GG, 2009, PHYS MED BIOL, V54, P5359, DOI 10.1088/0031-9155/54/18/001; Edvardsson A, 2019, ACTA ONCOL, V58, P95, DOI 10.1080/0284186X.2018.1512153; Gevaert T, 2013, RADIOTHER ONCOL, V106, P192, DOI 10.1016/j.radonc.2012.07.002; Hansen C.R., 2017, ACTA ONCOL, V56, P1; Huss M, 2015, J APPL CLIN MED PHYS, V16, P3, DOI 10.1120/jacmp.v16i6.5255; Krayenbuehl J, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0896-7; McIntosh C, 2017, PHYS MED BIOL, V62, P5926, DOI 10.1088/1361-6560/aa71f8; Minniti G, 2005, J CLIN ENDOCR METAB, V90, P800, DOI 10.1210/jc.2004-1152; Murphy ES, 2011, INT J RADIAT ONCOL, V79, P985, DOI 10.1016/j.ijrobp.2010.10.010; Nishio S, 1998, ACTA NEUROCHIR, V140, P763, DOI 10.1007/s007010050177; Park JM, 2018, PHYS MEDICA, V46, P1, DOI 10.1016/j.ejmp.2018.01.004; RON E, 1988, NEW ENGL J MED, V319, P1033, DOI 10.1056/NEJM198810203191601; Rossi L, 2018, ACTA ONCOL, V57, P1490, DOI 10.1080/0284186X.2018.1479068; Rossi L, 2012, PHYS MED BIOL, V57, P5441, DOI 10.1088/0031-9155/57/17/5441; Samii M, 1997, NEUROSURGERY, V40, P248, DOI 10.1097/00006123-199702000-00005; Schlaefer A, 2008, MED PHYS, V35, P2094, DOI 10.1118/1.2900716; SHAPIRO S, 1989, PEDIATR NEUROSCI, V15, P176, DOI 10.1159/000120465; Sharfo AWM, 2015, RADIOTHER ONCOL, V114, P395, DOI 10.1016/j.radonc.2015.02.006; Sung K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196664; Tol JP, 2016, MED PHYS, V43, P1818, DOI 10.1118/1.4944063; Tol JP, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0388-6; Vanderstraeten B, 2018, INT J RADIAT ONCOL, V102, P443, DOI 10.1016/j.ijrobp.2018.05.063; Voet PWJ, 2014, INT J RADIAT ONCOL, V88, P1175, DOI 10.1016/j.ijrobp.2013.12.046; Watanabe S, 2016, J NEUROSURG, V125, P64, DOI 10.3171/2016.7.GKS161494; Zarepisheh M, 2014, MED PHYS, V41, DOI 10.1118/1.4875700; Zhang Q, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140362	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2019	14	2							e0210279	10.1371/journal.pone.0210279	http://dx.doi.org/10.1371/journal.pone.0210279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK4EL	30726214	Green Published, gold, Green Submitted			2022-12-26	WOS:000457874000018
J	Bochnia, M; Sander, J; Ziegler, J; Terhardt, M; Sander, S; Janzen, N; Cavalleri, JMV; Zuraw, A; Wensch-Dorendorf, M; Zeyner, A				Bochnia, Mandy; Sander, Johannes; Ziegler, Joerg; Terhardt, Michael; Sander, Stefanie; Janzen, Nils; Cavalleri, Jessika-M. V.; Zuraw, Aleksandra; Wensch-Dorendorf, Monika; Zeyner, Annette			Detection of MCPG metabolites in horses with atypical myopathy	PLOS ONE			English	Article							ACKEE BLIGHIA-SAPIDA; COA DEHYDROGENASE-DEFICIENCY; JAMAICAN VOMITING SICKNESS; HYPOGLYCIN-A; ACUTE ENCEPHALITIS; QUANTIFICATION; IDENTIFICATION; INGESTION; MECHANISM; CHILDREN	Atypical myopathy (AM) in horses is caused by ingestion of seeds of the Acer species (Sapindaceae family). Methylenecyclopropylacetyl-CoA (MCPA-CoA), derived from hypoglycin A (HGA), is currently the only active toxin in Acer pseudoplatanus or Acer negundo seeds related to AM outbreaks. However, seeds or arils of various Sapindaceae (e.g., ackee, lychee, mamoncillo, longan fruit) also contain methylenecyclopropylglycine (MCPG), which is a structural analogue of HGA that can cause hypoglycaemic encephalopathy in humans. The active poison formed from MCPG is methylenecyclopropylformyl-CoA (MCPF-CoA). MCPF-CoA and MCPA-CoA strongly inhibit enzymes that participate in beta-oxidation and energy production from fat. The aim of our study was to investigate if MCPG is involved in Acer seed poisoning in horses. MCPG, as well as glycine and carnitine conjugates (MCPF-glycine, MCPF-carnitine), were quantified using high-performance liquid chro-matography-tandem mass spectrometry of serum and urine from horses that had ingested Acer pseudoplatanus seeds and developed typical AM symptoms. The results were compared to those of healthy control horses. For comparison, HGA and its glycine and carnitine derivatives were also measured. Additionally, to assess the degree of enzyme inhibition of beta-oxidation, several acyl glycines and acyl carnitines were included in the analysis. In addition to HGA and the specific toxic metabolites (MCPA-carnitine and MCPA-glycine), MCPG, MCPF-glycine and MCPF-carnitine were detected in the serum and urine of affected horses. Strong inhibition of beta-oxidation was demonstrated by elevated concentrations of all acyl glycines and carnitines, but the highest correlations were observed between MCPF-carnitine and isobutyryl-carnitine (r = 0.93) as well as between MCPA-(and MCPF-) glycine and valeryl-glycine with r = 0.96 (and r = 0.87). As shown here, for biochemical analysis of atypical myopathy of horses, it is necessary to take MCPG and the corresponding metabolites into consideration.	[Bochnia, Mandy; Zeyner, Annette] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Grp Anim Nutr, Halle, Saale, Germany; [Sander, Johannes; Terhardt, Michael; Sander, Stefanie; Janzen, Nils] Screening Labor Hannover, Hannover, Germany; [Ziegler, Joerg] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany; [Janzen, Nils] Hannover Med Sch, Dept Clin Chem, Hannover, Germany; [Cavalleri, Jessika-M. V.] Univ Vet Med Hannover, Clin Horses, Hannover, Germany; [Zuraw, Aleksandra] Definiens AG, Munich, Germany; [Wensch-Dorendorf, Monika] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Grp Biometr, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; AstraZeneca; Martin Luther University Halle Wittenberg	Bochnia, M (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Grp Anim Nutr, Halle, Saale, Germany.	mandy.bochnia@landw.uni-halle.de	Ziegler, Jörg/W-7645-2019	Bochnia, Mandy/0000-0001-7924-7281; Janzen, Nils/0000-0002-2313-3311; Cavalleri, Jessika/0000-0002-8575-7402				Agnihotri G, 2002, BIOCHEMISTRY-US, V41, P1843, DOI 10.1021/bi0119363; ALBASSAM SS, 1981, BIOCHEM PHARMACOL, V30, P2817, DOI 10.1016/0006-2952(81)90420-2; Barceloux DG, 2009, DM-DIS MON, V55, P318, DOI [10.1016/j.disamonth.2009.03.006, 10.1016/j.disamonth.2009.03.005, 10.1016/j.disamonth.2009.03.010, 10.1016/j.disamonth.2009.03.007, 10.1016/j.disamonth.2009.03.011, 10.1016/j.disamonth.2009.03.002, 10.1016/j.disamonth.2009.03.004, 10.1016/j.disamonth.2009.03.003, 10.1016/j.disamonth.2009.03.008]; Blake OA, 2006, FOOD CHEM TOXICOL, V44, P207, DOI 10.1016/j.fct.2005.07.002; Bochnia M, 2018, EQUINE VET EDUC, V30, P24, DOI 10.1111/eve.12596; Bochnia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136785; Bowen-Forbes CS, 2011, J AGR FOOD CHEM, V59, P3869, DOI 10.1021/jf104623c; BROWN M, 1992, J FOOD SAFETY, V12, P167, DOI 10.1111/j.1745-4565.1991.tb00075.x; CHEN KK, 1957, J PHARMACOL EXP THER, V121, P272; Dakoji S, 2001, J AM CHEM SOC, V123, P9749, DOI 10.1021/ja011226k; FOWDEN L, 1973, PHYTOCHEMISTRY, V12, P1677, DOI 10.1016/0031-9422(73)80387-5; GHISLA S, 1990, PROG CLIN BIOL RES, V321, P185; GRAY DO, 1962, BIOCHEM J, V82, P385, DOI 10.1042/bj0820385; HASSALL C H, 1955, West Indian Med J, V4, P83; HASSALL CH, 1954, NATURE, V173, P356, DOI 10.1038/173356b0; Isenberg SL, 2016, J AGR FOOD CHEM, V64, P5607, DOI 10.1021/acs.jafc.6b02478; Isenberg SL, 2015, CHEM RES TOXICOL, V28, P1753, DOI 10.1021/acs.chemrestox.5b00205; John TJ, 2014, CURR SCI INDIA, V106, P1184; Joskow R, 2006, CLIN TOXICOL, V44, P267, DOI 10.1080/15563650600584410; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; MELDE K, 1989, BIOCHEM J, V259, P921, DOI 10.1042/bj2590921; MELDE K, 1991, BIOCHEM J, V274, P395, DOI 10.1042/bj2740395; MINAKATA H, 1985, EXPERIENTIA, V41, P1622, DOI 10.1007/BF01964840; Phan NT, 2018, EMERG INFECT DIS, V24, P1435, DOI 10.3201/eid2408.171004; Paireau J, 2012, EMERG INFECT DIS, V18, P1817, DOI 10.3201/eid1811.111761; Sander J, 2017, J AGR FOOD CHEM, V65, P2603, DOI 10.1021/acs.jafc.7b00224; Sander J, 2016, J VET DIAGN INVEST, V28, P98, DOI 10.1177/1040638715624736; SCOTT H. Harold, 1916, Annals of Tropical Medicine and Parasitology, V10, P1; Shrivastava A, 2015, MMWR-MORBID MORTAL W, V64, P49; Sponseller BT, 2012, J VET INTERN MED, V26, P1012, DOI 10.1111/j.1939-1676.2012.00957.x; TANAKA K, 1976, NEW ENGL J MED, V295, P461, DOI 10.1056/NEJM197608262950901; TANAKA K, 1990, PROG CLIN BIOL RES, V321, P167; TANAKA K, 1972, J BIOL CHEM, V247, P7465; Valberg SJ, 2013, EQUINE VET J, V45, P419, DOI 10.1111/j.2042-3306.2012.00684.x; VONHOLT C, 1964, BIOCHIM BIOPHYS ACTA, V90, P611, DOI 10.1016/0304-4165(64)90242-9; Votion DM, 2014, EQUINE VET J, V46, P146, DOI 10.1111/evj.12117; Westermann CM, 2008, NEUROMUSCULAR DISORD, V18, P355, DOI 10.1016/j.nmd.2008.02.007; Wu L, 2008, ORG LETT, V10, P3355, DOI 10.1021/ol801267e; Zuraw A, 2016, EQUINE VET J, V48, P418, DOI 10.1111/evj.12460	39	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0211698	10.1371/journal.pone.0211698	http://dx.doi.org/10.1371/journal.pone.0211698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721263	gold, Green Published, Green Submitted			2022-12-26	WOS:000457746300021
J	Degu, H; Wondimagegnehu, A; Yifru, YM; Belachew, A				Degu, Hiwot; Wondimagegnehu, Abigiya; Yifru, Yared Mamushet; Belachew, Ayele			Is health related quality of life influenced by diabetic neuropathic pain among type II diabetes mellitus patients in Ethiopia?	PLOS ONE			English	Article								Background Polyneuropathy is one of the commonest complications of long-standing diabetes. Progressive sensory loss can predispose patients to foot ulcer and the neuropathy oftentimes causes pain. The pain can significantly affect the quality of life of patients. Objectives To describes the health-related quality of life of patients with type II diabetes mellitus suffering from painful diabetic peripheral neuropathy at two referral hospitals in Addis Ababa, Ethiopia, 2017. Methods An institution based cross sectional study with internal comparison was conducted among a sample of 220 type II diabetes mellitus patients in a 1:1 matched ratio of those with and without diabetes associated peripheral neuropathic pain. All were having regular follow up at two hospitals in Addis Ababa, Ethiopia. The Short Form (SF-36) health-related quality of life instrument was used to collect data on quality of life while basic socio-demographic and other disease specific features were collected using a structured questionnaire. Descriptive statistics was used to examine the mean scores of health related quality of life. Cronbach's alpha coefficient and Pearson's correlation coefficient were applied to estimate the internal consistency, and the level of agreement between the different domains of SF-36, respectively. To measure association between health related quality of life domains and explanatory variables, independent T-test and ANOVA were performed followed by multiple linear regression analyses. Results The health related quality of life of type II diabetes mellitus patients with peripheral neuropathic pain was poorer than those without pain in all the eight domains and the two summary scores by SF-36 (p < 0.001). Higher mean score difference was observed in Mental Component Summary Score (MCS) (14.6) compared to Physical Component Score (PCS) (9.3). Among the eight domains, the largest mean difference was found with the physical one (39.1) followed by mental health (38.2) and physical functioning (30). Pain intensity had a statistically significant negative correlation with all domains as well as the two summary scores. Younger age, a higher level of education, being single, a higher monthly income, normal body mass index, HbA1c less than seven mmo/L, absence of other diabetic complications and taking only oral hypoglycemic agents were found to predict better health related quality of life. Conclusion The presence of diabetic peripheral neuropathic pain was found to negatively influence the health-related quality of life of type II diabetic patients; the greatest impact being on the 'role physical' and 'mental health' domains. Older age, presence of diabetes related complications, longer duration of illness negatively influenced the health-related quality of life.	[Degu, Hiwot; Wondimagegnehu, Abigiya; Belachew, Ayele] Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Yifru, Yared Mamushet] Addis Ababa Univ, Sch Med, Dept Neurol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Belachew, A (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia.	kalayeleb@gmail.com		Aschalew, Ayele/0000-0002-4547-3309	Addis Ababa University, school of public health	Addis Ababa University, school of public health	The funding institution is the Addis Ababa University, school of public health. This funding is obtained because all investigators and authors are employees of the university. In fact the university has played role in the design, data collection and analysis, decision to publish, or preparation of the manuscript through us.	Abdul H Z, 2009, HLTH ADM, V22, P95; Andrea D B, 2003, GLOBALIZATION HLTH, V9, P62; Andrew J, 2014, J INT MED RES, V42; Annabel B, 2003, SOC SCI MED, V57, P1289; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; Dobrota VD, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0171-7; Duarte RV, 2016, QUAL LIFE RES, V25, P1771, DOI 10.1007/s11136-015-1211-4; Genga E., 2014, ASSESSMENT PERCEIVED, V4, P15; Gilron I, 2015, MAYO CLIN PROC, V90, P532, DOI 10.1016/j.mayocp.2015.01.018; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hussein A., 2009, Sudanese Journal of Public Health, V4, P331; International Diabetes Federation, 2015, IDF DIABETES ATLAS; John W, 1993, SF 36 HLTH SURVEY MA; Kasim K., 2010, INT J DIABETES MELLI, V2, P20, DOI [10.1016/j.ijdm.2009.10.002, DOI 10.1016/J.IJDM.2009.10.002]; Kebede A, 2014, AFRICAN J AIDS RES, V9, P31; Kebede D, 2004, ETHIOPIAN MED J, V42, P289; Kececi H., 2015, NEUROSCI MED, V6, P98, DOI [10.4236/nm.2015.63017, DOI 10.4236/NM.2015.63017]; Khaled J. Y I, 2014, SUDANESE J PUBLIC HL, V9, P4852; Ko SH, 2012, DIABETES METAB J, V36, P6, DOI 10.4093/dmj.2012.36.1.6; Nazir SUR, 2016, J PHARM BIOALLIED SC, V8, P64, DOI 10.4103/0975-7406.171734; Peasgood T, 2016, MED DECIS MAKING, V36, P1020, DOI 10.1177/0272989X16658660; Pichon-Riviere A, 2015, INT J HEALTH POLICY, V4, P475, DOI 10.15171/ijhpm.2015.80; Sandireddy R, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674987; Schlenk EA, 1977, QUAL LIFE RES, V7, P57; Tesfaye S, 2011, DIABETES-METAB RES, V27, P629, DOI 10.1002/dmrr.1225; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; Wang R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-292; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHITSELL LJ, 1962, CALIF MED, V96, P14; *WHO, 1999, WHONCD992; Yordanova S, 2014, BIOTECHNOL BIOTEC EQ, V28, P769, DOI 10.1080/13102818.2014.935572	32	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211449	10.1371/journal.pone.0211449	http://dx.doi.org/10.1371/journal.pone.0211449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2LY	30716109	gold, Green Published			2022-12-26	WOS:000457744200022
J	Shahriyari, L; Abdel-Rahman, M; Cebulla, C				Shahriyari, Leili; Abdel-Rahman, Mohamed; Cebulla, Colleen			BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BRCA1-ASSOCIATED PROTEIN-1; MUTATION; GENES	BAP1 is a tumor suppressor gene important to the development and prognosis of many cancers, especially uveal melanoma (UM). Its role in more common cancers such as breast and colon cancer is largely unknown. We collected the transcriptome profiling data sets from the TCGA uveal melanoma (TCGA-UVM), breast cancer (TCGA-BRCA), and colon cancer (TCGA-COAD) projects to analyze the expression of BAP1. We found that patients with UM and breast cancer, but not colon cancer, who died had a lower level of BAP1 gene expression compared to surviving patients. Importantly, in breast cancer patients, the lowest BAP1 expression levels corresponded to the dead young patients (age at diagnosis < 46). Since the number of cases in TCGA-BRCA was much higher than TCGA-UVM, we obtained highly correlated genes with BAP1 in invasive breast carcinomas. Then, we tested if these genes are also highly correlated with BAP1 in UM and colon cancer. We found that BAP1 is highly positively correlated with RBM15Band USP19expression in invasive breast carcinoma, UM, and colon adenocarcinoma. All three genes are located in close proximity on the 3p21 tumor suppressor region that is commonly altered in many cancers.	[Shahriyari, Leili] Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA; [Abdel-Rahman, Mohamed] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; [Abdel-Rahman, Mohamed; Cebulla, Colleen] Ohio State Univ, Dept Ophthalmol & Visual Sci, Wexner Med Ctr, Havener Eye Inst, Columbus, OH 43210 USA	University of Texas System; University of Texas Arlington; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Shahriyari, L (corresponding author), Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA.	leili.shahriyari@uta.edu			Mathematical Biosciences Institute [DMS 1440386]; National Science Foundation [DMS 1440386]; National Eye Institute [K08EY022672]; Ohio Lions Eye Research Foundation; Patti Blow Fund in Ophthalmology; Ohio State University Department of Ophthalmology and Visual Science; NATIONAL CANCER INSTITUTE [R21CA191943] Funding Source: NIH RePORTER	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ohio Lions Eye Research Foundation; Patti Blow Fund in Ophthalmology; Ohio State University Department of Ophthalmology and Visual Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 1440386, and by National Eye Institute award K08EY022672. Additional funds were provided by the Ohio Lions Eye Research Foundation, the Patti Blow Fund in Ophthalmology, and The Ohio State University Department of Ophthalmology and Visual Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2012, EXP EYE RES, V100, P26, DOI 10.1016/j.exer.2012.04.010; Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Angeloni Debora, 2007, Briefings in Functional Genomics & Proteomics, V6, P19, DOI 10.1093/bfgp/elm007; Cebulla C, 1993, BAP1 TUMOR PREDISPOS; Chui J, 2017, PATHOLOGY, V49, P557, DOI 10.1016/j.pathol.2017.03.008; Hakiri S, 2015, CANCER SCI, V106, P990, DOI 10.1111/cas.12698; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Lake S, 2012, NCRI CANC C; Langholtz J, 2011, MDS PATIENTS CHROMOS; Loyer P, 2011, J BIOL CHEM, V286, P147, DOI 10.1074/jbc.M110.192518; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Njauw CNJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035295; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Piva F, 2015, ONCOTARGET, V6, P32161, DOI 10.18632/oncotarget.5147; Rai K, 2016, CLIN GENET, V89, P285, DOI 10.1111/cge.12630; Ricketts CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140257; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Shahriyari L, 2017, BRIEF BIOINFORM, P1; Tsai MH, 2011, ANN SURG ONCOL, V18, P2662, DOI 10.1245/s10434-011-1603-9; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wing SS, 2013, INT J BIOCHEM CELL B, V45, P2130, DOI 10.1016/j.biocel.2013.05.002; XIANG JL, 1994, J BIOL CHEM, V269, P15786	28	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211507	10.1371/journal.pone.0211507	http://dx.doi.org/10.1371/journal.pone.0211507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716094	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200029
J	Vanhauteghem, D; Audenaert, K; Demeyere, K; Hoogendoorn, F; Janssens, GPJ; Meyer, E				Vanhauteghem, Donna; Audenaert, Kris; Demeyere, Kristel; Hoogendoorn, Fred; Janssens, Geert P. J.; Meyer, Evelyne			Flow cytometry, a powerful novel tool to rapidly assess bacterial viability in metal working fluids: Proof-of-principle	PLOS ONE			English	Article							SYNTHETIC METALWORKING FLUID; IN-SITU HYBRIDIZATION; MYCOBACTERIUM-IMMUNOGENUM; MICROBIAL-GROWTH; NONFORMALDEHYDE BIOCIDES; ANTIMICROBIAL PROPERTIES; PSEUDOMONAS-FLUORESCENS; PATHOGENIC BACTERIA; COMMUNITY STRUCTURE; FORMALDEHYDE	Metalworking fluids (MWF) are water-or oil-based liquids to cool and lubricate tools, work pieces and machines, inhibit corrosion and remove swarf. One of the major problems in the MWF industry is bacterial growth as bacterial enzymes can cause MWF degradation. In addition, bacteria can form biofilms which hamper the functioning of machines. Last but not least, some bacterial by-products are toxic (e.g. endotoxins) and present potential health risks for metalworking machine operators via the formation of aerosols. Therefore, a novel fast yet accurate analytical method to evaluate and predict the antibacterial capacity of MWF would be an important asset. As such a tool is currently lacking, the present study aimed to develop a protocol based on flow cytometry (FCM) to assess the antibacterial potential of newly developed MWF independent of bacterial growth. Results of this novel method were compared to a biochallenge test currently used in MWF industry and also to traditional plate counts. Our results represent a proof-of-principle that FCM can reliably predict the antibacterial capacity of MWF already within one day of incubation with Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis, being substantially faster than the current growth-based methods.	[Vanhauteghem, Donna; Janssens, Geert P. J.] Univ Ghent, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium; [Vanhauteghem, Donna; Demeyere, Kristel; Meyer, Evelyne] Univ Ghent, Dept Pharmacol Toxicol & Biochem, Lab Biochem, Fac Vet Med, Ghent, Belgium; [Audenaert, Kris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci Engn, Valentin Vaerwyckweg 1, Ghent, Belgium; [Hoogendoorn, Fred] Quaker Chem BV, Ind Weg 7, Uithoorn, Netherlands	Ghent University; Ghent University; Ghent University	Vanhauteghem, D (corresponding author), Univ Ghent, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium.; Vanhauteghem, D (corresponding author), Univ Ghent, Dept Pharmacol Toxicol & Biochem, Lab Biochem, Fac Vet Med, Ghent, Belgium.	donna.vanhauteghem@ugent.be	Janssens, Geert/C-2264-2008					Auty MAE, 2001, APPL ENVIRON MICROB, V67, P420, DOI 10.1128/AEM.67.1.420-425.2001; Bakalova S, 2008, BIOTECHNOL BIOTEC EQ, V22, P716, DOI 10.1080/13102818.2008.10817540; Bakalova S, 2007, BIOTECHNOL BIOTEC EQ, V21, P437, DOI 10.1080/13102818.2007.10817490; BENNETT EO, 1979, J GEN APPL MICROBIOL, V25, P63, DOI 10.2323/jgam.25.63; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Borokhov O, 2007, ACS SYM SER, V967, P412; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Brinksmeier E, 2015, CIRP ANN-MANUF TECHN, V64, P605, DOI 10.1016/j.cirp.2015.05.003; Chang SC, 2005, J IND MICROBIOL BIOT, V32, P629, DOI 10.1007/s10295-005-0238-x; Chang SC, 2004, INT BIODETER BIODEGR, V54, P105, DOI 10.1016/j.ibiod.2004.03.019; CHAZAL PM, 1995, EUR J EPIDEMIOL, V11, P1, DOI 10.1007/BF01719939; Falcioni T, 2008, APPL ENVIRON MICROB, V74, P1767, DOI 10.1128/AEM.01668-07; Fishwick D, 2005, OCCUP MED-OXFORD, V55, P238, DOI 10.1093/occmed/kqi049; FOXALLVANAKEN S, 1986, APPL ENVIRON MICROB, V51, P1165, DOI 10.1128/AEM.51.6.1165-1169.1986; Gilbert Y, 2010, J APPL MICROBIOL, V108, P437, DOI 10.1111/j.1365-2672.2009.04433.x; Kapoor R, 2014, FEMS MICROBIOL ECOL, V87, P664, DOI 10.1111/1574-6941.12254; Khan IUH, 2004, MOL CELL PROBE, V18, P67, DOI 10.1016/j.mcp.2003.09.004; Laitinen S, 1999, INT ARCH OCC ENV HEA, V72, P443, DOI 10.1007/s004200050397; Lange JL, 1997, APPL ENVIRON MICROB, V63, P1557, DOI 10.1128/AEM.63.4.1557-1563.1997; Liu HM, 2010, AEROBIOLOGIA, V26, P339, DOI 10.1007/s10453-010-9169-8; MATTSBYBALTZER I, 1989, APPL ENVIRON MICROB, V55, P2681, DOI 10.1128/AEM.55.10.2681-2689.1989; Murat JB, 2012, APPL ENVIRON MICROB, V78, P34, DOI 10.1128/AEM.06230-11; Passman FJ, 2009, TRIBOL T, V52, P788, DOI 10.1080/10402000903097486; Perkins SD, 2010, FEMS MICROBIOL ECOL, V74, P643, DOI 10.1111/j.1574-6941.2010.00976.x; Rossmoore H. W., 1995, P133; ROSSMOORE HW, 1991, INT BIODETERIOR, V27, P145, DOI 10.1016/0265-3036(91)90006-D; Saha R, 2012, APPL MICROBIOL BIOT, V94, P1119, DOI 10.1007/s00253-012-4055-7; Saha R, 2012, APPL MICROBIOL BIOT, V94, P799, DOI 10.1007/s00253-011-3647-y; SANDIN M, 1991, INT BIODETERIOR, V27, P61, DOI 10.1016/0265-3036(91)90024-L; Selvaraju SB, 2005, APPL ENVIRON MICROB, V71, P542, DOI 10.1128/AEM.71.1.542-546.2005; Selvaraju SB, 2011, INT J MOL SCI, V12, P725, DOI 10.3390/ijms12010725; Selvaraju SB, 2008, MOL CELL PROBE, V22, P273, DOI 10.1016/j.mcp.2008.06.002; Shamir I., 2009, FRONTIERS BIOL CHINA, V4, P424, DOI 10.1007/s11515-009-0050-5; Sloyer J, 2002, J IND MICROBIOL BIOT, V29, P323, DOI 10.1038/sj.jim.7000305; SONDOSSI M, 1984, DEV IND MICROBIOL, V25, P515; Thorne PS, 1996, AM IND HYG ASSOC J, V57, P1163, DOI 10.1080/15428119691014288; van der Gast CJ, 2005, BIOTECHNOL BIOENG, V89, P357, DOI 10.1002/bit.20351; van der Gast CJ, 2003, ENVIRON MICROBIOL, V5, P453, DOI 10.1046/j.1462-2920.2003.00428.x; van der Gast CJ, 2002, J IND MICROBIOL BIOT, V29, P20, DOI 10.1038/sj.jim.7000271; van der Gast CJ, 2001, INT BIODETER BIODEGR, V47, P113, DOI 10.1016/S0964-8305(01)00036-1; Van Nevel S, 2017, WATER RES, V113, P191, DOI 10.1016/j.watres.2017.01.065; Vanhauteghem D, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00938-17; Vanhauteghem D, 2012, AMINO ACIDS, V43, P245, DOI 10.1007/s00726-011-1068-y; Vanhauteghem D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060328; Wallace RJ, 2002, APPL ENVIRON MICROB, V68, P5580, DOI 10.1128/AEM.68.11.5580-5584.2002; WATANABE S, 1988, J AM OIL CHEM SOC, V65, P1479, DOI 10.1007/BF02898312; Webster AR, 2005, J OCCUP ENVIRON HYG, V2, P213, DOI 10.1080/15459620590930282; Williams T.M., 2007, POWER PLANT CHEM, V9, P14; Wu LN, 2016, SCI CHINA CHEM, V59, P30, DOI 10.1007/s11426-015-5518-3	49	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211583	10.1371/journal.pone.0211583	http://dx.doi.org/10.1371/journal.pone.0211583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707728	Green Submitted, Green Published, gold			2022-12-26	WOS:000457742900034
J	Gioia, T; Logozzo, G; Marzario, S; Zeuli, PS; Gepts, P				Gioia, Tania; Logozzo, Giuseppina; Marzario, Stefania; Zeuli, Pierluigi Spagnoletti; Gepts, Paul			Evolution of SSR diversity from wild types to US advanced cultivars in the Andean and Mesoamerican domestications of common bean (Phaseolus vulgaris)	PLOS ONE			English	Article							GENETIC DIVERSITY; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; LINKAGE MAP; ORIGIN; LANDRACES; SOFTWARE; PROGRAM; GENOME; L.	Progress in common bean breeding requires the exploitation of genetic variation among market classes, races and gene pools. The present study was conducted to determine the amount of genetic variation and the degree of relatedness among 192 selected common bean advanced cultivars using 58 simple-sequence-repeat markers (SSR) evenly distributed along the 11 linkage groups of the Phaseolus reference map. All the lines belonged to commercial seed type classes that are widely grown in the USA and include both dry bean and snap beans for the fresh and processing markets. Through population structure, principal components analyses, cluster analysis, and discriminant analysis of principal components (DAPC), Andean and Mesoamerican genotypes as well as most American commercial type classes could be distinguished. The genetic relationship among the commercial cultivars revealed by the SSR markers was generally in agreement with known pedigree data. The Mesoamerican cultivars were separated into three major groups-black, small white, and navy accessions clustered together in a distinct group, while great northern and pinto clustered in another group, showing mixed origin. The Andean cultivars were distributed in two different groups. The kidney market classes formed a single group, while the green bean accessions were distributed between the Andean and Mesoamerican groups, showing inter-gene pool genetic admixture. For a subset of 24 SSR markers, we compared and contrasted the genetic diversity of the commercial cultivars with those of wild and domesticated landrace accessions of common bean. An overall reduction in genetic diversity was observed in both gene pools, Andean and Mesoamerican, from wild to landraces to advanced cultivars. The limited diversity in the commercial cultivars suggests that an important goal of bean breeding programs should be to broaden the cultivated gene pool, particularly the genetic diversity of specific commercial classes, using the genetic variability present in common bean landraces.	[Gioia, Tania; Gepts, Paul] Univ Calif Davis, Dept Plant Sci MS1, Sect Crop & Ecosyst Sci, Davis, CA 95616 USA; [Gioia, Tania; Logozzo, Giuseppina; Marzario, Stefania; Zeuli, Pierluigi Spagnoletti] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, Potenza, Italy	University of California System; University of California Davis; University of Basilicata	Gepts, P (corresponding author), Univ Calif Davis, Dept Plant Sci MS1, Sect Crop & Ecosyst Sci, Davis, CA 95616 USA.	plgepts@ucdavis.edu	Gioia, Tania/AAT-9961-2021; Gepts, Paul/O-8229-2019	Gepts, Paul/0000-0002-1056-4665; LOGOZZO, Giuseppina/0000-0002-7951-2425	USDA, National Institute of Food and Agricultural (NIFA), Agriculture and Food Research Initiative (AFRI) [2009-01929]	USDA, National Institute of Food and Agricultural (NIFA), Agriculture and Food Research Initiative (AFRI)	This research was supported by the USDA, National Institute of Food and Agricultural (NIFA), Agriculture and Food Research Initiative (AFRI), Project #2009-01929 BeanCAP, to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rabah'ah MA, 2004, MOL ECOL, V13, P1075, DOI 10.1111/j.1365-294X.2004.02142.x; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; Ariani A, 2018, MOL BIOL EVOL, V35, P119, DOI 10.1093/molbev/msx273; Ariani A, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0512-9; Becerra Velasquez Viviana L., 1994, Genome, V37, P256, DOI 10.1139/g94-036; Beebe S, 2001, CROP SCI, V41, P854, DOI 10.2135/cropsci2001.413854x; Bitocchi E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00722; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blair MW, 2007, THEOR APPL GENET, V116, P29, DOI 10.1007/s00122-007-0644-8; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Blair MW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-100; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Buso GSC, 2006, MOL ECOL NOTES, V6, P252, DOI 10.1111/j.1471-8286.2006.01210.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Lobaton JD, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.08.0068; Diaz LM, 2006, THEOR APPL GENET, V114, P143, DOI 10.1007/s00122-006-0417-9; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Freyre R, 1998, THEOR APPL GENET, V97, P847, DOI 10.1007/s001220050964; Fujii H., 2007, PLANT AN GEN 15 C 20, P322; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Gioia T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075974; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Grisi MCM, 2007, GENET MOL RES, V6, P691; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Benchimol LL, 2007, GENET RESOUR CROP EV, V54, P1747, DOI 10.1007/s10722-006-9184-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; MCCLEAN PE, 1993, CROP SCI, V33, P190, DOI 10.2135/cropsci1993.0011183X003300010034x; McClean PE, 2004, GENOME, V47, P266, DOI [10.1139/g03-103, 10.1139/G03-103]; McClean PE, 2002, J HERED, V93, P148, DOI 10.1093/jhered/93.2.148; McClean PE, 2007, GENOME, V50, P203, DOI 10.1139/G07-001; Mohan A, 2007, CROP SCI, V47, pS3, DOI [10.2135/cropsci2006.05.0322, 10.2135/cropsci2006-06-0376tpg]; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rendon-Anaya M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1190-6; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SINGH SP, 1991, ECON BOT, V45, P379, DOI 10.1007/BF02887079; SINGH SP, 1991, CROP SCI, V31, P23, DOI 10.2135/cropsci1991.0011183X003100010005x; SONNANTE G, 1994, THEOR APPL GENET, V89, P629, DOI 10.1007/BF00222458; Takezaki N, 1996, GENETICS, V144, P389; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; Vlasova A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0883-6; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1990, GENETIC DATA ANAL; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429	61	25	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211342	10.1371/journal.pone.0211342	http://dx.doi.org/10.1371/journal.pone.0211342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703134	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600037
J	Zheng, HG; Liu, LL; Zhang, H; Kan, FM; Wang, S; Li, Y; Tian, HQ; Meng, SD				Zheng, Huaguo; Liu, Lanlan; Zhang, Han; Kan, Fangming; Wang, Shuo; Li, Yang; Tian, Huaqin; Meng, Songdong			Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CANCER; IMMUNOTHERAPY; GENERATION; VACCINES; VACCINATION; MATURATION	Defining and loading of immunogenic and safe cancer antigens remain a major challenge for designing dendritic cell (DC)-based cancer vaccines. In this study, we defined a prototype strategy of using DC-based vaccines pulsed with placenta-derived heat shock protein gp96 to induces anti-tumor T cell responses. Placental gp96 was efficiently taken up by CD11c+ bone marrow-derived DCs (BMDCs) and resulted in moderate BMDC maturation. Splenocytes and cytotoxic T cells (CTLs) generated with mouse BMDCs pulsed with placental gp96 specifically lysed B16 melanoma and LLC lung carcinoma cells. In both transplantable melanoma and lung carcinoma mice models, immunization with placental gp96-stimulated BMDCs led to a significant decrease in tumor growth and mouse mortality with respect to mice treated with liver gp96-pulsed BMDCs or placental gp96 alone. This vaccine induced strong cross-reactive tumor-specific T cell responses. Our results revealed that DCs pulsed with placenta-derived gp96 represent an effective immunotherapy to induce tumor-reactive immune responses, possibly via loading DCs with its associated carcinoembryonic antigens.	[Zheng, Huaguo; Liu, Lanlan; Zhang, Han; Kan, Fangming; Wang, Shuo; Li, Yang; Meng, Songdong] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Tian, Huaqin] Foshan Hosp Tradit Chinese Med, Foshan, Guangdong, Peoples R China; [Meng, Songdong] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Meng, SD (corresponding author), Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.; Meng, SD (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.	mengsd@im.ac.cn			National Key RD Program [2016YFC1303402]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB030404]; One Belt and One Road International Science and Technology Cooperation of Chinese Academy of Sciences [153211KYSB20170001]; National Natural Science Foundation of China [81761128002, 81621091, 81471960, 81672815]	National Key RD Program; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); One Belt and One Road International Science and Technology Cooperation of Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Songdong Meng (SM) received the following awards: National Key R&D Program (grant number: 2016YFC1303402) http://www.most.gov.cn/; Strategic Priority Research Program of the Chinese Academy of Sciences (grant number: XDPB030404) http://www.cas.cn/; One Belt and One Road International Science and Technology Cooperation of Chinese Academy of Sciences (grant number: 153211KYSB20170001) http://www.cas.cn/; National Natural Science Foundation of China (grant numbers: 81761128002, 81621091, 81471960, 81672815) http://www.nsfc.gov.cn/.	Binder RJ, 2014, J IMMUNOL, V193, P5765, DOI 10.4049/jimmunol.1401417; Bloy N, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.963424; Brewer BG, 2009, EXP MOL PATHOL, V86, P192, DOI 10.1016/j.yexmp.2008.12.002; Constantino J, 2017, IMMUNOL RES, V65, P798, DOI 10.1007/s12026-017-8931-1; Crane CA, 2013, CLIN CANCER RES, V19, P205, DOI 10.1158/1078-0432.CCR-11-3358; Dong W, 2010, CANCER IMMUNOL IMMUN, V59, P1697, DOI 10.1007/s00262-010-0899-9; Facciponte JG, 2006, CANCER IMMUNOL IMMUN, V55, P339, DOI 10.1007/s00262-005-0020-y; Garcia-Hernandez MD, 2008, CANCER RES, V68, P861, DOI 10.1158/0008-5472.CAN-07-0445; Garg AD, 2017, TRENDS IMMUNOL, V38, P577, DOI 10.1016/j.it.2017.05.006; Ge CL, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3859-3; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kinner-Bibeau LB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15648; Labeur MS, 1999, J IMMUNOL, V162, P168; Liu HY, 2017, CANCER LETT, V411, P182, DOI 10.1016/j.canlet.2017.09.022; Manzotti CN, 2002, EUR J IMMUNOL, V32, P2888, DOI 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F; Matsutake Toyoshi, 2010, Cancer Immun, V10, P7; Meng SD, 2002, J IMMUNOL METHODS, V264, P29, DOI 10.1016/S0022-1759(02)00093-5; Messmer MN, 2013, J IMMUNOL, V191, P4456, DOI 10.4049/jimmunol.1300827; Mikyskova R, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1362528; Montico B, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1356964; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; Nouri-Shirazi M, 2018, IMMUNOL LETT, V193, P58, DOI 10.1016/j.imlet.2017.10.015; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Pawaria S, 2011, IMMUNOL RES, V50, P255, DOI 10.1007/s12026-011-8221-2; Ramirez SR, 2005, CELL STRESS CHAPERON, V10, P221, DOI 10.1379/CSC-117R.1; Santos PM, 2018, J IMMUNOL, V200, P443, DOI 10.4049/jimmunol.1701024; Shinagawa N, 2008, CANCER IMMUNOL IMMUN, V57, P165, DOI 10.1007/s00262-007-0359-3; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Strbo N, 2013, IMMUNOL RES, V57, P311, DOI 10.1007/s12026-013-8468-x; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Zhao B, 2013, SCI REP-UK, V3, DOI 10.1038/srep01947	32	7	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211490	10.1371/journal.pone.0211490	http://dx.doi.org/10.1371/journal.pone.0211490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703157	Green Submitted, Green Published, gold			2022-12-26	WOS:000457301600052
J	de Sousa, CB; Cox, CJ; Brito, L; Pavao, MM; Pereira, H; Ferreira, A; Ginja, C; Campino, L; Bermejo, R; Parente, M; Varela, J				de Sousa, Carolina Bruno; Cox, Cymon J.; Brito, Luis; Pavao, Maria Madalena; Pereira, Hugo; Ferreira, Ana; Ginja, Catarina; Campino, Lenea; Bermejo, Ricardo; Parente, Manuela; Varela, Joao			Improved phylogeny of brown algae Cystoseira (Fucales) from the Atlantic-Mediterranean region based on mitochondrial sequences	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; GENUS CYSTOSEIRA; PHAEOPHYCEAE; MARKERS; MACROALGAE; CHEMISTRY; ALIGNMENT; LONG; IDENTIFICATION; LAMINARIALES	Cystoseira is a common brown algal genus widely distributed throughout the Atlantic and Mediterranean regions whose taxonomical assignment of specimens is often hampered by intra- and interspecific morphological variability. In this study, three mitochondrial regions, namely cytochrome oxidase subunit 1 (COI), 23S rDNA (23S), and 23S-tRNAVal intergenic spacer (mt-spacer) were used to analyse the phylogenetic relationships of 22 Cystoseira taxa (n = 93 samples). A total of 135 sequences (48 from COI, 43 from 23S and 44 from mt-spacer) were newly generated and analysed together with Cystoseira sequences (9 COI, 31 23S and 35 mt-spacer) from other authors. Phylogenetic analysis of these three markers identified 3 well-resolved clades and also corroborated the polyphyletic nature of the genus. The resolution of Cystoseira taxa within the three clades improves significantly when the inclusion of specimens of related genera was minimized. COI and mt-spacer markers resolved the phylogeny of some of the Cystoseira taxa, such as the C. baccata, C. foeniculacea and C. usneoides. Furthermore, trends between phylogeny, embryonic development and available chemotaxonomic classifications were identified, showing that phylogenetic, chemical and morphological data should be taken into account to study the evolutionary relationships among the algae currently classified as Cystoseira. The resolution of Cystoseira macroalgae into three well supported clades achieved here is relevant for a more accurate isolation and identification of natural compounds and the implementation of conservation measures for target species.	[de Sousa, Carolina Bruno; Cox, Cymon J.; Brito, Luis; Pavao, Maria Madalena; Pereira, Hugo; Varela, Joao] Univ Algarve, Ctr Ciencias Mar, Faro, Portugal; [Ferreira, Ana] Univ Acores, Fac Ciencias & Tecnol, Ponta Delgada, Acores, Portugal; [Ginja, Catarina] Univ Porto, Ctr Invest Biodivers & Recursos Genet, CIBIO InBIO, Campus Agrario Vairao, Vairao, Portugal; [Campino, Lenea] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal; [Bermejo, Ricardo] Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Area Ecol, Cadiz, Spain; [Bermejo, Ricardo] Natl Univ Ireland, Irish Seaweed Res Grp, Galway, Ireland; [Bermejo, Ricardo] Natl Univ Ireland, Ryan Inst, Earth & Ocean Sci Dept, Galway, Ireland; [Bermejo, Ricardo] Natl Univ Ireland, Sch Nat Sci, Galway, Ireland; [Parente, Manuela] Univ Acores, Dept Biol, Ctr Invest Biodivers & Recursos Genet, InBIO Lab Associado,CIBIO Acores, Ponta Delgada, Portugal	Universidade do Algarve; Universidade dos Acores; Universidade do Porto; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidad de Cadiz; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Universidade do Porto; Universidade dos Acores	Varela, J (corresponding author), Univ Algarve, Ctr Ciencias Mar, Faro, Portugal.	jvarela@ualg.pt	Bermejo, Ricardo/GQA-3836-2022; de Sousa, Carolina Bruno/L-1967-2019; Parente, Manuela I/M-2277-2013; Bermejo, Ricardo/N-9881-2013; Parente, Manuela/AAE-1346-2020; Sousa, Carolina A. F. B./J-9538-2015; Pereira, Hugo/E-9360-2015; Cox, Cymon/D-1303-2012	Bermejo, Ricardo/0000-0003-3838-9093; de Sousa, Carolina Bruno/0000-0002-2276-8630; Parente, Manuela I/0000-0003-0204-7155; Bermejo, Ricardo/0000-0003-3838-9093; Parente, Manuela/0000-0003-0204-7155; Sousa, Carolina A. F. B./0000-0002-2276-8630; Pereira, Hugo/0000-0002-1369-2099; Campino, Lenea/0000-0003-4512-9660; Cox, Cymon/0000-0002-4927-979X; Ginja, Catarina/0000-0003-2278-7089; Fonseca Brito, Luis/0000-0001-9884-695X	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/78062/2011, SFRH/BD/105541/2014, IF/00866/2014, CCMAR/Multi/04326/2013, PEst-OE/EQB/LA0023/2011]; Spanish Ministry of Education	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Education(Spanish Government)	CBS, HP and CG were supported by Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/index.phtml.pt) doctoral (SFRH/BD/78062/2011 and SFRH/BD/105541/2014, respectively) and contract (IF/00866/2014) grants. RB holds a Training programme for Academic Staff fellowship of the Spanish Ministry of Education. This work was supported by Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/index.phtml.pt), projects CCMAR/Multi/04326/2013 and PEst-OE/EQB/LA0023/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aly SM, 2014, CROAT MED J, V55, P19, DOI 10.3325/cmj.2014.55.19; AMICO V, 1985, Bollettino dell'Accademia Gioenia di Scienze Naturali, V18, P887; AMICO V, 1995, PHYTOCHEMISTRY, V39, P1257, DOI 10.1016/0031-9422(95)00199-H; Andrade PB, 2013, FOOD CHEM, V138, P1819, DOI 10.1016/j.foodchem.2012.11.081; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Assis J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44348; Ballesteros E, 1981, AN U MURCIA, V42, P237; Ballesteros E, 2004, PRADERAS BOSQUES MAR, P199; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellan G, 1972, MARINE POLLUTION SEA, P396; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bermejo R, 2016, MAR POLLUT BULL, V105, P255, DOI 10.1016/j.marpolbul.2016.02.017; Bermejo R, 2015, ESTUAR COAST SHELF S, V155, P17, DOI 10.1016/j.ecss.2015.01.009; Bermejo R, 2013, MAR POLLUT BULL, V72, P107, DOI 10.1016/j.marpolbul.2013.04.011; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Bucar F, 2013, NAT PROD REP, V30, P525, DOI 10.1039/c3np20106f; Bulleri F, 2002, J EXP MAR BIOL ECOL, V267, P89, DOI 10.1016/S0022-0981(01)00361-6; CALVO MA, 1986, MYCOPATHOLOGIA, V93, P61, DOI 10.1007/BF00437016; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Cho GY, 2006, PHYCOLOGIA, V45, P512, DOI 10.2216/05-48.1; CLAYTON MN, 1990, AUST J ECOL, V15, P439, DOI 10.1111/j.1442-9993.1990.tb01469.x; Coleman MA, 2005, MAR ECOL PROG SER, V300, P63, DOI 10.3354/meps300063; Colombo P, 1982, AGARDH NATURALISTA S, V6, P81; Comarci M, 1992, B I OCEANOGRAPHIQUE, V9, p[21, 1345], DOI [10.1111/j.1529-8817.2010.00891.x, DOI 10.1111/J.1529-8817.2010.00891.X]; Cormaci M., 2012, B ACCAD GIOENIA SCI, V45, P1, DOI DOI 10.1111/jpy.12436; Coyer JA, 2006, MOL PHYLOGENET EVOL, V39, P209, DOI 10.1016/j.ympev.2006.01.019; de los Reyes C, 2016, J NAT PROD, V79, P395, DOI 10.1021/acs.jnatprod.5b01067; de Sousa CB, 2017, TETRAHEDRON-ASYMMETR, V28, P1486, DOI 10.1016/j.tetasy.2017.10.014; de Sousa CB, 2017, EXP PARASITOL, V174, P1, DOI 10.1016/j.exppara.2017.01.002; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Draisma SGA, 2010, J PHYCOL, V46, P1329, DOI 10.1111/j.1529-8817.2010.00891.x; Garcia-Fernandez A, 2016, AN JARDIN BOT MADRID, V73, DOI 10.3989/ajbm.2403; Giaccone G, 1973, ATTI I VENETO SCI LE, V131, P59; Gianni Fabrizio, 2014, Advances in Oceanography and Limnology, V4, P83, DOI 10.1080/19475721.2013.845604; Gomez-Garreta A., 2001, FLORA PHYCOLOGICA IB, V1, P99, DOI DOI 10.1017/S0967026202003530; Gomez-Garreta A, 1994, BOT COMPLUTENSIS, V19, P109, DOI DOI 10.5209/BOCM.7331; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guern M, 1962, VIE MILIEU, V13, P649; Guiry MD, 2017, ALGAEBASE; Harvey JBJ, 2006, J PHYCOL, V42, P707, DOI 10.1111/j.1529-8817.2006.00215.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jegou C, 2010, TALANTA, V83, P613, DOI 10.1016/j.talanta.2010.10.003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kucera H, 2008, BOTANY, V86, P1065, DOI 10.1139/B08-056; Lam DW, 2016, MOL PHYLOGENET EVOL, V94, P730, DOI 10.1016/j.ympev.2015.10.015; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Leal MC, 2016, NAT PROD REP, V33, P747, DOI 10.1039/c5np00130g; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Mattio L, 2010, CRYPTOGAMIE ALGOL, V31, P467; McDevit DC, 2009, PHYCOL RES, V57, P131, DOI 10.1111/j.1440-1835.2009.00530.x; Mhadhebi L, 2011, AFR J BIOTECHNOL, V10, P16682, DOI 10.5897/AJB11.218; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Nylander JAA, 2004, MRMODELTEST 2 0; Phillips NE, 2005, PHYCOL RES, V53, P1; PIATTELLI M, 1990, NEW J CHEM, V14, P777; Pujol CA, 2012, INT J BIOL MACROMOL, V51, P412, DOI 10.1016/j.ijbiomac.2012.05.028; Rambaut A, 2009, FIGTREE SOFTWARE; Roberts M., 1978, MODERN APPROACHES TA; Rousseau F, 1999, EUR J PHYCOL, V34, P53, DOI 10.1017/S096702629900195X; Rozic S, 2012, ACTA ADRIAT, V53, P447; Sales M, 2011, ESTUAR COAST SHELF S, V92, P347, DOI 10.1016/j.ecss.2011.01.008; Saunders GW, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-9; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Sherwood AR, 2010, CRYPTOGAMIE ALGOL, V31, P451; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Spavieri J, 2010, PHYTOTHER RES, V24, P1095, DOI 10.1002/ptr.3072; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Susini M-L., 2006, THESIS; Susini ML, 2007, PHYCOLOGIA, V46, P605, DOI 10.2216/06-100.1; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thibaut T, 2015, MEDITERR MAR SCI, V16, P206, DOI 10.12681/mms.1032; Thibaut T, 2014, MAR POLLUT BULL, V89, P305, DOI 10.1016/j.marpolbul.2014.09.043; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; VALLS R, 1993, PHYTOCHEMISTRY, V32, P961, DOI 10.1016/0031-9422(93)85236-K; Valls R, 1995, BIOCHEM SYST ECOL, V23, P723, DOI 10.1016/0305-1978(95)00068-2; Vizetto-Duarte C, 2016, PEERJ, V4, DOI 10.7717/peerj.1704	89	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210143	10.1371/journal.pone.0210143	http://dx.doi.org/10.1371/journal.pone.0210143			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699208	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600021
J	Villafruela, JPM; Olmedo, I; Berlanga, FA; de Adana, MR				Manuel Villafruela, Jose; Olmedo, Ines; Berlanga, Felix A.; Ruiz de Adana, Manuel			Assessment of displacement ventilation systems in airborne infection risk in hospital rooms	PLOS ONE			English	Article							LOCK-UP PHENOMENON; AIR-DISTRIBUTION; EXHALED CONTAMINANTS; INDOOR ENVIRONMENTS; PERSONAL EXPOSURE; CFD ANALYSIS; FLOW; TRANSMISSION; PERFORMANCE; DISPERSION	Efficient ventilation in hospital airborne isolation rooms is important vis-a-vis decreasing the risk of cross infection and reducing energy consumption. This paper analyses the suitability of using a displacement ventilation strategy in airborne infection isolation rooms, focusing on health care worker exposure to pathogens exhaled by infected patients. The analysis is mainly based on numerical simulation results obtained with the support of a 3-D transient numerical model validated using experimental data. A thermal breathing manikin lying on a bed represents the source patient and another thermal breathing manikin represents the exposed individual standing beside the bed and facing the patient. A radiant wall represents an external wall exposed to solar radiation. The air change efficiency index and contaminant removal effectiveness indices and inhalation by the health care worker of contaminants exhaled by the patient are considered in a typical airborne infection isolation room set up with three air renewal rates (6 h(-1), 9 h(-1) and 12 h(-1)), two exhaust opening positions and two health care worker positions. Results show that the radiant wall significantly affects the air flow pattern and contaminant dispersion. The lockup phenomenon occurs at the inhalation height of the standing manikin. Displacement ventilation renews the air of the airborne isolation room and eliminates the exhaled pollutants efficiently, but is at a disadvantage compared to other ventilation strategies when the risk of exposure is taken into account.	[Manuel Villafruela, Jose] Univ Valladolid, Dept Energy & Fluid Mech, ITAP, Valladolid, Spain; [Olmedo, Ines; Berlanga, Felix A.; Ruiz de Adana, Manuel] Univ Cordoba, Dept Phys Chem & Appl Thermodynam, Cordoba, Spain	Universidad de Valladolid; Universidad de Cordoba	Villafruela, JPM (corresponding author), Univ Valladolid, Dept Energy & Fluid Mech, ITAP, Valladolid, Spain.	manolo@eii.uva.es	Villafruela, José Manuel/H-3396-2012; Olmedo, Ines/AAZ-2741-2020; Cañete, Félix Antonio Berlanga/ABH-3417-2020; Ruiz de Adana, Manuel/K-9185-2014	Villafruela, José Manuel/0000-0003-0491-4371; Cañete, Félix Antonio Berlanga/0000-0001-5617-389X; Ruiz de Adana, Manuel/0000-0002-7890-7505	Ministry of Finance and Competitiveness, State Secretariat for Research, Development and Innovation, Spain, the National RD project [DPI2014-55357-C2-1-R]; European Regional Development Fund (ERDF)	Ministry of Finance and Competitiveness, State Secretariat for Research, Development and Innovation, Spain, the National RD project; European Regional Development Fund (ERDF)(European Commission)	The authors acknowledge the financial support received from the Ministry of Finance and Competitiveness, State Secretariat for Research, Development and Innovation, Spain, the National R&D project with reference DPI2014-55357-C2-1-R, entitled "Ventilation system influence on airborne transmission of human exhaled bioaerosols. Cross infection risk evaluation". This project is co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHRAE, 2017, 1702021 ASHRAE; AusHFG, 2009, AUSTR HLTH FAC GUID; Berlanga FA, 2018, ENERG BUILDINGS, V177, P207, DOI 10.1016/j.enbuild.2018.07.053; Berlanga FA, 2018, ENERG BUILDINGS, V158, P209, DOI 10.1016/j.enbuild.2017.09.100; Bivolarova M, 2017, BUILD ENVIRON, V125, P216, DOI 10.1016/j.buildenv.2017.08.043; Bjorn E, 2002, INDOOR AIR, V12, P147, DOI 10.1034/j.1600-0668.2002.08126.x; Bolashikov ZD, 2009, BUILD ENVIRON, V44, P1378, DOI 10.1016/j.buildenv.2008.09.001; Bolashikov ZD, 2012, HVAC&R RES, V18, P602, DOI 10.1080/10789669.2012.682692; Bulinska A., 2015, COMPUT ASSIST METHOD, V22, P213; CDC, 2005, MMWR-MORBID MORTAL W, P142; Curry Francis J., 2007, TUBERCULOSIS INFECT; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Einberg G, 2005, BUILD ENVIRON, V40, P601, DOI 10.1016/j.buildenv.2004.08.020; FLUENT, 2009, FLUENT 12 0 US GUID; Gao NP, 2012, BUILD SIMUL-CHINA, V5, P51, DOI 10.1007/s12273-012-0068-5; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Hayashi T, 2002, BUILD ENVIRON, V37, P219, DOI 10.1016/S0360-1323(01)00029-4; Hyttinen M, 2011, INDOOR BUILT ENVIRON, V20, P584, DOI 10.1177/1420326X11409452; Jurelionis A, 2015, ENERG BUILDINGS, V86, P305, DOI 10.1016/j.enbuild.2014.10.014; Kao PH, 2006, J HOSP INFECT, V62, P338, DOI 10.1016/j.jhin.2005.07.019; Kaoutar B, 2004, J HOSP INFECT, V58, P268, DOI 10.1016/j.jhin.2004.06.006; Khan JA, 2006, BUILD ENVIRON, V41, P851, DOI 10.1016/j.buildenv.2005.04.002; Khankari K., 2017, REHVA J, V5, P52, DOI DOI 10.1063/5.0013318; Knight KJ, 2005, ASME FLUID ENG DIV, V261, P587; Kowalski W, 2012, HOSPITAL AIRBORNE INFECTION CONTROL, P1; Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x; Li Y, 1992, INDOOR AIR, V2, P225, DOI DOI 10.1111/j.1600-0668.1992.00005.x; LI YG, 1993, ENERG BUILDINGS, V19, P263, DOI 10.1016/0378-7788(93)90011-I; Licina D, 2015, INDOOR AIR, V25, P21, DOI 10.1111/ina.12120; Liu L, 2017, INDOOR AIR, V27, P452, DOI 10.1111/ina.12314; Liu L, 2012, SIMULATION INTERPERS; Villafruela JM, 2013, ENERG BUILDINGS, V57, P210, DOI 10.1016/j.enbuild.2012.10.053; Mateus NM, 2015, BUILD ENVIRON, V84, P50, DOI 10.1016/j.buildenv.2014.10.029; Melikov A, 2004, REHVA GUIDEBOOK 23; Melikov AK, P CLIMA 2010; Memarzadeh F, 2012, BUILD SIMUL-CHINA, V5, P15, DOI 10.1007/s12273-011-0053-4; Mendez C, 2008, ENERG BUILDINGS, V40, P849, DOI 10.1016/j.enbuild.2007.06.003; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Nielsen PV, 2009, J R SOC INTERFACE, V6, pS747, DOI 10.1098/rsif.2009.0228.focus; Olmedo I, 2012, INDOOR AIR, V22, P64, DOI 10.1111/j.1600-0668.2011.00736.x; Qian H, 2004, BUILT ENVIRONMENT AND PUBLIC HEALTH, PROCEEDINGS, P355; Qian H, 2008, BUILD ENVIRON, V43, P344, DOI 10.1016/j.buildenv.2006.03.025; Roos A., 1999, EFFECTIVENESS VENTIL; Rydock JP, 2004, BEST PRACTICE DESIGN, P57; Saarinen PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130667; Sehulster LM, 2003, GUIDELINES ENV INFEC, P249; Siegel JD, 2007, 2007 GUIDELINE ISOLA; Subhash SS, 2013, AM J INFECT CONTROL, V41, P452, DOI 10.1016/j.ajic.2012.06.004; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066663; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059970; Tang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034818; Tham KW, 2013, HVAC R RES, V19, P947, DOI [DOI 10.1089/jam.2007.0610, 10.1080/10789669.2013.842447, DOI 10.1080/10789669.2013.842447]; VACIC, 2007, GUID CLASS DES IS RO; Villafruela JM, 2016, BUILD ENVIRON, V106, P340, DOI 10.1016/j.buildenv.2016.07.005; Villafruela JM, 2013, BUILD ENVIRON, V62, P191, DOI 10.1016/j.buildenv.2013.01.022; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Xu C, 2015, INDOOR AIR, V25, P198, DOI 10.1111/ina.12135; Zhang HL, 2015, PROCEDIA ENGINEER, V121, P1365, DOI 10.1016/j.proeng.2015.09.023; Zhou Q, 2017, BUILD ENVIRON, V116, P246, DOI 10.1016/j.buildenv.2017.02.010	61	18	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211390	10.1371/journal.pone.0211390	http://dx.doi.org/10.1371/journal.pone.0211390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699182	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600074
J	Cimler, R; Maresova, P; Kuhnova, J; Kuca, K				Cimler, Richard; Maresova, Petra; Kuhnova, Jitka; Kuca, Kamil			Predictions of Alzheimer's disease treatment and care costs in European countries	PLOS ONE			English	Article							GLOBAL PREVALENCE; SOCIETAL COSTS; DEMENTIA; IMPACT; MILD; BURDEN	Background Given the increasing lifespan of the elderly and the higher proportion of older people in the global population, the incidence rate of neurodegenerative diseases is increasing. The aim of this study is to evaluate, by means of computer simulations, developments in the costs of treating and caring for people suffering from Alzheimer's disease (AD) in the EU 28 by 2080, while assuming the introduction of drug administrations at various disease stages. Methods Impact analysis leverages a mathematical model that compares five different population development scenarios when introducing different types of drugs to the scenarios but without changing the treatment. Changes in the economic burden are considered as of 2023, when new drugs are expected to enter the market. Findings The results of the simulations show that by prolonging the length of a person's 'stay' in the Mild, Moderate, or Severe stage, the total cost of care for all persons with AD will increase by 2080. For individual scenarios, the percentage of patients and costs increased as follows: Mild by one year, by 10.61%; Mild by two years, by 17.73%; Moderate by one year, by 16.79%; Moderate by two years, by 34.88%; and Severe by one year, by 23.79%. The change in cost development when prolonging the stay in the Mild cognitive impairment stage (by lowering the incidence by 10%, 30%, or 50%) reduced the cost (by 4.88%, 16.78% and 32.48%, respectively). Interpretation The results unambiguously show that any intervention prolonging a patient's stay in any stage will incur additional care costs and an increase in the number of persons with AD. Therefore, extending lifespan is important in terms of improving the quality of life of patients, and the introduction of new drugs must consider the additional costs imposed upon society.	[Cimler, Richard; Kuhnova, Jitka] Univ Hradec Kralove, Fac Sci, Hradec Kralove, Czech Republic; [Maresova, Petra; Kuca, Kamil] Univ Hradec Kralove, Fac Informat & Management, Hradec Kralove, Czech Republic	University of Hradec Kralove; University of Hradec Kralove	Kuca, K (corresponding author), Univ Hradec Kralove, Fac Informat & Management, Hradec Kralove, Czech Republic.	kamil.kuca@uhk.cz	Kuhnova, Jitka/C-7564-2016; Kuca, Kamil/D-1396-2011	Kuhnova, Jitka/0000-0001-9223-5672; Kuca, Kamil/0000-0001-9664-1109	Grant Agency of Excellence UHK FIM; project TACR [TL01000300]	Grant Agency of Excellence UHK FIM; project TACR	The support of the Grant Agency of Excellence UHK FIM is gratefully acknowledged. Financial support of the project TACR TL01000300 is also gratefully acknowledged.	Anderson R., 2018, THESIS; [Anonymous], 2015, INNOVATION ACTIVE HL; Arizaga RL, 2005, DEMENTIA MULTIDISCIP, V2, P7; Boada M, 1999, MED CLIN-BARCELONA, V113, P690; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cimler R, 2018, CURR ALZHEIMER RES, V15, P789, DOI 10.2174/1567205015666180202094551; Cummings J., 2017, ALZHEIMERS DEMENTIA; Dodel R, 2015, ALZHEIMERS DEMENT, V11, P933, DOI 10.1016/j.jalz.2015.02.005; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Ernst RL, 1997, ARCH NEUROL-CHICAGO, V54, P687, DOI 10.1001/archneur.1997.00550180013006; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gustavsson A, 2017, ALZHEIMERS DEMENT, V13, P312, DOI 10.1016/j.jalz.2016.12.005; Ikeda S, 2002, DEMENT GERIATR COGN, V13, P33, DOI 10.1159/000048631; Keogh-Brown MR, 2016, EBIOMEDICINE, V4, P184, DOI 10.1016/j.ebiom.2015.12.019; Maresova P, 2018, J ALZHEIMERS DIS, V63, P227, DOI 10.3233/JAD-171028; Maresova P, 2016, NEUROL SCI, V37, P1917, DOI 10.1007/s10072-016-2679-6; Maresova P, 2016, APPL ECON, V48, P1936, DOI 10.1080/00036846.2015.1111986; Maresova P, 2015, CURR ALZHEIMER RES, V12, P903, DOI 10.2174/156720501209151019111448; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Mesterton J, 2010, CURR ALZHEIMER RES, V7, P358, DOI 10.2174/156720510791162430; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Prince M, 2015, WORLD ALZHEIMERS REP; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Schwarzkopf L, 2011, VALUE HEALTH, V14, P827, DOI 10.1016/j.jval.2011.04.005; Skoldunger A, 2013, CURR ALZHEIMER RES, V10, P207, DOI 10.2174/1567205011310020011; Smith DH, 2001, INT J TECHNOL ASSESS, V17, P236, DOI 10.1017/S0266462300105094; Spackman DE, 2012, CURR ALZHEIMER RES, V9, P1050; Suh GH, 2009, VALUE HEALTH, V12, pS49, DOI 10.1111/j.1524-4733.2009.00627.x; Tomaskova H, 2016, NEUROPSYCH DIS TREAT, V12, P1589, DOI 10.2147/NDT.S107969; Wimo A, 2009, COST ILLNESS BURDEN; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006	34	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210958	10.1371/journal.pone.0210958	http://dx.doi.org/10.1371/journal.pone.0210958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682120	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500079
J	Guo, Z; Han, JC; Li, J; Xu, Y; Wang, XL				Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan; Wang, Xiaoli			Effects of long-term fertilization on soil organic carbon mineralization and microbial community structure	PLOS ONE			English	Article							LAND-USE; BIOMASS; SEQUESTRATION; ECOSYSTEMS; GRASSLANDS; DYNAMICS; NITROGEN; MATTER; SIZE	Soil microorganisms play a pivotal role in carbon mineralization and their diversity is crucial to the function of soil ecosystems. However, the effects of long-term fertilization on microbial-mediated carbon mineralization are poorly understood. To identify the relative roles of microbes in carbon mineralization of yellow paddies, we investigated the long-term fertilization effects on soil properties and microbial communities and their relationships with carbon mineralization. The treatments included: no fertilization (CK), chemical fertilizer (NPK), organic fertilizer (M), and constant organic-inorganic fertilizer (MNPK). NPK treatment significantly increased soil water content (WC), while M and MNPK treatments significantly increased the content of soil organic carbon (SOC), total nitrogen (TN), soil microbial bio-mass carbon (SMBC), soil microbial biomass nitrogen (SMBN), and WC. Strong increases in CO2 emissions, potential mineralized carbon, and turnover rate constant were observed in both organic-fertilizer treatments (M and MNPK), relative to the CK treatment. These changes in soil properties can be attributed to the variation in microbial communities. NPK treatment had no significant effect. Different fertilization treatments changed soil microbial community; SOC and SMBN were the most important contributors to the variance in microbial community composition. The variations in community composition did not significant influence carbon mineralization; however, carbon mineralization was significantly influenced by the abundance of several non-dominant bacteria. The results suggest that SOC, SMBN, and non-dominant bacteria (Gemmatimonadetes and Latescibacteria), have a close relationship to carbon mineralization, and should be preferentially considered in predicting carbon mineralization under long-term fertilization.	[Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Shaanxi, Peoples R China; [Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Shaanxi, Peoples R China; [Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Minist Land & Resources China, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Shaanxi, Peoples R China; [Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Shaanxi, Peoples R China; [Wang, Xiaoli] Guizhou Univ, Coll Agr, Guiyang, Guizhou, Peoples R China	Ministry of Natural Resources of the People's Republic of China; Guizhou University	Wang, XL (corresponding author), Guizhou Univ, Coll Agr, Guiyang, Guizhou, Peoples R China.	15202974884@163.com	Guo, Zhen/P-4584-2018	Guo, Zhen/0000-0003-3383-6341	Open Fundation of Chang'an University Key Laboratory of Land Rehabilitation of Shaanxi Provincial [2018-JC18]; National Natural Science Foundation of China [31860160]; Shaanxi Provincial Land Engineering Construction Group Co., Ltd.	Open Fundation of Chang'an University Key Laboratory of Land Rehabilitation of Shaanxi Provincial; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Land Engineering Construction Group Co., Ltd.	This research was supported by The Open Fundation of Chang'an University Key Laboratory of Land Rehabilitation of Shaanxi Provincial (2018-JC18) and The National Natural Science Foundation of China (31860160). The funding organizations had no role in the design, management, analysis, or interpretation of the data, nor in the preparation, review or approval of the manuscript. The funder, Juan Li, provided support in the funding acquisition and project administration of this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company, Shaanxi Provincial Land Engineering Construction Group Co., Ltd. (Chairman of the board, Jichang Han), provided support in the form of salaries for authors [Zhen Guo, Juan Li], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Creamer CA, 2015, SOIL BIOL BIOCHEM, V80, P175, DOI 10.1016/j.soilbio.2014.10.008; Dai XQ, 2017, SCI TOTAL ENVIRON, V580, P556, DOI 10.1016/j.scitotenv.2016.11.212; Dai XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082147; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eo J, 2016, AGR ECOSYST ENVIRON, V231, P176, DOI 10.1016/j.agee.2016.06.039; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fangueiro D, 2007, SOIL BIOL BIOCHEM, V39, P2608, DOI 10.1016/j.soilbio.2007.05.012; Garcia-Pausas J, 2011, SOIL BIOL BIOCHEM, V43, P1705, DOI 10.1016/j.soilbio.2011.04.016; Grunwald D, 2016, SOIL TILL RES, V164, P11, DOI 10.1016/j.still.2016.01.002; IPCC, 2001, CLIMATE CHANGE 2001; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Li J, 2018, PLOS ONE, V13; Liu ZJ, 2014, BIOL FERT SOILS, V50, P537, DOI 10.1007/s00374-013-0864-9; LONG SP, 1991, ECOL APPL, V1, P139, DOI 10.2307/1941807; Mi J, 2015, LANDSCAPE ECOL, V30, P1683, DOI 10.1007/s10980-014-0040-0; Minasny B, 2011, EUR J SOIL SCI, V62, P728, DOI 10.1111/j.1365-2389.2011.01386.x; Nelson D.W., 1996, METHODS SOIL ANAL PA, V5, P961, DOI [10.2136/sssabookser5.3.c34, DOI 10.2136/SSSABOOKSER5.3.C34]; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Ribeiro HM, 2010, J PLANT NUTR SOIL SC, V173, P39, DOI 10.1002/jpln.200900015; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Wagai R, 1998, SOIL BIOL BIOCHEM, V30, P1501, DOI 10.1016/S0038-0717(98)00041-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang HJ, 2015, BIOL FERT SOILS, V51, P137, DOI 10.1007/s00374-014-0957-0; Zhou P, 2016, AGR ECOSYST ENVIRON, V219, P93, DOI 10.1016/j.agee.2015.12.012	33	57	61	37	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211163	10.1371/journal.pone.0211163	http://dx.doi.org/10.1371/journal.pone.0211163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682124	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500116
J	Nakayama, T; Nagata, E; Masuda, H; Asahara, T; Takizawa, S				Nakayama, Taira; Nagata, Eiichiro; Masuda, Haruchika; Asahara, Takayuki; Takizawa, Shunya			Regeneration-associated cell transplantation contributes to tissue recovery in mice with acute ischemic stroke	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; FOCAL CEREBRAL-ISCHEMIA; INDUCED ANGIOGENESIS; INTERLEUKIN-10; GROWTH; INJURY; NEOVASCULARIZATION; INHIBITION; MODEL; TUMOR	Various cell-based therapeutic strategies have been investigated for vascular and tissue regeneration after ischemic stroke. We have developed a novel cell population, called regeneration-associated cells (RACs), by quality- and quantity-controlled culture of unfractionated mononuclear cells. RACs were trans-arterially injected into 10-week-old syngeneic male mice at 1, 3, 5 or 7 days after permanent middle cerebral artery occlusion (MCAO) to determine the optimal timing for administration in terms of outcome at day 21. Next, we examined the effects of RACs injection at day 1 after MCAO on neurological deficits, infarct volume, and mediators of vascular regeneration and anti-inflammation at days 7 and 21. Infarct volume at day 21 was significantly reduced by transplantation of RACs at day 1 or 3. RACs injected at day 1 reduced the infarct volume at day 7 and 21. Angiogenesis and anti-inflammatory mediators, VEGF and IL-10, were increased at day 7, and VEGF was still upregulated at day 21. We also observed significantly enhanced ink perfusion in vivo, tube formation in vitro, and definitive endothelial progenitor cell colonies in colony assay. These results suggest that RAC transplantation in MCAO models promoted significant recovery of neural tissues through intensified anti-inflammatory and angiogenic effects.	[Nakayama, Taira; Nagata, Eiichiro; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa, Japan; [Masuda, Haruchika] Tokai Univ, Sch Med, Dept Physiol, Isehara, Kanagawa, Japan; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University	Takizawa, S (corresponding author), Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa, Japan.	shun@is.icc.u-tokai.ac.jp		Nagata, Eiichiro/0000-0001-6902-8309; Takizawa, Shunya/0000-0002-4567-6384	Japan Society for the Promotion of Science; SENSHIN Medical Research Foundation [26461320]; Japan Agency for Medical Research and Development [15bk0104012h003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Society for the Promotion of Science and SENSHIN Medical Research Foundation, http://www.jsps.go.jp/english/index.html, Scientific Research (C) 26461320, S.T. received the funding; Japan Agency for Medical Research and Development, https://www.amed.go.jp/en/index.html, Grant 15bk0104012h003, T.A. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bai YY, 2015, STROKE, V46, P1938, DOI 10.1161/STROKEAHA.114.008495; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chen C, 2014, STEM CELLS, V32, P2679, DOI 10.1002/stem.1754; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Cole N, 2003, INFECT IMMUN, V71, P1328, DOI 10.1128/IAI.71.3.1328-1336.2003; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2014, STROKE, V45, P1510, DOI 10.1161/STROKEAHA.113.004075; Garcia-Hernandez ML, 2002, IMMUNOLOGY, V105, P231, DOI 10.1046/j.1365-2567.2002.01363.x; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Hatanaka H, 2001, CLIN CANCER RES, V7, P1287; Hecht N, 2014, J CEREBR BLOOD F MET, V34, P1297, DOI 10.1038/jcbfm.2014.78; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Huang SY, 1999, J INTERF CYTOK RES, V19, P697, DOI 10.1089/107999099313532; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Noisa P, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/647437; Ohta T, 2006, NEUROSURGERY, V59, P679, DOI 10.1227/01.NEU.0000229058.08706.88; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Shen WC, 2013, STEM CELLS DEV, V22, P1408, DOI 10.1089/scd.2012.0445; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Silvestre JS, 2000, CIRC RES, V87, P448; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Stearns ME, 1999, CLIN CANCER RES, V5, P189; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Torrent R, 2015, J CLIN MED, V4, P548, DOI 10.3390/jcm4040548; Vaughan EE, 2012, CELL TRANSPLANT, V21, P1095, DOI 10.3727/096368911X623880; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Wang HB, 2014, J NEUROPATH EXP NEUR, V73, P548, DOI 10.1097/NEN.0000000000000077; Yukami T, 2015, STROKE, V46, P1657, DOI 10.1161/STROKEAHA.114.008062; ZHANG FG, 1992, J CEREBR BLOOD F MET, V12, P962, DOI 10.1038/jcbfm.1992.133; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	45	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210198	10.1371/journal.pone.0210198	http://dx.doi.org/10.1371/journal.pone.0210198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682162	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500027
J	Potts, AH; Guo, YP; Ahmer, BMM; Romeo, T				Potts, Anastasia H.; Guo, Yinping; Ahmer, Brian M. M.; Romeo, Tony			Role of CsrA in stress responses and metabolism important for Salmonella virulence revealed by integrated transcriptomics	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; ESCHERICHIA-COLI; MESSENGER-RNA; GENE-EXPRESSION; OXIDATIVE STRESS; H-NS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR CHARACTERIZATION; INTRACELLULAR ENVIRONMENT	To cause infection, Salmonella must survive and replicate in host niches that present dramatically different environmental conditions. This requires a flexible metabolism and physiology, responsive to conditions of the local milieu. The sequence specific RNA binding protein CsrA serves as a global regulator that governs gene expression required for pathogenicity, metabolism, biofilm formation, and motility in response to nutritional conditions. Its activity is determined by two noncoding small RNAs (sRNA), CsrB and CsrC, which sequester and antagonize this protein. Here, we used ribosome profiling and RNA-seq analysis to comprehensively examine the effects of CsrA on mRNA occupancy with ribosomes, a measure of translation, transcript stability, and the steady state levels of transcripts under in vitro SPI-1 inducing conditions, to simulate growth in the intestinal lumen, and under in vitro SPI-2-inducing conditions, to simulate growth in the Salmonella containing vacuole (SCV) of the macrophage. Our findings uncovered new roles for CsrA in controlling the expression of structural and regulatory genes involved in stress responses, metabolism, and virulence systems required for infection. We observed substantial variation in the CsrA regulon under the two growth conditions. In addition, CsrB/C sRNA levels were greatly reduced under the simulated intracellular conditions and were responsive to nutritional factors that distinguish the intracellular and luminal environments. Altogether, our results reveal CsrA to be a flexible regulator, which is inferred to be intimately involved in maintaining the distinct gene expression patterns associated with growth in the intestine and the macrophage.	[Potts, Anastasia H.; Guo, Yinping; Romeo, Tony] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Ahmer, Brian M. M.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Potts, Anastasia H.] Takara Bio USA Inc, Mountain View, CA USA; [Guo, Yinping] Univ Georgia, Natl Environm Sound Prod Agr Lab, Tifton Campus, Tifton, GA USA	State University System of Florida; University of Florida; University System of Ohio; Ohio State University; Takara Bio Inc.; University System of Georgia; University of Georgia	Romeo, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	tromeo@ufl.edu	Ahmer, Brian M. M./F-2228-2010	Ahmer, Brian M. M./0000-0002-4267-7322; Guo, Yinping/0000-0003-1796-6584	National Institutes of Health [R01AI097116, R01GM059969]; National Science Foundation Graduate Research Fellowship Program [DGE-1315138]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01AI097116 to T.R. and B.M. M.A., R01GM059969 to T.R.]; and the National Science Foundation Graduate Research Fellowship Program [DGE-1315138 to A.H.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Akbar S, 2003, MOL MICROBIOL, V47, P715, DOI 10.1046/j.1365-2958.2003.03322.x; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ali MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004209; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Altendorf Karlheinz, 2009, EcoSal Plus, V3, DOI 10.1128/ecosalplus.5.4.5; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Alvarez-Ordonez A, 2011, MICROBIOL-SGM, V157, P3268, DOI 10.1099/mic.0.050351-0; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Balaji B, 2005, APPL ENVIRON MICROB, V71, P8273, DOI 10.1128/AEM.71.12.8273-8283.2005; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Borisov Vitaliy B, 2015, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0012-2015; Brenneman KE, 2013, J BACTERIOL, V195, P3062, DOI 10.1128/JB.00104-13; Brown NF, 2014, MBIO, V5, DOI 10.1128/mBio.01727-14; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Chakraborty S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002116; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chen CY, 1996, INFECT IMMUN, V64, P4739, DOI 10.1128/IAI.64.11.4739-4743.1996; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; D'Costa VM, 2015, CELL REP, V12, P1508, DOI 10.1016/j.celrep.2015.07.063; Dandekar T, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00191; Daniels JJD, 1996, INFECT IMMUN, V64, P5075, DOI 10.1128/IAI.64.12.5075-5084.1996; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Desai SK, 2016, ELIFE, V5, DOI 10.7554/eLife.10747; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Erhardt M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00949; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Esquerre T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25057; Esquerre T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1482-8; Faber F, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006129; Faber F, 2016, NATURE, V534, P697, DOI 10.1038/nature18597; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Fang FC, 2016, CELL HOST MICROBE, V20, P133, DOI 10.1016/j.chom.2016.07.009; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Finn S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00331; Finn S, 2013, APPL ENVIRON MICROB, V79, P4376, DOI 10.1128/AEM.00515-13; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gillis CC, 2018, CELL HOST MICROBE, V23, P54, DOI 10.1016/j.chom.2017.11.006; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Holmqvist E, 2016, EMBO J, V35, P991, DOI 10.15252/embj.201593360; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; IUCHI S, 1994, J BACTERIOL, V176, P1695, DOI 10.1128/jb.176.6.1695-1701.1994; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones-Carson J, 2016, MBIO, V7, DOI 10.1128/mBio.02052-16; Jorgensen MG, 2013, GENE DEV, V27, P1132, DOI 10.1101/gad.214734.113; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Katsowich N, 2017, SCIENCE, V355, P735, DOI 10.1126/science.aah4886; Kim JS, 2011, INFECT IMMUN, V79, P1440, DOI 10.1128/IAI.01231-10; KINGSLEY R, 1995, FEMS IMMUNOL MED MIC, V11, P257, DOI 10.1016/0928-8244(95)00031-2; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Knuff K, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00335; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kristoffersen SM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r30; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kulkarni PR, 2014, NUCLEIC ACIDS RES, V42, P6811, DOI 10.1093/nar/gku309; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; Leng YY, 2016, MOL MICROBIOL, V99, P627, DOI 10.1111/mmi.13259; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Lopez CA, 2015, INFECT IMMUN, V83, P3470, DOI 10.1128/IAI.00351-15; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Martinez LC, 2014, J BACTERIOL, V196, P3746, DOI 10.1128/JB.01799-14; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; McKee AE, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-79; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Nickerson CA, 1997, INFECT IMMUN, V65, P1814, DOI 10.1128/IAI.65.5.1814-1823.1997; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Park H, 2015, J BACTERIOL, V197, P3751, DOI 10.1128/JB.00721-15; Parker A, 2017, MOL MICROBIOL, V105, P309, DOI 10.1111/mmi.13702; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Perez-Morales D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006497; Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Potts AH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01613-1; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Revelles O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066386; Rivera-Chavez F, 2016, MBIO, V7, DOI 10.1128/mBio.00960-16; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Rivera-Chavez F, 2015, ANNU REV MICROBIOL, V69, P31, DOI 10.1146/annurev-micro-091014-104108; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Rowbury RJ, 1997, LETT APPL MICROBIOL, V24, P319, DOI 10.1046/j.1472-765X.1997.00065.x; Ryan D, 2015, APPL ENVIRON MICROB, V81, P8054, DOI 10.1128/AEM.02172-15; Scallan E, 2013, PEDIATR INFECT DIS J, V32, P217, DOI 10.1097/INF.0b013e31827ca763; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; SHI XL, 1994, J BACTERIOL, V176, P7017, DOI 10.1128/JB.176.22.7017-7023.1994; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Sterzenbach T, 2013, EMBO J, V32, P2872, DOI 10.1038/emboj.2013.206; Subramaniam AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01501; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Unden Gottfried, 2008, EcoSal Plus, V3, DOI 10.1128/ecosalplus.3.2.2; Vakulskas CA, 2016, NUCLEIC ACIDS RES, V44, P7896, DOI 10.1093/nar/gkw484; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Viala JP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006556; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Wilson JA, 1998, MICROBIOL-UK, V144, P1823, DOI 10.1099/00221287-144-7-1823; Wu JK, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00945-17, 10.1128/iai.00945-17]; Wu JK, 2018, J AGR FOOD CHEM, V66, P212, DOI 10.1021/acs.jafc.7b04237; Xu X, 2010, INFECT IMMUN, V78, P49, DOI 10.1128/IAI.00931-09; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; YIM HH, 1992, J BACTERIOL, V174, P3637, DOI 10.1128/JB.174.11.3637-3644.1992; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zere TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145035; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	153	25	25	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211430	10.1371/journal.pone.0211430	http://dx.doi.org/10.1371/journal.pone.0211430			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682134	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500169
J	Takayama, T; Yamamoto, K; Saito, H; Tatebayashi, K				Takayama, Tomomi; Yamamoto, Katsuyoshi; Saito, Haruo; Tatebayashi, Kazuo			Interaction between the transmembrane domains of Sho1 and Opy2 enhances the signaling efficiency of the Hog1 MAP kinase cascade in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; OSMOTIC-STRESS; PBS2 MAPKK; YEAST; GLYCEROL; PATHWAY; OSMOSTRESS; EXPRESSION; GROWTH	To cope with increased extracellular osmolarity, the budding yeast Saccharomyces cerevisiae activates the Hog1 mitogen-activated protein kinase (MAPK), which controls a variety of adaptive responses. Hog1 is activated through the high-osmolarity glycerol (HOG) pathway, which consists of a core MAPK cascade and two independent upstream branches (SHO1 and SLN1 branches) containing distinct osmosensing machineries. In the SHO1 branch, a homo-oligomer of Sho1, the four-transmembrane (TM) osmosensor, interacts with the transmembrane co-osmosensors, Hkr1 and Msb2, and the membrane anchor protein Opy2, through their TM domains, and activates the Ste20-Ste11-Pbs2-Hog1 kinase cascade. In this study, we isolated and analyzed hyperactive mutants of Sho1 and Opy2 that harbor mutations within their TM domains. Several hyperactive mutations enhanced the interaction between Sho1 and Opy2, indicating the importance of the TM-mediated interaction between Sho1 and Opy2 for facilitating effective signaling. The interaction between the TM domains of Sho1 and Opy2 will place their respective cytoplasmic binding partners Pbs2 and Ste11 in close proximity. Indeed, genetic analyses of the mutants showed that the Sho1-Opy2 interaction enhances the activation of Pbs2 by Ste11, but not Hog1 by Pbs2. Some of the hyperactive mutants had mutations at the extracellular ends of either Sho1 TM4 or Opy2 TM, and defined the Sho1-Opy2 binding site 1 (BS1). Chemical crosslinking and mutational analyses revealed that the cytoplasmic ends of Sho1 TM1 and Opy2 TM also interact with each other, defining the Sho1-Opy2 binding site 2 (BS2). A geometric consideration constrains that one Opy2 molecule must interact with two adjacent Sho1 molecules in Sho1 oligomer. These results raise a possibility that an alteration of the conformation of the Sho1-Opy2 complex might contributes to the osmotic activation of the Hog1 MAPK cascade.	[Takayama, Tomomi; Yamamoto, Katsuyoshi; Saito, Haruo; Tatebayashi, Kazuo] Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Tokyo, Japan; [Tatebayashi, Kazuo] Univ Tokyo, Inst Med Sci, Frontier Res Unit, Lab Mol Genet, Tokyo, Japan; [Takayama, Tomomi; Tatebayashi, Kazuo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Tatebayashi, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Tokyo, Japan.; Tatebayashi, K (corresponding author), Univ Tokyo, Inst Med Sci, Frontier Res Unit, Lab Mol Genet, Tokyo, Japan.; Tatebayashi, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.	tategone@ims.u-tokyo.ac.jp	Tatebayashi, Kazuo/L-8595-2017; Saito, Haruo/AAF-6113-2019	Tatebayashi, Kazuo/0000-0002-3131-7030; Saito, Haruo/0000-0001-7891-1689	JSPS KAKENHI [JP25440042, JP24247034, JP16H04761]; Sumitomo Foundation [150075]; Salt Science Research Foundation [1732]; Japan Foundation for Applied Enzymology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Salt Science Research Foundation; Japan Foundation for Applied Enzymology	This work was supported by JSPS KAKENHI Grant Number JP25440042 to KY, JSPS KAKENHI Grant Number JP24247034 to HS; JSPS KAKENHI Grant Number JP16H04761 to KT (https://www.jsps.go.jp/english/index.html); The Sumitomo Foundation (number 150075)(http://www.sumitomo.or.jp/e/index.html); The Salt Science Research Foundation (number 1732) (http://www.saltscience.or.jp/english.html) and the Japan Foundation for Applied Enzymology (https://www.jfae.or.jp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Yoshikazu Nakamura and Sumiko Watanabe for their generous supports, and Ms. M. Umeda for her assistance. This work was supported in part by JSPS KAKENHI Grant Number JP25440042 to K.Y, JP24247034 to H.S, and JP16H04761 to K.T, and by grants to K.T. from The Sumitomo Foundation (number 150075), The Salt Science Research Foundation (number 1732), and the Japan Foundation for Applied Enzymology.	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; BLOMBERG A, 1989, J BACTERIOL, V171, P1087, DOI 10.1128/jb.171.2.1087-1092.1989; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; de Nadal Eulalia, 2008, V20, P81, DOI 10.1007/4735_2007_0244; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; FOREMAN PK, 1994, GENE, V144, P63, DOI 10.1016/0378-1119(94)90204-6; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Horie T, 2008, MOL CELL BIOL, V28, P5172, DOI 10.1128/MCB.00589-08; Lee J, 2013, GENE DEV, V27, P2590, DOI 10.1101/gad.229310.113; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Nishimura A, 2016, MOL CELL BIOL, V36, P1109, DOI 10.1128/MCB.01017-15; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; ROSE MD, 1991, METHOD ENZYMOL, V194, P195; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004780; Tatebayashi K, 2003, EMBO J, V22, P3624, DOI 10.1093/emboj/cdg353; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Tatebayashi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7975; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yang HY, 2009, EMBO J, V28, P1380, DOI 10.1038/emboj.2009.104	39	11	14	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211380	10.1371/journal.pone.0211380	http://dx.doi.org/10.1371/journal.pone.0211380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682143	Green Submitted, gold, Green Published			2022-12-26	WOS:000457037500161
J	Triguero-Ocana, R; Barasona, JA; Carro, F; Soriguer, RC; Vicente, J; Acevedo, P				Triguero-Ocana, Roxana; Barasona, Jose A.; Carro, Francisco; Soriguer, Ramon C.; Vicente, Joaquin; Acevedo, Pelayo			Spatio-temporal trends in the frequency of interspecific interactions between domestic and wild ungulates from Mediterranean Spain	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; AFRICAN-SWINE-FEVER; RISK-FACTORS; CATTLE IMPLICATIONS; CONTACT RATES; BOAR; LIVESTOCK; BOVIS; DISEASES; TRANSMISSION	Controlling infections shared by wildlife and livestock requires the understanding and quantification of interspecific interactions between the species involved. This is particularly important in extensive multi-host systems, in which controlled domestic animals interact with uncontrolled, abundant and expanding wild species, such as wild ungulates. We have, therefore, quantified the interspecific interactions between wild boar (Sus scrofa) and free-ranging cattle in Mediterranean Spain, along with their spatio-temporal variability. GPS-GSM-collars were used to monitor 12 cows and 14 wild boar in the Donana National Park between 2011 and 2013. Interactions were defined as encounters between cattle and wild boar within a spatio-temporal window of 52 m and 1 hour. On average, each wild boar interacted with one cow 1.5 +/- (SE) 0.5 times per day, while each cow interacted with one wild boar 1.3 +/- 0.4 times per day. The frequency of interaction was significantly higher during crepuscular hours owing to the overlap of both species' activity, and also during spring and autumn, probably owing to a higher individual aggregation around shared resources. Finally, the frequency of interaction was higher near the most significant shared resources (e.g. water points) but was lower in areas with dense vegetation. The results presented here show the usefulness of GPS monitoring as regards quantifying interactions and helping to clarify the process of pathogen transmission at the wildlife-livestock interface in Mediterranean Spain, along with the main spatio-temporal risk factors. In a changing scenario in which European populations of wild ungulates are increasing, more efficient measures with which to control interactions are required to meet the demands of farmers and managers. Our results, therefore, provide directional hypotheses that could be used to design disease control programmes.	[Triguero-Ocana, Roxana; Vicente, Joaquin; Acevedo, Pelayo] UCLM, CSIC, JCCM, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain; [Barasona, Jose A.] Univ Complutense Madrid, Anim Hlth Dept, VISAVET Ctr, Madrid, Spain; [Carro, Francisco; Soriguer, Ramon C.] CSIC, Estn Biol Donana, Seville, Spain; [Vicente, Joaquin; Acevedo, Pelayo] UCLM, Escuela Tecn Super Ingn Agron, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad de Castilla-La Mancha	Triguero-Ocana, R (corresponding author), UCLM, CSIC, JCCM, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain.	roxana.triguerocana@gmail.com	Carro, Francisco/ABH-4548-2020; Barasona, Jose/ABH-7368-2020; Acevedo, Pelayo/L-6737-2013; Casimiro-Soriguer, Ramon/J-1494-2014	Barasona, Jose/0000-0003-4066-8454; Acevedo, Pelayo/0000-0002-3509-7696; Casimiro-Soriguer, Ramon/0000-0002-9165-7766; Triguero Ocana, Roxana/0000-0003-4875-4306	MINECO [AGL2013-48523-C3-1-R]; UCLM; "Juan de la Cierva" contract from MINECO-UCM [FJCI-201523643]; MINECO-UCLM through a "Ramon y Cajal" contract [RYC-2012-11970]	MINECO(Spanish Government); UCLM; "Juan de la Cierva" contract from MINECO-UCM; MINECO-UCLM through a "Ramon y Cajal" contract	The present work has benefited from the financial aid of a research grant funded by MINECO (AGL2013-48523-C3-1-R). RTO holds a pre-doctoral scholarship from UCLM. JAB is supported by a "Juan de la Cierva" contract (FJCI-201523643) from MINECO-UCM. PA is supported by MINECO-UCLM through a "Ramon y Cajal" contract (RYC-2012-11970).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barasona JA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-107; [Anonymous], 2011, COEFPLOT2 COEFFICIEN; Apollonio M., 2010, EUROPEAN UNGULATES T; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Artois M, 2002, REV SCI TECH OIE, V21, P287, DOI 10.20506/rst.21.2.1332; Barasona JA, 2017, TRANSBOUND EMERG DIS, V64, P1148, DOI 10.1111/tbed.12480; Barasona JA, 2013, PREV VET MED, V111, P42, DOI 10.1016/j.prevetmed.2013.03.009; Barasona JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115608; Barasona JA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0122-7; Bates D, 2015, J STAT SOFT; Bayan B, 1995, AGUAS SUPERFICIALES, V3340, P17; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Brivio F, 2017, MAMM BIOL, V84, P73, DOI 10.1016/j.mambio.2017.01.007; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carrasco-Garcia R, 2016, EUR J WILDLIFE RES, V62, P65, DOI 10.1007/s10344-015-0974-9; Carro F, 2017, INTEGR ZOOL, V12, P49, DOI 10.1111/1749-4877.12212; Clemente L., 2004, INVESTIG CIENC, P72; Cooper SM, 2010, J WILDLIFE DIS, V46, P152, DOI 10.7589/0090-3558-46.1.152; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Cowie CE, 2014, EUR J WILDLIFE RES, V60, P113, DOI 10.1007/s10344-013-0757-0; Dohna HZ, 2014, PREV VET MED, V113, P447, DOI 10.1016/j.prevetmed.2013.12.004; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Garcia-Saenz A, 2014, SPAT SPATIO-TEMPORAL, V10, P1, DOI 10.1016/j.sste.2014.06.002; Gaynor KM, 2018, SCIENCE, V360, P1232, DOI 10.1126/science.aar7121; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2016, EUR J WILDLIFE RES, V62, P511, DOI 10.1007/s10344-016-1033-x; Gortazar C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004129; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2010, WILDLIFE RES, V37, P668, DOI 10.1071/WR10031; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Guta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104383; Hardstaff JL, 2014, RES VET SCI, V97, pS86, DOI 10.1016/j.rvsc.2013.12.002; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Judge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028941; Keuling O, 2008, EUR J WILDLIFE RES, V54, P729, DOI 10.1007/s10344-008-0204-9; Kukielka E, 2013, PREV VET MED, V112, P213, DOI 10.1016/j.prevetmed.2013.08.008; Kukielka EA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00031; LaHue NP, 2016, PREV VET MED, V128, P101, DOI 10.1016/j.prevetmed.2016.04.011; Latham ADM, 2015, NEW ZEAL J ECOL, V39, P143; Lavelle MJ, 2016, PREV VET MED, V135, P28, DOI 10.1016/j.prevetmed.2016.10.009; Martinez-Lopez B, 2014, PREV VET MED, V116, P268, DOI 10.1016/j.prevetmed.2013.11.002; Miguel E, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00239.1; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Oganesyan AS, 2013, VIRUS RES, V173, P204, DOI 10.1016/j.virusres.2012.12.009; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Putman R, 2011, MAMMAL REV, V41, P175, DOI 10.1111/j.1365-2907.2010.00173.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; Russo L, 1997, ETHOL ECOL EVOL, V9, P287, DOI 10.1080/08927014.1997.9522888; Schijven J, 2005, RISK ANAL, V25, P13, DOI 10.1111/j.0272-4332.2005.00563.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; Thurfjell H, 2014, ACTA THERIOL, V59, P467, DOI 10.1007/s13364-014-0185-x; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Vicente J, 2014, UNPUB; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Williams DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084368; Woodroffe R, 2016, ECOL LETT, V19, P1201, DOI 10.1111/ele.12654; Wozniakowski G, 2016, ARCH VIROL, V161, P189, DOI 10.1007/s00705-015-2650-5; Zvidzai M., 2013, INT J DEV SUSTAINABI, V2, P455	65	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211216	10.1371/journal.pone.0211216	http://dx.doi.org/10.1371/journal.pone.0211216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682123	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500127
J	Dai, W; Xu, XH; Wang, DY; Wu, J; Wang, JK				Dai, Wei; Xu, Xinhui; Wang, Danyang; Wu, Jian; Wang, Jinke			Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system	ONCOGENE			English	Article							GENOME; RNA; MAINTENANCE; IMETELSTAT; INHIBITOR; SEQUENCE; TOOL	Cancer is caused by a series of alterations in genome and epigenome and exists in multiple complex forms, making it difficult to be prevented and/or treated. Telomerase, an enzyme responsible for the maintenance of telomere, is silent in most normal somatic cells but activated in 90% of cancer cells, making it an excellent target for cancer therapy. Therefore, various telomerase activity inhibitors have been developed to treat cancer but all failed due to side effects. Here we acted oppositely to develop a cancer gene therapy named telomerase-activating gene expression (Tage) system by utilizing the telomerase activity in cancer cells. The Tage system consisted of an effector gene expression vector that carried a 3' telomerase-recognizable stick end and an artificial transcription factor expression vector that could express dCas9-VP64 and an sgRNA targeting telomere repeat sequences. By using Cas9 as an effector gene, the Tage system effectively killed various cancer cells, including HepG2, HeLa, PANC-1, MDA-MB-453, A549, HT-29, SKOV-3, Hepa1-6, and RAW264.7, without affecting normal cells MRC-5, HL7702, and bone marrow mesenchymal stem cell (BMSC). More importantly, a four-base 3' stick end produced by the homothallic switching endonuclease in cells could be recognized by telomerase, allowing the Tage system to effectively kill cancer cells in vivo. The Tage system could effectively and safely realize its in vivo application by using adeno-associated virus (AAV) as gene vector. The virus-loaded Tage system could significantly and specifically kill cancer cells in mice by intravenous drug administration without side effects or toxicity.	[Dai, Wei; Xu, Xinhui; Wang, Danyang; Wu, Jian; Wang, Jinke] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China	Southeast University - China	Wang, JK (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	wangjinke@seu.edu.cn	Wang, Jinke/AAT-7832-2021	Wang, Jinke/0000-0002-3352-4690	National Natural Science Foundation of China [61571119]; National Key Research and Development Program of China [2017YFA0205502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the National Natural Science Foundation of China (61571119) and the National Key Research and Development Program of China (2017YFA0205502).	Aschacher T, 2016, ONCOGENE, V35, P94, DOI 10.1038/onc.2015.65; Banerjee Budhaditya, 2017, Curr Opin Syst Biol, V1, P1, DOI 10.1016/j.coisb.2016.12.016; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BLACKBURN EH, 1984, CELL, V37, P7, DOI 10.1016/0092-8674(84)90295-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/NMETH.3871, 10.1038/nmeth.3871]; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunbar CE, 2018, SCIENCE, V359, P175, DOI 10.1126/science.aan4672; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; George LA, 2017, BLOOD ADV, V1, P2591, DOI 10.1182/bloodadvances.2017009878; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Khan FA, 2016, ONCOTARGET, V7, P52541, DOI 10.18632/oncotarget.9646; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Maciejowski J, 2017, NAT REV MOL CELL BIO, V18, P175, DOI 10.1038/nrm.2016.171; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Mosoyan G, 2017, LEUKEMIA, V31, P2458, DOI 10.1038/leu.2017.78; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nissim L, 2017, CELL, V171, P1138, DOI 10.1016/j.cell.2017.09.049; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Sachdeva M, 2015, CANCER GENE THER, V22, P509, DOI 10.1038/cgt.2015.54; Samanta MK, 2016, TRANSGENIC RES, V25, P561, DOI 10.1007/s11248-016-9953-5; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Stewart SA, 2010, CANCER RES, V70, P7365, DOI 10.1158/0008-5472.CAN-10-1373; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tefferi A, 2015, NEW ENGL J MED, V373, P908, DOI 10.1056/NEJMoa1310523; Valdmanis PN, 2017, HUM GENE THER, V28, P361, DOI 10.1089/hum.2016.171; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Wright WE, 1996, DEV GENET, V18, P173; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589	46	15	15	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4110	4124		10.1038/s41388-019-0707-8	http://dx.doi.org/10.1038/s41388-019-0707-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30696954	Green Submitted			2022-12-26	WOS:000468740200010
J	Fang, S; Liu, M; Li, L; Zhang, FF; Li, Y; Yan, Q; Cui, YZ; Zhu, YH; Yuan, YF; Guan, XY				Fang, Shuo; Liu, Ming; Li, Lei; Zhang, Fei-Fei; Li, Yun; Yan, Qian; Cui, Yu-Zhu; Zhu, Ying-Hui; Yuan, Yun-Fei; Guan, Xin-Yuan			Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway	ONCOGENE			English	Article							SIGNALING PATHWAY; GENE-EXPRESSION; WNT; CELLS; SURVIVAL; LEF-1; TRANSLOCATION; LEUKEMIA; TARGET; SPLIT	The poorly differentiated hepatocellular carcinoma (HCC) cells are usually characterized by immature hepatic progenitor cell-like properties, such as enhanced self-renewal ability, resistance to chemotherapeutic drugs, and a loss of mature hepatocyte proteins. However, the molecular mechanisms governing this process still remain unclear. In this study, we found the lymphoid enhancer-binding factor-1 (LEF1), a transcriptional factor, was frequently overexpressed in HCCs, which was significantly associated with poor prognosis and tumor cell differentiation. Functional studies have found that LEF1 enhanced cell growth, foci formation, colony formation in soft agar, and tumor formation in nude mice. Different from its canonical roles in the WNT signaling pathway, we found that LEF1 could activate the critical members (e.g., NOTCH1 and NOTCH2) of the NOTCH signaling pathway through directly binding to their promoter regions. Further studies have found that LEF1 could enhance the self-renewal ability, drug resistance, dedifferentiation, and invasion of HCC cells. The oncogenic functions and the effects of LEF1 on cancer stemness could be effectively inhibited by NOTCH inhibitor. Further characterization of LEF1 may lead to the development of novel therapeutic strategies for HCC treatment.	[Fang, Shuo; Zhang, Fei-Fei; Li, Yun; Yan, Qian; Cui, Yu-Zhu; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Peoples R China; [Fang, Shuo; Zhang, Fei-Fei; Li, Yun; Yan, Qian; Cui, Yu-Zhu; Guan, Xin-Yuan] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China; [Fang, Shuo] Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen, Peoples R China; [Liu, Ming] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou, Guangdong, Peoples R China; [Li, Lei; Zhu, Ying-Hui; Yuan, Yun-Fei; Guan, Xin-Yuan] Sun Yat Sen Univ, State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Guangzhou Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Guan, XY (corresponding author), Univ Hong Kong, Dept Clin Oncol, Hong Kong, Peoples R China.; Guan, XY (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China.; Guan, XY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.	xyguan@hku.hk	SHUO, FANG/GQP-5192-2022; /A-3639-2009	SHUO, FANG/0000-0002-1724-404X; Yuan, Yunfei/0000-0003-2467-3683; LIU, MING/0000-0003-3222-8715; /0000-0003-1874-9805	Hong Kong Research Grant Council (RGC) [17143716, 767313, C7038-14G, C7027-14G, T12-704/16-R]; National Natural Science Foundation of China [81772554, 81272416, 81372583]; Shenzhen Peacock Team Project [KQTD 2015033117210153]	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Team Project	This work was supported by grants from the Hong Kong Research Grant Council (RGC), including GRF (17143716 and 767313), Collaborative Research Funds (C7038-14G and C7027-14G), Theme-based Research Scheme (T12-704/16-R), and National Natural Science Foundation of China (81772554, 81272416, and 81372583). This work was also supported by the Shenzhen Peacock Team Project (KQTD 2015033117210153). Professor XY Guan is a Sophie YM Chan Professor in Cancer Research.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen LL, 2011, GUT, V60, P534, DOI 10.1136/gut.2010.224071; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen LL, 2009, HEPATOLOGY, V50, P122, DOI 10.1002/hep.22933; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collu GM, 2014, CELL MOL LIFE SCI, V71, P3553, DOI 10.1007/s00018-014-1644-x; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; Dhanasekaran R., 2016, F1000 RES, V5, P879; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Heitzler P, 1996, DEVELOPMENT, V122, P161; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Kabos P, 2002, J BIOL CHEM, V277, P8763, DOI 10.1074/jbc.C100758200; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kohn A, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.21; Kopan R, 2002, J CELL SCI, V115, P1095; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Liu M, 2016, HEPATOLOGY, V63, P1544, DOI 10.1002/hep.28437; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; McGregor SM, 2009, THESIS; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Nakahara F, 2014, BLOOD, V123, P3932, DOI 10.1182/blood-2013-01-476747; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Park HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132992; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Tong MJ, 2010, J CLIN GASTROENTEROL, V44, pE63, DOI 10.1097/MCG.0b013e3181b4b68b; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Ungerback J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017957; Valenti L, 2013, DIABETES, V62, P4052, DOI 10.2337/db13-0769; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wu W, 2016, ONCOTARGET, V7, P21631, DOI 10.18632/oncotarget.7795; Zhang Y, 2013, INT J MED SCI, V10, P738, DOI 10.7150/ijms.5693	46	22	23	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 23	2019	38	21					4061	4074		10.1038/s41388-019-0704-y	http://dx.doi.org/10.1038/s41388-019-0704-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HZ3HX	30696957				2022-12-26	WOS:000468740200007
J	Tang, B; Wu, J; Zhu, MX; Sun, XM; Liu, JJ; Xie, R; Dong, TX; Xiao, YF; Carethers, JM; Yang, SM; Dong, H				Tang, Bo; Wu, Jilin; Zhu, Michael X.; Sun, Xuemei; Liu, Jingjing; Xie, Rui; Dong, Tobias Xiao; Xiao, Yufeng; Carethers, John M.; Yang, Shiming; Dong, Hui			VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism	ONCOGENE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CELL-PROLIFERATION; CA2+; VIP; RECEPTOR; ACTIVATION; OVEREXPRESSION; EXPRESSION; SECRETION; CATENIN	Although VPAC1 and its ligand vasoactive intestinal peptide (VIP) are important in gastrointestinal physiology, their involvements in progression of gastrointestinal tumor have not been explored. Here, we found that higher expression of VIP/VPAC1 was observed in gastric cancer compared to the adjacent normal tissues. The increased expression of VIP/VPAC1 in gastric cancer correlated positively with invasion, tumor stage, lymph node, distant metastases, and poor survival. Moreover, high expression of VIP and VPAC1, advanced tumor stage and distant metastasis were independent prognostic factors. VPAC1 activation by VIP markedly induced TRPV4-mediated Ca2+ entry, and eventually promoted gastric cancer progression in a Ca2+ signaling-dependent manner. Inhibition of VPAC1 and its signaling pathway could block the progressive responses. VPAC1/TRPV4/Ca2+ signaling in turn enhanced the expression and secretion of VIP in gastric cancer cells, enforcing a positive feedback regulation mechanism. Taken together, our study demonstrate that VPAC1 is significantly overexpressed in gastric cancer and VPAC1/TRPV4/Ca2+ signaling axis could enforce a positive feedback regulation in gastric cancer progression. VIP/VPAC1 may serve as potential prognostic markers and therapeutic targets for gastric cancer.	[Tang, Bo; Sun, Xuemei; Liu, Jingjing; Xie, Rui; Xiao, Yufeng; Yang, Shiming; Dong, Hui] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Tang, Bo; Dong, Tobias Xiao; Dong, Hui] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Wu, Jilin; Zhu, Michael X.] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Wu, Jilin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Xie, Rui] Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Zunyi, Peoples R China; [Carethers, John M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Army Medical University; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Texas System; University of Texas Health Science Center Houston; Zunyi Medical University; University of Michigan System; University of Michigan	Yang, SM; Dong, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China.; Dong, H (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.	shimingyang@yahoo.com; h2dong@ucsd.edu		Dong, Xiao/0000-0001-5500-7099	National Key Research and Development Program of China [2016YFC1302200]; National Natural Science Foundation of China [81602577]; Basic Science and Frontier Technology Research Project of Chongqing [cstc2017jcyjAX0149]; NATIONAL CANCER INSTITUTE [R01CA206010] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Science and Frontier Technology Research Project of Chongqing; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Key Research and Development Program of China (No. 2016YFC1302200 to HD), National Natural Science Foundation of China (No. 81602577 to BT), and Basic Science and Frontier Technology Research Project of Chongqing (No. cstc2017jcyjAX0149 to BT).	Andrikopoulos P, 2015, J BIOL CHEM, V290, P18412, DOI 10.1074/jbc.M114.628156; Badgwell B, 2016, LANCET ONCOL, V17, P1628, DOI 10.1016/S1470-2045(16)30521-6; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chen F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0278-7; Chen YF, 2016, BBA-MOL CELL RES, V1863, P1427, DOI 10.1016/j.bbamcr.2015.11.030; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Deliot N, 2015, BBA-BIOMEMBRANES, V1848, P2512, DOI 10.1016/j.bbamem.2015.06.009; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Evans AM, 2016, SCI CHINA LIFE SCI, V59, P749, DOI 10.1007/s11427-016-5071-0; Favia A, 2014, P NATL ACAD SCI USA, V111, pE4706, DOI 10.1073/pnas.1406029111; Fernandez-Martinez AB, 2012, HISTOL HISTOPATHOL, V27, P1093, DOI 10.14670/HH-27.1093; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Hagen BM, 2006, AM J PHYSIOL-CELL PH, V291, pC375, DOI 10.1152/ajpcell.00495.2005; Hahm SH, 1998, ANN NY ACAD SCI, V865, P10, DOI 10.1111/j.1749-6632.1998.tb11158.x; Hejna M, 2001, ANTICANCER RES, V21, P1183; Herrera JL, 2009, J CELL MOL MED, V13, P3209, DOI 10.1111/j.1582-4934.2009.00662.x; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hogan PG, 2017, CELL CALCIUM, V63, P66, DOI 10.1016/j.ceca.2017.01.014; Holzer P, 2011, CURR PHARM BIOTECHNO, V12, P24, DOI 10.2174/138920111793937862; Kodama D, 2013, BIOCHEM BIOPH RES CO, V437, P239, DOI 10.1016/j.bbrc.2013.06.047; Leuner K, 2010, MOL PHARMACOL, V77, P368, DOI 10.1124/mol.109.057513; Li D, 2013, INVEST OPHTH VIS SCI, V54, P2872, DOI 10.1167/iovs.12-11264; Liu F, 2015, ONCOTARGET, V6, P11585, DOI 10.18632/oncotarget.3412; Liu SH, 2014, TUMOR BIOL, V35, P6397, DOI 10.1007/s13277-014-1852-x; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Reubi JC, 2000, CANCER RES, V60, P3105; Schwarz EC, 2013, BBA-MOL CELL RES, V1833, P1603, DOI 10.1016/j.bbamcr.2012.11.016; Seoane IV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149141; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song WQ, 2014, CANCER RES, V74, P2444, DOI 10.1158/0008-5472.CAN-13-2136; Storch U, 2017, P NATL ACAD SCI USA, V114, pE37, DOI 10.1073/pnas.1612263114; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Tompkins JD, 2010, J MOL NEUROSCI, V42, P390, DOI 10.1007/s12031-010-9367-4; Vacas E, 2013, CANCER LETT, V336, P196, DOI 10.1016/j.canlet.2013.04.033; Vacas E, 2013, MOL CELL ENDOCRINOL, V365, P212, DOI 10.1016/j.mce.2012.10.021; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Valdehita A, 2009, MOL CELL ENDOCRINOL, V302, P41, DOI 10.1016/j.mce.2008.11.024; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; White CM, 2010, CNS NEUROL DISORD-DR, V9, P661; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Xiao G, 2015, ONCOTARGET, V6, P14165, DOI 10.18632/oncotarget.3690; Xie R, 2017, CANCER RES, V77, P6499, DOI 10.1158/0008-5472.CAN-17-0360; Yin YL, 2016, P NATL ACAD SCI USA, V113, pE3773, DOI 10.1073/pnas.1604519113; Zhang SA, 2010, J PHYSIOL SCI, V60, P389, DOI 10.1007/s12576-010-0107-x; Zhou ZC, 2014, GASTROENTEROLOGY, V147, P1043, DOI 10.1053/j.gastro.2014.07.021; Zhu MX, 2016, SCI CHINA LIFE SCI, V59, P743, DOI 10.1007/s11427-016-5098-2	51	24	24	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3946	3961		10.1038/s41388-019-0709-6	http://dx.doi.org/10.1038/s41388-019-0709-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30692637	Green Submitted			2022-12-26	WOS:000468035600013
J	Mohr, J; Voggel, J; Vohlen, C; Dinger, K; Dafinger, C; Fink, G; Gobel, H; Liebau, MC; Dotsch, J; Alcazar, MAA				Mohr, Jasmine; Voggel, Jenny; Vohlen, Christina; Dinger, Katharina; Dafinger, Claudia; Fink, Gregor; Goebel, Heike; Liebau, Max C.; Doetsch, Joerg; Alcazar, Miguel A. Alejandre			IL-6/Smad2 signaling mediates acute kidney injury and regeneration in a murine model of neonatal hyperoxia	FASEB JOURNAL			English	Article						CKD; inflammation; nephrogenesis; neonatal chronic lung disease	INTRAUTERINE GROWTH RESTRICTION; YOUNG-ADULT AGE; OXIDATIVE STRESS; PRETERM INFANTS; RENAL-FUNCTION; RISK-FACTORS; FACTOR-BETA; INTERLEUKIN-6; BIRTH; EXPRESSION	Prematurity is linked to incomplete nephrogenesis and risk of chronic kidney diseases (CKDs). Oxygen is life-saving in that context but induces injury in numerous organs. Here, we studied the structural and functional impact of hyperoxia on renal injury and its IL-6 dependency. Newborn wild-type (WT) and IL-6 knockout (IL-6(-/-)) mice were exposed to 85% O-2 for 28 d, followed by room air until postnatal d (P) 70. Controls were in room air throughout life. At P28, hyperoxia reduced estimated kidney cortex area (KCA) in WT; at P70, KCA was greater, number of glomeruli was fewer, fractional potassium excretion was higher, and glomerular filtration rate was slightly lower than in controls. IL-6(-/-) mice were protected from these changes after hyperoxia. Mechanistically, the acute renal injury phase (P28) showed in WT but not in IL-6(-/-) mice an activation of IL-6 (signal transducer and activator of transcription 3) and TGF- [mothers against decapentaplegic homolog (Smad)2] signaling, increased inflammatory markers, disrupted mitochondrial biogenesis, and reduced tubular proliferation. Regenerative phase at P70 was characterized by tubular proliferation in WT but not in IL-6(-/-) mice. These data demonstrate that hyperoxia increases the risk of CKD through a novel IL-6-Smad2 axis. The amenability of these pathways to pharmacological approaches may offer new avenues to protect premature infants from CKD.Mohr, J., Voggel, J., Vohlen, C., Dinger, K., Dafinger, C., Fink, G., Gobel, H., Liebau, M. C., Dotsch, J., Alejandre Alcazar, M. A. IL-6/Smad2 signaling mediates acute kidney injury and regeneration in a murine model of neonatal hyperoxia.	[Mohr, Jasmine; Vohlen, Christina; Dinger, Katharina; Alcazar, Miguel A. Alejandre] Univ Cologne, Fac Med, Translat Expt Pediat, Cologne, Germany; [Mohr, Jasmine; Voggel, Jenny; Vohlen, Christina; Dinger, Katharina; Dafinger, Claudia; Fink, Gregor; Liebau, Max C.; Doetsch, Joerg; Alcazar, Miguel A. Alejandre] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany; [Mohr, Jasmine; Vohlen, Christina; Dafinger, Claudia; Liebau, Max C.; Alcazar, Miguel A. Alejandre] Univ Cologne, Fac Med, CMMC, Cologne, Germany; [Dafinger, Claudia; Liebau, Max C.] Univ Cologne, Fac Med, Nephrol Res Lab, Dept Med 2, Cologne, Germany; [Goebel, Heike] Univ Cologne, Fac Med, Inst Pathol, Cologne, Germany; [Goebel, Heike] Univ Hosp Cologne, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Alcazar, MAA (corresponding author), Univ Cologne, Translat Expt Pediat Expt Pulmonol, Dept Pediat & Adolescent Med, Kerpener Str 62, D-50937 Cologne, Germany.	miguel.alejandre-alcazar@uk-koeln.de	Liebau, Max Christoph/K-3470-2019	Liebau, Max Christoph/0000-0003-0494-9080; Voggel, Jenny/0000-0001-9120-2203; Goebel, Heike/0000-0002-0171-7025; Fink, Gregor/0000-0001-7042-1706; Alejandre Alcazar, Miguel Angel/0000-0002-3176-0411	Marga und Walter Boll Stiftung; Center of Molecular Medicine Cologne (CMMC), University Hospital Cologne; Deutsche Forschungsgemeinschaft [1632/2-1]	Marga und Walter Boll Stiftung; Center of Molecular Medicine Cologne (CMMC), University Hospital Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Larsson Laboratory (Max Planck Institute for Biology of Ageing, Cologne, Germany) for kindly providing polyclonal rabbit anti-mitochondrial transcription factor A antibody. This work was supported by Marga und Walter Boll Stiftung (M.A.A.A.); the Center of Molecular Medicine Cologne (CMMC), University Hospital Cologne (M.A.A.A.); and Deutsche Forschungsgemeinschaft (1632/2-1; M.A.A.A.). The authors declare no conflicts of interest.	Alcazar MAA, 2012, ENDOCRINOLOGY, V153, P1397, DOI 10.1210/en.2011-1670; Alcazar MAA, 2011, NEPHROL DIAL TRANSPL, V26, P2453, DOI 10.1093/ndt/gfq825; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Askenazi D, 2015, PEDIATR NEPHROL, V30, P1511, DOI 10.1007/s00467-015-3087-5; Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Bartram MP, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0053-1; Bienaime F, 2016, J AM SOC NEPHROL, V27, P3690, DOI 10.1681/ASN.2015091014; Black MJ, 2015, AM J PHYSIOL-REG I, V309, pR1153, DOI 10.1152/ajpregu.00403.2014; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; Caglar K, 2002, KIDNEY INT, V62, P1408, DOI 10.1111/j.1523-1755.2002.kid556.x; Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009; Choi CW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035250500404085; Cooper R, 2009, INT J EPIDEMIOL, V38, P235, DOI 10.1093/ije/dyn154; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Faa G, 2010, J MATERN-FETAL NEO M, V23, P129, DOI 10.3109/14767058.2010.510646; Georgeson GD, 2002, EUR J OBSTET GYN R B, V103, P136, DOI 10.1016/S0301-2115(02)00050-7; GOLDSTEIN RS, 1988, FASEB J, V2, P2241, DOI 10.1096/fasebj.2.7.3280378; Gubhaju L, 2009, AM J PHYSIOL-RENAL, V297, pF1668, DOI 10.1152/ajprenal.00163.2009; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Jiang JS, 2015, PEDIATR NEONATOL, V56, P235, DOI 10.1016/j.pedneo.2014.11.003; Kandasamy Y, 2013, PEDIATR NEPHROL, V28, P1791, DOI 10.1007/s00467-013-2462-3; Kasper P, 2017, ENDOCRINOLOGY, V158, P3399, DOI 10.1210/en.2017-00489; Keijzer-Veen MG, 2010, PEDIATR NEPHROL, V25, P499, DOI 10.1007/s00467-009-1371-y; Keijzer-Veen MG, 2005, J AM SOC NEPHROL, V16, P2762, DOI 10.1681/ASN.2004090783; Lawlor KE, 2014, BBA-GEN SUBJECTS, V1840, P1433, DOI 10.1016/j.bbagen.2013.08.014; Lecart C, 2000, BIOL NEONATE, V77, P217, DOI 10.1159/000014219; Lee Yuan-Shun, 2005, Chang Gung Med J, V28, P846; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Murakami K, 1997, PEDIATR NEPHROL, V11, P334, DOI 10.1007/s004670050289; Navarro G, 2014, SEMIN ARTHRITIS RHEU, V43, P458, DOI 10.1016/j.semarthrit.2013.08.001; Nicholas SB, 2015, ADV CHRONIC KIDNEY D, V22, P6, DOI 10.1053/j.ackd.2014.07.002; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Perrone S, 2007, CLIN BIOCHEM, V40, P656, DOI 10.1016/j.clinbiochem.2007.01.012; Popescu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082421; Ratner V, 2009, AM J RESP CELL MOL, V40, P511, DOI 10.1165/rcmb.2008-0341RC; Reckelhoff JF, 1997, AM J PHYSIOL-REG I, V272, pR1985, DOI 10.1152/ajpregu.1997.272.6.R1985; Rivera L, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00033; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Ryan D, 2018, EBIOMEDICINE, V27, P275, DOI 10.1016/j.ebiom.2017.12.016; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Starr MC, 2018, CURR OPIN PEDIATR, V30, P228, DOI 10.1097/MOP.0000000000000607; Stritzke Amelie, 2017, Mol Cell Pediatr, V4, P2, DOI 10.1186/s40348-016-0068-0; Sureshbabu A, 2015, REDOX BIOL, V4, P208, DOI 10.1016/j.redox.2015.01.001; Sutherland MR, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12887; Sutherland MR, 2013, AM J PHYSIOL-RENAL, V304, pF1308, DOI 10.1152/ajprenal.00172.2012; Takahashi T, 2000, RENAL FAILURE, V22, P345, DOI 10.1081/JDI-100100878; THOMPSON NL, 1989, J CELL BIOL, V108, P661, DOI 10.1083/jcb.108.2.661; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251	59	11	12	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5887	5902		10.1096/fj.201801875RR	http://dx.doi.org/10.1096/fj.201801875RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30721632				2022-12-26	WOS:000466932600008
J	Fritzen, AM; Lundsgaard, AM; Jeppesen, JF; Sjoberg, KA; Hoeg, LD; Deleuran, HH; Wojtaszewski, JFP; Richter, EA; Kiens, B				Fritzen, Andreas Maechel; Lundsgaard, Anne-Marie; Jeppesen, Jacob Fuglsbjerg; Sjoberg, Kim Anker; Hoeg, Louise Dalgas; Deleuran, Henrik Hall; Wojtaszewski, Jorgen F. P.; Richter, Erik A.; Kiens, Bente			Fatty acid type-specific regulation of SIRT1 does not affect insulin sensitivity in human skeletal muscle	FASEB JOURNAL			English	Article						sirtuins; nutrition; lipid metabolism; NAD	MITOCHONDRIAL-FUNCTION; ENERGY-EXPENDITURE; GENE-EXPRESSION; OLEIC-ACID; SHORT-TERM; METABOLISM; MICE; DIET; RESISTANCE; OXIDATION	The nicotinamide adenine dinucleotide-dependent deacetylase, sirtuin (SIRT)1, in skeletal muscle is reduced in insulin-resistant states. However, whether this is an initial mechanism responsible for mediating insulin resistance in human skeletal muscle remains to be investigated. Also, SIRT1 acts as a mitochondrial gene transcriptional regulator and is induced by a short-term, high-fat diet (HFD) in human skeletal muscle. Whether saturated or unsaturated fatty acids (FAs) in the diet are important for this is unknown. We subjected 17 healthy, young men to a eucaloric control (Con) diet and 1 of 2 hypercaloric [+75% energy (E%)] HFDs for 3 d enriched in either saturated (Sat) FA (79 E% fat; Sat) or unsaturated FA (78 E% fat; Unsat). After Sat, SIRT1 protein content and activity in skeletal muscle increased (P < 0.05; similar to 40%) while remaining unchanged after Unsat. Whole-body insulin sensitivity and insulin-stimulated leg glucose uptake were reduced (P < 0.01; similar to 20%) to a similar extent compared to Con after both HFDs. We demonstrate a novel FA type-dependent regulation of SIRT1 protein in human skeletal muscle. Moreover, regulation of SIRT1 does not seem to be an initiating factor responsible for mediating insulin resistance in human skeletal muscle.	[Fritzen, Andreas Maechel; Lundsgaard, Anne-Marie; Jeppesen, Jacob Fuglsbjerg; Sjoberg, Kim Anker; Hoeg, Louise Dalgas; Deleuran, Henrik Hall; Wojtaszewski, Jorgen F. P.; Richter, Erik A.; Kiens, Bente] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark	University of Copenhagen	Kiens, B (corresponding author), Univ Copenhagen, Univ Pk 13, DK-2100 Copenhagen, Denmark.	bkiens@nexs.ku.dk	Richter, Erik A./Y-8131-2019; Fritzen, Andreas/D-4103-2015; Sjoberg, Kim/D-7612-2015; Kiens, Bente/B-1375-2015	Richter, Erik A./0000-0002-6850-3056; Fritzen, Andreas/0000-0001-8793-9739; Sjoberg, Kim/0000-0001-6880-4804; Kiens, Bente/0000-0001-5705-5625; wojtaszewski, jorgen/0000-0001-8185-3408; Lundsgaard, Anne-Marie/0000-0002-5584-2366	Danish Ministry of Food, Agriculture, and Fisheries; Danish Medical Research Council; Lundbeck Research Foundation; Novo-Nordisk Research Foundation; European Union [LSHM-CT-2004-005272]; Danish Ministry of Science, Technology, and Innovation; Danish Diabetes Academy [NNF17SA0031406]; Alfred Benzon Foundation; Council for Independent Research/Medicine [4092-00309]	Danish Ministry of Food, Agriculture, and Fisheries; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Research Foundation(Lundbeckfonden); Novo-Nordisk Research Foundation(Novo Nordisk Foundation); European Union(European Commission); Danish Ministry of Science, Technology, and Innovation; Danish Diabetes Academy; Alfred Benzon Foundation; Council for Independent Research/Medicine	The authors acknowledge the skilled technical assistance of Irene Bech Nielsen, Betina Bolmgren, and Nicoline Resen Andersen (University of Copenhagen). This study was supported by grants from the Danish Ministry of Food, Agriculture, and Fisheries; the Danish Medical Research Council; the Lundbeck Research Foundation; the Novo-Nordisk Research Foundation; and an integrated project funded by the European Union (LSHM-CT-2004-005272). This work was carried out as a part of the Investment Capital for University Research (UNIK) Program: Food, Fitness, and Pharma for Health and Disease. The UNIK Project was supported by the Danish Ministry of Science, Technology, and Innovation. Postdoctoral fellowships of A.M.F. and A.M.L. were funded by The Danish Diabetes Academy, which is funded the Novo Nordisk Foundation (Grant NNF17SA0031406). Furthermore, A.M.F. was supported by the Alfred Benzon Foundation. K.A.S. was supported by a postdoctoral research grant from the Council for Independent Research/Medicine (4092-00309). The authors declare no conflicts of interest.	Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bakke SS, 2012, BBA-MOL CELL BIOL L, V1821, P1323, DOI 10.1016/j.bbalip.2012.07.001; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bergouignan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030164; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brandon AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121959; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Cui XN, 2017, AM J PHYSIOL-ENDOC M, V313, pE493, DOI 10.1152/ajpendo.00122.2017; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Draznin B, 2012, HORM METAB RES, V44, P650, DOI 10.1055/s-0032-1312656; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fritzen AM, 2016, J PHYSIOL-LONDON, V594, P745, DOI 10.1113/JP271405; Fritzen AM, 2015, J PHYSIOL-LONDON, V593, P4765, DOI 10.1113/JP270821; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Helge JW, 1998, J APPL PHYSIOL, V85, P1342, DOI 10.1152/jappl.1998.85.4.1342; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hoeg LD, 2011, DIABETES, V60, P64, DOI 10.2337/db10-0698; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; JONES PJH, 1985, AM J CLIN NUTR, V42, P769, DOI 10.1093/ajcn/42.5.769; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lim JH, 2013, J BIOL CHEM, V288, P7117, DOI 10.1074/jbc.M112.415729; Lowry H., 1972, FLEXIBLE SYSTEM ENZY; Lundsgaard AM, 2017, DIABETES, V66, P2583, DOI 10.2337/db17-0046; Lundsgaard AM, 2017, MOL METAB, V6, P22, DOI 10.1016/j.molmet.2016.11.001; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Pehmoller C, 2012, DIABETES, V61, P2743, DOI 10.2337/db11-1572; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Seyssel K, 2014, J CLIN ENDOCR METAB, V99, pE1254, DOI 10.1210/jc.2013-4379; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Svensson K, 2017, ACTA PHYSIOL, V221, P193, DOI 10.1111/apha.12897; Tsintzas K, 2007, J CLIN ENDOCR METAB, V92, P3967, DOI 10.1210/jc.2007-1104; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; White AT, 2014, AM J PHYSIOL-ENDOC M, V307, pE764, DOI 10.1152/ajpendo.00001.2014; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	50	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5510	5519		10.1096/fj.201801950R	http://dx.doi.org/10.1096/fj.201801950R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30707625				2022-12-26	WOS:000462888500070
J	Nagappa, LK; Satha, P; Govindaraju, T; Balaram, H				Nagappa, Lakshmeesha Kempaiah; Satha, Pardhasaradhi; Govindaraju, Thimmaiah; Balaram, Hemalatha			Phosphoglycolate phosphatase is a metabolic proofreading enzyme essential for cellular function in Plasmodium berghei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; glycolysis; gene knockout; malaria; protozoan; metabolic regulation; 2-phospho-L-lactate; 2-phosphoglycolate; 4-phosphoerythronate; phosphoglycolate phosphatase (PGP); Plasmodium berghei	ESCHERICHIA-COLI; 2-PHOSPHOGLYCOLATE PHOSPHATASE; HAD SUPERFAMILY; NUCLEOTIDASES; DIVERSITY; YJJG	Plasmodium falciparum (Pf) 4-nitrophenylphosphatase has been shown previously to be involved in vitamin B1 metabolism. Here, conducting a BLASTp search, we found that 4-nitrophenylphosphatase from Pf has significant homology with phosphoglycolate phosphatase (PGP) from mouse, human, and yeast, prompting us to reinvestigate the biochemical properties of the Plasmodium enzyme. Because the recombinant PfPGP enzyme is insoluble, we performed an extended substrate screen and extensive biochemical characterization of the recombinantly expressed and purified homolog from Plasmodium berghei (Pb), leading to the identification of 2-phosphoglycolate and 2-phospho-L-lactate as the relevant physiological substrates of PbPGP. 2-Phosphoglycolate is generated during repair of damaged DNA ends, 2-phospho-L-lactate is a product of pyruvate kinase side reaction, and both potently inhibit two key glycolytic enzymes, triosephosphate isomerase and phosphofructokinase. Hence, PGP-mediated clearance of these toxic metabolites is vital for cell survival and functioning. Our results differ significantly from those in a previous study, wherein the PfPGP enzyme has been inferred to act on 2-phospho-D-lactate and not on the L isomer. Apart from resolving the substrate specificity conflict through direct in vitro enzyme assays, we conducted PGP gene knockout studies in P. berghei, confirming that this conserved metabolic proofreading enzyme is essential in Plasmodium. In summary, our findings establish PbPGP as an essential enzyme for normal physiological function in P. berghei and suggest that drugs that specifically inhibit Plasmodium PGP may hold promise for use in anti-malarial therapies.	[Nagappa, Lakshmeesha Kempaiah; Balaram, Hemalatha] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India; [Satha, Pardhasaradhi; Govindaraju, Thimmaiah] Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Bioorgan Chem Lab, Bengaluru 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Balaram, H (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India.	hb@jncasr.ac.in	Govindaraju, Thimmaiah/H-1471-2012	Govindaraju, Thimmaiah/0000-0002-9423-4275; Satha, Pardhasaradhi/0000-0002-8924-2510; KN, Lakshmeesha/0000-0002-7034-2378; Balaram, Hemalatha/0000-0002-8821-1288	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR11294/BRB/10/1291/2014, BT/PR13760/COE/34/42/2015, BT/INF/22/SP27679/2018]; Science and Engineering Research Board, Department of Science and Technology, Government of India [EMR/2014/001276, 2017/000920]; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research; Department of Science and Technology, Government of India [DST/SJF/CSA-02/2015-2016]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Science and Engineering Research Board, Department of Science and Technology, Government of India; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This project was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India Grants BT/PR11294/BRB/10/1291/2014, BT/PR13760/COE/34/42/2015, and BT/INF/22/SP27679/2018; Science and Engineering Research Board, Department of Science and Technology, Government of India Grant EMR/2014/001276; and institutional funding from the Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Council of Scientific and Industrial Research for junior and senior research fellowships.; Supported by a Science and Engineering Research Board, Department of Science and Technology, Government of India for postdoctoral fellowship (Grant 2017/000920).; Supported by Department of Science and Technology, Government of India Grant DST/SJF/CSA-02/2015-2016.	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Collard F, 2016, NAT CHEM BIOL, V12, P601, DOI [10.1038/NCHEMBIO.2104, 10.1038/nchembio.2104]; Dumont L., 2018, METABOLIC REPAIR ENZ, DOI [10.1101/415505, DOI 10.1101/415505]; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; GUGGISBERG A, 2018, A R, V9, pe0119, DOI DOI 10.1128/MBIO.01193-18; Guggisberg AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5467; Huang H, 2015, P NATL ACAD SCI USA, V112, pE1974, DOI 10.1073/pnas.1423570112; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Knockel J, 2008, MOL BIOCHEM PARASIT, V157, P241, DOI 10.1016/j.molbiopara.2007.10.010; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Michaelis L, 1913, BIOCHEM Z, V49, P333; Mony BM, 2009, INT J PARASITOL, V39, P1441, DOI 10.1016/j.ijpara.2009.05.011; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; NOWAK T, 1972, BIOCHEMISTRY-US, V11, P2819, DOI 10.1021/bi00765a014; Pei Y, 2013, CELL MICROBIOL, V15, P1508, DOI 10.1111/cmi.12124; Pellicer MT, 2003, J BACTERIOL, V185, P5815, DOI 10.1128/JB.185.19.5815-5821.2003; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; Schwarte S, 2007, PLANT PHYSIOL, V144, P1580, DOI 10.1104/pp.107.099192; Segerer G, 2016, SCI REP-UK, V6, DOI 10.1038/srep35160; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smialowski P, 2012, FEBS J, V279, P2192, DOI 10.1111/j.1742-4658.2012.08603.x; Srinivasan B, 2015, EXP PARASITOL, V151, P56, DOI 10.1016/j.exppara.2015.01.013; Srinivasan Bharath, 2007, In Silico Biology, V7, P187; Titz B, 2007, FEMS MICROBIOL LETT, V270, P49, DOI 10.1111/j.1574-6968.2007.00646.x; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; Weiss B, 2007, J BACTERIOL, V189, P2186, DOI 10.1128/JB.01645-06	34	4	4	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4997	5007		10.1074/jbc.AC118.007143	http://dx.doi.org/10.1074/jbc.AC118.007143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700551	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000463985600023
J	Yamamoto, N; Kashiwagi, M; Ishihara, M; Kojima, T; Maturana, AD; Kuroda, S; Niimi, T				Yamamoto, Naoka; Kashiwagi, Manabu; Ishihara, Manami; Kojima, Takaaki; Maturana, Andres D.; Kuroda, Shun'ichi; Niimi, Tomoaki			Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; protein conformation; protein domain; protein-protein interaction; structural model	CHONDROGENIC DIFFERENTIATION; CELL-ADHESION; AXON GUIDANCE; EXPRESSION; SMART; SLIT; CRANIOSYNOSTOSIS; ROUNDABOUT; MOLECULES; MICE	The signaling pathways that are mediated by Slit ligands and their Roundabout (Robo) family of receptors play multifunctional roles in the development of the nervous system and other organs. A recent study identified neural epidermal growth factor-like (NEL)-like 2 (NELL2) as a novel ligand for Robo3. In this study, we carried out a comprehensive analysis of the interaction between NELL1 and the Robo family of receptors and demonstrated that Robo2 contains a cryptic binding site for both NELL1 and NELL2. NELL1/2 binds to the first fibronectin type III (FNIII) domain of Robo2 but not to intact Robo2. Mutation analysis revealed that several amino acids within the first FNIII domain are critical for NELL1 binding to Robo2 but not to Robo1. The Robo2 deletion mutants without the fourth immunoglobulin domain and single amino acid substitution mutants that can influence the architecture of the ectodomain facilitated binding to NELL1/2. Acidic conditions increased the binding affinity of Robo2 for NELL1. These results suggest that Robo2 functions as a receptor for NELL1/2, particularly under circumstances where Robo2 undergoes proteolytic digestion. If this is not the case, conformational changes of the ectodomain of Robo2 may unmask the binding site for NELL1/2.	[Yamamoto, Naoka; Kashiwagi, Manabu; Ishihara, Manami; Kojima, Takaaki; Maturana, Andres D.; Niimi, Tomoaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kuroda, Shun'ichi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Nagoya University; Osaka University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	tniimi@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [26350959, 17K01946]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 26350959 and 17K01946. The authors declare that they have no conflicts of interest with the contents of this article.	Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021; Ballard MS, 2012, ADV CANCER RES, V114, P187, DOI 10.1016/B978-0-12-386503-8.00005-3; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Hasebe A, 2012, MOL BIOTECHNOL, V51, P58, DOI 10.1007/s12033-011-9440-4; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hohenester E, 2008, BIOCHEM SOC T, V36, P251, DOI 10.1042/BST0360251; James AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8362; Jaworski A, 2015, SCIENCE, V350, P961, DOI 10.1126/science.aad2615; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kim BJ, 2018, J CLIN INVEST, V128, P1429, DOI 10.1172/JCI91086; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li CS, 2016, TISSUE ENG PT A, V22, P272, DOI [10.1089/ten.tea.2015.0250, 10.1089/ten.TEA.2015.0250]; Li CS, 2018, AM J PATHOL, V188, P392, DOI 10.1016/j.ajpath.2017.09.020; Li CS, 2017, AM J PATHOL, V187, P963, DOI 10.1016/j.ajpath.2016.12.026; Li Y, 2017, EXP CELL RES, V361, P73, DOI 10.1016/j.yexcr.2017.10.002; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Nakamura Y, 2014, J BIOL CHEM, V289, P9781, DOI 10.1074/jbc.M113.507020; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Phan HP, 2009, PROTEIN EXPRES PURIF, V68, P79, DOI 10.1016/j.pep.2009.07.005; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seiradake E, 2016, ANNU REV CELL DEV BI, V32, P577, DOI 10.1146/annurev-cellbio-111315-125008; Seki M, 2010, FEBS LETT, V584, P2909, DOI 10.1016/j.febslet.2010.05.009; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Takahashi K, 2015, FEBS LETT, V589, P4026, DOI 10.1016/j.febslet.2015.11.032; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Yom-Tov G, 2017, J MOL BIOL, V429, P3606, DOI 10.1016/j.jmb.2017.10.002; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190; Zhang X, 2010, J DENT RES, V89, P865, DOI 10.1177/0022034510376401; Zhang XL, 2012, J CRANIOFAC SURG, V23, P61, DOI 10.1097/SCS.0b013e318240c8c4; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375; Zhao JJ, 2018, CARDIOVASC RES, V114, P794, DOI 10.1093/cvr/cvy061	43	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4693	4703		10.1074/jbc.RA118.005819	http://dx.doi.org/10.1074/jbc.RA118.005819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30700556	Green Published, hybrid			2022-12-26	WOS:000462969500034
J	Han, M; Pan, B; Liu, YB; Yu, HZ; Liu, YR				Han, Mei; Pan, Bin; Liu, Yu Bin; Yu, Hao Zhe; Liu, Yan Rong			Wetland biomass inversion and space differentiation: A case study of the Yellow River Delta Nature Reserve	PLOS ONE			English	Article							PLANT BIOMASS	With wetlands categorized as one of the three major ecosystems, the study of wetland health has global environmental implications. Multiple regression models were employed to establish relationships between Landsat-8 images, vegetation indices and field measured biomass in the Yellow River Delta Nature Reserve. These models were then used to estimate the spatial distribution of wetland vegetative biomass. The relationships between wetland vegetative biomass and soil factors (organic matter, nitrogen, phosphorus, potassium, water soluble salt, pH and moisture) were modeled. We were able to achieve higher correlations and improved model fits using vegetative indices and spectral bands 1-5 as independent variables. Several important soil factors were isolated, including soil moisture and salt concentrations, which affect wetland biomass spatial distributions. Overall, wetland biomass decreased from land to the ocean and from the river courses outward.	[Han, Mei; Pan, Bin; Liu, Yu Bin; Yu, Hao Zhe; Liu, Yan Rong] Shandong Normal Univ, Sch Geog & Environm, Jinan, Shandong, Peoples R China	Shandong Normal University	Han, M (corresponding author), Shandong Normal Univ, Sch Geog & Environm, Jinan, Shandong, Peoples R China.	hanmei568568@126.com			Natural Science Foundation of China NSFC General Projects [41371517]; Scientific and Technological Project of Shandong Province [2013GSF11706]	Natural Science Foundation of China NSFC General Projects(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shandong Province	This study was supported by the Natural Science Foundation of China NSFC General Projects (41371517) and the Scientific and Technological Project of Shandong Province (2013GSF11706) to MH. The URLs is http://www.nsfc.gov.cn/and http://jihlx.sdstc.gov.cn/stdpms/, respectively. The funders made the decision to publish.	Adam E, 2010, WETL ECOL MANAG, V18, P281, DOI 10.1007/s11273-009-9169-z; Austin JE, 2007, WETLANDS, V27, P570, DOI 10.1672/0277-5212(2007)27[570:EOHMTO]2.0.CO;2; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Daniels JS, 2010, WETLANDS, V30, P231, DOI 10.1007/s13157-010-0018-x; DONG Lei, 2009, REMOTE SENSING TECHN, V24, P325; Feng ZJ, 2008, RES SOIL WATER CONSE, V15, P171; [傅新 Fu Xin], 2012, [生态学报, Acta Ecologica Sinica], V32, P5355; Fuller DO, 2014, WETLANDS, V34, P67, DOI 10.1007/s13157-013-0483-0; Gao M, 2013, ACTA ECOLOGICA SINIC, V33, P543; Guneralp I, 2014, INT J APPL EARTH OBS, V33, P119, DOI 10.1016/j.jag.2014.05.004; [韩颖 Han Ying], 2014, [遥感技术与应用, Remote Sensing Technology and Application], V29, P224; [贾建伟 Jia Jianwei], 2010, [生态学报, Acta Ecologica Sinica], V30, P4529; [匡耀求 Kuang Yaoqiu], 2005, [生态环境, Ecology and Environment], V14, P134; [李凤秀 LI FengXiu], 2008, [湿地科学, Wetland Science], V6, P51; Li Rendong, 2002, Journal of Geographical Sciences, V12, P35; Li Y, 2011, GEOGRAPHICAL RES, V30, P134; [刘双娜 Liu Shuangna], 2012, [生态学报, Acta Ecologica Sinica], V32, P2320; [马泽清 MA Zeqing], 2008, [自然资源学报, Journal of Natural Resources], V23, P467; Mirik M, 2005, RANGELAND ECOL MANAG, V58, P459, DOI 10.2111/04-18.1; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; [宋巍巍 Song Weiwei], 2012, [生态学报, Acta Ecologica Sinica], V32, P7440; Valk AGVD, 1993, VEGETATIO, V109, P81; Wang SG, 2006, GEOGRAPHY GEOINFORMA, V20, P104; Wen HL, 1978, RESOURCES SCI, V1, P71; Wu GP, 2015, ACTA ECOLOGICA SINIC, V67, P221; Yang Xiao-Xia, 2014, Chinese Journal of Plant Ecology, V38, P159, DOI 10.3724/SP.J.1258.2014.00014; Ye Y, 2011, THESIS; Zeng LX, 2008, ACTA ECOLOGICA SINIC, V28, P3809; [章文龙 Zhang Wenlong], 2013, [自然资源学报, Journal of Natural Resources], V28, P2056; Zhao CC, 2008, J ARID LAND RESOURCE, V22, P89; [周德民 Zhou Demin], 2006, [遥感技术与应用, Remote sensing Technology and Application], V21, P577	31	7	7	14	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2019	14	2							e0210774	10.1371/journal.pone.0210774	http://dx.doi.org/10.1371/journal.pone.0210774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2MO	30721238	Green Published, gold, Green Submitted			2022-12-26	WOS:000457746300006
J	Bozinovic, K; Sabol, I; Rakusic, Z; Jakovcevic, A; Sekerija, M; Lukinovic, J; Prgomet, D; Grce, M				Bozinovic, Ksenija; Sabol, Ivan; Rakusic, Zoran; Jakovcevic, Antonia; Sekerija, Mario; Lukinovic, Juraj; Prgomet, Drago; Grce, Magdalena			HPV-driven oropharyngeal squamous cell cancer in Croatia - Demography and survival	PLOS ONE			English	Article							PAPILLOMAVIRUS-RELATED HEAD; NECK-CANCER; OLDER PATIENTS; RISK-FACTOR; CARCINOMA; TONSILLAR; TRENDS; REQUIREMENT; MORTALITY; SMOKING	Objectives Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide. Main HNSCC risk factors are tobacco, alcohol, and high-risk human papillomavirus (HPV). HPV+ oropharyngeal squamous cell cancer (OPSCC) usually have different etiology, increasing incidence and often show an improved survival when compared to HPV-negative cases. The objective of the current study was to retrospectively examine the influence of HPV on the survival of OPSCC patients in a non-Western population setting. Materials and methods We determined the presence of HPV DNA and/or RNA in 99 formalin-fixed paraffin embedded (FFPE) tissue samples of OPSCC patients treated between 2002 and 2015. Patients were compared based on laboratory, demographic, clinical, life style characteristics and survival. Results HPV RNA was found in 29.3% cases. However, groups based on HPV data (either RNA, DNA or retrospectively collected p16 staining) did not show significant differences. Overall, 5-year survival was 30% with minimal influence of the HPV positivity. Conclusions The HPV influence on survival of OPSCC patients is not identical between populations probably due to other factors overshadowing the HPV effect. This should be taken into account when treatment or policy decisions are made in each particular setting.	[Bozinovic, Ksenija; Sabol, Ivan; Grce, Magdalena] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Rakusic, Zoran] Univ Hosp Ctr Zagreb, Dept Radiat Oncol, Oncol Clin, Zagreb, Croatia; [Rakusic, Zoran] Univ Zagreb, Sch Med, Zagreb, Croatia; [Jakovcevic, Antonia] Univ Hosp Ctr Zagreb, Clin Dept Pathol & Cytol, Zagreb, Croatia; [Sekerija, Mario] Croatian Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Sekerija, Mario] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, Zagreb, Croatia; [Lukinovic, Juraj; Prgomet, Drago] Univ Hosp Ctr Zagreb, Clin Ear Nose & Throat Dis, Zagreb, Croatia; [Lukinovic, Juraj; Prgomet, Drago] Univ Hosp Ctr Zagreb, Head & Neck Surg, Zagreb, Croatia	Rudjer Boskovic Institute; University of Zagreb; University of Zagreb; University of Zagreb; University of Zagreb; University of Zagreb; University of Zagreb	Sabol, I; Grce, M (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	ivan.sabol@irb.hr; grce@irb.hr	GRCE, MAGDALENA/ABD-2768-2020; Sekerija, Mario/W-8550-2019; Sabol, Ivan/B-7455-2012; Rakusic, Zoran/F-9542-2018	Sekerija, Mario/0000-0001-7508-1501; Sabol, Ivan/0000-0002-5753-8528; Grce, Magdalena/0000-0001-6178-8418; Rakusic, Zoran/0000-0002-5148-336X	Croatian Science Foundation [IP-2013-11-4758]	Croatian Science Foundation	This research has been supported by the Croatian Science Foundation: Grant code IP-2013-11-4758 (MG); Epigenetic changes in head and neck squamous cell carcinoma - EpiC-HNSCC (http://www.hrzz.hr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16918-w; Anantharaman D, 2018, ORAL ONCOL, V81, P89, DOI 10.1016/j.oraloncology.2018.04.016; Anantharaman D, 2016, INT J EPIDEMIOL, V45, P752, DOI 10.1093/ije/dyw069; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; Berthiller J, 2016, INT J EPIDEMIOL, V45, P835, DOI 10.1093/ije/dyv146; Boscolo-Rizzo P, 2016, CANCER TREAT REV, V42, P24, DOI 10.1016/j.ctrv.2015.10.009; Chaturvedi AK, 2018, CANCER-AM CANCER SOC, V124, P2893, DOI 10.1002/cncr.31383; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Commar A., 2018, WHO GLOBAL REPORT TR; Croatian National Cancer Registry, 2014, 39 CROAT I PUBL HLTH; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Descamps G, 2016, J CANCER RES CLIN, V142, P2185, DOI 10.1007/s00432-016-2203-7; Dok R, 2016, CANCERS, V8, DOI 10.3390/cancers8040041; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Hafkamp HC, 2008, INT J CANCER, V122, P2656, DOI 10.1002/ijc.23458; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Hussein AA, 2017, EUR J CANCER, V82, P115, DOI 10.1016/j.ejca.2017.05.026; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Keck MK, 2015, CLIN CANCER RES, V21, P870, DOI 10.1158/1078-0432.CCR-14-2481; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lesnikova Iana, 2010, Infect Agent Cancer, V5, P2, DOI 10.1186/1750-9378-5-2; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; Majchrzak E, 2014, RADIOL ONCOL, V48, P1, DOI 10.2478/raon-2013-0057; Marcu LG, 2016, CRIT REV ONCOL HEMAT, V103, P27, DOI 10.1016/j.critrevonc.2016.05.002; Marron M, 2012, EUR J EPIDEMIOL, V27, P499, DOI 10.1007/s10654-012-9699-1; Mehanna H, 2016, HEAD NECK-J SCI SPEC, V38, pE1863, DOI 10.1002/hed.24336; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nygard M, 2012, EUR J CANCER, V48, P1341, DOI 10.1016/j.ejca.2012.03.014; O'Rorke MA, 2012, ORAL ONCOL, V48, P1191, DOI 10.1016/j.oraloncology.2012.06.019; Osazuwa-Peters N, 2017, ORAL ONCOL, V74, P90, DOI 10.1016/j.oraloncology.2017.09.015; Padjen I, 2012, CENT EUR J PUBL HEAL, V20, P5, DOI 10.21101/cejph.a3702; Prigge ES, 2015, INT J CANCER, V136, P1589, DOI 10.1002/ijc.29130; Ramqvist T, 2015, VIRUSES-BASEL, V7, P1332, DOI 10.3390/v7031332; Rettig E, 2015, EXPERT REV ANTICANC, V15, P35, DOI 10.1586/14737140.2015.957189; Rettig EM, 2018, ORAL ONCOL, V83, P147, DOI 10.1016/j.oraloncology.2018.06.013; Robinson M, 2012, HEAD NECK PATHOL, V6, pS83, DOI 10.1007/s12105-012-0370-7; Rodrigo JP, 2014, INT J CANCER, V134, P487, DOI 10.1002/ijc.28355; Seiwert T, 2013, ANN ONCOL, V24, P2711, DOI 10.1093/annonc/mdt417; Siroglavic KJ, 2017, CROAT MED J, V58, P358, DOI 10.3325/cmj.2017.58.358; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Stephen Josena K, 2013, Cancer Clin Oncol, V2, P51; Taberna M, 2017, ANN ONCOL, V28, P2386, DOI 10.1093/annonc/mdx304; Windon MJ, 2018, CANCER-AM CANCER SOC, V124, P2993, DOI 10.1002/cncr.31385; World Health Organization, 2018, AIR POLL CHILD HLTH; Yan W, 2011, AM J CANCER RES, V1, P275; Znaor T, 2013, ACTA OTO-LARYNGOL, V133, P305, DOI 10.3109/00016489.2012.743031	53	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211577	10.1371/journal.pone.0211577	http://dx.doi.org/10.1371/journal.pone.0211577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707715	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000457742900033
J	Fagua, JC; Ramsey, RD				Fagua, J. Camilo; Ramsey, R. Douglas			Geospatial modeling of land cover change in the Choco-Darien global ecoregion of South America; One of most biodiverse and rainy areas in the world	PLOS ONE			English	Article							RADAR TOPOGRAPHY MISSION; ATLANTIC FOREST; DEFORESTATION-DRIVEN; TIME-SERIES; AMAZON; CLASSIFICATION; CONSERVATION; SUCCESSION; NDVI; TRANSITIONS	The tropical rain forests of northwest South America fall within the Choco-Darien Global Ecoregion (CGE). The CGE is one of 25 global biodiversity hotspots prioritized for conservation due to its high biodiversity and endemism as well as threats due to deforestation. The analysis of land-use and land-cover (LULC) change within the CGE using remotely sensed imagery is challenging because this area is considered to be one of the rainiest places on the planet (hence high frequency of cloud cover). Furthermore, the availability of high-resolution remotely sensed data is low for developing countries before 2015. Using the Random Forest ensemble learning classification tree system, we developed annual LULC maps in the CGE from 2002 to 2015 using a time series of cloud-free MODIS vegetation index products. The MODIS imagery was processed through a Gaussian weighted filter to further correct for cloud pollution and matched to visual interpretations of land cover and land use from available high spatial resolution imagery (WorldView-2, Quick Bird, Ikonos and GeoEye-1). Validation of LULC maps resulted in a Kappa of 0.87 (Sd = 0.008). We detected a gradual replacement of forested areas with agriculture (mainly grassland planted to support livestock grazing), and secondary vegetation (agriculture reverting to forest) across the CGE. Forest loss was higher between 2010-2015 when compared to 2002-2010. LULC change trends, deforestation drivers, and reforestation transitions varied according to administrative organization (countries: Panamanian CGE, Colombian CGE, and Ecuadorian CGE).	[Fagua, J. Camilo; Ramsey, R. Douglas] Utah State Univ, Dept Wildland Resources, RS GIS Lab, Logan, UT 84322 USA; [Fagua, J. Camilo; Ramsey, R. Douglas] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Fagua, J. Camilo] Inst Geog Agustin Codazzi, CIAF, Bogota, DC, Colombia; [Fagua, J. Camilo] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Northern Arizona University	Fagua, JC (corresponding author), Utah State Univ, Dept Wildland Resources, RS GIS Lab, Logan, UT 84322 USA.; Fagua, JC (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.; Fagua, JC (corresponding author), Inst Geog Agustin Codazzi, CIAF, Bogota, DC, Colombia.; Fagua, JC (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.	Camilo.Fagua@nau.edu	Fagua, Jose/AAI-3722-2020	Fagua, Jose/0000-0002-0908-3039	COLCIENCIAS-Colombia [529-2011]; Fulbright-US; Remote Sensing/GIS lab of Utah State University-US; Ecology Center	COLCIENCIAS-Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fulbright-US; Remote Sensing/GIS lab of Utah State University-US; Ecology Center	We acknowledged COLCIENCIAS-Colombia (529-2011) and Fulbright-US to support this research, Ecology Center and Remote Sensing/GIS lab of Utah State University-US to provide additional financial and technical support, DigitalGlobe Foundation to provide the high spatial resolution imagery, IDEAM-Colombia and IGAC-Colombia to provide data and technical support, and IDEA WILD to provide equipment.; We acknowledged COLCIENCIAS-Colombia (529-2011) and Fulbright-US to support this research, Ecology Center and Remote Sensing/ GIS lab of Utah State University- US to provide additional financial and technical support, DigitalGlobe Foundation to provide the high spatial resolution imagery, IDEAM-Colombia and IGAC-Colombia to provide data and technical support, and IDEA WILD to provide equipment.	Ackerman S, 2006, DISCRIMINATING CLEAR; Ackerman SA, 1998, J GEOPHYS RES-ATMOS, V103, P32141, DOI 10.1029/1998JD200032; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; Aldrich SP, 2006, ECON GEOGR, V82, P265; Arguelles L., 2010, ESTRATEGIA I PREVENC; Armenteras D, 2009, BIOL CONSERV, V142, P1411, DOI 10.1016/j.biocon.2009.02.002; BCE BC de E, 2010, EC ECUATORIANA LUEG; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breunig FM, 2015, INT J APPL EARTH OBS, V35, P294, DOI 10.1016/j.jag.2014.09.017; Brown CG, 2005, IEEE T GEOSCI REMOTE, V43, P1707, DOI 10.1109/TGRS.2005.851789; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Buitrago D, 2013, EVOLUCION EC COLOMBI; Calmon M, 2011, RESTOR ECOL, V19, P154, DOI 10.1111/j.1526-100X.2011.00772.x; Castiblanco C, 2015, ENERG ECON, V49, P676, DOI 10.1016/j.eneco.2015.02.025; Castillo MJ, 2014, SERIE DOCUMENTOS TRA, V144, P71; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davalos LM, 2014, BIOL CONSERV, V170, P64, DOI 10.1016/j.biocon.2013.12.018; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DeLeon A, 2014, 388 CTR GLOB DEV, P52; Desarrollo P, 2014, ESTRATEGIA TERRITORI, P189; Didan K, 2017, NASA EOSDIS LAND PRO; Didan K., 2006, MODIS VEGETATION IND; Aguiar APD, 2012, GLOBAL CHANGE BIOL, V18, P3346, DOI 10.1111/j.1365-2486.2012.02782.x; Eastman J.R., 2015, TERRSET MANUAL; Etter A, 2006, J ENVIRON MANAGE, V79, P74, DOI 10.1016/j.jenvman.2005.05.017; Etter A, 2008, ANN ASSOC AM GEOGR, V98, P2, DOI 10.1080/00045600701733911; Etter A, 2006, GLOBAL CHANGE BIOL, V12, P1409, DOI 10.1111/j.1365-2486.2006.01168.x; Fagua JC, 2013, REV BIOL TROP, V61, P301; FAO F and AO of the UN, 2010, GLOB FOR RES ASS 201; FEDEPALMA, 2011, GUIA AMB SUBS AGR PA; FEDEPALMA FN de cultivadores de palma de aceite, 2017, CID PALM; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finagro F para el F del SA, 2014, PERSP SECT AGR COL; Fisher E., 2015, INVESTIG PENSAM CRIT, V3, P47; Florez CG, 2012, REV I ALTOS ESTUD EU, P7; Freema AE, 2016, MODELMAP R PACKAGE M; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; GENTRY A H, 1986, Caldasia, V15, P71; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Godar J, 2012, FOREST ECOL MANAG, V267, P58, DOI 10.1016/j.foreco.2011.11.046; Goebertus Estrada Juanita, 2008, colomb.int., P152; Gonzalez JJ, 2011, ANALISIS TENDENCIAS; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Helmer EH, 2012, FOREST ECOL MANAG, V279, P147, DOI 10.1016/j.foreco.2012.05.016; Hird JN, 2009, REMOTE SENS ENVIRON, V113, P248, DOI 10.1016/j.rse.2008.09.003; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Huete A., 1999, MODIS VEGETATION IND, V3, P295; IDEAM, 2017, MON SEG FEN DEF COL; IDEAM] Instituto de Hidrologia Meteorologia y Estudios Am-bientales, 2010, LEYENDA NACL COBERTU; IGAC IGAC, 2015, SUEL TIERR COL; INER I de ER de la U de A, 2003, MAGD MED DES REG TAR; INPE IN de PEPP, 2015, PROJ PROD MON FLOR A; Kellndorfer J, 2004, REMOTE SENS ENVIRON, V93, P339, DOI 10.1016/j.rse.2004.07.017; Lambin, 2001, LUCC REPORT SERIES, V4, P116; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leyva P., 1993, AGR LITORAL PACIFICO; Li L, 2017, J VOLCANOL GEOTH RES, V345, P109, DOI 10.1016/j.jvolgeores.2017.07.014; Li W, 2016, INT J APPL EARTH OBS, V47, P30, DOI 10.1016/j.jag.2015.12.006; Li ZF, 2010, PROCEDIA ENVIRON SCI, V2, P964, DOI 10.1016/j.proenv.2010.10.108; Liaw A., 2015, PACKAGE RANDOMFOREST; Lieberman M., 1985, J TROP ECOL, V1, P97, DOI DOI 10.1017/S026646740000016X; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; Lowry JH, 2008, PHOTOGRAMM ENG REM S, V74, P1509, DOI 10.14358/PERS.74.12.1509; Luque S, 2018, METHODS ECOL EVOL, V9, P1784, DOI 10.1111/2041-210X.13057; Lyapustin AI, 2012, REMOTE SENS ENVIRON, V127, P385, DOI 10.1016/j.rse.2012.09.002; MAG MDAYG, 2003, INF REC ZOOG EC; Marrugo Arnedo Verena, 2013, rev. econ. Caribe, P127; Matsuki K, 2016, SCI STUD READ, V20, P20, DOI 10.1080/10888438.2015.1107073; Mellor A, 2015, ISPRS J PHOTOGRAMM, V105, P155, DOI 10.1016/j.isprsjprs.2015.03.014; Meyerson FAB, 2007, FRONT ECOL ENVIRON, V5, P182, DOI 10.1890/1540-9295(2007)5[182:MAEITC]2.0.CO;2; Mingorance F, 2004, CULTIVO PALMA AFRICA; Ministerio del Ambiente del Ecuador, 2012, LIN BAS DEF EC CONT; Minsalud M de la PC, 2011, PROD INT BRUT INFL C; Montano N, 2008, REV LUNA AZUL, V27, P113; Mosquera RR, 1978, B SOC GEOGRAFICA COL, V111, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nitze I, 2015, INT J APPL EARTH OBS, V34, P136, DOI 10.1016/j.jag.2014.08.001; Norden N, 2015, P NATL ACAD SCI USA, V112, P8013, DOI 10.1073/pnas.1500403112; O'Loughlin FE, 2016, REMOTE SENS ENVIRON, V182, P49, DOI 10.1016/j.rse.2016.04.018; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PEC M de C de la PE y competitividad, 2011, AG TRANSF PROD TERR; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pettorelli N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0190; Pfaff A., 2013, ENCY ENERGY NATURAL, P144, DOI DOI 10.1111/J.1523-1739.2012.01930.X; Phillips J. F., 2011, ESTIMACION RESERVAS; Potter LM, 2011, EUTOPIA, V1, P39; Poveda G, 2000, GEOPHYS RES LETT, V27, P1675, DOI 10.1029/1999GL006091; Primack RB, 2009, TROPICAL RAIN FOREST; ProEcuador I de promocion de exportaciones e inversiones de E, 2014, PERF SECT AGR INV; Rangel O, 2011, COLOMBIA DIVERSIDAD, VIV, P769; Rangel O, 2010, COLOMBIA DIVERSIDAD, VIX, P35; Sabogal CR, 2013, CUAD ECON-BOGOTA, V32, P683; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodriguez N, 2012, BIOTROPICA, V44, P123, DOI 10.1111/j.1744-7429.2011.00770.x; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Sanchez-Cuervo AM, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00207.1; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Schlawin J, 2008, J VEG SCI, V19, P485, DOI 10.3170/2008-8-18387; Sierra R., 2013, PATRONES FACTORES DE; Simard M, 2006, PHOTOGRAMM ENG REMOT, V72; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Swann ALS, 2015, AGR FOREST METEOROL, V214, P12, DOI 10.1016/j.agrformet.2015.07.006; Tanase MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131079; UNFCCC UNFC on CC, 2015, C PART ITS 21 SESS H; UNODC UNO on D and C, 2015, MON CULT COC 2014; Varga K, 2015, OPEN GEOSCI, V7, P15, DOI 10.1515/geo-2015-0002; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Wardlow BD, 2010, INT J REMOTE SENS, V31, P805, DOI 10.1080/01431160902897858; WBG WBG, 2017, WORLD BANK OP DAT; Witten JG, 2013, INTRO STAT LEARNING; WWF WWF, 2016, CHOC DAR MOIST FOR; Zapata V., 2013, REV EC ADM, V10, P135	119	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211324	10.1371/journal.pone.0211324	http://dx.doi.org/10.1371/journal.pone.0211324			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2LM	30707720	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900021
J	Uekermann, F; Simonsen, L; Sneppen, K				Uekermann, Florian; Simonsen, Lone; Sneppen, Kim			Exploring the contribution of exposure heterogeneity to the cessation of the 2014 Ebola epidemic	PLOS ONE			English	Article							VIRUS DISEASE; FINAL SIZE; TRANSMISSION; LIBERIA; MODELS	The unexpected early cessation of the recent West Africa Ebola outbreak demonstrated shortcomings of popular forecasting approaches and has not been fully understood yet. A popular hypothesis is that public health interventions mitigated the spread, such as ETUs and safe burials. We investigate whether risk heterogeneity within the population could serve as an alternative explanation. We introduce a model for spread in heterogeneous host population that is particularly well suited for early predictions due to its simplicity and ease of application. Furthermore, we explore the conditions under which the observed epidemic trajectory can be explained without taking into account the effect of public health interventions. While the obtained fits closely match the total case count time series, closer inspection of sub-population results made us conclude that risk heterogeneity is unlikely to fully explain the early cessation of Ebola; other factors such as behavioral changes and other interventions likely played a major role. More accurate predictions in a future scenario require models that allow for early sub-exponential growth, as well as access to additional data on patient occupation (risk level) and location, to allow identify local phenomena that influence spreading behavior.	[Uekermann, Florian; Sneppen, Kim] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Simonsen, Lone] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark	University of Copenhagen; Niels Bohr Institute; Roskilde University	Simonsen, L (corresponding author), Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark.	lonesimo@ruc.dk	Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526	European Research Council under the European Union [740704]	European Research Council under the European Union(European Research Council (ERC))	This work was supported by European Research Council under the European Union's Seventh Framework Programme (FP/2007 2013)/ERC Grant Agreement n. 740704.; We thank Viggo Andreasen for helpful discussions. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007 2013) / ERC Grant Agreement n. 740704.	Achenbach J, 2014, OMINOUS MATH EBOLA E; Agua-Agum J, 2016, NEW ENGL J MED, V375, P587, DOI 10.1056/NEJMsr1513109; ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; Andreasen V, 2011, B MATH BIOL, V73, P2305, DOI 10.1007/s11538-010-9623-3; Arino J, 2007, MATH BIOSCI ENG, V4, P159, DOI 10.3934/mbe.2007.4.159; Cane V., 1982, J APPL PROBAB A, V19A, P173, DOI DOI 10.2307/3213558; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2015, PLOS CURR OUTBREAKS, DOI [10.1371/currents.outbreaks. 8b55f4bad99ac5c5db3663e916803261, DOI 10.1371/CURRENTS.OUTBREAKS.8B55F4BAD99AC5C5DB3663E916803261]; Chowell G, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0811-y; Chretien JP, 2015, ELIFE, V4, DOI 10.7554/eLife.09186; Dean NE, 2016, CLIN INFECT DIS, V62, P1277, DOI 10.1093/cid/ciw114; DIEKMANN O, 1990, J MATH BIOL, V28, P365; GART JJ, 1968, BIOMETRICS, V24, P557, DOI 10.2307/2528318; Hyman JM, 1999, MATH BIOSCI, V155, P77, DOI 10.1016/S0025-5564(98)10057-3; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Kupferschmidt K, 2014, SCIENCE, V345, P1108, DOI 10.1126/science.345.6201.1108; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Majumder Maimuna S, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Nishiura H, 2014, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.36.20894; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Piot P, 2014, SCIENCE, V345, P1221, DOI 10.1126/science.1260695	23	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0210638	10.1371/journal.pone.0210638	http://dx.doi.org/10.1371/journal.pone.0210638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707729	Green Published, Green Submitted, gold			2022-12-26	WOS:000457742900011
J	Crawley, JAH; Lahdenpera, M; Seltmann, MW; Htut, W; Aung, HH; Nyein, K; Lummaa, V				Crawley, Jennie A. H.; Lahdenpera, Mirkka; Seltmann, Martin W.; Htut, Win; Aung, Htoo Htoo; Nyein, Kyaw; Lummaa, Virpi			Investigating changes within the handling system of the largest semi-captive population of Asian elephants	PLOS ONE			English	Article							AFRICAN ELEPHANTS; CONSERVATION; CAPTIVITY; BEHAVIOR; DRIVERS; WELFARE; MAHOUTS; HERD	The current extinction crisis leaves us increasingly reliant on captive populations to maintain vulnerable species. Approximately one third of Asian elephants (Elephas maximus) are living in semi-captive conditions in range countries. Their relationship with humans stretches back millennia, yet elephants have never been fully domesticated. We rely on the expertise of traditional handlers (mahouts) to manage these essentially wild animals, yet this profession may be threatened in the modern day. Here, we study the handling system of semi-captive timber elephants in Myanmar; the largest global semi-captive population (similar to 5 000). We investigate how recent changes in Myanmar may have affected the keeping system and mahout-elephant interactions. Structured interviews investigated changes to mahout attitude and experience over the last two decades, as perceived by those who had worked in the industry for at least 10 years (n=23) and as evaluated in current mahouts (n=210), finding mahouts today are younger (median age 22yrs), less experienced (median experience 3yrs), and change elephants frequently, threatening traditional knowledge transfer. Mahout-elephant interactions manifested as 5 components ('job appreciation'; 'experience is necessary'; 'human-elephant interaction'; 'own knowledge'; 'elephant relationship'), according to Principal Components Analysis. Experienced mahouts and mahouts of bulls and younger elephants were more likely to agree that 'experience is necessary' to be a mahout. Mahouts with difficult elephants scored lower on 'human-elephant interaction' and a mahout's perception of their 'own knowledge' increased with more experience. Our finding of change in terms of mahout experience, age and commitment in the largest semi-captive elephant population suggests need for formal training and assessment of impacts on elephant welfare; these are findings applicable to thousands of elephants under similar management.	[Crawley, Jennie A. H.; Lahdenpera, Mirkka; Seltmann, Martin W.; Lummaa, Virpi] Univ Turku, Dept Biol, Turku, Finland; [Htut, Win; Aung, Htoo Htoo; Nyein, Kyaw] Myanma Timber Enterprise, Yangon, Myanmar	University of Turku	Crawley, JAH (corresponding author), Univ Turku, Dept Biol, Turku, Finland.	jahcra@utu.fi	Lummaa, Virpi/AHB-0181-2022	Crawley, Jennie/0000-0001-5509-652X; Lahdenpera, Mirkka/0000-0003-0062-6284; Seltmann, Martin Walter/0000-0001-6060-885X	European Research council as part of Horizon 2020; Academy of Finland; Kone Foundation	European Research council as part of Horizon 2020; Academy of Finland(Academy of Finland); Kone Foundation	JAHC and VL were funded by the European Research council as part of Horizon 2020 (https://h2020.org.tr/en/h2020/erc) and VL also by the Academy of Finland (http://www.aka.fi/en).MS and ML were both funded by Kone Foundation (https://koneensaatio.fi/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADB, 2016, MYANM TRANSP SECT PO; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Bansiddhi P, 2018, CHANGING TRENDS ELEP, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Campos-Arceiz A, 2008, ECOL RES, V23, P1057, DOI 10.1007/s11284-008-0466-4; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dinno A., 2012, PARAN HORNS TEST PRI; Dobermann T., 2016, URBAN MYANMAR; Duffy R, 2011, J SUSTAIN TOUR, V19, P589, DOI 10.1080/09669582.2011.566927; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Gardener D., 2015, MADE MYANMAR ENTRENC; Gifford R, 2009, J ENVIRON PSYCHOL, V29, P1, DOI 10.1016/j.jenvp.2008.06.001; Golosova OS, 2017, MAMMAL RES, V62, P387, DOI 10.1007/s13364-017-0322-4; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Hart L, 2000, ANTHROZOOS, V13, P34, DOI 10.2752/089279300787000055; Hart L, 2007, ENCY HUMAN ANIMAL RE; HART LA, 1994, APPL ANIM BEHAV SCI, V40, P297, DOI 10.1016/0168-1591(94)90070-1; IUCN/SSC, 2014, GUID US EXS MAN SPEC; Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73; Kontogeorgopoulos N, 2009, CURR ISSUES TOUR, V12, P429, DOI 10.1080/13683500903042873; Lair R.C., 1997, GONE ASTRAY CARE MAN; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Laule G, 2009, PROTECTED CONTACT EL; Lim CL, 2017, CONSERV BIOL, V31, P1362, DOI 10.1111/cobi.12984; Ling R, 2015, INT J COMMUN-US, V9, P3583; Locke P, 2011, GAJAH, V34, P32; Mar K. U., 2007, THESIS; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Miller David, 2015, Veterinary Medicine International, P614690, DOI 10.1155/2015/614690; MINOO Z, 2010, GAJAH, V33, P58; OWEN M, 1988, ORNIS SCAND, V19, P58, DOI 10.2307/3676528; Parmar PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121212; Phuangkum P., 2005, ELEPHANT CARE MANUAL; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; R Core Team, 2021, R LANGUAGE ENV STAT; Radhakrishnan M.C., 2011, GAJAH, V34, P18; Revelle William, 2020, CRAN; Schmidt-Burbach J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139092; Sorato E, 2006, GEN COMP ENDOCR, V146, P265, DOI 10.1016/j.ygcen.2005.11.020; Srinivasaiah N. M., 2014, DOCUMENTING INDIGENO; Stagni E, 2017, RES VET SCI, V113, P122, DOI 10.1016/j.rvsc.2017.09.014; Standley CJ, 2011, VECTOR-BORNE ZOONOT, V11, P169, DOI 10.1089/vbz.2010.0156; Sukumar R., 2006, International Zoo Yearbook, V40, P1, DOI 10.1111/j.1748-1090.2006.00001.x; Sukumar R., 2003, LIVING ELEPHANTS EVO; Suter Ingrid C., 2013, Human Dimensions of Wildlife, V18, P279, DOI 10.1080/10871209.2013.788235; U Khin Zaw, 1997, Gajah, V17, P9; Ungerfeld R, 2008, WILDLIFE BIOL, V14, P350, DOI 10.2981/0909-6396(2008)14[350:RIASHO]2.0.CO;2; Vanitha V., 2009, GAJAH, V30, P8; Varma S., 2015, CAPTIVE ELEPHANTS IN; Varma Surendra, 2010, CAPTIVE ELEPHANTS FO; Venables WN., 2002, MODERN APPL STAT S, V4; Ward SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140237; Young JC, 2018, METHODS ECOL EVOL, V9, P10, DOI 10.1111/2041-210X.12828	59	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0209701	10.1371/journal.pone.0209701	http://dx.doi.org/10.1371/journal.pone.0209701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703121	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600011
J	Roscher, C; Karlowsky, S; Milcu, A; Gessler, A; Bachmann, D; Jesch, A; Lange, M; Mellado-Vazquez, P; Strecker, T; Landais, D; Ravel, O; Buchmann, N; Roy, J; Gleixner, G				Roscher, Christiane; Karlowsky, Stefan; Milcu, Alexandru; Gessler, Arthur; Bachmann, Dorte; Jesch, Annette; Lange, Markus; Mellado-Vazquez, Perla; Strecker, Tanja; Landais, Damien; Ravel, Olivier; Buchmann, Nina; Roy, Jacques; Gleixner, Gerd			Functional composition has stronger impact than species richness on carbon gain and allocation in experimental grasslands	PLOS ONE			English	Article							ISOTOPE COMPOSITION; DIVERSITY; BIODIVERSITY; TIME; STARCH; C-13	Numerous experiments have shown positive diversity effects on plant productivity, but little is known about related processes of carbon gain and allocation. We investigated these processes in a controlled environment (Montpellier European Ecotron) applying a continuous (CO2)-C-13 label for three weeks to 12 soil-vegetation monoliths originating from a grassland biodiversity experiment (Jena Experiment) and representing two diversity levels (4 and 16 sown species). Plant species richness did not affect community- and species-level C-13 abundances neither in total biomass nor in non-structural carbohydrates (NSC). Community-level C-13 excess tended to be higher in the 16-species than in the 4-species mixtures. Community-level C-13 excess was positively related to canopy leaf nitrogen (N), i.e. leaf N per unit soil surface. At the species level, shoot C-13 abundances varied among plant functional groups and were larger in legumes and tall herbs than in grasses and small herbs, and correlated positively with traits as leaf N concentrations, stomatal conductance and shoot height. The C-13 abundances in NSC were larger in transport sugars (sucrose, raffi-nose-family oligosaccharides) than in free glucose, fructose and compounds of the storage pool (starch) suggesting that newly assimilated carbon is to a small portion allocated to storage. Our results emphasize that the functional composition of communities is key in explaining carbon assimilation in grasslands.	[Roscher, Christiane] UFZ, Dept Physiol Div, Helmholtz Ctr Environm Res, Leipzig, Germany; [Roscher, Christiane] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Karlowsky, Stefan; Lange, Markus; Mellado-Vazquez, Perla; Gleixner, Gerd] Max Planck Inst Biogeochem, Jena, Germany; [Milcu, Alexandru; Landais, Damien; Ravel, Olivier; Roy, Jacques] Natl Ctr Sci Res CNRS, Montpellier European Ecotron UPS 3248, Montferrier Sur Lez, France; [Milcu, Alexandru] Univ Montpellier 3, Univ Montpellier, Ctr Ecol Fonct & Evolut UMR 5175, CNRS,EPHE,IRD, Montpellier, France; [Gessler, Arthur] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Gessler, Arthur] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland; [Bachmann, Dorte; Buchmann, Nina] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Jesch, Annette] Univ Freiburg, Dept Geobot, Fac Biol, Freiburg, Germany; [Strecker, Tanja] Univ Gottingen, JF Blumbach Inst Zool & Anthropol, Gottingen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; University of Gottingen	Gleixner, G (corresponding author), Max Planck Inst Biogeochem, Jena, Germany.	ggleix@bgc-jena.mpg.de	Gleixner, Gerd/M-8519-2017; Gessler, Arthur/C-7121-2008; Gleixner, Gerd/O-4215-2019; Buchmann, Nina/E-6095-2011; Milcu, Alexandru/X-6267-2018	Gleixner, Gerd/0000-0002-4616-0953; Gessler, Arthur/0000-0002-1910-9589; Gleixner, Gerd/0000-0002-4616-0953; Buchmann, Nina/0000-0003-0826-2980; Karlowsky, Stefan/0000-0002-3369-2272; Milcu, Alexandru/0000-0002-2889-1234	German Research Foundation [FOR456/1451]; Swiss National Science Foundation [315230E-131194]	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Research Foundation (FOR456/1451). N. Buchmann and D. Bachmann acknowledge funding of the Swiss National Science Foundation (315230E-131194). This study benefited from the CNRS human and technical resources allocated to the ECOTRONS Research Infrastructure as well as from the state allocation "Investissement d'Avenir" AnaEE-France ANR-11-INBS-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anten NPR, 2005, ANN BOT-LONDON, V95, P495, DOI 10.1093/aob/mci048; Anten NPR, 2003, ECOLOGY, V84, P955, DOI 10.1890/0012-9658(2003)084[0955:SSLPAD]2.0.CO;2; Bachmann D, 2017, PANGEA, DOI [10.1594/PANGAEA.877686, DOI 10.1594/PANGAEA.877686]; Bachmann D, 2018, OIKOS, V127, P935, DOI 10.1111/oik.04533; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Field C., 1986, EC PLANT FORM FUNCTI, P22; Galiano L, 2017, PLANT CELL ENVIRON, V40, P1711, DOI 10.1111/pce.12972; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gottlicher S, 2006, RAPID COMMUN MASS SP, V20, P653, DOI 10.1002/rcm.2352; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; HIROSE T, 1995, ECOLOGY, V76, P466, DOI 10.2307/1941205; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Karlowsky S, 2018, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.3s57p.3, DOI 10.5061/DRYAD.3S57P.3]; Klumpp K, 2007, BIOGEOSCIENCES, V4, P385, DOI 10.5194/bg-4-385-2007; Laliberte E, 2010, R PACKAGE VERSION 1; Lange M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7707; Lattanzi FA, 2012, ECOLOGY, V93, P169, DOI 10.1890/11-1166.1; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Mellado-Vazquez PG, 2016, SOIL BIOL BIOCHEM, V94, P122, DOI 10.1016/j.soilbio.2015.11.012; Milcu A, 2014, ECOL LETT, V17, P435, DOI 10.1111/ele.12243; Monsi TM, 1953, JAP J BOT, V14, P22; Niinemets U, 2004, PLANT BIOLOGY, V6, P254, DOI 10.1055/s-2004-817881; Niinemets U, 2015, NEW PHYTOL, V205, P973, DOI 10.1111/nph.13096; Ostler U, 2016, NEW PHYTOL, V210, P471, DOI 10.1111/nph.13800; Poorter H, 2006, J EXP BOT, V57, P355, DOI 10.1093/jxb/erj002; R Core Team, 2021, R LANGUAGE ENV STAT; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; Richardson AD, 2013, NEW PHYTOL, V197, P850, DOI 10.1111/nph.12042; Richter A, 2009, RAPID COMMUN MASS SP, V23, P2476, DOI 10.1002/rcm.4088; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; Rinne KT, 2015, PLANT CELL ENVIRON, V38, P2340, DOI 10.1111/pce.12554; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2017, PANGEA, DOI [10.1594/PANGAEA.877647, DOI 10.1594/PANGAEA.877647]; Roscher C, 2011, ANN BOT-LONDON, V107, P965, DOI 10.1093/aob/mcr044; Roscher C, 2011, PERSPECT PLANT ECOL, V13, P1, DOI 10.1016/j.ppees.2010.11.001; Salmon Y, 2014, FUNCT PLANT BIOL, V41, P850, DOI 10.1071/FP13212; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Studer MS, 2014, BIOGEOSCIENCES, V11, P1637, DOI 10.5194/bg-11-1637-2014; Thoms R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184247; Turgeon R, 2004, PLANT PHYSIOL, V136, P3795, DOI 10.1104/pp.104.042036; Van den Ende W, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00247; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Weisser WW, 2017, BASIC APPL ECOL, V23, P1, DOI 10.1016/j.baae.2017.06.002; Wild B, 2010, J EXP BOT, V61, P1375, DOI 10.1093/jxb/erq006	52	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0204715	10.1371/journal.pone.0204715	http://dx.doi.org/10.1371/journal.pone.0204715			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703101	Green Published, gold, Green Submitted			2022-12-26	WOS:000457301600005
J	Biskou, O; Casanova, V; Hooper, KM; Kemp, S; Wright, GP; Satsangi, J; Barlow, PG; Stevens, C				Biskou, Olga; Casanova, Victor; Hooper, Kirsty M.; Kemp, Sadie; Wright, Graham P.; Satsangi, Jack; Barlow, Peter G.; Stevens, Craig			The type III intermediate filament vimentin regulates organelle distribution and modulates autophagy	PLOS ONE			English	Article							PROTEIN-DEGRADATION; CELL ARCHITECTURE; VACUOLE; MICROTUBULES; CYTOSKELETON; WITHAFERIN; MACHINERY; ACTIN; YEAST	The cytoskeletal protein vimentin plays a key role in positioning of organelles within the cytosol and has been linked to the regulation of numerous cellular processes including autophagy, however, how vimentin regulates autophagy remains relatively unexplored. Here we report that inhibition of vimentin using the steroidal lactone Withaferin A (WFA) causes vimentin to aggregate, and this is associated with the relocalisation of organelles including autophagosomes and lysosomes from the cytosol to a juxtanuclear location. Vimentin inhibition causes autophagosomes to accumulate, and we demonstrate this results from modulation of mechanistic target of rapamycin (mTORC1) activity, and disruption of autophagosome-lysosome fusion. We suggest that vimentin plays a physiological role in autophagosome and lysosome positioning, thus identifying vimentin as a key factor in the regulation of mTORC1 and autophagy.	[Biskou, Olga; Casanova, Victor; Hooper, Kirsty M.; Kemp, Sadie; Wright, Graham P.; Barlow, Peter G.; Stevens, Craig] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Satsangi, Jack] Univ Edinburgh, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Satsangi, Jack] John Radcliffe Hosp, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford, England	Edinburgh Napier University; University of Edinburgh; University of Oxford	Stevens, C (corresponding author), Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland.	C.Stevens@napier.ac.uk	Barlow, Peter/O-4078-2019	Barlow, Peter/0000-0002-6516-9312; Biskou, Olga/0000-0002-6239-5269; Stevens, Craig/0000-0003-0372-6299; Hooper, Kirsty/0000-0003-2900-3849; Casanova, Victor/0000-0002-4917-260X	MRC [G0800759] Funding Source: UKRI; Medical Research Council [G0800759] Funding Source: Medline; Chief Scientist Office [ETM/137, ETM/395, ETM/389] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Chang HW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00634; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Clarke EJ, 2002, CURR BIOL, V12, pR596, DOI 10.1016/S0960-9822(02)01102-8; Cogli L, 2013, BBA-MOL CELL RES, V1833, P1283, DOI 10.1016/j.bbamcr.2013.02.024; Danielsson F, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100147; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; DOHERTY FJ, 1987, BIOCHEM J, V241, P793, DOI 10.1042/bj2410793; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; EARL RT, 1987, BIOCHEM J, V241, P809, DOI 10.1042/bj2410809; Erie C, 2015, EUR J NEUROSCI, V42, P1941, DOI 10.1111/ejn.12957; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Ghosh K, 2017, TOXICOL IN VITRO, V44, P330, DOI 10.1016/j.tiv.2017.07.025; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Guignot J, 2008, MICROB PATHOGENESIS, V45, P415, DOI 10.1016/j.micpath.2008.09.007; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kruppa AJ, 2016, TRAFFIC, V17, P878, DOI 10.1111/tra.12410; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Li X, 2016, AUTOPHAGY, V12, P1521, DOI 10.1080/15548627.2016.1191722; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Mahesh PP, 2016, SCI REP-UK, V6, DOI 10.1038/srep21526; Mak TN, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020018; Margiotta A, 2017, BBA-MOL CELL RES, V1864, P367, DOI 10.1016/j.bbamcr.2016.11.020; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Musiwaro P, 2013, AUTOPHAGY, V9, P1407, DOI 10.4161/auto.25455; Nakamura S, 2017, J CELL SCI, V130, P1209, DOI 10.1242/jcs.196352; Nimmo ER, 2011, GASTROENTEROLOGY, V141, P972, DOI 10.1053/j.gastro.2011.05.043; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sirianni A, 2016, EMBO REP, V17, P1029, DOI 10.15252/embr.201541832; Steffan JJ, 2010, TRAFFIC, V11, P274, DOI 10.1111/j.1600-0854.2009.01012.x; Stevens C, 2013, GUT, V62, P695, DOI 10.1136/gutjnl-2011-301775; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zaarur N, 2014, MOL CELL BIOL, V34, P1336, DOI 10.1128/MCB.00103-14	52	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0209665	10.1371/journal.pone.0209665	http://dx.doi.org/10.1371/journal.pone.0209665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699149	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600013
J	Gurgul, A; Jasielczuk, I; Semik-Gurgul, E; Pawlina-Tyszko, K; Stefaniuk-Szmukier, M; Szmatola, T; Polak, G; Tomczyk-Wrona, I; Bugno-Poniewierska, M				Gurgul, Artur; Jasielczuk, Igor; Semik-Gurgul, Ewelina; Pawlina-Tyszko, Klaudia; Stefaniuk-Szmukier, Monika; Szmatola, Tomasz; Polak, Grazyna; Tomczyk-Wrona, Iwona; Bugno-Poniewierska, Monika			A genome-wide scan for diversifying selection signatures in selected horse breeds	PLOS ONE			English	Article							SKELETAL-MUSCLE; BLOOD-FLOW; MULTIGENE FAMILY; WITHERS HEIGHT; EXERCISE; TAURINE; IDENTIFICATION; PATHWAYS; CHOLESTEROL; ASSOCIATION	The genetic differentiation of the current horse population was evolutionarily created by natural or artificial selection which shaped the genomes of individual breeds in several unique ways. The availability of high throughput genotyping methods created the opportunity to study this genetic variation on a genome-wide level allowing detection of genome regions divergently selected between separate breeds as well as among different horse types sharing similar phenotypic features. In this study, we used the population differentiation index (F-ST) that is generally used for measuring locus-specific allele frequencies variation between populations, to detect selection signatures among six horse breeds maintained in Poland. These breeds can be classified into three major categories, including light, draft and primitive horses, selected mainly in terms of type (utility), exterior, performance, size, coat color and appearance. The analysis of the most pronounced selection signals found in this study allowed us to detect several genomic regions and genes connected with processes potentially important for breed phenotypic differentiation and associated with energy homeostasis during physical effort, heart functioning, fertility, disease resistance and motor coordination. Our results also confirmed previously described association of loci on ECA3 (spanning LCORL and NCAPG genes) and ECA11 (spanning LASP1 gene) with the regulation of body size in our draft and primitive (small size) horses. The efficiency of the applied F-ST-based approach was also confirmed by the identification of a robust selection signal in the blue dun colored Polish Konik horses at the locus of TBX3 gene, which was previously shown to be responsible for dun coat color dilution in other horse breeds. F-ST-based method showed to be efficient in detection of diversifying selection signatures in the analyzed horse breeds. Especially pronounced signals were observed at the loci responsible for fixed breed-specific features. Several candidate genes under selection were proposed in this study for traits selected in separate breeds and horse types, however, further functional and comparative studies are needed to confirm and explain their effect on the observed genetic diversity of the horse breeds.	[Gurgul, Artur; Jasielczuk, Igor; Semik-Gurgul, Ewelina; Pawlina-Tyszko, Klaudia; Szmatola, Tomasz; Bugno-Poniewierska, Monika] Natl Res Inst Anim Prod, Dept Anim Mol Biol, Balice, Poland; [Stefaniuk-Szmukier, Monika] Agr Univ Krakow, Dept Horse Breeding, Al Krakow, Poland; [Polak, Grazyna; Tomczyk-Wrona, Iwona] Natl Res Inst Anim Prod, Dept Horse Breeding, Balice, Poland; [Bugno-Poniewierska, Monika] Agr Univ Krakow, Inst Vet Sci, Al Krakow, Poland	National Research Institute of Animal Production; Agricultural University Krakow; National Research Institute of Animal Production; Agricultural University Krakow	Gurgul, A (corresponding author), Natl Res Inst Anim Prod, Dept Anim Mol Biol, Balice, Poland.	artur.gurgul@izoo.krakow.pl	Semik-Gurgul, Ewelina/M-9490-2015; Jasielczuk, Igor/AAR-4103-2021; Jasielczuk, Igor/M-8660-2015; Gurgul, Artur/M-9480-2015; POLAK, GRAZYNA/ABH-7954-2020; Stefaniuk, Monika/J-4550-2019; Bugno-Poniewierska, Monika/L-6201-2015	Jasielczuk, Igor/0000-0001-8583-3850; Jasielczuk, Igor/0000-0001-8583-3850; Gurgul, Artur/0000-0001-5979-144X; Stefaniuk, Monika/0000-0003-4158-771X; Semik-Gurgul, Ewelina/0000-0003-4667-5495; Pawlina-Tyszko, Klaudia/0000-0003-3926-9595; Bugno-Poniewierska, Monika/0000-0001-7537-6641; Szmatola, Tomasz/0000-0003-1588-4198	National Research and Development Center (Poland) under the Strategic Research and Development Program: "Environment, Agriculture and Forestry" - BIOSTRATEG [BIOSTRATEG2/297267/14/NCBR/2016]	National Research and Development Center (Poland) under the Strategic Research and Development Program: "Environment, Agriculture and Forestry" - BIOSTRATEG	The study was financed from funds of the project: "Directions for use and conservation of livestock genetic resources in sustainable development" co-financed by the National Research and Development Center (Poland) under the Strategic Research and Development Program: "Environment, Agriculture and Forestry" - BIOSTRATEG, the decision number BIOSTRATEG2/297267/14/NCBR/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Al Abri MA, 2018, J EQUINE VET SCI, V60, P67, DOI 10.1016/j.jevs.2017.05.008; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Bollag WB, 2014, COMPR PHYSIOL, V4, P1017, DOI 10.1002/cphy.c130037; Boushel R, 2000, J PHYSIOL-LONDON, V524, P305, DOI 10.1111/j.1469-7793.2000.t01-2-00305.x; Boyko AR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-259; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cagan A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-015-0579-7; Claes GRF, 2016, EUR HEART J, V37, P1815, DOI 10.1093/eurheartj/ehv522; Dawson R, 2002, AMINO ACIDS, V22, P309; Gouveia JJD, 2014, GENET MOL BIOL, V37, P330, DOI 10.1590/S1415-47572014000300004; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Frischknecht M, 2016, ANIM GENET, V47, P370, DOI 10.1111/age.12416; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Golynski M, 2011, VET MED-CZECH, V56, P423, DOI 10.17221/3205-VETMED; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Halverstadt A, 2007, METABOLISM, V56, P444, DOI 10.1016/j.metabol.2006.10.019; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Imsland F, 2016, NAT GENET, V48, P152, DOI 10.1038/ng.3475; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kim YB, 1999, BIOCHEM BIOPH RES CO, V254, P720, DOI 10.1006/bbrc.1998.9940; Korzeniewski B, 2003, BIOCHEM J, V374, P37, DOI 10.1042/BJ20030526; Laughlin M.H., 1996, HDB PHYSL SECTION 12, P705; LEWONTIN RC, 1973, GENETICS, V74, P175; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Ma Y, 2015, HEREDITY, V115, P426, DOI 10.1038/hdy.2015.42; Mackowski M, 2015, ARCH TIERZUCHT, V58, P23, DOI 10.5194/aab-58-23-2015; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Meissner M, 2011, ATHEROSCLEROSIS, V218, P323, DOI 10.1016/j.atherosclerosis.2011.06.040; Metzger Julia, 2013, PLoS One, V8, pe56497, DOI 10.1371/journal.pone.0056497; Metzger J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1977-3; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyazaki T, 2004, J GASTROENTEROL, V39, P557, DOI 10.1007/s00535-003-1342-1; Moon S, 2015, ASIAN AUSTRAL J ANIM, V28, P1525, DOI 10.5713/ajas.14.0696; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Pan Y, 2011, PROG NEURO-PSYCHOPH, V35, P154, DOI 10.1016/j.pnpbp.2010.10.016; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Ramachandran S, 2005, ATHEROSCLEROSIS, V178, P33, DOI 10.1016/j.atherosclerosis.2004.08.010; RAUB RH, 1992, J EQUINE VET SCI, V12, P106, DOI 10.1016/S0737-0806(06)81290-6; Ricard A, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00089; Ropka-Molik K, 2017, PHYSIOL GENOMICS, V49, P318, DOI 10.1152/physiolgenomics.00130.2016; Ropka-Molik K, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0499-1; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarelius I, 2010, ACTA PHYSIOL, V199, P349, DOI 10.1111/j.1748-1716.2010.02129.x; Schroder W, 2012, ANIM GENET, V43, P392, DOI 10.1111/j.1365-2052.2011.02265.x; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Sheikh F, 2015, GENE, V569, P14, DOI 10.1016/j.gene.2015.06.027; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Stachurska A, 2014, CZECH J ANIM SCI, V59, P257, DOI 10.17221/7496-CJAS; Stefaniuk-Szmukier M, 2017, J EQUINE VET SCI, V49, P60, DOI 10.1016/j.jevs.2016.10.003; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; Wright S, 1931, GENETICS, V16, P0097; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zhang C, 2018, EVOL BIOINFORM, V14, DOI 10.1177/1176934318775106; Zhang WG, 2016, SCI REP-UK, V6, DOI 10.1038/srep38073; Zhao FP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0127-3; Zhong M, 2010, EUR J HUM GENET, V18, P1148, DOI 10.1038/ejhg.2010.60	73	38	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210751	10.1371/journal.pone.0210751	http://dx.doi.org/10.1371/journal.pone.0210751			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699152	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600051
J	Hildyard, JCW; Finch, AM; Wells, DJ				Hildyard, John C. W.; Finch, Amber M.; Wells, Dominic J.			Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MOLECULAR-BASIS; UP-REGULATION; MUSCLE; MICE; DEFICIENT; PHENOTYPE; ISOFORMS; REVEALS; AGE	The mdx mouse is the most widely-used animal model of the human disease Duchenne muscular dystrophy, and quantitative PCR analysis of gene expression in the muscles of this animal plays a key role in the study of pathogenesis and disease progression and in evaluation of potential therapeutic interventions. Normalization to appropriate stably-expressed reference genes is essential for accurate quantitative measurement, but determination of such genes is challenging: healthy and dystrophic muscles present very different transcriptional environments, further altering with disease progression and muscle use, raising the possibility that no single gene or combination of genes may be stable under all experimental comparative scenarios. Despite the pedigree of this animal model, this problem remains unaddressed. The aim of this work was therefore to comprehensively assess reference gene suitability in the muscles of healthy and dystrophic mice, identifying reference genes appropriate for specific experimental comparisons, and determining whether an essentially universally-applicable set of genes exists. Using a large sample collection comprising multiple muscles (including the tibialis anterior, diaphragm and heart muscles) taken from healthy and mdx mice at three disease-relevant ages, and a panel of sixteen candidate reference genes (FBXO38, FBXW2, MON2, ZFP91, HTATSF1, GAPDH, ACTB, 18S, CDC40, SDHA, RPL13a, CSNK2A2, AP3D1, PAK1IP1, B2M and HPRT1), we used the geNorm, BestKeeper and Normfinder algorithms to identify genes that were stable under multiple possible comparative scenarios. We reveal that no single gene is stable under all conditions, but a normalization factor derived from multiple genes (RPL13a, CSNK2A2, AP3D1 and the widely-used ACTB) appears suitable for normalizing gene expression in both healthy and dystrophic mouse muscle regardless of muscle type or animal age. We further show that other popular reference genes, including GAPDH, are markedly disease-or muscle-type correlated. This study demonstrates the importance of empirical reference gene identification, and should serve as a valuable resource for investigators wishing to study gene expression in mdx mice.	[Hildyard, John C. W.; Finch, Amber M.; Wells, Dominic J.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of London; University of London Royal Veterinary College	Hildyard, JCW (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, London, England.	jhildyard@rvc.ac.uk	Hildyard, John/AAB-2260-2021	Hildyard, John/0000-0003-2283-2118; Wells, Dominic/0000-0002-1425-6344	Royal Veterinary College (rvc.ac.uk); Duchenne UK (duchenneuk.org); Muscular Dystrophy UK (musculardystrophyuk.org) [17GRO-PG12-0204]	Royal Veterinary College (rvc.ac.uk); Duchenne UK (duchenneuk.org); Muscular Dystrophy UK (musculardystrophyuk.org)	The work presented here was funded by the Royal Veterinary College (rvc.ac.uk), Duchenne UK (duchenneuk.org) and Muscular Dystrophy UK (musculardystrophyuk.org, project grant 17GRO-PG12-0204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, ZOOL SCI, V26, P315, DOI 10.2108/zsj.26.315; Albuquerque-Pontes GM, 2018, LASER MED SCI, V33, P755, DOI 10.1007/s10103-017-2405-5; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baker PE, 2006, NEUROGENETICS, V7, P81, DOI 10.1007/s10048-006-0031-7; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Chen ZS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07684-w; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; DiMario JX, 2018, AM J PATHOL, V188, P1263, DOI 10.1016/j.ajpath.2018.01.014; Feder D, 2014, BRAZ J MED BIOL RES, V47, P966, DOI 10.1590/1414-431X20143858; Ferry A, 2015, MUSCLE NERVE, V52, P788, DOI 10.1002/mus.24604; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Gouin K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1347019; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hildyard J, 2018, NEUROMUSCULAR DISORD, V28, pS18, DOI 10.1016/S0960-8966(18)30342-0; Hildyard John C W, 2018, J Neuromuscul Dis, V5, P177, DOI 10.3233/JND-170267; Hildyard John C W, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.faafdde4bea8df4aa7d06cd5553119a6; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kang YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0403-6; Kaur R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191558; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Kornegay JN, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0124-z; Kunert-Keil C, 2014, J PHYSIOL PHARMACOL, V65, P317; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Lodish H, 2000, MOL CELL BIOL; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Molina CE, 2018, CARDIOVASC RES, V114, P247, DOI 10.1093/cvr/cvx182; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nakao R, 2015, MUSCLE NERVE, V51, P276, DOI 10.1002/mus.24310; Nakayama T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19834-9; Nikishin DA, 2018, J ASSIST REPROD GEN, V35, P1851, DOI 10.1007/s10815-018-1263-9; Pelosi L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1987218; Peng S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00892; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pisani C, 2018, BBA-MOL BASIS DIS, V1864, P1172, DOI 10.1016/j.bbadis.2018.01.030; Saddhe AA, 2018, PEERJ, V6, DOI 10.7717/peerj.5226; Sandercock DA, 2017, RES VET SCI, V114, P493, DOI 10.1016/j.rvsc.2017.09.025; Schaefer C, 2001, CANCER J, V7, P52; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Selsby JT, 2015, ILAR J, V56, P116, DOI 10.1093/ilar/ilv015; Shaydurov VA, 2018, J MOL NEUROSCI, V64, P431, DOI 10.1007/s12031-018-1037-y; Shin JH, 2013, MOL THER, V21, P750, DOI 10.1038/mt.2012.283; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Singhal N, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0028-0; Sui TT, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032201; Sun CC, 2016, J APPL PHYSIOL, V120, P377, DOI 10.1152/japplphysiol.00721.2015; Swiderski K, 2016, GROWTH HORM IGF RES, V30-31, P1, DOI 10.1016/j.ghir.2016.07.002; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Valadan R, 2015, DATA BRIEF, V4, P384, DOI 10.1016/j.dib.2015.06.009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walling JG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196966; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; Wells DJ, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.035774; Wright CR, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7043429; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2	64	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0211384	10.1371/journal.pone.0211384	http://dx.doi.org/10.1371/journal.pone.0211384			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699165	gold, Green Submitted, Green Published			2022-12-26	WOS:000457155600073
J	Huang, TY; Zhao, B				Huang, Tian-Yuan; Zhao, Bin			Measuring popularity of ecological topics in a temporal dynamical knowledge network	PLOS ONE			English	Article								As interdisciplinary branches of ecology are developing rapidly in the 21st century, contents of ecological researches have become more abundant than ever before. Along with the exponential growth of number of published literatures, it is more and more difficult for ecologists to get a clear picture of their discipline. Nevertheless, the era of big data has brought us massive information of well documented historical literature and various techniques of data processing, which greatly facilitates the implementation of bibliometric analysis on ecology. Frequency has long been used as the primary metric in keyword analysis to detect ecological hotspots, however, this method could be somewhat biased. In our study, we have suggested a method called PAFit to measure keyword popularity, which considered ecology-related topics in a large temporal dynamical knowledge network, and found out the popularity of ecological topics follows the "rich get richer" and "fit get richer" mechanism. Feasibility of network analysis and its superiority over simply using frequency had been explored and justified, and PAFit was testified by its outstanding performance of prediction on the growth of frequency and degree. In addition, our research also encourages ecologists to consider their domain knowledge in a large dynamical network, and be ready to participate in interdisciplinary collaborations when necessary.	[Huang, Tian-Yuan; Zhao, Bin] Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai, Peoples R China; [Huang, Tian-Yuan; Zhao, Bin] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Shanghai, Peoples R China	Fudan University; Fudan University	Zhao, B (corresponding author), Fudan Univ, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai, Peoples R China.	zhaobin@fudan.edu.cn	Zhao, Bin/I-3651-2013	Zhao, Bin/0000-0002-3530-2469; Huang, Tian-Yuan/0000-0002-3591-4203; Huang, Tian-Yuan/0000-0002-4151-3764				Aleixandre-Benavent R, 2018, TRENDS GLOBAL RES DE, P293; AlTaie MZ, 2017, ADV INFORM KNOWL PRO, P1, DOI 10.1007/978-3-319-53004-8; Barabasi A, 1999, EMERGENCE SCALING RA, P509; Bianconi G, 2001, COMPETITION MULTISCA, P436; Borgatti S. P, 2018, EGOCENTRIC NETWORK A, V44, DOI [10.1017/9781316443255, DOI 10.1017/9781316443255]; Budilova EV, 1997, PRINCIPAL TRENDS MOD, P147; Chen D, 2016, BIBLIOMETRIC VISUALI, P285; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Fan J, 2017, ABRUPT TRANSITIONS C; Fisher B, 2009, DEFINING CLASSIFYING, P643; Ings TC, 2009, REV ECOLOGICAL NETWO, P253; Kim JY, 2018, 100 YEARS ECOLOGICAL; Li J, 2011, TRENDS RES GLOBAL CL, P13; Li Y, 2017, BIBLIOMETRIC ANAL GL, P11; Liu X, 2011, GLOBAL BIODIVERSITY, P807; Luke D. A., 2015, USERS GUIDE NETWORK; Newman M., 2018, NETWORKS, DOI [10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman ME, 2009, 1 MOVER ADVANTAGE SC, P68001; Nimon K., 2013, YHAT INTERPRETING RE; Nunez Mir GC, 2016, AUTOMATED CONTENT AN, P1262; Oksanen J., 2013, PACKAGE VEGAN, DOI 10.1109/MSPEC.2006.1611759; Pedersen T., 2018, TIDYGRAPH TIDY API G; Pedersen T.L, 2018, GGRAPH IMPLEMENTATIO; Ray-Mukherjee J, 2014, USING COMMONALITY AN, P320; Romanelli JP, 2018, ASSESSING ECOLOGICAL, P311; Ronda-Pupo GA, 2018, EVOLUTIONS RICH GET, P363; Song Y, 2013, BIBLIOMETRIC ANAL GL, P204; Stork H, 2014, TRENDS BIODIVERSITY, P354; Thompson JN, 2001, FRONTIERS ECOLOGY EC, P15; Thong P, 2016, JOINT ESTIMATION PRE, P32558; Wang L, 2015, BIBLIOMETRIC ANAL RE, P1223; Wang Y, 2015, BIBLIOMETRIC ANAL RE, P272; Worster Donald, 1994, NATURES EC HIST ECOL; Wu Y, 2016, EGOSLIDER VISUAL ANA, P260; Yang B, 2017, MAPPING SCI RES NON, P4352; Yin J, 2018, LARGE SCALE ASSESSME; Zhuang Y, 2013, GLOBAL REMOTE SENSIN, P203	37	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0208370	10.1371/journal.pone.0208370	http://dx.doi.org/10.1371/journal.pone.0208370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699118	Green Published, Green Submitted, gold			2022-12-26	WOS:000457155600007
J	Park, SJ; Park, H; Kang, D; Park, TK; Park, J; Cho, J; Chung, CR; Jeon, K; Guallar, E; Cho, J; Suh, GY; Yang, JH				Park, So Jin; Park, Hyejeong; Kang, Danbee; Park, Taek Kyu; Park, Jinkyeong; Cho, Joongbum; Chung, Chi Ryang; Jeon, Kyeongman; Guallar, Eliseo; Cho, Juhee; Suh, Gee Young; Yang, Jeong Hoon			Association of statin therapy with clinical outcomes in patients with vasospastic angina: Data from Korean health insurance review and assessment service	PLOS ONE			English	Article							CORONARY SPASTIC ANGINA; ENDOTHELIAL FUNCTION; LOWERING THERAPY; 000 PARTICIPANTS; METAANALYSIS; CHOLESTEROL; EFFICACY; SAFETY; ATHEROSCLEROSIS; INFLAMMATION	There is conflicting evidence for the clinical benefit of statin therapy in patients with vasospastic angina (VSA). We investigated the association of statin therapy with clinical outcomes in relatively large populations with clinically suspected VSA from a nationwide population-based database. Data were collected from the Health Insurance Review and Assessment database records of 4,099 patients that were in an intensive care unit with VSA between January 1, 2008 and May 31, 2015. We divided the patients into a statin group (n = 1,795) and a non-statin group (n = 2,304). The primary outcome was a composite of cardiac arrest and acute myocardial infarction (AMI). The median follow-up duration was 3.8 years (interquartile range: 2.2 to 5.8 years). Cardiac arrest or AMI occurred in 120 patients (5.2%) in the statin group, and 97 patients (5.4%) in the non-statin group (P = 0.976). With inverse probability of treatment weighting, there was no significant difference in the rate of cardiac arrest or AMI between the two groups (adjusted hazard ratio [HR], 0.99; 95% confidence interval [CI], 0.76-1.30; P = 0.937), or even between the non-statin group and high-intensity statin group (adjusted HR, 1.08; 95% CI, 0.69-1.70; P = 0.75). The beneficial association of statin use with the primary outcome was consistently lacking across the various comorbidity types. Statin therapy was not associated with reduced cardiac arrest or AMI in patients with VSA, regardless of statin intensity. Prospective, randomized trials will be needed to confirm our findings.	[Park, So Jin] Samsung Med Ctr, Dept Pharmaceut Serv, Seoul, South Korea; [Park, Hyejeong; Kang, Danbee; Guallar, Eliseo; Cho, Juhee; Suh, Gee Young] Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea; [Park, Taek Kyu; Yang, Jeong Hoon] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Park, Jinkyeong; Cho, Joongbum; Chung, Chi Ryang; Jeon, Kyeongman; Suh, Gee Young; Yang, Jeong Hoon] Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Guallar, Eliseo; Cho, Juhee] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yang, JH (corresponding author), Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.; Yang, JH (corresponding author), Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	jhysmc@gmail.com	Kang, Danbee/AAN-5933-2020; Park, Jinkyeong/GLV-1649-2022; Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019; Cho, Juhee/ABD-2280-2021; Park, Jinkyeong/AGB-3445-2022	Kang, Danbee/0000-0003-0244-7714; Park, Jinkyeong/0000-0002-8833-9062; Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; 				Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gassett AJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001726; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ishii M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003426; Kim Kye Hun, 2013, J Cardiovasc Ultrasound, V21, P58, DOI 10.4250/jcu.2013.21.2.58; Kim Kyoung Hoon, 2010, J Prev Med Public Health, V43, P42, DOI 10.3961/jpmph.2010.43.1.42; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kugiyama K, 1996, CIRCULATION, V94, P266, DOI 10.1161/01.CIR.94.3.266; Lee EK., 2017, DATA GOVERNANCE ARRA; Lee YS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8160838; Mohri M, 1998, LANCET, V351, P1165, DOI 10.1016/S0140-6736(97)07329-7; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Oh MS, 2016, INT J CARDIOL, V223, P791, DOI 10.1016/j.ijcard.2016.08.229; Okumura K, 1996, J AM COLL CARDIOL, V27, P45, DOI 10.1016/0735-1097(95)00432-7; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rodriguez F, 2017, JAMA CARDIOL, V2, P47, DOI 10.1001/jamacardio.2016.4052; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tani S, 2008, J CARDIOVASC PHARM, V52, P28, DOI 10.1097/FJC.0b013e31817d4507; YASUE H, 1974, CIRCULATION, V50, P534, DOI 10.1161/01.CIR.50.3.534	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210498	10.1371/journal.pone.0210498	http://dx.doi.org/10.1371/journal.pone.0210498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699150	Green Submitted, Green Published, gold			2022-12-26	WOS:000457155600037
J	Yumoto, T; Naito, H; Ihoriya, H; Yorifuji, T; Nakao, A				Yumoto, Tetsuya; Naito, Hiromichi; Ihoriya, Hiromi; Yorifuji, Takashi; Nakao, Atsunori			Mortality in trauma patients admitted during, before, and after national academic emergency medicine and trauma surgery meeting dates in Japan	PLOS ONE			English	Article							WEEKEND; TIMES; CARE; ICU	Annually, many physicians attend national academic meetings. While participating in these meetings can have a positive impact on daily medical practice, attendance may result in reduced medical staffing during the meeting dates. We sought to examine whether there were differences in mortality after trauma among patients admitted to the hospital during, before, and after meeting dates. Using the Japan Trauma Data Bank, we analyzed in-hospital mortality in patients with traumatic injury admitted to the hospital from 2004 to 2015 during the dates of two national academic meetings-the Japanese Association for Acute Medicine (JAAM) and the Japanese Association for the Surgery of Trauma (JAST). We compared the data with that of patients admitted with trauma during identical weekdays in the weeks before and after the meetings, respectively. We used multiple logistic regression analysis to compare outcomes among the three groups. A total of 7,491 patients were included in our analyses, with 2,481, 2,492, and 2,518 patients in the during, before, and after meeting dates groups, respectively; their mortality rates were 7.3%, 8.0%, and 8.5%, respectively. After adjusting for covariates, no significant differences in in-hospital mortality were found among the three groups (adjusted odds ratio [95% CI] of the before meeting dates and after meeting dates groups; 1.18 [0.89-1.56] and 1.23 [0.93-1.63], respectively, with the during meeting dates group as the reference category). No significant differences in in-hospital mortality were found among trauma patients admitted during, before, and after the JAAM and JAST meeting dates.	[Yumoto, Tetsuya; Naito, Hiromichi; Ihoriya, Hiromi; Nakao, Atsunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency Crit Care & Disaster Med, Okayama, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama, Japan	Okayama University; Okayama University	Yumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency Crit Care & Disaster Med, Okayama, Japan.	tyumoto@cc.okayama-u.ac.jp	Naito, Hiromichi/AHD-6916-2022	Naito, Hiromichi/0000-0002-7308-1716				Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Carr BG, 2010, J TRAUMA, V69, P1042, DOI 10.1097/TA.0b013e3181f6f958; Ford K, 2016, WEST J EMERG MED, V17, P549, DOI 10.5811/westjem.2016.7.29812; Giannoudis V, 2016, INJURY, V47, P2385, DOI 10.1016/j.injury.2016.10.007; Guly HR, 2006, EMERG MED J, V23, P276, DOI 10.1136/emj.2005.028746; Hemmila MR, 2018, JAMA SURG, V153, P747, DOI 10.1001/jamasurg.2018.0985; Hjortdahl M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-48; Japan Trauma Care and Research, 2012, JAP TRAUM DAT BANK A; Jena AB, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008230; Jena AB, 2015, JAMA INTERN MED, V175, P237, DOI 10.1001/jamainternmed.2014.6781; Khoshchehreh M, 2016, INT J CARDIOL, V210, P164, DOI 10.1016/j.ijcard.2016.02.087; Kitamura T, 2016, J EPIDEMIOL, V26, P155, DOI 10.2188/jea.JE20150100; Laupland Kevin B, 2009, J Trauma Manag Outcomes, V3, P8, DOI 10.1186/1752-2897-3-8; Mains C, 2009, J TRAUMA, V66, P1315, DOI 10.1097/TA.0b013e31819d96d8; Mazahir S, 2015, INJURY, V46, P610, DOI 10.1016/j.injury.2015.01.016; Metcalfe D, 2018, J SURG RES, V222, P219, DOI 10.1016/j.jss.2017.10.019; Metcalfe D, 2016, EMERG MED J, V33, P836, DOI 10.1136/emermed-2016-206049; Mizuno S, 2016, INT J CARDIOL, V220, P929, DOI 10.1016/j.ijcard.2016.06.168; Nanchal R, 2012, CHEST, V142, P690, DOI 10.1378/chest.11-2663; Neuraz A, 2015, CRIT CARE MED, V43, P1587, DOI 10.1097/CCM.0000000000001015; Ono Y, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0095-1; Roberts SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131836; Schwartz DA, 2014, J TRAUMA ACUTE CARE, V76, P134, DOI 10.1097/TA.0b013e3182ab0cfc; Sewalt CA, 2018, J TRAUMA ACUTE CARE, V85, P810, DOI 10.1097/TA.0000000000002043; Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393; Uusaro A, 2003, INTENS CARE MED, V29, P2144, DOI 10.1007/s00134-003-2035-1	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0207049	10.1371/journal.pone.0207049	http://dx.doi.org/10.1371/journal.pone.0207049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695039	Green Published, Green Submitted, gold			2022-12-26	WOS:000457046400004
J	De-Arteaga, M; Chen, JS; Huggins, P; Elmer, J; Clermont, G; Dubrawski, A				De-Arteaga, Maria; Chen, Jieshi; Huggins, Peter; Elmer, Jonathan; Clermont, Gilles; Dubrawski, Artur			Predicting neurological recovery with Canonical Autocorrelation Embeddings	PLOS ONE			English	Article							CARDIAC-ARREST; INTENSIVE-CARE; COMATOSE SURVIVORS; RESUSCITATION; ASSOCIATION; SUPPRESSION; VALIDATION; WITHDRAWAL; PROGNOSIS; UPDATE	Early prediction of the potential for neurological recovery after resuscitation from cardiac arrest is difficult but important. Currently, no clinical finding or combination of findings are sufficient to accurately predict or preclude favorable recovery of comatose patients in the first 24 to 48 hours after resuscitation. Thus, life-sustaining therapy is often continued for several days in patients whose irrecoverable injury is not yet recognized. Conversely, early withdrawal of life-sustaining therapy increases mortality among patients who otherwise might have gone on to recover. In this work, we present Canonical Autocorrelation Analysis (CAA) and Canonical Autocorrelation Embeddings (CAE), novel methods suitable for identifying complex patterns in high-resolution multivariate data often collected in highly monitored clinical environments such as intensive care units. CAE embeds sets of datapoints onto a space that characterizes their latent correlation structures and allows direct comparison of these structures through the use of a distance metric. The methodology may be particularly suitable when the unit of analysis is not just an individual datapoint but a dataset, as for instance in patients for whom physiological measures are recorded over time, and where changes of correlation patterns in these datasets are informative for the task at hand. We present a proof of concept to illustrate the potential utility of CAE by applying it to characterize electroencephalographic recordings from 80 comatose survivors of cardiac arrest, aiming to identify patients who will survive to hospital discharge with favorable functional recovery. Our results show that with very low probability of making a Type 1 error, we are able to identify 32.5% of patients who are likely to have a good neurological outcome, some of whom have otherwise unfavorable clinical characteristics. Importantly, some of these had 5% predicted chance of favorable recovery based on initial illness severity measures alone. Providing this information to support clinical decision-making could motivate the continuation of life-sustaining therapies for these patients.	[De-Arteaga, Maria] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [De-Arteaga, Maria] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [De-Arteaga, Maria; Chen, Jieshi; Huggins, Peter; Dubrawski, Artur] Carnegie Mellon Univ, Sch Comp Sci, Auton Lab, Pittsburgh, PA 15213 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Clermont, Gilles] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Sch Med, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	De-Arteaga, M (corresponding author), Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA.; De-Arteaga, M (corresponding author), Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA.; De-Arteaga, M (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Auton Lab, Pittsburgh, PA 15213 USA.	mdeartea@andrew.cmu.edu		Chen, Jieshi/0000-0003-2660-4913; De-Arteaga, Maria/0000-0003-2297-3308	Defense Advanced Research Projects Agency (DARPA) [FA8750-12-2-0324, FA8750-17-2-0130]; National Institutes of Health (NIH) [5K12HL109068, 1K23NS097629]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS097629] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been partially supported by Defense Advanced Research Projects Agency (DARPA) under awards FA8750-12-2-0324 and FA8750-17-2-0130. Dr. Elmer is supported by National Institutes of Health (NIH) through grants 5K12HL109068 and 1K23NS097629.	Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; Branges L. D., 1959, P AM MATH SOC, V10, P822, DOI [10.1090/s0002-9939-1959-0113131-7, 10.2307/2033481, DOI 10.2307/2033481]; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chen Lujie, 2015, AMIA Annu Symp Proc, V2015, P1841; Cloostermans MC, 2012, CRIT CARE MED, V40, P2867, DOI 10.1097/CCM.0b013e31825b94f0; Coppler PJ, 2015, RESUSCITATION, V89, P86, DOI 10.1016/j.resuscitation.2015.01.020; Cortes C, 2016, LECT NOTES ARTIF INT, V9925, P67, DOI 10.1007/978-3-319-46379-7_5; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; El-Arini K, 2006, LECT NOTES ARTIF INT, V4213, P495; Elmer J, 2017, SEMIN NEUROL, V37, P19, DOI 10.1055/s-0036-1597833; Elmer J, 2016, NEUROCRIT CARE, V25, P415, DOI 10.1007/s12028-016-0263-9; Elmer J, 2016, RESUSCITATION, V108, P48, DOI 10.1016/j.resuscitation.2016.09.008; Elmer J, 2016, ANN NEUROL, V80, P175, DOI 10.1002/ana.24697; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Fiterau M., 2012, ADV NEURAL INFORM PR, P3023; Forstner W., 2003, GEODESY THE CHALLENG, P299, DOI [DOI 10.1007/978-3-662-05296-9_31, 10.1007/978-3-662-05296-9_31]; Friman O, 2002, NEUROIMAGE, V16, P454, DOI 10.1006/nimg.2002.1067; Gold B, 2014, RESUSCITATION, V85, P211, DOI 10.1016/j.resuscitation.2013.10.030; Gorski J, 2007, MATH METHOD OPER RES, V66, P373, DOI 10.1007/s00186-007-0161-1; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Hofmeijer J, 2014, CLIN NEUROPHYSIOL, V125, P947, DOI 10.1016/j.clinph.2013.10.017; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Ignaccolo M, 2010, J BIOL PHYS, V36, P185, DOI 10.1007/s10867-009-9171-y; KORTH B, 1976, PSYCHOMETRIKA, V41, P531, DOI 10.1007/BF02296973; KRZANOWSKI WJ, 1979, J AM STAT ASSOC, V74, P703, DOI 10.2307/2286995; Lakkaraju H, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P275, DOI 10.1145/3097983.3098066; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madras D., 2017, ARXIV171106664; Menegazzi JJ, 2004, CIRCULATION, V109, P926, DOI 10.1161/01.CIR.0000112606.41127.D2; Mulder M, 2014, CRIT CARE MED, V42, P2493, DOI 10.1097/CCM.0000000000000540; Sandroni C, 2014, INTENS CARE MED, V40, P1816, DOI 10.1007/s00134-014-3470-x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todros K, 2012, PR IEEE SEN ARRAY, P361, DOI 10.1109/SAM.2012.6250511; Wiens J., 2012, ICML WORKSH MACH LEA; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210966	10.1371/journal.pone.0210966	http://dx.doi.org/10.1371/journal.pone.0210966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689648	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800016
J	Araujo, ACM; Almeida, EB; Rocha, CQ; Lima, AS; Silva, CR; Tangerina, MMP; Neto, JSL; Costa, LM				Araujo, Ana Cassia M.; Almeida, Eduardo B., Jr.; Rocha, Claudia Q.; Lima, Aldilene S.; Silva, Carolina R.; Tangerina, Marcelo M. P.; Lima Neto, Jose S.; Costa-Junior, Livio M.			Antiparasitic activities of hydroethanolic extracts of Ipomoea imperati (Vahl) Griseb. (Convolvulaceae)	PLOS ONE			English	Article							TANNIFEROUS PLANT-EXTRACTS; VITRO LARVAL MIGRATION; HAEMONCHUS-CONTORTUS; ANTHELMINTIC ACTIVITY; INFECTIVE LARVAE; EXSHEATHMENT; 3RD-STAGE; TANNINS	Ipomoea imperati is widely used in tropical areas to treat several pathological conditions. The effect of this plant against parasitic species has not been investigated even being used for this purpose in the Brazilian northeastern. This study aimed to evaluate the anthelmintic and acaricide potential of a hydroethanolic extract of I. imperati leaves and stolons. I. imperati leaves and stolons were crushed and subjected to maceration in ethanol 70% (v/v), after which the solvent was removed using a rotary evaporator. The chromatographic profile of the extract was obtained by UV Spectrum high-performance liquid chromatography and compounds were identified by liquid chromatography/electrospray ionization tandem mass spectrometry. Identification of the compounds present in the extract was achieved by comparing their retention times and UV spectra with data in the literature. Anthelmintic activity was evaluated by larval exsheathment inhibition assays using Haemonchus contortus larvae and five concentrations of each extract ranging from 0.07 to 1.2 mg/mL. Acaricide activity was evaluated via larval immersion of Rhipicephalus microplus in eight concentrations of each extract ranging from 5.0 to 25.0 mg/mL. Live and dead larvae were counted after 24 hours. The median inhibitory concentration (IC50) for H. contortus larvae and the median lethal concentration (LC50) for R. microplus larvae were calculated. Twelve compounds were observed in the hydroethanolic extract of leaves, with a predominance of the aglycone form of flavonoids and tannins. This extract was effective against H. contortus larvae, presenting an average inhibitory concentration of 0.22 mg/mL, but showed no activity toward R. microplus larvae. The stolon hydroethanolic extract presented 11 compounds, with phenolic acids and glycosylated flavonoids prevailing. This extract showed low activity on R. microplus and no effect on inhibiting H. contortus larval exsheathment at the concentrations tested. This study is the first to assess the anthelmintic and acaricidal activities of I. imperati. Data reported confirm promising potential of I. imperati leaves hydroethanolic extract against H. contortus. This effect could be due to its secondary compounds presents in this extract, such as procyanidin, kaempferol, isoquercitrin and rutin.	[Araujo, Ana Cassia M.] Univ Fed Maranhao, Ctr Ciencias Biol & Saude, Programa Posgrad Biodivers & Conservac, Sao Luis, Maranhao, Brazil; [Almeida, Eduardo B., Jr.] Univ Fed Maranhao, Dept Biol, Sao Luis, Maranhao, Brazil; [Rocha, Claudia Q.; Lima, Aldilene S.] Univ Fed Maranhao, Dept Quim, Sao Luis, Maranhao, Brazil; [Rocha, Claudia Q.; Silva, Carolina R.; Costa-Junior, Livio M.] Univ Fed Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil; [Tangerina, Marcelo M. P.] Univ Estadual Paulista, Inst Biociencias, Lab Bioprospeccao Prod Nat, Sao Vicente, SP, Brazil; [Lima Neto, Jose S.] Univ Fed Piaui, Dept Farm, Lab Geoquim Organ, Teresina, Piaui, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal do Piaui	Almeida, EB (corresponding author), Univ Fed Maranhao, Dept Biol, Sao Luis, Maranhao, Brazil.; Costa, LM (corresponding author), Univ Fed Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil.	ebaj25@yahoo.com.br; livio.martins@ufma.br	Araujo, Ana Cássia Medeiros/AAD-7659-2019; Rocha e Silva, Carolina/HHN-8484-2022; Tangerina, Marcelo M P Marucci Pereira/L-3580-2016; Rocha, Cláudia Quintino da/C-2320-2013; da Rocha, Claudia Quintino/U-8013-2019; de Sousa Lima Neto, José/E-6937-2015; Tangerina, Marcelo/AEF-1225-2022; Lima-Neto, José/T-3483-2019; Costa-Junior, Livio M/H-7530-2012	Tangerina, Marcelo M P Marucci Pereira/0000-0002-4236-094X; Rocha, Cláudia Quintino da/0000-0002-3578-1869; da Rocha, Claudia Quintino/0000-0002-3578-1869; de Sousa Lima Neto, José/0000-0002-3933-6391; Costa-Junior, Livio M/0000-0002-1475-049X; Rocha e Silva, Carolina/0000-0001-8667-1064	Financiadora de estudos e projetos by "FINEP Chamada Apoio Institucional" [03/2016]; Fundacao de Amparo a Pesquisa e ao Desenvolvimento cientifico e tecnologico do Maranhao (FAPEMA) by "IECT Biotecnologia"; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (Coordination for the Improvement of High Higher Education Personnel, Brazil); FAPEMA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (National Council for Scientific and Technological Development)	Financiadora de estudos e projetos by "FINEP Chamada Apoio Institucional"; Fundacao de Amparo a Pesquisa e ao Desenvolvimento cientifico e tecnologico do Maranhao (FAPEMA) by "IECT Biotecnologia"; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (Coordination for the Improvement of High Higher Education Personnel, Brazil); FAPEMA(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study had financial support by Financiadora de estudos e projetos by "FINEP Chamada Apoio Institucional 03/2016" to LMCJ and Fundacao de Amparo a Pesquisa e ao Desenvolvimento cientifico e tecnologico do Maranhao (FAPEMA) by "IECT Biotecnologia" to LMCJ. The author CRS received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (Coordination for the Improvement of High Higher Education Personnel, Brazil). The authors ACMA and ASL received scholarship from FAPEMA. The author LMCJ received a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (National Council for Scientific and Technological Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari H, 2016, VET MED-CZECH, V61, P308, DOI 10.17221/169/2015-VETMED; Ali A, 2016, CIENC RURAL, V46, P1240, DOI 10.1590/0103-8478cr20151416; Alonso-Diaz MA, 2008, VET PARASITOL, V153, P313, DOI 10.1016/j.vetpar.2008.01.042; Alonso-Diaz MA, 2011, VET PARASITOL, V181, P360, DOI 10.1016/j.vetpar.2011.03.052; Athanasiadou S, 2007, ANIMAL, V1, P1392, DOI 10.1017/S1751731107000730; Austin DF, 1996, TAXON, V45, P3, DOI 10.2307/1222581; Azando EVB, 2011, VET PARASITOL, V180, P292, DOI 10.1016/j.vetpar.2011.03.010; Bahuaud D, 2006, PARASITOLOGY, V132, P545, DOI 10.1017/S0031182005009509; Barrau E, 2005, PARASITOLOGY, V131, P531, DOI 10.1017/S0031182005008024; Brito DRB, 2017, SEMIN-CIENC AGRAR, V38, P1963, DOI 10.5433/1679-0359.2017v38n4p1963; de Oliveira LMB, 2011, REV BRAS PARASITOL V, V20, P155, DOI 10.1590/S1984-29612011000200011; Brunet S, 2011, PARASITOL INT, V60, P419, DOI 10.1016/j.parint.2010.09.011; Cai CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095931; Chougule MB, 2016, PROG DRUG RES, V71, P11, DOI 10.1007/978-3-319-26811-8_3; Costa Neto SV, 2000, B MUS PARA EMILIO GO, V16, P163; De Paula-Zurron ACB, 2010, REV BRAS FARMACOGN, V20, P180, DOI 10.1590/S0102-695X2010000200008; Dhembare A. J., 2015, Der Pharmacia Lettre, V7, P262; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Soares AMD, 2015, REV BRAS PARASITOL V, V24, P396, DOI 10.1590/S1984-29612015072; Estrada-Pena A, 2013, AGRICULTURE-BASEL, V3, P221, DOI 10.3390/agriculture3020221; Felger Richard S., 2012, Journal of the Botanical Research Institute of Texas, V6, P459; Ferreira P. P. A., 2009, Revista Brasileira de Biociencias, V7, P440; Ghosh S, 2014, ASIAN J PHARM CLIN R, V7, P162; Grisi L, 2014, REV BRAS PARASITOL V, V23, P150, DOI 10.1590/S1984-29612014042; Hoste H, 2012, VET PARASITOL, V186, P18, DOI 10.1016/j.vetpar.2011.11.042; Jardim MAG., 2005, REV BRASILEIRA FARMA, V86, P117; Kamaraj C, 2010, PARASITOL RES, V106, P1071, DOI 10.1007/s00436-010-1750-0; Klafke GM, 2006, VET PARASITOL, V142, P386, DOI 10.1016/j.vetpar.2006.07.001; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Lasisi A. A., 2011, African Journal of Plant Science, V5, P469; Lonard RI, 1999, J COASTAL RES, V15, P645; Malakar C., 2015, ASIAN J PHARM CLIN R, V8, P60; Meira M, 2012, REV BRAS FARMACOGN, V22, P682, DOI 10.1590/S0102-695X2012005000025; Mengistu G, 2017, VET PARASITOL, V237, P110, DOI 10.1016/j.vetpar.2016.12.020; Minho Alessandro P, 2008, Rev Bras Parasitol Vet, V17 Suppl 1, P144; Miyahara MRM, 2011, REV BRAS FARMACOGN, V21, P978, DOI 10.1590/S0102-695X2011005000143; Moreno-Gonzalo J, 2013, VET PARASITOL, V197, P235, DOI 10.1016/j.vetpar.2013.05.010; O'Connor LJ, 2006, VET PARASITOL, V142, P1, DOI 10.1016/j.vetpar.2006.08.035; Oliveira AF, 2017, VET PARASITOL, V236, P121, DOI 10.1016/j.vetpar.2017.02.005; Paula ACB, 2003, BRAZ J MED BIOL RES, V36, P105, DOI 10.1590/S0100-879X2003000100014; Pavela R, 2016, RES VET SCI, V109, P1, DOI 10.1016/j.rvsc.2016.09.001; Qadir S, 2010, VET WORLD, V3, P515; Qamar M. F., 2011, Science International (Lahore), V23, P295; Quijada J, 2015, J AGR FOOD CHEM, V63, P6346, DOI 10.1021/acs.jafc.5b00831; Roeber F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-153; SON-DE FERNEX E.V, 2012, EXPT PARASITOLOGY NE, V131, P413, DOI DOI 10.1016/J.EXPPARA.2012.05.010; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Zaman MA, 2017, INT J AGRIC BIOL, V19, P957, DOI 10.17957/IJAB/15.0289; Zhang BY, 2015, CHEM PHARM BULL, V63, P255, DOI 10.1248/cpb.c14-00765; Zhou X, 2014, J PARASITOL, V100, P848, DOI 10.1645/14-556.1; Zia-Ul-Haq M, 2012, MOLECULES, V17, P13132, DOI 10.3390/molecules171113132	51	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211372	10.1371/journal.pone.0211372	http://dx.doi.org/10.1371/journal.pone.0211372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682142	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500157
J	Choi, JW; Budzevich, M; Wang, SW; Gage, K; Estrella, V; Gillies, RJ				Choi, Jung W.; Budzevich, Mikalai; Wang, Shaowei; Gage, Kenneth; Estrella, Veronica; Gillies, Robert J.			In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes	PLOS ONE			English	Article							PET; FLOW; PERFUSION; SPECT; CU-62-PTSM; GENERATOR; QUANTIFICATION; PERFORMANCE; CU-62-ATSM; HYPOXIA	99m-Technetium-labeled (Tc-99m) erythrocyte imaging with planar scintigraphy is widely used for evaluating both patients with occult gastrointestinal bleeding and patients at risk for chemotherapy-induced cardiotoxicity. While a number of alternative radionuclide-based blood pool imaging agents have been proposed, none have yet to achieve widespread clinical use. Here, we present both in vitro and small animal in vivo imaging evidence that the high physiological expression of the glucose transporter GLUT1 on human erythrocytes allows uptake of the widely available radiotracer 2-deoxy-2-(F-18) fluoro-D-glucose (FDG), at a rate and magnitude sufficient for clinical blood pool positron emission tomographic (PET) imaging. This imaging technique is likely to be amenable to rapid clinical translation, as it can be achieved using a simple FDG labeling protocol, requires a relatively small volume of phlebotomized blood, and can be completed within a relatively short time period. As modern PET scanners typically have much greater count detection sensitivities than that of commonly used clinical gamma scintigraphic cameras, FDG-labeled human erythrocyte PET imaging may not only have significant advantages over Tc-99m-labeled erythrocyte imaging, but may have other novel blood pool imaging applications.	[Choi, Jung W.; Gage, Kenneth; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Diagnost Imaging, Tampa, FL 33612 USA; [Choi, Jung W.; Budzevich, Mikalai; Estrella, Veronica; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Physiol, Tampa, FL 33612 USA; [Wang, Shaowei] Univ S Florida, Dept Med Engn, Tampa, FL USA; [Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Program Canc Biol & Evolut, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Choi, JW (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Diagnost Imaging, Tampa, FL 33612 USA.; Choi, JW (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Physiol, Tampa, FL 33612 USA.	Jung.Choi@Moffitt.org	Gage, Kenneth/AAH-8391-2021; Choi, Jung/G-8127-2016	wang, shaowei/0000-0002-8860-4436; Gillies, Robert/0000-0002-8888-7747; Choi, Jung/0000-0001-8206-4259	NCI NIH HHS [P30 CA076292] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1991, Ann ICRP, V21, P1; Bailey DL, 2016, SEMIN NUCL MED, V46, P428, DOI 10.1053/j.semnuclmed.2016.04.007; Basuli F, 2015, NUCL MED BIOL, V42, P219, DOI 10.1016/j.nucmedbio.2014.11.011; Bonte Frederick J, 2011, Int J Mol Imaging, V2011, P409101, DOI 10.1155/2011/409101; Bratosin D, 2005, CYTOM PART A, V66A, P78, DOI 10.1002/cyto.a.20152; BUROW RD, 1977, CIRCULATION, V56, P1024, DOI 10.1161/01.CIR.56.6.1024; Christy M, 1987, SPECIFIC ABSORBED FR; De Langen AJ, 2008, ONCOLOGIST, V13, P631, DOI 10.1634/theoncologist.2007-0235; Fan AP, 2016, J CEREBR BLOOD F MET, V36, P842, DOI 10.1177/0271678X16636393; Flower MA, 2001, EUR J NUCL MED, V28, P99, DOI 10.1007/s002590000410; Goffin K, 2008, SEMIN NUCL MED, V38, P227, DOI 10.1053/j.semnuclmed.2008.02.004; GREEN MA, 1988, J NUCL MED, V29, P1549; GREEN MA, 1990, J NUCL MED, V31, P1989; Groch MW, 2001, J NUCL MED, V42, P1773; Haynes NG, 2000, J NUCL MED, V41, P309; Herrero P, 1996, J NUCL MED, V37, P1294; Ibaraki M, 2008, J NUCL MED, V49, P50, DOI 10.2967/jnumed.107.044008; ICRP, 2002, ANN ICRP, V32, P5; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Kim SJ, 2005, INT J CARDIOVAS IMAG, V21, P261, DOI 10.1007/s10554-004-6133-0; Lamas GA, 2014, AM HEART J, V168, P37, DOI 10.1016/j.ahj.2014.02.012; Lewis M, 2012, J MED IMAG RADIAT ON, V56, P187, DOI 10.1111/j.1754-9485.2012.02347.x; Lodge MA, 2008, J NUCL MED, V49, P1620, DOI 10.2967/jnumed.108.052076; MacDonald A, 2008, J NUCL MED TECHNOL, V36, P132, DOI 10.2967/jnmt.108.051383; Matsusaka Y, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0266-3; Montel-Hagen A, 2008, BLOOD, V112, P4729, DOI 10.1182/blood-2008-05-159269; Niu G, 2014, J NUCL MED, V55, P1150, DOI 10.2967/jnumed.114.139642; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pelletier-Galarneau M, 2019, J NUCL CARDIOL, V26, P1857, DOI 10.1007/s12350-018-1251-6; Pretorius E, 2016, CELL PHYSIOL BIOCHEM, V39, P1977, DOI 10.1159/000447895; Rahmim A, 2008, NUCL MED COMMUN, V29, P193, DOI 10.1097/MNM.0b013e3282f3a515; Raja S, 2014, NUCL MED COMMUN, V35, P1156, DOI 10.1097/MNM.0000000000000182; Saatchi K, 2012, INT J PHARMACEUT, V422, P418, DOI 10.1016/j.ijpharm.2011.10.036; SHELTON ME, 1990, CIRCULATION, V82, P990, DOI 10.1161/01.CIR.82.3.990; Stabin MG, 2005, J NUCL MED, V46, P1023; Stabin MG, 2003, HEALTH PHYS, V85, P294, DOI 10.1097/00004032-200309000-00006; Stabin MG, 2008, FUNDAMENTALS NUCL ME; THORNE DA, 1987, J NUCL MED, V28, P514; Viskupicova J, 2015, REDOX BIOL, V5, P381, DOI 10.1016/j.redox.2015.06.011; Wallhaus TR, 2001, J NUCL CARDIOL, V8, P67, DOI 10.1067/mnc.2001.109929; Wang ZG, 2015, GENET MOL RES, V14, P14947, DOI 10.4238/2015.November.24.2; Welch MJ, 2000, J NUCL MED, V41, P315; Wong TZ, 2008, AM J ROENTGENOL, V190, P427, DOI 10.2214/AJR.07.2876; Zhang T, 2013, AM J ROENTGENOL, V201, pW698, DOI 10.2214/AJR.12.9698	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211012	10.1371/journal.pone.0211012	http://dx.doi.org/10.1371/journal.pone.0211012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682160	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500089
J	Duffy, KA; Luber, B; Adcock, RA; Chartrand, TL				Duffy, Korrina A.; Luber, Bruce; Adcock, R. Alison; Chartrand, Tanya L.			Enhancing activation in the right temporoparietal junction using theta-burst stimulation: Disambiguating between two hypotheses of top-down control of behavioral mimicry	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; SHARED REPRESENTATIONS; SELF; RECOGNITION; SCHIZOPHRENIA; AFFILIATION; INHIBITION; MECHANISMS; IMITATION; RELEVANCE	Whereas previous research has focused on the role of the rTPJ when consciously inhibiting mimicry, we test the role of the rTPJ on mimicry within a social interaction, during which mimicking occurs nonconsciously. We wanted to determine whether higher rTPJ activation always inhibits the tendency to imitate (regardless of the context) or whether it facilitates mimicry during social interactions (when mimicking is an adaptive response). Participants received either active or sham intermittent theta-burst stimulation (iTBS: a type of stimulation that increases cortical activation) to the rTPJ. Next, we measured how much participants mimicked the hair and face touching of another person. Participants in the active stimulation condition engaged in significantly less mimicry than those in the sham stimulation condition. This finding suggests that even in a context in which mimicking is adaptive, rTPJ inhibits mimicry rather than facilitating it, supporting the hypothesis that rTPJ enhances representations of self over other regardless of the goals within a given context.	[Duffy, Korrina A.; Adcock, R. Alison; Chartrand, Tanya L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Luber, Bruce; Adcock, R. Alison] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Adcock, R. Alison] Duke Univ, Dept Neurobiol, Durham, NC USA; [Chartrand, Tanya L.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Duffy, Korrina A.] Natl Canc Inst, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Rockville, MD 20892 USA; [Luber, Bruce] NIMH, Expt Therapeut & Pathophysiol Branch, Bethesda, MD 20892 USA	Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Duffy, KA (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.; Duffy, KA (corresponding author), Natl Canc Inst, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Rockville, MD 20892 USA.	korrina.duffy@nih.gov	Adcock, R Alison/AAX-6649-2020	Adcock, R Alison/0000-0002-7859-5484				Balconi M, 2014, SOC NEUROSCI-UK, V9, P82, DOI 10.1080/17470919.2013.861361; Banissy MJ, 2011, J NEUROSCI, V31, P1820, DOI 10.1523/JNEUROSCI.5759-09.2011; Barth KS, 2011, FRONT PSYCHIATRY, V2, P1; Beeney JE, 2016, PERSONAL DISORD, V7, P28, DOI 10.1037/per0000127; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chartrand TL., 2009, OXFORD HDB HUMAN ACT, P458; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Christopeit M, 2014, BRAIN STIMUL, V7, P141, DOI 10.1016/j.brs.2013.07.006; Cook JL, 2014, NEUROSCI BIOBEHAV R, V42, P298, DOI 10.1016/j.neubiorev.2014.02.007; Cross KA, 2013, NEUROIMAGE, V83, P493, DOI 10.1016/j.neuroimage.2013.06.060; Cross KA, 2013, HUM BRAIN MAPP, V34, P213, DOI 10.1002/hbm.21428; Davis MH, 1980, JSAS CAT SEL DOC PSY, V10, DOI [10.1080/00223891, DOI 10.1080/00223891]; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Duffy KA, 2017, PSYCHONEUROENDOCRINO, V76, P174, DOI 10.1016/j.psyneuen.2016.11.017; Duffy KA, 2015, PSYCHOL SCI, V26, P1795, DOI 10.1177/0956797615600890; Eddy CM, 2016, J PSYCHIATR RES, V81, P102, DOI 10.1016/j.jpsychires.2016.07.002; Farley SD, 2014, J NONVERBAL BEHAV, V38, P195, DOI 10.1007/s10919-014-0174-4; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Ganos C, 2012, MOVEMENT DISORD, V27, P1222, DOI 10.1002/mds.25103; Hogeveen J, 2015, SOC COGN AFFECT NEUR, V10, P1003, DOI 10.1093/scan/nsu148; Holle H, 2013, NEUROIMAGE, V83, P1041, DOI 10.1016/j.neuroimage.2013.07.073; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Karremans JC, 2008, PERS SOC PSYCHOL B, V34, P939, DOI 10.1177/0146167208316693; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leary MR, 2013, J PERS ASSESS, V95, P610, DOI 10.1080/00223891.2013.819511; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Maddux WW, 2008, J EXP SOC PSYCHOL, V44, P461, DOI 10.1016/j.jesp.2007.02.003; Matzke B, 2014, PSYCHOPATHOLOGY, V47, P101, DOI 10.1159/000351122; McAdams CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P54, DOI 10.1016/j.pscychresns.2011.06.016; McAdams CJ, 2013, FRONT PSYCHIATRY, V4, P1, DOI [10.3389/fpsyt.2013.00001, DOI 10.3389/FPSYT.2013.00001]; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Nihonsugi T, 2015, J NEUROSCI, V35, P3412, DOI 10.1523/JNEUROSCI.3885-14.2015; Oberman LM, 2009, DEVELOPMENTAL SCI, V12, P510, DOI 10.1111/j.1467-7687.2008.00796.x; Plaze M, 2011, SCHIZOPHRENIA BULL, V37, P212, DOI 10.1093/schbul/sbp081; Riva P, 2015, SOC NEUROSCI-UK, V10, P46, DOI 10.1080/17470919.2014.946621; Riva P, 2012, PSYCHOL SCI, V23, P1473, DOI 10.1177/0956797612450894; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Santiesteban I, 2015, CORTEX, V71, P116, DOI 10.1016/j.cortex.2015.06.019; Santiesteban I, 2012, CURR BIOL, V22, P2274, DOI 10.1016/j.cub.2012.10.018; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; SNYDER M, 1986, J PERS SOC PSYCHOL, V51, P125, DOI 10.1037/0022-3514.51.1.125; Sowden S, 2015, CEREB CORTEX, V25, P1107, DOI 10.1093/cercor/bht306; Spengler S, 2010, SOC NEUROSCI-UK, V5, P401, DOI 10.1080/17470911003687905; Spengler S, 2009, HUM BRAIN MAPP, V30, P3704, DOI 10.1002/hbm.20800; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van den Bos W, 2014, SOC COGN AFFECT NEUR, V9, P2059, DOI 10.1093/scan/nsu003; Varcin KJ, 2010, J INT NEUROPSYCH SOC, V16, P621, DOI 10.1017/S1355617710000329; Wang GR, 2016, BEHAV BRAIN RES, V303, P71, DOI 10.1016/j.bbr.2016.01.047; Ward J, 2015, COGN NEUROSCI-UK, V6, P118, DOI 10.1080/17588928.2015.1042444	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211279	10.1371/journal.pone.0211279	http://dx.doi.org/10.1371/journal.pone.0211279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682141	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500140
J	Zhang, T; Han, WQ; Zhao, KX; Yang, WL; Lu, XY; Jia, YW; Qin, A; Qian, Y				Zhang, Tan; Han, Weiqi; Zhao, Kangxian; Yang, Wanlei; Lu, Xuanyuan; Jia, Yewei; Qin, An; Qian, Yu			Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts	FASEB JOURNAL			English	Article						natural products; bone repair; osteoclastogenesis; osteoblastogenesis; ERK signaling pathway	EXTRACELLULAR-MATRIX; HEPATIC-FIBROSIS; CATHEPSIN K; DIFFERENTIATION; INHIBITION; PATHWAYS; ERK; POPULATION; REPAIR; CELLS	Bone fracture healing is a complex, dynamic process that involves various cell types, with osteoclasts and osteoblasts playing indispensable roles. In this study, we found that psoralen, the main active ingredient in Psoralea corylifolia L. fruit extract, enhanced bone fracture healing through activation of osteoclast and osteoblast activity via the ERK signaling pathway. In detail, psoralen promoted receptor activator of nuclear factor-kappa B ligand-induced osteoclastogenesis, mRNA expression of osteoclast-specific genes, and osteoclastic bone resorption in primary bone marrow-derived macrophages. Meanwhile, psoralen induced osteogenic differentiation by promoting the mRNA expression of the osteoblast differentiation markers alkaline phosphatase, runt-related transcription factor 2, osterix, and osteocalcin. At the molecular level, psoralen preferentially activated ERK1/2 but not JNK or p38 MAPKs. Further experiments revealed that psoralen-induced osteoclast and osteoblast differentiation was abrogated by a specific inhibitor of phosphorylated ERK. In addition, psoralen accelerated bone fracture healing in a rat tibial fracture model, and the numbers of osteoclasts and osteoblasts were increased in psoralen-treated fracture callus. Taken together, our findings indicate that psoralen accelerates bone fracture healing through activation of osteoclasts and osteoblasts via ERK signaling and has potential as a novel drug in the orthopedic clinic for the treatment of bone fractures.	[Zhang, Tan; Han, Weiqi; Zhao, Kangxian; Yang, Wanlei; Lu, Xuanyuan; Jia, Yewei; Qian, Yu] Zhejiang Univ, Sch Med, Shaoxing Peoples Hosp, Dept Orthopaed, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China; [Qin, An] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Orthoped Implants, Dept Orthoped,Shanghai Peoples Hosp 9, Shanghai, Peoples R China	Zhejiang University; Shanghai Jiao Tong University	Qian, Y (corresponding author), Zhejiang Univ, Sch Med, Shaoxing Peoples Hosp, Dept Orthopaed, 568 Zhongxing North Rd, Shaoxing 312000, Zhejiang, Peoples R China.	doctor120@hotmail.com		Jia, Yewei/0000-0001-5447-973X	National Natural Science Foundation of China [81871801, 81572126]; Natural Science Foundation of Zhejiang Province [LY15H060005]; Zhejiang Basic Public Welfare Research Project [LGF18H060010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Basic Public Welfare Research Project	The authors thank Wang Linxia (Shaoxing University, Zhejiang, China) for skillful molecular technical assistance. This study was funded by the National Natural Science Foundation of China (Grant 81871801), the National Natural Science Foundation of China (Grant 81572126), the Natural Science Foundation of Zhejiang Province (Grant LY15H060005), and the Zhejiang Basic Public Welfare Research Project (LGF18H060010). The authors declare no conflicts of interest.	Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Che CT, 2016, MOLECULES, V21, DOI 10.3390/molecules21030239; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fang QL, 2018, BBA-MOL BASIS DIS, V1864, P252, DOI 10.1016/j.bbadis.2017.09.026; Gentile MA, 2014, BONE, V66, P72, DOI 10.1016/j.bone.2014.04.032; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Han WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36330; Hankenson KD, 2015, ADV DRUG DELIVER REV, V94, P3, DOI 10.1016/j.addr.2015.09.008; Hankenson KD, 2014, INJURY, V45, pS8, DOI 10.1016/j.injury.2014.04.003; He LH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42385; He YX, 2012, OSTEOPOROSIS INT, V23, P377, DOI 10.1007/s00198-011-1812-x; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Karvande A, 2017, J PHARM PHARMACOL, V69, P1381, DOI 10.1111/jphp.12764; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.95; Kostenuik P, 2017, J ORTHOP RES, V35, P213, DOI 10.1002/jor.23460; Li FM, 2017, EXP THER MED, V14, P2385, DOI 10.3892/etm.2017.4771; Lin X, 2016, CELL PHYSIOL BIOCHEM, V40, P1422, DOI 10.1159/000453194; Linder M, 2018, CELL DEATH DIFFER, V25, P1094, DOI 10.1038/s41418-017-0054-7; Luchetti F, 2014, J PINEAL RES, V56, P382, DOI 10.1111/jpi.12133; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Mehta S, 2015, J MED ECON, V18, P1102, DOI 10.3111/13696998.2015.1083361; Mills LA, 2017, ACTA ORTHOP, V88, P434, DOI 10.1080/17453674.2017.1321351; Oh JH, 2015, MOL CELLS, V38, P279, DOI 10.14348/molcells.2015.2340; Okada T, 2006, DIABETES, V55, P1666, DOI 10.2337/db05-1285; Pajarinen J, 2019, BIOMATERIALS, V196, P80, DOI 10.1016/j.biomaterials.2017.12.025; PARFITT AM, 1988, BONE, V9, P67, DOI 10.1016/8756-3282(88)90029-4; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Soung DY, 2013, BONE, V55, P248, DOI 10.1016/j.bone.2013.02.010; Srivastava S, 2014, BIOCHIMIE, V101, P132, DOI 10.1016/j.biochi.2014.01.005; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Tang DZ, 2011, BIOCHEM BIOPH RES CO, V405, P256, DOI 10.1016/j.bbrc.2011.01.021; Wang P, 2017, INT J BIOL SCI, V13, P996, DOI 10.7150/ijbs.19986; Wang T, 2017, J CELL PHYSIOL, V232, P913, DOI 10.1002/jcp.25641; Wong RWK, 2011, J ORTHOP RES, V29, P158, DOI 10.1002/jor.21124; Wu CY, 2013, FITOTERAPIA, V91, P205, DOI 10.1016/j.fitote.2013.09.005; Wu HB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0540-y; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xu LL, 2015, FASEB J, V29, P1143, DOI 10.1096/fj.14-254169; Yang BY, 2016, J ETHNOPHARMACOL, V191, P107, DOI 10.1016/j.jep.2016.05.017; Yang HL, 2016, BIOMATERIALS, V80, P1, DOI 10.1016/j.biomaterials.2015.11.046; Yang WL, 2018, J CELL PHYSIOL, V233, P4606, DOI 10.1002/jcp.26372; Zalli D, 2016, J BONE MINER RES, V31, P1701, DOI 10.1002/jbmr.2851; Zhai ZJ, 2014, BRIT J PHARMACOL, V171, P663, DOI 10.1111/bph.12463; Zhang XP, 2012, ACUPUNCT MED, V30, P324, DOI 10.1136/acupmed-2012-010167; Zhang ZR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060588; Zou WG, 2011, J CLIN INVEST, V121, P4383, DOI 10.1172/JCI59041	53	32	38	5	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5399	5410		10.1096/fj.201801797R	http://dx.doi.org/10.1096/fj.201801797R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30702934	Bronze			2022-12-26	WOS:000462888500062
J	Pearsall, EA; Cheng, R; Matsuzaki, S; Zhou, KL; Ding, LX; Ahn, B; Kinter, M; Humphries, KM; Quiambao, AB; Farjo, RA; Ma, JX				Pearsall, Elizabeth A.; Cheng, Rui; Matsuzaki, Satoshi; Zhou, Kelu; Ding, Lexi; Ahn, Bumsoo; Kinter, Michael; Humphries, Kenneth M.; Quiambao, Alexander B.; Farjo, Rafal A.; Ma, Jian-xing			Neuroprotective effects of PPARa in retinopathy of type 1 diabetes	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; DOWN-REGULATION; ALPHA; MODEL; FENOFIBRATE; DEFICITS; NEURODEGENERATION; ISOMEROHYDROLASE; DEGENERATION	Diabetic retinopathy (DR) is a common neurovascular complication of type 1 diabetes. Current therapeutics target neovascularization characteristic of end-stage disease, but are associated with significant adverse effects. Targeting early events of DR such as neurode-generation may lead to safer and more effective approaches to treatment. Two independent prospective clinical trials unexpectedly identified that the PPAR alpha agonist fenofibrate had unprecedented therapeutic effects in DR, but gave little insight into the physiological and molecular mechanisms of action. The objective of the present study was to evaluate potential neuroprotective effects of PPAR alpha in DR, and subsequently to identify the responsible mechanism of action. Here we reveal that activation of PPAR alpha had a robust protective effect on retinal function as shown by Optokinetic tracking in a rat model of type 1 diabetes, and also decreased retinal cell death, as demonstrated by a DNA fragmentation ELISA. Further, PPAR alpha ablation exacerbated diabetes-induced decline of visual function as demonstrated by ERG analysis. We further found that PPAR alpha improved mitochondrial efficiency in DR, and decreased ROS production and cell death in cultured retinal neurons. Oxidative stress biomarkers were elevated in diabetic Ppare(-/-) mice, suggesting increased oxidative stress. Mitochondrially mediated apoptosis and oxidative stress secondary to mitochondrial dysfunction contribute to neurodegeneration in DR. Taken together, these findings identify a robust neuroprotective effect for PPAR alpha in DR, which may be due to improved mitochondrial function and subsequent alleviation of energetic deficits, oxidative stress and mitochondrially mediated apoptosis.	[Pearsall, Elizabeth A.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA USA; [Pearsall, Elizabeth A.; Cheng, Rui; Zhou, Kelu; Ding, Lexi; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Matsuzaki, Satoshi; Ahn, Bumsoo; Kinter, Michael; Humphries, Kenneth M.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Humphries, Kenneth M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73190 USA; [Quiambao, Alexander B.; Farjo, Rafal A.] EyeCRO LLC, Oklahoma City, OK USA; [Ma, Jian-xing] Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK 73104 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ma, JX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.; Ma, JX (corresponding author), Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu	Ahn, Bumsoo/AAK-3818-2021; Ahn, Bumsoo/GNP-7749-2022	Ahn, Bumsoo/0000-0002-2743-7099; Ding, Lexi/0000-0002-7501-4883; Pearsall, Elizabeth/0000-0003-1013-6238; Humphries, Kenneth/0000-0002-6167-3175	NIH [GM104934, T32EY005318, P30AG050911, EY012231, EY018659, EY019309, P20GM104934, EY021725, GM103639]; JDRF [2-SRA-2014-147-Q-R, 3-PDF-2014-107-A-N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447, P20GM104934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH T32EY005318 (EAP); JDRF 3-PDF-2014-107-A-N (RC); NIH P30AG050911 (MK); NIH EY012231, EY018659, EY019309, P20GM104934, JDRF 2-SRA-2014-147-Q-R (JXM), and center grants NIH EY021725, NIH GM103639 and NIH GM104934. We note that two of the authors, Alexander B. Quiambao and Rafal A. Farjo are Employed by a commercial company, EyeCRO LLC. EyeCRO did not play a role in study design, data collection and analysis, preparation of the manuscript, or decision to publish the manuscript. The only financial support provided was for the authors' salaries.	Agarwal S, 2017, BIOCHEM BIOPH RES CO, V483, P1166, DOI 10.1016/j.bbrc.2016.08.043; Anand SK, 2013, ADV VIROL, V2013, DOI 10.1155/2013/738794; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Bogdanov P, 2015, ACTA DIABETOL, V52, P113, DOI 10.1007/s00592-014-0610-2; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Ding LX, 2014, AM J PATHOL, V184, P2709, DOI 10.1016/j.ajpath.2014.06.021; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Fu D, 2012, DIABETOLOGIA, V55, P3128, DOI 10.1007/s00125-012-2692-0; Garcia-Ramirez M, 2016, ACTA DIABETOL, V53, P109, DOI 10.1007/s00592-015-0759-3; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; Hu Y, 2013, P NATL ACAD SCI USA, V110, P15401, DOI 10.1073/pnas.1307211110; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Imai H, 2009, DEV OPHTHALMOL, V44, P56, DOI 10.1159/000223946; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Kinter CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050016; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pearsall EA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0451-x; PRECHT W, 1979, EXP BRAIN RES, V37, P183, DOI 10.1007/BF01474264; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Samuels IS, 2012, VISUAL NEUROSCI, V29, P267, DOI 10.1017/S0952523812000326; Seigel GM, 2014, MOL VIS, V20, P301; Stem MS, 2013, CURR MED CHEM, V20, P3241, DOI 10.2174/09298673113209990027; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; Vanlandingham PA, 2017, INVEST OPHTH VIS SCI, V58, P2095, DOI 10.1167/iovs.16-20641; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510; Zhu SS, 2011, DIABETOLOGIA, V54, P2440, DOI 10.1007/s00125-011-2226-1	39	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0208399	10.1371/journal.pone.0208399	http://dx.doi.org/10.1371/journal.pone.0208399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716067	Green Published, gold, Green Submitted			2022-12-26	WOS:000457744200003
J	Piquet, B; Shillito, B; Lallier, FH; Duperron, S; Andersen, AC				Piquet, Berenice; Shillito, Bruce; Lallier, Francois H.; Duperron, Sebastien; Andersen, Ann C.			High rates of apoptosis visualized in the symbiont-bearing gills of deep-sea Bathymodiolus mussels	PLOS ONE			English	Article							SULFUR-OXIDIZING SYMBIONTS; CELL-DEATH; CHEMOSYNTHETIC SYMBIONTS; RELATIVE ABUNDANCES; METHANE; TISSUE; ULTRASTRUCTURE; IDENTIFICATION; ENDOSYMBIONTS; POPULATIONS	Symbiosis between Bathymodiolus and Gammaproteobacteria allows these deep-sea mussels to live in toxic environments such as hydrothermal vents and cold seeps. The quantity of endosymbionts within the gill-bacteriocytes appears to vary according to the hosts environment; however, the mechanisms of endosymbiont population size regulation remain obscure. We investigated the possibility of a control of endosymbiont density by apoptosis, a programmed cell death, in three mussel species. Fluorometric TUNEL and active Caspase-3-targeting antibodies were used to visualize and quantify apoptotic cells in mussel gills. To control for potential artefacts due to depressurization upon specimen recovery from the deep-sea, the apoptotic rates between mussels recovered unpressurised, versus mussels recovered in a pressure-maintaining device, were compared in two species from hydro thermal vents on the Mid-Atlantic Ridge: Bathymodiolus azoricus and B. puteoserpentis. Results show that pressurized recovery had no significant effect on the apoptotic rate in the gill filaments. Apoptotic levels were highest in the ciliated zone and in the circulating hemocytes, compared to the bacteriocyte zone. Apoptotic gill-cells in B. aff. boomerang from cold seeps off the Gulf of Guinea show similar distribution patterns. Deep-sea symbiotic mussels have much higher rates of apoptosis in their gills than the coastal mussel Mytilus edulis, which lacks chemolithoautotrophic symbionts. We discuss how apoptosis might be one of the mechanisms that contribute to the adaptation of deep-sea mussels to toxic environments and/or to symbiosis.	[Piquet, Berenice; Lallier, Francois H.; Andersen, Ann C.] Sorbonne Univ, CNRS,SBR, Team Adaptat & Biol Invertebres Marins Condit Ext, Lab Adaptat & Divers Milieu Marin,AD2M,ABICE,UMR, Roscoff, France; [Piquet, Berenice; Shillito, Bruce; Duperron, Sebastien] Sorbonne Univ, CNRS, Lab Biol Organismes & Ecosyst Aquat BOREA,UMR 720, Team Adaptat Milieux Extremes,AMEX,IRD,UCN,UA,MNH, 7 Quai St Bernard, Paris, France; [Duperron, Sebastien] CNRS, Team Cyanobacteries Cyanotoxines & Environm, Lab Mecanismes Commun & Adaptat Microorganismes, Museum Natl Hist Nat,CCE,UMR 7245, 12 Rue Buffon, Paris, France; [Duperron, Sebastien] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Institut Universitaire de France	Andersen, AC (corresponding author), Sorbonne Univ, CNRS,SBR, Team Adaptat & Biol Invertebres Marins Condit Ext, Lab Adaptat & Divers Milieu Marin,AD2M,ABICE,UMR, Roscoff, France.; Duperron, S (corresponding author), Sorbonne Univ, CNRS, Lab Biol Organismes & Ecosyst Aquat BOREA,UMR 720, Team Adaptat Milieux Extremes,AMEX,IRD,UCN,UA,MNH, 7 Quai St Bernard, Paris, France.; Duperron, S (corresponding author), CNRS, Team Cyanobacteries Cyanotoxines & Environm, Lab Mecanismes Commun & Adaptat Microorganismes, Museum Natl Hist Nat,CCE,UMR 7245, 12 Rue Buffon, Paris, France.; Duperron, S (corresponding author), Inst Univ France, Paris, France.	sebastien.duperron@mnhn.fr; andersen@sb-roscoff.fr		duperron, sebastien/0000-0002-6422-6821; Lallier, Francois/0000-0001-8979-8917	Institut Universitaire de France project ACSYMB; Universite Pierre et Marie Curie; ARED Region Bretagne project FlexSyBi [9127]; BALIST program [ANR-08-BLAN-0252]; EU project EXOCET/D [FP6-GOCE-CT-2003-505342]; EU project MIDAS (FP7/2007-2013) [603418]; CNRS; IFREMER	Institut Universitaire de France project ACSYMB; Universite Pierre et Marie Curie; ARED Region Bretagne project FlexSyBi; BALIST program; EU project EXOCET/D; EU project MIDAS (FP7/2007-2013); CNRS(Centre National de la Recherche Scientifique (CNRS)); IFREMER	This research was supported by Institut Universitaire de France project ACSYMB, Universite Pierre et Marie Curie and ARED Region Bretagne project FlexSyBi (contract number 9127, grant to BP), BALIST program (ANR-08-BLAN-0252), EU projects EXOCET/D (FP6-GOCE-CT-2003-505342), MIDAS (FP7/2007-2013, grant agreement no 603418) and CNRS and IFREMER for cruise funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 1988, OCEANOL ACTA, P173; Barros I, 2016, J AQUAC RES DEV, P7, DOI [10.4172/2155-9546.1000464, DOI 10.4172/2155-9546.1000464]; Barry JP, 2002, INVERTEBR BIOL, V121, P47; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boutet I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-530; Cambon-Bonavita M-A, 2014, BICOSE CRUISE POURQU, DOI [10.17600/14000100, DOI 10.17600/14000100]; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; CHILDRESS JJ, 1978, DEEP-SEA RES, V25, P419, DOI 10.1016/0146-6291(78)90568-4; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Company R, 2004, MAR ENVIRON RES, V58, P377, DOI 10.1016/j.marenvres.2004.03.083; Cosel R., 1999, VELIGER, V42, P218; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Duperron S, 2011, GEOBIOLOGY, V9, P481, DOI 10.1111/j.1472-4669.2011.00300.x; Duperron S, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00016; Duperron S, 2010, TOP GEOBIOL, V33, P137, DOI 10.1007/978-90-481-9572-5_6; Elisabeth NH, 2012, MICROSC RES TECHNIQ, V75, P1136, DOI 10.1002/jemt.22041; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; Fiala-Medioni A, 1994, CR HEBD ACAD SCI, V317, P239; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; FISHER CR, 1987, MAR BIOL, V96, P59, DOI 10.1007/BF00394838; Foster JS, 1998, DEV GENES EVOL, V208, P295, DOI 10.1007/s004270050185; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goedken M, 2005, J SHELLFISH RES, V24, P177; Guezi H, 2014, SYMBIOSIS, V63, P19, DOI 10.1007/s13199-014-0284-0; Guezi H, 2013, FISH SHELLFISH IMMUN, V34, P1709, DOI 10.1016/j.fsi.2013.03.223; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Halary S, 2008, ISME J, V2, P284, DOI 10.1038/ismej.2008.3; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; Kadar E, 2008, MAR BIOL, V153, P995, DOI 10.1007/s00227-007-0872-0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kiss T, 2010, APOPTOSIS, V15, P313, DOI 10.1007/s10495-009-0446-3; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Lallier F, 2013, BIOBAZ 2013 CRUISE P, DOI [10.17600/13030030, DOI 10.17600/13030030]; LEPENNEC M, 1984, OCEANOL ACTA, V7, P517; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Mone Y, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3112; Motta CM, 2013, J EXP ZOOL PART A, V319, P548, DOI 10.1002/jez.1817; Olu K., 2011, WACS CRUISE POURQUOI, DOI [10.17600/11030010, DOI 10.17600/11030010]; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Pflugfelder B, 2009, CELL TISSUE RES, V337, P149, DOI 10.1007/s00441-009-0811-0; Pradillon Florence, 2007, Reviews in Environmental Science and Bio/Technology, V6, P181, DOI 10.1007/s11157-006-9111-2; Pradillon F, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P271, DOI 10.1079/9781845938147.0271; Raulfs EC, 2004, J MAR BIOL ASSOC UK, V84, P229, DOI 10.1017/S0025315404009087h; Ravaux J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064074; Riou V, 2008, BIOGEOSCIENCES, V5, P1681, DOI 10.5194/bg-5-1681-2008; Riou V, 2010, MAR ECOL PROG SER, V405, P187, DOI 10.3354/meps08515; Romero A, 2015, FISH SHELLFISH IMMUN, V46, P79, DOI 10.1016/j.fsi.2015.03.038; Shillito B, 2008, DEEP-SEA RES PT I, V55, P881, DOI 10.1016/j.dsr.2008.03.010; Shillito B, 2014, J MAR SCI TECH-TAIW, V22, P97, DOI 10.6119/JMST-013-0718-3; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Streams ME, 1997, MAR BIOL, V129, P465, DOI 10.1007/s002270050187; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Szafranski KM, 2015, DEEP-SEA RES PT I, V101, P7, DOI 10.1016/j.dsr.2015.03.003; Vigneron A, 2014, CURR BIOL, V24, P2267, DOI 10.1016/j.cub.2014.07.065; VONCOSEL R, 1994, VELIGER, V37, P374; Wentrup C, 2014, ENVIRON MICROBIOL, V16, P3699, DOI 10.1111/1462-2920.12597; Wentrup C, 2013, ISME J, V7, P1244, DOI 10.1038/ismej.2013.5; Wong YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16597; Yuan JY, 2016, CELL, V167, P1693, DOI 10.1016/j.cell.2016.11.047; Zheng P, 2017, MOL ECOL, V26, P5133, DOI 10.1111/mec.14160	70	7	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2019	14	2							e0211499	10.1371/journal.pone.0211499	http://dx.doi.org/10.1371/journal.pone.0211499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LY	30716127	Green Published, Green Submitted, gold			2022-12-26	WOS:000457744200028
J	Levy, C; Varon, E; Ouldali, N; Wollner, A; Thollot, F; Corrard, F; Werner, A; Bechet, S; Bonacorsi, S; Cohen, R				Levy, Corinne; Varon, Emmanuelle; Ouldali, Naim; Wollner, Alain; Thollot, Franck; Corrard, Francois; Werner, Andreas; Bechet, Stephane; Bonacorsi, Stephane; Cohen, Robert			Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; MIDDLE-EAR; CHILDREN; SEROTYPES; RESISTANCE; IMPACT	After pneumococcal conjugate vaccine (PCV) implementation, the number of acute otitis media (AOM) episodes has decreased, but AOM still remains among the most common diagnoses in childhood. From 2% to 17% of cases of AOM feature spontaneous perforation of the tympanic membrane (SPTM). The aim of this study was to describe the bacteriological causes of SPTM 5 to 8 years years after PCV13 implementation, in 2010. From 2015 to 2018, children with SPTM were prospectively enrolled by 41 pediatricians. Middle ear fluid was obtained by sampling spontaneous discharge. Among the 470 children with SPTM (median age 20.8 months), no otopathogen was isolated for 251 (53.4% [95% CI 48.8%; 58.0%]): 47.1% of infants and toddlers, 68.3% older children (p<0.001). Among children with isolated bacterial otopathogens (n = 219), non-typable Haemophilus influenzae (NTHi) was the most frequent otopathogen isolated (n = 106, 48.4% [95% CI 41.6%; 55.2%]), followed by Streptoc-cocus pyogenes (group A streptococcus [GAS]) (n = 76, 34.7% [95% CI 28.4%; 41.4%]) and Streptococcus pneumoniae (Sp) (n = 61, 27.9% [95% Ci 22.0%; 34.3%]). NTHi was frequently isolated in infants and toddlers (53.1%), whereas the main otopathogen in older children was GAS (52.3%). In cases of co-infection with at least two otopathogens (16.9%, n = 37/219), NTHi was frequently involved (78.4%, n = 29/37). When Sp was isolated, PCV13 serotypes accounted for 32.1% of cases, with serotype 3 the main serotype (16.1%). Among Sp strains, 29.5% were penicillin-intermediate and among NTHi strains, 16.0% were beta-lactamase-producers. More than 5 years after PCV13 implementation, the leading bacterial species recovered from AOM with SPTM was NTHi for infants and toddlers and GAS for older children. In both age groups, Sp was the third most frequent pathogen and vaccine serotypes still played an important role. No resistant Sp strains were isolated, and the frequency of beta-lactamaseproducing NTHi did not exceed 16%.	[Levy, Corinne; Ouldali, Naim; Wollner, Alain; Corrard, Francois; Bechet, Stephane; Cohen, Robert] ACTIV, St Maur Des Fosses, France; [Levy, Corinne; Ouldali, Naim; Bechet, Stephane; Cohen, Robert] GPIP, Paris, France; [Levy, Corinne; Thollot, Franck; Werner, Andreas] AFPA, St Germain En Laye, France; [Levy, Corinne; Cohen, Robert] Univ Paris Est, IMRB GRC GEMINI, Creteil, France; [Levy, Corinne; Cohen, Robert] Ctr Hosp Intercommunal Creteil, CRC, Creteil, France; [Varon, Emmanuelle] Ctr Hosp Intercommunal Creteil, Natl Reference Ctr Pneumococci, Creteil, France; [Ouldali, Naim] Hop Robert Debre, AP HP, INSERM, ECEVE,UMR 1123,Unite Epidemiol Clin, Paris, France; [Bonacorsi, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Bonacorsi, Stephane] Hop Robert Debre, AP HP, Microbiol Serv, F-75019 Paris, France; [Cohen, Robert] Ctr Hosp Intercommunal Creteil, Serv Neonatal, Unite Court Sejour, Petits Nourrissons, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil	Levy, C; Cohen, R (corresponding author), ACTIV, St Maur Des Fosses, France.; Levy, C; Cohen, R (corresponding author), GPIP, Paris, France.; Levy, C (corresponding author), AFPA, St Germain En Laye, France.; Levy, C; Cohen, R (corresponding author), Univ Paris Est, IMRB GRC GEMINI, Creteil, France.; Levy, C; Cohen, R (corresponding author), Ctr Hosp Intercommunal Creteil, CRC, Creteil, France.; Cohen, R (corresponding author), Ctr Hosp Intercommunal Creteil, Serv Neonatal, Unite Court Sejour, Petits Nourrissons, Creteil, France.	corinne.levy@activ-france.fr; robert.cohen@wanadoo.fr	LEVY, Corinne/AAM-3541-2021; Cohen, Robert/AAM-4426-2021; Bonacorsi, Stéphane/HGB-3185-2022	LEVY, Corinne/0000-0002-1927-6360; Cohen, Robert/0000-0001-6151-0686; 	Association Clinique et The rapeutique Infantile du Val de Marne (Clinical and Therapeutic Association of Val de Marne)	Association Clinique et The rapeutique Infantile du Val de Marne (Clinical and Therapeutic Association of Val de Marne)	The authors received no specific funding for this work. This study was supported by our institution, Association Clinique et The rapeutique Infantile du Val de Marne (Clinical and Therapeutic Association of Val de Marne).	Ben-Shimol S, 2016, CLIN INFECT DIS, V63, P611, DOI 10.1093/cid/ciw347; Brook I, 2009, PEDIATR INFECT DIS J, V28, P640, DOI 10.1097/INF.0b013e3181975221; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Cilveti R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170316; Cohen Robert, 2017, Expert Rev Vaccines, V16, P625, DOI 10.1080/14760584.2017.1320221; Couloigner V, 2012, PEDIATR INFECT DIS J, V31, P154, DOI 10.1097/INF.0b013e3182357c8d; Dagan R, 2016, LANCET INFECT DIS, V16, P480, DOI 10.1016/S1473-3099(15)00549-6; Grevers G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-312; Kaur R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0181; Kaur R, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0640-y; Leibovitz E, 2009, PEDIATR INFECT DIS J, V28, P1105, DOI 10.1097/INF.0b013e3181b20e7a; Lewnard JA, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00727-17, 10.1128/iai.00727-17]; Liese JG, 2014, EPIDEMIOL INFECT, V142, P1778, DOI 10.1017/S0950268813002744; Marchisio P, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.01.010; Marchisio P, 2013, INFECTION, V41, P629, DOI 10.1007/s15010-012-0371-1; Marchisio P, 2017, PEDIATR INFECT DIS J, V36, P521, DOI 10.1097/INF.0000000000001485; Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924; Martinot A, 2013, ARCH PEDIATRIE, V20, P837, DOI 10.1016/j.arcped.2013.05.016; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Naziat H, 2018, PEDIATR INFECT DIS J, V37, P715, DOI [10.1097/INF.0000000000002077, 10.1097/inf.0000000000002077]; Ngo CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150949; Pichichero M, 2018, LANCET CHILD ADOLESC, V2, P561, DOI 10.1016/S2352-4642(18)30168-8; Principi N, 2017, EUR J CLIN MICROBIOL, V36, P11, DOI 10.1007/s10096-016-2783-9; Rybak A, 2018, PEDIATR INFECT DIS J, V37, pE72, DOI [10.1097/INF.0000000000001862, 10.1097/inf.0000000000001862]; Segal N, 2005, CLIN INFECT DIS, V41, P35, DOI 10.1086/430605; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; Shulman ST, 2005, CLIN INFECT DIS, V41, P42, DOI 10.1086/430609; Silva-Costa C, 2018, EMERG INFECT DIS, V24, P1307, DOI 10.3201/eid2407.180029; Stamboulidis K, 2011, PEDIATR INFECT DIS J, V30, P551, DOI 10.1097/INF.0b013e31821038d9; van der Linden M, 2015, EUR J PEDIATR, V174, P355, DOI 10.1007/s00431-014-2409-0; van Dongen TMA, 2013, PEDIATR INFECT DIS J, V32, P549, DOI 10.1097/INF.0b013e318280ab45; Van Dyke MK, 2017, PEDIATR INFECT DIS J, V36, P274, DOI 10.1097/INF.0000000000001420; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Wayne P., 2008, CLSI SUPPLEMENT M100; Xu QF, 2011, INT J PEDIATR OTORHI, V75, P239, DOI 10.1016/j.ijporl.2010.11.008	35	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211712	10.1371/journal.pone.0211712	http://dx.doi.org/10.1371/journal.pone.0211712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HK2LM	30707730	Green Published, gold, Green Submitted			2022-12-26	WOS:000457742900042
J	Tudorache, V; Traila, D; Marc, M; Oancea, C; Manolescu, D; Tudorache, E; Timar, B; Albai, A; Fira-Mladinescu, O				Tudorache, Voicu; Traila, Daniel; Marc, Monica; Oancea, Cristian; Manolescu, Diana; Tudorache, Emanuela; Timar, Bogdan; Albai, Alin; Fira-Mladinescu, Ovidiu			Impact of moderate to severe obstructive sleep apnea on the cognition in idiopathic pulmonary fibrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; OXYGEN DESATURATION; LUNG-VOLUME; STANDARDIZATION; DEPRESSION; IMPAIRMENT; SURVIVAL; DISEASE; COPD; MOCA	Introduction Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive lung disease with a fatal prognosis to whose rapid evolution multiple comorbidities may contribute, one of the most common being obstructive sleep apnea (OSA). There are several potential factors and conditions for the emergence of a cognitive deficit in relation to IPF or associated morbidities. Objectives The goals of this study were to assess cognition in patients with IPF in stable phase and to identify clinical cognition modifiers. Methods In a cross-sectional study, 23 patients with IPF were evaluated using Montreal Cognitive Assessment (MoCA), an instrument for detecting mild cognitive impairments and were screened for OSA through overnight cardiorespiratory polygraphy and for anxiety and depression with three specific scale (Generalized Anxiety Disorder 7-item scale: GAD-7; the Patient Health Questionnaire: PHQ-9; Hospital Anxiety and Depression Scale: HADS). Results MoCA score was lower in patients with IPF when compared to controls subjects (24 [21,26] vs. 27 [26,28], p = 0.003) but not as significantly as in COPD patients (21 [18.8,23.3], p< 0.0001). OSA was diagnosed in 19 (82.6%) IPF patients, 12 patients showed the presence of moderate-severe forms (63.15%). IPF patients with cognitive impairment (MoCA< 23) exhibit a higher severity of OSA (apneea hypopnea index-AHI: 33.0 +/- 19.1 vs. 12.44 +/- 8.2, p = 0.018), and a higher Epworth score (7.1 +/- 3.3 vs. 4.3 +/- 1.8, p = 0.013). Anxiety and depression scores were not correlated with MoCA results. Conclusions Impaired cognition in patients with IPF is mild and affect the areas of visuospatial abilities, language and working memory. OSA could be a possible predictor of IPF cognition deficit. Given the high prevalence of multiple types of sleep disorders in IPF patients, these should be investigated at least by cardiorespiratory polygraphy.	[Tudorache, Voicu; Traila, Daniel; Marc, Monica; Oancea, Cristian; Tudorache, Emanuela; Fira-Mladinescu, Ovidiu] Victor Babes Univ Med & Pharm, Dept Pulmonol, Timisoara, Romania; [Manolescu, Diana] Victor Babes Univ Med & Pharm, Dept Radiol, Timisoara, Romania; [Timar, Bogdan] Victor Babes Univ Med & Pharm, Dept Funct Sci, Timisoara, Romania; [Albai, Alin] Victor Babes Univ Med & Pharm, Dept Internal Med, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Traila, D (corresponding author), Victor Babes Univ Med & Pharm, Dept Pulmonol, Timisoara, Romania.	trailadaniel@yahoo.com	Manolescu, Diana/AGZ-1956-2022; Tudorache, Emanuela/AAP-7131-2020; Fira-Mladinescu, Ovidiu/C-5736-2011; Albai, Alin/AAW-8396-2021	Manolescu, Diana/0000-0002-4602-7730; Fira-Mladinescu, Ovidiu/0000-0002-9034-5218; Traila, Daniel/0000-0003-3499-8430				Akhtar AA, 2013, CHRON RESP DIS, V10, P127, DOI 10.1177/1479972313493098; Amin A, 2014, AAMJ, V12; Barnes JN, 2015, ADV PHYSIOL EDUC, V39, P55, DOI 10.1152/advan.00101.2014; Bors M, 2015, CHRON RESP DIS, V12, P365, DOI 10.1177/1479972315603552; Bosi M, 2017, LUNG, V195, P643, DOI 10.1007/s00408-017-0031-4; Carson N, 2018, INT J GERIATR PSYCH, V33, P379, DOI 10.1002/gps.4756; De Vries J, 2001, EUR RESPIR J, V17, P954, DOI 10.1183/09031936.01.17509540; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Glaspole IN, 2017, RESPIROLOGY, V22, P950, DOI 10.1111/resp.12989; Heinzer RC, 2005, AM J RESP CRIT CARE, V172, P114, DOI 10.1164/rccm.200404-552OC; INCALZI RA, 1993, AM REV RESPIR DIS, V148, P418, DOI 10.1164/ajrccm/148.2.418; King CS, 2017, LANCET RESP MED, V5, P72, DOI 10.1016/S2213-2600(16)30222-3; Kolilekas L, 2013, J CLIN SLEEP MED, V9, P593, DOI 10.5664/jcsm.2758; Kreuter M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151425; Lacedonia D, 2013, RESP MED, V107, P310, DOI 10.1016/j.rmed.2012.10.012; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mermigkis C, 2017, CHEST, V152, P1327, DOI 10.1016/j.chest.2017.07.019; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nena E, 2012, SLEEP BREATH, V16, P181, DOI 10.1007/s11325-010-0472-y; Oancea C, 2018, COPD AN UPDATE PATHO, P67; Oldham JM, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00123; PEREZPADILLA R, 1985, AM REV RESPIR DIS, V132, P224; Raghu G, 2015, EUR RESPIR J, V46, P1113, DOI 10.1183/13993003.02316-2014; Roncero C, 2016, INT J CHRONIC OBSTR, V11, DOI 10.2147/COPD.S100850; Ryerson CJ, 2011, CHEST, V139, P609, DOI 10.1378/chest.10-0608; Sharp C, 2016, THORAX, V71, pA237, DOI 10.1136/thoraxjnl-2016-209333.417; Sprunger DB, COGNITIVE FUNCTION C, DOI [10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A4059, DOI 10.1164/AJRCCM-CONFERENCE.2009.179.1_MEETINGABSTRACTS.A4059]; Tagaito Y, 2007, J APPL PHYSIOL, V103, P1379, DOI 10.1152/japplphysiol.00026.2007; Toma CL, 2017, ROM J MORPHOL EMBRYO, V58, P261; Torres-Sanchez I, 2015, J BRAS PNEUMOL, V41, P182, DOI 10.1590/S1806-37132015000004424; Travis WD, 2013, AM J RESP CRIT CARE; Troy LK, 2014, WORLD J CLIN CASES, V2, P828, DOI 10.12998/wjcc.v2.i12.828; Tudorache E, 2017, CLIN INTERV AGING, V12, P1281, DOI 10.2147/CIA.S145002; Villeneuve S, 2012, CHEST, V142, P1516, DOI 10.1378/chest.11-3035	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2019	14	2							e0211455	10.1371/journal.pone.0211455	http://dx.doi.org/10.1371/journal.pone.0211455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HK2LM	30707735	gold, Green Submitted, Green Published			2022-12-26	WOS:000457742900025
J	Berbel, LO; Banczek, ED; Karousis, IK; Kotsakis, GA; Costa, I				Berbel, Larissa O.; Banczek, Everson do P.; Karousis, Ioannis K.; Kotsakis, Georgios A.; Costa, Isolda			Determinants of corrosion resistance of Ti-6Al-4V alloy dental implants in an In Vitro model of peri-implant inflammation	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TITANIUM; BEHAVIOR; ALBUMIN; FLUORIDE; PH	Background Titanium (Ti) and its alloys possess high biocompatibility and corrosion resistance due to Ti ability to form a passive oxide film, i.e. TiO2, immediately after contact with oxygen. This passive layer is considered stable during function in the oral cavity, however, emerging information associate inflammatory peri-implantitis to vast increases in Ti corrosion products around diseased implants as compared to healthy ones. Thus, it is imperative to identify which factors in the peri-implant micro-environment may reduce Ti corrosion resistance. Methods The aim of this work is to simulate peri-implant inflammatory conditions in vitro to determine which factors affect corrosion susceptibility of Ti-6Al-4V dental implants. The effects of hydrogen peroxide (surrogate for reactive oxygen species, ROS, found during inflammation), albumin (a protein typical of physiological fluids), deaeration (to simulate reduced pO(2) conditions during inflammation), in an acidic environment (pH 3), which is typical of inflammation condition, were investigated. Corrosion resistance of Ti-6Al-4V clinically-relevant acid etched surfaces was investigated by electrochemical techniques: Open Circuit Potential; Electrochemical Impedance Spectroscopy; and Anodic Polarization. Results Electrochemical tests confirmed that most aggressive conditions to the Ti-6Al-4V alloy were those typical of occluded cells, i.e. oxidizing conditions (H2O2), in the presence of protein and deaeration of the physiological medium. Conclusions Our results provide evidence that titanium's corrosion resistance can be reduced by intense inflammatory conditions. This observation indicates that the micro-environment to which the implant is exposed during peri-implant inflammation is highly aggressive and may lead to TiO2 passive layer attack. Further investigation of the effect of these aggressive conditions on titanium dissolution is warranted.	[Berbel, Larissa O.; Costa, Isolda] Inst Pesquisas Energet & Nucl, Ctr Ciencia & Tecnol Mat, Sao Paulo, SP, Brazil; [Banczek, Everson do P.] Univ Estadual Centro Oeste, Unictr, Dept Chem, Guarapuava, PR, Brazil; [Karousis, Ioannis K.] Univ Athens, Dept Periodont, Athens, Greece; [Kotsakis, Georgios A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade Estadual do Centro Oeste; National & Kapodistrian University of Athens; University of Texas System; University of Texas Health San Antonio	Costa, I (corresponding author), Inst Pesquisas Energet & Nucl, Ctr Ciencia & Tecnol Mat, Sao Paulo, SP, Brazil.; Kotsakis, GA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA.	kotsakis@uthscsa.edu; isolda_costa@yahoo.com.br	Costa, Isolda/X-4487-2019; Costa, Isolda/E-8506-2012	Costa, Isolda/0000-0002-4987-3334; Costa, Isolda/0000-0002-4987-3334; Kotsakis, Georgios/0000-0002-8635-9422; BERBEL, LARISSA/0000-0002-8097-2920	CAPES [PROEX 0041041]; Hack Estate Fund	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hack Estate Fund	One of the authors, L.O.B., is being sponsored by CAPES for her Ph.D. (Grant PROEX 0041041) and this work is part of her Ph.D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ms. Sophia Nguyen, Clinical and Periodontal Research Lab, University of Washington, Seattle, WA for here editorial assistance. Part of this work was performed at University of Washington, Department of Periodontics & Clinical Periodontal Research Lab, Seattle, WA (Kotsakis, GA) with support from the Hack Estate Fund.	Al-Mobarak NA, 2006, MATER CHEM PHYS, V99, P333, DOI 10.1016/j.matchemphys.2005.10.032; Assis S. L., 2006, ELECTROCHIMICA ACTA, V51; Barao VAR, 2012, CLIN ORAL IMPLAN RES, V23, P1055, DOI 10.1111/j.1600-0501.2011.02265.x; Bhola R, 2009, RES LETT PHYS CHEM; Brooks E, 2014, J BIOMED MATER RES B, V102, P1445, DOI 10.1002/jbm.b.33123; Chaturvedi T. P., 2009, INDIAN J DENT RES, V20; Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047; Daubert D., 2018, CLIN IMPLANT DENT; De Assis S. L., 2006, THESIS; Farrugia A, 2010, TRANSFUS MED REV, V24, P53, DOI 10.1016/j.tmrv.2009.09.005; Ferreira A L, 1997, Rev Assoc Med Bras (1992), V43, P61; Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4; Fonseca-Garcia A, 2016, MAT SCI ENG C-MATER, V66, P119, DOI 10.1016/j.msec.2016.04.035; Guo M, 2015, W INDIAN MED J, V64, P419, DOI 10.7727/wimj.2014.105; Ide K, 2003, DENT MATER J, V22, P359, DOI 10.4012/dmj.22.359; Karimi S, 2011, CORROS SCI; Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8; Konstantinidis IK, 2015, EUR J ORAL IMPLANTOL, V8, P75; Kuhn AT, 1986, USE SYNTHETIC ENV CO; Kusakawa Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1521593; Lemes SS, 2008, THESIS; Lucas L C, 1992, Adv Dent Res, V6, P32; Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004; Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [DOI 10.2174/1877610801002010040, 10.2174/1877610801002010040]; METTRAUX GR, 1984, J PERIODONTOL, V55, P516, DOI 10.1902/jop.1984.55.9.516; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mouhyi J, 2012, CLIN IMPLANT DENT R, V14, P170, DOI 10.1111/j.1708-8208.2009.00244.x; Nogueira RFP, 2007, QUIM NOVA, V30, P400, DOI 10.1590/S0100-40422007000200030; Oliveira MN, 2018, J PERIODONTAL RES, V53, P1, DOI 10.1111/jre.12479; Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3; Pan J, 1996, J BIOMED MATER RES, V30, P393; Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P3828; Pozhitkov AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140393; RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3; Rezende M. C. R., 2015, ARCH HLTH INVEST, V4; Rodrigues DC, 2016, RSC ADV, V6, P48283, DOI 10.1039/c6ra07760a; Safioti LM, 2017, J PERIODONTOL, V88, P436, DOI 10.1902/jop.2016.160524; Sridhar S., 2015, CLIN IMPLANT DENT RE; Tamam E, 2014, J ORAL IMPLANTOL, V40, P153, DOI 10.1563/AAID-JOI-D-11-00083; Tanner A, 1997, CLIN INFECT DIS, V25, pS213, DOI 10.1086/516243; Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7; Wilson Jr T. G., 2014, J PERIODONTOL, V85; Wilson TG, 2015, J PERIODONTOL, V86, P9, DOI 10.1902/jop.2014.140363; Yu F., 2015, ACTA BIOMATERIALIA; Zhang C, 2018, J BIOMED NANOTECHNOL, V14, P609, DOI 10.1166/jbn.2018.2533	45	34	35	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0210530	10.1371/journal.pone.0210530	http://dx.doi.org/10.1371/journal.pone.0210530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703125	Green Submitted, gold, Green Published			2022-12-26	WOS:000457301600020
J	Guo, QY; Ebihara, K; Shimodaira, T; Fujiwara, H; Toume, K; Dibwe, DF; Awale, S; Araki, R; Yabe, T; Matsumoto, K				Guo, Qing-Yun; Ebihara, Ken; Shimodaira, Takafumi; Fujiwara, Hironori; Toume, Kazufumi; Dibwe, Dya Fita; Awale, Suresh; Araki, Ryota; Yabe, Takeshi; Matsumoto, Kinzo			Kami-shoyo-san improves ASD-like behaviors caused by decreasing allopregnanolone biosynthesis in an SKF mouse model of autism	PLOS ONE			English	Article							ENDOGENOUS BRAIN ALLOPREGNANOLONE; GABA(A) RECEPTORS; EGR-1 EXPRESSION; ANIMAL-MODEL; FEAR MEMORY; MICE; MEDICINE; DEFICITS; STRESS; 5-ALPHA-DIHYDROPROGESTERONE	Dysfunctions in the GABAergic system are associated with the pathogenesis of autism spectrum disorder (ASD). However, the mechanisms by which GABAergic system dysfunctions induce the pathophysiology of ASD remain unclear. We previously demonstrated that a selective type I 5a-reductase inhibitor SKF105111 (SKF) induced ASD-like behaviors, such as impaired sociability-related performance and repetitive grooming behaviors, in male mice. Moreover, the effects of SKF were caused by a decrease in the endogenous levels of allopregnanolone (ALLO), a positive allosteric modulator of the GABA(A) receptor. In this study, we used SKF-treated male mice as a putative animal model of ASD and examined the effects of Kami-shoyo-san (KSS) as an experimental therapeutic strategy for ASD. KSS is a traditional Kampo formula consisting of 10 different crude drugs and has been used for the treatment of neuropsychiatric symptoms. KSS dose-dependently attenuated sociability deficits and suppressed an increase in grooming behaviors in SKF-treated mice without affecting ALLO content in the prefrontal cortex. The systemic administration of the dopamine D-1 receptor antagonist SCH23390 reversed the ameliorative effects of KSS. On the other hand, the dopamine D-2 receptor antagonist sulpiride and GABA(A) receptor antagonist bicuculline only attenuated the ameliorative effect of KSS on repetitive self-grooming behaviors. The present results indicate that KSS improves SKF-induced ASD-like behaviors by facilitating dopamine receptor-mediated mechanisms and partly by neurosteroid-independent GABA(A) receptor-mediated neurotransmission. Therefore, KSS is a potential candidate for the treatment of ASD.	[Guo, Qing-Yun; Ebihara, Ken; Shimodaira, Takafumi; Fujiwara, Hironori; Toume, Kazufumi; Dibwe, Dya Fita; Awale, Suresh; Matsumoto, Kinzo] Univ Toyama, Inst Nat Med, Toyama, Japan; [Araki, Ryota; Yabe, Takeshi] Setsunan Univ, Fac Pharmaceut Sci, Lab Funct Biomol & Chem Pharmacol, Osaka, Japan	University of Toyama; Setsunan University	Fujiwara, H (corresponding author), Univ Toyama, Inst Nat Med, Toyama, Japan.	arawijuf@inm.u-toyama.ac.jp	Awale, Suresh/G-1995-2012; Toume, Kazufumi/A-2632-2012; Dibwe, Dya Fita/M-6179-2018; GUO, QINGYUN/HCH-4738-2022	Awale, Suresh/0000-0002-5299-193X; Toume, Kazufumi/0000-0002-3315-145X; Dibwe, Dya Fita/0000-0003-3433-3834; Guo, Qingyun/0000-0002-4168-5021; Araki, Ryota/0000-0002-0881-9737	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [15K15269]; Kobayashi International Scholarship Foundation; Institute of Natural Medicine, University of Toyama; University of Toyama	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobayashi International Scholarship Foundation; Institute of Natural Medicine, University of Toyama; University of Toyama	This study was supported in part by a Grant-in-Aid for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to KM (15K15269), 2014 and 2018 Grants-in-Aid from Kobayashi International Scholarship Foundation (KM and HF), and Grants-in-Aid for the 2016 and 2017 Cooperative Research Project I from the Institute of Natural Medicine, University of Toyama (RA and HF), and 2018 Director Leadership Expenses, University of Toyama to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Buxbaum JD, 2013, NEUROSCIENCE OF AUTISM SPECTRUM DISORDERS, P113, DOI 10.1016/B978-0-12-391924-3.00008-9; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; Dong E, 2001, P NATL ACAD SCI USA, V98, P2849, DOI 10.1073/pnas.051628598; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ebihara K, 2017, BEHAV BRAIN RES, V334, P6, DOI 10.1016/j.bbr.2017.07.019; Fujiwara H, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1710-7; Gepner B, 2009, NEUROSCI BIOBEHAV R, V33, P1227, DOI 10.1016/j.neubiorev.2009.06.006; Guidotti A, 2001, BRAIN RES REV, V37, P110, DOI 10.1016/S0165-0173(01)00129-1; Han S, 2014, NEURON, V81, P1282, DOI 10.1016/j.neuron.2014.01.016; Hara Y, 2016, AUTISM RES, V9, P926, DOI 10.1002/aur.1596; Hidaka T, 2013, J OBSTET GYNAECOL RE, V39, P223, DOI 10.1111/j.1447-0756.2012.01936.x; HOLT DA, 1990, J MED CHEM, V33, P943, DOI 10.1021/jm00165a010; Kim KC, 2016, BIOMOL THER, V24, P207, DOI 10.4062/biomolther.2016.061; Lee Y, 2018, MOL NEUROBIOL, V55, P5658, DOI 10.1007/s12035-017-0770-5; Matsumoto K, 2003, PHARMACOL BIOCHEM BE, V75, P831, DOI 10.1016/S0091-3057(03)00169-2; Matsumoto K, 2007, STRESS, V10, P3, DOI 10.1080/10253890701200997; Matsumoto K, 2012, NEUROSCI RES, V73, P257, DOI 10.1016/j.neures.2012.04.004; Mizowaki M, 2001, LIFE SCI, V69, P2167, DOI 10.1016/S0024-3205(01)01290-5; Mizuki D, 2014, J PHARMACOL SCI, V124, P457, DOI 10.1254/jphs.13252FP; Nguyen M, 2014, NEUROCHEM INT, V66, P15, DOI 10.1016/j.neuint.2014.01.002; Oblak A, 2009, AUTISM RES, V2, P205, DOI 10.1002/aur.88; Oblak AL, 2010, J NEUROCHEM, V114, P1414, DOI 10.1111/j.1471-4159.2010.06858.x; Okada R, 2015, NEUROSCIENCE, V299, P134, DOI 10.1016/j.neuroscience.2015.04.064; Okada R, 2014, NEUROCHEM RES, V39, P875, DOI 10.1007/s11064-014-1283-5; Ouchi H, 2013, BEHAV BRAIN RES, V238, P146, DOI 10.1016/j.bbr.2012.10.029; Park SW, 2007, PSYCHIAT CLIN NEUROS, V61, P401, DOI 10.1111/j.1440-1819.2007.01676.x; Puia G, 2003, NEUROPHARMACOLOGY, V44, P49, DOI 10.1016/S0028-3908(02)00341-6; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; STARR BS, 1986, NEUROPHARMACOLOGY, V25, P455, DOI 10.1016/0028-3908(86)90168-1; STARR BS, 1986, PHARMACOL BIOCHEM BE, V24, P837, DOI 10.1016/0091-3057(86)90421-1; Sugiyama K, 1996, NEUROSCI LETT, V216, P147, DOI 10.1016/S0304-3940(96)13000-7; Terauchi M, 2011, ARCH GYNECOL OBSTET, V284, P913, DOI 10.1007/s00404-010-1779-4; WACHTEL SR, 1992, PSYCHOPHARMACOLOGY, V109, P41, DOI 10.1007/BF02245478; Yoshimura A, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/9475919; Zager A, 2012, BEHAV BRAIN RES, V232, P30, DOI 10.1016/j.bbr.2012.03.036; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	39	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211266	10.1371/journal.pone.0211266	http://dx.doi.org/10.1371/journal.pone.0211266			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ6LR	30703109	gold, Green Published, Green Submitted			2022-12-26	WOS:000457301600033
J	Ma, J; Zhai, YJ; Chen, M; Zhang, K; Chen, Q; Pang, XY; Sun, F				Ma, Jun; Zhai, Yujia; Chen, Ming; Zhang, Kai; Chen, Quan; Pang, Xiaoyun; Sun, Fei			New interfaces on MiD51 for Drp1 recruitment and regulation	PLOS ONE			English	Article							MITOCHONDRIAL FISSION; CRYSTAL-STRUCTURE; FUSION; PROTEINS; MFF; OLIGOMERIZATION; MEMBRANES; DYNAMICS; MID49	Mitochondrial fission is facilitated by dynamin-related protein Drp1 and a variety of its receptors. However, the molecular mechanism of how Drp1 is recruited to the mitochondrial surface by receptors MiD49 and MiD51 remains elusive. Here, we showed that the interaction between Drp1 and MiD51 is regulated by GTP binding and depends on the polymerization of Drp1. We identified two regions on MiD51 that directly bind to Drp1, and found that dimerization of MiD51, relevant to residue C452, is required for mitochondrial dynamics regulation. Our Results have suggested a multi-faceted regulatory mechanism for the interaction between Drp1 and MiD51 that illustrates the potentially complicated and tight regulation of mitochondrial fission.	[Ma, Jun; Zhai, Yujia; Zhang, Kai; Pang, Xiaoyun; Sun, Fei] Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing, Peoples R China; [Ma, Jun; Zhang, Kai; Sun, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Ming; Chen, Quan] Chinese Acad Sci, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS	Pang, XY; Sun, F (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing, Peoples R China.; Sun, F (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	pangxy@moon.ibp.ac.cn; feisun@ibp.ac.cn		Zhang, Kai/0000-0001-8617-2855; Ma, Jun/0000-0002-3823-8714	National 973 Program from the Chinese Ministry of Science and Technology [2014CB910700, 2011CB910301]; Strategic Priority Research Program from the Chinese Academy of Sciences (CAS) [XDB08030202]	National 973 Program from the Chinese Ministry of Science and Technology; Strategic Priority Research Program from the Chinese Academy of Sciences (CAS)	This project is financially supported by the National 973 Program from the Chinese Ministry of Science and Technology to F. S.(Grants 2014CB910700 and 2011CB910301), and the Strategic Priority Research Program (XDB08030202) to F. S. from the Chinese Academy of Sciences (CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Atkins K, 2016, CLIN SCI, V130, P1861, DOI 10.1042/CS20160030; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clinton RW, 2016, J BIOL CHEM, V291, P478, DOI 10.1074/jbc.M115.680025; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Griffin EE, 2006, BBA-MOL CELL RES, V1763, P482, DOI 10.1016/j.bbamcr.2006.02.003; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Liu T, 2013, EXP CELL RES; Loson OC, 2013, MOL BIOL CELL; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Palmer CS, 2013, J BIOL CHEM; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Richter V, 2014, J CELL BIOL, V204, P477, DOI 10.1083/jcb.201311014; Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wada J, 2016, ACTA MED OKAYAMA, V70, P151; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	44	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211459	10.1371/journal.pone.0211459	http://dx.doi.org/10.1371/journal.pone.0211459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703167	Green Published, Green Submitted, gold			2022-12-26	WOS:000457301600047
J	Michel, LL; Sommer, L; Silos, RG; Bermejo, JL; von Au, A; Seitz, J; Hennigs, A; Smetanay, K; Golatta, M; Heil, J; Schutz, F; Sohn, C; Schneeweiss, A; Marme, F				Michel, Laura L.; Sommer, Laura; Silos, Rosa Gonzalez; Bermejo, Justo Lorenzo; von Au, Alexandra; Seitz, Julia; Hennigs, Andre; Smetanay, Katharina; Golatta, Michael; Heil, Joerg; Schuetz, Florian; Sohn, Christof; Schneeweiss, Andreas; Marme, Frederik			Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; REGIONAL RECURRENCE; TUMOR RECURRENCE; PRIMARY THERAPY; CONSERVATION; HIGHLIGHTS; SURVIVAL	Background Locoregional recurrence after neoadjuvant chemotherapy for primary breast cancer is associated with poor prognosis. It is essential to identify patients at high risk of locoregional recurrence who may benefit from extended local therapy. Here, we examined the prediction accuracy and clinical applicability of the MD Anderson Prognostic Index (MDAPI). Methods Prospective clinical data from 456 patients treated between 2003 and 2011 was analyzed. The Kaplan-Meier method was used to examine the probabilities of locoregional recurrence, local recurrence and distant metastases according to individual prognosis score, stratified by type of surgery (breast conserving therapy or mastectomy). The possible confounding of the relationship between recurrence risk and MDAPI by established risk factors was accounted for in multiple survival regression models. To define the clinical utility of the MDAPI we analyzed its performance to predict locoregional recurrence censoring patients with prior or simultaneous distant metastases. Results Mastectomized patients (42% of the patients) presented with more advanced tumor stage, lower tumor grade, hormone-receptor positive disease and consequently lower pathological complete response rates. Only a few patients presented with high-risk scores (2,7% MDAPI >= 3). All patients with high-risk MDAPI score (MDAPI >= 3) who developed locoregional recurrence were simultaneously affected by distant metastases. Conclusion Our data do not support a clinical utility of the MDAPI to guide local therapy.	[Michel, Laura L.; Sommer, Laura; von Au, Alexandra; Seitz, Julia; Hennigs, Andre; Smetanay, Katharina; Golatta, Michael; Heil, Joerg; Schuetz, Florian; Sohn, Christof; Schneeweiss, Andreas; Marme, Frederik] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany; [Michel, Laura L.; Sommer, Laura; von Au, Alexandra; Seitz, Julia; Hennigs, Andre; Smetanay, Katharina; Golatta, Michael; Heil, Joerg; Schuetz, Florian; Sohn, Christof; Schneeweiss, Andreas; Marme, Frederik] Univ Hosp Heidelberg, Dept Obstet & Gynecol, Heidelberg, Germany; [Silos, Rosa Gonzalez; Bermejo, Justo Lorenzo] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Michel, LL; Marme, F (corresponding author), Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany.; Michel, LL; Marme, F (corresponding author), Univ Hosp Heidelberg, Dept Obstet & Gynecol, Heidelberg, Germany.	Laura.michel@med.uni-heidelberg.de; Frederik.marme@med.uni-heidelberg.de	Schneeweiss, Andreas/HHS-4098-2022; Golatta, Michael/AAH-8735-2021; Heil, Joerg/M-4998-2017	Golatta, Michael/0000-0002-2605-0060; Heil, Joerg/0000-0002-4684-9099				Abe O, 2005, LANCET, V366, P2087; Akay CL, 2012, ANN SURG ONCOL, V19, P901, DOI 10.1245/s10434-011-2006-7; Chen AM, 2004, J CLIN ONCOL, V22, P2303, DOI 10.1200/JCO.2004.09.062; Chen AM, 2005, CANCER-AM CANCER SOC, V103, P689, DOI 10.1002/cncr.20815; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hennigs A, 2016, BREAST CANCER RES TR, V160, P491, DOI 10.1007/s10549-016-4016-4; Huang EH, 2006, INT J RADIAT ONCOL, V66, P352, DOI 10.1016/j.ijrobp.2006.04.046; Ishitobi M, 2012, CANCER-AM CANCER SOC, V118, P4385, DOI 10.1002/cncr.27377; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Marme F, 2013, INT J CANCER, V133, P1006, DOI 10.1002/ijc.28094; Rouzier R, 2001, J CLIN ONCOL, V19, P3828, DOI 10.1200/JCO.2001.19.18.3828; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298	13	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2019	14	1							e0211337	10.1371/journal.pone.0211337	http://dx.doi.org/10.1371/journal.pone.0211337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ6LR	30703111	gold, Green Submitted, Green Published			2022-12-26	WOS:000457301600036
J	Budinski, I; Blagojevic, J; Jovanovic, VM; Pejic, B; Adnadevic, T; Paunovic, M; Vujosevic, M				Budinski, Ivana; Blagojevic, Jelena; Jovanovic, Vladimir M.; Pejic, Branka; Adnadevic, Tanja; Paunovic, Milan; Vujosevic, Mladen			Population genetic structure of the Mediterranean horseshoe bat Rhinolophus euryale in the central Balkans	PLOS ONE			English	Article							LONG-EARED BAT; INFORMATION-TRANSFER; MICROSATELLITE LOCI; NURSERY COLONIES; SWARMING SITES; RELATEDNESS; MYOTIS; PATTERNS; PHYLOGEOGRAPHY; MITOCHONDRIAL	Migratory behaviour, sociality and roost selection have a great impact on the population structure of one species. Many bat species live in groups, and movements between summer and hibernation sites are common in temperate bats. The Mediterranean horseshoe bat Rhinolophus euryale is a cave-dwelling species that exhibits roost philopatry and undertakes seasonal movements which are usually shorter than 50 km. Its distribution in Serbia is restricted to karstic areas in western and eastern parts of the country, with a lack of known roosts between them. In this study, microsatellite markers were used to evaluate genetic variation in this species in the Central Balkans. Specifically, spatial genetic structuring between geographic regions and relatedness within different colony types were assessed. All analysed loci were polymorphic, and there was no significant inbreeding coefficient recorded. A moderate degree of genetic differentiation among the sampled colonies was found, and significant isolation by distance was recorded. Our results revealed that populations show a tendency to segregate into three clusters. Unexpectedly, populations from Montenegro and Eastern Serbia tended to group into one cluster, while populations from Western Serbia and Slovenia represented second and third cluster, respectively. The majority of variance was partitioned within colonies, and only a small but significant portion among clusters. Average relatedness within colony members was close to zero, did not differ significantly between the different colony types, and kinship is unlikely to be a major grouping mechanism in this species.	[Budinski, Ivana; Blagojevic, Jelena; Jovanovic, Vladimir M.; Pejic, Branka; Adnadevic, Tanja; Vujosevic, Mladen] Univ Belgrade, Inst Biol Res Sinisa Stankov, Dept Genet Res, Belgrade, Serbia; [Paunovic, Milan] Nat Hist Museum, Dept Biol Collect, Belgrade, Serbia	University of Belgrade	Budinski, I (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankov, Dept Genet Res, Belgrade, Serbia.	ivana.budinski@ibiss.bg.ac.rs	Blagojević, Jelena/B-4593-2008; Budinski, Ivana/L-5470-2019	Blagojević, Jelena/0000-0001-7102-5510; Budinski, Ivana/0000-0001-8834-4200; Jovanovic, Vladimir/0000-0002-8056-5065; Bajic, Branka/0000-0002-4849-1756	Ministry of Education, Science and Technological Development of Serbia [173003]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The study was supported by the Ministry of Education, Science and Technological Development of Serbia [grant number 173003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Altringham John D., 2005, P280; [Anonymous], 2009, NYCTALUS NF; [Anonymous], 2008, BIOSCIENCE, V58, P737; Bilgin R, 2008, ACTA CHIROPTEROL, V10, P41, DOI 10.3161/150811008X331072; Bogdanowicz W, 2012, J MAMMAL, V93, P799, DOI 10.1644/11-MAMM-A-180.3; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Boston ESM, 2012, BEHAV ECOL, V23, P1015, DOI 10.1093/beheco/ars065; Brunet-Rossinni Anja K., 2009, P315; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Burland TM, 2001, MOL ECOL, V10, P1309, DOI 10.1046/j.1365-294X.2001.01273.x; Burland TM, 2001, BIOL REV, V76, P389, DOI 10.1017/S1464793101005747; Canadian Council on Animal Care, 2003, CRC, P1; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Dietz C., 2009, BATS BRITAIN EUROPE; Dinale G, 1968, ARCH ZOOL ITAL, V53, P51; Durovic P., 1998, SPELEOLOSKI ATLAS SR; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Frantz AC, J APPL ECOL, V42, P493; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Heymer A, 1964, RESULTATS BAGUAGE CH, V15, P765; Hutterer R, 2006, BAT MIGRATIONS EUROP; Johnson LNL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126309; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kerth G, 2005, MOL ECOL, V14, P3943, DOI 10.1111/j.1365-294X.2005.02719.x; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P203, DOI 10.1007/s00265-002-0499-6; Kunz TH, 2003, BAT ECOLOGY, P3; McCracken GF, 2006, FUNCTIONAL EVOLUTION, P149; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moussy C, 2013, MAMMAL REV, V43, P183, DOI 10.1111/j.1365-2907.2012.00218.x; Neuweiler G., 1993, BIOL FLEDERMAUSE; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Paunovic M., 2016, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille S, 2005, MOL ECOL NOTES, V5, P941, DOI 10.1111/j.1471-8286.2005.01123.x; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Racey Paul A., 2009, P249; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Rossiter SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P510, DOI 10.1007/s00265-002-0467-1; Rossiter SJ, 2007, MOL ECOL, V16, P4699, DOI 10.1111/j.1365-294X.2007.03546.x; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; StatSoft Inc, 1997, STAT WIND COMP PROGR; Strauss W M, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0202s42; Uhrin Marcel, 2012, Vespertilio, V16, P289; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Wilson GA, 2003, GENETICS, V163, P1177	65	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2019	14	1							e0210321	10.1371/journal.pone.0210321	http://dx.doi.org/10.1371/journal.pone.0210321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ4PJ	30699143	Green Published, gold, Green Submitted			2022-12-26	WOS:000457155600029
J	Zaccaria, A; Del Vicario, M; Quattrociocchi, W; Scala, A; Pietronero, L				Zaccaria, Andrea; Del Vicario, Michela; Quattrociocchi, Walter; Scala, Antonio; Pietronero, Luciano			PopRank: Ranking pages' impact and users' engagement on Facebook	PLOS ONE			English	Article								The advent of social networks revolutionized the way people access to information sources. Understanding the complex relationship between these sources and users is crucial. We introduce an algorithm, that we call PopRank, to assess both the Impact of Facebook pages as well as users' Engagement on the basis of their mutual interactions. The ideas behind the PopRank are that i) high impact pages attract many users with a low engagement, which means that they receive comments from users that rarely comment, and ii) high engagement users interact with high impact pages, that is they mostly comment pages with a high popularity. The resulting ranking of pages can predict the number of comments a page will receive and the number of its future posts. Pages' impact turns out to be slightly dependent on the quality of pages' informative content (e.g., science vs conspiracy) but independent of users' polarization.	[Zaccaria, Andrea; Quattrociocchi, Walter; Scala, Antonio; Pietronero, Luciano] UOS Sapienza, CNR, ISC, Rome, Italy; [Del Vicario, Michela] IMT Sch Adv Studies, Lucca, Italy; [Quattrociocchi, Walter] Ca Foscari Univ Venice, Venice, Italy; [Scala, Antonio] LIMS, London, England; [Pietronero, Luciano] Sapienza Univ Roma, Dipartimento Fis, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); IMT School for Advanced Studies Lucca; Universita Ca Foscari Venezia; Sapienza University Rome	Zaccaria, A (corresponding author), UOS Sapienza, CNR, ISC, Rome, Italy.	and.zaccaria@gmail.com	Scala, Antonio/H-9153-2019; Scala, Antonio/GRS-5823-2022; Quattrociocchi, Walter/L-4550-2016	Scala, Antonio/0000-0002-3414-2686; Quattrociocchi, Walter/0000-0002-4374-9324				Allen Robert, 2017, WHAT HAPPENS ONLINE; Angelini O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177360; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Battiston C., 2014, COMPLEXECONOMIC TIME, V41, P1; Bessi A, 2015, P 24 INT C WORLD WID; Bessi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159641; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134641; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Chavez J. C., 2017, REV REGIONAL STUDIES, V47; Cristelli M., 2015, GROWTH SCENARIOS SUB; Cristelli Matthieu, 2017, POLICY RES WORKING P; Del Vicario M, 2017, SOC NETWORKS, V50, P6, DOI 10.1016/j.socnet.2017.02.002; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kalogeropoulos A., 2017, REUTERS DIGITAL NEWS; Liao H, 2018, COMPLEXITY, DOI 10.1155/2018/2825948; Page L, 1998, TECHNICAL REPORT; Pugliese E., 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE.0168540; Pugliese E., 2017, SUSTAINING HIGH GROW; Pugliese E, 2016, EUR PHYS J-SPEC TOP, V225, P1893, DOI 10.1140/epjst/e2015-50118-1; Quattrociocchi W., 2018, ECHO CHAMBERS FACEBO, P1, DOI [10.2139/ssrn.2795110, DOI 10.2139/SSRN.2795110]; Schmidt AL, 2017, P NATL ACAD SCI USA, V114, P3035, DOI 10.1073/pnas.1617052114; Straka M. J., 2018, J STAT PHYS, P1; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Zaccaria A, 2016, J ECON INTERACT COOR, V11, P151, DOI 10.1007/s11403-015-0145-9; Zollo F, 2018, COMPUT SOC SCI, P177, DOI 10.1007/978-3-319-77332-2_10; Zollo F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181821	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211038	10.1371/journal.pone.0211038	http://dx.doi.org/10.1371/journal.pone.0211038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689652	Green Published, gold, Green Submitted			2022-12-26	WOS:000457041800018
J	Alvarez, LH; Gomes, DEB; Gonzalez, JEH; Pascutti, PG				Alvarez, Lilian Hernandez; Barreto Gomes, Diego Enry; Hernandez Gonzalez, Jorge Enrique; Pascutti, Pedro Geraldo			Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; MOLECULAR-DYNAMICS; TRYPANOSOMA-CRUZI; FOLDING FUNNELS; HEPARAN-SULFATE; ATOMIC CHARGES; PROTEIN; INHIBITORS; BINDING; INSIGHTS	Trypanosoma cruzi is the causative agent of Chagas disease, a neglected infection affecting millions of people in tropical regions. There are several chemotherapeutic agents for the treatment of this disease, but most of them are highly toxic and generate resistance. Currently, the development of allosteric inhibitors constitutes a promising research field, since it can improve the accessibility to more selective and less toxic medicines. To date, the allosteric drugs prediction is a state-of-the-art topic in rational structure-based computational design. In this work, a simulation strategy was developed for computational discovery of allosteric inhibitors, and it was applied to cruzain, a promising target and the major cysteine protease of T. cruzi. Molecular dynamics simulations, binding free energy calculations and network-based modelling of residue interactions were combined to characterize and compare molecular distinctive features of the apo form and the cruzain-allosteric inhibitor complexes. By using geometry-based criteria on trajectory snapshots, we predicted two main allosteric sites suitable for drug targeting. The results suggest dissimilar mechanisms exerted by the same allosteric site when binding different potential allosteric inhibitors. Finally, we identified the residues involved in suboptimal paths linking the identified site and the orthosteric site. The present study constitutes the first approximation to the design of cruzain allosteric inhibitors and may serve for future pharmacological intervention. Here, no major effects on active site structure were observed due to compound binding (modification of distance and angles between catalytic residues), which indicates that allosteric regulation in cruzain might be mediated via alterations of its dynamical properties similarly to allosteric inhibition of human cathepsin K (HCatK). The current findings are particularly relevant for the design of allosteric modulators of papain-like cysteine proteases.	[Alvarez, Lilian Hernandez; Hernandez Gonzalez, Jorge Enrique] Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil; [Barreto Gomes, Diego Enry] Inst Nacl Metrol Qual & Tecnol INMETRO, Diretoria Metrol Aplicada Ciencias Vida DIMAV, Rio De Janeiro, Brazil; [Barreto Gomes, Diego Enry] Univ Strasbourg, Inst Chim, Strasbourg, France; [Pascutti, Pedro Geraldo] Univ Fed Rio De Janeiro UFRJ, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade Federal do Rio de Janeiro	Alvarez, LH (corresponding author), Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil.	lilianhern@gmail.com	González, Jorge Enrique Hernández/AAB-2705-2019; Pascutti, Pedro/AAP-7752-2020	Pascutti, Pedro/0000-0002-5454-560X; Barreto Gomes, Diego Enry/0000-0003-4855-040X; Hernandez Gonzalez, Jorge Enrique/0000-0002-4770-8677	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/03911-8, 2016/24587-9]; Ministerio da Educacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [031/2013 PRO-DEFESA 3, 613]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Educacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant number No. 2018/03911-8 to LHA and 2016/24587-9 to JEHG), and by Ministerio da Educacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (grant number 031/2013 PRO-DEFESA 3 to LHA and PGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to Bruno Fernandes for technical support and to Prof. Jorge Chahine for his helpful discussions. We thank to Prof. Leandro Cristante de Oliveira for kindly provide computer time at Centro Nacional de Processamento de Alto Desempenho em Sao Paulo (CENAPAD) (grant 613). Also, we thank to mesocenter of Strasbourg for running time allocation. Finally, we thank to LMDM at UFRJ, and to the research group of Prof. Vitor Leite for their support with computational resources.	ALBER T, 1983, CIBA F SYMP, V93, P4; Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Arafet K, 2017, ACS CATAL, V7, P1207, DOI 10.1021/acscatal.6b03096; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertoldo JB, 2015, J ENZYM INHIB MED CH, V30, P299, DOI 10.3109/14756366.2014.920839; BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boulton S, 2016, CHEM REV, V116, P6267, DOI 10.1021/acs.chemrev.5b00718; Case DA, AMBER 142014; Chopra N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004826; Costa MGS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S5; Costa TFR, 2012, BBA-PROTEINS PROTEOM, V1824, P493, DOI 10.1016/j.bbapap.2011.12.006; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dalafave DS, 2015, BIOPHYS J, V108, p320A, DOI 10.1016/j.bpj.2014.11.1741; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; DELANO WL, 2004, ABSTR PAP AM CHEM 1, V228; DelNery E, 1997, BIOCHEM J, V323, P427, DOI 10.1042/bj3230427; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000676; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Greener JG, 2018, CURR OPIN STRUC BIOL, V50, P1, DOI 10.1016/j.sbi.2017.10.002; Grutsch S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004620; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Hernandez-Rodriguez M, 2016, CURR MED CHEM; Hertig S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004746; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hotez P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005479; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huey R., 2008, USING AUTODOCK 4 AUT, V01, P54; Humphris EL, 2008, STRUCTURE, V16, P1777, DOI 10.1016/j.str.2008.09.012; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jilkova A, 2014, STRUCTURE, V22, P1786, DOI 10.1016/j.str.2014.09.015; Jorgensen WL, 1998, J COMPUT CHEM, V19, P1179, DOI 10.1002/(SICI)1096-987X(19980730)19:10<1179::AID-JCC6>3.0.CO;2-J; Judice WAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080153; Judice WAS, 2001, EUR J BIOCHEM, V268, P6578, DOI 10.1046/j.0014-2956.2001.02612.x; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar S, 1999, CELL BIOCHEM BIOPHYS, V31, P141, DOI 10.1007/BF02738169; Kumawat A, 2017, P NATL ACAD SCI USA, V114, pE5825, DOI 10.1073/pnas.1705311114; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200; Liu J, 2017, P NATL ACAD SCI USA, V114, P7480, DOI 10.1073/pnas.1709071114; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mark W, 2011, CYSTEINE PROTEASES P; Marques AF, 2015, ARCH BIOCHEM BIOPHYS, V573, P92, DOI 10.1016/j.abb.2015.03.007; Marques AF, 2013, BIOORGAN MED CHEM, V21, P3667, DOI 10.1016/j.bmc.2013.04.047; Martinez-Mayorga K, 2015, DRUG DISCOV TODAY, V20, P890, DOI 10.1016/j.drudis.2015.02.004; MCGRATH ME, 1995, J MOL BIOL, V247, P251, DOI 10.1006/jmbi.1994.0137; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morra G, 2014, J CHEM THEORY COMPUT, V10, P5677, DOI 10.1021/ct500326g; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Mott BT, 2010, J MED CHEM, V53, P52, DOI 10.1021/jm901069a; Muchmore SW, 2003, CURR OPIN DRUG DISC, V6, P544; Naganathan AN, 2019, CURR OPIN STRUC BIOL, V54, P1, DOI 10.1016/j.sbi.2018.09.004; Novinec M, 2016, FEBS LETT, V590, P4507, DOI 10.1002/1873-3468.12495; Novinec M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/309718; Novinec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106642; Novinec M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4287; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Rastelli G, 2014, CELL CYCLE, V13, P2296, DOI 10.4161/cc.29295; Ribeiro AAST, 2016, CHEM REV, V116, P6488, DOI 10.1021/acs.chemrev.5b00543; Ribeiro AAST, 2015, J PHYS CHEM B, V119, P1835, DOI 10.1021/jp509906m; Ribeiro I, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000484; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rogers KE, 2012, CHEM BIOL DRUG DES, V80, P398, DOI 10.1111/j.1747-0285.2012.01416.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sajid M, 2011, ADV EXP MED BIOL, V712, P100, DOI 10.1007/978-1-4419-8414-2_7; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sercinoglu O, 2018, NUCL ACIDS RES; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Stank A, 2016, ACCOUNTS CHEM RES, V49, P809, DOI 10.1021/acs.accounts.5b00516; Stanley Nathaniel, 2015, In Silico Pharmacology, V3, P3, DOI 10.1186/s40203-015-0007-0; Swami A, 1997, SIGN PROC ADV WIR CO; Tan C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003751; Tang QL, 2017, HUM MUTAT, V38, P1132, DOI 10.1002/humu.23231; Trossini GHG, 2009, J MOL GRAPH MODEL, V28, P3, DOI 10.1016/j.jmgm.2009.03.001; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Van Wart AT, 2014, J CHEM THEORY COMPUT, V10, P511, DOI 10.1021/ct4008603; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Vettoretti G, 2016, SCI REP-UK, V6, DOI 10.1038/srep23830; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Wagner JR, 2016, CHEM REV, V116, P6370, DOI 10.1021/acs.chemrev.5b00631; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weinkam P, 2013, J MOL BIOL, V425, P647, DOI 10.1016/j.jmb.2012.11.041; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Xiao JJ, 2017, PHYS CHEM CHEM PHYS, V19, P24522, DOI 10.1039/c7cp03671j; Zhao HT, 2015, EUR J MED CHEM, V91, P4, DOI 10.1016/j.ejmech.2014.08.004; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	116	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211227	10.1371/journal.pone.0211227	http://dx.doi.org/10.1371/journal.pone.0211227			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682119	Green Published, Green Submitted, gold			2022-12-26	WOS:000457037500129
J	Carubbi, F; Alunno, A; Cipriani, P; Coletti, G; Bigerna, B; Manetti, M; Di Benedetto, P; Bistoni, O; Cipolloni, G; Liakouli, V; Ruscitti, P; Bartoloni, E; Giacomelli, R; Gerli, R				Carubbi, Francesco; Alunno, Alessia; Cipriani, Paola; Coletti, Gino; Bigerna, Barbara; Manetti, Mirko; Di Benedetto, Paola; Bistoni, Onelia; Cipolloni, Gianluca; Liakouli, Vasiliki; Ruscitti, Piero; Bartoloni, Elena; Giacomelli, Roberto; Gerli, Roberto			Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjogren's syndrome minor salivary glands	PLOS ONE			English	Article							ECTOPIC LYMPHOID NEOGENESIS; CLASSIFICATION CRITERIA; CONSENSUS; ORGANIZATION; BIOPSY	Objective A standardization of minor salivary gland (MSG) histopathology in primary Sjogren's syndrome (pSS) has been recently proposed. Although there is strong agreement that germinal center (GC)-like structures should be routinely identified, due to their prognostic value, a consensus regarding the best protocol is still lacking. Aim of this study was to compare the performance of different histological techniques and operators to identify GC-like structures in pSS MSGs. MSG biopsies from 50 pSS patients were studied. Methods Three blinded operators (one pathologist and two rheumatologists with different years of experience in pSS MSG assessment) assessed 50 MSGs of which one slide was stained with haematoxylin and eosin (H&E) and consecutive slides were processed to investigate CD3/CD20, CD21 and Bcl-6 expression. Results By assessing 225 foci, the best agreement was between H&E-stained sections evaluated by the rheumatologist with more years of experience in pSS MSG assessment and CD3/CD20 segregation. In the foci with CD21 positivity, the agreement further increased. Bcl-6 foci could display a GC, detected with other staining, but not vice versa. Conclusion GC assessment on H&E-stained sections should be performed with caution, being operator-dependent. The combination of H&E with CD3/CD20 and CD21 staining should be recommended as it is reliable, feasible, able to overcome the bias of operator experience and easily transferrable into routine practice.	[Carubbi, Francesco; Cipriani, Paola; Di Benedetto, Paola; Liakouli, Vasiliki; Ruscitti, Piero; Giacomelli, Roberto] Univ Aquila, Sch Med, Dept Biotechnol & Appl Clin Sci, Rheumatol Unit, Laquila, Italy; [Carubbi, Francesco] ASL1 Avezzano Sulmona Aquila, Dept Med, Laquila, Italy; [Alunno, Alessia; Bistoni, Onelia; Bartoloni, Elena; Gerli, Roberto] Univ Perugia, Dept Med, Rheumatol Unit, Perugia, Italy; [Coletti, Gino; Cipolloni, Gianluca] ASL1 Avezzano Sulmona Aquila, Biomed Dept, Pathol Unit, Laquila, Italy; [Bigerna, Barbara] Univ Perugia, Dept Med, Inst Haematol, Perugia, Italy; [Manetti, Mirko] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy	University of L'Aquila; University of Perugia; University of Perugia; University of Florence	Giacomelli, R (corresponding author), Univ Aquila, Sch Med, Dept Biotechnol & Appl Clin Sci, Rheumatol Unit, Laquila, Italy.	roberto.giacomelli@cc.univaq.it	Cipriani, Paola/AAC-7382-2022; Ruscitti, Piero/K-4184-2018; Bartoloni, Elena/R-5842-2019; Di Benedetto, Paola PDB/Y-9760-2018; Alunno, Alessia/AAC-8842-2022; Giacomelli, Roberto/AAB-9962-2022; Manetti, Mirko/AEH-9944-2022	Ruscitti, Piero/0000-0003-3487-8551; Di Benedetto, Paola PDB/0000-0003-2927-8703; Manetti, Mirko/0000-0003-3956-8480	European Commission [HarmonicSS GA 731944]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the European Commission: HarmonicSS GA 731944. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunno A, 2018, ANN RHEUM DIS, V77, DOI 10.1136/annrheumdis-2017-212108; Bombardieri M, 2007, J IMMUNOL, V179, P4929, DOI 10.4049/jimmunol.179.7.4929; Bombardieri M, 2017, NAT REV RHEUMATOL, V13, P141, DOI 10.1038/nrrheum.2016.217; Brito-Zeron P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.47; Carubbi F, 2014, SEMIN ARTHRITIS RHEU, V44, P314, DOI 10.1016/j.semarthrit.2014.05.015; Delli K, 2016, ANN RHEUM DIS, V75, P1933, DOI 10.1136/annrheumdis-2015-208304; Delli K, 2016, ANN RHEUM DIS, V75, DOI 10.1136/annrheumdis-2016-209480; Fisher BA, 2017, ANN RHEUM DIS, V76, P1161, DOI 10.1136/annrheumdis-2016-210448; Flenghi L, 1996, AM J PATHOL, V148, P1543; Guellec D, 2013, AUTOIMMUN REV, V12, P416, DOI 10.1016/j.autrev.2012.08.001; Haacke EA, 2018, ANN RHEUM DIS, V77, pE32, DOI 10.1136/annrheumdis-2017-212164; Haacke EA, 2017, ANN RHEUM DIS, V76, P1783, DOI 10.1136/annrheumdis-2017-211290; Jonsson MV, 2008, J ORAL PATHOL MED, V37, P515, DOI 10.1111/j.1600-0714.2008.00674.x; Risselada AP, 2014, ANN RHEUM DIS, V73, P1537, DOI 10.1136/annrheumdis-2013-204634; Risselada AP, 2013, SEMIN ARTHRITIS RHEU, V42, P368, DOI 10.1016/j.semarthrit.2012.07.003; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	18	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211142	10.1371/journal.pone.0211142	http://dx.doi.org/10.1371/journal.pone.0211142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682150	Green Published, gold, Green Submitted			2022-12-26	WOS:000457037500111
J	Cerritelli, F; van Dun, PLS; Esteves, JE; Consorti, G; Sciomachen, P; Lacorte, E; Vanacore, N; Marasco, ML; Maggiani, A; Cavallaro, A; Silvestri, D; Zurlo, J; Petracca, M; Fornari, M; Bersan, V; Lo Voi, G; Papa, L; Tamagnini, S; Filipazzi, R; Stirpe, T; Colonna, S; Gavazzi, A; Manzotti, A; Bergna, A; Marco, S; Franscini, F; Donnaquio, G; Parisi, A; Valente, M; Botti, E				Cerritelli, Francesco; van Dun, Patrick L. S.; Esteves, Jorge E.; Consorti, Giacomo; Sciomachen, Paola; Lacorte, Eleonora; Vanacore, Nicola; Marasco, Marcello Luca; Maggiani, Alberto; Cavallaro, Antonio; Silvestri, Dario; Zurlo, Joseph; Petracca, Marco; Fornari, Mauro; Bersan, Veronica; Lo Voi, Giacomo; Papa, Liria; Tamagnini, Sandro; Filipazzi, Roberta; Stirpe, Tatiana; Colonna, Saverio; Gavazzi, Alessandro; Manzotti, Andrea; Bergna, Andrea; Marco, Sbarbaro; Franscini, Federico; Donnaquio, Guglielmo; Parisi, Alessandro; Valente, Massimo; Botti, Emanuele		OPERA-IT Grp	The Italian Osteopathic Practitioners Estimates and RAtes (OPERA) study: A cross sectional survey	PLOS ONE			English	Article								The prevalence of osteopathic practitioners, their professional profile and features of their clinical practice, particularly where statutory regulation does not yet exist, are still significantly underreported. The Osteopathic Practitioners Estimates and RAtes (OPERA) project was developed as an European-based census dedicated to profiling the osteopathic profession across Europe. The present study aimed to describe the osteopathic practitioners and the profession in Italy. A voluntary, online based, closed-ended survey was distributed across Italy in the period between February and June 2017. An e-based campaign was set up to reach the Italian osteopathic professionals. Participants were asked to complete the forms by filling in the information regarding the demographics, working status and professional activities, education, consultation fees, patient complaints, treatment and management. The survey was completed by 4816 individuals. 196 people started the survey but did not finish, which corresponds to a 4% attrition rate. The majority of respondents were males (66.7%). The modal age group was 30-39 (40.0%). 73.8% of respondents had a previous academic degree, mainly in the fields of sports science (36.4%) and physiotherapy (25.3%). 25.6% declared not to have a previous academic degree. The majority of respondents declared to work alone (58.4%), while the remaining declared to work in association with other professionals. The osteopaths/citizens ratio was 8.0 osteopaths/100,000 citizens. The profile of osteopaths in Italy seems to be characterised by a self-employed young adult male working mostly as a sole practitioner, who has been trained as osteopath through a part-time curriculum and had a previous degree mostly in the fields of sports science or physiotherapy. These results provide important insights into the osteopathic profession in Italy. The varied professional educational backgrounds need to be considered with regard to the implementation of a professional licensing process and future pre-registration education in the country. The number of respondents is an estimate of the actual number of Italian osteopaths. Only the completion of the regulatory process and the creation of the mandatory official register will allow to know the number of Italy based osteopaths.	[Cerritelli, Francesco; Consorti, Giacomo] Fdn COME Collaborat, Clin Human Based Res Dept, Pescara, Italy; [van Dun, Patrick L. S.] Fdn COME Collaborat, Belgium Natl Ctr, Mechelen, Belgium; [Esteves, Jorge E.] Fdn COME Collaborat, Gulf Natl Ctr, Riyadh, Saudi Arabia; [Esteves, Jorge E.] Inst Piaget, Lisbon, Portugal; [Sciomachen, Paola] Registro Osteopati Italia, Milan, Italy; [Lacorte, Eleonora; Vanacore, Nicola] Natl Inst Hlth, Rome, Italy; [Marasco, Marcello Luca] ABEos, Laquila, Italy; [Maggiani, Alberto] AIMO, Saronno, Italy; [Cavallaro, Antonio] AISERCO, Palermo, Italy; [Silvestri, Dario] ASOMI, Turin, Italy; [Zurlo, Joseph; Petracca, Marco] CERDO, Rome, Italy; [Fornari, Mauro] CIO, Parma, Italy; [Bersan, Veronica] CSDOI, Verona, Italy; [Lo Voi, Giacomo] CSOT, Rome, Italy; [Papa, Liria] ICOM, Milan, Italy; [Tamagnini, Sandro] ICOMM, Rome, Italy; [Filipazzi, Roberta] IEMO, Genoa, Italy; [Stirpe, Tatiana] Meta Osteopatia, Rome, Italy; [Colonna, Saverio] OSCE, Bologna, Italy; [Gavazzi, Alessandro] SOFI, Rome, Italy; [Manzotti, Andrea; Bergna, Andrea] SOMA, Milan, Italy; [Marco, Sbarbaro] SSOI, Turin, Italy; [Franscini, Federico] APO, Turin, Italy; [Donnaquio, Guglielmo] Osteopatia Bambini, Imperia, Italy; [Parisi, Alessandro] SIOS, Imperia, Italy; [Valente, Massimo] Tuttosteopatia, Bisceglie, Italy; [Botti, Emanuele] Adv Osteopathy, Milan, Italy	Istituto Superiore di Sanita (ISS)	Cerritelli, F (corresponding author), Fdn COME Collaborat, Clin Human Based Res Dept, Pescara, Italy.	fcerritelli@comecollaboration.org	Cerritelli, Francesco/AAJ-5003-2020; Vanacore, Nicola/ABC-7196-2021; Cerritelli, Francesco/O-8416-2015	Lacorte, Eleonora/0000-0001-8530-9207; Consorti, Giacomo/0000-0003-3085-283X; Esteves, Jorge/0000-0001-9637-678X; Cerritelli, Francesco/0000-0002-2963-9620	Registro Osteopati d'Italia, ROI-2016	Registro Osteopati d'Italia, ROI-2016	This work was supported by the Registro Osteopati d'Italia, ROI-2016 (www.roi.it) to FC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OST OST MED GLOB VIE; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bleakley A, 2013, MED EDUC, V47, P59, DOI 10.1111/j.1365-2923.2012.04351.x; Burke SR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-227; CEN// TC. Project Committee, 2015, OST HEALTHC PROV MAI; Drumare J.-E., 2012, RAP OSEOSTEO OST EXC; Dubois TCJ, 2012, OSTEOPATHIC TEACHING; Dyson B, 2014, IMPROVING GEN PRACTI; Eumetra Monterosa, 2017, OP IT SULL; European Parliament, NUTS CLASS NOM TERR; Fawkes C, 2010, STANDARDISED DATA CO; Forum for Osteopathic Regulation in Europe, 2018, REGULATION; General Osteopathic Council, 2012, OST OP SURV; Guo YM, 2016, AM J PUBLIC HEALTH, V106, P1422, DOI 10.2105/AJPH.2016.303198; ISTAT, 2018, POP RES GENN 2018; Jamison JR, 1991, AUST J OSTEOPATHY, V3, P24; KPMG, 2011, OST PRACT; Landurier G, 2018, OBSERVATOIRE SOCIOEC; Licciardone JC, 2011, J AM OSTEOPATH ASSOC, V111, P670; McDonnell A, 2006, BRIT MED J, V332, P109, DOI 10.1136/bmj.332.7533.109; McGrath MC, 2015, INT J OSTEOPATH MED, V18, P130, DOI 10.1016/j.ijosm.2015.01.004; Orrock P, 2009, INT J OSTEOPATH MED, V12, P14, DOI 10.1016/j.ijosm.2008.04.002; Orrock PJ, 2009, INT J OSTEOPATH MED, V12, P128, DOI 10.1016/j.ijosm.2009.06.001; Osteopathic International Alliance, 2014, SCOP PRACT; van Dun PLS, 2016, INT J OSTEOPATH MED, V20, P3, DOI 10.1016/j.ijosm.2016.01.003; Vaucher P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023770; Vogel S, 2008, INT J OSTEOPATH MED, P153, DOI 10.1016/j.ijosm.2008.08.007; World Health Organization, 2010, BENCHM TRAIN TRAD CO	28	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211353	10.1371/journal.pone.0211353	http://dx.doi.org/10.1371/journal.pone.0211353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682169	gold, Green Published, Green Submitted			2022-12-26	WOS:000457037500154
J	Sato, J; Inagaki, H; Kusui, M; Yokosuka, M; Ushida, T				Sato, Jun; Inagaki, Hideaki; Kusui, Mayu; Yokosuka, Makoto; Ushida, Takahiro			Lowering barometric pressure induces neuronal activation in the superior vestibular nucleus in mice	PLOS ONE			English	Article							MIDDLE-EAR; ALTERNOBARIC VERTIGO; PARATYMPANIC ORGAN; METEOROLOGICAL CHANGES; ATMOSPHERIC-PRESSURE; WEATHER CONDITIONS; NERVE INJURY; RAT MODEL; PAIN; MORPHOLOGY	Weather changes accompanied by decreases in barometric pressure are suggested to trigger meteoropathy, i.e., weather-related pain. We previously reported that neuropathic pain-related behavior in rats is aggravated by lowering barometric pressure, and that this effect is abolished by inner ear lesions. These results suggest that mechanisms that increase vestibular neuronal activity may parallel those that contribute to meteoropathy generation. However, it remains unknown whether changes in barometric pressure activate vestibular neuronal activity. To address this issue, we used expression of c-Fos protein as a marker for neural activation. Male and female mice were placed in a climatic chamber, and the barometric pressure was lowered by 40 hPa, from 1013 hPa, for 50 min (LP stimulation). The total number of c-Fos-positive cells in the vestibular nuclei was counted bilaterally after LP stimulation. We also video-recorded mouse behaviors and calculated the total activity score during the LP stimulation. LP stimulation resulted in significant c-Fos expression in the superior vestibular nucleus (SuVe) of male and female mice. There was no effect of LP stimulation on the total activity score. These data show that distinct neurons in the SuVe respond to LP stimulation. Similar mechanisms may contribute to the generation of meteoropathy in humans.	[Sato, Jun] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi, Japan; [Sato, Jun; Inagaki, Hideaki; Kusui, Mayu; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan; [Yokosuka, Makoto] Nippon Vet & Life Sci Univ, Sch Vet Med, Fac Vet Sci, Musashino, Tokyo, Japan	Chubu University; Aichi Medical University; Nippon Veterinary & Life Science University	Sato, J (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi, Japan.; Sato, J (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan.	jsato@isc.chubu.ac.jp			Chubu University Grant [30AM17]; Japan Society for the Promotion of Science (JSPS) KAKENHI [23590710, 15K08206]	Chubu University Grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Chubu University Grant (30AM17) (https://www3.chubu.ac.jp/main/english/), and by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 23590710 and 15K08206) (http://www.jsps.go.jp/english/) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 2011, PSYCHONEUROENDOCRINO, V36, P1032, DOI 10.1016/j.psyneuen.2010.12.017; Bluestone CD, 2012, LARYNGOSCOPE, V122, P868, DOI 10.1002/lary.22182; BOSSUT DF, 1995, J NEUROPHYSIOL, V73, P1721, DOI 10.1152/jn.1995.73.4.1721; Breuner CW, 2013, J EXP BIOL, V216, P1982, DOI 10.1242/jeb.081067; DEVOR M, 1994, J NEUROPHYSIOL, V71, P38, DOI 10.1152/jn.1994.71.1.38; Eller-Smith OC, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00035; Endara-Bravo A, 2013, J CLIN SLEEP MED, V9, P1347, DOI 10.5664/jcsm.3288; Funakubo M, 2011, INT J BIOMETEOROL, V55, P319, DOI 10.1007/s00484-010-0339-8; Funakubo M, 2010, EUR J PAIN, V14, P32, DOI 10.1016/j.ejpain.2009.02.004; Funakubo M, 2009, J PHYSIOL SCI, V59, P162; Generaal E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-227; GUEDJ D, 1990, ANN RHEUM DIS, V49, P158, DOI 10.1136/ard.49.3.158; HENDLER NH, 1995, JNMS-J NEUROMUSC SYS, V3, P10; HOLLANDER JL, 1963, B AM METEOROL SOC, V44, P389; Imagawa M, 1998, NEUROSCI LETT, V240, P127, DOI 10.1016/S0304-3940(97)00944-0; IMAGAWA M, 1995, NEUROSCI LETT, V186, P87, DOI 10.1016/0304-3940(95)11288-8; JAMISON RN, 1995, PAIN, V61, P309, DOI 10.1016/0304-3959(94)00215-Z; Jang SH, 2018, NEURAL REGEN RES, V13, P727, DOI 10.4103/1673-5374.230304; KREITHEN ML, 1974, J COMP PHYSIOL, V89, P73, DOI 10.1007/BF00696164; LUNDGREN CE, 1966, AEROSPACE MED, V37, P178; LUNDGREN CE, 1965, BRIT MED J, V2, P511, DOI 10.1136/bmj.2.5460.511; Markia B, 2008, BRAIN STRUCT FUNCT, V213, P239, DOI 10.1007/s00429-008-0172-6; Mitchell SW, 1877, AM J MED SCI, V73, P305; NISHIHARA S, 1992, AM J OTOL, V13, P364; OHalloran KD, 1997, BRAIN RES, V759, P233, DOI 10.1016/S0006-8993(97)00261-8; Okuma H, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1592-4; Paxinos G, 2013, MOUSE BRAIN STEREOTA; Porter JD, 1997, J VESTIBUL RES-EQUIL, V7, P63; SATO F, 1989, J COMP NEUROL, V290, P423, DOI 10.1002/cne.902900310; Sato J, 2004, NEUROSCI LETT, V354, P46, DOI 10.1016/j.neulet.2003.09.057; Sato J, 2003, INT J BIOMETEOROL, V47, P55, DOI 10.1007/s00484-002-0156-9; Sato J, 2001, NEUROSCI LETT, V299, P17, DOI 10.1016/S0304-3940(00)01769-9; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Sato J, 1999, NEUROSCI LETT, V266, P21, DOI 10.1016/S0304-3940(99)00260-8; Sato J, 16 WORLD C PAIN 2016; Scheidt J, 2013, INT J BIOMETEOROL, V57, P649, DOI 10.1007/s00484-012-0582-2; SPROTT RL, 1967, SCIENCE, V157, P1206, DOI 10.1126/science.157.3793.1206; SUZUKI M, 1994, ACTA OTO-LARYNGOL, P9; Suzuki M, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P820; Suzuki M, 1998, ACTA OTO-LARYNGOL, V118, P712; Verges J, 2004, P W PHARMACOL SOC, P134; von Bartheld CS, 2011, J EXP ZOOL PART B, V316B, P402, DOI 10.1002/jez.b.21422; VONBARTHELD CS, 1994, BRAIN BEHAV EVOLUT, V44, P61, DOI 10.1159/000113570; VONBARTHELD CS, 1990, BRAIN BEHAV EVOLUT, V35, P1, DOI 10.1159/000115851; YATES BJ, 1995, BRAIN RES, V689, P197, DOI 10.1016/0006-8993(95)00569-C	45	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211297	10.1371/journal.pone.0211297	http://dx.doi.org/10.1371/journal.pone.0211297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682203	Green Submitted, Green Published, gold			2022-12-26	WOS:000457037500146
